{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions_in_experiment": 800
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023, and remained at $606 million in 2024. This indicates a deliberate debt reduction strategy, with the company actively managing its outstanding obligations related to these notes over the three-year period.",
      "llm_answer": "\nThe 5.000 % notes due April 2030 dropped from $1,086 million at the end of fiscal 2021 to $606 million by the close of fiscal 2022 (Chunk 1), and have remained unchanged at $606 million through fiscal 2023 and fiscal 2024 (Chunks 2‑3). This reduction reflects AVGO’s repayment and partial retirement of that senior‑note tranche as part of its broader debt‑management program, while the company’s total long‑term debt expanded to $66.3 billion in FY 2024 (Chunk 2‑3). The stable, modest $606 million exposure thereafter shows a deliberate shift toward a leaner capital structure—trimming a legacy high‑rate tranche while maintaining overall borrowing capacity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the timeline and amounts. According to the ground truth, AVGO's exposure was $1,086 million in 2022, dropped to $606 million in 2023, and remained at $606 million in 2024. However, the LLM claims the drop occurred from fiscal 2021 to 2022, which contradicts the original data. This misalignment in fiscal years undermines the quantitative accuracy. Additionally, the LLM references 'fiscal 2021' which is not part of the question's scope (2022–2024), introducing an incorrect time point. (2) The dollar amounts of $1,086 million and $606 million are correct in value but are assigned to the wrong years, making the numbers themselves accurate but their temporal placement incorrect. The claim that the amount remained unchanged through 'fiscal 2023 and fiscal 2024' partially aligns with the truth (it stayed at $606M from 2023 to 2024), but incorrectly implies no change from 2022 to 2023 when there was a major reduction. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a debt reduction strategy and contextualizes it within broader capital structure management. It also correctly notes that total long-term debt increased to $66.3 billion in FY2024 (contextual detail not in the ground truth but potentially from supporting data), showing some valid synthesis. However, the flawed timeline weakens the logical progression. (4) The contextual relevance is high because the answer addresses debt management strategy and interprets the trend meaningfully. However, due to the critical error in fiscal year mapping, the correctness score is low despite semantically plausible reasoning and correct individual numbers. A score of 4 reflects partial correctness with major factual flaws in temporal alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 488,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did MetLife's use of the modified coinsurance agreement, specifically as it relates to the closed block, evolve from 2022 to 2024, and what does the consistency in the percentage of risk transferred reveal about the company's long-term reinsurance strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer across all three years: 59.25% in 2022, 59% in 2023, and again 59% in 2024. The company accounted for this agreement using the deposit method of accounting each year and exercised its right of offset, combining the modified coinsurance deposit liability with the deposit recoverable. Despite significant growth in total net ceded reinsurance recoverables from $6.3 billion in 2021 (referenced in 2022 filing) to $17.6 billion in 2024, the proportion of the closed block reinsured remained stable. This consistency suggests a deliberate and sustained reinsurance strategy focused on maintaining risk transfer efficiency and capital optimization for the closed block over the three-year period.",
      "llm_answer": "\nMetLife continued to place essentially the same share of the closed‑block risk into a modified‑coinsurance arrangement with an unaffiliated third‑party reinsurer across the three reporting years—59.25 % in the 2022 filing (Chunk 1), 59 % in the 2023 filing (Chunk 2) and again 59 % in the 2024 filing (Chunk 3)—and in each year it accounts for the arrangement under the deposit method, offsetting the deposit liability with the related deposit‑recoverable (Chunks 1‑3).  \n\nThe near‑identical 59 %‑plus percentage over 2022‑2024 shows that the company’s long‑term reinsurance strategy is to maintain a stable, predetermined proportion of risk transfer for the closed block, using the modified‑coinsurance structure as a consistent capital‑management and risk‑mitigation tool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the percentage of closed block risk reinsured each year—59.25% in 2022, 59% in 2023, and 59% in 2024—matching the ground truth exactly. It also accurately states that MetLife used the deposit method of accounting and exercised the right of offset each year. These key facts are all correct. (2) Quantitatively, all percentages are accurate and properly attributed to the correct years. The minor rounding from 59.25% to '59% plus' in the summary is acceptable and does not distort meaning. However, the LLM omits the specific growth in total net ceded reinsurance recoverables from $6.3 billion (referenced in 2022 filing) to $17.6 billion in 2024, which was part of the original answer and provided important context about the scale of reinsurance activity despite stable risk transfer. This omission slightly weakens completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers that the stable percentage indicates a consistent long-term strategy focused on capital management and risk mitigation. The conclusion about using modified coinsurance as a 'consistent capital-management and risk-mitigation tool' aligns well with the ground truth's interpretation of 'risk transfer efficiency and capital optimization.' (4) The answer is highly relevant, directly addressing both parts of the question—evolution over time and strategic implications. The only shortcoming is the missing reference to the significant increase in total recoverables, which would have strengthened the contrast between growing reinsurance activity and stable closed block cession. Despite this, the core facts, calculations, and reasoning are correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 479,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Investments, advances and long-term receivables decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the collateral that ExxonMobil reports under master‑netting arrangements—recorded in the “Investments, advances and long‑term receivables” line of the balance sheet and disclosed as not offset against its derivatives—fell sharply: $1,494 million at the end of 2022, $800 million at the end of 2023, and $491 million at the end of 2024 (as shown in the 2022, 2023 and 2024 filings).  This steady reduction indicates the company is scaling back the amount of pledged collateral tied to its investments and receivables, suggesting a more efficient management of derivative credit risk and a lower reliance on collateral to offset derivative exposures.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1,494 million (2022), $800 million (2023), and $491 million (2024) are accurately reported with correct years and dollar amounts, matching the original answer exactly. Minor formatting differences (e.g., using ' ' thin space) do not affect accuracy. (2) The answer is complete, addressing both the change in collateral over time and the implication for derivative exposure management. (3) Entities—ExxonMobil, 'Investments, advances and long-term receivables', master netting arrangements, and the three-year timeframe—are correctly identified and contextualized. (4) The reasoning is sound: the multi-hop synthesis of year-over-year declines is correctly interpreted as indicating reduced reliance on collateral and improved risk management, which aligns with the original conclusion of 'strategic reduction in derivative exposure or improved offsetting mechanisms'. The LLM provides a slightly more detailed interpretation (e.g., 'more efficient management of derivative credit risk') but remains semantically equivalent and factually grounded. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 336,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did AVGO's financial exposure to the 3.625% notes due October 2024 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy around this instrument?",
      "original_answer": "In 2022, AVGO reported $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company no longer listed any outstanding principal for these notes, suggesting that the debt was either fully repaid or refinanced ahead of its maturity. This progression indicates a deliberate debt management strategy where AVGO addressed this specific liability between fiscal years 2023 and 2024.",
      "llm_answer": "\nAVGO’s 3.625 % senior notes that matured in October 2024 were carried at **$622 million** on the FY 2022 balance sheet (Chunk 1) and remained at that level through FY 2023 (Chunk 3), but the liability was **eliminated (‑)** on the FY 2024 filing (Chunk 2), indicating that the entire tranche had been **repaid or retired** as it came due.  This repayment reflects a deliberate debt‑management move: AVGO let the October 2024 note mature and removed it from the balance sheet, while simultaneously increasing total long‑term debt with newer issuances (e.g., the Assumed VMware and CA senior notes), thereby extending the maturity profile and refinancing the retired exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $622 million outstanding in 2022 and 2023, and elimination of the liability by 2024, matching the original answer. The maturity date (October 2024) is correctly stated. (2) The answer correctly identifies that the debt was repaid or retired, which is consistent with the ground truth's statement that the notes were 'no longer listed' in 2024, implying repayment or refinancing. (3) The reasoning is sound and adds value by contextualizing the repayment within a broader debt management strategy—specifically, retiring this tranche while issuing new debt (e.g., VMware and CA notes), thus extending the maturity profile. This insight goes slightly beyond the original answer but remains logically supported and relevant. (4) The only minor limitation is that the original answer emphasizes the time window 'between fiscal years 2023 and 2024' for the action, while the LLM implies it happened 'as it came due'—slightly less precise on timing—but still factually acceptable given the October 2024 maturity. All entities (AVGO, 3.625% notes, fiscal years) are correct. The answer is complete, addressing both the evolution of exposure and the strategic implication. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 395,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 through 2024, and what does this three-year trajectory indicate about the company's positioning in naval shipbuilding?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024, indicating sustained growth and strategic emphasis on this product line within the Marine Systems division.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue grew from **$2.56 billion in 2022** (reported in the 2022 10‑K, Chunk 2) to **$2.70 billion in 2023** (reported in the 2023 10‑K, Chunk 3) and then to **$2.82 billion in 2024** (reported in the 2024 10‑K, Chunk 2), reflecting a roughly 10 % increase over the three‑year period.  This consistent upward trajectory—supported by the recurring “Surface ships” line‑item across all three filings and the KG pattern that links GD as the disclosing and producing organization—indicates that the company is strengthening its position as a leading supplier in the naval shipbuilding market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the upward trajectory of General Dynamics' surface ship revenue across 2022–2024 with values that are numerically accurate when accounting for format differences: $2.56 billion = $2,561 million, $2.70 billion = $2,700 million (ground truth: $2,698 million — a negligible $2M rounding difference), and $2.82 billion = $2,820 million (ground truth: $2,819 million — again, a $1M rounding difference). These minor discrepancies are within acceptable rounding tolerance and do not affect factual correctness. (2) The percentage increase mentioned (~10%) is approximately correct: from $2,561M to $2,819M is a 10.07% increase, so the LLM’s characterization is accurate. (3) The multi-hop reasoning is sound — the model correctly identifies the revenue line item across three consecutive 10-K filings (2022, 2023, 2024), attributes them to General Dynamics’ Marine Systems division (implied through context and KG pattern), and synthesizes the trend into a strategic conclusion. (4) The qualitative interpretation — that the growth indicates strengthening positioning in naval shipbuilding — aligns with and reasonably extends the ground truth’s statement about 'sustained growth and strategic emphasis.' The answer is slightly more interpretive but remains factually grounded. All parts of the question are addressed: revenue evolution and its implication. Only a minor deduction in quantitative accuracy due to the $2M variance in 2023 and $1M in 2024; otherwise, the answer is complete, correct, and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 431,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year progression indicate about shareholder governance structure stability?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA consistently described A Class shares as having one vote per share and standard dividend rights, with no changes to these rights over the period. This consistency in governance and dividend policy indicates a stable shareholder structure for A Class shares despite broader market or regulatory changes.",
      "llm_answer": "\nThe A‑Class shares have retained the same rights throughout the three‑year period: each filing shows a $0.0001 par value, 3,000 million authorized shares, and “one vote per share with dividend rights” (Chunk 3 2022, Chunk 1 2023, and Chunk 2 2024 – the only difference being a typographical error in the 2024 wording). Because the disclosed relationship — MA → A Class Shares → MA — remains unchanged, the company’s shareholder governance structure has been stable, with no alteration to voting or dividend entitlements across 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that MA's A Class shares maintained consistent rights from 2022 to 2024: one vote per share and standard dividend rights, with no changes over time. The mention of $0.0001 par value, 3,000 million authorized shares, and the phrase 'one vote per share with dividend rights' across the three years is consistent with the source data (with a noted typographical variation in 2024, which does not affect meaning). All quantitative details are accurate. The reasoning correctly synthesizes information across multiple filings (multi-hop) and draws a valid conclusion about governance stability. The only minor shortcoming is that the original answer emphasizes the stability in the context of 'broader market or regulatory changes,' which the LLM answer omits—though the core conclusion about stability is still present. This small omission in contextual framing does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer fully addresses both parts of the question: evolution (no change) and implication (stable governance).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 328,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does the year-over-year growth indicate about the company's positioning in naval defense programs?",
      "original_answer": "General Dynamics' revenue from surface ships increased from $2,561 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This represents a consistent upward trend, suggesting the company's growing involvement in naval defense contracts and sustained demand for its surface ship capabilities.",
      "llm_answer": "\nGD’s surface‑ship revenue was $2.561 bn in 2022 (the 2022 column of Chunk 2 and Chunk 3), increased to $2.698 bn in 2023 (Chunk 2) – a 5.3 % year‑over‑year rise – and then to $2.819 bn in 2024 (Chunk 3), a further 4.5 % growth. This consistent double‑digit expansion of the disclosed “Surface ships” product line, linked to GD through the ORG‑[Discloses]‑PRODUCT relationship, demonstrates that General Dynamics is strengthening its position as a leading supplier in U.S. naval defense programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all revenue figures: $2,561 million in 2022, $2,698 million in 2023, and $2,819 million in 2024, matching the ground truth exactly (with acceptable format variation using 'bn' instead of 'million'). The year-over-year growth percentages (5.3% and 4.5%) are accurately calculated: (2,698 - 2,561)/2,561 ≈ 5.35% and (2,819 - 2,698)/2,698 ≈ 4.48%, both correctly rounded. 2) Quantitative accuracy is perfect—numbers, years, and calculations are correct. 3) The reasoning is sound: the model identifies the upward trend and links it to General Dynamics' role in naval defense programs, correctly inferring strategic positioning from revenue growth. The mention of 'ORg-[Discloses]-PRODUCT' suggests awareness of knowledge graph structure, though slightly technical. The phrase 'double-digit expansion' is incorrect—growth rates are single-digit (5.3% and 4.5%)—which slightly undermines qualitative accuracy. 4) Despite this minor error in characterizing growth as 'double-digit', the overall answer is factually correct, complete, and contextually relevant, addressing both the revenue evolution and its implication for the company's market position.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 332,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Linde's reliance on long-term contracts for industrial gas products evolve from 2022 to 2024, and what does this consistency suggest about the company's approach to cash flow stability amid fluctuating energy markets?",
      "original_answer": "Linde consistently emphasized its reliance on long-term contracts for industrial gas products across all three years (2022, 2023, and 2024), noting that these contracts provide stability in cash flow and allow for the pass-through of energy and feedstock cost changes to customers. Despite dynamic energy markets and inflationary pressures, the company maintained this contractual strategy without deviation, signaling a deliberate and stable approach to risk management and revenue predictability. This unwavering emphasis underscores Linde's prioritization of financial resilience and operational certainty over short-term pricing flexibility.",
      "llm_answer": "\nFrom 2022 through 2024 the company repeatedly states that **the majority of its industrial‑gas business is conducted through long‑term contracts** (see LIN 10‑K 2022, 2023 and 2024 filings). These agreements are highlighted as a source of **cash‑flow stability** and as a mechanism that lets Linde **pass through changes in energy and feedstock costs to customers**. The unbroken reliance on multi‑year contracts therefore signals a deliberate strategy to lock in supply and pricing ahead of market swings, insulating the firm’s cash flow from the volatility of energy markets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies Linde's consistent reliance on long-term contracts from 2022 to 2024, citing all three 10-K filings, which matches the ground truth. (2) There are no numerical inaccuracies—while no specific numbers (e.g., dollar amounts or percentages) are present, the qualitative financial mechanisms (cost pass-through, cash flow stability) are correctly described. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and filings to infer a stable strategic approach, correctly linking long-term contracts to risk management and financial resilience. (4) The answer fully addresses both parts of the question: the evolution (consistency over time) and the implication (cash flow stability amid energy market fluctuations). Wording differs slightly but conveys the same core meaning—emphasizing deliberate strategy, cost pass-through, and insulation from volatility. All entities (Linde, industrial gas, long-term contracts, energy markets) are accurate and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 318,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did GD's treatment of non-economic accounting changes within its ROIC calculation evolve from 2022 through 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculation across all three years (2022, 2023, and 2024), indicating a stable methodology in how the company defines and measures its core operational performance. This consistent exclusion suggests that GD views non-economic accounting changes as irrelevant to its underlying business performance and has institutionalized this principle in its financial reporting framework over time.",
      "llm_answer": "\nGD has applied the same accounting‑policy treatment throughout 2022‑2024, explicitly excluding “non‑economic accounting changes” (and goodwill impairments) from its ROIC calculation in each filing—2022 (p. 47), 2023 (p. 50) and 2024 (p. 49)—because such items are “not reflective of company performance.”  This consistent exclusion, highlighted in the disclosed accounting‑policy triplets linking GD → Non‑Economic Accounting Changes → GD, demonstrates that GD deliberately isolates only those metrics that capture genuine operational returns, underscoring a disciplined, performance‑focused approach to measuring core profitability.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that GD consistently excluded non-economic accounting changes from its ROIC calculation across 2022, 2023, and 2024—matching the original answer's claim of methodological consistency. The inclusion of specific page references (2022 p.47, 2023 p.50, 2024 p.49) adds verifiable detail not in the ground truth but does not contradict it, and supports the conclusion. (2) There are no numerical values requiring calculation (e.g., percentages or dollar amounts), but the temporal range (2022–2024) is correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes GD’s treatment of non-economic accounting changes across three years of filings and infers the implication—that this consistency reflects a disciplined, performance-focused approach to measuring core profitability. This goes beyond repetition of facts to interpret strategic intent, which is supported by the data. (4) The LLM answer conveys the same core information as the original answer—consistent exclusion of non-economic items, stability in methodology, and the inference about GD’s focus on operational performance—with enhanced specificity (e.g., mention of goodwill impairments and page numbers). Semantic equivalence is strong, and the reasoning is both logically sound and contextually appropriate. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 401,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did UnitedHealth Group's service level guarantee obligations evolve from 2022 to 2024, and what does the pattern of immaterial financial impact across these years suggest about the company's risk management effectiveness and contractual performance consistency?",
      "original_answer": "Across 2022, 2023, and 2024, UnitedHealth Group consistently disclosed that none of the amounts accrued, paid, or charged to income for service level guarantees were material. This consistent immateriality suggests that the company maintained strong risk management controls and contractual performance, avoiding significant financial penalties or obligations tied to service level guarantees over the three-year period.",
      "llm_answer": "\nUnitedHealth Group’s service‑level guarantee obligations remained immaterial throughout the 2022‑2024 period—none of the amounts accrued, paid or charged to income for those guarantees were material as of the 2022, 2023 or 2024 fiscal years (see Chunk 1, 2 and 3).  This consistent lack of material impact, despite changes in the underlying note‑payable balances, demonstrates that the company’s risk‑management controls and contractual performance have been stable and effective, producing no material financial volatility across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that UnitedHealth Group's service level guarantee obligations were immaterial in 2022, 2023, and 2024, with no material amounts accrued, paid, or charged to income—matching the original answer exactly in substance. (2) There are no numeric discrepancies; although no specific dollar amounts are provided (consistent with the source, which only states 'immaterial'), the characterization is quantitatively sound. (3) The multi-hop reasoning is appropriate: the model synthesizes disclosures across three years and correctly infers that consistent immateriality reflects stable risk management and contractual performance. The addition of 'despite changes in the underlying note-payable balances' introduces a detail not explicitly in the ground truth, but it does not contradict it and may reflect context from the cited chunks; however, since the original answer does not mention note-payable balances, this slight extrapolation prevents a perfect 10 on qualitative accuracy. (4) The answer is semantically equivalent to the original, addresses both parts of the question (evolution of obligations and implications for risk management), and maintains high contextual relevance. The conclusion about effective risk management is logically supported by the pattern described.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 380,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did General Dynamics' revenue from surface ships evolve from 2022 to 2024, and what does this progression indicate about the company's strategic positioning in naval defense platforms?",
      "original_answer": "General Dynamics' revenue from surface ships increased steadily from $2,328 million in 2022 to $2,698 million in 2023, and further to $2,819 million in 2024. This consistent growth suggests a strengthening role in naval shipbuilding and sustained demand for surface combatants, aligning with broader defense spending trends and the company's Marine Systems segment expansion.",
      "llm_answer": "\nGeneral Dynamics’ surface‑ship revenue rose from **$2.56 billion in 2022** (Chunk 1 & 2) to **$2.70 billion in 2023** (Chunk 1 & 2) and then to **$2.82 billion in 2024** (Chunk 2), continuing the upward trend that began with **$2.33 billion in 2021** (Chunk 3). This steady growth—highlighted by the KG pattern that GD **Produces** surface ships and **Discloses** the figures—signals a deliberate strategic focus on expanding its naval‑defense platform portfolio and reinforces GD’s positioning as a leading supplier of advanced surface combatants for the U.S. Navy and allied forces.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has inaccuracies in the 2022 revenue figure. The ground truth states $2,328 million (or $2.328 billion), but the LLM reports $2.56 billion, which is significantly off. The 2023 and 2024 figures are close—$2.70 billion vs. $2.698 billion and $2.82 billion vs. $2.819 billion—within acceptable rounding differences. (2) Calculations: The progression is correctly portrayed as upward, and the approximate growth rates align, but the incorrect 2022 baseline affects the accuracy of implied year-over-year changes. The mention of $2.33 billion in 2021 is consistent with ground truth ($2,328 million rounded), though not asked in the original question. (3) Multi-hop reasoning: The LLM correctly synthesizes revenue trends across years and links them to strategic positioning in naval defense, citing the Marine Systems segment and demand for surface combatants. It appropriately infers strategic implications from financial trends. (4) Despite the incorrect 2022 number, the overall narrative of steady growth and strategic expansion is sound and contextually appropriate. The error in a key data point reduces quantitative accuracy, but qualitative and contextual reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 352,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, financial exposure, and eventual divestiture?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive property and casualty insurer primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, noting EIC had assets of $541 million and liabilities of $378 million as of December 31, 2023. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic shift from operational ownership to full divestiture, with a significant loss recognized during the transition.",
      "llm_answer": "\nGE first placed its captive industrial insurer, Electric Insurance Company (EIC), into held‑for‑sale status in Q4 2022 (as noted in the 2022 10‑K), and by the end of 2023 the subsidiary showed $541 million of assets and $378 million of liabilities, prompting a $109 million loss on disposal that was recorded in other income (Chunk 1).  EIC, a property‑casualty insurer that primarily covered GE and its employees, carried modest net claim reserves of $0.2 billion (2021) and $0.3 billion (2020), underscoring its limited financial exposure relative to GE’s broader insurance portfolio (Chunk 3).  The evolution culminated in Q2 2024 when GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash proceeds, finalizing the divestiture that had been announced in 2022 (Chunk 2).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the timing of when EIC was placed into 'held for sale' status. The original answer states that in 2023, GE classified EIC as 'held for sale' and recorded the $109 million loss, while the LLM claims this occurred in Q4 2022 (as noted in the 2022 10-K). This misalignment affects the timeline and contradicts the ground truth, which does not mention 'held for sale' classification in 2022. (2) Quantitatively, all numbers are accurate: $541 million in assets, $378 million in liabilities (2023), $109 million loss, $120 million sale price, and $0.2 billion net claim reserves (2021) are correctly reported. The mention of $0.3 billion in 2020 is additional but not incorrect, as it aligns with the trend and doesn't contradict the ground truth. (3) The multi-hop reasoning is strong—LLM synthesizes classification, financial exposure (reserves, assets/liabilities), and divestiture outcome across years and entities (GE, EIC, Riverstone). It correctly identifies the strategic evolution despite the timing error. (4) Contextual relevance is perfect—the response directly addresses classification, financial exposure, and divestiture as asked. The qualitative accuracy is high due to correct entity identification and logical flow, but docked slightly for the incorrect timing of the 'held for sale' designation. Correctness score is 8 due to this meaningful but not central error in chronology.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Classifies]-> COMP <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 411,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent application of proceeds to share repurchases evolve from 2022 through 2024, and what does this progression indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, ConocoPhillips sold its remaining 91 million CVE common shares, which had been part of a paced monetization started in May 2021, and applied the proceeds to share repurchases under a $45 billion authorization. By the end of 2023, the company had repurchased 383 million shares at a cost of $29 billion since the program's inception. In 2024, the board approved an increase to the repurchase program by up to $20 billion (not to exceed $65 billion total), and by year-end, total repurchased shares reached 433 million at a cost of $34.3 billion. This shows a consistent and expanding capital return strategy funded in part by the CVE share monetization.",
      "llm_answer": "\nConocoPhillips launched a paced monetization of its CVE common shares in 2021, sold the remaining 91 million shares in Q1 2022, and applied the entire proceeds to its share‑repurchase program—an activity that is reflected in the valuation‑allowance adjustments tied to the CVE share dispositions noted in the 2021‑2022 tax disclosures (Chunk 1).  Building on that, the company increased its buy‑back authorization from $25 bn to $45 bn in October 2022 and then to a $65 bn ceiling in October 2024, resulting in cumulative repurchases of 383 million shares costing $29 bn through 2023 and 433 million shares costing $34.3 bn through 2024 (Chunks 2‑3).  This progression shows that ConocoPhillips’ capital‑allocation strategy has been to recycle the cash generated from its CVE stake into an expanding, opportunistic share‑repurchase program, prioritizing shareholder returns while retaining flexibility for future investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key numbers are correct: the 91 million CVE shares sold in 2022, $29 billion spent on 383 million shares by 2023, and $34.3 billion for 433 million shares by 2024. The $45 billion initial authorization and $65 billion total ceiling are correctly stated. However, the LLM claims the buyback authorization was increased from $25B to $45B in October 2022, while the ground truth only confirms the $45B authorization without specifying a prior $25B—this is a minor inaccuracy. (2) The timeline is mostly correct: the monetization began in 2021, and the remaining shares were sold in 2022, though the LLM specifies 'Q1 2022' which is not in the original and slightly over-specified. (3) The reasoning is sound: the LLM correctly synthesizes the link between CVE proceeds and share repurchases, and infers a capital allocation strategy focused on shareholder returns, which is consistent with the ground truth. (4) The answer is contextually excellent—addresses both the evolution from 2022–2024 and the strategic implication. The mention of 'valuation-allowance adjustments' and 'tax disclosures' adds detail not in the ground truth but does not contradict it and may reflect additional context. Overall, the answer demonstrates strong multi-hop reasoning across time, entities (CVE, share repurchases), and financial strategy. The minor over-precision on dates and the unverified $25B prior authorization prevent a perfect 10, but the core facts, calculations, and synthesis are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 432,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024 in terms of the percentage of the closed block reinsured and the accounting treatment, and what does this consistency or change reveal about its long-term risk transfer strategy?",
      "original_answer": "MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement across all three years (59.25% in 2022, 59% in 2023, and 59% in 2024). The company maintained the same accounting treatment throughout the period, applying the deposit method of accounting and exercising the right of offset between the modified coinsurance deposit liability and the deposit recoverable. This consistent approach indicates a stable long-term risk transfer strategy centered on managing longevity risk through a structured reinsurance arrangement with an unaffiliated third-party reinsurer.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife consistently reinsured about 59 % of the closed block (59.25 % in 2022, 59 % in 2023 and 2024) with an unaffiliated third‑party via a modified‑coinsurance agreement, and in each year it accounted for that arrangement under the **deposit method of accounting**, offsetting the deposit liability against the related deposit recoverable. This unchanged reinsurance share and the unchanged deposit‑accounting treatment show that MetLife’s long‑term risk‑transfer strategy is built on a stable, capital‑efficient cession of a fixed portion of closed‑block risk, using a predictable accounting framework to manage and offset related liabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the percentages of the closed block reinsured (59.25% in 2022, 59% in 2023 and 2024) match the original answer exactly, and the use of a modified coinsurance agreement with an unaffiliated third party is correctly identified. (2) The accounting treatment — deposit method with right of offset between deposit liability and recoverable — is accurately described and consistent across years. (3) The multi-hop reasoning is sound: the answer synthesizes data across three years and correctly infers that the consistency in both reinsurance percentage and accounting treatment reflects a stable long-term risk transfer strategy focused on managing longevity risk. (4) The conclusion about a 'stable, capital-efficient cession' and 'predictable accounting framework' aligns with and effectively rephrases the original insight about a structured, consistent strategy. No factual, numerical, or conceptual errors are present; minor wording differences do not affect meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 324,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer engagement with Target's financial products over time?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (as part of the RedCard/Target Circle Card suite) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual decrease in consumer engagement with Target's proprietary financial products relative to total sales, despite continued incentives like the 5% discount. The rebranding from RedCards to Target Circle Cards in 2024 did not reverse this decline, indicating a potential challenge in sustaining customer loyalty through financial offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the RedCard (Target MasterCard Credit Card) penetration fell from **20.5 % (Jan 29 2022)** to **19.8 % (Jan 28 2023)** to **18.6 % (Feb 3 2024)**, and the rebranded Target Circle Card continued the decline to **17.8 % (Feb 1 2025)** (Chunk 2; Chunk 3).  This steady drop occurred even as total sales grew faster than RedCard usage, a pattern noted in Chunk 1 where penetration declined while overall sales rose, indicating that fewer shoppers are relying on Target’s co‑branded credit products over time.  The trend suggests a weakening consumer engagement with Target’s financial offerings, likely driven by market competition and the transition from RedCards to the Target Circle Card program (Chunks 1‑3).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), it incorrectly adds a data point for Feb 1, 2025, with a penetration rate of 17.8%, which is not part of the original question or ground truth. The question only asks about 2022 through 2024, so introducing a future date and value is factually unsupported and misleading. (2) The original answer does not mention any 2025 data, nor does it state that the Target Circle Card had a penetration of 17.8%. This fabricated data point undermines the quantitative accuracy. However, the 2022–2024 percentages are correctly cited, and the trend direction (declining) is accurate. (3) The reasoning and synthesis are otherwise sound: the LLM correctly infers that declining penetration amid rising sales suggests weakening engagement, and it appropriately references the rebranding to Target Circle Cards as a context point. It also correctly identifies that the decline continued post-rebrand, aligning with the original answer’s implication of challenges in sustaining loyalty. (4) Contextually, the answer is highly relevant and addresses both parts of the question—evolution of penetration and implications for consumer engagement. The qualitative analysis is strong, but the inclusion of false data severely impacts factual correctness. Thus, while the core trend and interpretation are valid, the addition of an unsupported 2025 figure results in a significant deduction in quantitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 437,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve from 2022 to 2024, and what does this consistency or change reveal about PMI's strategic benchmarking approach for consumer product peers?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive Co. remained consistently included in Philip Morris International's (PMI) Peer Group, which is used for comparative benchmarking. The peer group was determined based on four characteristics: global presence, focus on consumer products, and similarity in net revenues and market capitalization to PMI. This consistent inclusion over three consecutive years highlights PMI's ongoing strategic alignment with large, globally present consumer product companies for performance and market comparison, indicating a stable benchmarking methodology.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings (Chunk 1, 2, 3) the PMI Peer Group is explicitly stated to be “the same as that used in the prior year,” and each year’s list of constituents includes **Colgate‑Palmolive Co.** alongside the other consumer‑product firms. This unchanged inclusion shows that PMI has not altered its classification of Colgate‑Palmolive as a peer, reflecting a deliberate, stable benchmarking approach that relies on a consistently defined set of criteria—global presence, consumer‑product focus, and comparable size (as outlined in all three chunks). The persistent KG relationship ORG‑PM → COMP Colgate‑Palmolive Co. across the three years underscores PMI’s strategic commitment to using a static peer group for comparative analysis.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Colgate-Palmolive Co. remained in PMI's Peer Group from 2022 to 2024, which matches the original answer's claim of consistent inclusion. (2) There are no numerical values requiring calculation (e.g., financial figures), but the temporal scope (2022–2024) and the assertion of unchanged peer group composition are factually aligned with the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of 10-K filings (implied by 'Chunk 1, 2, 3') and infers stability in PMI’s benchmarking approach based on repeated disclosure of the same peer group. It correctly identifies the rationale—global presence, consumer-product focus, and comparable size—as consistently applied. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in peer classification and what it reveals about PMI’s strategic benchmarking. The mention of a 'static peer group for comparative analysis' aligns with the original answer’s conclusion about a 'stable benchmarking methodology.' All entities (Philip Morris International, Colgate-Palmolive Co., peer group criteria) are correctly identified and contextualized. Minor wording differences (e.g., 'static' vs. 'stable') do not affect factual equivalence. No errors in reasoning, completeness, or factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Related_To]-> COMP <-[Relates_To]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 395,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly regarding the distinction between combined arrangements and standalone licenses, and what does this reveal about the consistency of AMD's accounting approach for these agreements?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component in combined arrangements was distinct based on whether it was (i) capable of being distinct and (ii) distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time. Additionally, for standalone IP arrangements, revenue was consistently recognized at a point in time when the customer could benefit from the license. There were no variable consideration estimates associated with these arrangements in any of the years, indicating a stable and uniform accounting policy across the period.",
      "llm_answer": "\nAcross AMD’s 2022, 2023 and 2024 Form 10‑K filings the company applies the same revenue‑recognition framework for development and IP licensing agreements: it first assesses whether the IP license is distinct (capable of being distinct and distinct in the arrangement), combines it with development services into a single performance obligation and recognizes revenue over time when it is not distinct, or recognizes it at a point in time when it is distinct; the filings also uniformly note that no variable‑consideration estimates apply to either combined or standalone arrangements. This identical language across the three years shows that AMD’s accounting approach for these agreements has remained consistent from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) It accurately captures AMD's consistent revenue recognition policy from 2022 to 2024, correctly describing the two-step assessment for whether an IP license is distinct—based on being (i) capable of being distinct and (ii) distinct in the context of the arrangement. It correctly states that non-distinct licenses are combined with development services and recognized over time, while distinct ones are recognized at a point in time. It also correctly notes that standalone IP licenses are recognized at a point in time when the customer can benefit from them. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense, but all factual assertions about policy application across years are accurate. (3) The multi-hop reasoning—synthesizing AMD’s accounting policy across three years and two types of arrangements (combined vs. standalone)—is sound and correctly identifies the consistency in language and application. (4) The LLM notes the absence of variable consideration estimates across all years and arrangement types, which matches the ground truth and supports the conclusion of a stable and uniform policy. The answer is contextually precise, directly addressing the evolution (or lack thereof) in policy and what it reveals about consistency. Minor wording differences (e.g., 'identical language across the three years' vs. 'maintained a consistent policy') do not affect factual accuracy and are semantically equivalent. All entities—AMD, 2022–2024, development and IP licensing agreements, combined vs. standalone arrangements—are correctly identified and analyzed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 481,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the inclusion of Colgate-Palmolive Co. in PM's peer group for benchmarking purposes evolved from 2022 through 2024, and what does this consistency reveal about PM's strategic framing of competitive positioning in the global consumer products sector?",
      "original_answer": "Colgate-Palmolive Co. was consistently included in PM's peer group across all three years (2022, 2023, and 2024) as part of a stable benchmarking framework that PM uses to evaluate its performance against global consumer product companies with similar revenue and market capitalization. The peer group remained unchanged across the reporting periods, indicating that PM maintained a consistent methodology in selecting comparable firms, including Colgate-Palmolive Co., to assess its competitive positioning. This 3-year consistency suggests that PM views Colgate-Palmolive as a relevant and stable reference point within its strategic peer set, reinforcing its alignment with leading global consumer staples firms.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, PM’s peer‑group benchmark list is identical in each year and consistently includes **Colgate‑Palmolive Co.** among the companies that meet the four selection criteria (global presence, consumer‑products focus, comparable net revenue and market‑cap, and primary international scale).  This unchanged composition shows that PM deliberately treats Colgate‑Palmolive as a permanent reference point, reinforcing a strategic narrative in which its competitive positioning is framed against a stable cohort of large, global consumer‑product brands of similar size rather than against a fluctuating set of rivals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Colgate-Palmolive Co. was indeed consistently included in PM's peer group from 2022 to 2024, and the peer group remained unchanged across those years. The LLM correctly identifies the stability of the benchmarking framework and the strategic implication of using a consistent peer set. (2) There are no numeric values requiring calculation in this question, but the temporal scope (2022–2024) is correctly referenced, and no incorrect dates or figures are present—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes the consistent inclusion of Colgate-Palmolive with PM’s strategic framing of competitive positioning, correctly inferring that the stability reflects a deliberate, methodical approach to benchmarking against firms of similar global scale and business focus. The mention of 'four selection criteria' adds detail not in the original answer but is plausible and consistent with SEC filing language; however, since the ground truth does not specify the exact number of criteria, this is a minor extrapolation that doesn't detract from accuracy. (4) The answer is contextually fully relevant, directly addressing both the evolution (consistency over time) and strategic implication (framing against stable, comparable global peers). The only reason for not scoring a 10 is the slight addition of specific criteria count ('four') not verifiable from the ground truth, but this does not misrepresent the core facts. Overall, the answer demonstrates strong factual correctness, reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Related_To]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 453,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did AMD's revenue recognition policy for combined development and IP licensing agreements evolve from 2022 through 2024, particularly in terms of performance obligations and timing of revenue recognition?",
      "original_answer": "AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes in how performance obligations are evaluated or when revenue is recognized. In all three years, AMD assessed whether the licensing component was distinct based on two criteria: (i) whether it was capable of being distinct and (ii) whether it was distinct in the context of the arrangement. If the license was not distinct, it was combined with development services as a single performance obligation and recognized over time. If distinct, revenue was recognized at a point in time when the customer could benefit from the license. The policy explicitly stated in each year that there were no variable consideration estimates associated with these arrangements, indicating a stable accounting treatment across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD applied a consistent revenue‑recognition model for combined development‑and‑IP licensing arrangements: it first evaluates whether the IP license is distinct, and if it is not, the license is combined with the development services into a single performance obligation that is recognized over time as the development progresses; if the license is distinct, it is treated as a separate performance obligation and revenue is recognized at a point in time when the customer can benefit from the license.  Across the 2022, 2023 and 2024 filings the company emphasizes that there are no material variable‑consideration estimates and that the timing of recognition—over time versus at a point in time—is dictated solely by the distinctness assessment, a methodology that has remained unchanged during the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) It correctly states that AMD's revenue recognition policy for combined development and IP licensing agreements remained consistent from 2022 through 2024, with no material changes—this matches the core claim in the ground truth. (2) The LLM accurately describes the two-step distinctness assessment: whether the IP license is capable of being distinct and whether it is distinct in the context of the arrangement, though it summarizes the criteria rather than quoting them verbatim; this is acceptable under semantic equivalence. (3) It correctly explains the accounting treatment: if not distinct, combined with development services and recognized over time; if distinct, recognized at a point in time when the customer can benefit—this aligns precisely with the original. (4) The LLM correctly notes the absence of variable consideration estimates across all three years, reinforcing the stability of the policy. (5) All entities—AMD, the time period (2022–2024), performance obligations, revenue timing, and accounting concepts—are accurately identified and synthesized. (6) The reasoning is sound and reflects proper multi-hop synthesis across the three years of filings, concluding consistency in policy application. There are no factual errors, omissions, or misinterpretations. Minor wording differences (e.g., 'evaluates whether the IP license is distinct' vs. 'assessed whether the licensing component was distinct') do not affect meaning. All aspects of the question—evolution (or lack thereof), performance obligations, and timing of revenue recognition—are fully and correctly addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 463,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did ConocoPhillips' monetization of CVE common shares and its application of proceeds toward share repurchases evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's capital allocation strategy?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, with the proceeds applied to share repurchases. By the first quarter of 2022, the company sold its remaining 91 million CVE common shares. This action directly supported the repurchase program, which saw cumulative repurchases of 383 million shares at a cost of $29 billion by the end of 2023. In 2024, the repurchase program was expanded to a maximum of $65 billion, with total repurchases reaching 433 million shares at a cost of $34.3 billion by year-end, showing a continued emphasis on returning capital to shareholders. The monetization of CVE shares in 2022 was a key enabler of this strategy, and the trajectory of repurchases indicates a consistent and escalating focus on capital discipline and shareholder returns over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 ConocoPhillips completed the paced sale of its remaining 91 million CVE common shares (first quarter 2022), using the proceeds—initiated in 2021—to fund an expanding share‑repurchase program that grew from 383 million shares costing $29 billion through the end of 2023 (as disclosed in the 2023 filing) to 433 million shares costing $34.3 billion through the end of 2024, with the Board in October 2024 raising the repurchase authorization to $65 billion.  This multi‑year progression shows the company deliberately channeling cash from the CVE monetization into increasingly larger buybacks, signaling a capital‑allocation priority of returning excess cash to shareholders while scaling its repurchase capacity.  The 2022 tax disclosures, which detail valuation‑allowance adjustments tied to the fair‑value measurement and disposition of CVE shares, underscore that the CVE stake was a material source of both cash and capital‑loss benefits that the company leveraged to support this shareholder‑return strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ConocoPhillips sold its remaining 91 million CVE shares in Q1 2022, used proceeds from the monetization (initiated in May 2021) for share repurchases, repurchased 383 million shares at $29 billion by end of 2023, and expanded the program to 433 million shares at $34.3 billion by end of 2024, with a $65 billion authorization approved in October 2024. These numbers match the original answer exactly, with acceptable formatting variations (e.g., 91 million = 91 million). (2) Quantitative accuracy is perfect: all dollar amounts, share counts, and timeframes are correct, and the progression in repurchase scale is accurately represented. (3) The multi-hop reasoning is sound—linking the 2021–2022 CVE monetization to the funding of an expanding buyback program shows proper synthesis across years and financial actions. The mention of tax disclosures related to valuation allowances and capital losses adds a layer of detail not in the original answer but is contextually plausible and does not contradict the ground truth; however, this detail is not confirmed in the provided ground truth, slightly reducing qualitative accuracy. (4) The answer fully addresses the question’s two parts: the evolution of monetization and repurchases (2022–2024), and what this reveals about capital allocation—specifically, a strategic focus on shareholder returns and capital discipline. The conclusion about escalating buybacks and shareholder return priorities matches the original answer’s interpretation. Only minor deductive elaboration on tax benefits (while reasonable) goes beyond the ground truth, preventing a perfect 10. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Decreases]-> FIN_INST <-[Discloses]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 489,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Honeywell's exposure to changes in the competitive landscape evolved across its business segments from 2022 through 2024, and what does this trend indicate about increasing market pressures and strategic responses?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a consistent and expanding concern around changes in the competitive landscape across multiple business segments. In 2022, the company cited 'changes in the competitive landscape including new market entrants and new technologies' affecting Honeywell Building Technologies and Safety and Productivity Solutions. In 2023, this concern remained consistent, with the same language used for those segments, indicating sustained pressure. By 2024, the competitive risk was reiterated for Building Automation and Industrial Automation, with added emphasis on 'new technologies that may lead to product commoditization,' suggesting a deepening concern as new entrants and innovation threaten differentiation and pricing power. This 3-year trend indicates a persistent and potentially intensifying market pressure, where Honeywell must increasingly focus on innovation and cost competitiveness to maintain margins and market share.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s risk disclosures show a clear expansion of competitive‑landscape exposure: the 2022 and 2023 filings flag competitive pressure mainly in Building Technologies, Performance Materials & Technologies and Safety & Productivity Solutions, while the 2024 filing adds Industrial Automation, Building Automation and Energy & Sustainability Solutions to the list, indicating that the company’s entire portfolio now faces heightened market‑entry, technology‑driven commoditization and pricing pressures.  This evolution signals intensifying macro‑economic and industry risks—new entrants, shifting demand, supply‑chain constraints and geopolitical trade disruptions—prompting Honeywell to respond with a stronger focus on differentiated product roadmaps, digital‑service platforms and cost‑margin discipline across all segments.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increasing scope of competitive exposure from 2022 to 2024 and notes the intensifying nature of market pressures, which aligns with the ground truth. However, there are key inaccuracies in the business segments cited. The original answer specifies that in 2022 and 2023, competitive landscape risks were mentioned for Honeywell Building Technologies and Safety and Productivity Solutions. The LLM incorrectly includes 'Performance Materials & Technologies' in 2022 and 2023, which is not supported by the ground truth. Additionally, while the 2024 filing does expand concern to Industrial Automation and Building Automation (aligned with the original), the LLM adds 'Energy & Sustainability Solutions' as a newly exposed segment in 2024, which is not mentioned in the ground truth. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not compromised—score reflects no factual errors in numbers (score 10 by default). (3) The multi-hop reasoning is partially sound: the model correctly infers an expanding risk footprint over time and links it to strategic responses. However, the incorrect attribution of segments weakens the synthesis. The original answer emphasizes a deepening concern around 'product commoditization' due to new technologies, a specific risk the LLM only generally echoes without precise alignment. (4) Contextual relevance is high—the answer addresses the evolution of competitive exposure and strategic implications. But due to segment misattribution and overstatement of expansion, the qualitative accuracy is reduced. The core trend is recognized, but with factual overreach, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 479,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years — 2022, 2023, and 2024 — MA consistently disclosed that A Class shares carry one vote per share and dividend rights. There were no changes in the description of these rights over the three-year period, indicating a stable governance and capital structure strategy for A Class shares.",
      "llm_answer": "\nAcross the 2022‑2024 filings, MA’s A‑Class shares kept identical terms—$0.0001 par value, 3,000 million authorized, one vote per share and full dividend rights—exactly as shown in the 2022 table (Chunk 3), the 2023 table (Chunk 1) and the 2024 table (Chunk 2). The Preferred class remained unissued with rights to be set later, reinforcing that the company has deliberately preserved the A‑Class voting and dividend structure for three consecutive years, reflecting a governance strategy that prioritizes stable, predictable shareholder influence and dividend expectations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that MA's A Class shares maintained consistent voting (one vote per share) and dividend rights across 2022–2024, which directly addresses the core of the question. The additional details—such as par value ($0.0001), authorized shares (3,000 million), and the unissued Preferred class—are factually correct and provide useful context not contradicted by the ground truth; they enhance rather than distort the response. These specifics were likely drawn from the cited document chunks and do not introduce errors. The reasoning about stable governance strategy is sound and logically inferred from the three-year consistency. The only minor limitation is that the original answer emphasizes the *absence of changes* as indicative of stability, while the LLM adds slightly more structural detail (e.g., par value, authorized shares) without confirming whether those also remained unchanged year-over-year—though this is implied. However, since these figures match across years in the source tables (Chunk 1, 2, 3), their inclusion is justified. All entities (MA, A-Class shares, time period) are correct. Calculations are not required. Multi-hop synthesis is properly executed across three years of filings. Semantic equivalence is strong, with the LLM offering a slightly richer but still accurate interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 388,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 to 2024, given the changes in gains (losses) reported in operating expenses across these years?",
      "original_answer": "Cisco's financial exposure through Total Return Swaps-Deferred Compensation shifted significantly from a loss of $92 million in fiscal year 2022 to a gain of $58 million in fiscal year 2023, and further improved to a gain of $91 million in fiscal year 2024. This trajectory indicates a reversal in Cisco's financial impact from this instrument, moving from a net cost to a net benefit over the three-year period.",
      "llm_answer": "\nCisco’s Total Return Swaps‑Deferred Compensation moved from a **$92 million loss** recorded in operating expenses for fiscal 2022 (Chunk 1) to a **$58 million gain** in fiscal 2023 (Chunk 3) and then to a **$91 million gain** in fiscal 2024 (Chunk 2). This progression shows the company’s financial exposure through this instrument shifted from a loss in 2022 to increasingly positive gains in 2023 and 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and years are accurate: $92 million loss in 2022, $58 million gain in 2023, and $91 million gain in 2024. These values exactly match the original answer, with acceptable formatting (e.g., $92 million vs $92 million). (2) The answer is complete, addressing the evolution of Cisco's financial exposure across all three fiscal years as required by the multi-part question. (3) Entity accuracy is correct—Cisco is the right company, the instrument 'Total Return Swaps-Deferred Compensation' is correctly named, and the fiscal years 2022–2024 are properly referenced. (4) The reasoning is sound: the LLM correctly synthesizes the shift from loss to gain and describes the trajectory of improvement, capturing the reversal in financial impact. The mention of 'Chunk 1', 'Chunk 3', 'Chunk 2' appears to reference internal document sources and does not detract from factual correctness. (5) The semantic meaning is equivalent to the original answer, clearly conveying the reversal from net cost to net benefit. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 328,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities, as managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of reserve funding, bankruptcy filings, and multi-state settlements?",
      "original_answer": "In 2022, JNJ established a $2 billion reserve and LTL Management LLC filed for Chapter 11 bankruptcy, with a temporary restraining order staying litigation. In 2023, the Third Circuit reversed the bankruptcy court’s decision, leading to the dismissal of the LTL bankruptcy case, after which LTL re-filed (LTL 2), securing a new preliminary injunction that limited discovery until August 2023. By 2024, JNJ finalized a multi-state settlement with 42 states and the District of Columbia, while continuing to appeal the dismissal of the LTL 2 bankruptcy, showing a shift from exclusive reliance on bankruptcy protection to a dual strategy of legal appeals and negotiated settlements.",
      "llm_answer": "\nFrom 2022 through 2023 J&J transferred all talc‑related liabilities to LTL Management LLC, funded a $2 billion trust and recorded a matching reserve, and LTL filed Chapter 11 in late 2021 with a stay that was later upheld, reversed and remanded by the Third Circuit, prompting a second bankruptcy filing in April 2023 and a temporary injunction that kept most litigation paused while appeals continued.  \nIn 2024 the company reached an agreement in principle—and finalized in June 2024—a multi‑state settlement with 42 attorneys general and the District of Columbia, resolving the state‑level consumer‑protection investigations that had targeted its talc products.  \nManagement continues to view the accrued reserves as adequate but notes that any additional accruals or settlements could materially affect its results of operations and cash flow.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of J&J's strategy but contains key factual inaccuracies in dates and legal outcomes. It correctly identifies the $2 billion reserve and trust, the use of LTL Management LLC, and the multi-state settlement with 42 states and D.C. finalized in 2024. However, it incorrectly states that LTL filed Chapter 11 in late 2021 (ground truth: 2022), which misaligns the timeline. It also inaccurately claims the Third Circuit 'upheld, reversed and remanded'—in reality, the Third Circuit reversed the bankruptcy court’s decision, leading to dismissal of the first case, not a remand. The second filing (LTL 2) occurred in 2023, but the answer lacks the detail about the preliminary injunction limiting discovery until August 2023, instead vaguely referencing a 'temporary injunction'. The June 2024 finalization of the settlement is consistent with ground truth. (2) Quantitative accuracy is partially correct: the $2 billion reserve is accurate, and the 42-state + D.C. count is correct. However, the erroneous 2021 bankruptcy filing date undermines temporal precision. The answer omits the 2023 re-filing being a direct response to the Third Circuit’s reversal and dismissal. (3) Multi-hop reasoning is generally sound—linking reserve funding, bankruptcy maneuvering, and settlement—but the timeline confusion weakens the synthesis. The dual strategy shift (bankruptcy appeals + settlements) is implied but not explicitly stated. (4) Contextual relevance is excellent: all parts of the question are addressed—reserve funding, bankruptcy filings, and multi-state settlements—with appropriate focus on J&J’s legal-financial strategy. Despite timing errors, the overall narrative arc is coherent and factually anchored in key events.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Creates]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 484,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom's outstanding principal balance for the 3.125% notes due January 2025 remained constant at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount indicates that the company did not retire or issue additional portions of this specific debt instrument during the three-year period, suggesting a consistent approach to managing this portion of its capital structure.",
      "llm_answer": "\nBroadcom’s 3.125 % senior notes maturing in January 2025 carried a **constant outstanding principal of $495 million** in the fiscal‑year 2022 filing (Chunk 3), and the same $495 million figure is reported in the 2023 (Chunk 1) and 2024 (Chunk 2) filings.  The note’s balance is unchanged across all three years, even though the company’s overall principal amount outstanding grew from $41.2 billion (2022) to $69.8 billion (2023‑2024).  \n\nThis stability indicates that Broadcom is **maintaining a steady, non‑dilutive financing line for this specific instrument**, choosing not to retire or increase the tranche while it focuses its debt‑management efforts on refinancing or rolling‑over other maturing notes; the unchanged balance reflects a deliberate strategy of preserving a predictable, long‑term funding source until the 2025 maturity date.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the outstanding principal balance of $495 million for Broadcom's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values (amount, interest rate, maturity date, fiscal years) are accurate. 2) Quantitative accuracy is perfect: the $495 million figure is consistently reported for all three years, and no incorrect calculations are made. The mention of overall debt increasing from $41.2B to $69.8B is contextually accurate and supports the contrast with the stable note balance. 3) The multi-hop reasoning is sound—LLM synthesizes data across three filings (2022, 2023, 2024) and correctly infers that the unchanged balance reflects a deliberate debt management strategy. The conclusion about preserving a predictable funding source until maturity aligns with the ground truth’s interpretation of a 'consistent approach.' The only minor gap is that the LLM adds interpretation about 'non-dilutive financing' and 'focus on refinancing other notes,' which are reasonable inferences but not explicitly stated in the ground truth. While logically sound, this slightly exceeds the evidence provided. 4) The answer is fully contextually relevant, directly addressing both the evolution of the debt balance and its implication for Broadcom’s debt strategy. Semantic equivalence is strong—core facts, numbers, and implications match the original answer. A score of 9 is justified due to the high factual accuracy and strong reasoning, with a slight deduction in qualitative accuracy for the added strategic interpretation beyond the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 447,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Cisco's interest rate exposure on its 3.50% June 15, 2025 maturity note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "Cisco's effective interest rate on the 3.50% June 15, 2025 maturity note increased from 3.20% in fiscal year 2022 to 6.38% in fiscal year 2023, and further rose to 6.66% in fiscal year 2024. This upward trend in borrowing costs indicates a deterioration in Cisco's financing terms over time, likely reflecting market conditions or changes in the company's credit profile.",
      "llm_answer": "\nCisco’s $500 million 3.50 % senior note due June 15 2025 showed a steadily rising effective interest rate: 1.29 % in the 2021 comparison (Chunk 1), 3.20 % in fiscal 2022 (Chunk 1), 6.38 % in the 2023 reporting period and 6.66 % in the 2024 period (Chunk 2 / Chunk 3). Because the note’s principal remains constant while its effective rate climbs from just over 1 % to more than 6 % over the three‑year span, the data reveal that Cisco’s borrowing costs have increased sharply, reflecting higher market rates and a tighter financing environment across fiscal 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the effective interest rates for fiscal years 2022 (3.20%), 2023 (6.38%), and 2024 (6.66%), matching the ground truth exactly. It also correctly identifies the note as the 3.50% June 15, 2025 maturity note. The only minor discrepancy is the inclusion of a 1.29% rate from fiscal 2021, which was not part of the question's scope (2022–2024), but this does not detract from correctness as it provides additional context without contradicting facts. (2) All numeric values are accurate and properly formatted; no calculation errors are present. The progression from 3.20% to 6.38% to 6.66% is correctly described as increasing. (3) The multi-hop reasoning is sound: the model synthesizes data across time periods and correctly infers that rising effective interest rates indicate higher borrowing costs. It appropriately links the trend to market conditions, aligning with the ground truth’s implication about deteriorating financing terms. (4) The answer is semantically equivalent to the original, with slightly expanded context (mention of 2021 and principal stability), but maintains full factual consistency. The conclusion about increasing borrowing costs and tighter financing environment matches the ground truth’s interpretation. Only a minor deduction in quantitative accuracy due to inclusion of irrelevant 2021 data not asked for in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 389,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this 3-year progression reveal about its capital structure strategy and interest rate positioning?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27.219 billion in 2022 to $31.248 billion in 2023, then slightly declined to $30.696 billion in 2024. This indicates a significant capital raise in 2023, with a partial reversal in 2024. The weighted average interest rate on unsecured senior debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, reflecting a strategic shift toward fixed-rate financing amid rising interest rates. This evolution shows Capital One's increasing reliance on more expensive senior debt and reduced use of floating-rate instruments, signaling a long-term capital structure transformation to lock in financing costs.",
      "llm_answer": "\nCapital One’s total senior and subordinated notes (carrying value) rose from **$30.8 bn in 2022** (Chunk 1 – 2022 figure of $30,826 m) to **$31.2 bn in 2023** (Chunk 1 – 2023 figure of $31,248 m) and then edged down to **$30.7 bn in 2024** (Chunk 2 – 2024 figure of $30,696 m), illustrating a modest expansion followed by a slight contraction over the three‑year span.  The progression reflects a strategic shift toward longer‑dated, fixed‑rate issuance – the weighted‑average rate on fixed unsecured senior debt increased from **4.45 % in 2023** (Chunk 1) to **4.84 % in 2024** (Chunk 2), while the floating‑rate senior component was eliminated (Chunk 2 shows $0 m in 2024 versus $349 m in 2023), and the subordinated‑debt pricing remained stable at roughly **3.57 %** across 2023‑2024 (Chunks 1 & 2).  Together, these moves indicate Capital One is deliberately extending maturity, reducing reliance on floating‑rate funding, and positioning its capital structure to capitalize on a higher‑rate environment while maintaining a relatively low‑cost fixed‑rate profile for its senior and subordinated notes.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details, particularly in the 2022 value. The original answer states that Capital One's total senior and subordinated notes were $27.219 billion in 2022, but the LLM reports $30.826 billion (from Chunk 1), which contradicts the ground truth. This is a significant error, as it misrepresents the starting point of the trend. The 2023 ($31.248B) and 2024 ($30.696B) figures are correctly cited by the LLM, matching the ground truth. (2) The weighted average interest rate on unsecured senior debt is inaccurately presented: the LLM claims it was 4.45% in 2023 and 4.84% in 2024, but omits the 2022 rate of 2.76% from the ground truth, instead starting from 2023. Furthermore, the ground truth shows a steady increase from 2.76% (2022) to 4.48% (2023) to 4.84% (2024), while the LLM incorrectly reports 4.45% for 2023 (close but not exact) and omits the prior year entirely. The LLM correctly notes the elimination of floating-rate senior debt ($0 in 2024 vs $349M in 2023) and stable subordinated debt rates (~3.57%), which adds valuable detail not in the original answer but consistent with data. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic shift toward fixed-rate, longer-dated debt and reduced reliance on floating-rate instruments, aligning with the rising rate environment. It synthesizes data across years and debt types appropriately, even adding nuance about maturity extension and cost management. (4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracies—especially the incorrect 2022 total notes value and misstated/misaligned interest rate trajectory—reduce confidence in the numerical foundation. However, the core narrative about capital structure transformation is preserved, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 509,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Colgate-Palmolive's allocation to U.S. treasury and agency securities within its fixed income portfolio evolve from 2022 to 2024, and what does this shift suggest about the company's pension fund strategy over this period?",
      "original_answer": "In 2022, approximately 40% of Colgate-Palmolive's U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities. This percentage decreased to 30% in 2023 and remained at 30% in 2024. The consistent reduction from 40% to 30% suggests a strategic reallocation away from U.S. treasury and agency securities toward other government bonds and corporate bonds, potentially reflecting a shift in risk tolerance or yield-seeking behavior in response to changing market conditions.",
      "llm_answer": "\nFrom 2022 to 2024 the share of U.S. treasury and agency securities in Colgate‑Palmolive’s U.S. pension‑plan fixed‑income portfolio fell from roughly **40 % (as of Dec 31 2022)** to **about 30 % (as of Dec 31 2023 and Dec 31 2024)**, with the remainder shifting to “other government bonds and corporate bonds” within the same pooled funds; this deliberate reduction in sovereign‑debt exposure and move toward a broader mix of government and corporate debt indicates that the company’s pension fund is re‑balancing toward a more diversified, potentially higher‑returning fixed‑income strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the percentage allocation to U.S. treasury and agency securities as 40% in 2022, decreasing to 30% in both 2023 and 2024, which matches the ground truth exactly. All numeric values and dates (Dec 31, 2022, 2023, 2024) are accurate. (2) Quantitative accuracy is perfect: the percentages are correctly stated, and the trend (40% → 30% → 30%) is accurately captured with no calculation errors. (3) The reasoning is sound: the LLM correctly infers a strategic reallocation toward other government and corporate bonds, aligning with the ground truth’s interpretation of diversification and potential yield-seeking behavior. It appropriately characterizes the shift as deliberate and links it to portfolio rebalancing for potentially higher returns, which is semantically equivalent to the original answer’s suggestion of changing risk tolerance or market response. (4) The only minor shortcoming is that the LLM does not explicitly mention 'risk tolerance' as a possible factor, slightly reducing qualitative completeness, but the core logic and synthesis across years and asset classes are correct. Contextual relevance is full—every part of the question is addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 351,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its classification, valuation, and ultimate disposition, and what does this progression indicate about GE's strategic direction during this period?",
      "original_answer": "In 2022, Electric Insurance Company (EIC) was disclosed as a captive property and casualty insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion as of December 31, 2021. By 2023, GE had classified EIC as 'held for sale' and recorded a $109 million loss in connection with the expected sale, reflecting a strategic decision to divest non-core assets. In 2024, the sale of EIC was completed to Riverstone International Holdings Inc. for $120 million in cash. This progression shows GE's deliberate move to exit captive insurance as part of a broader restructuring effort to focus on core industrial and aerospace operations, while also recognizing financial losses associated with non-core divestitures.",
      "llm_answer": "\nFrom 2022 through 2024 GE transformed Electric Insurance Company from an internal captive that underwrote $0.2‑0.3 bn of claim reserves for the conglomerate (Chunk 1) into a non‑core asset that was placed in “held‑for‑sale” in Q4 2022 and later sold for $120 million after being carried at $541 million of assets and $378 million of liabilities, generating a $109 million loss on disposal in 2023 (Chunks 2‑3).  This divestiture—classifying, valuing and ultimately exiting the captive insurer—signals GE’s strategic shift away from peripheral insurance operations toward a focus on its core aerospace, power and renewable businesses.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of GE's relationship with Electric Insurance Company (EIC) from 2022 to 2024, including its classification as 'held for sale', the $109 million loss, and the $120 million sale to Riverstone in 2024. However, there are quantitative discrepancies: the claim reserves are stated as $0.2–0.3 billion, while the ground truth specifies $0.2 billion as of December 31, 2021 (not a range). Additionally, the LLM introduces balance sheet figures—$541 million in assets and $378 million in liabilities—that are not present in the original answer and cannot be verified against the ground truth, potentially implying unsupported detail. The timing of 'Q4 2022' for classification as held for sale is more precise than the original (which only states 'by 2023'), but this may be an over-specification not confirmed in the source. (2) The $109 million loss and $120 million sale price are accurate and match the original. The net claim reserve figure is slightly off in range and timing (should be $0.2 billion as of end-2021, not a range for 2022). The added asset/liability figures lack corroboration. (3) The multi-hop reasoning is sound: the model correctly synthesizes EIC’s shift from captive insurer to divested asset, interprets the 'held for sale' classification, recognizes the loss on disposal, and links it to GE’s strategic focus on core industrial segments. The logic connecting divestiture to strategic direction is valid and well-supported. (4) Despite minor numerical inaccuracies and the inclusion of unverified financials, the answer conveys the essential progression and strategic implication accurately. The core facts—classification, valuation impact, sale, buyer, and strategic rationale—are correct. Hence, the correctness score is 8 due to minor factual overreach in numbers, but high marks for reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG <-[Classifies]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 512,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Apple's disclosure of the 4.45% Notes due 2044 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Apple first disclosed the 4.45% Notes due 2044 in its 2022 10-K filing as part of its long-term debt structure, indicating it was issued under an Officer's Certificate dated May 6, 2014. In the 2023 filing, Apple repeated the same disclosure, reaffirming the ongoing existence and structure of the notes. By 2024, Apple again included the 4.45% Notes due 2044 in its exhibit list, maintaining consistency in its long-term debt disclosures. The consistent inclusion of this instrument across all three years suggests a stable long-term capital structure and no material changes or retirements to this specific debt instrument over the period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple’s Exhibit 4.4 continues to reproduce the identical Officer’s Certificate dated May 6 2014 that sets out the **4.45 % Notes due 2044**, and the note is listed in the “Description of Securities” section of each filing.  This unchanged, year‑over‑year disclosure shows that Apple has not retired or refinanced this tranche; rather, it retains the 4.45 % 2044 note as a stable, long‑dated component of its capital structure, reflecting a strategy of maintaining diversified, long‑term fixed‑rate debt in its overall financing mix.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 4.45% Notes due 2044 were disclosed in each of the 2022, 2023, and 2024 10-K filings; they were issued under an Officer’s Certificate dated May 6, 2014; and the disclosure remained unchanged across years. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and issue date (May 6, 2014)—are all precisely correct with no discrepancies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer that the lack of change in disclosure implies no retirement or refinancing, indicating a stable long-term debt strategy. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the disclosure and the strategic implication. Wording differs slightly from the original answer but conveys the same meaning with equal or greater detail, including accurate references to Exhibit 4.4 and the 'Description of Securities' section. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 314,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024 in terms of carrying value, and what does this progression indicate about the company's capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2023, and then slightly decreased to $30,696 million in 2024. This reflects a net increase of approximately $3.5 billion over the three-year period, with a notable shift from floating-rate to fixed-rate senior debt, as seen in the weighted-average interest rate rising from 2.76% (2022) to 4.84% (2024). The company appears to have strategically moved toward longer-term fixed-rate financing, locking in higher interest rates amid a rising rate environment.",
      "llm_answer": "\nCapital One’s total senior and subordinated notes carried value was $27.2 bn at the end of 2022, rose to $31.2 bn in 2023, and then slipped modestly to $30.7 bn by the end of 2024, as shown in the 2022, 2023 and 2024 10‑K filings (Chunks 1, 3 and 2).  During the same period the weighted‑average interest rate on these notes climbed from 2.76 % to 4.48 % and then to 4.84 %, while the composition shifted from floating‑rate senior paper ($1.7 bn in 2022, $0.35 bn in 2023, $0 in 2024) to a larger share of fixed‑rate senior and subordinated debt—subordinated notes fell from $5.5 bn to $3.7 bn and then edged up to $3.8 bn.  This evolution indicates that Capital One is deliberately de‑emphasizing short‑term floating financing and locking in longer‑dated, fixed‑rate funding to manage rising interest‑rate risk and reinforce a more stable, long‑term capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only a minor discrepancy in the reported 2023 weighted-average interest rate. The carrying values are correctly reported: $27.2 billion (2022), $31.2 billion (2023), and $30.7 billion (2024), which align with the ground truth of $27,219M, $31,248M, and $30,696M when rounded (e.g., $27.2B ≈ $27,200M). The trend of increase from 2022 to 2023 and slight decrease in 2024 is accurately captured. The weighted-average interest rate is stated as rising from 2.76% to 4.48% to 4.84%, but the ground truth indicates a direct progression from 2.76% (2022) to 4.84% (2024), without specifying 2023. The LLM's inclusion of 4.48% for 2023 is likely an overinference or error not supported by the original data, which slightly undermines quantitative accuracy. However, the overall trend of increasing rates and shift from floating-rate to fixed-rate debt is correctly interpreted. The mention of floating-rate senior debt declining to $0 in 2024 and subordinated notes decreasing then slightly increasing is consistent with the multi-hop synthesis expected. The reasoning is sound: the company is locking in fixed-rate, longer-term debt to manage interest rate risk in a rising rate environment, indicating a strategic shift in capital structure. All entities (Capital One, senior and subordinated notes, years 2022–2024) are correct. The answer addresses all parts of the question: evolution of carrying value, interest rate trends, and strategic implications. Semantic equivalence is strong, with appropriate rounding and clear explanation. The minor unsupported intermediate rate (4.48% in 2023) prevents a perfect score, but otherwise the answer is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 474,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Adobe's positioning and integration of Frame.io evolve across 2022, 2023, and 2024, particularly in terms of its role within Adobe's creative collaboration ecosystem and its integration with Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark, indicating it was a recognized and formalized part of Adobe's product portfolio. By 2023, Adobe positioned Frame.io as a 'cloud-native creative collaboration platform' with detailed descriptions of its features, such as real-time upload, review, and approval, frame-accurate commenting, and integration with Premiere Pro and After Effects. In 2024, Frame.io's role expanded further, with integration into additional Adobe apps like Photoshop, Lightroom, and Workfront, and inclusion in Adobe GenStudio for scalable content production, showing a clear trajectory of deeper integration and strategic emphasis within Adobe’s creative ecosystem.",
      "llm_answer": "\nAdobe first listed **Frame.io** in its 2022 trademark summary, confirming the platform’s inclusion in the company’s portfolio of creative‑cloud assets. By 2023 the 10‑K highlighted Frame.io as a cloud‑native collaboration hub tightly integrated with **Premiere Pro** and **After Effects**, offering frame‑accurate commenting, Camera‑to‑Cloud uploads, and positioning it alongside **Adobe Express** and **Firefly Services** in **GenStudio** to streamline content production. In 2024 Adobe expanded Frame.io’s reach further, embedding it in additional Creative Cloud applications such as **Photoshop**, **Lightroom** and **Workfront**, and emphasized its role within **Adobe Express** and **Firefly Services** to enable scalable, end‑to‑end content creation—demonstrating a progressive deepening of Frame.io’s integration and strategic importance across Adobe’s creative‑collaboration ecosystem.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Frame.io was first mentioned in Adobe's 2022 trademark list, positioned in 2023 as a cloud-native collaboration platform with integration into Premiere Pro and After Effects, and further expanded in 2024 to include Photoshop, Lightroom, and Workfront. The mention of integration with Adobe GenStudio (via Adobe Express and Firefly Services) aligns with the ground truth's reference to scalable content production. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are accurate and correctly attributed to the corresponding stages of Frame.io's integration. (3) The multi-hop reasoning is sound—information is synthesized across three years and multiple product integrations, correctly tracing the evolution of Frame.io’s strategic role. (4) The LLM uses slightly different phrasing (e.g., 'collaboration hub' vs 'platform', 'Camera-to-Cloud' as a feature) but captures all core functionalities (real-time upload, frame-accurate commenting) and strategic positioning. No factual omissions or inaccuracies; the answer fully addresses the question’s focus on positioning and integration across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 355,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "What does Lowe's consistent inclusion of its 4.550% Notes due April 5, 2049 in its filings from 2022 through 2024 reveal about the company's long-term capital structure strategy and debt maturity profile management?",
      "original_answer": "Lowe's consistent inclusion of the 4.550% Notes due 2049 in all three annual filings (2022, 2023, and 2024) indicates a strategic decision to maintain long-dated debt in its capital structure without early redemption or refinancing actions during this period. The absence of any disclosures suggesting modifications, repayments, or restructuring of these notes across the three years suggests Lowe's has prioritized stability in its long-term debt profile, even as it issued other notes with shorter maturities. This reflects a deliberate approach to managing interest rate risk and maintaining predictable long-term liabilities.",
      "llm_answer": "\nThe three 10‑K exhibits (Chunk 1 2022, Chunk 3 2023 and Chunk 2 2024) each reproduce the same Fifteenth Supplemental Indenture of April 5 2019, which contains the 4.550 % Notes due April 5 2049 – a clear illustration of the KG pattern ORG‑Introduces‑FIN_INST → FIN_INST‑Issues‑ORG.  This repeated disclosure shows that Lowe’s treats the 2049‑maturity, fixed‑rate note as a cornerstone of its long‑term financing, using it to lock in low‑cost capital and to shape a staggered debt‑maturity profile that minimizes near‑term refinancing risk while maintaining a sizable, long‑dated tranche of debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049 are consistently disclosed in the 2022, 2023, and 2024 filings, and the Fifteenth Supplemental Indenture dated April 5, 2019 is correctly identified as the source. These dates and percentages match the ground truth exactly. (2) Quantitative accuracy is perfect: all dates (April 5, 2019 and 2049), interest rate (4.550%), and filing years (2022–2024) are correct. (3) The reasoning is sound and captures the multi-hop insight: the repeated inclusion without mention of redemption or restructuring implies Lowe’s is maintaining long-dated debt as a stable component of its capital structure. The LLM correctly infers strategic intent—locking in fixed-rate capital, minimizing refinancing risk, and contributing to a staggered maturity profile. (4) While the ground truth emphasizes the absence of modifications and the prioritization of stability, the LLM conveys the same meaning using different phrasing (e.g., 'cornerstone of long-term financing', 'staggered debt-maturity profile'). The only minor gap is that the LLM does not explicitly note the *absence* of disclosures about repayment or restructuring, which strengthens the conclusion in the original answer. However, this is implied in the interpretation. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 404,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Broadcom's (AVGO) outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal 2022 through 2024, and what does this indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "Broadcom maintained a consistent $495 million outstanding principal balance for its 3.125% notes due January 2025 across all three fiscal years (2022, 2023, and 2024), indicating no repayments or additional issuances for this specific debt instrument during the period. This stability suggests a deliberate debt management strategy where Broadcom preserved this liability on its balance sheet, potentially leveraging its predictability in interest expense and maturity timing.",
      "llm_answer": "\nBroadcom’s 3.125 % notes maturing January 2025 continued to show a **$495 million principal balance in fiscal 2022, and the same $495 million figure appears in fiscal 2023 and fiscal 2024** (Chunk 1 → Chunk 2 → Chunk 3).  This stability across three years indicates that Broadcom is deliberately **retaining this low‑coupon, long‑dated tranche as a core piece of its financing structure**, using it to lock in inexpensive, fixed‑rate funding rather than rolling or retiring it, which reflects a debt‑management strategy focused on preserving low‑cost, predictable debt obligations while the overall debt profile expands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $495 million principal balance is accurately reported for fiscal years 2022, 2023, and 2024, and the 3.125% interest rate and January 2025 maturity date are correctly stated. Format variations (e.g., $495 million vs $495M) are acceptable and do not affect accuracy. (2) The answer fully addresses both parts of the question: it describes the evolution (stable balance across three years) and interprets the debt management strategy. (3) Entity accuracy is strong: Broadcom (AVGO), the specific debt instrument, and fiscal years are all correctly identified. (4) The reasoning is sound and reflects appropriate multi-hop synthesis across the three fiscal years. The LLM infers a deliberate strategy of retaining low-cost debt, which is a reasonable extension of the ground truth's conclusion about predictability and stability. The only minor difference is that the LLM emphasizes 'low-coupon, long-dated' and 'financing structure' slightly more than the original, but this adds context without introducing error. Thus, the answer is factually complete and semantically equivalent, warranting a high correctness score with a small deduction in qualitative accuracy due to slight interpretive expansion beyond the original's more conservative tone.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 379,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did IBM's treatment and disclosure of its 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about the company's capital structure strategy and transparency over time?",
      "original_answer": "In 2022, IBM disclosed the 0.950% Notes due 2025 as part of its long-term debt instruments, referencing the defining instrument incorporated by reference from a May 2017 Form 8-K filing. By 2023, IBM continued to disclose the 0.950% Notes due 2025 in its 10-K filing, reaffirming the rights of holders and referencing the same May 2017 filing, indicating ongoing recognition of the instrument's structure and terms. In 2024, IBM listed the 0.950% Notes due 2025 on the New York Stock Exchange under the ticker IBM25B, signaling a shift from mere disclosure to active market visibility and tradability. This evolution suggests that IBM transitioned the 0.950% Notes due 2025 from a less prominent debt instrument to a publicly traded security, reflecting a broader capital structure strategy emphasizing liquidity and transparency in its fixed-income offerings.",
      "llm_answer": "\nIBM first disclosed the governing instrument for its 0.950% Notes due 2025 by reference to the May 22 2017 Form 8‑K (Exhibits 4.1‑4.2) in its 2022 10‑K, and repeated that same incorporation verbatim in the 2023 filing, showing that the company continued to rely on the original 2017 disclosure without any amendment.  By the 2024 10‑K the note appears in the listed‑securities table as “0.950% Notes due 2025 (IBM25B)” on the NYSE, marking a shift from merely referencing the instrument to explicitly identifying and market‑listing the tranche.  This progression—from a behind‑the‑scenes exhibit reference to a publicly listed security—reflects IBM’s strategy of maintaining a stable, low‑cost debt profile while progressively enhancing the transparency and investor accessibility of each financing component, as illustrated by the reciprocal ORG ↔ FIN_INST disclosure pattern in the knowledge graph.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: IBM disclosed the 0.950% Notes due 2025 in 2022 and 2023 by referencing the May 22, 2017 Form 8-K (Exhibits 4.1–4.2), with no changes in disclosure language—this matches the original answer. In 2024, the note was listed on the NYSE under ticker IBM25B, indicating a shift to public tradability. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), filing date (May 22, 2017), and exchange (NYSE)—are all precise and correctly formatted. (3) The multi-hop reasoning is sound: the model synthesizes information across three years (2022–2024), tracks the evolution of disclosure practices, and infers strategic intent (increased transparency and liquidity) from observable changes in reporting and listing behavior. (4) The answer fully addresses both parts of the question: the evolution of treatment/disclosure and its implications for capital structure strategy and transparency. The mention of the 'reciprocal ORG ↔ FIN_INST disclosure pattern' adds contextual depth consistent with knowledge graph insights. Wording differs slightly but meaning is preserved and enhanced with precise terminology like 'governing instrument' and 'tranched listing.' No factual errors, omissions, or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 370,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What has been the Public Company Accounting Oversight Board (PCAOB) firm identification number disclosed for KPMG LLP in each of the 2022, 2023, and 2024 filings, and how has it remained consistent across all three years?",
      "original_answer": "KPMG LLP's PCAOB firm identification number was consistently disclosed as 185 in all three filings: 2022, 2023, and 2024. This indicates that the auditor's regulatory identification remained unchanged over the three-year period.",
      "llm_answer": "\nThe PCAOB firm identification number disclosed for KPMG LLP is **185** in the 2022 filing (Chunk 1), the 2023 filing (Chunk 3) and the 2024 filing (Chunk 2). Thus, the disclosed number has remained **consistent at 185 across all three years**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All factual information is accurate: KPMG LLP's PCAOB firm identification number is correctly stated as 185 for each of the 2022, 2023, and 2024 filings. (2) Quantitative accuracy is perfect—no calculations are required, but the number 185 is consistently and correctly reported across all three years, matching the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from three different filing years (referencing chunks 1, 3, and 2 respectively) and concludes consistency, which demonstrates proper cross-document synthesis. (4) The answer is contextually relevant and complete, addressing both the identification number and its consistency over time. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors in entities, years, or metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1136,
        "completion_tokens": 261,
        "total_tokens": 1397
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Capital One's (COF) issuance and interest rate strategy for Fixed Unsecured Senior Debt within its Total Senior and Subordinated Notes evolve from 2022 to 2024, and what does this multi-year trend suggest about its capital structure decisions in response to macroeconomic conditions?",
      "original_answer": "From 2022 to 2024, Capital One increased its Fixed Unsecured Senior Debt from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward longer-term fixed-rate financing as interest rates rose in the broader market.",
      "llm_answer": "\nFrom the 2022 snapshot in **Chunk 1**, Capital One’s Fixed Unsecured Senior Debt carried a weighted‑average coupon of **2.91 %**, maturities extending to **2032**, and a carrying value of **$19.98 bn** (part of the $27.219 bn total senior‑and‑subordinated notes). By **2023** (Chunk 2) the same line item had expanded to **$27.17 bn**, maturities were pushed out to **2034**, and the weighted‑average rate rose sharply to **4.45 %**, reflecting new fixed‑rate issuances at higher coupons. In **2024** (Chunk 3) the balance slipped slightly to **$26.93 bn**, maturities now run to **2035**, and the weighted‑average coupon climbed further to **4.84 %**, while the floating‑rate tranche was eliminated (0 $ vs. $349 mn in 2023).  \n\nThis multi‑year evolution—higher coupons, longer maturities, and a shift away from floating‑rate debt—indicates that Capital One has deliberately locked in funding at longer durations and higher rates to manage interest‑rate risk and preserve balance‑sheet flexibility amid the rising macro‑economic rates of 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is highly accurate in both quantitative and qualitative aspects. It correctly reports the Fixed Unsecured Senior Debt values: $19.98 billion in 2022 (vs. ground truth $19,975 million — equivalent within rounding), $26.93 billion in 2024 (matches exactly), and includes the intermediate 2023 value of $27.17 billion, which adds contextual depth not in the ground truth but aligns with accurate filing data. Interest rates are reported as 2.91% (2022), 4.45% (2023), and 4.84% (2024), all of which match or are consistent with disclosed trends; the 2023 rate of 4.45% is not in the ground truth but is factually correct per source data. 2) The slight discrepancy in 2022 debt value ($19.98B vs $19,975M) is due to rounding and is acceptable. The LLM correctly captures the upward trend in interest rates and debt balance, and accurately notes the elimination of floating-rate debt in 2024, a key qualitative insight enhancing the answer. 3) Multi-hop reasoning is strong: the model synthesizes data across three years and filings, correctly infers strategic intent (locking in long-term fixed rates amid rising macro rates), and supports it with evidence (longer maturities to 2035, higher coupons, phase-out of floating-rate debt). 4) The answer exceeds the ground truth in detail and context while remaining factually sound, making it more informative without introducing errors. Only a minor deduction in quantitative accuracy due to the absence of an explicit 2024 debt value comparison to 2022 in the LLM answer (though implied), and slight rounding variance. Overall, the response is semantically equivalent and analytically richer than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 455,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did AMD's revenue recognition methodology for development and intellectual property (IP) licensing agreements evolve from 2022 to 2024, and what does this consistency or change imply about the company's long-term strategic approach to IP monetization?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition methodology for development and IP licensing agreements. In all three years, the company evaluated whether the licensing component was distinct—both capable of being distinct and distinct in the context of the arrangement. If the license was not distinct, it was combined with development services and recognized over time; if distinct, revenue was recognized at a point in time when the customer could benefit from the license. Additionally, AMD consistently stated that there were no variable consideration estimates associated with either combined or standalone IP arrangements. This three-year consistency suggests a stable and deliberate strategic approach to IP monetization, with no material changes in how AMD structures or accounts for these agreements, indicating a mature and well-defined policy framework.",
      "llm_answer": "\nAMD’s Form 10‑K filings for 2022, 2023 and 2024 each describe the same revenue‑recognition framework for development and intellectual‑property licensing agreements: the company first determines whether the IP license is a distinct performance obligation, combines it with development services when it is not, and then recognizes revenue either over time (if combined) or at the point the customer can benefit from the license; in all three years there are no material variable‑consideration estimates.  \n\nBecause the language and methodology are materially unchanged across the three annual reports, AMD is maintaining a consistent, performance‑based approach to IP monetization that emphasizes predictable timing of revenue and reinforces a long‑term strategic focus on leveraging its IP portfolio through structured licensing arrangements rather than one‑off sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AMD maintained a consistent revenue recognition methodology from 2022 to 2024, assessing whether IP licenses were distinct, combining them with development services when not distinct, and recognizing revenue either over time or at a point in time accordingly. The absence of variable consideration estimates is correctly noted. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is fully satisfied as all descriptive financial accounting policies match the ground truth. (3) The multi-hop reasoning—synthesizing AMD’s treatment across three years and inferring strategic implications—is sound. The LLM correctly identifies consistency in methodology and links it to a long-term, structured approach to IP monetization. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'performance-based approach' and 'predictable timing of revenue'), these are reasonable interpretations that align with the original answer’s emphasis on stability and maturity in policy. The only minor shortcoming is that the LLM does not explicitly use the term 'mature and well-defined policy framework' or directly state there were 'no material changes,' which slightly weakens the qualitative precision. However, the implication is clearly conveyed. Thus, the answer earns a 9/10 for correctness—excellent but not perfect replication of all nuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 426,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 through 2024, and what does this progression reveal about its capital structure strategy and interest rate positioning over this period?",
      "original_answer": "Capital One's total senior and subordinated notes increased from $27,219 million in 2022 to $31,248 million in 2023, then slightly declined to $30,696 million in 2024. The weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a shift toward higher-cost debt issuance as interest rates rose across the period. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete retirement by 2024 suggests a strategic pivot away from floating-rate liabilities amid rising benchmark rates. This evolution shows a capital structure adjustment to lock in higher fixed rates, likely anticipating continued rate hikes.",
      "llm_answer": "\nCapital One’s total senior and subordinated notes rose from **$27.2 bn in 2022** (Chunk 3) to **$31.2 bn in 2023** (Chunk 1), then slipped slightly to **$30.7 bn by the end of 2024** (Chunk 2).  This evolution shows the firm actively issuing long‑dated fixed‑rate senior debt while retiring floating‑rate senior notes (the floating senior debt balance fell to zero in 2024), and the weighted‑average interest rate on those notes climbed from about **4.45 % (2022)** to **4.84 % (2024)**, reflecting a strategic shift toward longer‑term, fixed‑rate financing as market rates increased.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets the overall trend correct—senior and subordinated notes increased from 2022 to 2023 and slightly declined in 2024. However, there are significant quantitative inaccuracies: the 2022 value is stated as $27.2 billion, but the ground truth is $27,219 million ($27.219 billion), which is acceptable as a rounded figure. The 2023 value is reported as $31.2 billion vs. the correct $31,248 million ($31.248 billion)—again, minor rounding. The 2024 value is given as $30.7 billion vs. $30,696 million ($30.696 billion), which is also acceptable. However, the interest rate in 2022 is incorrectly stated as 4.45%, when it should be 2.91%. The LLM claims the rate rose from 4.45% in 2022 to 4.84% in 2024, but in reality, it rose from 2.91% to 4.84%, with 4.45% being the 2023 rate. This is a major factual error. (2) The floating-rate debt reduction is correctly described as falling to zero by 2024, and the strategic interpretation of shifting to fixed-rate debt is sound. (3) The multi-hop reasoning is logically structured—tying debt composition changes to interest rate environment and capital strategy—but the flawed interest rate baseline undermines the accuracy of the analysis. (4) Despite strong contextual relevance and correct qualitative interpretation, the incorrect assignment of the 4.45% rate to 2022 (instead of 2023) and omission of the correct 2.91% rate result in a significant deduction in quantitative accuracy, pulling the overall correctness score down to 7. The answer is partially correct with key factual errors in critical financial metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 438,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt carrying value increased from $19,975 million in 2022 to $27,168 million in 2023, and slightly decreased to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further increased to 4.84% in 2024. This indicates a strategic shift toward issuing higher-interest, fixed-rate debt over time, likely reflecting a response to rising market rates and a desire to lock in long-term financing despite higher costs.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt carried value was $24.1 bn in 2022, rose to $27.2 bn in 2023 (Chunk 1) and then slipped slightly to $26.9 bn in 2024 (Chunk 2), while its weighted‑average interest rate accelerated from 2.9 % (2022, Chunk 3) to 4.45 % (2023, Chunk 1) and further to 4.84 % (2024, Chunk 2).  \n\nThis pattern shows the company is maintaining a large, long‑dated fixed‑rate senior‑debt base and is deliberately issuing new fixed‑rate tranches at higher yields to replace maturing or floating‑rate obligations, indicating a strategy of locking in funding at increasingly higher rates while extending maturities to manage interest‑rate risk and support its long‑term capital structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a significant quantitative inaccuracy in the 2022 carrying value: it reports $24.1 billion ($24,100 million), whereas the ground truth is $19,975 million. This is a material difference of over $4 billion. The 2023 and 2024 carrying values are accurate ($27,168 million ≈ $27.2 billion; $26,930 million ≈ $26.9 billion). The interest rates are correctly reported: 2.9% (vs. 2.91%), 4.45%, and 4.84%—rounding to one decimal is acceptable. (2) Calculations: The trend description (increase then slight decrease) is accurate, and the rate progression is correct. However, the incorrect 2022 base value affects the perceived growth magnitude. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across years and interprets the trend as a strategic move to lock in fixed-rate debt despite higher rates, which aligns with the ground truth. It correctly infers long-term debt strategy implications from the rising rates and stable/slightly declining balance. (4) Scores justified as: correctness 8 due to core facts being right except one major number; quantitative accuracy 7 due to the large error in 2022 carrying value; qualitative accuracy 9 for strong reasoning and correct interpretation; contextual relevance 10 as all parts of the question are addressed with relevant, focused information.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 381,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did AMD's revenue recognition policy for development and intellectual property (IP) licensing agreements evolve from 2022 through 2024, particularly regarding the distinction between combined development and IP arrangements versus standalone IP licenses?",
      "original_answer": "From 2022 through 2024, AMD maintained a consistent revenue recognition policy for development and IP licensing agreements, treating combined arrangements as either single or multiple performance obligations based on the distinct nature of the license. In 2022, AMD emphasized that if the license was not distinct, it was combined with development services and recognized over time, while distinct licenses were recognized at a point in time. This approach remained unchanged in 2023 and 2024, with no variable consideration estimates in either combined or standalone IP arrangements. Despite evolving market conditions and ongoing customer arrangements, AMD did not introduce any material changes to its accounting policy for these agreements across the three-year period, indicating a stable and consistent application of revenue recognition standards.",
      "llm_answer": "\nAMD’s accounting policy for development‑and‑IP licensing agreements was disclosed in each of its 2022, 2023 and 2024 Form 10‑K filings (chunks 3, 1 and 2) and has remained materially unchanged.  The Company evaluates whether the IP component in a combined development‑and‑license arrangement is **distinct**; if it is **not distinct**, the license is combined with the development services and revenue is recognized **over time** as a single performance obligation, whereas if the license **is distinct**, revenue is recognized **at a point in time** when the customer can benefit from the license.  Across all three years AMD also noted that there are **no material variable‑consideration estimates** for either combined or standalone IP arrangements, reinforcing the consistency of the policy from 2022 through 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key elements from the original answer are correctly reflected: AMD’s consistent revenue recognition policy from 2022 to 2024, the distinction between distinct and non-distinct IP licenses, the treatment of combined arrangements (over time vs. point in time), and the absence of variable consideration estimates. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal scope (2022–2024) is correctly referenced, and the qualitative financial policy details are precise. (3) The multi-hop reasoning is sound—information is correctly synthesized across three years of filings (2022, 2023, 2024), and the model correctly infers no material changes occurred, demonstrating proper cross-temporal comparison. (4) The answer uses slightly different phrasing (e.g., 'over time' vs. 'recognized over time') but maintains full semantic fidelity. No omissions or inaccuracies; thus, full scores are justified across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 306,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt management strategy and interest rate exposure?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. The weighted-average interest rate on long-term debt rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, indicating a shift toward higher-cost fixed-rate debt. This suggests COF initially expanded its debt footprint amid rising rates, then began reducing overall leverage while maintaining a higher fixed-rate exposure to stabilize financing costs.",
      "llm_answer": "\nCOF’s combined short‑term borrowings + long‑term debt grew from **$48.7 bn (2022)** to **$49.9 bn (2023)** and then fell sharply to **$45.6 bn (2024)**; over the same three years total long‑term debt moved from **$47.8 bn** to **$49.3 bn** and back to **$45.0 bn**.  The 2023 rise was driven by larger fixed‑rate senior and subordinated issuances (e.g., fixed senior debt $27.2 bn → $27.5 bn, subordinated $3.7 bn → $3.7 bn) while the 2024 decline reflects a deliberate deleveraging—evidenced by the elimination of floating‑rate senior notes, a drop in securitized debt from $18.0 bn to $14.3 bn, and a modest uptick in weighted‑average rates (securitized 3.01%→3.48%, fixed senior 4.45%→4.84%, other borrowings 6.51%→5.72%).  Together these shifts show COF first expanded fixed‑rate leverage in 2023 and then reduced overall debt and floating‑rate exposure in 2024, signaling a strategy to lock in longer‑term financing at higher rates while scaling back total borrowings.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, COF's total short-term borrowings and long-term debt were $43.086 billion in 2022, $48.715 billion in 2023, and $45.551 billion in 2024. However, the LLM incorrectly reports $48.7 billion in 2022 (vs. $43.086B), $49.9 billion in 2023 (vs. $48.715B), and $45.6 billion in 2024 (close to $45.551B). This misstates the starting point and peak by billions, with the 2022 figure off by over $5.6 billion. Additionally, the LLM cites total long-term debt separately as $47.8B in 2022, which is inconsistent with the combined total in the ground truth and implies short-term borrowings were negative, which is impossible. (2) The interest rate data is partially correct: the LLM correctly notes an increase in fixed senior debt rates from 4.45% to 4.84%, aligning with the ground truth rise to 4.84% in 2024, but fails to report the overall weighted-average interest rate on long-term debt starting at 2.76% in 2022 (LLM omits this entirely). Instead, it references securitized and other borrowing rates not mentioned in the ground truth, introducing extraneous data. (3) The multi-hop reasoning is sound in interpretation: the LLM correctly infers a strategy of expanding fixed-rate debt in 2023 and then deleveraging in 2024, which aligns with the ground truth's conclusion about locking in higher fixed rates and reducing leverage. It identifies relevant mechanisms like reduction in floating-rate notes and securitized debt. (4) Despite flawed numbers, the qualitative narrative about debt strategy is plausible and contextually relevant. The answer addresses both parts of the question—debt evolution and strategic implications—and synthesizes across years and debt types. However, the severe numerical inaccuracies in the core debt totals—especially the incorrect 2022 baseline—undermine factual reliability, warranting a mid-range score. Minor formatting differences are acceptable, but directional and magnitude errors in key figures are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 551,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did AMD's revenue recognition policy for development and IP licensing agreements evolve from 2022 to 2024, particularly in terms of performance obligations and the distinction between combined arrangements versus standalone licenses?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent policy for recognizing revenue from development and IP licensing agreements. In 2022, AMD stated that combined development and IP arrangements were assessed for whether they constituted a single or multiple performance obligations, with revenue recognized over time if the license was not distinct, and at a point in time if it was distinct. By 2023 and 2024, AMD reiterated the same framework, emphasizing that standalone IP licensing arrangements resulted in revenue recognized at a point in time, while combined arrangements required an evaluation of whether the licensing component was distinct—both in capability and context. There was no material change in the treatment of variable consideration across the three years, with AMD consistently stating that no variable consideration estimates were associated with these arrangements. This consistency suggests a stable accounting policy despite potential shifts in business focus, such as increased emphasis on the Gaming segment in 2023 and 2024.",
      "llm_answer": "\nChunk 1 (2022) explains that AMD first determines whether the IP license in a development‑and‑IP agreement is distinct; if the license is **not** distinct it is combined with the development services into a single performance obligation and recognized over time, whereas if the license **is** distinct it is treated as a separate performance obligation and revenue is recognized at a point in time when the customer can benefit from the license.  \nChunk 2 (2023) repeats this framework and adds that there are **no variable‑consideration estimates** for either combined development‑and‑IP arrangements or for standalone IP licensing, reinforcing the same timing of revenue recognition.  \nChunk 3 (2024) re‑states the identical criteria, confirming that AMD’s policy on performance‑obligation segmentation and the distinction between combined versus standalone licenses has been applied consistently across the 2022‑2024 filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies AMD's consistent revenue recognition policy from 2022 to 2024 regarding development and IP licensing agreements, accurately describing the evaluation of whether an IP license is distinct, which determines whether it is part of a single or multiple performance obligations. The distinction between combined arrangements (requiring evaluation) versus standalone licenses (recognized at a point in time) is correctly explained. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable in that sense; however, the years 2022, 2023, and 2024 are correctly referenced and aligned with the evolution (or lack thereof) in policy. (3) The multi-hop reasoning is sound: the model synthesizes information across three years and correctly concludes that the policy remained consistent, with no material changes, including the treatment of variable consideration (explicitly stated as absent in all years). (4) The answer is contextually relevant, directly addressing the evolution (or stability) of the policy, performance obligations, and the distinction between arrangement types. Minor wording differences (e.g., 're-states' vs 'reiterated') do not affect meaning. All key elements from the original answer are preserved and accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 399,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "What does the consistent reference to the Certificate of Designations of Series B Convertible Participating Preferred Stock across Visa's 2022, 2023, and 2024 filings suggest about the stability and ongoing relevance of this instrument in Visa's capital structure?",
      "original_answer": "The Certificate of Designations of Series B Convertible Participating Preferred Stock is consistently listed in Visa's filings for 2022 (Exhibit 4.5), 2023 (Exhibit 4.4), and 2024 (Exhibit 4.4), always referencing the same filing date of June 21, 2016. This indicates that the Series B instrument has remained a static but integral component of Visa’s capital structure over the three-year period, with no modifications required or implemented. The consistent citation of the same exhibit number and filing date across all three years suggests that Visa has maintained the same terms and conditions for this preferred stock, signaling long-term strategic stability in its capital governance framework despite evolving market conditions.",
      "llm_answer": "\nThe repeated appearance of **Exhibit 4.4 – “Certificate of Designations of Series B Convertible Participating Preferred Stock”** in Visa’s 2022, 2023 and 2024 filings (Chunk 1, 2 and 3) demonstrates that this governing document has been consistently disclosed and retained across all recent annual and quarterly reports.  In the knowledge‑graph pattern, Visa (ORG) continuously **introduces** the same FIN_INST (the Series B certificate) and the instrument again **introduces** Visa, underscoring that the rights, preferences and obligations tied to this series remain a stable, ongoing component of Visa’s capital structure rather than a transient or retired financing tool.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the consistent presence of the Certificate of Designations of Series B Convertible Participating Preferred Stock in Visa's 2022, 2023, and 2024 filings and interprets this as evidence of stability in Visa’s capital structure, which aligns with the ground truth. However, there is a critical factual inaccuracy in the exhibit numbers: the LLM claims Exhibit 4.4 appears in all three years, but the ground truth states that in 2022 it was listed as Exhibit 4.5, and only in 2023 and 2024 as Exhibit 4.4. This affects quantitative accuracy, as exhibit numbers are key identifiers in SEC filings and their incorrect reporting undermines precision. Additionally, the LLM fails to mention the June 21, 2016 filing date, a crucial detail indicating the instrument has remained unchanged for years, which supports the conclusion about long-term stability. While the reasoning about ongoing relevance and structural stability is sound and contextually appropriate (hence high qualitative and contextual scores), the omission of the original filing date and incorrect exhibit number in 2022 weakens the factual foundation. The multi-hop synthesis across years is partially correct but lacks full fidelity to the source data. Semantic equivalence is mostly preserved in intent, but not in specific factual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 370,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did RTX's stake and economic exposure in the International Aero Engines AG (IAE) collaboration evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about Pratt & Whitney's strategic positioning in the V2500 engine program?",
      "original_answer": "RTX's subsidiary Pratt & Whitney maintained a consistent 61% program share interest and 49.5% ownership interest in IAE across all three years (2022–2024), while its net program share interest after sub-collaborator participation remained stable at 57% throughout the period. This consistency in stake and economic exposure suggests that RTX did not alter its strategic positioning or risk profile in the V2500 engine program during this time, despite ongoing industry shifts and the emergence of newer engine technologies.",
      "llm_answer": "\nRTX’s stake in the International Aero Engines AG (IAE) collaboration was steady from 2022‑2024 – a 61 % program‑share interest and a 49.5 % equity ownership in IAE, plus a 59 % program‑share and 59 % ownership interest in the IAE LLC joint venture; after accounting for sub‑collaborator allocations, RTX’s net program‑share interest remained 57 % in IAE and 51 % in IAE LLC each year.  Because RTX is the primary beneficiary of these variable‑interest entities and therefore consolidates IAE and IAE LLC, it captures the bulk of the V2500 (and related) engine economics, underscoring a consistent, controlling strategic position in the V2500 program across the three fiscal years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies RTX's 61% program-share interest and 49.5% ownership in IAE as stable across 2022–2024, aligning with the ground truth. However, it introduces new entities and figures not present in the original answer—specifically, a 59% program-share and 59% ownership in 'IAE LLC' and net program-share interests of 57% in IAE and 51% in IAE LLC. The ground truth only references IAE (not IAE LLC) and a single net program-share interest of 57% after sub-collaborator participation. These additional details are unverified and contradict the simplicity and consistency of the original data. (2) The quantitative inaccuracies stem from the inclusion of IAE LLC and associated percentages (59%, 51%), which are not supported by the ground truth. While the 61%, 49.5%, and 57% figures for IAE are correct, the introduction of a second joint venture distorts the financial and structural picture. There is no evidence in the original answer of a dual-structure involving IAE and IAE LLC with differing stakes. (3) The multi-hop reasoning is partially sound—RTX’s consistent stake and economic exposure are correctly interpreted as indicating stable strategic positioning. The conclusion about RTX being the primary beneficiary and consolidating variable-interest entities adds context not in the original but is plausible from a financial reporting standpoint. However, the reasoning is based on an incorrect structural assumption (existence of IAE LLC with separate stakes), undermining the validity of the synthesis. (4) The answer is contextually relevant and addresses the evolution of RTX's stake and what it implies strategically. The core message of stability is correct, but the factual foundation is compromised by unsupported quantitative details. Hence, correctness is reduced to 6 due to significant but not fundamental errors—key facts are right, but the model overcomplicated the structure with unverified entities and percentages.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 533,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Medtronic's use of the Non-Employee Director Deferred Unit Award Agreement evolve across fiscal years 2022, 2023, and 2024, and what does this pattern suggest about the company's long-term director compensation strategy?",
      "original_answer": "Medtronic consistently referenced the Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan across all three years—2022, 2023, and 2024—indicating a stable and enduring approach to non-employee director compensation. In 2022 (Exhibit 10.41), the agreement was explicitly tied to the 2008 plan, and this same form of agreement was carried forward and referenced again in 2023 (Exhibit 10.52) and 2024 (Exhibit 10.52). Despite broader updates and amendments to other award agreements under the 2013 plan over this period, the deferred unit award for non-employee directors remained unchanged in structure and plan origin, suggesting that Medtronic maintained a consistent long-term incentive strategy for board members without transitioning them to newer plan versions.",
      "llm_answer": "\nIn its 2022 Form 10‑K (page 115), 2023 Form 10‑K (page 114) and 2024 Form 10‑K (page 114), Medtronic each reproduces the identical “Form of Non‑Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan” (Exhibit 10.52), showing that the same deferred‑unit arrangement has been retained across all three fiscal years.  This consistent citation reflects a deliberate, long‑term director‑compensation strategy that uses deferred equity units to align board interests with shareholders, with no substantive change observed between 2022, 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies that Medtronic used the same 'Form of Non-Employee Director Deferred Unit Award Agreement under the 2008 Stock Award and Incentive Plan' across fiscal years 2022, 2023, and 2024, citing Exhibit 10.52 in all three years. This aligns with the ground truth, which notes the agreement was carried forward from 2022 (originally Exhibit 10.41) and then referenced as Exhibit 10.52 in 2023 and 2024. The minor discrepancy is that in 2022, the agreement was listed as Exhibit 10.41, not 10.52—so the LLM incorrectly states it was Exhibit 10.52 in 2022. However, the substance—that the same form was used—is correct. (2) Quantitative accuracy is strong: fiscal years (2022–2024), exhibit numbers (with the noted exception), and plan name (2008 Stock Award and Incentive Plan) are accurate. (3) The reasoning is sound: the model correctly infers that the unchanged use of the agreement suggests a stable, long-term director compensation strategy focused on alignment with shareholders via deferred equity. It captures the multi-hop insight that despite updates to other plans (e.g., 2013 plan), this particular agreement remained static. (4) Contextual relevance is excellent—the response directly addresses the evolution (or lack thereof) and interprets the strategic implication. The only deduction is for the exhibit number inaccuracy in 2022, which slightly affects qualitative accuracy but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 424,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the progression in the notional amounts of these swaps reveal about the company's interest rate risk management strategy over time?",
      "original_answer": "LMT's use of variable interest rate swaps increased significantly from 2022 to 2024. In 2022, the notional amount of interest rate swaps was $500 million, rising to $1.3 billion by 2023, and remaining at $1.3 billion in 2024. This tripling of exposure indicates a strategic shift toward more active interest rate risk management, particularly in hedging fixed-rate borrowings against potential rate fluctuations. The consistency in the notional amount from 2023 to 2024 suggests that LMT stabilized its hedging position after the initial increase, likely reflecting a recalibrated and matured risk management approach.",
      "llm_answer": "\nLMT’s variable‑interest‑rate swaps remained at a **$1.3 billion notional** in 2022 (Chunk 1), stayed at the same $1.3 billion level in 2023 (Chunk 1) and again in 2024 (Chunk 2).  This continuity follows an earlier expansion from **$500 million in 2020 to $572 million in 2021** (Chunk 3), after which the company settled on the $1.3 billion size and has kept it steady through 2024.  The consistent notional—used to convert fixed‑rate borrowings into variable‑rate exposure (fair‑value hedges)—shows that LMT has reached a mature, calibrated interest‑rate‑risk management stance, maintaining a hedge level that adequately covers its fixed‑rate debt without further scaling.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative timeline. According to the ground truth, LMT's notional amount was $500 million in 2022, increased to $1.3 billion in 2023, and remained there in 2024. However, the LLM claims the notional was already $1.3 billion in 2022 and remained flat thereafter, which contradicts the documented progression. Additionally, the LLM introduces data from 2020 ($500 million) and 2021 ($572 million), which are not part of the original question or ground truth and appear irrelevant to the 2022–2024 scope. (2) The core calculation error is the misrepresentation of the 2022 value: stating $1.3 billion instead of $500 million invalidates the trend analysis. The tripling of exposure from 2022 to 2023—a key insight in the original answer—is completely missed. While the $1.3 billion figures for 2023 and 2024 are correct, the incorrect 2022 value undermines the entire temporal analysis. (3) The multi-hop reasoning is partially sound in interpreting the stabilization from 2023 to 2024 as a sign of mature risk management, which aligns with the original answer. However, because the model fails to recognize the significant increase between 2022 and 2023, it mischaracterizes the evolution as a period of stability rather than strategic expansion followed by stabilization. The synthesis across years is flawed due to incorrect input data. (4) Despite the factual errors, the answer remains contextually relevant by addressing interest rate swaps, notional amounts, hedging strategy, and risk management evolution. The explanation of the purpose of fair-value hedges is accurate and adds useful context. However, the quantitative inaccuracies severely limit correctness, warranting a low score on factual precision, though not zero due to partial alignment on 2023–2024 values and conceptual reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses for Hedging]-> FIN_INST <-[Depends_On]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 509,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this 3-year consistency suggest about the company's strategic posture toward takeover defenses?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently disclosed that stockholders may only remove directors for cause, as part of a broader set of anti-takeover provisions in its certificate of incorporation and by-laws. This provision remained unchanged over the three-year period, indicating a stable and deliberate governance strategy aimed at insulating the board from activist pressures and hostile takeovers. The persistence of this language, alongside other consistent provisions such as staggered board terms and supermajority voting requirements, suggests AbbVie's board and management intend to maintain strong control over corporate governance and strategic direction.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings (Chunks 1, 2 & 3), AbbVie repeatedly states that its amended and restated certificate of incorporation allows directors to be removed **only for cause**—a provision that is explicitly listed among its anti‑takeover measures each year.  \n\nBecause this “removal for cause” language appears verbatim in all three annual reports, the company has kept the rule unchanged for three consecutive years, underscoring a deliberate, stable governance strategy that preserves board cohesion and reinforces other defensive clauses (staggered board, special‑meeting ban, 80 % amendment threshold, Section 203) to deter hostile takeovers. This consistency signals that AbbVie’s strategic posture toward takeover defenses is to maintain a robust, unvarying shield against attempts to replace incumbent directors.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that AbbVie maintained the 'removal for cause only' provision in its governance documents across 2022, 2023, and 2024, with no changes—matching the original answer's claim of 3-year consistency. (2) There are no numerical values requiring calculation, but the years (2022–2024) and references to Form 10-K filings are correct and properly contextualized. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual filings, recognizes the repetition of identical language as evidence of policy stability, and correctly infers that this reflects a strategic, deliberate posture toward takeover defenses. It also appropriately links the director removal rule to other anti-takeover provisions (e.g., staggered board, supermajority amendment threshold, Section 203), which are consistent with the knowledge graph's understanding of AbbVie’s governance framework. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of the provision and the strategic implication of its consistency. Wording differs slightly but conveys the same meaning with equal or greater specificity (e.g., citing '80% amendment threshold' adds precision). No factual errors, omissions, or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 380,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve from 2022 to 2024, and what does this trend suggest about the company's short-term liquidity strategy amid fluctuating cash balances?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits increased from $12 million in 2022 to $21 million in 2023, then decreased to $10 million in 2024. This pattern reflects a short-term liquidity strategy that initially favored slightly higher placement in low-risk instruments before retreating, even as overall cash and equivalents fluctuated significantly—from $8,449 million in 2022 to $9,201 million in 2023 and then dropping to $5,524 million in 2024. The changes suggest a dynamic approach to liquidity management, adjusting exposure to money market funds in response to broader financial conditions.",
      "llm_answer": "\nAbbVie’s short‑term liquidity mix shows a clear swing: the company held $12 million of money‑market funds and time deposits in 2022 (as disclosed in the 2022 10‑K), raised that position to $21 million in 2023 (Chunk 2), then trimmed it back to $10 million by 2024 (Chunk 3), even as cash and equivalents fell sharply from $8.4 billion to $5.5 billion over the same period (Chunks 1‑3). This pattern indicates that AbbVie has been dynamically adjusting its cash‑equivalent allocation—leaning into higher‑yielding money‑market and time‑deposit instruments when cash balances were abundant, and scaling back as cash tightened—reflecting a flexible short‑term liquidity strategy that balances liquidity needs with opportunistic investment of excess funds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key figures: $12 million in 2022, $21 million in 2023, and $10 million in 2024 for money market funds and time deposits. It also accurately reflects the overall cash and equivalents trend—$8,449 million (rounded to $8.4 billion) in 2022, $9,201 million in 2023, and $5,524 million (rounded to $5.5 billion) in 2024. These values match the ground truth exactly or with acceptable rounding. (2) All numeric values are correct; minor rounding ($8,449M to $8.4B and $5,524M to $5.5B) is reasonable and common in financial communication. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and connects the allocation changes to broader cash balance trends. It infers a dynamic, flexible liquidity strategy, which aligns with the ground truth’s conclusion about a 'dynamic approach to liquidity management.' (4) The only minor shortcoming is that the LLM slightly overemphasizes 'higher-yielding' instruments without explicit confirmation from the source data that these allocations were yield-driven—this nuance is implied but not stated in the ground truth, slightly reducing qualitative accuracy. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 373,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve from 2022 through 2024, and what does this consistency suggest about the company's long-term strategy to deter hostile takeovers?",
      "original_answer": "AbbVie consistently maintained a provision across all three years (2022, 2023, and 2024) stating that stockholders may only remove directors for cause, as part of a broader set of governance mechanisms designed to deter hostile takeovers. This provision remained unchanged in each year's 10-K filing, indicating a deliberate and sustained effort to insulate the board from abrupt changes and maintain strategic continuity. The repeated emphasis on this governance structure suggests that AbbVie views director removal restrictions as a core component of its anti-takeover defense, reinforcing board stability and discouraging activist interventions.",
      "llm_answer": "\nAbbVie’s 10‑K filings for 2022, 2023 and 2024 each retain the same “stockholders may only remove directors for cause” provision (along with the staggered‑board, super‑majority amendment rules and Section 203‑style takeover defenses), indicating that the company has not altered or weakened this governance rule over the three‑year period. This steady retention of cause‑removal and related board‑stability measures reflects a deliberate, long‑term strategy to discourage hostile takeovers by making it difficult for an acquirer to replace incumbent directors and thereby preserving AbbVie’s defensive charter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that AbbVie's 10-K filings for 2022, 2023, and 2024 consistently included the provision that directors may only be removed for cause, which matches the original answer's claim of no changes across the three years. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly cited, and the description of governance provisions is precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes the consistency of the provision over time and links it to broader anti-takeover strategies, including references to staggered boards, supermajority amendment rules, and Section 203-style defenses—elements consistent with the type of governance framework described in the ground truth. While the original answer does not explicitly name 'staggered board' or 'Section 203-style' provisions, these are reasonable inferences given the context and do not contradict the source. (4) The semantic meaning fully captures the intent and facts of the original answer: the stability of the director removal rule reflects a long-term strategy to deter hostile takeovers and maintain board continuity. The only minor limitation is that the LLM adds slightly more detail on specific mechanisms not explicitly confirmed in the ground truth, but these are plausible and contextually appropriate. Thus, the answer is highly accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 408,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's positioning and technical roadmap for PowerVia evolve from 2022 through 2024, and what does this progression indicate about the company's strategy for backside power delivery in advanced process nodes?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technologies, signaling early development and strategic intent. By 2023, Intel positioned PowerVia as a key breakthrough technology to be introduced with Intel 20A, emphasizing its role in optimizing signal transmission by eliminating front-side power routing. In 2024, Intel shifted focus, integrating PowerVia specifically into the Intel 18A process node, which was now slated for high-volume manufacturing in 2025. This evolution shows a strategic pivot from initial introduction to realignment within a more refined roadmap, reflecting Intel's prioritization of practical implementation and external foundry offerings.",
      "llm_answer": "\nIntel first positioned PowerVia as the industry‑first backside‑power delivery mechanism in its 2021‑2022 roadmap (Chunk 1), highlighting it alongside RibbonFET as a key breakthrough for the upcoming Intel 20A node and linking the technology to the company’s broader product portfolio (KG triplet INTC → PowerVia → PowerVia).  By 2023‑2024 the focus shifted to Intel 18A, the first high‑volume commercial process that integrates PowerVia with gate‑all‑around RibbonFET, promising an additional ~10 % performance‑per‑watt gain and targeting high‑volume production of Panther Lake in 2025, while the earlier Intel 20A effort was cancelled in favor of this more advanced node (Chunk 2 & Chunk 3).  This evolution demonstrates Intel’s strategy of making backside power delivery a central differentiator for its leading‑edge nodes, leveraging PowerVia to boost density and efficiency and extending the capability to external foundry customers through its IFS business to sustain process‑technology leadership through 2025 (Chunk 1‑3 and the ORG‑→‑PRODUCT‑→‑ORG KG relationships).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Intel's introduction of PowerVia in 2022 as part of its roadmap, its initial association with Intel 20A, and the 2024 shift to Intel 18A for high-volume manufacturing in 2025. The claim that Intel 20A was 'cancelled in favor' of Intel 18A is slightly stronger than the original answer, which only states that PowerVia was realigned to 18A, but this is a reasonable interpretation given the strategic pivot. (2) Quantitatively, the ~10% performance-per-watt gain is not present in the original answer, but since it is not contradicted and comes from plausible technical context, it does not constitute a factual error—however, its inclusion without grounding in the provided truth reduces quantitative accuracy slightly. All dates (2022, 2023–2024, 2025) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes PowerVia’s evolution across years, nodes (20A to 18A), and strategic implications including IFS and external foundry offerings. It correctly links PowerVia with RibbonFET and explains the technical benefit (eliminating front-side power routing, improving efficiency). (4) The answer is contextually excellent, addressing all parts of the question: evolution from 2022–2024 and strategic implications. The only minor deviation is the unverified 10% figure and slightly stronger wording on Intel 20A cancellation, but overall the semantic meaning and factual core match the ground truth. Hence, a 9 is justified—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 428,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's assumptions for expected volatility in its Black-Scholes model evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's approach to valuing non-qualified stock options?",
      "original_answer": "In 2022, MDT based expected volatility solely on historical volatility of its ordinary shares without incorporating implied volatility. By 2023, the company began using a blend of historical and implied volatility derived from market-traded options, signaling a more market-sensitive approach. This blended methodology was maintained in 2024, with explicit mention of reliance on market-traded options for implied volatility. The evolution from purely historical to a hybrid model suggests MDT sought to align its option valuations more closely with real-time market expectations over the three-year period.",
      "llm_answer": "\nMDT’s expected‑volatility assumption has been defined in each of the 2022, 2023 and 2024 10‑K filings as a blend of the company’s historical stock‑price volatility and the implied volatility of its ordinary shares, the latter derived from market‑traded options.  The identical wording across the three years shows that MDT has kept this market‑referenced, blended‑volatility approach unchanged, indicating a deliberate, consistent methodology for valuing its non‑qualified stock options.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. According to the ground truth, MDT used only historical volatility in 2022, but began using a blend of historical and implied volatility in 2023 and continued it in 2024. The LLM incorrectly states that the blended approach was used in all three years, citing 'identical wording'—this contradicts the documented evolution. This misrepresents the multi-year progression entirely. The answer fails on quantitative and qualitative accuracy because it misstates the methodology for 2022, which is a critical part of the trend. While the mention of market-traded options in later years aligns with the truth, the failure to recognize the shift from pure historical to blended volatility undermines the reasoning. The conclusion about 'consistent methodology' is therefore false—the actual significance is the move toward market sensitivity, which the LLM overlooks. Contextual relevance is moderate because it discusses the right topic (volatility assumptions in Black-Scholes) and the right company and time frame, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 310,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its future process and packaging technology roadmap under the Intel 20A node, positioning it as an industry-first backside power delivery solution designed to optimize signal transmission. By 2023, Intel reiterated its commitment to PowerVia as a key component of Intel 20A, emphasizing its integration with RibbonFET to deliver up to a 15% performance-per-watt improvement over Intel 3. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core innovation, and announced plans to begin high-volume manufacturing of Panther Lake, its first processors on Intel 18A, in 2025. This evolution indicates that while the specific node name changed, PowerVia remained central to Intel's strategy for achieving performance gains in advanced logic chips.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved PowerVia from a roadmap concept (first introduced in the 2021 process‑technology update that outlined Intel 20A, RibbonFET and PowerVia) to the centerpiece of its next‑generation node, Intel 18A, after canceling the originally‑planned Intel 20A production (Chunk 1 + Chunk 3).  The company leveraged heavy R&D and IDM 2.0 investments to embed PowerVia—its industry‑first backside‑power delivery—into the Intel 18A process, which will enter high‑volume manufacturing in 2025 and is projected to deliver ~15 % performance‑per‑watt gains over Intel 3 while also supporting external foundry customers (Chunk 2).  This evolution shows PowerVia becoming a strategic pillar of Intel’s advanced‑node roadmap, driving both internal product leadership and the growth of its foundry (IFS) business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in framing. (1) All key facts are correct: PowerVia was introduced as part of Intel 20A, remained central after the shift to Intel 18A, delivers ~15% performance-per-watt improvement over Intel 3, and is set for high-volume manufacturing in 2025 with Panther Lake. The cancellation of Intel 20A productization (rephrased as 'canceling the originally-planned Intel 20A production') is correctly noted. (2) Quantitative accuracy is perfect: the ~15% performance-per-watt gain is correctly cited, and all dates (2022–2024 evolution, 2025 HVM) align with the original answer. Format variations like '~15%' vs 'up to 15%' are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes the transition from Intel 20A to 18A, retention of PowerVia, and implications for Intel's roadmap and foundry business (IFS), which is a valid inference supported by context. (4) The only minor shortcoming is that the original answer explicitly names Panther Lake as the first processor on Intel 18A, while the LLM mentions it but doesn't emphasize it as clearly—though it is present ('Panther Lake... in 2025'). Additionally, the LLM references a '2021 process-technology update', which slightly predates the 2022 timeframe in the question, but this is a minor contextual addition rather than an error. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 414,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did the assumptions used in the Black-Scholes model for valuing non-qualified stock options at MDT evolve from 2022 to 2024, and what does this progression suggest about the company's approach to estimating volatility and employee exercise behavior over time?",
      "original_answer": "In 2022, MDT used the Black-Scholes model for valuing non-qualified stock options, requiring assumptions about employee exercise behavior, risk-free interest rates, stock price volatility, and expected dividends. By 2023, the company began incorporating implied volatility based on market-traded options into its volatility assumptions, in addition to historical volatility. This method was retained in 2024, indicating a more sophisticated and market-informed approach to volatility estimation. The consistent use of the Black-Scholes model across all three years shows strategic continuity, while the addition of implied volatility in 2023 and 2024 suggests a shift toward aligning internal assumptions more closely with external market signals, reflecting increased confidence in market-based data for risk assessment.",
      "llm_answer": "\nIn 2022 MDT merely noted that the Black‑Scholes model requires assumptions about employee exercise behavior, risk‑free rates, volatility and dividends, without specifying how volatility is derived. By 2023 the filing refined this to state that expected volatility is a blend of historical volatility and implied volatility from market‑traded options, signaling a move toward a market‑based volatility estimate while still relying on assumptions about exercise behavior. The 2024 filing repeats this methodology, showing that MDT’s approach has stabilized around a market‑informed volatility calculation and consistent exercise‑behavior assumptions over the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that in 2022, MDT acknowledged the need for assumptions in the Black-Scholes model without specifying the source of volatility. It accurately notes the shift in 2023 to using a blend of historical and implied volatility from market-traded options, and confirms this approach was maintained in 2024. These points match the original answer exactly in substance. The only minor shortcoming is that the LLM answer does not explicitly state the broader implication mentioned in the ground truth—namely, that this evolution reflects 'increased confidence in market-based data for risk assessment' or a strategic alignment with external market signals. While the trend is described, the interpretive conclusion about MDT's growing reliance on market-informed data is slightly less emphasized, though implied. All entities (MDT, Black-Scholes model, non-qualified stock options), years (2022–2024), and financial concepts (implied volatility, historical volatility, employee exercise behavior) are correct and properly contextualized. There are no numerical inaccuracies (the question is qualitative, so dates and methodological descriptions are the key data points). The reasoning is sound, demonstrating multi-hop synthesis across three years of evolving disclosures. The answer is semantically equivalent to the original, with only slight nuance missing in the final interpretation. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Holds]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 439,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This declining trend indicates a strategic reduction in derivative-related exposure or an active management of margin requirements, potentially reflecting lower volatility in commodity markets or a shift in hedging strategies over the three-year period.",
      "llm_answer": "\nAccording to the 2022, 2023 and 2024 Form 10‑K filings, the collateral posted under master‑netting arrangements—reported within “Other assets, including intangibles – net”—was $1,494 million at the end of 2022, fell to $800 million in 2023 and to $491 million in 2024, a decline of roughly $1.0 billion over the two‑year span. This downward trend shows that ExxonMobil is reducing the amount of external collateral it must hold to support its derivative positions, indicating tighter management of derivative exposure and a greater reliance on offsetting contracts rather than additional security.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly. The statement that this represents a decline of 'roughly $1.0 billion' is accurate (actual decline is $1,003 million), so minor rounding is acceptable. 2) Quantitative accuracy is perfect—values, years, and the implied two-year trend are all correct. The calculation of the total drop is approximately correct and reasonably phrased as 'roughly $1.0 billion'. 3) The reasoning is sound and aligns with the ground truth: the downward trend is correctly interpreted as reduced collateral, indicating tighter management of derivative exposure. The LLM adds a plausible interpretation—'greater reliance on offsetting contracts rather than additional security'—which is consistent with, though not explicitly stated in, the original answer. The original emphasizes 'lower volatility' or 'shift in hedging strategies', while the LLM focuses on operational hedging efficiency. This is a valid inference, not a factual error. 4) The answer is fully contextually relevant, addressing both parts of the question: the change over time and its implication for derivative exposure management. The only minor gap is that the LLM does not explicitly mention 'master netting arrangements' in the interpretation (though it does in the data summary), but it does reference 'offsetting contracts', which relates directly. Overall, the answer is factually complete, numerically precise, and logically sound—just slightly less comprehensive in explanatory nuance than the original, warranting a 9 instead of 10 on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 456,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did NextEra Energy's exposure to Options - primarily gas evolve from 2022 through 2024 in terms of fair value and volatility assumptions, and what does this reveal about the company's risk positioning in gas derivatives?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of 'Options - primarily gas' decreased from $356 million in assets and $347 million in liabilities to $100 million in assets and $97 million in liabilities by 2023, and further to $100 million in assets and $102 million in liabilities by 2024. The implied volatility for these options also declined from a weighted average of 36% in 2022 to 50% in 2023 and 52% in 2024, indicating a reduction in perceived market volatility and risk over the three-year period.",
      "llm_answer": "\nNextEra Energy’s “Options – Primarily Gas” position shows a clear evolution in both fair‑value magnitude and volatility assumptions: in the 2021‑2022 reporting (Chunk 3) the instrument was valued at roughly **$356 million (asset) / $347 million (liability)** with implied volatilities spanning **17 %–295 %** (weighted‑average ≈ 36 %); by the end of 2023 (Chunk 1) the fair‑value had contracted to **$100 million (asset) / $97 million (liability)** and volatilities rose to a weighted‑average of **≈ 50 %** (range 20 %–233 %); and in the 2024 filing (Chunk 2) the exposure flipped to **$100 million (asset) / $102 million (liability)** while volatilities held steady near **≈ 52 %** (range 15 %–150 %) and implied correlations climbed to about **99 %**.  \n\nThis progression—from a sizable net‑asset stance in 2021, to a modest net‑neutral position by 2024, accompanied by only modestly higher volatility and markedly higher correlation assumptions—reveals that NEE is deliberately scaling back its directional gas‑price risk and shifting toward a more hedged, risk‑balanced posture in its gas‑derivative book.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in direction and structure but contains key quantitative inaccuracies. The fair value figures for 2022 ($356M asset / $347M liability), 2023 ($100M / $97M), and 2024 ($100M / $102M) match the ground truth and are accurate. However, the volatility figures are misrepresented: the ground truth states implied volatility decreased from 36% in 2022 to 50% in 2023 and 52% in 2024, but the LLM incorrectly claims volatility 'rose' and implies an increase from 36% to 50% to 52%, which contradicts the 'declined' direction in the original answer. This is a critical error because the trend (decreasing vs increasing volatility) affects the interpretation of risk positioning. Additionally, the LLM introduces volatility ranges (e.g., 17%–295%) and a correlation figure (99%) not present in the ground truth, which adds unsupported detail.\n\n2) Number verification: Fair values are correct across years. However, the volatility trend is factually wrong — the original answer says 'declined from 36% to 50% to 52%', which is logically inconsistent (50% and 52% are increases from 36%), suggesting a possible error in the ground truth or LLM interpretation. But per the ground truth as given, the LLM reports rising volatility, which aligns numerically with 36% → 50% → 52%, but contradicts the word 'declined'. The LLM likely trusted the numbers over the narrative, leading to a plausible but incorrect inference. This ambiguity reduces confidence but does not fully invalidate the LLM's number reporting.\n\n3) Multi-hop reasoning is sound: the LLM correctly synthesizes data across three years, identifies the shift from net asset to net neutral, and draws a reasonable conclusion about risk positioning. The interpretation that NEE is reducing directional risk is consistent with the shrinking net exposure, even if the volatility interpretation is flawed.\n\n4) Scores justified: Correctness is 7 due to accurate fair values and correct directional exposure trend but incorrect volatility trend interpretation and added unsupported details (ranges, correlations). Quantitative accuracy is 6 because while dollar amounts are correct, the volatility percentages — though numerically matching — are framed with incorrect directional language and extra unverified ranges. Qualitative accuracy is 8 due to strong synthesis and logical reasoning despite the volatility misstatement. Contextual relevance is 10 — the answer directly addresses all parts of the question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 665,
        "total_tokens": 2089
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, particularly in terms of face amount and annual debt service, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000 and annual debt service of $19,875 for Unsecured Notes - 35A. In 2023, these figures remained unchanged, indicating no new issuances or repayments during the year. By 2024, the face amount and annual debt service for Unsecured Notes - 35A were still consistent at $750,000 and $19,875, respectively. This stability over the three-year period suggests that SPG maintained a consistent long-term debt structure for this instrument, likely prioritizing predictability in its debt servicing obligations.",
      "llm_answer": "\nAcross the three fiscal years the data show that **Unsecured Notes‑35A retained the same structural terms**: the face amount was consistently reported as **$750 million** (shown as $750,000 in the “Dollars‑in‑thousands” tables) and the annual debt‑service charge remained **$19.875 million** (shown as $19,875) in 2022 (Chunk 1), 2023 (Chunk 3) and 2024 (Chunk 2).  \n\nThis stability reflects SPG’s **long‑term debt strategy of anchoring its capital structure to a low‑coupon, 30‑year fixed‑rate note (maturing 07/15/30) while it selectively adds newer, longer‑dated issuances (e.g., 38B, 39A‑B, 40A‑B) and adjusts overall unsecured indebtedness**. The unchanged 35A tranche provides a predictable, low‑cost financing pillar that supports the company’s growth and joint‑venture investments without requiring refinancing or materially altering debt‑service obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the face amount ($750,000 in thousands = $750 million) and annual debt service ($19,875 in thousands = $19.875 million) for Unsecured Notes - 35A across 2022, 2023, and 2024, matching the ground truth exactly in both values and trend (no change). These figures are accurately interpreted from 'Dollars in thousands' formatting, which is a valid and common practice in SEC filings.\n\n2) Quantitatively, all numbers are correct. The face amount and annual debt service are consistent year-over-year as stated in the original answer. The LLM correctly converts table values (in thousands) to full dollar amounts with proper units (million), which is semantically equivalent and improves readability.\n\n3) The multi-hop reasoning is sound: the model synthesizes data from three different years (2022, 2023, 2024) and correctly infers stability in the debt instrument. It goes beyond the ground truth by adding context about SPG’s broader debt strategy—mentioning the 30-year fixed-rate note maturing 07/15/30 and newer issuances (e.g., 38B, 39A-B, 40A-B)—which, while not in the original answer, is plausible and consistent with typical corporate debt management strategies. This additional insight enhances the qualitative analysis without contradicting facts.\n\n4) The only reason for not scoring a 10 is that the original answer does not mention the maturity date (07/15/30) or other note series (38B, etc.), so including them introduces external inference. However, since these details do not contradict the ground truth and support a reasonable interpretation of SPG’s long-term strategy, they do not constitute factual errors. The core facts are fully aligned, and the reasoning is logically sound. Hence, a 9 is justified for qualitative accuracy due to slight over-enrichment, but correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 500,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this 3-year progression indicate about the company's long-term positioning in the semiconductor industry?",
      "original_answer": "From 2022 to 2024, Texas Instruments (TXN) consistently emphasized embedded processing products as a core pillar of its business model, highlighting them in each year's 10-K filing as central to its four sustainable competitive advantages. In 2022, embedded processing was described as a key part of the company's broad product portfolio, offering more opportunity per customer and greater value on investments. This focus remained unchanged in 2023, with the same language used to describe the competitive advantage derived from embedded processing products. By 2024, the company continued to reinforce this strategic direction, maintaining that embedded processing contributes to its unique positioning in the semiconductor market by supporting customer diversity, channel reach, and long-term investment returns. The consistent emphasis across all three years indicates a stable, long-term strategy centered on embedded processing as a foundational element for generating free cash flow and maintaining competitive differentiation.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments repeatedly framed its growth strategy around **analog and embedded‑processing products**, consistently citing the same four sustainable competitive advantages—manufacturing strength, broad portfolio, market reach, and product diversity—that anchor its focus on embedded processing. The 2023 and 2024 MD&A sections reaffirm this emphasis, showing a deliberate reinforcement of investments in capacity and technology rather than a shift, underscoring a long‑term view that embedded processing is a core, cash‑generating pillar of TI’s semiconductor strategy. This continuity—captured in the KG relationship where **TXN ↔ Embedded Processing Products** is repeatedly highlighted—demonstrates TI’s sustained, strategic positioning of embedded processing as a foundational driver of its competitive advantage and free‑cash‑flow growth in the industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments (TXN) consistently emphasized embedded processing from 2022 to 2024 as part of its four sustainable competitive advantages, which include manufacturing strength, broad portfolio, market reach, and product diversity. The answer correctly identifies that this focus was reaffirmed in both 2023 and 2024, showing continuity rather than a shift. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of strategic emphasis, correctly inferring long-term positioning from consistent messaging in 10-K filings. It references the KG relationship 'TXN ↔ Embedded Processing Products' as evidence of repeated emphasis, which supports the conclusion of sustained strategic focus. (4) The LLM slightly broadens the framing by mentioning 'analog and embedded-processing products' together, which is factually accurate (TI emphasizes both), but the original answer focuses specifically on embedded processing. This addition does not distort the truth but adds context not emphasized in the ground truth. The core conclusion—that embedded processing is a foundational, long-term driver of competitive advantage and free cash flow—is semantically equivalent and well-supported. Minor deduction in qualitative accuracy due to slight reframing, but overall excellent fidelity to the source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 440,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CMCSA's strategy around shared data plans evolve from 2022 to 2024, particularly in terms of their positioning within bundled service offerings and the range of payment or plan options available to customers?",
      "original_answer": "From 2022 to 2024, CMCSA consistently offered shared data plans as part of its wireless service bundles for residential customers who subscribed to broadband services. In 2022, customers could choose from unlimited data plans, shared data plans, or per-gigabyte plans, with device financing options over 24 months. In 2023, the company maintained this structure, offering shared data plans alongside unlimited and per-gigabyte options, with similar device financing terms. By 2024, CMCSA expanded its domestic wireless offerings by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans. This evolution shows a strategic expansion in 2024 to include more flexible and prepaid options, while maintaining shared data plans as a core part of bundled offerings across all three years.",
      "llm_answer": "\nIn 2022 CMCSA began offering wireless services only as part of bundled broadband packages and provided shared‑data plans together with unlimited and per‑gigabyte options, allowing device purchases to be financed interest‑free for up to 24 months (Chunk 3). By 2023 the company retained this bundled‑service model—still selling shared‑data plans only with qualifying broadband subscriptions and continuing to offer financing up to 24 months (Chunk 1). In 2024 it evolved the strategy further by adding prepaid unlimited‑data plans under the NOW brand and extending financing to 24–48 months, while keeping shared‑data plans as a core component of the bundled offering (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA offered shared data plans as part of bundled broadband services from 2022 to 2024, alongside unlimited and per-gigabyte options, with device financing. In 2024, prepaid unlimited plans under the NOW brand were added. The LLM correctly identifies the continuity of shared data plans and the expansion in 2024. (2) Quantitative accuracy is perfect: '24 months' financing in 2022–2023 and the extension to '24–48 months' in 2024 are consistent with the source (though the original answer does not mention 48 months, this detail may come from an unprovided chunk and does not contradict the ground truth). All years and plan types (shared, unlimited, per-gigabyte, prepaid) are correctly cited. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly tracks the evolution of the strategy, emphasizing bundling, continuity, and expansion. The only minor discrepancy is the mention of 48-month financing in 2024, which is not in the original answer; however, since the original does not specify financing changes, this addition doesn't invalidate the response but introduces a detail not confirmed in the ground truth. (4) The answer is contextually relevant, directly addressing the evolution of shared data plans, their role in bundles, and changes in payment/plan options. The core message matches the original: shared data plans remained central, and 2024 brought expanded flexibility with NOW prepaid plans. Thus, the answer earns a 9 for correctness due to the unverified 48-month claim, but remains highly accurate overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 456,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent increase over the three-year period indicates a growing emphasis on stock buybacks as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nMastercard’s Class A Treasury Stock (the equity instrument disclosed by the company, as shown in the KG relationship ORG → FIN_INST ← ORG) fell from **$60.4 bn (2022)** – as reported in Chunk 1’s 2022 column – to **$51.4 bn (2023)**, a reduction of about **$9 bn**, and then surged to **$71.4 bn (2024)**, an increase of roughly **$20 bn** over the 2023 level (Chunk 2).  This pattern shows a deliberate pull‑back in share‑repurchase activity in 2023 followed by a renewed, aggressive buy‑back program in 2024, indicating that the firm is again allocating excess cash toward equity retirement to support per‑share earnings and return capital to shareholders.  The shift reflects a flexible capital‑allocation strategy that can scale repurchases up or down depending on cash‑flow conditions and market confidence.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for Mastercard's Class A Treasury Stock. According to the ground truth, the investment in treasury stock was $(36,658) million in 2022, $(60,429) million in 2023, and $(71,431) million in 2024—indicating a consistent increase in buybacks. However, the LLM incorrectly states that the value was $60.4 billion in 2022 and decreased to $51.4 billion in 2023 before rising to $71.4 billion in 2024. This misrepresents both the starting point and the trend, particularly the supposed decrease in 2023, which contradicts the ground truth of a continuous increase. The 2024 figure ($71.4 billion) is approximately correct (vs $71.431 billion), but the prior years are wrong. (2) Calculations are therefore also incorrect: the LLM claims a $9 billion reduction from 2022 to 2023, but in reality, there was an increase of about $23.8 billion. The 2023–2024 increase of ~$11 billion (actual: $71,431M - $60,429M = $11,002M) is misrepresented as $20 billion. (3) The multi-hop reasoning is partially sound in that the model attempts to interpret the trend in capital allocation, but because it is based on incorrect data, the conclusion about a 'pull-back in 2023' is invalid. The actual trend shows sustained and increasing buybacks, not a pause. (4) Despite the incorrect numbers, the LLM correctly identifies the relevance of treasury stock to capital allocation and shareholder returns, and the final interpretation about returning capital to shareholders aligns with the general logic—just not the specific strategy implied by the real data. Hence, contextual relevance is moderate, but quantitative and overall correctness scores are low due to fundamental factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 479,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 to 2024, and what does the pattern reveal about the company's service business trajectory during this period?",
      "original_answer": "General Dynamics' revenue from Repair and other services was $1,169 million in 2022, declined slightly to $1,132 million in 2023, and remained flat at $1,132 million in 2024. This represents a slight overall decline of about 3.2% from 2022 to 2024, suggesting a stagnation or potential contraction in the company's service business segment during this period.",
      "llm_answer": "\nGeneral Dynamics’ “Repair and other services” revenue was $1,169 million in 2022 (as shown in Chunk 2 and confirmed by Chunk 3), fell modestly to $1,132 million in 2023 (Chunk 2 and Chunk 3), and remained flat at $1,132 million in 2024 (Chunk 2). This pattern—peaking in 2022 and then flattening—reveals that the company’s service business has entered a plateau phase after a brief decline, suggesting maturity or stabilization rather than continued growth. The consistent disclosure of this product across all three 10‑K filings (Chunk 1, 2, 3) underscores that GD continues to report the same service line, but its growth trajectory has leveled off.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all revenue figures: $1,169 million in 2022, $1,132 million in 2023, and $1,132 million in 2024, matching the ground truth exactly. The statement that revenue declined slightly from 2022 to 2023 and remained flat in 2024 is accurate. (2) The quantitative accuracy is perfect—numbers, years, and trends are correct. The implied 3.2% decline (calculated as (1,169 - 1,132)/1,169 ≈ 3.17%) is consistent with the ground truth, though not explicitly stated in the LLM answer. (3) The reasoning is sound: the model correctly synthesizes data across multiple chunks (filings) and identifies the plateau in service revenue. The conclusion about 'maturity or stabilization' is a reasonable interpretation, though slightly more optimistic than the ground truth's 'stagnation or potential contraction.' This difference in tone does not make it factually incorrect but represents a nuanced divergence in qualitative framing. (4) All entities—General Dynamics, 'Repair and other services,' and the correct years—are accurately identified. The answer fully addresses both parts of the question: the revenue change and the business trajectory. Contextual relevance is excellent, with appropriate references to consistent reporting in 10-K filings. The only minor gap is the absence of the explicit percentage decline, but this does not detract significantly from the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 394,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did CVS's exposure to residential mortgage-backed securities evolve across 2022, 2023, and 2024, particularly in terms of fair value and unrealized losses, and what does this multi-year trajectory suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased significantly over the three-year period. In 2022, the company held RMBS with a fair value of $629 million, including $10 million in unrealized losses. By 2023, the fair value of RMBS dropped to $614 million, but unrealized losses increased to $60 million, indicating a deterioration in the portfolio's market value. In 2024, CVS's RMBS holdings were reduced further to $71 million, a sharp decline from prior years, suggesting a strategic reduction in exposure. This trajectory reveals a deliberate de-risking strategy, moving away from RMBS amid rising unrealized losses and potentially volatile market conditions.",
      "llm_answer": "\nIn 2022 CVS held residential mortgage‑backed securities with a recorded fair value of $721 million and $89 million of unrealized losses (Chunk 1), which declined slightly to $614 million in fair value by the end of 2023 while unrealized losses remained elevated at $60 million (Chunk 1); by 2024 the number of RMBS holdings increased from 51 to 71 and the overall debt‑securities portfolio grew to $3.5 billion in fair value (up from $3.2 billion) (Chunk 2), indicating that CVS deliberately expanded its exposure to this asset class, and the earlier rise in unrealized losses suggests a growing credit‑ and interest‑rate risk profile (Chunk 3).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, CVS's RMBS fair value was $629 million with $10 million in unrealized losses, but the LLM states $721 million and $89 million, which are both incorrect. The 2023 fair value of $614 million matches the ground truth, as does the $60 million in unrealized losses, so this part is accurate. However, the LLM incorrectly claims that RMBS holdings 'increased' in 2024 and that the debt securities portfolio grew, while the ground truth states RMBS exposure dropped sharply to $71 million in 2024, indicating a reduction, not expansion. The LLM also introduces irrelevant details like the number of holdings increasing from 51 to 71 and overall portfolio growth, which are not supported by the ground truth and contradict the de-risking narrative. (2) Quantitative accuracy fails on key 2022 figures and the 2024 trajectory. The $721M vs $629M and $89M vs $10M discrepancies are major. The 2024 value is entirely missing in the LLM answer, which instead discusses portfolio growth, directly contradicting the $71M figure. (3) Multi-hop reasoning is flawed: instead of identifying a de-risking trend due to rising unrealized losses and declining holdings, the LLM incorrectly infers increased exposure and rising risk, reversing the correct conclusion. The synthesis across years is invalid due to incorrect data and logic. (4) Contextual relevance is moderate because the answer addresses RMBS exposure over time and attempts to interpret risk, but the incorrect data and opposite conclusion severely undermine usefulness. The mention of credit- and interest-rate risk is plausible but misaligned with the actual strategy of de-risking. Overall, the answer is mostly incorrect with only one year's data accurate and a completely inverted interpretation of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 506,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Linde's contractual structure and pricing mechanisms for atmospheric gases evolve from 2022 to 2024, particularly in relation to on-site customer agreements and variable pricing components?",
      "original_answer": "From 2022 to 2024, Linde maintained a consistent focus on long-term on-site contracts for atmospheric gases, typically ranging from 10–20 years, with minimum purchase requirements and price escalation provisions. However, in 2023, the company explicitly noted that pricing in these contracts fluctuates with various price indices and that variable components of consideration are present but constrained. This clarification around variable pricing was not detailed in 2022. By 2024, the structure remained largely unchanged, but the documentation reinforced the application of the practical expedient for measuring progress toward performance obligations, aligning revenue recognition with invoicing rights. This 3-year progression reveals a growing emphasis on transparency in pricing mechanisms and contract performance under ASC 606, especially regarding how Linde manages revenue variability in long-term on-site contracts.",
      "llm_answer": "\nLinde’s on‑site atmospheric‑gas contracts remained long‑term total‑requirement agreements (typically 10‑20 years) that incorporate price‑escalation and index‑linked adjustments, with any variable pricing components treated as constrained under ASC 606. The 2023 filing adds that many of these plants also produce liquid products for the merchant market and are not dedicated to a single customer, while the 2024 filing clarifies that revenue is recognized over time as product is delivered and that the company uses a practical‑expedient to invoice when the right to payment arises. Across the 2022‑2024 disclosures the contractual structure—governed by ASC 606, with performance obligations satisfied at delivery and variable considerations constrained—has consistently relied on index‑based pricing and escalation provisions, even as the filings become more detailed about minimum purchase requirements and the ability to serve smaller‑volume customers through advanced air‑separation processes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Linde maintained long-term on-site contracts (10–20 years) from 2022 to 2024 with price escalation and index-linked pricing, variable consideration under ASC 606 is constrained, and the practical expedient for revenue recognition was emphasized in 2024. The clarification in 2023 about variable pricing and in 2024 about revenue recognition timing and invoicing rights is accurately reflected. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or financial metrics; timeframes (10–20 years) and years (2022–2024) are correctly cited. (3) Multi-hop reasoning is sound—information is synthesized across three years of disclosures, correctly identifying evolution in transparency and disclosure practices around pricing mechanisms and revenue recognition under ASC 606. The LLM correctly infers continuity in structure while noting increasing detail in disclosures. (4) The only minor gap is that the LLM mentions 'advanced air-separation processes' and serving 'smaller-volume customers,' which, while plausible, is not present in the original answer and slightly extends beyond the ground truth. However, this does not contradict it and adds context without introducing error. Overall, the answer is semantically equivalent, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 386,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did NextEra Energy's net exposure to forward gas contracts evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward gas contracts increased from $160 million in 2022 (assets of $191M - liabilities of $31M) to $300 million in 2023 (assets of $377M - liabilities of $77M), then declined slightly to $250 million in 2024 (assets of $296M - liabilities of $46M). This pattern shows a significant expansion in gas market participation in 2023 followed by a partial contraction in 2024, suggesting a strategic shift toward greater gas market exposure before reducing positions as market conditions evolved.",
      "llm_answer": "\nNextEra Energy’s net fair‑value exposure to forward gas contracts grew from about **$160 million in 2022** (assets $191 m – liabilities $31 m) to **$300 million in 2023** (assets $377 m – liabilities $77 m) and then settled at roughly **$250 million in 2024** (assets $296 m – liabilities $46 m) (see Chunks 3, 1 and 2).  This three‑year trajectory shows that NEE expanded its hedging of natural‑gas price risk in 2023, maintained a sizable net long position in 2024, and overall has been positioning itself to manage gas‑price volatility while retaining a net exposure that exceeds its liability side—consistent with the company’s disclosed practice of using forward gas contracts as a risk‑mitigation tool (KG pattern ORG → FIN_INST ← ORG).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values from the ground truth: net exposure of $160M in 2022 (from $191M assets - $31M liabilities), $300M in 2023 ($377M - $77M), and $250M in 2024 ($296M - $46M). All figures match exactly, and calculations are accurate. Minor formatting differences (e.g., $191 m vs $191M) are acceptable and do not affect meaning. (2) Quantitative accuracy is perfect—each year’s asset, liability, and net exposure values are correct and properly derived. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a trend of increased exposure in 2023 followed by a partial drawdown in 2024. The interpretation aligns with the ground truth, noting strategic positioning in gas markets. The only minor shortcoming is the use of 'hedging' and 'net long position' terminology, which slightly reframes the narrative toward risk mitigation, while the original emphasizes strategic expansion and contraction. However, this does not contradict the data and remains plausible given the context. (4) The answer is fully relevant, addressing both parts of the question: the evolution of net exposure and the implication for risk positioning. The reference to 'risk-mitigation tool' adds context supported by the knowledge graph. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy due to subtle interpretive framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 421,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its product portfolio evolve across 2022, 2023, and 2024, particularly in relation to its broader industrial product offerings and application markets?",
      "original_answer": "In 2022, AVGO described Industrial Fiber Optics as part of a broad variety of industrial products used across applications such as industrial automation, power generation, medical systems, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, Industrial Fiber Optics was listed among key product offerings under the Industrial end market, alongside optocouplers, sensors, motion encoders, and LED devices, targeting factory automation, renewable energy, and automotive electronics. By 2024, the product remained a core part of the Industrial segment, grouped with optocouplers, sensors, motion control subsystems, and Ethernet ICs, with continued emphasis on factory automation, renewable energy, and automotive applications. The consistent inclusion of Industrial Fiber Optics across all three years indicates a stable strategic role within AVGO's industrial portfolio, with no significant expansion or contraction relative to other product lines.",
      "llm_answer": "\nIn its 2022, 2023 and 2024 filings AVGO repeatedly listed Industrial Fiber Optics as a key product for the Industrial end‑market, placing it alongside other industrial items such as optocouplers, motion‑control encoders, LEDs and Ethernet PHYs. The company continued to target the same application domains—factory automation, renewable‑energy systems, automotive electronics and medical devices—showing a sustained strategic focus on integrating fiber‑optic technology within a diversified industrial product portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution—or lack thereof—of AVGO's positioning of Industrial Fiber Optics across 2022–2024. It correctly identifies that Industrial Fiber Optics was consistently listed as a key product within the Industrial end market across all three years and appropriately notes its grouping with related products like optocouplers, motion-control encoders, LEDs, and Ethernet ICs (referred to as Ethernet PHYs, which is semantically acceptable). The application markets cited—factory automation, renewable energy, automotive electronics, and medical devices—are consistent with the ground truth, though the LLM includes 'medical devices' in 2023–2024 while the original answer notes it was more prominent in 2022 and less emphasized in later years. This is a minor overgeneralization but not a factual error. The answer correctly infers a sustained strategic focus, aligning with the ground truth's conclusion of a stable strategic role. However, the LLM omits specific evolution details: in 2022, the product was described as part of a 'broad variety' across many applications including defense, aerospace, and power generation; by 2023–2024, the focus narrowed to factory automation, renewable energy, and automotive electronics. The consolidation and refinement of application focus is underemphasized. Additionally, the 2024 grouping with 'motion control subsystems' and 'Ethernet ICs' is partially reflected (via 'Ethernet PHYs'), but 'motion encoders' evolved into 'motion control subsystems', a nuance not captured. There are no numerical inaccuracies (quantitative accuracy is 10), and the reasoning is sound but lacks full granularity in tracing the subtle shifts in product grouping and application emphasis. Contextual relevance is perfect—the answer directly addresses the question's focus on portfolio evolution and market alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 509,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did SPG's interest obligations and face amounts tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "In 2022, SPG disclosed that Unsecured Notes - 31B had a face amount of $750,000,000 and an annual debt service of $24,375,000 at a 3.25% interest rate. In 2023, the same notes still showed a face amount of $750,000,000 with consistent annual debt service of $24,375,000, indicating no change in structure. By 2024, the face amount remained unchanged at $750,000,000, and the annual debt service continued at $24,375,000, with the interest rate still listed at 3.25%. This demonstrates a stable long-term debt strategy for this specific instrument, with no refinancing or restructuring observed over the three-year period.",
      "llm_answer": "\nThe data across all three filings show that the Unsecured Notes ‑ 31B tranche retains the same terms throughout 2022‑2024. Chunk 1 (the 2022 Form 10‑K, as of 12/31/2021) lists a **face amount of $750 000 (thousands)** and an **annual debt‑service of $24 375 (thousands)** at a **3.25 % interest rate** with a maturity of 11/30/26. Chunk 3 (the 2023 Form 10‑K, as of 12/31/2023) and Chunk 2 (the 2024 Form 10‑K, as of 12/31/2024) repeat **exactly the same $750 000 face amount and $24 375 annual debt‑service figure**.  \n\nThus, from 2022 through 2024 the interest obligations and face amount tied to Unsecured Notes ‑ 31B remained unchanged, revealing SPG’s long‑term debt strategy of **locking in a stable, low‑cost, fixed‑rate tranche with a 2026 maturity** to provide predictable financing and preserve liquidity amid its broader portfolio of longer‑dated and variable‑rate debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: face amount ($750,000,000), annual debt service ($24,375,000), interest rate (3.25%), and consistent values across 2022–2024. The formatting uses thousands (e.g., $750,000 thousands) which correctly scales to $750 million — this is a standard SEC reporting convention and is semantically equivalent to the ground truth. 2) All numbers match the original answer: $750,000,000 face amount and $24,375,000 annual obligation are accurately represented, even though expressed in thousands. The interest rate (3.25%) and maturity (11/30/26) are correct. 3) The multi-hop reasoning is sound — the model correctly synthesizes data from 2022, 2023, and 2024 filings to conclude no change in terms, demonstrating stable debt structure. 4) The qualitative interpretation about SPG’s long-term debt strategy — locking in fixed-rate, predictable financing — is a reasonable inference supported by the data and aligns with the ground truth’s conclusion of a 'stable long-term debt strategy.' The only minor shortcoming is that the original answer explicitly notes 'no refinancing or restructuring observed,' while the LLM implies it through 'unchanged' terms. This slight omission in phrasing does not detract from factual accuracy but prevents a perfect 10. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 385,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment in employee retirement benefits?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and remained stable at $76 million in 2024. This indicates a steady and slightly growing commitment to employee retirement benefits over the three-year period, with a total increase of approximately 8.6% from 2022 to 2024.",
      "llm_answer": "\nTexas Instruments’ U.S. defined‑contribution expense was $70 million in 2022 (as reported in the 2023 Form 10‑K, Chunk 2), increased to $75 million in 2023 (also Chunk 2), and rose further to $76 million in 2024 (Chunk 3). This steady climb—from $70 M in 2022 to $75 M in 2023 and $76 M in 2024—demonstrates that the company is progressively expanding its financial investment in employee retirement benefits, reflecting higher employer matching and fixed contribution levels across its qualified and enhanced plans as described across all three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $70 million in 2022, $75 million in 2023, and $76 million in 2024, matching the ground truth exactly. The trend description of a steady increase is accurate, and the final amount is correctly noted as stable compared to the prior year. (2) All numbers are correct and consistent with the original answer. The calculation of a total increase from $70M to $76M implies an 8.57% rise (~8.6%), which aligns with the ground truth; however, the LLM does not explicitly compute or mention this percentage, slightly reducing completeness on quantitative synthesis. (3) The multi-hop reasoning is sound—information is correctly pulled and synthesized across three years of filings (referencing appropriate chunks), and the conclusion about increasing investment in retirement benefits is logically supported. The characterization of a 'steady climb' is slightly stronger than the original answer’s 'slightly growing commitment', but still reasonable given the data. (4) The answer fully addresses both parts of the question: the evolution of expenses and the interpretation of the trend. Wording differs slightly but maintains semantic equivalence. The only minor gap is the lack of explicit percentage increase, which prevents a perfect score, but overall accuracy, reasoning, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 381,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 through 2024, and what does this consistency or change reveal about the company's performance evaluation methodology?",
      "original_answer": "GD consistently excluded non-economic accounting changes from ROIC calculations in 2022, 2023, and 2024, indicating a stable methodology in measuring core company performance. This consistent exclusion suggests that GD has maintained a disciplined approach to evaluating financial performance by removing items not directly reflective of operational results.",
      "llm_answer": "\nGD has consistently excluded non‑economic accounting changes from its ROIC calculation in each of the 2022, 2023 and 2024 10‑K filings, reiterating that such changes “are not reflective of company performance.”  This unchanged treatment signals that the company’s performance‑evaluation methodology relies on a stable, core‑operating metric—ROIC derived from invested capital net of goodwill impairments and non‑economic adjustments—rather than on accounting items that distort true operational results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that GD excluded non-economic accounting changes from ROIC in 2022, 2023, and 2024, which matches the original answer's claim of consistent exclusion. There are no numeric values requiring calculation, but the years (2022–2024) are correctly cited. (2) The answer addresses both parts of the question: the evolution (or lack thereof) in treatment and what it reveals about performance evaluation methodology. (3) Entities—GD, ROIC, non-economic accounting changes, and the three-year period—are correctly identified. (4) The reasoning is sound: the consistency in exclusion supports a stable, operationally focused evaluation methodology. The LLM adds minor elaboration (e.g., reference to goodwill impairments and quoting 'not reflective of company performance') that is plausible and contextually appropriate, though not explicitly in the ground truth. This does not introduce inaccuracy but slightly extends beyond the source, warranting a 9 instead of 10 for qualitative accuracy. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 325,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did CVS's Separate Accounts Assets evolve from 2022 through 2024, and what does the 3-year trend suggest about the company's investment positioning in long-term insurance products?",
      "original_answer": "CVS's Separate Accounts Assets decreased from $5,087 million in 2022 to $3,250 million in 2023, and slightly increased to $3,311 million in 2024. This represents a significant decline in 2023 followed by a marginal recovery in 2024, suggesting a strategic reduction or market-driven devaluation in long-term insurance-linked investments, followed by stabilization.",
      "llm_answer": "\nCVS’s separate‑accounts assets grew from **$3.22 billion at the end of 2022** (as reported in the 2023 10‑K, Chunk 1) to **$3.25 billion in 2023** and then to **$3.31 billion in 2024** (Chunk 2). This steady, incremental rise—approximately $0.03–$0.06 billion per year—demonstrates that the company is gradually expanding the assets held in its separate‑account structure, underscoring a continued and modestly increasing investment positioning in long‑term insurance products. The parallel growth of separate‑accounts liabilities (also $3.25 billion in 2023 and $3.31 billion in 2024) further reflects a deliberate, balanced approach to funding these long‑duration insurance holdings.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of change in CVS's Separate Accounts Assets. The ground truth states assets decreased from $5,087 million in 2022 to $3,250 million in 2023, then slightly increased to $3,311 million in 2024. The LLM incorrectly reports an increase from $3.22 billion in 2022 to $3.25 billion in 2023, misrepresenting a significant decline as growth. This fundamental error invalidates the conclusion. (2) Numeric values are wrong: $3.22B vs $5,087M (2022), $3.25B vs $3,250M (2023), $3.31B vs $3,311M (2024) — while 2023 and 2024 figures are numerically close (within rounding), the 2022 figure is drastically understated. The LLM appears to have misread or misattributed data, possibly confusing separate accounts with another line item or company. (3) Multi-hop reasoning failed: the model should have identified the sharp drop from 2022 to 2023 and slight recovery in 2024, then inferred a strategic or market-driven contraction in long-term insurance investments. Instead, it inferred expansion, which contradicts the data. (4) Contextual relevance is moderate — it addresses the right metric (separate accounts assets) and time frame, and attempts to interpret investment positioning, but due to incorrect data, the analysis is misleading. The mention of matching liabilities adds detail not in the original but does not compensate for factual errors. Overall, major factual and directional inaccuracies result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 416,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. evolve from 2022 through 2024, particularly in terms of amendments and contractual milestones?",
      "original_answer": "Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. saw continued maintenance and formal updates across the three-year period. In 2022, the agreement was referenced in its original form dated October 22, 2012, with the first amendment dated February 24, 2015. By 2023, the agreement was still in effect, and in 2024, a second amendment dated November 19, 2019, was explicitly listed. This indicates that the relationship was not only sustained but also formally evolved through structured amendments, showing long-term strategic alignment in their financial services partnership.",
      "llm_answer": "\nThe Credit Card Program Agreement that Target Corp – Target Enterprise Inc. – TD Bank USA, N.A. entered into on October 22 2012 (first disclosed in the 2012 10‑Q/A, see Chunk 1 & 2 & 3) was last updated by the **Second Amendment dated November 19 2019** (referenced as GG † in Chunk 3 and 10.21.2** + in Chunk 2); **no further amendments were filed through 2022‑2024**, so the agreement remained in its 2019 form in each subsequent filing (2022 10‑K, 2023 10‑Q, 2024 10‑Q) (Chunk 1 – Chunk 3).  While the credit‑card agreement itself was unchanged, Target’s broader credit relationships were refreshed in that period—the 2021 Five‑Year Credit Agreement was amended in 2022 and 2023 (Chunk 1 & 2) and a new 364‑Day Credit Agreement was entered into in 2023 and restated in 2024 (Chunk 1 & 2), but these updates did not alter the terms of the Credit Card Program Agreement.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding the evolution of Target Corporation's Credit Card Program Agreement with TD Bank USA, N.A. from 2022 to 2024, particularly in its core claim that no further amendments were filed after 2019. The original answer (ground truth) explicitly states that in 2024, the second amendment dated November 19, 2019, was 'explicitly listed,' indicating it was formally recognized and incorporated into disclosures during that period — which the LLM correctly notes as the latest amendment. However, the LLM incorrectly concludes that 'no further amendments were filed through 2022–2024,' which contradicts the original answer’s implication that the agreement was formally updated or reaffirmed in 2024 filings, showing evolution in disclosure and contractual recognition. While the LLM correctly identifies the October 22, 2012 agreement and the November 19, 2019 second amendment, it fails to acknowledge the significance of the 2024 reference as a contractual milestone, thus missing the multi-hop synthesis that sustained visibility and formal listing in 2024 constitutes an evolution in the agreement's status. Additionally, the LLM introduces potentially irrelevant information about other credit agreements (e.g., Five-Year Credit Agreement, 364-Day Credit Agreement), which, while factually possibly correct, distracts from the specific focus on the Credit Card Program Agreement. Quantitative accuracy is acceptable: dates (October 22, 2012; November 19, 2019) are correct, and no incorrect numbers are introduced. However, the reasoning is flawed in concluding no evolution occurred, when the ground truth interprets continued and explicit referencing as evidence of structured evolution. Thus, while entities and some facts are accurate, the conclusion misrepresents the contractual trajectory, leading to a low correctness score despite partial factual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 518,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did Linde's production and strategic positioning around rare gases evolve from 2022 to 2024, particularly in terms of its technological differentiation and integration with other product lines?",
      "original_answer": "From 2022 to 2024, Linde's production and strategic emphasis on rare gases evolved significantly. In 2022, rare gases were listed among Linde’s primary atmospheric gases, produced via air separation and distributed through the company’s three core methods—on-site, merchant, and packaged. By 2023, the company maintained its focus on rare gases as part of its atmospheric gas portfolio but began to emphasize its proprietary technologies and long-term contracts, particularly in the on-site segment, which often included price escalation clauses and variable pricing. In 2024, Linde elevated its strategic positioning by explicitly highlighting its leadership in non-cryogenic air separation technologies and its pioneering role in industrial gases, specifically noting rare gases like krypton, neon, and xenon as byproducts of air separation. Additionally, Linde underscored its technological innovations such as VPSA and membrane separation, which enabled more efficient on-site delivery and broader market expansion. This progression reflects a shift from a product-centric to a technology- and integration-driven approach in the rare gases segment.",
      "llm_answer": "\nFrom 2022 through 2024 Linde moved rare‑gas production from stand‑alone cryogenic on‑site plants (which also yielded merchant liquids for the bulk market) toward a fully integrated, technology‑driven supply chain that co‑produces rare gases together with oxygen, nitrogen and a growing portfolio of process gases; the 2024 filing highlights Linde’s market‑leading non‑cryogenic VPSA and membrane separation platforms that generate rare gases on‑site and feed them directly into merchant, bulk‑liquid and packaged‑gas distribution channels, while simultaneously supporting other product lines such as low‑carbon and renewable hydrogen, helium and specialty gases.  This evolution reflects a strategic positioning in which rare gases are no longer a peripheral by‑product but a differentiated, high‑value component woven into every distribution mode and tied to Linde’s broader equipment‑design and clean‑energy initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Linde's evolution from 2022 to 2024 in rare gas production, noting the shift from traditional cryogenic methods to integrated, technology-driven processes. While the original answer does not explicitly state that rare gases were produced in 'stand-alone cryogenic on-site plants' in 2022, it does confirm air separation as the method and lists rare gases as part of the atmospheric gas portfolio—consistent with co-production. The LLM's framing of integration with oxygen, nitrogen, and process gases is a reasonable interpretation of Linde’s broader gas portfolio strategy. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised; all time references (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes Linde’s technological differentiation (VPSA, membrane separation), integration across distribution channels (on-site, merchant, packaged), and linkage to other product lines (hydrogen, helium, specialty gases), which reflects the strategic integration emphasized in the original answer. The mention of 'non-cryogenic' platforms in 2024 matches the ground truth’s highlight of leadership in non-cryogenic air separation. (4) The only minor deviation is that the original answer emphasizes long-term contracts and pricing mechanisms in 2023, which the LLM omits. However, the core focus on technological evolution and integration is fully preserved and even enriched with context about clean energy and equipment design, which is consistent with Linde’s broader strategic themes. Overall, the LLM answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 480,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to advances to equity companies evolve from 2022 to 2024, and what does this trend suggest about the company's exposure to derivative liabilities tied to equity company relationships?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to equity company advances declined from $1,494 million in 2022 to $800 million in 2023, and further to $491 million in 2024. This consistent decrease suggests a strategic reduction in exposure to derivative liabilities associated with equity company relationships, potentially reflecting de-risking or portfolio optimization efforts.",
      "llm_answer": "\nFrom 2022 through 2024 the collateral that ExxonMobil reports under master‑netting arrangements tied to advances to equity companies fell sharply—from roughly **$1.5 billion in 2022** (Chunk 2) to **$0.8 billion in 2023** (Chunk 2) and then to **$0.49 billion in 2024** (Chunk 3).  This decline reflects a reduced need to post offsetting collateral for the derivative positions that arise from those equity‑company relationships, signaling that the company’s exposure to related derivative liabilities is diminishing as the required master‑netting collateral shrinks each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $1.5 billion (2022), $0.8 billion (2023), and $0.49 billion (2024) match the original values of $1,494 million, $800 million, and $491 million when rounded appropriately. Format variations (e.g., $1.5 billion vs $1,494 million) are acceptable and common in financial reporting. (2) The answer fully addresses both parts of the question: it describes the evolution of collateral from 2022 to 2024 and interprets the trend as a reduction in exposure to derivative liabilities, which matches the original conclusion. (3) Entity accuracy is strong: ExxonMobil is correctly identified, the metric 'collateral under master netting arrangements related to advances to equity companies' is accurately referenced, and the years 2022–2024 are correctly used. (4) The reasoning is sound—reduced collateral implies reduced derivative exposure, which logically suggests de-risking or portfolio optimization. The only minor shortcoming is that the LLM does not explicitly mention 'strategic reduction', 'de-risking', or 'portfolio optimization' as potential drivers (though 'diminishing exposure' captures the essence). This slight omission in nuance prevents a perfect 10 on qualitative accuracy, but the core logic and multi-hop synthesis across years and financial implications are correct. Overall, the answer is factually precise, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 406,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolved from 2022 through 2024, and what does this trend suggest about its risk mitigation strategy in competitive markets?",
      "original_answer": "NEER's reliance on long-term bilateral contracts has steadily increased from 92% of its net generating capacity in 2022, to 94% in both 2023 and 2024. This consistent rise indicates a strategic emphasis on revenue stability and risk mitigation, particularly in volatile energy markets. The company continues to use shorter-term bilateral contracts as a hedge when long-term agreements are not in place, reinforcing its approach to managing price risk in daily spot markets.",
      "llm_answer": "\nFrom 2022 through 2024 NEER’s net‑generating capacity covered by long‑term bilateral contracts rose modestly—from roughly 92 % (the 2021/2022 baseline shown in Chunk 3) to about 94 % by the end of 2023 (Chunk 1) and remained at that level in 2024 (Chunk 2).  This near‑universal commitment reflects NEER’s strategy of locking in revenue and hedging price risk: it enters long‑term contracts that may serve as physical or financial hedges (including “non‑qualifying” hedges that affect adjusted earnings), sells RECs alongside the power, and supplements the coverage with shorter‑term bilateral contracts when spot‑market exposure remains.  The consistent high percentage across the three years demonstrates that NEER’s risk‑mitigation approach relies on a diversified, long‑term contract portfolio to stabilize cash flows in competitive wholesale markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages and years are correct: 92% in 2022, 94% in 2023 and 2024—matching the original answer exactly. The minor phrasing 'roughly 92%' and reference to '2021/2022 baseline' does not detract from accuracy, as 92% is correctly attributed to the 2022 figure. (2) The answer fully addresses both parts of the question: the evolution of NEER's reliance on long-term bilateral contracts (2022–2024) and the implication for risk mitigation. (3) Entities—NextEra Energy Resources (NEER), long-term bilateral contracts, net generating capacity, and competitive markets—are correctly identified and contextualized. (4) The reasoning is sound: the LLM correctly infers that increasing and sustained contract coverage reflects a strategy of revenue stability and price risk mitigation, and it appropriately notes the use of shorter-term contracts as a hedge, which is consistent with the original answer. The only minor shortcoming is the slightly imprecise reference to '2021/2022 baseline' when the data point is specifically for 2022, and the addition of some extraneous detail (e.g., 'non-qualifying hedges', 'RECs') not present in the ground truth, which, while plausible, are not confirmed by the provided truth. However, these do not introduce factual errors. Overall, the answer demonstrates strong multi-hop synthesis and semantic equivalence to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into_Contract]-> FIN_INST <-[Contracts]- ORG <-[Enters_Contract]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 401,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did AVGO's outstanding principal balance for the 3.125% notes due January 2025 evolve from fiscal 2022 through fiscal 2024, and what does this reveal about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million from fiscal 2022 through fiscal 2023, but in fiscal 2024, it was still reported at $495 million despite approaching maturity, indicating no principal reduction over the three-year period. This suggests AVGO may be planning to refinance or use cash reserves to settle the obligation rather than amortizing it.",
      "llm_answer": "\nThe 3.125 % notes due January 2025 show a flat carrying amount of **$495 million** in the 2022 filing (Chunk 1) and remain **$495 million** in the 2023 and 2024 filings (Chunks 3 and 2), indicating no evolution in the outstanding principal across fiscal 2022 → 2024.  \n\nThis stability reveals that AVGO’s debt‑management strategy for this specific instrument is to **hold the legacy fixed‑rate note to maturity rather than refinance or retire it**, preserving a low‑cost source of long‑term financing while the company overall expands its debt base (total principal rising from $41.2 bn to $69.8 bn).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the outstanding principal balance of $495 million for the 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values—amount ($495 million), interest rate (3.125%), and maturity date (January 2025)—are accurate. (2) Quantitative accuracy is perfect: the dollar amount is consistent across all years and correctly reported with acceptable formatting (e.g., $495 million). There are no calculation errors. (3) The multi-hop reasoning is mostly sound—information is correctly synthesized across three fiscal years from different filings. However, the interpretation of AVGO’s debt management strategy diverges slightly from the ground truth: while the original answer suggests AVGO may refinance or use cash reserves (due to lack of amortization), the LLM concludes AVGO is holding the note to maturity 'rather than refinance or retire it,' which implies an intentional retention of low-cost debt. This contradicts the implication in the ground truth that no amortization suggests future refinancing or cash settlement is likely. Thus, the reasoning is plausible but not fully aligned with the intended inference. (4) Despite this interpretive difference, the answer is factually correct, complete, and highly relevant. The minor discrepancy in strategic interpretation does not undermine the core facts but slightly reduces qualitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 413,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Simon Property Group's unsecured notes - 37B evolve from 2022 through 2024 in terms of interest rate, face amount, and maturity date, and what does this 3-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Simon Property Group's unsecured notes - 37B remained consistent across all three years with a fixed interest rate of 2.25%, a face amount of $700,000,000, and a maturity date of January 15, 2032. This stability in key terms over the 3-year period suggests a deliberate long-term debt strategy focused on maintaining predictable financing costs and extending liability durations to align with the company's real estate portfolio, which typically generates stable, long-term cash flows.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes ‑ 37B disclosed by Simon Property Group retained the same terms: a fixed 2.25 % interest rate, a $700 million face amount, and a maturity date of 01/15/32, as shown in the 2022, 2023 and 2024 10‑K filings; this unchanged profile reflects the company’s long‑term debt strategy of securing low‑cost, long‑dated financing while it augments the overall debt mix with newer, higher‑rate notes of varying maturities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the interest rate (2.25%), face amount ($700 million), and maturity date (January 15, 2032, formatted as 01/15/32) are consistent across 2022–2024, matching the original answer. Format variations (e.g., $700 million vs $700,000,000) are acceptable and semantically equivalent. (2) Quantitative accuracy is perfect—no calculation errors or misstatements. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years of 10-K filings and infers a strategic pattern in debt management. (4) The qualitative interpretation adds value by noting that Simon Property Group is 'augmenting the overall debt mix with newer, higher-rate notes,' which is a reasonable inference beyond the ground truth but does not contradict it and reflects deeper contextual understanding. This addition does not detract from accuracy but slightly extends the original conclusion. Thus, while the core answer is fully correct and complete, the slight expansion beyond the provided ground truth (though logical) prevents a perfect 10. Contextual relevance is excellent—the response directly addresses all parts of the multi-part question: evolution over time, terms of the note, and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 365,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression reveal about the company's focus on analog versus embedded processing in that location?",
      "original_answer": "From 2022 to 2024, Texas Instruments maintained its operational presence in Melaka, Malaysia, consistently focusing solely on analog product lines without expanding into embedded processing. In 2022, Melaka was listed with an 'X' under Analog but not under Embedded Processing. This pattern remained unchanged in 2023 and 2024, indicating a stable, analog-only operational strategy in Melaka throughout the three-year period. This consistency suggests a targeted investment in analog capabilities rather than a diversification into embedded processing in that location.",
      "llm_answer": "\nTexas Instruments has maintained a continuous presence in Melaka, Malaysia across all three filings—2022 (marked with a dagger), 2023 (marked with an asterisk) and 2024 (marked with double‑asterisks)—and in each year the site appears only in the **Analog** column while the **Embedded Processing** column remains blank. This steady, analog‑only listing (reflected in the KG relationship TXN → Melaka, Malaysia via Operates_In) demonstrates that TI’s Melaka operation has been dedicated to analog semiconductor work and has not been used for embedded processing, highlighting a focused strategic emphasis on analog over embedded technologies at that location over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It accurately states that Texas Instruments maintained its presence in Melaka, Malaysia from 2022 to 2024, with operations listed only under Analog and not Embedded Processing each year. While the original answer notes the use of 'X' as the marker, the LLM correctly interprets the presence markers (dagger, asterisk, double-asterisk) as indicators of continued operation and correctly associates them with the Analog column. The slight difference in describing the symbols does not affect factual accuracy, as the key point is the consistent analog-only status. (2) There are no numerical values requiring calculation, but the years (2022–2024) are correctly referenced, and the absence of embedded processing is consistently noted—this satisfies quantitative accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic focus on analog over embedded processing based on the persistent pattern. (4) The answer is semantically equivalent to the original, with only minor stylistic differences (e.g., referencing symbols vs. 'X'). The conclusion about strategic emphasis is logically derived and contextually appropriate. Deducted 1 point from qualitative accuracy only because the LLM references formatting markers not mentioned in the ground truth, which could introduce ambiguity if those symbols were inconsistently applied, but this does not undermine the correctness of the core observation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 426,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024 in response to expanding real-time payment infrastructure across increasing numbers of global markets?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach was already robust, incorporating multiple layers of protection and working with issuers, acquirers, and governments to develop technical standards like EMV for secure transactions. At that time, real-time payments infrastructure was operational or being implemented in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets and emphasized intelligent routing with real-time application of fraud scoring and tokenization services across a globally integrated network. In 2024, with the expansion into China through a joint venture and the ability to process domestic transactions there, the security framework had to scale further to accommodate this new market while maintaining network integrity. The multi-layered approach continued to evolve, integrating third-party service risks and public-private partnerships to address emerging threats in an increasingly real-time, cross-border payment ecosystem.",
      "llm_answer": "\nMastercard’s multi‑layered security approach—formalized as an accounting policy that it “Implements” across its ecosystem—has been continuously reinforced as the company expands real‑time payment infrastructure.  In 2022 the program comprised a robust cyber‑ and information‑security framework, third‑party assessments, benchmarking, regular vulnerability testing, and collaboration with issuers, acquirers, merchants, governments and industry groups to adopt technical standards such as EMV; by the end of 2023 this framework was operating in 13 markets and covered roughly 60‑70 % of all switched transactions, including nearly all cross‑border flows.  Building on that base, the 2024 rollout added domestic processing in China through a joint venture and broadened real‑time clearing and settlement to additional jurisdictions, prompting the security program to scale its layered protections (fraud scoring, tokenization, intelligent routing, 24‑hour availability) and deepen third‑party validation while still guaranteeing only settlement exposure and not merchant payments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach from 2022 to 2024 in response to real-time payment expansion. It accurately notes the 2022 foundation with EMV standards and collaboration with stakeholders, the 2023 expansion to 13 markets (matching ground truth), and the 2024 milestone of domestic processing in China via a joint venture. However, the LLM introduces a specific percentage range—'60-70%' of switched transactions—that is not present in the original answer and cannot be verified from the provided ground truth, which weakens quantitative accuracy. (2) The numeric values for years (2022, 2023, 2024) and market count (13 in 2023) are correct. The original answer states 12 markets in 2022 and 13 in 2023, which the LLM correctly reflects by implication. However, the '60-70%' figure and 'nearly all cross-border flows' are unverified additions. The claim about 'settlement exposure and not merchant payments' is contextually plausible but not explicitly supported in the ground truth. (3) The multi-hop reasoning is strong: the LLM synthesizes the expansion of real-time infrastructure with corresponding security scaling, links China's domestic processing to security program adaptation, and connects fraud scoring, tokenization, and intelligent routing to real-time needs. It correctly infers that broader jurisdictional reach necessitates deeper third-party validation and continuous availability. (4) The answer is highly contextually relevant, directly addressing how security evolved in response to real-time payment growth. While it adds some plausible details not in the original, the core facts, timeline, and logical progression align well. The correctness score is 8 due to accurate key facts and reasoning, but docked for unsupported quantitative claims. Quantitative accuracy is 7 due to the unverified percentage; qualitative accuracy is 9 for strong reasoning and entity alignment; contextual relevance is 10 as the response fully addresses the question's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Has]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 553,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV programs?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, indicating a consistent and growing strategic emphasis on the LAV program. This upward trajectory suggests expanding defense contracts and a deepening commitment to fulfilling international demand for armored mobility platforms.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics’ Land Systems business lifted LAV output for the Canadian Army — 360 new LAVs in 2022, 399 in 2023 and 449 in 2024, with an additional 66 LRSS‑equipped vehicles planned for 2024 — showing a clear year‑over‑year increase.  This production ramp‑up, together with simultaneous investments in upgraded Ajax, Piranha and autonomous‑vehicle programs, signals GD’s strategic focus on expanding and deepening its land‑system portfolio, positioning LAV production as a core growth pillar of its defense business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the production volumes for LAVs for the Canadian Army as 360 in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. These numbers demonstrate a consistent year-over-year increase, which is accurately interpreted. However, the LLM adds that 'an additional 66 LRSS-equipped vehicles [are] planned for 2024,' a detail not present in the original ground truth. While this does not contradict the original answer, it introduces unverified information not supported by the provided knowledge graph, slightly reducing qualitative accuracy. (2) All numeric values and timeframes are correct. The progression from 360 → 399 → 449 is accurately stated, and no calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly infers a strategic focus on LAV programs from increasing production volumes. It further enriches the response with context about investments in Ajax, Piranha, and autonomous vehicles, which supports the conclusion about strategic emphasis, though these details are not in the ground truth. This shows strong qualitative reasoning but introduces external synthesis. (4) The answer is highly relevant and factually aligned with the original, conveying the same core message about growing production and strategic focus. The slight over-enrichment with unsupported details (LRSS, other programs) prevents a perfect 10 on correctness and qualitative accuracy, but the core facts and logic remain robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 415,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did CVS's allocation to hedge fund limited partnership investments through pension plan assets change from 2022 to 2024, and what does this three-year trajectory suggest about the company's evolving pension fund strategy?",
      "original_answer": "CVS's allocation to hedge fund limited partnership investments was $214 million in 2022, remained relatively stable at $225 million in 2023, and then increased to $252 million in 2024. This represents a gradual upward trend, with a total increase of 17.8% over the three-year period. The steady or slightly growing allocation suggests that CVS maintained a consistent, and potentially more confident, strategic approach to including alternative investments in its pension fund portfolio over time.",
      "llm_answer": "\nThe pension‑plan disclosures show that the amount of hedge‑fund limited‑partnership investments excluded from Level 3 assets grew each year: $214 million in the 2022 filing, $225 million in the 2023 filing, and $252 million in the 2024 filing – an increase of roughly $11 million in 2023 and $27 million in 2024. This three‑year upward trajectory signals that CVS is deliberately expanding its exposure to alternative‑asset hedge‑fund partnerships within the pension fund, reflecting a strategic shift toward greater diversification and higher‑return investments in the plan’s asset allocation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all dollar amounts: $214 million in 2022, $225 million in 2023, and $252 million in 2024, matching the ground truth exactly. The year-over-year increases of $11 million (2023) and $27 million (2024) are accurate calculations. The total percentage increase is not explicitly stated in the LLM answer (17.8% as in the original), but the upward trend is correctly described. (2) All numbers and calculations are factually correct; format variations (e.g., $214 million vs $214M) are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic trend in pension fund allocation. The conclusion about a 'strategic shift toward greater diversification and higher-return investments' is a reasonable interpretation of the increasing allocation, though slightly more assertive than the original's 'consistent, and potentially more confident, strategic approach.' This is a minor difference in tone, not factual inaccuracy. (4) The answer fully addresses both parts of the question: the change in allocation over time and the strategic implication. The contextual relevance is perfect, with precise data and logical interpretation. The only reason for not scoring a 10 is the omission of the total percentage increase (17.8%), which was present in the ground truth and adds quantitative completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 397,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend suggest about consumer adoption and engagement with Target's financial products?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card, as part of the broader RedCard/Circle Card offerings, declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in consumer adoption or engagement with Target's proprietary credit offerings, despite the continued incentive of a 5% discount. The drop in penetration indicates that while RedCard sales increased in dollar terms, total sales grew even faster, diluting the proportional use of the cards. This trend could signal shifting consumer preferences, increased competition in retail credit, or reduced sensitivity to the discount incentive.",
      "llm_answer": "\nThe disclosed penetration of the Target MasterCard (re‑branded as the Target Circle Card) fell from **20.5 % in fiscal 2022** (Chunk 3), to **19.8 % in fiscal 2023** (Chunk 1), and to **18.6 % in fiscal 2024** (Chunk 1 / Chunk 2), reflecting a consistent downward trend through 2022‑2024.  This decline indicates that consumer adoption and engagement with Target’s co‑branded credit product are weakening, suggesting the 5 % discount incentive is losing its ability to drive incremental purchases.  The trend is tracked across all three 10‑K filings (2022, 2023, 2024) because Target’s internal analysis links RedCard/Target Circle Card penetration to a meaningful share of incremental sales for the retailer (Chunk 1, Chunk 2, Chunk 3).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target MasterCard (rebranded as Target Circle Card) penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it reports 18.6% for 2024 instead of the correct 17.8%, introducing a factual error in the final and most recent data point. This discrepancy affects the quantitative accuracy significantly, as the magnitude of decline is understated. (2) The numbers for 2022 and 2023 are accurate and correctly attributed to the respective fiscal years. The 2024 figure is incorrect: ground truth states 17.8%, but LLM reports 18.6%, a difference of 0.8 percentage points. This error impacts the interpretation of the trend's severity. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across multiple 10-K filings and links the penetration rate to consumer adoption and engagement. It appropriately references the 5% discount incentive and ties the decline to weakening consumer response, which aligns with the original answer’s logic. The explanation about incremental sales and internal tracking adds contextual depth. (4) Despite the numerical error in 2024, the overall reasoning, entity identification (Target, RedCard/Circle Card, fiscal years), and synthesis across documents are strong. The answer remains contextually relevant and addresses both parts of the question—evolution of penetration and implications for consumer behavior. The minor wording differences (e.g., 're-branded as Target Circle Card') are acceptable and reflect updated branding. However, the incorrect 2024 percentage prevents a higher score, especially on quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Offers]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 458,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did NextEra Energy's fair value exposure related to FPL Cost Recovery Clauses evolve from 2022 through 2024, particularly in terms of total fair value contributions and the shift between significant other observable inputs and significant unobservable inputs?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value exposure tied to FPL Cost Recovery Clauses showed a notable evolution. In 2022, the total fair value was $1 million, with a negligible contribution from significant other observable inputs (-$5 million) and a small positive contribution from significant unobservable inputs (+$6 million). By 2023, the total fair value increased to $12 million, driven primarily by a -$12 million contribution from significant other observable inputs and a +$24 million contribution from significant unobservable inputs. In 2024, the fair value exposure rose sharply to $38 million, with significant other observable inputs contributing +$4 million and significant unobservable inputs contributing +$34 million. This indicates a growing reliance on unobservable inputs and a strengthening fair value position tied to FPL Cost Recovery Clauses over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 the fair‑value exposure tied to FPL Cost‑Recovery Clauses moved from a net‑negative $ (413) million (2022) to a much smaller net‑negative $ (128) million (2023) and then to $ (142) million (2024); the 2022 figure reflected only a modest $ 6 million of significant unobservable inputs offsetting $(5) million of observable inputs, while 2023 saw observable inputs turn more negative $(12) million and unobservable inputs rise to $ 24 million, producing a small net positive of $ 12 million, and 2024 shifted further toward unobservable inputs – $ 34 million versus $ 4 million of observable inputs – yielding a net $ 38 million despite the overall negative total. This evolution shows a clear swing from reliance on observable market prices toward increasingly dominant unobservable inputs across the three years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors despite capturing some elements of the reasoning structure. (1) Quantitative Accuracy: The total fair value figures are completely incorrect. The LLM states net-negative $413 million in 2022, $128 million in 2023, and $142 million in 2024, which contradicts the ground truth of positive $1 million (2022), $12 million (2023), and $38 million (2024). These numbers are not only wrong in magnitude but also in sign (e.g., claiming 'net-negative' when the actual values are positive). The only correct component values are the breakdowns for 2023 and 2024: -$12M observable / +$24M unobservable (2023) and +$4M observable / +$34M unobservable (2024), which sum correctly to $12M and $38M respectively. However, the LLM incorrectly embeds these within a false narrative of overall negative exposure. (2) Completeness: The answer attempts to cover all years and input types, so it is structurally complete. (3) Entity Accuracy: The company (NextEra Energy), instrument (FPL Cost Recovery Clauses), and input categories (observable vs unobservable) are correctly identified. (4) Reasoning: The qualitative observation about increasing reliance on unobservable inputs is valid and aligns with the ground truth, showing correct multi-hop synthesis in that aspect. However, the flawed total values undermine the conclusion. (5) Semantic Equivalence: While the direction of change and input shift are correctly interpreted, the gross misstatement of total fair value exposure renders the answer largely incorrect. The claim of 'net-negative' exposure contradicts the actual positive fair value, suggesting a fundamental misunderstanding or data error. Thus, despite correct component inputs for 2023–2024 and sound directional reasoning, the core financial facts are wrong, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 502,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the competitive positioning of NKE relative to Anta evolved from 2022 through 2024, particularly in terms of product innovation emphasis and brand engagement strategies?",
      "original_answer": "From 2022 to 2024, NKE consistently positioned itself as the global leader in athletic footwear and apparel and maintained Anta as a named competitor. In 2022, NKE emphasized product attributes such as quality, performance, and reliability, along with new product style and design innovation as key competitive differentiators. By 2023, NKE elevated the importance of 'innovation and development' ahead of performance and reliability, signaling a strategic shift toward reinforcing technological and design leadership in response to competitive pressures. In 2024, NKE further solidified this innovation focus and reiterated its commitment to digital experiences, social media interaction, and athlete endorsements as critical components of brand engagement. While Anta remained a named competitor across all three years, NKE’s evolving emphasis on innovation and digital engagement suggests a multi-year strategic effort to differentiate itself in a market where Anta and other regional/global competitors are gaining traction through localized and digitally native strategies.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings all list Anta as a principal competitor (NKE Competes With Anta ↔ Anta Competes With NKE) and repeatedly stress that the battle for market share hinges on **product innovation—new styles, performance technologies and R&D protected by patents and trademarks**—as well as **brand‑engagement tactics such as marketing, digital experiences, social‑media interaction and athlete endorsements**.  Across the three years Nike’s disclosures show a consistent emphasis on “innovation and development” and on building “consumer connection, engagement and affinity” through high‑visibility sponsorships and digital platforms, indicating that its competitive positioning relative to Anta has been maintained by continuously investing in product‑development and brand‑activation capabilities rather than by a strategic shift.  This continuity, highlighted in each of the three chunks, demonstrates that Nike’s edge over Anta rests on its sustained focus on innovation‑driven product differentiation and immersive brand engagement.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in listing Anta as a principal competitor of NKE across 2022–2024 and correctly identifies key competitive dimensions such as product innovation, R&D, digital engagement, and athlete endorsements. It accurately reflects that NKE emphasizes innovation and brand engagement, which aligns with the ground truth. However, the LLM misses a critical nuance in the evolution of NKE’s strategy: while it claims there is 'continuity' and 'no strategic shift,' the original answer highlights a clear progression—specifically, that in 2022, NKE emphasized quality, performance, and reliability, but by 2023 elevated 'innovation and development' ahead of those attributes, signaling a strategic shift. This evolution is central to the question about how competitive positioning has *changed* from 2022 to 2024. The LLM instead portrays the strategy as static, which contradicts the ground truth’s emphasis on a deliberate, multi-year shift toward technological and design leadership in response to competitive pressures. This misrepresentation of the strategic trajectory undermines the qualitative accuracy, despite correct entity and thematic identification. There are no numerical inaccuracies (hence full quantitative score), and the response remains contextually relevant by addressing product innovation and brand engagement. However, the failure to capture the dynamic shift in emphasis results in a partially correct, rather than fully accurate, synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 409,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the availability of shares under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about TI's ongoing use of this plan for director compensation?",
      "original_answer": "The availability of shares under the Texas Instruments 2003 Director Compensation Plan decreased from 2022 to 2024, indicating a gradual phase-out of the plan in favor of newer compensation vehicles. In 2022, the 2003 Director Compensation Plan was still referenced as active, with shares being issued under it. By 2023, the plan was no longer listed among those with remaining shares available for future issuance, though it was still referenced for outstanding grants. In 2024, the 2003 plan was no longer mentioned as part of the active compensation structure, with TI focusing on the 2024 LTIP and 2018 Director Plan for future awards. This reflects a strategic shift toward updated incentive structures while honoring existing commitments.",
      "llm_answer": "\nThe 2003 Director Compensation Plan is repeatedly listed in each filing (Chunk 1 (a), Chunk 2 (a), Chunk 3 (a)) as one of the plans that may issue shares, but the only quantitative reserve that can be tracked across the years is the share‑availability figure for its successor instruments – the 2018 Director Plan (and, in later years, the 2024 LTIP).  In 2022 the company reported 1,843,134 shares still reservable under the 2018 Director Plan (Chunk 1 (c)); this fell to 1,786,785 shares in 2023 (Chunk 2 (c)) and to 1,745,284 shares in 2024 (Chunk 3 (c)), while the comparable reserve for the 2009 LTIP also declined from 35,385,153 to 25,296,767 and then rose slightly to 33,049,176 shares (Chunks 1‑3 (c)).  The downward trend in the 2018‑Plan reserve – the closest proxy for the 2003 plan’s remaining share pool – shows that TI is exhausting the original share reserve and is increasingly relying on newer plans (the 2018 Director Plan and the 2024 LTIP) for future director‑compensation awards, indicating that the 2003 plan’s role is now largely legacy‑driven rather than a primary vehicle for ongoing director compensation.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies and misinterpretations that significantly affect correctness. (1) Quantitative Accuracy: The LLM incorrectly focuses on the 2018 Director Plan's share reserves as a 'proxy' for the 2003 plan, but the ground truth states that the 2003 plan was no longer listed as having available shares for future issuance by 2023. The numbers cited (e.g., 1,843,134 shares in 2022 for the 2018 plan) are accurate for that plan but are not relevant to the 2003 plan's availability, which is the actual subject of the question. The LLM invents a 'proxy' logic not supported in the ground truth. (2) Completeness: The question asks specifically about the evolution of share availability under the 2003 Director Compensation Plan, but the LLM never provides data on that plan’s actual share availability over time. Instead, it discusses successor plans, missing the core requirement. (3) Entity Accuracy: The LLM incorrectly implies the 2003 plan was still listed as issuible in all three years, while the ground truth confirms it was no longer listed for future issuance by 2023 and absent entirely in 2024. This is a critical factual error. (4) Reasoning: The multi-hop reasoning fails because the model does not track the 2003 plan’s status across years directly. It infers phase-out based on trends in unrelated plans, which is flawed logic. (5) Semantic Equivalence: While the general idea of a 'phase-out' is correct, the reasoning and evidence used are incorrect. The ground truth relies on the plan’s removal from 'available for future issuance' lists and eventual omission, not share reserve trends in successor plans. The conclusion is partially aligned but based on invalid premises. Thus, despite some contextual relevance and correct mention of newer plans, the answer lacks factual and quantitative fidelity to the actual 2003 plan, warranting a mid-low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 511,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CMCSA's integration and expansion of data-driven services within its advertising offerings evolve from 2022 through 2024, and what specific enhancements were made to its technology, tools, and marketplace solutions during this period?",
      "original_answer": "In 2022, CMCSA's advertising business offered technology, tools, data-driven services, and marketplace solutions to help advertisers better engage with target audiences, with a focus on digital platforms and multichannel video provider partnerships. By 2023, the company expanded these offerings, integrating data-driven services more deeply into its advertising ecosystem, including the use of cloud-based platforms and integrated search functionality across content sources. In 2024, CMCSA further refined its data-driven services by enhancing its digital advertising tools and strengthening its representation agreements with third parties, both domestically and internationally, to improve advertiser reach and targeting precision. The evolution from 2022 to 2024 reflects a strategic shift toward more integrated, technology-enabled advertising solutions that leverage CMCSA's cloud infrastructure and data analytics capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA moved its data‑driven advertising stack from a basic set of technology, tools and marketplace solutions (2022) to a fully integrated offering that combines the cloud‑based X1/Flex platforms, DOCSIS 4.0 multigigabit broadband and the 2023 launch of the ad‑supported NOW streaming service, which adds programmatic access to free‑streaming channels and a unified marketplace across linear, on‑demand and DTC content. By 2024 the company broadened this stack with representation agreements for third‑party ad sales, richer analytics and AI‑enabled targeting, and an expanded marketplace that spans its U.S. X1, UK/Sky Q and Italian platforms, delivering seamless, cross‑device ad engagement for advertisers.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of CMCSA's data-driven advertising services from 2022 to 2024 and correctly identifies a strategic shift toward integrated, technology-enabled solutions. However, it introduces specific details not present in the ground truth, which affects factual accuracy. The original answer states that in 2022, CMCSA offered technology, tools, and data-driven services with a focus on digital platforms and MVPD partnerships. The LLM response aligns broadly but adds unverified specifics like 'DOCSIS 4.0 multigigabit broadband' and the 'ad-supported NOW streaming service launch in 2023', which are not mentioned in the ground truth. Similarly, the 2024 enhancements in the original answer include strengthened representation agreements and refined digital tools, while the LLM adds 'AI-enabled targeting' and expansion across UK/Sky Q and Italian platforms—details absent from the verified answer. While the direction of evolution (increased integration, cloud platforms, broader marketplace) is consistent, the LLM over-specifies technologies and product names not confirmed in the source. Quantitatively, no hard numbers (e.g., dollar amounts, percentages) are involved, so accuracy hinges on correct naming and timing of initiatives. The years 2022–2024 are used appropriately, but the attribution of specific launches (e.g., NOW in 2023) lacks support. The reasoning is logically structured and shows multi-hop understanding of progression over time, but relies on potentially hallucinated details. Contextually, the answer is highly relevant and addresses all parts of the question with a coherent narrative. Thus, while the qualitative direction is correct, the inclusion of unsupported specifics reduces factual correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 485,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk positioning in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the company held $574 million in CMBS with $12 million in unrealized losses. By 2023, the fair value of CMBS dropped to $675 million, while unrealized losses increased to $100 million. In 2024, the CMBS holdings fell further to just $6 million with no significant unrealized losses reported. This indicates a strategic reduction in CMBS exposure, particularly in 2024, suggesting a de-risking move by CVS amid rising unrealized losses in 2023.",
      "llm_answer": "\nCVS’s commercial‑mortgage‑backed‑securities (CMBS) exposure grew from **$568 million in fair value with $12 million of unrealized losses in 2022** (Chunk 3) to **$675 million in fair value with $100 million of unrealized losses in 2023** (Chunk 1), indicating a modest rise in both size and credit‑related loss risk.  By 2024 the company had **drastically reduced that exposure to only $3 million in fair value** (Chunk 2), and while the 2024 filing does not separately report unrealized losses for CMBS, the steep decline signals a deliberate de‑risking of the portfolio, markedly lowering CVS’s exposure to the interest‑rate and credit risks inherent in this asset class.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in its overall narrative: CVS increased CMBS fair value from 2022 to 2023, experienced rising unrealized losses, and then drastically reduced exposure by 2024, indicating de-risking. However, there is a critical error in the 2022 fair value: the LLM reports $568 million, while the ground truth is $574 million. This $6M discrepancy, though relatively small, affects quantitative accuracy. Additionally, the 2024 fair value is reported as $3 million in the LLM answer versus $6 million in the ground truth—another minor but factual inaccuracy. The 2023 figures ($675M fair value, $100M unrealized losses) are correct. The absence of unrealized losses in 2024 is correctly noted as not separately reported, which aligns with the original answer stating 'no significant unrealized losses reported.'\n\n2) Quantitative accuracy is compromised by the incorrect 2022 and 2024 fair value figures. While the direction and magnitude of change are generally accurate (increase in 2023, sharp drop in 2024), precise values matter in financial analysis. The $568M vs $574M difference may stem from misreading a source, and $3M vs $6M in 2024 is unexplained. These errors prevent a higher score despite correct 2023 data.\n\n3) Qualitatively, the reasoning is sound: the LLM correctly infers that the steep reduction in 2024 suggests de-risking, especially after a large increase in unrealized losses in 2023. It appropriately links rising losses to credit and interest rate risks, demonstrating good synthesis and logical inference across years. The use of terms like 'deliberate de-risking' matches the original's 'strategic reduction' and 'de-risking move,' showing semantic equivalence.\n\n4) Contextual relevance is excellent—the answer directly addresses all parts of the question: evolution of exposure (fair value and unrealized losses), trend interpretation, and risk positioning. It synthesizes multi-hop data across three years and draws a valid conclusion. Despite minor numerical inaccuracies, the core message about risk reduction is preserved. Hence, correctness is scored at 7 due to factual errors in key numbers, but qualitative and contextual performance is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 588,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did the scope and value of merchandise discounts offered to employees evolve across Target's 2022, 2023, and 2024 disclosures, and what does this multi-year progression suggest about the company's employee benefit strategy?",
      "original_answer": "Across the three years, merchandise discounts remained a consistent component of Target's employee compensation package, but the framing and emphasis evolved alongside broader benefits enhancements. In 2022, merchandise discounts were listed among core benefits, alongside a minimum wage of $15/hour. By 2023, the wage range had expanded to $15–$24/hour, and merchandise discounts were included in a more detailed benefits package that now emphasized financial wellness components like 401(k) matching and tuition reimbursement. In 2024, merchandise discounts remained part of the compensation structure, but were presented within an expanded benefits ecosystem that included mental health services and virtual healthcare—suggesting a strategic shift toward holistic employee well-being while maintaining traditional perks. This evolution indicates a benefits strategy that preserves foundational offerings while layering in new, modern benefits to enhance employee satisfaction and retention.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 filings Target repeatedly lists “merchandise and other discounts” as a core element of its compensation package, with eligibility tied to full‑time/part‑time status, work location and tenure (Chunk 3; Chunk 1; Chunk 2). The wording and scope of this benefit remain essentially unchanged over the three years, consistently appearing alongside other financial, health and education perks (Chunk 1 & 2). This persistent inclusion—reflected in the KG relationship where Target (ORG) offers Merchandise Discounts (FIN_INST) to its workforce—demonstrates a deliberate, multi‑year employee‑benefit strategy aimed at enhancing financial well‑being and retention.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that merchandise discounts remained a core part of Target's employee benefits across 2022–2024 and were tied to employment status, location, and tenure. It correctly identifies the persistent inclusion of the benefit and links it to employee retention and financial well-being, which aligns with the ground truth. However, the LLM fails to capture the key evolution in framing and strategic emphasis described in the original answer. Specifically, it omits the wage increase from $15/hour in 2022 to $15–$24/hour in 2023, and does not mention the expansion of benefits to include 401(k) matching, tuition reimbursement, mental health services, and virtual healthcare in 2024. These omissions are significant because the question asks about the evolution of the benefit's scope and what it suggests about Target’s broader employee benefit strategy. The original answer highlights a strategic shift toward holistic well-being, which the LLM answer does not reflect. While the LLM correctly notes consistency in the discount offering, it misses the multi-hop synthesis of how other benefits evolved alongside it, leading to an incomplete and less nuanced conclusion. Quantitative accuracy is perfect—no numbers or dates are incorrect, and none are misrepresented. Contextual relevance is high because the answer addresses the core benefit and its role in compensation, but the lack of progression analysis reduces its overall correctness. Qualitative accuracy is moderate due to correct entity identification (Target, merchandise discounts) and logical structure, but flawed reasoning in capturing strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> FIN_INST <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 452,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Linde's emphasis on cultural challenges during acquisition integration evolve from 2022 to 2024, and what does this reveal about the company's strategic approach to managing cross-border integration risks?",
      "original_answer": "From 2022 to 2024, Linde consistently highlighted cultural challenges as a key risk in acquisition integration, but the depth and framing of the discussion evolved. In 2022, cultural challenges were listed among several integration risks, specifically tied to integrating employees from acquired companies and managing differences in operations across borders. By 2023, the company expanded on these concerns by emphasizing the broader context of global regulatory and compliance risks, indicating a more strategic awareness of how cultural differences could compound legal and operational complexities. In 2024, cultural challenges were again mentioned, but with a sharper focus on the potential negative impact on financial results if integration efforts fail to achieve synergies and retain key personnel. This progression shows that while cultural integration remained a persistent concern, Linde increasingly framed it in terms of strategic risk management and financial outcomes rather than just operational hurdles.",
      "llm_answer": "\nLinde’s focus on cultural challenges as a core integration risk remained constant from 2022 through 2024, but the wording evolved from a single bullet‑point in the 2022 filing to a repeated, more detailed warning in the 2023 and 2024 disclosures that explicitly ties cultural mis‑alignment to the difficulty of integrating cross‑border acquisitions and to the risk of failing to achieve synergies.  This progression shows that Linde treats cultural integration not only as an operational hurdle but also as a strategic priority, mitigating it through rigorous pre‑deal due‑diligence, targeted investment in integration tools, and alignment with broader regulatory compliance (e.g., anti‑corruption, sanctions and environmental rules) to manage the cross‑border risks that can otherwise impair financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Linde consistently emphasized cultural challenges from 2022 to 2024, with increasing depth. The evolution from a bullet-point mention in 2022 to more detailed disclosures in 2023 and 2024 is correctly captured. The linkage of cultural misalignment to synergy risks and cross-border integration is consistent with the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all years (2022, 2023, 2024) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes Linde’s evolving risk disclosures across years and correctly infers a strategic shift in framing cultural integration as a financial and compliance risk, not just operational. The mention of regulatory compliance (anti-corruption, sanctions, environmental rules) adds context supported by the 2023 expansion on regulatory risks in the ground truth. (4) The only minor gap is that the LLM introduces specific mitigation strategies—'rigorous pre-deal due-diligence, targeted investment in integration tools'—which, while plausible, are not explicitly stated in the ground truth. This slightly exceeds the evidence but does not contradict it. Overall, the answer captures the core evolution and strategic implications accurately, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 411,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 to 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, and further dropped to $491 million in 2024. This consistent decline suggests a strategic reduction in derivative exposure or improved offsetting mechanisms over the three-year period.",
      "llm_answer": "\nExxonMobil’s collateral that backs master‑netting arrangements and is tied to the “Notes and accounts receivable – net” line was $641 million at the end of 2022, rose to $800 million in 2023, and then fell to $491 million by the end of 2024 (as disclosed in the 2022, 2023 and 2024 10‑K filings).  This swing—upward in 2023 and downward in 2024—reflects a dynamic adjustment of the margin‑related collateral that the company maintains to offset derivative positions, indicating that ExxonMobil actively manages its derivative exposure by scaling the required collateral in response to changing market and credit conditions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, collateral decreased from $1,494 million in 2022 to $800 million in 2023 and further to $491 million in 2024. However, the LLM incorrectly states the 2022 value as $641 million (should be $1,494 million), and describes an increase from 2022 to 2023, which contradicts the actual downward trend. Only the 2023 and 2024 figures ($800M and $491M) are correct. (2) The calculation of change over time is therefore flawed: the true net change from 2022 to 2024 is a decrease of $1,003 million, but the LLM implies a peak in 2023 after an increase, misrepresenting the trend. (3) While the LLM correctly identifies the metric (collateral under master netting arrangements tied to Notes and accounts receivable - net), company (ExxonMobil), and years (2022–2024), the multi-hop reasoning is compromised due to incorrect base data. The qualitative interpretation about active management based on market conditions is plausible but diverges from the ground truth’s conclusion of a 'strategic reduction in derivative exposure or improved offsetting mechanisms.' The LLM infers volatility-driven adjustments, while the truth suggests a consistent strategic decline. (4) Despite incorrect numbers and reasoning, the answer remains contextually relevant by addressing both parts of the question—trend over time and implications for derivative exposure management—and referencing the correct financial line item and filings. Hence, partial credit is given for structure and relevance, but major deductions apply for factual inaccuracy, especially in the critical 2022 figure and overall trend description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 468,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with external tools, remediation processes, and alignment with broader cybersecurity strategies?",
      "original_answer": "In 2022, the Security Insights Platform was described as a solution that interprets and assesses mainframe security posture, identifies risks, and develops remediation steps, with data available for use with in-house tools for security information and event management (SIEM). By 2023, the platform maintained a similar description but was more explicitly tied to AVGO's broader cybersecurity portfolio, emphasizing proactive risk response and alignment with modern security practices. In 2024, the platform retained its core functionality but was now contextualized within an expanded mainframe software suite that included Cybersecurity, AIOps, and DevOps, indicating a more strategic role in enterprise-wide security planning and regulatory compliance. This evolution shows a shift from a standalone risk assessment tool toward a more integrated and strategically aligned component of AVGO’s cybersecurity offerings.",
      "llm_answer": "\nFrom 2022 to 2024 the Security Insights Platform evolved from a standalone mainframe‑security‑posture analyzer that identified risks and generated ad‑hoc remediation steps and fed those results into internal SIEM tools (Chunk 1) into a core element of a broader cybersecurity suite that not only continues to provide ongoing risk assessment and remediation but also shares its data with external security products—such as the Lateral Security Firewall and Advanced Threat Prevention—and integrates those outputs into DevOps/AIOps and automation workflows (Chunks 2 & 3).  This progression reflects a strategic alignment with overall cybersecurity objectives: tighter integration with open‑source and partner ecosystems, proactive risk‑response across both mainframe and distributed environments, and support for holistic, automated remediation that is coordinated with the company’s Beyond‑Code partnership and value‑stream management initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of AVGO's Security Insights Platform from 2022 to 2024 as described in the ground truth. It correctly identifies the platform’s initial role in 2022 as a standalone tool for assessing mainframe security posture and generating remediation steps, with integration into internal SIEM tools. The answer accurately reflects the 2023 shift toward alignment with broader cybersecurity strategies and proactive risk response. In 2024, it correctly notes the platform’s integration into a larger suite including DevOps and AIOps, and its expanded strategic role in enterprise security and compliance. The mention of integration with external tools like 'Lateral Security Firewall' and 'Advanced Threat Prevention' goes slightly beyond the ground truth, which does not name specific external tools but does support the idea of broader integration—this is a minor over-specification but does not contradict the truth. The reference to 'Beyond-Code partnership' and 'value-stream management' is contextually plausible but not explicitly confirmed in the ground truth; however, it aligns with the theme of strategic alignment. There are no numerical inaccuracies (quantitative accuracy is perfect as no numbers are misstated). The reasoning is sound, demonstrating multi-hop synthesis across years and strategic themes. The answer is semantically equivalent to the original, with slightly more detailed phrasing on integrations. Thus, the correctness score is 9 due to minor elaborations not present in the ground truth, but overall fidelity is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 438,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did SPG's face value and interest rate exposure to Unsecured Notes - 32B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "In 2022, SPG disclosed a face amount of $750,000,000 for Unsecured Notes - 32B with an interest rate of 3.38% maturing on June 15, 2027. In 2023, the same note was still outstanding with identical terms, indicating no principal reduction or refinancing activity. By 2024, the face amount and interest rate remained unchanged at $750,000,000 and 3.38%, respectively, with the maturity date still set for 2027. This consistent exposure over three years suggests a stable long-term debt strategy, where SPG has chosen to maintain the original terms of Unsecured Notes - 32B without early redemption or restructuring, despite potential shifts in market interest rates and overall debt composition.",
      "llm_answer": "\nAcross the 2022‑2024 filings, SPG’s Unsecured Notes – 32B kept the same face amount of $750 million (reported as 750,000) and a fixed coupon of 3.38 % in every year, with no new issuance, amendment or maturity disclosed in any of the three documents. This unchanged exposure shows that SPG’s long‑term debt strategy relies on preserving a stable, low‑cost funding pillar while it supplements liquidity through newer, higher‑rate notes and revolving facilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the face amount ($750 million, reported as 750,000 in thousands), interest rate (3.38%), and consistent terms across 2022–2024, matching the ground truth. The maturity date (2027) is implied by consistency in filings, though not explicitly restated in the LLM answer, which is a minor omission. (2) All numeric values are accurate: $750 million (correctly interpreted from 750,000 in thousands), 3.38% interest rate, and no changes over the three years. Format variation ($750 million vs. $750,000,000) is acceptable and common in financial reporting. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years and correctly infers no refinancing, early redemption, or amendment occurred. It accurately concludes that SPG maintained stable debt terms. (4) The qualitative interpretation slightly extends beyond the original answer by suggesting SPG supplements liquidity with 'newer, higher-rate notes and revolving facilities.' While plausible and contextually reasonable, this point is not directly supported by the provided ground truth and introduces external inference. However, it does not contradict the data and aligns with typical debt management behavior. Overall, the answer is factually correct, complete in core elements, and semantically equivalent to the ground truth with only minor interpretive addition.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 385,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the competitive threat posed by Lumen to CMCSA's broadband services evolved from 2022 through 2024, particularly in terms of fiber network expansion and service bundling strategies?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband market, with a clear escalation in competitive pressure as Lumen expanded its fiber-based infrastructure and emphasized bundled service offerings. In 2022, Lumen was noted as part of a group of wireline telecom companies building fiber infrastructure to deliver higher-speed services in CMCSA's footprint, with some bundling capabilities. By 2023, Lumen was explicitly called out as continuing to deploy fiber deeper into its network, enabling faster speeds and more competitive service packages. In 2024, the trend persisted, with Lumen still listed among top-tier wireline competitors, and the language suggested a continued focus on fiber expansion and bundled offerings as a core competitive strategy. This indicates a consistent and possibly intensifying competitive threat from Lumen over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Lumen steadily expanded its fiber‑to‑the‑home infrastructure, extending fiber deeper into the same markets CMCSA serves and delivering broadband speeds that exceed the traditional DSL limits that CMCSA’s network can provide—an evolution repeatedly noted in the 2022, 2023 and 2024 10‑K filings.  At the same time, Lumen has broadened its competitive pressure by bundling its fiber‑based broadband with video and wireless services (mirroring CMCSA’s own bundling strategies), thereby intensifying the threat to CMCSA’s broadband revenues over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Lumen's fiber expansion from 2022 to 2024 is accurately described, with consistent mention of fiber-to-the-home deployment and deeper network reach, matching the original answer's emphasis on 'deploying fiber deeper' and 'building fiber infrastructure.' The bundling of broadband with video and wireless services is correctly identified as a competitive strategy, mirroring CMCSA’s approach—this is consistent with the ground truth noting Lumen's bundling capabilities and intensified competitive posture. (2) There are no numeric values (e.g., dollar amounts, percentages, subscriber counts) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022–2024) are correctly used. (3) Multi-hop reasoning is sound: the LLM synthesizes information across the three years and correctly infers an intensifying competitive threat based on infrastructure and strategic developments. It correctly identifies Lumen as a persistent and evolving competitor, which reflects the knowledge graph's conclusion of a 'consistent and possibly intensifying competitive threat.' (4) The only reason for not scoring a perfect 10 is minor: the LLM slightly strengthens the claim by stating Lumen's speeds 'exceed the traditional DSL limits that CMCSA’s network can provide'—while plausible, this specific technical comparison is not explicitly confirmed in the ground truth, which focuses on fiber expansion and bundling without direct speed comparisons. However, this does not constitute a factual error but rather a small inferential step beyond the provided data. Overall, the answer is factually correct, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 480,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the penetration rate of Target's branded payment cards evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy over time?",
      "original_answer": "The penetration rate of Target's branded payment cards declined from 20.5% in 2022 to 19.8% in 2023, and further to 17.8% in 2024. This downward trend suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy or a shift in consumer payment behavior away from the branded cards during this period.",
      "llm_answer": "\nThe penetration of Target’s loyalty‑driven payment cards has been falling: RedCard (later rebranded as the Target Circle Card) penetration was 20.5 % in FY 2022, 19.8 % in FY 2023 and 18.6 % in FY 2024 (and 17.8 % in FY 2025), as reported in the 10‑K filings (Chunk 1 and Chunk 2). Because the 5 % discount tied to these cards is tracked specifically for generating incremental sales, the steady decline signals that the loyalty‑based payment strategy is becoming less effective at driving additional purchases over time (Chunk 3 provides the broader loyalty‑program context and the discount mechanism).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target's branded payment card penetration from 20.5% in 2022 to 19.8% in 2023, which matches the ground truth. However, it incorrectly states the 2024 penetration as 18.6%, whereas the ground truth reports 17.8%. It further introduces a figure for FY 2025 (17.8%), which was not part of the original question or ground truth, suggesting potential hallucination or misattribution. (2) The quantitative accuracy is compromised by the incorrect 2024 value and the inclusion of an out-of-scope 2025 figure. The correct values should be 20.5% (2022), 19.8% (2023), and 17.8% (2024). The calculation of trend direction (declining) is accurate, but the magnitude of decline in 2024 is misrepresented. (3) The reasoning is sound in interpreting the declining penetration as a sign of reduced effectiveness in Target's loyalty-driven payment strategy, aligning with the ground truth's conclusion. The mention of the 5% discount and its role in driving incremental sales adds relevant context supported by the filings, demonstrating good multi-hop synthesis between card penetration and loyalty program mechanics. (4) Despite the numerical error in the 2024 figure, the answer remains contextually relevant and addresses both parts of the question—evolution of penetration and strategic implication. The core conclusion is consistent with the ground truth, warranting a moderate score. The error in a key data point prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 424,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Chevron's financial and operational engagement with the Republic of Congo evolve from 2022 through 2024, particularly in terms of asset ownership, investment levels, and strategic positioning in the region?",
      "original_answer": "Chevron's engagement with the Republic of Congo evolved significantly from 2022 to 2024. In 2022, the Republic of Congo was listed among Chevron's key operational countries, indicating active presence and strategic importance. In 2023, Chevron invested approximately $0.7 billion in offshore development and natural gas projects across Africa, including the Republic of Congo, signaling continued capital commitment to the region. However, by 2024, Chevron sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, marking a strategic exit from its upstream assets in the country. This shift reflects a transition from active investment and development to divestiture, suggesting a realignment of Chevron's portfolio toward higher-priority regions.",
      "llm_answer": "\nChevron’s involvement in the Republic of Congo deepened from 2022 through 2024 as a non‑operated participant in offshore blocks—most notably holding a 31.5 % stake in the Haute Mer permit and a 15.75 % interest in the Congolese portion of the Lianzi field—while the company directed roughly **$0.7 billion** of its Africa‑wide capital program to offshore development and natural‑gas projects in Congo, a figure embedded in the $9.1 billion spent on oil‑and‑gas activities worldwide in 2023 (see Chunk 3).  This investment aligned with Chevron’s broader strategy of expanding gas‑focused production and securing a strategic foothold in Central‑African energy supplies, a positioning highlighted in the 2024 discussion of regional developments (Chunk 2).  However, by **January 2025** the company **sold** those interests, exiting its 31.5 % stake in Haute Mer and its 15.75 % stake in Lianzi, marking a strategic pull‑back from the specific Congolese assets while retaining a broader operational presence in the region (Chunk 2).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's asset ownership (31.5% in Haute Mer, 15.75% in Lianzi), the $0.7 billion investment in African offshore and gas projects including Congo, and the strategic divestiture. However, it incorrectly states the sale occurred in 'January 2025' instead of by 2024 as per the ground truth, which is a significant factual error in timing. This misrepresents the timeline of Chevron's exit. (2) Quantitatively, the percentages (31.5%, 15.75%) and dollar amount ($0.7 billion) are accurate and match the ground truth. The reference to $9.1 billion in global spending is contextually correct but not directly relevant to the question. The critical error is the date of the sale—'January 2025' contradicts the ground truth stating the divestiture was completed 'by 2024', making the quantitative accuracy score lower due to this key temporal inaccuracy. (3) The multi-hop reasoning is largely sound: the model synthesizes Chevron’s operational presence, investment, and eventual exit across years and documents. It correctly infers strategic positioning and portfolio realignment. However, the incorrect date undermines the logical flow of events, suggesting the exit happened after the reporting period (2022–2024), which is not consistent with the ground truth. (4) Despite the date error, the answer is contextually relevant and covers all aspects of the question—asset ownership, investment levels, and strategic positioning—with strong qualitative reasoning. The core narrative of engagement followed by divestiture is correct, warranting a correctness score of 7 due to the material but not fundamental nature of the error.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Invests_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 457,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the shift in fair value and implied volatility reveal about the company's risk positioning in gas markets over time?",
      "original_answer": "In 2022, NextEra Energy reported a fair value of $356 million in assets and $347 million in liabilities for options primarily tied to gas, with implied volatilities averaging 36%. By 2023, the fair value of these options dropped significantly to $100 million in assets and $97 million in liabilities, while implied volatilities increased to an average of 50%. In 2024, the fair value of gas-related options remained at $100 million in assets but slightly exceeded liabilities at $102 million, with implied volatilities decreasing to 52%. This trajectory shows a sharp reduction in exposure from 2022 to 2023, followed by stabilization, while volatility expectations increased and then slightly moderated, suggesting a strategic de-risking in gas options with a cautious outlook on price variability.",
      "llm_answer": "\nNextEra Energy’s gas‑related option book contracted markedly from 2022 to 2024: the fair‑value of the “Options – primarily gas” line fell from **$356 million (asset) and $347 million (liability)** in 2022 (Chunk 1) to **$100 million (asset) and $97 million (liability)** in 2023 (Chunk 2), and then remained essentially balanced at **$100 million (asset) and $102 million (liability)** by the end of 2024 (Chunk 3).  At the same time, the weighted‑average implied volatility of those options rose from **≈36 % in 2022** (Chunk 1) to **≈50 % in 2023** and **≈52 % in 2024** (Chunks 2‑3), signalling that market expectations of gas‑price swings intensified while the company’s position moved from a sizable net‑asset exposure toward a near‑neutral book, reflecting a more defensive or hedged risk posture as volatility increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key numerical values from the ground truth: fair values of assets and liabilities for gas-related options in 2022 ($356M assets, $347M liabilities), 2023 ($100M assets, $97M liabilities), and 2024 ($100M assets, $102M liabilities), as well as implied volatilities (36% in 2022, 50% in 2023, 52% in 2024). Minor formatting differences (e.g., '≈36%' vs '36%') are acceptable and do not affect factual accuracy. (2) All numbers match exactly or are semantically equivalent; no calculation errors are present. The net exposure trend (from net asset to near-neutral) is accurately described. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years, identifies the sharp reduction in exposure, links it to rising implied volatility, and infers a more defensive risk posture. The conclusion about strategic de-risking and cautious outlook is logically supported and aligns with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly use the phrase 'strategic de-risking' or 'cautious outlook' as in the original, though the meaning is effectively conveyed through 'near-neutral book' and 'defensive or hedged risk posture'. This slight omission in phrasing does not detract from factual correctness, hence a score of 9/10 on correctness and qualitative accuracy. Quantitative accuracy and contextual relevance are perfect, as all data points are correct and fully address the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 413,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Nike's treatment of FlyEase technology evolve from 2022 to 2024, and what does this progression indicate about its role in the company's innovation strategy?",
      "original_answer": "In 2022, Nike introduced FlyEase as part of its broader innovation portfolio, listing it alongside other technologies like Nike Air and Flyknit, signaling its initial strategic positioning. By 2023, the company expanded FlyEase's presence in product development, emphasizing its integration into various categories and consumer applications, which reflects a deliberate effort to scale the technology. In 2024, FlyEase was fully embedded in Nike's innovation narrative, appearing consistently in the product research and development section as a core technology, indicating its established role in the company's long-term design and performance strategy. This progression shows that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation pipeline.",
      "llm_answer": "\nFrom 2022 through 2024 Nike repeatedly listed **FlyEase** alongside its other performance technologies (Nike Air, Zoom, Free, Dri‑Fit, Flyknit, ZoomX, React, etc.) in the R&D sections of its 10‑K filings, but the 2023 and 2024 disclosures placed it in a more prominent “proliferation” context that ties the technology to the company’s broader innovation agenda and to inclusive design goals.  The knowledge‑graph links (NKE → FlyEase [PRODUCT] → FlyEase [ORG] → NKE) treat FlyEase as a strategic product entity owned by Nike, underscoring that the company views the technology not merely as a feature but as a core, organization‑level innovation pillar that drives new product experiences across footwear and apparel.  This progression signals that FlyEase has evolved from an ancillary capability to a central element of Nike’s innovation strategy—leveraging technical advances to enhance athletic performance, reduce injury, and expand accessibility while reinforcing the firm’s commitment to purpose‑driven, high‑performance product development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FlyEase was introduced in 2022 as part of Nike's innovation portfolio, gained prominence in 2023 with emphasis on proliferation and inclusive design, and by 2024 was embedded as a core technology in R&D—this progression is accurately captured. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense; however, the years (2022, 2023, 2024) are correctly used and consistent with the original answer, earning full marks. (3) The multi-hop reasoning is sound: the LLM synthesizes FlyEase’s evolving role across years and connects it to broader strategic themes like inclusive design and innovation scaling, correctly interpreting its elevation from ancillary feature to core pillar. The mention of knowledge-graph links adds analytical depth without contradicting facts. (4) Semantic equivalence is strong—the LLM conveys that FlyEase evolved from a newly introduced concept to a foundational element of Nike’s innovation strategy, using different but equivalent phrasing (e.g., 'ancillary capability' → 'central element'). The only minor gap is that the original answer explicitly states FlyEase was 'fully embedded' and 'consistently appearing' in R&D sections by 2024, while the LLM implies this through 'proliferation context' and strategic ownership; this nuance is present but slightly less explicit. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Expands]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 434,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial obligations tied to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's financial obligations tied to Unsecured Notes - 35A remained consistent at $750,000 in face amount across all three years (2022, 2023, and 2024), with an unchanged interest rate of 2.65% and annual debt service of $19,875. However, the maturity date for these notes was consistently listed as 07/15/30 across all disclosures, indicating a stable long-term commitment to this debt instrument. This consistency reveals that SPG maintained a steady approach to this segment of its capital structure, avoiding refinancing or restructuring of these notes despite market fluctuations.",
      "llm_answer": "\nFrom 2022 through 2024 SPG’s Unsecured Notes‑35A stayed constant at a $750 million face amount, a 2.65 % interest rate and roughly $19.9 million of annual debt service, maturing on 7/15/30 (see Chunk 1, 2 & 3).  During the same period the company’s total consolidated unsecured indebtedness grew from $20.0 bn (2022) to $21.0 bn (2023) and then declined to $19.4 bn (2024), causing the 35A tranche’s proportion of overall debt to dip slightly, while SPG’s “Our Share of Consolidated Indebtedness” peaked in 2023 and fell in 2024 (Chunks 1‑3).  This steady, low‑cost, long‑dated obligation shows SPG’s long‑term debt strategy of anchoring its capital structure with a fixed‑rate, far‑out‑maturity tranche to lock in financing and reduce refinancing risk while it manages the laddered maturities of its other debt facilities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key financial figures. The ground truth states that the face amount of Unsecured Notes - 35A is $750,000, but the LLM incorrectly reports it as $750 million—a 1,000-fold error. Similarly, the annual debt service is stated as $19,875 in the original answer, but the LLM rounds it to $19.9 million, which is off by three orders of magnitude. The interest rate (2.65%) and maturity date (07/15/30) are correctly reported. (2) These quantitative inaccuracies severely undermine the answer’s reliability. While the LLM correctly notes consistency across years, the magnitude of the numerical errors renders the financial portrayal misleading. The additional context about total consolidated unsecured indebtedness and 'Our Share' is not part of the ground truth and appears to be inferred or pulled from unrelated data, introducing unverified information. (3) The multi-hop reasoning is partially sound in that the model attempts to situate the 35A notes within a broader debt strategy, discussing refinancing risk and maturity laddering. However, this reasoning is built on false quantitative foundations and includes extraneous data not supported by the original answer, weakening the logical synthesis. (4) The contextual relevance is high because the LLM addresses both parts of the question—evolution of obligations and implications for debt strategy—and provides a coherent narrative. However, due to the critical numerical inaccuracies, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because the conceptual framework (stable long-term tranche reducing refinancing risk) aligns with the original answer’s implication, but it is undermined by incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 482,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent positioning reveal about its long-term growth strategy centered on free cash flow per share?",
      "original_answer": "Texas Instruments has consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024, framing them as a key driver in achieving long-term growth in free cash flow per share. In 2022, the company highlighted the tangible benefits of its four competitive advantages, including a broad portfolio of analog and embedded processing products that offer more opportunity per customer and more value for investments. In 2023, TI reiterated this strategic focus, underscoring that embedded processing products are central to its unique business model and long-term investment decisions. In 2024, the company maintained this narrative, emphasizing that embedded processing products continue to be foundational in leveraging its competitive advantages and guiding capital allocation. This consistent emphasis reveals that TI views embedded processing as a stable, high-margin, and scalable segment that supports its long-term objective of maximizing free cash flow per share.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 MD&A excerpts (Chunk 3, Chunk 1 and Chunk 2), Texas Instruments repeatedly states that its **strategic emphasis on analog and embedded‑processing products is a core pillar of the same four sustainable competitive advantages** and that this focus is maintained year‑over‑year.  By consistently positioning embedded‑processing products within its portfolio—and by tying every strategic decision to the **long‑term growth of free cash flow per share**—the company signals that these products are the primary cash‑generating engine it will continue to invest in, leverage for margin strength, and use to drive shareholder value.  This steady, multi‑year emphasis reveals a long‑term growth strategy that is **capital‑disciplined, efficiency‑focused, and centered on converting the cash‑flow potential of its embedded‑processing business into sustained per‑share returns**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer, with only minor differences in emphasis. (1) All factual elements are correct: Texas Instruments' consistent strategic emphasis on embedded processing products across 2022, 2023, and 2024 is accurately represented, and the connection to free cash flow per share as a long-term growth objective is clearly and correctly stated. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across the three years (referencing MD&A excerpts from Chunk 3, 1, and 2) and links the sustained focus on embedded processing to TI’s competitive advantages and capital allocation strategy. It accurately infers that this consistency reflects a capital-disciplined, efficiency-focused strategy aimed at maximizing per-share cash flow. (4) The LLM slightly generalizes the year-specific details (e.g., doesn’t explicitly break down what was said in each year like the original), but it captures the essence of each year’s messaging by emphasizing continuity. The original answer provides more granular year-by-year context (e.g., 'in 2022, the company highlighted...'), which the LLM condenses. However, this does not detract from factual correctness. The LLM also correctly identifies that embedded processing is part of a broader portfolio including analog products and ties this to competitive advantage and shareholder value. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 458,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Disney's strategic use of the Marvel brand across its streaming platforms evolve from 2022 to 2024, and what does this evolution indicate about its financial strategy in driving subscriber growth, particularly on Disney+ where Marvel became a top-level tile by 2023 and remained a key intangible asset in 2024?",
      "original_answer": "In 2022, Marvel was listed as an indefinite-lived intangible asset, alongside ESPN and Pixar, highlighting its brand value as a core asset on Disney's balance sheet. By 2023, Marvel had transitioned into an active strategic component of Disney+'s user interface, becoming a top-level 'tile' with branded programming, which was a key differentiator in the competitive DTC market. This shift was supported by Disney's plan to launch ESPN+ as a tile in early fiscal 2025, indicating a broader strategy to leverage its branded content for platform engagement. In 2024, Marvel remained listed as an indefinite-lived intangible asset, showing continued recognition of its brand equity. This 3-year progression reflects a financial and strategic pivot from passive asset recognition to active brand utilization in driving subscriber engagement — a shift that aligns with Disney's reported Disney+ subscriber base of 123 million as of September 28, 2024. The integration of Marvel content into the core streaming interface likely contributed to subscriber retention and growth, leveraging brand strength to justify continued asset valuation and platform differentiation.",
      "llm_answer": "\nIn 2022 and again in 2024 Disney lists Marvel trademarks (alongside ESPN, Pixar and FCC licenses) as indefinite‑lived intangible assets, highlighting their long‑term strategic value (Chunk 1 & Chunk 3). By 2023 Marvel was elevated to a top‑level “tile” on Disney+—and, through Disney+ Hotstar, reached global audiences—while the company merged its former Star+ service into a single Disney+ offering by June 2024, contributing to paid subscriber totals of roughly 123 million on Disney+ and 36 million on Disney+ Hotstar as of September 2024 (Chunk 2). This evolution shows Disney’s financial strategy of using the Marvel brand as a subscriber‑growth engine across its DTC platforms, monetizing the intangible asset through higher subscription fees and advertising while sustaining growth in a competitive streaming market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel is correctly identified as an indefinite-lived intangible asset in 2022 and 2024; its elevation to a top-level tile on Disney+ in 2023 is accurately reported; the subscriber numbers (123 million for Disney+ and 36 million for Disney+ Hotstar as of September 2024) match the source data. These numbers are presented with correct context and formatting. (2) Quantitative accuracy is perfect: dates (2022, 2023, 2024), subscriber counts, and the June 2024 merger of Star+ are all factually correct. (3) Multi-hop reasoning is sound—LLM correctly synthesizes balance sheet treatment (intangible asset) with strategic UI changes and subscriber growth, linking financial asset valuation to platform strategy. It also correctly infers that Marvel is being leveraged as a growth engine. (4) The only minor shortcoming is that the original answer emphasizes a broader strategic parallel with ESPN+ (planned as a tile in 2025), which the LLM omits. While not critical, this nuance strengthens the strategic pattern in the ground truth. Otherwise, the LLM captures the core evolution and financial strategy accurately, with excellent contextual relevance and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 357,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the associated reinsurance recoverable balances?",
      "original_answer": "In 2022, MetLife reinsured 59.25% of the closed block through a modified coinsurance agreement, with $3.6 billion in unsecured reinsurance recoverable balances. By 2023, the percentage reinsured slightly decreased to 59%, while unsecured balances increased to $4.4 billion. In 2024, the percentage reinsured remained at 59%, but unsecured balances slightly declined to $4.2 billion. This indicates a relatively stable strategic use of the modified coinsurance agreement, with minor fluctuations in unsecured exposure.",
      "llm_answer": "\nFrom the 2022 Form 10‑K (Chunk 1) MetLife disclosed that 59.25 % of the closed block was reinsured under a modified‑coinsurance agreement and that net ceded reinsurance recoverables were $6.3 billion, of which $4.1 billion (65 %) came from its five largest reinsurers, including $1.9 billion that were unsecured. In the 2023 filing (Chunk 2) the same 59 % coverage persisted, but net ceded recoverables jumped to $16.7 billion, with 84 % ($14.1 billion) attributable to the five largest reinsurers and $2.5 billion of those balances unsecured. By the 2024 filing (Chunk 3) the coverage remained at 59 % while net ceded recoverables rose modestly to $17.6 billion, of which 84 % ($14.7 billion) were with the top five reinsurers and $2.4 billion were unsecured; in each year the arrangement is accounted for under the deposit method, with the deposit liability offset against the recoverable.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values compared to the ground truth. The percentage of the closed block reinsured is mostly correct—59.25% in 2022 and 59% in 2023 and 2024—but the reinsurance recoverable balances are incorrect. The LLM reports $1.9 billion unsecured in 2022, $2.5 billion in 2023, and $2.4 billion in 2024, whereas the ground truth specifies $3.6 billion in 2022, $4.4 billion in 2023, and $4.2 billion in 2024. These are major discrepancies in dollar amounts, with the LLM underreporting by over $1 billion each year. Additionally, the LLM references 'net ceded reinsurance recoverables' of $6.3B, $16.7B, and $17.6B, which are not mentioned in the ground truth and appear to be misinterpreted or conflated with other line items. (2) The calculations and comparisons are not accurate. For example, the LLM claims $2.5 billion of unsecured balances in 2023, but ground truth is $4.4 billion—a difference of nearly $2 billion. The trend of increasing then slightly decreasing unsecured balances is misrepresented due to incorrect base figures. (3) The multi-hop reasoning is partially sound in that the model tracks the evolution over three years and identifies the modified coinsurance agreement’s stability in percentage terms. However, it fails to correctly extract and synthesize the actual unsecured reinsurance recoverable balances, which are central to the question. The mention of the deposit method and concentration among top reinsurers adds contextual detail but is not part of the original question’s focus. (4) The contextual relevance is high because the answer addresses the evolution over time and the structure of the reinsurance agreement, but the severe quantitative inaccuracies drastically reduce correctness. The qualitative accuracy is low due to incorrect data sourcing, though the logical framework of year-over-year comparison is appropriate. Overall, the answer conveys a misleading picture due to wrong financial figures, warranting a low correctness score despite correct percentages and proper framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 564,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did CVS's investment in residential mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trend suggest about the company's risk exposure and strategic positioning in fixed-income assets?",
      "original_answer": "CVS's investment in residential mortgage-backed securities (RMBS) increased significantly from $629 million in 2022 to $614 million in 2023, and then declined sharply to $71 million in 2024. This pattern indicates a strategic pivot away from RMBS in 2024, following a multi-year period of relatively high exposure. The unrealized losses also rose from $10 million in 2022 to $60 million in 2023, reflecting increased risk exposure during that time. The sharp reduction in 2024 suggests a deliberate de-risking or reallocation strategy, likely in response to market conditions or internal portfolio rebalancing.",
      "llm_answer": "\nCVS’s residential‑mortgage‑backed‑securities (RMBS) position fell from $625 million in 2022 (Chunk 1) to $614 million in 2023 (Chunk 2) and then dropped sharply to $71 million in 2024 (Chunk 3), while unrealized losses expanded from $10 million to $60 million and would have continued to weigh on earnings; this contraction signals a deliberate de‑risking of the fixed‑income book as the firm reduced exposure to a higher‑volatility asset class and shifted toward more liquid, lower‑credit‑risk securities. The knowledge‑graph pattern—CVS → Residential mortgage‑backed securities (FIN_INST) and the instrument’s own link back to CVS—captures that the decline is a strategic repositioning rather than a passive market movement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and interpretation but contains a minor factual error in the 2022 RMBS value: it states $625 million instead of the correct $629 million from the ground truth. This small discrepancy affects quantitative accuracy. The 2023 ($614M) and 2024 ($71M) values are correct, as are the unrealized losses ($10M in 2022, $60M in 2023). (2) Calculations are not explicitly performed, but the trend description (decline from 2022 to 2023 to 2024) is accurate despite the initial number being off by $4M. The increase in unrealized losses is correctly noted. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across years and links the reduction in RMBS to de-risking and strategic repositioning, aligning with the ground truth’s conclusion about reduced risk exposure and portfolio rebalancing. It appropriately infers intent from quantitative trends. (4) The answer is contextually relevant and addresses both parts of the question—evolution of investment and implications for risk/strategy. Wording differs but meaning is semantically close. The minor numerical inaccuracy prevents a higher score, but reasoning and completeness are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 341,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did MetLife's use of the modified coinsurance agreement evolve from 2022 to 2024, particularly in terms of the percentage of the closed block reinsured and the accounting treatment under the deposit method?",
      "original_answer": "From 2022 to 2024, MetLife consistently reinsured approximately 59% of the closed block through a modified coinsurance agreement with an unaffiliated third-party reinsurer, and the accounting treatment remained unchanged under the deposit method with the right of offset applied. In 2022, the exact percentage was 59.25%, while in both 2023 and 2024, it was reported as 59%. The accounting policy remained consistent across all three years, with the Company offsetting the modified coinsurance deposit liability with the deposit recoverable. This indicates a stable strategic and accounting approach to managing the closed block through this specific reinsurance structure.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife continued to reinsure essentially the same share of its closed block—about **59 %** (59.25 % in 2022, 59 % in 2023 and 2024)—through an **unaffiliated third‑party modified coinsurance agreement**.  In each of the three years the company accounted for that arrangement under the **deposit method of accounting**, offsetting the deposit‑liability against the related deposit‑recoverable in its financial statements.  Thus, while the absolute amounts of ceded recoverables grew (e.g., $6.3 bn in 2021 to $16.7 bn in 2022 and $17.6 bn in 2024), the **percentage of the closed block reinsured remained steady at roughly 59 %**, and the **deposit‑method accounting treatment with offsetting was unchanged** across the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the percentages are correct: 59.25% in 2022 and 59% in 2023 and 2024, matching the original answer. The mention of increasing absolute amounts (e.g., $6.3B to $16.7B to $17.6B) is consistent with the growth in ceded recoverables over time, though these specific figures were not in the ground truth; however, they do not contradict it and may reflect additional context from filings. (2) The accounting treatment is correctly described: deposit method with offsetting of the liability and recoverable, unchanged across years. (3) Entity accuracy is strong—MetLife, closed block, modified coinsurance, unaffiliated third-party reinsurer, and correct years (2022–2024) are all properly identified. (4) Multi-hop reasoning is sound: the answer synthesizes data across years and correctly infers stability in both reinsurance percentage and accounting policy despite changing dollar amounts. The only minor shortcoming is the introduction of specific dollar figures not present in the ground truth, which, while plausible, are not verifiable from the provided truth and slightly extend beyond the given data. However, this does not detract significantly from correctness, as the core facts, trends, and reasoning are accurate. Thus, the answer earns a 9/10 for correctness, with high scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Accounts_For]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 387,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did NextEra Energy's net exposure to forward contracts for gas evolve from 2022 through 2024, and what does this trend suggest about the company's risk positioning in natural gas markets?",
      "original_answer": "NextEra Energy's net exposure to forward contracts for gas was $160 million in 2022 (assets of $191 million and liabilities of $31 million), decreased to $300 million in 2023 (assets of $377 million and liabilities of $77 million), and then declined to $250 million in 2024 (assets of $296 million and liabilities of $46 million). This trend indicates a general reduction in net exposure from 2023 to 2024, suggesting a more cautious stance or rebalancing in natural gas market commitments after a period of increased forward contracting.",
      "llm_answer": "\nNextEra Energy’s disclosed gas‑forward contracts show a net long position that grew and then modestly contracted from 2022‑2024.  Using the fair‑value tables, the net exposure (assets – liabilities) was roughly **$160 million long at the end of 2021 (the latest comparable figure in the 2022 filing), expanded to about $300 million long by the end of 2023, and pulled back to roughly $250 million long by the end of 2024**.  The decline in 2024—reflected by lower asset and liability values for forward contracts‑gas—suggests the company trimmed part of its earlier gas‑price hedge, moving toward a more neutral or de‑risked stance as market volatility eased.  This evolution, tracked across all three 10‑K disclosures, indicates a deliberate shift in NEE’s risk positioning in the natural‑gas market over the period.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net exposure values for 2023 ($300 million) and 2024 ($250 million), which match the ground truth. However, it incorrectly states that the $160 million net exposure corresponds to the end of 2021 based on the 2022 filing, while the ground truth clearly assigns $160 million to 2022 (with $191M assets and $31M liabilities). This misattribution of the year is a significant factual error. (2) The calculation of net exposure (assets minus liabilities) is conceptually correct and aligns with the ground truth methodology. The 2022 value of $160M is accurate in amount but wrongly labeled as 2021 data. The 2023 and 2024 figures are both numerically and temporally correct. (3) The multi-hop reasoning is sound—LLM synthesizes data across three years and interprets the trend in risk positioning appropriately. It correctly infers that the decline from $300M to $250M suggests de-risking or a more cautious stance, which matches the original answer’s conclusion. (4) Despite the year mislabeling for the first data point, the overall trend description and qualitative interpretation are accurate and relevant. The answer addresses both parts of the question: evolution of net exposure and its implication for risk positioning. The quantitative accuracy is penalized due to the incorrect year assignment, though the number itself is correct. Qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 408,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did AVGO's positioning of Industrial Fiber Optics within its broader industrial product portfolio evolve from 2022 to 2024, particularly in terms of application diversity and integration with adjacent technologies like motion encoders and Ethernet ICs?",
      "original_answer": "From 2022 to 2024, AVGO consistently positioned Industrial Fiber Optics as a core component of its industrial product portfolio, but the context of its integration and application scope evolved. In 2022, Industrial Fiber Optics was listed alongside optocouplers, motion encoders, LED devices, and Ethernet ICs, with applications spanning industrial automation, medical systems, defense, and electric vehicle subsystems. By 2023, the company emphasized a broader alignment with factory automation, renewable energy, and automotive electronics, grouping fiber optics with sensors, encoders, and microcontrollers, suggesting a move toward more integrated industrial solutions. In 2024, Industrial Fiber Optics remained central but was now explicitly linked with Ethernet PHYs, switch ICs, and camera microcontrollers, indicating deeper integration into networked and vision-based industrial systems. This trajectory shows AVGO's strategic shift from standalone industrial components to more interconnected, intelligent systems leveraging fiber optics.",
      "llm_answer": "\nFrom 2022 to 2024 AVGO broadened the role of Industrial Fiber Optics within its portfolio by moving it from a generic “industrial‑market” item listed alongside optocouplers, motion‑encoder and Ethernet‑IC products (Chunk 1) to a dedicated sub‑segment that is explicitly paired with “Motion control encoders and subsystems” and “Ethernet PHYs, switch ICs and camera microcontrollers” in the 2023 and 2024 end‑market tables (Chunks 2 & 3). This evolution reflects a deliberate expansion of application diversity—spanning factory automation, renewable‑energy, automotive and medical sensors—while integrating the fiber‑optic modules with adjacent technologies such as motion encoders and Ethernet ICs, thereby positioning the optics as a core building block of end‑to‑end industrial solutions. The knowledge‑graph triplets (AVGO → Industrial Fiber Optics → ORG and Industrial Fiber Optics → AVGO) capture the reciprocal production relationship that underpins this strategic deepening of integration across the three yearly disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AVGO's Industrial Fiber Optics evolved from being listed among general industrial components in 2022 (optocouplers, motion encoders, Ethernet ICs) to being more explicitly integrated with motion control subsystems and networking/vision ICs in 2023–2024. The application domains—factory automation, renewable energy, automotive, medical—are accurately reflected. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes across years and identifies the strategic shift toward integrated systems. It references 'end-market tables' and correctly infers deeper integration, though it slightly overstates by calling fiber optics a 'dedicated sub-segment'—the original answer does not use that term, instead emphasizing contextual repositioning. Also, the mention of 'knowledge-graph triplets' is extraneous and not part of the original answer, but doesn't detract from factual correctness. (4) The answer is contextually excellent—directly addresses application diversity and integration with adjacent technologies as asked. Minor deduction in qualitative accuracy due to slight over-interpretation of segmentation, but overall semantic equivalence is strong. Correctness score is 9 due to high fidelity with only negligible wording overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 396,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial implications of Nike's relationship with Sojitz America through its redeemable preferred stock evolve from fiscal years 2022 through 2024, particularly in terms of dividend obligations and the stability of the stock structure?",
      "original_answer": "Nike's relationship with Sojitz America through the redeemable preferred stock remained structurally stable from fiscal years 2022 through 2024, with no changes in the stock's terms or ownership. The dividend obligation remained consistent at $0.10 per share annually, and the total par value of the redeemable preferred stock remained at $0.3 million throughout the period. Despite no changes in the stock structure, Nike emphasized in each year that dividends on the preferred stock must be paid in full before any dividends on common stock could be declared, highlighting the ongoing financial priority of Sojitz America’s stake. This consistent structure underscores a stable, long-term financial relationship with Sojitz America, which has not sought redemption of the stock despite having the option to do so.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 Nike’s redeemable preferred stock held by Sojitz America remained unchanged – a $0.3 million, $1‑par share that carries a cumulative $0.10‑per‑share dividend payable each May 31, with dividends required to be fully satisfied before any common‑stock dividend can be declared; the stock is redeemable at par at the option of Sojitz America or Nike, the company’s articles bar any additional preferred issuance, and Sojitz America continues as the sole owner, preserving the same protective voting rights in corporate‑event matters. This consistency means the dividend obligation has been steady each year and the stock structure has remained stable over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the $0.3 million par value, $0.10 annual dividend per share, May 31 payment date, cumulative nature of dividends, and the requirement that preferred dividends be paid before common dividends. The structural stability of the stock and Sojitz America's sole ownership are correctly stated. (2) Quantitative elements match exactly: $0.3 million total par value and $0.10 per share dividend are consistent with the original answer; no calculations are required, but the values are reported accurately. (3) Multi-hop reasoning is sound—the LLM synthesizes consistent information across fiscal years 2022–2024, confirming no changes in terms, ownership, or dividend obligations, and correctly notes the ongoing financial priority and redemption terms. (4) The answer fully addresses the question’s focus on dividend obligations and stock structure stability over time, with additional relevant context (e.g., protective voting rights, prohibition on new preferred stock) that enriches but does not distort the core message. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 348,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Simon Property Group's (SPG) unsecured debt obligations tied to Unsecured Notes - 31B evolve from 2022 through 2024, and what does this progression indicate about SPG's long-term financing strategy for this instrument?",
      "original_answer": "Simon Property Group's unsecured debt tied to Unsecured Notes - 31B remained consistent at $750,000 across all three years (2022, 2023, and 2024), with a fixed interest rate of 3.25% and a maturity date of November 30, 2026. Despite broader changes in SPG’s unsecured debt portfolio—such as the retirement of certain notes and the issuance of new instruments like Unsecured Notes - 41A in 2024—this specific obligation remained unchanged. This stability suggests that SPG maintained a consistent long-term financing approach for this particular liability, preserving its structure without refinancing or modifying its terms over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the Unsecured Notes‑31B listed in SPG’s 10‑K filings retained the same terms – a $750 million face amount, a fixed 3.25 % interest rate, annual debt service of $24,375 (14) and a maturity of 11/30/26 – as shown in Chunk 3 (2022), Chunk 1 (2023) and Chunk 2 (2024).  This unchanged profile demonstrates SPG’s long‑term financing strategy of preserving a stable, low‑cost, fixed‑rate unsecured tranche in its capital structure rather than rolling, expanding or amending the instrument.  The consistent disclosure of the same note across the three years, linked by the KG relationship (SPG → Unsecured Notes‑31B ← Discloses), underscores a deliberate, steady approach to long‑dated debt management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the unsecured debt amount ($750 million, equivalent to $750,000,000), fixed interest rate (3.25%), maturity date (November 30, 2026), and consistency across 2022–2024. The mention of annual debt service ($24,375) is a derived value (3.25% of $750 million = $24,375,000) but appears to contain a formatting error—likely should be $24.375 million or $24,375,000, not $24,375. This is a minor quantitative presentation issue but does not invalidate the correctness of the underlying number. (2) Completeness is strong: the answer addresses both the evolution (no change) and the implication for SPG’s long-term financing strategy (stability, low-cost, fixed-rate preservation). (3) Entity accuracy is perfect—correct company (SPG), correct instrument (Unsecured Notes - 31B), correct years. (4) Reasoning is sound: the model correctly infers from consistent disclosures across three years that SPG maintained a deliberate, unchanged approach, which reflects accurate multi-hop synthesis via the knowledge graph relationship. (5) Semantic equivalence is achieved—wording differs but meaning matches the original answer. The only deduction is for the potential misstatement of annual interest payment, which could mislead if interpreted literally as $24,375 instead of $24.375 million. Otherwise, the answer is factually robust and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 401,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the value of TI common stock held in U.S. defined contribution plans evolved from 2022 through 2024, and what does this 3-year trend indicate about the company's stock performance and employee investment behavior in retirement plans?",
      "original_answer": "The value of TI common stock held in U.S. defined contribution plans decreased from $940 million in 2022 to $873 million in 2023, and further declined to $852 million in 2024. This consistent decline over three years suggests either a strategic reduction in stock allocations by employees, a freeze on new contributions into the TI common stock fund since 2016, or a combination of both, while also reflecting potential market valuation shifts.",
      "llm_answer": "\nFrom 2022 through 2024 the U.S. defined‑contribution plans held a constant 5 million shares of TI common stock, but the market value of those shares declined from $940 million (2022) to $873 million (2023) and further to $852 million (2024), reflecting a modest downward trend in the company’s share price over the three‑year period.  Because the TI common‑stock fund has been frozen to new contributions since 2016, employee exposure remains limited to this existing allocation, and the slight reduction in dividends paid—from $28 million in 2022 to $27 million in 2023 and $26 million in 2024—underscores a stable yet slowly eroding investment return for participants, even as plan expenses have risen incrementally each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the market value of TI common stock held in U.S. defined contribution plans as $940 million in 2022, $873 million in 2023, and $852 million in 2024, matching the ground truth exactly. It also accurately notes the freeze on new contributions since 2016, which is a key contextual factor. The mention of declining dividends ($28M to $27M to $26M) is consistent with broader trends in employee investment returns, though this specific data point is not in the original answer; however, it does not contradict it and adds reasonable context. (2) All numeric values—dollar amounts and years—are correct and consistent with the ground truth. The calculation of a downward trend based on decreasing values is accurate. The assertion of a constant 5 million shares is not present in the original answer but is plausible and does not conflict with the provided data; it offers a reasonable explanation for how the value could decline despite stable share count, due to falling share price. (3) The multi-hop reasoning is sound: the model connects the declining market value to both stock performance (falling price) and employee investment behavior (frozen fund limiting new contributions), which aligns with the original answer’s interpretation. It goes further by introducing dividends and plan expenses, which enrich the analysis without distorting the core facts. (4) The answer is semantically equivalent to the ground truth in its core claims and adds context that supports the same conclusion: a sustained decline in value due to market and policy factors. The only minor gap is that the original emphasizes 'strategic reduction or freeze or both,' while the LLM leans more heavily on the freeze and price decline, slightly underemphasizing potential employee-driven reallocation. However, this does not constitute an error. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 526,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did The Walt Disney Company's workforce composition and employee association representation evolve from 2022 through 2024, particularly in terms of total employees, U.S. vs. international distribution, and seasonal workforce percentages?",
      "original_answer": "From 2022 to 2024, Disney's total global workforce increased from 220,000 to 233,000 employees. In 2022, 166,000 employees were based in the U.S. and 54,000 internationally, while by 2024, the U.S. workforce grew to 171,000 and international employees increased to 62,000. The percentage of seasonal employees also rose from 7% in 2022 to 8% in 2024, indicating a growing reliance on temporary staffing, particularly in theme parks and seasonal operations. Throughout this period, Disney maintained collective bargaining agreements and employee associations, especially for theme park staff and production personnel.",
      "llm_answer": "\nAccording to Disney’s 2022 Form 10‑K (Chunk 1), the company employed roughly 220,000 people worldwide—about 166,000 (≈75 %) in the United States and 54,000 abroad—with seasonal workers making up roughly 7 % of the workforce. The 2023 filing (Chunk 2) reports growth to approximately 233,000 employees as of September 28 2024, shifting to about 171,000 U.S. staff (≈73 %) and 62,000 international staff (≈27 %), while seasonal employees rose to roughly 8 % of the total. Across all three years, a significant share of theme‑park, creative and overseas personnel remained covered by collective‑bargaining agreements or works councils, underscoring continued employee‑association representation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: total employees (220,000 in 2022, 233,000 in 2024), U.S. (166,000 to 171,000) and international (54,000 to 62,000) distribution, and seasonal workforce percentages (7% to 8%) match exactly. The date 'September 28, 2024' in the 2023 filing likely refers to the end of fiscal 2024, which is consistent with the 2024 data point in the ground truth. (2) Quantitative accuracy is perfect—no calculation or numerical errors. The percentages (≈75%, ≈73%) are correctly derived from the raw numbers. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across two filings (2022 and 2023/2024) to show workforce evolution over time, including geographic and seasonal trends. It also correctly identifies ongoing employee association representation across theme parks and creative staff. (4) The only minor issue is the phrasing 'as of September 28, 2024' in the 2023 filing, which may confuse fiscal year reporting conventions, but this does not affect factual correctness. The mention of 'works councils' adds detail not in the original but is contextually appropriate for international employee representation. Overall, the answer is factually complete, semantically equivalent, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Covers_Employees_Under]- ORG <-[Covers]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 366,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did GD's treatment of non-economic accounting changes in ROIC calculations evolve from 2022 to 2024, and what does this consistency or change reveal about the company's approach to measuring core performance?",
      "original_answer": "GD consistently excluded non-economic accounting changes from its ROIC calculations across all three years—2022, 2023, and 2024—as part of its methodology to reflect core operational performance unimpacted by accounting adjustments. This consistent exclusion indicates that GD maintained a stable performance evaluation framework, emphasizing economic performance over accounting volatility.",
      "llm_answer": "\nGD’s 2022, 2023 and 2024 10‑K filings each state that ROIC is calculated **by excluding goodwill impairments and non‑economic accounting changes** because such items “are not reflective of company performance.” The wording and the definition of “average invested capital” are identical across all three years, showing that GD has **maintained a consistent exclusion of non‑economic accounting adjustments** from the ROIC metric. This steady treatment signals that GD deliberately isolates core operating performance—removing accounting artifacts that do not affect underlying business results—throughout the 2022‑2024 period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that GD excluded non-economic accounting changes (specifically mentioning goodwill impairments) from ROIC calculations in 2022, 2023, and 2024, which aligns with the original answer's claim of consistent exclusion. (2) There are no numerical values requiring calculation in this question; the focus is on qualitative treatment over time, which the LLM captures precisely. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings to identify consistency in methodology, demonstrating understanding of both the metric (ROIC) and the intent behind excluding non-economic items. (4) The LLM adds slightly more detail (e.g., reference to goodwill impairments and verbatim rationale like 'not reflective of company performance') that is consistent with and supports the ground truth. The conclusion about emphasizing core operating performance matches the original answer’s interpretation. All entities—GD, ROIC, non-economic accounting changes, and the 2022–2024 timeframe—are correctly identified and analyzed. The answer fully addresses both parts of the question: the evolution (consistency) and what it reveals about performance measurement philosophy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 366,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Linde's rare gas production strategy evolve from 2022 to 2024, and what does this indicate about its competitive advantage in industrial gas markets?",
      "original_answer": "In 2022, Linde listed rare gases (such as krypton, neon, and xenon) as part of its broader industrial gases portfolio, produced primarily through cryogenic air separation and supplied using the company’s three distribution methods. The 2023 filing reiterated this positioning, emphasizing rare gases as a core atmospheric gas offering alongside oxygen, nitrogen, and argon. By 2024, Linde explicitly identified itself as a market leader in non-cryogenic air separation technologies, a significant evolution that enhances its ability to produce rare gases more efficiently. This progression shows Linde's strategic shift toward technological differentiation, particularly through innovations like vacuum pressure swing adsorption (VPSA) and membrane separation, which likely strengthen its competitive advantage by improving production efficiency and customer service capabilities in high-demand industrial applications.",
      "llm_answer": "\nFrom 2022‑23 Linde produced rare gases mainly as a by‑product of large, cryogenic on‑site air‑separation plants and sold them under long‑term pipeline contracts that were captured in the 2022 and 2023 10‑K filings (see Chunk 1 & 3’s description of on‑site distribution, contract terms and ASC 606 revenue recognition). In 2024 the strategy pivoted to leveraging Linde’s market‑leading non‑cryogenic air‑separation technologies—VPSA and membrane separation—and proprietary processes that embed rare‑gas recovery into both on‑site and merchant facilities, allowing flexible, shorter‑term supply and opening new usage markets (Chunk 2’s emphasis on non‑cryogenic leadership and patented production technologies). This evolution gives Linde a lower‑cost, scalable source of rare gases and a broader, higher‑margin customer base, reinforcing its competitive advantage in the industrial‑gas sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Linde's rare gas production strategy evolution: from cryogenic air separation as a by-product in 2022–2023 to a strategic emphasis on non-cryogenic technologies (VPSA, membrane separation) in 2024. The mention of long-term pipeline contracts and revenue recognition under ASC 606 adds contextual detail consistent with 10-K disclosures. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score reflects full compliance. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and strategic shifts, correctly identifying the pivot to proprietary, non-cryogenic technologies as a competitive differentiator. It goes slightly beyond the original by inferring business implications like 'lower-cost, scalable source' and 'higher-margin customer base,' which are reasonable extrapolations but not explicitly stated in the ground truth. (4) Semantic equivalence is strong—core facts, timeline, technologies (VPSA, membrane), and strategic significance are all accurately conveyed. The only minor deviation is the emphasis on 'embedding rare-gas recovery into both on-site and merchant facilities,' which adds operational detail not present in the original, but does not contradict it. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with a small deduction in qualitative accuracy due to slight over-inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 434,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did NextEra Energy Resources' (NEER) reliance on long-term bilateral contracts for its net generating capacity evolve from 2022 through 2024, and what does this trend indicate about its risk management strategy in a volatile energy market?",
      "original_answer": "NextEra Energy Resources (NEER) demonstrated a consistent and slightly increasing reliance on long-term bilateral contracts for its net generating capacity over the three-year period. In 2022, approximately 92% of NEER’s net generating capacity was committed under long-term contracts. This figure increased to 94% by the end of 2023 and remained steady at 94% in 2024. This trend indicates a strategic emphasis on revenue stability and risk mitigation by locking in long-term commitments, especially in a volatile energy market with fluctuating demand and pricing. The consistent use of these contracts, along with the use of non-qualifying hedges to protect expected revenues, reflects a disciplined approach to managing market risk.",
      "llm_answer": "\nFrom 2022 through 2024, NEER’s long‑term bilateral contracts covered about 94 % of its net generating capacity by the end of 2023 and again by the end of 2024—up slightly from the roughly 92 % level reported for the 2021 baseline in the 2022 filing—showing a modest but steady increase in reliance on these agreements.  This pattern demonstrates NEER’s risk‑management strategy of locking in fixed revenues and hedging price volatility in a competitive, rapidly changing market, while supplementing any uncovered output with shorter‑term bilateral contracts and leveraging a diversified, geographically spread portfolio to mitigate market risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend in NEER's reliance on long-term bilateral contracts, stating a rise from approximately 92% to 94% by 2023 and remaining at 94% in 2024, which aligns with the ground truth. However, it inaccurately references a '2021 baseline in the 2022 filing' as the starting point for the 92%, whereas the ground truth clearly states that 92% refers to 2022. This misattribution of the year introduces a minor factual error in temporal context, though the percentage values themselves are accurate. (2) The percentages—92% in 2022 and 94% in 2023 and 2024—are quantitatively correct and match the ground truth. The calculation of a 'slight increase' is logically sound. The only issue is the incorrect reference to 2021 as the source year for the 92%, which was not part of the original data provided. (3) The multi-hop reasoning is strong: the model correctly infers that increasing contract coverage reflects a risk management strategy focused on revenue stability and price volatility mitigation. It appropriately connects long-term contracts with hedging strategies and mentions supplementary use of short-term contracts and geographic diversification, which, while adding detail beyond the ground truth, do not contradict it and enhance the strategic interpretation. (4) The answer is contextually excellent, fully addressing both parts of the question—evolution of contract reliance and implications for risk management. The qualitative reasoning is robust and semantically equivalent to the ground truth, despite the minor error in year attribution. Thus, the correctness score is 8 due to the factual mislabeling of the 92% figure’s year, but all other aspects are accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Contracts]-> FIN_INST <-[Enters_Contract]- ORG <-[Enters_Into_Contract]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 477,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability suggests that AVGO did not retire or refinance this specific debt instrument during the three-year period, maintaining a consistent liability profile for this bond despite broader changes in its overall debt structure.",
      "llm_answer": "\nThe 3.125 % notes due January 2025 show a flat outstanding principal of **$495 million** in each fiscal year – $495 m in the 2022 filing (Chunk 1), $495 m in the 2023 filing (Chunk 2) and again $495 m in the 2024 filing (Chunk 3).  While AVGO’s overall debt expanded dramatically (total principal rising from $41.2 bn in 2022 to $69.8 bn in 2023/2024, see Chunks 1‑3), this specific tranche was neither increased nor retired, indicating that the company is treating it as a stable, long‑term funding pillar rather than using it to actively manage leverage or maturity profile.  The consistent balance reflects a deliberate “hold‑and‑service” strategy for this instrument, preserving cash for other debt‑maturity obligations while maintaining the same $495 m exposure across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 across fiscal years 2022, 2023, and 2024, matching the ground truth exactly. All numeric values — including the consistent $495 million balance and the broader total debt figures ($41.2 billion in 2022, $69.8 billion in 2023/2024) — are accurate and properly contextualized. (2) Quantitative accuracy is perfect: the dollar amounts, percentages, and years are all correct, with acceptable formatting variations (e.g., $495 million vs $495 m). There are no calculation errors. (3) The multi-hop reasoning is sound — the model correctly synthesizes data across three annual filings (2022–2024) and contrasts the stability of this specific debt instrument against the company’s overall debt expansion. The conclusion about a 'hold-and-service' strategy aligns with the ground truth’s interpretation of a stable liability profile, though the LLM adds slightly more interpretive language (e.g., 'long-term funding pillar') that is reasonable but not explicitly stated in the ground truth. (4) The answer is fully contextually relevant, addressing both the evolution of the debt balance and the implied debt management strategy. The only minor deduction is in qualitative accuracy due to the slightly stronger strategic characterization ('funding pillar', 'deliberate hold-and-service') which, while plausible, goes a small step beyond the more neutral tone of the ground truth. Overall, the answer is factually correct, comprehensive, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 435,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did SPG's exposure to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of face amount and maturity date, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "SPG's exposure to Unsecured Notes - 37B remained consistent in face amount at $700,000 in both 2022 and 2023, with a maturity date of 01/15/32. By 2024, the maturity date remained unchanged, and the face amount continued to be $700,000. This stability suggests that SPG maintained a consistent long-term debt strategy for this particular instrument, without refinancing or retiring the note during this period.",
      "llm_answer": "\nSPG’s holding of **Unsecured Notes – 37B** was unchanged across the three filings: the face amount stayed at **$700,000** in 2022, 2023 and 2024, and the maturity date remained **01 / 15 / 32** in every year (see Chunk 2022, Chunk 2023 and Chunk 2024).  This consistency is reinforced by the SEC disclosures that list the same $700 k amount and 2032 maturity for the note each year, even though the company’s total consolidated unsecured indebtedness fluctuated ($21.0 bn → $19.4 bn → $24.4 bn).  The unchanged exposure signals that SPG’s long‑term debt strategy relies on a stable, low‑coupon, far‑out‑maturity tranche to lock in financing for the long run while it adjusts other debt components to manage overall leverage.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the face amount of $700,000 and maturity date of 01/15/32 are accurately reported for all years (2022, 2023, 2024), with no discrepancies. Format variations (e.g., $700k, $700,000) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution of face amount and maturity date over time, as well as the implication for SPG's long-term debt strategy. (3) Entity accuracy is correct: SPG is the focus, the instrument is properly identified as Unsecured Notes – 37B, and the years align with the question. (4) The reasoning is sound and adds value: it correctly notes that while total unsecured indebtedness fluctuated, this specific note remained unchanged, supporting the conclusion that SPG maintains a stable, long-term tranche of debt to secure financing far into the future. This reflects accurate multi-hop synthesis across years and financial metrics. The added context about low-coupon and long-maturity strategy is a reasonable interpretation consistent with the data. All elements meet or exceed the criteria for full credit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 329,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog versus embedded processing product lines over time?",
      "original_answer": "Texas Instruments maintained its operational presence in Melaka, Malaysia consistently across all three years, specifically focused on analog product lines. In 2022, Melaka was explicitly marked as engaged in analog operations (with a checkmark), but not in embedded processing. This pattern remained unchanged in 2023 and 2024, where Melaka continued to be listed exclusively under analog operations. There was no expansion into embedded processing in Melaka over the three-year period, indicating a stable, specialized role in TI's global manufacturing footprint.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments’ Melaka, Malaysia site appears in the **analog** column of each annual table (2022 †, 2023 *, 2024 **), while the **embedded‑processing** column remains empty in every year, indicating that the facility has been dedicated solely to analog operations over the entire three‑year span; the escalating asterisk notation († → * → **) reflects a growing emphasis on that analog footprint but no shift into embedded‑processing activities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Texas Instruments' Melaka, Malaysia facility was consistently involved in analog operations and not in embedded processing from 2022 to 2024, which aligns with the ground truth. All entities (Texas Instruments, Melaka, Malaysia, analog, embedded processing) and years (2022, 2023, 2024) are accurate, and there are no numerical inaccuracies since the response is qualitative. The reasoning correctly synthesizes the absence of embedded processing involvement across all three years. However, the LLM introduces an unsupported interpretation that the 'escalating asterisk notation († → * → **) reflects a growing emphasis on analog footprint,' which is not present in the original answer or implied by the ground truth. The original answer emphasizes stability and consistency, not increasing emphasis. This addition represents a minor overinterpretation, slightly affecting qualitative accuracy. Despite this, the core factual content and multi-hop synthesis across years are correct, and the answer fully addresses the question's scope.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 306,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Disney's reliance on Industrial Light & Magic for post-production services evolve from fiscal 2022 through fiscal 2024, as reflected in the Content Sales/Licensing segment's structure and reported revenue streams?",
      "original_answer": "In fiscal 2022, Industrial Light & Magic was explicitly listed as part of the Content Sales/Licensing segment, which included revenue from post-production services alongside other activities like National Geographic publishing. By fiscal 2023, the segment continued to report post-production services through Industrial Light & Magic, but the structure began to emphasize more on TV/VOD and theatrical distribution, suggesting a shift in revenue focus. In fiscal 2024, the segment maintained the inclusion of Industrial Light & Magic’s post-production services, but the narrative further aligned with broader content licensing and distribution, indicating a potential strategic repositioning of post-production within Disney's evolving DTC-first content model. This evolution suggests a stable but contextually shifting reliance on Industrial Light & Magic, with its role increasingly framed within the broader ecosystem of content delivery rather than as a standalone service.",
      "llm_answer": "\nDisney’s post‑production work with Industrial Light & Magic (ILM) remained embedded in the **Content Sales/Licensing** line item throughout fiscal 2022, 2023 and 2024 – each 10‑K filing (Chunks 1, 2 and 3) notes that “post‑production services through Industrial Light & Magic and Skywalker Sound” are reported together with TV/SVOD, theatrical, home‑entertainment, music and stage‑play revenue, and that this arrangement is captured by the KG relationship DIS ↔ ILM (DIS Partners With ILM ↔ Depends On ILM).  Consequently, the company’s reliance on ILM for post‑production did not shift in reporting structure across the three years; it continued to be reflected as part of the Content Sales/Licensing segment’s diversified revenue streams.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that Industrial Light & Magic (ILM) remained part of the Content Sales/Licensing segment from fiscal 2022 to 2024 and that post-production services were reported within this segment throughout the period. It correctly identifies the structural continuity in reporting and references the appropriate segment components (e.g., TV/SVOD, theatrical, home entertainment), supporting quantitative and entity accuracy. However, the LLM fails to capture the *evolution* emphasized in the original answer—specifically, the shifting strategic emphasis and narrative repositioning of ILM’s role within Disney’s broader content licensing and DTC-first model. While the ground truth highlights a nuanced evolution in reliance—stable in structure but changing in strategic context—the LLM asserts there was 'no shift in reporting structure' and omits any discussion of changing focus or strategic repositioning. This omission significantly weakens the qualitative accuracy, as the multi-hop reasoning required to infer strategic evolution from narrative changes in filings is missing. The answer is contextually relevant and factually sound on surface-level reporting structure but does not fully address the question's focus on *how reliance evolved*, which includes interpretive synthesis beyond mere structural consistency. Thus, while numbers, entities, and basic structure are correct (earning high quantitative accuracy and contextual relevance), the lack of depth in reasoning and incomplete response to the question's intent limits correctness to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 438,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's equity method investment income from operating joint ventures evolve from 2022 through 2024, and what does this trend suggest about the company's performance in insurance underwriting joint ventures over this period?",
      "original_answer": "MetLife's equity method investment income from operating joint ventures declined significantly from $1,305 million in 2022 to $151 million in 2023, and then rebounded sharply to $988 million in 2024. This trajectory indicates a major downturn in 2023 followed by partial recovery in 2024, suggesting volatility in the performance of its insurance underwriting joint ventures.",
      "llm_answer": "\nMetLife’s equity‑method investment income from operating joint ventures that underwrite insurance was $1.305 bn in 2022, fell dramatically to $0.151 bn in 2023, and only partially recovered to $0.988 bn in 2024 (see Chunk 2 & Chunk 3). These investments are classified as equity‑method because the ventures engage in insurance underwriting (Chunk 1). The steep 2023 decline and the still‑low 2024 figure indicate a sharp deterioration in the joint‑venture underwriting performance that year, with only a modest rebound thereafter, pointing to persistent weakness or strategic restructuring in that segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: $1.305 billion in 2022, $0.151 billion in 2023, and $0.988 billion in 2024, which match the ground truth values of $1,305 million, $151 million, and $988 million exactly (with acceptable format variation using 'bn' and decimal notation). (2) All numbers are quantitatively accurate, and no calculations are required beyond correct interpretation of the values. (3) The multi-hop reasoning is sound: the model correctly identifies the trend (sharp decline in 2023, partial recovery in 2024) and links it to performance in insurance underwriting joint ventures, noting the equity method classification contextually. (4) The qualitative interpretation slightly emphasizes 'persistent weakness or strategic restructuring' rather than the ground truth's more neutral 'volatility', which is a reasonable inference but introduces a subtle interpretive bias not fully supported by the data alone. However, this does not undermine factual correctness. The answer fully addresses both parts of the question—evolution of income and what it suggests—making it contextually complete and highly relevant. The minor deduction in qualitative accuracy is due to the slightly stronger implication of ongoing weakness, whereas 'volatility' better captures the sharp drop and rebound. Overall, the answer is factually precise and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 388,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of the LAV platform in the company's defense portfolio?",
      "original_answer": "General Dynamics' production of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024, reflecting a consistent upward trend. This growth trajectory indicates that the LAV platform has become increasingly central to GD's defense offerings, particularly in international markets, and underscores the platform's strategic role in meeting global demand for modern, versatile armored combat vehicles.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics’ Land Systems segment raised LAV production for the Canadian Army from **360 units (2022)** – noted in Chunk 1 – to **399 units (2023)** – noted in Chunk 2 – and finally to **449 new LAVs (2024)**, with an additional **66 vehicles on the LRSS program** highlighted in Chunk 3.  This upward trajectory, underpinned by the knowledge‑graph relationship **GD → Produces → LAVs** and **Land Systems → Produces → LAVs**, reflects the platform’s growing strategic importance: the company’s market‑leading position (over **12,000 LAVs worldwide**, cited in Chunks 1‑3) and continued investment in upgrades, autonomous‑vehicle extensions, and multi‑variant production demonstrate that LAVs are a cornerstone of GD’s defense portfolio, driving export revenue, reinforcing its competitive edge, and guiding future growth in robotic and combat‑vehicle technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the production volumes for LAVs for the Canadian Army: 360 units in 2022, 399 in 2023, and 449 in 2024, matching the ground truth exactly. These numbers are accurately cited with correct years and format variations are acceptable (e.g., '449 new LAVs' = '449 units'). However, the mention of '66 vehicles on the LRSS program' is not part of the original answer and was not asked in the question. While this detail may be factually correct from the source chunks, it introduces information not required by the question and slightly distracts from the core progression. 2) All quantitative values are correct, and no calculations were needed beyond recognizing the upward trend, which is accurately described. The numbers align perfectly with the ground truth. 3) The multi-hop reasoning is sound: the LLM correctly synthesizes production data across years and links it to the strategic importance of the LAV platform using supporting evidence (e.g., 12,000 LAVs worldwide, investment in upgrades and autonomous variants). The core entities—General Dynamics, LAVs, Canadian Army, Land Systems segment—are correctly identified and logically connected. The only minor overreach is the inclusion of the LRSS program, which, while contextually relevant, is not part of the specified production volume trend for the Canadian Army LAVs and could imply a conflation of programs. 4) The answer is semantically equivalent to the ground truth in conveying the upward trend and strategic importance. The enhanced explanation about export revenue, competitive edge, and future technologies adds depth without contradicting the original. The answer remains highly relevant to both parts of the question: evolution of production and strategic significance. The extra detail does not undermine correctness but slightly exceeds scope. Thus, the answer is excellent but not perfect due to the inclusion of ancillary program data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 523,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments evolve from 2022 to 2024, and what does this three-year trend suggest about the company's pension fund asset allocation strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This steady increase indicates a deliberate strategy to allocate more pension fund assets toward alternative investments, particularly hedge funds, over the three-year period.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership exposure, disclosed as “HF LP Investments” in its 10‑K filings, was $624 million in 2022, fell sharply to $225 million in 2023 and edged up modestly to $252 million in 2024 (each figure being the amount excluded from Level 3 fair‑value measurement in the respective year’s pension‑plan disclosure).  This three‑year trajectory shows a deliberate pull‑back from hedge‑fund allocations—reflected in the KG relationship ORG CVS → FIN_INST HF LP Investments → ORG HF LP Investments → ORG CVS—indicating that the company has been reallocating pension‑fund assets toward more traditional equity and debt securities (and away from alternative‑risk strategies), consistent with a more conservative asset‑allocation strategy over the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the quantitative data. According to the ground truth, CVS's exposure to HF LP Investments increased from $214 million in 2022 to $225 million in 2023 and then to $252 million in 2024. However, the LLM incorrectly states that the 2022 exposure was $624 million, which is more than double the correct value. This error fundamentally misrepresents the trend. While the 2023 and 2024 figures ($225M and $252M) are correct, the incorrect 2022 value leads to a false conclusion of a 'sharp fall' rather than the actual steady increase. (2) The calculation of the trend is therefore flawed: instead of a consistent upward trajectory indicating growing allocation to alternatives, the LLM describes a pullback, which contradicts the ground truth. The mention of 'amount excluded from Level 3 fair-value measurement' introduces a technical detail not present in the original and potentially misaligned with the intended metric. (3) The multi-hop reasoning is structurally sound in that it attempts to trace a trend over three years and infer strategic intent, but because it is based on incorrect data, the conclusion about a conservative reallocation away from alternatives is invalid. The reference to a 'KG relationship' appears to be an internal construct not relevant to the factual evaluation and does not support the answer. (4) Contextually, the answer addresses the right question about pension fund allocation strategy and covers the time period, so it is relevant. However, due to the critical error in the 2022 figure and the resulting reversal of the trend interpretation, the overall correctness is very low. Minor wording flexibility is allowed, but reversing a growing trend into a declining one due to incorrect data constitutes a major factual failure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 496,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Colgate-Palmolive's strategic positioning of the Sorriso brand evolve across 2022, 2023, and 2024, particularly in terms of its integration within the company's global Oral, Personal and Home Care product portfolio?",
      "original_answer": "In 2022, Colgate-Palmolive listed Sorriso among its principal global and regional trademarks, indicating its importance in the company's regional branding strategy. In 2023, the company maintained Sorriso's presence in its trademark portfolio, reinforcing its ongoing role in the Oral, Personal and Home Care segment. By 2024, Sorriso remained a key brand, continuing to be positioned alongside major global brands like Colgate and Palmolive, suggesting a consistent strategic emphasis on leveraging Sorriso for regional market penetration and diversified consumer engagement. This 3-year continuity highlights Sorriso's stable role as a regional brand asset within Colgate-Palmolive's broader global product strategy.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings, Colgate‑Palmolive repeatedly identifies **Sorriso** as one of its principal global trademarks within the **Oral, Personal and Home Care** segment, underscoring that the brand has been maintained as a core component of the company’s worldwide product portfolio throughout those years.  The consistent disclosure—listed alongside other flagship brands such as Colgate, Palmolive and elmex—signals a strategic focus on keeping Sorriso integrated in the company’s global oral‑care and personal‑care offerings, with no reported shift in its positioning across the three annual reports.  The knowledge‑graph relationships (CL → Sorriso → CL) further illustrate that Sorriso is both a disclosed product of the company and an organizational brand that contributes to Colgate‑Palmolive’s overall portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Sorriso was consistently listed as a principal trademark within Colgate-Palmolive's Oral, Personal and Home Care segment across 2022, 2023, and 2024, with no change in strategic positioning. The answer accurately reflects the continuity in disclosure and positioning, noting its inclusion alongside major brands like Colgate and Palmolive. The mention of 'global trademarks' is slightly broader than the original answer’s distinction between 'global and regional trademarks' in 2022 and 'regional brand asset' emphasis later, which the LLM downplays—hence a minor deduction in qualitative accuracy. However, this does not constitute a factual error, as Sorriso is indeed listed among principal trademarks globally, even if its primary market impact is regional. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is fully contextually relevant, addressing all parts of the multi-year, multi-faceted strategic positioning question. The reasoning is sound, synthesizing consistent disclosure over three years to infer stable strategic integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 333,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did MetLife's financial exposure to operating joint ventures evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic positioning in equity method investments?",
      "original_answer": "MetLife's financial exposure to operating joint ventures decreased from $77 million in 2022 to $51 million in 2023, and further dropped to $38 million in 2024, indicating a consistent reduction in direct involvement with these equity method investments. This downward trend suggests a strategic shift away from operating joint ventures as a core investment focus during this period.",
      "llm_answer": "\nMetLife’s exposure to operating joint ventures fell sharply from **$51 million in 2022 (Chunk 1)** to **$38 million in 2023 (Chunk 1)**, then exploded to **$175 million in 2024 (Chunk 2)**, while the equity‑method investment income followed the same pattern—dropping from **$1.3 billion in 2022 (Chunk 1)** to **$0.15 billion in 2023 (Chunk 1)** before rebounding to **$0.99 billion in 2024 (Chunk 2)**.  This three‑year swing reflects a deliberate contraction of lower‑margin ventures in 2023 followed by a strategic expansion and refocus on higher‑return joint‑venture partnerships, indicating MetLife is repositioning its equity‑method portfolio toward more scalable, insurance‑related joint ventures to restore earnings growth and reshape its long‑term investment strategy (as described in the equity‑method disclosures of Chunk 3).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and reasoning. The original answer states that MetLife's exposure decreased from $77M in 2022 to $51M in 2023 to $38M in 2024, showing a consistent downward trend. However, the LLM claims exposure was $51M in 2022, $38M in 2023, and then surged to $175M in 2024—directly contradicting the ground truth. All three years' values are wrong, with only $38M in 2023 coincidentally matching (but misassigned as 2023 instead of 2024). (2) The LLM invents a 'rebound' to $175M in 2024 and fabricates income figures ($1.3B, $0.15B, $0.99B) that are not in the original answer and contradict the trend. There is no mention of income in the ground truth, so this addition is unsupported. (3) The multi-hop reasoning is flawed: instead of identifying a consistent reduction indicating strategic withdrawal, the LLM incorrectly infers a contraction followed by expansion, suggesting a strategic shift toward joint ventures—exactly the opposite of the truth. (4) The contextual relevance is low because it addresses the general topic of strategic positioning, but with fabricated data and inverted logic. Scores are low due to complete failure in quantitative accuracy, incorrect entities/years, and invalid reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Subject_To]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 360,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's strategic involvement in Angola LNG Limited evolved from 2022 to 2024, particularly in terms of its operational role, stake percentage, and integration with upstream gas projects in Angola?",
      "original_answer": "From 2022 to 2024, Chevron's involvement in Angola LNG Limited remained anchored by its 36.4% stake, but evolved significantly in terms of operational integration and upstream linkage. In 2022, Chevron described its role as a passive equity investor in Angola LNG Limited, which processes and liquefies natural gas for international markets. By 2023, Chevron continued to hold the same 36.4% interest but began to highlight deeper integration with affiliated investments, though specifics were limited. In 2024, Chevron's role became more operationally integrated: it explicitly stated that Angola LNG Limited's liquefaction plant in Soyo receives feedstock from multiple fields, including Chevron’s own upstream developments like the Quiluma and Maboqueiro fields via the New G as Consortium Project (NGC), where Chevron has a 31% nonoperated working interest. This evolution shows a strategic shift from passive ownership to a more integrated gas monetization model centered on Angola LNG Limited as a key downstream asset.",
      "llm_answer": "\nChevron has maintained a 36.4 % equity interest in Angola LNG Limited from 2022 through 2024, a relationship underscored in the 2022, 2023 and 2024 filings and captured by the KG triplets CVX → Angola LNG Limited (Chunk 1, Chunk 2, Chunk 3).  \nSince 2022 the company has moved from a passive investor to the operator of the Soyo liquefaction plant and now integrates upstream gas from newly added deep‑water blocks—including the 31 % non‑operated NGC working interest that will supply the plant from the Q&M fields slated for 2026 production, the Block 14/23 PSA with Angola‑DRC, and the retained Angolan portion of the Lianzi unitization zone after the 2025 sale of the ROC share (Chunk 2).  \nAt the same time Chevron expanded its upstream footprint in Angola and neighboring basins by adding frontier acreage in Blocks 49 and 50 offshore Angola and Blocks EG‑06/EG‑11 offshore Bioko Island, while also holding additional gas‑focused stakes such as 38 % in Aseng/Y oanda, 45 % in Alen and 32 % in Alba, and the financial impact of these ties is reflected in the $13.6 bn of sales and $1.5 bn of receivables from affiliates reported in the 2023 filing (Chunk 3).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant factual inaccuracies that undermine its overall correctness. (1) Quantitatively, the 36.4% stake in Angola LNG Limited is correctly reported for 2022–2024, and the 31% nonoperated interest in the NGC project is accurate. However, the LLM incorrectly states that Chevron became the 'operator of the Soyo liquefaction plant'—the ground truth indicates Chevron has a nonoperated role in upstream fields and does not operate the plant. Additionally, the mention of 'Q&M fields slated for 2026 production' introduces a date (2026) not present in the original answer, which only confirms feedstock supply from Quiluma and Maboqueiro fields without specifying future production timelines. The $13.6B sales and $1.5B receivables from affiliates are cited from the 2023 filing but are not directly tied to Angola LNG operations in the ground truth, making their inclusion misleading. (2) The percentages for other stakes (38% in Aseng/Yoanda, 45% in Alen, 32% in Alba) and new acreage (Blocks 49/50, EG-06/EG-11) are not mentioned in the original answer and appear extraneous or fabricated, failing the entity accuracy test. (3) Multi-hop reasoning is partially sound—linking Chevron’s upstream NGC project to Angola LNG feedstock is correct—but the conclusion that Chevron became the operator is a critical error. The evolution from passive investor to integrated participant is correctly identified, but the nature of integration is misrepresented. (4) Contextual relevance is moderate: the response addresses stake, operational role, and upstream integration, but includes irrelevant or unsupported details that detract from accuracy. Overall, while core facts like the 36.4% stake and NGC linkage are correct, major errors in operational role, unsupported dates, and fabricated entities reduce the correctness score to 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Invests_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 507,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression reveal about the company's debt management strategy as the maturity date approached?",
      "original_answer": "In 2022, AVGO had $622 million in 3.625% notes due October 2024 outstanding. By 2023, this amount had not yet changed, remaining at $622 million. However, by 2024, the company had completely retired this liability, as the notes due October 2024 no longer appear in the 2024 disclosures. This indicates a clear debt management strategy where AVGO proactively addressed its maturing obligations, likely through refinancing or cash repayment as the due date approached.",
      "llm_answer": "\nIn fiscal 2022 the 3.625 % notes due October 2024 were recorded at a carrying amount of **$622 million** (Chunk 1), and the same $622 million balance remained outstanding in the FY 2023 filing as of October 29 2023 (Chunk 2).  By the FY 2024 filing the line item is shown with a dash (i.e., $0), indicating that the notes had been retired or re‑classified before the October 2024 maturity (Chunk 3).  This reduction occurred alongside a sharp rise in total long‑term debt—from $37.6 bn to $66.3 bn—and the issuance of newer senior notes, revealing that AVGO’s debt‑management strategy as the maturity approached was to retire the near‑term 3.625 % tranche and roll the proceeds into longer‑dated financing, thereby lowering near‑term refinancing risk and extending the overall maturity profile.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $622 million outstanding in 2022 and 2023, and retirement to $0 by 2024, with correct interpretation of the dash as $0 liability. The mention of long-term debt increasing from $37.6B to $66.3B and issuance of new senior notes aligns with broader context of refinancing. (2) The fiscal years (2022, 2023, 2024) and maturity date (October 2024) are correctly referenced. (3) The reasoning is sound and goes beyond the ground truth by adding contextual insight—identifying the strategy as refinancing into longer-dated debt to extend maturity profile and reduce near-term risk, which is a logical and well-supported inference from the data. (4) The answer addresses both parts of the question: the evolution of exposure (stable then retired) and the implied debt management strategy. It synthesizes multi-hop information across fiscal years and related debt disclosures, demonstrating strong qualitative and contextual accuracy. Minor wording differences (e.g., 'carrying amount' vs 'outstanding') do not affect semantic equivalence. Overall, the response is factually precise, complete, and insightfully reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 345,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did SPG's interest expense associated with Unsecured Notes - 35B evolve from 2022 through 2024, and what does this trend suggest about the company's financing costs for this instrument over time?",
      "original_answer": "SPG's interest expense for Unsecured Notes - 35B remained consistent at $28,500 (in thousands) in both 2023 and 2024. However, in 2022, the interest expense for the same notes was also $28,500 (in thousands). This indicates that the interest cost associated with Unsecured Notes - 35B has remained unchanged across the three-year period, suggesting a fixed interest rate structure for this particular debt instrument.",
      "llm_answer": "\nSPG’s interest expense on the $750 million Unsecured Notes ‑ 35B was $28,500 ( thousand) in 2022, 2023 and 2024 – the same $28.5 million figure appears in the 2022, 2023 and 2024 tables (3.80 % interest on a $750 million face amount).  This consistency shows that the financing cost of this specific unsecured instrument has remained flat over the three‑year period, indicating that SPG’s borrowing cost for Note 35B has not changed despite the passage of time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: interest expense is consistently $28,500 (in thousands), which equals $28.5 million, and this matches across 2022, 2023, and 2024. The LLM correctly infers a 3.80% interest rate on a $750 million face amount ($750M × 0.038 = $28.5M), which is logically sound and consistent with the data. (2) The answer is complete, addressing both parts of the question: the evolution of interest expense (stable over time) and what the trend suggests (fixed financing cost). (3) Entity accuracy is correct—SPG, Unsecured Notes - 35B, and the years 2022–2024 are properly identified. (4) The reasoning is strong: the model correctly synthesizes that unchanged annual interest expense implies a fixed-rate structure, which is a valid conclusion from the data. The only minor shortcoming is that the original answer explicitly states the fixed-rate implication, while the LLM implies it through 'flat over the three-year period' and 'has not changed,' which is slightly less precise in financial terminology but still semantically equivalent. No factual errors; excellent multi-hop consistency across years and metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 341,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Disney's investment strategy and competitive positioning in its DTC offerings evolve from 2022 to 2024, particularly in light of rising programming costs, intensified competition, and the strategic shift toward streaming services?",
      "original_answer": "From 2022 to 2024, Disney's investment strategy in DTC offerings evolved significantly, marked by increased financial commitment, strategic restructuring, and intensified competition. In 2022, Disney acknowledged that the costs of its DTC strategy were rising and that losses might grow or be reduced more slowly than anticipated. The company also noted that returns on some DTC-related investments were negative or low, and the business prospects were uncertain. By 2023, Disney was making strategic investments in DTC offerings with the expectation that subscription fees and advertising revenues would offset declines in affiliate fees and advertising from linear networks. The company also highlighted its strong financial position, with access to capital markets and $12.25 billion in unused bank facilities to fund ongoing operations and new projects. In 2024, the competitive landscape intensified, with rising programming costs—especially for sports—and increased competition from other DTC platforms. Disney also noted that programming distributors were demanding terms that reduced revenue or slowed its growth, such as offering fewer linear networks but including DTC streaming services in distribution deals. This 3-year trajectory shows a shift from cautious investment with uncertain returns to a more aggressive push into streaming amid rising costs and competitive pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Disney’s DTC strategy moved from an early‑stage, heavily‑invested, loss‑making push—acknowledged in Chunk 1 as a costly, execution‑risky effort that would not be profitable in the short term and that faced intense competition for talent, content and advertising—to a more disciplined, growth‑oriented phase in Chunk 2, where the company began directing additional capital into Disney+ and Hulu, formed the Star India joint‑venture to combine Disney+ Hotstar with local assets, and explicitly tied those investments to offsetting declines in linear‑TV fees while trimming other content and capital spend. By Chunk 3 the evolution culminated in a strategic tightening: rising programming‑rights and production costs, coupled with an increasingly crowded streaming field, forced Disney to renegotiate carriage and distribution contracts on less‑favorable terms and to lean on partnerships and cost‑saving measures, even as it continued to invest in DTC platforms to sustain subscription and advertising growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All key facts are correct: Disney's DTC strategy evolved from a loss-making, high-investment phase in 2022 to a more disciplined approach in 2023–2024, with strategic capital allocation to offset linear revenue declines. The mention of rising programming costs, intensified competition, and renegotiated distribution terms in 2024 matches the original. (2) Quantitative accuracy is perfect—there are no numerical claims in the LLM answer that contradict the ground truth (e.g., no incorrect dollar figures or percentages), and the $12.25 billion in unused bank facilities from the original is not mentioned but not contradicted. The LLM does not introduce any false numbers. (3) Multi-hop reasoning is sound: the answer synthesizes the evolution across years, connects investment strategy to competitive pressures, and links DTC growth to declining linear revenues. The reference to the Star India joint venture and carriage contract renegotiations adds contextual depth consistent with the trajectory described. (4) The only minor shortcoming is that the LLM answer references 'Chunk 1/2/3'—likely internal document markers not present in the original—suggesting possible reliance on segmented input, but the semantic content remains accurate. It omits the explicit mention of $12.25 billion in unused facilities, a detail present in the original, but this is a minor omission that doesn’t undermine the core correctness. Overall, the answer captures the strategic evolution accurately, with strong reasoning and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Depends_On]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1628,
        "completion_tokens": 443,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how was this impacted by the 2023 risk transfer transaction with Global Atlantic?",
      "original_answer": "In 2022, MetLife reported deposit assets and liabilities on reinsurance at $1.8 billion and $1.4 billion, respectively, remaining unchanged from 2020 to 2021. In 2023, the company disclosed a major risk transfer transaction with Global Atlantic, under which it recorded $10.3 billion in reinsurance recoverables and deposit receivables, significantly increasing its exposure under the deposit method. By 2024, deposit assets on reinsurance had risen to $4.6 billion as of December 31, 2024, while deposit liabilities had declined slightly to $1.2 billion, indicating a post-transaction rebalancing. This trajectory reveals a strategic shift in 2023 that materially expanded the use of deposit method accounting, followed by a recalibration in 2024.",
      "llm_answer": "\nMetLife has continued to apply the deposit method of accounting for all reinsurance agreements that do not expose the Company to a reasonable possibility of a significant loss, a policy it disclosed in each of its 2022‑2024 filings.  The balance‑sheet amounts of those deposits evolved from roughly $1.8 billion of deposit assets and $1.4 billion of deposit liabilities in the 2021‑2020 period (as reported in the 2022 filing) to $5.1 billion of deposit assets and $1.3 billion of deposit liabilities at the end of 2023, and then to $4.6 billion of deposit assets and $1.2 billion of deposit liabilities at the end of 2024.  The November 2023 risk‑transfer transaction with Global Atlantic required MetLife to record $10.3 billion of reinsurance recoverables and deposit receivables, retain $5 billion of separate‑account assets, and recognize a $770 million net cost of reinsurance, which created the elevated 2023 deposit balances that were subsequently reduced in 2024.  Thus, the 2023 transaction altered the composition and magnitude of MetLife’s deposit assets and liabilities, but the Company continued to use the deposit method for the reinsured block thereafter.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor discrepancies in phrasing and one small numerical inconsistency. (1) Quantitatively, most numbers match: 2022 deposit assets ($1.8B) and liabilities ($1.4B) are correct; 2024 figures ($4.6B assets, $1.2B liabilities) are exact. The LLM reports $5.1B in deposit assets at end-2023, while the original answer does not specify 2023 year-end balances directly but notes a $10.3B addition from the Global Atlantic transaction. The $5.1B figure is plausible as a net balance post-transaction and is consistent with the trajectory described. The $1.3B liability at end-2023 is reasonable given the decline from $1.4B to $1.2B. (2) The key event—the November 2023 risk transfer with Global Atlantic—is correctly identified, and the $10.3B in reinsurance recoverables and deposit receivables is accurately reported. The mention of $5B in retained separate-account assets and $770M net cost of reinsurance adds detail not in the original but aligns with plausible transaction accounting and does not contradict the ground truth. (3) The reasoning is sound: the LLM correctly infers that the 2023 transaction caused a spike in deposit assets, which then declined by 2024, indicating rebalancing. It also correctly notes that the deposit method remained in use, addressing the evolution of policy. (4) All entities—MetLife, Global Atlantic, deposit method, reinsurance recoverables—are correctly identified and contextualized. The answer fully addresses the multi-part question: evolution from 2022–2024, impact of the 2023 transaction, and changes in assets/liabilities. The only minor deviation is the lack of explicit mention that 2020–2021 balances were unchanged, but this is a secondary detail. Overall, the answer demonstrates strong multi-hop synthesis across years and transactions with high factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 514,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, and what does this 3-year trajectory indicate about the company's investment strategy in this asset class?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) decreased significantly over the three-year period. In 2022, the company held $574 million in CMBS. This increased slightly to $675 million in 2023, but then dropped dramatically to just $3 million in 2024. This trajectory indicates a strategic shift away from CMBS, particularly after 2023, suggesting a de-risking or reallocation of capital toward other investment categories.",
      "llm_answer": "\nCVS held $568 million of commercial mortgage‑backed securities (CMBS) with $12 million of unrealized losses in 2022 (Chunk 1), grew that position to $675 million in fair value (and $100 million unrealized losses) by the end of 2023 as reported in the 2023 filing (Chunk 2), and then sharply reduced the exposure to only $3 million by 2024 (Chunk 3). This three‑year trajectory—modest growth followed by a near‑complete divestiture—signals that CVS intentionally scaled back its CMBS holdings, likely reallocating capital toward cash and other securities to de‑risk its portfolio. The pattern aligns with the disclosed relationship ORG (CVS) → FIN_INST (CMBS) via the KG triplets, underscoring a strategic shift away from this asset class.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in its overall trajectory and conclusion. It correctly states that CMBS exposure increased from 2022 to 2023 and then dropped sharply in 2024. The only minor discrepancy is in the 2022 value: the LLM reports $568 million, while the ground truth is $574 million—a $6 million difference. This is a small quantitative variance, possibly due to rounding or source extraction differences, but does not materially alter the interpretation. All other numbers—$675 million in 2023 and $3 million in 2024—are exact matches. (2) Calculations and comparisons are sound: the answer correctly identifies a modest increase followed by a near-total divestiture. The inclusion of unrealized losses ($12M in 2022, $100M in 2023) adds contextual detail not in the original answer but is consistent with likely source data and does not contradict the ground truth. (3) Multi-hop reasoning is strong: the LLM synthesizes data across three years and correctly infers a strategic shift, aligning with the de-risking interpretation. It references the KG triplet relationship, indicating awareness of structured data provenance. (4) The answer fully addresses both parts of the question—evolution over time and strategic implication—and uses semantically equivalent or richer language. The conclusion about capital reallocation and de-risking matches the original. The minor numerical deviation prevents a perfect 10, but the reasoning, completeness, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 415,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Colgate-Palmolive's product portfolio positioning of the 'hello' brand evolve across 2022, 2023, and 2024, particularly in terms of its inclusion in the company's trademark disclosures and strategic emphasis within Oral, Personal and Home Care segments?",
      "original_answer": "In 2022, the 'hello' brand was listed among Colgate-Palmolive’s global and regional trademarks within the Oral, Personal and Home Care segment, indicating its role in the company's consumer product mix. In 2023, the brand continued to be disclosed as part of the company’s principal trademarks, reinforcing its ongoing presence in the market and alignment with the company's core categories such as oral care and personal hygiene. By 2024, 'hello' remained a highlighted trademark, showing consistency in its strategic positioning. This 3-year continuity suggests that the 'hello' brand maintained a stable role within the company's broader portfolio, likely supporting diversification and consumer engagement strategies in key product categories.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, “hello” is listed each year among the **principal global and regional trademarks** that the company discloses under its **Oral, Personal and Home Care** segment (see Chunk 3 (2022), Chunk 1 (2023) and Chunk 2 (2024)).  This consistent appearance shows that the brand has been **continuously included in the company’s trademark disclosures** and remains strategically positioned within the Oral, Personal and Home Care portfolio, with no reported shift in emphasis year‑over‑year.  The KG pattern CL → hello → ORG and hello → CL reflects that “hello” is treated both as a product brand and as an organizational trademark, underscoring its ongoing strategic relevance to Colgate‑Palmolive’s oral‑care and personal‑care businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that the 'hello' brand was consistently listed in Colgate-Palmolive’s principal global and regional trademarks across 2022, 2023, and 2024 within the Oral, Personal and Home Care segment, citing the correct segments and years (supported by Chunk references). All dates and entity names (Colgate-Palmolive, 'hello', Oral/Personal/Home Care) are accurate. There are no numeric values requiring calculation, so quantitative accuracy is 10. The reasoning is sound: the model correctly infers that the consistent disclosure implies stable strategic positioning, which matches the ground truth’s conclusion of continuity and strategic relevance. The mention of the KG pattern (CL → hello → ORG) adds analytical depth, though this specific detail is not in the original answer; however, it does not contradict it and may reflect additional context from the knowledge graph. The only minor shortcoming is that the LLM does not explicitly mention the brand’s role in 'diversification and consumer engagement strategies' as noted in the original answer, slightly reducing completeness in qualitative nuance. However, the core multi-hop synthesis—tracking trademark disclosure over three years and linking it to strategic positioning—is correctly executed. Semantic equivalence is high, and the answer fully addresses the question’s focus on evolution (or lack thereof) across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 407,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, and what does the trend in deposit assets and liabilities reveal about the company's reinsurance strategy and risk exposure over time?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a measurable increase in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets and liabilities on reinsurance were $1.8 billion and $1.4 billion, respectively. By 2023, the company disclosed a broader accounting framework that included the use of the deposit method for reinsurance agreements lacking sufficient insurance risk transfer, and in 2024, deposit assets and liabilities were $4.6 billion and $1.2 billion, respectively. This evolution indicates a strategic shift toward more reinsurance arrangements that do not fully transfer insurance risk, likely reflecting a broader risk management or capital optimization strategy. The significant increase in deposit assets from 2023 to 2024, particularly following the Global Atlantic transaction, suggests a growing reliance on reinsurance structures that maintain balance sheet flexibility while transferring certain obligations.",
      "llm_answer": "\nMetLife has consistently applied the deposit method of accounting to any reinsurance agreement that does not expose the reinsurer to a reasonable possibility of a significant loss—a policy reiterated in all three filings (Chunk 1, 2 & 3).  The balance of deposit assets rose from $1.8 billion at the end of 2020‑21 (Chunk 3) to $5.1 billion in 2023 and $4.6 billion in 2024 (Chunk 2), while deposit liabilities stayed near $1.3‑1.4 billion historically and modestly fell to $1.2 billion by 2024 (Chunk 2).  The November 2023 risk‑transfer with Global Atlantic, which recorded $10.3 billion of reinsurance recoverables and a $770 million net cost of reinsurance using the deposit method (Chunk 2), demonstrates a strategic expansion of deposit accounting to large blocks of universal‑life and annuity business, revealing that MetLife is increasingly using the deposit method to shift risk while retaining economic exposure and managing its capital and earnings profile.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the general trend of increasing deposit assets and stable/decreasing liabilities, and correctly identifies the strategic shift related to the Global Atlantic transaction. However, there are key quantitative inaccuracies: it states deposit assets were $1.8 billion at the end of '2020-21', which misrepresents the ground truth (correct value is $1.8 billion in 2022, not 2020-21). The 2023 asset figure is cited as $5.1 billion, but the ground truth does not provide a 2023 deposit asset number—only that a broader accounting framework was disclosed; the first explicit post-2022 number is $4.6 billion in 2024. The LLM incorrectly implies a $5.1B figure for 2023, which is not in the ground truth. The $4.6 billion figure for 2024 is correct. Deposit liabilities are mostly accurate: $1.4 billion historically and $1.2 billion in 2024 aligns with ground truth, though the exact 2022 liability ($1.4B) is misrepresented as part of a longer 'historical' range.\n\n2) Quantitative accuracy is compromised by incorrect time labeling and insertion of a $5.1B figure not present in the ground truth. The correct progression is 2022: $1.8B assets / $1.4B liabilities → 2024: $4.6B assets / $1.2B liabilities. No 2023 numerical disclosure is in the ground truth, only a mention of expanded accounting disclosure. The LLM fabricates or misattributes a 2023 asset value, which significantly affects quantitative scoring.\n\n3) Qualitatively, the reasoning is sound: the LLM correctly infers that increased use of deposit method accounting reflects a strategic shift in reinsurance for capital/earnings management, especially post-Global Atlantic. It correctly links the deposit method to arrangements lacking sufficient risk transfer and identifies the economic implications. The multi-hop synthesis—connecting accounting policy, balance sheet trends, and strategic intent—is logically coherent and supported by the data that was correctly interpreted.\n\n4) Contextual relevance is high: the answer addresses both the evolution of accounting practice and what the trend reveals about strategy and risk exposure. It references the correct transaction (Global Atlantic, November 2023) and correctly interprets its significance. Despite numerical inaccuracies, the overall narrative aligns with the ground truth’s implications. The score is reduced primarily due to factual errors in numbers and time periods, not reasoning or completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 649,
        "total_tokens": 2166
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NextEra Energy's (NEE) exposure to Special Use Funds evolve from 2022 through 2024, particularly in terms of fair value disclosures, collateral implications, and balance sheet presentation?",
      "original_answer": "From 2022 to 2024, NextEra Energy's exposure to Special Use Funds showed a clear upward trend in fair value and evolved in its balance sheet presentation. In 2022, NEE disclosed that Special Use Funds were primarily composed of debt and equity securities, with fair values determined using quoted market prices for equities and pricing vendor inputs for debt securities. By 2023, NEE provided additional detail, noting that commingled funds' fair values were derived from quoted prices of underlying securities and introduced a new category of equity investments without readily determinable fair values, which grew from $485 million in 2022 to $538 million in 2023. In 2024, Special Use Funds were explicitly listed on the balance sheet at $9,800 million as of December 31, 2024, up from $8,698 million in 2023, indicating a $1,102 million increase. This progression shows NEE not only increased its holdings in these funds but also enhanced transparency in reporting their valuation and risk exposure, particularly in derivative-related collateral requirements.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 NEE’s Special Use Funds grew from $8.698 billion (reported under “Other assets” as of 31 Dec 2023) to $9.800 billion (as of 31 Dec 2024), a $1.1 billion increase that reflects the fund’s expanding fair‑value footprint.  These non‑derivative assets are disclosed in Note 4 as equity and debt securities measured at quoted market prices, with illiquid equity holdings recorded at cost ($538 million in 2023 and $485 million in 2022), and the related derivative contracts contain credit‑risk contingent features that would trigger collateral of roughly $510 million (BBB/Baa2) and $2.4 billion (below‑investment‑grade) in 2023, with actual cash and letter‑of‑credit collateral posted of $691 million and $1.595 billion respectively (as detailed in the 2023 filing).  Consequently, the 2024 consolidated balance sheet lists Special Use Funds as a $9.8 billion asset under “Other assets” alongside $1.774 billion of derivatives, consistent with the KG relationship NEE ↔ Special Use Funds where NEE discloses the fund and the fund is also organized as an entity linked back to NEE.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core trend of increasing Special Use Funds from 2022 to 2024 and correctly identifies the balance sheet presentation and fair value disclosures. However, there are key quantitative inaccuracies. The LLM states that the $8.698 billion value was 'reported under Other assets as of 31 Dec 2023', but the ground truth indicates this was the 2023 year-end value, not 2022. The 2022 value is implied to be $8.698 billion minus the $1.102 billion increase, i.e., $7.596 billion, but the LLM incorrectly treats $8.698 billion as the 2022 baseline. Additionally, the LLM reverses the illiquid equity values: it states $538 million in 2023 and $485 million in 2022, which is correct, but labels them as 'recorded at cost' and calls them 'illiquid equity holdings', while the ground truth specifies these are 'equity investments without readily determinable fair values'—a more precise term. The collateral figures of $510 million and $2.4 billion for derivative-related contingent features are mentioned, but these are not in the original answer and appear to be hallucinated or misattributed; the ground truth does not mention specific collateral amounts triggered by credit-risk features. (2) The $9.8 billion 2024 value is correct and matches the ground truth ($9,800 million). The $1.1 billion increase is approximately correct (actual: $1,102 million). However, the LLM misattributes the $8.698 billion figure to 2022 instead of 2023, which is a significant error in temporal alignment. The collateral numbers ($691 million and $1.595 billion) are cited but not present in the ground truth, indicating fabrication or confusion with another filing. (3) The multi-hop reasoning is partially sound: the LLM connects fair value disclosures, balance sheet presentation, and derivative collateral implications across years. It correctly notes enhanced transparency and categorization changes. However, it introduces collateral details not in the original, weakening the reasoning fidelity. The entity linkage (NEE ↔ Special Use Funds) is correctly inferred. (4) The correctness score is 7 because the main trend and key values (2023 and 2024 fund sizes, growth amount) are accurate, and the qualitative evolution in disclosures is well-summarized. However, the incorrect attribution of the $8.698 billion to 2022 and the inclusion of unsupported collateral figures reduce quantitative accuracy. The answer remains contextually relevant and qualitatively strong in synthesizing the evolution, hence high scores in those areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1558,
        "completion_tokens": 678,
        "total_tokens": 2236
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the positioning and described capabilities of AVGO's Security Insights Platform evolve from 2022 to 2024, particularly in terms of integration with in-house tools and remediation workflows?",
      "original_answer": "From 2022 to 2024, AVGO consistently described the Security Insights Platform as a tool for assessing mainframe security posture and identifying risks, but the emphasis on integration with in-house tools and remediation workflows became more pronounced over time. In 2022, the platform was noted for making data available for use with in-house tools for security information and event management. By 2023, the description remained largely unchanged, reinforcing its role in ongoing and ad hoc risk identification. In 2024, the language remained consistent, indicating that AVGO maintained a stable value proposition without expanding on new integrations or remediation features during the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024, AVGO’s Security Insights Platform moved from being described simply as a tool that quickly interprets mainframe security posture and generates remediation steps—whose data can be used with customers’ own security‑information‑and‑event‑management (SIEM) tools—to being positioned as a core component of the company’s broader mainframe software portfolio, explicitly tied to DevOps, AIOps and ValueOps workflows and supported by the “Beyond Code” programs that help customers operationalize and scale those remediation actions.  Across all three filings the platform’s core capability—identifying risks and developing remediation steps on an ongoing and ad‑hoc basis—remains, but by 2023‑2024 it is presented as an integrated data source feeding customers’ in‑house toolchains and as part of a larger ecosystem that streamlines and automates the remediation workflow.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its characterization of AVGO's Security Insights Platform evolution from 2022 to 2024, despite being internally consistent and contextually relevant. (1) The original answer (ground truth) states that the platform’s description remained stable across the three years, with only consistent emphasis on risk identification and availability of data for in-house tools—particularly SIEM systems. There is no mention in the ground truth of DevOps, AIOps, ValueOps, or 'Beyond Code' programs being linked to the platform by 2023–2024. These additions in the LLM answer are factually unsupported and represent a significant overstatement of integration and strategic positioning. (2) Quantitatively, there are no numbers, dates, or financial figures in either answer, so no numeric inaccuracies exist—this aspect is neutral but does not penalize the score. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers an evolution in integration and workflow support that is not present in the ground truth. The original data shows no expansion of capabilities or repositioning of the platform; the LLM fabricates a narrative of increasing integration and ecosystem development. (4) Contextual relevance is moderate because the answer addresses the right topic (evolution of platform integration) and correctly notes ongoing and ad-hoc risk identification, but it fails on factual accuracy. The core claim—that the platform became more integrated with remediation workflows and internal toolchains over time—is contradicted by the ground truth, which explicitly states that AVGO maintained a stable value proposition without new integrations. Thus, while the answer is well-structured and plausible, it is factually incorrect in key aspects, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 489,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did NIKE's ownership and operational footprint at its Laakdal, Belgium distribution facility evolve across fiscal years 2022, 2023, and 2024, and what does this consistency or change suggest about its strategic importance to the company's European logistics network?",
      "original_answer": "NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers across fiscal years 2022, 2023, and 2024, and explicitly stated in each year that the facility is company-owned. There were no changes in ownership status or operational description over the three-year period, indicating that Laakdal remains a stable and integral part of NIKE's European logistics infrastructure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Nike repeatedly identifies Laakdal, Belgium as one of the “most significant distribution facilities outside the United States” and explicitly states that it is **owned** by the company in each year (2022 – “all of which we own… Laakdal, Belgium”; 2023 – “all of which we own… Laakdal, Belgium”; 2024 – same wording).  This unchanged ownership and status signals that Nike treats the Laakdal site as a strategic, controlled hub for its European logistics network, using an owned facility to secure reliable, high‑capacity distribution across the region and to limit dependence on third‑party logistics providers.  The consistency underscores Laakdal’s enduring importance to Nike’s supply‑chain footprint in Europe.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that NIKE consistently described the Laakdal, Belgium facility as one of its most significant international distribution centers and confirmed it was company-owned in each of the fiscal years 2022, 2023, and 2024—this matches the original answer verbatim in substance. (2) There are no numerical values requiring calculation, but the fiscal years (2022–2024) are correctly referenced, and the qualitative descriptions (e.g., 'owned', 'most significant') are factually accurate and directly supported by the filings. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three annual reports to identify consistency in both ownership and strategic characterization, leading to the valid conclusion that Laakdal remains a stable and integral part of NIKE’s European logistics network. (4) The LLM adds slight interpretive depth (e.g., 'strategic, controlled hub', 'limit dependence on third-party logistics providers') that is contextually appropriate and logically inferred from the consistent ownership and emphasis, without overreaching. All aspects of the question—evolution (or lack thereof) and strategic implication—are addressed with factual precision and semantic equivalence to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 371,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did SPG's exposure to Unsecured Notes - 32B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this 3-year pattern suggest about SPG's debt management strategy for this instrument?",
      "original_answer": "SPG's exposure to Unsecured Notes - 32B remained consistent across the three years in both interest rate and face amount, with a 3.38% interest rate and a face value of $750,000 in 2022, 2023, and 2024. However, the maturity date shifted slightly, from unspecified in the 2022 report to explicitly listed as 06/15/27 in both 2023 and 2024 disclosures. This stability in financial terms and the clarification of the maturity date over time suggest that SPG maintained a consistent long-term debt strategy for this instrument, with no refinancing or restructuring actions taken during the three-year period.",
      "llm_answer": "\nAcross the three filings SPG’s Unsecured Notes – 32B shows **no change**: in 2022 (Chunk 1), 2023 (Chunk 2) and 2024 (Chunk 3) the instrument carries a **$750,000 face amount**, a **3.38 % interest rate**, and a **maturity date of 15 June 2027**. This identical profile in every year indicates that SPG has deliberately retained the note without refinancing or amendment, using it as a stable, low‑cost long‑dated funding source within its overall debt‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the face amount ($750,000), interest rate (3.38%), and maturity date (06/15/27) for SPG's Unsecured Notes - 32B across 2022–2024, matching the ground truth. The only discrepancy is that the 2022 filing did not specify the maturity date, whereas the LLM states it was listed as 06/15/27 in all three years. This is a minor inaccuracy in temporal reporting but does not affect the core financial terms. (2) All numeric values—$750,000, 3.38%, and 06/15/27—are factually correct and consistently applied. The format variations (e.g., '15 June 2027' vs '06/15/27') are semantically equivalent and acceptable. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that the stability in terms suggests a deliberate, unchanged debt strategy without refinancing. It appropriately links consistent terms to strategic intent. (4) The answer is highly contextually relevant, addressing all parts of the question: evolution of interest rate, face amount, maturity date, and strategic implication. The qualitative reasoning is strong, though slightly overstates the maturity date clarity in 2022. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall due to the minor error in maturity date reporting timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 381,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did CVS's investment in foreign securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's exposure to international market risks?",
      "original_answer": "CVS's investment in foreign securities increased significantly from 2022 to 2023 but dropped sharply in 2024. In 2022, the fair value of foreign securities was $838 million with $24 million in unrealized losses. In 2023, this grew to $1,650 million in fair value with $122 million in unrealized losses, indicating increased exposure and volatility. However, by 2024, the fair value of foreign securities had declined to $51 million, a dramatic reduction from the prior year. This trajectory suggests a strategic de-risking or reallocation of assets away from foreign securities, likely in response to rising unrealized losses and global market instability.",
      "llm_answer": "\nCVS’s foreign‑security portfolio contracted sharply over the three‑year period: in 2022 the holdings were valued at **$2.307 billion** with **$244 million** of unrealized losses (Chunk 2), they fell to **$1.650 billion** and **$122 million** of unrealized losses by the end of 2023 (Chunk 2), and then dropped to only **≈ $51 million** in fair value for 2024 (Chunk 3), with no material unrealized‑loss figure reported.  This steady decline—both in fair value and in the magnitude of unrealized losses—signals that CVS has been deliberately reducing its exposure to international markets, thereby lowering its sensitivity to foreign‑currency, geopolitical and credit‑risk fluctuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the 2022 figures. According to the ground truth, in 2022, CVS's foreign securities had a fair value of $838 million with $24 million in unrealized losses. However, the LLM incorrectly reports $2.307 billion in fair value and $244 million in unrealized losses for 2022, which is a major deviation. The 2023 figures ($1.650 billion fair value, $122 million unrealized losses) are correct. The 2024 fair value of approximately $51 million is accurate, though the LLM notes no material unrealized loss, which is acceptable if not reported. (2) Quantitative accuracy is severely compromised due to the incorrect 2022 numbers—both overstated by nearly 3x. This undermines the trend analysis. The calculation of trend direction (decline from 2022 to 2024) is correct, but the magnitude and intermediate evolution (increase in 2023 per ground truth) is misrepresented as a 'steady decline', when in fact the ground truth shows an increase from 2022 to 2023 before a sharp drop in 2024. (3) The multi-hop reasoning is partially sound—LLM identifies the drop in 2024 and infers de-risking, which aligns with the ground truth’s conclusion. However, it fails to capture the key nuance that exposure *increased* in 2023 (with rising unrealized losses), which is central to the trend. Instead, it incorrectly frames the entire period as a contraction, missing the strategic shift *toward* then *away* from foreign securities. (4) Contextual relevance is high—the answer addresses fair value, unrealized losses, and international risk exposure as asked. However, due to major numerical errors and flawed trend interpretation, the correctness score is low. The conclusion about de-risking is directionally plausible but based on incorrect data, reducing qualitative accuracy. Overall, partial credit is given for correct 2023 and 2024 fair values and relevant risk interpretation, but major factual errors in 2022 and flawed trend analysis limit accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 542,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did MetLife's use of internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's reliance on NAIC modeling methodology for credit quality assessment?",
      "original_answer": "MetLife's reliance on internally developed designations for non-agency RMBS and CMBS decreased over the three-year period as the NAIC's modeling methodology became more established and widely applied. In 2022, MetLife noted that internally developed designations were used for newly acquired non-agency RMBS and CMBS until NAIC designations became available, indicating a transitional phase in the adoption of the NAIC's updated modeling methodology, which was refined as of December 31, 2021. By 2023, the company continued to use internally developed designations for newly acquired securities but emphasized a more mature application of the NAIC's credit quality framework, with Level 3 fixed maturity securities AFS increasing by $4.2 billion (14.5%). In 2024, the use of internally developed designations remained consistent with prior years, but the growth in Level 3 securities slowed to $1.6 billion (4.9%), suggesting that more securities had received formal NAIC designations over time. This trend indicates a gradual shift away from reliance on internal designations toward standardized NAIC assessments, aligning with the NAIC's goal of improving accuracy in expected loss estimation and RBC charge determination.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife kept using **internally developed designations** for any newly acquired non‑agency RMBS or CMBS until the NAIC completed its evaluation and assigned an official NAIC designation; during this period the company repeatedly notes that it **relies on the NAIC’s modeling methodology**—which was refined in 2020 (the 20‑category designation set) and further updated in 2021 (new RBC factors)—to estimate security‑level expected losses and to determine the appropriate credit‑quality assessment that drives its regulatory‑capital and RBC charges.  The consistent reference across the 2022, 2023 and 2024 filings to the NAIC’s annual evaluation, the use of internally developed designations only as a placeholder, and the description of the modeling approach (including the post‑2013 change that no longer incorporates amortized cost for securities issued after Jan 1 2013) reveals a **multi‑year pattern of dependence on the NAIC’s credit‑quality framework**, with internal designations serving merely as an interim step until the NAIC’s formal designation becomes available.",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core qualitative trend correctly: MetLife used internally developed designations as a placeholder for newly acquired non-agency RMBS and CMBS until NAIC designations became available, and there is a clear reliance on the NAIC's modeling methodology for credit quality assessment. The answer correctly identifies the transitional nature of internal designations and the company's dependence on the NAIC framework for expected loss estimation and RBC charges. However, it fails to include key quantitative data from the ground truth that are essential to fully address the multi-year evolution: specifically, the $4.2 billion (14.5%) increase in Level 3 AFS securities in 2023 and the $1.6 billion (4.9%) increase in 2024. These figures are critical to demonstrating the slowing growth in Level 3 securities over time, which supports the conclusion of reduced reliance on internal designations. The LLM incorrectly states the NAIC methodology was 'refined in 2020' and 'updated in 2021', while the ground truth specifies the refinement date as December 31, 2021—this minor date discrepancy is acceptable, but the introduction of a 2020 refinement is unsupported. Additionally, the answer omits the inference that the slowing growth in Level 3 securities indicates more securities are receiving formal NAIC designations over time, which is a key analytical point in the original answer. While the reasoning is logically sound and contextually relevant, the absence of specific, correct numerical trends reduces quantitative accuracy. The multi-hop synthesis across years is partially achieved but lacks the numerical anchoring needed for full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 456,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Chevron's investment and operational footprint in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital allocation and asset ownership changes?",
      "original_answer": "In 2022, Chevron operated in the Republic of Congo, indicating active involvement in the region, though specific investment figures were not disclosed. In 2023, the company allocated approximately $0.7 billion to offshore development and natural gas projects in Africa, which included the Republic of Congo among other countries like Nigeria and Angola. By 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi, signaling a strategic exit from its holdings in the country. This trajectory shows a shift from active operation and investment in 2022 and 2023 to a full divestiture in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron deepened its upstream presence in the Republic of Congo, allocating roughly **$0.7 billion of 2023 capital** to offshore development and natural‑gas projects there (Chunk 1) – a continuation of the Congo exposure that was already listed among the company’s global operations in the 2022 overview (Chunk 3).  During this period the firm held working‑interest stakes in the offshore **Haute Mer permit (31.5 % non‑operated)** and the **Lianzi block (15.75 %)**, but in early 2025 it **sold those interests**, marking a clear shift in asset ownership (Chunk 2).  The investment‑operate linkage captured by the KG triplets (CVX → Republic of Congo, Republic of Congo → CVX) shows that while Chevron’s capital was directed to Congo’s development activities, the later divestiture reflects a strategic pull‑back of those specific holdings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's presence in the Republic of Congo in 2022, the $0.7 billion capital allocation in 2023 to African offshore and natural gas projects (including Congo), and the ownership stakes (31.5% in Haute Mer, 15.75% in Lianzi). However, it incorrectly states the divestiture occurred in 'early 2025' instead of 2024 as per the ground truth, which is a significant factual error in timing. (2) All numeric values (percentages, dollar amount) are accurate and match the ground truth. The $0.7 billion figure is correctly attributed to 2023, and the stake percentages are exact. The only quantitative issue is the misplacement of the sale to 2025, which contradicts the 'by 2024' timeline in the original answer. (3) The multi-hop reasoning is mostly sound—linking 2022 operations, 2023 investment, and eventual divestiture shows synthesis across time and assets. However, the incorrect year for the sale undermines the conclusion about the 2024 strategic exit, weakening the logical flow. (4) Contextual relevance is high—the answer addresses capital allocation, asset ownership, and strategic evolution. The core narrative of investment followed by divestiture is correct, but the timeline error reduces factual precision. Hence, correctness is penalized to 7 due to the critical misdating of the divestiture event.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 379,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "Texas Instruments has consistently emphasized Embedded Processing Products as a core component of its business model across 2022, 2023, and 2024. In 2022, the company described the broad portfolio of analog and embedded processing products as a key driver of customer opportunity and investment value. In 2023, the narrative reinforced this stance, highlighting embedded processing as integral to leveraging customer design projects and deepening market insight. By 2024, the company maintained this strategic focus, reiterating the importance of embedded processing in enabling broader customer reach and diversified, long-term returns. While the language evolved slightly across years, the consistent emphasis indicates a stable and enduring strategic pillar within TI's competitive framework.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments has treated **Embedded Processing Products** as the core pillar of its four sustainable competitive advantages, repeatedly emphasizing in the 2022, 2023 and 2024 MD&A that a broad portfolio of analog and embedded‑processing products (the “(b) A broad portfolio of analog and embedded processing products…” advantage) expands opportunity per customer and maximizes the value of its investments.  Each year’s discussion underscores that the company will **invest to strengthen these advantages** and tie that effort directly to its long‑term goal of growing free‑cash‑flow‑per‑share, while the KG relationships show that Embedded Processing Products is both a key product stake and an organizational stake that TI holds and that holds TI, cementing its central and evolving role across the strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Texas Instruments' consistent strategic emphasis on Embedded Processing Products from 2022 to 2024 as a core component of its sustainable competitive advantages, specifically referencing the 'broad portfolio of analog and embedded processing products' as one of the four advantages. The narrative evolution across years—expanding customer opportunity, deepening market insight, enabling broader reach and long-term returns—is accurately reflected through the lens of investment value and free cash flow per share. (2) There are no numeric values, dates, or financial figures in dispute; all temporal references (2022, 2023, 2024) are correct, and no calculations are required. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years and ties embedded processing to TI’s competitive advantages, investment strategy, and long-term financial goals. It also correctly references the MD&A sections and the structural role of embedded processing in TI’s strategy. (4) While the LLM adds slight interpretive depth (e.g., 'organizational stake that holds TI'), this does not contradict the ground truth but enriches it without introducing error. The only minor deviation is the stronger claim that embedded processing is 'the core pillar'—the original answer suggests it is a 'stable and enduring strategic pillar' among others, implying shared importance. This slight overstatement prevents a perfect 10 but does not undermine factual correctness. Overall, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 453,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Cisco's interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's borrowing costs over time?",
      "original_answer": "In fiscal year 2022, Cisco reported an effective interest rate of 3.20% on the $500 million 3.50% Senior Note maturing in June 2025. By fiscal year 2023, the effective rate on this same note had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This indicates a significant increase in Cisco's borrowing costs on this instrument over the three-year period, reflecting either market rate increases or shifts in investor risk perception.",
      "llm_answer": "\nCisco’s $500 million 3.50 % Senior Note remained on the balance sheet through fiscal 2022‑2024 (shown in all three filings), but its effective interest rate climbed from **3.20 % in the 2022 filing** to **6.66 % in the 2023 and 2024 filings**, a change that reflects higher market rates and hedge‑accounting adjustments disclosed in the later reports. Consequently, the note’s annual interest expense rose from roughly **$16 million (2022)** to about **$33 million (2023‑2024)**, illustrating a clear upward trend in Cisco’s borrowing costs over the period. The progression is captured by the KG relationship **CSCO → 3.50 % Note**, which links the issuer to the instrument across all three disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported effective interest rates. According to the ground truth, the effective rate was 3.20% in 2022, 6.38% in 2023, and 6.66% in 2024. However, the LLM incorrectly states that the rate was 6.66% in both 2023 and 2024, merging the 2024 value for both years and omitting the correct 2023 figure of 6.38%. This is a critical error in quantitative precision. (2) The interest expense calculation is approximately correct: 3.20% of $500M ≈ $16M, and 6.66% of $500M ≈ $33.3M, so the $16M and $33M estimates are reasonable. However, the model attributes the same $33M expense to both 2023 and 2024 despite different rates, which slightly misrepresents the trend. (3) The multi-hop reasoning is sound in that the model correctly identifies the note’s continuity across fiscal years and links changes in effective rates to borrowing cost trends. It also correctly identifies the $500M 3.50% Senior Note and its presence across filings, showing proper entity tracking. (4) The conclusion about rising borrowing costs is valid and aligns with the ground truth, and the mention of market rate increases and hedge accounting (from Cisco’s disclosures) adds relevant qualitative context, even if not in the original answer. However, the conflation of 2023 and 2024 rates undermines the accuracy of the progression narrative. Thus, while the overall direction and interpretation are correct, the specific numerical evolution is flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 424,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints and strategic flexibility?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was subject to U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight and its impact on business operations. By 2023, it specifically reiterated that shareholder returns could be limited by U.S. banking laws, Delaware law, and the failure to pay full and timely dividends on preferred stock. In 2024, the language remained largely consistent with 2023, but the company added a stronger emphasis on liquidity management and the potential consequences of failing to meet regulatory standards such as 'well capitalized' and 'well managed' status. This progression reveals a sustained focus on regulatory constraints, with increasing emphasis on the interplay between capital planning, liquidity risk, and shareholder returns under evolving regulatory expectations.",
      "llm_answer": "\nAcross the 2022‑2024 annual reports, BNY Mellon repeatedly states that its ability to plan capital and return cash to shareholders is constrained by U.S. banking laws, Delaware statutes, Board discretion and the requirement to remain “well‑capitalized” and “well‑managed,” with any material downgrade of the bank or its subsidiaries’ credit ratings potentially raising funding costs and limiting activities; this recurring language shows a multi‑year regulatory framework that ties dividend and share‑repurchase flexibility to capital‑adequacy rules. Because the parent is a non‑operating holding company that depends on dividends from its subsidiaries and must satisfy well‑capitalized and liquidity standards, its strategic flexibility to allocate capital is continuously bounded by these regulatory caps, a limitation highlighted each year alongside other risk factors such as Title I/II resolution plans, credit‑rating exposure, ESG and tax considerations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns from 2022 to 2024. It correctly identifies the recurring constraints tied to U.S. banking laws, Delaware statutes, and the requirement to remain 'well-capitalized' and 'well-managed,' which aligns with the ground truth. The answer accurately reflects that the parent company’s reliance on subsidiary dividends and regulatory capital standards limits strategic flexibility—a key point in the original answer. It also appropriately notes the continuity across years and the binding nature of these regulations. While the original answer highlights a progressive emphasis on liquidity management and consequences of failing regulatory standards in 2024, the LLM answer incorporates 'liquidity standards' and credit-rating impacts, which are contextually relevant and consistent with the trend, though slightly less precise in marking the 2024 shift. There are no numerical inaccuracies (quantitative accuracy is 10), and all entities (BNY Mellon, U.S. banking laws, Delaware law, well-capitalized status) are correctly identified. The reasoning is sound, demonstrating multi-hop synthesis across years and regulatory domains. The answer is semantically equivalent to the ground truth with only minor differences in emphasis, warranting a correctness score of 9 rather than 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 395,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did General Dynamics' revenue from Repair and other services change from 2022 ($1,169M) to 2023 ($1,132M), and why did it remain flat in 2024 ($1,132M), and what does this pattern suggest about the stability or strategic focus of this business segment?",
      "original_answer": "General Dynamics' revenue from Repair and other services declined slightly from $1,169 million in 2022 to $1,132 million in 2023, and then remained flat in 2024 at $1,132 million. This pattern suggests limited growth or strategic prioritization of the segment during this period, as it did not rebound in 2024 despite overall growth in other areas like nuclear-powered submarines and surface ships. The stagnation may indicate either market saturation, resource reallocation to higher-priority programs, or operational constraints affecting expansion of repair services.",
      "llm_answer": "\nGeneral Dynamics’ “Repair and other services” generated $1,169 M in 2022, slipped to $1,132 M in 2023 (a $37 M, ~3 % decline) – as shown in Chunk 1’s 2022‑2023 figures – and then held steady at $1,132 M in 2024, matching the 2023 level reported in Chunk 2. This pattern, reinforced by the historical range in Chunk 3 (e.g., $1,081 M in 2021), indicates that after an initial dip the segment has settled into a flat, stable revenue base rather than growing, suggesting GD is now maintaining rather than expanding this line of business. The KG triplets confirm that “Repair and other services” is a distinct product/organization linked to GD, underscoring its isolated, steady‑state role within the company’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all revenue figures: $1,169M in 2022, $1,132M in 2023, and flat at $1,132M in 2024, matching the ground truth. The calculation of a $37M decline (~3%) is accurate and appropriately contextualized. (2) Quantitative accuracy is perfect: all numbers, years, and calculations (difference and percentage change) are correct. Format variations (e.g., $1,132 M) are acceptable and semantically equivalent. (3) The reasoning is largely sound: the LLM identifies the decline and subsequent stability, and infers that the segment has settled into a 'flat, stable revenue base' and that GD is 'maintaining rather than expanding.' This aligns with the ground truth's interpretation of limited growth or strategic prioritization. However, the LLM does not explicitly mention possible reasons like market saturation, resource reallocation to submarines/surface ships, or operational constraints—factors present in the original answer that provide deeper strategic context. While the conclusion of a 'steady-state role' is reasonable, it omits the comparative note that other segments grew, which weakens the multi-hop synthesis slightly. (4) Scores reflect near-perfect factual accuracy and relevance, with a minor deduction in qualitative accuracy due to incomplete exploration of explanatory factors. Contextual relevance is full, as all parts of the question are addressed with appropriate financial and strategic framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 402,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did UnitedHealth Group's venture investments and equity method investments in healthcare businesses evolve from 2022 to 2024, particularly in terms of dollar value and strategic emphasis?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's venture investments were part of its broader equity securities portfolio, which grew from $3.7 billion in 2022 to $4.9 billion in 2023 and remained stable at $4.9 billion in 2024. Meanwhile, its equity method investments in healthcare businesses showed a significant increase, rising from $1.5 billion in 2023 to $3.8 billion in 2024, after remaining flat at $1.4 billion in 2023 compared to 2022. This indicates a strategic shift in 2024 toward deeper, more integrated investments in operating businesses within the healthcare sector.",
      "llm_answer": "\nUnitedHealth Group’s equity‑method investments in health‑care operating businesses grew from $1.3 bn (reported for 2022) to $1.5 bn in 2023 and then surged to $3.8 bn by the end of 2024, while its venture‑investment portfolio—reflected in total equity securities of $3.7 bn in 2022, $4.9 bn in 2023 and $4.9 bn in 2024—remained a stable, though larger, component of its equity holdings. The company consistently emphasized health‑care‑focused deployments, allocating the bulk of its equity‑method exposure to health‑care businesses and using venture investments as a core pillar of its strategic investment focus. This progression underscores a strategic shift toward deeper, higher‑value health‑care investments while maintaining a steady venture‑investment base across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it states that UnitedHealth Group's equity-method investments were $1.3 billion in 2022, whereas the ground truth reports $1.4 billion in both 2022 and 2023 (with a flat year-over-year). The $1.5 billion figure for 2023 in the LLM answer is incorrect—this value actually corresponds to the 2022 equity-method investment in the original answer. The surge to $3.8 billion in 2024 is correctly reported. The venture investment figures (as part of total equity securities) are accurate: $3.7B in 2022, $4.9B in 2023, and $4.9B in 2024. (2) Calculations and comparisons are otherwise sound: the stability of the venture portfolio and the sharp increase in equity-method investments in 2024 are correctly highlighted. The strategic interpretation—that UnitedHealth shifted toward deeper, integrated investments in 2024 while maintaining a steady venture base—is consistent with the ground truth. (3) Multi-hop reasoning is strong: the model synthesizes trends across three years for two distinct investment types (venture vs. equity-method), correctly identifying the shift in strategic emphasis. (4) Despite the small error in the 2022/2023 equity-method investment values, the overall narrative and strategic conclusion align well with the original answer. The core facts—growth in equity-method investments in 2024 and stable venture holdings—are correct, warranting a high score, but the numerical discrepancy prevents a 9 or 10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 423,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Philip Morris International's (PMI) peer group classification of Colgate-Palmolive Co. evolve across 2022, 2023, and 2024, and what does this multi-year consistency reveal about PMI's strategic benchmarking framework?",
      "original_answer": "Across 2022, 2023, and 2024, Colgate-Palmolive Co. remained consistently included in the PMI Peer Group, which was established based on four characteristics: global presence, focus on consumer products, net revenues, and market capitalization similar to PMI. This classification was unchanged year-over-year, indicating a stable peer benchmarking framework. The repeated inclusion of Colgate-Palmolive Co. in the peer group across all three years suggests that PMI maintained a consistent strategic lens for evaluating its competitive positioning within the broader consumer products sector, even as it excluded direct tobacco industry peers from the comparison.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings (Chunks 1, 2 and 3), PMI’s peer group—including **Colgate‑Palmolive Co.**—was explicitly described as “the same as that used in the prior year,” and each filing listed Colgate‑Palmolive among the companies that constitute the PMI Peer Group. This multi‑year consistency shows that PMI’s strategic benchmarking framework relies on a stable, criteria‑driven set of peers (global presence, consumer‑product focus, comparable net revenues and market capitalization, and primary international tobacco companies), ensuring that Colgate‑Palmolive remains a constant benchmark for PMI’s performance analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Colgate-Palmolive Co. was consistently included in PMI's peer group across 2022, 2023, and 2024, and that the peer group was described as unchanged from the prior year in each filing—this matches the original answer’s claim of year-over-year consistency. (2) There are no numeric values (e.g., revenue, market cap figures) in either the question or ground truth, so quantitative accuracy is not applicable beyond correct referencing of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of 10-K filings (implied by 'Chunks 1, 2, 3') and correctly infers that the repeated use of the same peer group indicates a stable benchmarking framework. The only minor inaccuracy is the inclusion of 'primary international tobacco companies' as a criterion—this contradicts the ground truth, which explicitly states that PMI excluded direct tobacco industry peers. This slightly misrepresents the rationale but does not undermine the core conclusion about stability and criteria-based selection. (4) The answer is contextually relevant, directly addressing both the evolution (no change) and strategic implications (stable framework). Semantic equivalence is strong, with only slight overstatement in peer criteria. Thus, correctness is docked slightly to 9 for that error, but remains high due to overall fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Related_To]-> COMP <-[Has_Stake_In]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 408,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its expanding credit products and third-party risk dependencies, and what does this trend suggest about the company's fraud mitigation effectiveness over time?",
      "original_answer": "PayPal's exposure to abusive behaviors increased in complexity and scale across the three-year period. In 2022, the company noted that third parties attempted to abuse access to payment services through stolen identities, financial instruments, and fraudulent transactions, emphasizing the difficulty in detecting such schemes in digital environments. By 2023, PayPal had expanded its credit offerings significantly, including a €40 billion multi-year agreement to sell BNPL loan receivables in Europe, which introduced new risks related to third-party fraud and abuse at a much larger scale. In 2024, PayPal reiterated concerns about abusive behaviors, particularly in the context of third-party reliance and digital fraud attacks, while also facing regulatory uncertainty regarding the validity of loan receivables post-sale, which could further expose the company to fraudulent claims or abusive practices in receivables management. The consistent emphasis across all three years suggests that while PayPal has invested in detection systems, the evolving nature and scale of digital payments and credit offerings have outpaced mitigation effectiveness, increasing exposure risk.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behaviors grew in step with its expanding credit portfolio—beginning with U.S. consumer and merchant financing in 2022 (Chunk 3), adding a multi‑year BNPL receivables sale and forward‑flow funding arrangement in 2023 (Chunk 1), and continuing those third‑party‑dependent credit structures in 2024 (Chunk 2); throughout, the company repeatedly cites reliance on unaffiliated lenders, payment processors and other partners that introduce operational, regulatory and fraud risk.  This progression is reflected in the knowledge‑graph relationship PYPL → Abusive Behaviors (RISK_FACTOR) ← Impacted_By ← PYPL, showing that the larger and more diversified the credit and third‑party ecosystem becomes, the greater the opportunity for fraudsters to exploit the platform.  As a result, the trend indicates that fraud‑mitigation effectiveness is being stretched by the scale and complexity of PayPal’s credit products and third‑party dependencies, requiring ever‑more robust detection and prevention measures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's exposure to abusive behaviors increased from 2022 to 2024 alongside expansion in credit products and third-party dependencies. The 2023 €40 billion BNPL receivables sale is correctly referenced (though the currency is omitted in the LLM answer, it is implied as European and contextually accurate). No incorrect numbers or dates are present. (2) Quantitative accuracy is strong: while the LLM does not explicitly state '€40 billion,' it accurately references the multi-year BNPL receivables sale and forward-flow funding, which matches the ground truth in substance. The absence of the exact figure is a minor omission but not a factual error, especially as the focus is on trend and risk rather than precise valuation. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and entities, linking credit expansion (especially BNPL) with increased third-party risk and fraud exposure. It appropriately infers that growing complexity challenges fraud mitigation, matching the ground truth's conclusion. (4) The answer is contextually excellent—directly addressing the evolution of risk, the role of credit products and third parties, and implications for fraud mitigation. The use of knowledge-graph notation (PYPL → Abusive Behaviors) adds analytical depth without distorting meaning. Only a minor deduction from qualitative accuracy due to the lack of explicit mention of regulatory uncertainty around loan receivables in 2024, which is part of the ground truth. Otherwise, the answer is semantically equivalent and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 456,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Southern Company's use of natural gas options for hedging evolved from 2022 through 2024, and what does this 3-year trend suggest about its risk management strategy in response to natural gas price volatility?",
      "original_answer": "Southern Company's use of natural gas options for hedging fluctuated significantly from 2022 through 2024. In 2022, the company reported 253 million mmBtu in natural gas options. This increased sharply to 339 million mmBtu in 2023, indicating a more aggressive hedging posture. However, by 2024, the volume dropped to 176 million mmBtu, suggesting a strategic reduction in exposure or a shift toward alternative hedging instruments like swaps. This pattern reflects a dynamic response to market volatility, with an initial increase in options usage likely to mitigate rising gas prices, followed by a de-risking move as market conditions may have stabilized or as the company adjusted its hedging mix.",
      "llm_answer": "\nSouthern Company’s natural‑gas option hedge expanded from **214 million mmBtu at the end of 2022** (Chunk 3) to **339 million mmBtu at the end of 2023** (Chunk 2 & Chunk 3), then was **reduced to 176 million mmBtu by the end of 2024** (Chunk 2), while its swap volumes remained broadly steady across the three years (see Chunk 1 for 2020‑2021 baseline and Chunk 2/Chunk 3 for 2023‑2024 swap figures).  \nThis 3‑year pattern—rapid scaling up during the 2023 price spike and a subsequent pull‑back in 2024—reveals an adaptive risk‑management strategy that enlarges option‑based protection when natural‑gas volatility intensifies and then trims the hedge as market expectations shift, underscoring the company’s use of options to balance price‑risk coverage with cost efficiency.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the upward trend from 2022 to 2023 and the sharp decline in 2024, and accurately reports the 2023 (339 million mmBtu) and 2024 (176 million mmBtu) figures. However, it reports 214 million mmBtu for 2022 instead of the ground truth 253 million mmBtu, which is a significant numerical discrepancy. This error affects the quantitative accuracy, though the overall directional trend remains correct. (2) The calculation of changes over time is not explicitly performed, but the qualitative description of 'expansion' and 'reduction' aligns with the data. The swap volume context is correctly noted as stable, which adds useful context not in the original answer but supported by the data (Chunks 1–3), enhancing completeness. (3) The multi-hop reasoning is sound: the model synthesizes data across years and instruments (options vs. swaps), infers strategic intent from volume changes, and links the pattern to market volatility (e.g., 2023 price spike), demonstrating strong qualitative reasoning. The conclusion about adaptive risk management and cost efficiency is a reasonable interpretation consistent with the trend. (4) The answer is highly contextually relevant, addressing both parts of the question: evolution over time and implications for risk strategy. Despite the incorrect 2022 number, the core narrative of dynamic hedging adjustment is preserved, warranting a high correctness score with a deduction for the factual inaccuracy in the initial year's volume.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 419,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Texas Instruments' aggregate expense for U.S. defined contribution plans evolve from 2022 through 2024, and what does this trend suggest about the company's long-term employee benefit strategy in relation to its non-qualified defined benefit pension plan?",
      "original_answer": "Texas Instruments' aggregate expense for U.S. defined contribution plans increased from $70 million in 2022 to $75 million in 2023, and further to $76 million in 2024. This steady increase indicates a growing financial commitment to employee retirement benefits, particularly for those not accruing benefits under the non-qualified defined benefit pension plan. The trend suggests a strategic emphasis on supporting employees who have opted out of the defined benefit plan and are participating in the enhanced defined contribution plan, aligning with the company's long-standing structure of offering flexible retirement options since the defined benefit plans were closed to new participants in 1997.",
      "llm_answer": "\nTexas Instruments' aggregate U.S. defined‑contribution expense climbed from $70 million in 2022 (as disclosed in the 2022 filing, chunk 2) to $75 million in 2023 (chunk 3) and $76 million in 2024 (chunk 2), extending the upward trend first seen in the $63 million expense recorded for 2021 (chunk 1).  \nThis increase coincides with the company’s long‑standing non‑qualified defined‑benefit pension plan, which all three filings describe as unfunded and closed to new participants (chunks 2 & 3), suggesting a strategic shift toward relying more on defined‑contribution funding while keeping the legacy non‑qualified pension as a limited, unfunded liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the aggregate U.S. defined contribution plan expenses for 2022 ($70M), 2023 ($75M), and 2024 ($76M), matching the ground truth exactly. It also accurately references the $63M expense for 2021, which, while not required, adds useful context and shows correct data extraction. All numbers and years are factually correct, satisfying quantitative accuracy.\n\n2) The answer addresses both parts of the question: the evolution of expenses (increasing trend from 2022–2024) and the implication for long-term employee benefit strategy in relation to the non-qualified defined benefit pension plan. It correctly notes that the defined benefit plan is unfunded and closed to new participants, aligning with the ground truth.\n\n3) The reasoning is sound: the LLM infers a strategic shift toward defined contribution plans as the defined benefit plan remains a closed, unfunded legacy liability. This aligns with the ground truth's interpretation of a strategic emphasis on defined contribution plans for employees who are not accruing benefits under the pension plan.\n\n4) The only minor shortcoming is that the LLM does not explicitly mention the 1997 closure date of the defined benefit plan to new participants—a detail included in the original answer that strengthens the historical context of the strategy. While the LLM notes the plan is closed, the absence of the 1997 milestone slightly weakens the depth of the strategic narrative, though the core logic remains intact.\n\n5) Semantic equivalence is high: the LLM conveys the same factual trajectory and strategic interpretation as the ground truth, with only slight omission of a contextual detail. Wording differences do not affect meaning.\n\nThus, the answer is highly accurate, with full quantitative correctness and strong qualitative reasoning, meriting a 9/10 overall for near-perfect performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 509,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did General Motors' long-term rate of return assumptions for U.S. pension plans evolve from 2022 through 2024, and what does this trend suggest about the company's shifting expectations for asset performance and risk tolerance?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on assets (ROA) of 5.4% for U.S. pension plans, reflecting updated capital market assumptions. By 2023, this rate remained unchanged at 6.3%, indicating a stabilization in expectations following prior adjustments. In 2024, the rate increased to 6.5%, signaling a more optimistic outlook on long-term asset performance. This upward trend from 5.4% in 2022 to 6.5% in 2024 suggests that GM's strategic asset mix and risk mitigation approach became more confident over time, aligning with improved funded status objectives and a greater tolerance for market exposure.",
      "llm_answer": "\nGM’s U.S. pension long‑term rate of return assumption was 6.3 % for both 2022 and 2023 (the 2023 study notes the rate “remains unchanged at 6.3 % at December 31, 2023 and 2022”), and rose to 6.5 % in the 2024 study (an increase from 6.3 % at year‑end 2023).  This upward revision—following the 5.4 % level recorded in the 2021 study—reflects a more optimistic outlook on future asset performance and a modest shift toward a slightly higher‑return, higher‑risk asset mix that is calibrated to improve funded positions while still aligning with each plan’s risk‑tolerance and liability‑funding objectives.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the long-term rate of return was 5.4% in 2022, not 6.3% as stated in the LLM answer. The LLM incorrectly claims the rate was 6.3% in both 2022 and 2023, but the truth is it increased from 5.4% in 2022 to 6.3% in 2023 (not unchanged). The 2024 figure of 6.5% is correctly reported. The LLM references a '2021 study' with 5.4%, but the question and ground truth focus on 2022–2024, and the 5.4% is explicitly attributed to 2022 in the original, making the timeline misaligned. (2) Calculation-wise, the trend from 5.4% to 6.5% is upward, but the LLM misrepresents the starting point and path by claiming stability between 2022 and 2023 when in fact there was a significant increase. (3) The reasoning about a more optimistic outlook and shift toward higher-return, higher-risk assets aligns with the ground truth’s interpretation and shows sound qualitative synthesis. The mention of funded status and risk tolerance objectives is contextually appropriate and semantically consistent. (4) Despite correct contextual framing and directional interpretation, the quantitative inaccuracies—especially the wrong 2022 value and false claim of no change from 2022 to 2023—are severe enough to undermine the answer’s factual reliability, warranting a moderate correctness score of 6. The answer gets partial credit for correct 2024 value and reasonable interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 410,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Cisco's financial exposure through total return swaps linked to deferred compensation evolve from fiscal years 2022 through 2024, particularly in terms of realized gains or losses, and what does this progression indicate about the company's risk management or compensation strategy?",
      "original_answer": "Cisco's financial exposure through total return swaps tied to deferred compensation shifted significantly across the three-year period. In fiscal 2022, the company reported a loss of $92 million related to these swaps. By fiscal 2023, this position improved to a gain of $58 million, and in fiscal 2024, the gain increased further to $91 million. This progression indicates a notable turnaround in the performance of these instruments, potentially reflecting improved market conditions or strategic adjustments in Cisco's deferred compensation design or hedging practices.",
      "llm_answer": "\nThe tables in Cisco’s 2022‑2024 10‑K filings show that the realized gain/loss on **total‑return swaps‑deferred compensation**—recorded in “Operating expenses and other”—was **$(92) million** in the year ended July 30 2022 (Chunk 1), **+$58 million** in the year ended July 29 2023 (Chunk 2), and **+$91 million** in the year ended July 27 2024 (Chunk 3).  This swing from a loss to progressively larger gains demonstrates that Cisco is using market‑linked swaps to offset its deferred‑compensation liability, adjusting the instrument’s position to align compensation expense with market performance and thereby managing the financial risk associated with those obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: a loss of $92 million in fiscal 2022, a gain of $58 million in 2023, and a gain of $91 million in 2024. The fiscal year-end dates (July 30, 2022; July 29, 2023; July 27, 2024) align with Cisco's reporting and are correctly cited. (2) The answer addresses all parts of the question: it traces the evolution of Cisco's exposure through total return swaps over three fiscal years, reports realized gains/losses accurately, and interprets the trend in terms of risk management and compensation strategy. (3) Entity accuracy is perfect: Cisco is the correct company, the financial instrument (total return swaps linked to deferred compensation) is correctly identified, and the years are properly matched to the data. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the shift from loss to increasing gains indicates Cisco is using these swaps to hedge deferred compensation liabilities, aligning expense with market performance—a logical conclusion supported by the data. The interpretation about risk management is semantically equivalent to the ground truth’s suggestion of 'strategic adjustments' or improved hedging. Minor wording differences (e.g., 'market-linked swaps' vs 'total return swaps') do not affect factual accuracy. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 406,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its control over pricing, use of third-party payment processors, and transaction expense recognition?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with explicit acknowledgment in all filings that it recognized fees paid to third-party payment processors and financial institutions as transaction expense. In 2022, the company emphasized its discretion in setting fees independent of incurred costs. In 2023, it reiterated this exposure and clarified that tiered pricing based on volume did not constitute a future material right. In 2024, PayPal again confirmed its principal role in transactions, maintaining that it bears full margin risk and continues to recognize fees paid to processors as transaction expense, despite the adoption of new segment reporting disclosures. This shows a consistent exposure to margin risk without structural changes in how it recognizes transaction costs or pricing control.",
      "llm_answer": "\nAcross 2022, 2023 and 2024 PayPal repeatedly disclosed that it acts as the **principal** in payment transactions, **controls the fee charged to customers independently of its own costs**, and therefore **bears full margin risk** – a risk that is captured by recording the fees paid to third‑party processors and other financial institutions as **transaction expense** (see Chunk 1, 2 and 3).  The company’s tiered, volume‑based pricing is adjusted only within a range normally offered to similar customers and does not create a material future right, so the underlying margin‑risk profile has remained essentially unchanged; the only evolution is the 2024 adoption of new segment‑reporting guidance, which adds disclosure requirements but does not alter the way margin risk is incurred.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original (ground truth) answer. (1) All key facts are accurately conveyed: PayPal consistently acted as principal in transactions across 2022–2024, maintained control over pricing independent of costs, bore full margin risk, and recognized fees paid to third-party processors as transaction expense. The answer correctly notes that tiered pricing does not confer a material future right, preserving the margin risk structure. It also accurately identifies the 2024 change in segment reporting as a disclosure-only update with no impact on margin risk recognition. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) are correctly used and aligned with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years, connects the role of principal to margin risk, links pricing discretion to risk exposure, and correctly interprets the accounting treatment of third-party fees. It also integrates the nuance about tiered pricing and the immateriality of the 2024 reporting change. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in margin risk in relation to pricing control, third-party processors, and expense recognition. Wording differs slightly but meaning is preserved with high fidelity. No errors in entities, years, or financial concepts. All scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Bears]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 413,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 through 2024, and what does this trend suggest about the company's strategic positioning in liquefied natural gas markets?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased steadily over the three-year period. In 2022, natural gas consumed in operations was 592 million cubic feet per day, rising to 596 million cubic feet per day in 2023, and further increasing to 609 million cubic feet per day in 2024. This upward trajectory indicates a growing operational emphasis on LNG production in Angola, aligning with Chevron's broader strategy to strengthen its position in global LNG markets despite asset divestitures in other regions.",
      "llm_answer": "\nChevron’s “as‑sold” natural‑gas volumes linked to Angola LNG grew from roughly **7.11 trillion cubic feet per day in 2022** (570 MMcf of gas consumed in operations) to **7.15 trillion cubic feet in 2023** (596 MMcf) and then to **7.57 trillion cubic feet in 2024** (609 MMcf), reflecting a steady upward trend across the three fiscal years covered in Chunks 1‑3.  This increase occurs while Chevron has divested non‑core assets in Indonesia, Canada and Myanmar (as noted in Chunks 1‑2), underscoring a strategic pivot toward expanding its LNG portfolio and cementing Angola LNG as a key growth pillar in its long‑term energy mix.  The pattern therefore signals Chevron’s intent to deepen its stake in the global LNG market by leveraging its ownership in Angola LNG to capture rising demand.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in quantitative values. It incorrectly states 'as-sold' natural gas volumes in trillions of cubic feet per day (e.g., 7.11 trillion cubic feet per day), which is physically implausible and grossly incorrect—actual values are in million cubic feet per day (MMcf/d). The ground truth reports consumed volumes (not 'as-sold') of 592, 596, and 609 MMcf/d for 2022–2024. The LLM confuses units, reporting trillions instead of millions, inflating numbers by a factor of over 1,000. While the 596 and 609 MMcf figures are correctly cited as inputs, they are misrepresented as 'as-sold' volumes and embedded in absurdly large totals. The 2022 figure is also wrong—570 MMcf is cited instead of 592. (2) Calculations and comparisons are therefore invalid due to unit confusion and incorrect base numbers. The trend direction (increasing) is correct, but the magnitude and units are catastrophically off. (3) The reasoning partially captures the strategic pivot—mentioning divestitures in Indonesia, Canada, and Myanmar and linking Angola LNG growth to LNG portfolio expansion—but incorrectly frames the data source as 'as-sold' volumes rather than gas consumed in operations. The multi-hop synthesis is conceptually sound (linking Angola growth to global LNG strategy amid divestitures), but based on distorted data. (4) Correctness and quantitative accuracy are severely penalized due to the unit and value errors. Qualitative accuracy is moderate because the strategic interpretation aligns with the ground truth, despite flawed inputs. Contextual relevance is high as the answer addresses both parts of the question and attempts proper synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 463,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did the treatment and reporting of scheduled payments under outdoor lighting contracts evolve across Southern Power's disclosures in 2022, 2023, and 2024, and what does this reveal about the growing materiality or structural importance of these contracts over time?",
      "original_answer": "In 2022, Southern Power noted that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were immaterial. By 2023, the company began including scheduled payments to be received under these contracts in maturity analyses alongside tolling arrangements and PPAs, signaling increased attention to their financial structure. In 2024, Southern Power explicitly integrated outdoor lighting contracts into its broader lease income reporting framework, presenting them alongside significant revenue-generating arrangements like PPAs. This progression indicates a growing materiality and structural integration of outdoor lighting contracts within Southern Power’s financial disclosures over the three-year period.",
      "llm_answer": "\nSouthern Power’s 2022 filing (Chunk 1) described the undiscounted cash flows from outdoor‑lighting contracts—accounted for as operating leases at Mississippi Power—as “immaterial,” essentially treating them as a footnote. By 2023 (Chunk 3) and especially 2024 (Chunk 2), the same contracts are no longer marginal: scheduled payments are now presented in formal maturity analyses and their lease income is incorporated into wholesale revenues alongside PPAs and tolling arrangements, signaling a deliberate shift to report them as material lease components. This evolution—from an immaterial footnote in 2022 to a disclosed, revenue‑generating lease line in 2023‑2024—reveals that outdoor‑lighting contracts have become increasingly central to Southern Power’s financial structure and are now material enough to be highlighted in maturity schedules and included in reported earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, outdoor lighting contract cash flows were deemed immaterial; by 2023, scheduled payments were included in maturity analyses with tolling and PPAs; in 2024, they were integrated into lease income reporting alongside major revenue arrangements. These points match the original answer exactly. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022, 2023, 2024) are correctly used and sequenced. (3) The multi-hop reasoning is sound—LLM synthesizes information across three years and correctly infers increasing materiality and structural importance based on evolving disclosure practices. It accurately connects the shift from 'immaterial footnote' to inclusion in maturity analyses and revenue reporting as evidence of growing significance. (4) The only minor shortcoming is slight compression of the 2024 development: while the LLM mentions lease income being incorporated into wholesale revenues, the original answer more precisely notes integration into a 'broader lease income reporting framework' and explicit presentation alongside PPAs. This nuance is implied but not fully articulated. However, the semantic meaning and conclusion—that these contracts became materially important—are equivalent. Wording differences are acceptable and do not affect factual accuracy. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 414,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing segments over this period?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for the Analog segment. In 2023, the operation in Melaka was still limited to the Analog segment. By 2024, the company continued to operate in Melaka, Malaysia only for the Analog segment. This indicates that, over the three-year period, Melaka's role remained consistent and limited to Analog operations without any expansion into Embedded Processing.",
      "llm_answer": "\nAcross the 2022‑2024 fiscal years Texas Instruments kept its Melaka, Malaysia site on the books as part of its global operations (TXN → Melaka, Malaysia → TXN), but the site was listed only under the **Analog** column in each year’s disclosure—never under **Embedded Processing**. In the 2022 table the entry is marked †, in 2023 it appears with * and in 2024 with **, indicating its continued presence and growing relevance, yet the segment classification remains exclusively Analog throughout the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly conveys that Texas Instruments' Melaka, Malaysia site was exclusively involved in the Analog segment throughout 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the ground truth. All entities (TXN, Melaka, Malaysia, Analog, Embedded Processing) and time periods (2022–2024) are accurate. The answer correctly reflects the consistent segment classification over the three years, confirming no expansion into Embedded Processing. The mention of symbols (†, *, **) is not present in the ground truth but does not contradict it; these may refer to footnote markers in source filings and do not affect factual correctness. This is a minor addition that suggests attention to document detail but doesn't alter or distort the core facts. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning correctly synthesizes multi-hop information across years and segments. The semantic meaning fully aligns with the original answer. The only reason for not scoring a 10 is the slight introduction of potentially extraneous symbols interpretation, which, while plausible, is not confirmed in the ground truth and could imply unsupported inference. Otherwise, the response is complete, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 360,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did AMT's relationship with the 1.600% Notes evolve from 2022 through 2024 in terms of principal amount, interest payment schedule, and par call date, and what does this multi-year progression indicate about the company's debt management strategy?",
      "original_answer": "From 2022 to 2024, AMT's 1.600% Notes remained consistent in aggregate principal amount at $700.0 million. However, the adjustments to principal amount related to these notes decreased from (2.6) in 2023 to (1.5) in 2024, suggesting a reduction in modifications or adjustments to the note structure over time. The interest payment schedule remained unchanged, with payments due semi-annually on April 15 and October 15. The par call date also remained stable at March 15, 2026, indicating no change in early redemption terms. This consistency suggests that AMT maintained a stable approach to managing this specific debt instrument over the three-year period, with only minor adjustments in administrative or accounting treatments.",
      "llm_answer": "\nAMT’s 1.600 % Notes have remained a $700 million issue from 2022‑2024, with a fixed semi‑annual interest schedule (April 15 and October 15) and a constant par‑call date of 15 March 2026; the 2023 filing records a –$2.6 million adjustment to principal and the 2024 filing a further –$1.5 million adjustment, indicating systematic principal reductions while the call provision stayed unchanged.  This steady balance, predictable interest payments and unaltered call date reveal AMT’s debt‑management strategy of retaining low‑cost, long‑dated fixed‑rate financing and retiring the notes on schedule rather than refinancing or restructuring the obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the principal amount of $700 million is consistent across 2022–2024; interest payments are correctly identified as semi-annual on April 15 and October 15; the par call date is accurately stated as March 15, 2026. The adjustments to principal are correctly reported as -$2.6 million in 2023 and -$1.5 million in 2024, matching the ground truth values (presented as (2.6) and (1.5)). (2) Quantitative accuracy is perfect—numbers, dates, and formatting (e.g., $700 million vs $700 million) are equivalent and correctly interpreted. (3) The reasoning is sound: the LLM correctly infers that the stable structure indicates a strategy of maintaining low-cost, long-term fixed-rate debt, with minor principal adjustments likely reflecting amortization or accounting changes. The conclusion that AMT is retiring the notes on schedule rather than restructuring is a reasonable interpretation of the stability. (4) The only minor gap is that the original answer notes the reduction in adjustments 'suggesting a reduction in modifications or adjustments to the note structure,' while the LLM interprets the adjustments as 'systematic principal reductions,' which may slightly overstate the case—these could be non-cash or accounting adjustments rather than actual principal paydowns. However, this does not materially misrepresent the data. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Debt]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 424,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition and effective interest rate, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Cisco's utilization of its 5.90% Note remained consistent at $2,000 million across fiscal years 2022, 2023, and 2024, with the effective interest rate holding steady at 6.11% throughout the period. However, the composition of Cisco's total debt changed significantly — total long-term debt increased from $8,416 million in 2022 to $19,621 million in 2024, while short-term debt decreased from $499 million to $488 million. This indicates that Cisco has been increasingly relying on long-term fixed-rate instruments, including the 5.90% Note, as part of a broader strategy to stabilize financing costs amid rising debt levels.",
      "llm_answer": "\nCisco continues to disclose the same $2,000 million 5.90 % senior note due 2039 in each filing (Chunk 1 – 2022, Chunk 2 – 2023, Chunk 3 – 2024), and its effective interest rate stays constant at 6.11 % across the three years; however, the overall debt mix shifts dramatically—total debt rises from $8.9 billion (with $8.4 billion long‑term) in FY22 to $20.1 billion (with $19.6 billion long‑term) in FY23/24, while short‑term borrowings fall from $2.5 billion to $0.5 billion, and the note now represents only about 10 % of the enlarged long‑term balance.  This shows that Cisco is preserving the 5.90 % tranche as a stable, long‑dated financing pillar while expanding its capital structure with a broader set of newer, lower‑coupon notes, indicating a strategy of diversifying and extending maturities rather than retiring the legacy high‑cost debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Cisco's 5.90% Note remained at $2,000 million and the effective interest rate stayed at 6.11% across FY2022–2024, which matches the ground truth. However, there are significant quantitative inaccuracies in the total debt figures. The LLM states total debt rose from $8.9 billion in FY22 to $20.1 billion in FY23/24, but the ground truth reports total long-term debt increasing from $8,416 million ($8.4 billion) in 2022 to $19,621 million ($19.6 billion) in 2024, with short-term debt decreasing from $499M to $488M—not $2.5B to $0.5B as claimed. The LLM overstates short-term debt in FY22 and misrepresents the timeline (e.g., implying FY23/24 are the same). (2) Calculations: The LLM’s claim that the note represents 'about 10%' of long-term debt is approximately correct ($2B / $19.6B ≈ 10.2%), so this inference is acceptable. However, the incorrect base values for short-term debt and total debt reduce quantitative accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across three years and identifies the strategic shift toward long-term debt and maturity extension, even if it mischaracterizes the cost as 'high-cost' (the 5.90% note is not necessarily high-cost in context). The conclusion about diversifying and extending maturities aligns with the ground truth’s interpretation of stabilizing financing costs. (4) Scores justified: Correctness is 7 due to accurate core facts (note amount, rate, trend in long-term debt) but major errors in short-term debt and total debt figures. Quantitative accuracy is 6 due to material number discrepancies. Qualitative accuracy is 8 because reasoning and strategy interpretation are strong despite some flawed inputs. Contextual relevance is 9—response directly addresses all parts of the question with high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 500,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did General Dynamics' production volume of Light Armored Vehicles (LAVs) for the Canadian Army evolve from 2022 through 2024, and what does this progression indicate about the company's strategic focus on LAV manufacturing?",
      "original_answer": "General Dynamics' production volume of LAVs for the Canadian Army increased from 360 units in 2022 to 399 units in 2023, and further to 449 units in 2024. This consistent growth indicates a strengthening strategic focus on LAV manufacturing, supported by additional programs like the Light Armoured Vehicle Reconnaissance Surveillance System (LRSS) in 2024, which added 66 specialized LAVs equipped with advanced surveillance systems. The multi-year expansion reflects GD's deepening commitment to land systems and armored vehicle capabilities.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics’ Canadian LAV production rose steadily—360 units in 2022, 399 units in 2023, and 449 new LAVs (plus an additional 66 LRSS‑equipped vehicles in 2024)—reflecting an expanding order book for the Canadian Army across eight variants and ongoing fleet upgrades. This upward trajectory underscores GD’s strategic focus on scaling LAV manufacturing, leveraging its market‑leading position while reinvesting in related platform capabilities such as robotic and autonomous systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the production volumes for 2022 (360 units), 2023 (399 units), and 2024 (449 units), matching the ground truth exactly. It also accurately includes the additional 66 LRSS-equipped LAVs in 2024, which aligns with the original answer's mention of the Light Armoured Vehicle Reconnaissance Surveillance System adding 66 specialized units. All numeric values and years are correct. (2) Quantitative accuracy is perfect—no calculation errors or misstatements; the progression and additional program numbers are factually consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes production volume trends with strategic implications, noting the expansion reflects growing orders and fleet upgrades, and ties in the LRSS program as a driver of increased output. The conclusion about strategic focus on scaling LAV manufacturing and reinvesting in platform capabilities is logically supported and semantically equivalent to the original's 'deepening commitment to land systems.' (4) The only minor gap is that the LLM mentions 'eight variants' and 'robotic and autonomous systems,' which are plausible details but not present in the ground truth; however, these do not contradict it and fall within reasonable inference. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only slight deduction in qualitative accuracy due to minor unsupported additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 414,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these ongoing funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS periodically altering the methodologies used to calculate these payments. In 2022, the company noted that CMS had previously reduced or frozen benchmarks and made changes to risk adjustment calculations, prompting selective benefit and premium adjustments, withdrawal from certain counties, and intensified cost management. In 2023, the company reiterated these pressures, noting that CMS had again made changes to risk adjustment payment methodologies and that UnitedHealth had responded with similar strategies, including recalibrating bids and managing medical costs. By 2024, the company continued to highlight the ongoing risk from CMS adjustments to payment mechanisms, particularly around beneficiary health status data submissions, and maintained its strategic focus on cost control and selective market participation. The consistent evolution of CMS's risk adjustment framework required sustained operational agility from UnitedHealth to mitigate financial impact.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes intensified as CMS repeatedly froze or reduced benchmarks and revised the risk‑adjustment methodology, compounding the pressure with audit‑driven recoupments; in response, the company progressively broadened its mitigation toolkit—starting with selective benefit and premium adjustments and the withdrawal of plans from certain counties in 2022, expanding to intensified medical‑cost and operating‑expense controls and heightened risk‑adjustment data submissions in 2023, and culminating in 2024 with a more aggressive cost‑structure overhaul and deeper integration of Optum’s analytics to offset the persistent payment volatility.  \nThese actions reflect a continuous effort to align the firm’s cost structure and revenue mix with evolving government payment rules while leveraging Optum’s capabilities to better manage risk‑adjustment exposures across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group's exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 is accurately described, including CMS's repeated changes to benchmarks and methodologies. The strategic responses—selective benefit and premium adjustments, county withdrawals, cost controls, bid recalibration, and data submission improvements—are all consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes evolving regulatory pressures and corresponding strategic shifts across three years, correctly identifying continuity and progression in UnitedHealth’s response. The mention of Optum’s analytics integration adds contextual depth and is plausible given Optum’s role, though not explicitly stated in the ground truth—this is a minor elaboration but not factually incorrect. (4) The LLM conveys semantic equivalence with enhanced narrative flow, capturing the sustained nature of CMS pressure and UnitedHealth’s adaptive strategy. The only reason for not scoring a 10 is that the original answer does not mention 'audit-driven recoupments' or 'aggressive cost-structure overhaul' explicitly, which are reasonable inferences but slightly extend beyond the documented response. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1546,
        "completion_tokens": 436,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion in carrying value across all three years (2022–2024), indicating a consistent long-term debt strategy around this instrument despite broader changes in its debt portfolio. While other notes matured or were refinanced, PYPL maintained its position in the 2029-dated 2.850% notes, signaling strategic intent to preserve this liability structure.",
      "llm_answer": "\nPYPL’s fixed‑rate 2.850 % notes issued in September 2019 remain fully outstanding at **$1.5 billion** in every reporting year – the amounts are shown as $1,500 million in the 2022 10‑K (Chunk 3), as $1,500 million as of Dec 31 2023 in the 2023 filing (Chunk 1), and as $1,500 million as of Dec 31 2024 in the 2024 filing (Chunk 2).  Because this tranche’s balance does not change across 2022‑2024, the company is deliberately maintaining a large, long‑dated fixed‑rate position (maturing 10/1/2029) as a stable funding pillar, while supplementing its overall debt profile with newer issuances of varying tenors and rates.  This steady exposure underscores a long‑term debt strategy that prioritises predictable interest costs and a durable source of capital rather than expanding or reducing that particular note series.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $1.5 billion (or $1,500 million) carrying value of the 2.850% notes is accurately reported for all three years (2022–2024), with correct citation of the amounts from the respective 10-K filings. The maturity date (10/1/2029) is correctly identified, aligning with the '2029-dated' reference in the original answer. (2) The answer addresses both parts of the question: the evolution (no change in exposure) and the strategic implication (stable funding, predictable costs). (3) Entity accuracy is perfect: PYPL is correctly identified, the instrument (2.850% fixed-rate notes issued in 2019) is accurately described, and the years 2022–2024 are properly referenced. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers from consistent reported values across three separate filings that the balance remained unchanged, and logically concludes that this reflects a deliberate long-term debt strategy—preserving a fixed-rate, long-dated liability while managing other parts of the debt portfolio. The interpretation that this serves as a 'stable funding pillar' and supports 'predictable interest costs' is semantically equivalent to the ground truth's 'strategic intent to preserve this liability structure.' Wording differs but meaning is identical. No errors in facts, calculations, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Notes]-> FIN_INST <-[Issues_Debt]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 393,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Chevron's strategic positioning in Angola LNG Limited evolve from 2022 through 2024, and what does this multi-year progression reveal about the company's long-term natural gas monetization strategy in Angola?",
      "original_answer": "Chevron maintained a consistent 36.4 percent ownership stake in Angola LNG Limited throughout 2022, 2023, and 2024. However, the strategic context of this investment evolved significantly. In 2022 and 2023, Chevron's involvement was primarily described in terms of processing and liquefying natural gas for international markets. By 2024, Chevron had expanded its upstream gas portfolio in Angola through new exploration acreage in Blocks 49 and 50, and had also advanced the Quiluma and Maboqueiro (Q&M) gas fields within the New G as Consortium Project, which included direct connectivity to the Angola LNG plant. This evolution shows that Chevron's stake in Angola LNG Limited transitioned from being a standalone LNG export facility into a more integrated hub for gas monetization, supported by expanding upstream development and regional infrastructure integration.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron deepened its 36.4 % stake in Angola LNG Limited—first noted in 2022 as a stand‑alone equity investment that processes Angola’s associated gas for export—and by 2023 was operating a 1.1 billion‑cubic‑foot‑per‑day liquefaction plant whose feedstock comes from multiple fields and operators. In 2024 the company expanded its upstream footprint by acquiring frontier acreage (Blocks 49 and 50) and a 31 % non‑operated interest in the New G as Consortium Project, whose first production is slated for 2026 and will be tied directly to the Angola LNG plant, while divesting peripheral interests (e.g., the ROC portion of Lianzi and the Haute Mer permit) to sharpen its focus on Angolan gas. This multi‑year progression reveals Chevron’s long‑term strategy to monetize Angola’s offshore and associated natural gas by integrating new discoveries and joint‑development areas into a dedicated LNG value chain that secures sustained feedstock for the Soyo plant and future expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly states Chevron's consistent 36.4% ownership in Angola LNG Limited from 2022–2024. The description of strategic evolution—from standalone LNG export to integrated gas monetization via upstream expansion—is factually sound and matches the original answer. (2) Quantitative accuracy: The 36.4% stake is correct; Blocks 49 and 50 are accurately named; the 31% non-operated interest in the New Gas Consortium Project is plausible (though not explicitly in ground truth, it does not contradict and adds specificity without error). The 1.1 billion-cubic-foot-per-day plant capacity and 2026 first production timeline are reasonable contextual details not contradicted by the ground truth. No calculation errors. (3) Multi-hop reasoning is strong: the LLM synthesizes Chevron’s consistent equity stake with evolving strategic context, links upstream developments (Blocks 49/50, Q&M fields via New Gas Consortium) to the Angola LNG plant, and infers strategic integration. It correctly identifies the shift toward an integrated hub model. (4) Minor deviation: the original answer emphasizes Quiluma and Maboqueiro (Q&M) fields and connectivity to Angola LNG, while the LLM refers to the broader New Gas Consortium without naming Q&M—this is a slight omission but not inaccurate. The mention of divestments (Lianzi, Haute Mer) adds detail beyond the ground truth but supports the strategic focus narrative and is not incorrect. Overall, the answer conveys semantic equivalence with high fidelity, strong reasoning, and excellent relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> COMP <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 441,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Southern Company's investments in trusts, particularly in domestic equity and private equity, evolve from 2022 through 2024, and what does this progression indicate about the company's long-term capital allocation strategy?",
      "original_answer": "Southern Company's investments in trusts showed a strategic shift over the three-year period. In 2022, domestic equity investments totaled $1,016 million, with private equity at $150 million. By 2023, domestic equity had decreased to $829 million, while private equity increased slightly to $161 million. In 2024, domestic equity rebounded to $1,099 million, and private equity rose to $181 million. This pattern indicates a growing emphasis on private equity as part of a broader diversification and long-term growth strategy, while domestic equity allocations remained relatively stable with minor fluctuations.",
      "llm_answer": "\nSouthern Company’s trust‑held domestic equity grew from $829 million (reported at Dec 31 2022 in Chunk 3) to $1.10 billion (Dec 31 2024 in Chunk 2), while private‑equity holdings rose from $161 million in 2022 (Chunk 3) to $181 million in 2024 (Chunk 2), having been $150 million in 2021 (Chunk 1).  All of these investments are classified under Level 3 fair‑value measurements, indicating reliance on internal valuation for illiquid assets.  This steady increase in both domestic equity and private‑equity allocations—particularly the expansion of private‑equity from $150 M to $181 M—demonstrates a deliberate shift toward higher‑return, longer‑horizon assets, reflecting Southern Company’s long‑term capital‑allocation strategy of diversifying into alternative investments to drive future growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that domestic equity was $829 million at the end of 2022, but the ground truth reports $1,016 million for 2022. The correct 2022 domestic equity value is misattributed to 2023 in the LLM answer. Similarly, the LLM claims private equity was $161 million in 2022, but the ground truth shows $150 million in 2022 and $161 million in 2023. The LLM incorrectly uses 2021 data ($150M) as a baseline but mislabels the 2022 and 2023 figures. While the 2024 numbers ($1.10 billion ≈ $1,099 million and $181 million) are correct, earlier years are swapped. (2) Calculations: The directional trend (increase in private equity from $150M to $181M) is correct, but the intermediate values are misassigned to wrong years, undermining the year-by-year evolution. The claim of 'steady increase' in domestic equity is incorrect—ground truth shows a dip in 2023 to $829M before rebounding, which the LLM omits. (3) Multi-hop reasoning: The model identifies the correct entities (Southern Company, domestic equity, private equity, trusts) and time frame, and correctly infers a strategic shift toward alternative investments. It appropriately notes Level 3 classification and links it to illiquidity and internal valuation, which adds context not in the original answer but is factually plausible. However, due to incorrect year-to-value mapping, the synthesis across years is flawed. (4) Despite incorrect year-specific data, the overall qualitative interpretation—that Southern is increasing private equity as part of a long-term growth and diversification strategy—is consistent with the ground truth. The answer is contextually relevant and well-structured, but the quantitative errors in key data points reduce factual reliability. Hence, correctness is partially compromised: core strategy interpretation is sound, but factual foundation is shaky.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 519,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did the impact of Eliminations/Reclassifications on GM's total net sales and revenue evolve from 2022 through 2024, and what does this trend reveal about the company's internal reporting adjustments across its business segments?",
      "original_answer": "In 2022, Eliminations/Reclassifications reduced GM's total net sales and revenue by $105 million, increasing to $107 million in 2023, and significantly rising to $296 million in 2024. This represents a consistent upward trend in the magnitude of internal reporting adjustments, suggesting increasing complexity or changes in segment reporting structures over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the elimination amount subtracted from GM’s consolidated net sales and revenue expanded sharply—​$(107) million in 2022 (Chunk 1), $(296) million in 2024 (Chunk 2), after having been roughly $(105) million in the 2021 baseline (Chunk 3)—​indicating a growing internal adjustment to the company’s reporting. This upward trend reveals that GM’s segment‑level consolidations, especially the increasingly material inter‑segment sales of Cruise and GM Financial, are driving larger reclassifications that reduce total revenue, underscoring a shift toward more granular and complex internal reporting across its business units.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. It states that the elimination amount was $(107) million in 2022, but the ground truth reports $105 million for 2022. It correctly identifies $296 million for 2024, but incorrectly references a 2021 baseline of $(105) million without being asked about 2021, creating confusion. The correct sequence per the original answer is $105M (2022), $107M (2023), $296M (2024); the LLM omits 2023 entirely and misassigns values to years. (2) The calculation and trend analysis are flawed: while the upward trend is real, the LLM incorrectly frames the 2022 figure as $107M and skips 2023, failing to show the consistent year-over-year increase. The reference to 'Chunk 1', 'Chunk 2', 'Chunk 3' suggests reliance on misaligned source data. (3) The multi-hop reasoning is partially sound in interpreting that increasing eliminations reflect greater internal reporting complexity, and it plausibly attributes this to Cruise and GM Financial, which aligns with GM’s segment dynamics. However, this insight is built on incorrect numerical foundations. (4) Contextual relevance is fair—the answer addresses the evolution of eliminations and attempts to interpret the trend—but due to major quantitative errors and omission of a key year (2023), the overall correctness score is low. Minor formatting variations like $(107) million vs $107 million are acceptable, but misattribution of values to wrong years is not. The answer fails to accurately represent the three-year trend, undermining its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 435,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 through 2024, particularly in terms of its documentation status and integration with other compensation frameworks?",
      "original_answer": "In 2022, Netflix's Performance Bonus Plan was listed as a historical exhibit (Exhibit 10.6†) with a filing date of April 28, 2014, indicating no updates during that year. In 2023, the plan was amended and restated (Exhibit 10.5†), with a filing date of December 9, 2022, showing active revision and formalization. By 2024, the Amended and Restated Performance Bonus Plan (Exhibit 10.5†) was carried forward without further changes, remaining consistent with the 2023 version and continuing to serve as a foundational document integrated with newer compensation structures like performance-based restricted stock unit agreements. This progression reveals a strategic update in 2023 followed by stabilization in 2024.",
      "llm_answer": "\nNetflix first introduced its Performance Bonus Plan in 2014 (Exhibit 10.6 in the 2022 10‑K) and, as shown in the 2023 and 2024 filings, restated and amended it on December 9 2022 (Exhibit 10.5† in the 2023 10‑K and again listed as Exhibit 10.5† in the 2024 10‑K), keeping the plan continuously documented as Exhibit 10.5 in subsequent 8‑K and 10‑K filings.  The restated plan is integrated with other compensation frameworks—being filed alongside the Amended and Restated Executive Severance and Retention Incentive Plan, the 2020 Stock Plan, and related stock‑option and RSU agreements—reflecting its status as both an accounting policy and an organizational entity within Netflix’s broader incentive structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the original 2014 filing date, the December 9, 2022 amendment and restatement (filed in the 2023 10-K as Exhibit 10.5†), and its carry-forward in the 2024 10-K without changes. The exhibit numbering transition from 10.6† in 2022 to 10.5† in 2023–2024 is accurately reflected. (2) Quantitative accuracy is perfect: dates (December 9, 2022), exhibit numbers (10.5†, 10.6†), and years (2022, 2023, 2024) match the ground truth exactly. (3) Multi-hop reasoning is sound—LLM correctly infers the evolution across three years, identifies the lack of change in 2024, and notes integration with other compensation frameworks like the 2020 Stock Plan and RSU agreements. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2022 version was labeled as a 'historical exhibit' with no updates, which slightly weakens the qualitative completeness. However, the implication is clear from context. The integration with newer compensation structures is well-articulated, and the answer captures the strategic update in 2023 and stabilization in 2024. Overall, the response is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Enters_Into]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 350,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did BK's disclosure of its 'Business Relationships and Related Party Transactions Policy' evolve across its 2022, 2023, and 2024 filings, and what does this reveal about the consistency of its corporate governance disclosures related to director independence and committee structures?",
      "original_answer": "BK consistently disclosed its 'Business Relationships and Related Party Transactions Policy' in all three years (2022, 2023, and 2024) within the context of Item 13, specifically under 'Corporate Governance and Board Information.' In each filing, the policy was linked to the discussion of 'Director Independence' and detailed committee structures, including the '- Audit Committee,' '- Corporate Governance, Nominating and Social Responsibility Committee,' and '- Human Resources and Compensation Committee.' The consistent placement and linkage of the policy to director independence and committee charters across all three years indicate a stable and uniform approach to corporate governance disclosures, suggesting that BK maintained a consistent framework for managing related party transactions and ensuring board independence.",
      "llm_answer": "\nBK’s “Business Relationships and Related Party Transactions Policy” is disclosed in each of the 2022, 2023 and 2024 Form 10‑K filings as part of Item 13 (Certain Relationships and Related Party Transactions, and Director Independence) and is consistently incorporated by reference to the same Proxy‑statement sections—namely the “Business Relationships and Related Party Transactions Policy” and “Director Independence” under the heading “Item 1 – Election of Directors – Corporate Governance and Board Information.”  All three filings also list the identical committee structure (Audit Committee; Corporate Governance, Nominating and Social Responsibility Committee; and Human Resources and Compensation Committee) and reference the “Report of the HRC Committee” to furnish the related disclosures, demonstrating that the company’s corporate‑governance narrative—particularly director‑independence and committee oversight—has remained stable across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BK disclosed its 'Business Relationships and Related Party Transactions Policy' in the 2022, 2023, and 2024 filings within Item 13, linked to 'Director Independence' and corporate governance disclosures. The committee structures—Audit Committee, Corporate Governance, Nominating and Social Responsibility Committee, and Human Resources and Compensation Committee—are accurately listed and consistent across years. (2) There are no numeric values requiring calculation, but the years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years and connects the policy to director independence and committee oversight, demonstrating consistency in corporate governance disclosures. (4) The only minor difference from the ground truth is that the LLM mentions incorporation by reference to proxy statements and cites the 'Report of the HRC Committee,' which adds detail not present in the original answer but does not contradict it. This additional context does not detract from accuracy but slightly shifts emphasis. Overall, the semantic meaning and factual content match the ground truth, showing strong qualitative and contextual alignment. The answer fully addresses the evolution (consistency over time) and what it reveals (stable governance framework).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 397,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did UnitedHealth Group's fair value and carrying value of Debt Securities - Held-to-Maturity evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's investment strategy and valuation assumptions?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's fair value of Debt Securities - Held-to-Maturity decreased from $643 million to $596 million in 2023, and further declined to $508 million in 2024. Similarly, the carrying value dropped from $641 million in 2022 to $603 million in 2023, and then to $512 million in 2024. This consistent decline suggests a strategic reduction in exposure to held-to-maturity debt securities over the three-year period, with a notable shift away from Level 3 unobservable inputs by 2023 and 2024, indicating greater reliance on more liquid or observable market pricing.",
      "llm_answer": "\nUnitedHealth Group’s Debt Securities – Held‑to‑Maturity showed a fair‑value decline from **$679 million (2022 – Chunk 2)** to **$596 million (2023 – Chunk 2)** and then to **$482 million (2024 – Chunk 3)**, while the carrying values fell correspondingly from **$696 million (2022)** to **$603 million (2023)** and **$512 million (2024 – Chunk 3)**. This three‑year downward trend signals that the company is actively reducing its held‑to‑maturity portfolio and marking the remaining securities down to current market conditions, reflecting a more conservative investment stance and valuation assumptions that prioritize present‑day market rates and credit spreads over historical cost.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the fair value in 2022 was $643 million, but the LLM reports $679 million. Similarly, the 2024 fair value is stated as $482 million by the LLM, whereas the correct value is $508 million. The carrying values for 2022 ($696M vs $641M) and 2023 ($603M correct) and 2024 ($512M correct) also show a major error in 2022. These discrepancies affect the reliability of the trend analysis. (2) Calculations and comparisons based on these incorrect numbers are therefore flawed. While the direction of the trend (decline) is correct, the magnitude and specific values are not. The LLM also references 'Chunk 2' and 'Chunk 3', which are not part of the original data and appear to be artifacts from document retrieval, undermining credibility. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic reduction in the held-to-maturity portfolio and links it to more conservative valuation assumptions. It correctly identifies the decline in carrying value and fair value over time and draws a reasonable conclusion about investment stance. However, it misses the key qualitative insight from the ground truth about the shift away from Level 3 unobservable inputs, which is a critical component of the valuation assumption change. (4) Despite numerical inaccuracies, the answer remains contextually relevant and addresses both parts of the question—trend in values and implications for strategy/assumptions. The reasoning is logical and well-structured, just based on incorrect input data. Hence, correctness is penalized heavily due to factual errors in core numbers, but qualitative and contextual scores remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 477,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did PayPal's exposure to bad transactions through its BNPL loan receivables evolve from 2022 through 2024, particularly in light of its June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and what does this reveal about the company's risk mitigation strategy over time?",
      "original_answer": "In 2022, PayPal highlighted its exposure to bad transactions through its credit and merchant financing products, including the risk of defaults and the impact of fraud and abusive behaviors on its loss rate. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to reduce its exposure to bad transactions by offloading a substantial portion of its BNPL portfolio. By 2024, PayPal continued to emphasize the risks associated with bad transactions but noted that the sale of BNPL receivables was subject to certain conditions, and if not satisfied, could delay the expected benefits. This evolution shows PayPal's increasing focus on mitigating bad transaction risk through asset sales and forward-flow arrangements, while still acknowledging the ongoing challenges of fraud and abuse in its digital payments ecosystem.",
      "llm_answer": "\nPayPal’s BNPL‑related loan receivables were originally recorded on its balance sheet, creating a direct credit‑risk exposure that could lead to charge‑offs and required external funding for purchase and continued origination — a risk highlighted in the 2022 filing (Chunk 3).  In June 2023 the company entered into a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL receivables and to run a forward‑flow arrangement for future originations, moving a substantial portion of that exposure off‑balance‑sheet and transferring the credit risk to third‑party buyers, though the sale is contingent on meeting specified conditions that could delay or limit the intended risk‑transfer — the very mechanism described in Chunks 1 and 2.  The 2024 filing confirms that this sale strategy remains central to PayPal’s risk‑mitigation, showing that the company’s approach has shifted from internal credit‑risk management to external securitization while still depending on third‑party funding, regulatory stability and fraud‑prevention measures to guard against future bad‑transaction losses (Chunks 1‑3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk exposure, the June 2023 agreement to sell up to €40 billion of U.K. and European BNPL receivables, and the contingent nature of the sale affecting risk mitigation. The mention of forward-flow arrangements and off-balance-sheet risk transfer is consistent with the original answer. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, the June 2023 timing is accurate, and no calculations are required. Format (€40 bn) is acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes information across 2022 (risk exposure), 2023 (sale agreement), and 2024 (ongoing conditions and strategy), correctly inferring a strategic shift toward external risk mitigation via securitization and third-party sales. (4) The only minor shortcoming is a slightly stronger emphasis on 'third-party funding' and 'regulatory stability' than present in the original, which focuses more on fraud and abuse persistence. However, these are reasonable inferences and do not detract from factual correctness. Overall, the answer captures the evolution and strategic implications accurately, meriting a 9 for qualitative accuracy and 9 overall for correctness due to slight wording emphasis differences, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 376,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Chevron's (CVX) upstream production volumes in Myanmar evolve from 2022 through 2024, and what strategic shift in operations is reflected by these changes?",
      "original_answer": "Chevron's upstream production in Myanmar declined from 17 thousand barrels per day (MBD) in 2022 to 15 MBD in 2023, and the company completely withdrew from Myanmar in April 2024, signaling a full exit from the region. This reflects a strategic shift in portfolio optimization and risk management.",
      "llm_answer": "\nChevron’s Myanmar upstream output slipped from **17 MBD (oil‑equivalent) in 2022 to 15 MBD in 2023** (with natural‑gas liquids at **87 MMCFD in 2023 versus 94 MMCFD in 2022**), and the company formally **withdrew from Myanmar in April 2024**.  This exit—coming after the 2023 sale of Indonesia deep‑water assets and the 2024 disposal of Canada Duvernay/AOSP—signals a **strategic shift away from lower‑return on‑shore/offshore markets toward higher‑margin deep‑water and LNG projects**.  Myanmar had been part of Chevron’s broader **Asia upstream portfolio**, but the withdrawal reflects a deliberate reallocation of capital to more profitable assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Chevron's upstream production in Myanmar declined from 17 MBD in 2022 to 15 MBD in 2023 and that the company withdrew in April 2024, matching the ground truth. It adds granular detail on natural gas liquids (94 MMCFD in 2022 to 87 MMCFD in 2023), which is not in the original answer but does not contradict it and may reflect additional data from filings. (2) All key numbers and dates are accurate: 17 MBD, 15 MBD, April 2024 exit. The added MMCFD figures are plausible and consistent with the direction of decline, though not present in the ground truth; they do not detract from accuracy. (3) The reasoning correctly identifies the withdrawal as part of a broader strategic shift. While the original answer cites 'portfolio optimization and risk management,' the LLM elaborates with specific examples (Indonesia deep-water, Canada Duvernay/AOSP) and frames the shift as moving toward higher-margin deep-water and LNG projects. This is a reasonable interpretation and adds depth without misrepresenting the strategy. (4) The answer fully addresses both parts of the question: production evolution and strategic implications. Semantic equivalence is maintained, with enhanced contextual detail. Minor deduction in quantitative accuracy only because the MMCFD data, while plausible, is not in the ground truth and could be seen as overreach if unverified. Otherwise, the answer is factually sound, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 409,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did the relative revenue contribution of PC & Notebooks within Texas Instruments' Personal Electronics segment evolve from 2022 to 2024, and what does this trend suggest about the company's strategic positioning in the consumer computing market?",
      "original_answer": "In 2022, the Personal Electronics segment accounted for 24% of TI's revenue, with PC & Notebooks listed as a key subcategory. By 2023, the Personal Electronics segment had declined to 15% of TI's revenue, indicating a reduced emphasis on consumer computing. In 2024, the segment further decreased to 20% of revenue, with PC & Notebooks still included but appearing lower in the list of priorities compared to mobile phones and portable electronics. This trend suggests a strategic shift away from PC & Notebooks as TI increasingly focused on higher-growth or higher-margin areas within Automotive and Industrial markets.",
      "llm_answer": "\nThe share of Texas Instruments’ Personal Electronics segment that is attributable to PC & Notebooks dropped from roughly 24 % of total TI revenue in 2022 (when the segment itself was 24 % of revenue) to about 15 % in 2023, and then edged up to 20 % in 2024; in each filing PC & Notebooks are listed as a distinct sub‑category under “Personal electronics,” confirming that their contribution moved from a larger‑share position in 2022 to a smaller‑share position in 2023 before a modest rebound in 2024. This pattern shows that TI has been steadily scaling back its consumer‑computing exposure—letting the PC & Notebook business shrink as a proportion of both the segment and overall revenue—while reallocating resources toward higher‑margin industrial and automotive markets, suggesting a strategic shift away from the consumer computing arena.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the first sentence: it states that the share attributable to PC & Notebooks dropped from 'roughly 24%' in 2022, implying that PC & Notebooks alone accounted for 24% of TI's total revenue. However, the ground truth clarifies that the entire Personal Electronics segment was 24% in 2022, with PC & Notebooks being a subcategory within it — not the whole segment. This misrepresents the magnitude of PC & Notebooks' contribution. Similarly, the LLM incorrectly implies that the 15% and 20% figures in 2023 and 2024 are the shares of PC & Notebooks specifically, when in fact those percentages refer to the entire Personal Electronics segment. (2) The years (2022, 2023, 2024) and directional trends (decline to 15%, then increase to 20%) are correct for the Personal Electronics segment, but the misattribution of these percentages to PC & Notebooks undermines quantitative accuracy. No calculations are performed, so no calculation errors, but the misassignment of segment-level data to a subcategory is a significant numerical misrepresentation. (3) The reasoning about TI’s strategic shift away from consumer computing toward Automotive and Industrial markets is sound and aligns with the ground truth. The LLM correctly infers a strategic reallocation based on declining segment share, demonstrating good multi-hop synthesis between revenue trends and strategic implications. (4) Despite the quantitative misattribution, the answer captures the correct trend direction and strategic interpretation, and addresses both parts of the question — evolution of contribution and strategic implication — making it contextually relevant and qualitatively strong. However, the numerical inaccuracies prevent a higher correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 487,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Motors' indemnification obligations to Stellantis evolve from 2022 through 2024, particularly in terms of known liabilities, accruals, and potential future exposures related to legacy Opel/Vauxhall matters?",
      "original_answer": "In 2022, GM continued to have ongoing commercial relationships with Stellantis, including supply and engineering services, but no specific indemnification accruals or liabilities were disclosed. By 2023, GM disclosed that it indemnified Stellantis for certain losses tied to pre-sale representations and warranties, emissions claims, product liabilities, and recalls, with an immaterial indemnification already paid and an inability to estimate reasonably possible future losses. In 2024, GM expanded on these obligations, noting accruals of an immaterial amount related to a European Commission and UK CMA investigation into end-of-life vehicle practices from the Opel era, and reiterated that while further indemnification for Takata-related recalls was possible, it was considered remote. The trend shows increasing specificity and emerging regulatory risk exposure over time, though financial impact remained immaterial.",
      "llm_answer": "\nGeneral Motors’ indemnification obligations to Stellantis arise from the 2017 Master Agreement, under which GM (through its Seller) must indemnify Stellantis for losses tied to inaccurate representations, warranties, emissions claims, product liabilities and recalls, with such obligations subject to time limits, thresholds and caps.  The financial exposure has been tracked through accruals that evolved from $561 million of product‑liability accruals and a $2.6 billion accrual for the Chevrolet Bolt recall in 2022 (with a $0.6 billion balance at year‑end 2023) to a reduced $0.3 billion remaining balance for the Bolt matter and continued $615 million (2023) / $561 million (2022) product‑liability accruals by the end of 2024, while GM continues to state that any further indemnification—e.g., for additional Takata‑related recalls—is remote but not quantifiable.  Ongoing European Commission and UK CMA investigations of legacy Opel/Vauxhall emissions matters have so far resulted in only an immaterial accrual, underscoring that potential future exposures remain limited and unquantifiable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, which severely undermines its correctness. (1) Quantitative Accuracy: The LLM incorrectly states that GM had $561 million in product-liability accruals in 2022 and $615 million in 2023, and ties these to indemnification obligations to Stellantis—this is false. The ground truth states that no specific indemnification accruals were disclosed in 2022, and any payments made were immaterial. The $2.6 billion Bolt recall accrual and its reduction to $0.6 billion by end-2023 and $0.3 billion by 2024 are real figures but are unrelated to Stellantis indemnification; they pertain to GM’s own recall liabilities. These numbers are misattributed and miscontextualized. (2) Completeness: While the LLM mentions relevant categories like emissions claims, product liabilities, and Takata recalls, it fails to accurately reflect the evolution of disclosures—specifically, the increasing specificity of indemnification obligations in 2023 and 2024 related to Opel-era investigations. It incorrectly implies ongoing material accruals tied to Stellantis, when the ground truth emphasizes immateriality. (3) Entity Accuracy: The entities (GM, Stellantis, Opel/Vauxhall, EC, UK CMA) are correctly identified, and the reference to the 2017 Master Agreement is contextually plausible, though not confirmed in the ground truth. (4) Reasoning: The multi-hop synthesis is flawed—the LLM conflates GM’s general product liability accruals with specific indemnification obligations to Stellantis, failing to distinguish between internal liabilities and cross-party indemnifications. This misrepresents the financial exposure evolution. (5) Semantic Equivalence: The overall message suggests growing but limited exposure, which aligns loosely with the trend, but the factual foundation is incorrect. The conclusion that further Takata-related indemnification is 'remote' matches the ground truth, and the mention of immaterial accruals for EC/CMA investigations is partially correct, though overstated in context. Overall, the answer is misleading due to incorrect numerical attributions and lack of proper isolation of Stellantis-specific indemnification items.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Depends_On]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 594,
        "total_tokens": 2119
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did American Tower Corporation's issuance of the 1.450% Senior Notes due 2026 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's debt management strategy?",
      "original_answer": "The 1.450% Senior Notes due 2026 were consistently referenced across all three years—2022, 2023, and 2024—as part of Supplemental Indenture No. 10, indicating that the notes remained an active and stable component of AMT’s debt portfolio. In 2022, the notes were introduced in the 10-K filing under Exhibit 4.25, dated September 27, 2021. In 2023, the same notes were referenced under Exhibit 4.22, and in 2024 under Exhibit 4.21, maintaining continuity in documentation and structure. The consistent inclusion of these notes across filings suggests a deliberate and stable debt management strategy, with no refinancing or material modification of the instrument over the three-year period.",
      "llm_answer": "\nThe 1.450 % Senior Notes due 2026 were created through Supplemental Indenture No. 10 dated September 27 2021, a document that first appears as Exhibit 4.25 in the 2022 Form 10‑K, is re‑filed unchanged as Exhibit 4.22 in the 2023 Form 10‑K and as Exhibit 4.21 in the 2024 Form 10‑K, confirming that the notes remained issued and outstanding and were continuously disclosed across those three years.  This repeated filing shows that American Tower has kept a stable, long‑dated fixed‑rate tranche in its capital structure, using supplemental indentures to update the paperwork and manage debt‑maturity concentration while preserving financing flexibility.  The knowledge‑graph pattern (AMT → introduces → 1.450 % Senior Notes due 2026 ← introduces ← AMT) captures the reciprocal relationship between the issuer and the security, highlighting that the company’s debt‑management strategy centers on issuing and periodically amending senior notes with staggered maturities to maintain liquidity and control funding costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.450% Senior Notes due 2026 were issued under Supplemental Indenture No. 10 on September 27, 2021; they were first included as Exhibit 4.25 in the 2022 10-K, then re-filed as Exhibit 4.22 in 2023 and Exhibit 4.21 in 2024. These exhibit numbers and dates match the original answer exactly. (2) Quantitative accuracy is perfect: percentages, dates, and exhibit numbers are correctly reported with no errors. Format variations (e.g., spacing in '1.450 %') do not affect meaning. (3) The multi-hop reasoning is sound—by tracking the same note across three years of filings and noting unchanged re-filing, the model correctly infers stability in debt management. The conclusion about a stable, long-dated fixed-rate tranche and staggered maturities is a reasonable interpretation supported by the data. (4) The only minor shortcoming is the mention of a 'knowledge-graph pattern (AMT → introduces → ... ← introduces ← AMT)', which introduces an abstract concept not present in the source data and slightly overreaches semantically, though it doesn't invalidate the core correctness. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 392,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did The Bank of New York Mellon Corporation's use of the 2019 Long-Term Incentive Plan evolve from 2022 through 2024, particularly in relation to the introduction of new deferred stock unit agreements and performance share unit agreements across those years?",
      "original_answer": "In 2022, the company referenced the 2019 Long-Term Incentive Plan alongside the introduction of the 2019 Form of Performance Share Unit Agreement and the 2019 Form of Restricted Stock Unit Agreement, indicating early implementation of the plan through structured equity instruments. In 2023, the company introduced the 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors,' extending the plan’s application to director-level compensation. By 2024, the company continued building on the 2019 plan by incorporating newer forms such as the 2022 Form of Performance Share Unit Agreement, showing a sustained and expanding reliance on the plan as a foundational framework for long-term compensation design. This progression demonstrates a multi-year strategic alignment of executive and director incentives under the 2019 plan, with incremental refinements and broader application over time.",
      "llm_answer": "\nFrom 2022 through 2024 the company deepened its use of the 2019 Long‑Term Incentive Plan by layering successive Performance‑Share‑Unit (PSU) agreements: the 2020 PSU agreement first appears in the 2020 filing and is carried forward in the 2022 filing (exhibit 10.18 of the 2022 10‑K), the 2021 PSU agreement is introduced in the 2021 filing and remains listed in the 2023 and 2024 exhibits, and the 2022 PSU agreement is disclosed for the first time in the 2022 filing (exhibit 10.18 of the 2022 10‑K) and is retained in the 2023 and 2024 filings.  The only Deferred‑Stock‑Unit (DSU) form still referenced is the original director DSU agreement from 2008, which continues to be reproduced in the 2023 and 2024 exhibits but is not replaced or updated during this period.  Thus, the evolution is marked by the progressive addition of new PSU agreements under the same 2019 plan, while the DSU framework stays unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly claims the 2020 and 2021 Performance Share Unit (PSU) agreements were carried forward and used in 2022–2024 filings, but the ground truth states the company introduced the 2019 Form of PSU Agreement initially and then the 2022 Form of PSU Agreement by 2024—there is no mention of 2020 or 2021 forms in the original answer. (2) The LLM incorrectly asserts that the only Deferred Stock Unit (DSU) agreement in use is the 2008 form for directors, which contradicts the ground truth stating that in 2023 the company introduced a new 'Form of Long-Term Incentive Plan Deferred Stock Unit Agreement for Directors'—a key evolution under the 2019 plan. This is a major factual error, as the introduction of the new DSU agreement in 2023 is a central point in the original answer. (3) The LLM’s reasoning about 'progressive addition of new PSU agreements' is partially aligned with the idea of expanding use of the plan, but it misidentifies the specific agreements and their timing. The ground truth emphasizes structured rollout of 2019 and then 2022 PSU forms under the 2019 plan, showing refinement and expansion, whereas the LLM fabricates intermediate forms (2020, 2021) not mentioned in the original. (4) The contextual relevance is moderate because the answer addresses the general theme of evolving use of the 2019 plan with new agreements, but the specific entities, dates, and instruments are incorrect. Overall, the answer fails on core factual elements—dates, agreements, and the key 2023 DSU update—resulting in a low correctness score despite some thematic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 456,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did General Dynamics' focus on aerostructures within its Combat Systems segment evolve from 2022 through 2024, and what does this 3-year trend reveal about its strategic positioning in next-generation missile subsystems?",
      "original_answer": "In 2022, General Dynamics emphasized its production of missile subsystems with critical aerostructures as part of its broader Combat Systems portfolio, which included next-generation weapon systems for air and shipboard applications like those on the F-35. In 2023, the Combat Systems segment accounted for 20% of consolidated revenue, with aerostructures explicitly mentioned as part of next-generation missile provisioning. By 2024, GD continued to highlight its role in producing critical aerostructures for next-gen missiles, while the Combat Systems segment slightly declined to 19% of consolidated revenue. This indicates a consistent strategic focus on aerostructures within Combat Systems, despite slight revenue share fluctuations, underscoring GD's sustained positioning in advanced missile subsystems.",
      "llm_answer": "\nFrom 2022 → 2023 → 2024 the Combat‑Systems segment’s revenue share moved from **18 % → 20 % → 19 %**, indicating a deliberate shift toward aerostructure‑intensive missile subsystems; GD’s 10‑K filings (chunks 1 & 2) repeatedly cite “critical aerostructures, control actuators, high‑performance warheads and cutting‑edge hypersonic rocket cases” as core to both legacy and next‑generation missiles.  The knowledge‑graph pattern (GD → Aerostructures → GD) shows that aerostructures are an internal product line supplied to GD, and chunk 3 (2022) reinforces OTS’s market‑leading role in providing those aerostructures for tactical/strategic missiles and next‑gen weapons.  Together, the three‑year trend reveals that GD is consolidating its aerostructure expertise to position itself as a primary supplier for emerging missile‑subsystem programs, especially hypersonic and high‑performance missile platforms.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core strategic trend correctly: General Dynamics maintained a consistent focus on aerostructures within its Combat Systems segment from 2022 to 2024, particularly for next-generation missile subsystems, including hypersonic applications. This aligns with the ground truth's emphasis on sustained strategic positioning. However, the revenue share for 2022 is incorrect: the LLM states 18%, while the ground truth reports no specific percentage for 2022, only that in 2023 Combat Systems was 20% and in 2024 it declined to 19%. The ground truth does not provide a 2022 percentage, so asserting 18% is an unsupported addition. 2) Quantitative accuracy is partially flawed due to the fabricated 2022 revenue share. While 20% in 2023 and 19% in 2024 match the original answer, the inclusion of 18% for 2022 introduces a factual error not present in the source. No calculations are performed, so no arithmetic errors, but the unsupported extrapolation reduces quantitative reliability. 3) The multi-hop reasoning is strong: the model synthesizes information across years and connects aerostructures to next-gen missiles, hypersonics, and internal supply chains (referencing OTS and internal product lines). It correctly identifies the strategic intent behind the trend, even adding context about hypersonic rocket cases and control actuators that enriches the narrative. However, the mention of 'knowledge-graph pattern (GD → Aerostructures → GD)' and 'chunk 3 (2022)' suggests reliance on external chunk references not present in the original answer, which may reflect overinterpretation. 4) Despite the numerical inaccuracy in 2022, the overall reasoning and conclusion about strategic consolidation in missile subsystems are sound and relevant. The answer adds value by specifying component types and program focus, which are consistent with the ground truth's direction. Hence, correctness is reduced mainly due to the incorrect 2022 figure, but the qualitative and contextual strengths keep the score in the high 7s.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 547,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Philip Morris International's positioning and strategic emphasis on its local cigarette brand Jackpot in the Philippines evolve from 2022 through 2024, and what does this multi-year progression indicate about the brand's role in PMI's broader regional and product portfolio strategy?",
      "original_answer": "In 2022, PMI identified Jackpot as one of its key local cigarette brands in the Philippines, alongside Fortune, indicating its importance in the regional market. In 2023, PMI reiterated its commitment to Jackpot as part of its local brand portfolio in the Philippines, maintaining its strategic focus amid broader global restructuring and integration of Swedish Match. By 2024, PMI continued to highlight Jackpot as a core local brand in the Philippines, even as it expanded its smoke-free product footprint to 95 markets and emphasized its IQOS and ZYN brands. This consistent mention of Jackpot across three years shows that, despite PMI’s long-term vision of a smoke-free future, traditional cigarette brands like Jackpot remain strategically relevant in key regional markets like the Philippines.",
      "llm_answer": "\nFrom 2022 through 2024 PMI repeatedly listed **Jackpot** among its key local cigarette brands in the Philippines—first in the 2022 filing (where it appeared alongside Fortune and other regional labels), again in the 2023 filing (noting its presence in roughly 175 markets and Marlboro’s 39 % share of 2023 cigarette volume), and once more in the 2024 filing (where Marlboro’s share rose to ~40 % and total shipment volume grew 2.5 % to 756.6 billion units, with heated‑tobacco units reaching 139.7 billion).  The knowledge‑graph triplets *PM → Jackpot (PRODUCT)*, *Jackpot (PRODUCT) → Jackpot (ORG)*, *Jackpot (ORG) → PM (ORG)* illustrate that the brand is treated both as a product owned by PMI and as an organizational entity with a stake in PMI, reflecting a mutually reinforced relationship.  \n\nThis multi‑year progression shows that PMI is using established local brands like Jackpot as a stable market‑share anchor in Southeast Asia while simultaneously expanding its reduced‑risk portfolio (heated‑tobacco and smoke‑free products), thereby integrating the brand into a broader regional strategy that blends traditional cigarette sales with the company’s shift toward smoke‑free and wellness‑focused offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. The ground truth does not mention that Jackpot was present in 'roughly 175 markets'—this figure is unsupported and incorrect. Similarly, the LLM introduces cigarette volume data (756.6 billion units), heated-tobacco units (139.7 billion), Marlboro’s market share (39%, rising to ~40%), and a 2.5% shipment growth—all of which are absent from the original answer and not tied to Jackpot or the Philippines. These numbers, while possibly from PMI filings, are misapplied here and not relevant to the question about Jackpot’s strategic role in the Philippines. (2) No calculations are required in the original answer, but the inclusion of extraneous and unverified metrics undermines quantitative accuracy. The original answer focuses on qualitative positioning, not volume or market share statistics. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that Jackpot remains strategically important as it is consistently mentioned across years, and it appropriately links this to PMI’s broader dual strategy of maintaining traditional brands while expanding smoke-free products. However, the use of knowledge-graph triplets (*PM → Jackpot (PRODUCT)*, etc.) introduces a speculative organizational relationship ('Jackpot (ORG) → PM (ORG)') that is not supported by the original answer or typical corporate semantics—Jackpot is a brand, not an organization with a stake in PMI. This misrepresents the entity relationship. (4) Despite the factual errors, the LLM captures the core strategic theme: Jackpot serves as a regional anchor in the Philippines amid PMI’s global smoke-free transition. This contextual understanding supports a moderate score for qualitative accuracy and high contextual relevance, but the fabrication of specific metrics severely undermines correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 520,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Chevron's investment and operational focus in the Republic of Congo evolve from 2022 through 2024, particularly in terms of capital deployment and asset disposition?",
      "original_answer": "In 2022, Chevron listed the Republic of Congo as one of its key operational areas, signaling ongoing presence and strategic importance. In 2023, the company invested approximately $0.7 billion across offshore development and natural gas projects in Africa, which included activity in the Republic of Congo, indicating active capital deployment in the region. However, by 2024, Chevron had sold its 31.5% nonoperated working interest in the offshore Haute Mer permit area and its 15.75% interest in the Republic of Congo portion of Lianzi in January 2025, reflecting a strategic exit from its upstream assets in the country. This 3-year trajectory shows a shift from operational continuity to active divestiture in the Republic of Congo.",
      "llm_answer": "\nChevron’s presence in the Republic of Congo grew from a modest operational footprint in 2022 (as noted in the 2022 filing that lists the country among its global operating areas) to a targeted capital‑spending phase in 2023, when the company allocated roughly **$0.7 billion of African offshore and natural‑gas development funds to projects in the Republic of Congo** as part of its broader Africa‑wide $0.7 billion outlay.  Building on that investment, the 2024 disclosures show a strategic shift toward **asset disposition**: Chevron announced the sale of its **31.5 % non‑operated interest in the Haute Mer offshore permit and its 15.75 % stake in the Republic of Congo portion of the Lianzi field (finalised in early 2025)**, signalling a pull‑back from further upstream development and a move to monetize or exit those Congolese holdings.  This evolution reflects a transition from capital deployment on new development in 2023 to a focused divestiture of those interests by 2024‑25.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Chevron listed the Republic of Congo as an operational area in 2022; invested approximately $0.7 billion in African offshore and natural gas projects in 2023, which included activity in Congo; and sold its 31.5% nonoperated interest in Haute Mer and 15.75% in the Congo portion of Lianzi, with the transaction finalized in early 2025. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, and dates match the original answer. The $0.7 billion is correctly attributed to Africa-wide spending that included Congo, and the stake percentages are exact. (3) The reasoning is sound and captures the multi-hop evolution: from operational presence (2022), to capital deployment (2023), to strategic divestiture (2024–2025). The only minor issue is the phrasing that suggests the full $0.7 billion was allocated specifically to Congo, rather than being part of a broader African outlay that included Congo—this could imply over-attribution, but the answer correctly notes it was part of a larger regional investment. (4) Contextual relevance is excellent: the response directly addresses the evolution in investment and operational focus, capital deployment, and asset disposition. The conclusion about a strategic shift is well-supported. Thus, the answer earns a 9/10 for correctness due to slight imprecision in fund allocation wording, but remains factually robust and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 412,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Southern Company's treatment and valuation of outdoor lighting contracts as operating leases change from 2022 to 2024, particularly in terms of materiality, revenue allocation, and lease payment structure across its subsidiaries?",
      "original_answer": "In 2022, Southern Company noted that outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial, with no significant value disclosed. In 2023, the company began disclosing scheduled lease payments under outdoor lighting contracts as part of maturity analyses, indicating a more structured approach to lease accounting. By 2024, the company expanded this disclosure to include the initial terms of outdoor lighting contracts and further clarified that lease income from PPAs was included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power, suggesting a growing emphasis on transparency and standardization in lease valuation across subsidiaries.",
      "llm_answer": "\nSouthern Company has continued to account for its outdoor‑lighting contracts as operating leases, but the way the leases are disclosed and valued has expanded from 2022 to 2024: in 2022 the undiscounted cash flows from the Mississippi Power contracts were judged immaterial and were not shown in the lease‑maturity table, whereas the 2023 and 2024 filings explicitly present the scheduled (and variable) payments from those contracts—and from related tolling arrangements and PPAs—in maturity analyses and include the related lease income in wholesale revenues for Alabama Power, Georgia Power and Southern Power, allocating revenue to non‑lease components based on stand‑alone selling price.  Consequently, while the lease‑payment structure (scheduled or variable payments tied to energy production) remains unchanged, the treatment shifted from an off‑table, immaterial classification to a formally disclosed lease accounting across a broader set of subsidiaries, with materiality now reflected only in the disclosed immaterial cash‑flow note.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, outdoor lighting leases at Mississippi Power were deemed immaterial and excluded from maturity tables; by 2023–2024, scheduled lease payments were included in maturity analyses, and lease income from PPAs was explicitly included in wholesale revenues for Alabama Power, Georgia Power, and Southern Power. The expansion of disclosure and the shift toward greater transparency are correctly captured. (2) There are no numeric inaccuracies—while exact dollar amounts aren't provided in either answer, the treatment of immateriality and disclosure practices are consistent with the original. The mention of variable payments tied to energy production and allocation based on stand-alone selling price adds detail not contradicted by the ground truth. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes changes over time (2022 to 2024), across subsidiaries (Mississippi Power vs. Alabama Power, Georgia Power, Southern Power), and across accounting aspects (materiality, revenue allocation, lease structure). (4) The only minor gap is that the original answer emphasizes the 2024 addition of 'initial terms' of contracts, which the LLM answer does not explicitly mention. However, the core evolution in treatment, materiality, and revenue classification is fully and accurately conveyed. Wording differs but semantic meaning matches. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 435,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Cisco's 3.50% Note evolve across fiscal years 2022, 2023, and 2024 in terms of its carrying amount and effective interest rate, and what does this progression indicate about the company's debt valuation and market conditions over time?",
      "original_answer": "In fiscal year 2022, Cisco reported a carrying amount of $500 million for the 3.50% Note with an effective interest rate of 3.20%. By fiscal year 2023, the carrying amount remained at $500 million, but the effective rate increased to 6.38%, and in fiscal year 2024, the effective rate further rose to 6.66%, maintaining the same $500 million carrying amount. This upward trend in the effective rate indicates a shift in market conditions or internal risk assessments affecting the valuation of this long-term debt instrument over the three-year period.",
      "llm_answer": "\nCisco’s 3.50 % senior note due June 15 2025 carried a constant carrying amount of **$500 million** in fiscal 2022, 2023 and 2024, but its disclosed effective‑interest rate climbed from **3.20 % in 2022** (2022 10‑K) to **6.38 % in 2023** (2023 10‑K) and further to **6.66 % in 2024** (2024 10‑K). This progression—shown by the KG relationship CSCO → 3.50 % Note → CSCO and reflected in each filing’s “Effective Rate” column—indicates that the note’s market‑derived yield was being repriced upward as broader interest‑rate environments tightened, highlighting a rising valuation of Cisco’s debt amid shifting market conditions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying amount of $500 million is correctly reported for all three fiscal years (2022, 2023, 2024), and the effective interest rates—3.20% in 2022, 6.38% in 2023, and 6.66% in 2024—are exactly as stated in the original answer. Minor formatting differences (e.g., spacing in '3.50 %' or 'June 15 2025') do not affect factual accuracy. (2) The answer is complete, addressing both the evolution of the carrying amount and effective interest rate across all three years, as well as interpreting the trend in the context of market conditions. (3) Entity accuracy is perfect: Cisco (CSCO), the 3.50% Note, correct fiscal years, and proper attribution to 10-K filings are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly infers that despite a constant coupon and carrying value, the rising effective rate reflects market-driven repricing due to tighter interest rate environments, which aligns with the ground truth’s conclusion about shifting market conditions and debt valuation. The mention of 'KG relationship CSCO → 3.50% Note → CSCO' indicates accurate internal knowledge graph traversal. (5) Semantic equivalence is strong—the LLM conveys the same core facts and interpretation as the original, with enhanced contextual detail (e.g., maturity date, source documents) that adds value without introducing error. All scoring categories warrant the highest rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 425,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Simon Property Group's exposure to Unsecured Notes - 35A evolve from 2022 through 2024, and what does this multi-year pattern reveal about their long-term debt management strategy?",
      "original_answer": "Simon Property Group maintained a consistent $750 million face value exposure to Unsecured Notes - 35A across all three years (2022, 2023, and 2024), with identical 2.65% interest rates and July 15, 2030 maturity dates. This stability contrasts with broader changes in their unsecured debt portfolio, including new issuances like the 2024 $1 billion Unsecured Notes - 41A and refinancing of credit facilities. The sustained presence of this specific instrument suggests a deliberate strategy to maintain stable long-term financing commitments while selectively refinancing or adding new debt instruments in response to market conditions.",
      "llm_answer": "\nFrom the 2022 filing (Chunk 1), the 2023 filing (Chunk 2) and the 2024 filing (Chunk 3) Simon Property Group’s face exposure to **Unsecured Notes - 35A** is unchanged at **$750 million** (shown as $750,000 in the tables) with a consistent annual debt service of **$19.875 million** each year.  This $750 million tranche represents roughly **3.7 % of total consolidated unsecured indebtedness**, which rose slightly from $20.0 bn (2022) to $21.0 bn (2023) before falling back to $19.4 bn (2024), underscoring that SPG treats the 35A notes as a stable, long‑dated fixed‑rate component within a broadly diversified, laddered debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $750 million face value of Unsecured Notes - 35A is accurately reported across 2022–2024, and the $19.875 million annual debt service (2.65% of $750M = $19.875M) is correctly derived and consistent. The percentages of total unsecured indebtedness (~3.7%) are reasonably estimated given the total unsecured debt values cited ($20.0B, $21.0B, $19.4B), which match the context. Minor rounding in percentage calculation is acceptable. (2) The answer correctly identifies Simon Property Group and the specific debt instrument (Unsecured Notes - 35A) across all three years, satisfying entity accuracy. (3) Multi-hop reasoning is sound: the model synthesizes data across three annual filings to establish stability in the 35A notes while contextualizing them within broader debt portfolio changes, such as fluctuations in total unsecured debt. (4) While the original answer emphasizes the contrast with new issuances (e.g., 2024's $1B Unsecured Notes - 41A) and refinancing activity as evidence of strategic debt management, the LLM infers a 'laddered debt strategy' and stable long-dated component—semantically equivalent and logically supported. The only minor gap is the lack of explicit mention of the maturity date (July 15, 2030) and interest rate (2.65%), though the rate is implicitly confirmed via debt service calculation. Overall, the answer captures the core insight: sustained exposure reflects deliberate long-term financing stability amid broader portfolio adjustments. Thus, correctness is excellent, with only a slight deduction for missing explicit mention of rate and maturity, which are part of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 475,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 through 2024, particularly in terms of its role within the company's four sustainable competitive advantages?",
      "original_answer": "From 2022 through 2024, Texas Instruments consistently emphasized Embedded Processing Products as a core component of its business model, maintaining its position as the second of four sustainable competitive advantages. In 2022, the company described the broad portfolio of analog and embedded processing products as offering 'more opportunity per customer and more value for our investments.' This language remained consistent in 2023 and 2024, with identical phrasing used each year to describe the value derived from the product portfolio. While the strategic framing remained stable, the repeated emphasis over three consecutive years underscores the sustained importance of Embedded Processing Products in TI's long-term value creation model, particularly in enabling deeper customer engagement and diversified returns on investment.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments has kept **Embedded Processing Products at the core of its strategy**, repeatedly identifying them in the MD&A (items (b) of the 2022, 2023 and 2024 10‑Ks) as a key driver of the “broad portfolio of analog and embedded processing products” that “offers more opportunity per customer and more value for our investments.”  The company’s messaging across all three filings shows a **steady evolution toward deeper investment in this portfolio**—using it to reinforce manufacturing‑technology control, market‑channel reach, and product‑longevity—all aimed at strengthening the four sustainable competitive advantages and delivering the free‑cash‑flow‑per‑share growth that is the firm’s ultimate performance metric.  The KG relationships (TXN ↔ Embedded Processing Products) treat the segment both as a product offering and as an organizational capability, underscoring how TI integrates embedded processing into the very structure of its competitive advantage.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and aligns with the ground truth in key areas, but introduces subtle interpretive claims not supported by the original answer, affecting qualitative accuracy. (1) Correct elements: The LLM accurately identifies that Texas Instruments emphasized Embedded Processing Products from 2022 to 2024 and correctly quotes the consistent phrase 'offers more opportunity per customer and more value for our investments' used across the three years. It correctly references the MD&A sections of the 10-K filings and ties the product line to TI's sustainable competitive advantages. (2) Quantitative accuracy is perfect: no numerical data is misstated, and all years (2022–2024) are correctly referenced. (3) Multi-hop reasoning is partially sound—while the LLM correctly synthesizes the repeated strategic emphasis, it goes beyond the ground truth by asserting a 'steady evolution toward deeper investment' and linking embedded processing directly to manufacturing-technology control, market-channel reach, and product longevity. The original answer makes no such claim about evolving investment or direct integration into all four advantages—only that it remains a consistent, stable component. This overinterpretation weakens the reasoning. (4) Contextual relevance is high, as the response directly addresses the strategic role of Embedded Processing Products over time and their connection to competitive advantages. However, the original answer emphasizes stability and consistency, whereas the LLM implies progression and deepening integration, which is not substantiated in the ground truth. Thus, while factually aligned on key points, the LLM adds narrative layers not present in the source, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 487,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did CMCSA's wireless shared data plan offerings evolve from 2022 through 2024, particularly in terms of plan flexibility and international expansion?",
      "original_answer": "In 2022, CMCSA offered shared data plans exclusively as part of bundled service offerings to residential customers in the U.S. who subscribed to broadband services. By 2023, the company maintained this structure but emphasized the flexibility of customers being able to choose between unlimited data plans, shared data plans, or per-gigabyte plans. In 2024, CMCSA expanded its wireless offerings internationally and introduced prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans and further diversifying plan options for domestic and international customers. This evolution shows increasing flexibility and geographic diversification of shared data plan offerings.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA’s wireless shared‑data plans grew from a basic suite of unlimited, shared‑data or per‑gigabyte options bundled with its residential MVNO service on Verizon’s network (Chunk 1) to a more flexible offering that added prepaid unlimited “NOW” plans, expanded gigabyte‑tier choices and longer financing (up to 48 months) for both domestic and international customers (Chunk 2).  At the same time, the company broadened the service internationally—launching wireless service in the United Kingdom via an arrangement with Virgin Media O2 and extending financing terms to 24‑48 months for overseas subscribers (Chunk 3).  This progression reflects a clear shift toward greater plan flexibility and a deliberate expansion of shared‑data offerings into new international markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of CMCSA's wireless shared data plans from 2022 to 2024 in terms of flexibility and international expansion, aligning well with the ground truth. It correctly identifies that in 2022, shared data plans were part of bundled residential offerings (implied via 'bundled with its residential MVNO service'). The emphasis on increased flexibility in 2023 by offering unlimited, shared, or per-gigabyte options is accurately reflected. The 2024 international expansion is correctly noted, including the launch in the UK via Virgin Media O2 and the introduction of prepaid unlimited plans under the NOW brand. However, the LLM adds specific details not present in the ground truth: (1) 'longer financing (up to 48 months)' and 'extending financing terms to 24-48 months for overseas subscribers' — these financing terms are not mentioned in the original answer and cannot be verified from the provided truth; (2) 'expanded gigabyte-tier choices' is plausible but not explicitly stated in the ground truth. These additions slightly over-specify implementation details beyond the source, reducing quantitative and qualitative accuracy. Despite this, the core multi-hop reasoning — synthesizing changes over time in plan flexibility and geographic reach — is sound and semantically equivalent to the original. The answer is fully contextually relevant and addresses both sub-questions (flexibility and international expansion) across the three-year horizon. Minor factual overreach prevents a 9-10, but the key facts and trajectory are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 436,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 to 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this progression indicate about the growing complexity of risk management in its digital payments ecosystem?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to abusive behaviors increased in complexity and scope, particularly in relation to its credit products and third-party fraud schemes. In 2022, PayPal highlighted the risk of fraud through fictitious account creation, stolen financial instruments, and abusive schemes that were difficult to detect due to the digital nature of its services. By 2023, the company expanded on this risk by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which introduced new exposure to third-party fraud in large-scale loan portfolios. In 2024, PayPal further detailed the evolving tactics of fraudsters, including account takeovers and synthetic identity fraud, while also facing legal uncertainty around the validity of loan receivables purchased from FDIC-insured banks. This 3-year progression shows an increasing sophistication in abusive behaviors, requiring PayPal to continuously enhance its detection systems and risk mitigation strategies across a more complex and globalized payments ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behaviors moved from a primary focus on credit‑product default risk and generic third‑party fraud threats (Chunk 1) to a more layered risk profile that added the sale of BNPL receivables, dependence on external funding and the migration of payment‑processor arrangements (Chunk 2), and finally to a landscape complicated by regulatory clarifications on loan‑sale treatment and increasingly sophisticated fraud schemes that exploit the scale of its digital‑payments platform (Chunk 3).  This evolution reflects a growing complexity in risk management, where PayPal must now coordinate credit‑product finance, third‑party funding and processor transitions, and evolving regulatory and fraud dynamics—all of which are captured by the “Abusive Behaviors” risk factor that both impacts and is driven by PYPL itself in the knowledge‑graph pattern.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolving nature of PayPal's exposure to abusive behaviors from 2022 to 2024, noting increasing complexity in fraud schemes and risk management. It accurately references the BNPL receivables sales and the broader risk landscape. However, it omits the specific €40 billion figure for the U.K. and European BNPL loan receivables sale mentioned in the ground truth, which is a notable factual omission despite correctly identifying the transaction type and intent. (2) There are no incorrect numbers or dates; the LLM does not introduce any false quantitative data. Since it avoids specifying the €40 billion amount, it neither confirms nor denies it—this is a case of omission rather than inaccuracy, hence quantitative accuracy remains high. (3) The multi-hop reasoning is generally sound: the model synthesizes information across years and connects credit products, third-party fraud, regulatory issues, and operational changes. However, it generalizes some details (e.g., 'regulatory clarifications on loan-sale treatment' instead of specifying the FDIC-related legal uncertainty) and introduces concepts not in the original, such as 'migration of payment-processor arrangements,' which is not mentioned in the ground truth and may reflect overinterpretation. (4) The answer is contextually relevant and well-structured, addressing all key dimensions of the question. The correctness score is 7 because core facts are accurate and the overall progression is correctly characterized, but key specifics (like the €40B receivables sale and synthetic identity fraud) are either missing or underdeveloped, reducing completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Risks]- ORG",
      "token_usage": {
        "prompt_tokens": 1525,
        "completion_tokens": 461,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has GILD's utilization of its El Segundo, California facility evolved from 2022 through 2024, particularly in relation to its cell therapy manufacturing capabilities and strategic facility investments?",
      "original_answer": "In 2022, GILD identified El Segundo, California as a principal manufacturing facility, specifically for clinical and commercial manufacturing and processing of its cell therapy products. By 2023, the company emphasized its clinical and commercial manufacturing capabilities at El Segundo, highlighting its role in cell therapy processing alongside other facilities like Santa Monica and Frederick. In 2024, GILD reaffirmed its reliance on El Segundo for cell therapy manufacturing, while also underscoring the broader context of facility ownership and lease arrangements, and the importance of third-party manufacturers and supply chain risk management. This continuity indicates a strategic focus on scaling and maintaining cell therapy production capabilities at El Segundo, with no indication of reduced emphasis or facility changes over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GILD has continuously used its El Segundo, California site as a dedicated hub for both clinical and commercial manufacturing and processing of its cell‑therapy products— the facility appears in the 2022, 2023 and 2024 property listings as one of the company’s cell‑therapy manufacturing locations (Chunk 1, 2).  At the same time the company has been expanding its cell‑therapy infrastructure, adding new dedicated sites in Santa Monica, Frederick, Maryland and Hoofddorp, Netherlands and investing in process‑development and scale‑up capabilities to support growth of those therapies (Chunk 1’s reference to “established clinical and commercial manufacturing facilities” for cell therapy and Chunk 3’s discussion of strategic transactions and capital investments).  Consequently, while El Segundo’s utilization has remained central to GILD’s cell‑therapy supply chain, the broader strategic investment in multiple cell‑therapy facilities—including El Segundo—has deepened over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that GILD has consistently used the El Segundo, California facility from 2022 to 2024 for clinical and commercial manufacturing and processing of cell therapy products, which matches the original answer's timeline and characterization. The mention of El Segundo appearing in property listings across all three years supports the continuity claim. The LLM also accurately notes the expansion of GILD’s cell therapy infrastructure, including new sites in Santa Monica, Frederick, and Hoofddorp, which is consistent with the strategic investment context in the ground truth. While the original answer does not explicitly name Hoofddorp, the broader point about expanded investments and multi-facility reliance is valid and supported. There are no numerical inaccuracies—dates (2022–2024) are correct, no erroneous figures are introduced, and all entities (GILD, El Segundo, Santa Monica, Frederick) are correctly identified. The reasoning is sound: the LLM synthesizes information across years and facilities to conclude that El Segundo remains central while the overall network expands—this reflects proper multi-hop reasoning. The only minor gap is that the original answer emphasizes risk management and third-party manufacturers in 2024, which the LLM omits, but this is a contextual nuance rather than a factual error. Overall, the answer is semantically equivalent, highly relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 413,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the maturity structure of Costco's 2.750% Senior Notes evolve across filings from 2022 through 2024, and what does this reveal about the company's debt management strategy over time?",
      "original_answer": "The maturity structure of Costco's 2.750% Senior Notes remained consistent across the 2022, 2023, and 2024 filings, with all references indicating a fixed maturity date of May 18, 2024. Despite the multi-year span of disclosures, the notes were not refinanced or extended during this period, suggesting that Costco maintained a static approach to this specific debt instrument. This consistency implies a deliberate capital structure decision to allow the notes to mature without modification, aligning with a broader strategy of predictable debt repayment.",
      "llm_answer": "\nThe 2.750 % Senior Notes were originally issued in 2017 and, as shown in Exhibit 4.6 of the 2022 10‑K (filed 5/16/2017), carry a single maturity of May 18 2024; this same exhibit appears in the 2023 and 2024 10‑K filings, confirming that the note remained outstanding through 2024 and was the only near‑term senior debt maturing in that window.  At the same time, all three filings disclose a broader series of senior notes with later dates—2027, 2030 and 2032—indicating that Costco is laddering its maturity profile by issuing longer‑dated securities to replace the 2024 obligation and extend the overall debt tenor.  This pattern reveals a debt‑management strategy that staggers repayments and relies on longer‑term financing to smooth cash‑flow and reduce refinancing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the maturity date of the 2.750% Senior Notes as May 18, 2024, consistent across the 2022–2024 filings, which aligns with the ground truth. However, it introduces a significant factual error by stating the notes were issued in 2017 and that Exhibit 4.6 was filed on 5/16/2017—this date is incorrect, as the 2022 10-K would have been filed in 2022, not 2017. The exhibit is reused across years, but the filing date cited is wrong, undermining quantitative accuracy. (2) The financial terms (2.750%, May 18, 2024) are accurate, but the erroneous issuance/filing date and lack of confirmation that the notes were not refinanced (a key point in the ground truth) reduce precision. The mention of other senior notes (2027, 2030, 2032) may be factually correct in broader context but are not directly tied to the evolution of the 2.750% notes, introducing extraneous inference. (3) The reasoning partially supports multi-hop synthesis by connecting disclosures across years and inferring a laddering strategy. However, the ground truth emphasizes that the 2.750% notes were held to maturity without change, indicating a static strategy for that instrument—whereas the LLM interprets this as active laddering via new issuances, which is not explicitly supported by the provided truth. This overinterpretation weakens the qualitative accuracy. (4) Despite the reasoning leap, the answer remains contextually relevant, addressing both the maturity evolution and strategic implications. The core fact of unchanged maturity is present, but the incorrect date and unsupported conclusion about refinancing via new notes prevent a higher score. Correctness is penalized due to the critical filing date error and unsupported inference about debt replacement.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 501,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Chevron's natural gas production volumes associated with Angola LNG evolve from 2022 to 2024, and what does this three-year trajectory indicate about the company's gas production strategy in Africa?",
      "original_answer": "Chevron's natural gas production volumes tied to Angola LNG increased from 7,107 million cubic feet per day in 2022, to 7,148 million cubic feet per day in 2023, and further rose to 7,569 million cubic feet per day in 2024. This steady upward trend indicates a strengthening production output from the Angola LNG asset, suggesting that Chevron maintained or expanded its operational focus on natural gas in Africa despite broader asset divestitures elsewhere in its portfolio.",
      "llm_answer": "\nChevron’s “as‑sold” natural‑gas volumes that are attributed to its African affiliate—specifically Angola LNG—rose from **7.11 billion cf/d in 2022 to 7.15 billion cf/d in 2023 and then to 7.57 billion cf/d in 2024** (the figures reported in the 2022‑2024 Form 10‑K filings).  This steady increase—modest growth from 2022‑23 followed by a sharper jump in 2024—demonstrates that Chevron is deliberately expanding its LNG output in Africa, using the Angola LNG stake as a core pillar of its African gas‑production strategy while divesting non‑core assets elsewhere.  The upward trajectory reflects a strategic shift toward higher‑margin, long‑term LNG contracts and reinforces Chevron’s focus on growing its African gas portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. The reported natural gas volumes for 2022 (7.11 billion cf/d), 2023 (7.15 billion cf/d), and 2024 (7.57 billion cf/d) are accurate representations of the ground truth values (7,107, 7,148, and 7,569 million cubic feet per day), with minor rounding (e.g., 7,107 MCF/d ≈ 7.11 BCF/d). These rounding differences are within acceptable limits and do not affect factual correctness. (2) Quantitative accuracy is high: the progression from ~7.11 to ~7.57 BCF/d matches the upward trend and magnitude in the original data. The description of 'modest growth' from 2022–2023 and 'sharper jump' in 2024 aligns with the actual increase of ~41 MCF/d in the first year and ~421 MCF/d in the second, supporting the characterization. (3) The multi-hop reasoning is sound: the LLM correctly attributes the volumes to Angola LNG in Africa, identifies the three-year trend, and synthesizes this with Chevron’s broader strategy of divesting non-core assets while maintaining or expanding focus on African gas, particularly LNG. The conclusion about strategic emphasis on higher-margin LNG contracts and long-term portfolio growth in Africa is a reasonable inference supported by the upward trajectory. (4) The answer is contextually excellent—fully addressing both parts of the question: the volume evolution and the strategic implication. The only reason for not scoring a 10 is the slight rounding of numbers (e.g., 7,107 to 7.11 instead of 7.107), which, while standard, introduces negligible imprecision. Overall, the answer is semantically equivalent, factually accurate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 450,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's deferred compensation strategy and market-linked volatility?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, this turned into a gain of $58 million; and by 2024, the gain further increased to $91 million. This trajectory indicates a transformation from a net liability to a net benefit, suggesting either improved market conditions for the underlying assets or a strategic shift in how Cisco manages its deferred compensation obligations using these swaps.",
      "llm_answer": "\nCisco’s total‑return‑swap deferred‑compensation exposure moved from a **$92 million loss in FY 2022** (Chunk 3) to **$58 million of gains in FY 2023** (Chunk 2) and **$91 million of gains in FY 2024** (Chunk 2), showing a clear turnaround from market‑driven losses to positive returns as market conditions improved. This progression reveals that Cisco has deliberately refined its deferred‑compensation strategy—using market‑linked swaps to offset volatility and align executive payouts with performance—while the disclosed KG relationships (CSCO ↔ Total Return Swaps‑Deferred Compensation) confirm the instrument is an internal, disclosed component of the company’s compensation framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$92 million loss in FY 2022, $58 million gain in FY 2023, and $91 million gain in FY 2024—matching the ground truth exactly. Number formats are consistent and acceptable (e.g., $92 million vs $92M). (2) Quantitatively, all values are accurate and correctly attributed to the respective fiscal years. There are no calculation errors, and the progression is correctly described as a shift from loss to increasing gains. (3) The multi-hop reasoning is sound: the model synthesizes data across years and correctly infers that the change reflects improved market conditions and/or a strategic refinement in deferred compensation management. It appropriately references the use of total return swaps as a tool to manage market-linked volatility and align with performance, which aligns with the ground truth’s implication of strategic or market-driven shifts. The mention of 'disclosed KG relationships' adds context but does not distort the factual content. (4) The only minor shortcoming is the slightly stronger assertion of 'deliberately refined its deferred-compensation strategy'—while plausible, the ground truth presents this more cautiously as 'suggesting either improved market conditions... or a strategic shift.' The LLM leans slightly more toward intent than the evidence strictly supports, but the overall reasoning remains logically consistent and semantically equivalent. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 451,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Lowe's approach to supplier practices related to environmental and human rights standards evolve from 2022 to 2024, particularly in terms of policy updates, monitoring enhancements, and third-party certifications?",
      "original_answer": "From 2022 to 2024, Lowe's approach to supplier practices evolved significantly, with increasing emphasis on environmental stewardship and human rights. In 2022, Lowe's monitored suppliers through its Vendor Code of Conduct and human rights policy, which included enhanced environmental standards and a wood sourcing policy ensuring products came from well-managed, non-endangered forests. By 2023, Lowe's had updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process. In 2024, the company further strengthened its approach by implementing a more robust risk-based framework for wood sourcing, improving monitoring practices, and continuing to expand its offering of independently certified products. This progression indicates a deepening commitment to transparency, accountability, and sustainability across the supply chain.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s refined its supplier‑related policies by updating its human‑rights framework (originally refreshed in fiscal 2021) and, more prominently, its wood‑sourcing policy—adding country‑level risk ratings, a formal forestry‑grievance process and enhanced, risk‑based monitoring in 2023‑24.  The company also deepened supplier oversight and third‑party validation, achieving independent CDP verification of Scope 1‑2 emissions, expanding its EPA SmartWay participation toward 100 % certification, and growing its portfolio of independently certified products that meet ENERGY STAR and WaterSense standards.  Finally, Lowe’s strengthened its quantitative commitments, raising its interim climate targets (from 40 %/22.5 % reductions in 2023 to 42 %/25 % by 2030) and maintaining six consecutive years of inclusion in the Dow Jones Sustainability North America Index, underscoring a continuous evolution of environmental and human‑rights standards across its supply chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Lowe's supplier practices from 2022 to 2024, particularly around wood sourcing policy, monitoring enhancements, and third-party certifications. It correctly identifies key developments: the update to the wood-sourcing policy with country-level risk ratings, the introduction of a forestry grievance process, and enhanced risk-based monitoring in 2023–2024. It also accurately notes the expansion of independently certified products (e.g., ENERGY STAR, WaterSense), which aligns with the ground truth. However, there are some quantitative and attribution issues. The claim about CDP verification of Scope 1–2 emissions and EPA SmartWay participation toward 100% certification is not present in the ground truth and cannot be verified from the provided knowledge graph. Similarly, the specific climate targets (40%/22.5% to 42%/25% by 2030) and inclusion in the Dow Jones Sustainability Index, while plausible, are not mentioned in the original answer and represent unverified additions. These details, while contextually relevant, introduce unsupported specifics that affect quantitative accuracy. The reasoning is strong—correctly synthesizing policy updates over time and linking them to broader environmental and human rights commitments—and the answer addresses all parts of the question (policy updates, monitoring, certifications). Wording differs but semantic meaning overlaps significantly with the original. Thus, the answer earns a high score for qualitative accuracy and contextual relevance, but loses some points on quantitative accuracy due to unsupported percentages and program details not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Monitors]-> RISK_FACTOR <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 459,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the competitive threat from wireless telecommunications companies to CMCSA's broadband and wireless services evolve from 2022 through 2024, particularly in terms of technological capabilities (e.g., 4G, 5G, fixed wireless), bundling strategies, and specific competitors named across the filings?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA intensified due to advancements in wireless technology and bundling strategies. In 2022, CMCSA noted that wireless companies were offering internet services using 4G and 5G wireless broadband, which posed a growing threat to its broadband services. By 2023, the filings specifically named major wireless competitors such as AT&T, T-Mobile, and Verizon in the U.S., and highlighted that these companies were increasingly deploying 5G fixed wireless networks as a competitive tool. In 2024, the filings emphasized that wireless companies were not only enhancing their network capabilities but also bundling DTC streaming services with wireless plans, creating a more integrated and attractive offering for consumers. This evolution shows a clear trend of increasing pressure from wireless providers leveraging both technological improvements and strategic bundling to capture market share.",
      "llm_answer": "\nFrom 2022 through 2024 the threat to CMCSA’s broadband and wireless businesses evolved from generic 4G/5G wireless‑broadband offerings and basic product bundling (e.g., voice‑wireless‑Internet packages) into a more aggressive, technology‑driven assault: by 2023 wireless carriers were expanding 5G fixed‑wireless networks and began bundling DTC‑streaming services such as Peacock and Disney+ into unlimited‑data plans, and by 2024 consolidation enabled incumbents—chiefly AT&T, T‑Mobile, Verizon (and European rivals BT and Virgin Media)—to combine voice, wireless, broadband and streaming into exclusive, lower‑cost bundles that directly compete with CMCSA’s connectivity and content offerings. This progression reflects a shift from merely providing 4G/5G internet speeds to leveraging those capabilities in bundled, data‑heavy packages that erode CMCSA’s market share.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of competitive threats from wireless telecom companies to CMCSA from 2022 to 2024. (1) It accurately captures the progression from 4G/5G wireless broadband as a growing threat in 2022, to the expansion of 5G fixed wireless by 2023, and the strategic bundling of DTC streaming services by 2024. The named competitors AT&T, T-Mobile, and Verizon are correctly identified as key U.S. rivals. However, the inclusion of BT and Virgin Media as 'European rivals' introducing competitive pressure on CMCSA in this context is not supported in the original answer, which focuses solely on U.S. competition and does not mention European companies as direct competitors in the broadband/wireless space for CMCSA during this period. This is a minor overreach in entity accuracy. (2) There are no numerical values, dates, or calculations in the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes technological evolution (4G to 5G to fixed wireless), service bundling trends, and competitive strategy over time. The logic that bundling DTC services like Peacock (which CMCSA owns) into wireless plans by competitors erodes CMCSA’s advantage is a reasonable inference, though the original answer does not specify that competitors bundled Peacock—only that they bundled DTC services generally. This is a slight over-specificity but not a major error. (4) The answer is highly contextually relevant, directly addressing technological capabilities, bundling, and named competitors across the three years. Overall, the core facts and trajectory are correct, but minor issues with entity scope and one unsupported detail prevent a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_Against]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 495,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its transaction pricing strategy, use of payment processors, and revenue incentives, and what does this multi-year trend reveal about the company's control over pricing and cost management?",
      "original_answer": "From 2022 to 2024, PayPal consistently bore full margin risk when completing payment transactions, indicating a stable strategic stance on pricing control despite evolving incentives and cost structures. In 2022, PayPal emphasized its discretion in setting fees independent of costs incurred through payment processors, which were recognized as transaction expenses. In 2023, the company expanded its discussion on incentives to merchants and consumers, including discounts, rebates, and rewards, which were recognized as reductions to revenue, adding complexity to margin management. By 2024, PayPal maintained its stance on bearing full margin risk and further detailed its transaction revenues, including contractual compensation from sellers violating terms (e.g., fraud or counterfeiting), which introduced new revenue streams potentially affecting margin dynamics. Despite these evolving factors, PayPal's consistent recognition of transaction processor fees as expenses and its control over pricing decisions across all three years suggests a disciplined, centralized approach to margin risk management.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal repeatedly disclosed that it records transaction revenue on a **gross basis and bears full margin risk** – i.e., it controls the fee charged to customers independently of the costs incurred when it uses payment processors or other financial institutions (Chunk 1, 2, 3).  The company’s **tiered, volume‑based pricing** adjusts the per‑transaction fee up or down with Total Payment Volume, and it accrues **incentives and refund provisions** that reduce revenue when performance targets are met or when refunds are expected (Chunk 2, 3).  Across the three filings the firm continues to treat processor fees as a **transaction expense** and to recognize protection‑program costs in transaction and credit losses, showing that its pricing strategy and margin exposure have remained stable: pricing is set by PayPal’s discretion, not by cost pass‑through, and the company manages margin risk through volume‑linked fees, accrued incentives, and explicit expense recognition of processor and incentive costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PayPal bears full margin risk and records transaction revenue on a gross basis from 2022 to 2024, which matches the original answer's core claim. It accurately notes that PayPal sets fees independently of processor costs, which are treated as transaction expenses—this is consistent across all three years. The discussion of incentives (e.g., rebates, discounts) as reductions to revenue is correctly framed, and the mention of volume-based pricing and accruals for refunds/incentives reflects the evolving complexity in margin management. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable in a traditional sense; however, all referenced financial treatments (gross revenue recognition, expense classification) are factually correct, earning a 10. (3) The qualitative reasoning is strong: the LLM synthesizes multi-year disclosures about pricing discretion, cost treatment, and incentive structures, showing sound multi-hop reasoning across strategic, accounting, and operational dimensions. The only minor gap is that the 2024 addition of contractual compensation from sellers for violations (e.g., fraud) is not mentioned—an element that adds nuance to new revenue streams affecting margins. This omission prevents a perfect 10 but does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing the evolution of margin risk in relation to pricing strategy, processor use, and revenue incentives, and correctly concludes that PayPal maintains centralized control over pricing and cost management.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 476,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from fiscal year 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuation?",
      "original_answer": "In fiscal year 2022, Costco disclosed that free-rent periods and step-rent provisions were recognized on a straight-line basis over the original lease term and any extension options that were reasonably certain to be exercised, using the incremental borrowing rate to calculate the present value of lease payments. By fiscal year 2023, the company maintained the same accounting policy but emphasized that leases with periodic rent increases based on price indices or sales volume were recognized as variable lease payments. In fiscal year 2024, Costco reiterated its consistent application of these policies while reaffirming that leases did not contain material residual value guarantees or restrictive covenants, indicating a stable and consistent approach to lease accounting across the three-year period.",
      "llm_answer": "\nCostco’s treatment of free‑rent periods has remained materially the same from FY 2022 through FY 2024: the Company records the right‑of‑use (ROU) asset and lease liability using the present value of **all** lease payments over the full lease term—i.e., the non‑cancelable period plus any renewal or extension options that are reasonably certain to be exercised—and it recognizes rent‑free or step‑rent provisions on a straight‑line basis over that entire term.  This accounting policy is disclosed in each 10‑K filing (2022, 2023 and 2024) and is reflected in the KG relationship COST → Free‑Rent Periods → ACCOUNTING_POLICY, showing that the same straight‑line recognition rule and the same lease‑term assumption (including extensions) were applied each year.  Because the lease term used in the discounted‑cash‑flow calculation expands to include any reasonably certain extensions, the present‑value of payments—and therefore the initial ROU‑asset amount—is larger when extensions are deemed likely, but the methodology itself did not change; the only evolution across the three years is the addition of more detailed impairment disclosures in FY 2024, while the core free‑rent accounting and ROU‑asset valuation remained consistent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that Costco applied a consistent accounting policy from FY 2022 to FY 2024, recognizing free-rent and step-rent provisions on a straight-line basis over the lease term, including extension options that are reasonably certain to be exercised. This matches the original answer’s description of policy continuity. (2) The use of the incremental borrowing rate to discount lease payments is implied in the reference to present value calculations, and while not explicitly mentioned in the LLM answer, it is not contradicted. (3) The LLM correctly identifies that the methodology for ROU asset valuation remained unchanged, with lease terms including reasonably certain extensions affecting the present value—this is a key multi-hop insight supported by the knowledge graph. (4) The only minor deviation is the mention of 'more detailed impairment disclosures in FY 2024,' which is not present in the original answer; however, this does not contradict the core facts and may reflect additional context not in the ground truth summary. The LLM accurately captures the stable treatment of free-rent periods and their impact on ROU assets across all three years. All entities (Costco, fiscal years 2022–2024, lease terms, ROU assets, straight-line recognition) are correct. Wording differs but semantic meaning is equivalent. No numerical inaccuracies—no specific dollar amounts or percentages were required. The reasoning is sound and synthesizes policy consistency across years. Thus, the answer earns a 9 for correctness and qualitative accuracy due to the slight addition of impairment detail, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Includes]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 475,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 to 2024, particularly in relation to its transaction pricing model, use of payment processors, and contract structure changes across those years?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to margin risk remained consistent in its core description — the company continued to bear full margin risk when completing payment transactions, recognizing fees on a gross basis and paying third-party processors as transaction expense. However, in 2023, PayPal added language clarifying how incentives provided to users were recognized as a reduction of revenue based on performance targets or amortized over the contractual term, which introduced more variability into its margin structure. In 2024, PayPal adopted new segment reporting disclosures under ASU 2023-07, which increased transparency around segment-level expenses, potentially affecting how margin risk is analyzed across business units. Despite these changes, the fundamental pricing model — tiered, volume-based pricing without material rights — remained unchanged, suggesting margin risk exposure was structurally stable but operationally nuanced over the three-year period.",
      "llm_answer": "\nPayPal’s margin‑risk profile stayed centered on bearing the full risk of each payment transaction, with variable fees linked to total payment volume and tiered, volume‑based pricing that adjusts the fee up or down but does not create a material future right—an approach first detailed in the 2022 filing (Chunk 1). By 2023 the company refined its revenue‑recognition rules, explicitly treating discounts, rebates and other incentives as reductions of revenue while still recording processor fees as transaction expense and continuing to assume full margin risk regardless of processor use (Chunk 2). In 2024 the only structural evolution was the adoption of new segment‑reporting guidance, which added disclosures about these expenses but left the underlying contract terms—open‑ended, automatically renewing agreements with volume‑based pricing and no material right—unchanged, so PayPal’s exposure to margin risk remained the same, now simply more transparent in its segment disclosures (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer, with only minor differences in emphasis. (1) All key facts are correct: PayPal continued to bear full margin risk across 2022–2024, used gross revenue recognition, paid third-party processors as transaction expenses, maintained tiered, volume-based pricing without material rights, and adopted ASU 2023-07 in 2024 for enhanced segment reporting. The 2023 clarification on revenue recognition for incentives (rebates, discounts) is correctly noted as reducing revenue, adding nuance to margin structure. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but all dates (2022, 2023, 2024) and financial terms (gross basis, transaction expense, volume-based pricing) are used accurately. (3) Multi-hop reasoning is sound: the model synthesizes information across the three years, correctly identifying continuity in core risk exposure while noting incremental changes in accounting treatment and disclosure. (4) The only minor shortcoming is that the LLM does not explicitly mention the amortization of incentives over the contractual term (only that they are treated as revenue reductions), slightly reducing completeness compared to the original. However, the phrase 'based on performance targets or amortized over the contractual term' in the original is partially omitted, which slightly affects qualitative precision. Despite this, the overall meaning and factual correctness remain intact. Contextual relevance is perfect—the response directly addresses all parts of the question: pricing model, processor use, contract changes, and margin risk evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 460,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy and financing costs over this period?",
      "original_answer": "Cisco consistently reported a $2,000 million outstanding balance for the 5.90% Note maturing in February 2039 across all three fiscal years (2022, 2023, and 2024), with the effective interest rate remaining constant at 6.11%. This stability in both principal and effective rate suggests that Cisco has maintained this long-term debt instrument without modification or refinancing over the three-year period, indicating a consistent approach to managing this portion of its capital structure despite broader changes in its debt portfolio.",
      "llm_answer": "\nCisco’s 5.90 % senior note remained unchanged in both size and cost across the three fiscal years – the note’s outstanding principal stayed at **$2,000 million** and its **effective interest rate held steady at 6.11 %** in fiscal 2022, 2023 and 2024 (as shown in Chunk 3, Chunk 1 and Chunk 2).  This consistency signals that Cisco is maintaining a deliberate, long‑term fixed‑rate financing position, locking in capital at a known cost rather than repeatedly refinancing, which helps stabilize its interest‑expense profile and reflects a strategy of managing long‑term debt through steady, long‑dated issuances.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the outstanding principal of $2,000 million and the effective interest rate of 6.11% are accurately reported for all three fiscal years (2022, 2023, 2024), with correct formatting variations accepted (e.g., $2,000 million = $2,000M). (2) The answer is complete, addressing both the utilization (stable principal) and effective interest rate (unchanged at 6.11%) over the specified period. (3) Entity accuracy is correct: Cisco is the subject, the 5.90% Note is properly identified, and fiscal years align with the question. (4) The reasoning is sound and reflects appropriate multi-hop synthesis: the model correctly infers from consistent values across years that Cisco has maintained this debt without refinancing, indicating a stable long-term financing strategy. The conclusion about locking in fixed-rate financing and stabilizing interest expenses is semantically equivalent to the ground truth’s interpretation of a consistent capital structure approach. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 315,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the positioning and strategic emphasis on Lowe's private brand 'Kobalt' evolved from fiscal 2022 through fiscal 2024, based on its mention in intellectual property disclosures across those years?",
      "original_answer": "The strategic emphasis on 'Kobalt' remained consistent across the three years, with Lowe's continuing to highlight Kobalt as a key private brand within its intellectual property portfolio. In fiscal 2022, Kobalt was listed among other private brand names like 'STAINMASTER' and 'allen+roth' as part of the company's wholly-owned trademarks. In fiscal 2023 and 2024, Kobalt retained its position as one of the named private brand product lines, indicating ongoing brand importance. However, there was no explicit increase or decrease in Kobalt's prominence in disclosures, suggesting a stable strategic role rather than an expanding one.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Lowe’s intellectual‑property disclosures each list “Kobalt” as a private‑brand product name owned by a wholly‑owned subsidiary, underscoring a sustained strategic focus on the Kobalt brand; the repeated inclusion of Kobalt in the trademark/brand‑ownership language of each annual filing demonstrates that Lowe’s has consistently positioned Kobalt as a core private‑label brand throughout the three‑year period.  This continuity is reflected in the knowledge‑graph pattern LOW → Kobalt → Kobalt → LOW, showing Kobalt treated both as a product and as an organizational brand entity owned by Lowe’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Kobalt was consistently mentioned in Lowe's intellectual property disclosures across fiscal 2022, 2023, and 2024 as a private brand owned by a wholly-owned subsidiary, reflecting a stable strategic emphasis. The answer captures the core conclusion from the original response: that Kobalt maintained a consistent position without evidence of increased or decreased prominence. The mention of the 'knowledge-graph pattern LOW → Kobalt → Kobalt → LOW' adds interpretive detail not in the original but does not contradict it and supports the idea of bidirectional brand ownership and identity. There are no numerical inaccuracies (quantitative accuracy is perfect, though no calculations were required), and all entities (Lowe's, Kobalt, fiscal years) are correct. The reasoning is sound and reflects multi-hop synthesis across years. The only minor shortcoming is that the LLM does not explicitly state that there was 'no explicit increase or decrease in prominence,' which slightly weakens the completeness of the qualitative analysis, but the implication of stability is clearly conveyed. Thus, the answer is semantically equivalent and highly accurate overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Owns]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 353,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Simon Property Group's unsecured debt obligations tied to Unsecured Notes - 37B evolve from 2022 through 2024, particularly in terms of interest rate, face amount, and maturity date, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "Simon Property Group maintained a consistent interest rate of 2.25% and a face amount of $700,000 for Unsecured Notes - 37B from 2022 through 2024, with the maturity date remaining at 01/15/32 throughout this period. This stability suggests that SPG did not alter its long-term financing structure for this specific note, potentially reflecting confidence in its debt management approach and favorable market conditions for maintaining fixed-rate obligations over the three-year horizon.",
      "llm_answer": "\nSimon Property Group’s Unsecured Notes‑37B has remained a $700 million, 2.25 % coupon issuance with a 15 January 2032 maturity across the 2022‑2024 reporting periods (interest‑rate, face‑amount and maturity are identical in the 2021‑2024 tables of Chunks 1, 2 and 3, reflecting the same KG link SPG → Unsecured Notes‑37B → SPG).  During the same span the company’s total consolidated unsecured indebtedness moved from $20.0 bn (2021) to $21.0 bn (2023) and then to $19.4 bn (2024) (Chunks 1‑3), while the premium/discount and issuance‑cost balances shifted, indicating that SPG is actively refinancing toward longer‑dated, low‑cost paper and extending the overall maturity ladder of its unsecured portfolio.  This pattern—maintaining a stable, long‑dated 37B tranche amid a broader ladder of maturities—shows a deliberate long‑term financing strategy that locks in cheap capital while gradually reducing leverage and diversifying funding sources.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts for Unsecured Notes - 37B: face amount ($700 million, equivalent to $700,000 thousand in KG), interest rate (2.25%), and maturity date (01/15/32, reported as 15 January 2032). These match the ground truth exactly in substance, with acceptable formatting differences. (2) Quantitative accuracy is perfect: all numbers and dates are correct, and the LLM accurately reports the stability of these metrics from 2022 through 2024. The additional context on total unsecured indebtedness ($20.0B in 2021, $21.0B in 2023, $19.4B in 2024) is consistent with the knowledge graph and supports broader analysis. (3) Multi-hop reasoning is sound: the LLM synthesizes data across years and distinguishes between the stable 37B note and the company’s overall unsecured debt portfolio, correctly inferring a long-term financing strategy of locking in low-cost, long-dated debt while managing leverage. (4) The only minor deviation from the original answer is the inclusion of data points outside the 2022–2024 window (e.g., 2021) and a slightly more expansive interpretation of SPG’s strategy. However, this does not introduce inaccuracies and enhances contextual understanding. The core answer fully aligns with the ground truth in both fact and interpretation, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 374,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve across 2022, 2023, and 2024, specifically in terms of its involvement in Analog and Embedded Processing business segments over time?",
      "original_answer": "In 2022, Texas Instruments operated in Melaka, Malaysia exclusively for its Analog business, with no involvement in Embedded Processing. This remained unchanged in 2023, where Melaka continued to support only the Analog segment. By 2024, the operational focus in Melaka remained solely on Analog, with no indication of expansion into Embedded Processing. This 3-year consistency highlights a stable, specialized role for Melaka within TXN's global operations, centered exclusively on Analog product development and manufacturing.",
      "llm_answer": "\nTexas Instruments continued to list its Melaka, Malaysia facility under the **Analog** business segment in each of the 2022, 2023 and 2024 10‑K filings (the “X” appears in the Analog column for Melaka, Malaysia every year), while the **Embedded Processing** column is blank for that site in all three years—showing that the plant’s activities remained confined to analog manufacturing throughout the period.  The foot‑note symbols († in 2022, * in 2023, ** in 2024) indicate a progressively higher notation of the Melaka location, but the nature of its involvement—solely analog and never embedded‑processing—does not change across the three years.  This consistent pattern is reflected in the knowledge‑graph relationship TXN → Melaka, Malaysia (GPE) and the mutual “Operates_In” links that tie the company to that Malaysian entity.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Texas Instruments' Melaka, Malaysia facility was involved exclusively in the Analog business segment in 2022, 2023, and 2024, with no involvement in Embedded Processing—matching the original answer exactly in factual content. (2) There are no numerical values requiring calculation (e.g., financial amounts or percentages), but the temporal accuracy (2022–2024) is precise and consistent with the ground truth. The mention of footnote symbols (†, *, **) adds contextual detail from the filings without distorting the core fact. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings, identifies the consistent 'X' marker in the Analog column and absence in Embedded Processing, and draws the correct conclusion about operational stability. (4) The answer addresses all parts of the question: the evolution (or lack thereof) over time, the geographic location (Melaka, Malaysia), and the two business segments (Analog and Embedded Processing). Wording differs slightly but conveys identical meaning. All entities (TXN, Melaka, Malaysia, Analog, Embedded Processing, 2022–2024) are correctly identified. No factual errors, omissions, or misinterpretations.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 368,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained constant at $1.5 billion from 2022 through 2024, indicating a consistent long-term liability with no principal repayments or retirements over the period. This stability suggests that PYPL maintained its long-term debt structure without altering the principal amount of this specific note, even as it issued new debt and refinanced other tranches. The lack of change in this liability contrasts with PYPL's active debt management in other areas, such as the retirement of its 1.350% notes by 2023 and the introduction of new high-interest notes in 2024.",
      "llm_answer": "\nPYPL’s fixed‑rate 2.850 % notes have been held at roughly **$1.5 billion** from 2022 through 2024 – the 2022 filing lists $1,500 million, the 2023 filing still shows $1,500 million outstanding, and the 2024 filing again reports $1,500 million (with the note’s 2029 maturity unchanged).  This steady balance indicates that PYPL is deliberately **maintaining a long‑dated, low‑cost fixed‑rate tranche as a core component of its debt profile**, while supplementing the overall capital structure with newer, higher‑coupon issuances; the unchanged exposure reflects a strategy of preserving stable, predictable financing and managing maturity concentration over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that PYPL's exposure to the 2.850% fixed-rate notes remained constant at $1.5 billion (or $1,500 million) from 2022 through 2024, with the maturity date in 2029, which aligns perfectly with the ground truth. All numeric values—amount, percentage rate, and years—are accurate and consistently reported across the three years. Format variations (e.g., $1,500 million vs. $1.5 billion) are acceptable and semantically equivalent.\n\n2) Quantitatively, the answer is fully accurate. It correctly reports the principal amount in each year and references the unchanged maturity, confirming no repayments or retirements occurred. No calculations are required beyond consistency checks, which the model passes.\n\n3) The reasoning is sound and reflects correct multi-hop synthesis across the 2022, 2023, and 2024 filings. The LLM infers a strategic intent—maintaining a stable, low-cost debt tranche—as part of PYPL’s broader capital structure management. This interpretation is logically supported by the data and closely matches the ground truth’s conclusion about consistent liability management.\n\n4) The only minor gap is that the LLM answer does not explicitly contrast this stability with PYPL’s retirement of the 1.350% notes by 2023 or the issuance of new high-interest notes in 2024, which the original answer includes to highlight active management in other areas. While the LLM mentions 'supplementing with newer, higher-coupon issuances,' it does so more generally. This omission slightly reduces qualitative completeness but does not undermine the core correctness.\n\nOverall, the answer is factually precise, contextually appropriate, and demonstrates strong reasoning. The missing comparative detail prevents a perfect 10 but does not justify a lower correctness score than 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Has_Stake_In]- ORG <-[Issues_Notes]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 492,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility evolved across 2022, 2023, and 2024 in terms of its role in the company's global manufacturing strategy for cell therapy products?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as a principal manufacturing facility, indicating its strategic importance in its global operations. By 2023, the company explicitly stated that Hoofddorp was being utilized for the commercial manufacturing and processing of its cell therapy products, signaling a specific functional role in its production pipeline. In 2024, Gilead reiterated the same utilization of the Hoofddorp facility, maintaining its focus on commercial manufacturing and processing of cell therapy products, suggesting continuity and deepening of its strategic role in this therapeutic area. This progression indicates a consistent and growing emphasis on Hoofddorp as a dedicated hub for cell therapy manufacturing over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead has listed Hoofddorp, Netherlands as one of its principal manufacturing sites (Chunk 3) and, beginning in 2023, explicitly uses the facility for **commercial manufacturing and processing of its cell‑therapy products** (Chunks 1 & 2).  This role has remained consistent, making the Dutch location a key hub in Gilead’s global cell‑therapy manufacturing strategy and supporting the European supply chain for those products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Hoofddorp was listed as a principal manufacturing site starting in 2022 (implied strategic importance), and accurately notes the key evolution in 2023 when Gilead began explicitly using the facility for commercial manufacturing and processing of cell therapy products. The answer correctly states that this role continued through 2024, indicating consistency. All dates and functional roles are correct, and there are no numerical inaccuracies (the question does not involve financial figures or calculations, so quantitative accuracy is based on correct time periods, which are accurate). The reasoning is sound and reflects proper multi-hop synthesis across years and strategic roles. The only minor shortcoming is that the answer does not explicitly mention the 2024 reiteration as a distinct data point (though it implies continuity), slightly reducing qualitative completeness. However, the core progression and strategic significance are correctly conveyed, and the answer is fully contextually relevant to the question about the evolution of the facility's role in global cell therapy strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 338,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 through 2024, particularly in terms of long-term debt composition and current portion classification?",
      "original_answer": "Costco maintained a consistent principal amount of $1,250 million for the 1.375% Senior Notes due June 2027 across all three years (2022–2024). However, the classification of the current portion of long-term debt changed significantly over time: in 2022, the current portion was $73 million, by 2023 it spiked to $1,081 million, and in 2024 it dropped to $103 million. This reflects shifting debt maturity profiles and short-term obligations tied to these notes.",
      "llm_answer": "\nCostco’s 1.375% Senior Notes due June 2027 stayed on the books at a $1.25 billion face amount in 2022, 2023 and 2024, but the accounting classification shifted: in 2022 only $73 million of the total long‑term debt was shown as the current portion, whereas by 2024 the current‑portion line had risen to $103 million (with the 2023 comparative column reporting $1,081 million), causing the “long‑term debt, excluding current portion” to decline from $6.484 billion in 2022 to $5.794 billion in 2024. This reflects a gradual re‑classification of a larger share of the notes (and of overall debt) into current liabilities as the securities approached maturity, while the composition of long‑term debt contracted from $6.590 billion in 2022 to $5.919 billion in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the consistent principal amount of $1,250 million (stated as $1.25 billion) for the 1.375% Senior Notes due June 2027 across 2022–2024, which matches the ground truth. The current portion values are accurately reported: $73 million in 2022, $1,081 million in 2023, and $103 million in 2024. These numbers are factually correct and reflect the spike and subsequent drop in the current portion. (2) Quantitative accuracy is high: all key figures (principal, current portions) are correct. However, the LLM introduces additional aggregate figures not in the original answer—namely, total long-term debt and long-term debt excluding current portion (e.g., $6.484B, $5.794B, $5.919B)—which, while potentially accurate, are not part of the ground truth and were not requested in the question. Their inclusion does not contradict the truth but adds unverified detail. (3) The reasoning is sound: the LLM correctly interprets the reclassification as the note approaches maturity and explains the shift in current vs. long-term classification. However, the phrase 'gradual re-classification' is slightly misleading given the sharp spike in 2023 ($1,081M) followed by a drop in 2024 ($103M), which is more indicative of a temporary reclassification (possibly due to refinancing or repayment timing) rather than a gradual trend. This nuance is missed. (4) The answer is highly contextually relevant, addressing both the composition of long-term debt and the current portion classification. It synthesizes multi-hop information correctly across years. The minor deduction in correctness is due to the introduction of unverified aggregate debt figures and slight mischaracterization of the trend as 'gradual.' Overall, core facts and multi-hop synthesis are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 488,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did PayPal's (PYPL) financial obligations related to its Fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this reveal about the company's long-term debt management strategy?",
      "original_answer": "PayPal's financial obligations related to the Fixed-rate 2.850% notes remained consistent at $1.5 billion across all three years (2022, 2023, and 2024), indicating that the company did not reduce or refinance this particular tranche of debt during the period. In 2022, the note was part of a $5.0 billion September 2019 issuance and was scheduled to mature on October 1, 2029, with an effective interest rate of 2.96%. This maturity date and carrying amount remained unchanged in 2023 and 2024, despite active debt issuance and refinancing activity in other tranches during those years. The lack of change in this obligation suggests that PayPal prioritized refinancing or issuing new debt with different maturities and rates, while maintaining its exposure to the 2.850% notes. This reflects a strategy of preserving capital structure stability in certain long-term liabilities while adapting to changing interest environments in other areas.",
      "llm_answer": "\nPayPal’s $1.5 billion Fixed‑rate 2.850% notes due 2029 remained unchanged in principal throughout 2022‑2024, with the carrying amount staying at $1.5 billion each year (Chunk 1‑3), while the company’s overall term‑debt balance grew from $9.0 billion (2022) to $10.6 billion (2023) and $10.574 billion (2024) and the current‑portion of debt fell from $1.249 billion (2023) to $1.191 billion (2024) (Chunk 2‑3). This stability reflects a long‑term debt strategy that anchors a low‑cost, mid‑term tranche while progressively extending maturity and diversifying funding through newer, higher‑rate issuances (e.g., the May 2024 5.15% and 5.5% notes and the June 2023 ¥‑denominated bonds) (Chunk 2‑3). Consequently, PayPal is managing its capital structure by preserving a steady, relatively inexpensive debt pillar and using fresh issuances to roll‑over maturing obligations and capture current market rates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $1.5 billion carrying amount of the 2.850% notes is accurately reported for 2022–2024; the overall term debt balances ($9.0B in 2022, $10.6B in 2023, $10.574B in 2024) and current portion of debt ($1.249B to $1.191B) match the data. The maturity date (2029) and issuance context (September 2019) are implied via 'due 2029' and consistent carrying value, though the exact issuance date isn't mentioned. (2) The LLM correctly identifies that this tranche remained stable while other debt activity occurred, citing specific new issuances (May 2024 5.15%/5.5% notes, June 2023 yen-denominated bonds), which supports the strategy of refinancing elsewhere. (3) The reasoning is sound: it infers a strategy of maintaining a low-cost debt pillar while adapting to market conditions via new issuances—this matches the ground truth’s conclusion about capital structure stability and selective refinancing. (4) Minor deduction in qualitative accuracy because the effective interest rate (2.96%) is omitted, and the September 2019 issuance context is not explicitly referenced. However, the core multi-hop synthesis—linking stable obligations to strategic debt management amid broader refinancing—is correctly executed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect: all information directly addresses the evolution of the notes and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Has_Stake_In]- ORG <-[Issues_Notes]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 414,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did NextEra Energy's exposure to gas-related options evolve from 2022 through 2024, and what does the multi-year trend in fair value and volatility assumptions reveal about the company's risk positioning in gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas-related options decreased from $356 million (assets) and $347 million (liabilities) in 2022, to $100 million (assets) and $97 million (liabilities) in 2023, and further to $100 million (assets) and $102 million (liabilities) in 2024. The implied volatility assumptions for these options also declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024, indicating a reduction in expected market volatility and potentially a strategic de-risking in gas market exposure over the three-year period.",
      "llm_answer": "\nNextEra Energy’s gas‑related options declined sharply in fair‑value: from a net asset of **$356 m** (2021, Chunk 1) to **$100 m** assets and **$97 m** liabilities (2023, Chunk 3) and then to **$100 m** assets with **$102 m** liabilities (2024, Chunk 2), showing a deliberate reduction of notional exposure over the period.  At the same time the weighted‑average implied volatilities used in the option valuations rose from **≈36 %** (2021) to **≈50 %** (2023) and **≈52 %** (2024), indicating that the company priced its remaining options under markedly higher price‑swing expectations despite the smaller book.  This multi‑year trend reveals that NextEra has shifted from a sizable hedging position to a more modest, volatility‑aware stance, reducing direct gas‑price risk while still accounting for elevated market volatility in its valuations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both dates and numbers. It incorrectly states that the $356 million asset value was from 2021 instead of 2022, misaligning the entire timeline. The ground truth shows data for 2022, 2023, and 2024 — but the LLM references 2021, which is not part of the original trend. While the 2023 and 2024 values for assets and liabilities are correct ($100M assets, $97M liabilities in 2023; $100M assets, $102M liabilities in 2024), the 2022 figures are misattributed to the wrong year. (2) The implied volatility figures are also misstated: the LLM claims volatility increased from 36% in 2021 to 50% in 2023 and 52% in 2024, but the ground truth states volatility declined from 36% in 2022 to 50% in 2023 and then to 52% in 2024 — however, this too appears to be a typo in the original answer (36% to 50% to 52% is an increase, not a decline). Despite this confusion, the LLM correctly reports the numerical volatility inputs (36%, 50%, 52%) and associates them with rising expectations, which is logically consistent with the numbers. (3) The multi-hop reasoning is partially sound: the model correctly infers that decreasing fair value suggests reduced exposure and that rising implied volatility reflects heightened price-swing expectations. Its conclusion about a shift to a more 'volatility-aware stance' is reasonable and contextually insightful. However, the misdating undermines the trend analysis. (4) The contextual relevance is high — it directly addresses both parts of the question: evolution of exposure and interpretation of volatility trends. The qualitative reasoning is strong despite the quantitative errors. The correctness score is 6 due to major date/number misalignment, but not complete failure; quantitative accuracy is penalized heavily (5/10) for the year error and potential misinterpretation of trend direction, while qualitative and contextual scores remain moderate to high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 531,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the financial performance of Cisco's available-for-sale (AFS) debt investments impact other income (loss), net across fiscal years 2022 through 2024, and what does this reveal about the volatility of its investment portfolio during this period?",
      "original_answer": "In fiscal 2022, Cisco disclosed the composition and value of its AFS debt investments, indicating active portfolio management. By fiscal 2023, the company reported higher losses from these AFS debt investments, which negatively impacted its other income (loss), net. This trend continued into fiscal 2024, where AFS debt investment losses again contributed to a decline in other income (loss), net, despite offsetting gains from equity and private investments. The recurring negative impact from AFS debt investments over two consecutive years reveals a trend of increasing volatility in Cisco’s investment portfolio, particularly in its debt holdings, which has affected overall financial stability in non-operational income streams.",
      "llm_answer": "\nAcross fiscal 2022 – 2024 Cisco’s available‑for‑sale (AFS) debt investments generated the dominant source of volatility in its “other income (loss), net,” with each filing stating that **higher losses in those AFS debt holdings drove the change in other income** (Chunk 2 & Chunk 3), only partially offset by foreign‑exchange impacts and gains on marketable‑equity and privately‑held investments (Chunk 1 & Chunk 2).  The repeated negative impact of AFS‑debt losses on the other‑income line—reflected in the KG relationship CSCO ‑[Negatively_Impacts]→ AFS Debt Investments → CSCO—shows that Cisco’s investment portfolio is highly sensitive to market movements, producing swing‑y earnings that can quickly turn a profit into a loss and back again.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AFS debt investment losses were a dominant source of volatility in 'other income (loss), net' from fiscal 2022 to 2024, with higher losses in AFS debt holdings negatively impacting other income—consistent across both 2023 and 2024, as stated in the original answer. (2) There are no explicit numerical values (e.g., dollar amounts or percentages) in either the question or the ground truth, so quantitative accuracy is not compromised; all references to time periods (fiscal 2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes the impact of AFS debt investments over three fiscal years, recognizes their recurring negative effect, and links it to portfolio volatility and sensitivity to market movements—correctly inferring increasing instability in non-operational income. It also acknowledges offsetting gains from equity and private investments, matching the original answer’s nuance. (4) The only minor shortcoming is the slightly stronger characterization of AFS debt as the 'dominant source of volatility' and 'swing-y earnings,' which, while reasonable, goes a bit beyond the original answer’s more measured conclusion about 'increasing volatility' and 'trend' in the portfolio. However, this does not constitute a factual error but rather a slight intensification of tone. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST <-[Discloses]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 410,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Lowe's Companies, Inc.'s issuance and documentation of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about the company's long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049, in its filings across 2022, 2023, and 2024, indicating a stable long-term debt structure. The Fifteenth Supplemental Indenture dated April 5, 2019, which includes the 4.550% Notes, was disclosed in all three years, showing no change in the documentation or terms of this specific note over time. This consistency suggests that Lowe's maintained a steady approach to long-term financing through this instrument without modifications or early redemptions during the observed period.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s repeatedly filed the same **Fifteenth Supplemental Indenture (Exhibit 4.16)** in its annual Form 8‑K filings (pages 82 – 2022, 76 – 2023, 75 – 2024), each time reproducing the clause that creates the **4.550 % Notes due April 5 2049** and confirming that they remain governed by **U.S. Bank National Association** as successor trustee under the 1995 indenture.  This continual re‑filing shows that the company has not retired or replaced the tranche but has kept it on its balance sheet as a stable, long‑dated fixed‑rate component of its capital structure.  \n\nThe pattern—where Lowe’s **issues** and **introduces** the 4.550 % Notes and then **re‑introduces** the identical supplemental indenture year after year—signals a deliberate long‑term debt strategy: lock in low‑cost, 30‑year financing at a fixed coupon and maintain a predictable, extended maturity profile without needing new issuance or complex refinancing, thereby reinforcing debt‑capacity stability and investor confidence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes due April 5, 2049, are consistently referenced; the Fifteenth Supplemental Indenture dated April 5, 2019, is correctly identified and noted as being re-filed annually; and U.S. Bank National Association is accurately named as the successor trustee. The exhibit number (4.16) and filing types (Form 8-K) with page numbers across years (82 in 2022, 76 in 2023, 75 in 2024) are precise and support the claim of repeated disclosure. (2) Quantitative elements—interest rate (4.550%), maturity date (April 5, 2049), and indenture date (April 5, 2019)—are all factually correct and match the original answer. No calculations were required, but the temporal consistency is properly interpreted. (3) The reasoning is sound: the model correctly infers that the repeated filing of the same document indicates no change in terms or retirement of the notes, reflecting a stable long-term debt strategy. The conclusion about locking in fixed-rate, long-dated financing and maintaining a predictable maturity profile is a reasonable interpretation of the pattern. (4) The only minor deviation from the original answer is the use of the word 'issues' and 'introduces' in the context of re-filing, which could imply new issuance, but in context it is clear the model means 're-introduces' via disclosure. This does not undermine the factual correctness but slightly affects phrasing precision. Overall, the answer demonstrates strong multi-hop synthesis across years and documents, with excellent contextual relevance and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 448,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did Simon Property Group's (SPG) face value and interest rate exposure on Unsecured Notes - 35B evolve from 2022 through 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "From 2022 to 2024, Simon Property Group maintained a consistent face value of $750,000,000 for Unsecured Notes - 35B, while the interest rate remained unchanged at 3.80%. However, the maturity date was extended from 07/15/50 in 2022 to the same date in 2024, indicating a stable long-term financing approach with no refinancing or restructuring of this particular debt instrument over the period. This suggests SPG's confidence in managing long-dated liabilities and maintaining favorable interest terms.",
      "llm_answer": "\nSimon Property Group’s Unsecured Notes – 35B kept the same **$750 million face amount** and **3.80 % coupon** in every filing that covers the period – the 2021 10‑K (Chunk 1) first lists the issue at that size and rate, the 2023 filing (Chunk 2) repeats the identical $750 million face and 3.80 % interest, and the 2024 filing (Chunk 3) again shows $750 million face and 3.80 % interest (the same maturity of 07/15/50).  This consistency, despite the company adding newer unsecured issues in 2023‑24, demonstrates that SPG’s long‑term debt strategy is to **maintain a large, fixed‑rate, long‑dated unsecured tranche** to lock in financing costs, limit exposure to interest‑rate fluctuations, and preserve stable cash‑flow predictability over the life of the notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the face value ($750 million), interest rate (3.80%), and maturity date (07/15/50) across the 2022–2024 period, matching the ground truth exactly. All numeric values are accurate and consistently reported across filings. Format variations (e.g., $750 million vs $750,000,000) are acceptable and correctly interpreted. (2) Quantitative accuracy is perfect: the face value, interest rate, and maturity date are all factually correct and stable over time as per the original answer. (3) The multi-hop reasoning is sound—LLM synthesizes data from multiple filings (2021, 2023, 2024) to infer stability in this debt instrument, even though the question focuses on 2022–2024. The mention of consistent terms despite new issuances in 2023–24 adds context not in the ground truth but does not contradict it. The only minor gap is that the original answer emphasizes the lack of refinancing or restructuring, while the LLM focuses on strategic benefits (fixed-rate, long-dated) without explicitly stating no change occurred—this nuance slightly affects qualitative depth. (4) The answer is highly relevant, directly addressing both the evolution (or lack thereof) and the implications for SPG’s long-term debt strategy. The conclusion about locking in financing costs and reducing rate exposure aligns semantically with the ground truth’s interpretation of stable long-term financing. Minor deduction in qualitative accuracy due to slightly less precise emphasis on 'no refinancing' but overall excellent alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 426,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 to 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what does this multi-year trend reveal about the company's risk management strategy and operational resilience?",
      "original_answer": "In 2022, PayPal highlighted risks around bad transactions tied to credit defaults, particularly in its U.S. consumer credit product through Synchrony Bank, and emphasized concerns about fraud and synthetic identities. In 2023, the company entered a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic shift to reduce balance sheet exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize fraud and abuse risks, particularly in digital payments, while also noting legal uncertainty around the 'valid-when-made' doctrine for purchased loan receivables, which could impact U.S. credit products. The trend shows a transformation from internal risk absorption to external risk mitigation through asset sales and legal contingency planning, indicating a more proactive and diversified risk management approach over time.",
      "llm_answer": "\nIn 2022 PayPal’s bad‑transaction risk stemmed from credit‑product defaults, cross‑border‑trade exposure and heavy reliance on third‑party lenders and payment processors, as the 2022 filing warned that rising non‑payment rates and regulatory constraints could erode revenue‑share with Synchrony Bank and impair the purchase of merchant‑financing receivables.  \nBeginning in 2023 the company reduced that exposure by entering a multi‑year €40 bn sale of U.K. and European BNPL receivables and by diversifying its payment‑processor network, while still depending on third‑party funding and forward‑flow arrangements that are subject to economic conditions and could delay expected benefits, as disclosed in the 2023 filing.  \nBy 2024 PayPal continued to manage the evolving risk through regulatory navigation of the “valid‑when‑made” doctrine, sustained fraud‑prevention efforts and a focus on cross‑border‑trade resilience, illustrating a multi‑year strategy that combines securitization, third‑party diversification and compliance to reinforce operational resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk exposure to credit defaults (especially via Synchrony Bank), cross-border trade, and third-party dependencies; the 2023 €40 billion multi-year sale of U.K. and European BNPL receivables; and 2024's focus on the 'valid-when-made' doctrine, fraud prevention, and operational resilience. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited (ground truth: €40 billion; LLM: €40 bn), years (2022–2024) match exactly, and no calculations are required. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years, connects credit products, cross-border exposure, and third-party risks, and correctly infers a strategic shift toward external risk mitigation via asset sales and diversification. It adds value by explicitly mentioning 'securitization' and 'forward-flow arrangements,' which are contextually accurate though not in the original. (4) Minor deduction in qualitative accuracy due to slight rephrasing of the risk management evolution: the original emphasizes a shift from internal absorption to external mitigation and legal contingency planning, while the LLM frames it as 'securitization, third-party diversification and compliance'—semantically similar but slightly less precise in capturing the strategic transformation. However, the core insight about a proactive, diversified risk strategy is preserved. Contextual relevance is perfect: all parts of the multi-part question are addressed with appropriate depth and synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Risks]- ORG",
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 440,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How did the competitive positioning of Costco (COST) relative to BJ's Wholesale Club evolve from 2022 through 2024, particularly in terms of the company's emphasis on private-label brands like Kirkland Signature as a differentiator?",
      "original_answer": "From 2022 to 2024, Costco consistently emphasized its competition with BJ's Wholesale Club, but the depth and framing of its differentiation strategy—particularly around its private-label brand Kirkland Signature—remained stable. In 2022, Costco highlighted Kirkland Signature products as high-quality, lower-priced alternatives to national brands, contributing to higher margins and differentiation. In 2023, the company reiterated this positioning, underscoring Kirkland Signature's role in lowering costs and enhancing merchandise offerings. By 2024, the messaging remained consistent, with no significant shift in strategy, indicating a stable competitive approach to maintaining market leadership in the warehouse club segment against BJ's Wholesale Club.",
      "llm_answer": "\nAcross its 2022, 2023 and 2024 Form 10‑K filings, Costco repeatedly lists BJ’s Wholesale Club (alongside Sam’s Club and other discounters) as a core warehouse‑club competitor and stresses that its private‑label brand, Kirkland Signature, delivers high‑quality merchandise at lower prices, lowers overall costs and earns higher margins—key differentiators against BJ’s and other rivals.  Each year’s filing notes that Costco continues to invest in and expects to increase the sales penetration of Kirkland Signature, indicating a sustained strategic focus on this private‑label brand as the primary means of distinguishing its offering from BJ’s and other competitors throughout 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that from 2022 to 2024, Costco consistently listed BJ's Wholesale Club as a competitor and emphasized Kirkland Signature as a strategic differentiator, which aligns with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either response, so quantitative accuracy is not compromised—no calculations were required. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying the continuity in strategy and competitive framing. It accurately captures that Costco's emphasis on Kirkland Signature—its quality, cost advantages, margin benefits, and increasing sales penetration—remained a sustained focus, with no significant shift through 2024. (4) The only minor difference is that the LLM answer adds the detail that Costco 'expects to increase the sales penetration' of Kirkland Signature, which is a slightly more forward-looking emphasis than the original answer's focus on consistency. However, this does not contradict the ground truth and may reflect additional nuance from the filings. Overall, the answer is complete, contextually relevant, and factually correct, warranting a high score with only a slight deduction in qualitative accuracy due to the subtle shift in emphasis, though still within acceptable semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 401,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did NextEra Energy's exposure to gas forward contracts evolve from 2022 through 2024, particularly in terms of fair value of assets and liabilities, and what does this 3-year progression indicate about the company's risk positioning in natural gas markets?",
      "original_answer": "From 2022 to 2024, NextEra Energy's fair value of gas forward contract assets increased from $191 million to $296 million, while liabilities rose more sharply from $31 million to $46 million. This indicates a growing but increasingly balanced exposure to natural gas markets, with a notable spike in 2023 where assets reached $377 million. The trend suggests a strategic expansion in gas market participation, accompanied by rising market risk.",
      "llm_answer": "\nBased on the three filings, NEE’s gas‑forward‑contract position was $191 million in assets and $31 million in liabilities in the 2022 report (chunk 1); it expanded to $377 million in assets and $77 million in liabilities by the end of 2023 (chunk 3), reflecting a markedly larger hedged book; and then contracted to $296 million in assets and $46 million in liabilities in the 2024 filing (chunk 2). This three‑year trajectory shows that NEE increased its natural‑gas forward‑contract exposure in 2023 but pulled back in 2024, indicating a shift toward a more conservative risk stance as market conditions evolved.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the asset values for 2022 ($191M) and 2024 ($296M), and the liability values for 2022 ($31M) and 2024 ($46M), which match the ground truth. However, it incorrectly states the 2023 liabilities as $77M, whereas the ground truth reports $46M in liabilities for 2023 (with liabilities only rising to $46M by 2024, not in 2023). The 2023 asset value of $377M is correct and aligns with the spike noted in the original answer. (2) The quantitative inaccuracies are limited to the 2023 liability figure—this is a significant error as it overstates liabilities by $30M (100% increase from actual $46M). Other numbers are accurate, and the overall trend direction (increase then partial decrease) is preserved. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic expansion in 2023 followed by a pullback in 2024. However, the conclusion about a 'more conservative risk stance' differs slightly from the original answer’s interpretation of 'growing but increasingly balanced exposure' and 'strategic expansion with rising market risk.' While both acknowledge increased activity and risk, the LLM leans toward de-risking in 2024, which is plausible but not fully supported by the original answer’s emphasis on continued growth and balance. (4) The contextual relevance is perfect—the response directly addresses the evolution of exposure, fair value changes, and risk positioning. Due to the material error in the 2023 liability figure, the quantitative accuracy is reduced to 6, pulling the overall correctness to 7. Qualitative reasoning and entity identification (NextEra Energy, gas forward contracts, years) are accurate, warranting an 8. Contextual relevance is 10 as all question components are addressed with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 497,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Lowe's use of forward interest rate swaps evolve from 2022 through 2024, and what does this progression indicate about the company's interest rate risk management strategy in response to changing market conditions?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, noting their impact on other comprehensive income and earnings over a multi-year period (2019–2021), indicating active hedging of interest rate exposure. In 2023, the company held forward interest rate swaps valued at $251 million as of February 3, 2023, classified under other current assets, showing a concrete and current financial commitment to hedging. By 2024, Lowe's no longer held forward interest rate swaps, as they were not listed among the derivative instruments as of January 31, 2025, suggesting a strategic unwind or replacement of these instruments, possibly in response to stabilized interest rates or refinancing activities. This 3-year trajectory shows a deliberate use and subsequent release of forward interest rate swaps as part of Lowe’s broader interest rate risk management strategy.",
      "llm_answer": "\nLowe’s disclosed in **2022** (Note 3) that its forward‑interest‑rate swaps were accounted as cash‑flow hedges, with the effective portion of gains and losses recorded in other‑comprehensive income and later amortized to interest expense (Chunk 1).  \nBy the end of **2023** the company reported **$251 million** of such swaps recorded in “Other current assets” (Level 2 fair‑value measurement), but the 2024 column in the fair‑value table shows essentially no balance, indicating that the swaps were either terminated or rolled as market rates changed (Chunk 2).  \nIn its **2024** filing the firm explains that it continued to use forward swaps to hedge exposure to forecasted debt issuances, while also holding **fixed‑to‑floating swaps** as fair‑value hedges on existing borrowings and evaluating them under the shortcut method (Chunk 3).  \n\n**Together, this progression shows a shift from relying primarily on cash‑flow hedges for future debt to a blended strategy that adds fair‑value hedges on existing obligations—reflecting a more proactive interest‑rate risk‑management approach as benchmark rates rose and the company sought to lock in financing costs.**",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but includes a critical factual error that undermines the overall accuracy. (1) Quantitatively, the $251 million figure for forward interest rate swaps as of 2023 is accurate and correctly attributed to February 3, 2023. The reference to their classification in 'Other current assets' and Level 2 fair value measurement aligns with the ground truth. However, the claim that Lowe's 'continued to use forward swaps' in 2024 is factually incorrect — the ground truth explicitly states that by 2024 (as of January 31, 2025), Lowe's no longer held forward interest rate swaps, and they were not listed among derivative instruments. This contradicts the LLM’s assertion of ongoing use. (2) The reasoning is partially sound in identifying a strategic shift, but it draws the wrong conclusion: instead of a 'blended strategy' including forward swaps in 2024, the company had actually exited these positions, suggesting a wind-down rather than continuation. The mention of fixed-to-floating swaps as fair-value hedges may be accurate, but it does not compensate for the central error regarding forward swaps. (3) Multi-hop synthesis is attempted — connecting 2022 hedging accounting, 2023 balances, and 2024 strategy — but fails at the final step by misrepresenting the 2024 status. (4) Contextual relevance is high, as the answer addresses the evolution and strategic implications, and uses appropriate financial terminology. However, the core conclusion about strategy evolution is flawed due to incorrect 2024 data. Thus, while numbers and some context are correct, the key factual claim about 2024 is wrong, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Holds]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 458,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the competitive positioning of CMCSA against Lumen evolve from 2022 through 2024, particularly in terms of fiber-based broadband infrastructure expansion and its implications on service offerings in overlapping markets?",
      "original_answer": "From 2022 to 2024, CMCSA consistently identified Lumen as a key competitor in the broadband space, with Lumen actively expanding its fiber-based network infrastructure. In 2022, Lumen was noted as one of the wireline telecommunications companies building fiber infrastructure to offer higher-speed data transmission services in CMCSA's service areas. By 2023, this trend continued, with Lumen further extending its fiber-based services, increasing competitive pressure through enhanced speeds and bundled offerings. In 2024, Lumen remained a prominent competitor, with its fiber infrastructure expansion continuing to overlap with CMCSA’s footprint, intensifying competition in broadband services. The consistent mention of Lumen across all three years underscores its growing influence as a fiber-based competitor, directly impacting CMCSA's market positioning and service strategies.",
      "llm_answer": "\nFrom 2022 through 2024, Lumen’s wireline incumbency continued to expand fiber‑based infrastructure into many of the same territories where CMCSA delivers cable broadband—a progression documented in the 2022 filing (which lists Lumen among the carriers building fiber), reiterated in the 2023 filing (which again notes Lumen’s ongoing fiber builds and the competitive pressure they create), and reinforced in the 2024 report (which highlights that Lumen and other incumbents such as AT&T and Verizon are still extending fiber networks and that federal broadband‑deployment funding may accelerate such overlapping deployments).  This parallel fiber rollout has forced CMCSA to respond by tightening its broadband bundles, emphasizing higher‑speed tiers, and leveraging promotional or bundled services to protect its subscriber base in the contested markets.  Consequently, the evolution of the competitive positioning between CMCSA and Lumen is defined by a sustained, mutually aggressive fiber expansion that reshapes service offerings and pricing strategies across their overlapping footprints.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Lumen is consistently identified as a fiber-expanding competitor to CMCSA from 2022 to 2024, with overlapping infrastructure deployments. The answer correctly reflects that Lumen was listed in CMCSA's 2022 filing as building fiber, reiterated in 2023, and reinforced in 2024, including the role of federal funding in accelerating deployments. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the temporal references (2022–2024) are accurate and correctly attributed to the evolution of competitive dynamics. (3) The multi-hop reasoning is sound: the answer synthesizes information across three years of filings, correctly identifying the continuity and escalation of competitive pressure due to fiber expansion. It also infers CMCSA’s strategic response (bundling, speed tiers, promotions), which is a logical and documented market reaction. (4) The LLM adds contextual depth—mentioning AT&T and Verizon as parallel competitors and federal funding—without contradicting the ground truth, enhancing relevance. Wording differs but meaning aligns fully. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 358,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did PayPal's focus on seamless checkout experiences evolve from 2022 to 2024, particularly in terms of its integration with consumer credit offerings, global currency support, and omnichannel merchant solutions?",
      "original_answer": "From 2022 to 2024, PayPal's focus on seamless checkout experiences matured significantly. In 2022, the company emphasized expanding its global capabilities and increasing customer use of its products, including creating seamless checkout experiences and supporting transactions in over 100 currencies. By 2023, PayPal had expanded currency support to approximately 150 and highlighted the importance of simplifying shopping experiences through platform enhancements and security measures. In 2024, the company deepened integration by embedding buy now, pay later (BNPL) solutions into its branded checkout experiences and offering PayPal- and Venmo-branded debit and credit cards, while also providing omnichannel merchant solutions through Zettle and unbranded payment processors like Braintree. This evolution reflects a strategic shift from global scale and usability to enhanced financial services integration and comprehensive merchant enablement.",
      "llm_answer": "\nFrom 2022 through 2024 PayPal (PYPL) repeatedly refined its **Seamless Checkout Experiences** product—starting with a global payments platform that already enabled transactions in >100 currencies and 200 markets (Chunk 1), expanding currency coverage to ≈150 currencies and adding merchant‑focused risk‑management and buyer‑protection tools while deepening strategic partnerships (Chunk 2), and finally embedding consumer‑credit options such as BNPL and PayPal Credit, broadening omnichannel merchant solutions (Braintree, PayPal Complete Payments, Zettle POS) and supporting balances in 24 currencies (Chunk 3). This evolution tied together **global currency support**, **consumer credit integration**, and **omnichannel merchant capabilities** into a single, seamless checkout ecosystem that drives higher conversion for merchants and greater engagement for consumers.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies PayPal's evolution from 2022 to 2024 in seamless checkout, covering all three key areas: global currency support, consumer credit integration, and omnichannel merchant solutions. (2) Quantitatively, it states >100 currencies in 2022 (matches ground truth), expands to ≈150 currencies by 2023 (correct), and mentions support for balances in 24 currencies in 2024—this specific '24 currencies' detail is not in the original answer but does not contradict it and may reflect a more granular aspect (e.g., balance-holding capability vs. transaction support), so it's not considered a factual error. (3) The reasoning is sound: it traces a logical progression from global scale to enhanced financial services and merchant enablement, correctly synthesizing multi-hop information across years and product lines. It accurately references BNPL, PayPal Credit, PayPal- and Venmo-branded cards (implied in 'consumer-credit options'), and omnichannel tools like Zettle and Braintree (also correctly listed as 'PayPal Complete Payments'). (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'merchant-focused risk-management and buyer-protection tools'), these are consistent with the original's emphasis on security and platform enhancements. The only minor gap is that the original explicitly mentions the strategic shift in focus, which the LLM implies but doesn't state as clearly. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> PRODUCT <-[Produces]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 434,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about its role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (as part of RedCards/Target Circle Cards) declined from 20.5% in 2022 to 18.6% in 2023, and further to 17.8% in 2024. This consistent decline over three years suggests a diminishing role of the card in driving incremental sales, despite its continued value proposition of a 5% discount. The drop indicates a potential weakening in customer engagement with the payment loyalty program, which Target had internally linked to increased sales.",
      "llm_answer": "\nThe Target Debit Card’s “RedCard” (or Target Circle Card) penetration fell steadily – 20.5 % in fiscal 2022, 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024 (as disclosed in the 2022‑2024 Form 10‑K filings) – reflecting a modest year‑over‑year decline.  Because Target’s own analysis notes that a meaningful share of purchases made with these cards are **incremental sales**, the downward trend suggests that while the card still delivers a 5 % discount and loyalty benefits that generate some additional spend, its ability to **drive new, incremental revenue is weakening** as market saturation grows.  This pattern is consistent across the three filings, which also tie the card to the broader loyalty program that contributes deferred revenue (Chunk 1) and to the profit‑sharing arrangement with TD (Chunk 1), underscoring its financial relevance despite the slowing penetration.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative inaccuracies: it reports penetration rates of 20.5% in 2022 (correct), but then 19.8% in 2023 and 18.6% in 2024, whereas the ground truth states 18.6% in 2023 and 17.8% in 2024. This misstates both the magnitude and trend of the decline. (2) The numbers are critical to the question about evolution over time, and the incorrect values undermine the accuracy of the trend analysis. While the direction (decline) is correct, the rate of decline is misrepresented. (3) The qualitative reasoning is sound: the LLM correctly infers that declining penetration suggests weakening incremental sales impact, ties the card to Target’s loyalty program and incremental spend, and references Target’s internal analysis—this shows proper multi-hop synthesis across financial and strategic contexts. (4) Contextual relevance is high—the response addresses both parts of the question (trend and implication), uses appropriate terminology (incremental sales, loyalty program), and references Form 10-K filings. However, the quantitative errors significantly reduce overall correctness, especially since precise percentages are central to the question. Minor formatting variations (e.g., spacing) are acceptable, but the actual values must match. Thus, correctness is penalized heavily due to incorrect data points despite otherwise logical reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 382,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did AMD's revenue recognition approach for development and IP licensing agreements evolve from 2022 to 2024, particularly in relation to the distinction between combined arrangements and standalone licensing deals?",
      "original_answer": "From 2022 to 2024, AMD maintained a consistent revenue recognition framework for development and IP licensing agreements, recognizing revenue over time for combined arrangements and at a point in time for standalone licenses. In 2022, AMD emphasized that combined development and IP arrangements were evaluated for distinct performance obligations, with non-distinct licenses combined with development services and recognized over time. By 2023 and 2024, this policy remained unchanged, with the company continuing to recognize revenue for distinct licenses at a point in time when the customer can benefit from the IP, and for non-distinct licenses over time. Despite no explicit quantitative metrics being disclosed, the consistency in policy suggests a stable approach to IP monetization across all three years.",
      "llm_answer": "\nAMD’s revenue‑recognition policy for development and IP‑licensing arrangements has remained materially unchanged from 2022 through 2024: each year’s filing (2022 10‑K, 2023 10‑K, 2024 10‑K) states that the company first determines whether the IP license is distinct, and if it is **not** distinct the license is combined with the related development services and recognized over time, whereas a distinct license is recognized at a point in time when the customer can benefit; the disclosures also note that there are no material variable‑consideration estimates for either combined or standalone licensing deals. This consistent “distinct‑license” test and the corresponding timing of revenue recognition are presented in all three chunks, showing that the approach did not evolve substantively but was consistently applied across the three fiscal years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly states that AMD maintained a consistent revenue recognition approach from 2022 to 2024, distinguishing between distinct and non-distinct IP licenses, with revenue recognized at a point in time for distinct licenses and over time when combined with development services. This aligns exactly with the original answer. (2) There are no numeric discrepancies—both answers note the absence of explicit quantitative metrics or material variable consideration, which is consistent across filings. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years (2022–2024) and correctly identifies the continuity in policy, referencing the 'distinct-license' test as the key determinant in each year. (4) All entities—AMD, IP licensing, development agreements, 10-K filings, and the relevant accounting treatment—are accurately identified and contextualized. The answer directly addresses the evolution (or lack thereof) in policy, fulfilling the question’s requirement. Minor wording differences (e.g., 'materially unchanged' vs. 'consistent') do not affect meaning. All criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 345,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the strategic positioning of FlyEase technology within Nike's innovation portfolio evolve from fiscal 2022 through fiscal 2024?",
      "original_answer": "In fiscal 2022, FlyEase was newly introduced as part of Nike's innovation pipeline, listed among other emerging technologies aimed at enhancing athletic performance and comfort. By fiscal 2023, FlyEase had transitioned to being consistently named alongside established technologies like Nike Air and Zoom, indicating growing strategic importance and market integration. In fiscal 2024, FlyEase was no longer highlighted as a new innovation but was instead listed among mature technologies such as Nike React and Air Max, suggesting it had become a core part of Nike’s product development framework. This progression reflects FlyEase moving from a novel concept to a foundational technology within Nike’s portfolio over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Nike repeatedly placed **FlyEase** in the same “proliferation of … FlyEase …” list that defines its emerging‑technology portfolio, but each year the wording shifted from a simple mention (2022) to a sustained emphasis (2023, 2024), indicating that the company was moving the platform from an experimental add‑on to a core strategic pillar of its innovation pipeline.  At the same time the underlying supply‑chain footprint expanded—Tier‑2 supplier count grew from **139 (2022)** to **169 (2024)** and footwear factories rose to **96 (2024)**, with production concentrated in Vietnam, Indonesia and China—showing that Nike deliberately scaled the manufacturing capacity to support a broader, more mature deployment of FlyEase across its product categories.  Thus, the evolution reflects a deliberate transition: FlyEase went from being listed among a suite of new technologies to becoming a central, strategically positioned component of Nike’s innovation portfolio, backed by an increasingly robust global manufacturing network.",
      "correctness_score": 4,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative domain. The ground truth states that FlyEase evolved from being a newly introduced technology in fiscal 2022, to being grouped with established technologies like Nike Air and Zoom in 2023, and then listed among mature technologies such as Nike React and Air Max in 2024—indicating a clear progression in strategic positioning. The LLM captures the general directional trend of FlyEase becoming more central to Nike’s innovation strategy, which supports a moderate qualitative accuracy score. However, it fabricates specific quantitative details not present in the original answer: there is no mention in the ground truth of Tier-2 supplier counts (139 in 2022, 169 in 2024) or footwear factories (96 in 2024), nor any supply chain expansion data. These numbers are entirely absent from the original answer, making the quantitative accuracy very low. Additionally, the original answer does not reference a 'proliferation of ... FlyEase ...' list or wordings shifting from 'simple mention' to 'sustained emphasis'—these are speculative characterizations not supported by the source. While the LLM synthesizes a plausible narrative and addresses the evolution question contextually, it fails on factual correctness due to invented metrics and unsupported details. The reasoning is logically structured but based on non-existent data, undermining the conclusion's validity. Thus, while the answer is relevant and partially aligned in theme, it is significantly compromised by hallucinated numbers and unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Expands]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 438,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "What does the trend in the principal amount of AMT's 1.250% Notes suggest about the company's debt management strategy across 2022, 2023, and 2024?",
      "original_answer": "The principal amount of AMT's 1.250% Notes decreased from $609.1 million in 2022, to $551.9 million in 2023, and further to $517.7 million in 2024, indicating a consistent reduction in outstanding debt. The interest payment terms remained consistent across all three years, with payments due in May and maturing in February 2033. This progressive decline in principal suggests a managed amortization or repurchase strategy, potentially aimed at reducing long-term debt obligations while maintaining stable interest payment schedules.",
      "llm_answer": "\nThe data show a clear downward trajectory in the outstanding balance of AMT’s 1.250 % Notes across the three filings: $609.1 million was reported when the series was initially issued (first interest payment 2022) in the 2022 10‑K (Chunk 3), the amount fell to $551.9 million in the 2023 filing (Chunk 1), and by the 2024 filing it had been reduced further to $517.7 million (Chunk 2).  This steady decline—while the notes remain scheduled to mature only in 2033—indicates that AMT is deliberately shrinking the legacy low‑coupon tranche, likely to lower interest expense and re‑allocate capital toward newer, higher‑rate issuances (e.g., the 5.8 % and 5.2 % notes disclosed in Chunks 1‑2).  In other words, the company’s debt‑management strategy from 2022 through 2024 appears to be a purposeful move away from the 1.250 % Notes toward more flexible or cost‑effective financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amounts for AMT's 1.250% Notes across 2022 ($609.1 million), 2023 ($551.9 million), and 2024 ($517.7 million), matching the ground truth exactly. The maturity date (February 2033) is correctly implied as 'scheduled to mature only in 2033'. Interest payment timing (May) is not explicitly mentioned in the LLM answer but is not central to the trend analysis. (2) All numeric values are accurate and properly sequenced; the downward trend is correctly characterized. No calculations are required beyond recognizing the decline, which is accurately presented. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic debt reduction. It goes further by contextualizing the reduction within a broader capital reallocation strategy involving newer, higher-rate notes (5.8% and 5.2%), which, while not part of the original answer, is a reasonable inference from external context (Chunks 1–2) and does not contradict the ground truth. However, this added speculation slightly deviates from the more conservative 'managed amortization or repurchase' interpretation in the original, hence a minor deduction in qualitative accuracy. (4) The answer is highly relevant, directly addressing the trend and its implications for debt management. The core factual content and interpretation align closely with the ground truth, with only minor stylistic and inferential differences. Overall, the response is factually excellent and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Financial_Instruments]-> FIN_INST <-[Discloses]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 428,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year trajectory reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal year 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal year 2023, this value had decreased to $851 million, indicating a reduction in the liability's fair value. In fiscal year 2024, the notes were carried at $1,000 million with an effective interest rate of 3.54%, showing a stabilization in valuation. This trajectory suggests NVIDIA's long-term debt strategy involved managing liability values through market fluctuations while maintaining consistent long-term obligations.",
      "llm_answer": "\nNVIDIA’s 3.50 % Notes Due 2040 were carried at a fair‑value of **$1.07 bn** in fiscal 2022 (Chunk 1), fell to **$0.85 bn** in fiscal 2023 as market pricing shifted (Chunk 2), and by fiscal 2024 the same series was reflected on the balance sheet with a **carrying amount of $1.00 bn**, a remaining weighted‑average term of **15.2 years** and an **effective interest rate of 3.54 %** (Chunk 3).  \n\nThis multi‑year pattern shows that the company has treated the 2040 notes as a stable, long‑term financing pillar—allowing market‑driven valuation fluctuations while retaining a sizable, low‑coupon tranche well into the future to fund ongoing growth and preserve financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in all quantitative aspects: $1.07 billion in 2022 matches the ground truth $1,066 million (rounded), $0.85 billion aligns with $851 million, and $1.00 billion in 2024 matches exactly. The effective interest rate of 3.54% is correctly reported. The remaining weighted-average term of 15.2 years is additional accurate context not in the original answer but does not contradict it. 2) All numbers are accurate with acceptable formatting variations (e.g., $1.07 bn = $1,066 million). No calculation errors. 3) The reasoning is sound: the LLM correctly identifies the fluctuation in fair value (2022–2023) and stabilization in 2024, and infers a strategic use of long-term debt for financial flexibility, which is logically consistent with the ground truth’s conclusion about managing liabilities through market fluctuations. 4) The answer is semantically equivalent and slightly enriched with relevant context (term length), while fully addressing both parts of the question—evolution of valuation and strategic implications. The only minor gap is that the original emphasizes 'carrying at $1,000 million' in 2024 rather than fair value, which the LLM correctly reflects but could have clarified slightly more. Overall, excellent multi-hop synthesis across years and documents with precise, relevant, and correctly interpreted data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 378,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Netflix's strategy around membership plans evolve from 2022 to 2024, particularly in terms of service expansions (e.g., games, ad-supported tiers, live programming) and pricing adjustments, and what were the stated risks regarding member acquisition and retention tied to these changes in each respective year?",
      "original_answer": "In 2022, Netflix introduced games as a new component of its service offering and warned that if these efforts were not valued by members, it could negatively impact member acquisition and retention. In 2023, the company expanded its membership plans by introducing a lower-priced ad-supported subscription tier and noted that such adjustments might not be well-received by consumers, potentially leading to higher churn or reduced sign-ups. By 2024, Netflix had further diversified its offerings with the inclusion of live programming and continued to emphasize the risk that changes to pricing, plans, or service features could adversely affect member satisfaction and retention. Across all three years, Netflix consistently highlighted the risk that if consumers did not perceive the evolving service offering as valuable — whether due to new features, pricing changes, or content mix — the company could face challenges in both retaining existing members and acquiring new ones.",
      "llm_answer": "\nFrom 2022 to 2024 Netflix layered its membership‑plan strategy: in 2022 it introduced a games catalog and warned that if games or any pricing changes failed to resonate, member acquisition and retention could suffer; in 2023 it launched a lower‑priced ad‑supported subscription tier and tightened enforcement of multi‑household sharing rules, noting that poorly received features or price adjustments could dampen growth; by 2024 it added live programming and expanded into consumer products and live experiences, while again cautioning that the new ad‑supported plan, live‑programming offerings, or stricter sharing limits might be unpopular and could negatively impact member acquisition and retention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Netflix introduced games in 2022, launched an ad-supported tier in 2023, and added live programming by 2024. The stated risks around member acquisition and retention due to potential lack of consumer acceptance of new features, pricing, or sharing policy changes are accurately reflected. (2) There are no numeric values in the question or answer requiring quantitative verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the answer synthesizes Netflix’s evolving strategy across three years and correctly links each strategic move to associated risks. One minor addition not present in the original answer is the mention of 'tightened enforcement of multi-household sharing rules' and 'expanded into consumer products and live experiences' in 2024. While these may reflect real developments, they are not part of the ground truth provided, which focuses only on live programming and pricing/plan changes. This introduces slight over-specification but does not contradict the original answer or impair correctness. (4) The answer is contextually fully relevant, addressing all parts of the question: service expansions, pricing adjustments, and associated risks per year. The core information matches the original answer with strong semantic equivalence. A score of 9 is justified due to the inclusion of minor unverified elements, but overall factual accuracy and completeness remain very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 441,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did UnitedHealth Group's venture investment exposure evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses, and what does this progression indicate about the company's strategic positioning in the sector?",
      "original_answer": "UnitedHealth Group's venture investment exposure, primarily within equity securities and equity method investments in healthcare businesses, showed a clear upward trend from 2022 to 2024. In 2022, the company held $3.7 billion in equity securities, which increased to $4.9 billion by 2023 and remained steady at that level in 2024. Meanwhile, equity method investments in healthcare businesses rose from $1.3 billion in 2022 to $1.4 billion in 2023, and significantly jumped to $3.8 billion in 2024. This trajectory indicates a deliberate strategic shift toward deeper engagement in healthcare innovation and operating businesses, aligning with UnitedHealth's broader focus on integrated health services and long-term sector transformation.",
      "llm_answer": "\nUnitedHealth Group’s equity‑securities portfolio expanded from **$3.7 billion in 2022** (Chunk 1) to **$4.9 billion in both 2023 and 2024** (Chunks 1 & 2), while its equity‑method investments in health‑care operating businesses rose from **$1.5 billion in 2022** (Chunk 1) to **$1.4 billion in 2023** (Chunk 1) and then **$3.8 billion in 2024** (Chunk 2). This trajectory reflects a deliberate scaling‑up of venture‑style stakes in the health‑care ecosystem—particularly a sharp increase in 2024—indicating that UNH is positioning itself more actively as a strategic investor and partner within the sector rather than merely holding passive securities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key factual error in the equity-method investment amount for 2022. The ground truth states $1.3 billion, but the LLM reports $1.5 billion, which is incorrect. All other numbers are accurate: equity securities correctly listed as $3.7B (2022), $4.9B (2023 and 2024), and equity-method investments correctly at $1.4B in 2023 and $3.8B in 2024. (2) Calculations and trends are otherwise sound—recognizing the steady growth in equity securities and the sharp 2024 increase in equity-method investments. However, the incorrect 2022 baseline undermines the accuracy of the progression analysis. (3) Multi-hop reasoning is strong: the model synthesizes data across years and investment types, correctly infers strategic intent from financial trends, and distinguishes between equity securities and equity-method investments. The conclusion about UnitedHealth positioning itself as an active strategic investor aligns with the ground truth’s interpretation of deeper engagement in healthcare innovation. (4) Contextual relevance is excellent—the answer directly addresses all parts of the question, including evolution over time and strategic implications. Due to the significant but isolated numerical error in a key metric, the quantitative accuracy is penalized more heavily, pulling the overall correctness score to 7. Wording and logic are otherwise semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 403,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Nike's financial and strategic relationship with Sojitz America evolve from fiscal years 2022 through 2024, particularly in terms of preferred stock ownership, dividend obligations, and the role of the entity in Nike’s international operations?",
      "original_answer": "Nike's relationship with Sojitz America remained consistent in terms of preferred stock ownership and dividend obligations across fiscal years 2022 to 2024. Sojitz America continued to be the sole holder of Nike's redeemable preferred stock, with a par value of $0.3 million, and the cumulative annual dividend of $0.10 per share remained unchanged throughout the period. However, in fiscal 2024, Nike explicitly highlighted Sojitz America's ongoing role in providing import-export financing services since 1972, underscoring its strategic importance in supporting Nike’s international operations amid rising global trade risks. This evolution reflects a shift from purely financial engagement (noted in 2022 and 2023) to a more operationally strategic role by 2024, particularly as Nike faced increasing trade protectionism and supply chain volatility.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike’s redeemable preferred stock remained fully owned by Sojitz America, with a fixed $0.3 million par value and a cumulative $0.10‑per‑share dividend payable each May 31; importantly, any common‑stock dividend could be declared only after the preferred dividend was satisfied, and Sojitz America’s voting rights are limited to a separate class vote on events such as asset sales, mergers or trademark assignments, with no additional preferred shares permitted under Nike’s charter.  Sojitz America also continues to provide import‑export financing and strategic support for Nike’s international operations, a relationship highlighted by Nike’s disclosures on trade‑risk monitoring, the use of a tax‑holiday that generated $338 million of benefit in FY 2024 (and may be extended) and the company’s reliance on Sojitz America to navigate protectionist measures and supply‑chain challenges.  Thus, the partnership’s financial terms stayed constant while its strategic role deepened, tying Sojitz America’s stake to Nike’s global tax planning, trade‑policy advocacy and overall international footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Sojitz America remained the sole holder of Nike's redeemable preferred stock with a $0.3 million par value and a $0.10-per-share annual dividend across fiscal years 2022–2024. The dividend payment date (May 31) and structural details (e.g., preferred dividend precedence, limited voting rights) are correctly included, though not in the original answer—these are plausible details consistent with SEC disclosures and do not contradict the ground truth. (2) Quantitatively, all numbers match: $0.3 million par value and $0.10 dividend are correct. However, the LLM introduces a $338 million tax-holiday benefit in FY2024, which is not mentioned in the original answer and cannot be verified from the provided ground truth. This is a minor factual overreach, though such tax benefits may exist in actual filings; its inclusion slightly undermines quantitative accuracy. (3) Qualitatively, the reasoning is sound: the LLM correctly identifies the financial consistency and the strategic deepening of Sojitz America’s role, especially in import-export financing and navigating trade risks and supply chain challenges—directly reflecting the multi-hop synthesis of financial and operational roles over time. (4) Contextual relevance is excellent: the answer addresses all parts of the question—preferred stock ownership, dividend obligations, and strategic role in international operations—and captures the evolution from financial to strategic emphasis by 2024. The only deduction is for the unverified $338M tax figure, which, while contextually plausible, is not in the ground truth and slightly affects overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Has_Stake_In]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 468,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value of its 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2023, then increased to $2,000 million in fiscal 2024. This fluctuation indicates a temporary reduction in long-term debt exposure in 2023 followed by a strategic repositioning to increase long-term liabilities in 2024.",
      "llm_answer": "\nNVIDIA’s 3.50 % Notes Due 2050 showed a U‑shaped evolution: the fair‑value amount disclosed in the 2022 filing was **$2,147 million** (Chunk 1), it fell to **$1,604 million** in the 2023 filing (Chunk 2), and by the end of fiscal 2024 the net carrying amount reported was **$2,000 million** (Chunk 3). This rebound after the 2023 dip indicates that the company is deliberately maintaining a stable, long‑term debt position—using the 2050 tranche as a core funding pillar while adjusting its market exposure in response to shifting interest‑rate conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all carrying values for the 3.50% Notes Due 2050 across fiscal years 2022 ($2,147 million), 2023 ($1,604 million), and 2024 ($2,000 million), matching the ground truth exactly. These values are presented with accurate formatting variations (e.g., $2,147 million = $2,147M), which is acceptable. (2) All numeric values are correct and consistent with the original answer; no calculation errors are present. The trend—decrease from 2022 to 2023, then increase in 2024—is accurately described as a 'U-shaped evolution,' which semantically aligns with the ground truth's description of a 'temporary reduction' followed by 'strategic repositioning.' (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers a strategic pattern in NVIDIA's long-term debt management. While the original answer attributes the 2024 increase to 'strategic repositioning to increase long-term liabilities,' the LLM interprets this as maintaining a 'stable, long-term debt position' and using the notes as a 'core funding pillar,' which is a reasonable and contextually supported interpretation. The mention of 'shifting interest-rate conditions' adds explanatory context not in the original but does not contradict it and is plausible given market conditions; however, this slight extrapolation prevents a perfect qualitative score. (4) The answer is fully contextually relevant, addressing both the quantitative evolution and the implication for NVIDIA's long-term debt positioning. Overall, the response is factually accurate, complete, and logically sound, warranting a high correctness score with only minor interpretive expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 467,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did MetLife's dependence on global funding markets evolve from 2022 through 2024, particularly in terms of its use of short-term debt like commercial paper and its reliance on diverse funding sources to lower the cost of capital?",
      "original_answer": "From 2022 to 2024, MetLife consistently emphasized the importance of diversifying its global funding sources to reduce market dependence and lower the cost of capital. In 2022, the company highlighted its use of commercial paper programs supported by unsecured revolving credit facilities, with MetLife Funding extending loans to affiliates. In 2023, MetLife reiterated its strategy of funding flexibility through a variety of sources, including short-term debt such as commercial paper, and reaffirmed confidence in its lending counterparties. By 2024, the company maintained the same core funding structure, again emphasizing its diversified global funding sources to limit dependence on any single market. Despite no major structural changes, the consistent mention of commercial paper and credit facilities across all three years shows a stable reliance on short-term debt markets as part of a broader liquidity strategy.",
      "llm_answer": "\nMetLife sustained its reliance on global funding markets through 2022‑2024 by continuously tapping a broad mix of sources—preferred and common stock, long‑term debt, collateral‑financing arrangements, policy‑holder‑linked funding (PABs), credit and committed facilities, and especially its commercial‑paper programs that are backed by the unsecured revolving credit facility (as disclosed in the 2022 financing‑cash‑flow discussion and reiterated in the 2023‑2024 “Liquidity and Capital Sources” sections).  The repeated emphasis in each filing that this diversification “enhances funding flexibility, limits dependence on any one market or source of funds and generally lowers the cost of funds” shows that the company deliberately expanded and maintained a diversified funding base, using short‑term paper together with equity and longer‑dated securities to keep overall financing costs low and to reduce concentration risk across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MetLife's use of commercial paper backed by unsecured revolving credit facilities is accurately described for 2022–2024, and the emphasis on diversified funding sources to lower cost of capital and reduce market dependence is consistently reflected. The mention of specific instruments—preferred/common stock, long-term debt, PABs, credit facilities—adds detail not contradicted by the original. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes disclosures across three years and correctly infers a stable, intentional strategy of diversification and reliance on short-term debt as part of a broader liquidity framework. The conclusion that MetLife 'deliberately expanded and maintained' a diversified base is a slight interpretive stretch—the original emphasizes consistency rather than expansion—but does not materially misrepresent the intent. (4) The answer is contextually excellent, addressing both parts of the question: evolution of dependence on global funding markets and the role of short-term debt and diversification in lowering cost of capital. Only a minor deduction in qualitative accuracy due to the implication of strategic 'expansion' not explicitly supported in the ground truth, which stresses stability over change. Overall, the semantic meaning matches the original answer, with richer elaboration but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 443,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did UnitedHealth Group's service level guarantees in conjunction with its notes payable to subsidiaries evolve from 2022 through 2024, and what does this reveal about the company's liquidity commitments and contractual risk exposure over time?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's notes payable to subsidiaries increased significantly, rising from $8.1 billion in 2022 to $9.9 billion in 2023, and then dropping sharply to $2.0 billion in 2024. Throughout this period, the company consistently disclosed that its service level guarantees under certain contracts were not material in any given year. However, the volatility in notes payable suggests shifting liquidity strategies or contractual obligations tied to its internal financing arrangements. Despite these fluctuations, the company maintained that the financial impact of service level guarantees did not pose a material risk to its financial statements in any of the three years. This trend indicates a stable risk profile for service level guarantees even amid changing internal debt structures.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth’s notes payable to subsidiaries shifted markedly: the short‑term, on‑demand portion fell from $8.7 billion (as of 2022, Chunk 1) to $2.0 billion (as of 2024, Chunk 2), while a new long‑term commitment of $14.4 billion appeared in 2024 (Chunk 2), indicating a move from near‑term cash‑call exposure to larger, stable long‑term financing; the 2022‑year reference in Chunk 3 shows the prior baseline of $8.1 billion (2021) and $4.9 billion (2020), underscoring the long‑term trend.  In every filing the service‑level guarantees were disclosed as part of the company’s accounting policy but were judged immaterial to income, with no accrued, paid or charged amounts in 2022, 2023 or 2024 (Chunk 1, Chunk 2, Chunk 3).  Consequently, the evolution of the notes payable reveals that UnitedHealth’s primary liquidity commitment—and thus its contractual risk exposure—has transitioned toward long‑term debt obligations, while the unchanged immaterial guarantee exposure suggests limited additional risk from service‑level commitments.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, UnitedHealth Group's notes payable to subsidiaries were $8.1B in 2022, $9.9B in 2023, and dropped to $2.0B in 2024. However, the LLM states that the 'short-term, on-demand portion' was $8.7B in 2022 and omits the $9.9B figure for 2023 entirely. Instead, it introduces a new 'long-term commitment of $14.4B in 2024' not mentioned in the original answer, which fundamentally misrepresents the data. These figures do not align with the ground truth and suggest confusion or incorrect sourcing. (2) The original answer emphasizes a rise then sharp drop in internal debt, while the LLM describes a reclassification into long-term debt, implying a refinancing strategy not supported in the ground truth. The $14.4B figure is particularly problematic as it has no counterpart in the reference. (3) On qualitative accuracy, the LLM correctly identifies that service level guarantees were consistently immaterial across all years and that no accruals or payments were made—this aligns with the ground truth and shows correct synthesis across time periods. It also correctly infers that service-level guarantees pose limited risk. However, its reasoning about liquidity commitments shifting to long-term debt is based on incorrect data, undermining the validity of the conclusion. (4) Contextually, the response addresses both parts of the multi-hop question—evolution of notes payable and service level guarantees—and attempts to draw an inference about liquidity and risk exposure, which is relevant and appropriate. Despite flawed numbers, the structure and intent of the analysis are sound. Overall, partial credit is given for correct handling of the service guarantees and conceptual framework, but major deductions apply due to incorrect financial figures and unsupported claims about long-term debt.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 515,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other global networks, and the company's strategic responses to these dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with card networks has evolved from a position of strong competitive differentiation to one marked by increasing regulatory dependency and external pressure. In 2022, Amex emphasized its global position as the fourth-largest general-purpose card network behind China UnionPay, Visa, and Mastercard, competing aggressively on brand value, rewards programs, and premium customer experiences. By 2023, the company highlighted intensified competition not only from traditional card networks but also from alternative payment platforms like Alipay, PayPal, and Venmo, as well as regional payment systems such as the National Payments Corporation of India. This growing competitive landscape underscored the need for innovation and investment in digital and mobile services. In 2024, the tone shifted significantly as Amex became a Category III firm under the U.S. federal bank regulatory framework, subjecting it to heightened regulatory expectations and constraints. Regulatory scrutiny over interchange fees, network routing, and cobrand arrangements—especially in the EU—led to Amex exiting its network licensing businesses in the EU and Australia, and facing uncertainty over future regulatory interpretations. This evolution reflects a trajectory where Amex's independence and competitive edge have been increasingly shaped and constrained by regulatory forces, transforming its strategic posture from one of market-driven competition to one of regulatory navigation and compliance adaptation.",
      "llm_answer": "\nFrom 2022 through 2024 American Express stayed the fourth‑largest global general‑purpose card network, continuing to battle Visa, Mastercard, China UnionPay and other networks for issuers, merchants and premium cobrand relationships while also confronting rapid growth in alternative payment platforms (chunks 1 & 3).  Between 2022 and 2024 regulatory pressure mounted—new interchange‑fee caps, network‑routing rules, the 2024 Category III designation and the exit of its EU/Australia network‑licensing operations—deepening the firm’s reliance on card‑network compliance and reshaping its strategic options (chunks 2 & 3).  To preserve its competitive edge, American Express has poured resources into compliance, exited regulated licensing businesses, and sharpened its value proposition for high‑spending card members, balancing intensified competition with a more constrained regulatory landscape (chunks 1, 2 & 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's competitive positioning and regulatory dependency from 2022 to 2024. (1) All key facts are correct: Amex remained the fourth-largest global general-purpose card network behind Visa, Mastercard, and China UnionPay; it faced growing competition from alternative platforms like PayPal, Venmo, Alipay, and regional systems (e.g., NPCI); and by 2024, it became a Category III firm under U.S. bank regulation, leading to increased compliance burdens. The exits from EU and Australia network-licensing operations are correctly noted. (2) There are no numeric inaccuracies—dates (2022–2024), regulatory milestones (Category III designation in 2024), and business actions (exits from licensing) align with the ground truth. Format variations (e.g., 'interchange-fee caps' vs. 'scrutiny over interchange fees') are semantically equivalent. (3) Multi-hop reasoning is sound: the model synthesizes competitive dynamics, regulatory developments, and strategic responses across time, correctly inferring that Amex’s independence has been increasingly constrained by regulation. The synthesis of competition and regulation shaping strategic choices (investment in compliance, exit from licensing, focus on premium customers) matches the original answer’s logic. (4) Minor deduction in qualitative accuracy due to slightly less detailed mention of specific competitors (e.g., National Payments Corporation of India is implied but not named) and less emphasis on the shift in tone from market-driven competition to regulatory navigation. However, the core trajectory is preserved. Contextual relevance is perfect—the response directly addresses all parts of the question with appropriate focus and depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1651,
        "completion_tokens": 480,
        "total_tokens": 2131
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did ConocoPhillips' cash-settled PSU compensation strategy evolve from 2022 to 2024, particularly regarding the dividend equivalent payment structure for performance periods beginning in 2018 or later, and what does this reveal about the company's long-term incentive alignment approach?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent framework for cash-settled PSUs initiated after the 2012 downstream separation, with vesting tied to either five years or retirement eligibility. The dividend equivalent structure, however, showed a clear evolution: for performance periods before 2018, no payments were made during the performance period but began after its conclusion, while for periods starting in 2018 or later, recipients received accrued reinvested dividends paid at settlement. This shift—from deferred dividend equivalents to accrued reinvestment—suggests a strategic move toward stronger long-term alignment by deferring rewards until performance outcomes are fully realized. The consistent classification of cash-settled PSUs as liabilities on the balance sheet across all three years further underscores the company's commitment to cash-based incentive structures tied directly to stock value at settlement.",
      "llm_answer": "\nConocoPhillips’ cash‑settled PSU program shifted from a “no dividend‑equivalent” treatment for performance periods that began before 2018—where recipients only received a quarterly cash dividend‑equivalent after the performance period ended—to a unified “accrued reinvested dividend equivalent” for all periods beginning in 2018 or later, which is recorded as compensation expense and paid only at settlement (Chunks 1‑3).  This change, reflected in the 2021‑2024 disclosures (fair‑value totals of $13 M, $21 M, $29 M and zero remaining unrecognized cost), ties a larger portion of employee pay to the company’s long‑term stock performance and ensures that payouts are contingent on sustained value creation, demonstrating a deliberate long‑term incentive alignment that rewards executives and staff for multi‑year results rather than short‑term earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in ConocoPhillips' dividend equivalent structure: no payments during the performance period for pre-2018 awards, versus accrued reinvested dividends paid at settlement for 2018 and later periods. This matches the original answer’s key point about the shift to stronger long-term alignment. (2) The quantitative data cited—fair-value totals of $13M, $21M, $29M, and zero unrecognized cost from 2021–2024—is consistent with the knowledge graph and supports the narrative of increasing liability recognition over time. While the original answer does not include these specific figures, their presence adds detail without contradicting the ground truth; they are plausible and contextually appropriate. (3) The reasoning correctly synthesizes multi-hop information: linking the change in dividend treatment to long-term incentive alignment, recognizing the cash-settled nature of PSUs as liabilities, and interpreting the strategic intent behind deferring rewards. (4) Minor deduction in correctness and quantitative accuracy is due to the introduction of specific dollar amounts not present in the ground truth, which, while not implausible, cannot be verified as correct from the provided truth. However, since such figures are often disclosed in footnotes and the trend (increasing expense, zero remaining cost) logically implies full recognition, this does not constitute a factual error but adds unverified granularity. Overall, the answer captures the core evolution and strategic rationale accurately, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Grants]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 459,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "What does the evolution of NextEra Energy's Special Use Funds from 2022 to 2024 reveal about the company's liquidity positioning in relation to its derivative-related collateral obligations across this period?",
      "original_answer": "The company's Special Use Funds increased from $8,698 million in 2023 to $9,800 million in 2024, following detailed disclosures in 2022 about derivative-related collateral requirements that could reach up to $2.7 billion in the event of a credit downgrade. In 2023, collateral posting requirements in the event of a downgrade to below investment grade dropped significantly from $5.2 billion in 2022 to $2.4 billion in 2023, while actual collateral posted in cash increased to $691 million in 2023 from $84 million in 2022. This suggests the company strengthened its liquidity position through growth in Special Use Funds while simultaneously reducing its potential derivative-related collateral exposure, indicating a strategic improvement in risk management positioning.",
      "llm_answer": "\nThe Special Use Funds of NextEra Energy grew from roughly **$8.7 billion at the end of 2023 to $9.8 billion at the end of 2024**, expanding the cash‑and‑restricted‑cash pool that the company can draw on to meet collateral demands—a trend that began in 2022 and reflects a larger, higher‑quality liquid asset base.  This increase occurs alongside derivative‑related collateral obligations that, under rating‑downgrade or cross‑default triggers, could require **up to about $2–$5 billion** of posting, yet NEE has already posted **≈ $1.6 billion in cash and letters of credit** and maintains credit‑facility capacity well above those stressed‑scenario thresholds, demonstrating that its liquidity position is being reinforced to satisfy those obligations.  Consequently, the evolution of the Special Use Funds, together with the disclosed collateral‑posting figures and the company’s ability to access credit facilities without a rating‑maintenance condition, shows that NextEra Energy is positioning its liquid assets to comfortably cover potential derivative‑related collateral calls across the 2022‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in key numerical values and omits critical year-over-year changes that are central to the ground truth. While it correctly notes the increase in Special Use Funds from $8.7B in 2023 to $9.8B in 2024 (aligning with the $8,698M → $9,800M in the original), it fails to mention the 2022 baseline or any data from 2022 regarding Special Use Funds, which is a gap in completeness. More critically, the LLM misrepresents derivative-related collateral obligations: the ground truth specifies a drop in potential downgrade-triggered collateral from $5.2B (2022) to $2.4B (2023), but the LLM vaguely states 'up to about $2–$5B' without capturing this downward trend, thus missing a key point about reduced risk exposure. Additionally, the LLM claims NEE has posted '≈ $1.6B in cash and letters of credit', but the original answer only reports $691M in cash posted in 2023 (up from $84M in 2022); there is no mention of letters of credit or a $1.6B total in the ground truth, making this a significant factual overstatement. (2) Number verification: Special Use Funds — $8.7B (2023) and $9.8B (2024) are acceptable approximations of $8,698M and $9,800M. However, the $1.6B collateral posted is unsupported; actual cash posted was $691M in 2023. The $2–$5B range for obligations is imprecise and conflates years, failing to reflect the specific $2.7B (potential in 2022) and $2.4B (2023) figures. (3) Multi-hop reasoning: The LLM correctly infers that growing Special Use Funds improve liquidity positioning and that derivative obligations are a risk, but it fails to synthesize the key insight from the ground truth — that both actual collateral posted increased *and* potential exposure decreased, indicating strategic risk reduction. Instead, it emphasizes credit facility capacity not mentioned in the original, introducing extraneous reasoning. (4) Correctness score is 6 due to partial factual accuracy on Special Use Funds but major errors in collateral figures and omission of critical trends. Quantitative accuracy is low (5) due to incorrect numbers. Qualitative accuracy is moderate (7) — reasoning structure is sound but based on flawed data. Contextual relevance is high (9) — the answer stays on topic and addresses the core question about liquidity and collateral.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 620,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Tower's (AMT) outstanding principal and amortization trajectory for its 1.600% Notes evolve from 2022 through 2024, and what does this multi-year pattern suggest about its debt management strategy for this instrument?",
      "original_answer": "The outstanding principal for AMT's 1.600% Notes remained constant at $700.0 million across all three years (2022, 2023, and 2024). However, the adjustments to principal (likely representing amortization or accrued interest) decreased over time, from (3.7) million in 2022 to (2.6) million in 2024, indicating a gradual reduction in associated liabilities or accrued costs. This consistent principal amount with declining adjustments suggests a stable long-term debt strategy for this specific note, with predictable amortization patterns.",
      "llm_answer": "\nAmerican Tower issued $700 million of 1.600% senior notes on 29 Mar 2021 with a 15 Apr 2026 maturity and semi‑annual interest on 15 Apr/Oct, and the notes remain outstanding through 2024 with no scheduled principal repayment until the 15 Mar 2026 par‑call date (see Chunk 3’s issuance terms and Chunk 2’s par‑call disclosure). The carrying amount of the notes has been reduced by $2.6 million of premium amortization in 2022 and $1.5 million in 2023, reflected as the negative adjustments shown for the 1.600% Notes in Chunk 1 and Chunk 2, indicating a steady de‑leveraging of the premium over the life of the instrument. This multi‑year amortization pattern demonstrates that American Tower is managing this debt by holding the long‑dated, low‑cost note to maturity while gradually amortizing the premium, preserving cash and maintaining a stable capital structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative details. The ground truth states that the outstanding principal remained constant at $700.0 million from 2022 to 2024, which the LLM correctly identifies. However, the adjustments to principal (interpreted as amortization) are reported incorrectly: the LLM claims premium amortization of $2.6 million in 2022 and $1.5 million in 2023, while the ground truth reports adjustments of (3.7) million in 2022 and (2.6) million in 2024—values that are both different in magnitude and trend. The LLM’s numbers do not match the trajectory described in the original answer, and there is no mention of the 2024 adjustment being (2.6) million. Additionally, the LLM introduces a maturity date of 15 Apr 2026 and issuance date of 29 Mar 2021, which are not present in the ground truth and were not asked for, suggesting overreach. (2) The calculation and comparison of amortization amounts are incorrect. The ground truth shows a decline from (3.7) to (2.6) over three years, but the LLM reports only two years with different values and an inconsistent trend. The LLM also mislabels the adjustments as 'premium amortization' without confirming the nature of the adjustment, whereas the ground truth cautiously labels it as 'likely representing amortization or accrued interest.' (3) The multi-hop reasoning is partially sound—the LLM correctly infers that no principal repayment occurs before maturity and links this to a stable debt strategy. However, it fails to fully synthesize the three-year pattern of declining adjustments, instead relying on only two years of data and misrepresenting the amounts. (4) The contextual relevance is high because the answer addresses the debt instrument, its principal stability, and management strategy. However, due to major quantitative errors and incomplete/misaligned data synthesis, the correctness score is limited to 4—partially correct but with significant factual flaws that affect the validity of the conclusion about amortization trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 555,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 to 2024, and what strategic adjustments did the company make in response to these regulatory shifts across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering calculation methodologies each year. In 2022, the company noted CMS had previously reduced or frozen benchmarks and was making changes to risk adjustment calculations. In response, UNH adjusted benefits and premiums selectively and intensified cost management. In 2023, similar pressures persisted, with the company continuing to adapt by modifying benefits, exiting certain counties, and managing medical costs more aggressively. By 2024, CMS had again made changes to the risk adjustment payment methodology, prompting UNH to further refine its strategies, including more selective benefit design and intensified cost controls. The consistent theme across all three years was the company's evolving response to CMS's recalibrations of risk adjustment payments, which required ongoing adjustments to pricing, benefits, and operational efficiency to maintain profitability and competitiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UnitedHealth Group repeatedly warned that CMS’s periodic revisions to Medicare Advantage risk‑adjustment payment calculations created a material exposure to payment reductions and recoupments—first flagging the risk in the 2022 filing, underscoring its potential to materially affect results in the 2023 filing, and confirming that the exposure persisted and could again reduce capitation payments in the 2024 filing. In response, the company progressively adjusted member benefits and premiums, ceased offering plans in unprofitable counties, intensified medical and operating‑cost management, refined its bidding assumptions for Medicare Advantage and Part D contracts, and strengthened cost‑efficiency and audit‑risk mitigation across its Optum businesses to offset the funding pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UnitedHealth Group faced ongoing exposure to CMS changes in Medicare Advantage risk adjustment payments from 2022 to 2024, and responded with strategic adjustments each year. The LLM correctly identifies the continuity of risk across the three years and the nature of CMS's methodological changes. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes UnitedHealth’s evolving disclosures across three years of filings, correctly noting the progression from identifying the risk (2022) to emphasizing material impact (2023) to confirming ongoing exposure (2024). Strategic responses—adjusting benefits and premiums, exiting unprofitable counties, cost management, refining bids, and strengthening audit controls—are consistent with and expand slightly on the original answer, adding specificity (e.g., 'refined bidding assumptions', 'audit-risk mitigation') that are plausible and contextually appropriate. (4) Semantic equivalence is strong; the LLM captures the core theme of persistent regulatory pressure and adaptive strategy. The only minor gap is that the original emphasizes 'selective' benefit design and 'consistent theme' of evolving response, which the LLM implies but doesn’t explicitly frame as a through-line. However, this does not detract from factual accuracy. No incorrect entities, years, or metrics are present. The answer is fully relevant and comprehensive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 453,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the scope and structure of merchandise discounts offered to employees evolve from 2022 through 2024, and what does this progression indicate about Target's strategy in supporting employee financial well-being?",
      "original_answer": "From 2022 to 2024, Target consistently offered merchandise and other discounts as part of its employee compensation and benefits package, but the context and broader financial well-being strategy surrounding these discounts evolved. In 2022, merchandise discounts were listed among a suite of benefits including healthcare, 401(k) plans, and tuition reimbursement, with a starting wage of at least $15 per hour. By 2023, the starting wage range had expanded to $15–$24 per hour, and merchandise discounts were mentioned alongside new additions like sick pay and tuition-free education assistance, signaling a more comprehensive approach to employee financial support. In 2024, merchandise discounts remained a consistent offering, but were now framed within a broader narrative of equitable pay and belonging, with continued emphasis on financial wellness through benefits like free virtual healthcare and expanded mental health services. This 3-year trend indicates that while merchandise discounts remained a stable benefit, Target increasingly positioned them as part of a holistic financial and well-being strategy aimed at attracting and retaining talent.",
      "llm_answer": "\nAcross the 2022‑2024 filings, Target’s “merchandise and other discounts” evolve from a standalone benefit noted in the 2022 Compensation and Benefits section (Chunk 1) to a more structured component of a broader compensation package that includes a $15‑$24 hourly wage range and dollar‑for‑dollar 401(k) matching (first added in the 2023 filing, Chunk 2) and is retained with the same wage range and expanded wellness perks in the 2024 filing (Chunk 3).  This progression shows Target is integrating discounts into a comprehensive financial‑well‑being strategy that combines higher base wages, retirement savings incentives, and other benefits to boost employee financial security and retention.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Target's merchandise discounts and their integration into a broader financial well-being strategy. Quantitatively, all figures are accurate: the $15 starting wage in 2022 and the $15–$24 range in 2023–2024 are correctly reported, and the mention of dollar-for-dollar 401(k) matching (introduced in 2023) aligns with the ground truth. The LLM correctly identifies that merchandise discounts were consistently offered and became part of a more comprehensive package over time. However, the LLM omits key elements from the ground truth: it does not mention sick pay or tuition-free education assistance (added in 2023), nor does it reference the 2024 emphasis on equitable pay, belonging, free virtual healthcare, or expanded mental health services—important aspects of the holistic well-being narrative. While the LLM correctly infers that discounts are being integrated into a broader financial security strategy, it misses the shift in framing from compensation to inclusion and holistic wellness. The reasoning is sound and multi-hop synthesis across years is appropriate, but the qualitative depth is slightly reduced due to these omissions. Wording differences are acceptable under semantic equivalence, but the absence of specific new benefits in 2023 and 2024 slightly weakens completeness. Contextual relevance is strong—the answer directly addresses the question’s focus on evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> FIN_INST <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 408,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did American Express's investment in Foreign Government Bonds and Obligations evolve from 2022 through 2024 in terms of yield and maturity distribution, and what does this 3-year pattern suggest about the company's risk appetite and asset allocation strategy?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a weighted average yield of 1.74% for securities due within one year and 2.42% for those due after one but within five years. By 2023, the yield for bonds due within one year increased significantly to 6.45%, while those due after one but within five years had a yield of 4.48%. In 2024, the yield for bonds due within one year decreased slightly to 5.86%, and those due after one but within five years dropped sharply to 2.03%. This pattern indicates a shift in American Express's strategy from relatively stable, low-yield foreign government bonds in 2022 to more aggressive short-term investments in 2023, followed by a partial retreat in 2024 with reduced long-term exposure, suggesting a dynamic response to market conditions and interest rate changes.",
      "llm_answer": "\nIn 2022 the foreign‑government bond holding was essentially $630 million – $628 million due within one year with only $1 million each maturing in the 1‑5 and 5‑10 year buckets, and the portfolio’s weighted‑average yield was 2.08 % (Chunk 3); by 2023 the same category showed a weighted‑average yield of 6.45 % (6.45 % for <1‑year and 4.48 % for 1‑5 year maturities) (Chunk 1), and in 2024 the yield fell to 5.86 % for the under‑one‑year slice and 2.03 % for the 1‑5 year slice, totaling 5.85 % (Chunk 2). This three‑year pattern of declining yields combined with a consistently short‑duration profile—over 99 % of the exposure remaining under one year while only a tiny fraction extends beyond five years—reveals a deliberate emphasis on liquidity and capital preservation, indicating a low‑risk appetite and an asset‑allocation strategy that prioritizes short‑term, high‑quality government securities over longer‑dated or higher‑yielding assets. Consequently, the evolution suggests American Express is intentionally maintaining a highly liquid, low‑duration position in foreign sovereign debt as part of a conservative investment stance.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. While the ground truth states that in 2022, American Express held $630 million in Foreign Government Bonds with yields of 1.74% (within one year) and 2.42% (1-5 years), the LLM incorrectly claims a single weighted average yield of 2.08% and fabricates a maturity breakdown ($628M due within one year, $1M in 1-5 and 5-10 years) that does not appear in the original answer. This is a significant deviation. The 2023 and 2024 yield figures (6.45%, 4.48%; 5.86%, 2.03%) are correctly reported. However, the LLM introduces a 'total' yield of 5.85% in 2024, which is not in the original and not clearly justified. (2) Calculations: No explicit calculation errors, but the synthesis of a 'total' yield for 2024 is unsupported and potentially misleading. The original answer does not provide a single weighted average for 2023 or 2024, so this addition reflects incorrect inference. (3) Multi-hop reasoning: The LLM correctly identifies the trend in yields across years and the short-duration focus, but misrepresents the 2022 maturity distribution, undermining the validity of its synthesis. The conclusion about a 'consistently short-duration profile' is based on fabricated data, so the reasoning is flawed despite some correct surface-level observations. (4) The interpretation of risk appetite as 'low-risk' and 'conservative' contradicts the original answer’s conclusion of a 'dynamic response' and 'more aggressive short-term investments in 2023', followed by a retreat—indicating tactical shifts rather than static conservatism. Thus, while the answer addresses all parts of the question and is contextually relevant, the incorrect data and mischaracterization of strategy reduce its correctness. Quantitative accuracy is partially correct (6/10), qualitative reasoning is compromised by incorrect premises (5/10), and overall correctness is moderate due to key factual errors in the 2022 data and misinterpretation of strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 547,
        "total_tokens": 2074
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements related to 'Other assets, including intangibles - net' decreased from $1,494 million in 2022 to $800 million in 2023, and further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative-related exposure or a shift in risk management practices over the three-year period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports under master‑netting arrangements—recorded in the “Other assets, including intangibles – net” line—declined sharply over the three years: it was $1.49 billion at the end of 2022 (Chunk 3), fell to $0.80 billion at the end of 2023 (shown in both Chunk 3 and Chunk 2), and then dropped further to $0.49 billion at the end of 2024 (Chunk 2).  \n\nThis downward trend shows that the company has been reducing the amount of collateral it must post to support its derivative positions, indicating a deliberate unwinding or offsetting of derivatives and a more streamlined management of its derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the decreasing trend in collateral under master netting arrangements for ExxonMobil from 2022 to 2024, with accurate values: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024. The LLM uses equivalent formats ($1.49 billion ≈ $1,494 million, $0.80 billion = $800 million, $0.49 billion ≈ $491 million), which are acceptable and semantically equivalent. 2) All numbers match the ground truth exactly when converted to the same unit (millions), and the temporal sequence (2022 → 2023 → 2024) is correct. There are no calculation errors. 3) The multi-hop reasoning is sound: the model correctly synthesizes data across years and links the trend to derivative exposure management. The conclusion about reduced collateral indicating a strategic reduction in derivative exposure or improved risk management aligns with the original answer. 4) The only minor shortcoming is that the LLM refers to 'Chunk 3' and 'Chunk 2', which are internal references not present in the original answer and may confuse readers, but they do not affect factual correctness. Otherwise, the answer is complete, contextually relevant, and accurately interprets the trend’s implications. Thus, the answer is highly accurate with only negligible stylistic imperfection.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 361,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AMT's issuance and interest rate terms for the 2.700% Notes evolve from 2022 through 2024, and what does this reveal about the company's financing strategy and market conditions over this period?",
      "original_answer": "In 2022, AMT disclosed the 2.700% Notes with an aggregate principal amount of $700.0 million, issued on March 29, 2021, maturing on April 15, 2031, and a par call date of January 15, 2031. In 2023, the 2.700% Notes were listed with an aggregate principal of $700.0 million, with interest payments due in April and October, and a maturity date of January 15, 2031. By 2024, the 2.700% Notes retained the same $700.0 million principal, with interest payments still scheduled in April and October, and a maturity date unchanged at January 15, 2031, though the interest rate spread had decreased from (5.0) to (4.4). This indicates a consistent long-term financing strategy with stable principal and maturity, but a slight reduction in borrowing costs by 2024.",
      "llm_answer": "\nAMT originally issued $700 million of 2.700% senior notes on March 29 2021 with semi‑annual interest payments on April 15 and October 15 and a final maturity of April 15 2031 (see the “2.700% Notes” row in Chunk 3 and the detailed schedule in Chunk 1).  Subsequent filings confirm that the same tranche remained outstanding through 2022‑2024, but the market‑observed yields reported in 2024 rose to roughly 4.4‑5.0% (Chunk 2), while the company used that period to supplement its funding with higher‑coupon issuances such as 5.2%‑5.8% notes maturing in 2028‑2033 (Chunk 1 & 2).  This evolution shows AMT’s financing strategy of locking in a low‑cost, long‑dated fixed‑rate tranche early, then adapting to a rising‑rate environment by issuing higher‑yield debt while maintaining the original 2.700% notes as a stable, low‑rate pillar of its capital structure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key quantitative details. Most critically, it states the maturity date as April 15, 2031, which matches the 2022 disclosure but contradicts the updated maturity of January 15, 2031, reported in 2023 and 2024 filings. This is a major error. It also incorrectly states the interest payment dates as April 15 and October 15, while the ground truth specifies April and October without exact dates—this is a minor discrepancy. The LLM claims market-observed yields rose to 4.4–5.0% in 2024, but the ground truth indicates the interest rate *spread* decreased from (5.0) to (4.4), implying lower borrowing costs, not rising yields. This misrepresents the trend. The original issuance date (March 29, 2021) and principal amount ($700 million) are correct. (2) Calculations: No explicit calculations are made, but the interpretation of yield movement is inverted—ground truth shows a reduction in spread (favorable), while LLM suggests rising yields (unfavorable), which is incorrect. (3) Multi-hop reasoning: The LLM correctly identifies that the same note remained outstanding across years and attempts to contextualize AMT’s financing strategy, which shows sound qualitative synthesis. However, it fails to note the maturity date change from April 15, 2031 to January 15, 2031, a critical evolution. It also introduces 'higher-coupon issuances' (5.2%–5.8%) not mentioned in the original answer, which may be factually present in filings but are not part of the ground truth response and distract from the focus on the 2.700% Notes. (4) The correctness score is 5 due to mixed accuracy: core principal and issuance facts are right, but key dates and yield interpretation are wrong. Quantitative accuracy is low (4) due to incorrect maturity date and misstated yield trend. Qualitative accuracy is moderate (6) because the strategic interpretation is plausible but based on flawed data. Contextual relevance is high (8) as the answer addresses the question’s intent and structure appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Financial_Instruments]-> FIN_INST <-[Discloses]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 553,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did NVIDIA's financial obligations related to the 2.00% Notes Due 2031 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "In 2022, NVIDIA reported a fair value of $1.2 billion for the 2.00% Notes Due 2031. By 2023, this amount slightly increased to $1.044 billion at the beginning of the year, and then remained stable at $1.057 billion by the end of the year. In 2024, the carrying value of the 2.00% Notes Due 2031 was $1.25 billion, with no short-term portion, indicating a consistent long-term debt position. This shows a relatively stable approach to this particular long-term liability, suggesting strategic consistency in managing this component of its capital structure.",
      "llm_answer": "\nNVIDIA first disclosed a $1.2 bn fair‑value balance for the 2.00% Notes Due 2031 in its 2022 filing (Chunk 1), which slipped to $1.06 bn in the 2023 filing as market prices adjusted (Chunk 2); by the 2024 filing the carrying amount of the same series had risen to $1.25 bn, with a remaining maturity of 6.4 years and an effective rate of 2.09% (Chunk 3). This pattern—initial issuance at low coupon, modest market depreciation, then a modest increase in recorded balance—shows that NVIDIA is maintaining a steady, low‑cost long‑term debt profile, extending maturities and relying on staggered, inexpensive notes to fund growth while keeping overall leverage modest.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the quantitative details. According to the ground truth, the fair value was $1.2 billion in 2022, increased slightly to $1.044 billion at the beginning of 2023, and then remained stable at $1.057 billion by the end of 2023. However, the LLM states it 'slipped to $1.06 bn' in 2023, which misrepresents both the timing (beginning vs end of year) and the actual value (overstates the 2023 fair value). Additionally, the LLM omits the $1.044 billion beginning-of-year 2023 figure entirely. The 2024 carrying value is correctly reported as $1.25 billion. (2) The LLM introduces details not present in the ground truth, such as a 'remaining maturity of 6.4 years' and an 'effective rate of 2.09%', which were not mentioned in the original answer and cannot be verified from the provided context. These additions reduce quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies a trend across three years and attempts to interpret the company's debt strategy. It correctly infers that NVIDIA is maintaining a steady, low-cost long-term debt profile, which aligns with the ground truth's conclusion about strategic consistency. However, the reasoning is based on slightly inaccurate data points, weakening the synthesis. (4) Despite numerical inaccuracies, the LLM captures the overall direction and intent of the answer—assessing the evolution of the note and interpreting its implications for long-term debt strategy—making the response contextually relevant and qualitatively reasonable, though not fully factually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 446,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance agreements evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and what does this trend indicate about the company's reinsurance strategy?",
      "original_answer": "MetLife's use of the deposit method of accounting for reinsurance agreements showed a clear upward trend in both deposit assets and liabilities from 2022 to 2024. In 2022, deposit assets on reinsurance were $1.8 billion, increasing to $5.1 billion by the end of 2024. Similarly, deposit liabilities rose from $1.4 billion in 2022 to $1.3 billion in 2023, and then to $1.2 billion in 2024, indicating a slight decline in liabilities in the final year. This increase in deposit assets suggests that MetLife engaged in more reinsurance agreements that did not expose the company to a significant loss from insurance risk, particularly in 2023 with the Global Atlantic transaction involving $10.3 billion in reinsurance recoverables. The trend reflects a strategic shift toward managing risk exposure through reinsurance structures that align with the deposit method, while maintaining a relatively stable liability position despite the increased asset transfers.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife’s deposit‑method reinsurance balances moved from **$1.8 bn of deposit assets and $1.4 bn of deposit liabilities (2022)** – as disclosed in the 2022 filing – to **$5.1 bn of deposit assets and $1.3 bn of deposit liabilities (2023)**, and then to **$4.6 bn of deposit assets and $1.2 bn of deposit liabilities (2024)**, reflecting the November 2023 risk‑transfer transaction with Global Atlantic that introduced $10.3 bn of reinsurance recoverables, $9.5 bn of transferred assets and a $770 m net‑cost amortization (Chunk 2).  The company continues to apply the deposit method to reinsurance agreements that do not expose it to a reasonable possibility of a significant loss, a practice highlighted in the accounting‑policy description (Chunk 1) and reinforced by the 2023‑2024 transaction details (Chunk 2).  This evolution indicates a strategic shift toward larger, more structured risk‑transfer programs that limit exposure while using the deposit method to smooth earnings and manage capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increasing deposit assets and declining liabilities, and correctly identifies the Global Atlantic transaction as a key driver, which aligns with the original answer's strategic interpretation. However, there are significant quantitative inaccuracies: the LLM states deposit assets were $5.1 billion in 2023 and dropped to $4.6 billion in 2024, while the ground truth shows deposit assets reached $5.1 billion by the end of 2024 (not 2023), with no data provided for 2023 assets beyond the 2022 and 2024 figures. The LLM incorrectly implies a decrease in assets from 2023 to 2024, whereas the original answer indicates a continuous increase to $5.1 billion by 2024. Additionally, the LLM introduces specific figures like $9.5 billion in transferred assets and $770 million net-cost amortization not present in the ground truth, which only mentions $10.3 billion in reinsurance recoverables related to the transaction. The liability figures are mostly correct: $1.4 billion (2022), $1.3 billion (2023), and $1.2 billion (2024), matching the original. The reasoning about MetLife’s strategic shift toward structured reinsurance with limited risk exposure is well-supported and semantically equivalent to the original. The answer is contextually relevant and synthesizes policy with transactional data, but the incorrect timing and magnitude of asset changes, along with fabricated details, reduce factual accuracy. Multi-hop reasoning is partially sound but compromised by inaccurate numerical synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 422,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did UnitedHealth Group's (UNH) investment in Debt Securities - Held-to-Maturity evolve from 2022 to 2024 in terms of fair value and carrying value, and what does this 3-year progression suggest about the company's investment strategy and market valuation adjustments?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group's Debt Securities - Held-to-Maturity showed a consistent decline in both fair value and carrying value: in 2022, fair value was $679 million and carrying value was $696 million; in 2023, these figures were $596 million and $603 million; and in 2024, they dropped further to $508 million and $512 million. This downward trend indicates a strategic reduction or repositioning of the portfolio, possibly in response to market conditions or internal capital reallocation decisions.",
      "llm_answer": "\nFrom the 2022 10‑K (Chunk 3) UnitedHealth’s held‑to‑maturity debt securities were recorded at a fair value of **$679 million** and a carrying value of **$696 million**; by the 2023 filing (Chunk 1) those amounts had fallen to **$596 million** fair value and **$603 million** carrying value; and in the 2024 filing (Chunk 2) they declined further to **$508 million** fair value and **$512 million** carrying value. This steady three‑year reduction in both fair and carrying values shows that UNH is deliberately shrinking its HTM portfolio—likely to re‑allocate capital amid rising interest‑rate pressures and to shift toward a more liquid, lower‑risk investment mix—while the market’s valuation adjustments are reflected in the progressively lower fair‑value figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All numeric values are correct and match the ground truth exactly: 2022 fair value $679M / carrying $696M; 2023 fair $596M / carrying $603M; 2024 fair $508M / carrying $512M. Formatting variations (e.g., $679 million vs $679M) are acceptable and semantically equivalent. (2) The LLM correctly identifies the downward trend across all three years in both fair and carrying values, accurately reflecting the quantitative progression. (3) The multi-hop reasoning is sound—information is correctly synthesized across three annual filings (2022, 2023, 2024), and the conclusion about strategic portfolio reduction is logically supported. The LLM adds interpretive depth by suggesting capital reallocation and a shift toward liquidity and lower risk, which is a reasonable inference from the trend and aligns with the original answer’s implication of strategic repositioning. (4) The only minor difference from the ground truth is that the LLM answer introduces slightly more specific reasoning (e.g., 'rising interest-rate pressures') not explicitly stated in the original answer. However, this is a plausible and contextually appropriate extension rather than a factual error, so it does not detract significantly from accuracy. Overall, the answer is factually correct, complete, and contextually well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 370,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's credit card strategy in driving incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend suggests a gradual reduction in the proportion of purchases made using the credit card, which may indicate weakening engagement or shifting consumer preferences despite Target's continued emphasis on card-linked discounts and loyalty benefits. However, Target's internal analysis still indicates that a meaningful portion of incremental purchases on the card contribute to incremental sales, suggesting some ongoing strategic value.",
      "llm_answer": "\nThe Target Credit Card (RedCard) penetration fell steadily from about 20.5 % of purchases in fiscal 2022 to 19.8 % in fiscal 2023 and 18.6 % in fiscal 2024 (the later “Target Circle Card” data shows 19.8 % → 18.6 % → 17.8 % for the same three years).  Because Target tracks this metric precisely—citing internal analysis that a “meaningful portion” of purchases made with RedCards are incremental sales—and because the card program is linked to a 5 % discount, profit‑sharing with TD Bank, and the company’s SG&A and gross‑margin performance, the declining penetration suggests that the credit‑card strategy is becoming less effective at driving additional sales growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the downward trend in Target Credit Card penetration from 20.5% in 2022 to 19.8% in 2023 and 18.6% in 2024, which matches the ground truth. However, it introduces a significant factual error by referencing a 'Target Circle Card' with different data (19.8% → 18.6% → 17.8%) that is not present in the original answer or implied by the question. This fabricated metric undermines quantitative accuracy. (2) The core numbers for the Target Credit Card (RedCard) are accurate: 20.5%, 19.8%, and 18.6% across 2022–2024. But the addition of an unmentioned 'Target Circle Card' with conflicting and incorrect figures (e.g., 17.8% in 2024 vs. 18.6% in ground truth) introduces false data and suggests miscalculation or confusion between card programs. (3) The reasoning about declining effectiveness is partially sound and aligns with the original answer’s suggestion of weakening engagement. The LLM correctly links the card to the 5% discount and incremental sales, and references internal analysis about incremental purchases. However, it overstates the conclusion by asserting the strategy is 'becoming less effective' without acknowledging the original answer’s nuance that 'a meaningful portion' still contributes to incremental sales—thus missing the balanced interpretation. (4) The contextual relevance is high as it addresses both parts of the question: trend evolution and strategic implications. The qualitative accuracy is moderate because while the logic is coherent, it adds unsupported entities and slightly misrepresents the strategic assessment. The correctness score is reduced due to the introduction of incorrect data via the 'Target Circle Card,' which constitutes a significant factual deviation despite correct core numbers for the RedCard.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 490,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Nike's ownership and operational footprint in Laakdal, Belgium evolve from fiscal years 2022 through 2024, and what does this indicate about its strategic focus in European logistics infrastructure?",
      "original_answer": "Nike maintained ownership of its significant distribution facility in Laakdal, Belgium throughout fiscal years 2022 to 2024. In 2022, the facility was described as one of the most significant international distribution centers. This characterization remained consistent in 2023 and 2024, with no changes noted in ownership status or operational role. The consistency suggests a stable strategic focus on maintaining direct control over key logistics nodes in Europe.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike repeatedly identifies Laakdal, Belgium as one of the “most significant distribution facilities outside the United States” and explicitly states that the site is **owned** by the company in each filing.  The 2022 10‑K (p. 27) lists Laakdal among the owned overseas hubs; the 2023 10‑K (p. 29) repeats the same description; and the 2024 10‑K (p. 29) again confirms ownership while noting that other leases run to 2058, underscoring that Laakdal is a **permanently owned** logistics asset.  This consistent ownership across three years signals Nike’s strategic intent to anchor its European supply chain on a controlled, high‑capacity distribution hub in Belgium, reinforcing a long‑term focus on building and protecting its European logistics infrastructure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual elements are accurate: Nike maintained ownership of the Laakdal, Belgium facility throughout fiscal years 2022–2024, and it was consistently described as one of the most significant international distribution centers. The LLM correctly identifies that the site is owned (not leased), and this is confirmed across all three 10-K filings. (2) There are no numeric values requiring calculation, but the LLM accurately references the correct pages (2022 p.27, 2023 p.29, 2024 p.29) and correctly interprets the lease expiration note (2058) as contextual evidence reinforcing the permanence of the asset, which does not contradict the ground truth. (3) The multi-hop reasoning is sound—by synthesizing information across three years of filings, the LLM confirms consistent ownership and operational status, leading to the valid conclusion about Nike’s strategic focus. (4) The LLM adds slight interpretive depth (e.g., 'permanently owned', 'anchor its European supply chain') that is reasonably inferred from the consistent disclosures and does not overstate the evidence. These enhancements improve clarity without introducing inaccuracies. All aspects of the question—ownership, operational footprint, and strategic implication—are addressed with factual precision and logical coherence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 381,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the competitive positioning of Lumentum Holdings in NVIDIA’s disclosed competitor landscape evolved from fiscal years 2022 through 2024, particularly in relation to NVIDIA’s expanding supply chain and IP protection strategies?",
      "original_answer": "Lumentum Holdings remained consistently positioned as a competitor to NVIDIA across fiscal years 2022, 2023, and 2024, specifically in the domain of networking products such as optical modules and interconnect solutions. In 2022, NVIDIA highlighted its competitive environment, listing Lumentum Holdings among suppliers of interconnect, switch, and cable solutions. By 2023, NVIDIA reiterated this competitive relationship, placing Lumentum in the broader context of increased competition from companies offering semiconductor-based high-performance interconnect products. In 2024, NVIDIA again named Lumentum Holdings Inc. as a competitor, while emphasizing its own strategic moves to strengthen supply chain resilience and expand IP protection. The consistent mention of Lumentum across three years indicates that it remains a persistent competitive force, even as NVIDIA enhances its manufacturing partnerships (e.g., with TSMC, Samsung) and extends its patent portfolio (with expiration dates moving from 2022 to 2045 across the years). This suggests that despite NVIDIA’s strategic supply chain and IP advancements, Lumentum has maintained its relevance in the competitive landscape.",
      "llm_answer": "\nAcross fiscal 2022 through 2024 Lumentum Holdings stayed on NVIDIA’s list of networking‑product competitors in every filing, showing a continuous competitive link (KG : NVDA → Lumentum Holdings ← Competes_With ← NVDA).  At the same time NVIDIA’s supply‑chain strategy evolved – it expanded relationships with multiple foundries (TSMC, Samsung), secured non‑cancellable inventory and built redundancy to meet growing demand – while its IP protection matured, with patent expirations shifting later (2022‑2045 → 2024‑2043 → 2025‑2045) and a stronger emphasis on global IP enforcement.  These developments suggest that Lumentum’s role as a high‑performance interconnect supplier grew in importance as NVIDIA broadened its supply base, even as NVIDIA’s expanded IP safeguards increasingly constrained Lumentum’s ability to rely on overlapping patented technologies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately states that Lumentum Holdings remained a consistent competitor to NVIDIA across fiscal years 2022–2024 in the networking products domain, specifically citing interconnect solutions. The answer correctly references NVIDIA’s evolving supply chain strategy, including expanded foundry relationships with TSMC and Samsung, and notes the shift in patent expiration dates from 2022–2045 to later ranges (e.g., 2025–2045), which matches the trend in the original answer. However, there is a minor inaccuracy in the presentation of patent expiration timelines: the LLM implies a progression from '2022-2045 → 2024-2043 → 2025-2045', which introduces a specific sequence and shortening of the range (to 2043) not present in the original answer. The original only states that expirations moved from 2022 to 2045 'across the years' without specifying intermediate shifts, so this added precision is unsupported. This affects quantitative accuracy slightly. The reasoning is sound and captures the multi-hop synthesis: Lumentum remains a competitor despite NVIDIA’s strategic advances in supply chain and IP. The conclusion that Lumentum’s role grew in importance while being constrained by IP safeguards is a reasonable inference, though slightly more interpretive than the original’s neutral tone. All entities (Lumentum Holdings, NVIDIA, TSMC, Samsung) and fiscal years are correctly identified. The answer is fully contextually relevant and addresses all parts of the question. Minor over-precision in patent dates prevents a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 440,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Netflix's reliance on rights holders for content licensing evolved from 2022 through 2024, and what does this reveal about the company's content acquisition strategy amid rising competition and regulatory changes?",
      "original_answer": "From 2022 to 2024, Netflix's reliance on rights holders for content licensing has remained a core risk factor but has been increasingly framed in the context of rising competition and regulatory pressures. In 2022, the company emphasized the risk of content unavailability due to rights holders withdrawing content or increasing licensing costs, especially as studios launched their own streaming services. By 2023, the discussion remained consistent, with a focus on the variability of license terms and the importance of maintaining a compelling mix of content to support membership growth. In 2024, the narrative evolved to include regulatory impacts—such as content quotas and investment obligations in various countries—as additional constraints on content availability and ownership rights. This progression indicates a strategic shift toward securing exclusive and original content while navigating a more regulated and competitive global environment.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s dependence on external rights holders intensified: the 2022 filing warns that studios, content providers and CMOs can withdraw or withhold titles and demand ever‑higher fees, a risk reiterated in the 2023 and 2024 disclosures; the 2023 and 2024 sections further note that license periods vary and that new cultural‑support regulations are expanding content‑quota, levy and ownership‑restriction rules that limit how much of a title Netflix can own or control. As a result, the company is pivoting its acquisition strategy—relying more on exclusive, original productions and carefully curated licensing deals that can satisfy both rising competition and the increasingly restrictive regulatory environment disclosed across all three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: Netflix's reliance on rights holders is consistently highlighted from 2022 to 2024, with increasing emphasis on rising licensing costs, content withdrawal risks, variability in license terms, and the emergence of regulatory constraints such as content quotas and ownership restrictions by 2024. The strategic pivot toward original and exclusive content is correctly inferred. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are used correctly. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures, correctly identifying the evolution from competitive pressures (2022–2023) to include regulatory impacts (2024), and draws a logical conclusion about strategic shifts in content acquisition. (4) Minor phrasing differences exist (e.g., 'CMOs' and 'cultural-support regulations' are not in the original but are plausible interpretations of regulatory bodies and content rules), but they do not distort meaning. The LLM adds slight specificity (e.g., 'levy', 'ownership-restriction rules') that are consistent with but not explicitly stated in the ground truth—this is acceptable under semantic equivalence. No critical omissions or inaccuracies. A score of 9 is given because while the core answer is fully correct, the original answer more precisely frames the 2024 regulatory evolution as part of a progression, whereas the LLM implies all three filings equally disclose regulatory issues, when in fact 2024 is when this emphasis notably increases.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 467,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Southern Company's treatment and disclosure of scheduled lease payments under outdoor lighting contracts evolve from 2022 to 2024, particularly in terms of materiality, revenue classification, and presentation within maturity analyses?",
      "original_answer": "In 2022, Southern Company disclosed that the undiscounted cash flows from outdoor lighting contracts accounted for as operating leases at Mississippi Power were considered immaterial. By 2023, the company began including scheduled lease payments from outdoor lighting contracts in the maturity analyses alongside tolling arrangements and PPAs, signaling a shift toward more structured reporting. In 2024, the disclosure expanded further, with Southern Company explicitly stating that scheduled payments under outdoor lighting contracts’ initial terms were included in maturity analyses, reflecting a consistent and more transparent treatment of these contracts over time. This progression shows an increasing emphasis on formalizing the visibility of outdoor lighting lease obligations and payments within financial reporting.",
      "llm_answer": "\nFrom 2022 → 2024 Southern Company moved from describing the cash‑flows under its outdoor‑lighting operating leases as “immaterial” and not shown in any table (Chunk 1) to explicitly presenting the scheduled lease payments—along with those from tolling arrangements and PPAs—in maturity analyses and disclosing the related lease income as part of wholesale revenues (Chunks 2 & 3).  In the 2023 and 2024 filings the company classified the lease income from PPAs (including Alabama Power, Georgia Power and Southern Power) within wholesale revenues and included the scheduled payments in maturity tables, thereby elevating the previously immaterial outdoor‑lighting lease amounts to a disclosed, material line‑item within the lease‑payment maturity schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution from 2022 to 2024: in 2022, outdoor lighting lease cash flows were deemed immaterial and not presented in tables; by 2023 and 2024, they were included in maturity analyses alongside tolling arrangements and PPAs. The answer accurately reflects that these payments went from being unreported due to immateriality to being explicitly disclosed and structured in financial reporting. (2) There are no numeric values (e.g., dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes over time across disclosures, correctly identifying the shift in materiality treatment, inclusion in maturity tables, and classification of lease income as part of wholesale revenues. However, the mention of 'PPAs (including Alabama Power, Georgia Power and Southern Power)' slightly conflates entities; the original answer focuses on Mississippi Power in 2022 and does not specify those subsidiaries for the lease income classification, so this is a minor overextension. (4) Despite this small overattribution, the core facts—materiality shift, presentation in maturity analyses, and revenue classification—are correct and well-reasoned. The answer is contextually complete and directly addresses all aspects of the question: materiality, revenue classification, and presentation in maturity analyses across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 427,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did AVGO's outstanding principal balance for the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 was $1,086 million in fiscal year 2022, decreased to $606 million in fiscal year 2023, and remained unchanged at $606 million in fiscal year 2024. This indicates a deliberate debt reduction strategy in 2023, with no further repayments in 2024, suggesting either capital allocation priorities shifted or a strategic decision to maintain this liability level.",
      "llm_answer": "\nThe 5.000 % notes due April 2030 carried an outstanding principal of **$606 million** in the FY 2022 filing (Chunk 3), and that same **$606 million** balance is reported in both the FY 2023 (Chunk 1) and FY 2024 (Chunk 2) statements, showing no increase or decrease over the three fiscal years.  \n\nThis flat evolution indicates that AVGO’s debt‑management strategy for this specific tranche has been to **maintain a stable, long‑term funding level**, using the note as a fixed‑rate pillar while the company refinances or retires other debt rather than expanding or shrinking this particular borrowing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, the outstanding principal was $1,086 million in FY 2022, not $606 million as stated by the LLM. The LLM claims the balance was $606 million in all three years, but in reality, it decreased from $1,086M to $606M in FY 2023 and remained flat in FY 2024. This misrepresentation completely alters the narrative. (2) The numbers are inaccurate: the LLM incorrectly reports FY 2022 balance, misses the reduction in FY 2023, and falsely asserts stability over the period. Even allowing for format variations, the values are factually wrong. (3) The multi-hop reasoning is flawed because the model fails to correctly extract and compare data across the three fiscal years. Instead of identifying a reduction in 2023 followed by stability, it incorrectly assumes no change, leading to an erroneous conclusion about debt strategy. (4) The qualitative reasoning about 'stable, long-term funding' is plausible only if the data supported it, but since the premise is false, the conclusion is invalid. The contextual relevance is moderate because the answer addresses the right instrument and timeframe, and attempts to interpret strategy, but the factual foundation is unsound, severely undermining correctness and accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 372,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve from 2022 through 2024, and what does this 3-year trend indicate about the company's strategic asset mix adjustments in response to market conditions?",
      "original_answer": "In 2022, General Motors reported a weighted-average long-term rate of return on U.S. pension plan assets of 5.4%, which remained unchanged at 6.3% in 2023, and then increased to 6.5% in 2024. This trajectory shows a 1.1 percentage point increase over two years, indicating a more optimistic outlook in asset performance and a potential shift toward higher-risk, higher-return investment strategies as part of the company's evolving strategic asset mix.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s weighted‑average long‑term rate of return on U.S. pension assets was 6.3 % in 2022 (the rate “remains unchanged at 6.3 % at Dec 31 2023 and 2022” in Chunk 3), stayed at 6.3 % in 2023, and then rose to 6.5 % in 2024 after the December 2024 investment‑policy study (Chunk 2) raised it from 6.3 % to 6.5 % – a trend that builds on the periodic‑study methodology first described in Chunk 1.  \nEach year GM conducts an investment‑policy study (2021, 2023, 2024) and adjusts the target asset allocations and risk‑mitigation strategies—using derivatives, leverage and tailored mixes to improve funded positions while managing volatility—so the evolution of the return assumption reflects deliberate strategic mix changes across all three filings (Chunk 1, 2, 3).  \nThe flat 6.3 % assumption for two consecutive years followed by a modest increase to 6.5 % signals that GM is gradually shifting toward a slightly more return‑oriented, de‑risked portfolio as market conditions improve, while still prioritizing funded‑status strength and fiduciary risk tolerance (integrating information from every provided chunk).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the reported 2022 rate of return. The ground truth states that the rate was 5.4% in 2022, but the LLM incorrectly claims it was 6.3% in 2022, citing 'Chunk 3' as evidence. This misrepresents the starting point of the trend and invalidates the accuracy of the evolution. The 2023 value (6.3%) and 2024 value (6.5%) are correct. (2) The calculation of the overall change is therefore wrong: the LLM implies a 0.2 percentage point increase from 6.3% to 6.5%, whereas the actual 3-year trend reflects a 1.1 percentage point increase from 5.4% to 6.5%. This is a significant quantitative inaccuracy. (3) The reasoning about strategic asset mix adjustments and periodic investment-policy studies is qualitatively sound and reflects appropriate multi-hop synthesis across the described chunks, showing understanding of GM’s methodology for adjusting assumptions. The interpretation of a gradual shift toward a more return-oriented strategy is plausible and contextually aligned, even if based on incorrect data. (4) While the contextual relevance is high—addressing both parts of the question (evolution and strategic implication)—the foundational error in the 2022 figure severely undermines the correctness score. The qualitative accuracy is moderate due to correct use of conceptual framework, and quantitative accuracy is low due to the incorrect starting value and resulting mischaracterization of the trend.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 407,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "What does the treatment of American Tower's 2.700% Senior Notes due 2031 across its 2022-2024 filings indicate about its long-term financing strategy?",
      "original_answer": "The consistent referencing of the 2.700% Senior Notes due 2031 across all three filings indicates a stable long-term financing strategy centered on maintaining this specific debt instrument as a core component of American Tower's capital structure. In 2022, the company referenced Supplemental Indenture No. 8 dated March 29, 2021, for these notes (AMT_10k_2022.pdf). In 2023, the same Supplemental Indenture No. 8 was again referenced (AMT_10k_2023.pdf), showing continuity in documentation and treatment. In 2024, the filings continued to reference this same indenture structure for the 2.700% Senior Notes due 2031 (AMT_10k_2024.pdf). This consistent treatment over three consecutive years suggests that the company has maintained a steady approach to this long-term debt instrument without modifications, indicating confidence in its financing terms and alignment with the company's strategic financial planning.",
      "llm_answer": "\nThe 2.700 % Senior Notes due 2031 appear in every supplemental indenture disclosed in the 2022‑2024 filings (Chunk 1 Exhibit 4.25; Chunk 2 Exhibit 4.19 and 4.21; Chunk 3 Exhibit 4.20 and 4.21), showing that the same 2031‑maturity tranche is repeatedly added to and reinforced within American Tower’s existing indenture framework.  This consistent re‑introduction—linking the note both from the issuer (AMT) and from the trustee under the same indenture—demonstrates a deliberate long‑term financing strategy that locks in low‑cost capital, extends maturity to 2031 and maintains a stable, diversified debt base through staggered senior‑note issuances.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and interpretation. (1) Quantitatively, all key details—2.700% Senior Notes, due 2031, and references across 2022–2024 filings—are accurate. The mention of specific exhibits (e.g., 4.25, 4.19, 4.20, 4.21) adds precision, though the ground truth does not require exhibit-level detail, so this is a minor enhancement rather than an error. (2) The core reasoning—that American Tower consistently maintains this debt instrument as part of its long-term financing strategy—is sound and supported by the filings. The conclusion about locking in low-cost capital and maintaining a diversified debt base is a reasonable inference, though slightly more interpretive than the original answer, which focused on documentation continuity via Supplemental Indenture No. 8. (3) However, the LLM states the note is 'repeatedly added to and reinforced,' which may imply new issuances or re-openings of the tranche, a claim not explicitly supported in the ground truth. The original answer emphasizes consistent *treatment* and referencing of the same indenture (No. 8), not repeated additions. This introduces a slight overinterpretation of the action being taken. (4) Despite this nuance, the answer correctly identifies the strategic stability and long-term intent. Thus, the correctness and qualitative accuracy are high but not perfect due to the subtle mischaracterization of 're-introduction' versus passive continuation. Contextual relevance is full, as all content directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 433,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and cross-border transactions, and what strategic actions were taken to mitigate these risks across the three-year period?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in the context of its credit products, noting that third parties were increasingly using stolen identities and financial instruments to commit fraud at scale. By 2023, PayPal had taken a strategic step to mitigate credit risk by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a shift in how the company managed exposure to fraudulent and abusive transactions in its credit portfolio. In 2024, PayPal continued to emphasize the persistent threat of abusive behaviors, particularly in digital payments, and noted the complexity of detecting and preventing fraud attacks that could undermine consumer and merchant confidence. The company also highlighted its ongoing reliance on third-party lenders and processors, which introduced additional operational and reputational risks tied to abusive behaviors. The three-year trajectory shows PayPal's evolving approach—from identifying the risk (2022), to offloading a significant portion of the exposure (2023), to reinforcing detection and prevention mechanisms while managing third-party dependencies (2024).",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s exposure to abusive behaviors intensified as it broadened U.S. consumer credit and cross‑border BNPL transactions, a risk that the 2022 filing identifies as a key threat linked to its credit products and third‑party origination model (PYPL –[Impacted_By]→ Abusive Behaviors). In 2023 the company began to curb that exposure by signing a multi‑year agreement to sell €40 bn of U.K. and European BNPL receivables and a forward‑flow facility while diversifying its payment‑processor network and migrating away from a single U.S. processor, thereby reducing reliance on third‑party lenders and funding constraints. By 2024 it further mitigated abusive‑behavior risk through stricter fraud‑detection controls, leveraging the FDIC “valid‑when‑made” regulatory clarification to protect its installment and BNPL products, and by continuing to manage third‑party relationships and cross‑border trade pressures via compliance, pricing and ongoing monitoring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal identified abusive behaviors in 2022 related to credit products and third-party fraud; in 2023, it signed a multi-year agreement to sell up to €40 billion of U.K. and European BNPL receivables; in 2024, it emphasized ongoing risks and enhanced detection controls. The numbers (€40 billion, years 2022–2024) are accurate and correctly formatted. (2) Quantitative accuracy is perfect—no calculation errors or misstatements. (3) The multi-hop reasoning is sound: the answer traces PayPal’s evolving strategy across three years, linking credit products, cross-border transactions, third-party risk, and mitigation actions. It correctly synthesizes the shift from risk identification to offloading exposure to strengthening controls. (4) Minor deduction in qualitative accuracy due to the addition of some details not in the original, such as 'diversifying its payment-processor network,' 'migrating away from a single U.S. processor,' and 'leveraging the FDIC valid-when-made clarification,' which, while plausible, are not present in the ground truth. These additions do not contradict but slightly extend the provided information. Otherwise, the answer is semantically equivalent, complete, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 371,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did UNP's pension plan allocation to Collective Trust and Other Funds change from 2022 through 2024, and what does this trend suggest about the company's evolving investment strategy for long-term employee benefits?",
      "original_answer": "UNP's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, and then in 2024, while no updated dollar value is provided, the company emphasized the use of NAV-based valuation for these funds, indicating a strategic focus on transparency and accurate reporting despite the reduced allocation. This represents a significant downward trend in direct exposure to these funds over the three-year period, suggesting a de-risking or rebalancing of the pension portfolio.",
      "llm_answer": "\nUNP’s pension plan reduced its allocation to “Collective Trust and Other Funds” from $756 million in 2022 (Chunk 1) to $382 million in 2023 (Chunk 2), and the 2024 filing (Chunk 3) still references the same category but does not disclose a new dollar amount—indicating a continued shift away from that less‑liquid, higher‑risk exposure. This downward trend, disclosed through UNP’s ORG → FIN_INST ← ORG relationships, suggests the company is increasingly favoring more liquid, transparent assets (e.g., Level 1 and Level 2 securities) to safeguard long‑term employee benefit obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the dollar amounts for 2022 ($756 million) and 2023 ($382 million) as per the ground truth, and accurately notes the absence of a disclosed dollar value in 2024. These figures match the ground truth exactly, satisfying quantitative accuracy. (2) The quantitative accuracy is perfect—no calculation errors, and the values are correctly attributed to the right years. The format ($756 million vs $756 million) is semantically equivalent and acceptable. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic shift despite missing 2024 dollar figures. It appropriately links the reduced allocation to a broader trend of de-risking, aligning with the ground truth’s conclusion about rebalancing. The mention of NAV-based valuation is missing, but the inference about transparency and shift to more liquid assets (Level 1/2 securities) is a reasonable interpretation consistent with the trend. (4) The answer is contextually fully relevant, addressing both the quantitative change and the implied investment strategy evolution. The only minor shortcoming is not explicitly mentioning the 2024 emphasis on NAV-based valuation, which slightly reduces qualitative accuracy, but the overall reasoning remains strong and factually grounded. Hence, correctness is rated 9—very close to perfect, with only a minor omission in qualitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 399,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did Pfizer's treatment and valuation methodology for Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, outstanding status, and accounting treatment?",
      "original_answer": "In 2022, Pfizer disclosed the issuance of 1,165 thousand BPAs at a weighted average intrinsic value of $38.73 per share, with 859 thousand BPAs outstanding at year-end valued at $59.05 per share. By 2023, no BPAs were granted and none remained outstanding, indicating a discontinuation or full vesting/forfeiture of previously issued awards. In 2024, Pfizer detailed a new valuation methodology for BPAs using the intrinsic value method based on the closing stock price at grant date, with expense recognition amortized over the probable vesting term and adjusted quarterly for stock price changes and performance probability assessments. This evolution shows a shift from active BPA issuance and valuation in 2022 to no active BPAs in 2023, followed by a formalized valuation and accounting framework in 2024.",
      "llm_answer": "\nIn 2022 Pfizer granted 1.165 million Breakthrough Performance Awards (BPAs) – measured at an intrinsic value of $38.73 per share – and held 859 000 unvested shares outstanding, recording the expense using an intrinsic‑value method that is amortized straight‑line over the probable vesting term and adjusted each period for performance achievement and stock‑price changes; by the end of 2023 the company disclosed that **no BPAs were granted or outstanding**, effectively ending the program, and the 2024 filing clarifies that any future BPAs would be awarded to selected non‑executive employees with payouts ranging from 0% to 600% of target contingent on pipeline milestones, again valued by intrinsic value, amortized over the expected vesting period, and adjusted periodically for changes in share price and estimated performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, all numbers are correct: 1.165 million BPAs granted in 2022 (equivalent to 1,165 thousand), intrinsic value of $38.73 per share, 859,000 outstanding at year-end, and no grants or outstanding awards in 2023. The LLM correctly notes the shift in 2024 to a formalized intrinsic value method with amortization and periodic adjustments. (2) The accounting treatment is accurately described across years—use of intrinsic value method, straight-line amortization over probable vesting term, and quarterly adjustments for stock price and performance probability. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across 2022–2024, identifying the discontinuation of the program in 2023 and the re-establishment of a structured methodology in 2024. (4) The only minor shortcoming is that the original answer emphasizes the 2024 framework as potentially applying to future awards (implied by 'any future BPAs' in LLM answer), while the ground truth presents it as a new formalized framework without explicitly stating it's forward-looking. However, this is a nuance in framing rather than a factual error. The LLM also adds detail about payout range (0% to 600%) and non-executive recipients not present in the original, which may be accurate but are not in the ground truth—this does not detract from correctness as long as it doesn't contradict. Overall, the answer is factually aligned, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Valuates]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 435,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did ExxonMobil's (XOM) collateral under master netting arrangements related to Investments, advances and long-term receivables change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over time?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements fluctuated significantly from 2022 to 2024: it was $1,494 million at the end of 2022, decreased to $800 million by the end of 2023, and further declined to $491 million by the end of 2024. This downward trend suggests a reduction in derivative exposure or a strategic adjustment in margin requirements over the three-year period.",
      "llm_answer": "\nExxonMobil’s collateral that is pledged under master‑netting arrangements and **not** offset against its derivatives fell sharply over the three‑year span – from **$1.494 billion at the end of 2022** (Chunk 3), to **$0.800 billion at the end of 2023** (Chunk 2 & 3), and further down to **$0.491 billion at the end of 2024** (Chunk 2).  Because this collateral is tied to the company’s “Investments, advances and long‑term receivables” and serves as initial margin for its derivative positions, the declining balance signals that ExxonMobil’s derivative exposure and the associated margin requirements have been **shrinking** each year, reflecting a reduced need for offsetting collateral as its derivative book and related margin calls contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: $1,494 million (2022), $800 million (2023), and $491 million (2024) are reported accurately, with acceptable format variations (e.g., $1.494 billion = $1,494 million). (2) The answer fully addresses both parts of the question: it describes the change in collateral over time and interprets the trend in terms of derivative exposure and margin requirements. (3) Entities are correct—ExxonMobil (XOM), the time periods (2022–2024), and the financial metric (collateral under master netting arrangements related to Investments, advances and long-term receivables) are all accurately identified. (4) The reasoning is sound: the downward trend is correctly interpreted as indicating shrinking derivative exposure and reduced margin requirements, which is consistent with the original answer’s conclusion about reduced exposure or strategic adjustment. The only minor limitation is the inclusion of 'Chunk 2 & 3' references, which appear to be internal retrieval markers and are not relevant to the final answer, but they do not affect factual correctness. Overall, the answer demonstrates strong multi-hop synthesis and semantic equivalence to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 353,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Broadcom's (AVGO) positioning of Industrial Fiber Optics evolve across 2022, 2023, and 2024 in terms of its industrial product portfolio and application scope, and what does this reveal about the company's strategic focus in industrial markets?",
      "original_answer": "In 2022, Broadcom positioned Industrial Fiber Optics as part of a broad industrial product suite used across applications like industrial automation, power systems, medical equipment, defense, aerospace, and automotive subsystems, including electric vehicles. In 2023, the company maintained this positioning but placed Industrial Fiber Optics within a structured table format that emphasized its role in Factory Automation, Renewable Energy, and Automotive Electronics. By 2024, Industrial Fiber Optics remained a core offering under the Industrial end markets, listed alongside optocouplers, sensors, encoders, and Ethernet ICs, but with a more streamlined presentation that emphasized integration with broader semiconductor solutions. This evolution shows a consistent strategic focus on industrial markets, with increasing emphasis on structured, application-specific clarity in product communication.",
      "llm_answer": "\nBroadcom continued to list **Industrial Fiber Optics** in its industrial portfolio in the 2023 and 2024 filings (Chunks 1 & 2), but the 2022 filing (Chunk 3) uniquely emphasized that these optics, together with optocouplers, motion‑control encoders, LEDs and Ethernet PHYs, serve a wide‑ranging set of end‑markets—including factory automation, renewable‑energy systems, automotive electronics, medical and defense/aerospace equipment, and especially electric‑vehicle powertrain and ADAS applications.  This progression shows that the company has deliberately **narrowed the narrative around industrial fiber optics to a core enabling technology for high‑growth industrial and automotive sectors**, while still leveraging a broader suite of industrial semiconductors to support that strategic focus.  The KG relationship — AVGO produces Industrial Fiber Optics, and Industrial Fiber Optics is linked back to AVGO—underscores the mutual, strategic positioning of the product within Broadcom’s industrial market agenda.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies that Industrial Fiber Optics remained part of Broadcom's portfolio across 2022, 2023, and 2024, and correctly notes the broad application scope in 2022 including industrial automation, automotive (especially EVs), medical, defense/aerospace, and power systems. The emphasis on electric-vehicle powertrain and ADAS is a slight expansion beyond the original answer, which mentions 'automotive subsystems, including electric vehicles' but does not specify ADAS—this is a minor over-specification but not factually incorrect. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable; however, the use of years (2022, 2023, 2024) is correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in presentation and emphasis across years, noting the shift from broad market listing in 2022 to a more focused narrative in 2023–2024. It correctly infers a strategic narrowing toward high-growth sectors, which is consistent with the ground truth’s observation of increasing application-specific clarity. However, it misses the specific detail about the 'structured table format' in 2023 and the 2024 integration with broader semiconductor solutions (e.g., being listed alongside optocouplers, sensors, etc.), which weakens the qualitative accuracy slightly. (4) The answer is highly contextually relevant, directly addressing the evolution of positioning and strategic focus. The conclusion about strategic narrowing is a valid interpretation, though the original answer emphasizes structural and presentational evolution more than narrative narrowing. Overall, the answer captures the core truth with minor omissions in descriptive detail, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 504,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did PayPal's exposure to margin risk evolve from 2022 through 2024, particularly in relation to its control over transaction pricing and use of third-party payment processors across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bore full margin risk when completing payment transactions and had full discretion over fee pricing, independent of costs incurred with third-party processors. In 2023, the company reiterated this stance, emphasizing that fees paid to payment processors and financial institutions were recognized as transaction expense, maintaining its exposure to margin risk. By 2024, PayPal continued to affirm its role as the principal in transactions, bearing full margin risk, and maintaining discretion over pricing despite using third-party processors. The consistent narrative across all three years indicates a stable margin risk profile, with no material changes in how PayPal manages pricing or third-party cost exposure.",
      "llm_answer": "\nPayPal’s margin‑risk profile stayed anchored in its role as the principal that sets and collects transaction fees while assuming full liability for refunds, charge‑backs, incentives and protection‑program costs; from 2022 through 2024 the company repeatedly disclosed that it **bears the entire margin risk on every payment it authorizes, even when it relies on third‑party processors to execute the transaction**.  \n\n- In the **2022 filing** the firm explained that it controls the fee, can adjust it based on volume, and records the fees paid to processors as transaction expense, thereby shouldering full margin risk.  \n- The **2023 filing** added that incentives paid to merchants or consumers are booked as revenue reductions and that protection‑program expenses are recorded in transaction and credit losses, further expanding the items that can erode margins.  \n- The **2024 filing** re‑affirms this stance under the new segment‑reporting guidance, emphasizing again that fee determination is independent of processor costs and that the company continues to bear full margin risk despite the expanded use of external processors for services such as crypto, cross‑border transfers and instant‑transfer payouts.  \n\nThus, across the three years PayPal’s exposure to margin risk evolved only in the granularity of the costs it tracks (incentives, protection‑program losses) but not in the underlying risk driver: **its control over transaction pricing and its reliance on third‑party processors continue to place the full financial risk of each payment on PayPal itself**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: PayPal bore full margin risk in 2022, 2023, and 2024; it maintained control over transaction pricing; third-party processor costs were recorded as transaction expenses; and the company remained the principal in transactions. There are no numeric inaccuracies—though no specific dollar amounts are cited, the qualitative financial disclosures (e.g., treatment of incentives, protection-program costs) align with the original answer. (2) The answer correctly synthesizes multi-hop information across three years of filings, accurately reflecting the evolution (or stability) of PayPal’s margin risk exposure. (3) The reasoning is sound: it identifies that while the granularity of cost tracking expanded (e.g., incentives and protection programs in 2023), the core risk model did not change. (4) The LLM adds contextual detail not in the original (e.g., crypto, cross-border, instant transfers in 2024) that is consistent with known PayPal operations and enhances relevance without introducing error. Wording differs but meaning matches exactly. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 341,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 to 2024, particularly in terms of financial impact, contractual arrangements, and strategic positioning, and what does this progression indicate about Pfizer's long-term focus in this business area?",
      "original_answer": "Pfizer's relationship with Meridian underwent a clear transformation from 2022 to 2024. In 2022, Meridian was still presented as part of discontinued operations, indicating it was a legacy business being phased out. By 2023, Pfizer had completed the sale of Meridian in late 2021 for $51 million in cash, recognizing a $167 million net loss, and was operating under a Manufacturing Supply Agreement (MSA) that extended for three years post-sale with a two-year extension option. In 2024, Meridian was listed in Pfizer's glossary as 'Meridian Medical Technologies, Inc.', indicating a formalized but likely reduced relationship. This evolution shows Pfizer's strategic shift away from direct ownership of Meridian toward a more arms-length, contract-based relationship, consistent with a broader refocusing on core therapeutic areas and platform technologies like mRNA.",
      "llm_answer": "\nPfizer sold Meridian Medical Technologies in December 2021, recording an after‑tax loss of roughly $167 million (Chunk 1), and thereafter operated under interim transition‑service agreements and a three‑year Manufacturing Supply Agreement that were fully wound down by 31 December 2023, generating only immaterial revenues in 2022‑23 (Chunk 1 & 2).  The 2023 Form 10‑K confirms these post‑sale arrangements are now non‑material and that Pfizer’s strategic focus has shifted toward high‑growth areas such as mRNA and oncology, reflecting a deliberate divestiture of legacy assets like Meridian (Chunk 2 & 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the sale of Meridian Medical Technologies in December 2021 for a $167 million after-tax loss, aligning with the ground truth. It accurately notes the three-year Manufacturing Supply Agreement (MSA) and its conclusion by December 31, 2023, with only immaterial revenues in 2022–2023. However, the original answer specifies that the MSA had a two-year extension option, which the LLM omits, representing a minor but relevant contractual detail. Additionally, the 2024 update—Meridian being listed in Pfizer’s glossary as 'Meridian Medical Technologies, Inc.'—is missing in the LLM response, reducing completeness regarding the current state of the relationship. (2) Quantitatively, all numbers and dates are accurate: $167 million loss, December 2021 sale, and post-sale arrangements ending by end of 2023. The term 'immaterial revenues' is consistent with the ground truth implication of reduced financial impact. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the timeline from divestiture to wind-down of transitional agreements and links it to Pfizer’s strategic refocusing on mRNA and oncology. It infers the broader strategic intent from financial and contractual changes, which is well-supported. (4) The answer is highly contextually relevant, directly addressing financial impact, contractual evolution, and strategic positioning. The omission of the extension option and the 2024 glossary mention prevents a top score, but core facts and strategic interpretation are correct. Hence, correctness is rated 8/10, with high marks for quantitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Partners_With]- ORG <-[Sells]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 450,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the impact of product regulation on Philip Morris International's competitive positioning evolved from 2022 to 2024, particularly in terms of restrictions on product differentiation and adult consumer communication for reduced-risk products (RRPs/SFPs)?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International's ability to differentiate its reduced-risk products (RRPs) and later its smoke-free products (SFPs), with growing regulatory pressure evident across all three years. In 2022, the company noted that product regulation limited its ability to differentiate tobacco products and restricted adult consumer access to truthful information about RRPs. By 2023, the language evolved to emphasize that such regulation not only restricted communication but also disproportionately impacted the commercialization of RRPs relative to competitors. In 2024, the company replaced 'RRPs' with 'SFPs' and reiterated similar concerns, indicating a continued regulatory burden on product differentiation and consumer engagement, suggesting a deepening regulatory challenge that has persisted and possibly intensified over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 the regulatory pressure on PMI’s reduced‑risk products has intensified: the 2022 filing warned that product regulation could “diminish the ability to differentiate tobacco products and restricts adult consumer access to truthful and non‑misleading information about our RRPs” (Chunk 1), while the 2023 and 2024 disclosures add that regulations may create “unfair competition,” “limit branding, communication and product differentiation,” and “disproportionately impact the commercialization of our SFPs” while also emphasizing the need for “effective adult consumer engagement, including communication about product characteristics and usage of SFPs” (Chunks 2‑3). Consequently, the evolving rules have progressively narrowed PMI’s ability to differentiate its RRPs/SFPs and to communicate their benefits, directly weakening its competitive positioning across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of regulatory pressure from 2022 to 2024 is accurately described, with proper emphasis on constraints on product differentiation and adult consumer communication for RRPs/SFPs. The shift in terminology from RRPs to SFPs in 2024 is correctly noted. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—but all dates (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, correctly identifying the progression in language and regulatory impact. It captures the increasing severity of regulatory constraints and the strategic implications for PMI’s competitive positioning. (4) The answer is contextually excellent, directly addressing the question about evolving regulatory impact on competitive positioning through restrictions on differentiation and communication. The only minor shortcoming is that the LLM slightly overemphasizes 'unfair competition' and 'weakening competitive positioning' as direct consequences, while the original answer frames the competitive impact more cautiously as 'disproportionate impact' and 'continued regulatory burden.' This is a nuance in tone rather than a factual error, hence the 9/10 on qualitative accuracy and correctness. Overall, the answer is factually complete, semantically equivalent, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 429,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did ExxonMobil's (XOM) exposure to collateral under master netting arrangements related to Notes and accounts receivable - net change from 2022 through 2024, and what does this trend suggest about the company's derivative risk management practices?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements tied to Notes and accounts receivable - net decreased from $1,494 million in 2022 to $800 million in 2023, then further declined to $491 million in 2024. This downward trend indicates a strategic reduction in derivative exposure or a shift in risk management practices, potentially reflecting lower margin requirements or proactive risk mitigation in a volatile energy market.",
      "llm_answer": "\nExxonMobil’s collateral that is held under master‑netting arrangements and is **not** offset against its derivatives fell sharply from **$1.494 billion in 2022 → $0.800 billion in 2023 → $0.491 billion in 2024** (the figures cited in the 2022, 2023 and 2024 10‑K filings).  This downward trend—while the “Notes and accounts receivable – net” line remains a disclosed balance‑sheet component—indicates that the company is **reducing its external collateral buffer**, relying more on internal netting and tighter counterparty limits, which points to a **more proactive and streamlined derivative‑risk‑management practice** as it moves toward lower exposure and greater offsetting of positions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1,494 million in 2022, $800 million in 2023, and $491 million in 2024, matching the ground truth exactly (with acceptable format variation: $1.494 billion = $1,494 million). These figures are correctly attributed to the respective years and tied to collateral under master netting arrangements related to Notes and accounts receivable - net.\n\n2) Quantitatively, the answer is fully accurate. The values are consistent with the ground truth, and the temporal progression (2022 → 2023 → 2024) is correctly presented. No calculations are required beyond reporting the trend, which is done accurately.\n\n3) The reasoning is sound and adds value: the LLM correctly infers that the declining collateral suggests reduced external collateral usage and interprets this as a shift toward more proactive risk management, tighter counterparty limits, and greater internal netting. While the original answer emphasizes 'strategic reduction in derivative exposure or shift in risk management,' the LLM expands this with plausible, contextually appropriate details (e.g., 'internal netting,' 'tighter counterparty limits') that are consistent with industry practices and do not contradict the ground truth. This constitutes a slightly more detailed but still semantically aligned interpretation.\n\n4) The entity identification is correct: ExxonMobil (XOM), the correct financial metric (collateral under master netting arrangements), and the correct time frame (2022–2024) are all accurately referenced. The answer addresses both parts of the question: the quantitative change over time and the implication for derivative risk management.\n\n5) The only reason for not scoring a perfect 10 is that the LLM slightly reframes the implication by introducing concepts not explicitly in the ground truth (e.g., 'internal netting,' 'tighter counterparty limits'), which, while reasonable, go a small step beyond the original answer’s more conservative interpretation. However, these inferences are logical and do not introduce factual errors.\n\nOverall, the answer is factually correct, complete, and contextually appropriate, with excellent multi-hop synthesis across years and financial disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 597,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Duke Energy's expected volatility assumption in its TSR-based performance award model relative to the predefined peer group evolve from 2022 to 2024, and what does this trend suggest about the company's market risk perception over time?",
      "original_answer": "Duke Energy's expected volatility assumption in its TSR-based performance award model decreased from 26.9% in 2022 to 28.6% in 2023, and then dropped significantly to 18.7% in 2024. This trend indicates a notable decline in the perceived market risk associated with Duke Energy's stock performance over the three-year period, despite a short-term increase in 2023. The drop in volatility by 2024 suggests a shift in how the company's stock is behaving relative to its peers, possibly indicating improved market stability or strategic changes affecting its risk profile.",
      "llm_answer": "\nDuke Energy’s expected relative‑TSR volatility used in the performance‑award model was 26.9 % for grants made in 2021 (the most recent prior disclosure), rose to 28.6 % for 2023 grants, and then fell to 18.7 % for 2024 grants, while the grant‑date fair‑value of vested shares grew from $45 M (2021) to $52 M (2023) to $55 M (2024) and unrecognized compensation cost fluctuated between $33 M and $37 M. This trajectory—an increase through 2023 followed by a sharp decline in 2024—indicates that the company’s perception of market risk heightened in the early period but was reassessed downward by 2024, reflecting a more cautious view of equity price volatility. The shift is embedded in the model’s reliance on three‑year historical volatilities of the predefined peer group, underscoring how Duke Energy’s risk assumptions evolve over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant error in the timeline: it states that the 26.9% volatility was for grants made in 2021, while the ground truth specifies 2022. This misalignment affects the temporal evolution described in the question, which asks specifically about 2022 to 2024. The 28.6% for 2023 and 18.7% for 2024 are correct. Additionally, the LLM introduces financial data (grant-date fair-value of vested shares and unrecognized compensation cost) not present in the original answer and not requested in the question, which adds extraneous information. (2) Quantitative accuracy is partially compromised due to the incorrect assignment of 26.9% to 2021 instead of 2022. The dollar amounts ($45M, $52M, $55M, $33M–$37M) are not part of the ground truth and appear to be fabricated or misattributed, introducing factual inaccuracies. However, the core volatility figures for 2023 and 2024 are correct. (3) The multi-hop reasoning is sound in interpreting the trend—an increase followed by a sharp decline—and linking it to changing market risk perception. The explanation about the model relying on historical peer-group volatility adds context and shows understanding of the mechanism, even if not in the original answer. (4) Despite the incorrect starting year and inclusion of unsupported financial figures, the LLM captures the essential trend and its implication about declining risk perception by 2024. The reasoning and conclusion are logically consistent with the corrected data, warranting a moderate score. The answer is contextually relevant and addresses the broader question about risk perception evolution, but the factual errors in dates and added numbers reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 469,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Broadcom's (AVGO) financial obligations tied to its 3.125% notes due January 2025 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's short-term debt management and refinancing strategy?",
      "original_answer": "Broadcom's financial obligation related to the 3.125% notes due January 2025 remained stable at $495 million in both fiscal years 2022 and 2023, indicating no principal repayment or issuance changes during that period. However, by fiscal year 2024, the note had transitioned into its current portion of long-term debt, suggesting that the company was approaching the final year of this obligation. This pattern reveals a consistent short-term debt structure for this specific note over two years, followed by an impending maturity that likely triggered internal refinancing or liquidity planning in 2024.",
      "llm_answer": "\nIn fiscal 2022 the 3.125% notes due January 2025 carried a principal balance of **$495 million** (Chunk 3), a figure that remains unchanged in the 2023 and 2024 tables where the same $495 million amount is reported (Chunks 1‑2).  At the same time the **current portion of total long‑term debt declined from $1,563 million in 2023 to $1,245 million in 2024** (Chunks 1‑2), showing that maturing near‑term obligations—including the 3.125% notes—were being refinanced into longer‑dated senior securities assumed in the VMware and CA acquisitions (Chunks 1‑2).  This pattern reveals Broadcom’s short‑term debt management strategy of rolling off near‑term maturities and extending the overall debt profile through strategic acquisitions and new, longer‑dated note issuances.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the principal amount of the 3.125% notes due January 2025 as $495 million for fiscal years 2022, 2023, and 2024, which matches the ground truth. This demonstrates accurate quantitative reporting across all years. However, the ground truth states that the note only transitioned into the current portion of long-term debt in 2024—implying a change in classification—not that the principal was paid down or refinanced yet. The LLM incorrectly infers that the $495 million was actively refinanced by 2024 based on a decline in the total current portion of long-term debt from $1,563M to $1,245M. While this decline is factually reported, attributing it directly to refinancing of the 3.125% note lacks direct support; the decrease could stem from other debt maturities or new issuances unrelated to this specific note. (2) All numbers—$495M (note balance), $1,563M, and $1,245M (current long-term debt)—are accurately cited, satisfying quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects the stable note balance across years and observes a trend in current debt, but overreaches by linking the decline to refinancing of this specific note without explicit evidence. The ground truth emphasizes that the 2024 classification shift signals impending maturity and likely *planning* for refinancing, not completed refinancing. (4) The answer is contextually relevant and well-structured, but the qualitative leap in reasoning—asserting active refinancing via acquisition-related debt—introduces unsupported speculation. Thus, while core facts are correct, the interpretation slightly misrepresents the strategic implication, warranting a score of 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 479,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did AMD's strategic positioning with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB Manufacturers against price reductions, indicating a stable policy to maintain channel partner confidence. In 2022, AMD highlighted that AIBs build and sell board-level products using AMD technology to system integrators, retailers, and sub-distributors. By 2023 and 2024, this relationship remained consistent, with AMD continuing to offer component-level graphics and chipset products to AIBs, reinforcing the importance of discrete graphics solutions as a differentiation tool for AIBs and system integrators. Despite no explicit quantitative changes in AIB-related revenue disclosed, the repeated emphasis on short design cycles, rapid response to new technologies, and the role of discrete graphics in differentiation suggests a sustained strategic focus on AIBs as a key channel for expanding AMD's GPU technology in competitive markets.",
      "llm_answer": "\nAcross 2022 through 2024 AMD kept its AIB partners’ inventory protected by contractual price‑shielding and limited return rights—starting with “return rights with respect to any product that we have removed from our price book that is less than 12 months older” (2022) and later expanding to “certain return rights with respect to any product that we have removed from our price book or otherwise subject to discontinuation” (2023‑2024), while also allowing stock‑rotation provisions in each year.  At the same time, discrete graphics remained a key differentiator for system integrators, who used AMD’s GPU solutions to add value and distinguish their board‑level products, a relationship emphasized in every chunk’s discussion of AIB and SI collaborations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor over-specifications not present in the original answer. (1) Correct elements: The core facts about AMD's inventory protection policies for AIBs are accurate—AMD provided protection against price reductions, with return rights related to products removed from the price book. The evolution from a 12-month threshold in 2022 to broader 'certain return rights' in 2023–2024 is consistent with the knowledge graph's indication of stable but ongoing support. The emphasis on discrete graphics as a differentiation tool for system integrators (SIs) and AIBs is correctly highlighted across all years. (2) Quantitative accuracy: No explicit numerical data (e.g., dollar amounts, percentages) are present in either answer, so scoring is based on precision of temporal and policy descriptions. The mention of '12 months' in 2022 and expanded language in 2023–2024 matches plausible interpretations of the original, though the exact phrasing ('return rights...', 'stock-rotation') may reflect inference beyond what the ground truth explicitly states. The original does not specify contractual mechanisms like 'stock-rotation provisions,' which the LLM introduces without direct support. (3) Multi-hop reasoning: The LLM successfully synthesizes information across years and entities (AMD, AIBs, SIs), correctly identifying continuity in strategy and subtle policy broadening. However, the ground truth does not confirm specific contractual terms like 'stock-rotation,' making this a minor factual overreach. (4) The answer is contextually excellent—directly addressing inventory protection evolution and the strategic role of discrete graphics. It earns a high qualitative score due to strong reasoning, though slight deductions are made for introducing unverified specifics. Overall, the semantic meaning is very close to the original, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Supplies]- ORG <-[Sells_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 525,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Disney's strategic approach to DTC offerings evolve from 2022 to 2024, particularly in terms of investment focus, competitive positioning, and expectations for revenue growth?",
      "original_answer": "In 2022, Disney acknowledged the financial risks of its DTC strategy, noting that the costs and associated losses 'may continue to grow or be reduced more slowly than anticipated' and that returns on new investments, including DTC offerings, 'may be negative or lower than prior to the change in strategy.' By 2023, Disney shifted toward more confident strategic investment, stating that it expected DTC investments to 'lead to growth in subscription fees and advertising revenues that will more than offset impacts on affiliate fees and advertising revenue from declines in linear network subscribers.' In 2024, Disney's relationship with DTC offerings became more operationally critical, as it noted that DTC streaming services 'compete for customers with an increasing number of competitors' DTC offerings' and that subscription fees and advertising rates were being impacted by competitive pressures. This evolution shows a shift from cautious investment in 2022 to a more integrated and strategically dependent posture by 2024, despite growing competitive intensity.",
      "llm_answer": "\nDisney’s DTC strategy evolved from a 2022 launch marked by heavy, loss‑making investments and a warning that growth would be uneven and dependent on execution amid intense competition (Chunk 1), to a 2023 shift toward targeted spending on DTC platforms—highlighted by the expectation that subscription‑fee and advertising revenue from these services would grow enough to more than offset declines in linear‑network fees and ad sales, and by the planned integration of DTC with the Star India joint‑venture to broaden its international footprint (Chunk 3); and finally, by 2024 the company was refining its competitive positioning through differentiated content, technology upgrades and partnerships, while explicitly stating that DTC‑derived subscription and ad revenues would drive overall revenue growth and that it would manage costs and capital allocation to sustain that trajectory (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer in terms of the evolution of Disney's DTC strategy from 2022 to 2024. (1) All key facts are correct: in 2022, Disney acknowledged financial risks and potential continued losses in DTC; in 2023, it expressed confidence that DTC subscription and ad revenue growth would offset declines in linear affiliate fees; and by 2024, it recognized increasing competitive pressures on DTC offerings. The LLM correctly identifies the shift from cautious investment to strategic dependence. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and strategic phases, correctly linking changes in investment focus, competitive positioning, and revenue expectations. It adds slightly more detail (e.g., Star India joint venture, technology upgrades, partnerships) not present in the original answer, but these are plausible contextual enhancements that do not contradict the ground truth and may reflect broader knowledge. However, the original answer does not mention the Star India integration or technology upgrades, so including them introduces minor content not verified by the ground truth, slightly reducing qualitative accuracy. (4) The answer is fully contextually relevant, addressing all parts of the question: investment focus, competitive positioning, and revenue growth expectations across the three years. Overall, the LLM captures the core evolution accurately with only minor additions beyond the source material, warranting a correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Invests_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 472,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did PayPal's (PYPL) relationship with its Fixed-rate 2.850% notes evolve from 2022 through 2024, particularly in terms of its debt structure and maturity obligations across these years?",
      "original_answer": "PayPal's Fixed-rate 2.850% notes remained consistently outstanding at $1.5 billion from 2022 through 2024, with no repayments or changes in principal across the three years. However, the broader debt structure around these notes evolved significantly: in 2022, the company carried $9.0 billion in total term debt, which increased to $10.638 billion by 2023 before slightly declining to $10.574 billion in 2024. The maturity of the 2.850% notes is set for 2029, indicating a long-term liability that remained unchanged while PYPL issued new debt instruments with higher interest rates in 2024 (e.g., 5.150% and 5.500% notes), suggesting a shift in financing strategy while maintaining the same long-term obligation to the 2.850% notes.",
      "llm_answer": "\nPayPal’s Fixed‑rate 2.850 % notes issued in September 2019 remain the same $1.5 billion obligation maturing on 10/1/2029 at a 2.96 % effective rate throughout 2022‑2024 – the notes are listed with a $1,500 million balance in the 2022 table (Chunk 1), again with $1,500 million outstanding in 2023 (Chunk 3) and still $1,500 million shown in 2024 (Chunk 2), never being increased or retired.  While the principal amount stayed constant, the notes’ place in PYPL’s debt structure shifted as the company added later‑dated issuances (e.g., the 2022‑2024 May and June debt issuances that pushed total term debt to $10.6 billion in 2023 and $10.57 billion in 2024), and the carrying amount was adjusted for amortization of premiums/discounts and the growing current‑portion reclassification (current portion rising from $999 m in 2022 to $1,191 m in 2024).  This evolution reflects a stable long‑term 2.850 % note component within PYPL’s broader debt portfolio, linked by the Issues_Debt and Has_Stake_In relationships that tie the financial instrument back to PayPal as its issuer and primary stakeholder.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key figures are correct: the $1.5 billion principal amount of the 2.850% notes is consistently reported for 2022–2024, matching the ground truth. The maturity date of October 1, 2029 (10/1/2029) is more precise than the ground truth’s general '2029' and is acceptable as additional detail. Total term debt values are approximately correct: $10.638B in 2023 and $10.574B in 2024 in the ground truth vs. $10.6B and $10.57B in the LLM answer—minor rounding is acceptable. The current portion increase from $999M to $1,191M is an accurate detail not in the ground truth but does not contradict it. (2) The effective interest rate of 2.96% is mentioned in the LLM answer but not in the ground truth; this is a minor addition that may come from filing details and does not detract from correctness. (3) The LLM correctly synthesizes multi-hop information: it identifies the stability of the 2.850% notes over three years while contextualizing them within a changing broader debt structure, including new issuances in 2022–2024 and shifts in total term debt. It also notes PayPal’s continued obligation and issuer relationship, capturing the evolution in structure. (4) The mention of new higher-rate debt (5.150%, 5.500%) in 2024 is implied in the LLM’s reference to 'later-dated issuances' but not explicitly stated—this is a minor omission but not a factual error. Overall, the answer is factually sound, well-reasoned, and contextually complete, warranting a high score with only a one-point deduction for slight over-specificity on the effective rate and less explicit emphasis on the strategic shift in financing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Issues_Notes]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 464,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did UNP's allocation to Corporate Stock within its pension plan assets evolve from 2022 to 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "UNP's allocation to Corporate Stock within its pension plan assets significantly declined from $1,990 million in 2022 to $181 million in 2023, and by 2024, the company had reclassified its common stock holdings as Level 1 investments while maintaining a smaller, more structured equity exposure through preferred shares classified as Level 2. This represents a dramatic reduction in equity exposure and a strategic shift toward more transparent and observable valuation methodologies for remaining stock investments.",
      "llm_answer": "\nUNP’s pension‑plan equity exposure fell sharply: in 2022 corporate stock held $1.99 bn of the $3.87 bn fair‑value assets (≈51 % of plan assets), but by 2023 that figure dropped to just $181 m of the $3.39 bn total (≈5 %). The 2024 filing (Chunk 3) only re‑states the valuation methodology for corporate stock and does not report a new allocation, confirming that the company has largely moved away from equities and now emphasizes fixed‑income and other assets in its pension strategy. This shift reflects a deliberate rebalancing toward more stable, lower‑volatility investments rather than continued heavy weighting in corporate equities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the sharp decline in UNP's allocation to Corporate Stock: from $1,990 million in 2022 to $181 million in 2023, which matches the ground truth. The dollar amounts are accurate (with acceptable formatting: $1.99 bn = $1,990 million; $181 m = $181 million). However, the LLM introduces percentages (51% in 2022, 5% in 2023) not present in the original answer. While these calculations are mathematically correct (1,990 / 3,870 ≈ 51.4%; 181 / 3,390 ≈ 5.3%), they are not part of the ground truth and add interpretation beyond the source. The 2024 information is partially accurate — the LLM correctly notes no new allocation is reported and references valuation methodology, but misses the key detail that common stock was reclassified as Level 1 and preferred shares (Level 2) now represent a structured equity exposure. This omission affects completeness and qualitative accuracy.\n\n2) Quantitative accuracy is high: all dollar figures and implied totals (e.g., $3.87bn and $3.39bn total plan assets) align with known data. The percentages, while correctly calculated, are inferential and not in the original answer, slightly reducing precision in representation.\n\n3) The multi-hop reasoning is mostly sound: the model connects 2022 and 2023 data correctly and infers a strategic shift. However, it fails to incorporate the 2024 reclassification detail (Level 1 common stock, Level 2 preferred shares), which is a key component of the ground truth’s explanation of ongoing equity strategy. This limits the depth of the synthesis.\n\n4) The answer is contextually relevant and addresses both parts of the question — the evolution of allocation and the implication for investment strategy. The conclusion about shifting to stable, lower-volatility investments aligns with the ground truth’s emphasis on transparency and valuation methodology, though it frames the shift more broadly in terms of risk rather than the specific move toward observable valuations (Level 1/Level 2 classification). This is a valid interpretation but not fully equivalent to the original’s focus on valuation transparency.\n\nOverall, the answer is factually strong and well-reasoned but misses a critical nuance in the 2024 update regarding investment classification, which slightly diminishes completeness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 623,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Pfizer's long-term investment in private equity securities at cost change from 2022 to 2024, and what does this trend suggest about the company's strategic allocation to illiquid alternative investments over this period?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, then slightly declined to $719 million in 2024. This indicates a short-term growth strategy in alternative investments in 2023, followed by a modest retrenchment in 2024, suggesting a cautious approach to illiquid asset allocation despite broader shifts in Pfizer's investment portfolio.",
      "llm_answer": "\nPfizer’s private‑equity holdings at cost fell from **$800 million in 2022** (Chunk 2) to **$755 million in 2023** (Chunk 3) and then to **$719 million in 2024** (Chunk 3), a cumulative reduction of roughly **$81 million (≈10 %)**. This steady decline—reflected in the disclosed “Private equity securities at cost” line item across all three filings (KG: PFE → Private Equity Securities at Cost) — signals that the company is scaling back its exposure to illiquid alternative investments and likely reallocating capital toward more liquid or core pharmaceutical assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the starting value: it claims Pfizer's long-term investment in private equity securities at cost was $800 million in 2022, whereas the ground truth is $623 million. This is a major quantitative inaccuracy. The values for 2023 ($755 million) and 2024 ($719 million) are correct and match the ground truth. However, due to the incorrect 2022 figure, the calculated change (cumulative reduction of $81 million, ≈10%) is also wrong. The actual increase from 2022 to 2023 was +$132 million, followed by a decrease to $719 million in 2024. (2) Calculations: The claimed 'steady decline' and 'cumulative reduction' are invalid because the trend began with an increase, not a decrease. The LLM incorrectly frames the entire period as a downward trajectory, which contradicts the ground truth showing growth in 2023. (3) Multi-hop reasoning: The model fails to correctly synthesize the trend across years—instead of identifying the rise then slight fall, it assumes a continuous decline, indicating flawed reasoning. It also references 'Chunk 2' and 'Chunk 3', suggesting internal document tags not present in the original data, raising concerns about source fidelity. (4) Despite incorrect numbers and trend interpretation, the answer is contextually relevant—addressing the right metric, company, and strategic implications—and attempts qualitative analysis about capital reallocation. However, the conclusion about 'scaling back' and 'steady decline' is unsupported due to the erroneous baseline. The qualitative reasoning would have been stronger had it used accurate data. Thus, while the structure and intent are sound, the factual foundation is partially incorrect, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 482,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Mastercard's implementation of its multi-layered security approach evolve from 2022 through 2024, particularly in terms of third-party collaboration, real-time payment infrastructure expansion, and resilience against cyber threats?",
      "original_answer": "From 2022 to 2024, Mastercard's implementation of its multi-layered security approach became more robust and externally collaborative. In 2022, the company emphasized a multi-layered approach involving Security Operations Centers, Fusion Centers, and the Mastercard Intelligence Center, working internally and through public-private partnerships to monitor and respond to threats. It also highlighted its work with stakeholders to develop technical standards like EMV for secure transactions. By 2023, Mastercard expanded this approach by explicitly including third-party service providers in its threat monitoring and response framework and noted that it was operating or implementing real-time payment infrastructure in 13 markets as of year-end, enhancing the security footprint across more jurisdictions. In 2024, the company further deepened its external collaboration, noting that it worked with experts across the organization and through third-party providers to monitor and respond to cyber threats, while also expanding its real-time payments infrastructure globally. This evolution shows a strategic shift toward broader ecosystem integration and enhanced resilience through both technological and partnership-driven security layers.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard deepened its third‑party collaboration—working with issuers, acquirers, merchants, governments and industry associations, leveraging benchmarking, public‑private partnerships and EMV‑type technical standards—while expanding its joint‑venture processing in China (2024) and extending domestic card acceptance there.  Simultaneously, it broadened real‑time payment infrastructure, moving from operating or implementing real‑time capabilities in 12 of the top‑50 GDP markets by the 2021 baseline (2022 reference) to 13 markets by end‑2023 and to full domestic processing in China in 2024, thereby scaling account‑to‑account and ACH‑batch services globally.  Throughout this evolution the multi‑layered security program maintained resilience via continuous testing, an enterprise‑resilience and insurance program, Security Operations Centers, Fusion Centers and the Mastercard Intelligence Center, all assessed by third parties to ensure robust protection against cyber threats across the network.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Mastercard's multi-layered security approach from 2022 to 2024, with accurate emphasis on third-party collaboration, real-time payment infrastructure expansion, and cyber resilience. It correctly notes the increase in real-time payment infrastructure from 12 to 13 markets by end-2023, aligning with the ground truth. However, it introduces a claim not present in the original answer—specifically, the 'joint-venture processing in China (2024)' and 'full domestic processing in China in 2024'—which is not mentioned in the ground truth and represents an unsupported addition. Additionally, the reference to '12 of the top-50 GDP markets by the 2021 baseline (2022 reference)' slightly misrepresents the original, which only states the 13-market figure for 2023 without a 2022 baseline comparison. (2) Quantitatively, the 13-market figure for 2023 is correct, but the 12-market figure for 2022 is inferred and not explicitly confirmed in the ground truth, introducing uncertainty. The lack of a clear 2022 baseline in the original answer makes this a minor inaccuracy. (3) The multi-hop reasoning is strong: the LLM synthesizes third-party collaboration, infrastructure growth, and security resilience across years, correctly identifying the trend toward broader ecosystem integration. The mention of EMV standards, public-private partnerships, and internal security centers (SOCs, Fusion Centers, Intelligence Center) matches the original. (4) Despite the minor factual overreach on China operations and the unverified 12-market claim, the answer is contextually highly relevant and conveys a semantically close evolution of Mastercard’s security strategy. The core facts on collaboration, real-time payments, and threat resilience are accurate, warranting a high correctness score with a deduction for unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 511,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did ExxonMobil's (XOM) reported collateral under master netting arrangements related to 'Other assets, including intangibles - net' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure management over time?",
      "original_answer": "ExxonMobil's reported collateral under master netting arrangements, which are tied to 'Other assets, including intangibles - net', increased from $641 million at the end of 2021 (reported in the 2022 filing), peaked at $800 million at the end of 2022 (reported in the 2023 filing), and then declined to $491 million at the end of 2023 (reported in the 2024 filing). This represents a 38% decrease from 2022 to 2024. The trend suggests a shift in the company's derivative exposure management, potentially reflecting reduced initial margin requirements or strategic adjustments in derivative positions during this period.",
      "llm_answer": "\nThe collateral that ExxonMobil reports under master‑netting arrangements—recorded in the “Other assets, including intangibles – net” line—fell sharply over the three years: $1.49 billion at the end of 2022, $0.80 billion at the end of 2023, and $0.49 billion at the end of 2024.  This steady decline shows that the company has been reducing the amount of segregated collateral it must hold against its derivative positions, indicating a more efficient netting strategy and a lower reliance on large margin‑requirement buffers to manage derivative exposure over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. According to the ground truth, the collateral values are: $641M at end of 2021 (reported in 2022 filing), $800M at end of 2022 (reported in 2023 filing), and $491M at end of 2023 (reported in 2024 filing). The LLM incorrectly states $1.49B at end of 2022, $0.80B at end of 2023, and $0.49B at end of 2024 — all of which are wrong in both magnitude and timing. The LLM also references a 2024 value ($0.49B), but the latest available data is for end of 2023 (reported in 2024 filing), so the time frame is misrepresented. (2) The quantitative inaccuracies are severe: the starting value is more than double the true amount ($1.49B vs $800M), and the decline is portrayed over incorrect years. The 38% decrease cited in the ground truth (from $800M to $491M) is accurate, but the LLM does not calculate or reference this correctly. (3) The multi-hop reasoning is partially sound — the LLM correctly identifies that changes in collateral relate to derivative exposure management and infers reduced margin requirements — but this conclusion is based on incorrect data. The logic about more efficient netting strategy is plausible but not fully supported due to data errors. (4) Contextual relevance is fair because the answer addresses the right metric, company, and conceptual link between collateral and derivative management. However, due to major numerical and temporal errors, the correctness score is low. The answer fails on core factual accuracy, which is critical in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 436,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the expected volatility of Duke Energy's stock, as determined by its relative TSR model against a predefined peer group, change from 2022 through 2024, and what might this multi-year shift suggest about the company's market risk perception?",
      "original_answer": "The expected volatility of Duke Energy's stock in its TSR model was 26.9% in 2022, increased to 28.6% in 2023, and then decreased to 18.7% in 2024. This trajectory indicates a peak in perceived market risk in 2023, followed by a significant decline in 2024, suggesting a stabilization or reduced uncertainty in Duke Energy's market position relative to its peers over the three-year period.",
      "llm_answer": "\nThe relative‑TSR model disclosed in the Duke Energy 10‑K filings values performance awards by incorporating the company’s expected three‑year volatility relative to a predefined peer group (KG: DUK → Predefined Peer Group).  The filings show that the expected volatility used for the performance‑award calculations was about 28.6 % in the 2023 grant year (Chunk 3), fell to 18.7 % in the 2024 grant year (Chunk 2), and had been roughly 26.9 % for the earlier 2021/2022 cycles (Chunk 1).  This multi‑year decline in expected volatility indicates that the market now perceives Duke Energy’s stock as less risky relative to its peers, reflecting a reduced expectation of large price swings.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the volatility values of 26.9%, 28.6%, and 18.7% for the respective years, which matches the ground truth. However, it mislabels the 2022 value as belonging to '2021/2022 cycles' and does not clearly assign 26.9% specifically to 2022 as required by the question. This introduces ambiguity, though the number itself is accurate. The 2023 (28.6%) and 2024 (18.7%) values are correctly attributed. (2) All numeric values are factually correct and match the ground truth, but the chronological framing is slightly off—referring to '2021/2022 cycles' instead of cleanly stating 2022 weakens precision. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes volatility data across multiple years and correctly infers a declining trend post-2023, linking it to reduced market risk perception. The conclusion about stabilization aligns with the ground truth. (4) The answer is contextually excellent—directly addresses the question’s focus on trend and implication. The minor issue in year labeling prevents a perfect score, but overall factual and semantic accuracy is high. Thus, correctness is rated 8 due to slight incompleteness in cleanly mapping all values to the exact years asked (2022–2024), despite having the right numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 367,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did General Motors' indemnification obligations and accruals related to Stellantis evolve from 2022 through 2024, particularly in relation to legacy Opel/Vauxhall emissions claims and Takata recalls?",
      "original_answer": "In 2022, GM disclosed that it indemnified Stellantis for an immaterial amount related to certain recalls, including those involving Takata inflators in legacy Opel vehicles, and noted the potential for future indemnification obligations. By 2023, GM reiterated the immaterial indemnification and stated that further indemnification related to Takata recalls was considered remote. In 2024, GM continued to emphasize that any potential future indemnification obligations for Stellantis’ Takata recalls remained remote, while also noting that it had accrued an immaterial amount related to European Commission and UK CMA investigations into conduct by Opel prior to the sale. This indicates a consistent stance that the financial exposure to Stellantis-related indemnifications remained minimal and stable across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 General Motors repeatedly disclosed that it indemnifies Stellantis for any losses stemming from the 2017 sale of Opel/Vauxhall—including emissions‑related claims and Takata‑inflator recalls—yet the indemnity is capped, time‑limited and GM has been unable to estimate a material loss, recording only an immaterial accrual (or none at all) for these matters; in the 2022 filing it said it could not quantify any reasonably possible loss, in the 2023 filing it reported $615 million/$561 million of product‑liability accruals that are unrelated to the Stellantis indemnity, and in the 2024 filing it still indemnified Stellantis for an immaterial amount for Takata recalls and accrued an immaterial sum related to the European Commission and UK CMA investigations, indicating that any further indemnification is remote.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding financial figures. The mention of '$615 million/$561 million of product-liability accruals' in the 2023 filing is not supported by the ground truth, which states that GM disclosed only an immaterial indemnification and that further obligations were considered remote. These specific numbers are not referenced in the original answer and appear to be fabricated or misattributed. Additionally, the ground truth does not mention any cap or time limit on the indemnity, which the LLM introduces without support. (2) Quantitative accuracy is low because the cited dollar amounts ($615M, $561M) are incorrect and not present in the original answer. The original answer emphasizes 'immaterial' accruals across all years, with no specific dollar figures provided. The LLM’s inclusion of precise but unsupported numbers severely undermines factual reliability. (3) The multi-hop reasoning is partially sound in that the model attempts to synthesize GM’s indemnification obligations across years and link them to both Takata recalls and emissions claims. However, it fails to accurately represent the consistency of GM’s stance—namely, that exposures remained immaterial and future obligations remote—due to the introduction of erroneous data. The mention of accruals related to European Commission and UK CMA investigations in 2024 is correct and aligns with the original answer. (4) Contextual relevance is high because the response addresses the core topics—indemnification evolution, Takata recalls, Opel/Vauxhall emissions—and spans the correct time frame. However, the introduction of unsupported specifics, especially numerical ones, reduces overall correctness. The qualitative accuracy is moderate due to correct entity identification (GM, Stellantis, Opel/Vauxhall, Takata, EC, CMA) and general timeline accuracy, but flawed reasoning due to unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Guarantees]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 528,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did AMD's reference to the 2011 Executive Incentive Plan evolve across its filings in 2022, 2023, and 2024, and what does this consistency suggest about its long-term executive compensation strategy?",
      "original_answer": "AMD consistently referenced the 2011 Executive Incentive Plan in its filings for 2022, 2023, and 2024 without introducing any amendments or new disclosures about the plan itself. In 2022, the plan was listed as Exhibit 10.1 and was described as filed on April 2, 2011. In 2023 and 2024, the same description and reference were maintained, indicating no changes to the plan were made during this period. This consistent referencing of the original filing suggests that AMD maintained a stable executive compensation framework without material modifications to the 2011 plan over the three-year span.",
      "llm_answer": "\nAMD continues to file the **2011 Executive Incentive Plan** as Exhibit 10.1 in its 2022, 2023 and 2024 Form 10‑K/10‑Q filings (see Chunk 1 *10.1, Chunk 2 *10.1, Chunk 3 *10.1), each time stating that the exhibit is “hereby incorporated by reference.”  This repeated incorporation—linked across the three years via the KG pattern AMD → 2011 Executive Incentive Plan (ACCOUNTING_POLICY) → AMD—shows that the plan remains a core, unchanged component of AMD’s executive‑compensation framework.  The consistency signals a long‑term strategy that relies on the 2011 plan to align executive pay with performance and shareholder interests, reinforcing stability and continuity in the company’s compensation philosophy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities—AMD, the 2011 Executive Incentive Plan, Exhibit 10.1, and the years 2022–2024—are correctly identified. The consistent referencing of the plan as Exhibit 10.1 in each year matches the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts or percentages), but the dates and exhibit numbers are correct and consistent with the ground truth. The statement that the plan was originally filed on April 2, 2011, while not repeated in the LLM answer, is not contradicted, and the use of 'incorporated by reference' correctly reflects standard SEC filing practice. (3) The multi-hop reasoning is sound: the LLM correctly infers from repeated incorporation across three years that the plan remained unchanged, which supports the conclusion about strategic consistency. The mention of a KG pattern (AMD → 2011 Executive Incentive Plan → AMD) reflects an understanding of cross-year document linkage, though slightly technical in phrasing. (4) The LLM adds interpretive value by stating the plan aligns executive pay with performance and shareholder interests—this is a reasonable inference about compensation philosophy and enhances the answer without overreaching. The only minor gap is that the original answer explicitly notes no amendments or new disclosures were made, which the LLM implies but does not state directly. Overall, the answer is semantically equivalent, highly relevant, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Files]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 430,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's exposure to bad transactions risk evolve from 2022 through 2024, particularly in relation to its credit products, cross-border trade, and third-party dependencies, and what strategic actions were taken in 2023 to mitigate this risk?",
      "original_answer": "In 2022, PayPal highlighted increasing risks of bad transactions tied to credit defaults, particularly in its U.S. consumer credit product with Synchrony Bank, and noted that economic conditions like recessions and high unemployment could exacerbate non-payment rates. In 2023, PayPal responded by entering a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, aiming to reduce exposure to bad transactions in its credit portfolio. By 2024, PayPal continued to emphasize the risks of fraud and bad transactions, particularly in digital payments, and noted ongoing challenges related to third-party reliance and regulatory uncertainty, especially around the validity of loan sales post-transfer. The strategic move in 2023 to offload BNPL receivables was a key mitigation step, reflecting a broader shift to manage credit risk and reduce exposure to bad transactions.",
      "llm_answer": "\nPayPal’s bad‑transaction risk in 2022 was rooted in credit‑product defaults and the resulting charge‑off exposure on the receivables it purchases (U.S. merchant‑financing and international credit), a heavy reliance on third‑party lenders and payment processors, and the strategic importance of cross‑border trade that could be disrupted by fraud, regulatory changes or economic stress (Chunk 1).  \nIn 2023 the company introduced a strategic mitigation plan: it entered into a multi‑year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables with a forward‑flow structure (sale began in October 2023 and is subject to conditions) and, at the same time, began diversifying its payment‑processor network and migrating its arrangements to other providers to reduce concentration risk, while also exploring additional third‑party funding sources for future credit products (Chunk 3).  \nThese actions—off‑loading a large portion of BNPL exposure, creating a conditional forward‑flow sale, and broadening third‑party funding and processor options—re‑shaped PayPal’s risk profile from a primarily credit‑default exposure in 2022 to a more managed, asset‑sale and partnership‑driven model by 2024, while the underlying cross‑border and fraud‑related threats remain but are now addressed through the same diversification and regulatory‑compliance measures highlighted in the 2024 filing (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's 2022 risk exposure included credit defaults (especially in U.S. consumer credit), third-party dependencies, and cross-border trade vulnerabilities. In 2023, the strategic action was the multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, which began in October 2023—this timing and amount match the ground truth. By 2024, ongoing risks around fraud, third-party reliance, and regulatory uncertainty (e.g., loan sale validity post-transfer) are correctly noted. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly stated, and the October 2023 start date for the sale is an additional precise detail not in the original answer but consistent with plausible elaboration. No calculations were required. (3) Multi-hop reasoning is sound: the LLM synthesizes risk evolution across three years, connects credit products, cross-border trade, and third-party dependencies, and correctly identifies the 2023 receivables sale as the central mitigation. It adds value by noting forward-flow structure and processor diversification, which are reasonable inferences or minor expansions supported by context (labeled as 'Chunk 3' evidence). (4) The only reason for not scoring 10 is that the original answer does not explicitly mention diversifying payment processors or exploring new funding sources—these are plausible strategic extensions but not confirmed in the ground truth. However, they do not contradict it and fit contextually. Overall, the answer is factually correct, comprehensive, and semantically equivalent to the original with slightly enhanced detail. Hence, correctness is 9 due to minor addition of unconfirmed (but not incorrect) details, while quantitative accuracy and contextual relevance remain perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1605,
        "completion_tokens": 509,
        "total_tokens": 2114
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Union Pacific's ownership and aging profile of Multiple Purpose Locomotives evolve from 2022 to 2024, and what does this indicate about the company's fleet management and modernization strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's owned Multiple Purpose Locomotives decreased slightly from 6,204 to 5,973 units, while leased units dropped more significantly from 1,038 to 920. Over the same period, the average age of the Multiple Purpose Locomotive fleet increased from 22.5 years to 25.2 years, indicating a continued reliance on older assets despite reductions in leased equipment. This suggests a fleet management strategy that prioritizes cost control over aggressive modernization, as the company reduced leasing but did not substantially increase new purchases to offset aging.",
      "llm_answer": "\nFrom 2022 to 2024 Union Pacific’s Multiple Purpose Locomotive fleet contracted and aged: the owned count fell modestly from 6,204 (Chunk 1) to 5,971 (Chunk 2) then edged up to 5,973 (Chunk 3), while leased units dropped from 1,038 (Chunk 1) to 1,037 (Chunk 2) and then to 920 (Chunk 3), pushing total units down from 7,242 to 7,008 to 6,893; concurrently the average age rose from 22.5 years (Chunk 1) to 24.3 years (Chunk 2) and 25.2 years (Chunk 3). This pattern—slightly shrinking, increasingly older owned assets and a growing share of retained ownership versus leased capacity—signals Union Pacific’s strategy of consolidating a smaller, legacy‑heavy owned base while curbing reliance on external leased locomotives, underscoring a focus on long‑term fleet modernization and phased retirement of the oldest units.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several inaccuracies in the quantitative details. While the starting 2022 owned units (6,204) and leased units (1,038) are correct, the intermediate and final figures are misrepresented. The LLM states owned units went to 5,971 in 2023 and then 5,973 in 2024, but the ground truth shows a direct decrease to 5,973 in 2024 with no intermediate data provided—thus the stepwise progression is fabricated. Similarly, leased units are said to decline to 1,037 in 2023 before dropping to 920 in 2024, but the ground truth does not support an intermediate 1,037 figure; it only reports 1,038 in 2022 and 920 in 2024. The average age progression is also incorrect: the LLM reports 22.5 → 24.3 → 25.2 years, but the ground truth only provides 22.5 in 2022 and 25.2 in 2024—no 24.3 figure is supported. These fabricated intermediate values undermine factual accuracy.\n\n2) Calculations: The total fleet sizes (7,242 = 6,204 + 1,038; 6,893 = 5,973 + 920) are mathematically correct, but the intermediate total of 7,008 (based on 5,971 + 1,037) relies on incorrect inputs. While arithmetic is sound, the inputs are not fully accurate, leading to misleading trends.\n\n3) Multi-hop reasoning: The LLM correctly identifies the overall trend of decreasing fleet size and increasing age, and it attempts to interpret strategic implications. However, its conclusion—that the company is focusing on 'long-term fleet modernization and phased retirement'—contradicts the ground truth interpretation, which emphasizes cost control *over* aggressive modernization due to lack of new purchases. This misreads the strategic implication: aging fleet + reduced leasing without replacement suggests restraint, not active modernization. Thus, the reasoning is partially flawed in synthesis.\n\n4) Despite these issues, the answer is contextually relevant and addresses all parts of the question: ownership changes, aging profile, and strategic interpretation. The core direction of trends (fewer units, older fleet) is correct, and the entity (Union Pacific), metric (Multiple Purpose Locomotives), and time frame (2022–2024) are accurate. Wording differences are acceptable, but the inclusion of unsupported intermediate data and the incorrect strategic inference reduce correctness. Quantitative accuracy is low due to fabricated data points; qualitative reasoning is moderate but flawed in conclusion; relevance is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Owns]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 641,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has ExxonMobil's collateral exposure under master netting arrangements related to equity company receivables changed from 2022 to 2024, and what does this trend suggest about their derivative risk management approach?",
      "original_answer": "ExxonMobil's collateral exposure under master netting arrangements was $641 million in 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This trend shows a peak in 2023 followed by a decline in 2024, indicating a potential shift in derivative risk management strategy. The use of level 3 fair value inputs for equity company receivables and long-term obligations, as disclosed across all three years, suggests continued reliance on internal models for valuation, but the drop in 2024 may signal reduced exposure or improved credit conditions. The fluctuation reflects dynamic risk positioning in response to market conditions.",
      "llm_answer": "\nExxonMobil’s collateral that is pledged under master‑netting arrangements and tied to receivables from equity‑company affiliates fell sharply from **$1.494 billion at the end of 2022** (Chunk 1) to **$800 million in 2023** and further to **$491 million by the end of 2024** (Chunk 2).  This reduction of roughly **$1.0 billion (≈ 67 %)** over the two‑year span reflects a deliberate pull‑back in the amount of collateral it uses to support derivative positions.  The trend signals that ExxonMobil is adopting a more conservative derivative‑risk approach—relying less on extensive offsetting collateral and instead emphasizing initial‑margin requirements and tighter control of counterparty exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant quantitative errors. According to the ground truth, collateral exposure was $641 million in 2022, not $1.494 billion as stated by the LLM. The 2023 value ($800 million) and 2024 value ($491 million) are correct. The claimed reduction of $1.0 billion (67%) is therefore inaccurate due to the incorrect 2022 baseline. (2) Calculations are flawed: a drop from $1.494B to $491M is ~67%, but from the correct $641M to $491M is only a ~23% decrease, making the LLM's percentage misleading. The direction of change (increase then decrease) is partially correct (2022–2023 increase, 2023–2024 decrease), but the LLM incorrectly portrays a continuous decline from 2022. (3) The qualitative reasoning about a more conservative risk approach is plausible but contradicts the ground truth interpretation: the actual trend (641 → 800 → 491) shows a peak in 2023, suggesting increased exposure before retrenchment, not a steady pullback. The LLM misses this nuance and incorrectly infers a 'deliberate pull-back' starting in 2022. However, it correctly identifies the relevance of collateral in derivative risk management and ties it to counterparty exposure. (4) Entity accuracy (ExxonMobil, years, metric) is correct, and the answer addresses both parts of the question (change over time and implications), satisfying completeness and contextual relevance. Despite incorrect numbers, the answer attempts multi-hop synthesis and draws a reasonable (though misinformed) conclusion based on flawed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 418,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the revenue composition of Starbucks' 'Other' category, which includes single-serve coffees, evolve from 2022 to 2024, based on the specific items listed in each year's 10-K filing?",
      "original_answer": "The 'Other' category, which includes single-serve coffees, remained relatively stable in its composition from 2022 to 2024. In 2022, 'Other' primarily consisted of packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, serveware, and ready-to-drink beverages. In 2023, the description remained largely unchanged, with the same key components listed. By 2024, the structure of the 'Other' category was consistent with prior years, continuing to include packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware. There was no explicit mention of new product categories or significant shifts in this segment over the three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings, Starbucks consistently defines “Other” as encompassing packaged and single‑serve coffees and teas, royalty and licensing revenues, beverage‑related ingredients, serveware and similar items – explicitly listing single‑serve coffee as a component each year. Consequently, the revenue composition of the “Other” category, which includes single‑serve coffees, shows no material change in its constituent items from 2022 through 2024, remaining centered on those packaged and single‑serve coffee products along with related royalty, ingredient and serveware revenues. This stability is reflected in the identical description of the “Other” segment in the three filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that the 'Other' category, which includes single-serve coffees, remained stable from 2022 to 2024, with no material changes in composition. (2) There are no numerical figures involved in this question, so quantitative accuracy pertains to correct use of years (2022, 2023, 2024), which are all accurately referenced. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings and correctly infers consistency in the segment description, concluding no significant shifts occurred. (4) The LLM accurately lists the components of the 'Other' category—packaged and single-serve coffees and teas, royalty and licensing revenues, beverage-related ingredients, and serveware—and notes that single-serve coffee is explicitly mentioned each year. The conclusion of 'no material change' and 'identical description' aligns with the ground truth assertion of consistency and absence of new categories. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 323,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the monetization of advertising inventory through Google Ad Manager evolve across Google Network properties from 2022 to 2024, particularly in terms of impression-based revenue recognition and gross revenue reporting?",
      "original_answer": "From 2022 to 2024, Google consistently monetized advertising inventory through Google Ad Manager on Google Network properties using impression-based and click-based revenue models. In 2022, Google recognized impression-based revenues by dividing total impression-based and click-based revenues by the number of impressions, with a focus on cost-per-impression as a key metric. In 2023, Google clarified that it generally reports advertising revenues for ads placed on Google Network properties on a gross basis, meaning the full amount billed to customers is recorded as revenue. This approach remained consistent in 2024, with further emphasis on the company's role as principal in these transactions, reinforcing its control over the advertising inventory and supporting the gross revenue recognition model. The evolution shows a consistent monetization strategy with increasing transparency and accounting clarity over time.",
      "llm_answer": "\nFrom 2022 through 2024 the company consistently recognized impression‑based advertising revenue on Google Network properties (via AdMob, AdSense and Google Ad Manager) when an ad was displayed, refining the counting methodologies for impressions and the associated cost‑per‑impression metric each year; this evolution is reflected in the 2022 description of impression‑based revenue, the 2023 confirmation that such inventory is evaluated for principal‑vs‑agent treatment and is reported on a gross‑basis (billing amount recorded as revenue, partner payments as cost of revenue), and the 2024 clarification that Google retains control of the advertising inventory before it is transferred to customers, reinforcing the gross‑basis reporting and the central role of the Google Ad Manager product—produced by and dependent on GOOGL—across the Google Network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google used impression-based and click-based revenue models via Google Ad Manager across Google Network properties from 2022 to 2024. The evolution in accounting treatment—particularly gross revenue reporting and principal-vs-agent evaluation—is accurately described for each year. (2) There are no numeric values (e.g., dollar amounts, percentages, impression counts) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and accounting concepts—impression-based recognition in 2022, gross reporting confirmation in 2023, and control rationale in 2024—demonstrating understanding of the evolving disclosure in financial filings. (4) The LLM adds slight elaboration (e.g., mentioning AdMob and AdSense, specifying partner payments as cost of revenue, noting GOOGL as the producer), which is contextually accurate but not in the original answer; however, these do not introduce errors and enhance completeness without distorting meaning. The only minor gap is that the original emphasizes 'cost-per-impression as a key metric' in 2022, which the LLM mentions but doesn't emphasize as strongly. Overall, the answer is semantically equivalent, factually correct, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 410,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has MDLZ's exposure to sales and media marketing restrictions evolved across 2022, 2023, and 2024, particularly in relation to front-of-pack labeling requirements and jurisdictional expansion of extended producer responsibility (EPR) policies?",
      "original_answer": "In 2022, MDLZ noted that over 25 EU countries had implemented EPR policies and that restrictions on advertising products with specified nutrient profiles were in place, with similar policies being considered in India, Vietnam, Indonesia, and the Philippines. By 2023, the company reiterated the same EPR expansion but emphasized increased attention to front-of-pack labeling based on nutrient profiles and environmental claims, while also noting that single-use plastic bans and taxes were being considered in Indonesia and the Philippines. In 2024, MDLZ observed that the EU had formally adopted the Packaging and Packaging Waste Directive, and EPR policies were now being implemented or contemplated in India, Vietnam, and U.S. states, indicating a shift from contemplation to enforcement. The trend shows a growing regulatory burden across more jurisdictions, with increasing specificity around marketing restrictions tied to health and environmental claims.",
      "llm_answer": "\nMDLZ’s exposure to front‑of‑pack labeling and sales/media‑marketing restrictions has remained a core regulatory theme across all three filings, with the company repeatedly noting that its products are subject to nutrient‑profile‑based labeling rules and promotional limits in the jurisdictions where it operates. Beginning in 2022 the firm highlighted existing labeling and marketing curbs, and by 2023 it pointed to the expansion of extended‑producer‑responsibility (EPR) policies—already enacted in more than 25 EU member states and now being contemplated in India, Vietnam and several U.S. states—thereby widening the jurisdictional scope of those restrictions. The 2024 filing reiterates that EPR initiatives are being implemented or considered in additional regions, confirming a steady evolution from awareness to a broader, multi‑jurisdiction regulatory footprint that continues to shape MDLZ’s compliance landscape.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of MDLZ's exposure to front-of-pack labeling and EPR policies across 2022–2024. It accurately notes that in 2022, MDLZ highlighted existing marketing and labeling restrictions, with EPR policies in over 25 EU countries—a key quantitative detail correctly preserved. The 2023 update correctly identifies continued EPR expansion and growing attention to front-of-pack labeling, though the LLM omits the specific mention of single-use plastic bans and taxes being considered in Indonesia and the Philippines, which were part of the original 2023 developments. The 2024 update correctly states that EPR policies are now being implemented or considered in India, Vietnam, and U.S. states, aligning with the ground truth’s shift from contemplation to enforcement. However, the LLM fails to mention the formal adoption of the EU’s Packaging and Packaging Waste Directive in 2024, a significant regulatory milestone. While the overall trend of increasing jurisdictional reach and regulatory burden is correctly synthesized, the omission of specific policy developments and regional nuances (e.g., environmental claims in labeling, plastic taxes) results in minor incompleteness. Quantitatively, all numbers (e.g., 'over 25 EU countries') are accurate and consistently reported. The reasoning is sound, showing multi-hop synthesis across years and jurisdictions, though slightly less precise in 2024 details. The answer remains contextually highly relevant, directly addressing the question’s focus on temporal evolution and jurisdictional expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 438,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency across three years indicate about MA's capital structure strategy?",
      "original_answer": "Across 2022, 2023, and 2024, A Class shares consistently maintained one vote per share and dividend rights, indicating no changes in their voting or dividend entitlements over the three-year period. This stability suggests that MA has maintained a consistent capital structure strategy with respect to A Class shares, preserving their governance and economic rights without alteration.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings (Chunks 1‑3), the A Class shares consistently retained a $0.0001 par value, 3,000 million authorized shares, one vote per share and full dividend rights, with no change in these attributes in any year. This unchanged voting‑and‑dividend structure over three consecutive years reflects MA’s deliberate capital‑structure strategy of preserving ownership control and predictable return characteristics while keeping the authorized share base stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that A Class shares maintained one vote per share and full dividend rights across 2022, 2023, and 2024, which matches the original answer's core claim of consistency. (2) The additional details—$0.0001 par value and 3,000 million authorized shares—are factually correct (based on typical MA filings) and enhance completeness without contradicting the ground truth; these were not included in the original answer but are contextually relevant and accurate. (3) The reasoning about MA’s capital structure strategy—preserving ownership control and return predictability—is a reasonable interpretation of the stability observed, and the multi-hop synthesis across three years is sound. (4) The only minor gap is that the original answer emphasizes the *lack of change* as indicating strategic consistency, while the LLM infers 'deliberate strategy' with slightly stronger causal language, which is plausible but slightly beyond the data. However, this does not constitute an error. All entities (A Class shares, MA, years 2022–2024) and financial attributes are correct. Number formats are consistent and accurate. The answer fully addresses both parts of the question: evolution (no change) and strategic implication. Thus, the answer earns a 9 for correctness due to slight over-interpretation, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 401,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ExxonMobil's collateral under master netting arrangements related to 'Investments, advances and long-term receivables' change from 2022 through 2024, and what does this trend suggest about the company's derivative exposure and margin requirements over this period?",
      "original_answer": "ExxonMobil's collateral under master netting arrangements not offset against derivatives was $641 million at the end of 2022, increased to $800 million in 2023, and then decreased to $491 million in 2024. This fluctuation suggests a dynamic derivative exposure profile, with a notable increase in margin requirements in 2023, followed by a significant reduction in 2024, potentially reflecting changes in market volatility, hedging strategies, or credit conditions.",
      "llm_answer": "\nExxonMobil’s collateral that is tied to the “Investments, advances and long‑term receivables” line fell sharply over the period – it was $1,494 million at the end of 2022, dropped to $800 million by the end of 2023, and then to $491 million by the end of 2024 (as disclosed in the 2022, 2023 and 2024 10‑K filings).  This decline reflects a reduction in the amount of master‑netting collateral that must be posted, indicating that the company’s derivative exposure and the associated initial‑margin requirements have been shrinking each year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, collateral was $641 million in 2022, increased to $800 million in 2023, and decreased to $491 million in 2024. However, the LLM incorrectly states that the 2022 value was $1,494 million, which is not supported by the ground truth. This major error affects the entire trend interpretation. The 2023 and 2024 figures ($800M and $491M) are correct. (2) The calculation and comparison of changes are therefore flawed: the LLM describes a 'sharp fall' from $1,494M to $800M to $491M, implying a consistent downward trend, but the actual data shows an increase from 2022 to 2023 before a drop in 2024. This misrepresents the volatility in margin requirements. (3) The reasoning is partially sound in linking collateral changes to derivative exposure and margin requirements, which is contextually appropriate. However, because the initial data point is wrong, the conclusion that exposure 'has been shrinking each year' is incorrect — the real trend is non-monotonic, suggesting more complex dynamics such as increased hedging or market volatility in 2023. (4) Despite the factual error in the 2022 number, the answer correctly identifies the metric, time frame, and financial context, and attempts proper multi-hop synthesis across three years of data. The qualitative logic would have scored higher if based on accurate numbers. Contextual relevance is high as it directly addresses the question’s focus on trends and implications for derivatives and margin. Quantitative accuracy is low due to the incorrect 2022 figure, which skews the analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 451,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Starbucks' forward-looking supply chain commitments to coffee producers evolve from fiscal 2022 through fiscal 2024, and what does this progression indicate about the company's strategy for managing coffee price volatility and supply risk?",
      "original_answer": "In fiscal 2022, Starbucks secured an adequate supply of green coffee through purchase commitments expected to last through fiscal 2023. By fiscal 2023, the company extended its forward-looking commitments, projecting adequate supply through fiscal 2025. This trend continued into fiscal 2024, with Starbucks maintaining the same extended supply assurance through 2025, indicating a strategic shift toward longer-term stability in sourcing and price hedging. The company also consistently utilized forward contracts, futures contracts, and collars across all three years to manage 'C' price exposure, showing an evolving but consistent risk mitigation approach in response to coffee price volatility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024, Starbucks lengthened its forward‑looking green‑coffee purchase horizon—from commitments that would secure supply only through fiscal 2023 (Chunk 1) to commitments adequate through fiscal 2025 (Chunks 2 & 3)—while consistently using fixed‑price and price‑to‑be‑fixed contracts together with forward, futures and collar hedges to lock in “C”‑price exposure (Chunks 2 & 3). This evolution reflects a strategy that blends longer‑term contractual diversification and price‑hedging with deepened producer relationships and farmer‑support programs to mitigate coffee‑price volatility and supply risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and timeframes are correct: Starbucks' supply commitments evolved from covering through fiscal 2023 (in 2022) to extending through fiscal 2025 (in 2023 and 2024). These timeframes match the original answer exactly. (2) The LLM correctly identifies the consistent use of forward contracts, futures, and collars to manage 'C' price exposure across the years, which is explicitly stated in the ground truth. (3) The reasoning is sound: the extension of purchase commitments reflects a strategic move toward longer-term supply stability and price hedging, which the LLM captures by describing a strategy of 'longer-term contractual diversification and price-hedging.' While the original answer emphasizes 'strategic shift toward longer-term stability,' the LLM adds slight elaboration on 'deepened producer relationships and farmer-support programs'—information not explicitly confirmed in the ground truth. This addition does not contradict but slightly extends the provided facts, which prevents a perfect 10. (4) All entities—Starbucks, green coffee, fiscal years 2022–2024, 'C' price—are correctly identified and synthesized across the multi-hop timeline. The answer fully addresses both parts of the question: the evolution of commitments and the strategic implication for managing price volatility and supply risk. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually excellent with only minor extrapolation, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 439,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did ACN's target asset allocation mix for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment strategy and risk-adjusted return objectives?",
      "original_answer": "ACN's target asset allocation for its defined benefit pension plans showed a strategic shift over the three-year period. In fiscal 2023, the target allocation was referenced in the 2022 10-K filing, which outlined the investment return objective as exceeding inflation over the long term based on the target asset mix for each plan. By fiscal 2024, the company continued to emphasize risk-adjusted returns aligned with the overall investment strategy, maintaining a diversified portfolio of fixed income and equities, with specific attention to matching debt securities' duration to plan liabilities. In fiscal 2025, the target allocation was again referenced in the 2024 10-K, showing continuity in strategy but with updated flexibility ranges to respond to market conditions and required cash flows. This evolution suggests a consistent yet adaptive long-term investment approach focused on balancing return generation with liability matching and risk mitigation.",
      "llm_answer": "\nFrom fiscal 2023 through fiscal 2025 ACN’s target allocation for its defined‑benefit pension plans moved progressively from a more bond‑heavy mix toward a higher‑weighting of equities and other growth assets, as shown by the disclosed 2025 target percentages alongside the weighted‑average allocations reported for 2024 and 2023.  This multi‑year shift reflects ACN’s long‑term strategy of pursuing risk‑adjusted returns that outpace inflation—emphasizing capital appreciation, liability‑driven duration matching, and diversified exposure—while maintaining a flexible, risk‑aware investment policy across all three fiscal years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in describing ACN's long-term investment objectives such as risk-adjusted returns, inflation outperformance, and liability matching. However, it introduces a significant factual inaccuracy by claiming a 'progressive shift' from bond-heavy to equity-heavy allocation from fiscal 2023 to 2025, which is not supported by the ground truth. The Original Answer states there was strategic continuity with updated flexibility ranges, not a directional shift toward equities. (2) There are no specific percentages or numerical allocations mentioned in either the ground truth or the LLM response, but the LLM implies quantitative changes (e.g., 'disclosed 2025 target percentages', 'weighted-average allocations') that are not present in the source data, suggesting fabrication or misrepresentation of quantitative trends. This severely undermines quantitative accuracy. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies the relevant time frame and company, it incorrectly infers a trend of increasing equity exposure without evidence. The ground truth emphasizes consistency and adaptive management within a stable framework, not a structural reallocation. The synthesis across years is therefore invalid. (4) Despite the factual error, the LLM captures relevant themes—risk-adjusted returns, inflation goals, duration matching, diversification—giving it moderate qualitative and contextual relevance. However, the core claim about allocation evolution is incorrect, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 437,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus and intellectual property protection timeline?",
      "original_answer": "In 2022, Amgen was investigating Olpasiran, an siRNA drug, in phase 2 trials for the treatment of atherosclerotic cardiovascular (CV) disease. By 2023, the company disclosed that Olpasiran had U.S. and European patent protection for 'Compounds' estimated to expire in 2036, signaling strong intellectual property positioning. In 2024, Olpasiran was listed as being indicated for 'Cardiovascular disease,' suggesting a continued focus on CV applications and a transition from phase 2 investigation toward more advanced development or potential regulatory preparation. This progression reflects a strategic evolution from early clinical investigation to therapeutic consolidation and IP protection.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen moved Olpasiran from an early‑stage (phase 2) investigation of its Lp(a)‑lowering effect for atherosclerotic cardiovascular disease (Chunk 1) to a fully defined cardiovascular‑disease program that remained its core therapeutic focus (Chunk 3), while simultaneously securing compound‑level patent protection that extends to 2036 in both the United States and Europe (Chunk 2). This timeline ensures that Amgen’s strategic positioning of Olpasiran as a next‑generation CV‑therapy is protected by intellectual‑property exclusivity well into the 2030s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Olpasiran was in phase 2 trials in 2022 for atherosclerotic cardiovascular disease; it received U.S. and European patent protection for 'Compounds' expiring in 2036 (disclosed in 2023); and by 2024, its indication was listed as 'Cardiovascular disease,' reflecting continued CV focus. (2) Quantitative accuracy is perfect: the 2036 patent expiry date is correctly cited, and no calculations are required. (3) Multi-hop reasoning is sound—information is synthesized across years and domains (clinical development, IP, therapeutic focus). The only minor shortcoming is that the LLM does not explicitly mention the 2024 transition toward advanced development or regulatory preparation, which slightly reduces qualitative completeness. (4) The answer is fully contextually relevant, directly addressing the evolution of therapeutic focus and IP timeline. Wording differs but meaning is semantically equivalent. Minor deduction from 10 to 9 due to slight omission in developmental progression nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 312,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did American Express's reliance on aggregators evolve from 2022 through 2024, and what risks associated with these third-party relationships were emphasized in each year's disclosures?",
      "original_answer": "From 2022 to 2024, American Express increasingly emphasized its reliance on aggregators and the associated risks, particularly around merchant steering, surcharging, and third-party operational disruptions. In 2022, AXP expressed concern over how aggregators might act against AXP's interests, potentially impacting card usage and merchant acceptance. In 2023, the company noted an increased dependency on aggregators and processors to manage merchant relationships, with added emphasis on how surcharging and steering could reduce transaction volumes. By 2024, AXP highlighted broader operational and legal risks, including litigation exposure and potential changes in business practices due to third-party failures or regulatory actions. The trend shows a growing awareness and formalization of risks tied to aggregator relationships, shifting from a focus on merchant behavior to broader systemic and legal concerns.",
      "llm_answer": "\nAmerican Express’s dependence on third‑party aggregators deepened over the three years—​the 2022 filing first warned that reliance on aggregators could enable surcharging or steering that discriminates against Amex and thereby shrink cards‑in‑force, the 2023 filing explicitly noted an “increasingly relied‑on” relationship with merchant acquirers, aggregators and processors and flagged that any such discrimination could materially harm the business, and the 2024 filing portrayed these aggregators as a core operational dependency that subjects the firm to heightened regulatory scrutiny, potential litigation over non‑discriminatory merchant‑contract provisions, and the risk of vendor‑driven operational or cyber disruptions.  \n\nEach year’s disclosure also highlighted distinct risks: in 2022 the threat was market‑acceptance loss and the possible loss of key redemption partners (Amazon, Delta) that could weaken the Membership Rewards program; in 2023 the focus shifted to the cost‑control challenges of rewards, marketing and merchant‑acceptance initiatives and the vulnerability of third‑party redemption options; and in 2024 the emphasis was on regulatory enforcement, potential interchange‑fee caps and lawsuit‑driven changes to surcharge rules that could force adjustments to merchant agreements and expose Amex to brand‑damaging litigation and third‑party service interruptions.  \n\nThese statements reflect the mutual “AXP ↔ Aggregators” dependency captured in the KG pattern, with each filing adding a new layer of risk tied to that relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key points about the evolution of American Express's reliance on aggregators from 2022 to 2024 are correctly captured: increasing dependency, merchant steering, surcharging, and expanding risk focus toward operational, legal, and regulatory concerns. The progression across years is logically presented and semantically equivalent to the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes risks disclosed across three years and correctly identifies the shift from market acceptance (2022) to cost and operational vulnerabilities (2023) to regulatory and litigation risks (2024). One minor discrepancy: the mention of 'loss of key redemption partners (Amazon, Delta)' and 'cost-control challenges of rewards, marketing' in 2022 and 2023 adds detail not present in the ground truth. While plausible and contextually relevant, these specifics were not part of the original knowledge graph answer and slightly extend beyond the provided truth. This does not make the answer incorrect but introduces unverified detail. (4) Contextual relevance is excellent—the response directly addresses both parts of the question: evolution of reliance and risks emphasized each year. The reference to the 'AXP ↔ Aggregators' dependency pattern shows appropriate synthesis. Overall, the answer is factually correct, well-structured, and only slightly exceeds the ground truth with plausible but unconfirmed details, warranting a 9 instead of a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1630,
        "completion_tokens": 474,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through fiscal 2024, and what changes occurred in the company's forward supply commitments during this period?",
      "original_answer": "Starbucks consistently cited commodity index funds as a factor influencing green coffee price volatility across all three fiscal years. In 2022, the company expected its purchase commitments and inventory to cover supply needs through fiscal 2023. By 2023, Starbucks extended its supply outlook to fiscal 2025, signaling increased confidence in its forward contracting strategy amid ongoing price pressures from futures market activity. This forward-looking supply assurance remained unchanged in 2024, indicating a stabilized hedging and procurement strategy despite continued exposure to commodity index fund trading in arabica coffee futures. The multi-year extension of supply commitments suggests a strategic shift toward longer-term risk mitigation in response to market volatility driven by financial participants like index funds.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks moved its coffee‑hedging program from a supply horizon that was projected to cover only fiscal 2023 (as noted in 2022) to a longer‑term commitment that now extends through fiscal 2025 (as disclosed in 2023 and 2024), while maintaining the use of fixed‑price and price‑to‑be‑fixed purchase contracts together with forward, futures and collar instruments to hedge “C”‑price exposure that is tied to commodity‑index‑fund trading activity.  This evolution reflects a deliberate extension of forward supply commitments—from an FY 2023 target to an FY 2025 target—designed to secure green‑coffee supply amid heightened price volatility driven in part by hedge‑fund and commodity‑index‑fund market actions.  Consequently, the company’s exposure to those index funds persisted but was managed over a broader timeframe, with purchase‑commitment periods lengthened to protect against future supply disruptions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Starbucks cited commodity index funds as influencing green coffee price volatility throughout 2022–2024; forward supply coverage extended from fiscal 2023 (as stated in 2022) to fiscal 2025 (disclosed in 2023 and maintained in 2024). (2) Quantitative elements—fiscal years (2022, 2023, 2025)—are correctly reported with no calculation errors. Format and phrasing (e.g., 'FY 2023' vs 'fiscal 2023') are consistent in meaning. (3) Multi-hop reasoning is sound: the answer synthesizes changes over time in hedging strategy and supply commitments across three fiscal years, correctly identifying the strategic shift toward longer-term risk mitigation in response to index fund-driven volatility. (4) The LLM accurately captures the persistence of exposure to commodity index funds while emphasizing improved management via extended commitments, aligning fully with the original answer’s conclusion. Wording differs slightly but conveys identical meaning and depth. No omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 313,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this multi-year trajectory indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase strategy showed a significant upward trajectory from fiscal 2022 through fiscal 2024. In fiscal 2022, the company had an aggregate available authorization of $3,129,296 for share purchases and redemptions. By fiscal 2023, the company had purchased 2,000,308 Class A ordinary shares for $605 million under the open-market program, and the total available authorization stood at $2,694 million as of August 31, 2024. In fiscal 2024, Accenture further bolstered its repurchase capacity by securing an additional $4,000 million in authority, raising the total outstanding repurchase authorization to $6,694 million by September 25, 2024. This demonstrates a consistent and expanding commitment to returning capital to shareholders through share repurchases, with increasing authorization and active execution over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the open‑market share‑purchase program’s remaining authorization fell from about **$3.13 billion (as of Aug 31 2022)** to **$2.69 billion (as of Aug 31 2024)**, and on **September 25 2024 the board approved an additional $4 billion**, bringing total outstanding authority to **$6.69 billion**—a program that has no expiration date.  In fiscal 2024 the company repurchased **2,000,308 shares for $605 million** under the program (plus 72,255 shares for employee‑tax withholding that do not affect the authorization), illustrating a multi‑year, uninterrupted capital‑return strategy centered on ongoing share‑buybacks.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer contains several correct elements: the initial authorization of $3.13 billion in fiscal 2022 matches the ground truth ($3,129,296 ≈ $3.13B), the $4 billion additional authorization approved on September 25, 2024 is accurate, and the resulting total authorization of $6.69 billion is correct ($2.694B + $4B = $6.694B). The repurchase of 2,000,308 shares for $605 million is correctly attributed to fiscal 2024 in the LLM answer, but this is a critical error: the ground truth states this repurchase occurred in fiscal 2023, not 2024. Additionally, the LLM incorrectly states that the remaining authorization fell from $3.13B to $2.69B over the period, implying no net increase despite the new $4B authorization, which misrepresents the trajectory. The $2.69B figure is actually the balance as of August 31, 2024 (end of fiscal 2024), before the new $4B was added, but the LLM presents it as a reduction without clarifying that repurchases occurred and a major increase followed.\n\n2) Quantitative accuracy issues: The fiscal year misattribution of the $605M repurchase is a significant factual error. While the number of shares and dollar amount are correct, placing the activity in fiscal 2024 instead of 2023 distorts the year-by-year evolution. The answer also omits the fiscal 2022 repurchase activity (if any) and does not clarify how the drop from $3.13B to $2.69B occurred—i.e., what was repurchased in fiscal 2023. The $2.69B figure is accurate (matching $2,694 million), and the final $6.69B total is correct post-addition.\n\n3) Reasoning and synthesis: The LLM correctly infers a consistent capital return strategy and notes the program’s permanence, which aligns with the ground truth’s interpretation. However, the misplacement of the $605M repurchase in fiscal 2024 undermines the multi-hop timeline. The answer should have shown: (1) starting balance in 2022, (2) repurchases in 2023 reducing available authorization, (3) new $4B authorization in 2024. Instead, it implies repurchases occurred in 2024 while the authorization was declining, which contradicts the ground truth sequence.\n\n4) Despite these errors, the answer captures the overall strategic direction—increasing authorization and sustained buybacks—and includes relevant details like tax-withholding shares (though not in the original answer, this is a reasonable addition). Contextual relevance is high as it directly addresses the question’s focus on evolution and strategy. The correctness score is reduced due to the fiscal year misplacement of key repurchase activity, which affects the accuracy of the multi-year narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 693,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the value of Google's marketable equity securities subject to long-term lock-up restrictions change from 2022 to 2024, and what does this fluctuation suggest about the company's investment strategy in illiquid assets over this period?",
      "original_answer": "The value of Google's marketable equity securities under long-term lock-up restrictions was $1.4 billion in 2022, decreased to $803 million in 2023, and then returned to $1.4 billion by 2024. This fluctuation suggests a cyclical or strategic rebalancing of the company's holdings in illiquid investments, potentially reflecting changes in market conditions, liquidity needs, or long-term strategic positioning.",
      "llm_answer": "\nThe long‑term portion of Google’s marketable equity securities that is subject to lock‑up restrictions grew from **$803 million as of December 31 2022** (Chunk 2) to **$1.4 billion as of December 31 2023/2024** (Chunks 1 & 3), representing roughly a 75 % increase.  This rise indicates that Google has been deliberately expanding its exposure to illiquid, long‑term equity investments—likely to capture higher strategic returns—while still complying with the regulatory lock‑up constraints tied to those holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both direction and magnitude of change. According to the ground truth, the value was $1.4 billion in 2022, decreased to $803 million in 2023, and returned to $1.4 billion in 2024. However, the LLM incorrectly states it grew from $803 million in 2022 to $1.4 billion in 2023/2024, reversing the actual trend. This misrepresents the entire fluctuation pattern. (2) The quantitative inaccuracies are severe: the starting value is wrong (claims $803M in 2022 vs. actual $1.4B), the 2023 value is omitted, and the 2024 value is conflated with 2023. The claimed 75% increase is based on incorrect base values and does not reflect the actual cyclical pattern. The correct change from 2022 to 2023 was a ~42.6% decrease, followed by a ~74% increase from 2023 to 2024. (3) The multi-hop reasoning is flawed: instead of identifying the drop and recovery across three years, the model incorrectly synthesizes a two-year increase, likely due to misattributing the 2023 value as the 2022 baseline. It fails to recognize the temporary reduction and subsequent rebound, which is central to the correct interpretation. (4) While the answer attempts to interpret strategic implications (expanding illiquid investments), this conclusion contradicts the actual data showing a temporary drawdown. The contextual relevance is moderate because it addresses the right topic and metric, but the factual foundation is incorrect, leading to an invalid strategic inference. Minor formatting issues (e.g., 'long‑term portion' vs. 'subject to long-term lock-up') are acceptable under semantic equivalence, but the core numerical and directional errors severely undermine accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 468,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did GE's relationship with Electric Insurance Company evolve from 2022 through 2024, particularly in terms of its strategic positioning, valuation, and ultimate disposition, and what financial impact did this progression have on GE across the three-year period?",
      "original_answer": "In 2022, GE disclosed that Electric Insurance Company (EIC) was a captive industrial insurance subsidiary primarily serving GE and its employees, with net claim reserves of $0.2 billion at year-end. By 2023, GE had classified EIC as held for sale, with assets of $541 million and liabilities of $378 million as of December 31, 2023, and recorded a $109 million loss related to the expected sale. In 2024, GE completed the sale of EIC to Riverstone International Holdings Inc. for $120 million in cash. This progression shows a strategic exit from a non-core business, with a significant loss recognized in 2023 and final monetization in 2024, indicating a shift in GE's portfolio toward more focused industrial operations.",
      "llm_answer": "\nFrom 2022 through 2024 GE transformed Electric Insurance Company from an internal captive that provided property‑and‑casualty coverage to GE and its employees (see Chunk 1) into a non‑core asset that was divested; in Q4 2022 the company classified EIC as held‑for‑sale and, after recording a $109 million impairment loss in 2023 (Chunk 3), completed the sale in Q2 2024 for $120 million cash (Chunk 2).  The $120 million proceeds provided a cash inflow that offset the earlier loss and allowed GE to streamline its balance sheet and focus on its core aerospace and power businesses, while the earlier classification as held‑for‑sale and the $109 million charge also reflected the strategic repositioning away from the captive insurance operation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic evolution of GE's relationship with Electric Insurance Company (EIC), noting its role as a captive insurer, classification as held-for-sale, a $109 million loss in 2023, and sale in 2024 for $120 million cash. However, there is a critical error in timing: the LLM states that EIC was classified as held-for-sale in Q4 2022, while the ground truth indicates this occurred in 2023 (specifically by year-end 2023). This misplacement of a key event affects factual accuracy. (2) Quantitative accuracy issues: the $120 million sale price and $109 million loss are correct, but the LLM omits the key balance sheet figures from 2023—EIC’s $541 million in assets and $378 million in liabilities—which are important for valuation context. Also, the claim reserves of $0.2 billion in 2022 from the original answer are missing. While the cash proceeds and impairment loss are accurate, the omission of EIC’s net asset value (assets - liabilities = $163M) makes the valuation analysis incomplete. (3) Reasoning and synthesis are generally sound: the LLM correctly infers that the divestiture reflects a strategic shift toward core industrial operations (aerospace and power), aligns the impairment with repositioning, and notes the cash inflow offsetting prior losses. However, the incorrect timing of the held-for-sale classification weakens the multi-hop timeline accuracy. (4) Contextual relevance is high—the answer addresses strategic positioning, valuation, disposition, and financial impact as asked. Despite missing some financial details and one major timing error, the core narrative and intent of the original answer are preserved, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Classifies]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 472,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did Amgen's Phase 3 clinical program portfolio evolve from 2022 through 2024, and what does the progression from 13 to 25 programs reveal about the company's R&D pipeline expansion and strategic focus during this period?",
      "original_answer": "Amgen's Phase 3 clinical program portfolio grew significantly from 13 programs in 2022 to 24 programs in 2024, with a notable increase to 18 programs in 2023. This growth reflects the company's strategic expansion in late-stage drug development, including the acquisition of five programs from Horizon in 2023 and the continued initiation of new Phase 3 studies. By 2024, Amgen had added one more program, bringing the total to 25, while also achieving regulatory approvals in both the U.S. and Japan. This trajectory indicates a focused effort to build a robust and diversified late-stage pipeline.",
      "llm_answer": "\nFrom February 2022 (still 13 Phase 3 programs, as noted in Chunk 1) to January 2023 Amgen’s late‑stage pipeline grew to 18 programs (Chunk 2), then to 24 programs by January 2024 after acquiring five Horizon assets, launching three new Phase 3 studies and securing one FDA approval (Chunk 2). By February 2025 the count reached 25 programs, driven by five additional Phase 3 initiations and further regulatory approvals in the United States and Japan (Chunk 3), illustrating a clear expansion of Amgen’s R&D pipeline and a strategic focus on advancing a broader, more diversified set of late‑stage candidates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its description of Amgen's Phase 3 pipeline growth but contains key factual inaccuracies in timing and program counts. The ground truth states the portfolio grew from 13 in 2022 to 24 in 2024, with 18 in 2023, and reached 25 by 2024. However, the LLM claims the count reached 25 by February 2025, which misaligns with the 2024 endpoint in the question and original answer. Additionally, the original answer confirms the total was 25 in 2024, not 2025, making the LLM's timeline incorrect. (2) Quantitatively, the LLM correctly identifies the 13 → 18 → 24 progression but incorrectly attributes the rise to 25 to February 2025 instead of 2024. The mention of 'five additional Phase 3 initiations' is not supported in the ground truth, which attributes growth to the Horizon acquisition (five programs), new studies, and an additional program by 2024—no breakdown of 'five initiations' is given. The FDA approval and approvals in the U.S. and Japan are correctly noted, but the sequencing is slightly off. (3) The multi-hop reasoning is sound in linking acquisitions, new studies, and approvals to pipeline expansion, and the strategic focus on diversification is accurately inferred. The synthesis of Horizon acquisition and regulatory milestones aligns with the original answer. (4) Despite the strong qualitative reasoning and relevance to the question’s strategic implications, the quantitative inaccuracies in timing and unsupported specifics (e.g., 'five additional initiations') reduce the correctness score. The answer is semantically close but factually imprecise on critical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Discloses]- ORG <-[Increases]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 449,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has American Express's relationship with global card networks evolved from 2022 to 2024 in response to regulatory pressures and competitive dynamics?",
      "original_answer": "From 2022 to 2024, American Express's relationship with global card networks shifted from a primarily competitive posture to a more complex dynamic influenced by increasing regulatory scrutiny. In 2022, AXP clearly positioned itself as a competitor to other card networks like Visa, Mastercard, and China UnionPay, emphasizing differentiation through premium benefits and cobrand partnerships. By 2023, this competitive stance remained, but there was growing emphasis on the challenges posed by alternative payment platforms like Alipay and PayPal, as well as increasing competition for unique partner offerings such as lounge access and travel benefits. In 2024, regulatory pressures significantly impacted AXP’s relationship with card networks, particularly in the EU and Australia, where AXP exited its network licensing businesses due to regulatory constraints. Additionally, AXP faced uncertainty regarding cobrand arrangements in the EU due to differing regulatory interpretations. This evolution shows a trajectory from direct competition to a more constrained environment shaped by regulatory dependencies, particularly in international markets.",
      "llm_answer": "\nFrom 2022 to 2024 American Express remained the fourth‑largest global general‑purpose card network, competing directly with Visa, Mastercard, China UnionPay and other networks while also facing intense rivalry from alternative payment platforms, digital wallets and buy‑now‑pay‑later services (Chunks 1 & 3).  However, the 2024 designation as a Category III bank holding company and new regulatory curbs on interchange fees and network‑licensing—exemplified by the company’s exit from EU and Australian network‑licensing businesses and the resulting downward pressure on discount revenue—forced a strategic shift in how it engages with card networks and partners (Chunk 2).  Consequently, the firm has had to increase compliance investments, adjust pricing and discount structures, and recalibrate its cobrand and agent relationships to mitigate both regulatory risk and competitive pressure from rivals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express's competitive position among global card networks (Visa, Mastercard, China UnionPay) and the rising threat from alternative platforms like digital wallets and BNPL services, consistent with the 2022–2023 context. It accurately notes the strategic shift in 2024 due to regulatory pressures, including AXP’s exit from network licensing in the EU and Australia—key facts from the original answer. The mention of downward pressure on discount revenue and recalibration of cobrand relationships reflects accurate synthesis. (2) There are no numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022–2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the model connects regulatory designation (Category III BHC), regulatory actions (interchange and licensing curbs), business responses (exits from EU/AU), and strategic adjustments (pricing, compliance, partnerships). The only minor gap is that the original emphasizes a shift from 'competitive posture' to 'regulatory dependency,' particularly in international markets, which the LLM implies but does not explicitly frame as a relational evolution with other networks. (4) Despite this nuance, the LLM captures all key facts, entities, and causal relationships. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses regulatory and competitive evolution across the time frame.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 432,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did ConocoPhillips' monetization of CVE common shares and subsequent use of proceeds for share repurchases evolve from 2022 through 2024, and what were the specific dollar amounts and share volumes associated with these actions across the three-year period?",
      "original_answer": "ConocoPhillips began a paced monetization of its CVE common shares in May 2021, which continued into 2022 when it sold its remaining 91 million CVE shares. In 2022, the company repurchased a total of 383 million shares at a cost of $29 billion under its share repurchase program. By 2024, the company had repurchased a cumulative total of 433 million shares at a cost of $34.3 billion since the inception of the program, with the share repurchase authorization increased to $65 billion in October 2024. This shows a clear progression of asset monetization followed by capital return to shareholders through share buybacks.",
      "llm_answer": "\nConocoPhillips began a paced monetization of its CVE common shares in 2021, a process that included a $218 million fair‑value measurement of dispositions (Chunk 1) and was completed when the remaining 91 million CVE shares were sold in the first quarter of 2022, with the proceeds directed to its share‑repurchase program (Chunk 2 & 3).  The repurchase program—expanded from a $25 billion to $45 billion authorization in Oct 2022 and later raised to a $65 billion limit in Oct 2024—had repurchased 383 million shares for $29 billion by the end of 2023 and grew to 433 million shares for $34.3 billion by the end of 2024, meaning an additional 50 million shares were bought back for roughly $5.3 billion in 2024 alone (Chunk 2 & 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key events and progression: ConocoPhillips monetized its CVE shares, completed the sale of 91 million shares in Q1 2022, and used proceeds for share repurchases. It accurately reports that 383 million shares were repurchased for $29 billion by the end of 2023 (implied from ground truth which states 2022), and that cumulative repurchases reached 433 million shares at a cost of $34.3 billion by 2024. The $65 billion authorization increase in October 2024 is correctly noted. However, the ground truth states that the $29 billion was spent by the end of 2022, not 2023 as implied in the LLM answer—this is a significant timing error. Additionally, the LLM introduces a $218 million fair-value measurement from 'Chunk 1' that is not present in the original answer and appears extraneous or misaligned with the ground truth. (2) The calculation of 50 million additional shares repurchased in 2024 for $5.3 billion is mathematically sound ($34.3B - $29B = $5.3B; 433M - 383M = 50M), but relies on the incorrect assumption that $29B was spent by end-2023 rather than end-2022. This shifts the timeline and misattributes repurchase activity across years. (3) The multi-hop reasoning is strong—linking asset monetization to share repurchases, tracking authorization increases, and inferring annual activity from cumulative totals. However, the misalignment in timing weakens the quantitative precision. (4) The answer is contextually excellent, addressing all parts of the question with appropriate synthesis. The core narrative is correct, but the quantitative accuracy is reduced due to the date misattribution and inclusion of unverified figures like $218M. Hence, correctness is high but not perfect—warranting an 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Decreases]- ORG <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 481,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the availability of shares under The Home Depot Omnibus Stock Incentive Plans evolve from 2022 through 2024, and what does this trend indicate about the company's stock-based compensation capacity and utilization over time?",
      "original_answer": "In 2022, there were 117 million shares available under the 2005 Plan. By 2023, under the newly amended Omnibus Plan, approximately 77 million shares remained available for future grants. This further declined to 70 million shares by 2024, indicating a consistent drawdown on available shares. This trend shows a steady utilization of the share pool for stock-based compensation, suggesting increased use of equity awards over the three-year period, even as the company maintained a replenishment mechanism tied to expirations and forfeitures.",
      "llm_answer": "\nUnder the Amended and Restated 2005 Omnibus Stock Incentive Plan, the number of shares reserved for future grants fell from roughly **117 million** at the end of January 2022 (Chunk 3) to about **77 million** on January 28 2024 (Chunk 1) and further to approximately **70 million** by February 2 2025 (Chunk 2). This steady decline shows that the company has been actively using its equity pool to award stock‑based compensation to employees and directors, indicating that while a substantial reserve remains, the capacity to issue new awards is being progressively consumed. Importantly, the older **1997 Plan** has been closed to any new grants since the 2005 Plan’s adoption (as noted in Chunks 2 and 3), so all future equity awards now come from the Omnibus Plan, whose shrinking share reserve signals increasing utilization of the company’s stock‑based compensation resources over the 2022‑through‑2024 period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key numbers—117 million shares in 2022, 77 million in 2023, and 70 million in 2024—as per the ground truth. However, it misstates the dates: it claims 77 million was available on January 28, 2024 (which corresponds to the 2023 fiscal year-end), but labels it as 2024, and further states 70 million by February 2, 2025 (which is the 2024 fiscal year-end), incorrectly projecting it to 2025 instead of 2024. This misalignment of fiscal years and calendar dates undermines quantitative accuracy. (2) The numbers themselves are factually correct and match the ground truth for the respective fiscal years, but the incorrect dating of the data points introduces confusion about the timeline. The calculation of the downward trend is accurate and correctly interpreted. (3) The reasoning is sound: the LLM correctly infers that the declining share availability indicates increased utilization of stock-based compensation and notes the closure of the 1997 Plan, which is contextually relevant and supports multi-hop synthesis. It correctly identifies that all new grants come from the Omnibus Plan. (4) The answer is highly contextually relevant, addressing both the evolution of share availability and the implication for compensation capacity and utilization. Despite the date inaccuracies, the core trend and interpretation align with the ground truth. The mislabeling of fiscal years as calendar years (e.g., reporting 2024 data as 2025) is a significant but not critical error, hence the 7/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 430,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By 2023 and 2024, this number had increased to 141,000,000, indicating a strategic expansion in the company's capacity to issue share-based awards. The increase suggests a growing emphasis on equity-based incentives as part of Accenture’s long-term compensation strategy, aligning executive and employee interests with shareholder value creation.",
      "llm_answer": "\nThe data show a clear step‑up in the pool of shares that can be used for equity awards: Chunk 3 (the 2022 Form 10‑K) reports that the Amended 2010 SIP was authorized for **127 million** Class A shares, while Chunk 1 (the 2023 filing) and Chunk 2 (the 2024 filing) both state the authorization was increased to **141 million** shares, with **27,381,461** shares available as of Aug 31 2022 and **27,270,917** shares available as of Aug 31 2024 respectively.  \n\nThis progression—from 127 M to 141 M authorized shares—reflects Accenture’s strategic decision to expand its share‑based compensation framework in step with its growing workforce and global ambitions, using a larger equity reserve to attract, retain, and motivate employees while efficiently recycling shares from expiring awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies the authorized share numbers: 127 million in 2022 and 141 million in 2023 and 2024, matching the ground truth exactly. It also accurately reports the available shares as of August 31, 2022 (27,381,461) and August 31, 2024 (27,270,917), which are additional details not in the original answer but factually correct and contextually relevant. These numbers confirm the increase in authorized shares, supporting the core claim.\n\n2) All numeric values are accurate. The progression from 127M to 141M is correctly stated. The specific available share counts are precise and consistent with typical 10-K disclosures. No calculation errors are present. Format variations (e.g., '127 million' vs '127,000,000') are acceptable and semantically equivalent.\n\n3) The multi-hop reasoning is sound: the model synthesizes data from 2022, 2023, and 2024 filings to show the evolution of authorized shares. It correctly infers that the increase indicates a strategic expansion in share-based compensation, linking it to talent retention and motivation. The mention of 'recycling shares from expiring awards' adds insightful context not in the original answer, showing deeper understanding.\n\n4) The LLM answer conveys the same core information as the ground truth and even enhances it with specific available share figures and operational details about share recycling. The strategic interpretation aligns with the original—emphasizing long-term compensation strategy and employee alignment—while expanding slightly on workforce growth and global ambitions, which is a reasonable inference. Only minor deduction from 10 is due to slightly rephrased emphasis, but no factual or logical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 464,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the weighted average yield on American Express's foreign government bonds and obligations change from 2022 to 2024, and what does this trend suggest about the company's exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations with a weighted average yield of 5.86% for instruments due within one year. By 2023, the weighted average yield on these same instruments due within one year had increased to 6.45%, suggesting heightened exposure to rising international interest rates. However, in 2024, this yield dropped back down to 5.86%, indicating a partial reversal in the trend, possibly due to stabilization or strategic portfolio adjustments. This trajectory reveals a volatile exposure to international interest rate movements over the three-year period, with a peak in 2023 followed by a return to 2022 levels by 2024.",
      "llm_answer": "\nThe weighted‑average yield on American Express’s foreign government bonds and obligations climbed from **5.46 % in 2022** (Chunk 1) to **6.45 % in 2023** (Chunk 3) and then eased slightly to **5.86 % in 2024** (Chunk 2). This trajectory shows that the company’s foreign‑sovereign‑debt holdings have been positioned to benefit from higher international rates, reflecting a notable exposure to global interest‑rate movements and a strategic tilt toward longer‑dated, higher‑yielding foreign obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the 2022 yield: it states 5.46%, while the ground truth is 5.86%. This is a significant factual inaccuracy that undermines the quantitative correctness. The 2023 yield (6.45%) and 2024 yield (5.86%) are correctly reported. The dollar amount ($630 million) and the focus on instruments due within one year are omitted, reducing completeness. (2) The calculation of trend—rising in 2023 and falling in 2024—is directionally correct, but the starting point is wrong due to the incorrect 2022 figure. The final 2024 value matching 2022 is accurate, but the LLM fails to highlight this symmetry due to the initial error. (3) The multi-hop reasoning is partially sound: the model correctly identifies the three-year trend and links yield changes to international interest rate exposure. However, it mischaracterizes the 2022–2024 trajectory by starting from an incorrect baseline, missing the full-circle return to the original yield. The suggestion of a 'strategic tilt toward longer-dated' obligations is speculative and not supported in the ground truth, which mentions possible stabilization or portfolio adjustments without specifying duration strategy. (4) Despite the numerical error, the answer addresses the question's core about yield change and interest rate exposure, and the reasoning is logically structured, earning moderate scores in qualitative accuracy and high in contextual relevance. The correctness score is limited primarily by the incorrect 2022 yield, which affects overall factual integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 431,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did American Express's yield profile from Foreign Government Bonds and Obligations evolve from 2022 to 2024, and what does the progression in weighted average yields (6.45% in 2023, 5.85% in 2024, and the 2022 fair value distribution) indicate about the company's investment strategy and market conditions?",
      "original_answer": "In 2022, American Express held $630 million in Foreign Government Bonds and Obligations with a majority (628 million) maturing within one year, indicating a short-duration focus. In 2023, the weighted average yield on these bonds was 6.45%, the highest among all categories. By 2024, the yield on Foreign Government Bonds and Obligations had decreased to 5.85%, still relatively high compared to other instruments. This decline suggests a potential shift in market conditions or a strategic adjustment in the composition of the portfolio, possibly reducing exposure to higher-yielding, shorter-duration instruments in favor of more stable or diversified maturities. The trend reflects either a response to falling interest rates or a deliberate risk management move.",
      "llm_answer": "\nAmerican Express held $630 million of foreign‑government bonds and obligations in 2022, with $628 million maturing within one year and only $1 million each in the 1‑5‑year and 5‑10‑year buckets (Chunk 1), establishing a heavily short‑term exposure. By 2023 the weighted‑average yield on that segment peaked at **6.45 %** (6.45 % for the under‑1‑year slice and 4.48 % for the 1‑5‑year slice) (Chunk 3), while in 2024 it slipped to **5.85 %** (5.86 % for the under‑1‑year slice and 2.03 % for the 1‑5‑year slice) (Chunk 2), indicating a deliberate shift toward shorter‑duration, lower‑yielding securities as market rates eased. This evolution—high 2023 yields followed by a modest decline in 2024—reflects AXP’s strategy of preserving capital and liquidity while adapting to a softer interest‑rate environment and maintaining a conservative stance on foreign‑government investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $630 million total in Foreign Government Bonds and Obligations in 2022 and the $628 million maturing within one year, aligning with the ground truth. It also accurately reports the 6.45% weighted average yield in 2023 and 5.85% in 2024. However, it introduces granular yield breakdowns by maturity buckets (e.g., 6.45% for under-1-year and 4.48% for 1-5-year in 2023; 5.86% and 2.03% in 2024) that are not present in the original answer and may not be supported by the ground truth, which only provides overall weighted average yields. These specific sub-yields could misrepresent the data and suggest overprecision or hallucination. (2) The dollar amounts and headline yields (6.45%, 5.85%) are correct and match the ground truth. The calculation of trend (decline from 6.45% to 5.85%) is accurate, but the additional yield splits by maturity are unsupported and reduce quantitative accuracy. (3) The multi-hop reasoning is sound: the model connects 2022 duration profile to 2023 and 2024 yields and infers strategic adaptation to market conditions. The conclusion about shifting toward shorter-duration, lower-yielding securities due to easing rates aligns with the original's interpretation of potential strategic or market-driven changes. However, the original suggests a possible reduction in higher-yielding short-duration exposure, while the LLM implies a shift into shorter-duration securities—this is a subtle but important contradiction in directionality. (4) Despite this, the answer remains contextually relevant and captures the core evolution and implications. The scores reflect high correctness but docked for unsupported numerical details and slight misdirection in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 479,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the presentation and disclosure of COP's 7% Debentures due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this multi-year progression indicate about the company's approach to reporting this debt instrument?",
      "original_answer": "In 2022, COP disclosed the 7% Debentures due 2029 alongside its Common Stock, listing both with the trading symbol and CUSIP number under the New York Stock Exchange. In 2023, the company separated the debentures into its own row in the registration table, providing clearer distinction as a separate class of security with its own CUSIP-718507BK1 identifier. By 2024, COP maintained this structured disclosure, reaffirming the debentures' separate registration and continuing to use the same CUSIP, indicating a consistent and more transparent treatment of this debt instrument over time. This evolution suggests a growing emphasis on clarity and specificity in debt disclosure practices.",
      "llm_answer": "\nThe 2022 filing listed the 7 % Debentures due 2029 only as part of the combined heading “Common Stock, $.01 Par Value 7 % Debentures due 2029” and gave the exchange registration without a CUSIP; the 2023 filing presented the debenture as a distinct class “7 % Debentures due 2029” and added its CUSIP‑718507BK1 and NYSE registration; and the 2024 filing returned to the bundled heading but now includes the same CUSIP and explicit NYSE listing, providing full identifying details. This progression—from a bundled description, to a separate, fully identified disclosure, and back to a consolidated presentation with complete registration data—shows ConocoPhillips deliberately refining the way it reports this debt instrument, moving toward clearer, more transparent, and regulatorily complete disclosure each year.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces a significant factual inaccuracy in the 2024 filing description. According to the ground truth, COP maintained the separated, clearer disclosure format in 2024, continuing to treat the debentures as a distinct class with its own CUSIP (718507BK1). However, the LLM claims that the 2024 filing 'returned to the bundled heading,' which contradicts the ground truth and misrepresents the trend. This error undermines the overall correctness of the multi-year progression narrative. (2) Quantitatively, all numbers and identifiers are accurate: the 7% interest rate, 2029 maturity, and CUSIP-718507BK1 are correctly cited. The years (2022, 2023, 2024) are also correct. There are no calculation errors since the task is descriptive. (3) The multi-hop reasoning is partially sound—the model correctly identifies changes between 2022 and 2023, noting the move from a combined listing to a separate class with a CUSIP. However, the incorrect reversal in 2024 breaks the logical synthesis across all three years, leading to a flawed conclusion about 'consolidated presentation' returning. The actual trend is one of progressive clarity, not oscillation. (4) Despite the key factual error in the 2024 characterization, the answer remains contextually relevant and attempts a comprehensive analysis of disclosure evolution. The conclusion about increasing transparency would be valid if the 2024 data were correct, but it is based on a misinterpretation. Hence, the correctness and qualitative accuracy scores are moderate due to this critical misstep in entity/state tracking over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 454,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did NVIDIA's financial exposure to its 2.00% Notes Due 2031 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt management strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1.2 billion in 2022 to $1.057 billion in 2023, and then rose further to $1.25 billion in 2024, indicating a consistent long-term debt position with this instrument. This pattern suggests that NVIDIA maintained or slightly increased its long-term liability in the Notes Due 2031 over the three-year period, reflecting a stable approach to long-term financing.",
      "llm_answer": "\nNVIDIA’s 2.00% Notes Due 2031 showed a fair‑value exposure of $1.20 billion at the end of FY2022 (Chunk 1), declined to $1.04 billion by the close of FY2023 (Chunk 3), and then rose to a $1.25 billion net carrying amount in FY2024 (Chunk 2), with an effective interest rate of 2.09% and a remaining maturity of 6.4 years. This progression reflects a deliberate long‑term debt strategy: NVIDIA maintains a low‑cost, long‑dated financing tranche and adjusts its size opportunistically—as seen by the 2024 increase—while extending the maturity profile to manage interest‑rate and liquidity risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in the reported values for NVIDIA's exposure to the 2.00% Notes Due 2031. According to the ground truth, the exposure was $1.2 billion in 2022, $1.057 billion in 2023, and $1.25 billion in 2024. However, the LLM reports $1.20 billion (correct), $1.04 billion (incorrect—should be $1.057B), and $1.25 billion (correct). The $1.04B figure is a material deviation from $1.057B and not within acceptable rounding variance, especially in financial reporting contexts. Additionally, the LLM introduces a 'net carrying amount' and 'effective interest rate of 2.09%' and 'remaining maturity of 6.4 years'—details not present in the original answer and unsupported by the provided context, suggesting hallucination or overinference. (2) Calculations: While the overall trend (down then up) is directionally similar, the 2023 value is quantitatively wrong. The ground truth shows a slight decrease from 2022 to 2023, whereas the LLM implies a sharper decline. (3) Multi-hop reasoning: The LLM correctly identifies the three-year evolution and attempts to interpret strategic implications, which aligns with the question’s requirement. However, the reasoning is based partly on incorrect data and augmented with unverified details (e.g., interest rate, maturity), weakening the validity of the synthesis. (4) Despite these issues, the LLM captures the general trend and provides a plausible interpretation of NVIDIA’s long-term debt strategy—stable, low-cost financing with opportunistic adjustments—consistent with the ground truth’s conclusion of a 'stable approach to long-term financing.' Thus, while the qualitative reasoning is sound and contextually relevant, the quantitative inaccuracies reduce overall correctness. Scores reflect partial accuracy with significant but not critical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 502,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Disney's strategic positioning of Marvel evolved across fiscal years 2022, 2023, and 2024, particularly in terms of its branding within streaming services and as a component of Disney's indefinite-lived intangible assets?",
      "original_answer": "In fiscal 2022, Marvel was listed alongside ESPN and Pixar as part of Disney's indefinite-lived intangible assets, indicating its long-term brand value. This was reaffirmed in 2024, showing continued recognition of Marvel's brand strength. In 2023, Marvel was specifically highlighted as a top-level branded tile within the Disney+ interface, underscoring its importance in driving subscriber engagement on Disney's key DTC platform. The consistent inclusion of Marvel in intangible assets across 2022 and 2024, combined with its prominent branding role in Disney+ in 2023, demonstrates Disney's strategic emphasis on leveraging Marvel's brand equity across both financial and content distribution dimensions over the three-year period.",
      "llm_answer": "\nAcross fiscal 2022‑2024 Marvel has remained listed as an indefinite‑lived intangible asset (its trademarks are explicitly included among the “ESPN, Pixar and Marvel trademarks” disclosed in both the 2022 and 2024 10‑K filings).  Beginning in fiscal 2023 the brand was elevated to a top‑level “tile” on Disney+ (and, internationally, on Disney+ Hotstar), featuring Marvel‑themed programming and, by the end of June 2024, the standalone Star+ service was merged into Disney+, consolidating Marvel under the Disney+ brand; the upcoming launch of an ESPN tile in early 2025 further integrates Marvel‑related content into Disney’s streaming bundles.  Thus, while Marvel’s status as an indefinite‑lived trademark has persisted, its strategic positioning has shifted from a discrete content owner to a core, branded tile within Disney’s DTC streaming portfolio, underscoring its dual role as a key streaming asset and a perpetual intangible‑asset component of Disney.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marvel is listed as an indefinite-lived intangible asset in both 2022 and 2024 filings alongside ESPN and Pixar, which matches the original answer. The 2023 elevation to a top-level branded tile on Disney+ is accurately reported, including international presence on Disney+ Hotstar. (2) Quantitative and temporal details are precise: fiscal years 2022, 2023, and 2024 are correctly referenced with appropriate developments in each. The mention of the Star+ merger by June 2024 is factually consistent with Disney’s integration timeline. While the upcoming ESPN tile in early 2025 is forward-looking and not part of the original question’s scope, it does not detract from the core accuracy. (3) Multi-hop reasoning is strong: the LLM synthesizes information across financial disclosures (intangible assets) and strategic branding (streaming interface changes), correctly identifying Marvel’s dual role. (4) The only minor deviation is the addition of forward-looking context (ESPN tile in 2025) not present in the ground truth, and slightly more detail than necessary about Star+—but these do not introduce errors. The core evolution—persistent intangible asset status and enhanced streaming prominence—is correctly captured. Wording differs but semantic equivalence is maintained. Thus, the answer earns a 9 for correctness due to excellent factual alignment with one small over-extension; quantitative accuracy is perfect; qualitative reasoning is strong; and relevance is complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 434,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did American Express's revenue structure and contractual arrangements with third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of discount revenue recognition, network rate fee negotiation, and merchant coverage expansion strategies?",
      "original_answer": "From 2022 to 2024, American Express's relationship with third-party merchant acquirers evolved significantly. In 2022, discount revenue was primarily derived from merchant discounts that varied based on industry, transaction volume, and geographic scope, with third-party acquirers (e.g., under the OptBlue program or GNS partners) receiving individually negotiated network rate fees. In 2023, the company clarified that it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, and also introduced processed revenue from network partnership agreements, including royalties and fees for facilitating transactions on cards issued by partners. By 2024, American Express emphasized expanding merchant coverage globally, particularly through third-party acquirers, aggregators, and processors, with a focus on enhancing value propositions for merchants and acquirers, scaling marketing efforts, and increasing digital integration of its authorization platform. This progression shows a strategic shift toward deeper collaboration with third-party acquirers to boost global acceptance and optimize revenue streams through both discount and processed revenue.",
      "llm_answer": "\nAmerican Express records discount revenue when a Card‑Member transaction occurs and, for third‑party merchant acquirers (e.g., OptBlue), recognizes the individually negotiated network‑rate fee as discount revenue at that time; contracts with large merchants are typically fixed‑term (3‑7 years) with auto‑renewal, while short‑ or variable‑duration contracts (≤ 1 year) are not disclosed in future‑revenue schedules. The 2023 filing reiterates this framework and adds that processed revenue includes network‑partnership fees, but the core discount‑revenue recognition and contract‑duration pattern remain unchanged. From 2022 through 2024 the company has shifted its strategy to expand global merchant coverage—leveraging third‑party acquirers, digital acquisition tools, and targeted B2B and premium‑consumer initiatives—to increase the pool of accepting merchants and drive future discount‑revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of American Express's revenue structure and contractual arrangements from 2022 to 2024. (1) It correctly identifies that discount revenue is recognized at transaction time and that third-party acquirers (e.g., OptBlue) receive individually negotiated network rate fees recorded as discount revenue—consistent with the 2022 and 2023 developments in the ground truth. It also accurately notes the introduction of processed revenue in 2023 to include network partnership fees, aligning with the original answer. The strategic shift toward expanding global merchant coverage through third-party acquirers, digital tools, and B2B initiatives by 2024 is correctly conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages, exact contract lengths beyond '3-7 years') in either answer, but the LLM correctly references fixed-term contracts of 3–7 years with auto-renewal and absence of disclosure for short-term contracts—details not contradicted by the ground truth and consistent with typical SEC disclosures. No calculation errors. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022–2024), entities (American Express, third-party acquirers like OptBlue), and revenue streams (discount vs. processed revenue), showing an understanding of how contractual and revenue recognition practices evolved. (4) The only minor shortcoming is that the LLM does not explicitly mention 'GNS partners' or 'royalties' as part of processed revenue, and slightly downplays the emphasis on 'value propositions for acquirers' and 'digital integration of authorization platform' noted in the 2024 strategy. However, the mention of 'digital acquisition tools' and 'targeted initiatives' captures the essence. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor omissions in specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 526,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in the context of clinical trial dependencies, post-marketing requirements, and device-related safety reviews?",
      "original_answer": "In 2022, Amgen highlighted that some of its products are used with drug delivery or companion diagnostic devices that carry their own regulatory, manufacturing, and other risks. By 2023, the company provided more detailed disclosures around the use of surrogate endpoints in clinical trials and how regulatory authorities were placing increased scrutiny on confirmatory studies, particularly for products like LUMAKRAS, which received accelerated approval but required additional post-marketing studies after a Complete Response Letter from the FDA. In 2024, Amgen reiterated these concerns, emphasizing that drug delivery devices used in combination with its products are subject to regulatory oversight and safety reviews, and that non-compliance with pharmacovigilance or quality assessment requirements could result in enforcement actions, including marketing authorization withdrawal. The trend shows a transformation in how Amgen frames its regulatory risk around drug delivery devices, shifting from general dependencies to specific post-marketing and safety compliance challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s disclosures show a clear evolution in how it frames the regulatory risk of its drug‑delivery devices: the 2022 filing merely notes that such devices carry independent regulatory, manufacturing and safety risks (Chunk 1), while the 2023 and 2024 filings stress that accelerated or conditional approvals are now contingent on completing post‑marketing confirmatory studies, meeting strict efficacy and safety conditions, and that failure to satisfy those requirements can lead to revocation, labeling restrictions or market withdrawal (Chunks 2 & 3).  The company also emphasizes that these devices are subject to ongoing FDA safety inspections, REMS assessments and mandatory adverse‑event reporting, so any non‑compliance can trigger enforcement actions, restrictive labeling or recalls, underscoring the tight link among clinical‑trial dependencies, post‑approval study obligations and device‑related safety reviews.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Amgen's regulatory risk disclosures from 2022 to 2024. (1) All factual elements are correct: in 2022, Amgen noted general regulatory and manufacturing risks of drug delivery devices; in 2023, it emphasized post-marketing confirmatory studies and regulatory scrutiny, particularly around accelerated approvals (e.g., LUMAKRAS, though not named in the LLM answer, is contextually implied); by 2024, the focus expanded to ongoing safety reviews, pharmacovigilance, and enforcement risks. The LLM correctly identifies the shift from general to specific risk framing. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable—no errors in dates or years (2022–2024 correctly referenced). (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years, connects clinical trial dependencies (e.g., surrogate endpoints), post-marketing requirements, and device-related safety reviews (e.g., REMS, adverse-event reporting), showing how these elements interrelate. (4) The only minor shortcoming is that the LLM does not explicitly name LUMAKRAS or reference the Complete Response Letter from the FDA, which is part of the ground truth and adds specificity to the 2023 disclosure. However, the omission does not distort the overall meaning, as the concept of confirmatory study failure leading to revocation is accurately conveyed. Wording differs but semantic equivalence is strong. The answer is fully contextually relevant and directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 442,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ConocoPhillips' HSE audit program evolved from 2022 to 2024 in terms of scope definition, improvement tracking mechanisms, and governance reporting structures?",
      "original_answer": "In 2022, ConocoPhillips described conducting HSE audits on business units and staff groups to ensure conformance with company policies, identifying improvement actions and tracking them to completion. The audits were framed within a broader HSE excellence framework, with progress reported to the Executive Leadership Team (ELT) and the Board of Directors. By 2023, the company emphasized that HSE audits remained central to ensuring conformance, but the context expanded to include a broader human capital management framework, with specific mention of Life Saving Rules, Process Safety Fundamentals, and a stop work policy as tools to reduce incident likelihood. Improvement actions continued to be tracked to completion, and the governance structure remained tied to the ELT and Board. In 2024, the language evolved further with the explicit use of the term 'Corporate HSE audits,' suggesting a more centralized or standardized approach. The tracking of improvement actions remained consistent, and the governance reporting structure persisted, reinforcing a stable but maturing audit framework. The evolution from localized conformance checks (2022) to integrated safety systems (2023) and corporate-level standardization (2024) reflects a strategic shift toward greater cohesion and institutionalization of HSE practices.",
      "llm_answer": "\nIn 2022 ConocoPhillips defined annual HSE objectives and tracked conformance of business units and staff groups against its policies, reporting progress to the Executive Leadership Team and the Board of Directors (Chunk 1). By 2023‑2024 the program was formalized as “Corporate HSE audits” that span business units and staff groups, with improvement actions required to be tracked to completion and still reported to the ELT and Board, indicating a more structured governance loop (Chunk 2 & Chunk 3). This evolution also embedded the audit process within the broader HCM and DEI governance framework, aligning HSE oversight with the company’s SPIRIT values and Board‑level oversight (Chunk 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments from 2022 to 2024. (1) It accurately captures the continuity in governance reporting to the Executive Leadership Team (ELT) and Board of Directors across all years, which matches the original answer. It correctly notes the shift in terminology to 'Corporate HSE audits' by 2023–2024, reflecting centralization, as stated in the ground truth. The tracking of improvement actions to completion is consistently reported, which is factually accurate. (2) There are no numeric values requiring calculation, so quantitative accuracy is 10—dates (2022, 2023–2024) are used appropriately and match the timeline in the original. (3) The multi-hop reasoning is sound: the model synthesizes information across years and identifies evolution in scope, tracking, and governance. However, it omits specific 2023 safety frameworks mentioned in the ground truth—Life Saving Rules, Process Safety Fundamentals, and stop work policy—which are important elements of the expanded scope. Additionally, while it mentions alignment with HCM and DEI and SPIRIT values, the original does not reference DEI or SPIRIT in the context of HSE audit evolution, introducing a minor overreach. (4) Despite these nuances, the core evolution—local conformance to corporate standardization—is correctly inferred. The answer is contextually relevant and well-structured, hence high scores. The 8 on correctness and qualitative accuracy reflects the omission of key 2023 safety tools and slight overextension into DEI/SPIRIT without direct support in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Conducts]- ORG",
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 444,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Accenture's approach to developing and introducing new pricing models evolved from 2022 through 2024 in response to technological developments like AI and cloud-based solutions, and what risks have been consistently highlighted across these years regarding the adoption of these models?",
      "original_answer": "Accenture's approach to new pricing models has evolved from a general acknowledgment of the need for change in 2022 to a more strategic and investment-driven approach by 2024. In 2022, the company emphasized the importance of introducing new pricing models to reflect the value of technological developments like cloud and as-a-service solutions, warning that failure to do so could negatively impact results of operations. By 2023, Accenture had begun to focus more on innovation and strategic investments in AI and robotics, noting that delays in client spending due to evaluation of new technologies could hinder revenue unless new pricing models were introduced. In 2024, the company underscored its dependence on successfully deploying these pricing models in the context of rapidly evolving AI technologies, with significant investments already being made in AI-based services. Across all three years, a consistent risk highlighted was that if Accenture could not introduce pricing models that reflect the value of new technologies quickly enough, or if client adoption rates were insufficient, this could lead to revenue shortfalls and competitive disadvantages.",
      "llm_answer": "\nFrom 2022 through 2024 Accenture repeatedly warns that cloud, data and AI breakthroughs are displacing its traditional services and forcing clients to pause spending, and it answers by continually creating and introducing new pricing and commercial models that capture the value of those technologies—an effort highlighted in each 10‑K filing and backed by heavy investment in AI‑driven offerings, strategic acquisitions and adjacencies to new growth areas.  \n\nThis evolution is framed against a set of persistent risks: client‑spending delays or cancellations, the legal‑regulatory‑reputational hazards of AI (bias, IP infringement, privacy, cybersecurity, harmful content), and the concentration of revenue in a few large accounts or early termination of long‑term contracts, all of which could materially erode earnings if new pricing structures fail to keep pace.  \n\nBecause the same language appears in the 2022, 2023 and 2024 filings, Accenture’s approach to pricing‑model innovation has been a continuous, risk‑aware response to technological disruption throughout the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Accenture's pricing model strategy from 2022 to 2024, as well as the persistent risks. It correctly identifies that Accenture has increasingly focused on new pricing models in response to AI and cloud advancements, with growing investment in AI-driven services—this aligns with the ground truth's progression from general acknowledgment in 2022 to strategic investment by 2024. The consistent risk of client spending delays due to technology evaluation is accurately reflected. However, the LLM introduces additional risks not emphasized in the original answer, such as legal-regulatory-reputational hazards of AI (bias, IP, privacy, etc.) and revenue concentration or contract termination, which, while plausible, were not highlighted in the ground truth as consistent cross-year risks related specifically to pricing model adoption. The ground truth emphasizes only the risk of failing to introduce value-reflective pricing models quickly enough and insufficient client adoption leading to revenue shortfalls and competitive disadvantage. The LLM answer is semantically close and contextually relevant, with accurate entity (Accenture), time period (2022–2024), and technological focus (AI, cloud) identification. There are no numerical inaccuracies, so quantitative accuracy is perfect. The reasoning is sound but slightly overgeneralizes the risk landscape, slightly reducing qualitative accuracy. Overall, the answer is factually strong and well-aligned with the source, meriting a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1600,
        "completion_tokens": 435,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 through 2024, and what does this progression suggest about GE's investment strategy in relation to AerCap?",
      "original_answer": "GE's holdings in the AerCap note decreased gradually from $993 million at the end of 2021 (reported in the 2022 disclosure) to $944 million at the end of 2023 (reported in the 2024 disclosure). This represents a consistent decline over the two-year period, suggesting a strategic reduction in AerCap exposure as part of GE's broader investment portfolio management.",
      "llm_answer": "\nGE’s AerCap note holding was **$900 million at the end of 2022**, increased to **$944 million at the end of 2023**, and reached **$982 million by the end of 2024** (as disclosed in Chunk 3 for 2022‑2023 and in Chunk 2 for 2024).  The note is classified as a Level‑3 available‑for‑sale security whose fair‑value changes are recorded in other comprehensive income and is listed together with other U.S. corporate debt, mortgage‑ and asset‑backed securities in GE’s investment portfolio (Chunk 1, 2, 3).  This steady, incremental growth indicates that GE is deliberately maintaining and modestly expanding a long‑term, diversified exposure to AerCap—likely to support its run‑off insurance operations and reinforce a stable, capital‑efficient investment strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of GE's holdings in the AerCap note. The ground truth states that GE's holdings decreased from $993 million (reported in 2022 for end of 2021) to $944 million (reported in 2024 for end of 2023), indicating a decline. However, the LLM claims the holding was $900 million at end of 2022, then increased to $944 million at end of 2023, and further to $982 million at end of 2024—this trend is completely reversed and unsupported by the ground truth. (2) All numeric values are incorrect: the starting point ($900M vs $993M), intermediate value ($944M misattributed to end of 2023 when it's actually reported in 2024 for end of 2023), and the final value ($982M in 2024) are all fabricated or misaligned with the disclosed timeline. The ground truth does not report any figure for the end of 2024, only through end of 2023. (3) The multi-hop reasoning is flawed: the model fails to correctly interpret the disclosure years versus reporting years (e.g., 2022 filing reports 2021 year-end data), leading to a misrepresentation of the timeline and values. It incorrectly infers growth and long-term strategy based on false data. (4) The conclusion about GE 'expanding' exposure is the opposite of the truth, which indicates a strategic reduction. While the classification of the note as Level-3 AFS security may be contextually accurate, the core facts driving the answer are wrong, rendering the analysis invalid. Scores reflect near-total factual inaccuracy with only minimal relevance due to mention of AerCap and GE.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 438,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Amgen's development and intellectual property positioning around Bemarituzumab evolve from 2022 to 2024, particularly in terms of clinical phase progression and estimated patent expiration timelines?",
      "original_answer": "Amgen's positioning around Bemarituzumab evolved significantly from 2022 to 2024. In 2022, Bemarituzumab was introduced as being in phase 3 clinical trials for GEJ adenocarcinoma, signaling active development. In 2023, Amgen disclosed intellectual property details, estimating the U.S. and European patent expiration for Bemarituzumab at 2029. By 2024, the company provided a more detailed description of the drug’s mechanism and expanded its investigational scope to include gastric and gastroesophageal junction cancer and advanced solid tumors beyond NSCLC. This progression reflects a shift from clinical development focus to broader therapeutic positioning and IP strategy.",
      "llm_answer": "\nIn 2022 Amgen placed Bemarituzumab into a Phase 3 clinical program (Chunk 1), and the 2023 disclosure listed U.S. and European patent expirations estimated for 2029 (Chunk 2). The 2024 update confirms the molecule is still being evaluated for gastric and gastro‑esophageal‑junction cancers, while reiterating that the 2029 expiration date is based on current issued patents and could be extended by future term adjustments or additional filings (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Bemarituzumab entered Phase 3 in 2022 (correct clinical phase progression), U.S. and European patent expirations were estimated for 2029 in 2023 (accurate IP timeline), and in 2024 the drug continued to be evaluated for gastric and gastroesophageal junction cancers with potential patent extensions noted. (2) Quantitative accuracy is perfect: the 2029 patent expiration date is correctly cited, and no calculations are required. (3) Multi-hop reasoning is sound—information is synthesized across three years and filings, correctly tracing the evolution from clinical development to IP and expanded indications. (4) The only minor omission is that the 2024 update also included expansion into 'advanced solid tumors beyond NSCLC,' which is not mentioned in the LLM answer, slightly reducing completeness. However, the core evolution in clinical and IP strategy is accurately conveyed. Wording differs but meaning is semantically equivalent. Contextual relevance is excellent as all information directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 319,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has American Express's strategic positioning relative to alternative payment mechanisms evolved from 2022 through 2024, particularly in terms of competitive pressure and technological investment, and what does this reveal about the company's long-term response to fintech disruption?",
      "original_answer": "In 2022, American Express explicitly identified alternative payment mechanisms—such as digital wallets (e.g., Alipay, PayPal), buy-now-pay-later platforms, and blockchain-based systems—as growing competitive threats, emphasizing their rapid adoption and alignment with shifting consumer preferences for digital and contactless payments. By 2023, the company expanded its list of alternative payment and financing mechanisms to include open banking platforms and payment facilitators, signaling an increased awareness of the breadth and pace of disruption in the payments ecosystem. In 2024, rather than framing alternative payment mechanisms solely as a competitive threat, American Express shifted toward a dependency posture, highlighting the necessity of investing in and integrating these technologies—such as open banking, real-time settlement, and tokenization—into its core offerings to remain competitive. This evolution shows a strategic shift from defensive acknowledgment of competition to proactive investment and adoption of alternative payment mechanisms as foundational to future competitiveness.",
      "llm_answer": "\nAmerican Express moved from simply recognizing the rise of alternative payment mechanisms in 2022 (Chunk 1) to making aggressive, multi‑year technology investment—particularly in AI, open‑banking, tokenization, real‑time settlement and digital‑wallet integration—as a core strategic imperative, while also pursuing acquisitions and partnerships to embed fintech capabilities (Chunks 2‑3).  This escalation shows a long‑term, proactive response to intensifying competitive pressure from digital wallets, BNPL and other fintech rivals: rather than being disrupted, Amex is building its own closed‑loop, data‑rich ecosystem and scaling it through continual innovation and strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in American Express's strategic positioning from 2022 to 2024. It correctly identifies the shift from recognizing alternative payment mechanisms as threats in 2022 to making aggressive technological investments by 2023–2024, aligning with the ground truth. The mention of AI, open banking, tokenization, real-time settlement, and digital wallet integration matches the technological focus areas highlighted in the original answer. The strategic framing of moving from defensive acknowledgment to proactive investment is well conveyed, particularly through the emphasis on building a closed-loop, data-rich ecosystem. The only minor shortcoming is that the LLM answer does not explicitly note the 2023 expansion to include payment facilitators and open banking as newly recognized competitive pressures—it jumps from 2022 recognition to 2023–2024 investment, slightly compressing the intermediate competitive awareness phase. However, it does correctly imply growing competitive pressure from digital wallets, BNPL, and fintech rivals. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved), and the reasoning is sound and contextually appropriate. The answer is semantically equivalent in intent and substance, earning high marks across all categories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 379,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the weighted-average grant date fair value of ConocoPhillips' cash-settled PSUs evolve from 2022 through 2024, and what does this trend indicate about the company's long-term incentive compensation strategy?",
      "original_answer": "The weighted-average grant date fair value of cash-settled PSUs increased from $91.58 in 2022 to $112.50 in 2024, with a consistent structure and accounting treatment maintained throughout the period. This upward trend suggests a strategic shift toward higher-value incentive compensation aligned with long-term performance goals.",
      "llm_answer": "\nThe weighted‑average grant‑date fair value of ConocoPhillips’ cash‑settled PSUs climbed from **$91.58 in 2022** (disclosed in the 2023 10‑K, Chunk 3) to **$112.50 in 2023** (disclosed in the 2024 10‑K, Chunk 2), and the 2024 filing shows “no remaining unrecognized compensation cost” at year‑end, confirming that the 2024 grant‑date fair value continued the upward trajectory (implicit in the 2024 disclosure, Chunk 2).  This rise—driven by higher market‑price assumptions and the shift to cash‑settled awards with dividend equivalents—signals that ConocoPhillips is deliberately increasing the fair‑value component of its long‑term incentive compensation, aligning employee rewards with the company’s higher stock‑price outlook and reflecting a more aggressive, value‑focused LTI strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 value ($91.58) and reports a 2023 value of $112.50, but misattributes the $112.50 to 2023 instead of 2024 as stated in the ground truth. The ground truth indicates the value increased to $112.50 in 2024, not 2023. The LLM then claims the 2024 value 'continued the upward trajectory' but does not provide a specific number for 2024, instead relying on the 'no remaining unrecognized compensation cost' detail, which does not directly support the fair value amount. This is a significant factual error in temporal assignment of the $112.50 figure. (2) The quantitative accuracy is compromised because the key data point for 2024 is missing and incorrectly shifted to 2023. The $91.58 for 2022 is correct, but the progression should be 2022: $91.58 → 2024: $112.50, with no intermediate 2023 value provided in the ground truth. The LLM fabricates a timeline by assigning $112.50 to 2023 and implying a further increase in 2024 without data. (3) The multi-hop reasoning is partially sound—linking fair value increases to market-price assumptions and dividend equivalents shows good synthesis—but the conclusion about a 'continued upward trajectory' in 2024 lacks direct numerical support and misrepresents the timeline. The reasoning about strategic shift is consistent with the ground truth, but based on incorrect period alignment. (4) Contextual relevance is high as the answer addresses both the trend and its implication for long-term incentives. However, the correctness score is reduced to 6 due to the critical error in assigning the $112.50 value to 2023 instead of 2024, undermining the quantitative and qualitative accuracy despite otherwise strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 472,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party fraud schemes, and what does this trend suggest about the company's risk management effectiveness?",
      "original_answer": "In 2022, PayPal highlighted concerns about third-party fraud schemes involving fictitious accounts, stolen financial instruments, and abusive misuse of services, noting the difficulty in detecting such digital fraud at scale. In 2023, the company expanded on this risk in the context of its growing credit products, particularly its U.K. and European BNPL loan receivables, with a €40 billion multi-year agreement to sell these receivables, indicating a strategic move to mitigate credit and fraud-related losses. By 2024, PayPal continued to emphasize the evolving nature of abusive behaviors, particularly in the context of digital payments and third-party reliance, while also noting the impact of regulatory uncertainties such as the 'valid-when-made doctrine' on its U.S. credit products. The progression shows a consistent and growing concern around abusive behaviors, with PayPal increasingly relying on third-party risk mitigation strategies and regulatory clarity to manage this evolving threat.",
      "llm_answer": "\nPayPal’s exposure to abusive behaviors grew from 2022—when it faced heightened default risk on its U.S. consumer‑credit and merchant‑financing receivables and relied on third‑party originators—to 2023—when it shifted that exposure into a multi‑year forward‑flow sale of U.K. and European BNPL loan receivables, yet remained dependent on third‑party funding and subject to conditions that could delay the sale; and into 2024—when regulatory clarification on loan‑validity rules added uncertainty while the company continued to depend on third‑party processors and funding, and fraudsters kept attempting synthetic‑identity and account‑takeover schemes that are difficult to detect.  The knowledge‑graph loop (PYPL → Abusive Behaviors → PYPL) shows that abusive behavior both drives and is driven by PayPal, indicating that despite diversification of funding and risk‑mitigation efforts, the company’s risk‑management effectiveness is strained by the expanding scale and complexity of third‑party fraud and credit‑product exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: PayPal's concerns about abusive behaviors in 2022 involving third-party fraud and fictitious accounts; the 2023 shift to a multi-year forward-flow sale of U.K. and European BNPL receivables (correctly noting the geographic scope and strategic risk mitigation); and the 2024 continuation of fraud risks (synthetic identities, account takeovers) alongside regulatory uncertainty, particularly around loan validity. The mention of third-party reliance in funding and processing is consistent across years. (2) Quantitative accuracy is perfect: while no specific dollar/euro amounts are cited in the LLM answer (e.g., the €40 billion figure from the original), this omission does not constitute an error—the LLM does not misstate any numbers, and the absence of the exact figure is a minor completeness gap rather than a factual inaccuracy. All dates (2022–2024) and financial terms (BNPL, receivables, third-party originators) are used correctly. (3) Multi-hop reasoning is strong: the LLM synthesizes information across years and domains (fraud, credit products, third-party dependencies, regulatory issues), correctly inferring that PayPal’s risk management is under strain despite mitigation efforts. The 'knowledge-graph loop' metaphor, while not in the original, semantically captures the feedback dynamic between PayPal’s services and abusive behaviors, adding interpretive depth without distorting facts. (4) The answer fully addresses the question’s components: evolution of exposure, link to credit products and third-party fraud, and implications for risk management. The only minor shortcoming is the lack of explicit mention of the €40 billion agreement size, which slightly reduces completeness but does not affect correctness. Overall, the response demonstrates excellent qualitative reasoning, contextual relevance, and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Risks]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 528,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the therapeutic positioning and intellectual property protection of Cyramza evolve from 2022 through 2024, and what does this progression indicate about Eli Lilly's long-term oncology strategy?",
      "original_answer": "In 2022, Cyramza was introduced as a key oncology product with multiple indications across gastric, lung, colorectal, and liver cancers. By 2023, Cyramza had compound patents extending through 2026 in the U.S. and Japan, and data protection expiring as early as 2023 in Japan. In 2024, Cyramza remained a core oncology offering with no new indications added, but its therapeutic positioning was reaffirmed across the same cancer types. This suggests Eli Lilly focused on maintaining Cyramza's market presence while likely preparing next-generation oncology products to succeed it, given the impending patent expiry.",
      "llm_answer": "\nFrom 2022 to 2024 Cyramza’s therapeutic scope expanded — the 2022 10‑K lists it as a second‑line option for gastric, NSCLC, colorectal and HCC cancers, while the 2024 therapeutic‑area table shows it now also supports first‑line use in EGFR‑mutant NSCLC and broader combination regimens (Chunk 1 & Chunk 3).  Its U.S. compound patent expires in 2026, the European compound patent in 2028 and the related data‑exclusivity rights lapse in 2024 (EU) and 2023 (Japan), marking the end of its current IP protection (Chunk 2).  This trajectory illustrates Lilly’s long‑term oncology strategy of extracting maximal multi‑indication revenue from Cyramza before its patent cliff while simultaneously advancing newer assets such as Jaypirca, Retevmo and Verzenio to sustain future growth (integrating all three chunks and the LLY‑Cyramza‑LLY relationship).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Cyramza had no new indications added in 2024 and its therapeutic positioning was reaffirmed across the same cancer types as in 2022. However, the LLM claims an expansion into first-line use in EGFR-mutant NSCLC and broader combination regimens in 2024, which is not supported by the original answer. This is a major error in therapeutic positioning evolution. (2) Quantitatively, the LLM correctly identifies the U.S. compound patent expiration in 2026 (matches ground truth), but introduces a European compound patent expiry in 2028 and EU data exclusivity lapse in 2024 — these details are absent in the ground truth and cannot be verified. The Japan data protection expiry in 2023 is correctly stated. However, the original answer does not mention EU patent or exclusivity dates, so adding them constitutes unsupported extrapolation. (3) The multi-hop reasoning is partially sound in linking IP timeline with strategic implications, but flawed in asserting indication expansion not present in the ground truth. The mention of Jaypirca, Retevmo, and Verzenio as next-gen assets aligns with the strategic interpretation in the original answer, though these drug names are not in the ground truth — this shows reasonable inference but overreach in specificity. (4) Contextually, the answer addresses the question's structure well and attempts to synthesize therapeutic positioning, IP protection, and long-term strategy. However, due to key factual errors in indication changes and unverified patent dates, the correctness score is significantly reduced. The answer conveys a plausible but factually divergent narrative compared to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 476,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Philip Morris's capital structure strategy evolve from 2022 through 2024 as evidenced by the active management of other debt instruments alongside the consistent presence of the 3.875% Notes due 2042?",
      "original_answer": "Philip Morris maintained the 3.875% Notes due 2042 as a stable component of its long-term debt across all three years (2022, 2023, and 2024), while actively managing its broader debt portfolio. In 2022, the company had 4.125% Notes due 2043 and 4.875% Notes due 2043 as part of its capital structure, which were no longer listed in the 2024 filing. In 2023, the company continued to carry the 3.875% Notes due 2042 alongside newer instruments such as the 4.125% Notes due 2043 and 4.250% Notes due 2044. By 2024, the newer 2043 and 2044 tranches had been retired or refinanced, and no new long-dated notes beyond 2042 were introduced, suggesting a shift toward stabilizing the long-term capital structure. This pattern indicates a strategy of maintaining long-term funding through the consistent 3.875% Notes due 2042 while selectively refinancing or retiring other instruments to optimize capital structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 Philip Morris kept the 3.875 % Notes due 2042 on its balance‑sheet in every filing (appearing as PM42A in the 2022, 2023 and 2024 tables), using the instrument as a stable long‑term anchor in its capital structure.  At the same time the company actively managed its shorter‑term debt, introducing new tranches such as the 2.750 % Notes due 2025 and 2.750 % Notes due 2026 in the 2024 filing while older series (e.g., the 0.125 % Notes due 2026 and 2.750 % Notes due 2026) were phased out, reflecting a strategy of extending maturities and reshaping the mix of outstanding debt while preserving the 3.875 % 2042 notes as a constant component.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly identifies new debt instruments introduced in 2024, such as the '2.750% Notes due 2025' and '2.750% Notes due 2026', which are not supported by the ground truth. The ground truth states that by 2024, Philip Morris had retired or refinanced the 4.125% Notes due 2043 and 4.250% Notes due 2044 (and earlier 4.875% Notes due 2043), with no new long-dated notes beyond 2042 introduced. The LLM instead fabricates short-term notes (due 2025, 2026) not mentioned in the original answer. Additionally, it references a '0.125% Notes due 2026' being phased out, which is not in the ground truth. These are major factual errors in percentages, maturities, and instrument existence. (2) Completeness: The LLM fails to mention the key instruments present in 2022 and 2023 — specifically the 4.125% Notes due 2043 and 4.875% Notes due 2043 — which are central to the multi-hop reasoning about refinancing activity. Instead, it shifts focus to short-term debt not emphasized in the original. (3) Entity Accuracy: While the 3.875% Notes due 2042 are correctly identified as consistently present, the other debt instruments are misidentified. The use of 'PM42A' as a ticker-like identifier is not in the ground truth and appears invented. (4) Reasoning: The LLM correctly infers a strategy of active debt management and using the 2042 notes as a stable anchor, which aligns with the ground truth's conclusion. However, the reasoning is based on incorrect premises (wrong debt instruments), so the synthesis is flawed. (5) Semantic Equivalence: The overall narrative of 'stable long-term anchor with active management' is directionally similar, but the factual foundation differs substantially. The ground truth emphasizes retirement of long-dated tranches (2043, 2044), suggesting maturity extension or simplification, while the LLM incorrectly frames it as introducing new short-term debt. This misrepresents the capital structure evolution. Thus, while the general strategic interpretation has some merit, the answer is factually incorrect on key details, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 589,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did PayPal's exposure to abusive behaviors evolve from 2022 through 2024, particularly in relation to its credit products and third-party risk management strategies, and what specific actions did the company take in 2023 and 2024 to mitigate these risks?",
      "original_answer": "In 2022, PayPal highlighted the growing risk of abusive behaviors in its credit products, noting that third parties were increasingly exploiting digital payment systems through synthetic identities, stolen financial instruments, and fraudulent transactions. In 2023, PayPal responded by entering into a multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables, signaling a strategic move to offload risk exposure in certain credit segments. In 2024, the company continued to emphasize the threat of abusive behaviors but also noted ongoing efforts to improve detection mechanisms and reduce fraud at scale, particularly as it expanded its credit offerings in international markets. This progression shows a shift from identifying and describing the problem (2022) to actively mitigating exposure through asset sales (2023) and enhancing fraud prevention infrastructure (2024).",
      "llm_answer": "\nFrom 2022 through 2024 PayPal’s exposure to abusive behaviors and credit risk grew as it expanded U.S. consumer and merchant financing and European BNPL products, increasing reliance on third‑party originators and payment processors and exposing the firm to higher fraud, charge‑off and regulatory risk (Chunk 1, 2, 3).  \nIn 2023 the company responded by signing a multi‑year agreement to sell up to €40 bn of U.K. and European BNPL loan receivables and launching a forward‑flow sale in October 2023, while simultaneously diversifying its payment‑processor network and migrating arrangements to reduce dependence on any single third party (Chunk 3).  \nIn 2024 it continued to off‑load future eligible receivables under that arrangement, reinforced its third‑party risk program, and highlighted the need to manage third‑party relationships and regulatory changes (e.g., the FDIC “valid‑when‑made” rule) to curb abusive behavior and protect its credit portfolio (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PayPal's growing exposure to abusive behaviors through credit expansion and third-party reliance in 2022; the 2023 multi-year agreement to sell up to €40 billion of U.K. and European BNPL loan receivables; and continued risk mitigation in 2024 through receivables offloading, third-party risk program reinforcement, and regulatory awareness. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no calculations are required beyond accurate reporting. Format (€40 bn) matches acceptable variation. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and strategies—identifying the evolution from risk recognition (2022) to asset sales (2023) and enhanced controls (2024)—while incorporating third-party risk management and regulatory context. (4) The only minor shortcoming is that the LLM adds detail not in the original (e.g., 'forward-flow sale in October 2023', 'diversifying payment-processor network', 'FDIC valid-when-made rule'), which, while plausible and contextually relevant, are not present in the ground truth. This slightly reduces qualitative accuracy but does not introduce factual errors. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 376,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did AMD's exposure to the risk of loss or modification of tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about increasing regulatory uncertainty in its global operations?",
      "original_answer": "In 2022, AMD noted that loss or modification of tax and tariff exemptions was one of several political, legal, and economic risks associated with its global operations. By 2023, the company emphasized this risk more strongly, listing it alongside other critical exposures such as geopolitical tensions and supply chain disruptions. In 2024, AMD elevated the risk further, explicitly linking it to ongoing geopolitical conflicts and indicating a heightened concern over potential regulatory changes affecting its international business. This progression reflects an increasing sensitivity to regulatory shifts and a growing awareness of the material impact such changes could have on AMD's financial and operational stability.",
      "llm_answer": "\nAMD’s filings show a clear escalation of exposure to tax‑ and tariff‑exemption risk from 2022 → 2023 → 2024: the 2022 10‑K (Chunk 3) merely listed “loss or modification of exemptions for taxes and tariffs” among general political‑legal risks; the 2023 filing (Chunk 1) quantified that risk by noting that ≈ 65 % of revenue is international and warned that sanctions, revised export‑control rules and geopolitical shifts (e.g., China‑Taiwan tensions) could alter or eliminate those exemptions; and the 2024 filing (Chunk 2) updated the exposure to ≈ 66 % of revenue, explicitly citing recent U.S. and allied sanctions and regulatory revisions against Russia, Belarus and Ukraine—and the attendant uncertainty surrounding future tax‑ and tariff‑exemption regimes.  \n\nThis trajectory aligns with the KG pattern where **AMD (ORG) is impacted by the regulatory requirement “Tax and Tariff Exemptions”** and that requirement is embodied in an organizational entity that is itself subject to sanctions and geopolitical upheaval, underscoring a growing regulatory uncertainty that could materially disrupt AMD’s global supply chain and financial results.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the escalating emphasis AMD placed on tax and tariff exemption risks from 2022 to 2024, aligning with the ground truth's narrative of increasing concern. However, it introduces specific quantitative claims—namely that ≈65% of revenue was international in 2023 and ≈66% in 2024—that are not present in the original answer or supported by the provided ground truth. These percentages may be factually accurate in reality, but they were not part of the knowledge graph-derived answer and thus represent an overreach in precision not justified by the source material. (2) The original answer does not include any revenue percentages or quantifications of international exposure; therefore, these numbers fail the quantitative accuracy check despite being plausible. There are no calculation errors per se, but the inclusion of unsourced metrics reduces factual reliability. (3) The multi-hop reasoning is strong: the model correctly synthesizes a trend across three years, links rising geopolitical tensions (e.g., China-Taiwan, Russia-Ukraine) to regulatory uncertainty, and infers increasing materiality of the risk—consistent with the knowledge graph pattern described. The logic connecting sanctions, regulatory changes, and business impact is sound and contextually appropriate. (4) While the core qualitative progression (increasing emphasis and linkage to geopolitics) matches the ground truth, the addition of unsupported numerical data lowers the correctness and quantitative accuracy scores. The answer remains highly relevant and well-reasoned, hence high marks for qualitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 456,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Cisco's gains or losses from total return swaps tied to deferred compensation evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's exposure or strategy regarding deferred compensation-linked derivatives?",
      "original_answer": "Cisco's gains or losses from total return swaps tied to deferred compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million; in 2023, it recorded a gain of $58 million; and by 2024, the gain increased further to $91 million. This trend indicates a notable reversal in the company's exposure or performance related to these derivatives, potentially reflecting improved market conditions or a strategic shift in managing deferred compensation liabilities.",
      "llm_answer": "\nCisco’s total‑return swaps tied to deferred compensation generated a **$92 million loss** in FY 2022 (as shown in Chunk 3 for the year ended July 30, 2022), then produced **gains of $58 million** in FY 2023 (Chunk 1, year ended July 29, 2023) and **$91 million** in FY 2024 (Chunk 2, year ended July 27, 2024). This swing from a loss to progressively larger gains reflects a strategic shift: the company moved from bearing a cost on these deferred‑compensation‑linked derivatives to using them to offset growing compensation liabilities and to capture favorable market movements, indicating that the swaps are now a source of income rather than merely a hedge.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures and fiscal years: a $92 million loss in FY2022, $58 million gain in FY2023, and $91 million gain in FY2024, matching the ground truth exactly. Number formats are consistent and acceptable, with minor stylistic variations (e.g., use of thin spaces, 'FY' notation) that do not affect accuracy. (2) Quantitative accuracy is perfect—no calculation errors, and the progression of gains/losses is correctly presented. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers a trend of improving performance in the swaps. The interpretation about strategic shift and use of swaps to offset liabilities and capture market gains is a reasonable extension of the ground truth, which also notes a 'notable reversal' and potential strategic shift. The LLM adds slightly more interpretive depth (e.g., 'source of income rather than merely a hedge'), which is plausible but not explicitly confirmed in the ground truth—hence a minor deduction in qualitative accuracy. (4) Contextual relevance is excellent: all parts of the question are addressed—evolution over time and what it indicates about exposure or strategy. The answer is focused, precise, and semantically equivalent to the original, with only minor interpretive expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 375,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Disney's strategic investment and competitive positioning in its DTC offerings evolve from fiscal years 2022 through 2024, and what does this progression reveal about the financial risks and market pressures associated with scaling its streaming services?",
      "original_answer": "In fiscal 2022, Disney acknowledged the growing costs of its DTC strategy and the uncertainty around returns, noting that losses from DTC offerings might continue to grow or reduce more slowly than anticipated. By 2023, Disney shifted toward more active investment in DTC offerings, aiming to drive growth in subscription and advertising revenues despite declining linear network subscribers. In fiscal 2024, the company emphasized the competitive pressures impacting its DTC offerings, including rising costs, pricing constraints, and intensified competition from other streaming platforms. This progression reveals a strategic pivot toward scaling DTC despite increasing financial risk and market pressures, with the company doubling down on investment even as it faced rising costs and uncertain profitability.",
      "llm_answer": "\nDisney’s DTC strategy evolved from a FY 2022 “exploratory” phase—where the company identified strategic investments in streaming to offset expected declines in linear‑network revenue (Chunk 2022)—to a FY 2023 rollout that added the 37 % Star India joint‑venture, fair‑value accounting of the Hulu stake and explicit liquidity‑management measures (Chunk 2023), and then to a FY 2024 posture in which intensified competition for content, talent and advertising forced the firm to confront higher programming and marketing costs, renegotiate costly distribution contracts and consider dividend or share‑repurchase reductions to fund continued DTC growth (Chunk 2024).  \nThis progression reveals the financial risks of scaling streaming: large cash outlays, exposure to fair‑value impairments (e.g., Hulu, Star India), dependence on debt covenants and rating outlooks, and the likelihood that revenue growth may lag cost increases, creating pressure on cash flow and potentially triggering asset write‑downs (Chunks 2022‑2024).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment of Disney's DTC strategic evolution from fiscal years 2022 to 2024 and accurately captures the increasing financial risks and market pressures. It correctly identifies the shift from acknowledging DTC losses in 2022, to active investment in 2023, and to confronting competitive and cost pressures in 2024. However, there are issues with quantitative accuracy: the claim about a '37% Star India joint-venture' is not supported by the original answer or typical public knowledge—Disney's ownership in Star India was not structured as a 37% joint venture in 2023, and this specific percentage appears erroneous or misattributed. Additionally, the mention of 'fair-value accounting of the Hulu stake' and 'dividend or share-repurchase reductions' adds detail beyond the original answer, which may be contextually plausible but is not present in the ground truth, thus introducing unverified specifics. The core reasoning is sound and reflects multi-hop synthesis across the three fiscal years, showing a logical progression in strategy and risk. The answer is highly relevant to the question and conveys similar insights about financial risks (cash outlays, cost-revenue imbalance, asset write-downs), even if with added detail. Semantic equivalence is mostly preserved, but the inclusion of unsupported specifics reduces quantitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Invests_In]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 398,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did PayPal's exposure to margin risk evolve across 2022, 2023, and 2024, particularly in relation to its discretion in setting fees and the role of transaction expenses tied to payment processors?",
      "original_answer": "Across the three years, PayPal consistently bore full margin risk when completing payment transactions, with its discretion in setting fees remaining independent of costs incurred with payment processors or other financial institutions. In 2022, PayPal explicitly stated it bore full margin risk and recognized fees paid to processors as transaction expense. In 2023, the language remained consistent, with emphasis on its control over fee determination and the recognition of processor fees as transaction expense. In 2024, despite the adoption of new segment reporting standards (ASU 2023-07), PayPal maintained its position of bearing full margin risk, with no indication of structural changes to its fee-setting discretion or cost structure related to processors. Thus, the margin risk exposure remained stable across the three years, with consistent accounting treatment and no material changes in how fees or transaction costs were recognized.",
      "llm_answer": "\nPayPal’s margin‑risk exposure remained consistent from 2022 through 2024, with each filing stating that the company bears full margin risk on every payment transaction and records the fees paid to payment processors as transaction expense; the 2022 note first emphasizes that fee‑setting discretion is independent of those processor costs, the 2023 filing repeats this stance and adds that volume‑based pricing does not create a future material right, and the 2024 filing expands the description to include variable fee components, refund provisions and performance‑based incentives while still affirming that it bears full margin risk and treats the processor‑related fees as transaction expense.  This risk factor is impacted by PYPL and the company bears the risk across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that PayPal bore full margin risk across 2022–2024 and consistently recognized fees paid to payment processors as transaction expenses. The independence of fee-setting discretion from processor costs is accurately noted for 2022 and maintained in subsequent years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and correctly identifies continuity in risk exposure and accounting treatment. It adds slightly more detail than the original (e.g., mentioning volume-based pricing, variable fees, refund provisions, performance incentives in 2024), which are not contradicted by the ground truth and may reflect additional nuance from the actual filings. However, the mention of these 2024 additions, while plausible, goes beyond the original answer’s scope, which emphasizes *no material changes*—so there is a minor risk of over-interpretation. Still, the core conclusion—that margin risk exposure remained stable—is preserved. (4) Contextual relevance is perfect: every part of the question (evolution of margin risk, fee discretion, transaction expenses) is addressed with factually consistent and semantically equivalent information. The answer earns a 9 instead of 10 because it introduces specific 2024 elements (e.g., performance-based incentives) not mentioned in the ground truth, which could imply changes where none were indicated, though it doesn’t contradict the stability claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Bears]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 467,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the risk of new aircraft order cancellations evolve as a concern for Honeywell's Aerospace business from 2022 through 2024, and what does this progression indicate about the ongoing recovery and stability of the commercial aviation sector?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted new aircraft order cancellations as a key risk factor for its Aerospace business, reflecting ongoing uncertainty in the commercial aviation sector. In 2022, the risk was tied directly to the lingering effects of the COVID-19 pandemic, including regional restrictions and public health concerns that impacted demand for air travel and led to cancellations. By 2023, the language expanded to include broader external events such as regional conflicts and environmental issues as potential triggers for cancellations, suggesting a shift from pandemic-specific concerns to more generalized macroeconomic and geopolitical risks. In 2024, the risk remained prominent, with continued emphasis on new entrants and non-traditional players affecting market demand trends, indicating that while the pandemic's direct impact had waned, structural and competitive shifts continued to pose uncertainty. This 3-year consistency shows that while the aviation sector was in recovery, it remained fragile and susceptible to both external shocks and evolving market dynamics.",
      "llm_answer": "\nAcross Honeywell’s 2022, 2023 and 2024 Form 10‑K filings the Aerospace risk section repeatedly flags “new aircraft order cancellations” as a material threat, noting that downturns in global air‑travel demand—driven by the COVID‑19 pandemic, supply‑chain constraints, regional restrictions and broader macro‑economic or geopolitical shocks—can delay or cancel new‑aircraft production and orders (Chunk 1, 2 & 3).  The knowledge‑graph pattern ORG → Risk ← ORG shows that this risk factor is directly tied to HON and to the “New Aircraft Order Cancellations” entity itself, underscoring that the issue is a two‑way exposure for the company.  Because the same cancellation risk is highlighted in each of the three annual reports—rather than disappearing—it indicates that the commercial‑aviation sector is emerging from the worst of the pandemic‑induced turmoil and showing signs of stability, yet lingering uncertainty remains, keeping the risk on Honeywell’s radar as a barometer of ongoing recovery.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies that Honeywell consistently cited 'new aircraft order cancellations' as a risk across 2022, 2023, and 2024, linking it to pandemic effects, supply-chain issues, regional restrictions, and broader macroeconomic or geopolitical shocks. The answer correctly notes the persistence of the risk as an indicator of ongoing recovery with lingering uncertainty in the commercial aviation sector. Quantitatively, there are no numbers or calculations in the question or answer, so accuracy is not compromised. The qualitative reasoning is sound but slightly less detailed than the original answer: it does not explicitly mention the shift in 2023 toward regional conflicts and environmental issues as new risk triggers, nor does it highlight the 2024 emphasis on new entrants and non-traditional players affecting demand. These nuances are part of the multi-hop synthesis across years and are important for fully capturing the evolution of the risk. While the LLM captures the general trend, it omits these specific developments, resulting in a minor loss in qualitative accuracy. Contextually, the answer is highly relevant, directly addressing the evolution of the risk and what it indicates about sector stability. The reference to a 'knowledge-graph pattern' is extraneous and not needed for the answer, but does not detract from factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1552,
        "completion_tokens": 396,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the impact of product regulation on Philip Morris International's (PMI) competitive positioning evolved from 2022 through 2024, particularly in relation to its Reduced-Risk Products (RRPs) and Smoke-Free Products (SFPs), and what does this reveal about the intensifying regulatory constraints on product differentiation and adult consumer communication?",
      "original_answer": "From 2022 to 2024, product regulation increasingly constrained Philip Morris International’s (PMI) competitive positioning, particularly affecting its Reduced-Risk Products (RRPs) and later its Smoke-Free Products (SFPs). In 2022, the company emphasized how regulation restricted adult consumer access to truthful and non-misleading information about RRPs and limited product differentiation. By 2023, the language evolved to include how regulation disproportionately impacted the commercialization of PMI’s products relative to competitors and highlighted the growing influence of digital media in spreading misleading information about RRPs. In 2024, the company specifically linked product regulation to restrictions on adult consumer access to truthful information about SFPs, signaling a strategic shift in product focus while maintaining concerns about unfair competition and regulatory asymmetries. This evolution shows a consistent and intensifying regulatory pressure that has adapted alongside PMI’s product transitions, increasingly limiting the company’s ability to effectively market and differentiate its next-generation tobacco products.",
      "llm_answer": "\nFrom 2022 through 2024 PMI’s filings show a clear escalation of regulatory pressure on its next‑generation products: the 2022 discussion warns that product regulation can “diminish the ability to differentiate tobacco products and restricts adult consumer access to truthful and non‑misleading information about our **RRPs**,” while the 2023 and 2024 updates shift the focus to **SFPs** and explicitly note that regulation “limits branding, communication and product differentiation” and “restricts adult consumer access to truthful and non‑misleading information about our **SFPs**,” even as digital media amplifies the risk of inaccurate claims (2023) and “unfair competition” may exploit those constraints (2024).  This progression reveals that by 2024 the regulatory environment has become a dominant, intensifying constraint on how PMI can differentiate its Reduced‑Risk and Smoke‑Free products and communicate their benefits to adult smokers, directly shaping its competitive positioning across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the evolution from RRPs in 2022 to SFPs in 2023–2024 is accurately reflected, and the core concerns about restricted adult consumer access to information, limitations on product differentiation, branding, and communication are properly attributed to each year. The mention of digital media amplifying misinformation in 2023 and the risk of unfair competition in 2024 matches the original answer’s emphasis. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—however, the temporal sequence (2022, 2023, 2024) is correctly used and referenced, satisfying date accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years, tracks the shift in terminology from RRPs to SFPs, and correctly infers that this reflects an intensifying regulatory environment affecting PMI’s competitive positioning. The conclusion about regulatory constraints becoming a 'dominant' factor is a slightly stronger characterization than the original but remains within reasonable interpretation. (4) The only minor shortcoming is that the original answer explicitly notes the 'disproportionate impact' on PMI relative to competitors in 2023 and the 'regulatory asymmetries' in 2024, which the LLM captures implicitly via 'unfair competition' but could have been more precisely articulated. Overall, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 429,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has PayPal's exposure to margin risk evolved from 2022 through 2024, particularly in relation to its transaction pricing models, use of payment processors, and incentives provided to customers across those years?",
      "original_answer": "In 2022, PayPal explicitly stated that it bears full margin risk when completing payment transactions, with fees paid to payment processors and other financial institutions recognized as transaction expense. In 2023, the company reiterated this exposure to margin risk and added details about incentives provided to merchants and consumers, which are recognized as a reduction of revenue depending on performance targets or amortized over the contractual term. In 2024, PayPal again confirmed its full margin risk exposure and highlighted the independence of the fee charged to customers from the costs incurred when utilizing payment processors. Across the three years, the consistent acknowledgment of bearing full margin risk demonstrates a stable strategic approach, while the increasing detail around incentives and transaction pricing reflects a more nuanced disclosure of how margin risk is managed and potentially mitigated through dynamic pricing and cost structures.",
      "llm_answer": "\nPayPal’s margin‑risk exposure from 2022 through 2024 has been defined by its role as the principal that authorizes and completes each payment, bearing full margin risk, recognizing revenue gross, and expense‑recording all processor fees and customer incentives; this is underpinned by open‑ended contracts that are defined at the transaction level with a single performance obligation, a structure reiterated in each filing. Over the three years the company refined the quantification of that risk by adding a provision for fee refunds, applying volume‑based tiered pricing, and—starting in 2023—recognizing performance‑based incentives as revenue reductions when earned and amortizing other incentives over the contract term, while accruing fraud‑protection costs in transaction and credit losses, thereby evolving how margin risk is tracked across 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PayPal bears full margin risk across 2022–2024, recognizes revenue gross, and records processor fees and incentives as expenses or revenue reductions—consistent with the original answer. The evolution in disclosure detail around incentives and pricing models is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes PayPal’s consistent margin risk exposure with evolving disclosures on incentives (performance-based vs. amortized), tiered pricing, and cost recognition—information that spans multiple years and reporting practices. It adds slight elaboration (e.g., 'fee refunds', 'fraud-protection costs') not explicitly in the ground truth, but these do not contradict and are plausible within context. (4) The LLM conveys semantic equivalence: while it uses more technical language (e.g., 'open-ended contracts', 'single performance obligation'), the core message—that PayPal maintains full margin risk and has enhanced transparency in how it manages that risk through pricing and incentive structures—is preserved. One minor point: the original emphasizes the independence of customer fees from processor costs in 2024, which the LLM does not explicitly mention, slightly reducing completeness. However, this does not undermine the overall correctness. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Bears]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 455,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did AMD's strategy and relationship with AIB Manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation for system integrators?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers against price reductions across all years. In 2022 and 2023, AMD highlighted that AIBs build and sell board-level products using AMD's graphics and chipset technology, which are then sold to system integrators (SIs), retailers, and sub-distributors. By 2024, AMD maintained this inventory protection policy but placed more emphasis on SIs selling based on regional or product-based strengths and responding quickly to new technologies. Throughout the period, AMD underscored the importance of discrete graphics solutions as a key differentiator for SIs to add value to their customers. However, in 2024, there was a subtle shift in language, indicating a more strategic alignment with SIs who integrate AMD-based AIB products into differentiated offerings, suggesting a deepening of the value proposition for AIBs within the broader ecosystem.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s supply relationship with AIB manufacturers stayed anchored by component‑level graphics and chipset products, but the **scope of its partner base evolved**: the 2022 filing notes close collaboration with OEMs and regional system integrators (including engineering‑fee arrangements), while the 2023 and 2024 filings stress a **growing emphasis on global system integrators and the VAR channel** that resell OEM systems to mid‑market and SMB customers.  \n\nAcross all three years AMD’s contracts with AIBs **protected their inventory**—shielding it from price reductions and granting return or stock‑rotation rights—so that AIBs could safely hold AMD‑based boards while the company **sold directly to select SIs**.  \n\nFinally, **discrete graphics solutions were repeatedly highlighted as the key differentiator for SIs**; they enable system integrators to add value, respond on short design cycles, and leverage the latest GPU capabilities to stand out in the market, a role that persisted and intensified as AMD deepened its focus on global SI and VAR partnerships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection for AIBs across 2022–2024, including price reduction safeguards and stock-rotation rights. The role of discrete graphics as a key differentiator for system integrators (SIs) is correctly emphasized throughout the period. The subtle strategic shift in 2024 toward deeper alignment with global SIs and the VAR channel is accurately reflected, even though the original answer uses slightly different phrasing (e.g., 'regional or product-based strengths'). (2) There are no numeric values to verify, so quantitative accuracy is perfect by default. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and entities (AMD, AIBs, SIs, VARs), correctly identifying evolving relationships and strategic emphasis. The mention of engineering-fee arrangements in 2022 and the shift to global SIs/VARs in 2023–2024 reflects nuanced understanding beyond the ground truth, but is consistent with plausible interpretation of strategic evolution. (4) Semantic equivalence is strong—while the LLM introduces slightly more detail (e.g., 'engineering-fee arrangements', 'VAR channel'), it does not contradict the original and enhances context without error. The only minor gap is that the original highlights a 'subtle shift in language' in 2024 regarding strategic alignment, which the LLM captures in substance but not explicitly as a linguistic observation. This does not detract from factual correctness. Overall, the answer is comprehensive, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> COMP <-[Sells_To]- ORG <-[Sells_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 449,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did The Walt Disney Company's management of investment credit exposure limits evolve from fiscal 2022 through fiscal 2024, particularly in terms of counterparty credit ratings, collateral requirements, and concentration thresholds?",
      "original_answer": "From fiscal 2022 through 2024, Disney maintained a consistent policy of transacting only with counterparties rated A- or better and requiring collateral if credit ratings fell below A- or exposures exceeded contractual limits. However, by fiscal 2024, the company reported a 24% concentration of cash and cash equivalents with a single financial institution, up from no such concentration in fiscal 2022, suggesting a shift in liquidity strategy despite continued emphasis on credit risk mitigation.",
      "llm_answer": "\nDisney’s policy of entering derivative transactions only with counterparties rated A‑ or better and of requiring collateral if a rating falls below A‑ — while also capping the amount of investment‑credit exposure to any single institution — is reiterated in all three filings (Chunks 1‑3).  The company continues to monitor counterparty credit quality and states it does not expect a material loss from a single‑counterparty default (Chunks 1‑3).  However, the concentration threshold has evolved: in fiscal 2022 no institution exceeded 10 % of cash and cash equivalents (Chunk 3), whereas by the end of fiscal 2024 a single counterparty represented 24 % of total cash and cash equivalents, indicating a higher concentration despite the unchanged rating and collateral requirements (Chunks 1‑2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Disney maintained its policy of transacting only with counterparties rated A- or better and requiring collateral if ratings fell below that threshold or exposures exceeded limits—this is consistently reported across fiscal 2022–2024. The 24% concentration of cash and cash equivalents with a single financial institution in fiscal 2024 is correctly stated, as is the absence of such concentration in fiscal 2022 (with explicit mention of no institution exceeding 10% in that year). (2) Quantitative accuracy is perfect: the 24% figure and the 10% threshold are correctly cited and match the original answer’s implication of increased concentration. No calculation errors. (3) Multi-hop reasoning is sound—the model synthesizes information across years and identifies a nuanced shift: despite unchanged credit rating and collateral policies, there was a strategic change in cash concentration, indicating evolving liquidity management. (4) The only minor shortcoming is that the original answer explicitly frames the 24% concentration as 'up from no such concentration in fiscal 2022,' while the LLM uses the 10% threshold as a proxy, which is valid but slightly less direct. Still, the inference is correct and well-supported. Wording differs slightly but meaning is semantically equivalent. No entity, metric, or year errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Limits]-> RISK_FACTOR <-[Depends_On]- ORG <-[Limits]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 394,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its 2029-maturing Fixed-rate 2.850% notes evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the Fixed-rate 2.850% notes maturing in 2029 remained consistently at $1,500 million across 2022, 2023, and 2024, indicating no principal reduction or refinancing activity for this specific instrument over the three-year period. Despite issuing new debt in 2023 and 2024, including higher-interest notes in 2024 such as the Fixed-rate 5.150% and 5.500% notes, PYPL maintained its $1,500 million liability for the 2029 notes. This suggests a strategic decision to retain this particular debt instrument, possibly to preserve favorable interest terms or manage cash flow predictability.",
      "llm_answer": "\nPYPL’s outstanding balance in the $1.5 billion Fixed‑rate 2.850 % notes maturing on 10/1/2029 was $1.5 bn in 2022 (as shown in the 2021‑2020 column of Chunk 3, indicating the original issuance size), remained $1.5 bn in 2023 (Chunk 1) and stayed at $1.5 bn in 2024 (Chunk 2).  This three‑year flat‑line demonstrates that PYPL is deliberately maintaining a steady, long‑term debt position for that tranche—using the 2029 notes as a core, low‑cost funding pillar rather than expanding or shrinking it—reflecting a disciplined, “hold‑to‑maturity” strategy that anchors its capital structure while it manages refinancing risk through other issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies that PYPL's exposure to the 2.850% fixed-rate notes maturing in 2029 remained constant at $1.5 billion across 2022, 2023, and 2024, matching the ground truth exactly in amount and time frame. The maturity date (10/1/2029) is an additional precise detail not contradicted by the ground truth. 2) All numeric values—$1.5 billion (or $1,500 million), 2.850%, and the three-year consistency—are factually accurate and correctly formatted; minor variation in presentation ($1.5 bn vs $1,500 million) is acceptable and semantically equivalent. 3) The reasoning correctly infers a strategic, deliberate retention of this debt tranche despite other financing activities, aligning with the ground truth’s interpretation of a long-term debt management strategy focused on preserving favorable terms. The phrase 'hold-to-maturity strategy' is a valid interpretation of maintaining a stable liability without refinancing. 4) The answer fully addresses both parts of the question: the evolution (no change) and the strategic implication. It synthesizes multi-year data correctly and draws a logical conclusion consistent with the ground truth, though it does not explicitly mention the issuance of higher-interest notes in 2024 (a minor omission in contextual support), which slightly reduces qualitative accuracy. However, the core reasoning remains sound and relevant. Overall, the answer is factually excellent and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Notes]-> FIN_INST <-[Issues_Debt]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 403,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 to 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted its exposure to raw material demand and supply risks in its Performance Materials and Technologies segment across all three years, but the framing and contextual emphasis evolved. In 2022, the company noted that operating results could be adversely impacted by raw material demand and supply, product commoditization, and illegal imports of hydrofluorocarbons into Europe. In 2023, this risk was reiterated with a continued emphasis on the impact of volatility in oil and natural gas prices on customer investment and product demand. By 2024, the segment was rebranded as Energy and Sustainability Solutions, and the exposure to raw material demand and supply remained a key risk factor, now linked more explicitly to the company’s ability to maximize production capacity and minimize downtime. The consistent presence of this risk across three years indicates a sustained vulnerability to commodity market volatility, despite strategic repositioning and operational adjustments.",
      "llm_answer": "\nAcross the 2022‑2024 risk‑factor sections, Honeywell repeatedly highlighted raw‑material demand and supply—especially the impact of oil‑ and natural‑gas price volatility on customers’ ability to fund refinery projects and on capacity‑utilization—as a material threat to the Performance Materials & Technologies segment, meaning that any downturn in commodity markets directly pressures the segment’s operating results; the knowledge‑graph relationship (HON → Raw Material Demand & Supply → HON) shows this risk feeds back into Honeywell each year, underscoring a persistent and growing vulnerability to commodity‑market volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the persistent exposure to raw material demand and supply risks in Honeywell's Performance Materials & Technologies segment from 2022 to 2024, and links this to commodity market volatility, which aligns with the ground truth. It accurately captures the recurring nature of the risk and the impact of oil and natural gas price volatility on customer investment and capacity utilization, particularly in 2023 and implicitly in other years. The mention of refinery projects and capacity utilization reflects accurate synthesis of the risk's operational implications. However, the LLM answer omits key details present in the original answer that are critical for full multi-hop understanding: (1) the specific 2022 risk related to illegal HFC imports into Europe, (2) the rebranding of the segment to Energy and Sustainability Solutions in 2024, and (3) the shift in framing the risk toward production capacity maximization and downtime reduction in 2024. These omissions reduce completeness and weaken the qualitative accuracy of the trend analysis across the three years. While the core financial and risk exposure facts are correct (hence high quantitative accuracy and contextual relevance), the absence of structural and framing changes over time limits the depth of the reasoning. The use of a 'knowledge-graph relationship' is interpretive and not directly stated in the filings, adding a layer of abstraction not supported by the source material. Overall, the answer is factually sound on recurring risks but lacks full evolution narrative, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 445,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "What was the trajectory of PM's peer group composition with respect to Imperial Brands PLC over the three-year period from 2022 to 2024, and what does this reveal about PM's benchmarking strategy in the global tobacco and consumer products sector?",
      "original_answer": "Imperial Brands PLC remained consistently included in PM's peer group across all three years (2022, 2023, and 2024), indicating that PM maintained a stable benchmarking strategy focused on companies with similar global presence, revenue scale, and market capitalization. This consistency suggests that PM viewed Imperial Brands as a relevant comparator throughout the period, reflecting strategic alignment in peer selection despite potential market or operational changes.",
      "llm_answer": "\nAcross the three fiscal years 2022‑2024 the peer‑group that PMI discloses in its annual reports remained unchanged, and Imperial Brands PLC was listed as a member of that group in every year. All three 10‑K filings (2022, 2023 and 2024) describe the same “PMI Peer Group” – a set of global consumer‑products and tobacco companies selected for worldwide presence, comparable net‑revenues and market‑capitalisation, and including the primary international tobacco firms – and each roster explicitly names Imperial Brands PLC. This consistency shows that PMI’s benchmarking strategy is to use a stable, size‑matched cohort of global tobacco and consumer‑products peers (including Imperial Brands) as a reference point, allowing the company to track performance against the same set of competitors over time. The knowledge‑graph relationship PM → Imperial Brands PLC (and the reciprocal links) underscores that Imperial Brands is treated as a direct peer in PMI’s comparative analysis.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly states that Imperial Brands PLC was consistently included in PM's (PMI's) peer group across 2022, 2023, and 2024, which matches the original answer's claim of 'consistently included across all three years.' (2) There are no numerical values requiring calculation, but the years (2022–2024) and the consistency of peer group composition are accurately cited, with correct reference to PMI's 10-K filings. (3) The multi-hop reasoning is sound: the model synthesizes information across three years of filings and correctly infers that the unchanging inclusion of Imperial Brands reflects a stable benchmarking strategy based on global presence, revenue, and market capitalization—directly mirroring the original answer's conclusion. (4) The LLM adds contextual detail (e.g., 'size-matched cohort,' 'track performance over time') that enriches but does not distort the meaning. It also correctly refers to the 'PMI Peer Group' and the rationale for inclusion, demonstrating proper entity identification (Imperial Brands PLC, PMI) and conceptual understanding. The answer is semantically equivalent and fully complete, addressing both the trajectory (stable inclusion) and strategic implication (consistent benchmarking). All scores are 10 due to perfect factual alignment, correct reasoning, and high relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Related_To]- ORG <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 387,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did PYPL's exposure to its fixed-rate 2.850% notes evolve from 2022 through 2024, and what does this progression indicate about its long-term debt management strategy?",
      "original_answer": "PYPL's exposure to the fixed-rate 2.850% notes remained stable at $1.5 billion in both 2022 and 2023, but by 2024, the company still carried the full $1.5 billion balance, indicating no repayments or refinancing actions over the three-year period. This suggests that PYPL has maintained a consistent long-term liability position for this specific note, possibly prioritizing other debt maturities or leveraging the low fixed rate as part of a broader capital structure strategy.",
      "llm_answer": "\nPYPL’s fixed‑rate 2.850 % notes—originally issued in September 2019 as part of a $5 bn tranche (Chunk 1)—showed a flat exposure of **$1.5 bn** in 2022, remained **$1.5 bn** as of year‑end 2023 (Chunk 3), and are still listed at **$1.5 bn** for 2024 (Chunk 2).  The notes carry a consistent effective interest rate of **2.96 %** and mature in 2029, so PYPL has kept this specific tranche unchanged throughout 2022‑2024.  This steadiness signals a long‑term debt‑management strategy that preserves a low‑cost, fixed‑rate funding pillar while the company supplements its balance sheet with newer, higher‑rate issuances to diversify maturities and manage interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that PYPL's exposure to the 2.850% fixed-rate notes remained at $1.5 billion in 2022, 2023, and 2024, matching the ground truth exactly. The effective interest rate of 2.96% and maturity in 2029 are accurate contextual details not in the original answer but do not contradict it and are factually correct. (2) All numeric values—$1.5 billion across all years—are quantitatively accurate. The mention of the 2019 issuance and 2029 maturity aligns with external knowledge and adds context without distorting the truth. (3) The multi-hop reasoning is sound: the model synthesizes data across years and correctly infers that no repayment or refinancing occurred, leading to a stable liability. The conclusion about PYPL’s long-term debt strategy—preserving low-cost funding while potentially using newer, higher-rate debt—is a reasonable extension of the ground truth’s suggestion about prioritizing other maturities or leveraging low fixed rates. (4) The answer is fully contextually relevant, addressing both the evolution of exposure and the strategic implication. The only minor deviation from the original answer is the slightly more detailed interpretation of strategy, but this is well-supported and does not introduce inaccuracies. Thus, the answer is factually excellent with only slight elaboration beyond the ground truth, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Debt]-> FIN_INST <-[Issues_Notes]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 399,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did ConocoPhillips' approach to HSE audits evolve from 2022 to 2024, particularly in terms of audit scope, conformance tracking, and integration with corporate governance?",
      "original_answer": "From 2022 to 2024, ConocoPhillips maintained a consistent emphasis on HSE audits as a core mechanism for ensuring conformance with company-wide safety and environmental standards. In 2022, the company conducted HSE audits across business units and staff groups, identifying improvement actions and tracking them to completion. By 2023, the company reinforced its HSE audit process by explicitly linking audit outcomes to annual objectives, targets, and deadlines, which were reported to the Executive Leadership Team (ELT) and the Board of Directors. In 2024, the company further refined its audit framework by specifying that audits were conducted at the corporate level, underscoring a more centralized oversight approach. This evolution shows a shift from localized conformance checks toward a more integrated, governance-driven audit model that aligns with strategic performance tracking.",
      "llm_answer": "\nFrom 2022 to 2024 ConocoPhillips broadened the scope of its HSE audits—moving from audits focused on individual business units and staff groups (2022) to a corporate‑wide audit program that is explicitly reported to the Executive Leadership Team and the Board (2023, 2024).  The company also tightened conformance tracking, requiring that every identified improvement action be assigned a deadline and reported to senior leadership, and it embedded audit oversight into its governance structure so that audit results directly inform ELT and Board accountability.  This evolution reflects a shift from unit‑level compliance checks to an integrated, governance‑driven audit framework that spans the entire organization.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of ConocoPhillips' HSE audit approach from 2022 to 2024. (1) It correctly identifies the shift in audit scope from business units and staff groups in 2022 to a corporate-wide, centralized program by 2023–2024. The mention of reporting to the Executive Leadership Team (ELT) and Board aligns with the ground truth. (2) All dates (2022, 2023, 2024) are used appropriately, and there are no numerical inaccuracies—this is a qualitative topic without financial figures, so quantitative accuracy is fully satisfied. (3) The multi-hop reasoning is sound: the model synthesizes information across years, correctly inferring a progression from decentralized audits to governance-integrated oversight. It accurately links conformance tracking to deadlines and senior reporting, and notes the integration with corporate governance via ELT and Board accountability. (4) The only minor shortcoming is that the original answer specifies that in 2024, audits were explicitly conducted at the 'corporate level,' emphasizing centralized oversight, which the LLM implies but does not state as clearly. However, the phrase 'corporate-wide audit program' and 'embedded audit oversight into its governance structure' convey a semantically equivalent meaning. Overall, the answer is factually correct, complete, and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Conducts]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 388,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did AMD's reliance on the 2011 Executive Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of its continued reference as a foundational governance document amid broader executive compensation plan disclosures?",
      "original_answer": "Across 2022, 2023, and 2024, AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document, indicating no material changes or replacements during this period. In 2022, the plan was listed as *10.1* in the 10-K filing, reiterating its role alongside other executive compensation arrangements like the AMD Executive Severance Plan and the AMD Deferred Income Account Plan. In 2023, AMD again cited the 2011 Executive Incentive Plan as *10.1* in its 10-K filing, showing continuity in its disclosure practices. In 2024, the plan remained listed as *10.1* in the 10-K, reaffirming its ongoing relevance despite the presence of newer agreements and amendments to other plans. The consistent citation of the 2011 plan across all three years suggests AMD's executive incentive framework remained anchored in this policy without significant revision, even as other compensation mechanisms evolved.",
      "llm_answer": "\nAcross AMD’s 2022, 2023 and 2024 annual reports the 2011 Executive Incentive Plan is repeatedly listed—appearing as Exhibit 10.1 in the 2022 and 2024 filings and as Exhibit 10.2 in the 2023 filing—and in each case the filing states that the plan is “hereby incorporated by reference,” underscoring that AMD continues to treat the 2011 plan as the foundational governance document for its executive‑compensation framework even as it discloses additional compensation arrangements. This consistent cross‑year reference demonstrates that the plan’s role has remained stable and central amid the broader set of executive‑pay disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in conveying that AMD consistently referenced the 2011 Executive Incentive Plan as a foundational governance document across 2022–2024, which aligns with the ground truth. The qualitative reasoning is sound: the model correctly infers stability and centrality of the plan based on repeated citation in filings. Contextual relevance is perfect—the response directly addresses the evolution (or lack thereof) of AMD’s reliance on the plan amid broader disclosures. However, there is a factual discrepancy in exhibit numbering: the LLM states the plan was Exhibit 10.2 in 2023, while the ground truth confirms it was consistently listed as *10.1* across all three years. This error affects quantitative accuracy, as exhibit numbers are specific identifiers akin to document metadata. While the core conclusion about continuity remains valid, the incorrect exhibit number for 2023 indicates a lapse in precision. The model also omits mention of other compensation plans (e.g., AMD Executive Severance Plan), slightly reducing completeness. Still, the overall synthesis across years and correct interpretation of 'incorporated by reference' demonstrate strong multi-hop reasoning. Thus, the correctness score is reduced to 8 due to the exhibit number inaccuracy, though the semantic meaning and main conclusion remain substantially aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Files]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 378,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did General Motors' indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls evolve from 2022 through 2024, and what does this progression indicate about GM's exposure to post-sale liabilities?",
      "original_answer": "From 2022 through 2024, GM's indemnification obligations to Stellantis related to legacy Opel/Vauxhall emissions claims and recalls remained a contingent liability with no material accruals recorded, but the geographic and legal scope of exposure expanded. In 2022, GM noted potential indemnification obligations for emissions claims and recalls, with no specific accrual. By 2023, lawsuits in Germany, the UK, and the Netherlands were explicitly mentioned, and Stellantis had initiated recalls tied to Takata inflators in legacy Opel vehicles, for which GM indemnified an immaterial amount. In 2024, the legal exposure widened further with the addition of Austria as a jurisdiction, and GM faced a new regulatory investigation by the European Commission and UK CMA related to end-of-life vehicle practices at Opel, prompting an immaterial accrual. While GM consistently maintained that further indemnification beyond current estimates was remote, the increasing number of legal and regulatory actions indicates a growing complexity and persistence of post-sale liabilities tied to the Opel/Vauxhall business.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification of Stellantis for the legacy Opel/Vauxhall portfolio remained confined to **immaterial, contract‑capped payments**—the 2022‑2023 filings note that GM “is unable to estimate any reasonably possible material loss” from the emissions‑related lawsuits in Germany, the UK, Austria and the Netherlands, and that any future Takata‑related recall indemnity is “remote,” while the 2024 update records only an **immaterial accrual** and stresses that the company “cannot estimate any reasonably possible material loss” from those actions.  The knowledge‑graph relationship — GM depends on Stellantis and both parties **guarantee** each other—underpins this limited exposure, and although GM continues to **purchase/supply** vehicles and services from Stellantis (Chunk 1) and may still face competition‑authority fines if Opel’s conduct is found infringing (Chunk 3), the progression shows that post‑sale liabilities have been largely transferred and are now only **monitored**, with exposure limited to the modest, time‑limited indemnity obligations disclosed.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some key elements correctly but contains significant inaccuracies in reasoning and entity synthesis that reduce factual correctness. (1) Quantitatively, the answer correctly notes 'immaterial accrual' in 2024 and absence of material loss estimates across years, aligning with the ground truth. It also correctly identifies jurisdictions (Germany, UK, Netherlands, Austria) and references Takata-related recalls and emissions claims. However, it incorrectly states that Austria was included in 2022–2023 filings—ground truth specifies Austria was added only in 2024, making the LLM’s grouping of Austria with earlier years factually wrong. (2) The claim that GM and Stellantis 'guarantee' each other and that they 'purchase/supply' vehicles is unsupported by the original answer and introduces extraneous, unverified relationships (e.g., 'knowledge-graph relationship') not present in the ground truth, indicating flawed multi-hop reasoning. (3) The conclusion that 'post-sale liabilities have been largely transferred' contradicts the ground truth, which emphasizes growing complexity and persistence of exposure despite immaterial accruals. The original answer stresses expanding legal scope and new investigations as signs of ongoing risk, whereas the LLM downplays exposure based on contractual caps, which were not mentioned in the ground truth. (4) While the LLM correctly identifies the immateriality of accruals and evolving litigation, it misrepresents the implications of the trend—failing to acknowledge the increasing regulatory and geographic breadth as an indicator of sustained liability risk. Thus, while some facts are accurate, the synthesis and interpretation are flawed, leading to a partially correct but misleading overall answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Guarantees]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 479,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Eli Lilly's (LLY) financial exposure to bamlanivimab evolve from 2022 to 2024, particularly in terms of royalty obligations to AbCellera and the product's contribution to revenue, and what does this reveal about the long-term strategic importance of the product?",
      "original_answer": "Eli Lilly's exposure to bamlanivimab declined significantly from 2022 to 2024. In 2022, the company still reported $2,008.9 million in U.S. revenue from 'COVID-19 antibodies,' which included bamlanivimab, and had ongoing royalty obligations to AbCellera based on tiered percentages ranging from mid-teens to mid-twenties on global sales. By 2023, U.S. revenue from the category had dropped to zero, signaling a full phase-out of the product's commercial relevance. In 2024, the product was no longer mentioned in revenue tables, confirming its complete exit from LLY's active portfolio. This trajectory shows that while bamlanivimab was a significant contributor during the pandemic, it has since lost strategic importance as demand waned and focus shifted to newer therapeutic areas like cardiometabolic health.",
      "llm_answer": "\nFrom 2022 to 2024 Lilly’s financial exposure to bamlanivimab collapsed: the antibody generated ≈ $2.0 bn in U.S. sales plus $14.7 m outside the U.S. in 2022 (the figure reported in the 2023 10‑K under “COVID‑19 antibodies (6)”), but by 2023 and 2024 the same line item shows a dash, indicating essentially $0 revenue; consequently the tiered mid‑teens‑to‑mid‑twenties royalties that Lilly owes AbCellera—recorded as cost of sales under the 2020 license agreement (Chunk 1)—have fallen in step with the dwindling sales.  This trajectory shows that, while bamlanivimab was once a strategically vital, high‑margin COVID‑19 product that helped fund Lilly’s broader pipeline, its long‑term contribution to earnings has faded to near‑zero, underscoring a shift away from reliance on the antibody toward newer franchises such as Mounjaro/Zepbound.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, it correctly reports $2.0 billion in U.S. revenue for bamlanivimab in 2022 (matching the ground truth $2,008.9 million, rounded appropriately) and adds $14.7 million in non-U.S. sales, which is consistent with detailed 10-K disclosures though not explicitly mentioned in the original answer—this additional precision does not contradict but enhances accuracy. The use of 'dash' to indicate zero revenue in 2023 and 2024 correctly reflects SEC filing conventions. Royalty obligations are accurately described as tiered mid-teens to mid-twenties, matching the original. (2) The only minor deviation is that the original answer emphasizes the complete removal of the product from 2024 revenue tables, while the LLM implies this via 'dash' without explicitly stating it was omitted—this is a slight completeness gap but not factually incorrect. (3) Multi-hop reasoning is sound: the model correctly links declining revenue to reduced royalty payments under the AbCellera agreement and infers strategic de-emphasis. It appropriately connects the phase-out to Lilly’s pivot toward newer products like Mounjaro/Zepbound, which is contextually valid and consistent with strategic trends in the filings. (4) Wording differs slightly (e.g., 'collapsed' vs 'declined significantly'), but semantic meaning is equivalent. The LLM even adds value by specifying non-U.S. sales, though this detail wasn't required. Overall, the answer is factually correct, well-reasoned, and fully relevant, meriting a 9 due to the slight omission of explicit confirmation that bamlanivimab was entirely removed from 2024 disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 460,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did Philip Morris International's strategic positioning around the Jackpot brand evolve from 2022 through 2024, and what does this 3-year trajectory reveal about its focus on local cigarette brands in key markets?",
      "original_answer": "From 2022 through 2024, Philip Morris International consistently listed Jackpot as a key local cigarette brand in the Philippines, indicating its ongoing commitment to maintaining a strong regional presence through localized offerings. In 2022, Jackpot was mentioned as part of a broader portfolio of local brands, including Fortune in the Philippines, signaling its importance in the region. In 2023, the company reiterated its reliance on local brands like Jackpot, emphasizing their role in complementing international brands and sustaining market share in key geographies such as the Philippines. By 2024, despite a broader strategic pivot toward smoke-free products and wellness, Jackpot remained a named local brand in the Philippines, suggesting that PMI continued to value its role in market-specific competitiveness. This 3-year consistency highlights PMI's dual strategy of leveraging local cigarette brands to maintain market relevance while transitioning toward a smoke-free future.",
      "llm_answer": "\nFrom 2022 through 2024 Philip Morris International deepened the role of **Jackpot**—the locally‑market cigarette brand sold in the Philippines that appears in all three filings as one of PMI’s “important local cigarette brands” (Chunk 1, 2 & 3).  After acquiring Swedish Match in 2022, PMI integrated the new assets into its four‑region structure and, by early 2024, began reporting the former Swedish Match results alongside the other geographical segments, a move that also placed brands such as Jackpot (and its partner Fortune) under the same regional oversight (Chunk 1 & 2).  The knowledge‑graph links—PM produces Jackpot, Jackpot (org) has a stake in PM, and Jackpot (product) is linked back to PM—reflect a joint‑venture‑style ownership that lets PMI leverage local brand equity while retaining control, underscoring a deliberate strategic focus on nurturing local cigarette brands in key emerging markets to complement its global portfolio of premium and international labels.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Jackpot as a key local cigarette brand in the Philippines mentioned across all three years (2022–2024), which aligns with the ground truth. However, it introduces significant inaccuracies: the acquisition of Swedish Match is correctly dated to 2022, but the integration of its results into regional reporting by early 2024 and the claim that Jackpot was placed under the same oversight due to this restructuring is not supported in the original answer and represents an unsupported inference. Additionally, the LLM fabricates a 'joint-venture-style ownership' structure with claims that 'Jackpot (org) has a stake in PM' and reciprocal links—these relationships are not present in the ground truth and contradict PMI’s typical wholly-owned brand model. (2) There are no numeric values, percentages, or financial figures in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound in tracking Jackpot’s consistent mention as a local brand, but fails in overextending the Swedish Match integration to imply organizational changes affecting Jackpot without evidence. The core trajectory of PMI’s strategic positioning—maintaining local brands while pivoting to smoke-free—is underemphasized and distorted by irrelevant details. (4) Contextually, the answer addresses the focus on local brands in key markets, but shifts emphasis to an unverified corporate restructuring narrative and fabricated ownership model, reducing accuracy. While it captures the surface-level continuity of Jackpot’s status, it misses the deeper strategic implication highlighted in the original: the dual strategy of sustaining local cigarette brands *while* transitioning to smoke-free products. This omission and the addition of unsupported details result in a partially correct but misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 522,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How did PayPal's exposure to bad transactions through its credit and BNPL products evolve from 2022 through 2024, particularly in light of the 2023 sale of up to €40 billion in U.K. and European BNPL loan receivables and the ongoing risks related to fraud and third-party processing disruptions?",
      "original_answer": "From 2022 to 2024, PayPal's exposure to bad transactions evolved significantly as it transitioned from managing a growing credit and BNPL portfolio to partially offloading that risk through a major asset sale in 2023, while continuing to face persistent threats from fraud and third-party dependencies. In 2022, PayPal highlighted increasing risks around bad transactions due to fraud, synthetic identities, and stolen financial instruments, particularly in its digital payment services. The company also noted its reliance on third-party lenders and processors, which introduced additional operational and reputational risks. In 2023, PayPal entered into a multi-year agreement in June to sell up to €40 billion in U.K. and European BNPL loan receivables, effectively reducing its direct exposure to bad transactions in that segment, although the sale was subject to conditions and execution risks. Despite this, PayPal still faced challenges in managing fraud and account takeover attempts. By 2024, the company continued to emphasize the risks of bad transactions, particularly from fraud schemes and third-party processing, but had shifted some of the credit risk burden through the BNPL receivables sale. However, uncertainty remained around regulatory challenges and the effectiveness of fraud detection systems, indicating that while the direct exposure to bad transactions had decreased, the underlying risks persisted.",
      "llm_answer": "\nIn 2022 PayPal warned that defaults on its U.S. consumer‑credit and international merchant‑financing receivables—driven by tighter underwriting, economic stress and rising fraud—could produce charge‑offs and shrink the revenue‑share it receives from partners such as Synchrony Bank (Chunk 1). The 2023 €40 billion sale of U.K. and European BNPL loan receivables, executed through a multi‑year forward‑flow agreement that began in October 2023, was intended to reduce that exposure but remains subject to closing conditions that could delay the transaction and leave PayPal with lingering credit risk and funding constraints (Chunks 1 & 2). By 2024 the company still depends on third‑party originators, payment processors and cross‑border channels, and the ongoing threat of fraud, synthetic‑identity abuse and processor disruptions—reiterated in the 2024 filing—means that any deterioration in those relationships could again raise loss rates and hinder growth of its credit and BNPL portfolio (Chunks 2 & 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 2023 €40 billion sale of U.K. and European BNPL loan receivables is accurately reported, including that it was a multi-year forward-flow agreement beginning in October 2023 (specific detail not in original answer but not contradictory). The mention of Synchrony Bank as a partner is an added detail supported by PayPal's filings and adds context without introducing error. (2) Quantitative accuracy is perfect: the €40 billion figure is correctly cited, and no other numbers (e.g., dates, amounts) are misstated. Format is consistent and precise. (3) Multi-hop reasoning is sound: the answer synthesizes PayPal’s evolving risk exposure across 2022 (rising fraud, credit risk), 2023 (BNPL sale reducing exposure but with execution risks), and 2024 (ongoing third-party and fraud risks), correctly tracing the shift in risk profile. It captures the nuance that while direct exposure decreased, residual and indirect risks remain. (4) The only minor shortcoming is that the original answer emphasizes the broader themes of synthetic identities and stolen instruments in 2022 more explicitly, while the LLM focuses on defaults and underwriting—slightly different framing but semantically overlapping. The LLM also does not explicitly note that the 2023 sale was announced in June (though 'October 2023' as start date is more precise). Overall, the answer is factually correct, contextually complete, and well-reasoned, warranting a 9/10 due to slight differences in emphasis but no material inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Risks]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1646,
        "completion_tokens": 439,
        "total_tokens": 2085
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment in 2022, Industrial Automation segment in 2024, and overall risk posture in 2023, and what does this evolution suggest about the company's sensitivity to retail demand volatility across its industrial portfolio?",
      "original_answer": "In 2022, Honeywell's Safety and Productivity Solutions segment identified 'fluctuations in retail markets' as a key risk factor that could lead to reduced investments in safety monitoring and process automation, directly impacting demand for its products and services. By 2023, this risk was reiterated as part of the broader macroeconomic and industry risks, with emphasis on how global economic instability and fluctuating demand could continue to affect customer investment behavior. In 2024, the risk was specifically tied to the newly restructured Industrial Automation segment, where 'fluctuations in retail markets' were again cited as a potential cause of slowdowns in demand for safety products and could result in lower market share and reduced margins. This progression shows that Honeywell's exposure to retail market volatility remained a consistent concern across three years, even as the company reorganized its business units, suggesting a persistent sensitivity to consumer-driven demand shifts within its industrial offerings.",
      "llm_answer": "\nHoneywell’s 2022 10‑K (Chunk 1) flags “fluctuations in retail markets” as a direct driver that can depress investments in process automation, safety monitoring and plant‑capacity initiatives, thereby hurting the Safety and Productivity Solutions segment’s margins; the 2024 10‑K (Chunk 3) repeats the same language for the Industrial Automation segment, noting that such retail‑market volatility can erode its operating results; and the 2023 10‑K (Chunk 2) treats “fluctuations in retail markets” as a macro‑economic risk factor that shapes the company’s overall risk posture, underscoring that the firm’s industrial portfolio is increasingly exposed to retail‑demand cycles.  The knowledge‑graph pattern (HON → Fluctuations in Retail Markets → HON) captures this mutual impact, illustrating that retail‑market swings are both a risk factor and an organizational entity that continually influences Honeywell’s segment performance and enterprise‑wide risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, 'fluctuations in retail markets' impacted the Safety and Productivity Solutions segment by reducing investments in safety monitoring and process automation; in 2023, it was part of the broader macroeconomic risk affecting overall risk posture; and in 2024, it was explicitly linked to the Industrial Automation segment, affecting operating results and margins. These match the original answer's claims. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk factor evolution across three years and three different segments/business structures, showing continuity despite reorganization. The mention of the 'knowledge-graph pattern' adds interpretive context not in the original but does not distort meaning. (4) Semantic equivalence is strong: the LLM captures the persistence of retail market sensitivity across Honeywell’s industrial portfolio, concluding that the company remains exposed to consumer-driven demand cycles—this matches the original’s implication. One minor point preventing a perfect 10 is the slightly interpretive phrase 'increasingly exposed,' which suggests growing sensitivity not explicitly stated in the ground truth (which says 'remained a consistent concern'). This is a subtle but notable difference in tone. Otherwise, the answer is complete, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 439,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the financial structure and strategic focus of LLY's collaboration with Incyte evolve from 2022 to 2024, particularly in terms of milestone payments, royalty structures, and the role of Olumiant in LLY's revenue base?",
      "original_answer": "From 2022 to 2024, LLY's collaboration with Incyte remained centered on Olumiant, but the financial obligations and strategic framing evolved. In 2022, LLY had capitalized $260.0 million in milestone payments tied to regulatory approvals in the U.S., Europe, and Japan, with Incyte eligible for up to an additional $200.0 million in contingent payments (split evenly between regulatory and sales milestones). The royalty structure was tiered, with rates up to 20% on general sales and an additional low teens royalty for sales exceeding a threshold related to the treatment of COVID-19. In 2023, the focus shifted to ongoing revenue recognition, with LLY continuing to record royalty payments to Incyte as cost of sales, indicating the maturity of the partnership and the product's established market presence. By 2024, the collaboration remained financially consistent, but LLY emphasized the broader strategic positioning of Olumiant, including its use under EUA and the inclusion of follow-on compounds, suggesting a long-term commitment to the partnership and therapeutic expansion. The consistent royalty structure and milestone eligibility across years show a stable financial framework, while the increasing emphasis on Olumiant’s expanded use indicates a deepening strategic alignment.",
      "llm_answer": "\nFrom 2022 through 2024 LLY’s JAK‑inhibitor collaboration with Incyte kept the same financial architecture: the agreement still provides Incyte with tiered, double‑digit royalties that can reach 20 % of worldwide net sales and, for COVID‑19 use, an extra low‑teens royalty once a sales threshold is exceeded (Chunk 1 & 3), while Incyte remains eligible for up to $100 million of regulatory milestones and $100 million of sales milestones (Chunk 1).  LLY records Olumiant sales as net product revenue and treats the royalties paid to Incyte as cost of sales, and the $260 million and $210 million milestones that were capitalized in 2021 and 2020 are being amortized into cost of sales over the partnership term (Chunk 1); the 2024 filing also notes a one‑time $300 million payment from a separate Boehringer Ingelheim amendment that adjusted commercialization responsibilities, illustrating a strategic diversification of revenue but leaving the Incyte royalty and milestone structure unchanged (Chunk 3).  This continuity means Olumiant’s earnings continue to flow through LLY’s revenue base, with royalties recorded as a cost‑of‑sales line item (Chunk 2).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core structure of the LLY-Incyte collaboration and correctly identifies key elements such as the tiered royalty rates (up to 20%) and an additional low-teens royalty for COVID-19 sales, which aligns with the ground truth. It also correctly states that Incyte is eligible for up to $200 million in contingent milestones ($100 million regulatory, $100 million sales), matching the original answer's $200 million total. However, there are significant quantitative inaccuracies: the LLM claims $260 million and $210 million milestones were capitalized in 2021 and 2020, while the ground truth specifies $260 million was capitalized in 2022 (not 2021) and makes no mention of a $210 million milestone. This misattribution of timing and amounts undermines factual reliability. Additionally, the mention of a 'one-time $300 million payment from Boehringer Ingelheim' is contextually relevant to LLY’s broader strategic moves but is not part of the Incyte collaboration and distracts from the specific evolution of that partnership. The answer fails to reflect the shift in strategic emphasis from milestone-driven development (2022) to revenue recognition (2023) and therapeutic expansion (2024), which is central to the original answer. While the financial framework continuity is noted, the evolution in strategic focus—especially the growing importance of Olumiant under EUA and follow-on compounds in 2024—is underdeveloped. The reasoning is partially sound but lacks synthesis across years, particularly in showing how the partnership matured. Overall, the answer is semantically close but contains critical factual errors in dates and figures, and misses key aspects of the multi-hop evolution requested in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1632,
        "completion_tokens": 472,
        "total_tokens": 2105
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Altria's structural relationship and financial exposure to UST evolve from 2022 to 2024, particularly in terms of intangible asset valuation, ownership structure, and integration into Altria's broader smoke-free transition strategy?",
      "original_answer": "In 2022, Altria's indefinite-lived intangible assets included $8.8 billion in MST and snus trademarks from UST, reflecting the legacy value of the 2009 acquisition. By 2023, UST remained a wholly owned subsidiary through its subsidiary USSTC, continuing to manufacture and sell MST and snus products, indicating sustained ownership and operational integration. In 2024, UST continued as a wholly owned subsidiary, with its subsidiary USSTC still engaged in MST production, but Altria's broader portfolio strategy shifted toward oral nicotine pouches via Helix and e-vapor via NJOY, suggesting a strategic evolution where UST's traditional MST business remained a core asset but was increasingly complemented by newer, potentially less harmful tobacco alternatives. This 3-year trajectory shows Altria maintaining UST's financial value while strategically diversifying around it.",
      "llm_answer": "\nAltria’s 2022 10‑K shows that the MST and snus trademarks acquired in 2009 (valued at $8.8 billion) and the cigar trademarks acquired in 2007 (valued at $2.6 billion) are recorded as indefinite‑lived intangible assets with no amortization, while definite‑lived intangibles are amortized at roughly $70 million per year (Chunk 1); by 2023‑2024 UST remains a wholly‑owned subsidiary (Chunk 2 & 3) and its oral‑tobacco brands are now grouped in Altria’s “oral tobacco products” segment, making the $11.4 billion of UST‑related intangibles a core financial exposure that directly supports the company’s “Moving Beyond Smoking” smoke‑free transition strategy (Chunk 2’s Vision and segment description).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies key facts: the $8.8 billion indefinite-lived intangible asset value for MST and snus trademarks from UST in 2022, UST's status as a wholly owned subsidiary through 2024, and its integration into Altria’s oral tobacco segment. It also accurately notes the lack of amortization for indefinite-lived intangibles and the $70 million annual amortization of definite-lived intangibles. However, it introduces a $2.6 billion cigar trademark value from 2007 not mentioned in the ground truth, which, while possibly true, is irrelevant to the UST relationship and distracts from the core focus. Additionally, it aggregates UST-related intangibles as $11.4 billion ($8.8B + $2.6B), implying this total is tied to UST, which is incorrect—only the $8.8B is linked to UST per the ground truth. This is a significant but not critical error in financial attribution.\n\n2) Quantitative accuracy is high: the $8.8 billion figure is correct for 2022, and the $70 million amortization is consistent with Altria’s reporting. The $2.6 billion cigar trademark value may be factually accurate but is not part of the UST valuation and was not in the ground truth, so its inclusion and summation into a $11.4B 'UST-related' total are incorrect. No other numerical errors are present.\n\n3) The multi-hop reasoning is mostly sound: the model connects UST’s ownership structure across years, links intangible assets to strategic segments, and ties them to Altria’s smoke-free transition. However, it misattributes the cigar trademarks (from 2007, pre-UST acquisition) to UST, undermining the precision of the financial exposure analysis. The strategic point about UST supporting the 'Moving Beyond Smoking' initiative is valid and aligns with the ground truth’s mention of Helix and NJOY, though the LLM does not mention those brands specifically.\n\n4) The answer is contextually relevant and addresses all components of the question—intangible valuation, ownership, and strategic integration—though with a minor factual overreach in asset aggregation. The core narrative of sustained UST ownership and its role in the smoke-free strategy is correct. The error in combining unrelated intangible assets reduces correctness slightly but does not invalidate the overall conclusion. Hence, a score of 8 is justified: strong factual alignment with one notable financial misattribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 634,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Cisco's (CSCO) interest rate exposure on its 3.50% Senior Note evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's borrowing costs and capital market conditions over this period?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Senior Note carried an effective interest rate of 3.20%. By fiscal year 2023, this rate had increased to 6.38%, and in fiscal year 2024, it further rose to 6.66%. This represents a significant upward trend in Cisco's effective borrowing cost on this instrument, rising from 3.20% to 6.66% over the three-year period. This evolution reflects tightening capital market conditions and potentially higher perceived risk or changing interest rate environments during this time frame.",
      "llm_answer": "\nIn fiscal 2022 (Chunk 1) Cisco’s $500 mm 3.50 % Senior Note was recorded with an effective rate of **3.20 %**, while the same tranche appears in fiscal 2023 (Chunk 3) at an effective rate of **≈6.38 %** (and rises to **6.66 %** in the fiscal 2024 disclosure, Chunk 2), with the principal amount remaining $500 mm. This more than two‑fold jump in the note’s effective rate—accompanied by a rise in total long‑term debt from $8.9 bn (Chunk 1) to $20.1 bn (Chunk 2)—shows that Cisco’s borrowing costs have climbed sharply as market rates increased, reflecting tighter capital‑market conditions and a higher cost of financing over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: 3.20% in 2022, ~6.38% in 2023, and 6.66% in 2024 for Cisco's 3.50% Senior Note. The principal amount ($500 million) is correctly noted, and the trend of increasing effective interest rates is accurately described. (2) Quantitative accuracy is perfect—values match the original answer exactly or with acceptable rounding (e.g., ≈6.38% is fine). The claim of a 'more than two-fold jump' is reasonable (3.20% to 6.66% is roughly a 2.08x increase). The additional context about total long-term debt rising from $8.9B to $20.1B is factually consistent and enhances the explanation, though not required. (3) Multi-hop reasoning is sound: the model correctly synthesizes data across fiscal years and filings (referencing 'Chunk 1', 'Chunk 2', 'Chunk 3'), correctly attributing changes over time to the same note. (4) The conclusion about rising borrowing costs and tighter capital market conditions is logically supported and semantically equivalent to the original. The only minor limitation is the inclusion of extra details (debt totals) not in the original answer, which, while accurate and relevant, slightly shift focus from the core trend in the specific note’s effective rate. However, this does not detract from correctness. Overall, the answer is factually precise, well-reasoned, and fully addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 392,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory indicate about the company's debt management strategy over this period?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion in 2022, decreased to $15.0 billion in 2023, and further declined to $13.0 billion in 2024. This consistent reduction indicates a deliberate debt management strategy to gradually retire this issuance over time, aligning with Amazon's broader trend of reducing long-term debt from $67.2 billion in 2022 to $52.6 billion in 2024.",
      "llm_answer": "\nAmazon’s 2017 Notes balance fell from **$16.0 bn at the end of 2022** (Chunk 2) to **$15.0 bn at the end of 2023** (Chunk 2 & Chunk 3) and then to **$13.0 bn by the end of 2024** (Chunk 3), a reduction from the original $17 bn issuance disclosed in 2017 (Chunk 1).  This decline is reflected across the company’s overall long‑term debt, which dropped from **$70.5 bn (2022)** to **$67.2 bn (2023)** to **$58.0 bn (2024)** (Chunk 2 & Chunk 3), showing that Amazon has been actively retiring and refinancing a portion of that debt through new note issuances and repayments.  The trajectory therefore signals a deliberate debt‑management strategy focused on lowering leverage and optimizing the cost‑structure of its long‑term financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the trajectory of Amazon's 2017 Notes balance as $16.0B in 2022, $15.0B in 2023, and $13.0B in 2024, which matches the ground truth exactly. However, it incorrectly states Amazon's overall long-term debt as $70.5B in 2022, $67.2B in 2023, and $58.0B in 2024. The ground truth reports long-term debt of $67.2B in 2022 and $52.6B in 2024 — the LLM's figures are therefore factually wrong for both 2022 and 2024, and no data for 2023 is provided in the ground truth to support the $67.2B claim. This undermines quantitative accuracy. (2) The calculation of the reduction in the 2017 Notes is correct: $16B → $15B → $13B is accurately described. However, the overall long-term debt trend is misrepresented numerically, and the LLM introduces a 'new note issuances' claim not present in the original answer or supported in the feedback context. (3) The multi-hop reasoning is partially sound — the model connects the 2017 Notes reduction to broader debt management, which is valid, but it draws an incorrect conclusion about overall debt trajectory due to inaccurate numbers. The synthesis is logical but based on flawed data. (4) The contextual relevance is high because the answer addresses both parts of the question — the evolution of the 2017 Notes and the implication for debt strategy. The reasoning about a deliberate debt reduction strategy is consistent with the ground truth. However, the use of incorrect aggregate debt figures significantly reduces factual correctness, warranting a moderate score of 6 for overall correctness. Quantitative accuracy is penalized more heavily (score 5) due to key number mismatches, while qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 472,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AVGO's outstanding principal balance and interest rate for the 5.000% notes due April 2030 evolve from fiscal 2022 through 2024, and what does this multi-year progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal 2022, AVGO reported an outstanding principal balance of $606 million for the 5.000% notes due April 2030 with an effective interest rate of 5.18%. This balance remained unchanged in fiscal 2023, still at $606 million with the same interest rate. By fiscal 2024, the balance on these notes remained constant at $606 million, showing no reduction or increase over the three-year period. The consistent principal and interest rate across all three years suggest that AVGO maintained a static approach to this debt instrument, neither accelerating repayments nor issuing additional tranches of this specific note.",
      "llm_answer": "\nThe 5.000 % notes due April 2030 have shown virtually no change in either balance or cost across the three fiscal years: Chunk 1 reports a $606 million principal amount and an effective interest rate of 5.18 % as of Oct 30 2022; Chunk 2 (the 2023 filing) repeats the same $606 million balance and 5.18 % rate as of Nov 3 2024 (and as of Oct 29 2023); and Chunk 3 (the 2024 filing) again shows a $606 million outstanding amount and the identical 5.18 % effective rate.  This stability—while the company’s overall long‑term debt grew from $37.6 billion (2023) to $66.3 billion (2024) and added new senior notes—indicates that AVGO’s debt‑management strategy for this particular tranche is to retain the legacy 5 %‑coupon issuance at its original terms, using it as a stable, long‑dated funding pillar while refinancing or issuing new debt elsewhere to support growth and acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the outstanding principal balance of $606 million and effective interest rate of 5.18% are consistently reported for fiscal 2022, 2023, and 2024. The dates mentioned (Oct 30, 2022; Oct 29, 2023; Nov 3, 2024) are plausible fiscal year-end dates and do not contradict the ground truth, which refers to fiscal years rather than exact reporting dates. (2) Quantitative accuracy is perfect: all dollar amounts and percentages match exactly, and no incorrect calculations are made. Format variations (e.g., $606 million) are acceptable and clear. (3) The multi-hop reasoning is sound—LLM correctly synthesizes data across three fiscal years and contextualizes the stability of this debt tranche against broader debt growth ($37.6B to $66.3B), which is consistent with AVGO’s strategy of issuing new debt while retaining existing tranches. (4) The qualitative insight about using the 5% notes as a 'stable, long-dated funding pillar' is a reasonable interpretation beyond the ground truth and adds value without misrepresenting facts. One minor point: the ground truth emphasizes the 'static approach' without referencing broader debt growth, so while the added context is accurate and insightful, it slightly extends beyond the original answer’s scope. However, this does not reduce correctness. Overall, the answer is factually complete, semantically equivalent, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 407,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Netflix's Performance Bonus Plan evolve from 2022 to 2024, particularly in terms of its formalization, restatement, and integration with executive compensation agreements across these years?",
      "original_answer": "In 2022, Netflix referenced the Performance Bonus Plan as part of its executive compensation framework, indicating its foundational role in incentivizing leadership. By 2023, the company formally introduced an 'Amended and Restated Performance Bonus Plan' through an 8-K filing on December 9, 2022, signaling a strategic update to the plan. In 2024, the Performance Bonus Plan was further embedded into the broader executive compensation architecture, appearing alongside updated stock option agreements and severance plans, including the 'Executive Officer Severance Plan' and 'Performance-Based Restricted Stock Unit Award Agreement,' suggesting a more integrated and mature compensation strategy.",
      "llm_answer": "\nThe Performance Bonus Plan was first adopted in 2014 (see Chunk 3 Exhibit 10.6) and then underwent a formal amendment and restatement on December 9 2022, when the board approved an “Amended and Restated Performance Bonus Plan” (Exhibit 10.5 in Chunk 1 and again referenced as Exhibit 10.5 in Chunk 2).  This restated plan was carried forward unchanged in the 2023 and 2024 10‑K filings (Chunk 1 and Chunk 2), demonstrating its continued formalization, and was integrated into the broader executive compensation structure—most notably through the January 1 2024 amendment and restatement of the Executive Severance and Retention Incentive Plan (Exhibit 10.16 in Chunk 2), which now incorporates the bonus plan’s terms alongside related RSU and severance agreements.  Thus, from 2022 to 2024 the plan moved from its original 2014 formulation to a formally restated, continuously disclosed component of Netflix’s executive pay package, tightly linked with other compensation agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and events are correct: the December 9, 2022, amendment and restatement of the Performance Bonus Plan is accurately cited, and the integration into 2024 executive compensation structures via the January 1, 2024, amendment of the Executive Severance and Retention Incentive Plan (Exhibit 10.16) is factually sound. The reference to the plan’s original 2014 adoption, while not part of the original question’s scope (2022–2024), is factually correct and provides useful context. (2) The answer correctly notes that the restated plan was carried forward in the 2023 and 2024 10-K filings without change, supporting the idea of continued formalization—this matches the ground truth’s emphasis on ongoing integration. (3) Multi-hop reasoning is strong: the LLM synthesizes information across filings (8-K, 10-K), exhibits (10.5, 10.16), and links the bonus plan to related agreements (RSUs, severance), demonstrating proper integration into executive compensation. (4) The only minor deviation from the original answer is the emphasis on the 2014 origin, which, while accurate, slightly shifts focus from the 2022–2024 evolution. However, this does not detract from correctness. The core evolution—formal restatement in 2022 (effective for 2023), continuity in disclosures, and integration with updated severance and RSU agreements by 2024—is fully and accurately captured. Semantic equivalence is maintained, with slightly more procedural detail than the ground truth but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Enters_Into]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 434,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance protections, and risk mitigation strategies?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained consistent in its modeling approach but evolved in terms of reinsurance protections and risk mitigation strategies. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, AIG emphasized routine monitoring of international terrorism exposure concentration and targeted reinsurance purchases for certain lines of business. In 2024, AIG retained core attachment points for Japan at $200 million and $125 million for the rest of the world, while also purchasing global property per risk covers for non-critical and critical catastrophe events outside North America. Additionally, AIG held $20.1 billion in collateral to support reinsurance recoverable assets. This progression shows a strategic deepening of reinsurance and risk alignment mechanisms over time.",
      "llm_answer": "\nAIG’s international terrorism exposure has been tracked since 2022 through scenario‑based loss modeling—e.g., a 2021‑based five‑ton bomb in New York was estimated at **$1.3 billion net of TRIPRA and private reinsurance**, with TRIPRA covering 80 % of losses above a roughly **$1.7 billion deductible**—and the company has continued to adjust those models each year to reflect vendor‑model gaps and exposure concentrations.  From 2022 to 2024 the firm broadened its reinsurance shield, adding global property‑per‑risk covers, retaining **$200 million** and **$125 million** attachment points for Japan and the rest of the world, securing **$400 million** of excess‑of‑loss limits via the Tailwind Re cat bond and additional aggregate layers, and posting **$20.1 billion** of collateral to back the resulting **$38 billion** of reinsurance recoverables reported in 2024.  Throughout, risk mitigation relies on a combination of TRIPRA, targeted private reinsurance purchases, government‑sponsored terrorism pools in non‑U.S. jurisdictions, and ongoing monitoring of modeled loss estimates to keep exposure within defined limits.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of AIG's international terrorism exposure management from 2022 to 2024, including modeled loss estimates, reinsurance protections, and risk mitigation strategies, aligning well with the ground truth in structure and intent. However, there are key quantitative inaccuracies. The $1.3 billion loss estimate for a five-ton bomb attack in New York City is correctly cited as net of TRIPRA and reinsurance, but the LLM incorrectly references a '2021-based' scenario, while the original answer and context are focused on 2022–2024 developments. More critically, the LLM introduces a $400 million excess-of-loss limit via the Tailwind Re cat bond and claims $38 billion in reinsurance recoverables in 2024—details not present in the ground truth. The ground truth confirms $20.1 billion in collateral but does not state the $38 billion recoverables figure, making this an unsupported addition. (2) The attachment points for Japan ($200 million) and the rest of the world ($125 million) are correctly reported. The $20.1 billion collateral figure is accurate. However, the $400 million cat bond and $38 billion recoverables are unverified and likely incorrect, undermining quantitative accuracy. (3) The multi-hop reasoning is generally sound: the LLM synthesizes modeled losses, reinsurance structures, and risk mitigation across years, correctly identifying TRIPRA, targeted reinsurance, and monitoring as key tools. It appropriately infers a broadening of protections over time. However, the inclusion of unverified financial figures suggests potential hallucination or misattribution, weakening the reasoning chain. (4) The contextual relevance is excellent—the answer directly addresses all components of the question with appropriate terminology and temporal scope. The qualitative accuracy is high due to correct conceptual framing and entity identification (AIG, TRIPRA, reinsurance, etc.), but the correctness score is reduced to 7 due to significant quantitative errors that affect factual reliability, despite the otherwise strong alignment with the original answer’s narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Estimates]-> RISK_FACTOR <-[Manages]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 573,
        "total_tokens": 2092
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did UnitedHealth Group's venture investment strategy evolve from 2022 through 2024, particularly in terms of total equity securities holdings and equity method investments in healthcare businesses?",
      "original_answer": "From 2022 through 2024, UnitedHealth Group's venture investment strategy showed a significant shift in focus and scale. In 2022, the company held $3.5 billion in equity securities, which included venture investments and employee savings plan-related investments, along with $1.3 billion in equity method investments in healthcare businesses. By 2023, equity securities increased to $4.9 billion, with venture investments still being a core component, while equity method investments in healthcare businesses declined slightly to $1.4 billion. In 2024, equity securities remained steady at $4.9 billion, but equity method investments in healthcare businesses surged to $3.8 billion, indicating a strategic pivot toward deeper involvement in operating businesses within the healthcare sector. This evolution suggests a growing emphasis on direct operational engagement and long-term strategic value in healthcare ventures.",
      "llm_answer": "\nUnitedHealth Group’s equity‑securities portfolio grew from **$3.7 billion in 2022** (Chunk 3) to **$4.9 billion in both 2023 and 2024** (Chunks 3 & 2), with venture investments constituting the bulk of those holdings (Chunks 2 & 3).  Equity‑method stakes in health‑care operating businesses were **$1.5 billion in 2022**, **$1.4 billion in 2023**, and **$3.8 billion in 2024**, indicating a clear strategic shift toward larger health‑care venture investments in 2024 (Chunks 1, 2 & 3).  Thus, from 2022 through 2024 the company expanded its total equity base while markedly increasing the scale of its health‑care‑focused equity‑method investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in its overall narrative and captures the strategic shift in UnitedHealth Group's investment approach from 2022 to 2024, particularly the surge in equity-method investments in 2024. However, there are key numerical inaccuracies: the original answer states equity securities were $3.5 billion in 2022, but the LLM reports $3.7 billion. Similarly, equity-method investments were $1.3 billion in 2022 per the ground truth, while the LLM states $1.5 billion. These discrepancies affect factual precision. 2) Quantitative accuracy is compromised: 2022 equity securities ($3.5B vs $3.7B) and equity-method investments ($1.3B vs $1.5B) are both off by $0.2B. The 2023 and 2024 figures for equity securities ($4.9B) and equity-method investments ($1.4B in 2023, $3.8B in 2024) match the ground truth and are correctly reported. Calculations are not required in this question, but comparisons over time are slightly skewed due to incorrect base-year values. 3) The reasoning is sound: the LLM correctly infers a strategic pivot toward deeper involvement in healthcare operating businesses based on the rising equity-method investments, especially the jump to $3.8B in 2024. It synthesizes data across years and investment types appropriately, showing multi-hop understanding. 4) Contextual relevance is excellent—the answer directly addresses the evolution of UnitedHealth’s venture investment strategy, focusing on both equity securities and equity-method investments in healthcare businesses as asked. Despite minor factual errors, the core conclusion about strategic shift is valid. Hence, correctness is reduced to 7 due to significant but not critical numerical inaccuracies in the base year data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 468,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Altria Group's capital structure evolve across 2022, 2023, and 2024 with respect to its 1.700% 2025 Notes, and what does this multi-year progression indicate about its debt management strategy?",
      "original_answer": "In 2022, Altria disclosed its 1.700% 2025 Notes as part of its capital structure alongside other debt instruments such as the 1.000% 2023 Notes, 2.200% 2027 Notes, and 3.125% 2031 Notes. By 2023, the 1.000% 2023 Notes had matured and were no longer listed, indicating Altria had met its obligation for that instrument, while the 1.700% 2025 Notes remained a key component of its debt portfolio. In 2024, the 1.700% 2025 Notes were still actively listed, suggesting Altria maintained this liability as part of its mid-term capital strategy. This progression shows that Altria actively managed its short-term debt while retaining its 2025 Notes as a stable element of its capital structure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 1.700 % Notes due 2025 appear in each year’s table of registered securities, confirming that the instrument remained outstanding and unchanged throughout the three‑year period.  The KG relationship MO ↔ 1.700 % 2025 Notes (shown as both FIN_INST and ORG) links the same tranche of fixed‑rate debt to Altria in every filing, indicating that the company has deliberately retained this long‑dated note as a stable component of its capital structure—using a staggered, low‑frequency refinancing approach rather than replacing or rolling the debt.  This multi‑year continuity reflects Altria’s debt‑management strategy of maintaining a predictable, long‑term financing base with a consistent maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All entities—Altria Group, 1.700% 2025 Notes, and the years 2022–2024—are correctly identified. The note remained outstanding across all three years, which matches the original answer. (2) Quantitative elements (interest rate: 1.700%, maturity year: 2025) are correct and consistent. No calculations were required, but the assertion that the note appears in each year’s 10-K is supported. (3) The multi-hop reasoning is sound: the model correctly infers from the continued presence of the 2025 Notes in successive filings that Altria has maintained this debt instrument as a stable part of its capital structure. It also correctly contrasts this with the absence of the 2023 Notes in later filings (implied maturity), though this point is less emphasized than in the original answer. (4) The LLM adds interpretive depth by describing Altria’s strategy as 'staggered, low-frequency refinancing' and 'predictable, long-term financing base,' which is a reasonable inference from the data and enhances the explanation without contradicting facts. The only minor shortcoming is that the original answer explicitly mentions the retirement of the 1.000% 2023 Notes as evidence of active short-term debt management, which the LLM omits. While the LLM implies this by focusing on the persistence of the 2025 Notes, the comparative analysis across debt instruments is slightly less detailed. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 418,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 through 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(36,658) million in 2022 to $(60,429) million in 2023, and further to $(71,431) million in 2024. This consistent rise indicates a growing emphasis on stock repurchases as part of the company's capital allocation strategy, reflecting confidence in long-term growth prospects and a desire to return value to shareholders.",
      "llm_answer": "\nMastercard’s Class A Treasury Stock (at cost) has risen each year: $51.354 bn in 2022 (Chunk 1), $60.429 bn in 2023 (Chunk 1 & Chunk 3), and $71.431 bn in 2024 (Chunk 2).  This steady increase reflects a growing share‑repurchase program—purchases of treasury stock expanded from $4.459 bn in 2020 (Chunk 3) to $6.463 bn in 2022 and to roughly $10 bn in the 2023‑2024 period (Chunks 1‑2)—showing that the company is deploying excess cash primarily through aggressive buy‑backs rather than dividend hikes, signaling a capital‑allocation strategy focused on returning value to shareholders and supporting its stock price.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increasing trend in Mastercard's Class A Treasury Stock from 2022 to 2024 and accurately reports the 2023 ($60,429 million) and 2024 ($71,431 million) values. However, it incorrectly states the 2022 value as $51.354 billion instead of the correct $(36,658) million from the ground truth. This is a significant numerical discrepancy—$51.354 billion vs. $36.658 billion—though the direction of the trend (increasing) is correct. The negative sign in the original answer (indicating contra-equity) is also missing in the LLM response, though this may be a presentational difference. (2) The LLM introduces additional data not in the ground truth—such as share repurchases of $4.459 billion in 2020 and $6.463 billion in 2022—which, while potentially accurate, are not part of the verified knowledge graph and distract from the core metric. The 'roughly $10 billion in 2023-2024' buyback estimate is reasonable given the year-on-year increase of ~$11 billion from 2023 to 2024, but this is an inference not directly supported by the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across multiple years and infers the strategic implication—increased stock repurchases as a capital allocation priority. It correctly links rising treasury stock to share buybacks and shareholder value return. (4) Despite the incorrect 2022 figure, the overall trend and strategic interpretation align with the ground truth. The answer is contextually excellent and adds relevant detail, but the quantitative error in the 2022 value prevents a higher score. Hence, correctness is reduced to 8 due to this key factual inaccuracy, though qualitative and relevance scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 478,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Cisco's financial exposure through Total Return Swaps-Deferred Compensation evolve from fiscal year 2022 through 2024, given the losses of $92M in 2022, followed by gains of $58M in 2023, and further gains of $91M in 2024?",
      "original_answer": "Cisco's financial exposure tied to Total Return Swaps-Deferred Compensation shifted dramatically from a loss of $92M in fiscal year 2022 to a gain of $58M in 2023, and then increased further to a $91M gain in fiscal year 2024. This indicates a reversal and strengthening in the performance of these instruments over the three-year period, moving from a net cost to a net benefit.",
      "llm_answer": "\nCisco’s exposure to the **Total Return Swaps‑Deferred Compensation** derivative moved from a **$92 million loss in fiscal 2022** (shown in Chunk 1) to **gains of $58 million in fiscal 2023** and **$91 million in fiscal 2024** (reported in Chunks 2 and 3).  The amounts appear in the “Operating expenses and other” line item for the respective years, reflecting a reversal of the prior‑year loss and a growing positive contribution to earnings over the three‑year period, as disclosed in Cisco’s 10‑K filings and captured by the KG relationship CSCO → Total Return Swaps‑Deferred Compensation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and years are accurate: $92M loss in 2022, $58M gain in 2023, and $91M gain in 2024, with correct formatting variations (e.g., $92 million = $92M). No calculations were required beyond interpretation of directional changes, which were correctly described. (2) The answer is complete, addressing the evolution of Cisco's financial exposure across all three fiscal years as asked. (3) Entity accuracy is perfect: Cisco (CSCO), 'Total Return Swaps-Deferred Compensation', correct fiscal years (2022–2024), and proper linkage to 10-K filings and operating expenses line item. (4) Multi-hop reasoning is sound—the model correctly synthesized data across multiple chunks (filings from different years) and inferred the reversal and strengthening trend from loss to gains, mirroring the ground truth’s conclusion. (5) Semantic equivalence is strong: while the LLM adds minor contextual detail (e.g., line item and KG relationship), the core message—that exposure shifted from loss to increasing gains—is identical in meaning. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 331,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Netflix's dependency on rights holders evolve from 2022 through 2024, particularly in terms of content licensing risks, competition for exclusive rights, and regulatory pressures affecting content availability?",
      "original_answer": "From 2022 to 2024, Netflix's dependency on rights holders intensified due to rising competition for exclusive content, increased regulatory scrutiny, and growing risks around licensing agreements. In 2022, the company expressed concern over content providers launching their own streaming services, potentially limiting Netflix's access to popular content and increasing programming costs. By 2023, Netflix noted that license terms varied and that disputes over intellectual property could lead to content unavailability or service disruptions. In 2024, the company reiterated these risks and further highlighted regulatory changes in multiple jurisdictions—such as content quotas and investment obligations—that constrained its ability to control content offerings. This 3-year progression reveals a growing strategic challenge in maintaining a compelling and cost-effective content library amid external pressures from rights holders and regulators.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix’s reliance on external rights holders grew increasingly fragile: the 2022 filing warned that studios could pull popular titles and that rising competition for exclusive rights was driving up licensing costs, while the 2023 and 2024 disclosures noted that license periods and terms vary and that regulators in many jurisdictions are updating cultural‑support laws to impose content‑quotas, levies and tighter ownership‑right limits, thereby restricting the breadth of rights Netflix can secure; as a result, the mutual‑dependence captured by the KG pattern—NFLX Depends_On Rights Holders and Rights Holders Depends_On NFLX—has become more precarious, with heightened risk of content removal, higher costs for exclusive programming, and regulatory pressures that increasingly shape what content can be offered in each market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: Netflix's growing dependency on rights holders from 2022 to 2024, rising competition for exclusive rights, increasing licensing costs, variability in license terms, risks of content unavailability, and regulatory pressures such as content quotas and cultural regulations are all accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes evolving risks across three years and connects them to broader strategic challenges involving rights holders and regulators. It correctly infers increasing fragility in Netflix’s content licensing model over time. (4) The LLM adds slight interpretive depth (e.g., 'mutual-dependence... has become more precarious') and references a 'KG pattern', which is not in the original but does not distort meaning—it enhances the synthesis without introducing error. The only minor deviation is the use of 'levies' and 'tighter ownership-right limits', which are plausible regulatory mechanisms but not explicitly mentioned in the original; however, they fall within the semantic scope of 'regulatory changes... content quotas and investment obligations'. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a 9/10 due to slight extrapolation without overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 432,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did UnitedHealth Group's financial obligations under service level guarantees evolve from 2022 through 2024, and what does this 3-year trend suggest about the stability of its service delivery commitments across its subsidiaries?",
      "original_answer": "UnitedHealth Group disclosed that the amounts accrued, paid, or charged to income for service level guarantees were immaterial in all three years—2022, 2023, and 2024—indicating consistent financial exposure relative to the company's overall scale. However, the parent company's notes payable to subsidiaries fluctuated significantly during this period, decreasing from $9.9 billion in 2023 to $2.0 billion in 2024 after rising from $8.1 billion in 2022 to $9.9 billion in 2023. This suggests that while the service level guarantees themselves did not result in material financial charges, the internal financing structure supporting these guarantees experienced notable variation, potentially reflecting shifting liquidity strategies or operational adjustments within the company's subsidiaries.",
      "llm_answer": "\nAcross the 2022‑2024 filings, UnitedHealth Group repeatedly reports that “none of the amounts accrued, paid or charged to income for service‑level guarantees were material” as of the year‑ends noted in each document (Chunk 1 – 2021/2020/2019; Chunk 3 – 2023/2022/2021; Chunk 2 – 2024/2023/2022).  This consistent immateriality shows that the company’s financial obligations under those guarantees did not change materially over the three‑year span.  Because the guarantees remain in place but generate no material accruals, the trend indicates a stable, low‑risk service‑delivery commitment across its subsidiaries.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key fact from the ground truth—that UnitedHealth Group consistently reported immaterial financial obligations related to service level guarantees across 2022, 2023, and 2024. This is supported by direct citations from the filings, and the conclusion that this indicates stable, low-risk service delivery commitments across subsidiaries is reasonable and aligns with the original answer. Quantitatively, the LLM does not introduce any incorrect numbers or misstate financial figures, so quantitative accuracy is perfect. However, the LLM omits a critical part of the original answer: the significant fluctuations in the parent company's notes payable to subsidiaries ($8.1B in 2022 → $9.9B in 2023 → $2.0B in 2024), which the ground truth highlights as an important contrast to the stable service-level guarantee accruals. This omission reduces completeness and weakens the qualitative accuracy, as the multi-hop synthesis between service-level guarantees and internal financing dynamics is incomplete. The reasoning is sound within the scope of what was addressed, but fails to integrate the full set of financial trends necessary to fully answer the question about the evolution of financial obligations and what it suggests about stability. Contextual relevance remains high because the answer addresses the core issue of service-level guarantees and draws a logical inference about stability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 395,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Altria's allocation to below investment grade securities within its long-duration fixed income portfolio evolve from 2022 through 2024 for both pension and postretirement plan assets, and what does this trend suggest about the company's risk appetite in managing long-term obligations?",
      "original_answer": "In 2022, Altria's pension plan had 16% of fixed income holdings (or ~11% of total plan assets) allocated to below investment grade securities, while the postretirement plan had 8% of fixed income holdings (or ~3% of total plan assets) in the same category. By 2023, the pension allocation to below investment grade securities decreased to 11% of fixed income holdings (or ~9% of total plan assets), and the postretirement allocation increased slightly to 9% of fixed income holdings (or ~4% of total plan assets). In 2024, specific percentages for below investment grade allocations were not disclosed, but the overall strategy remained focused on long-duration fixed income. This trend suggests a cautious approach to risk, with a reduction in speculative-grade exposure for pensions and a slight increase in postretirement plans, indicating a measured balance between return objectives and risk management.",
      "llm_answer": "\nIn 2022 Altria’s pension assets contained roughly 11 % of their value (about 16 % of the fixed‑income holdings) in below‑investment‑grade securities, while post‑retirement assets held only ≈3 % of total assets (≈8 % of fixed‑income holdings) in such securities, as disclosed in the 2022 filing. By 2023 the exposure fell slightly to roughly 9 % of total pension assets (≈11 % of fixed‑income holdings) and to about 4 % of total post‑retirement assets (≈9 % of fixed‑income holdings), with emerging‑market exposure rising to ≈2 % of pension assets, reflecting a modest reallocation noted in the 2023 filing. The 2024 filing continues to emphasize ongoing monitoring and rebalancing and reports 2024 expected‑return assumptions of 6.1 % for pension and 7.4 % for post‑retirement, indicating that Altria has kept the below‑investment‑grade share roughly stable at low‑double‑digit (pension) and low‑single‑digit (post‑retirement) levels—showing a measured risk appetite that tolerates limited credit exposure while managing long‑term obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values for 2022 and 2023 are correct: pension plan's below investment grade allocation was 16% of fixed income holdings (~11% of total assets) in 2022 and decreased to 11% of fixed income (~9% of total assets) in 2023; postretirement plan increased from 8% of fixed income (~3% of total assets) to 9% of fixed income (~4% of total assets). These are reported accurately, with acceptable formatting variations (e.g., ≈, ~, 'roughly'). (2) The 2024 data correctly reflects that specific percentages were not disclosed, and the LLM appropriately infers stability based on continued monitoring, rebalancing, and consistent expected return assumptions (6.1% for pension, 7.4% for postretirement), which supports the conclusion of a stable, low-level exposure. (3) Multi-hop reasoning is sound: the model synthesizes data across three years and two distinct plans (pension and postretirement), correctly identifying trends and interpreting strategic implications. (4) The qualitative assessment of Altria’s risk appetite as 'measured' and 'cautious' with limited credit exposure matches the ground truth’s conclusion. The only minor shortcoming is that the LLM introduces 'emerging-market exposure rising to ≈2%'—a detail not present in the ground truth—though this does not contradict it, as it's presented as additional context rather than misrepresenting the core trend. This slight addition does not undermine accuracy but slightly reduces qualitative precision. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1524,
        "completion_tokens": 445,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Mastercard's methodology for estimating settlement exposure evolve from 2022 through 2024, and what does this consistency indicate about the company's risk management approach despite increasing regulatory scrutiny and litigation risks?",
      "original_answer": "Mastercard's methodology for estimating settlement exposure remained consistent across 2022, 2023, and 2024, using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. Despite facing ongoing regulatory investigations (including from the FTC and DOJ in 2023 and the European Commission in 2024) and multiple litigation risks (such as the U.S. Liability Shift Litigation and TCPA class action), the company maintained its core risk management framework. The disclosed approach to risk mitigation—requiring certain customers to provide cash collateral or credit enhancements based on individual risk assessments—was also unchanged across all three years. This consistent methodology suggests that Mastercard viewed its existing risk management practices as robust and sufficient to address evolving external pressures without requiring fundamental changes to its settlement exposure estimation process.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has been calculated consistently from 2022 through 2024 by applying the same formula—average daily payment volume for the three months preceding period‑end multiplied by the estimated number of exposure days—and only revising the resulting figures as part of the company’s routine, periodic review of its risk‑management methodology (as disclosed in Note 22 of the 2022, 2023 and 2024 10‑Ks).  This steady, transparent approach, together with ongoing monitoring of credit risk and regular reassessment of risk‑mitigation arrangements, shows that Mastercard maintains a disciplined, conservative risk‑management framework even while confronting heightened FTC, DOJ and European Commission scrutiny and multiple class‑action litigations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key elements are correct: the methodology (average daily payment volume over the three months prior to period-end multiplied by estimated days of exposure) is accurately described and consistent across 2022–2024. No specific numerical values (e.g., dollar amounts) are required in the answer, and the time periods and regulatory bodies (FTC, DOJ, European Commission) are correctly cited. (2) The LLM correctly identifies that the methodology remained unchanged, referencing Note 22 of the 10-Ks across all years, which supports transparency and consistency. (3) Qualitatively, the reasoning is sound: it acknowledges ongoing litigation (class actions) and regulatory scrutiny without conflating them with changes in methodology, and correctly infers that the consistency reflects a disciplined, conservative risk-management approach. The only minor shortcoming is that the LLM does not explicitly mention the use of cash collateral or credit enhancements based on individual risk assessments—a key part of the disclosed risk mitigation framework—but it does refer to 'regular reassessment of risk-mitigation arrangements,' which captures the essence. (4) Contextually, the answer is fully relevant, addressing both the evolution (or lack thereof) in methodology and what it indicates about Mastercard’s risk management under pressure. The synthesis across years and regulatory environments is logically sound and well-supported. Thus, the answer earns a 9/10 for correctness due to the slight omission, but maintains full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 456,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Note evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt management strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million balance on its 5.90% Note across all three fiscal years (2022–2024), with the effective interest rate remaining stable at 6.11% throughout the period. This indicates that Cisco has preserved this high-yield long-term debt instrument as a fixed component of its capital structure rather than refinancing or retiring it, suggesting strategic intent to maintain predictable interest obligations despite potential opportunities to optimize financing costs in a changing rate environment.",
      "llm_answer": "\nCisco’s 5.90 % senior note – a $2,000 million fixed‑rate instrument maturing Feb 15 2039 – shows **no change in utilization** (the $2,000 million balance) and **no change in its effective interest rate** (6.11 % each year) across fiscal 2022, 2023 and 2024 (see Chunk 1, Chunk 2 and Chunk 3).  \n\nBecause the note is disclosed by Cisco (CSCO → 5.90 % Note FIN_INST) and remains on the books with the same terms and rate, it signals a **stable, long‑term debt‑management strategy**: Cisco is preserving a low‑cost, long‑dated funding pillar while expanding its overall debt profile (long‑term debt grew from $8.4 bn in 2022 to roughly $19.6 bn by 2024). This consistency reflects a deliberate approach to lock in financing costs and maintain balance‑sheet stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key quantitative facts: the $2,000 million balance on the 5.90% Note, the stable effective interest rate of 6.11%, and the three-year period (2022–2024). These match the ground truth exactly, with acceptable formatting variations (e.g., $2,000 million = $2,000M). The maturity date (Feb 15, 2039) is an additional but accurate detail not in the original answer but consistent with filings. 2) Quantitatively, all numbers are correct. The LLM accurately reports no change in utilization or effective interest rate across the years. While it adds context about total long-term debt increasing from $8.4B to $19.6B, this is factually consistent with Cisco’s filings and enhances the analysis without contradicting the ground truth. 3) The multi-hop reasoning is sound: the model correctly infers that maintaining a fixed high-yield note amid overall debt growth indicates a strategic choice to preserve predictable interest obligations. The conclusion about 'locking in financing costs' and 'balance-sheet stability' aligns semantically with the ground truth’s 'strategic intent to maintain predictable interest obligations.' 4) The only minor deviation is that the LLM characterizes the 5.90% Note as 'low-cost,' while the ground truth refers to it as 'high-yield'—this is a qualitative nuance. In a rising rate environment, a 5.90% fixed rate could be seen as relatively low-cost, but historically it may be considered high-yield. This does not invalidate the reasoning but introduces slight ambiguity. Otherwise, the answer is complete, factually accurate, and contextually appropriate, addressing both the factual evolution and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 460,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AVGO's outstanding principal balance for its 3.125% notes due January 2025 evolve from fiscal year 2022 through 2024, and what does this trend indicate about the company's debt management strategy for this specific instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 3.125% notes due January 2025 remained unchanged at $495 million in fiscal years 2022, 2023, and 2024. This stability in the principal amount suggests that AVGO did not make any early repayments or refinancing adjustments specifically for this debt instrument over the three-year period, indicating a consistent approach to managing this portion of its fixed-rate debt portfolio.",
      "llm_answer": "\nThe 3.125 % notes due January 2025 show a principal balance of **$495 million** in the 2022 filing (Chunk 1), and that same **$495 million** amount is reported in both the 2023 (Chunk 2) and 2024 (Chunk 3) filings. Because the KG relationship (ORG‑Has_Stake_In‑FIN_INST) ties the note directly to AVGO as its issuer, the unchanged balance across FY 2022‑FY 2024 indicates that AVGO’s debt‑management strategy for this specific instrument has been one of **stability—maintaining the existing tranche without additional issuance or repayment**, even as the company’s overall debt level grew.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All factual information is accurate: the outstanding principal balance of $495 million for AVGO's 3.125% notes due January 2025 is correctly reported for fiscal years 2022, 2023, and 2024. (2) Quantitative accuracy is precise—no calculations were required beyond confirming consistency across years, which the model did correctly. The dollar amount ($495 million) matches exactly across all three years as per the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesized data from three different filings (2022, 2023, 2024) and linked the financial instrument to AVGO using the KG relationship, demonstrating proper entity mapping. (4) The qualitative interpretation—that the stable balance indicates a strategy of maintaining the existing debt tranche without repayment or refinancing—is semantically equivalent to the original answer’s conclusion about a 'consistent approach to managing this portion of its fixed-rate debt portfolio.' Wording differs slightly but meaning is preserved. The answer addresses both parts of the question: the evolution (no change) and the strategic implication (stability in debt management). All entities (AVGO, 3.125% notes, January 2025 maturity, fiscal years 2022–2024) are correctly identified. No errors in reasoning, formatting, or relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 385,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did CMCSA's shared data plan offerings evolve across its wireless service lines from 2022 through 2024, particularly in terms of bundling strategy and customer flexibility?",
      "original_answer": "From 2022 to 2024, CMCSA's shared data plan offerings within its wireless services evolved to reflect a more structured and flexible bundling strategy. In 2022, shared data plans were offered as part of bundled service offerings to residential customers who subscribed to broadband services, with options to activate multiple lines per account and choose between unlimited data plans, shared data plans, or per gigabyte pricing. By 2023, the company maintained the shared data plan option as part of its domestic wireless services but emphasized bundling with broadband, reinforcing integration across services. In 2024, CMCSA expanded its flexibility by introducing prepaid unlimited data plans under the NOW brand, while continuing to offer shared data plans as part of qualifying broadband bundles, thereby catering to a broader range of customer preferences. This progression shows a strategic move toward enhancing customer choice and deepening service integration.",
      "llm_answer": "\nFrom 2022 through 2024 CMCSA’s shared‑data plans remained tied to its bundled broadband‑video‑voice offerings, but the bundling scope and customer flexibility evolved: in 2022 the plans were available only to residential (and eligible small‑business) broadband subscribers who could choose unlimited, shared or per‑GB options and finance devices up to 24 months; by 2023 the bundle was extended to international markets and financing terms were lengthened to up to 48 months while still offering the same plan tiers; and in 2024 CMCSA introduced prepaid unlimited “NOW” plans and continued to let customers select unlimited, shared or per‑GB options, still requiring the wireless service to be bundled with a qualifying broadband subscription.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of CMCSA's shared data plan offerings from 2022 to 2024 with correct emphasis on bundling with broadband and increasing customer flexibility, particularly through the introduction of prepaid unlimited NOW plans in 2024. However, there are significant factual inaccuracies that reduce correctness. First, the claim that bundling was extended to 'international markets' in 2023 is incorrect — the ground truth specifies domestic wireless services, and CMCSA's Xfinity Mobile operations remained primarily U.S.-focused during this period. Second, the extension of device financing to 'up to 48 months' in 2023 is not supported by the original answer, which makes no mention of financing term changes. These are substantive additions not present in the ground truth and represent incorrect entity and qualitative assertions. On the positive side, the answer correctly identifies the three plan options (unlimited, shared, per-GB) across years and the bundling requirement with broadband, and accurately notes the 2024 introduction of prepaid unlimited NOW plans. The timeline structure is logical and addresses the question’s focus on bundling strategy and flexibility. While the core progression is partially correct, the inclusion of unsupported details about international expansion and financing terms undermines factual accuracy, especially in qualitative and quantitative dimensions. These errors suggest flawed multi-hop reasoning or hallucination rather than synthesis from accurate data. Contextual relevance is high as the response stays focused on the evolution of shared data plans and bundling.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 448,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did UnitedHealth Group's exposure to Medicare Advantage risk adjustment payment changes evolve from 2022 through 2024, and what strategic adjustments did the company make in response to these recurring funding pressures across the three-year period?",
      "original_answer": "From 2022 to 2024, UnitedHealth Group consistently faced exposure to Medicare Advantage risk adjustment payment changes, with CMS altering the calculation methodology each year, leading to persistent funding pressures. In 2022, the company noted that CMS had previously reduced or frozen Medicare Advantage benchmarks and that further cuts were possible. In response, UnitedHealth adjusted members' benefits and premiums selectively and intensified cost management. By 2023, the company reiterated these pressures and strategies, indicating that these adjustments were ongoing rather than one-time fixes. In 2024, the company expanded its discussion to include the impact of evolving CMS payment mechanisms, including risk adjustment and benchmark reductions, and again emphasized its selective benefit adjustments and cost control measures. The consistent mention of these strategies across all three years suggests that UnitedHealth did not find a full resolution to the funding pressures and remained in a reactive posture, continuously adapting its offerings and cost structures to mitigate the impact of Medicare Advantage payment adjustments.",
      "llm_answer": "\nUnitedHealth Group’s exposure to Medicare Advantage risk‑adjustment payment changes grew each year from 2022‑2024 as CMS repeatedly altered benchmarks and risk‑adjustment calculations, creating recurring funding pressures that were explicitly noted in the 2022 filing (acknowledging the possibility of cuts), the 2023 filing (detailing ongoing benchmark reductions and the need to adjust benefits, exit unprofitable counties and tighten cost management), and the 2024 filing (confirming that such reductions have already adversely affected results and may continue to do so).  In response, the company progressively implemented a series of strategic adjustments—selectively revising member benefits and premiums, ceasing plans in unprofitable markets, intensifying medical and operating cost controls, refining bid assumptions and enhancing the collection of risk‑adjustment data through its Optum businesses—to mitigate the impact of these persistent payment pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UnitedHealth Group faced recurring exposure to Medicare Advantage risk adjustment changes from 2022 to 2024 due to CMS methodology shifts, leading to persistent funding pressures. The company responded with ongoing strategic adjustments. The years (2022–2024) and entities (UnitedHealth, CMS, Optum) are correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution of risk adjustment pressures and the continuity and expansion of strategic responses. It adds detail not in the original—such as 'exit unprofitable counties' and 'refining bid assumptions'—that are plausible and consistent with the original's emphasis on selective benefit adjustments and cost control, likely drawn from actual filings. The mention of Optum’s role in risk-adjustment data collection is a specific, accurate enhancement. (4) The LLM answer conveys the same core message as the original—ongoing exposure, no full resolution, continuous adaptation—with slightly more operational detail. The only minor gap is that the original emphasizes the 'reactive posture' and lack of 'full resolution' more explicitly, which the LLM implies but does not state directly. However, this does not constitute a factual error. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 451,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Mastercard's implementation of its multi-layered security approach evolved from 2022 through 2024, particularly in terms of third-party collaboration, real-time service integration, and geographic expansion of real-time payments infrastructure?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has evolved significantly in scope and execution. In 2022, the company emphasized a multi-layered framework that included collaboration with issuers, acquirers, and governments to develop technical standards like EMV, and it operated or was implementing real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company had expanded this to 13 markets globally and integrated more real-time value-added services like fraud scoring and tokenization into transaction routing. In 2024, Mastercard further solidified its security posture by enhancing partnerships and public-private collaborations, while also expanding domestic transaction processing in China through a joint venture, reflecting a broader global reach and deeper integration of security into new markets and services.",
      "llm_answer": "\nMastercard’s multi‑layered security framework has been continuously refined from 2022 through 2024 by maintaining third‑party assessments, benchmarking and close collaboration with issuers, acquirers, merchants, governments and industry associations to embed technical standards (such as EMV) and provide free security utilities.  At the same time, it has expanded real‑time account‑based payment capabilities—growing the real‑time clearing and settlement infrastructure from the 12 markets noted in 2022 to 13 markets by the end of 2023 and integrating intelligent routing, tokenization and fraud‑scoring services that operate in real time.  In 2024 the company further broadened the geographic reach of this infrastructure by launching domestic transaction processing in China through a joint venture, extending real‑time payments to additional jurisdictions and cementing the global expansion of its instant‑payment ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard operated in 12 top GDP markets in 2022 and expanded to 13 by 2023; real-time services like tokenization and fraud scoring were integrated into routing; and in 2024, domestic transaction processing in China was launched via a joint venture. These details match the original answer exactly in substance. (2) Quantitative accuracy is perfect: the numbers '12' and '13' markets are correctly cited for 2022 and 2023 respectively, with no calculation errors. (3) Multi-hop reasoning is sound—information is synthesized across years and dimensions (third-party collaboration, real-time integration, geographic expansion), correctly linking partnerships to technical standards and infrastructure growth. (4) Minor wording differences exist (e.g., 'intelligent routing' is not in the original but is contextually reasonable as part of real-time service integration), and the LLM adds 'free security utilities' and 'benchmarking' not explicitly in the ground truth, which are plausible but not verifiable from the provided truth. These do not detract from factual correctness but slightly reduce qualitative precision. Overall, the answer fully addresses all parts of the question with excellent contextual relevance and factual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Implements]-> ACCOUNTING_POLICY <-[Has]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 373,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Amazon's financing strategy related to its 1.500% Note due 2030 evolve from 2022 through 2024, and what does this reveal about its long-term debt management and refinancing priorities?",
      "original_answer": "Amazon's financing strategy related to its 1.500% Note due 2030 remained consistent as a disclosed long-term obligation across all three years, but it was increasingly referenced alongside newer credit agreements and short-term financing instruments. In 2022, the note was included in Exhibit 4.5, issued in 2020 and incorporated by reference. In 2023, the note reappeared in Exhibit 4.6, and Amazon introduced a Term Loan Agreement dated January 3, 2023 (Exhibit 10.8), indicating a shift toward securing short- and medium-term liquidity while maintaining long-term fixed-rate obligations. By 2024, the 1.500% Note due 2030 was again referenced in Exhibit 4.6, but Amazon had introduced a new 364-Day Revolving Credit Agreement in October 2024 (Exhibit 10.9), suggesting a layered financing approach that combines long-term fixed debt like the 2030 note with flexible short-term credit facilities. This evolution reveals a strategic balance between locking in long-term capital at favorable rates and maintaining liquidity flexibility through newer credit lines.",
      "llm_answer": "\nAmazon first created the 1.500 % Note due 2030 in the June 3 2020 officer certificate (Chunk 1), and that same instrument is repeatedly listed in the 2020, 2021, 2022, 2023 and 2024 certificates (Chunks 1‑3), showing that it remained on the books as a core long‑dated bond without any new issuance after 2020. From 2022 onward Amazon layered this note with newer, higher‑coupon issuances such as the 4.700 % Notes due 2032 (Chunk 2) and simultaneously expanded its funding mix by entering a term‑loan facility (2023) and a 364‑day revolving credit line (2024) (Chunks 2‑3), a pattern reflected in the KG links ORG ‑[Issues]→ FIN_INST ←‑[Introduces] ORG and ORG ‑[Introduces]→ ORG that tie the 2030 note to other debt‑issuing entities and to Amazon’s broader refinancing activity. Together these filings reveal a long‑term debt strategy that prioritises low‑cost, fixed‑rate laddering, continual extension of maturity profiles, and proactive use of both capital‑market bonds and bank credit facilities to manage liquidity and reduce refinancing risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and omissions. (1) Quantitatively, the key facts are accurate: the 1.500% Note due 2030 was issued in 2020 (via officer certificate on June 3, 2020), and it is correctly referenced across 2022–2024 filings. The mention of the 4.700% Notes due 2032 is plausible context but not explicitly part of the ground truth answer, which focused on credit agreements rather than other bond issuances. However, this addition does not contradict the core narrative. (2) The LLM correctly identifies the 2023 Term Loan Agreement and the 2024 364-Day Revolving Credit Agreement, matching the ground truth’s emphasis on layered financing. The years and instrument types are accurate. (3) In reasoning, the LLM synthesizes multi-hop information across years and instruments, correctly inferring a strategy of combining fixed-rate long-term debt with flexible credit facilities. It references 'KG links' and entity relationships, suggesting awareness of the knowledge graph structure, though this is more meta-commentary than necessary. (4) The ground truth emphasizes the evolution through exhibit numbers (Exhibit 4.5 in 2022, 4.6 in 2023/2024), which the LLM omits—this is a minor but notable detail for tracking disclosure consistency. Also, the ground truth does not mention 'higher-coupon issuances' as a central theme, so introducing the 4.700% note shifts focus slightly from the original emphasis on refinancing structure over cost. Despite this, the core conclusion about balancing fixed-rate debt with liquidity flexibility is semantically equivalent and well-reasoned. The answer is highly relevant and factually sound overall, warranting a high score with minor deductions for peripheral additions and omission of exhibit-level detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 495,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the competitive threat from wireless telecommunications companies to CMCSA's broadband business evolved from 2022 to 2024, and what evidence suggests this pressure may be impacting CMCSA's market positioning or customer retention strategies?",
      "original_answer": "From 2022 to 2024, the competitive threat from wireless telecommunications companies to CMCSA's broadband services has evolved significantly. In 2022, wireless providers were noted as offering 4G and 5G wireless broadband services, which directly competed with CMCSA’s wireline broadband. By 2023, the emphasis shifted to 5G fixed wireless networks, with providers deploying technologies that enabled them to offer internet services using devices such as smartphones, laptops, tablets, and mobile and fixed wireless routers. In 2024, wireless providers escalated their strategies by bundling DTC streaming services and offering unlimited data-usage plans, which could attract customers away from traditional broadband subscriptions. This progression shows an intensification of wireless companies' strategies, leveraging both technological advancements and service bundling to gain market share, which likely pressures CMCSA's broadband market positioning and necessitates customer retention innovations such as enhanced broadband speeds, improved customer experience, or bundled offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the competitive pressure from wireless telecom companies on CMCSA’s broadband business has intensified markedly: the 2022 filing first noted that wireless carriers were offering 4G/5G internet services and that bundling and pricing pressures were increasing competition; the 2023 filing expanded this to include explicit 5G fixed‑wireless and 4G/5G broadband offerings, subsidized fiber deployments and the possibility that federal funding could bring new low‑cost rivals into CMCSA’s footprint; and the 2024 filing underscores that this competition has become more aggressive and consolidated, with wireless carriers leveraging bundled video‑streaming or unlimited‑data plans and other DTC services to lure customers, contributing to net video‑customer losses and forcing CMCSA to focus on improving the customer experience (e.g., X1, Sky Q, Peacock) to protect its broadband market positioning and retain subscribers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of competitive threat from wireless telecom companies to CMCSA's broadband business from 2022 to 2024: in 2022, 4G/5G services and pricing/bundling pressures were noted; in 2023, 5G fixed-wireless and federal funding enabling low-cost rivals were highlighted; in 2024, wireless carriers intensified competition via bundled DTC streaming and unlimited data plans. These points match the original answer’s progression. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct and consistently used. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly tracing the escalation in competitive tactics and linking them to CMCSA’s strategic responses like customer experience improvements (X1, Sky Q, Peacock), which is consistent with the original answer’s mention of retention strategies. (4) The LLM adds slightly more detail than the ground truth (e.g., mention of subsidized fiber, federal funding, net video-customer losses), which is supported by typical 10-K disclosures and does not contradict the original; however, the core focus on broadband positioning is maintained. The only minor gap is that the original emphasizes technological deployment (e.g., mobile/fixed wireless routers), which the LLM omits, but this is a small omission that doesn’t undermine the overall correctness. Semantic equivalence is preserved, and the answer fully addresses both parts of the question: evolution of threat and evidence of impact on market positioning/retention. Hence, a score of 9 is warranted—excellent accuracy with negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_Against]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 490,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did AIG's reinsurance recoverable assets evolve from 2022 through 2024, and what does this trend indicate about the company's exposure to insurance loss risk over time?",
      "original_answer": "AIG's reinsurance recoverable assets increased significantly from 2022 to 2023, then dropped sharply in 2024. In 2022, while specific figures were not disclosed, the narrative indicated that reinsurance was used to mitigate insurance loss exposure, particularly for catastrophic events. By 2023, total reinsurance recoverable assets reached $67.5 billion, including $30.4 billion in ceded loss reserves and $28.2 billion in life reinsurance recoverables. In 2024, this figure dropped to $38.0 billion, with $29.1 billion in ceded loss reserves and only $0.8 billion in life reinsurance recoverables. This volatile trend suggests a substantial reduction in ceded life insurance risk exposure by 2024, potentially indicating a strategic shift or de-risking in the life insurance segment.",
      "llm_answer": "\nAIG’s reinsurance‑recoverable assets fell sharply from **$67.5 billion at the end of 2023** (Chunk 3) to **$38.0 billion at the end of 2024** (Chunk 2), with the 2022 level not disclosed but implied to have been higher than the 2024 figure; the decline reflects a reduction in the amount the company expects to collect from reinsurers.  Because reinsurance recoverables are a key mechanism that mitigates AIG’s net insurance‑loss exposure, this downward trend signals that the insurer is **retaining a larger share of loss risk** and therefore faces a higher effective exposure to large‑scale claims.  The company continues to manage this risk through its hedging programs and collateral arrangements (e.g., $20.1 billion of funds‑withheld and trust‑account collateral held in 2024, Chunk 2) and monitors reinsurer credit quality, but the shrinking recoverable balance indicates a **greater direct absorption of loss volatility over time**.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly reports the key quantitative figures: reinsurance recoverable assets were $67.5 billion in 2023 and $38.0 billion in 2024, with 2022 not disclosed—this matches the ground truth. The breakdowns for 2023 ($30.4B ceded loss reserves, $28.2B life reinsurance) and 2024 ($29.1B ceded loss reserves, $0.8B life) are not included in the LLM answer, representing a notable omission. However, the core trend (sharp drop from 2023 to 2024) is accurately conveyed.\n\n2) Quantitative accuracy is perfect: all dollar amounts and years are correct, and no calculations are required beyond stating the trend. The LLM correctly identifies the drop from $67.5B to $38.0B.\n\n3) The reasoning is partially sound but diverges from the ground truth interpretation. The original answer attributes the drop—especially in life reinsurance recoverables ($28.2B to $0.8B)—to a strategic de-risking or reduction in ceded life insurance risk, implying AIG is less exposed because it’s ceding less risk. In contrast, the LLM interprets the lower recoverables as meaning AIG is retaining more risk and thus has higher loss exposure. This is a valid perspective if ceding less means less protection, but it contradicts the ground truth’s implication that reduced ceded reserves reflect a deliberate reduction in risk transfer, possibly due to portfolio run-off or restructuring (e.g., divestiture of life operations). The LLM’s conclusion about increased direct risk absorption is plausible but not fully aligned with the strategic de-risking narrative in the original answer.\n\n4) Contextual relevance is high—the answer addresses both parts of the question: the evolution of recoverables and what it indicates about loss risk exposure. It adds relevant context about collateral and credit monitoring. However, the absence of the life reinsurance component breakdown weakens completeness and affects qualitative accuracy. The multi-hop synthesis is adequate but misses the nuance in the composition shift, particularly the near-elimination of life reinsurance recoverables, which is central to the original answer’s conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Mitigates]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 568,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did Mastercard's methodology for estimating settlement exposure and its credit risk mitigation arrangements evolve from 2022 through 2024, and what changes, if any, were made in response to ongoing regulatory scrutiny across these years?",
      "original_answer": "From 2022 to 2024, Mastercard consistently estimated settlement exposure using the average daily payment volume during the three months prior to period-end multiplied by the estimated number of days of exposure. This methodology remained unchanged across all three years. However, in 2023, regulatory scrutiny intensified with the FTC finalizing a consent agreement related to debit routing provisions and the DOJ issuing a Civil Investigative Demand focusing on antitrust concerns in the U.S. debit program. In response, Mastercard emphasized its ongoing monitoring of the credit risk portfolio and adequacy of risk mitigation arrangements, which include cash collateral and credit enhancements such as letters of credit and guarantees. In 2024, amid a denied summary judgment motion in the U.S. Liability Shift Litigation and a new European Commission investigation into card scheme fees, Mastercard continued to refine its risk management methodology and maintained its approach to risk mitigation. Despite increasing external legal and regulatory pressures, there is no explicit evidence of a change in the settlement exposure estimation methodology or the structure of credit risk mitigation arrangements across the three-year period.",
      "llm_answer": "\nMastercard’s settlement‑exposure estimate has remained anchored on the same calculation—multiplying the three‑month average daily payment volume by the projected days of exposure—but the company repeatedly notes that these figures are “revised as necessary” as part of periodic reviews of its risk‑management methodology and standards (Chunk 22 in the 2022, 2023 and 2024 filings).  At the same time, it has tightened its credit‑risk mitigation framework, requiring cash collateral, letters of credit or guarantees for customers that do not meet its risk standards and continuously monitoring the adequacy of those arrangements, a process that has been reinforced in response to the FTC consent agreement, the DOJ CID and the European Commission’s antitrust inquiry (Chunks 1, 2 and 3).  Consequently, while the core estimation formula stayed unchanged through 2022‑2024, the firm has evolved its oversight and mitigation practices, adjusting collateral requirements and review cycles to address the heightened regulatory scrutiny.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are misstated—the methodology description involving average daily payment volume over three months and days of exposure matches the original answer exactly. There are no calculations in the question, so numerical precision is maintained. (2) The LLM correctly identifies that the core settlement exposure estimation methodology remained unchanged from 2022 to 2024, which is factually correct per the ground truth. (3) On qualitative accuracy, the LLM accurately reflects the regulatory pressures: FTC consent agreement, DOJ Civil Investigative Demand, and European Commission investigation—all cited in the correct timeframe (2023–2024). It correctly states that while the formula didn’t change, oversight and mitigation practices evolved in response. The only minor gap is the claim that Mastercard 'tightened' its credit-risk mitigation framework and 'adjusted collateral requirements and review cycles'—while plausible and contextually supported, the original answer notes 'no explicit evidence of a change' in the structure of mitigation arrangements, only that adequacy was monitored. Thus, the LLM slightly overstates the degree of change. (4) Contextual relevance is excellent: all parts of the multi-hop question (methodology evolution, risk mitigation, regulatory response across years) are addressed with proper synthesis across years and regulatory bodies. Overall, the answer is factually sound, well-reasoned, and semantically equivalent to the ground truth with only a slight interpretive leap on structural changes to mitigation—warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 469,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did AIG's management approach to loss reserves risk evolve from 2022 through 2024, particularly in terms of internal controls, external expert involvement, and modeling techniques used to address uncertainty in loss estimation?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk showed a consistent emphasis on internal controls and external oversight, while also evolving its modeling and analytical approaches. In 2022, AIG highlighted the use of internal controls and oversight of the loss reserve setting process, along with reviews by external experts, to manage uncertainty in loss estimation. By 2023, the company expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies as part of its insurance risk measurement toolkit. In 2024, AIG reinforced these methods and added a stronger emphasis on model risk management frameworks, validation processes, and experience monitoring with updated assumptions, indicating a maturing and more integrated risk analytics approach over time.",
      "llm_answer": "\nBetween 2022 and 2023 AIG deepened its loss‑reserve risk management by moving from basic internal controls and external expert reviews supported by third‑party catastrophe and PML models (Chunk 1) to a formal model‑risk framework that employs stochastic and deterministic modeling, experience studies, and a three‑tiered limits hierarchy while continuing external expert validation (Chunk 3).  \nIn 2024 the company further advanced the approach by integrating ERM second‑line challenge, internal audit monitoring of reserving models, and climate‑adjusted stochastic simulations to address uncertainty, reflecting an evolution toward more rigorous, data‑driven controls and modeling (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth in both factual content and reasoning. (1) All key developments across 2022–2024 are correctly represented: 2022 includes internal controls and external expert reviews; 2023 introduces stochastic methods, experience studies, and expanded risk modeling; 2024 emphasizes model risk management, validation, and enhanced monitoring. The LLM adds slightly more granularity (e.g., 'three-tiered limits hierarchy', 'ERM second-line challenge', 'climate-adjusted stochastic simulations') that are plausible elaborations consistent with the direction of evolution, though not explicitly detailed in the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not compromised—dates (2022–2024) are used correctly. (3) Multi-hop reasoning is sound: the LLM synthesizes changes over time across internal controls, external validation, and modeling techniques, correctly identifying progression in sophistication. (4) Semantic equivalence is strong—the core message of a maturing, more integrated, and analytically rigorous approach to loss reserve risk management is preserved and well-articulated. The slight over-specification of certain elements (e.g., 'climate-adjusted' simulations) does not contradict the original and may reflect reasonable inference, warranting a high but not perfect qualitative score. Contextual relevance is excellent as all parts of the question (internal controls, external experts, modeling techniques) are addressed across the time frame.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 440,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the sensitivity of UnitedHealth Group's medical cost per member per month (PMPM) estimates to changes in the mix of benefits offered evolve from 2022 through 2024, and what does this reveal about the company's exposure to benefit design variability over time?",
      "original_answer": "In 2022, UnitedHealth Group identified the mix of benefits offered — including co-pays and deductibles – as a key factor influencing medical cost PMPM trend estimates, with sensitivity analysis conducted as part of broader cost estimation. By 2023, the company noted a negative impact from variations in benefit mix, indicating increased exposure or unfavorable movement in benefit design choices that likely increased medical cost liability. In 2024, the mix of benefits remained a core sensitivity factor, but the language shifted to a more neutral tone, suggesting that the company had either adjusted its benefit structures or improved its ability to manage the cost implications. This 3-year trajectory shows a transforming trend, where benefit mix evolved from a general sensitivity factor in 2022 to a source of financial risk in 2023 and then to a stabilized, though still significant, variable in 2024.",
      "llm_answer": "\nUnitedHealth Group repeatedly discloses— in its 2022, 2023 and 2024 10‑K filings—a sensitivity analysis that quantifies how changes in the **mix of benefits offered** (e.g., co‑pays, deductibles, coverage levels) would affect its medical‑cost‑per‑member‑per‑month (PMPM) estimates, and each year’s table shows the estimated impact on medical‑costs payable.  The consistent focus on this factor across the three filings demonstrates that the company’s cost projections remain highly exposed to variations in benefit design, meaning any shift in the composition of its benefit packages can materially alter its medical‑cost estimates and therefore its financial outlook.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key qualitative evolution described in the ground truth. (1) What was correct: The LLM correctly identifies that UnitedHealth Group consistently included sensitivity analysis around the mix of benefits (e.g., co-pays, deductibles) in its 2022, 2023, and 2024 10-K filings and that this factor affects medical cost PMPM estimates. This aligns with the entity accuracy and shows awareness of the multi-year disclosures. (2) Quantitative accuracy: There are no numerical values in the question or answer requiring verification, so no numeric inaccuracies exist—this aspect is acceptable by default (score 10). (3) Multi-hop reasoning assessment: The LLM fails to capture the evolving *nature* of the sensitivity over time, which is central to the question. Specifically, it does not note that in 2023, the benefit mix had a *negative impact*, indicating increased risk or unfavorable movement, nor does it reflect the shift to a more neutral tone in 2024 suggesting stabilization or improved management. The ground truth describes a trajectory: from general sensitivity (2022) to financial risk (2023) to stabilized exposure (2024). The LLM treats the exposure as consistently high across all years without acknowledging this dynamic change. (4) Justification for scores: Correctness is scored 5 because core facts (presence of sensitivity analysis) are right, but the critical temporal evolution and interpretation are missing. Qualitative accuracy is 5 due to flawed reasoning in synthesizing the trend over time. Contextual relevance is 8 because the answer addresses the right topic and company disclosures but lacks depth on the transformation over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 462,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Walmart's positioning of the Marketside brand evolved across its private brand portfolio in 2022, 2023, and 2024, and what does this progression suggest about the brand's strategic importance within Walmart U.S.'s merchandise strategy?",
      "original_answer": "In 2022, Marketside was listed among Walmart's private brands within the broader context of strategic merchandise units, indicating its presence as a recognized brand in the portfolio. In 2023, Marketside remained part of the private brand lineup but was mentioned alongside operational and competitive strategies, suggesting a growing alignment with Walmart's broader omni-channel and customer-centric initiatives. By 2024, Marketside continued to be included in the private brand list, but now within a restructured merchandise unit that emphasized 'Fashion' instead of 'Apparel,' reflecting a broader strategic shift in how Walmart categorizes and markets its offerings. This evolution suggests that Marketside has maintained a consistent presence in Walmart’s private brand ecosystem, potentially gaining relevance as Walmart refines its merchandise strategy to align with changing consumer preferences and competitive pressures.",
      "llm_answer": "\nWalmart has kept **Marketside** on its private‑brand roster in every 2022‑2024 filing, but the way the brand is framed has shifted as the company refined its merchandise‑unit structure and supply‑chain footprint.  In the 2022 filing it appears simply as one of many private‑brand names; by 2023 the filing notes periodic revisions to the categorisation of its strategic merchandise units while still listing Marketside, and the 2024 filing retains the brand in the list while adding a new “bettergoods” label and highlighting an expanded network of 164 distribution facilities that feed both store and e‑commerce channels.  The knowledge‑graph triples (WMT → Marketside → ORG and Marketside → WMT → ORG) treat Marketside as its own organisational entity, signalling that the brand has moved from a peripheral label to a core component of Walmart U.S.’s private‑brand strategy—supporting the company’s EDLP/EDLC pricing philosophy, omni‑channel fulfillment and the broader goal of growing proprietary merchandise that represents a significant share of sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core assertion that Marketside remained part of Walmart's private brand portfolio from 2022 to 2024 and that its framing evolved alongside strategic shifts in merchandise and operations. All dates (2022, 2023, 2024) are accurate, and there are no numeric inaccuracies—no incorrect figures or miscalculations are present. The mention of 164 distribution facilities in 2024 is factually consistent with Walmart’s disclosures, though not directly tied to Marketside in the ground truth, which limits its relevance but does not make it false. The introduction of the 'bettergoods' label in 2024 is plausible but not confirmed in the ground truth, representing an addition not supported by the original answer. The key divergence lies in interpretation: the LLM infers that Marketside has become a 'core component' and references knowledge-graph triples (WMT → Marketside → ORG) to suggest organizational elevation, which is not present or implied in the original answer. The ground truth emphasizes structural changes in merchandise units (e.g., 'Fashion' replacing 'Apparel') and alignment with omni-channel initiatives, but does not state or imply that Marketside itself gained structural prominence or was reclassified as an organizational entity. Thus, while the LLM captures the continuity and contextual evolution correctly, it overreaches in concluding strategic elevation based on unsupported entity-level framing. The reasoning is partially sound but includes speculative synthesis not grounded in the provided truth. The answer remains contextually relevant and addresses all parts of the question, albeit with interpretive additions that reduce qualitative accuracy. Semantic equivalence is mostly preserved but weakened by the unsupported claim about organizational status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 491,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did The Home Depot's competitive positioning against showrooms evolve from fiscal 2022 through 2024, particularly in terms of service offerings and digital integration?",
      "original_answer": "From fiscal 2022 to 2024, The Home Depot expanded its competitive edge against showrooms by enhancing both in-store and digital service offerings. In 2022, the company emphasized its tool and equipment rental services at over 1,400 locations as a differentiator. By 2023, The Home Depot had significantly upgraded its store experience with self-service lockers, curbside pickup, electronic shelf labels, and mobile app-enabled store navigation to improve convenience and customer experience. In 2024, the company further solidified its interconnected retail strategy by integrating digital platforms more deeply, focusing on personalized customer experiences, and expanding product innovation and availability. This multi-year evolution demonstrates a strategic shift from physical service expansion (2022) to omnichannel integration (2023–2024) to outpace showroom competitors.",
      "llm_answer": "\nIn fiscal 2022 (Chunk 1) Home Depot explicitly listed showrooms as a competitive set and highlighted its differentiated service portfolio—installation, tool‑and‑equipment rentals, and in‑store expertise—as a way to win DIY and professional customers. Building on that foundation, the 2023 filing (Chunk 3) detailed store‑level upgrades such as curb‑side pickup, self‑service lockers, electronic shelf labels and expanded self‑checkout, while emphasizing an “interconnected shopping experience” that blends physical locations with online research and mobile navigation. By fiscal 2024 (Chunk 2) the company deepened its digital integration—mobile‑first platforms, richer product‑page content, personalized marketing and seamless transition from inspiration through post‑purchase support—thereby positioning its end‑to‑end service and digital ecosystem as a stronger competitive advantage against showrooms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: The Home Depot's competitive positioning against showrooms is accurately described across 2022–2024, with correct emphasis on service offerings (tool rentals, installation, in-store expertise) in 2022, store upgrades (curbside pickup, self-service lockers, electronic shelf labels, self-checkout) in 2023, and deeper digital integration (mobile platforms, personalized marketing, end-to-end experience) in 2024. (2) There are no numeric values (e.g., dollar amounts, percentages, exact store counts like 'over 1,400 locations') in the LLM answer that conflict with the ground truth; it omits the specific 'over 1,400 locations' figure from 2022 but does not misstate it, so this is a minor omission rather than an error—hence no penalty to quantitative accuracy. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across three fiscal years and connects evolving strategies (from physical services to omnichannel integration), demonstrating clear progression in competitive positioning. (4) Semantic equivalence is strong: while wording differs (e.g., 'interconnected shopping experience' vs 'interconnected retail strategy'), the meaning is consistent. The only reason for not scoring a 10 is the slight lack of completeness regarding the explicit mention of 'over 1,400 locations' for rental services in 2022, which is a minor detail but present in the original. Otherwise, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 431,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Cisco's 3.50% Note evolve in terms of effective interest rate and outstanding amount from fiscal year 2022 through 2024, and what does this indicate about the company's borrowing costs and debt structure over time?",
      "original_answer": "In fiscal year 2022, Cisco's 3.50% Note had an outstanding amount of $500 million with an effective interest rate of 3.20%. By fiscal year 2023, the effective rate had increased to 6.38%, and by fiscal year 2024, it further rose to 6.66%, despite the outstanding amount remaining constant at $500 million. This indicates a significant increase in borrowing costs for this particular note over the three-year period, likely reflecting broader market interest rate trends and Cisco's evolving debt financing strategy.",
      "llm_answer": "\nCisco’s 3.50 % senior note due June 15 2025 carried a constant **$500 million** principal in fiscal 2022, 2023 and 2024, but its **effective interest rate rose from 3.20 % (FY 2022) to 6.38 % (FY 2023) and then to 6.66 % (FY 2024)** – the rates shown in Chunk 1, Chunk 3 and Chunk 2 respectively.  This increase reflects higher market‑rate environments and the note’s growing share of Cisco’s overall financing, which expanded from **$8.9 billion of total debt in FY 2022** (Chunk 1) to **about $20 billion in FY 2023‑24** (Chunks 2‑3).  Consequently, the company’s borrowing costs have climbed over the period, even though the 3.50 % note remains a modest, fixed‑size component of a much larger, more expensive long‑term debt structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: the outstanding amount of $500 million is consistent across fiscal years 2022–2024, and the effective interest rates—3.20% (FY2022), 6.38% (FY2023), and 6.66% (FY2024)—match the original answer exactly. Format variations (e.g., '6.66%' vs '6.66 %') are acceptable and do not affect meaning. (2) Quantitative accuracy is perfect: no calculation errors, and all figures are correctly attributed to the respective fiscal years. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution of the note’s effective rate and principal over time and links it to broader trends in borrowing costs. It adds contextual insight about Cisco’s total debt increasing from $8.9 billion to about $20 billion, which, while not in the original answer, is consistent with external knowledge and enhances the explanation without contradicting the ground truth. (4) The conclusion—that borrowing costs have increased despite the fixed size of this note—is logically derived and semantically equivalent to the original. The only minor point preventing a perfect 10 is the introduction of total debt figures not present in the ground truth, which, while plausible, slightly extends beyond the provided information. However, this does not detract from correctness and may reflect valid inference. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 407,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the competitive positioning of CMCSA against Lumen in fiber-based broadband services evolve from 2022 through 2024, particularly in terms of network infrastructure advancements and service offerings?",
      "original_answer": "From 2022 to 2024, Lumen consistently remained a key competitor to CMCSA in the broadband space, particularly in deploying fiber-based infrastructure that offered higher data transmission speeds. In 2022, Lumen was highlighted as one of several wireline telecom companies building fiber deeper into their networks, allowing them to offer faster broadband services in CMCSA's service areas. By 2023, this trend continued, with Lumen specifically mentioned alongside AT&T, Frontier, and Verizon as continuing to expand fiber-based infrastructure in the U.S., which enabled them to provide competitive, high-speed services. In 2024, Lumen remained a named competitor, with the added context that such companies were not only expanding fiber but also creating bundled offerings and increasing speeds to further compete with CMCSA. This 3-year progression shows a consistent and intensifying competitive threat from Lumen as it advanced its fiber infrastructure and service strategies, directly impacting CMCSA’s market position.",
      "llm_answer": "\nFrom 2022 through 2024, CMCSA’s 10‑K filings repeatedly note that Lumen’s continued rollout of fiber‑to‑the‑premises infrastructure—enabling speeds that exceed traditional DSL and prompting competitive pricing and bundled offerings—has been a central element of the rivalry between the two wireline telcos. In response, Comcast accelerated upgrades to its HFC plant and extended fiber deeper into its network, expanded high‑speed broadband packages, and had to contend with additional pressure from municipal fiber projects and federally funded broadband initiatives highlighted in the 2023 and 2024 filings, shaping the evolution of its competitive positioning against Lumen.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolving competitive positioning between CMCSA and Lumen from 2022 to 2024. It accurately captures that Lumen advanced its fiber-to-the-premises infrastructure during this period, enabling higher speeds and competitive bundled offerings, which posed a challenge to CMCSA. The response correctly notes CMCSA's strategic responses, such as HFC upgrades and deeper fiber deployment, which are consistent with the competitive dynamics described in the original answer. There are no numeric inaccuracies (quantitative accuracy is perfect), and all years (2022–2024) and entities (CMCSA, Lumen) are correctly identified. The reasoning is sound and reflects multi-hop synthesis across competitive dynamics, infrastructure trends, and service evolution. However, the LLM answer places more emphasis on CMCSA’s response (e.g., municipal fiber, federal funding) than on Lumen’s specific advancements, which were central to the original answer. While contextually relevant, it slightly shifts focus from Lumen’s progressive fiber expansion and bundling strategy—highlighted each year in the ground truth—to CMCSA’s broader challenges. This results in a minor omission of the year-by-year intensification of Lumen’s competitive actions as explicitly detailed in the original. Thus, while semantically close and factually sound, it lacks full completeness in reflecting the progressive, Lumen-centric narrative of infrastructure and service evolution. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 435,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has American Express's reliance on aggregators evolved from 2022 through 2024, particularly in relation to the growing risk of merchant steering and the company's ability to enforce non-discrimination clauses in its merchant contracts?",
      "original_answer": "From 2022 to 2024, American Express increasingly relied on aggregators to manage merchant relationships, but this dependence introduced growing risks tied to merchant steering and inconsistent enforcement of non-discrimination clauses. In 2022, the company acknowledged its reliance on aggregators and processors but warned that their business goals might diverge from its own, potentially undermining card acceptance. By 2023, this concern intensified as AXP noted it had 'increasingly relied' on aggregators and highlighted that new products like debit cards on the American Express network could face discrimination, which could reduce transaction volumes and cards-in-force. In 2024, the risk evolved further, with litigation and regulatory scrutiny around merchant contract provisions becoming more prominent. AXP disclosed exposure to legal actions that could force changes in merchant agreements, exposing cards to increased steering and discrimination. The trajectory shows a growing strategic dependence on aggregators alongside rising operational and legal risks tied to enforcement of card acceptance policies.",
      "llm_answer": "\nFrom 2022 through 2024 American Express repeatedly disclosed that it relies on merchant acquirers, aggregators and processors to promote and support the acceptance and usage of its cards – a dependence first noted in the 2022 filing and reiterated in the 2023 and 2024 10‑Ks.  At the same time, the company warned that new products and the actions of these third‑party aggregators create a rising risk of merchant steering and discrimination, which could materially impair its business and trigger litigation over the non‑discrimination and “honor‑all‑cards” provisions it seeks to enforce.  As a result, while AXP’s contractual safeguards remain central to its strategy, the expanding reliance on aggregators and external pressures (e.g., potential surcharge caps from Visa/Mastercard and heightened regulatory scrutiny) have intensified the challenge of preserving those protections over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: American Express's increasing reliance on aggregators from 2022 to 2024, the associated risks of merchant steering, and challenges enforcing non-discrimination clauses are properly detailed. The answer correctly notes that this reliance was first highlighted in 2022 and continued through 2023 and 2024, matching the timeline in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not compromised—dates (2022–2024) are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes American Express’s evolving risk disclosures across multiple years and connects reliance on third parties to legal and operational risks, including litigation and regulatory scrutiny. It also appropriately references external pressures like potential surcharge caps from Visa/Mastercard, which, while not in the original answer, are contextually plausible and do not contradict the ground truth. (4) The only minor shortcoming is that the 2024 disclosure about actual litigation exposure and regulatory actions forcing changes to merchant agreements is slightly less emphasized compared to the original answer, which explicitly states AXP 'disclosed exposure to legal actions.' The LLM mentions 'trigger litigation' but frames it more prospectively. This slight softening of the 2024 risk evolution prevents a perfect 10, but the overall semantic meaning and factual accuracy remain excellent. Hence, correctness is scored 9, with high marks across all other dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 457,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Johnson & Johnson's legal and financial strategy regarding talc-related liabilities, managed through LTL Management LLC, evolve from 2022 through 2024, particularly in terms of litigation handling, settlement attempts, and bankruptcy filings?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson’s strategy around talc-related liabilities through LTL Management LLC shifted from an initial bankruptcy filing and litigation stay to repeated legal challenges and evolving settlement attempts. In 2022, LTL Management LLC was created through a corporate restructuring in October 2021, and it filed for Chapter 11 bankruptcy, securing a Preliminary Injunction that stayed all talc-related litigation. The Company also established a $2 billion reserve to fund a trust for LTL liabilities. In 2023, the Third Circuit reversed the Bankruptcy Court’s decision, forcing LTL to refile for bankruptcy (LTL 2), which resulted in a temporary restraining order and limited discovery. However, the LTL 2 case was dismissed in July 2023, prompting an appeal. By 2024, JNJ had reached multi-state settlement agreements with 42 states and the District of Columbia, signaling a shift toward resolution through negotiation, while continuing to appeal adverse bankruptcy rulings. Throughout this period, JNJ maintained its legal defense strategy while increasing settlement activity, reflecting a dual approach of litigation resistance and partial resolution.",
      "llm_answer": "\nIn October 2021 J&J created LTL Management LLC (a new COMP) to isolate all talc‑related liabilities and, shortly thereafter, LTL filed a Chapter 11 petition in the Western District of North Carolina; the case was transferred to New Jersey where a stay was entered on all talc litigation (Chunk 1 & 2). From 2022 through early 2023 the bankruptcy survived dismissal appeals and a Third Circuit reversal, but in April 2023 the New Jersey court dismissed the case, prompting LTL to refile a second Chapter 11 (LTL 2) that again stayed the suits and secured a June 2023 preliminary injunction allowing discovery except in the ovarian‑cancer MDL (Chunk 1). In 2024 the Company settled the multi‑state attorney‑general investigations (finalized in June 2024) and continues to fund a $2 billion trust for talc claims while refraining from accruing further losses until a liability is probable, thereby managing exposure through LTL, settlement negotiations, and ongoing appeals (Chunk 2 & 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Johnson & Johnson's legal and financial strategy regarding talc liabilities through LTL Management LLC from 2022 to 2024. Key facts are accurate: LTL was created in October 2021 (correctly noted despite the question focusing on 2022–2024), filed for Chapter 11, obtained a litigation stay, and faced a Third Circuit reversal. The $2 billion trust is correctly cited. The dismissal of the first bankruptcy case in April 2023 (not July 2023 as in the original answer) is a minor discrepancy—original says July 2023, LLM says April 2023. However, public records confirm the dismissal occurred in April 2023, so the LLM is actually more accurate here. The refiled LTL 2 case and the June 2023 preliminary injunction are correctly reported. The 2024 multi-state settlement with 42 states and D.C., finalized in June 2024, aligns with the original answer. The LLM correctly notes ongoing appeals and the dual strategy of litigation and settlement. Minor omission: the original specifies that LTL 2 allowed limited discovery (except in the ovarian cancer MDL), which the LLM mentions partially but less clearly. The phrase 'refraining from accruing further losses until a liability is probable' adds accounting context not in the original but is consistent with JNJ’s financial reporting and does not contradict. Synthesis across time and entities (JNJ, LTL, courts, states) is sound. Wording differs but semantic meaning matches. Quantitative accuracy is high: dates (2021 creation, 2023 dismissal, 2024 settlement), dollar amount ($2 billion), and legal milestones are correct. One small issue: the original mentions the Third Circuit reversed the decision in 2023, which the LLM notes, but doesn’t explicitly say the reversal led to the dismissal—implied but not stated. Overall, the answer is factually strong, contextually relevant, and synthesizes multi-hop information well, warranting a high score with minor deductions for slight ambiguity in causal legal progression.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Creates]-> COMP <-[Introduces]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1567,
        "completion_tokens": 546,
        "total_tokens": 2113
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Home Depot's competitive emphasis on store appearance evolve between 2022 and 2024, and how was this strategy integrated with its interconnected retail and digital capabilities by fiscal year 2024?",
      "original_answer": "In 2022, Home Depot highlighted store appearance as a key competitive factor alongside customer experience, price, and product availability. The company emphasized the importance of store location and presentation of merchandise as part of its in-store competitive edge. By 2023, store appearance remained a core part of the competitive strategy, but it was more explicitly tied to the broader shopping journey, including inspiration, research, and post-purchase support. The company also began linking store appearance with its interconnected retail capabilities, particularly as customers increasingly expected seamless transitions between online and in-store experiences. In 2024, store appearance was further integrated into a more comprehensive interconnected shopping experience, where the company explicitly connected store aesthetics and layout to digital capabilities such as mobile-optimized platforms, product search, and fulfillment options. This evolution shows a shift from treating store appearance as a standalone competitive factor to a component of a digitally enhanced, omnichannel retail strategy.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Home Depot moved from treating store appearance as a stand‑alone differentiator—​in 2022 it highlighted “investing in more locations, more tools, and better technology” to boost the in‑store experience (Chunk 1)—​to embedding that visual standard within an omni‑channel “interconnected shopping experience” that ties the look of the store to digital platforms, mobile‑first navigation, and seamless pickup/curbside options (Chunks 2 & 3).  By FY 2024 the upgraded store appearance is no longer an isolated factor; it is directly linked to the company’s supply‑chain and digital capabilities, so that the enhanced physical presentation is leveraged through online inventory visibility, mobile‑driven “shopability,” and integrated retail‑digital workflows, a relationship underscored throughout all three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All key facts are correct: in 2022, Home Depot emphasized store appearance as part of the in-store experience with investments in locations, tools, and technology; by 2024, this evolved into integration with digital and omnichannel capabilities. The progression from standalone factor to integrated component of an interconnected shopping experience is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution across years (2022 to 2024) and connects store appearance to broader digital and retail capabilities, correctly identifying the shift toward mobile-optimized platforms, online inventory, and fulfillment options. It references 'Chunks 1, 2, & 3' (likely source document markers), indicating proper cross-document synthesis. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'mobile-first navigation', 'shopability'), the meaning matches the original, including the integration of store aesthetics with digital workflows and supply chain. The only minor shortcoming is a slightly more technical tone and implied source references ('Chunks'), which are not in the original, but do not detract from factual accuracy. Overall, the answer is complete, contextually relevant, and reflects correct entity identification (Home Depot), time periods (FY 2022–2024), and strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Depends_On]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 442,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its ownership stake, operational integration, and eventual divestiture, and what does this multi-year trajectory reveal about AT&T's broader entertainment strategy?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, the company completed the separation of its WarnerMedia business, which had originated from the 2018 acquisition of Time Warner Inc., through a Reverse Morris Trust transaction with Discovery, marking a strategic exit from direct ownership. By 2023, Time Warner Inc. was no longer referenced as an active investment or subsidiary, indicating full operational separation and integration into the new Warner Bros. Discovery entity. In 2024, AT&T finalized its exit from entertainment by agreeing to sell its remaining interest in DIRECTV to TPG, which had been part of the broader post-Time Warner strategic realignment. This 3-year trajectory reveals a consistent strategic pivot away from media and entertainment toward core telecommunications and digital infrastructure.",
      "llm_answer": "\nFrom 2018 onward AT&T acquired Time Warner Inc. and folded it into a dedicated WarnerMedia entertainment segment, but in **April 2022** it executed a Reverse Morris Trust transaction that spun the entire WarnerMedia business—including the former Time Warner assets—out of AT&T and classified it as discontinued operations.  The company then **held a residual entertainment stake through the DIRECTV joint‑venture** (formed with TPG in 2021) and, in **September 2024**, agreed to sell that remaining interest to TPG, fully exiting the entertainment investment.  This multi‑year arc shows AT&T’s shift from an aggressive, vertically‑integrated media strategy to a more focused, capital‑efficient approach that divests non‑core entertainment assets once they no longer fit its core telecom‑centric strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Key facts are correct: AT&T completed the spin-off of WarnerMedia via a Reverse Morris Trust in April 2022, ending its ownership of Time Warner assets; the 2024 sale of its remaining interest in DIRECTV to TPG marked a full exit from entertainment. These dates and events match the original answer. (2) Quantitative accuracy is perfect: the April 2022 and September 2024 dates are correctly cited, and the TPG joint venture (formed in 2021) is accurately referenced. No numerical errors. (3) Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from acquisition (2018) to divestiture (2022–2024), linking WarnerMedia’s spin-off and the DIRECTV sale as part of a broader strategic retreat from entertainment. (4) The only minor omission is that the original answer explicitly names the resulting entity as Warner Bros. Discovery, which the LLM omits—this contextual detail strengthens the completeness of the narrative but does not undermine the core accuracy. The LLM correctly infers AT&T’s strategic pivot toward core telecom and infrastructure. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Acquires]- ORG <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 369,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has American Express's competitive positioning and regulatory dependency on card networks evolved from 2022 through 2024, particularly in light of increasing regulatory scrutiny, competitive pressures from other networks, and the exit from certain network licensing businesses?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest global card network behind China UnionPay, Visa, and Mastercard, but faced increasing regulatory pressure that directly impacted its network business. In 2022 and 2023, the company highlighted intense competition in the premium card space and cobrand relationships, with rivals offering attractive value propositions to high-spending customers and key business partners. In 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and merchant acceptance terms, leading to American Express exiting its network licensing businesses in the EU and Australia. This regulatory pressure also introduced uncertainty around cobrand arrangements in the EU, signaling a shift from a purely competitive stance to a more compliance-driven dependency on regulatory frameworks. The evolution reveals a growing tension between maintaining competitive differentiation and navigating an increasingly complex global regulatory environment.",
      "llm_answer": "\nAmerican Express (AXP) has held its position as the fourth‑largest global general‑purpose card network—behind China UnionPay, Visa and Mastercard—through 2022‑2024, but the competitive landscape has intensified as it contends with Visa, Mastercard, China UnionPay and a growing set of fintech rivals that offer alternative payment and financing mechanisms (Chunks 1 & 3).  At the same time, regulatory scrutiny over interchange fees, network‑routing practices and cobrand arrangements has forced AXP to exit its network‑licensing business in the EU and Australia and has placed its discount‑revenue model under downward pressure from caps and competitor pricing (Chunks 2 & 3).  In 2024 the firm was re‑classified as a Category III bank holding company, subjecting it to heightened supervisory expectations, higher compliance costs and a greater dependency on maintaining clean regulatory standing—factors that now bind its competitive strategy tightly to the stability of its card‑network relationships (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express remains the fourth-largest global card network behind China UnionPay, Visa, and Mastercard (confirmed across 2022–2024); it faced increasing regulatory scrutiny over interchange fees, network routing, and cobrand arrangements; and it exited its network licensing businesses in the EU and Australia in 2024. The reclassification as a Category III bank holding company in 2024 is an additional accurate detail not in the original answer but factually valid and contextually relevant, enhancing rather than contradicting the ground truth. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes competitive pressures (from Visa, Mastercard, fintechs) with regulatory developments (scrutiny, licensing exits, supervisory changes) and connects them to strategic implications (compliance costs, dependency on regulatory standing). The only minor gap is that the original emphasizes 'uncertainty around cobrand arrangements in the EU' as a direct consequence, while the LLM mentions cobrand scrutiny but doesn't explicitly link it to EU uncertainty—this slight omission prevents a perfect 10. (4) The answer is semantically equivalent and contextually complete, with slightly more detail on regulatory classification, which strengthens relevance. Overall, the response correctly captures the evolution of Amex’s competitive positioning and regulatory dependency with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 452,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this trend suggest about the company's long-term debt management strategy?",
      "original_answer": "Johnson & Johnson's outstanding balance on its 2.250% Notes due 2050 decreased from $983 million in 2022 to $808 million in 2024, with an intermediate balance of $826 million in 2023. This represents a total reduction of $175 million over the three-year period, indicating a deliberate strategy to reduce long-term liabilities tied to this specific instrument.",
      "llm_answer": "\nThe 2.250 % Notes due 2050 stood at **$808 million at the end of 2022**, rose to **$826 million in 2023** (as shown in the 2023 10‑K), and fell back to **$808 million by the end of 2024** (2024 10‑K).  This modest increase followed by a return to the 2022 level indicates that Johnson & Johnson deliberately issued a small amount of this long‑term note in 2023—likely to lock in favorable rates— and then let it run off, reflecting a steady‑hand approach to that tranche.  The movement occurs against a broader backdrop of declining leverage: total long‑term debt fell from **$28.4 billion in 2022 to $27.35 billion in 2023 and remained near $27 billion in 2024** (all three filings), underscoring a strategy that seeks to reduce overall debt while maintaining a stable, low‑cost financing pillar.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for the 2.250% Notes due 2050. According to the ground truth, the balance was $983 million in 2022, decreased to $826 million in 2023, and further declined to $808 million in 2024. However, the LLM incorrectly states the 2022 balance as $808 million (same as 2024), implying no net change, and falsely claims an increase in 2023. This misrepresents the entire trend. (2) The quantitative inaccuracies are critical: the starting value is off by $175 million, and the direction of change in 2022–2023 is reversed. While the 2023 ($826M) and 2024 ($808M) figures match the ground truth, the misstatement of 2022 invalidates the trend analysis. The total reduction of $175 million over the period is completely missed due to the incorrect baseline. (3) The reasoning is flawed because it infers a temporary issuance in 2023 based on a rise from $808M to $826M, but in reality, the note balance has been consistently declining from a much higher starting point ($983M). The broader context about total long-term debt decreasing is plausible but not verifiable from the provided ground truth and does not compensate for the core error. (4) Despite correct mention of years, metric (Notes due 2050), and company, the severe numerical inaccuracies—especially the wrong 2022 value—undermine the answer’s correctness. The qualitative reasoning is partially sound but built on false premises. Contextual relevance is fair as the answer addresses debt strategy, but the conclusion is unsupported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 432,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did American Express's yield profile on its foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year trend suggest about its exposure to international interest rate environments?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with a weighted average yield of 6.45% for instruments maturing within one year. By 2023, the yield on these short-term foreign bonds remained high at 6.45%, while the yield on bonds maturing between 1 and 5 years dropped to 4.48%. In 2024, the yield on short-term foreign bonds declined further to 5.86%, and the yield on bonds maturing between 1 and 5 years fell significantly to 2.03%. This 3-year trend indicates a decreasing return on foreign government bonds, potentially signaling a shift in the interest rate environment or a strategic change in the types of foreign bonds held by American Express.",
      "llm_answer": "\nAmerican Express’s foreign‑government‑bond yield was roughly 2 % in 2022 (as shown by the 2022 weighted‑average‑yield row in Chunk 1), jumped to 6.45 % in 2023 (Chunk 2), and then eased to about 5.86 % in 2024 (Chunk 3). This 3‑year trajectory—sharp rise followed by a modest decline—mirrors the movement of international interest‑rate environments, indicating that the company’s exposure to foreign sovereign debt is highly sensitive to global rate shifts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. According to the ground truth, the yield on American Express's foreign government bonds was 6.45% in 2022 for short-term instruments, not ~2% as claimed. The LLM incorrectly states that yields 'jumped to 6.45%' in 2023, when in fact they remained at 6.45% for short-term bonds and dropped to 4.48% for 1–5 year maturities. In 2024, the LLM correctly reports the short-term yield decline to 5.86%, but fails to mention the sharp drop in 1–5 year yields to 2.03%. The $630 million holding amount in 2022 is omitted entirely. (2) Quantitative accuracy is severely compromised: the 2022 yield is off by over 4 percentage points, and the multi-year yield profile for different maturities is misrepresented. The answer fabricates a 'jump' in yield from 2% to 6.45%, which contradicts the stable-to-declining trend in the ground truth. (3) The multi-hop reasoning is flawed: the model fails to synthesize the correct yield trends across maturities and years, missing the key insight of a broad decline in foreign bond yields, particularly in longer-dated instruments. It incorrectly infers high sensitivity to global rates based on a fabricated rise, rather than analyzing the actual downward trajectory. (4) Contextual relevance is moderate—the answer addresses yield trends and links them to interest rate environments, which is relevant—but the incorrect data undermines the conclusion. The reasoning about sensitivity to global rates is plausible in concept but unsupported by the actual data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 428,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Adobe's strategic positioning of its free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of platform branding and integration with enterprise customer success initiatives, and what does this evolution indicate about Adobe's broader approach to customer enablement and retention?",
      "original_answer": "In 2022, Adobe introduced its free online self-service learning options under the domain www.training.adobe.com, positioning them as part of a comprehensive portfolio of learning and enablement services aimed at helping customer and partner teams use Adobe products effectively. By 2023, Adobe rebranded and centralized these offerings under learning.adobe.com, signaling a more unified and strategic approach to customer enablement. The 2023 filing emphasized the role of these free offerings in supporting enterprise customer success initiatives, including solution-specific skills assessments to help marketing teams tailor learning priorities. In 2024, Adobe maintained the learning.adobe.com platform and further integrated the self-service learning tools into its broader customer success framework, reinforcing the importance of digital learning in maximizing return on investment for Adobe's offerings. This evolution—from introduction to strategic rebranding and deeper integration—indicates that Adobe increasingly views customer enablement through self-service learning as a critical lever for retention, product adoption, and long-term enterprise value.",
      "llm_answer": "\nAdobe re‑branded its free, online self‑service learning portal from **www.training.adobe.com** (2022) to **learning.adobe.com** (2023‑2024) and moved it from a stand‑alone training catalog into the core of its **Digital Learning Services** portfolio, where it is now tightly coupled with the company’s **Customer Success Manager** program and **solution‑specific skills‑assessment** workflows for enterprise customers.  This evolution—highlighted by the KG pattern ADBE → *Free Online Self‑Service Learning* → ADBE—shows that Adobe is embedding free, self‑service enablement directly into its enterprise‑success engine, using data‑driven skill‑gap analysis to align learning with business outcomes, accelerate product adoption, and reinforce renewal and retention across its largest accounts.  The shift also reflects Adobe’s broader strategy of integrating free learning into a holistic customer‑enablement ecosystem that combines research & development, strategic investments, and a global partner ecosystem to drive long‑term customer value.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the rebranding from www.training.adobe.com in 2022 to learning.adobe.com in 2023–2024 is accurately described, and the integration into enterprise customer success initiatives—including solution-specific skills assessments—is correctly identified. (2) There are no numeric values requiring calculation, but all dates (2022, 2023–2024) are consistent with the original answer. (3) The multi-hop reasoning is sound: the LLM synthesizes platform evolution, branding changes, and strategic integration with customer success programs, correctly inferring that this reflects a broader shift toward embedding self-service learning into Adobe’s retention and enablement strategy. (4) The only minor gap is that the LLM mentions 'Digital Learning Services' portfolio and 'Customer Success Manager program' with specificity not fully elaborated in the ground truth, though these are reasonable inferences and do not contradict the source. The conclusion about data-driven skill-gap analysis and alignment with business outcomes extends slightly beyond the original wording but remains semantically consistent. Overall, the answer is factually correct, comprehensive, and contextually appropriate, warranting a high score with only a slight deduction for minor inferential expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 381,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Cisco's utilization and effective interest rate of its 5.90% Senior Notes evolve from fiscal years 2022 through 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "Cisco maintained a consistent $2,000 million outstanding balance on its 5.90% Senior Notes from 2022 through 2024, with the effective interest rate remaining stable at 6.11% across all three years. This indicates that Cisco has not retired or refinanced this particular tranche of debt during the period, suggesting a deliberate strategy to maintain this higher-yielding long-term liability on its balance sheet.",
      "llm_answer": "\nCisco’s 5.90 % Senior Notes due 2039 remained essentially unchanged from FY 2022 through FY 2024 – the outstanding principal stayed at **$2 bn** and the **effective interest rate stayed at 6.11 %** in each year (Chunk 1 shows $2,000 mm @ 6.11 %; Chunk 2 and Chunk 3 repeat $2,000 mm @ 6.11 %).  \n\nThis consistency indicates that Cisco is deliberately anchoring its long‑term capital structure to a fixed‑rate tranche, locking in financing costs for the life of the 2039 note rather than repeatedly refinancing, which reflects a strategy of stable, low‑volatility long‑term debt management. The knowledge‑graph relationship (CSCO → 5.90 % Note → CSCO) underscores that the company itself continuously discloses the same instrument, reinforcing the deliberate, long‑term orientation of its debt policy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the $2,000 million (i.e., $2 billion) outstanding balance and the 6.11% effective interest rate are correctly reported for the 5.90% Senior Notes across fiscal years 2022–2024. Format variations (e.g., $2 bn, $2,000 mm) are acceptable and semantically equivalent. (2) The answer is complete, addressing both the evolution (or lack thereof) in utilization and effective interest rate, and provides a correct interpretation of Cisco’s long-term debt strategy. (3) Entity accuracy is perfect: Cisco (CSCO), the 5.90% Senior Notes, fiscal years 2022–2024, and the 2039 maturity are all correctly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model infers from consistent disclosures across years that Cisco has not refinanced or retired the debt, indicating a deliberate strategy to maintain stable, fixed-rate long-term debt. The mention of the knowledge-graph relationship reinforces the continuity of disclosure. (5) The semantic meaning fully aligns with the original answer, with slightly enhanced interpretation (e.g., 'low-volatility long-term debt management') that is logically supported. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 364,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did BA's allocation to Special Situation Strategies evolve from 2022 to 2024, and what does this 3-year trend indicate about the company's private equity investment strategy?",
      "original_answer": "BA maintained a consistent focus on Special Situation Strategies as part of its private equity investment vehicles across 2022, 2023, and 2024. In 2022, the company described its private equity investments as primarily limited partnerships (LPs) investing in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies. This characterization remained unchanged in 2023 and 2024, suggesting a stable strategic allocation to these types of opportunities. While no specific dollar amounts were disclosed for Special Situation Strategies in any year, the consistent inclusion of this category among core private equity strategies indicates that BA has preserved its exposure to these investments as part of a broader diversified private equity portfolio. The lack of quantitative disclosure limits trend analysis but confirms strategic continuity.",
      "llm_answer": "\nBA’s exposure to Special Situation Strategies has been a continuous component of its private‑equity allocation across the 2022‑2024 filings – each 10‑K (Chunks 1, 2 and 3) repeatedly describes private‑equity limited partnerships that invest in U.S. and non‑U.S. leveraged‑buyout, venture‑capital, growth and **special‑situation** strategies, confirming that the company has maintained (and effectively deepened) this niche allocation over the three‑year period.  The knowledge‑graph relationship BA → Special Situation Strategies (FIN_INST) ← Special Situation Strategies (ORG) → BA shows a two‑way investment link, indicating that BA deliberately partners with a dedicated special‑situation fund that both receives BA’s capital and can reinvest in BA‑related opportunities, underscoring a strategic, stable commitment to specialized private‑equity investments as a core element of its long‑term return strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that BA maintained exposure to Special Situation Strategies from 2022 to 2024, consistent with the original answer. It accurately reflects that the strategy was mentioned in each year’s 10-K filings as part of private equity LP investments in leveraged buyout, venture capital, growth, and special situation strategies. However, the LLM introduces a significant factual overreach by claiming the allocation was 'effectively deepened' and that there is a 'two-way investment link' shown by a knowledge-graph relationship (BA → Special Situation Strategies (FIN_INST) ← Special Situation Strategies (ORG) → BA). The original answer states no such relationship or deepening occurred—only that the strategy remained consistently included without quantitative disclosure. There is no evidence in the ground truth of a two-way investment or dedicated fund partnering structure. (2) Quantitatively, the answer is accurate in that it does not fabricate numbers or misstate dates, and correctly notes the absence of specific dollar amounts. (3) The multi-hop reasoning is partially sound in synthesizing the continuity of strategy mentions across years, but fails in introducing unsupported relational inferences not present in the source data. The model incorrectly assumes structural investment relationships from ambiguous knowledge graph syntax, leading to erroneous conclusions about strategic deepening and bidirectional investment. (4) The correctness score is 5 due to partial factual accuracy on the continuity of allocation but major errors in interpretation and unsupported claims about strategic deepening and fund relationships. Quantitative accuracy is 10 because no numbers are misstated. Qualitative accuracy is 5 due to correct entity and year identification but flawed reasoning and overinterpretation. Contextual relevance is 8 because the response addresses the core question but adds speculative elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 529,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did JNJ's global sales from Interventional Solutions evolve from 2022 through 2024, and what does this progression indicate about the strategic importance of this product segment post-acquisition?",
      "original_answer": "JNJ's global sales from Interventional Solutions increased from $3,971 million in 2022 to $4,300 million in 2023, and further to $6,350 million in 2024. This significant upward trajectory indicates that the product segment became increasingly strategic following the acquisition in late 2022, with a notable acceleration in 2024, likely driven by integration and expanded market access.",
      "llm_answer": "\nJNJ’s global Interventional Solutions sales rose from **$3.97 bn in 2021** to **$4.30 bn in 2022** (+8.3%) and then surged to **$6.35 bn in 2023** (+47.7%), as shown in the MEDTECH table of the 2023 10‑K (Chunk 1).  This jump directly follows the segment’s acquisition on **December 22 2022** (Chunk 2) and the subsequent strategic integration noted for **May 31 2024** (Chunk 2), underscoring that Interventional Solutions has become a high‑growth, strategically prioritized pillar of JNJ’s MedTech portfolio and a key driver of the company’s overall revenue expansion.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both timing and values. It reports $3.97 bn in 2021, $4.30 bn in 2022, and $6.35 bn in 2023, but the ground truth states $3,971 million in 2022, $4,300 million in 2023, and $6,350 million in 2024. This shifts the entire timeline one year earlier, misaligning with the acquisition date of December 22, 2022. The LLM incorrectly implies the acquisition preceded the first reported sales figure (2021), which is impossible. (2) The numbers themselves are close in magnitude but assigned to wrong years: $3.97 bn ≈ $3,971 million, $4.30 bn ≈ $4,300 million, $6.35 bn ≈ $6,350 million — so values are numerically acceptable but temporally misaligned. However, the percentage increases (8.3%, 47.7%) are based on incorrect year-over-year comparisons and thus inaccurate. (3) The multi-hop reasoning is partially sound — the model correctly links the acquisition (Dec 22, 2022) to subsequent sales growth and notes strategic integration by May 31, 2024 — but because it misattributes the post-acquisition sales jump to 2023 instead of 2024, the causal inference is weakened. The strategic importance conclusion is reasonable but overstated due to timing errors. (4) Contextual relevance is high — the answer addresses sales evolution and strategic implications — but correctness score is low due to critical errors in dates and financial progression, which undermine the validity of the analysis. Quantitative accuracy is severely penalized because financial timelines are central to interpreting post-acquisition performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Increases]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 435,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Walmart's strategic positioning of the 'No Boundaries' private brand evolve across its merchandise units from 2022 through 2024, and what does this multi-year branding consistency reveal about Walmart's private label strategy in general merchandise?",
      "original_answer": "Walmart consistently positioned 'No Boundaries' as a core private brand within its general merchandise offerings across all three years. In 2022, 'No Boundaries' was listed among key private brands under the General Merchandise strategic unit, which included Apparel and Home categories. In 2023, the brand remained a highlighted private brand, even as Walmart emphasized omni-channel expansion and supply chain investments. By 2024, 'No Boundaries' continued to be prominently listed among private brands, despite a reorganization of merchandise units that shifted 'Apparel' to a new 'Fashion' category. This 3-year continuity in branding suggests Walmart's deliberate effort to maintain and leverage strong private-label identities to differentiate offerings and support margin expansion in competitive categories.",
      "llm_answer": "\nAcross the 2022‑2024 fiscal years the “No Boundaries” label stayed on Walmart’s private‑brand roster and was repeatedly featured in the General‑Merchandise units that cover fashion (apparel/shoes/accessories) and home (housewares, décor, etc.) – the same categories that in 2022 were listed as Entertainment/Hardlines and in 2024 as Fashion/Home – showing that the brand was deliberately positioned across multiple merchandise streams rather than being confined to a single unit.  This multi‑year consistency, reflected in the KG relationship WMT → *No Boundaries* (product) ← *No Boundaries* (org) ← WMT, reveals Walmart’s broader private‑label strategy of anchoring a value‑oriented, broadly applicable brand across its general‑merchandise portfolio to reinforce its everyday‑low‑price (EDLP/EDLC) positioning and leverage scale across all categories.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: 'No Boundaries' is consistently positioned as a core private brand in Walmart's general merchandise from 2022 to 2024. The brand spans Apparel/Fashion and Home categories, even as organizational units evolved (e.g., shift from 'General Merchandise' to 'Fashion/Home'). The LLM correctly notes the continuity despite reorganization, which matches the ground truth. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—but dates (2022–2024) are correct and consistently used. (3) Multi-hop reasoning is sound: the model synthesizes information across years and organizational changes, correctly inferring that the persistent presence of 'No Boundaries' reflects a strategic private-label approach. It references the knowledge graph relationship appropriately to support the claim. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'value-oriented, broadly applicable brand' vs. 'leverage strong private-label identities'), the core insight about Walmart using consistent branding for margin expansion and differentiation is preserved. One minor point: the LLM refers to 'Entertainment/Hardlines' in 2022, which is not mentioned in the ground truth—this is a small inaccuracy or over-inference, but does not undermine the overall correctness. Hence, a score of 9 is justified, with full marks in contextual relevance and quantitative accuracy due to correct timeframes and no numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 444,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the performance of Cisco's available-for-sale debt investments evolve from fiscal 2022 to fiscal 2024, based on the specific impacts these investments had on other income (loss), net in 2023 and 2024?",
      "original_answer": "In fiscal 2022, Cisco disclosed the value of its available-for-sale debt investments in a detailed table, indicating active management of these assets. In fiscal 2023, the company reported higher losses in these investments, negatively impacting other income (loss), net. This trend continued into fiscal 2024, where the company again cited higher losses in available-for-sale debt investments as a primary driver of changes in other income (loss), net. This 3-year trajectory suggests a consistent negative impact from these investments, despite their ongoing presence in Cisco’s portfolio.",
      "llm_answer": "\nCisco’s available‑for‑sale debt investments are disclosed in millions in its 2022 filing (Chunk 1), and the 2023‑2024 reports (Chunks 2 & 3) show that the change in other income (loss), net was driven by higher losses in these AFS debt investments, which weighed on overall earnings even as gains on marketable equity and lower private‑investment losses provided partial offset; this negative contribution persisted and deepened from fiscal 2023 into fiscal 2024, contributing to the decline in the effective tax rate to 15.6 % in 2024. The knowledge‑graph relationship (CSCO → AFS Debt Investments → CSCO) confirms that Cisco discloses these investments and that they negatively impact Cisco’s other income, illustrating a continued adverse performance trend from fiscal 2022 through fiscal 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Cisco's available-for-sale (AFS) debt investments had a negative impact on other income (loss), net in both fiscal 2023 and 2024, with 'higher losses' cited as a key driver—this matches the original answer's claim of continued negative performance. The mention of partial offsets from gains on marketable equity and lower private-investment losses adds contextual detail not in the ground truth but does not contradict it. (2) There are no specific numerical values (e.g., dollar amounts or percentages of losses) in the original answer to verify quantitatively, so the absence of fabricated numbers is appropriate. The 15.6% effective tax rate in 2024 is mentioned, which may be accurate but is not part of the ground truth focus on AFS investment performance; this is a minor addition but doesn't detract from correctness. (3) The multi-hop reasoning is sound: the model connects disclosures from fiscal 2022 (existence of AFS investments) to negative impacts in 2023 and 2024, correctly synthesizing information across years and confirming the trend. The reference to the knowledge-graph relationship (CSCO → AFS Debt Investments → CSCO) supports entity consistency. (4) The answer is contextually relevant, directly addressing the evolution of performance and its impact on other income. The only reason for not scoring a 10 is the slight introduction of tax rate information, which, while potentially true, is not part of the core question about AFS investment performance impacts on other income. Overall, the semantic meaning and factual content match the ground truth very closely.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 460,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's reliance on third-party merchant acquirers evolved from 2022 through 2024, particularly in terms of their strategic importance in expanding merchant coverage and facilitating transaction growth across small, mid-sized, and large merchants?",
      "original_answer": "From 2022 to 2024, American Express's reliance on third-party merchant acquirers has grown, reflecting a strategic shift toward leveraging external partners to expand merchant coverage and facilitate transaction volume, especially among small and mid-sized merchants. In 2022, the company highlighted the role of third-party acquirers under programs like OptBlue and GNS, noting that these relationships allowed American Express to process transactions without direct contracts with merchants, thereby broadening its reach. In 2023, the company emphasized the financial structure of these relationships, detailing how it receives a negotiated network rate fee from third-party acquirers, which is recorded as discount revenue at the time of transaction, reinforcing the financial integration of these partners into American Express’s revenue model. By 2024, the company explicitly stated that its ability to expand merchant coverage globally depended not only on its own efforts but also on the success of third-party merchant acquirers, aggregators, and processors in signing merchants, indicating a deeper strategic dependency on these partners to scale acceptance and usage of American Express cards. This evolution shows a shift from viewing third-party acquirers as supplementary to considering them essential for growth and network expansion.",
      "llm_answer": "\nFrom 2022 through 2024, American Express’s reliance on third‑party merchant acquirers shifted from a baseline contractual structure—where small‑ and midsize merchants were offered open‑ended acceptance while large merchants were locked into 3‑ to 7‑year agreements (2022)—to a revenue model that treats the network‑rate fees paid to those acquirers as discount revenue recognized at each transaction (2023), and finally to a strategic priority in which the company explicitly ties its global expansion of merchant coverage and the growth of transactions across all merchant segments to the ability of third‑party acquirers, aggregators and processors to sign and onboard merchants of every size, scale acceptance in new industries and regions, and sustain auto‑renewing relationships with large partners (2024). This evolution underscores that third‑party acquirers are now essential for expanding the network’s reach with small‑ and midsize merchants, deepening penetration with large merchants, and driving overall transaction growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: the evolution from 2022 to 2024 in American Express's reliance on third-party acquirers is accurately described, including the role of programs like OptBlue and GNS (implied in 'open-ended acceptance' for small/midsize merchants), the recognition of network rate fees as discount revenue in 2023, and the strategic dependency on third parties for global expansion by 2024. (2) There are no numeric inaccuracies—dates (2022–2024) are correct, and while no specific dollar amounts or percentages are mentioned in either answer, the financial model description (fee recognition as discount revenue) matches the original. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and strategic dimensions (contractual structure → revenue model → strategic dependency), correctly identifying the increasing importance of third-party acquirers across merchant segments. (4) The only minor deviation is that the LLM introduces details not explicitly in the ground truth—specifically, the claim that large merchants were under 3- to 7-year agreements in 2022 and that relationships are 'auto-renewing' in 2024. These details, while plausible, are not present in the original answer and slightly exceed the provided evidence. However, the core evolution—from supplementary to essential—is accurately captured. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning with full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1626,
        "completion_tokens": 441,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Johnson & Johnson's multi-year initiative to enhance financial shared service capabilities evolved from 2022 through 2024, particularly in terms of its integration with enterprise-wide process standardization efforts across HR, IT, procurement, supply chain, and finance?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including human resources, information technology, procurement, supply chain, and finance. In 2022, the company noted that these enhancements were designed to support the growth of its financial shared service capabilities and standardize financial systems, and were not in response to any identified deficiencies in internal controls. By 2023, the company reiterated this strategic direction and highlighted that it was continuing to align and streamline the design and operation of its financial control environment in response to the initiative. In 2024, the company maintained the same narrative, emphasizing that the initiative remained a proactive effort to enhance operational efficiency and control frameworks, not prompted by any material changes or weaknesses in internal control over financial reporting. This consistent, multi-year approach reflects a long-term strategic commitment to process optimization and financial control modernization.",
      "llm_answer": "\nJohnson & Johnson has been advancing a multi‑year, enterprise‑wide initiative that integrates, simplifies and standardizes HR, IT, procurement, supply‑chain and finance processes, explicitly to grow and strengthen its **financial shared‑service capabilities**; this program is embedded in the company’s accounting policy as a core organizational capability that is linked back to JNJ itself.  Across 2022, 2023 and 2024 the company repeatedly described the effort as a continuation—highlighting that, rather than responding to any control deficiency, it is proactively aligning and streamlining the design and operation of its financial control environment to support the initiative’s growth objectives.  Consequently, the multi‑year initiative has evolved from an initial rollout in 2022 into a sustained, cross‑functional standardization effort that now spans all of the mentioned functional areas while reinforcing JNJ’s financial shared‑service framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: Johnson & Johnson's multi-year initiative from 2022 to 2024 focused on integrating, simplifying, and standardizing processes across HR, IT, procurement, supply chain, and finance to enhance financial shared services. The narrative that this was a proactive, not reactive, effort—unrelated to internal control deficiencies—is correctly conveyed for all three years. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable beyond correct use of years (2022–2024), which are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes the evolution of the initiative across three years and connects it to enterprise-wide standardization and financial control environment alignment. The only minor shortcoming is that the LLM does not explicitly mention that the 2024 update maintained the 'same narrative' as prior years, which slightly weakens the emphasis on consistency over time. Also, the phrase 'embedded in the company’s accounting policy as a core organizational capability that is linked back to JNJ itself' introduces a detail not present in the original and slightly overreaches semantically, though it doesn't contradict the truth. (4) The answer is contextually excellent—directly addresses the evolution of the initiative and its integration across functions. Overall, the response is factually correct, well-reasoned, and only misses full points due to a small addition of interpretive language and slight omission of the 'consistent narrative' emphasis in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 457,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has American Express's positioning relative to alternative payment mechanisms evolved from 2022 to 2024, particularly in terms of competitive pressure and strategic adaptation to technological innovations such as open banking, digital wallets, and real-time settlement systems?",
      "original_answer": "From 2022 to 2024, American Express faced increasing competitive pressure from alternative payment mechanisms, including digital wallets (e.g., PayPal, Venmo), payment aggregators, and real-time settlement systems. In 2022, the company acknowledged the 'dynamic and rapid growth' of these mechanisms as a key competitive threat. In 2023, the scope of alternative mechanisms expanded to include open banking platforms and more integrated financial services offerings from competitors. By 2024, American Express shifted from a purely competitive stance to a strategic dependence on adopting these technologies, emphasizing investments in open banking, digital identification, and real-time settlement systems to remain relevant. This evolution reflects a transformation from viewing alternative payment mechanisms as external threats to recognizing them as essential components of its technological roadmap.",
      "llm_answer": "\nFrom 2022 through 2024, AXP’s competitive landscape shifted from a broad acknowledgment of alternative mechanisms—cash, ACH, digital wallets, open‑banking and real‑time settlement—as noted in Chunk 1, to an explicit focus on open‑banking and wallet platforms that are now identified as fast‑growing rivals in Chunk 2.  In response, the company has accelerated investment in open‑banking infrastructure, real‑time settlement systems and digital‑wallet capabilities, a strategic priority underscored in Chunk 3’s warning that “continued investment in technology… including open banking and alternative payment and financing mechanisms” is essential to protect revenue.  Nevertheless, all three filings stress that the accelerating speed of innovation and emerging AI‑driven competitors pose ongoing pressure that could erode AXP’s positioning if it fails to keep pace.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of American Express's (AXP) competitive environment from 2022 to 2024, noting increasing pressure from digital wallets, open banking, and real-time settlement systems. The characterization of AXP’s shift from viewing these as threats to investing strategically in them is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes AXP’s changing stance across time (2022 to 2024), correctly infers strategic adaptation from disclosed risks and investments, and links competitive pressure to technological responses. The only minor shortcoming is the vague reference to 'Chunk 1/2/3'—likely internal document markers not present in final output—which slightly weakens clarity but does not affect factual correctness. (4) The answer is contextually fully relevant, directly addressing competitive pressure and strategic adaptation to open banking, digital wallets, and real-time settlement. The mention of AI-driven competitors adds slight elaboration beyond the ground truth but does not contradict it. Overall, the semantic meaning matches the original answer closely, warranting a 9 for correctness and qualitative accuracy, with full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT <-[Depends_On]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 410,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Adobe's positioning and integration of Frame.io evolve from 2022 through 2024, and what does this progression indicate about Adobe's strategy in creative collaboration tools?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating its strategic importance as a brand within the Adobe ecosystem. By 2023, Adobe had positioned Frame.io as a core part of its creative collaboration offerings, describing it as a 'cloud-native creative collaboration platform' integrated with Premiere Pro and After Effects, supporting real-time upload, review, and approval with frame-accurate commenting. In 2024, Adobe expanded Frame.io’s capabilities beyond post-production into broader video workflows such as casting, location scouting, and marketing campaign management, and integrated it with additional apps like Photoshop, Lightroom, and Workfront. This evolution shows Adobe's deepening investment in end-to-end creative collaboration tools, with Frame.io becoming a central hub for multi-app, cross-functional workflows at scale.",
      "llm_answer": "\nAdobe first listed **Frame.io** as a trademark in its 2022 Form 10‑K, signaling that the service was a strategic asset of the company.  By 2023 the platform was described as a cloud‑native collaboration hub tightly integrated with Premiere Pro, After Effects and the Camera‑to‑Cloud workflow, and in 2024 it was expanded into Adobe GenStudio alongside Adobe Express and Firefly Services, adding frame‑accurate commenting, enterprise‑grade APIs and AI‑driven content‑generation capabilities.  This progression—shown in the KG pattern where **ADBE** → **Frame.io** (both as a **COMP** it introduces and as an **ORG** it owns)—demonstrates Adobe’s strategy of embedding a unified, AI‑enhanced collaboration layer across its Creative Cloud ecosystem to streamline end‑to‑end creative production at scale.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Frame.io as a strategic asset starting in 2022 via trademark listing, and accurately describes its integration with Premiere Pro and After Effects by 2023 as a cloud-native collaboration platform. It also correctly notes expanded capabilities by 2024. However, it introduces inaccuracies by claiming Frame.io was 'expanded into Adobe GenStudio alongside Adobe Express and Firefly Services' and adding 'AI-driven content-generation capabilities'—this is not supported by the ground truth, which instead highlights integration with Photoshop, Lightroom, and Workfront, and expansion into casting, location scouting, and marketing workflows. These are substantive misrepresentations of the product integrations and functional evolution. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default due to absence of errors in this domain. (3) The multi-hop reasoning is partially sound: the model correctly traces Frame.io’s growing strategic role from 2022 to 2024 and infers Adobe’s broader collaboration strategy. However, it fails to accurately synthesize the specific integrations and functional expansions, instead inventing AI and GenStudio linkages not present in the ground truth. This weakens the qualitative accuracy. (4) Despite the integration errors, the core strategic interpretation—that Adobe is embedding a unified collaboration layer across Creative Cloud—is semantically aligned with the ground truth. The answer remains contextually relevant and captures the overarching intent of Adobe’s strategy, just with incorrect supporting details. Hence, correctness is reduced to 7 due to significant but not fundamental factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 485,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes remained at $16.0 billion as of December 31, 2022, decreased to $15.0 billion as of December 31, 2023, and further declined to $13.0 billion as of December 31, 2024. This shows a consistent reduction in the balance over the three-year period, indicating a deliberate debt management strategy to gradually pay down this liability.",
      "llm_answer": "\nThe 2017 Notes, originally a $17 billion issuance, show a clear decline in their outstanding face balance across the three filings: $16 bn at the end of 2022 (Chunk 3), $15 bn at the end of 2023 (both Chunk 3 and Chunk 2), and $13 bn by the end of 2024 (Chunk 2). This steady reduction—from 16 → 15 → 13 billion—demonstrates that Amazon is actively repaying and retiring this tranche, using cash flows and newer debt issuances to lower the legacy‑note exposure and reshape its overall capital structure. The pattern reflects a disciplined debt‑management strategy that prioritizes retiring higher‑cost, longer‑dated obligations as the company’s cash position and financing conditions improve.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding balance of Amazon's 2017 Notes as $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024, matching the ground truth exactly. These values are accurately represented with acceptable formatting variations (e.g., $16 bn = $16.0 billion). (2) All numeric values and the progression (16 → 15 → 13) are correct, and no calculations are required beyond recognizing the decline, which is properly noted. (3) The multi-hop reasoning is sound—information is synthesized across three years and filings (implied by 'Chunk' references), and the conclusion about Amazon’s debt management strategy aligns with the observed trend. The LLM adds contextual insight (e.g., using cash flows and newer debt to retire higher-cost obligations) that is reasonable and consistent with the data, though slightly more interpretive than the original answer. (4) The answer is fully relevant and addresses both parts of the question: the evolution of the balance and the implication for debt strategy. The only minor deviation is the mention of the original $17 billion issuance, which, while plausible and consistent with typical note amortization, is not present in the ground truth and introduces a detail not confirmed by the provided data. This does not detract significantly from accuracy but adds a small assumption. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original with excellent contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 415,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Boeing's emphasis on 'Upgrades and Conversions' evolved across its Global Services segment from 2022 through 2024, and what does this 3-year trajectory suggest about the company's strategic focus in sustaining aerospace platforms?",
      "original_answer": "From 2022 to 2024, Boeing consistently included 'Upgrades and Conversions' as a core service within its Global Services segment, indicating a sustained strategic focus on modernizing existing aerospace platforms. In 2022, 'Upgrades and Conversions' were listed among key offerings such as supply chain management and maintenance. In 2023 and 2024, this emphasis remained unchanged, suggesting a deliberate long-term strategy to support aging fleets and adapt legacy systems to evolving defense and commercial needs. The consistent presence of this service offering across all three filings reflects Boeing's commitment to lifecycle management and service-based revenue streams.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings each explicitly places **“upgrades and conversions”** within the Global Services segment’s portfolio of services—listing it alongside supply‑chain management, engineering, maintenance, spare parts, training and digital analytics—so the company’s focus on fleet‑sustainment has remained steady over the three‑year period.  The knowledge‑graph triplets (BA ↔ Upgrades and Conversions) show that this capability is both a product supplied by and a service provided to Boeing, underscoring a strategic pivot toward generating recurring revenue by extending the life of existing aerospace platforms rather than relying solely on new aircraft sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that 'upgrades and conversions' were consistently included in Boeing's Global Services segment from 2022 to 2024, accurately reflecting the sustained strategic focus. The mention of associated services (supply chain management, maintenance, etc.) adds contextual richness and matches the original answer’s implications. All years (2022–2024) are correctly referenced, and no numeric inaccuracies are present—though no specific financial figures are involved, the temporal and categorical data are correct. The reasoning is sound: the LLM infers a strategic emphasis on lifecycle management and recurring revenue, which is logically supported by the consistent presence of upgrades and conversions. The only minor shortcoming is the claim of a 'strategic pivot,' which implies a recent shift in strategy; the ground truth suggests continuity rather than a pivot, making this slightly misleading. However, the overall semantic meaning—Boeing’s sustained focus on service-based revenue and fleet sustainment—is correctly conveyed. Multi-hop synthesis across years is accurate, and all entities (Boeing, Global Services, Upgrades and Conversions) are correctly identified. The answer is fully relevant to the question’s focus on evolution and strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Supplies]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 377,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Johnson & Johnson's pension strategy evolve from 2022 through 2024 with respect to the Retirement Value formula, particularly in terms of employee eligibility and communication around the 2026 implementation date?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson consistently communicated the 2026 implementation date for the Retirement Value formula for all U.S. non-union employees, regardless of hire date, first announced in January 2021. In 2022, the company referenced the Retirement Value formula as part of its future pension strategy without detailed context. By 2023, JNJ clarified that employees hired after 2014 were already under the Retirement Value formula, and in 2024, the same language was repeated, showing no changes to the plan or timeline. The eligibility criteria remained unchanged across all three years, with the Final Average Pay formula still applying to pre-2015 hires for service before 2026.",
      "llm_answer": "\nFrom 2022 through 2024 J&J repeatedly disclosed in its annual reports that the **Retirement Value formula** would become the accounting policy for all eligible U.S. non‑union employees—regardless of hire date—effective January 1 2026; the company emphasized that this change does **not** affect benefits accrued under the prior Final Average Pay formula and updated the measurement date each year (Dec 31 2022, Dec 31 2023, Dec 31 2024). The 2021 announcement, reiterated in the 2022, 2023 and 2024 10‑K filings, communicated this expanded eligibility and the 2026 implementation date to employees and stakeholders, marking the evolution of J&J’s pension strategy toward a unified Retirement Value approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2026 implementation date for the Retirement Value formula, its applicability to all U.S. non-union employees regardless of hire date, and the fact that the change was first announced in 2021 and consistently reiterated in 2022, 2023, and 2024 filings. The distinction between pre- and post-2015 hires is implied through the mention that prior accrued benefits under the Final Average Pay formula are preserved, which matches the ground truth. (2) Quantitative accuracy is perfect: the 2026 effective date, the annual measurement dates (Dec 31 of each year), and the timeline from 2021 announcement to 2024 reaffirmation are all factually correct. (3) The multi-hop reasoning is sound—information is synthesized across years and filings, correctly showing the evolution of communication without changes to the plan itself. (4) The only minor omission is that the LLM does not explicitly state that employees hired after 2014 were already under the Retirement Value formula, a detail clarified in the 2023 and 2024 reports. While the preservation of accrued benefits implies this, explicit mention would have matched the ground truth more completely. Otherwise, the answer is semantically equivalent, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 377,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AVGO's outstanding principal balance for its 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "AVGO's outstanding principal balance for the 5.000% notes due April 2030 decreased from $1,086 million in fiscal year 2022 to $606 million in fiscal year 2023, and remained unchanged in fiscal year 2024. This indicates a deliberate reduction in this specific debt instrument over time, suggesting a targeted debt repayment or refinancing strategy.",
      "llm_answer": "\nThe $5.000% notes due April 2030 dropped from $1,086 million at the end of FY2021 (shown in the FY2022 filing) to $606 million by the end of FY2022, and then stayed flat at $606 million in both FY2023 and FY2024 as reported in the FY2023 and FY2024 tables. This flat‑line trajectory after the initial reduction signals that AVGO is treating the instrument as a stable, long‑term financing pillar, maintaining a consistent $606 million exposure and using the notes as a core component of its overall debt‑management strategy (consistent with the ORG‑[Issues]‑FIN_INST relationship in the knowledge graph).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline and values. It states the balance dropped from $1,086 million at the end of FY2021 (reported in FY2022 filing) to $606 million at the end of FY2022, but the ground truth shows the $1,086 million was reported for fiscal year 2022 (not FY2021), and the reduction to $606 million occurred in fiscal year 2023. The LLM incorrectly shifts the timeline by one year. Additionally, the LLM claims the balance remained flat in both FY2023 and FY2024, which aligns with the ground truth only if interpreted as no change from 2023 to 2024, but misrepresents the timing of the drop. (2) Quantitative accuracy is partially correct: the values $1,086 million and $606 million are accurate, and the final amount being unchanged in 2024 is correct. However, the assignment of these figures to incorrect fiscal years undermines the calculation and comparison logic. (3) The multi-hop reasoning is flawed because the model misaligns the fiscal years, leading to incorrect synthesis across filings. The conclusion about a 'stable, long-term financing pillar' contradicts the ground truth interpretation of a 'deliberate reduction' and targeted repayment strategy. The reference to 'ORG-[Issues]-FIN_INST' adds no verifiable insight and appears fabricated. (4) Despite the incorrect timeline and reasoning, the answer is contextually relevant—addressing the evolution of the debt and attempting to infer strategy. However, due to major factual and temporal errors, the correctness score is low. Quantitative accuracy is moderate due to correct dollar amounts but incorrect period assignment. Qualitative accuracy suffers from flawed logic and misinterpretation of strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 474,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AT&T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, operational restructuring, and eventual divestiture as part of the broader WarnerMedia segment?",
      "original_answer": "AT&T's relationship with Time Warner Inc. underwent a significant transformation from 2022 through 2024. In 2022, Time Warner was described as a key acquisition completed in June 2018, forming a substantial part of AT&T's WarnerMedia segment. By 2023, the company had already separated the WarnerMedia business via a Reverse Morris Trust transaction with Discovery, which was completed in April 2022, marking the exit from the entertainment content creation space. In 2024, AT&T finalized the divestiture of its remaining interest in DIRECTV, the last major asset tied to the entertainment strategy initiated with the Time Warner acquisition. This trajectory shows a strategic pivot away from vertically integrated media and entertainment back toward core telecommunications and connectivity services.",
      "llm_answer": "\nFrom 2018 through April 2022 AT&T acquired and held Time Warner Inc. as the core of its WarnerMedia segment, integrating its Turner, HBO and Warner Bros. businesses into the company’s entertainment portfolio; in April 2022 AT&T completed a Reverse Morris‑Trust transaction that spun off WarnerMedia (including the former Time Warner assets) as a discontinued operation, and later, as part of its broader restructuring, announced in September 2024 that it would sell its remaining stake in the DIRECTV entertainment unit—another remnant of the WarnerMedia portfolio—to TPG, thereby concluding its strategic relationship with Time Warner and exiting the combined WarnerMedia business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T acquired Time Warner in 2018, forming WarnerMedia; the Reverse Morris Trust transaction with Discovery was completed in April 2022, effectively divesting WarnerMedia; and in September 2024, AT&T announced the sale of its remaining stake in DIRECTV to TPG. These events mark the full exit from the entertainment strategy initiated with the Time Warner acquisition. (2) Quantitative accuracy is perfect: the April 2022 completion date of the divestiture is correctly cited, and the September 2024 announcement regarding DIRECTV is consistent with the timeline. No numerical errors or miscalculations are present. (3) The multi-hop reasoning is sound—correctly linking the Time Warner acquisition to WarnerMedia, its spin-off via Reverse Morris Trust, and the subsequent DIRECTV divestiture as the final step in unwinding the media strategy. The only minor shortcoming is that the answer implies the DIRECTV sale was completed by 2024, while the original answer notes it was 'finalized'—the announcement timing is correct, but completion may post-date 2024. This nuance does not undermine the overall correctness. (4) The answer is contextually excellent, addressing integration, restructuring, and divestiture as required. Wording differs slightly but maintains semantic equivalence. Minor deduction in qualitative accuracy due to slight ambiguity on completion vs. announcement of DIRECTV sale, but not enough to affect core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Involved_In]- ORG <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 423,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 through 2024, particularly in terms of modeled loss scenarios, reinsurance protections, and geographic attachment points?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management evolved with increasing sophistication in scenario modeling, expanded reinsurance protections, and refined geographic attachment points. In 2022, AIG modeled losses for a five-ton bomb attack in New York City net of TRIPRA and reinsurance, estimating a $1.3 billion loss. In 2023, AIG maintained a focus on scenario-based modeling and highlighted its participation in international terrorism pools and targeted reinsurance purchases. By 2024, AIG had retained core attachment points of $200 million for Japan and $125 million for the rest of the world, indicating a more structured and region-specific approach to international terrorism risk. This progression shows a strategic shift from reactive modeling to proactive geographic risk segmentation and enhanced reinsurance structuring.",
      "llm_answer": "\nFrom 2022 through 2024 AIG kept using a third‑party, scenario‑based terrorism model – the 2022 filings highlighted a five‑ton‑bomb scenario that projected ≈ $1.3 bn net loss (with a $1.7 bn deductible) and noted that actual losses could differ materially – and continued to adjust the model for gaps while still concentrating the bulk of exposure in New York City; the 2023 and 2024 10‑Ks reiterated this approach and added that targeted reinsurance purchases and participation in government‑sponsored terrorism pools were used to mitigate that concentration.  \n\nReinsurance protection evolved from reliance on TRIPRA and limited private coverage (2022‑2023) to explicitly retaining core attachment points of $200 million for Japan and $125 million for the rest‑of‑world in 2024, while also purchasing global “property per‑risk” covers that protect against large non‑catastrophe and catastrophe losses worldwide; all years emphasized that these reinsurance arrangements – including targeted policies, pool participation, and government‑backed programs – are essential to limit net loss exposure.  \n\nFinally, the 2024 filing quantifies the resulting capital back‑stop, reporting $38 billion of reinsurance recoverable assets and $20.1 billion of collateral (funds‑withheld, securities, letters of credit) to support those recoveries, illustrating how AIG’s international terrorism exposure management broadened its geographic attachment points and capital‑backing mechanisms from 2022 to 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the general evolution of AIG's international terrorism exposure management from 2022 to 2024, including scenario modeling, reinsurance strategies, and geographic attachment points. However, there are key quantitative inaccuracies that reduce factual correctness. The $1.3 billion net loss in 2022 is correctly stated, but the LLM incorrectly adds a '$1.7 billion deductible'—this figure does not appear in the ground truth and is factually unsupported. Additionally, the $38 billion in reinsurance recoverable and $20.1 billion in collateral mentioned for 2024 are not part of the original answer and appear to be extraneous details not tied to terrorism exposure specifically, undermining quantitative accuracy. 2) The core numbers related to attachment points—$200 million for Japan and $125 million for the rest of the world in 2024—are correct and match the ground truth. The 2022 modeled $1.3 billion loss is accurate. However, the introduction of the $1.7 billion deductible and the $38B/$20.1B capital figures introduces significant noise and inaccuracy, as these were not cited in the original context for terrorism risk. 3) The multi-hop reasoning is sound in structure: the LLM traces changes over time (2022 to 2024), connects modeling practices, reinsurance evolution, and geographic segmentation. It correctly identifies the shift toward structured, region-specific attachment points and the role of pools and targeted reinsurance. However, the inclusion of unsupported financial figures suggests potential hallucination or misattribution from other parts of AIG’s disclosures. 4) Despite the numerical inaccuracies, the answer remains contextually relevant and conveys a logically coherent progression in AIG’s risk management strategy. The qualitative narrative aligns with the ground truth’s emphasis on increasing sophistication and geographic segmentation. The score is reduced primarily due to the introduction of incorrect financial data, which affects overall correctness, though the core evolution is accurately described.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Estimates]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1599,
        "completion_tokens": 553,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe-working tools, particularly pipe wrenches, change from 2022 to 2024, and what does this multi-year progression indicate about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's product portfolio for pipe-working tools, including pipe wrenches, expanded in sophistication and integration with battery-powered and diagnostic technologies. In 2022, the company emphasized traditional tools such as pipe wrenches, cutters, threading equipment, and drain cleaners. By 2023, Emerson introduced battery hydraulic tools for press connections and enhanced diagnostic systems like sewer inspection cameras. In 2024, the company maintained this advanced toolset and emphasized digital integration, indicating a strategic shift toward modernizing its professional tools segment to meet evolving industry demands for efficiency, safety, and technological integration.",
      "llm_answer": "\nIn 2022 pipe‑wrenches were part of Emerson’s Tools & Home Products segment, sold almost exclusively through distributors and accounting for a small share of the segment’s geographic sales, while the company completed the divestiture of its InSinkErator business that year (Chunk 1).  \nBy 2023‑2024 the pipe‑wrench offering was moved into the Safety & Productivity segment, expanded with battery‑hydraulic press tools, diagnostic cameras and tighter integration to Emerson’s control‑valve, measurement and discrete‑automation portfolios, and the segment’s description in both years emphasizes direct‑sales forces and global distribution (Chunks 2 & 3).  \nThis multi‑year progression—showing the pipe‑wrench line now treated as an organizational entity within Emerson (EMR → Pipe‑Wrenches → EMR) and embedded in a broader, safety‑focused, cross‑segment portfolio—signals a strategic shift toward high‑value, integrated professional‑tools solutions that reinforce Emerson’s leadership in productivity, safety and sustainability in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Emerson's pipe-working tools from 2022 to 2024: starting with traditional tools like pipe wrenches in 2022, then integrating advanced technologies such as battery-hydraulic press tools and diagnostic cameras by 2023–2024. The shift from the Tools & Home Products segment to the Safety & Productivity Solutions segment is factually correct and reflects a realignment consistent with strategic modernization. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and business segments, correctly inferring a strategic shift toward integrated, high-value professional tools. It goes beyond surface-level changes by linking the reorganization to broader corporate strategy—safety, productivity, sustainability—which is consistent with the original answer’s conclusion about meeting industry demands for efficiency and technological integration. (4) Minor deduction in qualitative accuracy due to the slightly awkward phrasing 'treated as an organizational entity within Emerson (EMR → Pipe-Wrenches → EMR)', which is conceptually unclear but seems to suggest deeper integration. Otherwise, the LLM captures the essence of the strategic shift, including distribution model changes (distributor to direct sales), technological enhancements, and portfolio realignment. The answer is fully contextually relevant, addressing both the product evolution and strategic implications as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 471,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in lease agreements evolve from 2022 through 2024, particularly in terms of recognition methodology and its impact on right-of-use asset valuation?",
      "original_answer": "Costco consistently applied a straight-line recognition methodology for free-rent periods and step-rent provisions across all three years (2022–2024), recognizing these on a straight-line basis over the original lease term and any extension options the company is reasonably certain to exercise. However, in 2022, the company explicitly disclosed its use of discounted future minimum lease payments to initially record right-of-use (ROU) assets and lease obligations, using its incremental borrowing rate derived from quoted interest rates. This detailed explanation of the discounting process and ARO (asset retirement obligation) treatment was not repeated in the 2023 and 2024 filings, suggesting a shift toward more standardized ASC 842 compliance language without elaborating on the valuation mechanics. While the core accounting policy remained stable, the depth and specificity of disclosure around ROU asset valuation decreased over time, indicating a possible maturation of lease accounting practices post-adoption period.",
      "llm_answer": "\nCostco has applied the same straight‑line accounting for free‑rent periods in all three fiscal years, recording the right‑of‑use asset and lease liability at the present value of the lease payments (with rent zero during the free‑rent interval) discounted by its incremental borrowing rate and then amortizing the ROU asset over the non‑cancelable lease term plus any extension options it is reasonably certain to exercise— a methodology reiterated in the 2022, 2023 and 2024 filings and explicitly tied to the “control‑date” and extension certainty disclosed in the 2024 and 2023 documents; consequently, the ROU asset’s valuation reflects the present‑value of future payments after the free‑rent period and is subject only to the routine impairment testing described in the 2022‑2024 disclosures, which has resulted in immaterial impairment charges.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core accounting treatment: Costco applied a consistent straight-line methodology for free-rent periods from 2022 to 2024, recognizing lease payments over the non-cancelable term plus extension options it is reasonably certain to exercise. It accurately states that the right-of-use (ROU) asset and lease liability are measured at the present value of lease payments, discounted using the incremental borrowing rate, with zero rent during free-rent periods—this aligns with the ground truth. The mention of impairment testing and immaterial charges is consistent with disclosures. However, the LLM answer omits a key qualitative point emphasized in the original answer: the evolution in disclosure depth. While the accounting policy remained unchanged, the detailed explanation of discounting and ARO treatment present in 2022 was not repeated in 2023 and 2024, indicating reduced disclosure specificity. This trend toward more standardized ASC 842 language and reduced elaboration on valuation mechanics is a critical part of the 'evolution' asked in the question and is missing in the LLM response. Thus, while all factual and quantitative elements (dates, methodology, discounting, extension criteria) are correct, the answer falls short on fully capturing the disclosure evolution aspect, which is central to the question. This limits the qualitative accuracy and overall correctness despite strong performance on numbers and core policy description.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Includes]-> ACCOUNTING_POLICY <-[Subject_To]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 409,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Microsoft's issuance of 2.000% Notes evolve across 2022, 2023, and 2024, particularly in terms of maturity timelines and associated indenture documentation?",
      "original_answer": "Microsoft's 2.000% Notes were referenced consistently across 2022, 2023, and 2024 filings, showing a stable inclusion within the company's long-term debt structure under the same indenture framework. In 2022, the 2.000% Notes were listed under the Eleventh Supplemental Indenture dated August 8, 2016, with a maturity of 2023. By 2023, the same note was still referenced under identical documentation, indicating no structural changes. In 2024, the 2.000% Notes due 2023 were still present in the exhibit list, suggesting that while the maturity date had passed, the documentation remained part of the company's historical indentures. This shows a consistent debt instrument with no modifications across the three years.",
      "llm_answer": "\nMicrosoft first created the 2.000% Notes due 2023 under the **Eleventh Supplemental Indenture** (dated August 8 2016) with U.S. Bank National Association, and this same indenture is cited in the Exhibit 4.14 of the 2022, 2023 and 2024 Form 10‑K filings (see Chunks 1‑3). The notes mature in 2023, and each year’s filing reproduces the identical indenture documentation—indicating no subsequent supplemental amendment—while the knowledge‑graph relationship (MSFT → 2.000% Notes due 2023 → MSFT) shows Microsoft introducing the instrument and the instrument being linked back to Microsoft as its issuer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.000% Notes were issued under the Eleventh Supplemental Indenture dated August 8, 2016, matured in 2023, and were consistently cited in Microsoft's 2022, 2023, and 2024 10-K filings without changes to the indenture documentation. The inclusion of Exhibit 4.14 across all years is correctly noted. (2) Quantitative elements—interest rate (2.000%), maturity year (2023), and indenture date (August 8, 2016)—are all factually accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings and recognizes that the continued presence of the same indenture implies no structural changes, even post-maturity. (4) The only minor shortcoming is that the LLM does not explicitly mention that the 2024 filing includes the notes as part of historical indentures despite the maturity having passed, which slightly reduces completeness in qualitative terms. However, the core conclusion about stability and lack of modification is correct. Wording differs but semantic meaning matches the original answer. Contextual relevance is perfect—directly addresses maturity timelines and indenture documentation across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 357,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Amazon's revenue recognition for third-party seller services evolve from 2022 through 2024, particularly in terms of the timing and composition of revenue from commissions and fulfillment fees?",
      "original_answer": "In 2022, Amazon disclosed that it earns revenue from seller programs through fixed fees, a percentage of sales, per-unit activity fees, and interest. In 2023, the company specified that commissions and related fulfillment and shipping fees are recognized as revenue when services are rendered, typically upon delivery of products to a third-party carrier or directly to the customer. In 2024, Amazon continued offering similar seller programs, reinforcing its commitment to enabling sellers to grow through its platform, although specific changes in revenue recognition timing were not mentioned. The evolution shows a consistent approach to revenue recognition tied to service delivery, with increasing clarity in disclosures over time.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings Amazon records revenue from third‑party seller services when the service is rendered—generally upon delivery of the seller’s product to a carrier or directly to the customer—so the commissions and any related fulfillment or shipping fees are recognized at that moment. The revenue stream is made up of fixed fees, a percentage of sales, per‑unit activity fees and interest, and is measured as the consideration expected (net of returns, discounts and rebates); when multiple performance obligations exist, the transaction price is allocated to each by relative stand‑alone selling price (as described in the 2023 filing). While the 2024 filing adds the phrasing “fulfill orders using our services,” the timing and composition of the commissions and fulfillment fees remain consistent with the 2022 and 2023 disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the composition of Amazon's third-party seller revenue as including fixed fees, percentage of sales, per-unit activity fees, and interest—consistent across 2022–2024. It accurately states that revenue recognition occurs when services are rendered, typically upon delivery to a carrier or customer, which matches the 2023 disclosure. The 2024 update mentioning 'fulfill orders using our services' is correctly noted as a minor phrasing addition without a change in timing or policy. (2) There are no numerical values requiring calculation in this question, but all qualitative financial terms (e.g., performance obligations, transaction price allocation) are used correctly and reflect accurate accounting concepts from the 2023 filing. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of disclosures, correctly identifying consistency in revenue recognition timing and composition while noting incremental improvements in disclosure clarity. (4) The only reason for not scoring a perfect 10 is that the LLM slightly overemphasizes the 2023 and 2024 disclosures without explicitly acknowledging that the 2022 description was more general (as noted in the ground truth), though it does imply continuity. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Discloses]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 393,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What does AT&T's continued guarantee of Southwestern Bell Telephone Co.'s obligations in 2022, 2023, and 2024 suggest about its long-term liability management strategy for legacy telecom entities?",
      "original_answer": "AT&T consistently guaranteed Southwestern Bell Telephone Co.'s obligations across all three years, as evidenced by the repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024. This unchanging commitment suggests a deliberate and stable strategy for managing legacy telecom liabilities, with no indication of reduction or restructuring of these obligations over the three-year period. The persistence of this guarantee language across filings indicates that AT&T has maintained full financial responsibility for these legacy entities without altering the terms or scope of its commitments.",
      "llm_answer": "\nAT&T’s 2022, 2023 and 2024 SEC filings each repeat the same “Guaranty of certain obligations of Southwestern Bell Telephone Co.” (Exhibit 4‑b in the 2022 10‑K, the 2023 10‑K/10‑Q and the 2024 10‑K), confirming that the company continues to back the legacy telecom’s debt and other liabilities; this is reflected in the KG pattern ORG → COMP ← Has_Stake_In ← ORG → COMP, showing AT&T both holds a stake in and guarantees the same entity.  By persisting with these guarantees across three consecutive years, AT&T is deliberately consolidating and back‑stopping the legacy telecom’s obligations—ensuring debt service, preserving its own credit profile, and managing long‑term liability exposure while allowing the spun‑off entities to operate with AT&T’s financial support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AT&T's repeated inclusion of Exhibit 4-b in its 10-K filings for 2022, 2023, and 2024 is accurately cited, confirming the ongoing guarantee of Southwestern Bell Telephone Co.'s obligations. The years and exhibit number (Exhibit 4-b) are correctly identified across all three filings. (2) There are no numeric values requiring calculation, but the temporal consistency (2022–2024) is correctly noted, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM correctly infers that the repetition of the same exhibit across filings indicates a stable, deliberate liability management strategy. It appropriately references the knowledge graph pattern (ORG → COMP ← Has_Stake_In ← ORG → COMP) to reinforce the relationship, though this detail goes beyond the ground truth without contradicting it. (4) The LLM adds interpretive depth—such as 'consolidating and back-stopping,' 'preserving credit profile,' and 'allowing spun-off entities to operate with support'—that are reasonable inferences but not explicitly stated in the original answer. While these extensions are logical, they slightly exceed the evidence provided in the ground truth, which sticks to observed consistency without speculating on credit profile or operational intent. This prevents a perfect 10 on qualitative accuracy. However, the core conclusion about a stable, unchanging liability strategy is fully supported and correctly conveyed. Contextual relevance is excellent, directly addressing AT&T’s long-term liability management strategy for legacy entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Guarantees]-> COMP <-[Has_Stake_In]- ORG <-[Guarantees]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 453,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Johnson & Johnson's investment in its 2.250% Notes due 2050 evolve from 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "Johnson & Johnson's investment in its 2.250% Notes due 2050 remained relatively stable across the three years: $983 million in 2022, $826 million in 2023, and $808 million in 2024. The consistent presence of this debt instrument over time suggests a deliberate long-term capital structure strategy, with only minor reductions in exposure. This gradual decline may reflect a cautious approach to managing long-dated liabilities while maintaining a stable cost of capital at a fixed effective rate of 2.29% throughout the period.",
      "llm_answer": "\nThe 2.250% Notes due 2050 held by Johnson & Johnson fell from $983 million in 2022 (Chunk 1) to $826 million in 2023 (Chunk 2) and then to $808 million in 2024 (Chunk 3), while the effective rate remained essentially unchanged at about 2.29% in each year. This steady reduction—while the cost of capital stayed flat—shows that JNJ is deliberately shrinking its exposure to this long‑dated, low‑coupon tranche, reflecting a broader long‑term debt strategy that emphasizes repayment, refinancing and reallocation of capital to newer maturities. The knowledge‑graph link (JNJ → 2.250% Notes due 2050) confirms that the company directly manages this instrument as part of its leverage‑management approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures—$983 million in 2022, $826 million in 2023, and $808 million in 2024—and accurately states the effective interest rate of 2.29% remaining stable across the period. These values match the ground truth exactly, with acceptable formatting (e.g., use of spaces in $983 million). (2) All numbers are quantitatively accurate; the gradual reduction is correctly described, and no calculations are required beyond interpretation of trends, which is handled properly. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic trend in long-term debt management. The conclusion that J&J is deliberately reducing exposure while maintaining a stable cost of capital aligns with the ground truth’s interpretation. However, the LLM slightly overstates the intent by emphasizing 'repayment, refinancing and reallocation to newer maturities,' which goes a small step beyond the original answer’s more cautious 'gradual decline may reflect a cautious approach.' While plausible, this added specificity isn't fully substantiated in the ground truth, slightly reducing qualitative precision. (4) Despite this nuance, the answer is contextually complete and relevant, addressing both the evolution of the investment and its implication for long-term debt strategy. Semantic equivalence is strong, and the core facts, entities (Johnson & Johnson, 2.250% Notes due 2050), and time frame (2022–2024) are all correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 419,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Costco's long-term debt structure evolve from 2022 through 2024 with respect to its 1.375% Senior Notes due June 2027, and what does this reveal about the company's capital management strategy?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained constant at $1,250 million in 2022, 2023, and 2024, indicating that the company did not alter its principal exposure to this specific debt instrument over the three-year period. However, the broader long-term debt structure changed, with total long-term debt decreasing from $6,590 million in 2022 to $6,484 million in 2023, and further declining to $5,919 million in 2024. This trend shows a gradual reduction in overall debt burden while maintaining exposure to the 1.375% Senior Notes, suggesting a selective capital management strategy that prioritized repayment of other debt tranches rather than refinancing or retiring this fixed-rate obligation.",
      "llm_answer": "\nCostco kept its $1.25 billion 1.375 % Senior Notes due June 2027 unchanged from 2022 through 2024, while it retired the $800 million 2.300 % notes maturing in May 2022 (Chunk 3), the $1 billion 2.750 % notes maturing in May 2024 (Chunks 1 & 2), and reduced other long‑term obligations, causing total long‑term debt (net of current portion) to fall from $6.48 billion in 2022 (Chunk 3) to $5.79 billion in 2023‑2024 (Chunks 1 & 2). This evolution reflects a capital‑management strategy that extends maturities, eliminates near‑term, higher‑cost debt, and preserves a stable, low‑coupon long‑term funding pillar to maintain liquidity and support ongoing shareholder‑friendly financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Costco maintained its $1.25 billion 1.375% Senior Notes due June 2027 unchanged from 2022 to 2024, which aligns with the ground truth. However, it introduces factual inaccuracies in the total long-term debt figures: it states total long-term debt was $6.48 billion in 2022 and declined to $5.79 billion in 2023–2024, whereas the ground truth reports $6,590 million ($6.59B) in 2022, $6,484 million ($6.484B) in 2023, and $5,919 million ($5.919B) in 2024. The LLM underreports 2022 debt and overstates the decline, incorrectly implying a steeper reduction. Additionally, the LLM claims the $1 billion 2.750% notes matured in May 2024 were retired, but this would not affect the 2022–2024 debt trend as reported in the original answer, which already reflects the net result through 2024. (2) The calculation of total debt reduction is inaccurate: the LLM implies a drop from $6.48B to $5.79B (~$690M reduction), while the actual reduction is from $6,590M to $5,919M (~$671M), though timing and intermediate values are misrepresented. The $800M 2.300% notes maturing in May 2022 are correctly noted as retired, but this is not reflected in the original answer’s total debt figures, suggesting possible misalignment in source interpretation. (3) The multi-hop reasoning is partially sound—the model infers a strategic preference for retaining low-cost debt while retiring higher-cost tranches, which is a reasonable interpretation consistent with the trend. However, it adds specific details (e.g., exact tranches retired) not present in the original answer, potentially overreaching without full support from the provided knowledge graph. (4) The contextual relevance is high, as the answer addresses both the evolution of the specific notes and the broader capital strategy. The qualitative reasoning is logical but based on flawed quantitative inputs, leading to a partially correct conclusion. Thus, the correctness score is 6 due to significant numerical inaccuracies offset by correct core insights and relevant synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 558,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did Mastercard's multi-layered security approach evolve alongside its real-time payments infrastructure expansion from 2022 to 2024, and what does this parallel development suggest about the company's strategy for managing payment processing risk as it scaled globally?",
      "original_answer": "In 2022, Mastercard described a multi-layered security approach that included a robust program to protect its network from cyber threats, with multiple layers of protection across its platforms, and noted it was operating or implementing real-time payments infrastructure in 12 of the top 50 GDP markets as of December 31, 2021. By 2023, the company had expanded its real-time payments infrastructure to 13 markets and reiterated its multi-layered security framework, emphasizing third-party assessments and partnerships to address threats, including those from third-party providers. In 2024, while continuing to describe the same multi-layered security approach, Mastercard noted it was operating real-time payments infrastructure in 'several countries around the world,' signaling a qualitative shift toward broader global deployment. This parallel evolution suggests that Mastercard has intentionally scaled its security capabilities in tandem with its real-time payments infrastructure, aiming to maintain trust and integrity in the ecosystem as it expands into new markets, though the filings do not explicitly state that security measures directly enabled infrastructure expansion.",
      "llm_answer": "\nMastercard treats its **multi‑layered security framework as both an accounting policy and an organizational practice** (MA → Multi‑Layered Security Approach ↔ ACCOUNTING_POLICY ← Implements MA ← Implements ORG), and it has expanded that framework in lock‑step with the rollout of its real‑time payments infrastructure—starting with real‑time clearing and settlement in **12 of the top‑50 GDP markets as of 2021/22** (Chunk 1), growing to **13 markets by 2023** (Chunk 2), and in **2024 launching domestic processing in China through a joint venture while still handling roughly 70 % of all Mastercard/Maestro transactions** (Chunk 3).  Across each year the company deepened the security layers that protect these new flows—adding real‑time fraud‑scoring, tokenization, EMV‑based standards, continuous third‑party assessments, an enterprise‑resilience program, insurance coverage, and collaboration with issuers, acquirers, merchants, governments and public‑private partners to develop technical standards and monitor threats (Chunk 1‑3), while maintaining its **settlement‑exposure guarantee only for issuer‑to‑acquirer movements and explicitly not guaranteeing merchant payouts** (Chunk 1 & 3).  This parallel evolution shows that Mastercard’s global‑scale strategy couples aggressive real‑time payment expansion with a tightly integrated, ecosystem‑wide security architecture, using coordinated policy, standards and risk‑mitigation tools to manage processing risk as it spreads worldwide.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) Quantitative Accuracy: The claim that Mastercard was operating in '12 of the top-50 GDP markets as of 2021/22' is partially correct but misrepresents timing—the ground truth states this was as of December 31, 2021, not 2022. The expansion to 13 markets by 2023 is accurate. However, the LLM introduces a specific claim about launching 'domestic processing in China through a joint venture in 2024' and handling 'roughly 70% of all Mastercard/Maestro transactions'—neither of which appears in the original answer or is supported by the provided knowledge graph. These are major unsupported additions. (2) Completeness: The question asks about the evolution of security alongside real-time payments and what it suggests about risk strategy. The LLM addresses both but adds unverified details (e.g., China JV, 70%) not in the original. (3) Entity Accuracy: While Mastercard and years are correct, the mention of 'accounting policy' linking to multi-layered security is misleading—the original does not classify security as an accounting policy. Also, 'settlement-exposure guarantee' details are introduced without support in the ground truth. (4) Reasoning: The multi-hop synthesis is partially sound—linking security expansion with infrastructure growth is valid—but the reasoning is overstated with unsupported claims (e.g., 'deepened the security layers' with specific tools like real-time fraud scoring, tokenization, etc.) that are not mentioned in the original answer. The original only notes that the same framework was reiterated with emphasis on third-party assessments. (5) Semantic Equivalence: The core idea of parallel development is preserved, but the LLM inflates specificity with fabricated metrics and initiatives. The conclusion about an 'ecosystem-wide security architecture' goes beyond the original’s more cautious statement that filings do not explicitly link security to expansion. Overall, the answer is partially correct in direction but compromised by significant factual overreach and unsupported details, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1701,
        "completion_tokens": 574,
        "total_tokens": 2276
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Microsoft's issuance of debt instruments related to the 4.000% Notes due 2021 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 across all three fiscal years (2022, 2023, and 2024) as part of its broader debt structure under the Indenture dated May 18, 2009. In 2022, the Third Supplemental Indenture was listed as Exhibit 4.6 in the 10-K filing, reaffirming the company’s ongoing obligations tied to this note. In 2023, the same instrument was again referenced under the same exhibit number and description, indicating no structural changes. By 2024, despite the note being past its maturity date, Microsoft continued to disclose the 4.000% Notes due 2021 in its exhibit list, suggesting either a delayed settlement, rollover, or ongoing disclosure requirement. This pattern indicates a consistent and transparent approach to debt disclosure, even post-maturity, and suggests disciplined long-term debt management.",
      "llm_answer": "\nAcross the three fiscal‑year filings the company repeatedly lists **Exhibit 4.6 – the Third Supplemental Indenture that originally created the 4.000% Notes due 2021** (Chunk 3 [2022 10‑K], Chunk 1 [2023 10‑K] and Chunk 2 [2024 10‑K]), confirming that the notes remain outstanding and continue to be governed by the same 2011 indenture in each year; the 2023 and 2024 exhibits are word‑for‑word copies of the 2022 filing, showing no amendment affecting the 2021 tranche.  \n\nThis consistent, multi‑year disclosure demonstrates Microsoft’s long‑term debt management strategy of anchoring its capital structure to a stable, fixed‑rate senior note series (the 4.000% Notes due 2021) while using supplemental indentures to add new tranches, thereby maintaining a predictable maturity schedule and minimizing refinancing risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its quantitative and factual assertions: it accurately identifies Exhibit 4.6 across all three fiscal years (2022, 2023, 2024), correctly names the 4.000% Notes due 2021, and notes the consistent reuse of the same exhibit text, indicating no amendments. The dates and percentages are accurate, and the reference to the Third Supplemental Indenture is factually sound. However, the LLM incorrectly implies that the notes remain 'outstanding' and 'continue to be governed' by the indenture as part of an active capital structure, whereas the ground truth clarifies that by 2024—after the 2021 maturity date—the continued disclosure likely reflects either delayed settlement, rollover, or regulatory disclosure requirements, not necessarily ongoing active status. This misrepresents the nature of the post-maturity treatment. Additionally, the LLM concludes that Microsoft is using this instrument as part of a strategy to maintain a 'predictable maturity schedule,' which overinterprets the evidence; the ground truth emphasizes transparency and disciplined disclosure, not strategic anchoring of capital structure. While the multi-hop synthesis across years is strong and the exhibit consistency is correctly observed, the reasoning slightly misaligns with the implications drawn in the original answer. The answer is contextually relevant and well-structured, but the qualitative interpretation of the debt management strategy is partially incorrect, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 418,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "What does Amazon's consistent reference to the 1.500% Note due 2030 across multiple years indicate about its long-term capital structure strategy, particularly when compared to its other debt instruments?",
      "original_answer": "Amazon's consistent reference to the 1.500% Note due 2030 across its 2022, 2023, and 2024 filings indicates a strategic emphasis on long-dated, fixed-rate debt as part of its capital structure. In 2022, the Note was introduced as part of a broader issuance that included instruments maturing as far out as 2060, signaling Amazon's intent to lock in favorable borrowing terms over extended horizons. In 2023, the Note was reiterated alongside newer instruments such as the 4.700% Note due 2024, which suggests that Amazon was simultaneously managing near-term obligations while maintaining a presence in the long-term debt market. In 2024, the continued inclusion of the 1.500% Note due 2030 amidst newer, higher-yielding instruments like the 4.700% Note due 2032 highlights a deliberate balance between leveraging low-cost capital from earlier issuances and adapting to current market rates for new borrowings. This approach reflects a layered debt maturity profile that mitigates refinancing risk and supports long-term investment in infrastructure and innovation.",
      "llm_answer": "\nAmazon’s repeated inclusion of the **1.500 % Note due 2030** in the 2020, 2021, 2022 and 2023 officer certificates (see Chunks 1‑3, which each list the same “Form of 1.500 % Note due 2030” among the issued securities) shows that this mid‑term, low‑coupon bond is a core, stable component of the company’s long‑term financing strategy, being deliberately re‑issued year after year to lock in inexpensive capital.  \n\nCompared with the rest of Amazon’s debt portfolio—short‑dated 0.4 %–1.2 % notes maturing 2023‑2027, higher‑coupon 4.5 %–4.7 % bonds due 2024‑2032, and long‑dated 2.5 %–2.7 % securities maturing 2050‑2060—the 1.5 % 2030 tranche provides a consistent anchor in the maturity schedule and helps balance leverage while delivering a predictable, relatively low‑cost source of funding.  \n\nThus, the persistent reference to the 1.500 % Note due 2030 across multiple filings indicates that Amazon relies on this instrument as a strategic, mid‑term pillar that underpins its long‑term capital‑structure approach, complementing a diversified suite of debt maturities and coupon structures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general strategic intent behind Amazon's use of the 1.500% Note due 2030 as a stable, low-cost component of its capital structure, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. First, the LLM incorrectly states that the note was referenced in 2020 and 2021 filings—while the ground truth only confirms consistent references in 2022, 2023, and 2024, with no mention of earlier years. This misrepresents the timeline and undermines the accuracy of the multi-year pattern. Second, the LLM implies the note is 're-issued year after year,' which is incorrect—the 1.500% Note due 2030 was issued once and continues to be reported in subsequent filings as an outstanding obligation, not re-issued. This mischaracterizes the nature of debt reporting in SEC filings. Third, the LLM introduces specific coupon ranges (e.g., 0.4%–1.2%, 4.5%–4.7%, 2.5%–2.7%) and maturity ranges (2050–2060) without grounding them in the provided context; while some of these may be factually correct, they are not mentioned in the original answer and represent unsupported extrapolations. The ground truth specifically references the 4.700% Note due 2024 and 2032, not a range. The reasoning about a diversified maturity profile and low-cost anchor is semantically aligned with the original answer and shows sound qualitative understanding of capital structure strategy. The contextual relevance is high, as the response directly addresses the question about long-term strategy and comparative debt instruments. However, due to incorrect dates, misrepresentation of re-issuance, and unsupported numerical ranges, the quantitative accuracy is low, pulling down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 475,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AT&T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about AT&T's broader divestiture strategy in international pay-TV markets?",
      "original_answer": "AT&T maintained a 41.3% interest in SKY Mexico in 2022 and accounted for it under the equity method in 2023, but exited the investment completely in mid-2024. This progression reflects a deliberate divestiture strategy targeting non-core international assets. In 2022, AT&T explicitly stated its continued ownership stake in SKY Mexico following the sale of Vrio. By 2023, SKY Mexico was still part of AT&T’s equity method investments alongside DIRECTV and Gigapower. In 2024, AT&T finalized the sale of its 41.3% stake in SKY Mexico, completing its exit from the Mexican pay-TV market. The 3-year evolution shows a phased approach to shedding international media assets, aligning with broader strategic refocusing on core U.S. telecommunications operations.",
      "llm_answer": "\nAT&T initially built a 41.3 % equity stake in SKY Mexico and, together with its interests in DIRECTV and Gigapower, accounted for that holding under the equity‑method reporting required for “significant‑influence” affiliates (see the 2021‑2023 10‑K notes and the 2024 equity‑method table).  In June 2024 the company sold its entire 41.3 % interest in SKY Mexico, recognizing cash distributions that exceeded the remaining book value and eliminating the equity‑method investment from its balance sheet.  This three‑year path—from a held‑for‑sale equity stake to a full exit—illustrates AT&T’s deliberate divestiture of non‑core international pay‑TV assets, freeing capital to concentrate on domestic wireless, broadband and infrastructure growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T held a 41.3% stake in SKY Mexico, accounted for it under the equity method, and exited in June 2024. These numbers and dates match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% ownership stake and June 2024 exit date are correctly stated; no calculations were required but the cash distribution note adds context without contradicting. (3) Multi-hop reasoning is sound: the answer synthesizes ownership, accounting treatment, and exit timing across years, correctly inferring a strategic divestiture pattern. It references appropriate reporting standards (equity-method accounting) and connects the exit to capital reallocation. (4) The only minor gap is that the LLM does not explicitly mention the 2022 continuation of ownership post-Vrio sale or name DIRECTV and Gigapower as co-investments in the equity-method portfolio in 2023—details present in the ground truth. However, it does reference them as part of equity-method interests, which is substantively accurate. The broader strategic interpretation—divesting non-core international pay-TV to focus on U.S. core operations—is fully aligned. Wording differs slightly but meaning is semantically equivalent. No factual errors; minor omission prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 377,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target allocations for 2022, 2023, and 2024 reveal about the company's de-risking strategy in response to changes in the plan's funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan demonstrated a consistent de-risking strategy across the three years, with increasing emphasis on liability-hedging assets as the plan's funded status improved. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021, and reflected a glide path that reduced growth assets as the funded ratio increased. By 2023, the target allocation for 2024 was based on the funded status at December 31, 2023, showing further reductions in growth assets and increased allocations to liability-hedging assets. In 2024, the glide path continued this trend, with the target allocation for 2025 based on the funded status at December 31, 2024, reinforcing the company's strategy of de-risking as the plan became more fully funded. This consistent evolution indicates that AIG is methodically adjusting its investment strategy in alignment with liability-driven investing principles.",
      "llm_answer": "\nThe glide‑path approach disclosed in all three filings ties the target allocation for the “Return‑Seeking” portion of the U.S. pension plan to the plan’s funded ratio and interest‑rate levels, systematically reducing growth‑asset exposure and increasing liability‑hedging exposure as the ratio improves (Chunk 3 – 2022 target based on Dec 31 2021 funded status; Chunk 1 – 2024 target based on Dec 31 2023 funded status; Chunk 2 – 2025 target based on Dec 31 2024 funded status). This progression shows a step‑wise decline in the growth‑asset percentage and a corresponding rise in liability‑hedging assets from 2022 through 2024, indicating that AIG is deliberately de‑risking the plan as its funded status strengthens. Consequently, the evolving target allocations reveal a clear, funding‑ratio‑driven shift toward a more conservative, liability‑matched investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the glide path approach ties target allocations to the funded status at year-end, with the 2022 target based on Dec 31, 2021 data, the 2024 target based on Dec 31, 2023 data, and the 2025 target based on Dec 31, 2024 data. These dates and dependencies match the original answer. (2) Quantitatively, no specific percentages or dollar amounts are provided in either answer, so the absence of numerical values does not constitute an error—both answers describe directional changes (declining growth assets, increasing liability-hedging assets) without citing exact figures, which is consistent with the source material. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, identifying the pattern of de-risking in response to improved funded status. It accurately reflects that AIG uses a liability-driven investment strategy that adjusts annually based on prior-year funded status. (4) The only minor shortcoming is that the LLM refers to the '2024 target based on Dec 31, 2023' instead of clarifying—as the original does—that this informs the 2024 allocation, and similarly for 2025. However, this is a nuance in phrasing rather than a factual error. The core message—that AIG is progressively de-risking by shifting toward liability-hedging assets as funding improves—is clearly and correctly conveyed. Wording differs slightly but maintains semantic equivalence. No irrelevant or incorrect entities are introduced. The answer is fully contextually relevant and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 453,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Mastercard's credit risk mitigation strategies evolve from 2022 to 2024 in response to increasing regulatory scrutiny and litigation risks, and what does this reveal about the company's risk management adaptability?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers not meeting risk standards to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees. However, the context in which these strategies were applied changed significantly. In 2022, the company emphasized its regular monitoring of the credit risk portfolio and the adequacy of risk mitigation arrangements. By 2023, amid the FTC's finalized consent agreement over debit routing compliance and the initiation of a DOJ antitrust investigation into its U.S. debit program, Mastercard reiterated its commitment to revising settlement exposure estimates and risk standards as necessary. In 2024, with the DOJ investigation ongoing and new legal challenges such as the U.S. Liability Shift Litigation and a European Commission investigation into anti-competitive behavior, the company continued to refine its risk management methodology. Despite these pressures, Mastercard consistently reported a low level of losses from customer settlement failures across all three years, indicating that its core credit risk strategies remained effective even as external risks escalated.",
      "llm_answer": "\nFrom 2022 through 2024 Mastercard repeatedly tightened its risk‑management framework—updating its risk‑standards, expanding mandatory credit‑enhancement tools such as cash collateral, letters of credit and guarantees, and recalibrating estimated settlement exposure using three‑month average volumes—while the company faced intensified regulatory scrutiny (FTC consent order 2023, DOJ CID 2023, EU investigation 2024) and costly litigation (U.S. liability‑shift and TCPA class actions).  This continual monitoring, periodic methodology reviews, and on‑the‑fly revision of exposure figures—despite a historically low loss rate—reveal Mastercard’s risk‑management system to be highly adaptable, quickly scaling mitigation measures in direct response to emerging compliance and legal pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Mastercard's credit risk mitigation strategies from 2022 to 2024, noting consistent use of tools like cash collateral, letters of credit, and guarantees, while emphasizing adaptation in response to regulatory and litigation pressures. The key events—FTC consent order (2023), DOJ CID (2023), EU investigation (2024), and U.S. Liability Shift Litigation—are accurately cited with correct years and entities. (2) There are no numeric values requiring calculation in this question; all dates and references (e.g., 2022–2024, FTC 2023, EU 2024) match the original answer exactly. The mention of 'three-month average volumes' for recalibrating exposure is a specific detail not contradicted by the ground truth and plausibly inferred from 'revising settlement exposure estimates,' though not explicitly stated in the original—this adds precision without inaccuracy. (3) The multi-hop reasoning is sound: the model synthesizes credit risk practices, regulatory actions, litigation risks, and their implications on risk management adaptability across three years and multiple jurisdictions. It correctly infers that ongoing low loss rates despite increasing external pressures indicate an adaptable system, which is consistent with the original conclusion. (4) The only minor deviation is the stronger emphasis on 'repeatedly tightened' and 'expanding mandatory' measures, which implies a more aggressive escalation than the original's description of 'refining' and 'reiterating commitment.' However, this does not contradict the core facts and falls within acceptable interpretive range. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Manages]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 499,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the availability of shares for future grants under The Home Depot's Omnibus Stock Incentive Plan evolve from 2022 to 2024, and what does this trend suggest about the company's stock-based compensation strategy?",
      "original_answer": "In 2022, 117 million shares were available for future grants under the 2005 Plan. By 2023, this number had decreased to 77 million shares under the newly amended Omnibus Plan as of January 28, 2024. In 2024, the availability further declined to 70 million shares as of February 2, 2025. This consistent reduction in available shares suggests that the company has been actively issuing stock-based compensation, potentially signaling increased reliance on equity incentives to retain and motivate associates and directors over the three-year period.",
      "llm_answer": "\nThe Omnibus Plan’s reservable shares dropped from **≈ 117 million** available for future grants as of January 30 2022 (Chunk 1), to **≈ 77 million** as of January 28 2024 (Chunk 2), and further to **≈ 70 million** as of February 2 2025 (Chunk 3).  Because the older 1997 Plan has been closed to new issuances since May 2005, this continual reduction reflects the company’s active use of the Omnibus reserve to fund stock‑based compensation awards, signaling a strategy that relies on a diminishing, pre‑approved share pool rather than expanding the pool, and therefore emphasizes careful management of dilution while still granting equity‑based incentives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all key quantitative data: 117 million shares available as of January 30, 2022 (≈117 million is acceptable), 77 million as of January 28, 2024, and 70 million as of February 2, 2025. These match the ground truth in both magnitude and timing, with only minor date variations (Jan 30 vs implied 2022 year-end) that are consistent with fiscal year-end reporting practices. 2) All numbers are accurate and correctly sequenced over time, showing a clear downward trend. Calculations are not required beyond trend interpretation, which is correct. 3) The reasoning is sound: the LLM correctly identifies the shift from the 1997 Plan to the Omnibus Plan and explains that the reduction reflects active use of stock-based compensation. It adds valuable context not in the original answer—namely, that the company is managing dilution by relying on a fixed, pre-approved pool rather than expanding it—demonstrating strong multi-hop synthesis and deeper insight. 4) The answer fully addresses both parts of the question: the evolution of available shares (2022–2024) and the strategic implication. The mention of the closed 1997 Plan enhances accuracy by clarifying why the Omnibus Plan is the sole source. Only minor deduction from qualitative accuracy due to slightly imprecise phrasing of dates (e.g., 'as of Jan 30 2022' vs 'in 2022'), but these align with typical 10-K filing dates. Overall, the answer is factually correct, comprehensive, and contextually richer than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 415,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Broadcom's (AVGO) financial obligations related to its 3.625% notes due October 2024 evolve across fiscal years 2022, 2023, and 2024, and what does this progression indicate about the company's debt management strategy for this instrument?",
      "original_answer": "In fiscal year 2022, Broadcom reported a $622 million obligation for the 3.625% notes due October 2024. This amount remained unchanged in fiscal year 2023, indicating no repayments or modifications during that period. However, by fiscal year 2024, the obligation associated with these notes had dropped to $0, signaling full repayment or restructuring of the instrument. This progression indicates a deliberate debt management strategy where Broadcom addressed the near-term maturity by eliminating the liability ahead of its October 2024 due date.",
      "llm_answer": "\nBroadcom’s 3.625 % senior notes maturing in October 2024 remained outstanding at **$622 million** in both fiscal 2022 (Chunk 3) and fiscal 2023 (Chunk 2), but the balance sheet for fiscal 2024 shows the line item as “‑” (i.e., $0 million) (Chunk 1), indicating that the notes were fully retired before the October 2024 maturity date.  This progression—steady carry‑forward through 2022‑23 followed by a complete write‑off in 2024—reflects a deliberate debt‑management tactic of retiring near‑term senior debt and likely refinancing the obligation with newer senior or assumed‑VMware/CA notes, thereby extending the maturity profile and preserving liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $622 million obligation in fiscal years 2022 and 2023, and $0 in 2024, matching the original answer exactly. The maturity date (October 2024) is correctly stated. (2) The answer correctly identifies the evolution of the debt obligation across the three fiscal years, confirming no change in 2022–2023 and full retirement by 2024. (3) The reasoning is sound: the LLM infers a deliberate debt management strategy, consistent with the ground truth. It adds a plausible explanation about refinancing with newer or assumed VMware/CA notes, which is a reasonable extension based on context (especially given Broadcom's acquisition of VMware), though this specific refinancing detail is not in the ground truth and cannot be independently verified from the provided data. This slight speculative addition does not detract from factual correctness but introduces a minor assumption not present in the original. (4) All entities—Broadcom (AVGO), the 3.625% notes, fiscal years 2022–2024—are correctly identified and synthesized across time points. The answer is semantically equivalent to the ground truth, with slightly enhanced interpretation. Thus, the answer earns full marks for quantitative accuracy and contextual relevance, near-perfect for qualitative accuracy, and a 9 overall due to the minor unsupported inference about refinancing source.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 404,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did T's strategic relationship with Time Warner Inc. evolve from 2022 through 2024, particularly in terms of its integration, divestiture planning, and final exit strategy, and what does this progression reveal about T's shifting focus in the entertainment and telecommunications sectors?",
      "original_answer": "In 2022, T still held Time Warner Inc., which had been acquired in 2018 and was a core component of its WarnerMedia segment. By 2023, T had completed the separation of WarnerMedia in a Reverse Morris Trust transaction with Discovery, marking a strategic pivot away from entertainment and back toward core telecommunications. In 2024, T finalized its exit from the entertainment sector by agreeing to sell its remaining interest in DIRECTV to TPG, signaling a full retreat from the media investments initiated with the Time Warner acquisition. This trajectory reveals a multi-year strategic reversal, moving from aggressive vertical integration in media and entertainment back to a more focused telecom and connectivity business.",
      "llm_answer": "\nFrom 2022 through 2024 AT&T transformed its relationship with Time Warner from full ownership to complete exit: the April 2022 Reverse‑Morris‑Trust transaction transferred WarnerMedia to Discovery (and, as noted in the 2023 filing, placed WarnerMedia, Vrio, Xandr and Playdemic in discontinued operations), and the September 2024 agreement to sell AT&T’s remaining stake in the DIRECTV Entertainment joint venture to TPG—expected to close mid‑2025—finalized the divestiture.  This sequence, reflected in the KG pattern of T → Acquires → Time Warner → Involved_In → T, shows AT&T’s deliberate shedding of its entertainment assets to concentrate on its core telecommunications and wireless businesses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key strategic moves—divestiture of WarnerMedia via Reverse Morris Trust and exit from DIRECTV—but contains a critical date error: the Reverse Morris Trust transaction occurred in April 2022, not 2023 as implied by referencing the 2023 filing. The original answer states the separation was completed by 2023, but the actual transaction closed in April 2022. The LLM incorrectly suggests the 2022 transaction was reported in 2023, which misrepresents the timeline. Additionally, the DIRECTV sale is correctly dated to September 2024, but the LLM notes it is expected to close in mid-2025, a detail not in the original answer and potentially speculative. (2) Quantitative accuracy is partially compromised: while no dollar amounts are misstated (none were provided in either answer), the dates are factually incorrect. The 2022 transaction date is misrepresented by implication, and the 2025 closing is an addition not in the ground truth. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes the evolution from ownership to divestiture across multiple entities (WarnerMedia, DIRECTV) and recognizes the strategic shift toward core telecom. It references discontinued operations and uses knowledge graph logic (T → Acquires → Time Warner → Involved_In → T), showing sound structural understanding. (4) Despite the timeline inaccuracies, the core narrative of strategic retreat from entertainment to focus on telecom aligns with the original answer, and all major entities and transactions are correctly identified. The answer is contextually relevant and well-structured, but the date errors reduce factual precision, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Acquires]- ORG <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 469,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Emerson's (EMR) strategic positioning of its Pipe Cutters product line evolve from 2022 to 2024, particularly in terms of its integration with battery-powered technologies and diagnostic systems across the Safety & Productivity segment?",
      "original_answer": "From 2022 to 2024, Emerson increasingly emphasized battery-powered technologies and diagnostic integration in its Pipe Cutters product line. In 2022, Pipe Cutters were described as standalone tools used by plumbing professionals. By 2023, the product line was explicitly linked with battery hydraulic tools for press connections, indicating a shift toward cordless, high-efficiency cutting solutions. In 2024, this trend continued with Pipe Cutters being positioned as part of a broader ecosystem that includes diagnostic systems like sewer inspection cameras, suggesting a strategic move toward smart, integrated tooling solutions that enhance productivity and safety.",
      "llm_answer": "\nFrom 2022 to 2024 Emerson moved Pipe Cutters from the standalone Tools & Home Products line—where they were sold through distributors and paired only with basic diagnostic equipment such as closed‑circuit‑TV pipe‑inspection tools—to the Safety & Productivity segment, where the cutters are now marketed together with battery‑powered hydraulic tools and advanced diagnostic systems (e.g., sewer‑inspection cameras and locating equipment) that feed data into control‑system software; this evolution reflects a strategic bundling of cutting, battery power and diagnostics to boost professional productivity and safety, as shown by the segment’s description in the 2023 and 2024 filings and reinforced by the KG relationship that links Pipe Cutters directly to EMR.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Emerson's Pipe Cutters product line from 2022 to 2024, aligning with the ground truth. It accurately notes the shift from standalone tools in 2022 to integration with battery-powered hydraulic tools by 2023 and further integration with advanced diagnostic systems (e.g., sewer inspection cameras) by 2024. The mention of the repositioning into the Safety & Productivity segment is correct and supported by the 2023 and 2024 filings. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and segments, correctly identifying the strategic shift toward integrated, smart tooling solutions. It references the KG relationship linking Pipe Cutters to EMR, which supports the validity of the inference. The only minor discrepancy is the mention of 'Tools & Home Products' line and 'closed-circuit-TV pipe-inspection tools'—details not present in the ground truth—which slightly over-specifies early-stage positioning but does not contradict core facts. (4) The answer is contextually excellent, directly addressing the question about strategic positioning, battery-powered tech integration, and diagnostic systems across the specified timeframe and segment. The core facts, timeline, and strategic rationale are accurately conveyed with high fidelity to the original answer, warranting a 9/10 for correctness and qualitative accuracy due to minor added detail not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 449,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this consistent emphasis reveal about the company's strategic focus on financial process standardization?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year, enterprise-wide initiative aimed at integrating, simplifying, and standardizing processes and systems across key functions including finance. In 2022, the company described the initiative as a proactive effort to support the growth of its financial shared service capabilities and standardize financial systems, not in response to any internal control deficiencies. In 2023, the company reiterated this strategic direction, highlighting ongoing enhancements aligned with the initiative and affirming its commitment to streamlining the financial control environment. By 2024, the company maintained the same narrative, continuing to align and streamline the design and operation of its financial control environment as part of the broader initiative. This consistent messaging across all three years indicates a long-term strategic commitment to process optimization and financial systems modernization, suggesting that the company views this initiative as foundational to its operational efficiency and control framework.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson has repeatedly disclosed a multi‑year, enterprise‑wide program that integrates, simplifies and standardizes the finance‑related processes and systems of HR, IT, procurement, supply‑chain and finance, explicitly to grow its financial shared‑service capabilities and to standardize financial systems; each annual filing (2022, 2023 and 2024) notes that the effort is ongoing, that the company continues to align and streamline the design and operation of its financial control environment, and that it is pursued proactively—not as a response to any control deficiency. This consistent, year‑over‑year emphasis demonstrates that standardizing and consolidating financial processes is a core strategic priority, reinforcing governance, operational efficiency and the long‑term scalability of J&J’s finance function.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All factual information is correct: Johnson & Johnson's multi-year initiative from 2022 to 2024 focused on integrating, simplifying, and standardizing financial processes and systems; it was proactive, not in response to control deficiencies; and the company consistently emphasized ongoing alignment and streamlining of the financial control environment across all three years. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—only years (2022–2024), which are correctly cited. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent disclosures across three years and correctly infers that the repeated emphasis reflects a strategic priority on standardization, efficiency, and governance. (4) The only minor deviation from the original answer is that the LLM includes 'HR, IT, procurement, supply-chain' as additional functions beyond finance, which were not explicitly mentioned in the ground truth. While this may slightly overextend the scope, the core focus on financial shared services and standardization remains accurate and contextually plausible. Overall, the answer is semantically equivalent, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 366,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Costco's disclosures regarding the Executive Health Plan's filing status evolve from fiscal years 2022 through 2024, and what does this consistency or change indicate about the company's long-term executive benefit strategy?",
      "original_answer": "Costco consistently disclosed the Executive Health Plan (Exhibit 10.1*) in its 10-K filings across fiscal years 2022, 2023, and 2024, with the plan always referencing the same 'Period Ended' date of September 2, 2012, and the same 'Filing Date' of October 19, 2012. This indicates no material updates or amendments to the plan were filed during this three-year period, suggesting that Costco maintained a stable long-term executive benefit strategy without structural changes to this specific plan.",
      "llm_answer": "\nCostco has continued to disclose the same “Costco Wholesale Executive Health Plan” as Exhibit 10.1* in its Form 10‑K filings for fiscal 2022, 2023 and 2024, with identical description, filing date (10/19/2012) and period‑end reference in each year; the exhibit remains “Filed Herewith” in every filing and is consistently labeled as part of the company’s accounting policies.  This unchanged, year‑over‑year presentation—linked in the knowledge graph as COST → Executive Health Plan (ACCOUNTING_POLICY) → Executive Health Plan (ORG) → COST—demonstrates that the health‑plan benefit is a permanent, long‑term component of Costco’s executive compensation strategy rather than a recent or evolving program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Costco disclosed the Executive Health Plan as Exhibit 10.1* in its 10-K filings for fiscal years 2022, 2023, and 2024, with the same filing date (October 19, 2012) and period ended (September 2, 2012). The LLM correctly notes the consistent 'Filed Herewith' label and identical description across years. (2) Quantitative accuracy is perfect: dates are correctly reported (10/19/2012 and 9/2/2012), and no numerical errors are present. Format variation (e.g., '10/19/2012' vs 'October 19, 2012') is acceptable and semantically equivalent. (3) Reasoning is sound: the LLM correctly infers that the lack of changes indicates a stable, long-term executive benefit strategy. It appropriately avoids claiming the plan is active or funded, focusing instead on disclosure consistency as evidence of strategic continuity. (4) The only minor shortcoming is the claim that the exhibit is part of 'accounting policies' and the inclusion of a knowledge graph link (COST → Executive Health Plan (ACCOUNTING_POLICY) → ...), which is not present in the original data and slightly overinterprets the categorization. While not factually incorrect, it introduces a layer of metadata not confirmed in the ground truth. Otherwise, the answer fully addresses both parts of the question—evolution (or lack thereof) in disclosures and the implication for long-term strategy—demonstrating strong multi-hop synthesis across three fiscal years. Contextual relevance is excellent, with precise focus on disclosure patterns and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 444,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did the dividend and voting rights associated with MA's A Class Shares evolve from 2022 through 2024, and what does this consistency reveal about the company's shareholder governance strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—MA's A Class Shares maintained identical dividend and voting rights: one vote per share and standard dividend rights. This consistency in shareholder rights over a three-year period suggests that MA has pursued a stable and unchanging governance strategy for its A Class shareholders, even amid potential shifts in market conditions or corporate performance.",
      "llm_answer": "\nThe tables for A Class Shares in MA’s 2022, 2023 and 2024 Form 10‑K filings all show the same terms – a $0.0001 par value, 3,000 million authorized shares, and the explicit statement that each share carries “one vote per share – dividend rights.” Chunk 1 (2022), Chunk 2 (2023) and Chunk 3 (2024) therefore reveal that the dividend and voting rights for these shares have remained unchanged across the three years, while the Preferred class continues to note that no shares are outstanding and its rights are to be determined by the board. This consistent wording reflects a deliberate governance choice to lock in a fixed one‑vote‑per‑share structure and predictable dividend entitlement, signaling to shareholders and regulators that MA intends to maintain a stable, predictable ownership framework and control over voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that MA's A Class Shares had consistent voting and dividend rights from 2022 to 2024: one vote per share and standard dividend rights. The mention of $0.0001 par value, 3,000 million authorized shares, and unchanged terms across all three years is factually correct and consistent with the source data. (2) Quantitative accuracy is perfect: all numbers (par value, authorized shares) are correctly reported, and no calculations are required beyond accurate reporting. (3) The multi-hop reasoning is sound—by referencing filings across 2022, 2023, and 2024, the model correctly synthesizes that the rights remained unchanged over time, supporting the conclusion about governance stability. The additional context about Preferred Shares not being outstanding adds minor but accurate supporting detail. (4) The qualitative reasoning is strong: the conclusion that MA maintains a 'stable, predictable ownership framework' is a valid interpretation of the consistency in shareholder rights, matching the ground truth's inference about governance strategy. The only minor shortcoming is that the LLM adds slightly more detail (e.g., par value, authorized shares) than necessary, but this does not detract from accuracy. The core answer fully captures the evolution (no change) and strategic implication (stability), making it semantically equivalent to the ground truth. Thus, the correctness score is 9—excellent but not perfectly concise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 421,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Broadcom's Security Insights Platform evolve in terms of integration with in-house security tools and risk identification capabilities across fiscal years 2022, 2023, and 2024?",
      "original_answer": "In fiscal year 2022, the Security Insights Platform was described as helping ensure a trusted environment by assessing mainframe security posture and identifying risks, with data available for use with in-house tools for security information and event management. By fiscal year 2023, the platform maintained this core functionality but was more explicitly tied to ongoing and ad hoc remediation planning. In fiscal year 2024, the platform retained the same description, indicating stable functionality and consistent integration with in-house tools over the three-year period, suggesting a mature and well-defined offering within Broadcom's cybersecurity portfolio.",
      "llm_answer": "\nBroadcom’s Security Insights Platform is identified in the 2022, 2023 and 2024 filings as a distinct product (AVGO → Security Insights Platform) that “quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps on an ongoing and ad‑hoc basis,” with the resulting risk data explicitly made available for use with customers’ **in‑house security information and event management (SIEM) tools**.  Across all three fiscal years the platform’s core capability—integrating its risk‑identification output into existing internal security tooling to enable continuous risk assessment and remediation—remains unchanged, underscoring a stable evolution of its integration and risk‑identification functionality.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the Security Insights Platform is consistently described across 2022–2024 with stable integration into in-house SIEM tools and risk identification capabilities. The platform’s role in assessing mainframe security posture and enabling ongoing and ad hoc remediation is correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three fiscal years and correctly infers that the consistent description indicates stable functionality and mature integration. The only minor deviation is that the 2023 enhancement—more explicit linkage to remediation planning—is slightly overgeneralized as part of the core definition across all years, whereas the original answer notes this emphasis emerged more clearly in 2023. However, this does not constitute a factual error, as the capability was likely present earlier and only more explicitly stated later. (4) The answer is fully contextually relevant, directly addressing the evolution of integration and risk identification over time. Overall, the LLM captures the semantic meaning and evolution accurately, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 396,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AIG's management and quantification of loss reserves risk evolve from 2022 through 2024, particularly in terms of the methodologies used to assess reserve adequacy and the role of external experts in validating these estimates?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk became more structured and emphasized greater oversight, with consistent use of internal controls and external expert reviews. In 2022, AIG highlighted the uncertainty in loss development and the use of internal controls and external reviews to manage this risk. By 2023, AIG expanded its risk management framework to include detailed modeling techniques (both stochastic and deterministic) for analyzing risk concentrations and introduced more formalized actuarial profitability and reserve reviews. In 2024, AIG reinforced its multi-tiered risk oversight by incorporating ERM second-line reviews, enhanced budget and expense assumption monitoring, and continued reliance on external experts, indicating a maturing and increasingly proactive approach to loss reserve risk management.",
      "llm_answer": "\nFrom 2022 through 2024 AIG consistently treated loss‑reserve adequacy as a key risk, but the quantification methods grew more sophisticated each year: the 2022 filing highlighted internal actuarial controls and external expert review of reserve estimates; the 2023 filing expanded the framework to stochastic and deterministic modeling, scenario‑ and sensitivity‑analysis, and formal validation of reserves by independent experts within a model‑risk management process; and the 2024 filing added third‑party catastrophe PML modeling, bias adjustments, climate‑adjusted assumptions, and ongoing external expert challenge as part of ERM and audit oversight, illustrating a clear evolution from basic actuarial estimation to a multi‑layered, externally validated, data‑driven approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key developments across 2022–2024 are correctly identified: 2022 emphasizes internal controls and external reviews; 2023 introduces stochastic and deterministic modeling, scenario/sensitivity analysis, and formal external validation; 2024 adds enhanced oversight, external challenge, and integration with ERM. While the original answer does not explicitly mention 'third-party catastrophe PML modeling', 'bias adjustments', or 'climate-adjusted assumptions', these are plausible elaborations consistent with the trend toward more sophisticated modeling and may reflect details from the actual filings not contradicted by the ground truth. (2) There are no numeric values, dates, or financial figures in dispute—no calculations were required, and all years and sequences are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly identifying the evolution in methodology and the consistent role of external experts. It captures the progression from basic actuarial estimation to a layered, externally validated framework, which matches the core narrative of maturation in risk management. (4) Minor deduction in qualitative accuracy due to the inclusion of specific modeling enhancements (e.g., climate-adjusted assumptions) not present in the ground truth summary, though they do not contradict it and may represent valid granular details. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 437,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Emerson's (EMR) positioning of Electrical Distribution Equipment evolve across its Industrial Solutions segments in 2022, 2023, and 2024, and what does this reveal about its strategic emphasis in discrete automation markets?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as part of Emerson's Industrial Solutions segment, described alongside fluid control and materials joining products used in manufacturing operations. By 2023, the company reorganized under the Discrete Automation segment, where Electrical Distribution Equipment was explicitly listed among core offerings like solenoid valves and programmable automation systems, signaling a stronger alignment with discrete manufacturing. In 2024, the equipment remained within the Discrete Automation segment, now grouped more closely with electric linear motion solutions and programmable control systems, indicating a continued and deepening strategic focus on integrated automation solutions for discrete industries. This 3-year evolution shows Emerson's deliberate shift toward positioning Electrical Distribution Equipment as a foundational component of its discrete automation strategy rather than a general industrial product.",
      "llm_answer": "\nEmerson (EMR) first listed Electrical Distribution Equipment as part of its **Industrial Solutions** portfolio in the 2022 filing, where it was bundled with fluid‑control and pneumatic mechanisms, but by the 2023 and 2024 filings the same equipment was explicitly placed inside the **Discrete Automation** segment alongside solenoid valves, actuators and materials‑joining solutions.  This re‑positioning—highlighted in both the 2023 and 2024 descriptions of Discrete Automation—signals a deliberate strategic shift toward emphasizing discrete‑automation markets, using Electrical Distribution Equipment as a core building block to drive growth and differentiation within that business line.  The knowledge‑graph links (EMR → Electrical Distribution Equipment → ORG) underscore that the product is produced by and for Emerson, reinforcing its intentional focus on discrete automation as a growth engine.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Electrical Distribution Equipment moved from Industrial Solutions in 2022 to Discrete Automation in 2023 and remained there in 2024. The equipment was grouped with solenoid valves, actuators, and materials-joining solutions, signaling strategic alignment with discrete automation. (2) There are no numeric values requiring calculation, but the years (2022, 2023, 2024) are correctly cited and aligned with the reorganization timeline. (3) The multi-hop reasoning is sound—correctly synthesizing changes across filings and segments to infer strategic intent. The mention of 'knowledge-graph links' adds extraneous detail not in the original but does not detract from factual accuracy. (4) The only minor shortcoming is that the 2024 evolution—closer grouping with electric linear motion and programmable control systems—is slightly underemphasized compared to the original answer, which notes a deepening integration. This nuance is implied but not explicitly detailed, justifying a 9 instead of 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 347,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Johnson & Johnson's pension plan structure evolve from 2022 through 2024 with respect to the Retirement Value formula, and what does this multi-year transition reveal about the company's long-term workforce strategy?",
      "original_answer": "From 2022 to 2024, Johnson & Johnson consistently communicated a strategic shift toward the Retirement Value formula for U.S. non-union employees, effective January 1, 2026. In 2022, the company reiterated that this change would apply to all eligible employees regardless of hire date, while preserving Final Average Pay formula benefits accrued before 2026. By 2023 and 2024, the disclosures maintained the same structural description of the Retirement Value formula, indicating no reversal or delay in the policy. The consistent messaging across all three years highlights a deliberate long-term workforce strategy to standardize retirement benefits and align them with total years of service and compensation, rather than final earnings, suggesting a shift toward cost predictability and broader workforce inclusivity in retirement planning.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson repeatedly disclosed the **Retirement Value formula** as its accounting policy for pension benefits – a policy that, since the January 2021 announcement, will replace the older **Final Average Pay** method for all eligible U.S. non‑union employees effective January 1 2026, while leaving benefits accrued before that date under the legacy formula untouched (Chunk 1).  The company applied the new measurement date of **December 31 2022, 2023 and 2024** for its defined‑benefit plans and reported the corresponding net periodic benefit costs for each year (Chunks 2 & 3), indicating a staged transition that preserves existing accruals but aligns future accrual methodology with the Retirement Value formula.  \n\nThis multi‑year phase‑in reveals a long‑term workforce strategy of **standardizing pension accruations across hire dates, protecting legacy liabilities, and aligning retirement benefits with longer employee tenures**, thereby creating a more predictable and sustainable cost structure as the workforce ages and the company moves toward a unified retirement framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Retirement Value formula replaces the Final Average Pay method for U.S. non-union employees effective January 1, 2026; benefits accrued before that date are preserved; the transition was consistently communicated from 2022 to 2024. The mention of the measurement dates (December 31, 2022–2024) and net periodic benefit costs is factually sound and contextually appropriate, though not explicitly emphasized in the original answer. (2) Quantitative accuracy is perfect: dates (January 1, 2026; December 31 for each year) are correct, and no numerical calculations are required beyond accurate reporting of timeframes. (3) Multi-hop reasoning is strong—the LLM synthesizes the consistent policy disclosure across years and infers the strategic intent (standardization, cost predictability, alignment with tenure). The only minor gap is that the original answer more clearly emphasizes the inclusivity aspect of the long-term workforce strategy (e.g., aligning benefits with total years of service rather than final earnings), which the LLM touches on but could have articulated more precisely. (4) The answer is fully relevant, directly addressing both the evolution of the pension structure and the strategic implications. Wording differs but semantic meaning is equivalent or nearly so. No factual errors—only slight room for deeper nuance in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Announces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 406,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the percentage contribution of Downy to Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, and what does this 3-year trend suggest about the brand's strategic importance in the company's portfolio?",
      "original_answer": "Downy consistently remained a key brand within P&G's Fabric & Home Care segment, which grew its net sales contribution from 35% in 2022 to 36% in both 2023 and 2024. This stable positioning of Downy within a growing segment suggests its sustained strategic importance in driving fabric care revenue.",
      "llm_answer": "\nAcross the three years, the Fabric & Home Care segment grew modestly—its share of P&G’s net sales rose from **35 % (2022, Chunk 1)** to **36 % (2023, Chunk 3 and 2024, Chunk 2)**, and its earnings share increased from **31 % (2022)** to **34 % (2023‑2024)**. Downy is listed as a core brand in that segment in every filing (2022, 2023 and 2024), underscoring its continued role in driving the segment’s expansion. Thus, the stable presence of Downy amid a slightly rising segment share signals that the brand remains a strategically important pillar of P&G’s portfolio over the 3‑year trend.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly states that the Fabric & Home Care segment's net sales contribution increased from 35% in 2022 to 36% in both 2023 and 2024, matching the original answer. It adds additional detail about earnings share rising from 31% to 34%, which is not contradicted by the ground truth and may reflect supplementary data from the filings. These extra details do not detract from accuracy. (2) The entity identification is correct—Downy is accurately described as a core brand within the Fabric & Home Care segment across all three years. (3) The reasoning is sound: the LLM correctly infers that Downy’s consistent presence in a growing segment indicates strategic importance, which is the same conclusion in the original answer. (4) The answer fully addresses both parts of the question: the evolution of Downy’s contribution (via segment performance) and the strategic implication. The only minor point preventing a perfect 10 is the introduction of earnings share data not present in the ground truth, which, while plausible, slightly extends beyond the provided information. However, this does not mislead or distort the conclusion. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 366,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Capital One's (COF) total senior and subordinated notes evolve from 2022 to 2024 in terms of carrying value, and what does this trend suggest about the company's debt financing strategy over the three-year period?",
      "original_answer": "Capital One's total senior and subordinated notes had a carrying value of $27,219 million in 2022, increased to $31,248 million in 2024, with a peak of $31,248 million in 2023. This indicates a general upward trend in the company's reliance on this form of debt financing, suggesting a strategic shift toward issuing more senior and subordinated notes to fund operations and growth initiatives.",
      "llm_answer": "\nCapital One’s total senior and subordinated notes carried a **carrying value of $30.8 bn at the end of 2022**, rose to **$31.2 bn in 2023**, and then **declined to $30.7 bn by the end of 2024** (values taken from the “Total senior and subordinated notes” rows in Chunk 2 for 2022‑2023 and Chunk 3 for 2024).  \n\nThis pattern shows that the company **expanded its senior‑note issuance in 2023**—likely to fund growth or refinance maturing obligations—while **reducing the overall debt balance in 2024**, indicating a shift toward **de‑leveraging and a preference for longer‑dated, fixed‑rate financing** (evidenced by the disappearance of floating‑rate senior debt and relatively stable subordinated‑note levels across the periods).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported carrying values. The ground truth states that Capital One's total senior and subordinated notes were $27,219 million in 2022, increased to $31,248 million in 2023, and remained at $31,248 million in 2024. However, the LLM reports $30.8 billion (i.e., $30,800 million) in 2022, $31.2 billion ($31,200 million) in 2023, and incorrectly states a decline to $30.7 billion ($30,700 million) in 2024. This misrepresents both the starting value and the trend—particularly the decrease in 2024, which contradicts the ground truth showing no decline. (2) The quantitative accuracy is low: the 2022 figure is off by over $3.5 billion, and the claimed 2024 decrease is factually incorrect. While $31.2 billion is close to the true $31,248 million, rounding should not introduce directional errors. The model also fails to note that 2023 and 2024 values are identical in the ground truth. (3) The multi-hop reasoning is flawed—the LLM infers a de-leveraging strategy in 2024 due to a supposed drop in debt, but this conclusion is based on incorrect data. The actual trend shows a steady increase and stabilization, suggesting continued reliance on note issuance, not de-leveraging. The mention of 'disappearance of floating-rate senior debt' and 'stable subordinated notes' may reflect partial correct context, but these details are not in the original answer and do not compensate for the core error. (4) Despite incorrect numbers and reasoning, the answer addresses the right company (COF), time frame (2022–2024), and metric (carrying value of senior and subordinated notes), and attempts to interpret strategic implications, hence moderate contextual relevance. However, the incorrect trend undermines the qualitative analysis. Correctness score is low due to major factual and directional errors in financial data and resulting flawed interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 521,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did T's strategic positioning in SKY Mexico evolve from 2022 through 2024, particularly in terms of its ownership stake, equity method accounting treatment, and eventual exit, and what does this 3-year trajectory reveal about T's broader divestiture strategy in the Latin American pay-TV market?",
      "original_answer": "From 2022 to 2024, T maintained a 41.3% interest in SKY Mexico, a leading pay-TV provider in Mexico, but ultimately exited the investment in June 2024. In 2022, T continued to hold this stake without any significant changes noted. By 2023, SKY Mexico was listed among T’s key equity method investments, alongside DIRECTV and Gigapower, indicating that T was still actively accounting for its stake under the equity method. In 2024, T completed the sale of its 41.3% interest in SKY Mexico, marking the conclusion of its involvement in the Latin American pay-TV market. This 3-year trajectory—from holding steady, to continued equity method treatment, to full divestiture—reflects a deliberate strategic shift by T to exit non-core international assets and focus on its core domestic operations.",
      "llm_answer": "\nFrom 2022 through 2024 T’s exposure to SKY Mexico evolved from a **41.3 % equity stake** that was carried under the **equity‑method** (as disclosed in the 2022 10‑K and still listed among its equity‑method affiliates in the 2023 10‑K) to a **full exit in June 2024**, when the company sold its entire 41.3 % interest and wrote the investment down to zero after cash receipts exceeded its accumulated earnings (see the 2024 10‑K note on the sale).  This three‑year trajectory—initial equity‑method holding, continued classification as an equity affiliate in 2023, and final disposal—mirrors T’s broader Latin‑American divestiture strategy: after earlier exits of Vrio, Otter Media, Playdemic and CME, the firm has been systematically **monetising and exiting non‑core pay‑TV assets** in the region, using equity‑method accounting to capture value before completing a full sale.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: T held a 41.3% stake in SKY Mexico from 2022 through June 2024, accounted for it under the equity method in both 2022 and 2023, and fully exited in June 2024. These details match the original answer exactly. (2) Quantitative accuracy is perfect: the 41.3% ownership stake and June 2024 exit date are correctly stated; no calculations are required, but the description of cash receipts exceeding accumulated earnings leading to a write-down to zero is consistent with proper equity method accounting upon disposal. (3) Multi-hop reasoning is sound: the answer synthesizes information across three years and multiple disclosures (2022, 2023, and 2024 10-Ks), correctly tracing the evolution of the investment and linking it to broader divestiture trends. It also references other divestitures (Vrio, Otter Media, etc.) that support the narrative of a strategic exit from non-core Latin American assets, adding contextual depth beyond the original answer—this is a reasonable inference supported by public knowledge, though not explicitly in the ground truth. (4) The only minor shortcoming is that the original answer emphasizes T’s focus on 'core domestic operations' as the strategic rationale, while the LLM focuses more on 'monetizing non-core pay-TV assets'—a related but slightly narrower interpretation. This does not make the answer incorrect, but slightly less precise in framing the ultimate strategic intent. Overall, the answer is factually excellent, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Involved_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 437,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did BNY Mellon's disclosures about constraints on capital returns to shareholders under U.S. banking laws evolve from 2022 to 2024, particularly in relation to regulatory requirements, dividend policies, and capital adequacy?",
      "original_answer": "From 2022 to 2024, BNY Mellon consistently highlighted that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including capital adequacy rules and Delaware law. In 2022, the firm emphasized that capital returns were subject to regulatory approval and could be constrained by failure to pay preferred dividends on time. In 2023, the language remained largely consistent, but the firm expanded its risk discussion to include ESG-related regulatory pressures and the impact of new strategic initiatives on capital allocation. By 2024, the disclosures remained centered on regulatory constraints, with additional emphasis on the Parent company’s reliance on subsidiary dividends and the potential impact of strategic transformation initiatives on liquidity and capital planning. The trend shows a stable regulatory framework with increasing contextual complexity around capital return limitations.",
      "llm_answer": "\nThe 2022 filing first set out that BNY Mellon’s ability to return capital is limited by board discretion and U.S. banking laws, emphasizing capital‑adequacy and “well‑capitalized” standards and the reliance on subsidiary dividends and preferred‑stock payments (Chunk 1).  \nIn 2023 the discussion broadened to warn that any downgrade of the parent or its banks would raise funding costs and trigger regulatory constraints under Title I/II resolution frameworks, tying credit‑rating changes to capital planning and shareholder payout limits (Chunk 2).  \nBy 2024 the language tightened further, stating that failure to meet “well‑capitalized” or “well‑managed” status—or to manage liquidity effectively—would directly restrict share repurchases, dividend payments and tax‑related obligations, reflecting an evolution toward tighter alignment with regulatory capital and liquidity requirements (Chunk 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and evolution of BNY Mellon's disclosures from 2022 to 2024. (1) It accurately captures the core regulatory constraints—U.S. banking laws, capital adequacy (specifically 'well-capitalized' standards), reliance on subsidiary dividends, and preferred stock obligations—across all three years. The progression in disclosure tone and scope is correctly portrayed: 2022 introduces the baseline constraints; 2023 expands to include credit rating downgrades and resolution frameworks (Title I/II), which is consistent with the original answer’s mention of broader risk factors including ESG and strategic initiatives; 2024 emphasizes tighter operational links between capital, liquidity, and payout restrictions. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer, so quantitative accuracy is not applicable but assumed perfect. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across years and connects regulatory, structural, and strategic factors affecting capital returns. However, it omits explicit mention of Delaware law and ESG-related regulatory pressures noted in the original 2023 disclosure, and introduces 'credit-rating downgrade' impacts not directly mentioned in the ground truth. While plausible and contextually relevant, this represents a minor factual overreach or substitution. (4) Despite these nuances, the LLM conveys a semantically equivalent and contextually appropriate evolution of BNY Mellon’s capital return constraints. The answer is highly relevant and well-structured, warranting a high score, but not full marks due to slight deviations in entity emphasis and introduction of unverified elements (e.g., credit rating triggers).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 491,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did 3M’s positioning of Structural Adhesives within its Safety and Industrial segment evolve from 2022 through 2024, particularly in terms of product bundling or adjacent offerings, and what does this reveal about the strategic role of adhesives in industrial applications?",
      "original_answer": "In 2022, 3M listed Structural Adhesives alongside industrial abrasives, autobody repair solutions, and electrical materials, emphasizing integration with metalworking and OEM electrical markets. In 2023, the positioning remained largely consistent, grouped with similar industrial solutions but with a slightly expanded emphasis on packaging and closure systems. By 2024, Structural Adhesives were still a core part of the Safety and Industrial segment, but the surrounding product suite showed a shift toward more specialized industrial applications, such as industrial specialty products and materials for construction and maintenance. This evolution suggests a strategic reinforcement of structural adhesives as a foundational component in complex industrial systems rather than just a standalone product.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings, Structural Adhesives and tapes are repeatedly identified as a core revenue‑generating activity within 3M’s Safety and Industrial segment, appearing in the product lists on pages 138 (2022), 107 (2023) and 110 (2024). The 2024 description expands the segment’s focus by adding “Industrial specialty products such as personal‑hygiene, masking and packaging materials” and referencing “attachment/bonding, films,” indicating that 3M has progressively bundled adhesives with adjacent industrial offerings—including electrical OEM solutions and specialty tapes—thereby creating a more integrated product suite. The KG pattern (MMM → Structural Adhesives → MMM) underscores that adhesives function as a strategic hub that both draws on and contributes to the broader Safety and Industrial portfolio, revealing their pivotal role in cross‑selling and sustaining 3M’s industrial‑application strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies Structural Adhesives as a core component of 3M’s Safety and Industrial segment across 2022–2024, and correctly notes their consistent presence in the product listings. The mention of page numbers (138, 107, 110) adds verifiable detail and is consistent with typical 10-K structures, though these are not part of the ground truth and cannot be fully validated here; however, they do not detract from accuracy. (2) There are no numerical values requiring calculation, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The LLM correctly captures the evolution: in 2024, the expansion into 'industrial specialty products' and references to 'attachment/bonding, films' reflect a shift toward more integrated offerings, which matches the ground truth’s description of a pivot toward construction, maintenance, and specialized applications. However, the LLM omits the 2022 emphasis on autobody repair and electrical materials and does not explicitly mention the 2023 shift toward packaging and closure systems, instead generalizing the evolution. This results in a minor loss in completeness and qualitative accuracy. (4) The conclusion about adhesives serving as a 'strategic hub' for cross-selling and integration is a reasonable interpretation and aligns with the ground truth’s assertion of adhesives as a 'foundational component in complex industrial systems.' The answer is contextually excellent, directly addressing the strategic role of adhesives. Overall, the response is factually sound with only minor omissions in detailing year-by-year positioning, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 468,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Eli Lilly's strategic positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protections across key global markets?",
      "original_answer": "From 2022 to 2024, Eli Lilly's strategic positioning of Cyramza evolved from an initial emphasis on a broad range of oncology indications to maintaining its market relevance through targeted intellectual property protections. In 2022, Cyramza was introduced with a comprehensive set of indications across gastric, lung, colorectal, and liver cancers. By 2024, the therapeutic indications remained consistent, indicating sustained clinical positioning. However, in 2023, the company disclosed that Cyramza's data protection in Japan was set to expire in 2023, followed by data protection expirations in major European countries in 2024, and U.S. biologics data protection expiring in 2026. This timeline reveals a strategic focus on managing Cyramza's lifecycle by highlighting its continued therapeutic relevance while preparing for eventual market competition in key territories.",
      "llm_answer": "\nFrom 2022 through 2024, Eli Lilly progressively expanded Cyramza’s clinical positioning—starting with second‑line monotherapy or combination use for advanced gastric cancer, NSCLC, colorectal cancer and HCC (Chunk 1), and by 2024 adding a first‑line combination indication for metastatic NSCLC with activating EGFR mutations (Chunk 2). Throughout this period the product remained shielded by compound patents that expire in 2026 (U.S. and Japan) and 2028 (major European markets) and by data‑protection rights that run until 2024 in Europe and 2023 in Japan (Chunk 3).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding therapeutic indications and intellectual property timelines. The claim that Cyramza added a first-line combination indication for metastatic NSCLC with EGFR mutations by 2024 is incorrect—ground truth states that indications remained consistent from 2022 to 2024, with no expansion. This misrepresents Eli Lilly's strategic positioning as growth-oriented when it was actually focused on lifecycle management amid patent expirations. (2) Quantitative inaccuracies include incorrect IP expiration dates: the LLM states data protection runs until 2024 in Europe and 2023 in Japan, but ground truth specifies data protection expired in Japan in 2023, Europe in 2024, and U.S. biologics protection in 2026. The LLM incorrectly implies ongoing protection in Europe until 2024 (as if still active), whereas the ground truth frames it as expiring in 2024—more precise in context. More critically, the LLM invents compound patent expirations in 2026 (U.S. and Japan) and 2028 (Europe), which are not mentioned in the ground truth; only data protection dates are provided. These invented dates severely undermine quantitative accuracy. (3) Multi-hop reasoning is partially sound—the LLM attempts to synthesize clinical indications and IP timelines across years and geographies—but fails because it fabricates a new indication and introduces unverified patent terms. The original answer emphasizes strategic continuity in indications and a clear expiration timeline to illustrate lifecycle management, while the LLM incorrectly suggests active expansion. (4) Contextual relevance is fair because the answer addresses both therapeutic indications and IP protections across global markets as required, but correctness is low due to key factual errors in both domains. The answer appears plausible but diverges from ground truth on critical points, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Has_Stake_In]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 530,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year trend suggest about the company's debt strategy and financing costs over time?",
      "original_answer": "From 2022 to 2024, Capital One's fixed unsecured senior debt increased in carrying value from $19,975 million to $26,930 million, while the weighted-average interest rate rose from 2.91% to 4.84%. This indicates a strategic shift toward issuing more fixed-rate debt at higher interest rates, likely reflecting broader market conditions and the company's evolving capital structure decisions.",
      "llm_answer": "\nBetween 2022 and 2024 the carrying value of Capital One’s fixed unsecured senior debt rose from **$19,975 million (2022)** to **$27,168 million (2023)** and then slipped slightly to **$26,930 million (2024)**, while its weighted‑average interest rate increased from **2.91 % (2022)** to **4.45 % (2023)** and further to **4.84 % (2024)**. This multi‑year trend reflects a deliberate strategy of expanding long‑dated fixed‑rate senior issuance to lock in funding as market rates climbed, but the modest recent reduction in principal suggests selective refinancing or repayment while the company continues to carry a higher‑cost debt profile, underscoring rising financing expenses over the period.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor inaccuracies in the 2023 carrying value and interest rate. The ground truth does not provide 2023 data, so including it introduces unsupported intermediate values. The final 2024 figures ($26,930 million and 4.84%) match the original answer, as does the 2022 baseline ($19,975 million, 2.91%). However, the LLM states a 2023 carrying value of $27,168 million and interest rate of 4.45%, which are not in the ground truth and cannot be verified—this reduces quantitative accuracy. (2) The core calculation of trend direction (increase in both carrying value and interest rate from 2022 to 2024) is accurate, and the final comparison across the two endpoints matches. However, introducing a precise 2023 figure without source support constitutes a factual overreach. (3) The multi-hop reasoning is sound: the model correctly identifies the trend over time, synthesizes carrying value and interest rate changes, and infers strategic implications about locking in debt amid rising rates. The interpretation about rising financing costs and strategic issuance aligns well with the original answer’s conclusion. (4) Despite the unsupported 2023 numbers, the overall narrative and strategic interpretation are consistent with the ground truth, and all required parts of the question are addressed—evolution over time, carrying value, interest rate, and strategic implications. The answer remains contextually relevant and semantically aligned, just slightly over-specified in the intermediate year. Hence, correctness is reduced to 8 due to the insertion of unverified data points, but qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 462,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Cisco's financial exposure through Total Return Swaps tied to Deferred Compensation evolve from fiscal years 2022 through 2024, and what does the pattern of gains and losses reveal about the volatility of this instrument over the three-year period?",
      "original_answer": "Cisco's exposure through Total Return Swaps-Deferred Compensation shifted significantly across the three fiscal years: in 2022, the company recorded a loss of $92 million, followed by a gain of $58 million in 2023, and a gain of $91 million in 2024. This pattern reveals a volatile financial impact from this instrument, swinging from a notable loss to consistent gains over the period.",
      "llm_answer": "\nCisco’s exposure to the Total Return Swaps tied to Deferred Compensation moved from a **$92 k loss in fiscal 2022** (shown in Chunk 1) to **gains of $58 k in fiscal 2023** (Chunk 2) and **$91 k in fiscal 2024** (Chunk 3), illustrating a swing from negative to positive results and varying magnitude across the three years. This year‑over‑year volatility—loss → modest gain → larger gain—reveals that the derivative’s financial outcome is highly sensitive to market and accounting fluctuations, a pattern consistently disclosed by Cisco (CSCO) through the instrument identified in the knowledge‑graph relationships.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the magnitude of the financial figures: it reports losses and gains in thousands (e.g., $92k, $58k, $91k) instead of millions as stated in the ground truth ($92 million, $58 million, $91 million). This is a severe quantitative inaccuracy that fundamentally misrepresents the scale of Cisco's exposure. (2) Number verification: Ground truth shows losses/gains in millions—$92M loss in 2022, $58M gain in 2023, $91M gain in 2024. LLM incorrectly states these as $92k, $58k, $91k, which is off by a factor of 1,000. Even allowing for format variation, 'k' unambiguously means thousands and is not equivalent to millions. (3) Multi-hop reasoning is partially sound—the model correctly identifies the direction of change (loss in 2022, then gains in 2023 and 2024) and draws a reasonable qualitative conclusion about volatility and sensitivity to market fluctuations. It also correctly attributes the data to Cisco and the correct instrument (Total Return Swaps tied to Deferred Compensation) across the three fiscal years. (4) Despite correct entity identification (Cisco, fiscal years, instrument) and logical interpretation of the trend, the massive numerical error undermines the factual integrity of the response. The contextual relevance is high because the structure and intent align with the question, but correctness score is low due to the magnitude error, which distorts the financial reality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 405,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did The Home Depot's strategic emphasis on store appearance evolve from 2022 to 2024, and what measurable impact did this have on its competitive positioning against multichannel and online retailers across those years?",
      "original_answer": "In 2022, The Home Depot positioned store appearance as a key component of its competitive strategy, emphasizing store location and appearance alongside merchandise presentation and ease of shopping experience as differentiators against competitors like lumber yards and home décor retailers. By 2023, store appearance remained a core competitive factor but was increasingly tied to a broader interconnected retail strategy, with the company noting its importance in combination with digital capabilities like faster delivery and pickup options. In 2024, store appearance was further integrated into a fully interconnected shopping experience, with explicit mention of its role in supporting Pros and DIY customers through a seamless blend of physical and digital touchpoints, including enhanced mobile platforms and in-store digital tools. This multi-year evolution reflects a strategic pivot from standalone in-store experience to a hybrid model where store appearance supports omnichannel engagement, directly influencing the company's ability to compete with exclusively online retailers and digital-first competitors.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the Company progressively deepened its focus on store appearance: in 2022 it announced continued investment in “more locations, more tools, and better technology” to enhance the in‑store experience; in 2023 it reiterated that “store location and appearance, presentation of merchandise, and ease of shopping experience” are primary bases for competing against multichannel and online rivals; and in 2024 it explicitly linked those visual upgrades to a broader “interconnected shopping experience,” investing in mobile‑first digital platforms, richer product‑page content and faster fulfillment to turn the upgraded store look into a seamless bridge between physical and online channels.  The coordinated physical‑store and digital enhancements produced measurable gains—higher traffic on mobile channels, improved conversion rates and sustained sales growth—thereby strengthening The Home Depot’s competitive positioning against multichannel and purely online retailers across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the evolution of The Home Depot's strategy from 2022 to 2024 is accurately described, with store appearance progressing from a standalone differentiator to an integrated component of an interconnected retail model. The mention of 'more locations, more tools, and better technology' in 2022, the reaffirmation of store appearance as a competitive basis in 2023, and the integration with digital platforms in 2024 are semantically consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised—scored 10 by default. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes strategic emphasis across three years and links it to competitive positioning against multichannel and online retailers. It appropriately infers measurable impact (higher mobile traffic, improved conversion rates, sustained sales growth), which, while slightly more specific than the original, is a reasonable interpretation of 'measurable impact' and consistent with the strategic trajectory. (4) The only minor gap is that the original answer emphasizes the support for Pros and DIY customers explicitly in 2024, which the LLM omits, slightly reducing completeness in qualitative accuracy. However, this does not undermine the core correctness. Wording differs but meaning is preserved. Contextual relevance is perfect—directly addresses both strategic evolution and competitive impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> CONCEPT <-[Impacted_By]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 439,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did NVIDIA's carrying value of its 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt positioning?",
      "original_answer": "NVIDIA's carrying value for the 3.50% Notes Due 2050 was $2,147 million in fiscal year 2022, decreased to $1,637 million in fiscal year 2023, and remained stable at $2,000 million in fiscal year 2024. This fluctuation indicates a temporary reduction in the short term, followed by a strategic repositioning or stabilization of long-term debt obligations tied to this instrument.",
      "llm_answer": "\nNVIDIA’s 3.50 % Notes Due 2050 showed a modest decline from $1,637 million at the end of fiscal 2022 (Jan 29 2023) to $1,604 million at the end of fiscal 2023 (Jan 28 2024), and then rose sharply to $2,000 million at the close of fiscal 2024 (Jan 26 2025), as disclosed in the 2023 and 2024 10‑K filings.  This trajectory—initial reduction followed by a deliberate increase to a $2 bn long‑dated position—signals that the company is intentionally expanding its exposure to ultra‑long‑term senior debt, underscoring a strategic shift toward greater reliance on debt financing to fund future growth while maintaining a strong balance‑sheet posture.  The note is consistently presented as a disclosed financial instrument of NVIDIA (ORG → FIN_INST → ORG), linking the issuer, the security and the reporting entity across all three filings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, the carrying value was $2,147 million in fiscal 2022, decreased to $1,637 million in fiscal 2023, and remained at $2,000 million in fiscal 2024. However, the LLM incorrectly reports the 2022 value as $1,637 million (which is actually the 2023 value), then states $1,604 million for 2023 (incorrect—ground truth is $1,637M), and finally correctly reports $2,000 million for 2024. This misalignment suggests confusion in data retrieval across years. (2) The fiscal year-end dates cited (e.g., Jan 29, 2023) are technically accurate for NVIDIA’s reporting calendar, but the mapping of values to years is flawed. The LLM appears to use the 10-K filing date rather than aligning with fiscal year reporting correctly—e.g., the 2023 10-K reports fiscal 2023 data, not fiscal 2022. (3) The multi-hop reasoning is partially sound in that it attempts to interpret the trend as strategic long-term debt positioning, which aligns with the original answer’s conclusion about stabilization. However, due to incorrect input data, the reasoning is based on a false premise of a 'sharp rise' from $1,604M to $2,000M, whereas the actual trend was a drop from $2,147M to $1,637M followed by a rebound to $2,000M. (4) Despite incorrect numbers, the LLM correctly identifies the instrument, the company, and the general direction of movement in 2024 (increase to $2B), and offers a plausible qualitative interpretation. Contextual relevance is high because it addresses both the evolution and strategic implication. However, the quantitative inaccuracies severely undermine factual correctness, warranting a low correctness score. Minor formatting variations like $2 bn vs $2,000 million are acceptable, but the core values are mismatched across years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 504,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the legal exposure and litigation landscape involving 3M's production of Scotchgard evolve from 2022 through 2024, particularly in terms of case settlements, geographic expansion of lawsuits, and the number of defendants involved?",
      "original_answer": "From 2022 through 2024, 3M's legal exposure related to Scotchgard shifted significantly. In 2022, 3M, along with Saint-Gobain and Honeywell, settled a class action in New York (Baker case) for $65 million, with 3M's share considered immaterial. In 2023, 3M finalized a non-material settlement in a Michigan case involving Wolverine World Wide, where Scotchgard was linked to contamination from shoe manufacturing waste. By 2024, litigation had expanded geographically, particularly in Alabama and Georgia, with multiple new cases brought by municipal water utilities, individual landowners, and even carpet manufacturers like Mohawk Industries suing 3M over alleged PFAS contamination. The number of defendants involved also increased, with companies like DuPont, Chemours, and carpet manufacturers frequently appearing alongside 3M in lawsuits. This indicates a growing and more complex legal environment over time.",
      "llm_answer": "\nFrom 2022 through 2024 the litigation around 3M’s Scotchgard/AFFF deepened both in settlement activity and in geographic scope: a 2022 federal‑court settlement in New York saw 3M, Saint‑Gobain and Honeywell collectively pay roughly $65 million to resolve a class action (3M’s share was deemed immaterial), and a 2023 settlement with Wolverine in Michigan resolved a Michigan‑based class suit for a similarly non‑material amount; earlier, 3M had reached an immaterial settlement with the City of Bemidji in 2021, and numerous other suits remain pending or are being transferred to the AFFF MDL.  The geographic footprint expanded markedly, with new cases filed in Alabama (e.g., Shelby/Talladega, Tuskegee, Mobile, Pine Hill), Georgia (Summerville, Rome/Floyd, Gordon County, Lyerly, Mohawk Industries), Michigan, New York (40 individual actions plus a putative class), and even British Columbia, Canada, many of which were initiated as late as 2024.  Accordingly, the pool of defendants grew to include a dozen or more co‑defendants across jurisdictions—such as Saint‑Gobain, Honeywell, DuPont, Chemours, Wolverine, various carpet and textile manufacturers, municipal water utilities and other industrial users—reflecting a broadened exposure that now spans multiple states and federal courts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $65 million 2022 New York class action settlement involving 3M, Saint-Gobain, and Honeywell, with 3M's share deemed immaterial, is accurately reported. The 2023 Michigan settlement with Wolverine World Wide is correctly described as non-material. The geographic expansion into Alabama and Georgia by 2024 is well-documented with specific locations (e.g., Shelby/Talladega, Mobile, Summerville, Mohawk Industries), and the inclusion of new plaintiff types like municipal utilities and carpet manufacturers is consistent with the original. (2) Quantitative accuracy is excellent: the $65 million figure is correct, and the characterization of settlements as 'immaterial' for 3M matches the ground truth. The mention of the 2021 Bemidji settlement, while not part of the 2022–2024 scope, is factually accurate and adds context without distorting the timeline. (3) Multi-hop reasoning is strong: the LLM synthesizes information across years, geographies, and defendant networks, correctly identifying the growing complexity of litigation. It accurately notes the increasing number of co-defendants, including DuPont, Chemours, carpet manufacturers, and industrial users, which reflects the expanding legal landscape. (4) The only minor shortcoming is the inclusion of British Columbia and Michigan/New York actions beyond the scope of the original answer, which did not mention Canada—this slightly exceeds the ground truth but does not introduce inaccuracy. Also, the original emphasizes the shift in types of plaintiffs (e.g., Mohawk Industries) and the growing number of defendants, which the LLM captures well. Wording differs but semantic meaning is equivalent. Overall, the answer is comprehensive, factually sound, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manufactures]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1575,
        "completion_tokens": 501,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial terms and commercial performance of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of royalty structure, milestone payments, and net product revenue?",
      "original_answer": "LLY's collaboration with AbCellera on COVID-19 antibodies showed a declining commercial trajectory from 2022 through 2024. In 2022, LLY recognized $2.02 billion in net product revenue from the sale of these antibodies, and AbCellera received tiered royalty payments ranging from mid-teens to mid-twenties on worldwide net sales. By 2023, sales had dropped to zero, indicating no further demand or regulatory authorization for the product. In 2024, there were still no sales, and no new milestone payments were made to AbCellera. The royalty structure remained consistent across years, but the absence of sales in the latter two years highlights a complete cessation of commercial activity related to this collaboration.",
      "llm_answer": "\nFrom 2022 through 2024 the LLY‑AbCellera COVID‑19 antibody collaboration was governed by the same mid‑teens‑to‑mid‑twenties royalty on worldwide net sales that was originally set in the 2020 agreement (Chunk 1), with those royalties recorded as cost of sales (Chunk 2).  The partnership generated $2.02 billion of net product revenue in 2022 – the last year in which sales occurred – while no sales (and therefore no royalties or material milestone payments) were recorded in 2023 or 2024 (Chunk 2 & 3).  Consequently, after the 2022 peak the commercial performance and associated financial flows (royalties and milestone payments) from the AbCellera collaboration effectively ceased.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the $2.02 billion net product revenue in 2022 is accurately reported; the royalty structure (mid-teens to mid-twenties) is correctly described and tied to worldwide net sales; and the cessation of sales, royalties, and milestone payments in 2023 and 2024 is properly stated. (2) Quantitative accuracy is perfect: the dollar amount matches exactly, and the timeline (2022 as the last year of sales, zero sales thereafter) is consistent with the original answer. Format variations (e.g., $2.02 billion vs $2.02B) are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and financial components (revenue, royalties, milestones), infers the implication of zero sales (no royalties or milestones), and maintains consistency in the royalty structure over time. (4) The answer addresses all parts of the question—royalty structure, milestone payments, net product revenue, and evolution over 2022–2024—with precise and relevant details. Wording differs slightly from the original but preserves full semantic equivalence. No omissions or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Partners_With]-> COMP <-[Depends_On]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 347,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Procter & Gamble's positioning of Dawn dish soap within its Fabric & Home Care segment evolve from 2022 to 2024, and what does this reveal about the product's strategic importance in the company's portfolio?",
      "original_answer": "Dawn remained a consistently highlighted brand within P&G's Fabric & Home Care segment across all three years (2022–2024), indicating its sustained strategic importance. In 2022, the segment accounted for 35% of net sales and 31% of earnings, with Dawn listed among key brands. By 2023, the segment maintained its dominance at 36% of net sales and 34% of earnings, again featuring Dawn prominently. In 2024, the Fabric & Home Care segment continued to represent 36% of net sales and 34% of earnings, with Dawn still positioned as a major brand. This consistency suggests that Dawn remained a core contributor to the segment's performance, with no indication of reduced emphasis or strategic repositioning over the three-year period.",
      "llm_answer": "\nProcter & Gamble continued to list **Dawn** among the core brands of its **Fabric & Home Care** segment in every annual filing (2022, 2023 and 2024), and the segment’s contribution to the company’s overall performance remained robust – **Net‑sales share rose modestly from 35 % (2022) to 36 % (2023‑2024)** while **earnings share climbed from 31 % to 34 %**, indicating that Dawn’s sales and profitability are increasingly pivotal to the segment’s growth.  This steady rise in the segment’s weight within P&G’s portfolio, coupled with Dawn’s persistent presence as a flagship brand, reveals that the dish‑soap line is a strategic anchor that drives both revenue expansion and margin improvement for the company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dawn is consistently listed as a core brand in the Fabric & Home Care segment from 2022 to 2024; the segment's net sales share was 35% in 2022 and 36% in 2023–2024; earnings share increased from 31% to 34%. These numbers match the original answer exactly, and formatting (e.g., 35%, $ amounts not needed) is appropriate. (2) Quantitative accuracy is perfect: percentages are correctly reported across years, and the trend description (modest rise in net sales, increase in earnings) is factually sound. (3) Reasoning is strong: the LLM correctly infers that Dawn’s persistent positioning as a highlighted brand, alongside the segment’s stable and slightly growing contribution, indicates strategic importance. The only minor deviation is the phrase 'increasingly pivotal' and 'drives both revenue expansion and margin improvement', which implies a growing strategic role. The original answer emphasizes consistency rather than increasing importance, suggesting no repositioning but not necessarily an upward trajectory. This is a subtle interpretive difference, not a factual error. (4) The answer fully addresses both parts of the question—evolution of positioning (none, consistently core) and strategic importance (remains a major, stable contributor). Contextual relevance is excellent, synthesizing multi-year data into a coherent narrative about portfolio strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 406,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, then declined to $45.551 billion in 2024. This trajectory shows a significant rise in debt levels during 2023, followed by a partial reduction in 2024. The composition of debt also shifted notably: floating unsecured senior debt dropped from $1.709 billion in 2022 to $349 million in 2023, and was entirely eliminated by 2024. Meanwhile, the weighted-average interest rate on fixed unsecured senior debt rose from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024, indicating a strategic shift toward fixed-rate debt amid rising interest rates.",
      "llm_answer": "\nCapital One’s combined short‑term borrowings and long‑term debt increased from $43.1 bn in 2022 (Chunk 1) to $49.9 bn in 2023 (Chunk 2) before declining to $45.6 bn in 2024 (Chunk 3).  This evolution reflects a shift from floating‑rate senior debt— which fell from $1.71 bn (Chunk 1) to $0.35 bn (Chunk 2) and $0 (Chunk 3)—to a larger proportion of fixed‑rate senior and subordinated notes, driving the weighted‑average interest rate up from 2.76 % (Chunk 1) to 4.84 % (Chunk 3) and indicating a deliberate reduction in interest‑rate exposure to floating unsecured senior borrowings over the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend in Capital One's total short-term borrowings and long-term debt—increasing from 2022 to 2023 and then declining in 2024—but contains significant numerical inaccuracies. The reported 2023 total debt is $49.9 billion, which deviates from the ground truth of $48.715 billion (an overstatement of ~$1.2 billion). The 2022 and 2024 figures are close ($43.1B vs $43.086B; $45.6B vs $45.551B), with minor rounding acceptable. (2) The floating unsecured senior debt values are mostly accurate: $1.71B (vs $1.709B), $0.35B (vs $349M), and $0 in 2024 (correctly noting elimination). However, the weighted-average interest rate on fixed unsecured senior debt is misstated: LLM reports 2.76% in 2022 vs ground truth 2.91%, and jumps directly to 4.84% in 2024 without acknowledging the 4.45% in 2023. This omits a key intermediate data point and weakens the trend analysis. (3) The multi-hop reasoning is sound—LLM correctly infers a strategic shift toward fixed-rate debt to reduce interest rate exposure amid rising rates, based on the decline in floating-rate debt and rising weighted-average rates. It synthesizes debt composition and interest rate trends appropriately. (4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracies—especially the inflated 2023 total debt and incorrect interest rate trajectory—prevent a higher score. The core narrative is correct, but precision on key financial metrics is lacking.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 414,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Cisco's utilization of its 5.90% Note evolve from fiscal year 2022 through 2024, particularly in terms of its total debt composition, effective interest rate, and long-term debt classification?",
      "original_answer": "Cisco maintained the $2,000 million principal amount of the 5.90% Note consistently across all three years (2022–2024), with the effective interest rate remaining unchanged at 6.11% throughout. However, the note's proportion within Cisco's total long-term debt shifted as overall debt levels increased significantly—from $8,416 million in long-term debt in 2022 to $19,621 million in 2024. This indicates Cisco expanded its debt portfolio substantially while keeping the 5.90% Note as a stable, fixed-rate component.",
      "llm_answer": "\nCisco’s 5.90 % senior note remained outstanding throughout FY 2022‑FY 2024 at the same $2 billion principal amount and a constant effective interest rate of **6.11 %**, and it was always recorded under **long‑term debt** (never re‑classified to short‑term).  However, the composition of the overall debt shifted markedly: total long‑term debt rose from **$9.0 bn (FY 2022)** to **$19.6 bn (FY 2023‑FY 2024)**, while short‑term debt fell from about **$2.5 bn to $0.5 bn**, reflecting the addition of new senior issues while the 5.90 % note continued to be reported as a long‑term instrument.  (All three filings list the note at $2 bn, 6.11 % effective rate, and within the long‑term‑debt line.)",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Cisco maintained a $2,000 million (i.e., $2 billion) principal amount of the 5.90% Note with a constant effective interest rate of 6.11% across FY2022–FY2024, and that it remained classified as long-term debt. These core facts are accurate and match the ground truth. However, there are key quantitative discrepancies: the LLM states total long-term debt was $9.0 billion in FY2022, whereas the ground truth reports $8,416 million (~$8.4 billion), and it claims $19.6 billion in FY2023–FY2024, while the truth shows $19,621 million in FY2024 (though $19.6B is a reasonable rounding). More critically, the LLM incorrectly implies that long-term debt was $19.6 billion in both FY2023 and FY2024, but the ground truth does not provide FY2023 data—only FY2022 and FY2024—so asserting stability across 2023–2024 is unsupported. Additionally, the mention of short-term debt declining from $2.5B to $0.5B introduces information not present in the original answer and is not responsive to the question, which focused on the 5.90% Note’s role in total debt composition, not short-term dynamics. (2) The principal amount ($2B), effective rate (6.11%), and long-term classification are correct. But the total long-term debt figures are inaccurate for FY2022 and overgeneralized for FY2023. (3) The multi-hop reasoning is partially sound—LLM correctly infers that the note remained stable while overall debt increased, altering its proportional weight. However, it adds extraneous details (short-term debt) and misrepresents the timeline by assuming FY2023 data. (4) Despite these issues, the core insight—that Cisco expanded its debt portfolio while keeping the 5.90% Note constant—is preserved, warranting a score of 7 for correctness. Quantitative accuracy is penalized due to incorrect totals and unsupported assertions. Qualitative and contextual scores remain high because the reasoning and focus on debt composition are largely appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 534,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the carrying value and effective interest rate of NVIDIA's 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this trend reveal about the company's long-term debt financing strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 increased from $1,200 million in fiscal year 2022 to $1,099 million in 2023, and then rose again to $1,250 million in 2024. The effective interest rate on these notes also increased from an implied rate based on market pricing in 2022 to 1.64% in fiscal year 2024. This pattern suggests that NVIDIA maintained or reacquired the notes after a temporary decrease in 2023, while also facing a modest increase in borrowing costs over time. The company appears to be strategically managing its long-term debt profile by maintaining consistent long-term obligations while navigating changing interest rate environments.",
      "llm_answer": "\nThe 1.55 % Notes Due 2028 grew from a reported fair‑value of **≈ $1.2 bn** in FY 2022 (Chunk 3) to a liability balance of **$1.099 bn** at the end of FY 2023 and **$1.115 bn** at the end of FY 2024 (Chunk 1), while the schedule in Chunk 2 shows the note’s **effective interest rate of 1.64 %** for the 2024‑25 reporting period (the same rate applied in the prior year).  This modest rise in carrying amount reflects the ongoing amortization of the original discount, and the stable, slightly‑above‑coupon effective rate demonstrates that NVIDIA is financing its long‑term growth with low‑cost, long‑dated debt whose borrowing cost remains tightly controlled and predictable.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, the carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in FY2022, decreased to $1,099 million in FY2023, and then increased to $1,250 million in FY2024. However, the LLM incorrectly reports the FY2024 carrying value as $1.115 billion (i.e., $1,115 million), which is materially lower than the correct $1,250 million. Additionally, the LLM refers to the FY2022 figure as a 'fair-value' and '≈ $1.2 bn', but the ground truth specifies it as the 'carrying value'—a distinct accounting concept—and the exact value is $1,200 million. These are not minor rounding differences but reflect misrepresentation of both the metric type and amount. (2) The effective interest rate is reported correctly as 1.64% for fiscal year 2024, matching the ground truth. However, the LLM claims this rate was 'the same rate applied in the prior year' without confirming the 2023 rate, and the ground truth only specifies an 'implied rate based on market pricing' in 2022 and does not provide the 2023 rate—so asserting stability lacks full support. (3) The multi-hop reasoning is partially sound: the model attempts to synthesize data across years and interpret the trend in financing strategy. However, it mischaracterizes the trend—claiming a 'modest rise' in carrying amount when the actual pattern is a dip in 2023 followed by a significant rebound in 2024 to above the initial level. This undermines the conclusion about amortization of discount, which contradicts the observed increase from $1.099B to $1.250B. The ground truth suggests possible reacquisition or strategic repositioning, while the LLM incorrectly implies a steady, predictable amortization. (4) Despite these errors, the answer is contextually relevant, addressing all parts of the question—evolution of carrying value, effective interest rate, and strategic implications—and uses appropriate financial terminology. The qualitative reasoning is plausible but based on incorrect data. Hence, correctness is scored low due to major quantitative errors, though not zero because some elements (like the 2024 rate) are accurate and the overall structure is responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 602,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Google's strategic emphasis on Pixel devices evolve from 2022 to 2024, particularly in terms of revenue categorization and investment in hardware innovation?",
      "original_answer": "In 2022, Google emphasized its long-term investment in hardware, listing Pixel phones among key devices like Fitbit wearables and Nest products, signaling a strategic push toward integrated AI-driven hardware. By 2023, Pixel devices were explicitly categorized under a distinct 'devices' segment within Google's Subscriptions, Platforms, and Devices revenue stream, indicating their growing importance as a standalone revenue contributor. In 2024, the continued inclusion of Pixel devices in the same segment, alongside more detailed revenue recognition policies for digital services and cloud offerings, suggests that Pixel devices were not only maintained as a core product line but also likely integrated with broader AI and cloud capabilities. This 3-year progression reflects a transformation from a hardware investment focus to a mature, strategically embedded product line within Google's ecosystem.",
      "llm_answer": "\nFrom 2022 to 2024 Google moved its hardware push from a loosely‑described “hardware” growth story (Pixel 5a/6 phones, Fitbit, Nest Cams, Nest Doorbell, and AI‑enabled devices) into a formally‑named “devices” revenue line that sits inside the broader **Google Subscriptions, Platforms, and Devices** category (Chunk 3 → Chunk 1 & 2).  In the 2023 and 2024 filings the company explicitly reports **Pixel‑family sales** as part of that devices line, explains that revenue fluctuates with product‑launch timing, and details the **cost‑of‑revenues** structure—including inventory, TAC payments to distribution partners, and other device‑related expenses (Chunk 1 & 2).  At the same time, the filings show continued **investment in hardware innovation**—new Pixel models, AI‑enhanced features (e.g., Gemini/VRM, Vertex AI) and tighter integration with Google Cloud and Workspace—funded through R&D and sales‑marketing spend, while noting that fluctuations in compensation and stock‑based awards can affect operating expenses (Chunk 1 & 2).  Thus, the strategic emphasis evolved from announcing a hardware roadmap to treating device sales as a distinct, measurable revenue stream while maintaining a multi‑year commitment to AI‑driven hardware development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All key facts are correct: Google's strategic shift from a general hardware investment narrative in 2022 to a formal 'devices' segment within 'Subscriptions, Platforms, and Devices' in 2023 and 2024 is accurately described. The inclusion of Pixel devices in this distinct revenue line is correctly noted, as is the emphasis on AI integration and innovation. (2) There are no numeric inaccuracies—while no specific dollar figures are mentioned in either answer, the LLM correctly references revenue recognition, cost-of-revenues components (inventory, TAC), and expense fluctuations without introducing false data. (3) Multi-hop reasoning is sound: the model synthesizes information across years and segments, correctly identifying the evolution in revenue categorization and linking it to ongoing R&D and AI integration. It appropriately infers that formal reporting implies increased strategic importance. (4) The only minor shortcoming is that the LLM answer adds detail not in the original (e.g., specific product names like Pixel 5a/6, Nest Doorbell), which, while plausible, are not confirmed in the ground truth. Also, references to 'Chunk 1 & 2' suggest reliance on source markers not available to the user, slightly reducing transparency. However, these do not affect factual correctness. Overall, the answer captures the core evolution accurately and with strong contextual and qualitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Invests_In]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 410,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did BNY Mellon's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistency or change in presentation reveal about the firm's audit relationship stability?",
      "original_answer": "BNY Mellon consistently incorporated the ratification of KPMG LLP by reference in the Proxy across all three years (2022, 2023, and 2024), with identical language stating that KPMG LLP’s PCAOB firm identification number is 185. There were no changes in the content or structure of the disclosure, indicating a stable and ongoing relationship with KPMG LLP as the principal accountant. This consistency suggests no disruptions or changes in the firm's external audit provider or related governance practices over the three-year period.",
      "llm_answer": "\nBNY Mellon’s filings from 2022 through 2024 each contain the identical “Item 3 – Ratification of KPMG LLP” disclosure in the Principal Accountant Fees and Services section, repeatedly stating that the ratification of KPMG LLP is incorporated by reference and that KPMG LLP’s PCAOB firm identification number is 185.  This unchanged language—present in Chunk 1 (2022), Chunk 2 (2023) and Chunk 3 (2024)—shows that the company has consistently reaffirmed KPMG LLP as its principal auditor each year, a stability reflected in the knowledge‑graph link Ratification of KPMG LLP (ACCOUNTING_POLICY) → Ratification of KPMG LLP (ORG) → BK (ORG).  The persistent presentation therefore signals an unbroken, steady audit relationship between BNY Mellon and KPMG LLP over the three‑year period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that BNY Mellon used identical disclosure language across 2022, 2023, and 2024 regarding the ratification of KPMG LLP as principal accountant, with the specific detail that KPMG’s PCAOB firm ID is 185—this matches the original answer exactly. (2) There are no numerical values requiring calculation, but the years (2022–2024) and the PCAOB ID (185) are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the unchanged disclosure over three years, across multiple filings (referred to as 'Chunks'), indicates a stable audit relationship. It also appropriately references the knowledge graph link to support the conclusion, demonstrating correct entity and relationship mapping. (4) The answer addresses both parts of the question: the evolution (or lack thereof) in disclosure and what it reveals about audit relationship stability. Wording differs slightly but conveys the same factual and inferential content. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 316,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did LLY's allocation to private alternative investments evolve across 2022, 2023, and 2024, and what does this multi-year trajectory suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to private alternative investments increased from $10,542.5 million in 2022 to $10,335.2 million in 2023, and then further rose to $10,051.0 million in 2024. Despite some fluctuations in specific categories like equity-like funds and hedge funds, the company maintained a consistently high exposure to private alternative investments, indicating a strategic emphasis on diversification and long-term growth through illiquid assets.",
      "llm_answer": "\nLLY’s private‑alternative‑investment allocation rose from about **$7.9 bn in 2022** (the sum of hedge‑fund, equity‑like, real‑estate and “other” private‑alt holdings disclosed in Chunk 1) to roughly **$8.9 bn in 2023** (Chunk 3’s $3.25 bn + $4.01 bn + $0.35 bn + $1.26 bn ≈ $8.87 bn) and held near **$8.6 bn in 2024** (Chunk 2’s $3.13 bn + $4.09 bn + $0.37 bn + $1.02 bn ≈ $8.61 bn).  \n\nThis steady upward trend—despite modest pull‑back in 2024—shows LLY’s deliberate, multi‑year commitment to building a larger exposure to illiquid private‑alt assets, underscoring a long‑term investment strategy that relies on Level‑3 (unobservable) valuations and seeks enhanced returns and diversification through these non‑public assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported dollar amounts. According to the ground truth, LLY's allocation to private alternative investments was $10,542.5 million in 2022, decreased to $10,335.2 million in 2023, and further declined to $10,051.0 million in 2024—indicating a downward trend. However, the LLM incorrectly reports allocations as $7.9 billion in 2022, rising to $8.9 billion in 2023, and $8.6 billion in 2024, which misrepresents both the absolute values and the trend direction. These numbers are not within acceptable rounding or formatting variance and reflect a fundamental error in data extraction or summation. (2) The calculations in the LLM answer are internally consistent (e.g., summing components to ~$8.87B and ~$8.61B), but they are based on incorrect underlying figures from the chunks, suggesting either misreading of data or referencing wrong documents. The ground truth shows allocations above $10 billion each year, not below $9 billion. (3) The multi-hop reasoning is structurally sound—the model attempts to synthesize annual data across years and interpret strategic implications—but the faulty input data leads to an incorrect conclusion about an 'upward trend.' In reality, the slight decline over three years still reflects sustained high exposure, not growth. (4) Despite incorrect numbers, the LLM correctly identifies the qualitative intent behind holding private alternatives (diversification, long-term growth, Level 3 assets), so the strategic interpretation is partially valid. Contextual relevance is high because the response addresses both parts of the question (evolution over time and strategic implication), but correctness is severely undermined by quantitative inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 481,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Procter & Gamble's positioning of Tampax within its Feminine Care portfolio evolve across 2022, 2023, and 2024, particularly in terms of category classification and associated product line emphasis?",
      "original_answer": "In 2022, Tampax was listed under 'Feminine Care' within the broader 'Baby, Feminine & Family Care' segment, which accounted for 25% of net sales, and was grouped alongside 'Adult Incontinence' and 'Baby Care' categories. By 2023, Tampax remained in the 'Feminine Care' category, but the segment was rebranded as 'Baby, Feminine & Family Care' and slightly decreased in sales contribution to 24% of net sales, with 'Menstrual Care' now explicitly replacing 'Feminine Care' as a sub-category. In 2024, Tampax continued under 'Menstrual Care' within the same segment, which remained at 24% of net sales, and the company further streamlined the segment by removing 'Baby Care' entirely, signaling a strategic shift toward focusing on feminine and family care products. This evolution reflects a growing strategic emphasis on adult feminine hygiene and away from infant-related product lines.",
      "llm_answer": "\nAcross 2022‑2024 Tampax has been housed in the **Feminine Care** sub‑category of P&G’s **Baby, Feminine & Family Care** reportable segment; the 2022 table lists it under “Feminine Care (Adult Incontinence, Feminine Care)” alongside Always and Tampax Bounty, while the 2023 and 2024 tables refine the description to “Feminine Care (Adult Incontinence, Menstrual Care)” and continue to list Tampax Bounty as a major brand. This shows a consistent emphasis on menstrual‑care products within the broader Baby, Feminine & Family Care portfolio, with the segment’s net‑sales share slipping slightly from **25 % (2022)** to **24 % (2023‑24)** while earnings remain stable. The knowledge‑graph links (Tampax → Tampax (org) → PG) confirm that Tampax is treated as a distinct brand owned by P&G throughout the three years.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the segment name (Baby, Feminine & Family Care) and the consistent placement of Tampax within it across 2022–2024. It accurately reports the net sales percentages: 25% in 2022 and 24% in 2023–2024, aligning with the ground truth. However, there are significant qualitative inaccuracies in the evolution of category classification. The LLM incorrectly states that 'Feminine Care' remained the sub-category throughout, when in fact the sub-category was rebranded from 'Feminine Care' to 'Menstrual Care' in 2023—a key strategic shift that the model fails to recognize. Additionally, the LLM invents a non-existent brand 'Tampax Bounty', which is not mentioned in the ground truth and appears to be a conflation of Tampax and Bounty (a P&G cleaning brand), indicating a serious entity error. The model also misses the 2024 strategic shift where 'Baby Care' was removed from the segment, signaling a move away from infant products—this critical point is entirely omitted. While the quantitative data (percentages, years) is mostly accurate and the context of segment-level reporting is relevant, the failure to capture the reclassification to 'Menstrual Care' and the strategic removal of 'Baby Care' undermines the multi-hop reasoning required. The answer shows partial understanding but contains key factual errors and omissions in entity identification and strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Announces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 390,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did Capital One's fair value and valuation assumptions for net derivative assets (liabilities) evolve from 2022 to 2024, particularly regarding the use of discounted cash flow models and key unobservable inputs like default rates and swap rates?",
      "original_answer": "In 2022, Capital One reported a net derivative assets (liabilities) fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end, though the specific valuation technique was not disclosed. By 2023, the fair value of net derivative assets (liabilities) was $58 million, and the company explicitly stated the use of discounted cash flow models, citing default rates ranging from 53-163% and swap rates of 3-5%. In 2024, the fair value remained at $58 million, with the valuation continuing to rely on discounted cash flows, maintaining the same swap rate range of 3-5%. This progression shows a shift toward more transparent and methodologically consistent valuation practices starting in 2023, with increased specificity in unobservable inputs, particularly around default rate assumptions.",
      "llm_answer": "\nCapital One’s net derivative assets (liabilities) were classified as Level 3 and valued using discounted‑cash‑flow models in every year shown.  In 2022 the balance stood at **$19 million** (Chunk 1), while by the end of 2023 the fair value had risen to **$58 million**, with the valuation now disclosed as a discounted‑cash‑flow model that incorporates a **default‑rate range of 53‑163 % (weighted‑average ≈ 4 %)** and a **swap‑rate range of 3‑5 % (weighted‑average ≈ 4 %)** (Chunk 2).  The 2024 filing (Chunk 3) retains the same discounted‑cash‑flow approach and reports a **$58 million** fair value, reiterating the **3‑5 % swap‑rate range (weighted‑average 4 %)** and the same default‑rate assumptions used in 2023, confirming that the evolution from 2022 to 2024 reflects a more than three‑fold increase in fair value driven by higher market values but consistent use of discounted‑cash‑flow inputs with stable default‑rate and swap‑rate estimates.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair values for 2022 ($19M) and 2023–2024 ($58M), matching the ground truth. It accurately states the use of discounted cash flow models starting in 2023 and the unobservable inputs: default rate range (53–163%) and swap rate range (3–5%). However, the LLM incorrectly implies that the same default rate assumptions were used in 2024 as in 2023 by saying 'the same default-rate assumptions used in 2023'—the ground truth does not confirm that default rates were re-stated in 2024, only that swap rates were reiterated. This is a minor overstatement. (2) Quantitatively, all dollar amounts and percentage ranges are correct. The addition of weighted-average figures (≈4%) is not in the original answer and is potentially misleading, though not necessarily incorrect if derived from the range; however, since the ground truth does not mention weighted averages, introducing them constitutes a small factual overreach. (3) The multi-hop reasoning is largely sound: the LLM correctly synthesizes data across 2022–2024, notes the shift in transparency starting in 2023, and links valuation method changes to increased disclosure. The conclusion about a 'more than three-fold increase in fair value' is accurate (from $19M to $58M ≈ 205% increase), though 'more than three-fold' slightly exaggerates (three-fold would be $57M). (4) Contextual relevance is excellent—the answer directly addresses the evolution of valuation assumptions, methods, and key inputs. The qualitative accuracy is slightly reduced due to the unsupported claim about 2024 default rates and the introduction of weighted averages not in the source. Overall, the answer is factually strong but contains minor overstatements, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 484,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Cisco's available-for-sale (AFS) debt investments impact its 'other income (loss), net' metric across fiscal years 2022 to 2024, and what does this reveal about the financial performance and risk profile of these investments over time?",
      "original_answer": "In fiscal 2022, Cisco disclosed the existence of its AFS debt investments through summarized tables, but no specific performance metrics were provided for that year, indicating no immediate material impact on financial results. In fiscal 2023, the company reported that higher losses in AFS debt investments were a primary driver of a decline in 'other income (loss), net,' signaling a material negative impact. This trend continued in fiscal 2024, where AFS debt investment losses again significantly contributed to a lower 'other income (loss), net' result, despite partial offsets from gains in equity investments. The consistent negative impact in 2023 and 2024, combined with the lack of performance data in 2022, reveals a growing financial risk associated with these investments over time.",
      "llm_answer": "\nAcross fiscal 2023 and 2024 Cisco disclosed that “higher losses in our available‑for‑sale debt investments” were the principal cause of the rise in **other income (loss), net**, with only modest offsets from gains on marketable equity and lower losses on privately‑held investments (Chunk 2 & Chunk 3).  This negative contribution is reflected in the knowledge‑graph relationship where AFS debt investments **Negatively_Impact** the parent’s other‑income line (Chunk 1 → AFS Debt Investments → CSCO), showing that the portfolio’s credit‑ and interest‑rate exposure directly depresses earnings.  Consequently, the trend from 2022 through 2024 highlights a material earnings‑volatility risk: despite a slight improvement in the effective tax rate, the AFS debt holdings remain a significant source of unpredictable losses that swing the “other income (loss), net” metric.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that higher losses in AFS debt investments were the 'principal cause of the rise in other income (loss), net', but according to the ground truth, these losses caused a decline (not a rise) in 'other income (loss), net'. This reverses the direction of the financial impact and fundamentally misrepresents the performance. Additionally, the LLM incorrectly implies that the negative impact began in 2023 and continued into 2024 without acknowledging the absence of disclosed performance data in 2022, which is a key point in the original answer about evolving risk visibility. (2) There are no explicit numbers (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not heavily penalized, but the directional misstatement (rise vs. decline) undermines financial accuracy. The mention of 'modest offsets from gains on marketable equity' aligns partially with the original's mention of equity gains partially offsetting losses in 2024, so some contextual detail is preserved. (3) The multi-hop reasoning is partially sound—the model correctly identifies a causal link between AFS debt investment losses and 'other income (loss), net' and references a knowledge graph relationship. However, it fails to correctly synthesize the temporal progression across 2022–2024, especially the lack of data in 2022 and the consistent negative impact in 2023 and 2024. The conclusion about 'material earnings-volatility risk' is reasonable but overstated given the incorrect framing of a 'rise' in other income. (4) Contextual relevance is high because the answer addresses the core topic—Cisco’s AFS debt investments and their impact on other income—with appropriate financial terminology and causal reasoning. However, due to the reversal of the financial impact direction and omission of the 2022 data silence, the overall correctness score is significantly reduced to 4, reflecting partial accuracy with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Negatively_Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 546,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Starbucks' projected green coffee supply adequacy evolve from fiscal 2022 through fiscal 2024, and what does this multi-year progression indicate about the company's sourcing strategy and risk mitigation approach?",
      "original_answer": "In fiscal 2022, Starbucks projected that its green coffee supply, including purchase commitments and inventory, would be adequate through fiscal 2023. By fiscal 2023, the company extended its supply adequacy projection to fiscal 2025, a trend that continued into fiscal 2024. This three-year progression indicates that Starbucks has been strengthening its sourcing strategy by securing longer-term purchase commitments and improving inventory management, thereby enhancing supply chain resilience and reducing delivery risk with coffee producers.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks lengthened its outlook for an adequate green‑coffee supply—initially stating that total purchase commitments and inventory would meet demand only through fiscal 2023 (Chunk 1), but later revising the projection to cover fiscal 2025 in both the 2023 and 2024 filings (Chunks 2 & 3).  This multi‑year extension reflects a sourcing strategy that relies on diversified, multi‑regional purchases, fixed‑price and price‑to‑fixed contracts, and active hedging with forward, futures and collar instruments, while reinforcing long‑term relationships with coffee producers and its farmer‑support centers to keep the risk of non‑delivery “remote.”",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates and projections are correct: fiscal 2022 outlook covered through fiscal 2023; by fiscal 2023 and 2024, the outlook was extended to fiscal 2025. These match the original answer exactly. (2) The answer correctly captures the multi-year progression: from adequacy through 2023 in the 2022 filing, to adequacy through 2025 in the 2023 and 2024 filings. (3) The reasoning is sound and adds valuable detail not in the original answer—such as hedging instruments (futures, collars), contract types, and farmer-support centers—which are consistent with Starbucks’ known sourcing practices and enhance the explanation of risk mitigation. While the original answer emphasizes longer-term commitments and inventory management, the LLM enriches this with specific mechanisms, which can be considered a valid elaboration rather than a deviation. (4) The only minor gap is that the LLM does not explicitly state that this reflects a 'strengthening' of strategy over three years, though the implication is clear from the progression. This slight omission in framing prevents a perfect 10, but the core facts, synthesis, and logic are correct. All entities (Starbucks, green coffee supply, fiscal years 2022–2024) are accurate. The answer is fully relevant and addresses both parts of the question: the evolution of supply adequacy and what it indicates about sourcing and risk mitigation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 405,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has NVIDIA's financial exposure to the 2.00% Notes Due 2031 evolved from fiscal year 2022 through 2024, and what does this trend reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 increased from $1,200 million in fiscal year 2022 to $1,044 million in 2023, and then rose again to $1,250 million in 2024. This fluctuation suggests a dynamic approach to long-term debt management, with the company maintaining a consistent presence in this instrument over time, despite short-term variations.",
      "llm_answer": "\nNVIDIA’s exposure to the 2.00 % Notes Due 2031 moved from a fair‑value of roughly **$1.20 bn in FY2022** (Chunk 3) to a carrying amount of **$1.057 bn in FY2023** (Chunk 1) and then **increased to $1.250 bn in FY2024**, where the note shows a remaining term of **6.4 years, an effective rate of 2.09 % and a net long‑term carrying amount of $8.463 bn** (Chunk 2). This shift reflects the company’s active management of its long‑term debt profile—maintaining a sizable low‑coupon position while extending maturity and adjusting issuance to balance financing costs, liquidity and overall leverage. The disclosed relationship (NVDA → 2.00 % Notes Due 2031 ← ORG) underscores that the 2031 tranche is a core component of NVIDIA’s strategic, long‑dated financing strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has a key numerical discrepancy in the FY2023 value. The ground truth states NVIDIA's exposure was $1,044 million in 2023, but the LLM reports $1.057 billion ($1,057 million), which is incorrect. The FY2022 ($1.20 billion = $1,200 million) and FY2024 ($1.250 billion = $1,250 million) values are accurate and match the ground truth. (2) The LLM introduces the term 'fair-value' for FY2022 and 'carrying amount' for FY2023 and FY2024, which adds nuance not present in the original answer. While these may reflect actual distinctions in financial reporting, the original answer does not make this distinction and simply reports exposure as a consistent metric across years. This added specificity is not incorrect per se but introduces complexity not supported by the ground truth. (3) The reasoning about NVIDIA’s long-term debt strategy is sound and aligns with the original answer’s interpretation—highlighting active management, low coupon rates, and strategic use of long-dated debt. The mention of a 6.4-year remaining term and 2.09% effective rate in FY2024 adds detail beyond the ground truth but does not contradict it. (4) The multi-hop synthesis is appropriate: the model connects NVIDIA to the 2.00% Notes Due 2031 and tracks changes over three fiscal years. However, the incorrect FY2023 figure reduces quantitative accuracy. Overall, the answer captures the trend direction (down then up) and strategic implication correctly, warranting a score of 7 for correctness—minor factual error but solid reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 439,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did MMM's positioning of Fall Protection Solutions within its Safety and Industrial segment evolve from 2022 to 2024, particularly in terms of product categorization and emphasis relative to other industrial safety offerings?",
      "original_answer": "In 2022, Fall Protection Solutions were listed alongside respiratory, hearing, and eye protection as part of a broader suite of safety offerings within the Safety and Industrial segment. By 2023, the listing order remained consistent, maintaining its position among core industrial safety products. In 2024, while still included within the Safety and Industrial segment, Fall Protection Solutions were presented with a slightly revised grouping that emphasized industrial specialty products and appeared to align more closely with broader industrial safety systems rather than being highlighted as a standalone category. This evolution suggests a subtle shift in how MMM framed fall protection within its industrial safety portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 MMM kept **Fall Protection Solutions** inside its **Safety and Industrial** segment, but the way it was framed shifted.  \n- In the 2022 filing the product appeared simply as “**Respiratory, hearing, eye and fall protection solutions**” listed alongside other safety gear.  \n- By 2023 the same phrasing was retained, yet the bullet list added “**Closure systems for personal hygiene products, masking, and packaging materials**,” signaling a broader safety‑related portfolio.  \n- In the 2024 filing the segment was expanded to include “**Industrial specialty products such as personal hygiene products, masking, and packaging materials**” while still retaining “**Respiratory, hearing, eye and fall protection solutions**,” indicating that fall‑protection remained a distinct offering but was now positioned within a larger suite of industrial‑specialty safety products.  \n\nThus, MMM’s positioning evolved from a standalone safety‑equipment line to a component of a more diversified safety‑and‑specialty portfolio, maintaining emphasis on fall protection while integrating it with other industrial safety offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Fall Protection Solutions remained within the Safety and Industrial segment from 2022 to 2024, and were consistently grouped with respiratory, hearing, and eye protection. The evolution in framing—from a standalone safety offering to a component within a broader industrial specialty portfolio—is accurately captured. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and used appropriately. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in product categorization and emphasis across three years of filings, noting both continuity and subtle shifts in presentation. The addition of closure systems and industrial specialty products in 2023 and 2024 is correctly identified as context for the repositioning. (4) The only minor shortcoming is that the LLM slightly overemphasizes the integration of fall protection into industrial specialty products, whereas the original answer notes it was 'presented with a slightly revised grouping' and 'appeared to align more closely'—a more cautious interpretation. The LLM's phrasing suggests a clearer strategic shift than the ground truth implies, but this does not constitute a factual error. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 404,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How did Eli Lilly's revenue from bamlanivimab evolve from 2022 through 2024, and what does this trend indicate about the company's reliance on its COVID-19 antibody portfolio over time?",
      "original_answer": "Eli Lilly's revenue from bamlanivimab, as part of its broader COVID-19 antibody portfolio, declined significantly from $2.01 billion in 2022 to $0 in 2023 and remained at $0 in 2024. This indicates a rapid decline in the company's reliance on this product as the pandemic response matured and demand for the antibody treatments waned.",
      "llm_answer": "\nEli Lilly’s COVID‑19 antibody sales – which consist of bamlanivimab (and related antibodies) – dropped from about **$2.0 billion in 2022** (the “COVID‑19 antibodies (6)” line shows $2,008.9 million in the U.S. and $14.7 million outside the U.S. for 2022 in the 2024 revenue table, and the same $2,008.9 million + $14.7 million figures appear in the 2022 column of the 2023 table) to **near‑zero in 2023 and 2024** (both years list a “‑” for the COVID‑19 antibodies row in their respective tables, indicating no revenue).  This decline is consistent with the context in chunk 1, which notes that the $2.24 billion of net product revenue from COVID‑19 antibodies was recorded in 2021 and that royalty payments to AbCellera are booked as cost of sales, and it shows that by 2023 the portfolio’s contribution had essentially vanished, signaling that Lilly’s reliance on its COVID‑19 antibody line has sharply receded over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the revenue decline from $2.01 billion in 2022 to $0 in 2023 and 2024. It accurately reports the 2022 figure as $2,008.9 million + $14.7 million = $2,023.6 million (~$2.02 billion), which aligns closely with the ground truth $2.01 billion (minor discrepancy likely due to rounding or reporting scope; within acceptable tolerance). The '‑' notation in the tables for 2023 and 2024 is correctly interpreted as $0 revenue, matching the ground truth. (2) All numeric values and timeframes are accurate: 2022 revenue is properly sourced from both the 2023 and 2024 filings, and the absence of revenue in 2023–2024 is correctly noted. The mention of $2.24 billion in 2021 adds contextual accuracy without contradicting the main trend. (3) The multi-hop reasoning is sound: the model synthesizes data across multiple tables and years, correctly infers that '‑' means no revenue, and connects the decline to reduced reliance on the COVID-19 antibody portfolio. It also correctly contextualizes bamlanivimab as part of a broader antibody line. (4) The answer is semantically equivalent to the ground truth, with slightly more granular detail (e.g., U.S. vs. international breakdown), and the conclusion about declining reliance is logically supported. The only minor shortcoming is not explicitly naming bamlanivimab as the sole or primary component of the 'COVID-19 antibodies' line in later years, but this does not detract significantly from accuracy. Scores reflect high correctness, perfect quantitative accuracy, excellent reasoning, and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 439,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Starbucks' exposure to commodity index funds through coffee price volatility evolve from fiscal 2022 through fiscal 2024, and what does this trend reveal about the company's risk management strategy in securing green coffee supply commitments extending through fiscal 2025?",
      "original_answer": "Starbucks consistently acknowledged the influence of commodity index funds on arabica coffee futures prices in all three fiscal years (2022, 2023, and 2024), reflecting ongoing exposure to financial market activities. However, the company extended its supply visibility and risk mitigation capabilities over time — from securing adequate supply through fiscal 2023 in 2022, to projecting adequacy through fiscal 2025 by 2024. This indicates a strengthening of risk management practices, particularly through increased use of forward contracts, futures contracts, and collars to hedge 'C' price exposure, even as commodity index fund activity continued to impact price volatility. The multi-year progression shows Starbucks improving its supply chain resilience while maintaining remote delivery risk assessments across all three years.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Starbucks lengthened its green‑coffee supply horizon—moving from commitments that secured supply only through FY 2023 (Chunk 1) to explicit commitments that now extend through FY 2025 (Chunks 2 & 3)—while continuing to manage price volatility with forward, futures and collar hedges and to remain exposed to commodity‑index‑fund activity that influences “C”‑price movements (all three chunks).  This progression reveals a risk‑management strategy that deepens long‑term supply contracts and broadens financial‑instrument hedging, including exposure to commodity index funds, to lock in green‑coffee availability and stabilize pricing out to fiscal 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Starbucks extended its green coffee supply commitments from covering through fiscal 2023 (as stated in FY2022) to covering through fiscal 2025 (by FY2024), and the company consistently acknowledged exposure to commodity index funds influencing 'C' price volatility across all three fiscal years. (2) Quantitative accuracy is perfect—dates (FY2022–FY2024), time horizons (through FY2023 and FY2025), and financial instruments (forward contracts, futures, collars) are correctly reported with no calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and documents to show a trend of improving risk management, linking longer supply visibility with continued use of hedging instruments despite ongoing market-driven volatility. (4) The only minor shortcoming is that the LLM slightly downplays the explicit mention of 'risk assessments for remote delivery' present in the original answer, which is a small omission in completeness but does not affect the overall correctness. Wording differences (e.g., 'lengthened supply horizon' vs 'extending supply visibility') are semantically equivalent. The answer fully addresses both parts of the question: evolution of exposure and what it reveals about risk strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 383,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Google's reliance on Google Ad Manager for impression-based monetization evolve from 2022 to 2024, particularly in light of the 2023 adjustment to server depreciation schedules and its implications for long-term profitability?",
      "original_answer": "In 2022, Google Ad Manager was central to Google Network properties' impression-based monetization, with revenue tied to impressions and cost-per-impression metrics. By 2023, Google adjusted the estimated useful life of servers from four to six years and certain network equipment from five to six years, reducing depreciation expense by $3.9 billion and increasing net income by $3.0 billion for the year — a change that directly affected infrastructure-heavy operations like Ad Manager. In 2024, Google continued to report advertising revenues from Google Network properties on a gross basis, reinforcing the strategic importance of Google Ad Manager in revenue generation. The combination of enhanced infrastructure longevity and consistent monetization through Ad Manager indicates a multi-year trend of optimizing cost structures to support long-term profitability in display advertising.",
      "llm_answer": "\nGoogle’s reliance on **Google Ad Manager** for impression‑based monetization grew steadily from 2022 through 2024, as reflected in the 2022‑2024 filings that repeatedly cite impressions and cost‑per‑impression as core metrics for revenue on Google Network properties (Chunk 1) and note that Ad Manager is both a product produced by and an organizational entity that depends on **GOOGL** (KG pattern).  In January 2023 the company extended server lifespans from 4 to 6 years, cutting depreciation expense by **$3.9 bn** and boosting net income by **$3 bn** (Chunk 3), which lowered capital‑cost pressure and enhanced the long‑term profitability outlook that underpins continued heavy use of Ad Manager for impression sales (Chunk 2’s gross‑basis reporting of Ad Manager revenue).  This combination of sustained impression‑driven revenue streams and reduced depreciation expense has strengthened Google’s profitability trajectory over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Google's reliance on Google Ad Manager from 2022 to 2024, accurately describing its role in impression-based monetization and the strategic importance reinforced in 2024. The key financial impact of the 2023 server depreciation change — a $3.9 billion reduction in depreciation expense and $3.0 billion increase in net income — is reported with exact figures, matching the ground truth. (2) Quantitative accuracy is perfect: all numbers ($3.9 billion, $3 billion), dates (2022–2024, January 2023), and metrics (depreciation, net income) are correct and properly contextualized. Minor formatting difference ($3 bn vs $3.0 billion) is acceptable under semantic equivalence. (3) The multi-hop reasoning is sound: the model correctly links the extension of server/network equipment useful life to reduced costs, connects this to improved profitability, and ties it to the sustained use of Google Ad Manager for monetization. It also correctly notes the gross-basis reporting in 2024 as evidence of strategic continuity. The only minor shortcoming is that it does not explicitly mention the change in network equipment depreciation (from five to six years), focusing only on servers — a small omission that slightly affects completeness but not overall correctness. (4) Contextual relevance is excellent: every part of the answer addresses the question directly, synthesizing financial, operational, and strategic elements across years and entities. The conclusion about strengthened profitability trajectory aligns with the ground truth’s emphasis on long-term optimization. Thus, the answer is highly accurate with only a minor gap in full completeness, warranting a 9/10 on correctness and qualitative accuracy, and full marks on quantitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 497,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did BK's use of Performance Share Unit Agreements evolve from 2022 to 2024 under the 2019 Long-Term Incentive Plan, and what does this progression indicate about the company's executive compensation strategy?",
      "original_answer": "BK's use of Performance Share Unit Agreements under the 2019 Long-Term Incentive Plan evolved from referencing 2021 agreements in 2022, to re-filing the 2019 plan in 2023, and incorporating 2022 agreements in 2024, indicating a consistent but adaptive approach to executive compensation that builds on prior frameworks while updating mechanisms to align with current performance metrics. In 2022, BK referenced the 2021 Form of Performance Share Unit Agreement (Exhibit 10.45). In 2023, BK re-filed the 2019 Long-Term Incentive Plan (Exhibit 10.14), suggesting a recommitment to its foundational structure. By 2024, BK included the 2022 Form of Performance Share Unit Agreement (Exhibit 10.18), showing a forward-moving update cycle. This pattern reflects a strategy that maintains the core of the 2019 plan while iteratively refining incentive mechanisms.",
      "llm_answer": "\nFrom 2022 through 2024 Bank of New York Mellon (BK) has continued to adopt a new, yearly‑issued **Performance Share Unit Agreement** under its **2019 Long‑Term Incentive Plan**—the 2022 form (Exhibit 10.18 in the 2024 filing) is the latest version disclosed, building on the 2020 and 2021 agreements first filed in 2019 (Chunks 1 & 2) and reiterated in subsequent filings (Chunk 3).  This incremental rollout shows that BK systematically updates the performance‑based equity terms each cycle to align executive pay with long‑term performance metrics, reflecting a deliberate compensation strategy that ties a larger portion of senior‑leadership rewards to sustained shareholder‑value creation rather than short‑term cash payouts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of BK updating its Performance Share Unit Agreements annually under the 2019 Long-Term Incentive Plan and correctly identifies the 2022 form (Exhibit 10.18) as the latest version disclosed in the 2024 filing. However, it contains significant factual inaccuracies in the timeline and document references. The original answer states that in 2022, BK referenced the 2021 agreement (Exhibit 10.45), in 2023 re-filed the 2019 plan (Exhibit 10.14), and in 2024 incorporated the 2022 agreement (Exhibit 10.18). The LLM incorrectly claims that 2020 and 2021 agreements were 'first filed in 2019'—this contradicts the ground truth, as the 2019 plan was established then, but the specific PSUs evolved post-2019. Additionally, the LLM implies a continuous yearly issuance starting from 2020, but the ground truth shows a more deliberate, non-annual update pattern with a recommitment to the 2019 plan in 2023. The reasoning about aligning pay with long-term performance is semantically aligned and contextually relevant, but the flawed timeline and misattribution of filing dates reduce quantitative and qualitative accuracy. The core idea of iterative refinement is present, but the multi-hop synthesis across years and exhibits is partially incorrect, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 367,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did 3M's (MMM) portfolio of electrical products evolve across 2022, 2023, and 2024 in terms of descriptive specificity and product categorization within the Safety and Industrial segment, and what does this evolution suggest about the company's focus on electrical OEM markets?",
      "original_answer": "In 2022, 3M described its electrical products as serving 'construction and maintenance, power distribution and electrical OEMs' within the Safety and Industrial segment. In 2023, the company refined this description, specifying 'electrical original equipment manufacturers (OEMs)' rather than just 'electrical OEMs', suggesting increased precision in identifying its target market. By 2024, the language evolved further to 'power distribution and electrical original equipment manufacturers (OEMs)', adding continuity in power systems while retaining the formalized OEM reference. This progression indicates a growing strategic emphasis on the electrical OEM space, with increasing specificity in how MMM positions its electrical products within industrial ecosystems across the three-year period.",
      "llm_answer": "\nAcross the three fiscal‑year tables, 3M’s Safety‑and‑Industrial segment repeatedly lists “Electrical products and materials for construction and maintenance, power distribution and **electrical original equipment manufacturers (OEMs)**,” but the wording becomes progressively more explicit: the 2022 entry simply cites “electrical OEMs,” while the 2023 and 2024 entries spell out “electrical **original equipment manufacturers (OEMs)**” and embed the abbreviation in parentheses. This added specificity signals that 3M is sharpening its focus on supplying electrical OEMs—both in its descriptive language and in the way it categorizes those offerings—indicating a strategic emphasis on deepening relationships with electrical‑equipment manufacturers rather than merely offering generic electrical supplies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in 3M's product description across 2022–2024: starting with 'electrical OEMs' in 2022 and shifting to the more formal 'electrical original equipment manufacturers (OEMs)' in 2023 and 2024. The answer accurately notes the increased specificity in language, particularly the spelling out of 'original equipment manufacturers' with parenthetical abbreviation, which reflects a real trend in 3M’s filing language. (2) There are no numerical values to verify, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and consistently referenced—thus scoring 10. (3) The qualitative reasoning is strong: the LLM correctly infers that the linguistic refinement signals a strategic sharpening of focus on electrical OEM markets, which matches the ground truth’s conclusion about growing strategic emphasis. However, the LLM omits the 2024 addition of 'power distribution and' as a structural change in ordering and continuity, slightly weakening completeness. The original answer notes that 2024 reintegrated 'power distribution' ahead of the OEM reference, suggesting a dual focus, which the LLM does not mention. This minor omission prevents a perfect 10 on qualitative accuracy. (4) Contextual relevance is excellent—the response directly addresses the evolution in descriptive specificity, product categorization, and strategic implications for electrical OEM markets, fulfilling all parts of the multi-hop question. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a minor detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 467,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve across 2022, 2023, and 2024 in terms of carrying value and weighted-average interest rate, and what does this multi-year progression indicate about the company's long-term debt strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt grew from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose steadily from 2.91% in 2022 to 4.45% in 2023 and further to 4.84% in 2024. This trajectory suggests a strategic shift toward securing more long-term fixed-rate financing during a rising interest rate environment, locking in capital at increasingly higher costs over time.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt balance was $24.1 bn with a weighted‑average interest rate of 4.45 % at the end of 2022 (Chunk 1), rose to $27.2 bn while the rate stayed at 4.45 % in 2023 (Chunk 1), and then slipped slightly to $26.9 bn with a higher 4.84 % rate by the end of 2024 (Chunk 2). This multi‑year progression—steady issuance growth through 2023 followed by a modest pull‑back and a noticeable increase in borrowing cost in 2024—reflects a strategic shift toward longer‑dated senior notes to fund expansion while adapting to a higher interest‑rate environment, a pattern that builds on the prior‑year levels disclosed in Chunk 3.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Capital One's fixed unsecured senior debt carrying value was $19,975 million in 2022, but the LLM states $24.1 billion, which is off by over $4 billion. This error persists in the narrative, as the LLM claims the debt rose from $24.1B in 2022 to $27.2B in 2023, whereas the truth shows a rise from $19,975M to $27,168M. The 2023 and 2024 carrying values are approximately correct ($27.2B vs $27,168M and $26.9B vs $26,930M), though slight rounding is acceptable. However, the interest rate for 2022 is incorrectly stated as 4.45%, which is actually the 2023 rate; the correct 2022 rate is 2.91%. The LLM repeats 4.45% for both 2022 and 2023, failing to reflect the increase from 2.91% to 4.45%. Only the 2024 rate (4.84%) is correct. (2) Calculations and comparisons are flawed due to incorrect base values. The progression of interest rates is misrepresented, undermining the analysis of cost trends. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward long-term financing in a rising rate environment, which aligns with the ground truth interpretation. It recognizes the pattern of issuance and increasing costs, showing adequate synthesis across years. (4) Despite correct qualitative direction and contextual relevance—addressing all parts of the question and drawing a reasonable strategic conclusion—the severe numerical inaccuracies in key metrics (especially 2022 values) significantly reduce factual correctness. The answer misrepresents the starting point of the trend, leading to an unreliable factual foundation. Hence, correctness and quantitative accuracy are penalized heavily, while qualitative reasoning and relevance retain moderate scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 491,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did NVIDIA's valuation and treatment of its 3.50% Notes Due 2040 evolve from fiscal years 2022 through 2024, and what does this multi-year progression reveal about the company's long-term debt strategy?",
      "original_answer": "In fiscal 2022, NVIDIA reported the fair value of its 3.50% Notes Due 2040 at $1,066 million. By fiscal 2023, this value had decreased slightly to $851 million. In fiscal 2024, the company no longer reported a fair value but instead listed a carrying amount of $1,000 million for the long-term portion of these notes. This evolution suggests a shift in how NVIDIA accounts for and manages its long-term debt obligations, potentially reflecting a more stable and strategic approach to long-term financing.",
      "llm_answer": "\nNVIDIA’s 3.50 % Notes Due 2040 were disclosed in FY 2022 with a fair‑value of **$1,066 million** (Chunk 1), fell to **$851 million** in the FY 2023 fair‑value estimate (Chunk 2), and by FY 2024 the carrying amount reported on the balance sheet was **$1,000 million** with a remaining term of **15.2 years** and an effective rate of **3.54 %** (Chunk 3).  The notes remain classified as long‑term debt—still listed under “Long‑term portion” of the liability schedule, with a modest net‑carrying‑amount decline and unchanged amortization of discount (Chunks 2 & 3).  This multi‑year trend shows that NVIDIA deliberately maintains a sizable, low‑coupon, far‑out maturity tranche as a stable source of financing, using the 2040 notes to lock in long‑term funding while gradually amortizing the discount, underscoring a strategic emphasis on preserving liquidity and managing interest cost over an extended horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct on all key quantitative points: the fair value of $1,066 million in FY 2022, $851 million in FY 2023, and the carrying amount of $1,000 million in FY 2024 are all accurate and match the ground truth. Additional details—such as the remaining term of 15.2 years and effective interest rate of 3.54%—are consistent with typical 10-K disclosures and do not contradict the ground truth; they add context without introducing error. 2) Quantitative accuracy is perfect: all dollar amounts, percentages, and timeframes are correct. Minor formatting differences (e.g., $1,066 million vs $1,066M) are acceptable and semantically equivalent. 3) The multi-hop reasoning is sound: the model correctly tracks the valuation treatment shift from fair value to carrying amount and infers a strategic long-term debt management approach. The conclusion about NVIDIA maintaining a stable, low-cost, long-term financing instrument aligns with and expands upon the ground truth’s interpretation. 4) The answer is fully contextually relevant, addressing both the evolution of valuation/treatment and the implications for long-term debt strategy. The only reason for not scoring a 10 is that the original answer did not include the effective rate or remaining term, so while those details are likely accurate, they go beyond the verified ground truth; however, they do not detract from correctness. Overall, this is a highly accurate, well-reasoned, and complete response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 408,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Amazon's outstanding balance on its 2017 Notes evolve from 2022 through 2024, and what does this reduction trajectory suggest about the company's debt management strategy for this issuance?",
      "original_answer": "Amazon's outstanding balance on its 2017 Notes decreased from $16.0 billion in 2022 to $15.0 billion in 2023 and further to $13.0 billion in 2024. This consistent reduction suggests a deliberate debt management strategy to gradually retire this issuance over time.",
      "llm_answer": "\nThe $17 bn 2017 Notes balance fell from $16 bn at the end of 2021 (Chunk 3) to $15 bn by Dec 2022 (Chunk 1), then to $13 bn by Dec 2023 (Chunk 2) and remained at $13 bn through Dec 2024 (Chunk 2), reflecting scheduled amortization plus early‑repayment of roughly $3 bn over the 2022‑2024 period.  This deliberate reduction shows Amazon is actively shrinking this tranche of debt—using cash flow and optional redemptions—to lower leverage and improve its overall debt‑management profile for the 2017 issuance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative evolution of Amazon's 2017 Notes balance. According to the ground truth, the balance was $16.0 billion in 2022, $15.0 billion in 2023, and $13.0 billion in 2024. However, the LLM claims the balance was $16 billion at the end of 2021 (not asked), $15 billion by Dec 2022 (incorrect—this should be 2023), $13 billion by Dec 2023 (should be 2024), and 'remained at $13 billion through Dec 2024'. This misaligns the entire timeline by one year. Additionally, the LLM incorrectly states the initial issuance was $17 billion, which is not supported by the ground truth. (2) The calculation of a $3 billion reduction is directionally correct ($16B to $13B), but the timing and attribution to 'early repayment' and 'scheduled amortization' go beyond the provided ground truth, which only states a consistent reduction without specifying mechanisms. (3) The multi-hop reasoning is partially sound in that it infers a strategic debt reduction, which aligns with the ground truth's interpretation. However, the synthesis across years is flawed due to incorrect year-to-balance mapping, undermining the reasoning. (4) The contextual relevance is high because the answer addresses the debt trajectory and strategy, but the correctness score is low due to major factual and temporal errors in the core data. Quantitative accuracy is severely penalized due to incorrect dollar amounts per year and misassigned dates. Qualitative accuracy is moderate because the conclusion about debt management is plausible but based on incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 442,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "What does Apple's inclusion of Floating Rate Notes due 2019 in its 2022, 2023, and 2024 filings suggest about its ongoing exposure to short-term debt instruments, and how might this affect its interest expense sensitivity in a rising rate environment?",
      "original_answer": "Apple's 2022, 2023, and 2024 filings all incorporate by reference the Officer's Certificate dated May 6, 2014, which includes forms of global notes representing Floating Rate Notes due 2019. The repeated disclosure of these notes across three consecutive years indicates that Apple maintained some level of exposure to these instruments through outstanding obligations or ongoing disclosure obligations, despite their 2019 maturity date. Since floating rate notes adjust with benchmark interest rates, Apple's interest expense on these notes would increase in a rising rate environment, heightening its short-term interest risk exposure. The persistence of these notes in disclosures suggests that Apple may have had rollover obligations or continuing commitments tied to this debt structure, influencing its liquidity planning and capital structure flexibility.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each incorporate by reference the same 2014 Officer’s Certificate that sets out its **Floating Rate Notes due 2019** (see Chunk 1, 2 & 3, Exhibit 4.4).  This repeated inclusion shows that the company continues to hold that short‑term, floating‑rate instrument as part of its capital structure.  Because the notes carry a coupon that resets with short‑term market rates, Apple’s interest expense is directly tied to prevailing short‑term rates, so any further rise in those rates would proportionally increase its financing costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key facts: Apple's 2022, 2023, and 2024 filings incorporate by reference the 2014 Officer’s Certificate (Exhibit 4.4) that includes Floating Rate Notes due 2019. The dates, document types, and exhibit numbers are accurate. The floating rate nature of the notes and their sensitivity to rising interest rates are correctly explained. (2) Quantitative accuracy is perfect: all years (2014, 2019, 2022–2024), document references, and financial instrument names match the ground truth. No numerical calculations are required, but all factual data points are correct. (3) However, the LLM makes a significant qualitative error by stating that Apple 'continues to hold that short-term, floating-rate instrument as part of its capital structure.' This is misleading because the notes matured in 2019; the continued disclosure is due to ongoing reporting obligations or potential rollover mechanisms, not active holding of the 2019 notes. The ground truth emphasizes disclosure persistence despite maturity, not continued ownership. This misrepresents the nature of Apple’s exposure. (4) The reasoning is partially sound but fails the full multi-hop synthesis: while it connects the floating rate feature to interest expense sensitivity correctly, it does not address the nuance of post-maturity disclosure, rollover obligations, or liquidity planning implications as stated in the original answer. Contextual relevance is high because the answer addresses both parts of the question—exposure and interest rate sensitivity—but with an incorrect underlying assumption about the status of the debt. Thus, correctness is reduced to 7 due to this key factual misinterpretation, despite strong performance on other dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 479,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Google's strategic approach to the Pixel family of devices evolve from 2022 to 2024, particularly in terms of investment focus, revenue contribution, and product maturity, and what does this progression indicate about its long-term positioning in the hardware market?",
      "original_answer": "In 2022, Google explicitly stated it was making long-term investments in hardware, specifically mentioning the Pixel 5a 5G and Pixel 6 phones as part of a strategy to build helpful, secure devices that combine AI, software, and hardware. By 2023, the Pixel family of devices was categorized under 'devices' as a distinct revenue stream, indicating that the product line had moved beyond just investment into contributing measurable financial performance. In 2024, the Pixel family was again listed as a core component of the 'devices' revenue category, and its inclusion in a more mature, structured revenue breakdown suggests that it had become a stable and strategic part of Google's hardware portfolio. This progression indicates that Google transitioned the Pixel line from a long-term investment focus to a revenue-generating product category, signaling increased confidence in its position within the competitive hardware market.",
      "llm_answer": "\nFrom 2022 through 2024 Google escalated its investment in the Pixel line—expanding the portfolio to include Pixel 5a/6 phones, Nest Cams and Fitbit wearables while embedding privacy‑by‑design and on‑device AI (Gemini/Vertex) to deepen ecosystem lock‑in (Chunk 1 & Chunk 3). By 2024 the Pixel family was reported as a distinct “devices” revenue stream with dedicated sales‑commission and cost‑of‑revenues accounting, showing that hardware has become a core, long‑term growth pillar for Google’s diversification beyond advertising (Chunk 2).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Google's strategic approach to the Pixel family from 2022 to 2024 in broad strokes—highlighting increased investment, integration with AI and ecosystem, and recognition as a distinct revenue stream by 2024. However, it introduces elements not present in the ground truth: specifically, the mention of Nest Cams and Fitbit wearables as part of the Pixel family is incorrect—these are separate hardware products and not part of the Pixel line. Additionally, references to 'Gemini/Vertex' and 'privacy-by-design' are not supported by the original answer and represent speculative or extraneous details. The core progression—from investment focus to revenue contribution—is accurately conveyed, and the conclusion about hardware becoming a core growth pillar aligns semantically with the original. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not compromised; all time references (2022–2024) are correct. (3) The multi-hop reasoning is partially sound: the model correctly infers that being reported as a distinct 'devices' revenue stream implies maturity and strategic importance. However, it conflates the Pixel family with other Google hardware products, failing to maintain entity accuracy. The original answer carefully limits the scope to the Pixel family, while the LLM incorrectly expands it. (4) The correctness score is 7 because the central claim about Pixel’s transition to a revenue-generating, strategically important product line is correct and well-supported across years. The qualitative accuracy is lower due to the inclusion of irrelevant products and technologies not mentioned in the ground truth. Contextual relevance remains high because the response directly addresses the question’s focus on investment, revenue, and long-term positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 509,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's collateral management strategy?",
      "original_answer": "In 2022, Schwab disclosed that clients with margin loans allowed the firm to pledge collateralized securities in accordance with federal regulations, though no specific dollar value was provided for the total available or pledged securities. In 2023, Schwab expanded on this by detailing that collateralized securities were used in margin lending and were not reflected in the consolidated financial statements, indicating a more formalized and possibly scaled-up collateral management process. By 2024, Schwab was actively pledging client securities to satisfy margin requirements for listed option contracts cleared by the Options Clearing Corporation and was providing cash as collateral in securities lending activities, showing a strategic evolution toward broader use of client assets for operational and regulatory needs. This 3-year progression reflects a growing reliance on client securities for risk mitigation and capital efficiency, while maintaining regulatory compliance.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab progressively intensified the use of client‑securities as collateral: the 2022 note disclosed the fair‑value of client securities that could be pledged, the 2023 filing explained that such securities are pledged to meet OCC margin requirements for option clearing and to satisfy cash‑collateral calls in its securities‑lending program, and the 2024 filing confirmed that Schwab continues to pledge client securities to clearing houses and to support margin‑lending obligations while also providing cash as collateral in its lending activities. This pattern—maintaining the pledged securities off its consolidated balance sheet and relying on off‑balance‑sheet sweeps under the 2023 IDA—shows that Schwab’s collateral‑management strategy centers on leveraging client‑held securities to meet regulatory margin and clearing requirements while minimizing on‑balance‑sheet exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right context and question structure. (1) Incorrect timeline: The LLM claims that in 2022, Schwab disclosed the 'fair-value' of client securities that could be pledged — but the ground truth states that no specific dollar value was provided in 2022. This is a critical quantitative and qualitative error. (2) Misattribution of activities across years: The LLM incorrectly states that the 2023 filing explained that securities were pledged to meet OCC margin requirements for option clearing — but according to the ground truth, this specific use (for listed option contracts cleared by OCC) was first reported in 2024, not 2023. Similarly, the LLM incorrectly attributes the use of cash as collateral in securities lending to 2023, while the ground truth assigns this detail to 2024. (3) The LLM introduces an entity/concept not in the original — the '2023 IDA' and 'off-balance-sheet sweeps' — which are not mentioned or supported by the ground truth, suggesting fabrication or hallucination. (4) While the LLM correctly identifies the trend of increasing use of client securities and off-balance-sheet treatment, the misplacement of key activities across years and the addition of unsupported details severely compromise the multi-hop reasoning. The answer is contextually relevant and attempts the right synthesis, but the factual backbone is flawed. Minor phrasing differences would be acceptable under semantic equivalence, but here the errors involve core facts, timing, and invented mechanisms, warranting a low correctness score despite structural alignment with the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Holds]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 460,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did GE's collaboration with primary insurers on long-term care premium rate increases evolve from 2022 through 2024, and what does this progression reveal about GE's reinsurance risk management strategy in its run-off insurance operations?",
      "original_answer": "From 2022 to 2024, GE maintained a consistent reliance on primary insurers to file long-term care premium rate increases with state regulators, while increasingly emphasizing collaboration and alignment with ceding companies. In 2022, GE described its indirect role in seeking rate increases and noted that the frequency of such increases varied by ceding company. By 2023, GE formalized its collaboration with primary insurers under reinsurance contractual terms, and highlighted its active participation in filing proposed increases, signaling a more structured approach. In 2024, GE reinforced this collaborative framework and added that it used recent experience from ceding companies and regulatory precedents to shape its expectations. This evolution indicates a strategic shift toward proactive risk management and tighter integration with primary insurers to stabilize future policy benefit reserves in its run-off insurance portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 GE kept its reinsurance‑risk strategy anchored on close collaboration with the primary insurers that issued its long‑term‑care policies—locking in the 2021 premium‑deficiency assumptions, then in 2022‑2023 working with those ceding companies to file the state‑required premium‑rate increase proposals (a frequency that varies by ceding company and is tied to lapse trends that extend to 2024), and finally in 2024 updating cash‑flow assumptions and recording a $196 million favorable and $(155) million unfavorable reserve adjustment after the latest rate‑increase filings were incorporated.  This progression reveals that GE’s run‑off risk‑management hinges on depending on primary insurers to drive premium hikes, locking in actuarial assumptions and discount rates, and retroactively revising reserves when actual rate‑increase experience shifts, thereby controlling the present‑value volatility of future benefit obligations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and introduces unsupported quantitative details not present in the ground truth. Most critically, it claims GE recorded a '$196 million favorable and $(155) million unfavorable reserve adjustment' in 2024, which is not mentioned or implied in the original answer and cannot be verified from the provided context. This is a major quantitative error. Additionally, the reference to 'locking in the 2021 premium-deficiency assumptions' and 'updating cash-flow assumptions' in 2024 is not supported by the ground truth, which focuses on collaboration evolution and use of regulatory precedents, not specific actuarial updates or reserve adjustments. (2) The years 2022–2024 are correctly framed, but the dollar amounts and specific reserve actions are fabricated or hallucinated. No such figures appear in the original answer, and there is no indication that GE itself filed or adjusted reserves based on '$196M' or '$(155)M' in 2024. These numbers fail verification and severely undermine quantitative accuracy. (3) The multi-hop reasoning is partially sound in that the LLM identifies the ongoing collaboration with primary insurers and the role of ceding companies in filing rate increases. It correctly notes variation by ceding company and ties this to lapse trends, which aligns with the 'frequency varies' point from 2022. The progression toward more structured collaboration in 2023 and 2024 is also conceptually consistent, though the LLM misattributes the nature of GE’s strategy as retroactively revising reserves based on rate-increase experience, whereas the original emphasizes proactive risk management through alignment and use of experience to shape expectations—not reserve recalibrations. (4) Contextual relevance is moderate: the answer addresses the evolution of collaboration and connects it to risk management in run-off operations, which is relevant. However, the emphasis on reserve volatility and actuarial assumption locking shifts focus away from the actual strategic shift toward proactive integration and structured collaboration. Overall, while some qualitative elements are directionally correct, the inclusion of unverified financial figures and misrepresentation of GE’s strategy significantly reduce correctness. The answer is partially correct but contains critical factual errors, warranting a score of 4/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 647,
        "total_tokens": 2145
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did CVS's investment exposure to residential mortgage-backed securities evolve from 2022 through 2024, and what does the 3-year trend reveal about the company's risk positioning in structured credit instruments?",
      "original_answer": "CVS's exposure to residential mortgage-backed securities (RMBS) decreased from $721 million in 2022 to $614 million in 2023, then increased to $71 million in 2024. This reflects a cautious reduction in RMBS holdings in 2023 amid rising unrealized losses, followed by a strategic rebalancing in 2024 with a smaller, more selective allocation. The trend suggests a dynamic risk management approach to structured credit amid macroeconomic uncertainty.",
      "llm_answer": "\nCVS held a sizable residential‑mortgage‑backed‑securities (RMBS) position in 2022 – the 10‑K reports $625 million of RMBS (with only $10 million of unrealized loss) and the detailed schedule shows $721 million fair value and $89 million of loss (Chunk 1 & Chunk 3).  By the end of 2023 the exposure had already begun to shrink to $614 million fair value and $60 million unrealized loss (Chunk 3), and in 2024 it fell dramatically to just $71 million (Chunk 2), a reduction of roughly 90 % from the 2022 level.  This three‑year trend reveals that CVS is deliberately de‑risking its structured‑credit portfolio, scaling back RMBS holdings and shifting toward higher‑quality, more liquid assets such as U.S. government securities, thereby lowering its credit and liquidity risk exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the 2024 RMBS exposure. The ground truth states that CVS's RMBS exposure increased to $71 million in 2024 from $614 million in 2023, but the LLM incorrectly claims it 'fell dramatically to just $71 million' and describes this as a 90% reduction from 2022. This misrepresents the trend: while $71M is indeed ~90% lower than $721M (2022), the key issue is that the exposure increased from $614M in 2023 to $71M in 2024 — a small increase, not a continued decrease. The LLM incorrectly frames the 2024 change as a further reduction, when in fact the ground truth shows a rebound from 2023 to 2024. (2) Quantitative accuracy: The 2022 ($721M) and 2023 ($614M) values are correct. The 2024 value is stated correctly as $71M, but the interpretation is wrong — it increased from 2023 to 2024, not decreased. The claim of a '90% reduction' from 2022 to 2024 is mathematically approximately correct ((721-71)/721 ≈ 90%), but misleading in context because the trend is not monotonic. The unrealized loss figures ($89M and $60M) are mentioned but not part of the original answer, so their inclusion is extra but not penalized. (3) Multi-hop reasoning is partially sound — the model identifies the correct data points across years and attempts to synthesize a trend, but draws the wrong conclusion about the direction of change in 2024. It fails to recognize that the increase to $71M in 2024 (from $614M) represents a reversal of the prior year's reduction, contradicting the 'de-risking' narrative. (4) The qualitative analysis incorrectly infers a continuous de-risking and shift to safer assets, while the ground truth describes a 'strategic rebalancing' after a 2023 reduction, implying a more nuanced, dynamic strategy. The LLM's conclusion oversimplifies and mischaracterizes the risk positioning trend. Contextual relevance is high — the answer addresses the right company, metric, and time frame, and discusses risk positioning appropriately, despite factual inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 548,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did COF's total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does this 3-year progression reveal about the company's capital structure and debt management strategy?",
      "original_answer": "COF's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then decreased to $45.551 billion in 2024. This pattern indicates a strategic shift in debt management, with a significant increase in 2023 followed by a deliberate reduction in 2024. The weighted-average interest rate on long-term debt also rose from 2.76% in 2022 to 4.48% in 2023, and further to 4.84% in 2024, suggesting rising borrowing costs over time. The reduction in floating unsecured senior debt from $1,709 million in 2022 to $349 million in 2023 and its complete elimination by 2024 reflects a move away from variable-rate instruments. This 3-year trend reveals a dynamic capital structure with a peak in 2023 followed by a strategic deleveraging in 2024, while facing increasing interest rate environments.",
      "llm_answer": "\nThe combined short‑term borrowings and long‑term debt was $48.7 bn at the end of 2022 (Chunk 1), rose modestly to $49.9 bn in 2023 (Chunk 1), and then fell to $45.6 bn by the end of 2024 (Chunk 2); during this span long‑term debt declined from $49.3 bn to $45.0 bn while short‑term borrowings stayed near $0.5 bn, edging up from $0.54 bn to $0.56 bn (Chunk 2), indicating a deliberate reduction of long‑term leverage. This three‑year progression—starting from the 2022 baseline shown in Chunk 1, passing through a modest 2023 increase, and culminating in a pronounced 2024 deleveraging—reveals a capital‑structure strategy that prioritizes cutting long‑term debt and reliance on securitized and senior notes while maintaining modest short‑term financing (Chunk 3’s 2021 data confirms the downward trend began earlier).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key numbers. The original answer states that COF's total short-term borrowings and long-term debt was $43.086 billion in 2022, but the LLM claims $48.7 billion—this is a significant discrepancy (~$5.6 billion off). The 2023 figure is closer ($49.9B vs. $49.856B), and the 2024 number is approximately correct ($45.6B vs. $45.551B). However, the incorrect 2022 baseline undermines the validity of the trend. Additionally, the LLM introduces long-term debt declining from $49.3B to $45.0B and short-term borrowings around $0.5B, which are not supported by the ground truth and misrepresent the composition. The ground truth does not provide a breakdown of short-term vs. long-term components in this way, so these specific figures appear fabricated or misattributed. (2) The calculation of the overall trend (increase then decrease) is directionally correct, but the magnitude of the starting point is wrong. The ground truth shows a more significant increase from 2022 to 2023 (from $43.086B to $49.856B, +$6.77B), whereas the LLM implies only a modest rise from a much higher base. This affects interpretation of the strategy. (3) The reasoning about a strategic deleveraging in 2024 is semantically aligned with the original answer and reflects sound multi-hop logic—recognizing a peak in 2023 and reduction in 2024. The mention of reducing reliance on securitized and senior notes aligns with the ground truth’s observation about eliminating floating unsecured senior debt. However, the LLM incorrectly references 'Chunk 3’s 2021 data' to support a trend, which is irrelevant to the 2022–2024 question scope and not part of the provided ground truth. (4) Despite incorrect base figures, the LLM captures the general trajectory (up then down) and infers a plausible debt management strategy, earning partial credit. Contextual relevance is high as it directly addresses the evolution and strategic implications. However, the quantitative inaccuracies—especially the wrong 2022 total—are severe enough to limit correctness. The qualitative reasoning is reasonable but based on flawed inputs. Final scores reflect partial correctness: 6/10 overall, 5 for quantitative accuracy due to major number errors, 7 for reasoning quality, and 9 for relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 618,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did NVIDIA's long-term liability related to the 3.50% Notes Due 2050 evolve from fiscal years 2022 through 2024, and what does this trend indicate about the company's capital structure strategy over time?",
      "original_answer": "NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,604 million in fiscal 2024, with a midpoint value of $1,637 million in fiscal 2023. This indicates a deliberate reduction in this long-term debt obligation over the three-year period, suggesting a strategic effort to manage and reduce long-dated liabilities.",
      "llm_answer": "\nNVIDIA’s 3.50 % Notes Due 2050 were disclosed as a long‑term liability of roughly **$2.31 bn** in FY2022 (fair‑value $2,308 m in the 2022 filing), fell to about **$1.64 bn** in FY2023 (fair‑value $1,637 m in the 2023 filing), and then rose to **$2.0 bn** in FY2024 (net carrying amount $2,000 m reported in the 2024 filing). This decline followed by a modest rebound shows that NVIDIA deliberately reduced its exposure to that long‑term debt in the early period, then re‑established a larger position, reflecting a flexible capital‑structure strategy that balances leverage, financing costs, and the need to fund ongoing growth initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, NVIDIA's liability for the 3.50% Notes Due 2050 decreased from $2,147 million in fiscal 2022 to $1,637 million in fiscal 2023 and further to $1,604 million in fiscal 2024. However, the LLM incorrectly reports $2.31 billion (vs. $2,147M) for 2022, $1.64 billion (close but not exact at $1,637M) for 2023, and most critically, states a rise to $2.0 billion in 2024 — which contradicts the ground truth showing a further decline to $1,604 million. The claim of an increase in 2024 is factually wrong. (2) Quantitative accuracy is poor: the 2022 figure is overstated by ~$160 million, and the 2024 figure is grossly overstated by ~$396 million. The LLM also confuses 'fair value' and 'carrying amount' — while these distinctions exist in filings, the original answer refers to liability amounts (likely carrying values), and the trend must reflect a consistent metric. The LLM’s use of different valuation bases (fair value vs. net carrying amount) across years introduces inconsistency and misrepresents the trend. (3) Multi-hop reasoning is flawed: instead of identifying a consistent downward trend indicating debt reduction, the LLM infers a 'decline followed by rebound', suggesting strategic re-leveraging — a conclusion unsupported by the data. This misreads the direction of the liability in 2024, undermining the entire analysis. (4) Contextual relevance is moderate — the answer addresses the right instrument, time frame, and general concept of capital structure strategy, but due to incorrect data and faulty trend interpretation, the qualitative assessment is invalid. The reasoning would be plausible if the numbers were correct, but they are not. Thus, the correctness score is low due to major factual and directional errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 499,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across 2022, 2023, and 2024, and what does this pattern indicate about the company's long-term debt disclosure strategy?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings across 2022, 2023, and 2024 shows a consistent disclosure pattern, indicating that the company continued to reference this historical debt instrument as part of its ongoing debt structure documentation, even though the notes were issued in 2013 and matured in 2016. This suggests Apple maintains legacy debt disclosures in its exhibits for transparency and legal continuity, rather than removing them immediately post-maturity.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple repeatedly includes the same Officer’s Certificate (Exhibit 4.3) that sets out the **0.45 % Notes due 2016**—originally issued under the 2013 Indenture—and the notes appear in each year’s “Description of Securities” (Exhibit 4.1).  The only change among the three filings is the amendment date of the bylaws (August 17 2022 vs. August 20 2024), but the debt‑instrument disclosure is unchanged, showing that Apple’s long‑term debt strategy is to keep legacy debt series continuously visible and to reaffirm their terms in every periodic filing.  This consistent re‑issuance reflects a deliberate, transparent approach to disclosing its historic long‑term debt throughout the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities are correct: Apple, 0.45% Notes due 2016, 2022–2024 10-K filings, and references to Exhibits 4.1 and 4.3 are factually accurate. The issuance under the 2013 Indenture is correctly noted. (2) Quantitative elements—interest rate (0.45%), maturity year (2016), and filing years (2022, 2023, 2024)—are all correct. The mention of amendment dates (August 17, 2022, and August 20, 2024) for bylaws is precise and supports the observation of unchanged debt disclosures. (3) The multi-hop reasoning is sound: the model correctly infers from repeated inclusion of the same exhibit that Apple maintains legacy debt disclosures across years, even post-maturity. This reflects synthesis across multiple filings and an understanding of disclosure practices. (4) The conclusion about Apple’s transparent, consistent long-term debt disclosure strategy matches the ground truth’s interpretation. The only minor limitation is that the LLM does not explicitly state that the notes *matured* in 2016, though this is implied by calling them 'due 2016' and discussing their persistence in later filings. This omission slightly affects completeness but does not undermine the core correctness. Overall, the answer demonstrates strong factual accuracy, contextual relevance, and logical reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 378,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Capital One's (COF) net derivative assets (liabilities) valuation and associated risk inputs evolve from 2022 to 2024, and what does this multi-year progression indicate about the company's exposure and modeling assumptions?",
      "original_answer": "Capital One's net derivative assets (liabilities) had a fair value of $31 million in 2022, with a net unrealized loss of $20 million still held. By 2023, the fair value of net derivative assets (liabilities) was $58 million, using 'default' as the significant unobservable input with a weighted average of 4%. In 2024, the fair value remained at $58 million, but the significant unobservable input shifted to 'swap rates' with a weighted average of 4%. This evolution indicates a shift in the key risk driver from default assumptions in 2023 to interest rate sensitivity in 2024, while maintaining a consistent valuation level. The reduction in realized losses from $43 million in 2022 to stable values in 2023 and 2024 suggests improved risk management or market stabilization.",
      "llm_answer": "\nBetween 2022 and 2024 the fair‑value of Capital One’s net derivative assets (liabilities) rose from a Level‑3 balance of **$19 million** (shown in the 2022 10‑K Level‑3 reconciliation – Chunk 3) to **$58 million** reported at year‑end 2023/2024 (Chunk 2).  Across all three years the valuation relied on discounted‑cash‑flow models that used essentially the same unobservable inputs: default‑rate ranges of **53 %–163 %** with a weighted average near **4 %** (Chunk 1 and Chunk 3) and swap‑rate ranges of **3 %–5 %** also averaging **≈ 4 %** (Chunk 1 and Chunk 2).  This multi‑year progression indicates that while the company’s derivative exposure has grown markedly, its core risk‑model assumptions—particularly the default and market‑rate inputs—have remained stable, suggesting consistent modeling of credit and market risk despite the larger asset‑liability footprint.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers and misrepresents the evolution of Capital One's net derivative assets. The ground truth states the 2022 fair value was $31 million, but the LLM claims $19 million, citing a 'Level-3 balance' not mentioned in the original answer. This is a critical error. Additionally, the LLM states the value rose from $19M to $58M, implying growth, while the ground truth shows $31M in 2022 and $58M in 2023 — a different magnitude and trend. The LLM incorrectly claims both default and swap rates were used across all years, while the ground truth indicates a shift in the *significant unobservable input* from 'default' in 2023 to 'swap rates' in 2024 — a key qualitative change missed by the model. The default-rate range of '53%–163%' is nonsensical and clearly erroneous (likely a misreading of basis points or a typo), as default rates cannot exceed 100% in standard financial modeling. (2) Calculations: The LLM does not perform any explicit calculation, but the use of incorrect base figures and implausible percentages undermines quantitative integrity. The 4% weighted average is correctly cited, but the context is wrong. (3) Multi-hop reasoning: The model attempts to synthesize across years and inputs but fails to capture the shift in risk drivers — a central point of the question. Instead, it asserts that assumptions 'remained stable,' contradicting the ground truth's indication of a shift from default to swap rates as the significant input. This misrepresents the company's evolving risk exposure. (4) Contextual relevance is high — the answer addresses the right company, metric, and time frame, and attempts to interpret modeling assumptions and exposure trends. However, due to major factual and conceptual errors, especially in numbers and risk input evolution, the correctness score is low. The answer is partially informed but fundamentally flawed in key areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Impacts]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 529,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did NVIDIA's financial exposure to the 1.55% Notes Due 2028 evolve from fiscal year 2022 through 2024, and what does this progression reveal about the company's long-term debt strategy?",
      "original_answer": "NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2 billion in 2022, remained relatively stable at $1.1 billion in 2023, and then increased to $1.25 billion in 2024. This indicates a consistent long-term debt position in this instrument over the three-year period, with a slight increase in 2024 after a minor reduction in 2023, suggesting a strategic maintenance of this liability as part of its capital structure.",
      "llm_answer": "\nNVIDIA’s 1.55% Notes Due 2028 disclosed a fair‑value exposure of **$1.20 bn in FY2022**, slipped to **$1.115 bn in FY2023**, and rebounded to **$1.250 bn in FY2024**, reflecting a modest pull‑back followed by a renewal at a slightly higher carrying amount.  The 2024 schedule shows the instrument with a **remaining weighted‑average term of 3.4 years** and an **effective interest rate of 1.64%**, and it is recorded as a Level‑2 liability whose $1.25 bn fair value is embedded in the company’s **$8.463 bn total long‑term debt** (after removing the $1.25 bn short‑term portion).  This progression demonstrates that NVIDIA maintains a deliberate long‑term debt strategy of issuing low‑coupon, long‑dated notes, periodically rolling or re‑pricing portions of its maturing obligations while preserving a sizable, stable base of long‑dated financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is highly accurate in both quantitative and qualitative aspects. The ground truth states NVIDIA's exposure to the 1.55% Notes Due 2028 was $1.2B in 2022, $1.1B in 2023, and $1.25B in 2024. The LLM reports $1.20B (2022), $1.115B (2023), and $1.250B (2024). The 2022 and 2024 figures match exactly (allowing for formatting: $1.2B = $1.20B). The 2023 value is slightly more precise ($1.115B vs $1.1B), but this does not contradict the ground truth—it may reflect a more granular disclosure. The minor discrepancy is not a factual error but a possible rounding difference in reporting; $1.115B rounds to $1.1B, so the core fact is preserved. (2) The LLM adds contextual details not in the original answer but consistent with plausible 10-K disclosures: effective interest rate (1.64%), remaining term (3.4 years), classification as Level-2 liability, and placement within total long-term debt ($8.463B). These enhance the answer without introducing inaccuracies. (3) The multi-hop reasoning is sound: the LLM correctly tracks the note’s value over three fiscal years, interprets the trend (pullback then rebound), and links it to NVIDIA’s broader debt strategy—issuing low-coupon, long-dated notes and managing maturities strategically. This aligns with and even enriches the ground truth’s conclusion about 'strategic maintenance' of the liability. (4) The answer is semantically equivalent and contextually complete, addressing both the evolution of exposure and its implications for long-term debt strategy. The slight over-precision in 2023 does not detract from correctness. Scores reflect near-perfect accuracy, excellent reasoning, and full relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 460,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did GE's exposure to trailing legal liabilities evolve from 2022 to 2024, particularly in relation to legacy matters from the Alstom acquisition and shareholder lawsuits tied to historical financial reporting, and what does this progression indicate about the persistence and financial impact of these contingent liabilities?",
      "original_answer": "From 2022 to 2024, GE's exposure to trailing legal liabilities remained a persistent risk, with specific reference to legacy matters from the 2015 Alstom acquisition and shareholder lawsuits tied to historical financial reporting. In 2022, GE noted that legacy legal proceedings from Alstom's pre-acquisition period, including claims of anti-competitive conduct or corruption, were resulting in ongoing cash outflows. Additionally, shareholder lawsuits related to GE’s financial performance and disclosure practices were highlighted as reputational risks. By 2023, the company reiterated its exposure to these same Alstom-related liabilities and emphasized that such legal matters could exceed current estimates, adversely affecting financial results. In 2024, GE continued to face shareholder lawsuits tied to legacy financial reporting issues, and the company acknowledged that these matters, along with contingent liabilities from exited businesses, could significantly impact its reputation and financial performance. This 3-year progression shows that these liabilities have not diminished but have remained a consistent and costly burden, indicating that GE's historical acquisitions and accounting practices continue to pose material financial and reputational risks.",
      "llm_answer": "\nGE’s exposure to trailing legal liabilities has remained steady from 2022 through 2024, with each filing (2022 ¹, 2023 ², 2024 ³) reiterating that the company continues to carry legacy matters stemming from its 2015 Alstom acquisition—including anti‑competition and corruption claims—as well as ongoing shareholder lawsuits tied to historical financial reporting; the company has established reserves for these matters but acknowledges that actual losses may exceed estimates and could generate cash outflows, and that the risk of further material financial impact persists. This repeated disclosure across all three years demonstrates the enduring nature of these contingent liabilities and highlights their potential to affect GE’s results of operations, financial position and cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of the ground truth. (1) All key facts are correct: GE's ongoing exposure to legacy liabilities from the 2015 Alstom acquisition (including anti-competitive conduct and corruption claims) and shareholder lawsuits tied to historical financial reporting are consistently mentioned across 2022–2024. The LLM correctly notes that reserves have been established but actual losses may exceed estimates, leading to potential cash outflows and material financial impact—this aligns with the original answer’s emphasis on persistent risk and uncertainty. (2) Quantitative accuracy is perfect: no specific dollar amounts are cited in either answer, but the LLM correctly references the years (2022, 2023, 2024) and the nature of contingent liabilities without introducing numerical errors. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and two types of liabilities (Alstom legacy issues and shareholder litigation), correctly inferring persistence and financial significance from repeated disclosures. (4) The only minor shortcoming is a slight lack of detail on reputational risk, which the original answer explicitly highlights for both Alstom and shareholder matters in all three years. While the LLM mentions financial position and cash flows, it downplays reputational impact, which is a consistent theme in the ground truth. However, this omission does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses evolution over time and implications for financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Negatively_Impacts]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 450,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did CVS's exposure to hedge fund limited partnership investments through HF LP Investments change from 2022 to 2024, and what does this evolution suggest about the company's pension fund strategy?",
      "original_answer": "CVS's exposure to hedge fund limited partnership investments increased from $214 million in 2022 to $225 million in 2023, and further to $252 million in 2024. This consistent upward trend indicates a strategic decision to maintain and gradually expand alternative investment allocations within its pension fund portfolio, despite market volatility and evolving economic conditions.",
      "llm_answer": "\nCVS’s hedge‑fund limited‑partnership exposure—reported as the amount excluded from fair‑value hierarchy measurement—rose from **$214 million in 2022** (Chunk 1) to **$225 million in 2023** (Chunk 3) and then to **$252 million in 2024** (Chunk 2), an increase of roughly **$38 million over the two‑year span**.  This steady growth in the NAV‑measured hedge‑fund allocation signals that CVS is deliberately expanding its pension‑fund exposure to alternative‑asset strategies, likely to chase higher returns and diversify beyond traditional equity and debt securities.  The trend, reflected across all three filings, suggests a shift toward a more aggressive, diversified pension‑fund strategy that leans on private‑equity and hedge‑fund partnerships.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all financial figures: $214 million in 2022, $225 million in 2023, and $252 million in 2024, matching the ground truth exactly. The calculated increase of $38 million ($252M - $214M) is accurate. 2) Quantitative accuracy is perfect—numbers, years, and the implied two-year increase are all correct, with acceptable formatting (e.g., million, spacing). 3) The multi-hop reasoning is sound: the model synthesizes data across three different chunks (filings for 2022, 2023, 2024) and correctly infers a strategic trend. The conclusion about expanding alternative investments aligns with the ground truth’s interpretation of a 'strategic decision to maintain and gradually expand.' The only minor deviation is the use of slightly stronger language—'deliberately expanding' and 'more aggressive'—which implies a bolder shift than the original's neutral 'maintain and gradually expand.' While reasonable, it introduces a subtle interpretive difference. 4) Contextual relevance is excellent: the answer directly addresses both parts of the question—quantitative change and strategic implication—and stays focused on CVS's pension fund strategy. Overall, the answer is factually flawless and well-reasoned, meriting a 9 due to a slightly more assertive tone in interpretation, but not enough to affect correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 375,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Colgate-Palmolive's financial and operational focus on the Africa/Eurasia region evolve from 2022 to 2024, considering operating profit in 2022, restructuring charges allocated to the region in 2023, and depreciation and amortization spending in 2024?",
      "original_answer": "In 2022, Colgate-Palmolive reported an operating profit of $203 million from the Africa/Eurasia region, indicating a relatively modest contribution compared to other regions. In 2023, as part of the 2022 Global Productivity Initiative, the company allocated 10% of its expected restructuring charges—approximately $20 to $24 million—to Africa/Eurasia, signaling a strategic effort to streamline operations in the region. By 2024, depreciation and amortization expenses for Africa/Eurasia had declined to $8 million, down from $9 million in both 2022 and 2023, suggesting reduced capital investment or aging asset bases. This 3-year trajectory reflects a consistent but low-level financial presence in the region, with limited growth investment and a focus on cost optimization rather than expansion.",
      "llm_answer": "\nIn 2022 the Africa/Eurasia operating profit was roughly $200 million (the $203 million reported for 2021, the latest figure in the 2022 filing), establishing the region’s profit baseline; depreciation and amortization spending for the region declined from $9 million in 2022 to $8 million in 2024 (see the 2024 D&A table), indicating a modest pull‑back in capital intensity; and the 2023 restructuring program channels about 10 % of the $200‑$240 million cumulative pre‑tax productivity charges to Africa/Eurasia, highlighting that the region’s cost‑restructuring share is a deliberate component of Colgate‑Palmolive’s evolving operational focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a significant error in the operating profit figure for 2022. It incorrectly states that the $203 million reported was from 2021 and is the 'latest figure in the 2022 filing', implying that 2022 data is not available. However, the ground truth confirms that $203 million is the actual 2022 operating profit for Africa/Eurasia. This misattribution undermines quantitative accuracy. The restructuring charge allocation of 10% of $200–$240 million (i.e., $20–$24 million) is correctly interpreted and aligns with the original answer. Depreciation and amortization figures are accurate: $9 million in 2022 and $8 million in 2024, correctly showing a decline. (2) Number verification: Operating profit — incorrect sourcing (misattributed to 2021); restructuring — correct at ~$20–24M; D&A — correct at $9M (2022) and $8M (2024). The calculation of trend (decline in D&A) is valid. (3) Multi-hop reasoning is sound: the model connects operating profit (2022), restructuring charges (2023), and D&A (2024) across years and correctly infers cost optimization focus. However, the error in attributing the $203M to 2021 weakens the temporal logic. (4) Scores justified: Correctness 7 due to core facts being mostly right but with a key factual misstatement; Quantitative 7 due to one major number misattribution despite correct ranges elsewhere; Qualitative 8 due to strong synthesis and logical flow despite the error; Contextual Relevance 10 as all parts of the question are addressed with appropriate focus on evolution over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> GPE <-[Operates_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 434,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did AIG's international terrorism exposure and reinsurance protections evolve from 2022 through 2024, particularly in terms of modeled loss estimates, attachment points, and reinsurance recoverable assets?",
      "original_answer": "In 2022, AIG estimated a $1.3 billion net loss from a five-ton bomb attack in New York City after TRIPRA and reinsurance recoveries, with a $1.7 billion deductible under TRIPRA. By 2023, AIG continued to actively monitor and model terrorism risk using third-party vendor models, with international terrorism exposure estimated via scenario-based modeling and targeted reinsurance purchases. In 2024, AIG's reinsurance recoverable assets reached $38.0 billion, including $29.1 billion in ceded loss reserves, reflecting an expansion in reinsurance protections. Over the three-year period, AIG maintained a consistent approach to terrorism risk modeling while increasing its reliance on reinsurance to manage global exposures, particularly outside the U.S., where it retained core attachment points of $200 million in Japan and $125 million elsewhere.",
      "llm_answer": "\nBetween 2022 and 2024 AIG’s modeled terrorism‑loss estimates grew from a 2022 scenario that projected a **$1.3 billion net loss** from a five‑ton bomb in New York (Chunk 3) to a 2023 third‑party vendor model that is regularly adjusted for gaps, and in 2024 the company retained core attachment points of **$200 million for Japan and $125 million for the rest of the world** while adding per‑risk excess‑of‑loss covers that extend protection to global non‑named catastrophe events (Chunk 1 & 2).  \n\nCorrespondingly, reinsurance protections evolved from limited private reinsurance and reliance on TRIPRA in 2022‑23 to a 2024 program that purchases property‑per‑risk covers, maintains aggregate excess‑of‑loss limits, and secures **$38 billion of reinsurance recoverable assets**—including $3.8 billion of paid losses, $29.1 billion of ceded loss reserves, $4.3 billion of unearned‑premium reserves and $0.8 billion of life‑reinsurance recoverable, all backed by $20.1 billion of collateral (Chunk 2), while still depending on government‑sponsored pools and targeted reinsurance purchases (Chunk 1).  \n\nThese developments illustrate the KG relationship where **AIG (ORG) manages International Terrorism Exposure (RISK_FACTOR)** that is estimated through scenario modeling and is mitigated by reinsurance contracts, with the size of the exposure and the associated recoverable assets directly influencing the company’s capital planning and risk‑management outcomes across the three years (Chunk 1‑3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.3 billion net loss estimate from the 2022 New York bomb scenario, the $200 million attachment point in Japan and $125 million elsewhere in 2024, and the $38.0 billion in reinsurance recoverable assets in 2024 (broken down into $29.1 billion ceded loss reserves, $3.8 billion paid losses, $4.3 billion unearned premium reserves, $0.8 billion life-reinsurance recoverable) match the original answer and supporting data. The mention of third-party modeling in 2023 and targeted reinsurance purchases is consistent. (2) Quantitative accuracy is perfect—no calculation errors, and all numbers match or are valid breakdowns of the total (e.g., $38B = sum of components). The format variations (e.g., $38 billion vs $38.0 billion) are acceptable. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and sources, correctly tracing the evolution of exposure modeling, attachment points, and reinsurance structure. It accurately links AIG’s risk management strategy to reinsurance growth and capital planning. (4) The only minor shortcoming is that the original answer emphasizes TRIPRA’s $1.7 billion deductible in 2022, which the LLM mentions only indirectly by referencing TRIPRA reliance without stating the deductible amount—this is a small omission but does not undermine the core correctness. Otherwise, the answer is comprehensive, well-structured, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Manages]-> RISK_FACTOR <-[Estimates]- ORG <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 421,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "What does the trend in NVIDIA's liability for the 2.00% Notes Due 2031 from fiscal years 2022 to 2024 suggest about the company's long-term debt management strategy, particularly in light of the $1.2 billion carrying amount in 2022, the slight reduction to $1.044 billion in 2023, and the return to $1.25 billion in 2024?",
      "original_answer": "The liability for NVIDIA's 2.00% Notes Due 2031 remained relatively stable across the three years, indicating a consistent long-term debt strategy. In 2022, the liability was reported at $1.2 billion. It slightly decreased to $1.044 billion in 2023, possibly reflecting minor debt repayments or reclassifications. However, by 2024, the carrying amount returned to $1.25 billion, suggesting that NVIDIA maintained its long-term capital structure and did not materially alter its exposure to this long-dated debt instrument. This pattern implies a strategic intent to preserve stable long-term liabilities, likely to support ongoing R&D and operational investments without significant refinancing risk.",
      "llm_answer": "\nThe trend shows that NVIDIA deliberately adjusted the outstanding balance of its 2.00 % Notes Due 2031 – holding a $1.2 bn carrying amount in 2022 (Chunk 1), trimming it to $1.044 bn in 2023 (Chunk 2), and then restoring it to roughly $1.25 bn in 2024 (Chunk 2 & Chunk 3) – indicating an active long‑term debt‑management strategy that uses selective repurchases or refinancings to fine‑tune the maturity profile and funding cost of this senior note.  This pattern, linked through the KG relationship NVDA → 2.00 % Notes Due 2031 → ORG (Chunk 1‑3), reflects the company’s effort to maintain a stable, low‑cost long‑term capital structure while responding to market conditions and the note’s extended 6.4‑year remaining term (Chunk 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports all numerical values: $1.2 billion in 2022, $1.044 billion in 2023, and $1.25 billion in 2024, matching the ground truth exactly. These figures are accurately attributed to the correct fiscal years and the specific debt instrument (2.00% Notes Due 2031), satisfying quantitative accuracy. 2) The answer addresses the trend across the three years and interprets the implications for NVIDIA's long-term debt management strategy. It correctly identifies the slight reduction and subsequent increase, aligning with the original answer’s observation of relative stability. 3) The reasoning is mostly sound but introduces the idea of 'selective repurchases or refinancings' and 'fine-tuning the maturity profile and funding cost' as deliberate actions, which are plausible but not directly supported by the ground truth. The original answer suggests stability and lack of material change, whereas the LLM implies active management, which is a slightly stronger interpretation. The mention of a '6.4-year remaining term' (Chunk 3) is contextually relevant but not present in the ground truth and not necessary for the conclusion. 4) Despite this interpretive difference, the core multi-hop synthesis—linking the liability trend over time to long-term debt strategy—is valid and relevant. The answer correctly identifies the entity (NVIDIA), the financial instrument, and the time series pattern. Semantic equivalence is largely preserved, though the emphasis on 'active' management slightly diverges from the ground truth's more neutral 'consistent' strategy. Thus, correctness is high but not perfect due to interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 451,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Apple's issuance of the 1.05% Notes due 2017 evolve across 2022, 2023, and 2024, and what does this reveal about the long-term visibility and continuity of Apple's debt structure referencing this specific instrument?",
      "original_answer": "Apple's reference to the 1.05% Notes due 2017 remained consistent across all three years—2022, 2023, and 2024—as part of its incorporated debt instruments, indicating that while the notes were issued well before this period, they continued to be a documented part of Apple's ongoing capital structure and financial obligations. Despite the notes having matured in 2017, their persistent inclusion in subsequent filings suggests they may have been rolled over, refinanced, or retained in documentation as historical instruments under the same indenture framework. This continuity implies a stable and transparent debt management strategy by Apple, with consistent disclosure practices around legacy instruments.",
      "llm_answer": "\nApple’s 1.05 % Notes due 2017 appear in the “Description of Securities” (Exhibit 4.4) of every annual filing from 2022 through 2024, each time listed alongside the same 2014 indenture and officer certificates that originally created the instrument.  This repeated disclosure—captured by the KG pattern AAPL → 1.05 % Notes due 2017 → AAPL—shows that the note remains an active, un‑retired component of Apple’s capital structure, preserving long‑term visibility and continuity of that specific debt instrument across the three fiscal years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is quantitatively accurate—correctly identifying the 1.05% Notes due 2017, the 2014 indenture, and their consistent disclosure in Apple's filings from 2022 to 2024. The numbers, percentages, and dates match the ground truth exactly, earning a perfect score on quantitative accuracy. Contextual relevance is high, as the response directly addresses the question about the evolution and continuity of the debt instrument over the three years. However, the qualitative accuracy is low due to flawed reasoning: the LLM concludes that the note 'remains an active, un-retired component' of Apple’s capital structure, which contradicts the ground truth stating the notes matured in 2017. The original answer correctly infers that the continued disclosure likely reflects refinancing, rollover, or documentation continuity under the same indenture framework—not that the original 2017 notes are still active. This misinterpretation represents a significant error in multi-hop reasoning, as the model fails to reconcile the maturity date (2017) with the post-2017 disclosures, leading to an incorrect conclusion about the instrument's current status. While the pattern of disclosure is correctly observed, the synthesis across time and financial logic is unsound. Thus, the overall correctness score is reduced to 6—partially correct in facts but significantly flawed in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 384,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024, and what were the key changes in migration limits and balance requirements under the IDA agreements during this period?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to limitations, and had already moved $10.1 billion by year-end. In 2023, under the newly executed 2023 IDA agreement, Schwab no longer exercised this migration option and was instead bound by new minimum and maximum balance thresholds. By 2024, Schwab continued to operate under the 2023 IDA agreement and did not move any IDA balances to its balance sheet, reflecting a strategic shift toward maintaining off-balance sheet deposits under stricter constraints. This evolution shows a transition from active migration to constrained off-balance sheet management.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s migration capability shifted from the original IDA framework—where, starting July 1 2021, it could move up to $10 billion of IDA balances every 12 months (subject to a $50 billion minimum balance and a requirement that at least 80 % of balances be designated fixed‑rate through June 2026, as noted in the 2022 filing)—to the 2023 IDA agreement, which eliminated the 80 % fixed‑rate rule and replaced it with new balance caps: maintaining balances above the total of outstanding unmatured fixed‑rate obligations with a $30 billion ceiling through September 10 2025, and thereafter a minimum of $60 billion and a maximum of $90 billion, while also extending the sweep term to July 1 2034; consequently, Schwab did not migrate any IDA balances in 2023 or 2024, relying instead on these revised limits and the extended term to govern future migrations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Schwab's IDA balance migration policy from 2022 to 2024 and correctly notes the shift from active migration to no migration under a new agreement. However, there are significant factual inaccuracies that reduce correctness. (1) The original answer states that in 2022, Schwab had already migrated $10.1 billion by year-end under the 2019 IDA agreement with a $10 billion annual limit—this is accurate. The LLM answer incorrectly references a July 1, 2021 start date and a 12-month rolling $10 billion migration window, which is not in the ground truth. (2) The LLM introduces specific balance thresholds—$30 billion ceiling through September 10, 2025, then $60–$90 billion range—which are not mentioned in the original answer. The original only states that the 2023 agreement introduced 'new minimum and maximum balance thresholds' without specifying amounts. (3) The LLM claims the 80% fixed-rate requirement was removed and the sweep term extended to July 1, 2034—details absent from the ground truth. These additions, while plausible, are unsupported by the provided truth and appear fabricated or hallucinated. (4) The core correct elements: Schwab stopped migrating balances in 2023 and 2024, shifted strategy under a new 2023 agreement, and moved from migration capability to off-balance sheet constraints. (5) Multi-hop reasoning is partially sound—linking changes in agreements to migration behavior—but undermined by insertion of unverified numerical and contractual details. Quantitative accuracy is low due to unsupported figures and dates. Qualitative accuracy is moderate due to correct directional narrative but incorrect specifics. Contextual relevance is high as the answer directly addresses the question’s scope and timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 484,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did GE's financial exposure and strategic handling of Bank BPH's borrower litigation evolve from 2022 through 2024, particularly in terms of estimated losses, capital contributions, and the carrying value of the mortgage portfolio?",
      "original_answer": "GE's financial exposure to Bank BPH's borrower litigation increased significantly in 2023, with estimated losses rising to $2,669 million by year-end from $1,359 million in 2022, and a $1,014 million charge recorded in Q2 2023 as part of a settlement program. Capital contributions also spiked in 2023, with a non-cash contribution of $1,797 million through intercompany loan forgiveness, following a $530 million cash contribution in 2022. By 2024, estimated losses slightly declined to $2,461 million, and no further contributions were required. Additionally, the carrying value of the Bank BPH mortgage portfolio dropped to zero by the end of 2024, indicating a full valuation write-down. This trajectory shows a worsening litigation environment through 2023 followed by stabilization in 2024, with GE absorbing significant losses and ultimately exiting active involvement in Bank BPH.",
      "llm_answer": "\nGE’s estimated losses for Bank BPH’s borrower litigation were $1.36 bn as of 31 Dec 2022, increased to $2.67 bn in 2023 and were revised to $2.46 bn by 31 Dec 2024, reflecting the growing number of Polish‑court rulings and the impact of recent ECJ and Supreme Court decisions (as noted in the 2022‑2024 disclosures).  \nTo meet regulatory‑capital requirements, GE injected $530 m of cash in 2022 and, beginning in 2023, executed $1.797 bn of non‑cash intercompany loan‑forgiveness (with no further cash contributions required in 2023 or 2024).  \nBy the end of 2024 the mortgage‑loan portfolio carried a zero net carrying value after valuation allowances, mirroring the company’s practice of writing down assets and adjusting reserves—similar to the $2.66 bn environmental‑remediation reserves recorded in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor wording differences. (1) All key facts are correct: estimated losses of $1.36B in 2022 (vs. $1,359M), $2.67B in 2023 (vs. $2,669M), and $2.46B in 2024 (vs. $2,461M) — these are within rounding tolerance. Capital contributions match exactly: $530M cash in 2022 and $1,797M non-cash via loan forgiveness in 2023. The zero carrying value of the mortgage portfolio by end-2024 is correctly stated. (2) Quantitative accuracy is perfect — all numbers align with the original answer when accounting for standard rounding (e.g., $1.36B = $1,360M ≈ $1,359M). The $1,014M charge in Q2 2023 is not explicitly mentioned, which is a minor omission, but the overall increase in losses and settlement context are implied through the $2.67B figure and reference to court rulings. (3) Multi-hop reasoning is sound: the LLM synthesizes data across years and entity relationships (GE → Bank BPH), correctly identifying shifts from cash to non-cash contributions and linking legal developments to financial impacts. (4) The mention of environmental reserves in 2021 is extraneous and slightly distracts, but does not undermine the correctness of the Bank BPH analysis. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth, warranting a high score with only a slight deduction in qualitative accuracy due to the minor omission of the specific Q2 charge and the tangential environmental reserve comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> COMP <-[Has_Stake_In]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 424,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did CVS's exposure to commercial mortgage-backed securities evolve from 2022 through 2024, particularly in terms of fair value and unrealized losses, and what does this trend suggest about the company's risk management strategy?",
      "original_answer": "CVS's exposure to commercial mortgage-backed securities (CMBS) declined significantly from 2022 to 2024. In 2022, the total fair value of CMBS was $574 million with $12 million in unrealized losses. By 2023, the fair value increased slightly to $675 million, but unrealized losses rose sharply to $100 million. In 2024, the fair value of CMBS dropped dramatically to just $3 million, indicating a major reduction in exposure. This trajectory suggests a strategic shift in 2024 to de-risk the portfolio, likely in response to the elevated unrealized losses and market volatility observed in 2023.",
      "llm_answer": "\nBased on the filings, CVS’s commercial‑mortgage‑backed‑securities (CMBS) position was $574 million with $12 million of unrealized losses in 2022 (Chunk 1), grew to $675 million and $100 million of unrealized losses in 2023 (Chunk 3), and then was cut sharply to only $3 million of fair‑value exposure in 2024 (Chunk 2, down from $6 million in 2023).  This trajectory shows that CVS initially expanded its CMBS holdings—accepting higher unrealized losses—before deliberately reducing the exposure in 2024 to limit further interest‑rate and credit risk, reflecting a risk‑management strategy that de‑riskes the portfolio once losses mount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures: $574 million fair value with $12 million unrealized losses in 2022, $675 million with $100 million unrealized losses in 2023, and $3 million in 2024. These match the ground truth exactly. The mention of $6 million in 2023 as a prior value for the 2024 exposure appears to be an extra detail not in the original answer but does not contradict it and may reflect interim data; it does not detract from accuracy. (2) All numbers are quantitatively accurate—no calculation errors or misstatements. Format variations (e.g., $675 million vs $675M) are acceptable and correctly interpreted. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and infers a strategic de-risking move in 2024 following rising unrealized losses in 2023. The conclusion about risk management aligning with market conditions and loss accumulation is logically supported and semantically equivalent to the original interpretation. (4) The only minor issue is the slight rewording of the risk management rationale—'de-riskes' [sic] the portfolio once losses mount'—which is slightly less precise than the original's emphasis on a 'strategic shift in 2024 to de-risk... in response to elevated unrealized losses and market volatility.' However, the core reasoning is intact. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall due to negligible wording imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 419,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Walmart's private brand portfolio featuring Marketside evolve from fiscal years 2022 to 2024, and what does this 3-year progression indicate about the company's private label strategy in the grocery segment?",
      "original_answer": "From 2022 to 2024, Walmart consistently included Marketside as part of its private brand portfolio, highlighting its ongoing commitment to the brand within the grocery category. In 2022, Marketside was listed among key private brands like Great Value and George, indicating its foundational role in Walmart's grocery offerings. In 2023, Marketside remained a named private brand, suggesting continuity in Walmart's strategy to maintain a diversified private label presence. By 2024, Marketside continued to be featured, even as Walmart introduced new private brands like 'bettergoods,' signaling a strategic expansion and modernization of its private label lineup while maintaining legacy brands like Marketside. This 3-year consistency in featuring Marketside, alongside the introduction of new brands, reflects Walmart's dual approach of preserving trusted private brands while innovating to meet evolving consumer preferences.",
      "llm_answer": "\nWalmart has carried **Marketside** as a staple private‑brand label in its grocery unit from FY 2022 through FY 2024—each of the three 10‑K filings lists “Marketside” among the company’s private‑brand portfolios (chunks 1, 2 & 3) and the knowledge‑graph triplets link **WMT → Marketside → WMT**, confirming the brand’s ongoing production by the retailer.  In FY 2024 the portfolio was broadened with the addition of the new sub‑brand **“bettergoods”** (visible only in the 2024 list, chunk 2), while the 2023 filing retained the same set of private brands, indicating a stable core of grocery‑focused private labels that is now being expanded with higher‑quality offerings.  This three‑year progression shows Walmart’s strategy of **consolidating and then modestly upgrading its grocery private‑label suite**, using brands like Marketside as a foundation to introduce newer, quality‑oriented lines and to deepen its direct‑to‑consumer merchandise offering in the grocery segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Marketside is consistently listed in Walmart's private brand portfolio from FY2022 to FY2024, and the introduction of 'bettergoods' in FY2024 is correctly noted. There are no errors in entities, years, or brand names. (2) Quantitative accuracy is perfect—no numerical data is misstated, and the timeline (2022–2024) matches exactly. The use of 'each of the three 10-K filings' correctly reflects the multi-year consistency. (3) Reasoning is sound: the LLM correctly infers that maintaining Marketside while adding 'bettergoods' indicates a strategy of building on a stable foundation while modernizing the private label lineup. The phrase 'consolidating and then modestly upgrading' is a valid interpretation of the dual strategy described in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention Walmart’s 'diversified private label presence' or the comparative context with other brands like Great Value and George (noted in 2022), which slightly reduces qualitative completeness. However, the core multi-hop synthesis—linking the persistence of Marketside with the strategic addition of new brands over three years—is well executed. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 377,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Lowe's evolve its monitoring and enforcement of supplier practices related to environmental and human rights standards from 2022 through 2024, and what specific policy enhancements and investments were made across those years to strengthen supply chain sustainability?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its monitoring and enforcement of supplier practices. In 2022, the company monitored suppliers through collaboration and management systems, holding them to standards outlined in its human rights policy, conflict minerals policy, and Vendor Code of Conduct, while also specifying that wood products must come from well-managed, non-endangered forests. In 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a new forestry grievance process, demonstrating a more structured and responsive approach. By 2024, the company had further strengthened its policies with a more robust risk-based approach to wood sourcing, including improved monitoring and a formalized grievance mechanism. These changes were supported by multi-year investments exceeding $550 million by 2022 and over $400 million through 2023 in operational sustainability initiatives, reflecting a consistent and growing commitment to supply chain responsibility and environmental stewardship.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s systematically deepened the monitoring and enforcement of supplier environmental and human‑rights performance by first updating its human‑rights, conflict‑minerals and Vendor Code of Conduct policies (2022) and then applying a more robust, risk‑based wood‑sourcing framework with new country‑level risk levels, an expanded forestry grievance process and heightened supplier monitoring (2023); it simultaneously disclosed a science‑based net‑zero goal, set interim GHG‑reduction targets (40 % scope 1‑2 and 22.5 % scope 3 cuts by 2030 in 2023, later sharpened to 42 % and 25 % respectively in 2024), and invested over **$550 million** (2022) and later **>$400 million** (2023) in energy‑efficiency upgrades such as LED lighting, high‑efficiency HVAC, building‑management systems and pallet grinders, while also spending **$25 million** on the Gable‑Grants skilled‑trade program (2024) to build a sustainable supply chain.  Throughout the three years Lowe’s reported progress in its Corporate Responsibility and CDP filings, maintained its Dow Jones Sustainability Index inclusion, and enforced supplier compliance through its human‑rights policy, conflict‑minerals policy and the Vendor Code of Conduct, thereby continuously strengthening supply‑chain sustainability.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Lowe's supplier monitoring and enforcement from 2022 to 2024, correctly identifying key policy updates such as the human rights policy, conflict minerals policy, Vendor Code of Conduct, and enhancements to wood sourcing with country-level risk assessments and grievance mechanisms in 2023 and 2024. However, it introduces information not present in the ground truth, notably the science-based net-zero goal, GHG reduction targets (40%, 22.5%, 42%, 25%), and the $25 million Gable-Grants skilled-trade program in 2024, which are not mentioned in the original answer and cannot be verified from the provided knowledge graph. (2) Quantitatively, the LLM correctly reports the $550 million investment by 2022 and over $400 million through 2023, aligning with the original answer’s 'exceeding $550 million by 2022' and 'over $400 million through 2023'. However, the addition of the $25 million program is unsupported and introduces a factual inaccuracy. The GHG targets and net-zero goal are specific numerical claims absent from the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is generally sound—linking policy updates across years and tying investments to sustainability initiatives—but overextends by incorporating unverified environmental targets and programs. The synthesis of policy evolution and investment trends is logical and well-structured, but the inclusion of extraneous details undermines factual precision. (4) The contextual relevance is high, as the response directly addresses the question’s focus on monitoring, enforcement, policy enhancements, and investments. The qualitative accuracy is strong in describing the progression of wood sourcing policies and supplier standards, though the unsupported additions prevent a higher score. Overall, the answer is mostly correct with strong structure and relevant details, but the inclusion of unverified metrics and programs reduces factual reliability, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Monitors]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1625,
        "completion_tokens": 550,
        "total_tokens": 2175
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Apple's disclosure of the 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this 3-year pattern indicate about the company's ongoing debt management strategy?",
      "original_answer": "Apple consistently included the 2.40% Notes due 2023 in its list of global notes in filings for 2022, 2023, and 2024, indicating sustained transparency around this debt instrument despite its impending maturity. In 2022, the note was listed among other global notes in the Officer's Certificate dated May 3, 2013. In 2023, the same note appeared in the filings, showing continuity in disclosure as the maturity date approached. By 2024, Apple still included the 2.40% Notes due 2023 in its exhibit list, even though the notes were set to mature within that year, suggesting a deliberate approach to managing and disclosing legacy debt obligations. This consistent inclusion across three years reflects a stable and transparent debt disclosure strategy.",
      "llm_answer": "\nApple first set out the terms of the 2.40 % Notes due 2023 in an Officer’s Certificate dated May 3 2013 (Exhibit 4.3) and has kept that exact language in the Exhibit 4.3 section of every subsequent 10‑K filing – 2022, 2023 and 2024 – without amendment or new issuance.  This three‑year repetition shows that Apple is not replacing or refinancing the notes but simply re‑filing the original disclosure, indicating a deliberate, long‑term debt‑management strategy that relies on a stable, low‑cost fixed‑rate borrowing position rather than actively issuing new debt.  The consistent KG linkage AAPL → 2.40 % Notes due 2023 ← Issues → AAPL underscores that the instrument remains a permanent component of Apple’s capital structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, percentages, and document references (e.g., Officer’s Certificate dated May 3, 2013, Exhibit 4.3, and consistent inclusion in 2022–2024 10-Ks), satisfying quantitative accuracy. The entity identification (Apple, 2.40% Notes due 2023) and timeline are correct. However, the reasoning contains a significant misinterpretation: stating that Apple 'is not replacing or refinancing the notes' and that the instrument remains a 'permanent component' of its capital structure contradicts the nature of a note due in 2023, which would mature and likely be repaid, not maintained indefinitely. The original answer correctly frames the continued disclosure as transparency around a legacy obligation nearing maturity, not as evidence of a permanent or unchanging debt strategy. The LLM overinterprets the repetition of the exhibit as a strategic choice rather than standard regulatory disclosure practice. While the multi-hop synthesis across years is sound and contextually relevant, the conclusion about Apple’s long-term debt strategy goes beyond the evidence provided in the ground truth, reducing qualitative accuracy. Semantic equivalence is partially met, but the implication of permanence is misleading.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 350,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did GE's holdings of the AerCap note evolve from 2022 to 2024, and what does this progression suggest about GE's investment strategy in financial instruments during this period?",
      "original_answer": "GE's holdings of the AerCap note decreased from $976 million in 2022 to $944 million in 2023, but then increased to $982 million in 2024. This fluctuation suggests a dynamic approach to managing financial assets, with a slight overall stability in AerCap note holdings despite broader changes in GE's portfolio composition, including significant shifts in U.S. corporate debt and mortgage-backed securities over the same period.",
      "llm_answer": "\nThe 2022 Form 10‑K (Chunk 1) records a $993 million AerCap note as of Dec 31 2021, establishing the baseline before the later filings. Subsequent filings show the note’s carrying amount grew to $900 million at the end of 2022 (Chunk 2), to $944 million at the end of 2023 (Chunk 2), and to $982 million at the end of 2024 (Chunk 3), a modest but consistent increase. This upward trajectory indicates that GE is deliberately expanding its exposure to the AerCap note—a Level 3 debt security in its investment‑securities portfolio—to reinforce a strategy of allocating capital to high‑quality financial instruments that generate stable cash flows and diversify earnings, particularly within its run‑off insurance operations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported values for GE's holdings of the AerCap note. According to the ground truth, the holdings were $976 million in 2022, decreased to $944 million in 2023, and increased to $982 million in 2024. However, the LLM incorrectly states that the amount was $900 million in 2022 (should be $976M), and falsely claims a 'consistent increase' from 2022 to 2024, when in fact there was a decrease from 2022 to 2023. Additionally, the LLM references a $993 million value as of Dec 31, 2021, which is not relevant to the question about 2022–2024 evolution and introduces confusion. (2) The quantitative inaccuracies are severe: the 2022 figure is off by $76 million, and the trend description contradicts the actual data. The correct progression is down then up, not consistently increasing. (3) The multi-hop reasoning fails because the model misrepresents the temporal pattern and draws an incorrect conclusion about GE's strategy—claiming a 'deliberate expansion' when holdings actually decreased year-over-year from 2022 to 2023. The synthesis across years is flawed. (4) While the mention of AerCap as a Level 3 debt security and GE’s run-off insurance operations may provide contextual color, the core facts are wrong, undermining the analysis. The answer is partially relevant but fundamentally incorrect in its numerical foundation and directional interpretation, warranting a low correctness score despite some structural relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 415,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 through 2024, and what does the progression of target asset allocations reveal about the plan's de-risking strategy in response to changing funded status?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan consistently guided the allocation between growth assets and liability-hedging assets based on the plan's funded status across 2022, 2023, and 2024. In 2022, the target allocation for 2022 was based on the funded status at December 31, 2021. By 2023, the target allocation for 2024 was set according to the funded status at December 31, 2022, and in 2024, the target allocation for 2025 was determined using the funded status at December 31, 2023. The glide path approach progressively reduced the allocation to growth assets while increasing the allocation to liability-hedging assets as the funded ratio improved over the years, reflecting a deliberate de-risking strategy aligned with liability-driven investing principles.",
      "llm_answer": "\nThe glide‑path policy—disclosed as an accounting policy (Chunk 3) and reiterated in the 2023 (Chunk 1) and 2024 (Chunk 2) filings—sets the “Return‑Seeking” (growth) target allocation based on the plan’s funded ratio and prevailing interest rates, with the rule that “allocation to growth assets is reduced and allocation to liability‑hedging assets is increased as the plan's funded ratio increases.”  As the funded ratio improved from the 2021 baseline (target allocation shown for 2022 in Chunk 3) to the 2023‑year target for 2024 (Chunk 1) and then to the 2024‑year target for 2025 (Chunk 2), the disclosed tables show a steady pull‑back in growth‑asset percentages and a corresponding rise in liability‑hedging holdings.  This progression reveals that AIG is systematically de‑risking the U.S. pension plan by shifting assets from volatile growth classes into more stable, liability‑matching assets as the plan’s funded status strengthens, consistent with the same glide‑path logic applied across all three reporting periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of AIG's glide path approach from 2022 to 2024, noting that target allocations for future years (e.g., 2024, 2025) are set based on the funded status of the prior year-end (e.g., 2022, 2023), which matches the original answer's description of the timing and decision logic. (2) While no specific percentages or funded ratios are cited (which are not provided in the ground truth either), the directional shift—reducing growth assets and increasing liability-hedging assets as funded status improves—is accurately described. There are no numerical inaccuracies, and the answer correctly infers the de-risking trend without fabricating figures. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across 2023 and 2024 filings (referencing 'Chunk 1', 'Chunk 2', 'Chunk 3') to show consistency in policy application over time, correctly linking funded status improvements to asset allocation changes. (4) The semantic meaning fully matches the original: it conveys the same de-risking strategy grounded in liability-driven investing, with consistent policy mechanics across years. The only minor limitation is the lack of explicit mention that the 2022 target was based on 2021 funded status (though implied via pattern), but this is compensated by clear articulation of the recurring mechanism. Wording differences are stylistic and do not affect factual equivalence. Overall, the answer is factually correct, contextually precise, and demonstrates strong qualitative and quantitative alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 448,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve from 2022 to 2024, and what does this multi-year consistency reveal about the role of this product line in driving long-term free cash flow per share growth?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently emphasized embedded processing products as a core component of its business model, underscoring their role in delivering long-term free cash flow per share growth. In 2022, the company highlighted embedded processing as one of two key product lines (alongside analog) that anchor its four sustainable competitive advantages. This focus persisted in 2023, with the company reiterating that embedded processing products provide 'more opportunity per customer and more value for our investments.' In 2024, Texas Instruments maintained this strategic narrative, describing embedded processing as central to its competitive model that enables supply chain control, customer reach, and diversified returns. The consistent emphasis across all three years indicates that embedded processing is not a tactical shift but a foundational pillar in TI's long-term cash flow generation strategy.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Management‑Discussion‑and‑Analysis sections (Chunk 1, Chunk 2 and Chunk 3), Texas Instruments (TXN) continues to describe its **strategic emphasis on analog and embedded‑processing products as a core pillar of the business model**, explicitly linking that focus to the four sustainable competitive advantages that drive long‑term cash generation.  The repeated wording in all three filings shows a multi‑year consistency: by anchoring its capital‑allocation, R&D and efficiency initiatives to this product line, TI secures a stable, high‑margin revenue base that underpins the **steady growth of free‑cash‑flow‑per‑share** that the company treats as the ultimate measure of value creation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core of the ground truth. (1) It correctly identifies Texas Instruments' multi-year strategic emphasis (2022–2024) on embedded processing as a core pillar alongside analog products, explicitly linking this to long-term free cash flow per share growth—matching the original answer’s key message. (2) There are no numeric values in the question or ground truth requiring calculation; the years (2022, 2023, 2024) are correctly referenced, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes consistent strategic language across three years from the MD&A sections, correctly inferring that the repetition reflects a foundational, not tactical, strategy. It accurately connects embedded processing to TI’s competitive advantages and capital allocation, though it slightly generalizes the specific phrases like 'more opportunity per customer' (2023) and 'supply chain control, customer reach, and diversified returns' (2024) without quoting them directly. (4) Despite minor omission of year-specific nuances, the LLM conveys semantic equivalence—emphasizing continuity, strategic centrality, and cash flow linkage. Wording differs but meaning aligns. Contextual relevance is perfect: it directly addresses both parts of the question—evolution of strategy and implications for cash flow. One point deducted from qualitative accuracy for not explicitly differentiating how the emphasis evolved slightly each year, though the consistency itself is the main point. Overall, a strong, factually correct response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 434,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Lowe's intellectual property strategy around its private brands, including Kobalt, evolve from fiscal 2022 through 2024, particularly in terms of brand portfolio emphasis and integration with digital transformation initiatives?",
      "original_answer": "In fiscal 2022, Lowe's explicitly highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as part of its private brand portfolio, while also listing 'RONA' and 'Reno Depot' as retail names under its intellectual property. This broader listing suggested a more expansive view of brand assets. In fiscal 2023, the company streamlined its disclosure to focus only on 'Kobalt', 'STAINMASTER', and 'allen+roth', omitting 'RONA' and 'Reno Depot', which may reflect a simplification or refocusing of brand emphasis in the intellectual property section. By fiscal 2024, the company continued to highlight the same three private brands but introduced new language around digital transformation, such as remote customer support and mobile checkout, which could signal a strategic integration of digital tools to enhance private brand customer experiences. The removal of certain brand names and the addition of digital context suggest a shift toward a more focused and digitally enabled private brand strategy over the three-year period.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Lowe’s repeatedly disclosed that the subsidiary owning the “Lowe’s” service mark also holds the private‑brand trademarks Kobalt, STAINMASTER and allen+roth (see the IP sections in Chunks 1, 2 and 3), confirming that the Kobalt brand remained under the same ownership structure across the three years.  Beginning in 2023 and expanding in 2024, the company tied that IP to its digital‑transformation agenda—launching a remote central‑selling team and enabling customers to complete quotes, contracts and checkout on lowes.com or the mobile app, thereby integrating the Kobalt brand experience with online project‑selling and installation workflows (Chunk 2).  This evolution reflects a strategic shift from merely protecting a static brand portfolio to leveraging those trademarks within a digitally enabled, end‑to‑end sales and installation process, as illustrated by the KG ownership loop LOW → Kobalt → ORG → LOW (Chunk 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Lowe's consistently highlighted 'Kobalt', 'STAINMASTER', and 'allen+roth' as key private brands from 2022 to 2024, which matches the original answer. It also accurately notes the omission of 'RONA' and 'Reno Depot' from later disclosures, though it does not explicitly mention their inclusion in 2022 and subsequent removal—this is a minor omission but not factually incorrect. (2) There are no numerical values to verify, so quantitative accuracy is 10. (3) The reasoning is sound: the LLM correctly infers a strategic shift from static IP protection to active integration with digital transformation, citing remote selling, online quotes, contracts, and mobile checkout as evidence—this aligns with the original answer’s emphasis on digital integration by 2024. The reference to a 'KG ownership loop' is interpretive but consistent with the knowledge graph logic. (4) The answer fully addresses both parts of the question—evolution of brand portfolio emphasis and integration with digital initiatives—and uses appropriate context from the filings. The only slight gap is the lack of explicit contrast in brand listing breadth between 2022 and later years, but the overall synthesis across years and domains (IP + digital) is strong. Hence, correctness is 9 due to high factual accuracy with a minor completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Owns]-> PRODUCT <-[Owns]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 393,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted client relationships and trust as a core competitive differentiator, but the context in which it was framed evolved. In 2022, IBM emphasized trust as part of its hybrid cloud and AI platform integration, particularly through deep industry expertise and a secure, open platform. By 2023, the company expanded this focus by linking client trust to its strategic partnerships with major tech firms like AWS, Microsoft, and SAP, indicating a broader ecosystem-driven approach to delivering client value. In 2024, IBM reinforced this positioning while also adding cybersecurity-focused partners like Palo Alto Networks to its strategic alliance list, suggesting a growing emphasis on security as a key component of client trust. This 3-year trajectory reveals a strategic evolution where trust is increasingly tied to both technical capabilities (AI, hybrid cloud) and a robust, secure partner ecosystem, aligning with the rising importance of data governance and digital transformation in enterprise IT decisions.",
      "llm_answer": "\nIBM’s 2022 10‑K first introduced **client relationships and trust** as a core differentiator that underpins its hybrid‑cloud and AI strategy, describing trust and security as integral to the open hybrid‑cloud platform and AI‑driven solutions that create sustained value for clients (Chunk 1).  \nIn the 2023 filing the same emphasis is expanded through a **broader ecosystem of strategic partnerships**—including Adobe, AWS, Microsoft, Oracle, Salesforce and others—where trust is reinforced by collaborative go‑to‑market efforts that can simultaneously involve competitors in other areas, while IBM continues to embed AI and cloud into its portfolio to deliver business outcomes (Chunk 2).  \nThe 2024 filing reiterates this multi‑year trajectory, positioning **trust‑centric differentiation** as the engine of accelerated growth in hybrid cloud and AI and as the foundation for future bets such as quantum computing, thereby cementing IBM’s strategic positioning around client‑relationship trust as the differentiator that sustains its leadership in the evolving hybrid‑cloud/AI market (Chunk 3).  \n\n*The knowledge‑graph pattern (IBM → Client Relationships and Trust ← IBM) reflects this cyclical dependence, showing that IBM’s competitive advantage is continuously reinforced by the very concept it relies on.*",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: IBM emphasized client relationships and trust as a competitive differentiator across 2022–2024, with evolving context each year. In 2022, trust was tied to hybrid cloud and AI platforms; in 2023, expanded via strategic partnerships (AWS, Microsoft, etc.); in 2024, trust was reinforced as foundational to growth and future bets like quantum computing. (2) There are no numeric inaccuracies—no figures were cited, so no calculation errors. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years of filings, showing progression in IBM’s strategic emphasis. One minor omission: the 2024 filing specifically added cybersecurity partners like Palo Alto Networks, which the LLM does not mention—this detail is present in the ground truth and adds nuance about security becoming a pillar of trust. The LLM instead emphasizes quantum computing as a future bet, which may be accurate but shifts focus slightly from the security aspect highlighted in the original. (4) Despite this omission, the overall trajectory and strategic interpretation are semantically equivalent and well-reasoned. The answer is contextually excellent, directly addressing the evolution and strategic implications. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1613,
        "completion_tokens": 400,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did the role and utilization of Gilead's El Segundo, California facility in cell therapy manufacturing evolve from 2022 through 2024, particularly in terms of its clinical and commercial production responsibilities?",
      "original_answer": "The role of Gilead's El Segundo, California facility in cell therapy manufacturing remained consistent across the three years, with no significant changes in its clinical and commercial production responsibilities. In 2022, the facility was described as being utilized for clinical and commercial manufacturing and processing of cell therapy products, reflecting its dual role in both trial-related and market-ready production. This utilization was reaffirmed in 2023, where the facility continued to serve as a key site for both clinical and commercial manufacturing of cell therapy products, indicating sustained operational importance. In 2024, the facility maintained its function, with no expansion or reduction in responsibilities documented in the filings, showing continuity in Gilead’s strategic use of El Segundo for cell therapy manufacturing. This consistency suggests a stable operational footprint at the El Segundo site for cell therapy despite broader changes in Gilead’s manufacturing network.",
      "llm_answer": "\nFrom 2022 through 2024, Gilead’s El Segundo, California site evolved from being listed simply as one of the company’s principal U.S. manufacturing locations (Chunk 1) to a dedicated cell‑therapy production hub that now handles both clinical‑trial material and commercial supply (Chunks 2 & 3).  The 2023 and 2024 filings explicitly state that the El Segundo facility is “utilized for clinical and commercial manufacturing and processing of our cell‑therapy products,” underscoring its expanded role alongside other cell‑therapy sites such as Santa Monica, Frederick, Maryland and Hoofddorp, Netherlands, and reflecting the growth of Gilead’s cell‑therapy portfolio over this period.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy in its core claim: it states that the El Segundo facility evolved from being a general manufacturing site in 2022 to a 'dedicated cell-therapy production hub' by 2023–2024, implying an expansion of role. However, the ground truth indicates that the facility's role remained consistent across all three years—specifically, it was used for both clinical and commercial manufacturing throughout 2022, 2023, and 2024, with no documented changes in responsibilities. The LLM incorrectly infers an 'evolution' or 'expansion' of function, which contradicts the original answer's emphasis on continuity and stability. While the LLM correctly cites the 2023 and 2024 descriptions of the facility as being used for clinical and commercial manufacturing (and quotes accurately), it misrepresents the 2022 status by suggesting it was only a 'principal U.S. manufacturing location' without specific cell therapy focus, which is not supported by the ground truth—El Segundo was already engaged in cell therapy manufacturing in 2022. There are no numerical errors (quantitative accuracy is high), and the context of cell therapy manufacturing is relevant. However, the reasoning is flawed in synthesizing a change over time that does not exist in the data, leading to a low qualitative and overall correctness score despite accurate phrasing in parts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 384,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Lowe's Companies, Inc.'s issuance and maturity structure of its 4.550% Notes evolve from 2022 through 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Lowe's Companies, Inc. consistently referenced the 4.550% Notes due April 5, 2049 across all three years (2022, 2023, and 2024) as part of its long-term debt structure under the Fifteenth Supplemental Indenture dated April 5, 2019. While the specific maturity date of April 5, 2049 remained unchanged, the consistent inclusion of this instrument across filings indicates a strategic emphasis on long-duration debt to finance long-term obligations and maintain capital flexibility. The stability in referencing this instrument over time suggests Lowe's commitment to managing its capital structure with a focus on extended maturities to avoid near-term refinancing risks.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s continued to carry the **4.550 % Notes that were first created under the Fifteenth Supplemental Indenture dated April 5 2019** (identified in all three 10‑K exhibits 4.16/4.17), which mature on **April 5 2049**; each year’s filing simply re‑presents the same indenture and note description without adding a new tranche.  This repeat‑reference across the 2022, 2023 and 2024 filings shows that the company’s long‑term debt strategy is to maintain a **single, large‑scale fixed‑rate issuance with a 2049 maturity**, using supplemental indentures only to restate and amend the underlying trust structure while preserving the original terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.550% Notes were issued under the Fifteenth Supplemental Indenture on April 5, 2019, and mature on April 5, 2049—this is consistent across 2022–2024 filings. These details match the original answer exactly. (2) Quantitative elements—interest rate (4.550%), issue date (April 5, 2019), and maturity date (April 5, 2049)—are all precisely stated with no errors. Format variations (e.g., spacing in dates) do not affect accuracy. (3) The reasoning correctly infers that the repeated reference to the same note without new tranches indicates a long-term debt strategy focused on long-duration, fixed-rate financing. The LLM adds a nuanced insight about supplemental indentures being used to amend trust structures while preserving original terms, which is plausible and consistent with SEC filing practices, though slightly more detailed than the ground truth. (4) The answer fully addresses both parts of the question: evolution (no change, consistent carryover) and strategic implication (emphasis on long-term maturities for stability and flexibility). The only minor gap is that the original answer emphasizes 'avoiding near-term refinancing risks' more explicitly, which the LLM implies but doesn't state verbatim. However, the semantic meaning is equivalent. Overall, the response demonstrates sound multi-hop reasoning across years and documents, with excellent factual precision and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 416,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the legal exposure and associated settlement costs related to 3M's Scotchgard product evolve from 2022 through 2024, and what does this trend reveal about the financial impact of PFAS-related litigation on the company?",
      "original_answer": "In 2022, 3M was defending multiple lawsuits in New York and Michigan, including a consolidated putative class action in Michigan related to Wolverine's disposal of Scotchgard, with 3M contributing to a $65 million settlement alongside Saint-Gobain and Honeywell. By 2023, the legal exposure had expanded, with 3M facing approximately 68 AFFF suits outside the MDL and additional PFAS-related suits, including a case in Illinois and a Canadian class action, while also finalizing a non-material settlement in Michigan related to Wolverine's disposal practices. In 2024, litigation expanded further into Alabama and Georgia, with multiple lawsuits from municipal water utilities, property owners, and carpet manufacturers, including a $65 million settlement in New York being finalized and ongoing litigation in Alabama with trial dates set for 2026. This trend reveals a growing financial burden from PFAS-related litigation, with increasing geographic spread and case complexity, suggesting that the company's liabilities and legal costs associated with Scotchgard are escalating over time.",
      "llm_answer": "\nFrom 2022 through 2024 the legal exposure tied to 3M’s Scotchgard‑derived PFAS products moved from a $65 million class‑action settlement in early 2022 (where 3M’s share was explicitly described as “not material”) and a modest June‑2023 settlement with Wolverine that was likewise deemed immaterial, to a rapid expansion of new PFAS suits filed across many states in 2024—including Alabama, Georgia, Michigan and New York—most of which are now stayed, dismissed or being transferred to the AFFF MDL, with no additional large settlement reported yet.  This progression, documented in all three source chunks (the 2022 Baker settlement and Wolverine payment in Chunk 1, the 2023‑2024 wave of state‑court filings and dismissals in Chunk 2, and the earlier MDL‑related motions and settlement context in Chunk 3), shows that while each individual resolution has been financially immaterial, the growing volume and geographic spread of litigation are inflating 3M’s overall contingent liability and signal that PFAS‑related claims could become a material financial risk for the company if future judgments or settlements exceed the current modest amounts.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general trend of increasing litigation and geographic spread from 2022 to 2024, and correctly identifies the $65 million settlement in 2022 and the immaterial nature of certain settlements. However, there are key factual inaccuracies affecting quantitative and qualitative accuracy. First, the $65 million settlement in 2022 was not solely 3M's but a shared amount with Saint-Gobain and Honeywell, and the LLM incorrectly implies 3M contributed the full amount. Second, the LLM misstates the timeline: the $65 million settlement was referenced in the context of 2022, but the original answer notes it was contributed during 2022 litigation—not finalized as a 2022 event—and then again referenced as being finalized in 2024 in New York, which the LLM misses entirely. The LLM also incorrectly claims that the 2023 Wolverine settlement was 'modest' and 'immaterial' without noting that the original answer does not describe it as such, only that it was 'non-material'—a subtle but important distinction in financial disclosures. Additionally, the LLM incorrectly states that most 2024 suits are 'stayed, dismissed or being transferred,' while the ground truth emphasizes that litigation is ongoing with trial dates set for 2026, particularly in Alabama. The LLM downplays the financial escalation by focusing on 'immaterial' outcomes, contradicting the original answer’s conclusion that liabilities are 'escalating over time.' While the multi-hop synthesis across years and geographies is partially correct, the reasoning is flawed in minimizing the financial trend. The contextual relevance is high as it addresses the core question about evolution and financial impact, but the factual inaccuracies in key settlements and litigation status reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Manufactures]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 484,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Gilead Sciences' utilization of its Foster City, California facility evolved from 2022 through 2024 in terms of R&D focus, manufacturing responsibilities, and strategic alignment with its global operations?",
      "original_answer": "From 2022 to 2024, Gilead Sciences' Foster City, California facility transitioned from being primarily described as housing administrative, manufacturing, and R&D activities (2022) to being more specifically aligned with process chemistry research, analytical method development, formulation, device development, and the manufacturing of API and drug product for clinical trials (2023–2024). In 2022, Foster City was noted as the corporate headquarters and a key hub within a broader network of global properties. By 2023 and 2024, the facility's role was more narrowly defined with an emphasis on early-stage development and clinical manufacturing, suggesting a strategic shift toward consolidating R&D and clinical production capabilities in Foster City while other locations (e.g., La Verne, Oceanside, and international sites) handled commercial-scale manufacturing and distribution.",
      "llm_answer": "\nFrom 2022 through 2024 the Foster City, California campus evolved from a broad corporate headquarters that housed Gilead’s administrative, manufacturing and R&D functions into a more specialized early‑stage R&D and API‑production hub, where the site concentrates on process‑chemistry research, analytical method development, formulation, device development and the manufacture of clinical‑trial drug substance.  This shift reflects a strategic realignment that moves large‑scale commercial production to other global sites (e.g., La Verne, Cork and Dublin) while keeping discovery‑related chemistry and API development centralized in Foster City, thereby tightly integrating the facility’s R&D and manufacturing output with Gilead’s worldwide manufacturing network and global operations.  The continuity of Foster City’s role—documented across the 2022, 2023 and 2024 filings—demonstrates its ongoing importance as the nexus for Gilead’s pipeline development and its alignment with the company’s worldwide manufacturing and strategic transaction strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: the evolution of Foster City's role from a broad administrative, R&D, and manufacturing site in 2022 to a more specialized hub focused on early-stage R&D, process chemistry, analytical development, formulation, device development, and clinical trial manufacturing in 2023–2024 is accurately described. The strategic realignment—shifting commercial-scale manufacturing to other sites like La Verne, Oceanside, Cork, and Dublin—is correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022–2024) are correct and consistently applied. (3) Multi-hop reasoning is sound: the model synthesizes changes over time and correctly infers strategic intent—centralizing early development in Foster City while decentralizing commercial manufacturing. The mention of international sites (Cork, Dublin) goes slightly beyond the original answer (which named La Verne and Oceanside as examples) but is consistent with Gilead’s known global footprint and does not introduce inaccuracy. (4) Semantic equivalence is strong: the LLM captures all core aspects of the original answer, with only minor expansion (e.g., 'strategic transaction strategy' is vague but not incorrect). One small point: the original emphasizes the narrowing of description in filings, while the LLM frames it as an operational shift—this is a subtle interpretive difference but does not undermine factual correctness. Overall, the answer is comprehensive, contextually relevant, and factually sound, warranting a 9/10 due to slight overstatement of strategic framing without direct citation of filing language.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 484,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 through 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews?",
      "original_answer": "From 2022 to 2024, AIG's approach to managing loss reserves risk remained consistently anchored in internal controls and external expert reviews, but evolved in sophistication and integration. In 2022, AIG emphasized the uncertainty in loss development and outlined internal oversight and external expert reviews as key tools. By 2023, AIG expanded its risk management framework to include sensitivity and scenario analyses, stochastic methods, and experience studies, indicating a more quantitative and layered approach to measuring insurance risk exposure. In 2024, AIG further integrated these practices into a broader enterprise risk management (ERM) framework, including second-line review and challenge of reserving models and assumptions, and enhanced reporting to committees and regulators. The progression shows a shift from reactive oversight to proactive, model-driven, and enterprise-wide risk governance.",
      "llm_answer": "\nFrom 2022 to 2024 AIG’s loss‑reserve oversight moved from a primarily internal‑control and external‑expert review framework (2022 – focus on deterministic reserve estimates and basic external expert validation) to a more layered risk‑governance structure in 2023 that added ERM second‑line challenge, dedicated reserve‑challenge processes and monitoring of reinsurance recoverability, and then to a fully integrated approach in 2024 where stochastic and scenario‑based modeling (including third‑party catastrophe PML models) is routinely adjusted for climate trends and fed into the three‑tier limits hierarchy, while external expert reviews, post‑catastrophe event studies and credit‑risk monitoring of reinsurers remain embedded in the reserve‑setting process. This evolution reflects a progressive deepening of oversight mechanisms, increasingly sophisticated modeling techniques, and systematic incorporation of external reviews across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All entities—AIG, years 2022–2024, loss reserves risk, oversight mechanisms, modeling approaches, external reviews—are correctly identified and addressed. The evolution across the three years is accurately portrayed: 2022 focused on internal controls and external expert reviews; 2023 introduced more quantitative methods like scenario analyses and stochastic modeling; 2024 integrated these into ERM with second-line challenge and enhanced reporting. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes changes over time across oversight, modeling, and external review dimensions. It correctly infers a progression toward more integrated, model-driven governance. The mention of 'three-tier limits hierarchy' and 'climate trends' adds specificity not in the original but does not contradict it and may reflect deeper filing insights; however, these details are not confirmed in the ground truth, slightly reducing qualitative accuracy. (4) The answer is semantically equivalent to the original—wording differs but meaning matches: shift from reactive to proactive, increasing sophistication in modeling, consistent use of external reviews. Only minor over-specification (e.g., 'credit-risk monitoring of reinsurers', 'third-party catastrophe PML models') slightly exceeds the original scope without introducing error. Thus, correctness is excellent but not perfect due to minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 461,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Texas Instruments' (TXN) operational footprint in Melaka, Malaysia evolve from 2022 to 2024, and what does this 3-year progression indicate about its Analog vs. Embedded Processing manufacturing focus in the region?",
      "original_answer": "From 2022 to 2024, Texas Instruments consistently maintained operations in Melaka, Malaysia, focusing exclusively on Analog manufacturing. There was no expansion into Embedded Processing in Melaka during this period, despite changes in other global locations. This indicates a stable but specialized role for Melaka in TXN’s global manufacturing strategy, limited to Analog product lines.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments’ Melaka, Malaysia location is documented in each filing—appearing with a dagger in 2022, an asterisk in 2023 and double‑asterisks in 2024—signaling a stepwise expansion of its footprint in the region; across all three years the site is listed only under the **Analog** column while the **Embedded Processing** column remains empty, indicating that the Melaka facility is dedicated exclusively to analog semiconductor manufacturing and that TI’s regional focus is on scaling analog production rather than embedded‑processing output.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that Texas Instruments maintained operations in Melaka, Malaysia from 2022 to 2024 and that the site was consistently listed only under Analog manufacturing, with no presence in Embedded Processing. The mention of typographical symbols (dagger, asterisk, double-asterisks) across filings reflects accurate observational detail from the source documents, and the interpretation that this signals a stepwise expansion is a reasonable inference, though the ground truth does not explicitly confirm expansion—only continuity and specialization. This leads to a minor deduction in qualitative accuracy, as the LLM infers 'scaling analog production' and 'stepwise expansion' which, while plausible, are not definitively supported by the ground truth statement of 'consistently maintained' and 'no expansion.' However, the core facts—exclusive Analog focus, no Embedded Processing, consistent presence—are all correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer fully addresses both parts of the multi-hop question: evolution over time and implications for manufacturing focus. Semantic equivalence is strong, with only slight overinterpretation of symbolic notation. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 371,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's hedging strategy around forecasted debt issuances?",
      "original_answer": "In fiscal 2022, Lowe's referenced forward interest rate swaps in the context of their impact on other comprehensive income and earnings, indicating active use of these instruments to hedge forecasted debt issuances over multiple prior periods (2019–2021). In fiscal 2023, the company disclosed a fair value of $251 million for forward interest rate swaps under other current assets, showing a concrete financial commitment to managing interest rate risk. By fiscal 2024, however, the company no longer held forward interest rate swaps, focusing instead on fixed-to-floating interest rate swaps as fair value hedges on existing debt, with no mention of forward swaps in the current or prior year positions. This progression indicates a strategic shift from hedging anticipated debt issuances to managing the interest rate exposure on existing debt, reflecting a change in financial risk management focus over the three-year period.",
      "llm_answer": "\nThe company’s forward‑interest‑rate swap program expanded from the 2022 baseline (where cash‑flow swaps were already being used to hedge anticipated debt issuances – see Note 3 in the 2022 10‑K) to a $251 million asset recorded in “Other current assets” as of February 3 2023 (Chunk 1). By the end of fiscal 2024 that same line shows a $‑ balance, while the related fixed‑to‑floating swaps fell from $88 million to $76 million (Chunk 1), indicating the swaps were unwound as the forecasted debt was issued and the effective portions of gains/losses were re‑classified from OCI to interest expense (Chunk 2). This trajectory reflects Lowe’s active cash‑flow hedging strategy—locking in benchmark rates ahead of financing needs and then letting the hedges run off after the debt was placed, thereby managing interest‑rate risk on future borrowings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in interpretation that prevents a top score. (1) Quantitatively, the key figures are accurate: the $251 million fair value of forward interest rate swaps in fiscal 2023 is correctly cited, and the absence of such swaps in fiscal 2024 is properly noted (reported as a '$- balance'). The mention of fixed-to-floating swaps decreasing from $88M to $76M is consistent with the data, though this detail was not in the original answer and may reflect additional context. (2) The timeline is correct: forward swaps were used in 2022 (referenced in Note 3 of the 10-K) to hedge forecasted debt, present as a $251M asset in 2023, and gone by 2024. (3) The reasoning is sound in describing the unwinding of cash flow hedges after debt issuance and the reclassification of gains/losses from OCI to interest expense, which is a standard accounting treatment. However, the LLM implies the strategy was simply 'run off' post-issuance, while the ground truth emphasizes a strategic shift in focus—from hedging *future* debt to managing *existing* debt via fair value hedges (fixed-to-floating swaps). The LLM downplays this strategic pivot and instead frames it as a natural lifecycle of cash flow hedges, missing the broader shift in risk management focus. (4) Entities (Lowe's, forward swaps, fixed-to-floating swaps, fiscal years 2022–2024) and financial concepts are correctly identified. The answer is highly relevant and well-structured. Minor deduction in qualitative accuracy due to incomplete characterization of the strategic shift. Overall, the answer is factually strong but slightly underdevelops the strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Depends_On]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 467,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did IBM's disclosure of the 6.50% Debentures due 2028 evolve across its 2022, 2023, and 2024 filings, and what does the consistency of its referenced filing date reveal about the long-term structure and documentation of this debt instrument?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 across all three years—2022, 2023, and 2024—by citing the same Exhibit 2 to Form 8-K filed on January 8, 1998. This shows that the documentation and legal structure of the debentures remained unchanged over the three-year period, indicating a stable and long-standing debt instrument with no material amendments or refinancing activity disclosed during this time.",
      "llm_answer": "\nIBM’s 2022 10‑K (Chunk 1) first notes that the rights of the 6.50 % Debentures due 2028 are set out in “Exhibit 2 to Form 8‑K, filed on January 8 1998, and is hereby incorporated by reference,” a description that is repeated verbatim in the 2023 10‑K (Chunk 2) and again in the 2024 10‑K (Chunk 3). Because the same exhibit number and the identical January 8 1998 filing date are cited in each filing, the debt instrument’s governing documentation has remained unchanged for more than two decades, reflecting a stable, long‑term capital‑structure where the terms of the 6.50 % Debentures were established at issuance and have not required amendment or restatement in subsequent SEC filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 6.50% Debentures due 2028 are consistently referenced across IBM's 2022, 2023, and 2024 10-K filings; the referenced document is correctly identified as 'Exhibit 2 to Form 8-K' filed on January 8, 1998, in all three years. (2) Quantitative elements—percentage (6.50%), maturity year (2028), and filing date (January 8, 1998)—are exact matches with no errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three separate filings (2022, 2023, 2024) and draws the valid conclusion that the unchanged reference indicates a stable, long-term debt structure with no amendments. (4) The answer addresses both parts of the question: the evolution (or lack thereof) of disclosure over time, and the implication of consistency in filing references. Wording differs slightly from the original (e.g., 'more than two decades' vs 'over the three-year period'), but this enhances rather than distorts meaning. All criteria for correctness, completeness, entity accuracy, and reasoning are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 327,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did the positioning of Reflective Signage within MMM's Transportation and Electronics segment evolve across 2022, 2023, and 2024, and what does this sequence suggest about its strategic importance in MMM's product portfolio?",
      "original_answer": "Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across all three years, but its relative positioning within the product list changed, potentially signaling shifts in strategic emphasis. In 2022, Reflective Signage was listed fifth among offerings, following advanced ceramics and attachment tapes but preceding light management films and electronics assembly solutions. In 2023, it moved up to the fourth position, directly after premium large format graphic films and before light management films and electronics assembly solutions. In 2024, Reflective Signage remained in the fourth position but was now placed after 'sound and temperature management' and before 'Light management films and electronics assembly solutions.' This consistent placement in the top half of the segment's offerings over three years suggests ongoing strategic relevance, with a slight early boost in prominence in 2023 that was maintained in 2024.",
      "llm_answer": "\nAcross the three fiscal years the company’s Transportation & Electronics segment continued to list **Reflective signage for highway and vehicle safety** as a core revenue‑generating activity—appearing in the 2022, 2023 and 2024 10‑K tables (Chunk 1, 2, 3).  The Knowledge‑Graph pattern (MMM → Reflective Signage → MMM) shows that the signage line is both a product created by 3M and an organizational entity that feeds back into 3M, underscoring its strategic centrality.  This consistent placement signals that Reflective Signage is a key, safety‑focused offering within the segment and a pivotal component of 3M’s broader product portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Reflective Signage remained a consistent offering within MMM's Transportation and Electronics segment across 2022, 2023, and 2024, which aligns with the ground truth. It also correctly emphasizes the strategic importance of the product line, noting its role in safety and as a core revenue-generating activity. However, the answer fails to provide the specific year-by-year positioning changes that are central to the question: in 2022 it was fifth, in 2023 it moved to fourth, and in 2024 it remained fourth but after a different preceding product ('sound and temperature management'). This omission significantly undermines the completeness and qualitative accuracy of the response, as the evolution of positioning is the key multi-hop element required. While no numeric values are incorrect (hence full marks for quantitative accuracy), the lack of detailed structural changes in the product list across years means the reasoning is incomplete. The mention of a 'Knowledge-Graph pattern (MMM → Reflective Signage → MMM)' introduces a concept not present in the original answer and does not substitute for the actual sequence data. Thus, while contextually relevant and factually sound in broad strokes, the answer misses critical details necessary to fully address the multi-part, multi-year comparative analysis requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 378,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Gilead's utilization of its Hoofddorp, Netherlands facility for cell therapy manufacturing evolved from 2022 through 2024, particularly in terms of its strategic importance to commercial production?",
      "original_answer": "In 2022, Gilead identified Hoofddorp, Netherlands as one of its principal manufacturing facilities, indicating its operational role within the company's global manufacturing footprint. By 2023, the facility was explicitly described as being utilized for the commercial manufacturing and processing of cell therapy products, aligning with Gilead's broader strategy to expand internal capabilities in this area. In 2024, Hoofddorp retained its designation as a key facility for commercial cell therapy manufacturing, underscoring its growing strategic importance in supporting Gilead's long-term growth needs in advanced therapies. This progression reveals an increasing emphasis on Hoofddorp as a dedicated hub for cell therapy, reflecting Gilead's commitment to scaling this segment.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead’s reliance on its Hoofddorp, Netherlands site grew from a general mention in 2022 of it being one of its “principal manufacturing facilities” (Chunk 1) to an explicit designation in 2023‑2024 as a location “utilized for commercial manufacturing and processing of our cell‑therapy products” (Chunk 2 & Chunk 3).  The knowledge‑graph links show that GILD operates in Hoofddorp (a GPE that is also treated as an ORG tied back to GILD), confirming that the Dutch facility is now a dedicated, strategically important hub for scaling Gilead’s cell‑therapy pipeline and supporting commercial sales across Europe and global markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the evolution of Gilead's Hoofddorp facility from 2022 to 2024: in 2022 it was listed as a principal manufacturing facility; by 2023 it was explicitly used for commercial cell therapy manufacturing; and in 2024 it remained a key site, indicating growing strategic importance. All dates and characterizations are correct, with no numerical errors (quantitative accuracy is perfect, scoring 10). The answer correctly synthesizes information across years and confirms the facility’s role in commercial production, demonstrating sound multi-hop reasoning. The only minor shortcoming is that it slightly condenses the nuance in the 2024 update—while accurate, it doesn’t fully emphasize the forward-looking strategic emphasis on long-term growth in advanced therapies as clearly as the original. However, the core facts, entities (Gilead, Hoofddorp, cell therapy, commercial manufacturing), and timeline are all correct. Wording differs but meaning is semantically equivalent. Contextual relevance is excellent, directly addressing the question’s focus on strategic evolution and commercial production. Thus, correctness is 9 (minor omission in depth of strategic emphasis), qualitative accuracy is 9 (strong reasoning with slight compression), and contextual relevance is 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 380,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the number of shares available for future issuance under the 2003 Director Compensation Plan evolve from 2022 to 2024, and what does this trend indicate about Texas Instruments' ongoing use of this plan for director compensation?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 1,843,134 shares in 2022 to 1,786,785 shares in 2023, and further declined to 1,745,284 shares in 2024. This consistent reduction indicates that Texas Instruments has been actively utilizing the 2003 Director Compensation Plan to issue shares for director compensation over the three-year period, with fewer shares remaining available for future grants each year.",
      "llm_answer": "\nThe 2003 Director Compensation Plan’s reserve of shares that can still be issued shrank from **1,843,134 shares in 2022 to 1,786,785 shares in 2023 and to 1,745,284 shares in 2024** – a steady decline of roughly 98 k shares per year (as disclosed in the 2022, 2023 and 2024 Form 10‑K filings).  \nThis downward trend shows that Texas Instruments is still **actively using the 2003 Director Compensation Plan for director compensation**, but the diminishing pool of available shares indicates that the plan is being increasingly utilized (and supplemented by newer equity‑based plans such as the 2024 LTIP) while the company continues to rely on the legacy plan to meet its director‑award obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the number of shares available for future issuance under the 2003 Director Compensation Plan for all three years: 1,843,134 in 2022, 1,786,785 in 2023, and 1,745,284 in 2024 — matching the ground truth exactly. The trend of consistent decline is accurately described. 2) Quantitative accuracy is perfect: all numbers are correct and properly cited across years. The approximate annual reduction of ~98k shares is a reasonable estimate (actual: 56,349 from 2022–2023; 41,501 from 2023–2024), though this rough average is acceptable as contextual commentary. 3) The reasoning correctly infers that the declining balance indicates ongoing use of the plan for director compensation. It adds value by noting the likely supplementation with newer plans like the 2024 LTIP, which is plausible and contextually sound, though not explicitly required by the question. This does not detract from accuracy but slightly extends beyond the ground truth. 4) All entities (Texas Instruments, 2003 Director Compensation Plan) and time periods are correct. The answer fully addresses both parts of the question: the evolution of shares and the implication for plan usage. The minor deduction in qualitative accuracy is due to the speculative mention of the 2024 LTIP without explicit grounding in the provided data, but this does not undermine the core correctness. Overall, the answer is factually accurate, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 404,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did IBM's treatment and market transparency of its 0.950% Notes due 2025 evolve from 2022 to 2024, and what does this progression suggest about its broader capital market strategy and investor engagement approach?",
      "original_answer": "In 2022, IBM referenced the 0.950% Notes due 2025 as part of a broader list of debt instruments, citing the May 22, 2017 Form 8-K filing (Exhibit 4.1) as the defining instrument. In 2023, IBM continued to reference the same May 2017 filing but began listing the 0.950% Notes due 2025 alongside newer instruments, suggesting increased prominence. By 2024, the 0.950% Notes due 2025 were explicitly listed with a dedicated trading symbol (IBM25B) on the New York Stock Exchange, indicating a shift from internal documentation to active market visibility. This evolution shows IBM's strategic move toward greater transparency and investor accessibility for this instrument over time.",
      "llm_answer": "\nIBM’s 0.950 % Notes due 2025 were first disclosed in the 2022 Form 10‑K (Chunk 1) only as part of a broad Exhibit 4.1/4.2 list that traced the instrument back to its original 2017 8‑K filing, positioning the security among many other debt issuances. The 2023 filing (Chunk 2) repeated that same 2017 reference without adding a separate market‑level disclosure, showing continuity but still lacking explicit identification. By the 2024 filing (Chunk 3) the note appears with its own trading symbol “IBM25B” and a dedicated line in the “Title of each class” table, reflecting a clear evolution toward greater market transparency, dedicated investor‑facing labeling, and a capital‑market strategy that segments and highlights each issuance to improve liquidity and engagement. This progression—​from a generic exhibit reference to a distinct, exchange‑listed security—​illustrates IBM’s shift to more proactive investor communication and a disciplined, transparent approach to managing its diversified debt portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the 0.950% Notes due 2025 were initially referenced via the May 22, 2017 Form 8-K in both 2022 and 2023 filings, with no additional market-level disclosure until 2024. The introduction of the trading symbol 'IBM25B' on the NYSE in 2024 is correctly identified. (2) Quantitative accuracy is perfect: percentages (0.950%), years (2022, 2023, 2024, 2017), and the trading symbol 'IBM25B' match the original. No calculations are required, but temporal progression is accurately represented. (3) Multi-hop reasoning is sound: the model synthesizes information across three years of filings, correctly identifying the evolution from passive documentation to active market visibility. It infers the strategic implication—improved transparency, investor engagement, and liquidity—consistent with the ground truth. (4) The answer addresses all parts of the question: treatment over time, market transparency changes, and implications for capital market strategy and investor engagement. Wording differs slightly but meaning is preserved and enriched with relevant context (e.g., 'dedicated line in the Title of each class table', 'improve liquidity and engagement'). No factual omissions or inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 365,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MetLife's use of the deposit method of accounting for reinsurance evolve from 2022 through 2024, particularly in terms of deposit assets and liabilities, and how does the 2023 Global Atlantic reinsurance transaction reflect a strategic shift in this accounting approach?",
      "original_answer": "From 2022 to 2024, MetLife's use of the deposit method of accounting for reinsurance showed a significant increase in both deposit assets and liabilities. In 2022, deposit assets and liabilities were $1.8 billion and $1.4 billion, respectively. By 2023, deposit assets rose to $5.1 billion and liabilities to $1.3 billion. In 2024, deposit assets slightly decreased to $4.6 billion while liabilities remained stable at $1.2 billion. The 2023 Global Atlantic transaction marked a strategic shift, as MetLife recorded $10.3 billion in reinsurance recoverables and deposit receivables, indicating a more aggressive use of the deposit method to manage risk exposure and restructure its life insurance portfolio.",
      "llm_answer": "\nMetLife has applied the deposit method to reinsurance contracts that do not expose it to a significant loss, reporting deposit assets of $1.8 bn and deposit liabilities of $1.4 bn in the 2021‑2022 periods (Chunk 1). By the end of 2023‑2024 those balances grew to $4.6‑5.1 bn in assets and $1.2‑1.3 bn in liabilities, a change driven by the November 2023 Global Atlantic risk‑transfer transaction in which the company recorded $10.3 bn of deposit receivables, transferred $9.5 bn of assets and recognized a $770 m net‑cost amortization (Chunk 2). This transaction marks a strategic shift from the relatively static deposit accounting of earlier years to a more substantial, structured reinsurance arrangement that incorporates asset transfers, separate‑account handling and amortization of net cost, reflecting MetLife’s broader risk‑management objectives (Chunk 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor inaccuracies in time period labeling and slight imprecision in presenting the year-by-year evolution. It refers to '2021-2022 periods' instead of specifically 2022, which is misleading even if the numbers themselves ($1.8 bn assets, $1.4 bn liabilities) are accurate. The 2023 and 2024 figures are presented as a range ($4.6–5.1 bn assets, $1.2–1.3 bn liabilities), which conflates two distinct years: 2023 had $5.1 bn assets / $1.3 bn liabilities, while 2024 had $4.6 bn assets / $1.2 bn liabilities. Presenting them as ranges obscures the trend of asset decrease from 2023 to 2024. However, the core numbers are present and accurate. The $10.3 bn deposit receivables from the Global Atlantic transaction are correctly cited, as is the $9.5 bn asset transfer and $770 million net-cost amortization (though the latter is not in the original answer and may be extraneous detail). (2) Quantitative accuracy is high: all dollar amounts match the ground truth when properly attributed to years. The error lies in presentation—using ranges instead of discrete annual values—and mislabeling the base year as '2021-2022' rather than 2022. No calculation errors are present. (3) Multi-hop reasoning is strong: the model correctly links the increase in deposit method usage to the Global Atlantic transaction and interprets it as a strategic shift involving structured reinsurance, asset transfers, and risk management—aligning with the original answer’s conclusion. The synthesis across time and events is logical and well-supported. (4) Scores reflect high factual correctness with minor but notable flaws in temporal precision and data presentation. The answer captures the strategic shift accurately and includes relevant context beyond the original answer (e.g., amortization), enhancing qualitative depth without contradicting facts. Contextual relevance is perfect—it directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 533,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did MMM's product portfolio related to Fall Protection Solutions evolve across its Safety and Industrial segment from 2022 to 2024, and what does this 3-year progression indicate about the company's focus on workplace safety solutions?",
      "original_answer": "From 2022 to 2024, MMM consistently included 'fall protection solutions' as part of its Respiratory, hearing, eye and fall protection solutions within the Safety and Industrial segment. In 2022, fall protection was listed among a broader set of safety offerings including respiratory, hearing, and eye protection. In 2023, the listing remained consistent, indicating continued emphasis on integrated safety solutions. By 2024, the phrasing slightly evolved to 'respiratory, hearing, eye and fall protection solutions,' maintaining the same product grouping but with a more concise presentation. This 3-year consistency suggests MMM maintained a stable strategic focus on comprehensive worker protection solutions, with fall protection remaining a core component of its industrial safety portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 the Safety & Industrial segment of 3M consistently listed “respiratory, hearing, eye **and fall‑protection solutions**” among its representative offerings, with the 2023 and 2024 tables retaining the same fall‑protection entry while only minor formatting changes occurred in the 2024 description.  The knowledge‑graph pattern — showing MMM produces Fall Protection Solutions, that product is itself modeled as an Org linked back to MMM — highlights that 3M treats fall‑protection not merely as a line‑item but as a dedicated organizational capability, underscoring a sustained strategic emphasis on workplace‑safety solutions across the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that from 2022 to 2024, 3M (MMM) consistently included fall protection solutions as part of its Safety and Industrial segment under a grouping that includes respiratory, hearing, eye, and fall protection solutions. The answer correctly notes minor formatting changes in 2024 (e.g., hyphenation: 'fall-protection') without substantive changes to the product portfolio, which matches the original answer's observation of 'slightly evolved phrasing.' The conclusion about sustained strategic emphasis on workplace safety is logically sound and supported by the consistency in reporting. The only minor shortcoming is that the LLM introduces a claim about the 'knowledge-graph pattern' and that fall protection is modeled as an 'Org' linked to MMM—this specific structural detail about the knowledge graph is not part of the original answer and cannot be verified from the provided ground truth, making it a slight overreach in interpretation. However, this does not detract from the factual correctness of the company's product portfolio evolution. All entities (MMM, Safety and Industrial segment, years 2022–2024), product categories, and timeframes are accurate. No numerical errors exist, and the reasoning across years is sound. The answer fully addresses both parts of the question: evolution of the product portfolio and what it indicates about strategic focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 402,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Altria's organizational structure and ownership of UST evolved from 2022 to 2024, and what does this progression reveal about Altria's strategic positioning in the smokeless tobacco market?",
      "original_answer": "In 2022, Altria highlighted UST as a key subsidiary, owning its trademarks valued at $8.8 billion, and emphasized amortization expenses tied to its acquisition. By 2023, Altria reaffirmed UST's role as a wholly owned subsidiary through its consolidated subsidiaries structure, maintaining its engagement in moist smokeless tobacco (MST) and snus products. In 2024, Altria further solidified UST's integration by describing it as a core operating company under its broader 'Moving Beyond Smoking' initiative, aligning UST's MST products with Altria's strategic pivot toward reduced-risk tobacco offerings. This evolution shows a consistent emphasis on UST as a strategic asset, with increasing alignment toward Altria's vision of transitioning adult smokers to less harmful products.",
      "llm_answer": "\nAltria has kept UST LLC as a wholly‑owned subsidiary throughout 2022‑2024 – the 2022 10‑K records the UST‑derived MST and snus trademarks as indefinite‑lived intangible assets, the 2023 10‑K reiterates that UST (via its USSTC unit) remains a core subsidiary, and the 2024 10‑K still lists oral‑tobacco products, with UST at the center of that segment.  At the same time, the knowledge‑graph “Involved_In” links (MO → UST ← MO) are reinforced by the 2023 joint‑venture with JTIUH (Horizon LLC, 75 % owned by Altria) and the 2024 re‑classification of oral‑tobacco as a distinct reportable line, showing that Altria is consolidating its smokeless portfolio around UST while expanding into oral nicotine‑pouch (Helix) and heated‑tobacco (Horizon) offerings to position itself as the leading U.S. provider of reduced‑risk tobacco products.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Altria maintained UST as a wholly owned subsidiary from 2022 to 2024, which aligns with the ground truth. It accurately references the 2022, 2023, and 2024 10-K filings and correctly notes UST's role in MST and snus products. However, the LLM introduces information not present in the original answer—specifically the 2023 joint venture with JTIUH (Horizon LLC, 75% owned by Altria) and the Helix oral nicotine pouch—as part of Altria’s strategic positioning. While these may be factually accurate in broader context, they are not mentioned in the ground truth and shift focus away from UST’s evolving integration toward other ventures, thereby adding unsupported multi-hop inferences. (2) Quantitative accuracy is high: no specific dollar amounts (e.g., $8.8 billion trademarks) are mentioned in the LLM answer, so it avoids inaccuracy, but also omits this key figure from the 2022 data in the ground truth. The 75% ownership in Horizon LLC is a precise number, but since it's extraneous to the ground truth and not required for the answer, it doesn't improve accuracy. (3) The reasoning is mostly sound—LLM traces UST’s structural continuity and increasing centrality in Altria’s portfolio. However, the synthesis overreaches by linking UST to Horizon LLC and Helix without evidence in the ground truth that these are part of UST’s integration or Altria’s strategic alignment of UST specifically. The ground truth emphasizes UST’s alignment with 'Moving Beyond Smoking' via MST products, not new nicotine ventures. (4) Despite the addition of external details, the core facts about UST’s ownership and strategic importance are correct and well-supported across years. The answer remains contextually relevant and captures the essence of Altria’s strategic positioning, though with minor misalignment in emphasis. Hence, correctness is high but not perfect—warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Involved_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 523,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What does Tesla's repeated reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its 2022, 2023, and 2024 filings suggest about the company's long-term financing strategy for solar energy initiatives?",
      "original_answer": "Tesla's continued reference to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 across its annual filings from 2022 through 2024 indicates a sustained reliance on structured solar financing mechanisms to support its renewable energy initiatives. In 2022, Tesla listed the One Hundred-and-Sixteenth Supplemental Indenture dated August 24, 2015, related to these bonds, reaffirming its legal and financial linkage to the instrument. This reference was repeated in 2023 and again in 2024, showing that Tesla continues to treat this bond series as a material component of its solar financing architecture. The consistent citation of this specific bond structure across three consecutive filings suggests that Tesla maintains a strategic commitment to securitized solar debt as a core funding source for its solar projects, likely reflecting confidence in the bond's performance and its alignment with Tesla's broader clean energy business model.",
      "llm_answer": "\nTesla’s continual citation of the SolarCity 5.45 % Solar Bonds, Series 2015/C92‑15 in its 2022, 2023 and 2024 10‑K filings—each time referencing a different supplemental indenture (e.g., Exhibit 4.62 in 2022, Exhibit 4.54 in 2023 and Exhibit 4.52 in 2024)—shows that the company treats this securitized bond issue as a core, long‑term financing pillar for its solar portfolio.  By repeatedly amending and re‑issuing the same bond series, Tesla is leveraging the original SolarCity debt structure to fund ongoing solar installations and to provide investors with a stable, fixed‑rate source of capital, underscoring a strategy that relies on legacy solar‑bond financing to sustain and expand its renewable‑energy projects.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all references to the SolarCity 5.45% Solar Bonds, Series 2015/C92-15 are correct, including the consistent mention across 2022–2024 filings. The bond interest rate (5.45%) and series designation are accurately stated. While the original answer does not specify exhibit numbers (e.g., Exhibit 4.62 in 2022), the LLM adds this detail—likely correct based on actual filings—and does not contradict the ground truth. (2) The LLM correctly infers that Tesla continues to rely on this bond series as a material, long-term financing mechanism, which matches the core conclusion of the original answer. (3) The reasoning is sound: the repeated citation and amendment of the same bond series across multiple years support the inference of a strategic, sustained reliance on securitized solar debt. The LLM correctly synthesizes information across years and interprets the significance of ongoing supplemental indentures. (4) Minor deduction in qualitative accuracy because the LLM emphasizes 'amending and re-issuing' the bond, while the original answer focuses on continued reference and legal linkage—slightly different emphasis, but not factually incorrect. Overall, the answer is semantically equivalent, contextually precise, and factually robust, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 377,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did IBM's exposure to stock exchange regulations evolve from 2022 to 2024 in relation to its debt and equity securities, and what does this multi-year progression reveal about its capital market risk management strategy?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted its exposure to stock exchange regulations as a key risk factor affecting both its debt and equity securities. In 2022, IBM noted that the value of its debt securities fluctuates due to factors like interest rates, exchange controls, and stock exchange regulations, with no assurance it could manage these risks successfully. In 2023, the company reiterated this exposure, emphasizing that external regulatory environments, including stock exchange regulations, remained a significant uncontrollable factor influencing its securities' value and liquidity. By 2024, IBM expanded on this risk by linking it to broader market liquidity conditions and customer credit risks, indicating a more integrated view of regulatory impact within its financial risk framework. This evolution shows IBM's increasing recognition of regulatory dynamics as a persistent and systemic component of its capital markets exposure, with no material reduction in dependency or mitigation strategy over the three-year period.",
      "llm_answer": "\nIBM’s filings show a clear evolution: in 2022 (Chunk 1) it merely warned that debt and equity securities are exposed to stock‑exchange and governmental regulations, a point reiterated in 2023 (Chunk 2) but now embedded in a broader risk‑management narrative that also covers cybersecurity and credit risk; by 2024 (Chunk 3) the company expands this to explicit financing‑ and capital‑market disclosures—pension‑funding obligations, currency and interest‑rate exposure, and market‑liquidity risks—demonstrating a layered, proactive approach. This multi‑year progression, reflected in the KG relationship where **IBM Depends_On Stock‑Exchange Regulations** and **Stock‑Exchange Regulations Subject_To IBM**, reveals that IBM’s capital‑market risk strategy has moved from generic regulatory awareness to an integrated framework that monitors, hedges and reports on allfinancing, currency, pension and liquidity risks tied to those regulatory requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant misrepresentations in reasoning and synthesis that deviate from the ground truth. (1) Correct elements: The answer correctly identifies IBM's exposure to stock exchange regulations across 2022–2024 and notes the evolution in risk disclosure. It accurately references the increasing integration of regulatory risks with broader financial risks. There are no numeric inaccuracies, as the question does not involve specific financial figures, percentages, or calculations—so quantitative accuracy is not applicable in a traditional sense but is scored highly due to absence of numerical errors. (2) However, the LLM mischaracterizes the nature of IBM’s strategy evolution. The ground truth states that IBM showed 'no material reduction in dependency or mitigation strategy' over the period, indicating persistent vulnerability without proactive mitigation. In contrast, the LLM claims a 'layered, proactive approach' involving hedging and monitoring, which is not supported by the original answer and overstates IBM’s risk management actions. (3) The multi-hop reasoning is flawed: while the model synthesizes across years, it infers a strategic advancement (e.g., 'moved from generic awareness to integrated framework that monitors, hedges and reports') that contradicts the ground truth’s conclusion of continued dependence without meaningful mitigation. The KG relationship mentioned ('IBM Depends_On Stock-Exchange Regulations' and reciprocal) introduces a bidirectional dependency not present in the original answer, which only describes a one-way exposure. (4) Contextual relevance is high because the answer addresses the temporal progression and regulatory linkage to capital markets. However, qualitative accuracy is reduced due to unsupported inferences about strategy proactiveness and risk mitigation capabilities. Thus, while semantically close in structure, the LLM answer diverges factually on the core conclusion about IBM’s risk management trajectory.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 542,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did MMM's focus on electrical products for construction and maintenance evolve across 2022, 2023, and 2024, and what does this multi-year progression indicate about the company's strategic positioning in industrial markets?",
      "original_answer": "MMM consistently listed 'Electrical products and materials for construction and maintenance, power distribution and electrical OEMs' as part of its Safety and Industrial segment in all three years. However, in 2022, the description included 'Closure systems for personal hygiene products, masking, and packaging materials' alongside electrical products, emphasizing a broader industrial offering. In 2023, MMM maintained the same focus on electrical products but added 'Industrial abrasives and finishing for metalworking applications' and 'Autobody repair solutions' as key components of the Safety and Industrial segment, suggesting a continued but slightly expanded industrial focus. By 2024, MMM retained the core electrical product line but rephrased the segment description to 'Industrial abrasives and finishing for metalworking applications' and 'Industrial specialty products such as personal hygiene products, masking, and packaging materials', indicating a potential shift toward emphasizing broader industrial specialties while maintaining electrical offerings. This 3-year progression shows MMM's consistent commitment to electrical products for construction and maintenance, while subtly evolving its industrial portfolio to align with broader market opportunities.",
      "llm_answer": "\nAcross the three fiscal years, 3M (MMM) repeatedly placed **electrical products and materials for construction and maintenance—including power‑distribution components and OEM solutions—at the core of its Safety & Industrial segment**, with the 2022 and 2023 filings describing the same offering and the 2024 filing sharpening the language to “electrical products and materials for construction and maintenance, power distribution and **original equipment manufacturers (OEMs)**” and tying it to broader “industrial specialty products.”  This consistent, progressively refined emphasis—captured in the KG pattern where **MMM → Electrical Products** and those products are treated both as a distinct product line and as an organizational entity that feeds back into MMM—signals that 3M is deliberately positioning its electrical portfolio as a strategic growth lever in industrial markets, reinforcing its foothold in construction‑related power infrastructure while expanding its industrial‑specialty footprint.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that MMM consistently included electrical products for construction and maintenance in its Safety and Industrial segment across 2022–2024, which aligns with the ground truth. It accurately notes the continuity of this focus and the refinement of language in 2024, particularly around OEMs and industrial specialty products. However, the LLM omits key details about the evolution of the segment composition: specifically, the 2022 inclusion of 'closure systems for personal hygiene products, masking, and packaging materials' as a co-emphasized offering, the 2023 addition of 'industrial abrasives and finishing' and 'autobody repair solutions', and the 2024 rephrasing that shifted emphasis toward 'industrial specialty products' while retaining electrical offerings. These omissions reduce completeness and weaken the multi-hop synthesis of how the segment’s strategic emphasis evolved beyond just language sharpening. While the LLM captures the consistent core, it misses the nuanced expansion and repositioning described in the original answer, instead framing it as a refinement rather than a strategic broadening. There are no numerical inaccuracies (quantitative accuracy is perfect as no calculations are involved), and the entities (MMM, Safety & Industrial segment, electrical products, years) are correct. The reasoning is partially sound but lacks full integration of the segment’s changing components across years. The answer remains contextually relevant and addresses the strategic positioning aspect well, but with incomplete support from the year-over-year analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 440,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has GILD's utilization of its Oceanside, California facility evolved from 2022 through 2024, particularly in relation to its biologics and retroviral vector manufacturing capabilities?",
      "original_answer": "In 2022, GILD's Oceanside facility was referenced as part of its broader operational footprint, indicating its role in research and development alongside other California-based sites. By 2023, the facility was specifically highlighted for its role in clinical manufacturing and process development of biologics candidates. In 2024, the Oceanside facility was further emphasized as the dedicated site for commercial retroviral vector manufacturing, in addition to continuing its role in clinical manufacturing and process development. This progression shows a strategic shift from general R&D to a more specialized and scaled-up function focused on biologics and retroviral vectors, aligning with GILD's broader biopharma manufacturing priorities.",
      "llm_answer": "\nFrom 2022 through 2024 GILD repeatedly disclosed that its Oceanside, California site is used “for commercial retroviral vector manufacturing and clinical manufacturing and process development of our biologics candidates,” listing the facility among its principal manufacturing locations in each year’s filing.  This consistent use shows that the Oceanside plant has remained a core hub for both the company’s retroviral‑vector production and the clinical‑stage manufacturing and process development of its biologics pipeline, underscoring a sustained and growing reliance on the site to advance those capabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy regarding the evolution of GILD's Oceanside facility. While it correctly identifies that the site is used for 'commercial retroviral vector manufacturing' and 'clinical manufacturing and process development of biologics candidates,' it incorrectly states that this description was consistently disclosed from 2022 through 2024. According to the ground truth, in 2022 the facility was only referenced as part of GILD’s broader R&D footprint without specific mention of retroviral vector manufacturing or biologics clinical manufacturing. The specialization began in 2023 (clinical manufacturing and process development of biologics) and expanded in 2024 to include commercial retroviral vector manufacturing. Thus, the LLM fails to capture the progressive evolution and instead implies a static role across all three years, which contradicts the documented strategic shift. There are no numerical values to assess, so quantitative accuracy is scored as 10 by default. Qualitative accuracy is reduced due to incorrect multi-hop reasoning—failing to distinguish year-over-year changes in facility utilization. Contextual relevance is high because the answer addresses the core topic and relevant capabilities, but it lacks the temporal progression that is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 376,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did AIG's glide path approach for its U.S. pension plan evolve from 2022 to 2024, as reflected in the target allocations for the Return-Seeking portion of the portfolio in 2022, 2023, and 2024?",
      "original_answer": "AIG's glide path approach for its U.S. pension plan remained consistent in strategy but evolved in target allocations for the Return-Seeking portion of the portfolio: in 2022, the target allocation was based on the funded status at December 31, 2021; in 2023, the target allocation was set for 2024 based on the funded status at December 31, 2023; and in 2024, the target allocation was set for 2025 based on the funded status at December 31, 2024. This shows a forward-looking, dynamic adjustment of asset allocation in response to the plan's funded status over time.",
      "llm_answer": "\nThe 2022 target allocation for the Return‑Seeking portion of AIG’s U.S. pension plan—shown in Chunk 1’s table based on the funded ratio as of December 31 2021—established a relatively higher growth‑asset weighting. By the 2024 target (presented in Chunk 2, derived from the funded status at December 31 2023) that growth‑asset share was reduced, reflecting the glide‑path’s de‑risking as the plan’s funded ratio improved. The subsequent target disclosed in Chunk 3 for 2025 continues this trajectory, confirming that from 2022 through 2024 AIG’s glide‑path approach steadily shifted the Return‑Seeking allocation from a higher‑growth stance toward a more liability‑hedged composition.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's glide path approach as a de-risking strategy in response to improved funded status, and correctly identifies the forward-looking nature of the target allocations (e.g., 2024 target set based on 2023 funded status). However, it introduces details not present in the ground truth, such as 'relatively higher growth-asset weighting' and 'reduced growth-asset share', which are qualitative characterizations not supported by the original answer. The ground truth does not mention actual asset classes (e.g., growth vs. liability-hedging) or specific shifts in weighting—only the timing and basis of target setting. (2) Quantitatively, the LLM answer does not provide specific percentages or numbers, so there are no numeric inaccuracies, but it also fails to reflect any quantifiable data that might have been in the source chunks (e.g., target allocation percentages), which limits verifiability. The years and time references (2021, 2022, 2023, 2024, 2025) are used appropriately and align with the ground truth’s forward-looking structure. (3) The multi-hop reasoning is sound in that it connects the target allocations across years to the funded status at prior year-ends and infers a de-risking trend. However, the original answer does not explicitly state that de-risking is occurring—this is an inference the LLM made. While reasonable, it goes beyond the factual content of the ground truth, which only describes the timing and basis of target setting, not the strategic shift in asset composition. (4) The contextual relevance is high because the answer directly addresses the evolution of the glide path from 2022 to 2024 and correctly references the linkage between funded status and future targets. The qualitative accuracy is good but docked slightly for over-interpretation. Quantitative accuracy is moderate due to lack of specific numbers and unsupported characterization of allocation changes. Correctness score is 7 because the core factual structure (timing, forward-looking targets, basis in funded status) is correct, but the answer adds interpretive content not in the ground truth and omits the explicit framing of consistency in strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 596,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, and what does this multi-year shift suggest about the company's long-term investment risk tolerance?",
      "original_answer": "In fiscal 2023, ACN set target allocations for the following year (fiscal 2024), indicating a strategy that emphasized flexibility around target asset allocations based on market conditions and cash flow needs. By fiscal 2024, the company extended its target allocation planning horizon to fiscal 2025, maintaining similar language around flexibility but continuing to emphasize risk-adjusted returns aligned with long-term investment strategies. The consistent focus on matching debt security durations to liabilities and diversifying equities suggests a measured, stable approach to risk. However, the forward-looking extension of target planning from one year (2023 → 2024) to two years (2024 → 2025) indicates increased confidence in long-term market outlook and a potentially more strategic, less reactive asset allocation stance.",
      "llm_answer": "\nACN’s target asset allocation moved from the fiscal 2023 mix described in the 2022 filing (Chunk 1) to a new fiscal 2025 mix disclosed in the 2023 and 2024 filings (Chunks 2 & 3), with the later documents outlining a revised, more diversified allocation and wider ranges that let the portfolio fluctuate around the targets without immediate rebalancing. This multi‑year shift—emphasizing liability‑driven duration matching for debt securities and a disciplined, risk‑adjusted equity overlay—reveals that ACN is deliberately adopting a more conservative, long‑term investment stance, signaling a measured tolerance for volatility while still pursuing inflation‑beating returns.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements of ACN's asset allocation strategy but introduces inaccuracies in reasoning and timeline interpretation, affecting overall correctness. (1) It incorrectly frames the evolution as a shift from a 'fiscal 2023 mix' to a 'fiscal 2025 mix', implying specific allocation percentages changed over time, which is not supported by the ground truth. The original answer emphasizes that the strategy evolved in terms of planning horizon (from one-year to two-year forward targets), not in specific asset mix numbers. (2) No actual percentages or dollar amounts are cited, so quantitative accuracy is not penalized—there are no incorrect numbers, but also no specific figures to verify changes. Format flexibility is not an issue here. (3) The multi-hop reasoning is partially sound: the model correctly identifies flexibility, duration matching, and risk-adjusted returns as themes. However, it mischaracterizes the nature of the 'shift' as a change in allocation strategy toward conservatism, whereas the ground truth describes a shift in planning horizon (from 2023→2024 to 2024→2025), indicating increased strategic confidence, not necessarily a more conservative stance. The conclusion about 'more conservative, long-term investment stance' is an unsupported inference. (4) Contextual relevance is high—the response addresses both parts of the question (evolution of strategy and risk tolerance implication) and uses appropriate financial terminology. However, the core reasoning flaw in interpreting the nature of the strategic evolution reduces qualitative and overall correctness. Semantic equivalence is partially achieved but undermined by incorrect causal interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 464,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's issuance and structuring of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern reveal about the company's solar financing strategy?",
      "original_answer": "Tesla's relationship with the 5.45% Solar Bonds, Series 2015/C25-15, originated from its acquisition of SolarCity and shows a consistent inclusion of this bond series in its 10-K filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured solar financing instrument. In 2022, Tesla referenced the bond as part of a broader set of solar bond issuances, including the 5.45% Solar Bonds Series 2015/C5-15, 2015/C10-15, and 2015/C20-15. By 2023, Tesla continued to reference the Series 2015/C25-15 alongside newer bond structures like Series 2015/C28-15 and 2015/C33-15, suggesting an expansion of its financing framework. In 2024, Tesla maintained the inclusion of Series 2015/C25-15 in its disclosures, reaffirming its long-term commitment to this financing model. The consistent presence of this bond series across filings indicates that Tesla continues to view these structured financings as integral to its solar deployment strategy.",
      "llm_answer": "\nTesla’s 5.45 % Solar Bonds, Series 2015/C25‑15 are tied to the Thirty‑Sixth Supplemental Indenture of 14 April 2015, which is cited as Exhibit 4.36 in the 2022 10‑K, reappears as Exhibit 4.29 in the 2023 10‑K, and is again listed as Exhibit 4.27 in the 2024 10‑K, showing that the same indenture is repeatedly disclosed across the three years. Each filing also references later supplemental indentures—such as the 44th for Series C33‑15 in 2023 and additional series (C20‑15, C24‑10, C27‑10) in 2023 and 2024—that expand the master‑trust structure while preserving the original 5.45 % rate and terms. This multi‑year pattern reveals Tesla’s solar‑financing strategy of using a layered, incremental series of supplemental indentures to broaden its asset‑backed bond program and continuously fund solar projects under a stable, long‑term securitization framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key details are correct: the 5.45% interest rate, the bond series 2015/C25-15, the April 14, 2015 date of the Thirty-Sixth Supplemental Indenture, and its consistent disclosure as an exhibit across 2022 (Exhibit 4.36), 2023 (Exhibit 4.29), and 2024 (Exhibit 4.27) filings. The mention of later supplemental indentures (e.g., 44th for C33-15) and additional series (C20-15, C24-10, C27-10) is factually consistent with the expansion of Tesla's solar financing framework. (2) The numbers, dates, and exhibit references are precise and match expected disclosures. (3) The multi-hop reasoning is sound: the model correctly infers from repeated exhibit disclosures and the addition of new series that Tesla maintains a long-term, structured securitization strategy rooted in the original 2015 indenture. It synthesizes information across three years and multiple bond series to reveal a strategic pattern. (4) While the original answer emphasizes the continuity and strategic importance of the C25-15 series, the LLM adds deeper structural insight—specifically about the master-trust and supplemental indenture mechanism—which is consistent with and enriches the ground truth. The only minor gap is that the LLM does not explicitly mention SolarCity’s origin of the bond, which is a key contextual point in the original answer, but this does not undermine the core correctness. Overall, the answer is factually robust, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 432,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AIG's international terrorism exposure management evolve from 2022 to 2024, particularly in terms of modeled loss estimates, reinsurance strategies, and risk mitigation mechanisms across global jurisdictions?",
      "original_answer": "From 2022 to 2024, AIG's international terrorism exposure management remained rooted in scenario-based modeling and participation in government-sponsored pools, but evolved in terms of reinsurance structure and global coverage specificity. In 2022, AIG estimated a $1.3 billion loss for a five-ton bomb attack in New York City, net of TRIPRA and reinsurance. By 2023, the focus shifted to active management and monitoring of exposure concentrations, with an emphasis on maintaining disciplined reinsurance purchases. In 2024, AIG enhanced its global property per risk covers, retained core attachment points for Japan at $200 million, and maintained reliance on scenario modeling and international terrorism pools. The reinsurance recoverable assets reached $38.0 billion by the end of 2024, indicating a significant scaling of risk transfer mechanisms.",
      "llm_answer": "\nFrom 2022 through 2024 AIG refined its international terrorism exposure management by (1) retaining the $1.3 bn net‑of‑TRIPRA modeled loss estimate but tightening its scenario modeling and keeping core attachment points of $200 m for Japan and $125 m for the rest‑of‑world, (2) expanding its reinsurance programme with global per‑risk covers that protect both non‑critical and critical catastrophe events and adding targeted reinsurance purchases and participation in government‑sponsored terrorism pools across multiple jurisdictions, and (3) strengthening risk mitigation through $20.1 bn of collateral (funds withheld, securities trusts, letters of credit) that backs the $38 bn of reinsurance recoverables reported in 2024, reflecting a shift from the 2022 reliance on limited private reinsurance and TRIPRA to a more diversified, globally‑aligned program that integrates updated loss estimates, enhanced attachment‑point structures, and proactive reinsurer credit monitoring.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of AIG's terrorism exposure management from 2022 to 2024 with strong qualitative accuracy, including scenario modeling, reinsurance expansion, and reliance on government pools. However, there are key quantitative discrepancies. The $1.3 billion modeled loss in 2022 is correctly cited from the ground truth, but the LLM incorrectly implies it was retained as-is through 2024 without change, while the original answer does not state that the estimate was updated or retained—only that it was used in 2022. More critically, the LLM introduces a $20.1 billion collateral figure (funds withheld, letters of credit) that is not present in the ground truth; the original only mentions $38.0 billion in reinsurance recoverables by 2024, which the LLM correctly reports but then incorrectly links to $20.1 billion in collateral backing—a detail absent in the source. This introduces a fabricated quantitative relationship. (2) The attachment point for Japan ($200 million) is correctly stated, but the LLM adds a $125 million attachment point for the rest of the world, which is not mentioned in the original answer and thus unsupported. (3) The multi-hop reasoning is strong: the LLM synthesizes information across years, correctly identifies the shift from TRIPRA reliance to broader reinsurance and global pools, and captures the strategic evolution toward active monitoring and diversified risk transfer. The narrative of progression from 2022 to 2024 is logically sound and contextually rich. (4) Contextual relevance is excellent—the response directly addresses modeled losses, reinsurance strategies, and risk mitigation across jurisdictions. Despite the addition of unsupported specifics, the overall direction and synthesis align well with the ground truth. The correctness score is 8 due to accurate core facts and logical flow, but docked for introducing unverified numbers and specifics not in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Estimates]-> RISK_FACTOR <-[Impacts]- ORG <-[Manages]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 531,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, and what specific risks within this segment were consistently highlighted as contributing to margin pressures over this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted the Safety and Productivity Solutions segment as being adversely impacted by industry economic conditions, with specific emphasis on reduced investments in process automation, fluctuations in retail markets, and product commoditization. In 2022, the segment cited reduced investments in process automation, retail market fluctuations, and new market entrants leading to commoditization and lower margins. In 2023, similar risks were reiterated, with additional mention of adverse industry economic conditions contributing to lower market share and reduced selling prices. By 2024, the restructured Industrial Automation segment (formerly part of Safety and Productivity Solutions) continued to face these pressures, with an explicit link drawn between adverse industry economic conditions and margin compression. This consistent linkage over three years indicates a persistent vulnerability in this business line despite broader organizational restructuring.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s Safety and Productivity Solutions segment saw its exposure to adverse industry economic conditions deepen each year—beginning with the COVID‑19‑driven demand shock in 2022, moving into a prolonged period of reduced capital spending and delayed automation and safety‑monitoring projects in 2023, and continuing into 2024 as macro‑economic slowdown, supply‑chain constraints and geopolitical trade restrictions kept customer investment low.  Across all three filings the company repeatedly highlighted specific risks that drove margin pressure: cutbacks in process‑automation and safety‑monitoring spending, a slowdown in demand for safety products, product commoditization and intensified competition, which together produced lower market share, price compression and eroding margins, while ongoing international‑trade and regulatory risks further amplified the segment’s vulnerability.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant factual inaccuracies and introduces unsupported details, leading to a partially correct response. (1) Correct aspects include the general trend of adverse economic conditions affecting the Safety and Productivity Solutions segment and the mention of reduced investments in process automation, product commoditization, and competition as margin pressures—consistent with the ground truth. However, critical errors include the false claim that the 2022 challenges were due to a 'COVID-19-driven demand shock,' which is not mentioned in the original answer and contradicts the documented reasons (reduced automation investment, retail fluctuations, commoditization). Additionally, the LLM incorrectly states that supply-chain constraints and geopolitical trade restrictions were cited in 2024, which are not part of the ground truth. The restructuring into the Industrial Automation segment in 2024 is omitted, and the evolution of risk emphasis across years is misrepresented. (2) There are no numeric values to verify, so quantitative accuracy is based on correct use of time periods (2022–2024), which are accurate—hence a score of 8. (3) Qualitative accuracy suffers because the LLM fabricates causal factors (e.g., COVID-19 impact, geopolitical trade) and fails to correctly trace the multi-hop evolution of risks across filings, especially the continuity of specific risks like retail market fluctuations and the rebranding into Industrial Automation. The synthesis across years is flawed. (4) Contextual relevance is moderate—the answer addresses the general theme of margin pressures and economic exposure but drifts into irrelevant or unsupported risk factors, reducing precision. Overall, the answer is directionally aligned but factually inconsistent with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 499,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Pfizer's treatment of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and recognition in financial statements?",
      "original_answer": "In 2022, Pfizer granted 1,165 thousand BPAs with a weighted average intrinsic value of $38.73 per share, and by the end of the year, 859 thousand BPAs remained nonvested. In 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a complete wind-down of the program. In 2024, Pfizer described the valuation and recognition methodology for BPAs, stating they are valued using the intrinsic value method and amortized over the probable vesting term, with adjustments based on stock price changes and performance goal probabilities. This shows a shift from active issuance and vesting in 2022 to no outstanding awards by 2023, followed by a detailed focus on valuation mechanics in 2024.",
      "llm_answer": "\nIn 2022 Pfizer continued to award Breakthrough Performance Awards—granting 1,165 shares (with 306 forfeited and 859 still non‑vested as of Dec 31 2021)—and recorded them at intrinsic value using the closing stock price, amortizing the expense straight‑line over the probable vesting term into cost of sales, SG&A or R&D as disclosed in the 2022 filing; by contrast, the 2023 10‑K notes that **no BPAs were granted and none were outstanding**, and the 2024 filing reiterates the same intrinsic‑value valuation and amortization methodology but reflects zero BPA activity, so grant activity ceased after 2022, the valuation approach remained unchanged, and recognition of BPAs in the financial statements disappeared once the awards were fully expired or forfeited.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the core evolution correctly: BPA grants occurred in 2022, ceased in 2023 with no outstanding awards, and the 2024 filing discussed valuation methodology despite no activity. However, there are key quantitative inaccuracies. The LLM states '1,165 shares' were granted in 2022, but the ground truth specifies '1,165 thousand' BPAs—this is a significant underreporting by a factor of 1,000. Additionally, the LLM incorrectly references 'Dec 31 2021' vesting data (859 thousand non-vested), but the original answer states this figure is as of the end of 2022, not 2021. The forfeiture of 306 thousand is not mentioned in the ground truth and appears to be an invented number (1,165 - 859 = 306, so it may be a derived error). 2) Quantitative accuracy is compromised due to the missing 'thousand' unit and the incorrect year attribution. While the $38.73 weighted average intrinsic value per share is omitted, the general valuation method (intrinsic value, straight-line amortization) is correctly described. 3) The reasoning is logically sound: the model correctly infers that grant activity stopped after 2022, no awards remained by 2023, and 2024 focused on methodology despite no activity. It synthesizes across years appropriately. 4) Contextual relevance is perfect—the answer directly addresses grant activity, valuation methodology, and financial statement recognition over the three years. Despite strong qualitative reasoning and relevance, the quantitative errors—especially the missing 'thousand' and misattributed year—prevent a higher score. The answer is semantically close but factually imprecise on critical numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Valuates]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 450,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3,129,296,000 for share purchases and redemptions. By fiscal 2023, the company had spent part of this authorization, and as of August 31, 2024, the remaining available authorization stood at $2,694 million, before receiving an additional $4,000 million in new repurchase authority, bringing the total outstanding authority to $6,694 million. This indicates a consistent and increasing commitment to returning capital to shareholders through share repurchases, with a notable increase in total authorized funds by fiscal 2024, despite a reduction in remaining available funds prior to the new authorization.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase authorization grew from $3.13 bn of available authority as of 31 Aug 2022 (Chunk 1) to $2.69 bn remaining as of 31 Aug 2024, and after the Board approved an additional $4 bn on 25 Sep 2024 the total outstanding authority rose to $6.69 bn (Chunk 2 & 3). In fiscal 2024 the company executed repurchases of 2.0 million Class A shares for $605 m under its open‑market program and an extra 72,255 shares via employee tax‑withholding, demonstrating continued use of the program without diminishing the remaining authorization (Chunk 2 & 3). This trajectory—expanding total buy‑back capacity while steadily deploying purchases—reflects a deliberate, ongoing capital‑return strategy that prioritizes returning excess cash to shareholders through share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures all key quantitative facts: the initial $3.13 billion authorization in fiscal 2022 (matching $3,129,296,000), the remaining $2.694 billion as of August 31, 2024, and the additional $4 billion authorization approved on September 25, 2024, resulting in a total outstanding authority of $6.694 billion. The formatting variations (e.g., $3.13 bn vs $3,129,296,000) are acceptable and semantically equivalent. The repurchase activity in fiscal 2024—2.0 million shares for $605 million—is accurately reported and adds useful detail not strictly required but enhances completeness. (2) All numbers and dates are factually correct. The calculation of total authorization after the new $4 billion addition ($2.694 + $4 = $6.694 billion) is accurate. The LLM correctly identifies the timing of the new authorization (after August 31, 2024), preserving the logical sequence. (3) The multi-hop reasoning is sound: the model synthesizes data from fiscal 2022, 2023, and 2024, correctly tracking the evolution of authorization and spending. It infers the strategic intent—consistent and increasing capital return—based on expanding capacity and active repurchases, aligning with the ground truth. (4) The only minor shortcoming is that the original answer emphasizes a 'reduction in remaining available funds prior to the new authorization' as a key point in the trend, which the LLM mentions implicitly but could have highlighted more explicitly for full qualitative parity. However, the overall reasoning and conclusion are correct. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 481,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial disclosures, operational agreements, and strategic alignment, given Meridian's status as a divested entity?",
      "original_answer": "In 2022, Meridian was referenced in the context of discontinued operations, with its operating results presented as part of that category for all periods presented. By 2023, Meridian had been fully divested, with Pfizer completing the sale on December 31, 2021, for approximately $51 million in cash and recognizing a loss of approximately $167 million, net of tax. In 2024, Meridian is only mentioned as a defined entity (Meridian Medical Technologies, Inc.) in the glossary of terms, indicating no active financial or operational relationship remained. This progression shows a complete strategic disengagement from Meridian, transitioning from operational integration (in prior periods), to divestiture, to mere definitional reference.",
      "llm_answer": "\nPfizer completed the sale of Meridian on December 31 2021, recorded an after‑tax loss of roughly $167 million and reported Meridian as a discontinued operation in its 2021 10‑K (Chunk 1).  Thereafter Pfizer and the buyer kept the relationship alive only through interim transition‑services agreements (TSAs) and a master‑services agreement (MSA) that were set to run for up to three years post‑sale with a two‑year extension, the TSAs expiring on December 31 2023 (Chunk 3).  Disclosures in the 2022 and 2023 filings show that no material amounts were recognized under these post‑sale arrangements, indicating that the operational and strategic ties that once linked Pfizer and Meridian had fully wound down after the divestiture.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Pfizer completed the sale of Meridian on December 31, 2021, and recognized an after-tax loss of approximately $167 million, which aligns with the ground truth. It also accurately notes that Meridian was reported as a discontinued operation, consistent with 2022 disclosures. The mention of transition services agreements (TSAs) and a master services agreement (MSA) extending up to three years with a possible two-year extension, expiring December 31, 2023, is factually plausible and contextually appropriate, though not explicitly confirmed in the ground truth. However, the ground truth emphasizes that by 2024, Meridian is only mentioned as a defined term in the glossary, indicating complete disengagement—this key point is missing in the LLM answer. (2) Quantitatively, all numbers and dates are accurate: $167 million loss, December 31, 2021 divestiture date, and TSA expiration in 2023. No calculation errors. (3) The reasoning is mostly sound: the LLM correctly infers reduced operational ties post-divestiture and interprets lack of material financial recognition as evidence of disengagement. However, it fails to complete the multi-hop synthesis by not addressing Meridian’s 2024 status as a mere definitional reference, which is critical to showing full strategic disengagement. (4) The answer is contextually relevant and well-structured, but lacks completeness in covering the full 2022–2024 evolution, particularly the 2024 status. Hence, correctness and qualitative accuracy are reduced due to omission of a key endpoint in the relationship timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> COMP <-[Sells]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 441,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term strategy regarding share-based compensation?",
      "original_answer": "In fiscal year 2022, a maximum of 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 shares in both fiscal years 2023 and 2024. The increase from 2022 to 2023 and the maintenance of that level into 2024 indicate a strategic decision to expand the capacity for share-based compensation, suggesting Accenture's intent to continue leveraging equity incentives as a key component of its employee retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million** in fiscal 2022 (Chunk 1) to **141 million** in fiscal 2023 and stayed at that level in fiscal 2024 (Chunks 2‑3), while the number of shares still available for future grants fell only slightly from **27.38 million** (2022) to **27.27 million** (2023/2024) (Chunks 1‑3). This upward step‑up in the ceiling—followed by a stable maximum—signals that Accenture is deliberately expanding its equity‑award capacity to sustain long‑term incentives for talent retention and growth, underscoring share‑based compensation as a core, enduring component of its compensation strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the authorized share numbers: 127 million in fiscal 2022 and 141 million in both 2023 and 2024, matching the ground truth exactly. It also accurately notes that the authorized level remained stable from 2023 to 2024. The mention of shares available for future grants (27.38M in 2022, 27.27M in 2023/2024) is factually correct and adds contextual detail not required by the question but does not detract from accuracy. (2) All numeric values are correct and properly formatted (e.g., 127 million = 127,000,000). No calculation errors. The incremental increase of 14 million shares is implied correctly. (3) The reasoning is sound: the LLM correctly infers that the increase in authorized shares followed by stability indicates a strategic expansion of equity compensation capacity. It appropriately links this to talent retention and long-term incentives, aligning with the ground truth's conclusion about employee retention and performance alignment. The addition of 'growth' and 'enduring component' slightly extends the original answer but remains semantically consistent. (4) The answer fully addresses both parts of the question: the evolution of authorized shares and the strategic implication. The extra detail on available shares is not requested but is relevant and accurate. Overall, the answer is factually complete, quantitatively precise, and contextually appropriate, warranting a high score with only minor elaboration beyond the original answer preventing a perfect 10 on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Issues]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 427,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Tesla's disclosures about its 4.70% Solar Bonds, Series 2015/C52-10, change or remain consistent across its 2022, 2023, and 2024 filings, and what does this pattern suggest about the company's ongoing obligations or strategic priorities related to this bond series?",
      "original_answer": "Tesla's disclosures regarding the 4.70% Solar Bonds, Series 2015/C52-10, remained consistent across all three years. In 2022, the Seventieth Supplemental Indenture related to this bond series was referenced with a filing date of June 16, 2015 (Exhibit 4.49). In 2023, the same Seventieth Supplemental Indenture was referenced again with the same filing date (Exhibit 4.42). In 2024, the identical document was once again disclosed, maintaining the same filing date and exhibit number (Exhibit 4.40). This consistent re-disclosure across three consecutive filings indicates that Tesla continued to carry forward the obligations and terms established under this bond series without material modification. As an investor, this pattern suggests that Tesla has maintained a stable financial commitment to this particular solar bond structure, reflecting ongoing alignment with its solar financing strategies.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Tesla repeatedly lists the same underlying “Seventieth Supplemental Indenture” – shown as Exhibit 4.49 in the 2022 filing, Exhibit 4.42 in the 2023 filing and Exhibit 4.4 in the 2024 filing – as the governing document for the 4.70 % Solar Bonds, Series 2015/C52‑10. The only variation is the exhibit number, indicating that no amendment or new issuance has been disclosed and the company’s legal obligations under that 2015 indenture remain unchanged. This consistent reference demonstrates that Tesla continues to honor the legacy SolarCity solar‑bond financing and maintains the associated trustee relationship as a stable element of its capital structure, with no strategic shift away from or termination of the bond series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the bond series (4.70% Solar Bonds, Series 2015/C52-10), the governing document (Seventieth Supplemental Indenture), the consistent reference across years, and the filing date (implied as June 16, 2015, though not explicitly restated in the LLM answer) are all accurate. The exhibit numbers (4.49, 4.42, 4.40) are correctly cited, with only a minor formatting discrepancy: the LLM states 'Exhibit 4.4' for 2024 instead of 'Exhibit 4.40'—this is a negligible typographical variance that does not affect factual correctness. (2) Quantitative accuracy is perfect: percentages, exhibit numbers, and years are all correct. No calculations are required, but the consistency of the 2015 indenture date is properly inferred. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures across three years and draws the logical conclusion that no amendments were made, indicating ongoing obligations. It appropriately infers strategic continuity in Tesla’s solar financing, including the nod to SolarCity legacy, which adds contextual insight supported by the ground truth’s mention of 'solar financing strategies.' (4) The answer is contextually excellent—directly addressing both the disclosure pattern and its implications for obligations and strategy. The only reason for not scoring a 10 is the slight exhibit number shorthand ('4.4' vs '4.40'), which, while commonly acceptable, deviates minutely from the precise labeling in the original. Overall, the answer demonstrates strong factual fidelity, correct entity identification, and valid inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 459,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Adobe's free online self-service learning offerings evolve from 2022 to 2024, particularly in terms of their positioning within Adobe's broader learning and enablement services and their role in customer adoption strategies?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of its comprehensive portfolio of learning and enablement services, hosted on www.training.adobe.com, aimed at assisting customer and partner teams in product adoption. By 2023, this offering remained central to Adobe’s strategy, with learning.adobe.com continuing to serve as the platform for these self-service options, and was explicitly linked to supporting both Digital Experience and Digital Media products. In 2024, Adobe maintained its emphasis on free online self-service learning as a key component of Adobe Digital Learning Services, reinforcing its role in enabling customers to adopt Adobe’s expanding suite of cloud-based and AI-driven tools. The consistent presence of this offering across all three years reflects Adobe’s strategic commitment to scalable, accessible learning solutions that complement its fee-based and custom learning programs.",
      "llm_answer": "\nFrom 2022 – when Adobe listed a large number of free online self‑service learning options on training.adobe.com – to the 2023‑2024 filings, the offering was reframed as a core component of the company’s Digital Learning Services portfolio, explicitly positioned alongside fee‑based classroom/virtual training, certifications and custom enterprise learning programs (as detailed in Chunks 1 and 2).  This free learning track is now embedded in Adobe’s broader enablement strategy, feeding into Customer Success Account Management, partner‑ecosystem enablement and solution‑specific skills assessments to drive faster product adoption and maximize ROI for enterprise customers (a relationship emphasized in all three chunks).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe's free online self-service learning was introduced in 2022 on training.adobe.com, evolved into a core component of Adobe Digital Learning Services by 2023–2024, and remained central to customer adoption strategies. The platforms mentioned (training.adobe.com, later learning.adobe.com) are correctly identified in their respective timeframes, with only a minor discrepancy in domain naming that does not affect factual accuracy—likely reflecting a rebranding or URL transition. (2) There are no numeric values, dates, or calculations in the question or answer that are incorrect; the years 2022, 2023, and 2024 are used appropriately and consistently. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across time periods and strategic contexts, linking free learning to broader enablement services, enterprise adoption, and complementary fee-based offerings. It accurately captures the strategic evolution from a standalone offering to an embedded component of customer success and partner enablement. (4) The answer conveys semantic equivalence to the original, with slightly more emphasis on enterprise ROI and skills assessments—details not contradicted by the ground truth but not explicitly highlighted. One minor point: the original specifies learning.adobe.com as the 2023 platform, while the LLM refers to training.adobe.com throughout; this is a small inconsistency but not a critical error given possible coexistence or migration. Overall, the response is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 455,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AIG's glide path approach for its U.S. qualified pension plan evolve from 2022 to 2024, as reflected in the shifting target allocations for the 'Return-Seeking' portion of the portfolio in response to changes in the plan's funded status?",
      "original_answer": "From 2022 to 2024, AIG consistently applied its glide path approach to de-risk the U.S. qualified pension plan by adjusting the allocation to growth assets based on the plan’s funded status. In 2022, the target allocation for 2022 was set based on the funded status at December 31, 2021. In 2023, the target allocation for 2024 was updated based on the funded status at December 31, 2023, and in 2024, the target allocation for 2025 was again adjusted according to the funded status at December 31, 2024. While the specific percentages for the 'Return-Seeking' portion are not listed in the provided excerpts, the glide path mechanism consistently guided these annual recalibrations, reflecting a strategic evolution in asset allocation in response to the pension plan's funded ratio over the three-year period.",
      "llm_answer": "\nThe 2022 disclosure (Chunk 1) sets the 2022 Return‑Seeking target allocation based on the plan’s funded ratio as of 31 Dec 2021; the 2023 filing (Chunk 2) shows that a stronger funded ratio by 31 Dec 2023 prompted the glide‑path to lower the 2024 Return‑Seeking target, reflecting the automatic de‑risking rule that reduces growth‑asset exposure as the funded ratio rises; and the 2024 filing (Chunk 3) indicates that the 2025 target continues this pattern, further trimming the Return‑Seeking share as the funded ratio improves.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the core mechanism of AIG's glide path approach: annual recalibration of the Return-Seeking allocation based on the prior year-end funded status. The years and timing (e.g., 2022 target based on Dec 2021 funded status) are correctly interpreted. (2) While the original answer notes that specific percentages are not available in the excerpts, the LLM appropriately avoids fabricating numbers and instead infers the directional change—decreasing Return-Seeking allocation as funded status improves—which is consistent with de-risking glide paths and supported by the disclosed logic. No actual numerical discrepancies exist because no specific figures were provided in the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across 2022, 2023, and 2024 filings to show a consistent pattern of de-risking in response to improving funded status, correctly tracing the evolution over time. (4) The answer is contextually precise, directly addressing how the glide path evolved and how target allocations shifted. The only minor limitation is a slightly stronger assertion of causality (e.g., 'prompted', 'automatic') without explicit confirmation of automation in the ground truth, but this is a reasonable inference. Overall, the answer reflects strong factual and logical alignment with the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 394,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Honeywell's exposure to raw material demand and supply risks evolve across its Performance Materials and Technologies segment from 2022 through 2024, and what does this trend suggest about the company's vulnerability to commodity market volatility?",
      "original_answer": "Honeywell consistently highlighted raw material demand and supply as a key risk factor for its Performance Materials and Technologies segment across all three years. In 2022, the risk was framed in the context of the ongoing impacts of the COVID-19 pandemic, including disruptions to global supply chains and customer capital availability. By 2023, the company emphasized continued exposure to raw material supply volatility, particularly in relation to chemical, refining, and semiconductor plant utilization rates. In 2024, the risk remained prominent, with additional emphasis on the impact of oil and natural gas price volatility on customer investment behavior. This 3-year progression indicates a sustained vulnerability to commodity-driven supply chain instability, with the risk profile intensifying as energy markets became more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 each Honeywell 10‑K (Chunks 1‑3) repeatedly identifies **raw‑material demand and supply** as a key risk for the **Performance Materials and Technologies** segment, tying it to capacity‑utilization swings, customers’ limited capital for refinery and petrochemical projects, and especially to **oil‑ and natural‑gas price volatility** that can curb customer investment and shrink demand. The consistent emphasis across the three filings shows that this commodity‑price exposure has remained—and in fact become more pronounced—as market swings directly threaten the segment’s earnings and margin, underscoring Honeywell’s heightened vulnerability to commodity market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Honeywell consistently identified raw material demand and supply risks in the Performance Materials and Technologies segment from 2022 to 2024. The evolution is accurately portrayed—starting with pandemic-related disruptions in 2022, continuing with supply volatility linked to chemical, refining, and semiconductor utilization in 2023, and intensifying in 2024 due to oil and natural gas price impacts on customer investment. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; all dates (2022–2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes risk factors across three years and correctly infers increasing vulnerability to commodity market volatility. The answer captures the progression and deepening of risk, particularly linking energy price swings to customer behavior. (4) Semantic equivalence is strong—while the LLM uses slightly more concise phrasing (e.g., 'capacity-utilization swings' for plant utilization rates), it preserves the core meaning and adds accurate interpretive depth (e.g., 'threaten the segment’s earnings and margin'). The only minor shortcoming is a slight compression of the 2022 context (less explicit mention of COVID-19 and capital availability), but the essential continuity and trend are correctly conveyed. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 433,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did ACN's investment in mutual fund equity securities evolve from 2022 to 2024, and what does the 3-year trend suggest about its strategic asset allocation?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This decline followed by stability suggests a strategic rebalancing in 2023, with no further adjustments in 2024, indicating a stabilized allocation approach to equity exposure through mutual funds.",
      "llm_answer": "\nFrom 2022 to 2024 ACN’s stake in **mutual‑fund equity securities** fell sharply from **$234,339 million (Chunk 1)** to **$188,796 million (Chunks 2 & 3)**, and then remained flat in 2024.  The decline coincides with rising balances in non‑U.S. government and corporate debt, mutual‑fund debt, cash, and insurance contracts (see Chunk 2/3), suggesting that ACN has been deliberately re‑weighting its portfolio away from equity‑heavy mutual‑fund exposures toward more stable fixed‑income and liquid assets.  This 3‑year trend points to a strategic shift toward a more conservative, diversified asset allocation that emphasizes income‑generating securities and cash preservation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. The original answer states that ACN's investment in mutual fund equity securities was $239.293 million in 2022 and $196.226 million in 2023, remaining flat in 2024. However, the LLM reports $234,339 million (i.e., $234.339 billion) in 2022 and $188,796 million ($188.796 billion) in 2023—both figures are off by a factor of 1,000 due to incorrect unit interpretation (‘million’ vs ‘thousand’). This is a critical error that severely undermines the answer’s validity. (2) The quantitative accuracy is very low because the dollar amounts are orders of magnitude off. Even allowing for format variation, $234,339 million ≠ $239.293 million—the values differ both in magnitude and precision. The correct decrease is ~$43 million, while the LLM implies a drop of ~$45.5 billion, which is nonsensical in context. (3) The qualitative reasoning is partially sound: the LLM correctly infers a strategic rebalancing toward fixed-income and liquid assets based on trends in other holdings (e.g., increases in debt securities, cash), which aligns with the idea of conservative reallocation. It also correctly notes stability in 2024. However, it fails to explicitly state that the equity investment remained unchanged in 2024, instead implying continuity without confirmation. The multi-hop synthesis across asset classes is reasonable but based on incorrect base data. (4) Contextual relevance is moderate—the response addresses the evolution and strategic implications as asked, uses appropriate financial terminology, and attempts cross-asset analysis. However, due to the severe numerical errors, the conclusion, while logically structured, is built on false premises. Thus, correctness is low despite some structural and interpretive strengths.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 499,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Adobe's strategic positioning and feature evolution of Adobe Document Cloud change between 2022 and 2024, particularly in terms of integration with AI-powered tools like Firefly and its role in enterprise digital workflows?",
      "original_answer": "In 2022, Adobe Document Cloud was primarily described as part of a broader 'document and forms platform' within the Publishing and Advertising segment, indicating a more foundational, legacy role in Adobe’s portfolio. By 2023, Document Cloud was elevated as a core component of the Digital Media segment, specifically tied to Adobe’s innovation momentum and positioned alongside AI-driven tools like Adobe Express and Firefly, signaling a shift toward modernization and integration with AI. In 2024, Document Cloud was explicitly detailed as a cloud-based subscription offering with deep integration into AI-powered workflows, including Firefly's generative AI features, and was highlighted for its role in automating enterprise document and signature workflows. This progression reveals Adobe’s transformation of Document Cloud from a legacy infrastructure component into a strategically positioned, AI-enhanced productivity suite for enterprise digital transformation.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Adobe moved Document Cloud from a legacy publishing‑and‑advertising offering (noted in the 2022 10‑K’s segment breakdown) to the center of its AI‑driven strategy; the 2023 filing already framed it as part of Adobe’s “vision for the digital world” and highlighted AI and innovation momentum, and the 2024 filing expands this by embedding Firefly‑powered generative AI directly into Document Cloud—offering free Generative Credits, enterprise‑grade Firefly Services and Custom Models, and Content‑Credential transparency—so that the platform now serves as an end‑to‑end, AI‑augmented engine that automates creation, collaboration and compliance across enterprise workflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the strategic shift of Adobe Document Cloud from a legacy component in 2022 (under Publishing and Advertising) to a central AI-integrated platform by 2024. The mention of Firefly integration, generative AI features, and enterprise workflow automation matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022, 2023, and 2024 filings to show evolution in strategic positioning and AI integration. It correctly maps Document Cloud’s transition across segments and its growing synergy with Firefly and AI capabilities. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on 'free Generative Credits' and 'Content-Credential transparency'—details not explicitly mentioned in the ground truth—though these are plausible extensions of Firefly integration and do not contradict known facts. Overall, the answer is semantically equivalent, comprehensive, and contextually precise, fully addressing the question’s focus on strategic positioning and feature evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 364,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its business segments from 2022 to 2024, particularly in terms of new market entrants, technological disruption, and resulting impacts on market share and pricing power?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted increasing exposure to changes in the competitive landscape across its business segments, with a growing emphasis on the impact of new market entrants and technological disruption. In 2022, Honeywell cited changes in the competitive landscape—including new entrants and new technologies—as a risk factor for Honeywell Building Technologies and Safety and Productivity Solutions, noting potential consequences such as lower market share, reduced selling prices, and lower margins. In 2023, the company expanded this risk to include Performance Materials and Technologies and Aerospace, indicating a broader recognition of competitive pressures across more divisions. By 2024, Honeywell restructured its business units and explicitly tied changes in the competitive landscape to Industrial Automation and Building Automation, with a sharper focus on product commoditization and the accelerating pace of new entrants. This 3-year progression reveals a deepening concern over competitive pressures, with increasing frequency and specificity in disclosures, suggesting a strategic shift toward addressing a more dynamic and disruptive market environment.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell’s “Changes in Competitive Landscape” risk factor grew increasingly acute across all of its segments—Aerospace, Building Technologies, Performance Materials & Technologies, and Safety & Productivity Solutions—because each year’s filing repeatedly cites **new market entrants and emerging technologies** that threaten commoditization; the 2023 and 2024 disclosures explicitly link these forces to **erosion of market share and downward pressure on pricing**, which the company warns leads to **lower selling prices and compressed margins**.  This evolution reflects a escalating impact of competitive disruption on Honeywell’s pricing power and overall financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Honeywell's exposure to competitive landscape changes from 2022 to 2024. It correctly identifies the key risk factors—new market entrants, emerging technologies, commoditization, market share erosion, and pricing pressure—and links them to financial consequences like lower selling prices and compressed margins. The answer accurately reflects that these risks were initially cited in 2022 for Building Technologies and Safety and Productivity Solutions, expanded in 2023 to include Performance Materials and Technologies and Aerospace, and further refined in 2024 with a focus on Industrial and Building Automation post-restructuring. The only minor shortcoming is that the LLM implies all segments were exposed 'from 2022 through 2024' and that the risk grew 'across all segments' each year, which slightly overgeneralizes the phased expansion described in the ground truth. The original answer notes a progressive broadening of the risk, not uniform exposure across all segments from the start. However, the LLM does correctly highlight the increasing severity and specificity over time, including the strategic implications for pricing power and financial results. There are no numerical inaccuracies (dates are correct, no incorrect figures), and the qualitative synthesis across years and segments is strong. The answer is fully contextually relevant and conveys semantic equivalence with minor simplification in the progression narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 415,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Pfizer's financial and operational relationship with Viatris evolve from 2022 through 2024, particularly in terms of transition service arrangements and intercompany balances?",
      "original_answer": "From 2022 to 2024, Pfizer's relationship with Viatris showed a gradual decline in intercompany balances and a winding down of transition service arrangements. In 2022, the net amounts due to Viatris under the agreements were $94 million, and services under the TSAs were largely completed by the end of 2023. By 2023, the net amounts due to Viatris had decreased to $33 million, and the TSAs were largely completed as of December 31, 2023. In 2024, the relationship was referenced only in terms of corporate definitions, indicating that the operational interdependencies had been fully resolved. This shows a consistent reduction in financial exposure and operational entanglement with Viatris over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s post‑spin‑off relationship with Viatris moved from an active transitional‑service regime to near‑completion; the interim TSAs and MSAs that were put in place after the 2020 Upjohn spin‑off were largely wound down by December 31 2023, and the net amount owed to Viatris under those agreements fell sharply from **$94 million at the end of 2022 to $33 million at the end of 2023** (Chunk 1 & Chunk 3).  The 2023 Form 10‑K confirms this balance and notes that cash flows from the TSAs are reported in operating activities, while a **$277 million cash payment to Viatris was made in 2021** and recorded in financing activities (Chunk 3).  Thus, the financial and operational tie‑up evolved from ongoing service billings and intercompany receivables/payables to a settled, minimal balance position by the end of 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key financial figures: $94 million due to Viatris at the end of 2022 and $33 million at the end of 2023, which matches the ground truth. It accurately notes that transition service arrangements (TSAs) were largely completed by December 31, 2023. However, the LLM introduces a $277 million cash payment to Viatris in 2021, which, while factually possibly correct, is not part of the 2022–2024 evolution asked in the question and distracts from the core timeline. More importantly, the original answer notes that in 2024, the relationship was referenced only in corporate definitions, indicating full resolution—this point is missing in the LLM answer, resulting in a minor omission. (2) Quantitative accuracy is high: the $94M to $33M reduction is correctly stated, and no calculation errors are present. The 2021 $277M payment is accurate per input but irrelevant to the 2022–2024 scope. (3) The multi-hop reasoning is sound—linking the decline in intercompany balances with the winding down of TSAs across years—but fails to fully project the 2024 status, which is a key endpoint in the original answer. (4) Scores reflect high factual accuracy and relevance, with a slight deduction in correctness and qualitative accuracy for missing the 2024 resolution detail and including marginally relevant 2021 data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 378,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did the composition and structure of Altria Group's debt instruments evolve from 2022 through 2024, particularly with respect to the 1.700% Notes due 2025 in relation to other note maturities, and what does this progression suggest about the company's capital structure strategy?",
      "original_answer": "In 2022, Altria had a 1.000% Note due 2023 in addition to the 1.700% Note due 2025 and longer-dated instruments. By 2023, the 1.000% Note due 2023 had matured or was no longer listed, while the 1.700% Note due 2025 remained as the shortest-dated instrument. In 2024, the 1.700% Note due 2025 was still listed, indicating that Altria did not issue a new near-term note to replace it as it approached maturity. This suggests a strategy of maintaining a consistent capital structure with a focus on intermediate and long-term debt rather than rolling over short-term obligations.",
      "llm_answer": "\nFrom 2022 through 2024 Altria’s debt ladder moved from a four‑issue structure that included a 1.000 % Notes due 2023 (MO23A) in 2022 to a three‑issue profile consisting only of the 1.700 % Notes due 2025 (MO25), the 2.200 % Notes due 2027 (MO27) and the 3.125 % Notes due 2031 (MO31) in 2023 and 2024; the 1.700 % 2025 notes remained listed on the NYSE under the same ticker (MO25) across all years, indicating a stable, longer‑dated financing base. This evolution—by retiring the short‑term 2023 issue and retaining the 2025, 2027 and 2031 notes—shows Altria’s capital‑structure strategy of extending maturity, reducing reliance on near‑term, low‑coupon debt, and maintaining a diversified ladder of fixed‑rate obligations to manage liquidity and interest‑rate risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its depiction of Altria's debt structure evolution. It accurately notes the presence of the 1.000% Note due 2023 in 2022 and its absence in 2023 and 2024, consistent with maturity or retirement. The 1.700% Note due 2025 is correctly identified as remaining listed through 2024. The additional notes (2.200% due 2027 and 3.125% due 2031) are plausible and do not contradict the ground truth, though the original answer does not specify them—this is a minor addition but not an error. 2) Quantitatively, all percentages (1.000%, 1.700%, 2.200%, 3.125%), maturities (2023, 2025, 2027, 2031), and the progression across years are accurate. The claim that the 1.700% Note remained listed under ticker MO25 is consistent with the ground truth’s implication of continued listing. No calculation errors. 3) The multi-hop reasoning is sound: the model correctly infers that retiring the 2023 note while retaining the 2025 note suggests a strategy of extending maturities and avoiding short-term rollover. The conclusion about reducing reliance on near-term debt and managing interest-rate risk aligns with the ground truth’s interpretation of a focus on intermediate and long-term debt. However, the original answer does not mention the 2027 and 2031 notes, so including them—while not incorrect—adds unverified detail that slightly reduces qualitative precision. 4) The answer is highly contextually relevant, addressing all parts of the question: evolution of debt composition, role of the 1.700% 2025 note, and strategic implications. The core message about capital structure strategy is semantically equivalent to the ground truth. Minor deduction in correctness and qualitative accuracy due to the introduction of specific notes not in the original answer, though they do not contradict it.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 492,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 to 2024 in terms of carrying value and weighted-average interest rate, and what does this trend suggest about the company's long-term borrowing strategy?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, and remained at $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, then slightly declined to 4.84% in 2024. This indicates a strategy shift toward issuing more long-term debt at higher interest rates, likely to capitalize on investor demand or to fund growth initiatives amid rising market rates.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt carrying value rose from **$19.975 bn (2022)** – disclosed in Chunk 1 with a weighted‑average interest rate of **2.91 %** – to **$27.168 bn (2023)** – shown in Chunk 3 at a 4.45 % rate – and then slipped slightly to **$26.93 bn (2024)** – reported in Chunk 2 with a 4.84 % rate. This trajectory, marked by a steady increase in both the amount of fixed senior debt and its weighted‑average interest rate across the three years, indicates that the company is deliberately expanding long‑term, fixed‑rate funding while accepting higher borrowing costs, likely to lock in stable financing as market rates rise and to reinforce its long‑term capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all carrying values and weighted-average interest rates for Capital One's fixed unsecured senior debt across 2022, 2023, and 2024, matching the ground truth exactly in both magnitude and year. The values are presented in billions ($19.975 bn = $19,975 million, $27.168 bn = $27,168 million, $26.93 bn ≈ $26,930 million) with acceptable rounding. Interest rates are accurately reported: 2.91%, 4.45%, and 4.84% for the respective years. (2) All numeric values are correct and consistent with the original answer; no calculation errors are present. The slight discrepancy in 2024 carrying value ($26.93 bn vs $26,930 million) is due to rounding and does not affect factual accuracy. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers a strategic shift toward issuing more long-term debt at higher rates, aligning with the rising interest environment. The conclusion about 'locking in stable financing as market rates rise' is a reasonable interpretation of the trend and matches the original answer’s implication. (4) The only minor shortcoming is that the original answer explicitly mentions the strategy may be 'to fund growth initiatives,' which the LLM omits, slightly weakening the qualitative completeness. However, the core reasoning and strategic interpretation remain strong. Overall, the answer is factually precise, contextually appropriate, and demonstrates correct multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 413,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15 evolved from 2022 through 2024, and what does this progression indicate about the company's solar financing strategy?",
      "original_answer": "Tesla's use of the 5.45% Solar Bonds, Series 2015/C92-15, shows a pattern of sustained reference but declining prominence in the company's solar financing strategy. In 2022 (TSLA_10k_2022.pdf), the bond was listed among key supplemental indentures, specifically in Exhibit 4.61, indicating its active inclusion in the company's financing documentation. In 2023 (TSLA_10k_2023.pdf), the bond was again referenced in Exhibit 4.54, maintaining its presence in Tesla’s capital structure disclosures, though not expanded upon. By 2024 (TSLA_10k_2024.pdf), while the bond remained listed in Exhibit 4.52, newer bond series such as C102-15 and C106-10 appeared in subsequent filings, suggesting a shift toward more recent financing structures. This multi-year pattern indicates that Tesla continued to honor and report on the C92-15 bond series but increasingly relied on newer bond structures, reflecting an evolving solar financing strategy that builds upon prior frameworks while introducing updated instruments.",
      "llm_answer": "\nFrom 2022 through 2024 Tesla’s Form 10‑K filings repeatedly cite the original 116th Supplemental Indenture (dated August 24 2015) for the 5.45 % Solar Bonds, Series 2015/C92‑15 (see Chunk 1 and Chunk 3), and in the 2024 filing an additional 129th Supplemental Indenture is added for a new 5.45 % Solar Bonds, Series 2015/C102‑15 (Chunk 2); the 2022 filing also references later amendments up to the 148th indenture (Chunk 3). This shows that rather than launching a fresh bond issue, Tesla has been continuously amending and expanding the same asset‑backed security—adding new tranches and updating terms—to roll over and extend financing for its solar portfolio, revealing a strategy of using a stable, securitized debt platform to fund and refinance solar installations over the long term.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but includes significant inaccuracies in both quantitative details and reasoning. (1) Quantitatively, the LLM correctly identifies the 5.45% interest rate and the 2015 issuance date of the Solar Bonds, Series 2015/C92-15, and correctly references its inclusion in Tesla's 10-K filings across 2022–2024. However, it incorrectly claims that a '129th Supplemental Indenture' for a new bond series C102-15 was added in the 2024 filing—this is not supported by the ground truth, which states that newer bonds like C102-15 and C106-10 appeared in subsequent filings but does not specify a 129th Supplemental Indenture or tie it to the 2024 filing. Additionally, the claim that the 2022 filing references amendments up to the '148th indenture' is not corroborated by the original answer and introduces unsupported specifics. (2) The original answer emphasizes declining prominence of C92-15 and a strategic shift toward newer instruments, while the LLM interprets the pattern as evidence of Tesla 'continuously amending and expanding the same asset-backed security'—a materially different conclusion. The ground truth indicates that C92-15 remains listed but not expanded upon, whereas the LLM suggests active expansion via new tranches, which overstates the continuity and misrepresents the evolution. (3) Multi-hop reasoning is partially sound—information is synthesized across years—but the interpretation misaligns with the evidence: referencing a bond in disclosures does not equate to actively amending or expanding it. (4) Contextual relevance is high because the response addresses Tesla’s solar financing strategy and traces developments over time, but the core conclusion about using a 'stable, securitized debt platform' to 'roll over and extend financing' is speculative and not directly supported by the provided truth. Overall, while some factual elements are correct, the misrepresentation of the bond amendment process and the erroneous citation of specific indenture numbers reduce factual accuracy and reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 557,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did AIG's management of loss reserves risk evolve from 2022 to 2024, particularly in terms of oversight mechanisms, modeling approaches, and integration of external reviews across the three years?",
      "original_answer": "From 2022 to 2024, AIG's management of loss reserves risk demonstrated a consistent yet maturing approach. In 2022, AIG emphasized internal controls and oversight of the loss reserve setting process, complemented by reviews from external experts. By 2023, the company expanded its risk management framework to include a broader set of tools such as sensitivity and scenario analyses, stochastic methods, and experience studies, while continuing to rely on external expert reviews. In 2024, AIG further integrated these practices into a more holistic enterprise risk management (ERM) system, with enhanced reporting to committees, audits by the Internal Audit Group, and more structured second-line reviews of reserving models and assumptions. This evolution reflects a growing emphasis on proactive risk identification, validation, and governance.",
      "llm_answer": "\nIn 2022 AIG identified loss‑reserves risk as a key exposure and managed it through internal controls and oversight of the reserve‑setting process together with periodic reviews by external experts (Chunk 1).  \nBy 2023 the oversight framework expanded to a risk‑adjusted‑return objective, introducing a three‑tiered limit hierarchy, stochastic and deterministic modeling techniques, and formal model‑risk validation, while still relying on external expert reviews as part of the reserve‑review process (Chunk 2).  \nIn 2024 AIG deepened the evolution by embedding ERM second‑line challenge and internal‑audit monitoring, maintaining external expert reviews, and integrating climate‑change considerations and more sophisticated aggregation modeling into loss‑reserve assessments (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth in both factual content and reasoning. (1) All entities—AIG, years 2022–2024, and key risk management components—are correctly identified. The evolution across the three years is accurately portrayed: 2022 focuses on internal controls and external reviews; 2023 introduces expanded modeling techniques (stochastic and deterministic methods, model-risk validation); and 2024 emphasizes ERM integration, second-line challenge, and internal audit monitoring. The mention of climate-change considerations and aggregation modeling in 2024 adds detail not in the original but does not contradict it and may reflect additional nuance from source data. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the LLM synthesizes changes over time across oversight, modeling, and external review dimensions as required by the question. The progression from internal controls to structured modeling to ERM integration reflects correct longitudinal synthesis. (4) Semantic equivalence is strong. While the LLM uses slightly different phrasing (e.g., 'three-tiered limit hierarchy', 'risk-adjusted-return objective'), these are plausible elaborations consistent with a maturing risk framework. The core elements—external expert reviews maintained throughout, enhanced modeling in 2023, and stronger governance in 2024—are all preserved. One minor point: the original emphasizes 'sensitivity and scenario analyses, stochastic methods, and experience studies' in 2023, while the LLM mentions 'stochastic and deterministic modeling' and 'model-risk validation'—slightly different emphasis but overlapping in substance. This justifies a 9 on qualitative accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR <-[Faces]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 522,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Altria's allocation to U.S. Treasury and foreign government securities evolve across 2022-2024, and what does this trend indicate about its pension asset strategy?",
      "original_answer": "Altria's allocation to U.S. Treasury and foreign government securities within its pension and postretirement plan assets decreased from 19% in 2022 to 16% in 2023, before dropping further to 8% in 2024. This steady decline indicates a strategic shift away from government-backed fixed income instruments toward other asset categories, likely reflecting a recalibration of risk exposure and return expectations. The reduction in allocation aligns with a broader trend of lowering exposure to below-investment-grade securities—from 11% of fixed income holdings in 2023 to 9% in 2024 for pension assets—and suggests a more conservative or diversified investment posture over time. Additionally, the expected rate of return on pension assets was reduced from 6.6% in 2022 to 6.1% in 2023 and remained at 6.1% in 2024, indicating a more cautious long-term outlook as the asset mix evolved.",
      "llm_answer": "\nAltria’s pension assets were invested in U.S. Treasury and foreign government securities at 8 % in 2022 (Chunk 3), increased to 19 % in 2023 (Chunk 1), and returned to 8 % in 2024 (Chunk 2), indicating a temporary overweighting that was later re‑balanced. This evolution reflects the company’s active, liability‑driven strategy—continuously monitoring and adjusting the mix to align with its long‑duration fixed‑income benchmark and to meet monthly benefit payment needs, as shown by the ongoing rebalancing, revised expected‑return assumptions (e.g., 6.1 % for 2024 pension vs. 6.6 % in 2021) and the emphasis on matching the pension‑obligation benchmark (Chunk 1, 3).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the allocation percentages and their direction of change. According to the ground truth, Altria's allocation to U.S. Treasury and foreign government securities decreased from 19% in 2022 to 16% in 2023, then sharply to 8% in 2024. The LLM incorrectly states it was 8% in 2022, increased to 19% in 2023, and returned to 8% in 2024—reversing the actual trend. This misrepresents the entire evolution and leads to an incorrect interpretation of strategy. (2) The quantitative inaccuracies are severe: the starting point (19% vs. 8%), the 2023 value (16% vs. 19%), and the trajectory are all wrong. The expected rate of return is partially correct—6.1% in 2024 is accurate—but the LLM references 2021 (6.6%) instead of 2022, and omits the 2023 reduction from 6.6% to 6.1%. (3) The reasoning is flawed due to incorrect data: the conclusion of a 'temporary overweighting' and 'rebalancing' contradicts the ground truth of a consistent downward trend indicating a strategic shift away from government securities. The mention of liability-driven strategy and benchmark alignment may reflect plausible context but is applied to incorrect data, undermining the multi-hop synthesis. (4) Contextual relevance is moderate—the answer addresses pension asset strategy and return assumptions, which are relevant—but the core factual errors in percentages and trend direction severely compromise correctness. The qualitative reasoning would score higher if based on accurate data. Overall, major factual and directional errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 443,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure, particularly in relation to changes in floating and fixed unsecured senior debt and securitized debt obligations?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a complex evolution in its debt structure. In 2022, securitized debt obligations were $14.994 billion with a weighted-average interest rate of 1.51%, while floating unsecured senior debt was $1.709 billion at a 1.01% rate. By 2023, securitized debt rose to $18.043 billion at a higher average rate of 3.01%, and floating unsecured senior debt increased to $349 million at 6.75%, signaling a shift toward higher-cost short-term funding. In 2024, securitized debt declined slightly to $14.264 billion but with a significantly higher average rate of 3.48%, and floating unsecured senior debt was fully retired (dropped to $0). This trajectory shows Capital One's increasing reliance on fixed-rate senior debt, which rose from $19.975 billion in 2022 to $26.930 billion in 2024, with a corresponding rise in weighted-average interest rate from 2.91% to 4.84%, suggesting a strategic shift to lock in longer-term financing amid rising interest rates.",
      "llm_answer": "\nFrom 2022 through 2024 Capital One’s combined short‑term borrowings and long‑term debt moved from **$43.1 bn (Chunk 1)** to **$49.9 bn (Chunk 3)** before declining to **$45.6 bn (Chunk 2)**, highlighting a peak in 2023 and a modest pull‑back in 2024.  The 2023 surge was powered by a jump in securitized debt from **$15.0 bn to $18.0 bn (Chunk 1→Chunk 3)** and an increase in fixed unsecured senior notes from **$20.0 bn to $27.2 bn (Chunk 1→Chunk 3)**, while floating unsecured senior debt collapsed from **$1.7 bn (Chunk 1)** to **$0.35 bn (Chunk 3)** and was fully eliminated by 2024 (**$0 in Chunk 2**).  As a result, the weighted‑average interest rate on securitized obligations rose from **1.5 % (Chunk 1) to 3.5 % (Chunk 3) to 3.5 % (Chunk 2)** and on fixed senior debt from **2.9 % (Chunk 1) to 4.5 % (Chunk 3) to 4.8 % (Chunk 2)**, indicating a strategic shift toward higher‑rate, longer‑dated fixed and securitized financing and a marked reduction in low‑cost floating‑rate exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall trend in Capital One's debt structure correctly: an increase from 2022 to 2023, followed by a decline in 2024, and a strategic shift toward fixed-rate and securitized debt with reduced floating-rate exposure. The narrative about increasing reliance on fixed-rate financing amid rising rates aligns with the ground truth.\n\n2) Quantitative inaccuracies include: (a) total debt in 2023 is reported as $49.9 billion (Chunk 3), but ground truth is $48.715 billion; (b) 2024 total debt is given as $45.6 billion (close to the correct $45.551 billion — acceptable); (c) securitized debt in 2024 is stated as 3.5% rate (LLM) vs. actual 3.48% (minor rounding OK), but incorrectly implies it was 3.5% in 2023 when ground truth is 3.01%; (d) fixed unsecured senior debt increased to $27.2 billion in 2023 (LLM) vs. actual $26.930 billion in 2024 — this misplaces the timing and magnitude; (e) floating unsecured senior debt in 2023 is reported as $0.35 billion ($350 million), which is close to $349 million — acceptable.\n\n3) Multi-hop reasoning is generally sound: the model identifies shifts across debt categories and links them to interest rate trends. It correctly infers a strategic move away from floating-rate debt (retired by 2024) and toward fixed and securitized debt. However, the incorrect assignment of $27.2 billion in fixed debt to 2023 (instead of 2024) distorts the year-over-year evolution and suggests flawed synthesis across time points.\n\n4) Despite some number inaccuracies, the qualitative interpretation and strategic conclusion are aligned with the ground truth. Contextual relevance is excellent — all parts of the question are addressed, including trends in debt types, interest rates, and implications for rate exposure. The main deduction is for quantitative precision, particularly the overstatement of 2023 total debt and mis-timing of fixed debt growth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 516,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "What does Tesla's repeated reference to the 5.45% Solar Bonds, Series 2015/C25-15 across its 2022, 2023, and 2024 10-K filings suggest about the company's reliance on this specific financing instrument for solar projects, and how does the consistent inclusion of this bond series across filings reflect its ongoing role in Tesla's capital structure?",
      "original_answer": "Tesla's 2022 filing includes the Thirty-Sixth Supplemental Indenture for the 5.45% Solar Bonds, Series 2015/C25-15, dated April 14, 2015. The same bond series appears in the 2023 filing with the Thirty-Sixth Supplemental Indenture dated April 14, 2015, and again in the 2024 filing with the identical bond referenced under the same date. This consistent inclusion across three years indicates that the Series 2015/C25-15 bonds remain an active and integral component of Tesla's capital structure, particularly for financing solar initiatives. The repeated disclosure suggests ongoing reliance on this instrument, implying that Tesla continues to view these bonds as a stable and strategic source of funding for its solar business, even several years after issuance.",
      "llm_answer": "\nTesla’s 2022, 2023 and 2024 10‑K filings each list the same “5.45 % Solar Bonds, Series 2015/C25‑15” in their exhibit indexes (Chunk 3 – exhibit 4.36; Chunk 1 – exhibit 4.29; Chunk 2 – exhibit 4.27), confirming that the instrument remains a core component of the company’s capital structure.  The repeated inclusion of this specific bond series—originally issued by SolarCity and now reflected in Tesla’s ongoing indenture amendments—shows that Tesla continues to rely on it as a primary financing source for its solar projects and that the bond’s terms continue to underpin the firm’s long‑term solar‑asset funding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the bond series '5.45% Solar Bonds, Series 2015/C25-15' is consistently referenced across Tesla's 2022, 2023, and 2024 10-K filings, and the original issuance date (April 14, 2015) is correctly implied as part of the bond's history, though not explicitly restated in the LLM answer. The percentage (5.45%) and bond designation are accurate. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates are presented. The mention of exhibit numbers (e.g., 4.36, 4.29, 4.27) adds precision and matches typical 10-K structure, though not in the original answer—this is a detail from the evidence chunks and does not contradict ground truth. (3) Reasoning is sound: the LLM correctly infers that the repeated inclusion of the bond in annual filings indicates its ongoing role in Tesla’s capital structure and its importance for solar project financing. It appropriately notes the bond’s origin with SolarCity and its continued relevance post-acquisition, which reflects correct multi-hop reasoning across corporate and temporal boundaries. (4) The answer is semantically equivalent to the original: while it does not explicitly name the 'Thirty-Sixth Supplemental Indenture' or the exact date (April 14, 2015), it captures the essential conclusion—that this bond remains a core, active financing instrument. The omission of the indenture name and date is minor and does not undermine the factual or inferential correctness. Contextual relevance is excellent, directly addressing both parts of the question: Tesla’s reliance on the bond and its ongoing role in capital structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 462,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Mastercard's investment in Class A Treasury Stock evolve from 2022 to 2024, and what does this trend suggest about the company's capital allocation strategy?",
      "original_answer": "Mastercard's investment in Class A Treasury Stock increased significantly from $(51,354) million in 2023 to $(60,429) million in 2023 and further to $(71,431) million in 2024. This represents a consistent upward trend in treasury stock purchases over the three-year period, indicating a growing emphasis on stock buybacks as part of the company's capital allocation strategy.",
      "llm_answer": "\nMastercard’s Class A Treasury Stock, recorded at cost, increased from **$51.354 bn** at the end of 2022 (shown in Chunk 2’s 2022 column) to **$60.429 bn** at the end of 2023 (Chunk 2’s 2023 column) and then to **$71.431 bn** by the end of 2024 (Chunk 3).  This steady rise—reflecting ongoing purchases of its own shares—indicates that the company is deliberately allocating excess cash to repurchase and retire stock, underscoring a capital‑allocation strategy focused on returning surplus capital to shareholders through buybacks rather than expanding dividends or other investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the evolution of Mastercard's investment in Class A Treasury Stock from 2022 to 2024 with accurate figures: $51.354 billion (2022), $60.429 billion (2023), and $71.431 billion (2024), matching the ground truth in magnitude and direction. The negative signs in the original answer (e.g., $(51,354) million) reflect accounting conventions (contra-equity), but the LLM presents absolute values in positive billions, which is common in narrative summaries and semantically acceptable. 2) All numeric values are correct and consistent with the ground truth when adjusted for format ($51.354 bn = $51,354 million). The progression is accurately described as a steady increase, and the trend is correctly interpreted. 3) The multi-hop reasoning is sound—LLM synthesizes data across years (2022, 2023, 2024) and correctly infers the strategic implication: increased stock buybacks as part of capital allocation. It correctly identifies the entity (Mastercard), metric (Class A Treasury Stock), and time frame. 4) The conclusion about capital allocation strategy—emphasizing buybacks over dividends or other investments—is logically derived and aligns with the ground truth. Minor deduction in qualitative accuracy because the LLM does not explicitly note the accounting treatment (treasury stock as a negative equity item), but this does not affect the overall correctness. Wording differences are within acceptable semantic equivalence. Contextual relevance is perfect—directly addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 423,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Honeywell's exposure to adverse industry economic conditions evolve across its Safety and Productivity Solutions segment from 2022 through 2024, particularly in terms of risks related to reduced investments in automation and plant capacity utilization, and what does this trend suggest about the macroeconomic pressures facing the industrial sector during this period?",
      "original_answer": "From 2022 to 2024, Honeywell consistently highlighted that its Safety and Productivity Solutions segment was increasingly exposed to adverse industry economic conditions, particularly due to reduced investments in process automation and plant capacity utilization. In 2022, the company cited these factors as contributors to lower market share and reduced margins. By 2023, the language remained largely consistent, but the context of ongoing global economic uncertainty was emphasized. In 2024, the risk was reiterated with a sharper focus on the broader macroeconomic volatility, including geopolitical instability and trade policy shifts, suggesting a deepening concern over sustained industrial sector weakness. This trajectory indicates a persistent and potentially worsening macroeconomic headwind affecting industrial demand and investment behavior over the three-year period.",
      "llm_answer": "\nHoneywell’s Safety & Productivity Solutions segment saw its exposure to adverse industry economic conditions deepen from 2022 through 2024, as each year’s risk‑factor disclosure highlighted a growing drag from reduced investments in process automation and plant‑capacity‑utilization initiatives that directly eroded market share, pricing power and margins.  The 2022 filing flagged early COVID‑related uncertainty and the first signs of cut‑back spending; by 2023 the language intensified, explicitly linking “adverse industry economic conditions” to lower automation spend and margin compression; and in 2024 the company tied the trend to broader macro‑economic pressures—including volatile oil‑and‑gas prices, geopolitical instability and tightening international trade restrictions—that amplified the risk of sustained under‑investment across the industrial sector.  Together, these disclosures illustrate a progressive macro‑economic strain on industrial customers, signaling heightened sensitivity of the segment to overall economic downturns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: Honeywell's Safety and Productivity Solutions segment faced increasing exposure to adverse economic conditions from 2022 to 2024, with consistent mention of reduced investments in automation and plant capacity utilization impacting market share, margins, and pricing. The evolution across years is accurately portrayed—2022 noted early signs linked to post-COVID uncertainty and spending cutbacks, 2023 intensified the language around economic headwinds and margin pressure, and 2024 expanded the context to include macro factors like geopolitical instability and trade restrictions. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable in a strict sense, but all temporal references (2022–2024) are correct, earning full marks. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes risk disclosures across three years and infers a progressive worsening of macroeconomic pressures affecting industrial investment. The only minor deviation from the original answer is the addition of 'volatile oil-and-gas prices' and 'tightening international trade restrictions' as specific macro factors—while plausible and contextually consistent, these are more detailed than the original's general reference to 'geopolitical instability and trade policy shifts.' This slight elaboration does not introduce inaccuracy but adds specificity beyond the source, which prevents a perfect 10. (4) The answer is fully contextually relevant, directly addressing all parts of the multi-faceted question about risk evolution and macroeconomic implications. Overall, the response demonstrates strong qualitative reasoning and semantic equivalence to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 503,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the lifecycle positioning of Cyramza evolve from 2022 through 2024, particularly in terms of its therapeutic indications and intellectual property protection timeline?",
      "original_answer": "Cyramza was introduced in 2022 with a defined set of oncology indications, including second-line treatments for gastric, lung, colorectal, and hepatocellular cancers. By 2024, it remained a key oncology product, maintaining the same therapeutic indications. Meanwhile, its intellectual property protection timeline shifted significantly between 2023 and 2024, with data protection expiring in Japan in 2023 and set to expire in major European countries in 2024, while compound patents in the U.S. and Europe extend to 2026 and 2028, respectively. This indicates a narrowing window of exclusivity in key international markets despite continued therapeutic relevance.",
      "llm_answer": "\nFrom 2022 through 2024 Cyramza’s therapeutic profile moved from a **second‑line** oncology product (approved in 2022 for gastric cancer, metastatic NSCLC, colorectal cancer and hepatocellular carcinoma, and later for first‑line EGFR‑mutated NSCLC) to a **broader first‑line** indication in 2024 that added EGFR‑mutated metastatic NSCLC and several combination regimens (as detailed in the 2024 filing).  At the same time, its **intellectual‑property shield** was waning: the compound‑patent portfolio expires in the U.S. and Japan in 2026 and in major European markets in 2028, while data‑exclusivity periods ended in 2023 (Japan) and 2024 (Europe), leaving only the 2026‑2028 compound‑patent window for market protection.  This timeline shows Cyramza transitioning toward the end of its commercial lifecycle, with indications expanding just before the core patent protection expires.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding therapeutic indications: it claims Cyramza expanded to include first-line EGFR-mutated NSCLC by 2024, but the ground truth states that the therapeutic indications remained unchanged from 2022 to 2024. This is a major error affecting the core of the multi-hop analysis. (2) Quantitatively, the patent expiration dates are mostly accurate—U.S. and Japan 2026 (matches ground truth), Europe 2028 (matches), and data exclusivity expiring in Japan in 2023 and Europe in 2024 (also correct). However, the LLM incorrectly groups Japan with the U.S. on compound patent expiry, while the ground truth specifies U.S. and Europe (not Japan) for 2026 and 2028, respectively—Japan's data protection expired in 2023, but compound patent details for Japan are not specified in the original, so the LLM overreaches. (3) The reasoning is partially sound in linking narrowing IP protection with lifecycle stage, but the conclusion that indications expanded just before patent expiry is incorrect due to the false therapeutic expansion claim. This undermines the multi-hop synthesis between clinical and IP timelines. (4) Contextually, the answer is well-structured and addresses both therapeutic positioning and IP timeline as required. Despite correct contextual framing and mostly accurate dates, the key clinical claim is unsupported by the ground truth, leading to a partial correctness score. Semantic equivalence fails on the indication evolution, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 426,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation evolve from 2022 to 2024, particularly in terms of fair value measurements and unobservable inputs used in their valuation models?",
      "original_answer": "Capital One's net derivative assets/liabilities had a fair value of $19 million in 2022, increased to $58 million in 2023, and remained at $58 million in 2024. In 2022, the valuation included net losses of $20 million still held in the portfolio, and incorporated unobservable inputs like swap rates and default rates. By 2023, the valuation methodology continued to rely on discounted cash flows and unobservable inputs such as default rates (53–163%) and swap rates (3–5%), with the latter being weighted at 4%. In 2024, the fair value remained at $58 million, with similar unobservable inputs (swap rates of 3–5%, weighted at 4%) still playing a key role in the valuation model. This indicates a significant increase in fair value from 2022 to 2023, followed by stabilization in 2024, reflecting a consistent modeling approach with swap rates as a core valuation input.",
      "llm_answer": "\nCapital One’s net derivative assets (liabilities) measured at Level 3 fair value grew from a $19 million balance at year‑end 2021 (the ending balance shown in the 2021 10‑K reconciliation that details beginning $31 m, gains/losses, purchases, settlements and transfers) to $58 million at year‑end 2023 – the amount reported in both the 2023 and 2024 10‑K tables.  In each period the fair value was derived using discounted‑cash‑flow models, and the unobservable inputs remained consistent across the years: swap rates of 3‑5 % (weighted‑average 4 %), default rates ranging 53‑163 % (weighted‑average 4 %), voluntary prepayment rates of 2‑19 % (weighted‑average 7 %), loss severity of 30‑80 % (weighted‑average 61 %), and discount rates of 5‑14 % (weighted‑average 5‑7 %).  Consequently, the valuation evolution from 2022 through 2024 reflects a larger derivative position and the same DCF methodology, with the ranges of key unobservable inputs staying stable as disclosed in the 2022, 2023 and 2024 filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the timeline and values. It incorrectly states that the $19 million balance was at year-end 2021, while the ground truth specifies 2022. This misalignment affects the evolution narrative from 2022 to 2024. The LLM correctly identifies the $58 million value in 2023 and 2024, but fails to mention the 2022 value explicitly, instead referencing 2021 data not asked for in the question. (2) The quantitative inaccuracies include the incorrect year attribution for the $19 million figure. Additionally, the LLM introduces extra unobservable inputs (voluntary prepayment rates, loss severity, discount rates) not mentioned in the original answer, which may be present in filings but were not part of the ground truth synthesis. The default rate range of 53–163% is correctly cited, but the claim that it has a weighted average of 4% is inconsistent with the ground truth, which only assigns the 4% weight to swap rates. (3) The multi-hop reasoning is partially sound—LLM correctly identifies the use of discounted cash flow models and some consistent unobservable inputs across years. However, it misrepresents the temporal evolution by anchoring to 2021 instead of 2022, undermining the core comparison requested. It also overgeneralizes input stability without confirming their presence in each specific year as per the original answer. (4) Despite these issues, the answer captures the key trend of growth to $58 million and stabilization, and correctly notes the continued use of swap rates (3–5%, weighted at 4%) in 2023–2024. The contextual relevance is high because it addresses fair value measurements and unobservable inputs, but the quantitative and qualitative inaccuracies reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 486,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Qualcomm's charitable match program evolve from 2022 to 2024 in terms of employee participation and number of supported organizations, and how does this progression align with the company's broader human capital goals tied to executive compensation during this period?",
      "original_answer": "In 2022, Qualcomm reported that thousands of employees utilized the charitable match program, benefiting over 1,500 organizations. By 2024, the program remained active with thousands of employees participating globally, though the number of supported organizations slightly decreased to over 1,300 in fiscal 2024. Throughout this period, the company consistently linked human capital advancements—including charitable engagement—to executive compensation, using progress toward these goals as a non-financial modifier (0.9 to 1.1) for executive bonuses. Despite a minor decline in the number of supported organizations, the sustained high level of employee participation indicates ongoing alignment with Qualcomm's broader human capital strategy, including its 2025 goals for diversity, equity, and inclusion.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the charitable‑match program kept thousands of employees active each year, with the grant‑recipient count growing from **more than 1,500 organizations in 2022** to **over 1,300 organizations in 2024**, underscoring a sustained focus on community impact.  This expansion is embedded in Qualcomm’s human‑capital strategy—progress on such initiatives is explicitly evaluated by the HR and Compensation Committee, which uses **human‑capital advancements as a non‑financial performance modifier that can adjust executive bonuses by a 0.9‑to‑1.1 multiplier for fiscal 2022, 2023 and 2024**, directly linking charitable‑match outcomes to the company’s broader talent‑development and inclusion goals.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a critical factual error in the quantitative trend: it states that the number of supported organizations grew from over 1,500 in 2022 to over 1,300 in 2024, which is incorrect. The ground truth indicates a decrease from over 1,500 to over 1,300, not growth. This misrepresents the direction of change and undermines the accuracy of the synthesis. Employee participation is correctly described as 'thousands' in both years, which aligns with the original answer. (2) The numbers themselves (1,500 and 1,300) are factually correct in value and year, but the comparative language ('growing from') introduces a significant error in interpretation. The executive compensation linkage is accurately described, including the 0.9-to-1.1 multiplier and its application across 2022–2024, which matches the ground truth. (3) The multi-hop reasoning is partially sound—linking charitable participation to human capital goals and executive compensation is valid and well-synthesized. However, the incorrect characterization of organizational growth weakens the logical conclusion, as the answer suggests expansion when there was actually a slight decline. (4) Despite strong contextual relevance and mostly accurate entities and frameworks, the reversal of a key trend (increase vs. decrease) results in a moderate correctness score. The answer captures the broader strategic context but fails on a core factual comparison essential to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Considers]-> CONCEPT <-[Guides_On]- ORG <-[Focuses_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 402,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Adobe's positioning of Acrobat evolve from 2022 to 2024, particularly in terms of its role within Document Cloud, integration with other Adobe services, and product enhancements disclosed in each year's filings?",
      "original_answer": "In 2022, Adobe positioned Acrobat as a core component of Adobe Document Cloud with a focus on achieving strong market adoption and maintaining a leadership position in document-intensive industries such as legal, financial services, and publishing. The 2022 filing emphasized Acrobat's role in modernizing document workflows and the ubiquity of PDF usage, with trillions of PDF documents created annually. In 2023, Adobe expanded Acrobat’s positioning by introducing it within a broader context of AI-powered innovation, as part of its Digital Media offerings, and highlighted Acrobat’s integration with Adobe Sign and other Creative Cloud tools to enhance digital document productivity. The 2023 filing also included forward-looking statements about new or enhanced offerings, including AI-driven features. By 2024, Acrobat was formally associated with AI capabilities through the introduction of 'Acrobat AI Assistant' as a registered trademark, signaling a strategic shift toward embedding intelligent automation into document workflows. This evolution shows a clear trajectory from a document standard to an AI-enhanced productivity platform within Adobe’s ecosystem.",
      "llm_answer": "\nAdobe first elevated Acrobat as the flagship service of Document Cloud in 2022, stressing its market‑leadership in PDF workflows and its tight integration with Adobe Sign and other document‑services (Chunk 1). Building on that foundation, the 2023 filing expanded Acrobat’s role within the broader Digital Media segment, linking its roadmap to AI‑driven innovation and positioning it alongside Creative Cloud tools such as Photoshop and the newly integrated Frame.io collaboration platform (Chunk 2). By 2024 Adobe introduced the Acrobat AI Assistant and highlighted it—alongside Acrobat Reader, Acrobat Sign and the Document Cloud trademark—in its trademark list, signaling a strategic shift toward AI‑enhanced document productivity and deeper convergence with Adobe Express, Firefly and other Adobe services (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Acrobat's positioning in 2022 as a core Document Cloud component with leadership in PDF workflows; the 2023 expansion into AI-driven innovation within Digital Media and integration with Creative Cloud tools; and the 2024 introduction of the Acrobat AI Assistant as a registered trademark, signaling AI integration. The mention of Adobe Sign, Adobe Express, and Firefly in 2024 is consistent with the strategic direction, even if not explicitly listed in the original answer—these represent plausible extensions of 'other Adobe services' and do not contradict the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all years (2022, 2023, 2024) are correctly used and contextualized. (3) The multi-hop reasoning is sound: the LLM synthesizes Acrobat’s evolving role across three years, linking it to Document Cloud, AI strategy, and integration with other Adobe services. The only minor deviation is the mention of Frame.io and Adobe Express in the 2023 context, which are not in the original answer—this adds detail beyond the ground truth but does not introduce factual errors. (4) The answer is semantically equivalent to the original, with slightly more product-specific detail but maintaining factual correctness and logical flow. The strategic trajectory—from document standard to AI-enhanced platform—is clearly conveyed. Hence, a correctness score of 9 is warranted due to slight over-specificity without error, but not full 10 due to minor unverified additions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 460,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did the financial implications of LLY's collaboration with AbCellera on COVID-19 antibodies evolve from 2022 through 2024, particularly in terms of net product revenue and royalty payments tied to bamlanivimab and bebtelovimab sales?",
      "original_answer": "In 2022, LLY recognized $2.02 billion in net product revenue from its sales of AbCellera-partnered COVID-19 antibodies (bamlanivimab and bebtelovimab), with royalty payments to AbCellera in the mid-teens to mid-twenties percentage range on worldwide net sales. In 2023, LLY had no sales of these antibodies, resulting in no royalty payments to AbCellera. In 2024, the trend continued with no sales reported, indicating a complete wind-down of the product line. This 3-year progression shows a sharp decline in revenue and corresponding royalty obligations after the peak in 2022, reflecting reduced demand or regulatory changes affecting EUA-based sales.",
      "llm_answer": "\nFrom 2022 through 2024 LLY’s net product revenue from its COVID‑19 antibody combo (bamlanivimab + bebtelovimab) dropped sharply—​$2.02 billion was recognized in 2022 (Chunk 1) but no sales occurred in 2023 or 2024 (Chunk 1 & Chunk 2), eliminating any related revenue thereafter.  Royalty payments to AbCellera, recorded as cost‑of‑sales at mid‑teens to mid‑twenties of worldwide net sales of those antibodies, therefore fell to zero once sales stopped, even though the collaboration agreement (linked by the KG pattern ORG‑Depends_On‑COMP and Partners_With) also allowed for tiered royalties and potential milestones that were never material (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: $2.02 billion in net product revenue for 2022, no sales in 2023 and 2024, and royalty payments in the mid-teens to mid-twenties percentage range on worldwide net sales. The statement that royalty payments fell to zero due to lack of sales is logically sound and factually consistent. (2) Quantitative accuracy is perfect: the dollar amount ($2.02 billion), years (2022–2024), and royalty range (mid-teens to mid-twenties) match the original answer exactly. No calculation errors. (3) Multi-hop reasoning is strong—the model correctly links the cessation of sales to the elimination of royalty obligations, and references the collaboration structure (e.g., tiered royalties, milestones) without overclaiming their impact. The mention of 'Chunk' references appears to be internal tracing and does not detract from factual content. (4) The answer is contextually relevant and fully addresses the evolution of financial implications across the three years, focusing on both net revenue and royalty payments. The only minor shortcoming is slightly less explicit emphasis on regulatory changes or reduced demand as drivers (mentioned in the original), but the core financial trajectory and causal logic are preserved. Hence, a score of 9 is warranted—excellent accuracy with negligible omission of explanatory context.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 391,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did MetLife's reliance on the modified coinsurance agreement as a percentage of its closed block evolve from 2022 through 2024, and what does this consistency reveal about the company's long-term risk transfer strategy?",
      "original_answer": "MetLife maintained a consistent 59% reinsurance of its closed block through the modified coinsurance agreement in all three years: 59.25% in 2022, 59% in 2023, and 59% in 2024. This stability suggests that the company intentionally preserved a long-term risk-sharing structure without altering the proportion of risk transferred, indicating strategic continuity in managing its closed block liabilities.",
      "llm_answer": "\nMetLife has kept the share of its closed‑block risk transferred through a modified‑coinsurance arrangement essentially unchanged—about 59 % in 2022, 2023 and 2024 (the 2021 filing noted 59.25 %)—and continues to account for that arrangement under the deposit method, offsetting the deposit liability with the related deposit‑recoverable. This steady 59 % cession, together with the consistent use of the deposit‑method accounting and the offsetting treatment reflected in the Accounts_For → Modified Coinsurance Agreement triplet, shows that MetLife’s long‑term risk‑transfer strategy is built on a fixed, predictable proportion of closed‑block risk moved to an external reinsurer, reinforcing capital discipline and a stable accounting policy across the years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the percentage of MetLife's closed block reinsured through the modified coinsurance agreement in each year: 59.25% in 2022 (noted as from the 2021 filing, which is a minor misstatement but does not affect factual accuracy), and approximately 59% in 2023 and 2024, matching the ground truth of 59.25%, 59%, and 59%. The slight rounding to 'about 59%' is acceptable and semantically equivalent. 2) All numeric values are accurate; the reference to the 2021 filing for the 59.25% figure is a small contextual error (should be 2022 filing), but the number itself is correct. No calculation errors. 3) The reasoning is sound: the LLM correctly infers that the consistency in reinsurance percentage reflects a deliberate, long-term risk transfer strategy focused on stability, capital discipline, and consistent accounting treatment (deposit method). It adds value by referencing accounting policy (deposit-recoverable offset), which supports the conclusion of strategic continuity. 4) The answer fully addresses both parts of the question: evolution over time (stable at ~59%) and what it reveals about long-term strategy. The added detail about accounting method enhances qualitative accuracy without introducing error. Minor deduction in qualitative accuracy only because of the misattribution of the 59.25% to the 2021 filing instead of 2022. Otherwise, entity names (MetLife, modified coinsurance agreement), years, and financial concepts are correct and well-synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Accounts_For]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Accounts_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 414,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Mastercard's multi-layered security approach evolved from 2022 to 2024, particularly regarding third-party collaboration and real-time payment infrastructure, and what does this indicate about its cybersecurity strategy?",
      "original_answer": "From 2022 to 2024, Mastercard's multi-layered security approach has consistently emphasized third-party collaboration and the expansion of real-time payment infrastructure, with increasing specificity and integration. In 2022, the company highlighted its multi-layered approach, including partnerships through public-private collaborations and third-party providers to monitor and respond to cyber threats, while operating real-time payments infrastructure in 12 of the top 50 GDP markets. By 2023, the company expanded its real-time infrastructure to 13 markets and explicitly mentioned working with third-party providers to address threats associated with outsourced services, indicating a more structured integration of third-party risk management into its security framework. In 2024, Mastercard continued this trajectory by operating real-time payments in 'several countries globally' and reinforcing its multi-layered security model with ongoing third-party assessments and resilience programs. This evolution demonstrates a strategic alignment between scaling real-time payment capabilities and enhancing cybersecurity through collaborative and resilient third-party engagement, signaling a proactive and adaptive security posture in response to growing digital payment risks.",
      "llm_answer": "\nFrom 2022 to 2024 Mastercard expanded its multi‑layered security by growing real‑time account‑based payments from 12 to 13 global markets (2023) and, in 2024, launching a joint‑venture that processes domestic transactions in China, thereby bringing both domestic and cross‑border flows onto its network; at the same time it deepened third‑party collaboration through public‑private partnerships, industry standards such as EMV, and direct work with issuers, acquirers, merchants and government agencies—efforts that are reflected in its Security Operations Centers, Fusion Centers and Mastercard Intelligence Center. This progression shows a cybersecurity strategy that is increasingly collaborative, standards‑driven and infrastructure‑focused, leveraging an ecosystem of partners to maintain resilience and protect the global payments ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly notes the expansion of real-time payments from 12 to 13 markets between 2022 and 2023, aligning with the ground truth. However, it introduces a claim about a 2024 joint venture processing domestic transactions in China that is not present in the original answer and cannot be verified from the provided ground truth, making it a significant factual overreach. The original answer only states that in 2024, Mastercard operated real-time payments in 'several countries globally'—a vague but safe generalization—whereas the LLM adds specific, unsupported strategic detail. (2) Quantitatively, the 12 to 13 market expansion is accurate, but the lack of mention of the 2024 update as 'several countries' (instead of introducing unverified China JV) reduces quantitative precision. No numerical calculations are required, but the use of '12 to 13' is correct. The introduction of new, unverified entities (e.g., China JV) harms entity accuracy. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a trend of growing third-party collaboration and infrastructure scaling. It accurately references public-private partnerships, EMV, and collaboration with issuers, acquirers, etc., which aligns with the ground truth’s emphasis on third-party integration. However, it fails to mention the increasing focus on third-party risk management and resilience programs explicitly highlighted in 2023 and 2024, instead substituting with organizational units (e.g., Fusion Centers) not mentioned in the original. This shifts focus from risk assessment to operational structure, missing a key strategic evolution. (4) The conclusion about a collaborative, standards-driven strategy is semantically close to the original’s 'proactive and adaptive security posture,' so reasoning is reasonably aligned. Contextual relevance is high as the answer addresses both third-party collaboration and real-time infrastructure evolution. However, the inclusion of unsupported specifics reduces factual correctness, warranting a moderate score of 6 for overall correctness, with higher marks for relevance and qualitative reasoning, and lower for quantitative accuracy due to unsupported claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY <-[Implements]- ORG <-[Implements]- ORG",
      "token_usage": {
        "prompt_tokens": 1553,
        "completion_tokens": 608,
        "total_tokens": 2161
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did LLY's allocation to private alternative investments, specifically equity-like funds, evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid assets?",
      "original_answer": "LLY's allocation to equity-like funds within private alternative investments increased from $2,844.7 million in 2022 to $4,093.7 million in 2024, with a slight dip in 2023 to $4,014.1 million. This upward trajectory indicates a strategic emphasis on long-duration, higher-return potential assets, suggesting LLY's growing confidence in private market investments as part of its broader pension and retiree benefit funding strategy.",
      "llm_answer": "\nLLY’s exposure to equity‑like private alternative funds rose from **$2.84 bn in 2022** (Chunk 3) to **$4.01 bn in 2023** (Chunk 1) and then to **$4.09 bn in 2024** (Chunk 2), a 41 % increase followed by a modest 2 % gain.  \nThis steady growth—evidenced by the rising Level‑3 valuation inputs (16.9 → 25.4 → 25.1)—shows that LLY is deliberately expanding its illiquid‑asset position.  \nBecause the Private Alternative Investments fund both discloses and invests in LLY (KG: Private Alternative Investments → LLY), the upward allocation trend signals a long‑term strategic shift toward private‑equity‑like holdings to capture premium, long‑horizon returns.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the overall upward trend in LLY's allocation to equity-like private alternative investments from 2022 to 2024 and captures the strategic implication accurately. However, there is a minor factual inaccuracy in the 2023 value: the LLM reports $4.01 billion, while the ground truth specifies $4,014.1 million ($4.0141 billion), which is close but not exact—this rounding is acceptable, but the LLM incorrectly labels it as an increase from 2022 to 2023, missing the slight dip mentioned in the original answer. The 2022 value is reported as $2.84 billion ($2,840 million), whereas the truth is $2,844.7 million—again, a negligible rounding difference. The 2024 value is correctly reported as $4.09 billion. (2) The percentage increase calculation (41%) from 2022 to 2023 is approximately correct given the rounded figures, but since the actual allocation dipped slightly in 2023, characterizing it as a '41% increase followed by a modest 2% gain' is misleading—it implies consistent growth, whereas the truth shows a small decline in 2023 before rising again in 2024. (3) The multi-hop reasoning is strong: the LLM references Level 3 valuation inputs (16.9 → 25.4 → 25.1), which supports the illiquidity argument and shows synthesis across disclosures. It also correctly infers strategic intent—long-horizon, higher-return assets—and ties it to pension/retiree funding strategy, aligning with the ground truth. The self-investment note (Private Alternative Investments investing in LLY) adds contextual depth, though not in the original answer, it doesn’t contradict it. (4) Scores reflect high qualitative and contextual accuracy; quantitative score is reduced due to misrepresentation of the 2023 trend as an increase rather than a slight dip, despite correct endpoint values.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 493,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did Procter & Gamble's positioning of Cascade within its Fabric & Home Care segment evolve from 2022 to 2024, particularly in terms of its product categorization and relative contribution to net sales?",
      "original_answer": "In 2022, Cascade was listed as part of the Fabric & Home Care segment, which contributed 35% of net sales. In 2023, the segment's net sales increased to 36%, and Cascade remained a key brand within this category, indicating continued strategic importance. By 2024, the segment maintained its 36% share of net sales, with Cascade still prominently featured, suggesting stable positioning and consistent contribution to the segment's performance over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Cascade is consistently listed in the **Fabric Care** sub‑category of P&G’s **Fabric & Home Care** segment and appears in the “Major Brands” column of each year’s table (Chunk 1 – 2022, Chunk 2 – 2023, Chunk 3 – 2024).  During this period the segment’s share of total net sales rose from **35 % (2022) to 36 % (2023‑2024)** and its earnings share increased from **31 % to 34 %**, indicating a modest uplift in the segment’s contribution while Cascade’s product categorization remained unchanged.  The knowledge‑graph links (PG → Cascade → Cascade → PG) treat Cascade both as a product and as an organizational brand, reinforcing its stable positioning within the segment across all three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the Fabric & Home Care segment's net sales contribution increased from 35% in 2022 to 36% in 2023 and remained at 36% in 2024, which matches the original answer. The additional detail about earnings share increasing from 31% to 34% is not present in the ground truth but does not contradict it and may reflect extra information from the filings; however, since the question did not ask about earnings, this addition does not detract from accuracy. (2) The product categorization of Cascade within Fabric Care (a sub-category of Fabric & Home Care) is correctly identified and consistent across all years, confirming stable positioning. (3) Multi-hop reasoning is sound: the model synthesizes data across three years and correctly infers that Cascade’s continued presence in the 'Major Brands' list indicates stable strategic importance. (4) The only minor shortcoming is the introduction of earnings share (31% to 34%), which, while likely accurate, is not part of the original answer and could distract if not relevant to the question. However, since it doesn't contradict any facts and adds context without misrepresenting, the impact on correctness is minimal. Overall, the answer fully addresses the question on product categorization and relative contribution with precise, verified data and logical synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 395,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Lowe's evolve its supplier sustainability monitoring and wood sourcing practices from 2022 through 2024, and what specific enhancements were made to its policy framework and investment strategy across those years?",
      "original_answer": "From 2022 to 2024, Lowe's significantly enhanced its supplier sustainability monitoring and wood sourcing practices. In 2022, the company emphasized monitoring supplier practices through policies like the Vendor Code of Conduct and a wood sourcing policy that ensured wood came from well-managed, non-endangered forests, while also investing over $550 million in environmental facility upgrades. By 2023, Lowe's updated its wood sourcing policy with new risk levels by country, enhanced monitoring practices, and introduced a forestry grievance process, while also committing to a $50 million Gable Grants program over five years to support skilled trades education. In 2024, the company further strengthened its sustainability framework by integrating a more robust risk-based approach into its wood sourcing policy and aligning its broader sustainability strategy with long-term shareholder value, continuing to emphasize supplier accountability through its human rights and environmental policies. This shows a consistent and evolving commitment to sustainable sourcing and supplier oversight.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s evolved its supplier‑sustainability monitoring from a basic “Supplier Practices” risk‑factor that it both monitors and discloses (LOW → Supplier Practices ← Discloses ← ORG) into a fully reported system that is verified by CDP, aligned with SASB/GRI/TCFD and supported by more than $550 million of spending in 2022 and an additional $400 million over the next three years on energy‑efficiency, renewable‑energy, pallet‑grinder and building‑management upgrades.  \nIts wood‑sourcing policy moved from a 2022 baseline requiring all wood to come from well‑managed, non‑endangered forests to a 2023‑2024 risk‑based approach that adds country‑level risk ratings, strengthened monitoring, a new forestry grievance process and stricter deforestation‑biodiversity safeguards, all incorporated into the Vendor Code of Conduct and human‑rights policy.  \nThe broader policy framework and investment strategy were also upgraded by setting a 2050 net‑zero goal with interim 2030 targets of a 42 % cut in scope 1‑2 emissions and a 25 % cut in scope 3 emissions (up from 40 %/22.5 % in 2023), maintaining Dow Jones Sustainability Index inclusion for three straight years, and continuing capital deployment to SmartWay transportation efficiency, waste‑diversion and water‑saving projects across its value chain.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Lowe's supplier sustainability and wood sourcing practices from 2022 to 2024 and includes relevant themes such as policy updates, risk-based approaches, grievance mechanisms, and investment in sustainability. However, there are significant quantitative inaccuracies that undermine factual correctness. The ground truth states that Lowe's invested over $550 million in environmental facility upgrades in 2022 and committed $50 million through the Gable Grants program over five years starting in 2023. The LLM incorrectly states '$550 million in 2022 and an additional $400 million over the next three years'—this $400 million figure is not supported by the original answer and contradicts the $50 million grant commitment. Additionally, the LLM introduces specific emissions targets (42% scope 1-2 reduction, 25% scope 3 reduction by 2030), net-zero by 2050, CDP verification, SASB/GRI/TCFD alignment, SmartWay, and Dow Jones Sustainability Index inclusion—none of which appear in the original answer. These additions, while plausible, are factually unsupported in the provided ground truth and represent hallucinated details. On the qualitative side, the model correctly identifies the shift to country-level risk ratings in wood sourcing (2023), the forestry grievance process, integration into the Vendor Code of Conduct, and alignment with human rights policies. It also correctly notes increased stringency in deforestation and biodiversity safeguards. However, the multi-hop synthesis is partially flawed due to the inclusion of unverified metrics and investments. Contextually, the answer is highly relevant and well-structured, addressing all aspects of the question with appropriate framing. While the reasoning flow is logical and the structure improves upon the original with more detail, the overreach in unsupported specifics reduces overall correctness. Semantic equivalence is partially achieved in policy evolution but not in investment or target figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Monitors]-> RISK_FACTOR <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1624,
        "completion_tokens": 541,
        "total_tokens": 2165
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Honeywell's exposure to changes in the competitive landscape evolve across its Safety and Productivity Solutions, Honeywell Building Technologies, and Industrial Automation businesses from 2022 through 2024, and what does this progression indicate about increasing market pressures and product commoditization risks over time?",
      "original_answer": "From 2022 to 2024, Honeywell's disclosures show a growing emphasis on the risk of changes in the competitive landscape across its Safety and Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024) businesses. In 2022, the company noted that changes in the competitive landscape, including new entrants and technology, could lead to product commoditization and lower margins in Safety and Productivity Solutions. In 2023, the risk was reiterated in Honeywell Building Technologies, with a specific mention of new market entrants and new technologies affecting competitive dynamics. By 2024, the risk was expanded to Industrial Automation, where the company again cited new entrants and technological advancements as drivers of commoditization and margin pressure. This 3-year progression indicates that Honeywell faced intensifying and broadening market pressures across multiple divisions, with commoditization risks becoming more systemic rather than isolated.",
      "llm_answer": "\nFrom 2022 through 2024 Honeywell repeatedly identified “changes in the competitive landscape” – including new entrants and technology that can commoditize products – as a material risk, and the scope of that risk expanded each year: Chunk 1 (2022) highlighted it only for Safety & Productivity Solutions, Chunk 3 (2023) added Building Technologies, and Chunk 2 (2024) extended it to Industrial Automation, showing a progressive broadening of exposure across the three businesses.  The KG pattern (ORG → RISK_FACTOR ← ORG) captures that this external competitive pressure is both a risk factor impacting Honeywell and an organizational driver shaped by other market participants, underscoring mounting market pressures and product‑commoditization risk over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies the progression of Honeywell's exposure to competitive landscape risks across the three business segments from 2022 to 2024: Safety & Productivity Solutions (2022), Honeywell Building Technologies (2023), and Industrial Automation (2024). The key drivers—new entrants and technological advancements leading to commoditization and margin pressure—are correctly cited for each year. The dates, entities, and risk factors match the original answer. The only minor issue is the reference to 'Chunk 1', 'Chunk 3', 'Chunk 2' which introduces ambiguous terminology not present in the original and could confuse readers, though it does not undermine the factual accuracy. This does not affect the correctness of the timeline or content. The reasoning is sound, showing a clear multi-hop synthesis across years and business units. The conclusion about broadening market pressures and increasing commoditization risk is logically supported and semantically equivalent to the ground truth. Number formats, years, and entity names are accurate. The answer fully addresses both parts of the question: the evolution of exposure and what it indicates about market pressures.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 352,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Qualcomm's strategic positioning in the digital cockpit market evolve from 2022 to 2024, based on its disclosures regarding automotive transformation, product revenue recognition, and segment reporting?",
      "original_answer": "In 2022, Qualcomm positioned itself as a key enabler of the digital cockpit transformation in automotive, citing analyst projections that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with digital cockpits enabling personalization and over-the-air updates. By 2023, Qualcomm explicitly recognized digital cockpit products as part of its automotive revenue stream, alongside connectivity and ADAS/AD, indicating a transition from strategic vision to monetization. In 2024, Qualcomm formalized its digital cockpit offerings as part of its QCT semiconductor business, grouping them with automotive connectivity and ADAS/AD under a structured segment reporting framework, signaling full integration into its core automotive strategy. This progression shows Qualcomm moving from a forward-looking market opportunity statement in 2022 to structured revenue recognition in 2023 and full operational integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm shifted its automotive focus from merely enabling cellular connectivity and basic infotainment toward powering a full‑stack digital cockpit and ADAS/AD, as reflected in its 2022 disclosures of 5G‑driven cockpit growth and the 19 % Level‑2+ autonomy forecast for 2025, and by 2023‑2024 it began recognizing revenue from automotive products—including connectivity, digital cockpit and ADAS/AD—in its QCT segment, where the CODM evaluates performance on segment EBT and allocates resources accordingly; the KG links (QCOM → Digital Cockpit → Digital Cockpit → QCOM) show that the digital cockpit is both a product and an organizational capability that Qualcomm now depends on and produces, cementing its strategic positioning in the automotive cockpit market.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Qualcomm's strategic positioning in the digital cockpit market from 2022 to 2024, correctly identifying the shift from enabling connectivity to full-stack digital cockpit and ADAS/AD integration. It accurately notes revenue recognition in the QCT segment by 2023–2024 and ties this to segment reporting and resource allocation by the CODM, aligning with the ground truth’s emphasis on monetization and integration. However, it introduces a specific percentage—'19% Level-2+ autonomy forecast for 2025'—that is not present in the original answer and cannot be verified from the provided ground truth, which only references digital cockpit adoption (70% of new vehicles with embedded cellular by 2028). This is a factual overreach. (2) Quantitative accuracy is partially compromised due to the inclusion of the unsupported 19% figure. The original answer only cites 'over 70%' for embedded cellular connectivity by 2028, which the LLM omits and replaces with an unrelated autonomy metric. While the $476M example was not in this question, the principle of numeric fidelity applies—introducing unverified percentages reduces quantitative precision. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes automotive transformation disclosures, revenue recognition practices, and segment reporting under QCT, linking digital cockpit products to operational integration and strategic dependence. The reference to CODM evaluation and resource allocation adds depth consistent with segment reporting formalization in 2024. The KG link mention ('QCOM → Digital Cockpit → ...') appears to reflect internal knowledge graph structure but does not detract from the reasoning. (4) Despite the erroneous 19% figure, the answer conveys the essential progression—vision to monetization to integration—and addresses all key dimensions (automotive transformation, revenue recognition, segment reporting). Wording differs but semantic meaning is largely equivalent. Hence, correctness is high but not perfect due to the unsupported statistic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 563,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Adobe's integration and functional expansion of Frame.io evolve from 2022 to 2024, particularly in terms of supported media types, cross-product integrations, and enterprise capabilities?",
      "original_answer": "In 2022, Frame.io was listed as a trademarked product within Adobe's portfolio, indicating its acquisition and branding alignment. By 2023, Adobe described Frame.io as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting real-time feedback on video, still images, design files, and PDFs. In 2024, Frame.io expanded further with support beyond post-production workflows—now including casting, location scouting, and marketing campaign management—and was integrated with additional Adobe apps such as Photoshop, Lightroom, and Workfront, while also being included in Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nFrom 2022 to 2024 Adobe evolved Frame.io from a newly listed trademark (Chunk 1) into a full‑featured collaboration hub that by 2023 supported still images, design files and PDFs and was tightly integrated with Premiere Pro and After Effects, adding Camera‑to‑Cloud upload capabilities (Chunk 2). By 2024 the platform broadened its media coverage to include casting, location scouting and marketing‑campaign workflows, added direct integrations with Photoshop, Lightroom and Workfront, and became available in Adobe GenStudio alongside Adobe Express and Firefly Services, positioning it as an enterprise‑scale content‑production engine (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io was a trademarked product in 2022, integrated with Premiere Pro and After Effects by 2023, supported video, images, design files, and PDFs, and expanded in 2024 to include casting, location scouting, and marketing campaign management. Integrations with Photoshop, Lightroom, Workfront, and inclusion in Adobe GenStudio are correctly stated. (2) There are no numeric values requiring calculation, but all years (2022, 2023, 2024) are used correctly and consistently. (3) The multi-hop reasoning is sound—information is synthesized across time points and product capabilities. The mention of 'Camera-to-Cloud' and 'Adobe Express and Firefly Services' adds detail not in the original answer; while plausible, these are not confirmed in the ground truth and represent minor over-specification, slightly reducing qualitative accuracy. (4) The answer fully addresses the question’s dimensions: supported media types, cross-product integrations, and enterprise capabilities. Semantic equivalence is strong, with only minor additions beyond the original answer. Thus, correctness is 9/10 due to slight extrapolation, but quantitative accuracy and contextual relevance are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 358,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the dividend and voting rights associated with MA's A Class shares evolve from 2022 through 2024, and what does this 3-year trend indicate about shareholder governance structure stability?",
      "original_answer": "Across the three-year period from 2022 to 2024, MA's A Class shares consistently maintained 'One vote per share' and 'Dividend rights' as disclosed in the annual filings. There were no changes to these rights in any of the years, indicating a stable governance and shareholder rights structure over time.",
      "llm_answer": "\nFrom 2022 through 2024 the filing for MA’s A‑Class shares shows an unchanged structure: each year the shares carry a $0.0001 par value, 3,000 million authorized shares, and the same rights—“one vote per share” together with dividend rights—are listed in the company’s 10‑K filings (2022 p.96, 2023 p.99, 2024 p.92). Because the dividend‑and‑voting rights language is identical across the three years and no new shares have been issued or altered, the pattern reflects a stable shareholder‑governance framework in which the A‑Class equity class retains consistent voting power and dividend entitlement over the entire period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that MA's A Class shares maintained 'one vote per share' and 'dividend rights' from 2022 to 2024, with no changes—this matches the original answer's core claim of stability. (2) The quantitative details—$0.0001 par value, 3,000 million authorized shares, and citation of specific 10-K pages (2022 p.96, 2023 p.99, 2024 p.92)—are factually consistent with typical SEC disclosures and do not contradict the ground truth; while the original answer does not include these specifics, their inclusion adds detail without introducing error. (3) The reasoning is sound: the model correctly synthesizes information across three years of filings and draws a valid conclusion about governance stability based on unchanged rights. (4) The answer is semantically equivalent to the ground truth, with slightly more detail but no factual deviation. The only reason for not scoring a 10 is that the original answer emphasizes the *absence of change* as the key indicator, while the LLM adds granular details not present in the ground truth (e.g., par value, authorized shares), which, while likely correct, are not confirmed by the knowledge graph and slightly shift focus. However, these do not impair accuracy. All multi-hop elements (tracking rights over time, cross-year comparison, governance inference) are handled correctly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 389,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Honeywell's exposure to fluctuations in retail markets impact its Safety and Productivity Solutions segment across fiscal years 2022, 2023, and 2024, and what does this reveal about the segment's vulnerability to consumer demand volatility over time?",
      "original_answer": "Honeywell consistently highlighted that its Safety and Productivity Solutions segment (in 2022) and its Industrial Automation segment (in 2024, previously named in 2023 as Safety and Productivity Solutions) were adversely impacted by fluctuations in retail markets across all three years. In 2022, the segment noted that retail market fluctuations could lead to reduced investments in process automation and safety monitoring, lower demand for safety products, and downward pressure on margins. In 2023, similar language was used, emphasizing the impact of retail volatility on demand for safety products and the risk of commoditization. By 2024, the restructured Industrial Automation segment retained this risk, indicating that despite organizational changes, the business remained sensitive to retail market instability. This consistent risk disclosure suggests that the segment has not significantly mitigated its exposure to retail demand swings over the three-year period.",
      "llm_answer": "\nHoneywell’s Safety and Productivity Solutions segment has faced a consistent, year‑over‑year exposure to retail‑market volatility: the 2022 filing (Chunk 1) warns that “fluctuations in retail markets” can depress investments, slow safety‑product demand and erode margins; the 2023 filing (Chunk 3) repeats the identical language, noting that such fluctuations “may adversely impact operating results” through reduced automation spend and lower market share; and the 2024 filing (Chunk 2) again flags “fluctuations in retail markets” under the Industrial‑Automation risk as a driver of slower demand and pricing pressure.  The knowledge‑graph triplets (HON → Fluctuations in Retail Markets ← ORG) map this risk directly onto Honeywell, confirming that the segment’s performance is tightly coupled to consumer‑demand swings and thus remains vulnerable to the same volatility across FY 2022, 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Honeywell's Safety and Productivity Solutions segment (renamed Industrial Automation in 2024) was consistently exposed to retail market fluctuations in 2022, 2023, and 2024. The impacts—reduced investments in automation, lower demand for safety products, margin pressure, and risk of commoditization—are accurately reflected, with only minor rewording (e.g., 'pricing pressure' instead of 'downward pressure on margins'). (2) There are no numeric values or calculations in the question or answer, so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2023, 2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound: the LLM correctly tracks the segment through its name change from Safety and Productivity Solutions to Industrial Automation, maintaining continuity of risk exposure across filings. It synthesizes information across three years and recognizes the persistence of the same risk despite organizational restructuring. (4) The only minor shortcoming is that the LLM does not explicitly mention 'commoditization' in the 2023 context, which was present in the original answer, and slightly simplifies the 2023 impact by referencing 'market share' instead of 'commoditization'—a subtle but relevant distinction in risk characterization. Otherwise, the answer is semantically equivalent, contextually precise, and fully addresses the question’s multi-part nature regarding impact and vulnerability over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 432,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the financial obligations and royalty structure between LLY and Incyte for Olumiant evolve from 2022 to 2024, particularly in terms of milestone payments, royalty rates, and the inclusion of new indications like COVID-19?",
      "original_answer": "From 2022 to 2024, LLY's financial relationship with Incyte around Olumiant evolved significantly. In 2022, Incyte was eligible to receive up to $100 million in additional regulatory milestones and $100 million in sales-based milestones, and royalty rates on worldwide net sales ranged up to 20%, with an additional low teens royalty for COVID-19 sales above a threshold. By 2023, milestone payments related to regulatory approvals and sales achievements were capitalized as intangible assets and amortized into cost of sales. In 2024, the agreement remained in place with the same royalty structure, but the focus shifted to ongoing royalty payments rather than new milestones, indicating that most contingent payments had likely been triggered or expired. This evolution reflects a shift from milestone-driven obligations to a more stable royalty-based payment model over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the LLY‑Incyte Olumiant partnership kept the same tiered, double‑digit royalty base (up to 20 % of worldwide net sales) but added a supplemental low‑teens royalty on COVID‑19 sales once a specified sales threshold was exceeded—a provision that was introduced in the 2020 amendment and remained in force in the 2023‑2024 filings.  Milestone obligations also stayed material: LLY had capitalized $260 million (2021) and $210 million (2020) of regulatory‑ and sales‑based milestones as intangible assets and amortized them into cost of sales, and it continued to be liable for up to $100 million of additional regulatory milestones and $100 million of sales‑based milestones, with the royalty payments to Incyte recorded as cost of sales in each year’s net‑product‑revenue tables.  Thus, while the royalty rate structure was unchanged, the 2020‑2024 evolution added a COVID‑19‑specific royalty tier and kept the milestone‑payment framework—including the amortization of previously capitalized milestones—active across the three reporting periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some key elements of the evolving financial relationship between LLY and Incyte for Olumiant but contains significant factual inaccuracies, particularly in the quantitative details and timeline. (1) Correct aspects: The answer correctly identifies the up to 20% royalty rate on worldwide net sales and the supplemental low-teens royalty on COVID-19 sales above a threshold, which remained consistent from 2022 to 2024. It also correctly notes that royalty payments were recorded as cost of sales and that milestone payments were capitalized and amortized. (2) Quantitative inaccuracies: The LLM incorrectly states that LLY capitalized $260 million in 2021 and $210 million in 2020 as milestones, which are not mentioned in the ground truth and contradict the 2022–2024 focus. The ground truth specifies that in 2022, Incyte was *eligible* for up to $100 million in additional regulatory and $100 million in sales-based milestones (i.e., potential future payments), not that large amounts were capitalized in prior years. The LLM misrepresents the timing and nature of these payments by implying ongoing liability for milestones in 2023–2024, whereas the ground truth states that by 2023, milestone payments were being amortized (indicating past capitalization), and by 2024, the focus had shifted to royalties, suggesting most milestones had been triggered or expired. (3) Reasoning and synthesis: The LLM fails to accurately reflect the evolution over time—specifically the shift from milestone-driven obligations to a stable royalty model. Instead, it suggests the milestone framework remained fully active through 2024, which contradicts the ground truth. (4) Contextual relevance is high, as the answer addresses all components of the question (milestones, royalties, new indications) and uses appropriate financial terminology. However, due to the incorrect use of historical milestone capitalizations and misrepresentation of the timeline and evolution, the overall correctness is significantly reduced. The answer is partially correct but contains major factual and inferential errors in the quantitative and temporal dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Partners_With]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 576,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did Procter & Gamble's strategic positioning of the Always brand within its Baby, Feminine & Family Care segment evolve from 2022 to 2024, particularly in relation to product categorization and its prominence compared to other brands in the segment?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care (Adult Incontinence, Feminine Care)' within the Baby, Feminine & Family Care segment, appearing alongside brands like Always Discreet, Tampax, Bounty, Charmin, and Puffs. By 2023, the product categorization shifted slightly to 'Feminine Care (Adult Incontinence, Menstrual Care)', and Always was more specifically associated with menstrual care, reflecting a more targeted positioning. In 2024, the categorization remained consistent with 2023, but Always continued to be listed as a major brand alongside Always Discreet and Tampax, maintaining its prominence within the segment. This evolution suggests a strategic sharpening of Always’ positioning around menstrual care while retaining its core role in the Feminine Care category.",
      "llm_answer": "\nFrom 2022 through 2024 P&G kept **Always** in the **Feminine Care** sub‑category of its **Baby, Feminine & Family Care** segment, but the way the brand was presented evolved: in the 2022 table it appeared alongside other brands (Luvs, Pampers Always, Always Discreet, Tampax Bounty, Charmin, Puffs), whereas the 2023 and 2024 tables list **Always** (and Always Discreet) as a primary “Major Brands” entry under the renamed “Feminine Care (Adult Incontinence, Menstrual Care)” category, signalling a strategic shift to treat the Always line as a core growth driver.  This focus is reinforced by the segment’s financial profile—sales share fell slightly from 25 % (2022) to 24 % (2023‑24) while earnings rose from 23 % to 25 %—indicating that Always and its sister brands are being leveraged for higher‑margin profitability relative to the broader segment.  The knowledge‑graph triplets (PG → Always (Produces) → Always (Org) and Always (Org) → PG) further illustrate that P&G treats the Always brand both as a product and as an organizational entity, underscoring its elevated strategic prominence.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Always' strategic positioning within Procter & Gamble's Baby, Feminine & Family Care segment from 2022 to 2024, noting the rebranding of the category to 'Feminine Care (Adult Incontinence, Menstrual Care)' and the increased prominence of Always as a major brand. However, there are significant factual inaccuracies that reduce correctness. First, the LLM incorrectly lists 'Luvs, Pampers Always, Tampax Bounty' as brands in the 2022 lineup—this is wrong; Luvs and Pampers are baby care brands and were not listed alongside Always in the same subcategory grouping in the source data. The original answer correctly identifies the 2022 grouping as Always, Always Discreet, Tampax, Bounty, Charmin, and Puffs. Second, the LLM introduces financial data—sales share falling from 25% to 24% and earnings rising from 23% to 25%—that is not present in the original answer or ground truth knowledge graph. There is no mention of segment sales or earnings shares in the ground truth, making these figures fabricated or hallucinated. This severely undermines quantitative accuracy. While the qualitative insight about strategic sharpening around menstrual care and organizational elevation of Always is reasonable and aligns with the ground truth's interpretation, the use of unsupported financial metrics and incorrect brand groupings constitutes major errors. The reasoning is partially sound in interpreting categorization changes, but the synthesis includes non-existent data. Contextually, the answer is highly relevant and addresses product categorization, brand prominence, and strategic implications. Overall, the core directional insight is correct, but the inclusion of false quantitative claims and misstated brand lists prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 484,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did ACN's target asset allocation strategy for defined benefit pension plans evolve across fiscal years 2023 (target for fiscal 2023 stated in 2022 filing), 2024 (target as of August 31, 2023 in 2023 filing), and 2025 (target allocation stated in both 2023 and 2024 filings), and what does this multi-year progression reveal about the company's approach to balancing risk-adjusted returns with liability duration matching?",
      "original_answer": "ACN's target asset allocation strategy for defined benefit pension plans showed a consistent framework across the three years, with a focus on risk-adjusted returns aligned with long-term investment strategies. In the 2022 filing, the target allocation for fiscal 2023 emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching the duration of individual plan liabilities to minimize asset volatility. The 2023 filing updated this with the weighted-average plan assets allocation as of August 31, 2023, while introducing the projected target allocation for fiscal 2025, which maintained the same structure but allowed flexibility based on market conditions and cash flow needs. The 2024 filing reaffirmed the fiscal 2025 target allocation, indicating strategic continuity. This evolution reveals that ACN maintained a stable investment framework, prioritizing liability duration matching and diversification, while allowing tactical flexibility in asset allocation decisions to respond to market dynamics.",
      "llm_answer": "\nAcross the three filings ACN’s disclosed target asset allocation moved from the fiscal‑2023 baseline (as set out in the 2022 filing) to a revised fiscal‑2024 mix (as of August 31 2023 in the 2023 filing) and then to the fiscal‑2025 target (first presented in the 2023 filing and reiterated in the 2024 filing), showing a progressive shift toward a higher‑duration, more equity‑weighted portfolio. This multi‑year progression, together with the repeated emphasis on achieving risk‑adjusted returns that align with each plan’s overall investment strategy and on matching the duration of debt securities to plan liabilities, reveals ACN’s systematic effort to balance return objectives with liability‑duration matching while retaining flexibility through range‑based allocations.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant inaccuracies in both quantitative and qualitative aspects, despite addressing the general context of ACN's pension asset allocation strategy. (1) The LLM incorrectly states that there was a 'progressive shift toward a higher-duration, more equity-weighted portfolio' across fiscal years 2023–2025. The ground truth indicates no such directional shift—instead, the strategy remained consistent with a stable framework emphasizing duration matching and diversification, with only tactical flexibility allowed. There is no evidence in the original answer of an increasing equity weighting or higher duration focus over time. (2) The LLM misrepresents the evolution: it claims a 'revised fiscal-2024 mix as of August 31, 2023' was disclosed, but the original answer clarifies that the 2023 filing introduced the *projected* target for fiscal 2025, not a revised 2024 allocation. The mention of 'weighted-average plan assets allocation as of August 31, 2023' in the ground truth is descriptive, not indicative of a strategic shift. (3) The multi-hop reasoning is flawed: the model infers a trend (increasing equity, higher duration) not supported by the source, failing to correctly synthesize the continuity emphasized in both 2023 and 2024 filings. (4) While the LLM correctly identifies the themes of risk-adjusted returns and liability-duration matching, and references the correct filings and timeframes (e.g., August 31, 2023; fiscal 2025 target in 2023 and 2024 filings), the core conclusion about strategic evolution is factually incorrect. This undermines the qualitative accuracy. (5) No specific percentages or dollar amounts were cited in either answer, so quantitative accuracy is not fully penalizable, but the directional claim (more equity, higher duration) introduces false precision. Overall, the answer is partially relevant and captures some correct context, but the central claim misrepresents the strategy’s evolution, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 537,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Lowe's exposure to forward interest rate swaps evolve from 2022 through 2024, and what does the change in their fair value classification and hedge accounting treatment reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, Lowe's referenced forward interest rate swaps in the context of cash flow hedges, with disclosures indicating that both matured and outstanding swaps impacted other comprehensive income and earnings for prior years (2021, 2020, 2019), though no current fair value was listed for 2022 itself. In 2023, the fair value of forward interest rate swaps was explicitly disclosed as $251 million, classified under 'Other current assets' and marked as Level 2 in fair value hierarchy, showing active hedging activity. By 2024, the company no longer held forward interest rate swaps, instead holding fixed-to-floating interest rate swaps as fair value hedges on certain debt, indicating a strategic shift from cash flow hedges to fair value hedges. This evolution suggests Lowe's transitioned from managing forecasted debt issuance risk to managing existing debt exposure, reflecting a more stable capital structure and reduced sensitivity to future interest rate volatility.",
      "llm_answer": "\nFrom 2022 through 2024 Lowe’s forward‑interest‑rate‑swap program was initially disclosed in 2022 as cash‑flow hedges that were recorded in other‑comprehensive income and amortized into earnings — a pattern confirmed in the 2024 filing where the company still classifies its forward swaps that hedge forecasted debt issuances as cash‑flow hedges and continues to amortize effective gains/losses to interest expense.  The 2023 fair‑value table shows the swaps’ fair value at **$251 million** (classified as a Level‑2 “Other current asset”), but by the end of 2024 that balance had fallen to zero (or was no longer reported), indicating that the swaps either matured or were unwound, while the company’s fixed‑to‑floating swaps on existing debt had already been re‑classified as fair‑value hedges (as noted for Jan 31 2025/Feb 2 2024).  This evolution—shifting from a sizable OCI‑recorded derivative position to a near‑zero balance and supplementing it with fair‑value hedges on existing debt—reveals a proactive, layered interest‑rate‑risk strategy that moves exposure from cash‑flow hedging of future issuances to direct hedging of existing liabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor contradiction in reasoning that affects qualitative accuracy. (1) Quantitatively, all key numbers and dates are accurate: the $251 million fair value in 2023 is correctly cited, and the absence of forward swaps by 2024 is properly noted. The classification as Level 2 and 'Other current assets' is accurate. (2) The answer correctly identifies the shift from forward interest rate swaps (cash flow hedges) to fixed-to-floating swaps (fair value hedges), and notes the strategic implication of moving from hedging forecasted issuances to managing existing debt. (3) However, there is a subtle but important inconsistency: the LLM states that in 2024, the company 'still classifies its forward swaps...as cash-flow hedges', which contradicts the ground truth that by 2024, Lowe's no longer held forward interest rate swaps at all. This creates a misleading impression that forward swaps still exist in 2024, even as their balance drops to zero. The correct interpretation is that the program was wound down, not that it continued with zero value. (4) Despite this, the overall reasoning about the strategic shift is sound and contextually relevant, and the synthesis across 2022–2024 is mostly accurate. The answer captures the core evolution and risk management implications, warranting a high score, but not full marks due to the entity/timing inaccuracy regarding the continuation of forward swaps in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 411,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did AVGO's financial exposure to the 5.000% notes due April 2030 evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's debt management strategy?",
      "original_answer": "AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in both 2023 and 2024, indicating a deliberate reduction in this specific debt obligation over the three-year period. This consistent decline suggests an active debt repayment or restructuring strategy focused on managing long-term liabilities.",
      "llm_answer": "\nAVGO’s 5.000 % notes due April 2030 remained flat at **$606 million** of outstanding principal in FY 2022 (Chunk 1), FY 2023 (Chunk 3) and FY 2024 (Chunk 2), with the same 5.18 % effective interest rate throughout.  During that same period the company’s total principal amount outstanding expanded dramatically—from **$40.8 bn** (reported in FY 2023, Chunk 3) to **$69.8 bn** (reported in FY 2024, Chunk 2)—so the 5.000 % tranche constitutes only a small, steady slice of AVGO’s long‑term debt.  This pattern shows that AVGO’s debt‑management strategy focuses on preserving a modest, fixed‑rate legacy issuance while aggressively growing overall leverage through newer senior notes (e.g., VMware and CA senior issues).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in its core quantitative claim. The original answer states that AVGO's exposure to the 5.000% notes due April 2030 decreased from $1,086 million in 2022 to $606 million in 2023 and 2024, indicating a reduction. However, the LLM claims the amount was flat at $606 million across all three years (2022–2024), which directly contradicts the ground truth. This error invalidates the entire analysis of debt strategy. (2) The LLM incorrectly reports the FY2022 value as $606M, when it should be $1,086M. The $606M figure is correct for 2023 and 2024. Additionally, the LLM introduces unrelated data about total debt increasing from $40.8B to $69.8B, which may be factually correct in context but is not in the ground truth and distracts from the specific debt tranche in question. The interest rate of 5.18% is not mentioned in the original answer and cannot be verified against it. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize the temporal change in the specific debt instrument. Instead of identifying a deliberate reduction in this note series, it concludes the amount is stable and interprets this as part of a broader strategy involving new debt—reasoning based on a false premise. While the model attempts to contextualize the debt within a larger capital structure, the foundational error undermines the logic. (4) The contextual relevance is moderate because the answer addresses AVGO’s debt management and discusses the specific note, but the factual inaccuracies—especially the incorrect principal amounts for 2022—severely limit usefulness. The qualitative reasoning would be stronger if based on correct data, but as stands, it misrepresents the company's actions. Correctness and quantitative accuracy are low due to the critical number mismatch.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 501,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly regarding interest rates, redemption terms, and maturity structure?",
      "original_answer": "From 2022 to 2024, UPS's 7.620% debentures remained consistent in principal amount ($276 million) and maturity date (April 1, 2030). However, the disclosures evolved in terms of clarity and emphasis on redemption terms. In 2022, UPS clarified that the interest rate had been reduced from 8.375% to 7.620% in April 2020 for the remaining term, while in 2023 and 2024, the interest rate was consistently reported as 7.620%, with no further changes. The redemption terms were consistent across all three years, with the debentures being callable at any time at UPS's option, with the redemption price based on either principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2024, the disclosure placed more emphasis on the semi-annual interest payment schedule and confirmed that the debentures are not subject to sinking fund requirements. This consistency in structure and increasing clarity in disclosure suggests a stable long-term debt instrument with well-defined terms.",
      "llm_answer": "\nFrom 2022 through 2024 UPS’s disclosure of the $276 million 7.620% debentures showed a clear evolution: the 2022 filing noted that the securities were issued at an 8.375% coupon that was reset to 7.620% on April 1 2020 and that they mature on April 1 2030, are callable at any time, and can be redeemed at the greater of principal + accrued interest or the present‑value of remaining payments discounted at a Treasury yield + 5 bps (with no sinking‑fund requirement); the 2023 filing simply listed the debentures (reported as $280 million) with the same 2030 maturity and redemption mechanics but did not restate the coupon; and the 2024 filing expanded the disclosure by reiterating the semi‑annual interest payments, restating the optional redemption formula, confirming the 2030 maturity and the absence of a sinking‑fund, thereby completing the picture of how the interest rate, redemption terms, and maturity structure have been treated over the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative discrepancy: it reports the debenture amount as $280 million in the 2023 filing, whereas the ground truth consistently states $276 million across all years. This is a factual error, though minor in magnitude. All other numbers—interest rate (7.620%), maturity date (April 1, 2030), prior rate (8.375%), reset date (April 1, 2020), and redemption terms (greater of principal plus accrued interest or present value discounted at Treasury yield + 5 bps)—are accurately reported. (2) The semi-annual interest payments and absence of sinking fund requirements are correctly noted in the 2024 disclosure, aligning with the ground truth’s emphasis on increased clarity over time. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of disclosures, identifying evolution in presentation—2022 providing historical context, 2023 offering a streamlined reference, and 2024 enhancing clarity—while recognizing that the underlying terms remained stable. (4) The answer addresses all components of the question: interest rates, redemption terms, and maturity structure over time. The qualitative assessment is strong, capturing the trend toward more complete and consistent disclosure. The $4 million discrepancy in principal amount prevents a higher quantitative score, but otherwise the response is factually rich and contextually accurate. Hence, correctness is rated 8 for minor factual inaccuracy, quantitative accuracy 7 due to the dollar amount error, qualitative accuracy 9 for strong reasoning and synthesis, and contextual relevance 10 as all aspects of the question are directly addressed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Pays_Interest_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 468,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did Amgen's development and strategic positioning of Olpasiran evolve from 2022 through 2024, particularly in terms of its therapeutic focus, clinical phase progression, and intellectual property protection timeline?",
      "original_answer": "In 2022, Olpasiran was described as an siRNA in phase 2 development aimed at lowering lipoprotein(a) for the treatment of atherosclerotic cardiovascular disease. By 2023, Amgen disclosed that Olpasiran had compound-related patents in both the U.S. and Europe, both expiring in 2036, signaling long-term IP protection. In 2024, Olpasiran was listed with a broader therapeutic indication simply as 'cardiovascular disease,' suggesting a potential expansion of its clinical application or regulatory strategy. This progression reflects Amgen's movement of Olpasiran from mid-stage development toward a more defined commercial and intellectual property strategy in cardiovascular care.",
      "llm_answer": "\nAmgen continued to advance **Olpasiran** as a therapeutic siRNA aimed at lowering lipoprotein(a) for **atherosclerotic cardiovascular disease**, keeping the program in **phase 2** throughout 2022‑2024 (as noted in the 2022 filing and reiterated in the 2024 product‑focus table).  The company’s strategic positioning therefore remained centered on cardiovascular risk reduction, while its **intellectual‑property estate**—covering the compound in both the United States and Europe—was secured through **2036**, ensuring market exclusivity well beyond the 2024 horizon.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but misses a key qualitative evolution in Olpasiran's therapeutic indication from 'atherosclerotic cardiovascular disease' in 2022 to a broader 'cardiovascular disease' in 2024. This shift, noted in the original answer, suggests a strategic expansion in clinical or regulatory positioning, which the LLM fails to mention. All quantitative elements are accurate: the drug remains in phase 2 from 2022–2024, and IP protection in the U.S. and Europe expires in 2036, correctly reported. Entity accuracy is strong—Amgen, Olpasiran, siRNA, lipoprotein(a), and correct timeframes are all properly identified. The reasoning is sound in linking continued development with IP protection as part of strategic positioning, but the multi-hop synthesis is incomplete because it does not connect the broadening of the therapeutic indication as part of Amgen’s evolving strategy. Wording differences are acceptable under semantic equivalence, but the omission of the indication expansion constitutes a meaningful gap in completeness, particularly for a question focused on strategic positioning evolution. Thus, while factually accurate and contextually relevant, the answer lacks full qualitative depth on strategic evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 357,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the positioning of Tampax within P&G's Feminine Care segment evolve from 2022 to 2024, particularly in terms of its categorization and prominence among major brands?",
      "original_answer": "In 2022, Tampax was listed under the 'Baby, Feminine & Family Care' segment as part of 'Feminine Care (Adult Incontinence, Feminine Care)', and was included among major brands like Always and Bounty. In 2023, P&G reclassified its feminine care offerings under 'Feminine Care (Adult Incontinence, Menstrual Care)', with Tampax still prominently listed among key brands. By 2024, the categorization remained consistent with 2023, but the segment name slightly changed to 'Baby, Feminine & Family Care' again, maintaining Tampax as a highlighted brand. This evolution shows a consistent strategic emphasis on Tampax within the Feminine Care category, with minor refinements in sub-category labeling over time.",
      "llm_answer": "\nFrom 2022 through 2024 Tampax remained classified under the **Feminine Care** sub‑category of P&G’s **Baby, Feminine & Family Care** segment, and in every year it was listed as a core brand—specifically “Tampax Bounty”—alongside Always, Always Discreet, Charmin and Puffs.  The segment’s financial weight grew slightly: its share of net sales stayed around 24‑25 % while its share of segment earnings rose from **23 % (2022)** to **25 % (2023‑2024)**, indicating that Tampax’s contribution became a marginally more prominent driver of profitability within the Feminine Care category, even though its categorization did not change.  The knowledge‑graph triplets (PG → Tampax, Tampax → Tampax, Tampax → PG) reflect that Tampax is treated both as a product and as an organizational brand within P&G’s portfolio, underscoring its sustained positioning and rising prominence over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that Tampax was listed as 'Tampax Bounty' is incorrect—Bounty is a separate brand under household care, and no such combined brand exists; this is a major entity error. (2) The quantitative claims about segment earnings (23% in 2022 rising to 25% in 2023–2024) and net sales (24–25%) are not supported by the original answer, which does not mention any financial metrics or profitability trends—these numbers are fabricated or hallucinated. (3) While the LLM correctly identifies Tampax as consistently part of the 'Baby, Feminine & Family Care' segment and associated with Feminine Care, it misrepresents the evolution: the original answer notes a reclassification in 2023 to 'Feminine Care (Adult Incontinence, Menstrual Care)', which the LLM omits entirely. (4) The LLM incorrectly states that categorization 'did not change' when in fact the original highlights a shift in sub-category labeling from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Menstrual Care' in 2023, then a segment name reversion in 2024—this evolution is central to the question and is missed. (5) The reasoning about rising prominence due to profitability is unsupported and introduces data not present in the ground truth, leading to an incorrect conclusion. (6) The mention of 'knowledge-graph triplets' appears fabricated and irrelevant. Despite these issues, the answer correctly maintains Tampax’s presence as a key brand throughout and identifies the broader segment correctly, preserving some contextual relevance. However, due to major quantitative and qualitative errors, the overall correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 461,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did MetLife's reliance on internally developed designations for non-agency RMBS and CMBS evolve from 2022 through 2024, and what does this multi-year trend indicate about the availability of NAIC designations and MetLife's acquisition strategy in this asset class?",
      "original_answer": "MetLife's use of internally developed designations for non-agency RMBS and CMBS remained a consistent practice across 2022 to 2024, reflecting ongoing acquisition activity in newly issued or less frequently evaluated securities. In 2022, MetLife noted that internally developed designations were applied when acquiring non-agency RMBS and CMBS that had not yet been evaluated by the NAIC. This practice continued in 2023 and 2024, indicating that MetLife continued to acquire such securities, and NAIC designations were not immediately available for all new holdings. The persistence of this policy across three years suggests a sustained strategy of investing in complex structured securities, where NAIC evaluations lag behind acquisition timelines, requiring internal credit assessments in the interim.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife kept assigning internally developed designations to non‑agency RMBS and CMBS that had not yet been evaluated by the NAIC, switching to an official NAIC designation only after the NAIC’s annual review assigned one.  The NAIC’s 2020‑2021 reforms—creating 20 more granular designation categories and new RBC factors (effective Dec 31 2020 and Dec 31 2021)—made NAIC designations more widely available, so the proportion of securities with official designations grew and the need for internal designations receded, though they were still used for newly acquired assets.  This multi‑year trend reflects both the improving availability of NAIC designations and MetLife’s acquisition strategy of buying non‑agency RMBS/CMBS before they receive an NAIC rating, requiring temporary internal designations until the NAIC can assess them.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. (1) Correct elements: It accurately states that MetLife used internally developed designations for non-agency RMBS and CMBS from 2022–2024 when NAIC evaluations were not yet available, and that internal designations were temporary until NAIC assigned official ones. This aligns with the ground truth’s core point about ongoing acquisition of newly issued securities. (2) Quantitative/chronological inaccuracies: The LLM incorrectly references NAIC reforms from 2020–2021 as context, stating they led to 'more widely available' NAIC designations and a 'receding' need for internal designations. However, the ground truth does not mention any reduction in reliance on internal designations or increased availability due to past reforms. In fact, the persistence of internal designations across 2022–2024 is presented in the original answer as a continued necessity, not a diminishing practice. This misrepresents the trend. (3) Multi-hop reasoning: The model attempts synthesis but introduces unsupported claims about the NAIC reform impact and a declining use of internal designations, which are not in the ground truth. There is no evidence in the original answer that the proportion of NAIC-designated securities increased or that internal designations became less necessary. (4) Contextual relevance is high because the answer addresses the evolution of designation use and links it to acquisition strategy, but the conclusion about improving NAIC availability and reduced reliance on internal models is speculative and factually misaligned. Thus, while some factual elements are correct, the overall trend interpretation is flawed, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 471,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Accenture's share repurchase activity and available authorization for its open-market share purchase program evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "Accenture's share repurchase program activity and available authorization show a clear upward trajectory over the three-year period. In fiscal 2022, the company had $3.13 billion in aggregate available authorization for share purchases. By fiscal 2023, this figure had increased, and during the fourth quarter of fiscal 2024, the company purchased 2,000,308 Class A ordinary shares for $605 million under the program. As of August 31, 2024, the available authorization stood at $2.69 billion, but this was subsequently increased by an additional $4 billion on September 25, 2024, bringing total outstanding authority to $6.69 billion. This indicates a consistent and growing commitment to returning capital to shareholders through share repurchases.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s open‑market share‑purchase authorization fell from **$3.13 billion (available as of Aug 31 2022)** – the amount reported in the 2022 filing – to **$2.69 billion (available as of Aug 31 2024)**, a reduction that reflects the **$605 million spent in Q4 FY2024** to buy 2,000,308 Class A shares under the publicly announced program (chunks 1 & 2).  At the same time, the Board has **continuously expanded the program’s size**: since 2001 it has authorized an aggregate **$50.1 billion**, and on **September 25 2024 it added $4 billion**, bringing the **total cumulative authority to $6.69 billion** while still leaving $2.69 billion of availability (chunks 1 & 2).  Purchases made for employee‑tax withholding do **not** affect the available authorization (chunks 1 & 2), and the open‑market program **has no expiration date** (chunks 1 & 2).  \n\n**What this trend indicates:** Accenture is pursuing an aggressive and growing capital‑return strategy, using a sizable, ever‑expanding share‑repurchase program to deploy cash to shareholders while maintaining ample future flexibility; the steady increase in authorized capacity underscores confidence in its cash‑generation and a commitment to returning excess capital on an ongoing basis.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key trends in Accenture's share repurchase activity and capital return strategy, with only a minor misstatement affecting quantitative accuracy. (1) Correct elements: The available authorization of $3.13 billion as of fiscal 2022 (Aug 31, 2022) is accurate. The $605 million spent in Q4 FY2024 to purchase 2,000,308 shares is correctly reported. The $4 billion increase on September 25, 2024, and the resulting total outstanding authority of $6.69 billion are correct. The distinction between open-market repurchases and employee-tax withholding is properly noted, as is the absence of an expiration date. (2) Quantitative issue: The LLM incorrectly frames the reduction from $3.13B to $2.69B as a net decline over the period, which is misleading. The ground truth clarifies that the authorization increased over time — the $2.69B as of Aug 31, 2024, is not a reduction in total program size but the remaining balance after repurchases and prior authorizations. The $3.13B in 2022 was the then-available amount, but the program has been replenished multiple times since, culminating in the $4B addition. Thus, the trend is upward in total authorization, not downward. This misrepresents the evolution slightly, though the final total authority is correctly stated. (3) Reasoning and synthesis: The LLM correctly infers that the repeated board authorizations and large cumulative commitments reflect a growing capital return strategy. It synthesizes information across fiscal years and correctly interprets the significance of the $4B boost. The conclusion about confidence in cash flow and ongoing commitment is logically sound and semantically equivalent to the ground truth. (4) Contextual relevance is excellent — all parts of the question are addressed, including the evolution over time and strategic implications. The answer includes helpful context (e.g., no expiration, employee withholding exclusion) that enhances understanding. The minor error in framing the trend as a decline rather than a net increase prevents a top score, but core facts and strategic interpretation are solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 572,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Broadcom's (AVGO) industrial fiber optics product positioning evolve across 2022, 2023, and 2024, and what does this reveal about the company's strategic emphasis in the industrial end market?",
      "original_answer": "In 2022, Broadcom's industrial fiber optics were described as part of a broad portfolio including optocouplers, motion encoders, LED devices, and Ethernet ICs, targeting applications like industrial automation, medical systems, and electric vehicle subsystems. By 2023, the product was listed in a structured table of key offerings under the Industrial end market, grouped with sensors, encoders, LEDs, and Ethernet components, indicating a more standardized categorization. In 2024, industrial fiber optics remained a consistent offering under the Industrial segment, now explicitly linked with applications in factory automation, renewable energy, and automotive electronics, and listed alongside more specific components like Ethernet PHYs and camera microcontrollers. This evolution shows a consistent presence in fiber optics for industrial use, with increasing alignment to strategic industrial applications over time, suggesting a maturing and application-focused product strategy.",
      "llm_answer": "\nAcross 2022‑2024 Broadcom repeatedly placed industrial fiber‑optic components in its industrial end‑market segment, listing them alongside optocouplers, motion‑control encoders, LEDs and Ethernet PHYs/switch ICs in the 2022 “Industrial End Markets” table (Chunk 1) and in the 2023 and 2024 market‑mapping tables (Chunks 2 & 3).  The knowledge‑graph relationship that Industrial Fiber Optics (product) → Industrial Fiber Optics (org) → AVGO (org) links the product directly back to the company, underscoring that Broadcom is deliberately positioning industrial fiber optics as a core, high‑performance connectivity pillar for automation, renewable‑energy, automotive and medical applications within its industrial end‑market strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies that Broadcom (AVGO) consistently positioned industrial fiber optics within its Industrial end-market segment across 2022–2024, and correctly notes the co-location of fiber optics with optocouplers, motion encoders, LEDs, and Ethernet ICs (referred to as Ethernet PHYs/switch ICs in the answer). The mention of key applications—automation, renewable energy, automotive, and medical—matches the original answer’s emphasis on factory automation, renewable energy, automotive electronics, and medical systems. However, the LLM answer does not clearly trace the *evolution* of product positioning year-by-year as required by the question. While it notes the presence of fiber optics in tables across years, it misses the nuance that in 2022 the product was described as part of a broad portfolio, in 2023 it was more formally categorized in a structured table, and in 2024 it was explicitly linked to specific applications and components—indicating increasing strategic alignment. This evolution is central to the question and only implied, not explicitly analyzed, in the LLM response. There are no numerical inaccuracies (quantitative accuracy is perfect as no calculations are involved), and entity identification (AVGO, industrial fiber optics, correct years) is accurate. The reasoning is sound but lacks depth in showing multi-hop synthesis across the three years’ documents to demonstrate strategic progression. Contextual relevance is high as the answer stays focused on Broadcom’s industrial strategy and product positioning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 443,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the role and delivery model of UPS SurePost evolve from 2022 through 2024, particularly in terms of its reliance on the U.S. Postal Service and any strategic changes implemented by UPS?",
      "original_answer": "From 2022 to 2024, UPS SurePost consistently served as a residential ground service for non-urgent, lightweight shipments, with final delivery frequently handled by the U.S. Postal Service. In 2022 and 2023, this arrangement remained unchanged, emphasizing the reliability of the UPS ground network while leveraging USPS for the last mile. However, in 2024, UPS announced a strategic shift to insource the final delivery for UPS SurePost, effective January 1, 2025, aiming to enhance control over service quality and customer experience. This marks a transformation from reliance on a third-party (USPS) to a more integrated and controlled delivery model.",
      "llm_answer": "\nFrom 2022 through 2024, UPS SurePost was positioned as a residential‑ground service that used the UPS ground network but still depended on the U.S. Postal Service for the final‑mile delivery of non‑urgent, lightweight shipments – a fact noted in all three filings (chunks 1‑3).  Beginning in 2024 the company announced that, effective January 1 2025, it would insource that final‑delivery function to reduce reliance on USPS and gain greater control over service quality, a move that aligns with its broader strategic investments such as the Happy Returns acquisition (chunks 1‑2) and reflects a clear evolution of SurePost’s role from a USPS‑dependent offering to a fully integrated, UPS‑controlled delivery solution.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UPS SurePost served as a residential ground service for non-urgent, lightweight shipments from 2022–2024 with final delivery handled by USPS; in 2024, UPS announced a strategic shift to insource final delivery effective January 1, 2025. (2) Quantitative accuracy is perfect: the date 'January 1, 2025' is correctly cited, and no numerical errors exist. Format variations are not needed as dates are presented clearly. (3) Multi-hop reasoning is sound—the model correctly synthesizes information across years and identifies the strategic evolution from reliance on USPS to insourcing, noting the continuity through 2022–2023 and the change announced in 2024. The mention of strategic alignment with Happy Returns acquisition (from source chunks) adds contextual depth without distorting the core answer. (4) Entity accuracy is strong: 'UPS SurePost', 'U.S. Postal Service', 'USPS', and 'Happy Returns' are correctly named and contextualized. The answer fully addresses the question’s focus on role, delivery model, reliance on USPS, and strategic changes. All scoring categories warrant top marks due to complete, precise, and logically structured response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 355,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did Amgen's Phase 3 programs evolve from 2022 through 2024 in terms of quantity and development milestones, and what does this progression indicate about the company's R&D expansion strategy?",
      "original_answer": "Amgen's Phase 3 programs increased significantly from 13 programs as of February 8, 2022, to 18 programs as of January 31, 2023, and further to 24 programs as of January 31, 2024. By February 4, 2025 (noted in the 2024 filing), the number had grown to 25 Phase 3 programs, driven by five new initiations and regulatory approvals in the U.S. and Japan. This indicates a clear and sustained strategy to expand its late-stage pipeline, including external growth through acquisitions like Horizon Therapeutics in 2023, which added five Phase 3 programs. The consistent increase in Phase 3 programs and the combination of internal development and external acquisition suggest a focused effort to build a robust and diversified product portfolio.",
      "llm_answer": "\nFrom February 2022 through January 2024 Amgen’s Phase 3 pipeline expanded — it remained at 13 programs in early 2022, rose to 18 by the end of 2023 (with five new studies launched and five Horizon‑acquired programs added), and reached 24 programs by January 2024, a growth driven by both internal initiations and strategic acquisitions; during this span the company also achieved three FDA approvals (and one in Japan) while terminating one program, underscoring a focused effort to broaden its late‑stage portfolio. This progression—from 13 to 24 Phase 3 candidates, marked by acquisitions, new study starts and regulatory wins—reveals Amgen’s R&D expansion strategy of scaling its pipeline through targeted asset purchases and rapid advancement of multiple candidates to sustain long‑term growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in both quantitative and qualitative aspects. It accurately reports the increase in Phase 3 programs from 13 in early 2022 to 24 by January 2024, aligning with the ground truth. However, it states the count rose to 18 'by the end of 2023', while the original answer specifies January 31, 2023 — a minor imprecision in timing. The LLM also omits the subsequent increase to 25 programs as of February 4, 2025 (noted in the 2024 filing), which is a small but relevant update showing continued growth. (2) The numbers are mostly accurate: 13 → 18 → 24 is correct, and the mention of five new initiations and five Horizon-acquired programs aligns with the knowledge graph. However, the LLM incorrectly implies that the five Horizon programs were added during the 2022–2024 period without clarifying they were acquired in 2023 and contributed to the increase. It also states three FDA approvals and one in Japan, while the ground truth only confirms 'regulatory approvals in the U.S. and Japan' without specifying the count — this is a slight over-precision. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes internal development, external acquisition (Horizon), and pipeline growth to infer a strategic R&D expansion. The conclusion about a focused effort to broaden the late-stage portfolio via acquisitions and internal advancement matches the original reasoning. (4) The answer is contextually excellent, addressing both the quantitative evolution and strategic implications. The minor omissions (25 programs, exact dates) and slight overstatement of approval numbers prevent a perfect 10, but overall accuracy and synthesis are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Increases]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 464,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's strategic use of share-based compensation?",
      "original_answer": "In fiscal year 2022, the maximum number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023 and continuing into 2024, this number increased to 141,000,000, indicating a strategic expansion in the company’s capacity to issue share-based awards. This increase suggests that Accenture placed greater emphasis on equity-based incentives as part of its long-term talent retention and performance alignment strategy over the three-year period.",
      "llm_answer": "\nThe authorized share reserve under the Amended 2010 SIP grew from **127 million Class A shares in fiscal 2022** (as reported in Chunk 3) to **141 million shares in fiscal 2023 and FY 2024** (Chunk 1 and Chunk 2).  Although the pool of shares still available for future grants stayed roughly steady—27.38 million in 2022 and 27.27 million in 2024—the increase in the overall authorization shows that Accenture deliberately expanded its equity‑incentive capacity to support continued talent recruitment and retention as it scaled its global operations.  This progression signals a strategic shift toward a broader, more flexible share‑based compensation program that can accommodate larger grant volumes while efficiently recycling shares from lapsed or cancelled awards.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the authorized share numbers: 127 million in fiscal 2022 and 141 million in fiscal 2023 and 2024, matching the ground truth exactly. The formatting (127 million vs 127,000,000) is semantically equivalent and acceptable. 2) All quantitative values are accurate—no calculation errors. The mention of remaining available shares (27.38 million in 2022, 27.27 million in 2024) adds contextual detail not in the original answer but does not contradict it and appears factually consistent. 3) The reasoning is sound: the increase in authorized shares is correctly interpreted as a strategic expansion of equity-incentive capacity. The LLM goes further than the ground truth by noting the stable pool of available shares and recycling mechanisms, which enhances the analysis without introducing error. This reflects strong multi-hop synthesis across time points and concepts. 4) The answer fully addresses both parts of the question: the evolution of authorized shares and the strategic implication. The interpretation aligns with and slightly enriches the ground truth’s conclusion about talent retention and performance alignment. Only reason for not scoring 10 is that the original answer emphasizes 'long-term talent retention and performance alignment' more directly, while the LLM focuses on 'talent recruitment and retention' and 'scaling global operations'—slightly different emphasis but still valid. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 418,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did Starbucks' projected duration of green coffee supply coverage evolve from fiscal 2022 through fiscal 2024, and what does this indicate about their inventory and risk management strategy?",
      "original_answer": "Starbucks' projected duration of green coffee supply coverage increased from fiscal 2022 through fiscal 2024. In fiscal 2022, the company stated that purchase commitments and existing inventory were expected to provide an adequate supply through fiscal 2023. By fiscal 2023, this projection extended to cover through fiscal 2025. In fiscal 2024, Starbucks maintained the same projected supply coverage through fiscal 2025. This indicates a more forward-looking inventory and risk management strategy, with increased emphasis on long-term supply assurance through extended purchase commitments and hedging mechanisms.",
      "llm_answer": "\nStarbucks’ own disclosures show the length of its planned green‑coffee coverage expanding over the three filings: the 2022 10‑K states that “total purchase commitments… are expected to provide an adequate supply of green coffee **through fiscal 2023**,” while the 2023 10‑K and the 2024 10‑K both update that horizon to **through fiscal 2025**.  This extension—from a 2023 horizon to a 2025 horizon and then maintained through the next filing—reflects a deliberate strategy of securing a longer‑term inventory buffer, locking in supply via fixed‑price and price‑to‑fixed purchase commitments, forward contracts, futures and collars, and relying on diversified relationships with coffee producers, outside traders and exporters (with the risk of non‑delivery characterized as “remote”).  The evolution therefore signals that Starbucks is actively managing commodity‑price volatility and supply risk by broadening its coverage horizon and embedding contractual and hedging safeguards throughout its supply chain.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the key dates and time horizons are accurate: fiscal 2022 coverage through fiscal 2023, then extended to fiscal 2025 in both fiscal 2023 and 2024 filings. These match the original answer exactly. (2) The answer is complete, addressing both parts of the question: the evolution of supply coverage duration (from 2023 to 2025 horizon) and the implication for inventory and risk management strategy. (3) Entity accuracy is perfect: Starbucks, correct fiscal years (2022, 2023, 2024), and proper reference to green coffee supply, purchase commitments, and hedging instruments (forward contracts, futures, collars). (4) The reasoning is sound and reflects multi-hop synthesis across three annual reports, correctly inferring a strategic shift toward longer-term supply assurance. The LLM also adds valuable context from the filings—such as diversified supplier relationships and characterization of non-delivery risk as 'remote'—that enriches the ground truth without introducing error. Semantic equivalence is strong: the core facts, timeline, and strategic interpretation align precisely with the original answer. Minor wording differences do not affect factual accuracy. All scores are maximized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 359,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did UPS's financial and strategic treatment of the UPS/IBT Full-Time Employee Pension Plan evolve from 2022 through 2024, particularly in terms of plan amendments, remeasurements, and collective bargaining impacts?",
      "original_answer": "From 2022 to 2024, UPS's treatment of the UPS/IBT Full-Time Employee Pension Plan evolved significantly. In 2022, the plan was remeasured following the enactment of the American Rescue Plan Act, resulting in a pre-tax mark-to-market gain of $3.3 billion ($2.5 billion after tax), which was included in investment income. In 2023, the plan remained a key part of UPS’s pension structure, and the ratification of a new five-year national master agreement with Teamsters employees led to wage and benefit rate increases that were recognized as part of the year-end measurement of the plan. By 2024, the plan was still maintained as a noncontributory defined benefit plan covering employees previously in the Central States Pension Fund and under certain collective bargaining agreements, with no indication of further structural changes, showing UPS's continued commitment to the plan despite broader pension modifications elsewhere. This three-year progression reflects UPS's strategic balance of pension obligations, collective bargaining dynamics, and regulatory responsiveness.",
      "llm_answer": "\nFrom 2022 through 2024 UPS progressively changed how it accounted for the UPS/IBT Full‑Time Employee Pension Plan: in 2022 it amended certain Canadian defined‑benefit plans to freeze future accruals (producing $34 million of curtailment gains recorded in investment income) and it re‑measured the plan after the 2021 UPS Freight divestiture, recognizing a $2.1 billion actuarial gain that was initially posted in AOCI and later affected earnings; in 2023 the company froze accruals for non‑union participants effective January 1 2023 and, following ratification of a new five‑year national Teamsters master agreement, incorporated wage and benefit increases for Teamsters‑covered employees into the year‑end measurement of both the UPS Pension Plan and the UPS/IBT plan; and in 2024 the plan remained a non‑contributory defined‑benefit pension with no new amendments, but its financial statements continued to reflect the earlier remeasurements and the ongoing collective‑bargaining impacts noted in the 2023 and 2024 filings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key events related to the UPS/IBT Full-Time Employee Pension Plan from 2022 to 2024. (1) Quantitatively, the LLM incorrectly states that in 2022, UPS amended Canadian plans and recognized a $2.1 billion actuarial gain from the UPS Freight divestiture. The ground truth specifies a $3.3 billion pre-tax ($2.5 billion after tax) mark-to-market gain due to the American Rescue Plan Act—not from the divestiture or Canadian plan changes. The $34 million curtailment gain from freezing Canadian plans is unrelated to the UPS/IBT plan and not mentioned in the original answer. (2) The LLM claims in 2023 that UPS froze accruals for non-union participants effective January 1, 2023, but this detail is absent from the ground truth and conflates other pension actions with the UPS/IBT plan. While the ratification of the new Teamsters agreement and inclusion of wage/benefit increases in year-end measurement is correctly noted, it is inaccurately tied to both the UPS Pension Plan and the UPS/IBT plan without distinction. (3) Qualitatively, the reasoning fails on multi-hop synthesis: the LLM conflates multiple pension plans (Canadian, UPS Pension Plan, UPS/IBT) and events (divestiture remeasurement, Canadian freeze, non-union freeze) that are not part of the ground truth narrative focused solely on the UPS/IBT plan’s evolution. The strategic emphasis on regulatory responsiveness (ARP Act), collective bargaining, and continuity through 2024 is missing. (4) Contextually, the answer addresses the general theme of pension treatment and collective bargaining, hence moderate relevance, but the core financial events and their causes are factually wrong. The 2024 status as a non-contributory defined benefit plan with no new amendments aligns with the original answer, but this single point does not compensate for the broader inaccuracies. Overall, the answer is largely incorrect due to fabricated numbers, misattributed events, and failure to identify the correct triggering factors (e.g., ARP Act).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG <-[Maintain]- ORG",
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 555,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Walmart's categorization and strategic positioning of the 'Holiday Time' private brand evolved across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's approach to seasonal merchandise within its broader private label portfolio?",
      "original_answer": "In fiscal 2022, Walmart categorized 'Holiday Time' within its private brands under the broader merchandise portfolio, alongside other private brands like 'George' and 'Great Value,' without specific strategic emphasis on seasonal offerings. In fiscal 2023, 'Holiday Time' remained listed among private brands but was mentioned in the context of broader merchandise lines without a distinct strategic role, as Walmart emphasized omni-channel offerings and supply chain automation. By fiscal 2024, 'Holiday Time' continued to be listed among private brands, but Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category under General Merchandise, signaling a more strategic placement of holiday-themed products within a dedicated seasonal framework. This evolution shows Walmart increasingly aligning 'Holiday Time' with structured seasonal planning, reflecting a shift toward optimizing private label offerings for time-sensitive retail cycles.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Walmart repeatedly lists “Holiday Time” in its private‑brand rosters (Chunk 1, 2, 3) and notes that it periodically revises the categorization of its strategic merchandise units, adjusting prior‑period presentations to maintain comparability (Chunk 1, 2).  In each filing the brand is placed under the Entertainment/seasonal‑merchandise segment of General Merchandise—a category that historically delivers its highest sales volume in the fiscal quarter ending January 31 (Chunk 1), indicating that Walmart strategically aligns Holiday Time with the peak holiday period.  This consistent positioning, together with the explicit seasonal labeling and the ongoing re‑classification adjustments, reveals that Walmart treats Holiday Time as a core seasonal private‑label offering that bolsters its broader private‑brand portfolio by capturing holiday demand in the company’s busiest quarter.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity interpretation compared to the ground truth. (1) Quantitatively, there are no numeric errors—the answer avoids specific numbers and thus does not contradict the original. (2) However, the qualitative analysis is flawed: the LLM claims that 'Holiday Time' was consistently categorized under 'Entertainment/seasonal-merchandise' in all three fiscal years, directly contradicting the ground truth, which states that it was only in fiscal 2024 that Walmart explicitly restructured its merchandise units to include 'seasonal merchandise' as a defined category. In 2022 and 2023, 'Holiday Time' was listed among private brands without strategic emphasis or distinct seasonal categorization. (3) The multi-hop reasoning fails—the LLM incorrectly assumes consistent strategic positioning across all years based on repeated listing, whereas the ground truth shows an evolution from generic inclusion to explicit seasonal structuring only in 2024. This misrepresents Walmart’s strategic shift. (4) Contextually, the answer addresses seasonal alignment and private label strategy, so it remains relevant, but the core claim of consistency contradicts the actual evolution described in the original. Thus, while the answer is well-structured and contextually plausible, it misses the key insight of strategic repositioning over time, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 401,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did ACN's investment in mutual fund equity securities evolve across 2022, 2023, and 2024, and what does this trend suggest about the company's strategic allocation to this asset class?",
      "original_answer": "ACN's investment in mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023, and remained unchanged in 2024. This represents a consistent decline in exposure to mutual fund equity securities over the three-year period, suggesting a strategic rebalancing away from this asset class.",
      "llm_answer": "\nACN’s holding of mutual‑fund equity securities fell from **$239.3 million in 2022** (Chunk 3) to **$196.2 million in both 2023 and 2024** (Chunks 1 & 2), marking an ≈18 % reduction and then a flat‑line trend.  This pull‑back—mirrored in the KG relationship ORG ACN → FIN_INST Mutual Fund Equity Securities and the disclosed “Invests_In” link—indicates a deliberate re‑allocation of capital toward other balance‑sheet categories such as fixed‑income, cash, insurance contracts and other assets, as evident from the parallel growth in those line items across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the quantitative trend: ACN's mutual fund equity securities decreased from $239.293 million in 2022 to $196.226 million in 2023 and remained at that level in 2024. The LLM rounds these figures to $239.3 million and $196.2 million, which is acceptable and common in financial reporting. The ≈18% reduction is accurate: (239.293 - 196.226) / 239.293 ≈ 18.0%. 2) All numbers and calculations are correct. The answer correctly notes no change between 2023 and 2024, matching the ground truth. Format variations (e.g., using 'million' vs numeric) are appropriate. 3) The multi-hop reasoning is sound: the LLM correctly synthesizes data across years and infers strategic rebalancing, supported by observed shifts to other asset classes (fixed-income, cash, etc.), which aligns with the ground truth's interpretation of 'strategic rebalancing away from this asset class.' The mention of 'KG relationship' and 'Invests_In' link shows awareness of structured data provenance, though slightly meta. 4) The semantic meaning fully matches the original answer: a decline followed by stability, indicating reduced strategic emphasis. The only minor shortcoming is slightly stronger emphasis on 'parallel growth' in other assets, which, while plausible, is not explicitly confirmed in the ground truth. Thus, the reasoning is slightly extended but not incorrect. Overall, the answer is factually precise, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Discloses]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 404,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Starbucks' exposure to commodity index funds through green coffee price volatility and hedging strategies evolve from fiscal 2022 through 2024, and what does this reveal about the company's risk management approach in the context of futures market influences?",
      "original_answer": "From fiscal 2022 through 2024, Starbucks consistently acknowledged its exposure to green coffee price volatility driven by trading activities in the arabica coffee futures market, including those by commodity index funds. In 2022, the company hedged 'C' price exposure using forward and futures contracts, with purchase commitments expected to cover needs through fiscal 2023. By 2023, Starbucks extended its hedging strategy and supply commitments through fiscal 2025, signaling increased confidence in managing long-term exposure. In 2024, the company maintained a similar narrative, continuing to emphasize its reliance on fixed-price and price-to-be-fixed contracts alongside futures instruments. This evolution shows a consistent and maturing risk management approach aimed at mitigating the influence of speculative trading in the futures market on its coffee sourcing costs.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Starbucks lengthened its green‑coffee purchase horizon—from a supply commitment through fiscal 2023 in the 2022 filing to an expected supply through fiscal 2025 in the 2023 and 2024 filings—while continuing to hedge “C” price exposure with forward, futures and collar contracts, a practice explicitly tied to the impact of commodity‑index funds and hedge‑fund activity on arabica futures; this shows that the company’s risk‑management strategy relies on extending contractual purchase commitments and diversifying supplier relationships to lock in supply, rather than trying to control futures‑market price swings directly.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and timeframes are correct: the extension from hedging through fiscal 2023 (in 2022) to through fiscal 2025 (in 2023 and 2024 filings) is accurately reported. There are no numerical inaccuracies. (2) The LLM correctly identifies Starbucks as the entity, the relevant fiscal years (2022–2024), and the use of 'C' price hedges via forward, futures, and collar contracts—consistent with the original answer’s mention of futures and forward contracts (collars are an added detail but plausible and not contradicted). (3) The reasoning is sound: the multi-hop synthesis across years shows Starbucks extending its hedging horizon, which reflects a maturing risk management strategy. The LLM correctly infers that the company focuses on locking in supply rather than controlling market swings, which is logically consistent with the ground truth’s emphasis on fixed-price and price-to-be-fixed contracts. (4) The only minor deviation is that the original answer emphasizes 'commodity index funds' as a driver of volatility, while the LLM broadens it to 'commodity-index funds and hedge-fund activity'—a slight expansion but still contextually valid. Also, the original does not mention 'diversifying supplier relationships,' which the LLM adds; this is a plausible inference but not explicitly supported in the ground truth. Despite these small additions, the core facts, timeline, and strategic interpretation are correct. Hence, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> FIN_INST <-[Impacted_By]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 451,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did AVGO's exposure to the 3.625% notes due October 2024 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's near-term debt management strategy?",
      "original_answer": "In 2022, AVGO had $622 million in principal outstanding for the 3.625% notes due October 2024. By 2023, this amount remained unchanged at $622 million, indicating no repayments or modifications during the year. However, by 2024, the company had completely retired this liability, as the notes no longer appeared in the debt schedule, suggesting that AVGO either repaid or refinanced the obligation ahead of its maturity. This progression shows a deliberate near-term debt management strategy where AVGO addressed maturing obligations before their due dates.",
      "llm_answer": "\nAVGO’s 3.625 % senior notes maturing in October 2024 were reported with a $622 million principal balance in the FY2022 filing (Chunk 1), remained unchanged at $622 million through FY2023 (Chunks 2 & 3), and then disappeared from the FY2024 balance sheet—indicating a full retirement of the note by the end of fiscal 2024.  This progression shows that AVGO deliberately extinguished this near‑term senior obligation, using cash flow or refinancing to replace it with longer‑dated debt, underscoring a debt‑management strategy focused on reducing near‑term maturities and extending the overall maturity profile of its capital structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the $622 million principal amount for the 3.625% notes due October 2024 is correctly stated for FY2022 and FY2023, and the complete retirement of the debt by FY2024 is properly inferred from its absence in the debt schedule. (2) Quantitative accuracy is perfect: the dollar amount ($622 million), interest rate (3.625%), and maturity date (October 2024) match the ground truth exactly; no calculations are required, but the progression across years is correctly described. (3) Multi-hop reasoning is sound: the model synthesizes data across three fiscal years (2022, 2023, 2024) and correctly interprets the disappearance of the debt in 2024 as full retirement, indicating repayment or refinancing. (4) The qualitative interpretation aligns with the original answer—AVGO’s strategy of proactively managing near-term maturities by retiring debt ahead of schedule is clearly and accurately articulated, with added context about extending the maturity profile, which is a reasonable inference. All entities (AVGO, 3.625% notes, fiscal years) are correct. The answer is complete, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 349,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Mastercard's credit risk mitigation strategies and settlement exposure evolve from 2022 through 2024, particularly in light of regulatory scrutiny and litigation risks that emerged during this period?",
      "original_answer": "From 2022 to 2024, Mastercard maintained a consistent framework for managing its credit risk portfolio, including requiring customers to enter into risk mitigation arrangements such as cash collateral, letters of credit, and guarantees based on individual risk assessments. In 2022, the company emphasized its historical experience of low losses from customer failures and its regular monitoring of the adequacy of risk mitigation arrangements. By 2023, regulatory scrutiny intensified, with investigations from the FTC and DOJ focusing on compliance with the Durbin Amendment and potential antitrust violations, prompting Mastercard to enter into a consent agreement with the FTC to improve debit transaction routing transparency. In 2024, litigation risks increased significantly, including a class-action lawsuit alleging a $1+ billion liability related to the EMV liability shift and a formal investigation by the European Commission into anticompetitive behavior tied to network fees. Despite these pressures, Mastercard continued to refine its risk management methodology and maintained its short-term settlement exposure estimation process, revising exposure amounts as necessary. The trend shows a transformation in the external risk environment, prompting Mastercard to reinforce its risk mitigation posture while maintaining stable internal controls.",
      "llm_answer": "\nMastercard has continued to enforce the same risk‑standard framework it disclosed in 2022—requiring cash collateral, letters of credit or guarantees for customers that do not meet those standards—and it monitors its credit‑risk portfolio on an ongoing basis, revising the estimated settlement exposure whenever its risk‑management methodology or the underlying circumstances change.  The 2023 FTC consent order (which mandated token‑routing for debit transactions), the 2023 DOJ civil investigative demand, the 2024 European Commission information request, and the series of class‑action suits (U.S. liability‑shift and TCPA) introduced new regulatory and litigation pressures that prompted the Company to re‑evaluate and, where needed, tighten its risk‑mitigation arrangements and to update the way it calculates settlement exposure (using the three‑month average daily payment volume multiplied by the estimated days of exposure).  Across all three filings (2022, 2023 and 2024) the Company notes that historical losses from settlement failures have remained low, but the heightened scrutiny has driven more frequent reviews and adjustments to both its credit‑risk mitigations and the exposure estimates disclosed in Note 22.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mastercard maintained its credit risk mitigation strategies (cash collateral, letters of credit, guarantees) from 2022 through 2024, with ongoing monitoring and adjustments. The regulatory and litigation developments are accurately reflected: 2023 FTC consent order (related to debit routing transparency, referred to as 'token-routing'—a minor terminology simplification but semantically acceptable), DOJ civil investigative demand in 2023, European Commission inquiry in 2024, and class-action lawsuits including the EMV liability shift (referred to as 'U.S. liability-shift') and TCPA. The statement about low historical losses and continued stability in settlement exposure is consistent with the original. (2) Quantitative accuracy is strong: no specific dollar amounts or percentages are misstated. The $1+ billion liability from the original is not explicitly mentioned, but the reference to 'class-action suits' including the liability-shift claim implies material exposure without misrepresenting figures. The description of the settlement exposure calculation (three-month average daily payment volume × estimated days of exposure) is a precise methodological detail not in the original but plausibly inferred and consistent with financial reporting practices; it does not contradict the ground truth, which states exposure is 'revised as necessary'. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years and regulatory bodies, linking external pressures to internal risk management refinements. It captures the evolution from stable controls in 2022 to increased scrutiny in 2023–2024 and adaptive responses. (4) The only minor shortcoming is the omission of the specific 'Durbin Amendment' reference and the exact nature of the FTC consent agreement (transparency in debit routing), though the substance is conveyed. Also, the EMV lawsuit’s potential $1+ billion liability is not quantified in the LLM answer, which slightly reduces completeness. However, these omissions do not undermine the core accuracy. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Manages]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1662,
        "completion_tokens": 605,
        "total_tokens": 2268
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Amgen's regulatory risk disclosures related to drug delivery devices evolve from 2022 through 2024, particularly in terms of compliance requirements, post-marketing obligations, and safety oversight across those years?",
      "original_answer": "In 2022, Amgen highlighted that its products used with drug delivery devices face distinct regulatory, manufacturing, and compliance risks, and that disruptions could affect clinical trials and product supply. By 2023, the company detailed increasing regulatory scrutiny around surrogate endpoints and conditional approvals, such as the requirement to complete confirmatory studies for products like Repatha and LUMAKRAS. In 2024, Amgen expanded on the regulatory oversight of drug delivery devices used in combination with its products, noting that these devices are subject to safety reviews and that failure to meet post-marketing requirements could lead to enforcement actions, including labeling changes or product withdrawal. The trend shows a growing emphasis on post-market compliance and safety monitoring of integrated drug-device products.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen’s disclosures show a clear tightening of regulatory expectations for the drug‑delivery devices that accompany its products. In the 2022 filing the company warned that its commercial success depends on obtaining and maintaining separate regulatory approvals for those devices, that they are subject to REMS‑related safety reporting and periodic FDA assessments, and that any manufacturing or supply‑chain disruption could trigger enforcement. By 2023 the focus shifted to heightened scrutiny of surrogate endpoints and the need to satisfy post‑marketing confirmatory studies, pediatric‑study obligations, and strict safety‑signal monitoring, with regulators increasingly able to demand label changes, additional trials or even market withdrawal if those conditions are not met. In the 2024 filing Amgen detailed that accelerated‑approval products now carry explicit post‑marketing study requirements, that REMS performance reports must be submitted regularly, and that failure to meet those obligations—or to demonstrate safety and efficacy—can result in FDA enforcement actions such as fines, warning letters or revocation of approval, underscoring a progressively stricter compliance and safety‑oversight regime across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All years (2022, 2023, 2024) are correctly referenced, and the evolution of Amgen's regulatory risk disclosures is accurately portrayed. While the original answer does not explicitly mention REMS (Risk Evaluation and Mitigation Strategies) or 'fines' and 'warning letters', these are reasonable inferences within the context of FDA enforcement actions such as labeling changes or product withdrawal. The LLM correctly identifies increasing scrutiny on surrogate endpoints (2023), post-marketing confirmatory studies (e.g., for Repatha and LUMAKRAS, though not named in the LLM answer, the concept is correct), and safety oversight. (2) There are no numerical values to verify, so quantitative accuracy is 10 by default—no errors in dates or financials. (3) The multi-hop reasoning is sound: the LLM synthesizes changes across three years, correctly identifying a progression from general compliance and supply risks (2022), to heightened post-marketing obligations (2023), to explicit enforcement consequences (2024). The mention of pediatric-study obligations and REMS reporting in 2024 adds detail not in the original but is contextually plausible and does not contradict it. (4) The answer is semantically equivalent to the ground truth, with slightly more regulatory terminology (e.g., REMS, enforcement types), but the core message—that Amgen faced increasing regulatory pressure on drug-device combination products with growing emphasis on post-market compliance and safety—is preserved. One minor point: the original specifies 'drug delivery devices used in combination with its products' as being under safety review, while the LLM generalizes slightly more broadly. This does not constitute an error but a slight expansion. Hence, correctness is 9 rather than 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 509,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Walmart's private brand 'Parent's Choice' evolve across its merchandise categorization strategies in fiscal years 2022, 2023, and 2024, and what does this reveal about Walmart's positioning of the brand within its baby and consumables portfolio?",
      "original_answer": "In fiscal 2022, 'Parent's Choice' was listed among Walmart's private brands under the Grocery unit, which included baby products. In fiscal 2023, the brand remained a key private label within the same category, indicating continuity in its positioning. By fiscal 2024, 'Parent's Choice' continued to be prominently featured under the Grocery merchandise unit, which now explicitly included 'baby products' as a defined category. This consistent placement over three years suggests Walmart's strategic intent to reinforce 'Parent's Choice' as a trusted, low-cost private brand in the baby care segment, aligning with its EDLP pricing philosophy and omni-channel convenience strategy.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Walmart repeatedly listed “Parent’s Choice” among its private‑brand portfolio (chunks 1‑3) and disclosed that the classification of its strategic merchandise units—especially the Grocery unit that encompasses baby and consumables—is revised each year to maintain comparability (chunks 1‑3). These periodic revisions have progressively sharpened the brand’s placement within the Grocery/baby‑and‑consumables segment, revealing Walmart’s intent to position Parent’s Choice as a core, high‑margin pillar of its baby‑and‑consumables portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity interpretation. (1) Quantitatively, there are no numeric values to verify (e.g., dollar amounts, percentages), so the score is 10 by default as no numbers were misstated. (2) The answer correctly identifies that 'Parent's Choice' was consistently listed as a private brand across fiscal years 2022–2024 and acknowledges Walmart’s periodic revisions to merchandise categorization. However, it incorrectly implies that the brand’s placement was progressively 'sharpened' due to these revisions, which is not supported by the ground truth. The original answer states that the brand remained consistently under the Grocery unit with increasing explicitness in categorization (baby products becoming a defined subcategory in 2024), not due to annual reclassifications for comparability. (3) The multi-hop reasoning is flawed: the LLM infers that 'Parent’s Choice' is a 'high-margin pillar', which contradicts the ground truth stating Walmart positions it as a 'low-cost private brand' aligned with EDLP (Everyday Low Price). This is a critical factual and strategic misrepresentation. (4) Contextually, the answer addresses the evolution of categorization and Walmart’s strategic intent, so relevance is high. However, the conclusion about high margins and 'core pillar' status without evidence from the source undermines qualitative accuracy. The correct takeaway—consistent positioning to reinforce trust and low-cost value—is missing. Thus, while structurally relevant and free of numeric errors, the answer fails on key qualitative dimensions of factual correctness and reasoning soundness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 458,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Tesla's issuance and structuring of the 4.70% Solar Bonds, Series 2015/C24-10 evolve across 2022, 2023, and 2024, and what does this multi-year pattern suggest about Tesla's solar financing strategy?",
      "original_answer": "In 2022, Tesla referenced the 4.70% Solar Bonds, Series 2015/C24-10 as part of a broader set of solar financing instruments, with the bond introduced via the Thirty-Fifth Supplemental Indenture dated April 14, 2015. In 2023, Tesla continued to reference this bond in the context of ongoing solar project financings, including alongside newer series such as Series 2015/C27-10 and 2015/C32-10, indicating a consistent reliance on this structure. In 2024, Tesla again referenced the 4.70% Solar Bonds, Series 2015/C24-10, but now in the context of a broader historical framework that included earlier series like C4-10 and C9-10, suggesting a matured and recurring financing model. The multi-year presence and repeated referencing of this bond structure indicate that Tesla maintained a consistent and scalable securitization strategy for solar assets across the three years.",
      "llm_answer": "\nThe 4.70 % Solar Bonds, Series 2015/C24‑10 are cited in each of Tesla’s 2022, 2023 and 2024 Form 10‑K filings (as Exhibit 4.35 in the 2022 filing, Exhibit 4.28 in the 2023 filing, and Exhibit 4.26 in the 2024 filing), all referring to the same April 14 2015 Thirty‑Fifth Supplemental Indenture between SolarCity and the Trustee that created the bond issue. This multi‑year repetition shows that the 2015 asset‑backed securitization remains outstanding and is continually disclosed, indicating that Tesla’s solar financing strategy relies on a stable, long‑term bond structure with a fixed 4.70 % coupon to fund and refinance its solar portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the bond series (4.70% Solar Bonds, Series 2015/C24-10), the April 14, 2015 Thirty-Fifth Supplemental Indenture, and its consistent referencing across 2022, 2023, and 2024 are correctly stated. The exhibit numbers (Exhibit 4.35, 4.28, 4.26) are precise and reflect actual filing details, which are not contradicted by the ground truth. (2) Quantitative accuracy is perfect: percentages (4.70%), dates (April 14, 2015), and exhibit numbers are correct. (3) Multi-hop reasoning is sound—the model correctly infers from repeated disclosure that the bond structure remains active and central to Tesla’s solar financing, indicating a stable, long-term securitization strategy. This aligns with the ground truth’s conclusion about a consistent and scalable model. (4) The only minor shortcoming is completeness: while the LLM notes the bond's continued disclosure, it omits mention of Tesla referencing newer series (e.g., C27-10, C32-10) in 2023 and earlier series (C4-10, C9-10) in 2024, which the ground truth includes to show evolution and maturation of the financing framework. This contextual nuance slightly enriches the strategy interpretation, but the LLM’s core conclusion about reliance on a stable structure remains valid and semantically equivalent. Thus, the answer is factually excellent with only a slight gap in contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 400,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Broadcom's positioning of its Security Insights Platform evolved across 2022, 2023, and 2024, particularly in terms of integration with enterprise security tools and emphasis on mainframe risk assessment?",
      "original_answer": "In 2022, Broadcom described the Security Insights Platform as a solution that 'quickly interprets and assesses mainframe security posture, identifying risks and developing remediation steps,' with data available for use with in-house tools for security information and event management (SIEM). In 2023, the description remained largely consistent, continuing to highlight the platform’s ability to 'identify risks and proactively respond to potential threats' within the mainframe environment. By 2024, the platform retained its core functionality but was presented with a slightly stronger emphasis on integration, noting that the data is available for use with 'in-house tools for security information and event management'—a subtle but meaningful reaffirmation of its role in enterprise security ecosystems. While the core capabilities remained stable across the three years, the 2024 presentation reflects a more deliberate alignment with enterprise-wide security strategies, suggesting a maturing narrative around mainframe integration into broader cybersecurity frameworks.",
      "llm_answer": "\nBroadcom first launched the Security Insights Platform in 2022 as a solution that rapidly interprets and assesses mainframe security posture, identifies risks and generates remediation steps, with the resulting data made available for integration into customers’ internal security‑information‑and‑event‑management (SIEM) tools — a capability highlighted in the 2022 10‑K (Chunk 1). The 2023 filing (Chunk 3) retained this same functional emphasis, reiterating the platform’s role in continuous mainframe risk assessment and its ability to feed actionable insights into enterprise security workflows, confirming that the positioning remained steady year‑over‑year. By 2024 (Chunk 2) Broadcom elevated the platform to a core component of its mainframe security portfolio, explicitly tying it to other security products such as the Lateral Security Firewall and Advanced Threat Prevention and promoting it as the primary engine for enterprise‑wide risk assessment and compliance, thereby deepening its integration with the broader security toolchain while still leveraging the same core risk‑assessment engine described in earlier years. (These relationships are reflected in the KG pattern AVGO → Security Insights Platform → AVGO, showing the platform’s dual identity as both a produced product and an organizational asset.)",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates and product descriptions, correctly identifying the Security Insights Platform's presence in Broadcom's 2022, 2023, and 2024 filings and its core functionality around mainframe risk assessment and SIEM integration. Quantitative accuracy is perfect: no numerical errors, and the years (2022–2024) are correctly attributed. Contextual relevance is high—the response directly addresses the evolution of the platform’s positioning over time with respect to integration and mainframe risk. However, the qualitative accuracy is compromised by overstatement in the 2024 description. The original answer notes only a 'slightly stronger emphasis on integration' and a 'subtle but meaningful reaffirmation' of SIEM compatibility, whereas the LLM claims Broadcom elevated the platform to a 'core component' and 'explicitly tying it to other security products such as Lateral Security Firewall and Advanced Threat Prevention'—details not present in the ground truth. This represents a significant interpretive leap not supported by the knowledge graph, suggesting deeper integration and strategic elevation beyond what was documented. While the multi-hop reasoning across years is sound and the synthesis of consistent core functionality is correct, the unsupported enhancement of 2024 developments reduces factual fidelity. Thus, while the answer captures the general trajectory, it introduces unverified claims about product bundling and strategic positioning, warranting a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1617,
        "completion_tokens": 422,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the status of A Class shares' voting rights and dividend entitlements evolve between 2022 and 2024, and what does this consistency reveal about MA's capital structure strategy across the three-year period?",
      "original_answer": "Across 2022, 2023, and 2024, MA's A Class shares consistently maintained one vote per share and dividend rights, with no changes to their voting or dividend entitlements. This stability in A Class shares' rights indicates a consistent capital structure strategy by MA, preserving the governance and income distribution framework over the three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, the table for **A Class shares** shows identical terms in every year—$0.0001 par value, 3,000 million authorized shares, **one vote per share and full dividend rights** (see Chunk 1, Chunk 2 and Chunk 3). This unchanged rights structure indicates that MA has deliberately kept the A‑class rights and its authorized capacity stable, using the class to preserve governance control and avoid dilution as part of a consistent capital‑structure strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that A Class shares maintained one vote per share and full dividend rights across 2022, 2023, and 2024, with no changes—matching the original answer's claim of consistency. (2) The quantitative details—$0.0001 par value, 3,000 million authorized shares—are factually correct and drawn from the filings, though not in the ground truth; they provide additional precision without contradicting it. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and filings (Chunk 1, 2, 3) to infer stability in rights, leading to the conclusion about MA's capital structure strategy. (4) The qualitative interpretation—that MA deliberately preserved governance control and avoided dilution—is a reasonable extension of the ground truth's claim about 'consistent capital structure strategy.' All parts of the question are addressed: evolution (no change), and what it reveals (strategic consistency in governance and structure). Wording differs but meaning aligns perfectly. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 326,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Amgen's development and patent strategy for Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical trial phases and intellectual property protection timelines?",
      "original_answer": "In 2022, Amgen initiated the phase 3 study for Bemarituzumab, marking the beginning of its advanced clinical development for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab's patent protection for polypeptides was estimated to expire in 2029 in both the U.S. and Europe, indicating a defined IP strategy. In 2024, Amgen provided further context on Bemarituzumab's therapeutic focus, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, and highlighted potential regulatory exclusivity periods that could extend its market protection. This progression shows a transition from early-phase development to a more mature pipeline asset with defined clinical and IP strategies.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen progressed Bemarituzumab from an early‑stage asset to a Phase 3‑ready candidate (Chunk 1), and by 2023 the company’s patent filings projected U.S. and European exclusivity for the polypeptide antibody until 2029, with the possibility of term extensions or supplemental protection certificates (Chunk 3). The 2024 disclosure reinforces this timeline, noting that patent expiration estimates are based on issued patents and may be prolonged by future applications, regulatory exclusivities, or other IP strategies, thereby safeguarding the asset through at least 2029 across its key markets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Bemarituzumab entered Phase 3 development by 2022 (referred to as 'Phase 3-ready' in the LLM answer, which is semantically acceptable), patent protection was projected to expire in 2029 in the U.S. and Europe as of 2023, and in 2024, Amgen emphasized potential extensions via regulatory exclusivity or supplementary protection. (2) Quantitative accuracy is perfect: the year 2029 is correctly cited for patent expiration, and no incorrect numbers are introduced. Format variations (e.g., 'until 2029') are consistent with the original. (3) Multi-hop reasoning is sound—information is synthesized across 2022 (clinical phase), 2023 (IP timeline), and 2024 (regulatory exclusivity context), correctly attributing developments to the right years and domains (clinical vs. IP). (4) The only minor shortcoming is that the LLM omits the specific mention of 'FGFR2b targeting' and 'gastric/GEJ cancer' from the 2024 update, which adds therapeutic context present in the original. While not critical to the core question about development and IP strategy, this detail enhances completeness. Despite this, the answer captures the strategic evolution accurately, making it a strong 9/10 in correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 360,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did Walmart's private brand 'No Boundaries' fit within the evolving strategic merchandise units from 2022 through 2024, and what does this reveal about the company's shifting focus in apparel and fashion categories?",
      "original_answer": "In 2022, 'No Boundaries' was listed under the 'Apparel' category within Walmart U.S.'s strategic merchandise units, indicating its primary role in clothing and accessories. By 2024, the company restructured its general merchandise categories, and 'No Boundaries' was now referenced under the broader 'Fashion' unit, which included adult and children's apparel, shoes, jewelry, and accessories. This shift aligns with Walmart's increased emphasis on omni-channel offerings and customer-centric experiences, suggesting a strategic realignment to strengthen its fashion positioning. The continuity of 'No Boundaries' in all three years (2022–2024) highlights its consistent importance as a private brand, while its categorization evolved in line with Walmart's broader merchandising strategy.",
      "llm_answer": "\nNo Boundaries appears in Walmart’s private‑brand lists in the 2022, 2023 and 2024 10‑K filings (Chunk 1, 2, 3) and is placed within the company’s apparel‑related strategic merchandise unit—labeled “Apparel” in the 2022 filing (Chunk 3) and renamed “Fashion” in the 2024 filing (Chunk 2), reflecting a periodic re‑categorization that Walmart notes maintains comparability across periods (Chunk 1). This evolution shows the retailer is moving the brand from a generic apparel slot into a dedicated fashion unit, underscoring a strategic shift toward expanding its fashion‑focused private‑label portfolio. The KG relationship (WMT → No Boundaries → WMT) treats the brand as an internal organization within Walmart, highlighting its importance to the retailer’s evolving apparel and fashion strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: 'No Boundaries' is present in Walmart's private-brand portfolio from 2022 to 2024, initially categorized under 'Apparel' in 2022 and later under 'Fashion' in 2024. The reclassification is correctly interpreted as a strategic shift reflecting Walmart's evolving merchandising structure. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across multiple 10-K filings (referencing chunks) and correctly infers that the re-categorization from 'Apparel' to 'Fashion' reflects a strategic realignment, not a change in brand importance. It also correctly notes the continuity of the brand across years. (4) The only minor shortcoming is that the LLM mentions the KG relationship (WMT → No Boundaries → WMT) as treating the brand as an 'internal organization,' which is not mentioned in the original answer and slightly overinterprets the data, though it doesn't contradict the ground truth. Otherwise, the answer is semantically equivalent, contextually relevant, and demonstrates strong qualitative reasoning. The shift toward a 'fashion-focused private-label portfolio' is a valid inference from the re-categorization into the broader 'Fashion' unit.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 395,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 through 2024, and what does this progression reveal about its hybrid cloud and AI strategy positioning?",
      "original_answer": "In 2022, IBM highlighted client relationships and trust as one of its principal methods of competition, alongside technology innovation and performance, indicating its foundational role in differentiating the company. By 2023, IBM reinforced this emphasis by explicitly linking client relationships and trust to its ability to deliver business value and solve complex client challenges through integrated technologies. In 2024, the company maintained this positioning but expanded the context by showcasing strategic partnerships with hyperscalers and global system integrators, suggesting that trust and relationships were being extended through ecosystem collaboration to enhance client outcomes. This evolution shows a consistent strategic focus on trust as a core asset, increasingly leveraged through partnerships and hybrid cloud/AI capabilities to drive client-centric innovation.",
      "llm_answer": "\nFrom 2022 through 2024 IBM repeatedly framed **client relationships and trust**—not just as a service attribute but as a strategic **ORG** asset that directly fuels its **hybrid‑cloud and AI** agenda, a linkage captured by the KG pattern *Client Relationships and Trust (CONCEPT) → Client Relationships and Trust (ORG) → IBM (ORG)*.  The 2022 filing (Chunk 1) lists trust among the principal methods of competition, while the 2023 (Chunk 3) and 2024 (Chunk 2) updates reinforce this by tying the differentiator to an expanding ecosystem of strategic partners (e.g., AWS, Microsoft, SAP) and by positioning IBM as a leader in hybrid‑cloud/AI growth, thereby showing that IBM’s AI‑driven cloud strategy is built on, and further validated by, its deep‑rooted client‑trust foundation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM emphasized client relationships and trust as a competitive differentiator in 2022, strengthened the link to business value and complex problem-solving in 2023, and expanded the narrative in 2024 to include ecosystem partnerships. The mention of hyperscalers (AWS, Microsoft) and global system integrators (SAP) is consistent with the original answer’s reference to strategic partnerships. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; all years (2022, 2023, 2024) are correctly attributed. (3) The multi-hop reasoning is sound—LLM synthesizes information across three years and connects trust to hybrid cloud/AI strategy and ecosystem collaboration. The only minor shortcoming is that the LLM slightly underemphasizes the progression in how trust was leveraged (e.g., from foundational to ecosystem-extended), though the core insight about trust enabling hybrid cloud/AI leadership is preserved. (4) The answer is contextually excellent, directly addressing the evolution of IBM’s strategy and its implications. The use of KG notation (*Client Relationships and Trust (CONCEPT) → ...*) adds technical detail not in the original but does not distort meaning. Overall, the answer is semantically equivalent and factually robust, warranting a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 394,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Tesla's (via SolarCity) issuance of the 5.45% Solar Bonds, Series 2015/C25-15 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's solar financing strategy?",
      "original_answer": "Tesla (via SolarCity) consistently referenced the 5.45% Solar Bonds, Series 2015/C25-15 in its filings across 2022, 2023, and 2024, indicating ongoing reliance on this structured debt instrument. In 2022, the bond was introduced as part of a broader series of solar bonds issued in early 2015, with Tesla referencing the Thirty-Sixth Supplemental Indenture dated April 14, 2015. In 2023, Tesla again referenced the same bond series in its filings, showing continued legal and financial linkage to this financing structure. In 2024, the bond remained a key exhibit, with Tesla reaffirming its inclusion in the broader solar bond framework. This 3-year persistence of the same bond series in disclosures suggests that Tesla maintained a consistent solar asset-backed financing strategy over time, reiterating the importance of these instruments in funding solar deployments.",
      "llm_answer": "\nAcross the three filings the 5.45 % Solar Bonds, Series 2015/C25‑15 are disclosed in Chunk 1 (2022) as Exhibit 4.36 – the Thirty‑Sixth Supplemental Indenture dated April 14 2015 – re‑appear in Chunk 2 (2023) as part of Exhibit 4.29 (the Forty‑Fourth Supplemental Indenture dated April 27 2015) and other later supplemental indentures, and are again reproduced in Chunk 3 (2024) as Exhibit 4.27 (the same Thirty‑Sixth Supplemental Indenture). This recurring appearance, reflected in the KG link TSLA → FIN_INST ← ORG that ties the bond instrument back to Tesla, shows that Tesla’s solar‑financing strategy relies on repeatedly amending and rolling forward the original 2015 bond structure through layered supplemental indentures, using the same asset‑backed security to fund and extend its solar projects over multiple years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 5.45% Solar Bonds, Series 2015/C25-15 are consistently referenced across 2022, 2023, and 2024; the Thirty-Sixth Supplemental Indenture is correctly dated April 14, 2015, and appears in both 2022 and 2024 filings; the 2023 filing references the Forty-Fourth Supplemental Indenture (April 27, 2015), indicating updated legal documentation. These dates and exhibit numbers match the expected data. (2) Quantitative accuracy is perfect: percentages, dates, and exhibit numbers are correct and consistently formatted (minor typographic variations like thin spaces are acceptable). (3) The multi-hop reasoning is sound: the model correctly infers that Tesla maintains a long-term solar financing strategy by reusing and amending the original 2015 bond structure through supplemental indentures, which is a valid interpretation supported by the recurring disclosures. (4) The LLM adds value by introducing the concept of 'layered supplemental indentures' and the KG link TSLA → FIN_INST ← ORG, which enhances the explanation beyond the original answer without introducing error. The only minor shortcoming is that the original answer emphasizes the 'asset-backed' nature more explicitly, but the LLM does mention 'asset-backed security,' so this is a nuance rather than a gap. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 403,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Emerson's Safety & Productivity segment evolve its pipe-working tool offerings from 2022 to 2024, particularly in terms of product innovation and integration of battery-powered technologies, and what does this progression suggest about the company's strategic positioning in the professional tools market?",
      "original_answer": "From 2022 to 2024, Emerson's Safety & Productivity segment significantly enhanced its pipe-working tool portfolio, particularly emphasizing innovation in battery-powered technologies. In 2022, the segment offered traditional pipe-working tools such as pipe wrenches, cutters, threading equipment, and diagnostic systems, including closed-circuit television for pipe inspection. By 2023, Emerson expanded its offerings to include battery hydraulic tools for press connections, indicating a clear shift toward cordless, high-efficiency solutions tailored for professional use. This trend continued into 2024, where the segment further integrated battery-powered tools into its lineup, specifically highlighting battery hydraulic tools for cutting and crimping electrical cables, alongside sewer inspection cameras and locating equipment. The consistent mention of pipe wrenches across all three years underscores their foundational role, while the progressive addition of battery-powered innovations signals Emerson's strategic move to modernize its toolset and align with industry demands for portability, efficiency, and advanced diagnostics. This evolution suggests a deliberate effort to strengthen Emerson's competitive position in the professional tools market by enhancing productivity and safety through technology integration.",
      "llm_answer": "\nEmerson’s pipe‑working portfolio began in 2022 as a mechanical suite of wrenches, cutters, threaders and diagnostic systems sold chiefly through distributor networks (Chunk 1), but by 2023‑2024 the Safety & Productivity segment had added battery‑hydraulic press‑connection tools, battery‑hydraulic cutters/crimpers and advanced diagnostic equipment such as sewer‑inspection cameras and locating systems (Chunks 2‑3).  This shift—highlighted across the 2022‑2024 disclosures and reflected in the ORG‑>PRODUCT‑>ORG KG links—shows Emerson is deliberately evolving its professional‑tools offering toward cordless, high‑productivity, safety‑enhanced solutions, positioning the company as a full‑stack, safety‑focused player that blends hardware innovation with digital diagnostics to capture higher‑margin market share in the professional tools arena.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Emerson's Safety & Productivity segment from 2022 to 2024. (1) It correctly identifies the shift from traditional mechanical tools in 2022 (pipe wrenches, cutters, threaders, diagnostic systems) to the introduction of battery-hydraulic tools for press connections in 2023 and expansion into battery-powered cutters/crimpers and advanced diagnostics (sewer cameras, locating systems) in 2024—matching the ground truth. (2) There are no numeric values or calculations in the question or answer, so quantitative accuracy is not applicable in a numerical sense, but all dates (2022, 2023, 2024) are used correctly and consistently. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time periods and product categories, correctly inferring a strategic shift toward cordless, high-productivity, safety-enhanced tools. It also correctly links this progression to Emerson’s broader positioning in the professional tools market. (4) The answer is contextually excellent—directly addressing product innovation, battery-tech integration, and strategic implications. The only minor shortcoming is a slight compression of the narrative flow compared to the original’s clarity on year-by-year progression, and the mention of 'ORG->PRODUCT->ORG KG links' introduces an internal reference not in the original, which slightly reduces qualitative precision. However, the semantic meaning and strategic interpretation are fully aligned with the ground truth. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1586,
        "completion_tokens": 451,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Gilead's capital allocation strategy for its El Segundo, California facility evolve from 2022 to 2024, particularly in relation to cell therapy manufacturing investments and their alignment with the company's broader biologics development priorities?",
      "original_answer": "In 2022, Gilead's 10-K listed El Segundo among several principal manufacturing facilities in California, indicating its role in general manufacturing and processing, but without specific emphasis on cell therapy (GILD_10k_2022.pdf:page_33:chunk_1). By 2023, the company explicitly identified El Segundo as a dedicated site for both clinical and commercial manufacturing and processing of cell therapy products, signaling a strategic shift toward specialization in this high-growth therapeutic area (GILD_10k_2023.pdf:page_11:chunk_1). In 2024, El Segundo retained this designation, and the filing also emphasized Gilead’s reliance on internal know-how and third-party confidentiality agreements to protect proprietary manufacturing technologies—suggesting increased investment in securing and scaling proprietary cell therapy processes at this site (GILD_10k_2024.pdf:page_10:chunk_1). This progression indicates a focused capital allocation strategy toward transforming El Segundo into a core node for cell therapy production, aligning with Gilead’s broader biologics development goals and potentially reflecting increased CAPEX or R&D spend tied to facility upgrades and process development.",
      "llm_answer": "\nGilead’s capital‑allocation strategy for its El Segundo, California campus shifted from a 2022 focus on financing strategic transactions—using cash and new debt to fund the site’s cell‑therapy manufacturing expansion while acknowledging the credit‑rating and liquidity risks highlighted in the 2022 10‑K—to a sustained, multi‑year investment plan that began in 2023 and continued through 2024.  In the 2023 and 2024 filings the company explicitly lists El Segundo (along with Santa Monica, Frederick and Hoofddorp) as a dedicated facility for clinical and commercial manufacturing and processing of cell‑therapy products, and it notes that it “continues to develop additional manufacturing capabilities and establish additional third‑party suppliers” to support future biologics candidates—demonstrating that the El Segundo investment is now integrated into Gilead’s broader biologics development priorities and is backed by the capital resources the firm has earmarked for long‑term growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, all referenced years (2022, 2023, 2024) are correctly used, earning full marks by default. The answer correctly identifies the shift in El Segundo's role from general manufacturing in 2022 to dedicated cell therapy manufacturing in 2023 and 2024, and notes alignment with broader biologics development—this addresses the core of the question and maintains contextual relevance. However, significant inaccuracies undermine the qualitative accuracy: the LLM incorrectly claims in 2022 that Gilead was already expanding El Segundo for cell therapy and financing it via debt and strategic transactions, which is not supported by the 2022 10-K. The ground truth states that in 2022, El Segundo was listed only as a general manufacturing site without specific mention of cell therapy. The strategic shift is first evident in 2023, not initiated in 2022 as the LLM suggests. Additionally, the LLM introduces unverified details about credit-rating and liquidity risks tied to El Segundo, which the 2022 filing does not link to this facility. The mention of Santa Monica, Frederick, and Hoofddorp is accurate per the 2023/2024 filings, but the synthesis is flawed because it retroactively projects 2023+ strategy into 2022. The answer also omits the key 2024 insight about reliance on internal know-how and confidentiality agreements to protect proprietary processes—critical evidence of increased investment in securing and scaling manufacturing. Thus, while the overall direction of evolution is partially correct, the reasoning is based on fabricated financial strategy details and misattributed timelines, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1574,
        "completion_tokens": 478,
        "total_tokens": 2052
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did IBM's relationship with the 1.250% Notes due 2027 evolve from 2022 through 2024, particularly in terms of its disclosure, issuance, and reference in filings across these years?",
      "original_answer": "In 2022, IBM disclosed the 1.250% Notes due 2027 as part of its exhibit list, referencing the instrument defining the rights of the holders filed on January 30, 2019. By 2023, IBM continued to reference the 1.250% Notes due 2027, specifically noting their inclusion in filings from February 8, 2022, and February 3, 2023. In 2024, IBM formally listed the 1.250% Notes due 2027 (trading symbol IBM27B) as an issued financial instrument on the New York Stock Exchange, indicating a shift from disclosure to active market presence. This progression shows a clear transition from internal documentation and reference to public issuance and trading.",
      "llm_answer": "\nIBM first set out the rights for its 1.250 % Notes due 2027 in a January 30 2019 Form 8‑K (shown in Chunk 1 and 3), and those disclosures were carried forward in the company’s 2022 10‑K (Chunk 1) and 2023 10‑K (Chunk 3) filings, each time reiterating the same exhibit references.  Beginning with the 2024 filing, the notes appeared explicitly in IBM’s capital‑stock table under the ticker IBM27B, confirming their ongoing public registration and market‑wide reference (Chunk 2).  Thus, from 2022 through 2024 IBM’s relationship with the 1.250 % Notes due 2027 evolved from a private‑placement disclosure to a continuously disclosed, listed security that remains cited in every annual report.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.250% Notes due 2027 were first disclosed in a January 30, 2019 Form 8-K, and this disclosure was carried forward in IBM's 2022 and 2023 10-K filings. In 2024, the notes were explicitly listed under the ticker IBM27B on the New York Stock Exchange, as confirmed in the capital-stock table. These details match the original answer's timeline and evolution. (2) Quantitative accuracy is perfect: dates (January 30, 2019), percentages (1.250%), and ticker symbol (IBM27B) are all correctly stated. No calculations are required, but references to filing years (2022, 2023, 2024) are accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across multiple filings (2022 10-K, 2023 10-K, 2024 filing) and tracks the instrument’s evolution from disclosure to listing. The only minor shortcoming is the use of the term 'private-placement disclosure,' which is not explicitly confirmed in the ground truth and slightly overinterprets the nature of the initial filing; the original answer describes it as 'internal documentation and reference' rather than specifying private placement. This does not make the answer factually wrong but adds a nuance not present in the source. (4) Contextual relevance is excellent—the response directly addresses the question’s focus on disclosure, issuance, and reference across the three years, and the conclusion about evolution from disclosure to listed status is fully supported. Overall, the answer is factually correct, well-reasoned, and only slightly less precise in wording than the original, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 461,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "What does Tesla's multi-year reference to the 5.45% Solar Bonds, Series 2015/C45-15 and its subsequent bond structures suggest about the evolution of its solar financing strategy from 2022 through 2024?",
      "original_answer": "Tesla's continued reference to the 5.45% Solar Bonds, Series 2015/C45-15, first introduced in filings as of May 26, 2015 (noted in the 2022 10-K), indicates a sustained reliance on structured solar financing mechanisms inherited from SolarCity. In 2023, Tesla not only referenced this original bond series but also built upon its framework with newer issuances like the 5.45% Solar Bonds, Series 2015/C53-15 (June 16, 2015), suggesting an iterative approach to expanding its securitization model. By 2024, Tesla further extended this pattern by referencing subsequent bonds such as the 5.45% Solar Bonds, Series 2015/C62-15 (June 29, 2015) and 2015/C72-15 (July 21, 2015), demonstrating a deliberate capital structure strategy of leveraging standardized, asset-backed instruments to fund solar deployments. This progression implies Tesla is refining a scalable, repeatable financing model for its solar business, reducing reliance on traditional corporate debt and aligning capital with asset performance.",
      "llm_answer": "\nThe 2022 10‑K (Chunk 1) first identifies the 5.45 % Solar Bonds, Series 2015/C45‑15 as one of the supplemental indentures dated May 26 2015, establishing the original instrument; the 2023 filing (Chunk 2) repeatedly references that same series while adding later supplemental indentures (e.g., the 70th and 71st) that create successor series such as C53‑15 and C57‑15, showing Tesla’s practice of rolling over and expanding the original tranche; and the 2024 filing (Chunk 3) continues to cite C45‑15 and introduces newer series like C62‑15 and C72‑15, indicating a multi‑year, incremental evolution of Tesla’s solar financing that refinances legacy SolarCity debt, extends the 5.45 % coupon structure, and integrates solar‑related capital‑market funding into Tesla’s overall capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 5.45% Solar Bonds, Series 2015/C45-15, are correctly identified as originating from the May 26, 2015 supplemental indenture, and subsequent series (C53-15, C62-15, C72-15) are accurately referenced with their correct issuance context. The LLM correctly notes the continuation of the 5.45% coupon and the incremental expansion of the bond structure across 2022–2024. (2) Quantitative accuracy is perfect: percentages (5.45%), dates (May 26, 2015), and series identifiers (C45-15, C53-15, etc.) match the ground truth. The mention of '70th and 71st' supplemental indentures adds detail not in the original but does not contradict it and plausibly aligns with the iterative issuance pattern. (3) Reasoning is sound: the LLM correctly infers an evolving, structured securitization model, refinancing legacy SolarCity debt and integrating solar financing into Tesla’s capital structure—consistent with the multi-hop synthesis required. (4) The only minor shortcoming is that the LLM does not explicitly state the strategic implication of 'standardized, asset-backed instruments' or 'scalable, repeatable model' in the same conceptual terms as the original, though the meaning is implied. Thus, qualitative accuracy is slightly lower but still strong. Contextual relevance is full—directly addressing the evolution of Tesla’s solar financing strategy across the three years.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 406,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Adobe's strategic positioning of Acrobat evolve from 2022 to 2024, particularly in terms of AI integration, market adoption in document-intensive industries, and the expansion of its digital document services platform?",
      "original_answer": "In 2022, Adobe emphasized Acrobat's strong market adoption and leadership position in document-intensive industries such as legal, financial services, and publishing, highlighting its integration with Adobe Sign and the Document Cloud platform to modernize digital workflows. By 2023, Adobe introduced forward-looking statements about AI innovation, including the vision to embed artificial intelligence across its offerings, signaling a strategic pivot toward AI-powered enhancements for Acrobat. In 2024, Adobe formally introduced the 'Acrobat AI Assistant' as part of its trademark portfolio, indicating a concrete realization of its AI integration strategy and positioning Acrobat as a next-generation, intelligent document solution. This evolution shows a clear trajectory from market leadership in document productivity to AI-driven innovation, with strategic emphasis on expanding the platform’s capabilities and reinforcing its role in digital transformation across industries.",
      "llm_answer": "\nAdobe first cemented Acrobat’s strategic role in 2022 by positioning it as the market‑leading PDF solution within the Digital Media segment, highlighting its leadership in document‑intensive industries such as government, financial services, pharma, legal, aerospace, insurance and publishing and describing the unified **Document Cloud** platform that integrates Acrobat, Acrobat Sign and PDF technology to deliver end‑to‑end digital document workflows (Chunk 1). Building on forward‑looking AI ambitions disclosed in 2023, Adobe pledged to embed AI‑driven capabilities—leveraging Adobe Sensei and generative‑AI models—into Acrobat to accelerate document productivity and expand its digital‑document services ecosystem (Chunk 3). By 2024 this vision materialized with the launch of the trademarked **Acrobat AI Assistant** and the continued growth of Document Cloud—now enriched with Frame.io’s collaboration tools and a broader suite of cloud‑based document services—reinforcing Acrobat’s expanded, AI‑enhanced position across the same industry verticals (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Acrobat's 2022 market leadership in document-intensive industries (legal, financial services, publishing, etc.) is accurately described, including integration with Adobe Sign and the Document Cloud platform. The 2023 forward-looking AI strategy leveraging Adobe Sensei and generative AI is correctly reported. In 2024, the launch of the trademarked 'Acrobat AI Assistant' is properly cited as the realization of that vision. (2) Quantitative accuracy is perfect: no numerical errors; all dates (2022, 2023, 2024) are correct and properly contextualized. (3) Multi-hop reasoning is sound—information is synthesized across time periods and strategic dimensions (AI integration, market adoption, platform expansion). The mention of Frame.io and expanded cloud services adds contextual richness without contradicting the original. (4) Minor deduction in qualitative accuracy due to slight overextension: the original does not mention 'pharma', 'aerospace', 'government', or 'insurance' as industry verticals—these are plausible but not in the ground truth. Also, Frame.io integration, while potentially accurate, is not in the original answer and may conflate developments outside the scope. However, these do not undermine the core factual correctness. Semantic equivalence is largely preserved, and the answer fully addresses all parts of the question: AI integration, industry adoption, and platform evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 415,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has Charles Schwab's provision of interactive tools for RIAs evolved from 2022 through 2024, particularly in terms of platform enhancements and integration capabilities?",
      "original_answer": "In 2022, Schwab provided RIAs with proprietary software and a dedicated website offering account servicing capabilities and access to third-party integrations such as CRM and portfolio management systems. By 2023, Schwab continued to emphasize the Advisor Services website as the core platform, reinforcing its role in delivering interactive tools and educational content to support RIAs transitioning to independence. In 2024, Schwab maintained this trajectory by highlighting Schwab Advisor Portfolio Connect, a free portfolio management solution with an intuitive experience, and continued to expand integrations with third-party platforms to support advisor needs. The evolution shows a consistent focus on enhancing digital tools and integrations to support RIA scalability and efficiency.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s Advisor Services platform evolved from launching the free, cloud‑based Schwab Advisor Portfolio Connect and adding interactive tools with multi‑year archiving and document‑search capabilities (Chunk 1), to enriching those tools with expanded educational content, thought‑leadership and deeper connections to third‑party CRM, portfolio‑management and trade‑order systems (Chunk 3).  By 2024 the platform further broadened its integration options, giving RIAs seamless access to a wider range of products while continuing to host industry‑focused events such as the annual IMPACT conference (Chunk 2).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and timeline, but contains a significant factual inaccuracy regarding the launch timing of Schwab Advisor Portfolio Connect. According to the ground truth, in 2022 Schwab already provided proprietary software and third-party integrations, with Portfolio Connect being highlighted in 2024 as a free portfolio management solution. However, the LLM incorrectly states that Portfolio Connect was launched between 2022 and 2023, which misrepresents the evolution. The mention of 'multi-year archiving', 'document-search capabilities', and 'industry-focused events like IMPACT' adds detail not present in the original answer; while potentially true, these specifics are not supported by the ground truth and introduce unverified enhancements. The qualitative reasoning is sound in tracking platform evolution and integration expansion, and all dates and entities (Schwab, RIAs, third-party CRM/portfolio systems) are correctly identified. The answer addresses platform enhancements and integration capabilities across years, fulfilling the question's core intent. Quantitative accuracy is perfect—no numerical errors, and no incorrect figures are cited. Contextually, the response is highly relevant, well-structured, and focused on the evolution of interactive tools for RIAs. However, due to the misplacement of the Portfolio Connect launch and inclusion of unsupported features, the correctness and qualitative accuracy scores are reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 410,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Emerson's (EMR) strategic positioning of Air Preparation Equipment evolve across its Discrete Automation segment in 2022, 2023, and 2024, particularly in terms of integration with other pneumatic and control technologies?",
      "original_answer": "In 2022, Air Preparation Equipment was positioned within a broader suite of pneumatic mechanisms used in food processing, life sciences, and petrochemical processing, emphasizing integration with solenoid and pneumatic valves, actuators, and pressure switches. By 2023, the equipment was more explicitly embedded within the Discrete Automation segment’s portfolio of programmable automation control systems and software, electrical distribution, and materials joining solutions, signaling a stronger alignment with digital and automated control ecosystems. In 2024, the positioning further evolved to highlight interoperability with smart actuation, predictive maintenance capabilities, and secure wireless communication, aligning Air Preparation Equipment with broader trends in Industry 4.0 and digital transformation. This 3-year progression shows a clear shift from a mechanical focus to a digitally integrated component within Emerson’s industrial automation strategy.",
      "llm_answer": "\nEmerson (EMR) positioned Air Preparation Equipment in 2022 as a foundational pneumatic component within the Discrete Automation segment, selling it alongside solenoid and pneumatic valves, smart actuation and pressure‑management products to provide reliable compressed‑air sources for industrial processes. By 2023 the offering broadened to include valve‑position indicators, cylinders, switches and integrated measurement instrumentation, linking the equipment to control‑system data streams that enable predictive maintenance and process optimization. In 2024 Emerson deepened the integration, embedding Air Preparation Equipment in programmable automation control systems and software (e.g., digital twins, asset‑performance management) that tie pneumatic functions to sustainability, safety and energy‑efficiency metrics, thereby framing it as a key enabler of end‑to‑end pneumatic‑control solutions across discrete industries – a relationship reflected in the KG triplets EMR → Air Preparation Equipment (Produces) and Air Preparation Equipment (ORG) → EMR (ORG).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in terms of the evolution of Emerson's Air Preparation Equipment positioning from 2022 to 2024. (1) All key facts are correct: in 2022, the equipment is described as part of a pneumatic suite integrated with valves and actuators; in 2023, it is linked to control systems and predictive maintenance; in 2024, integration with digital systems like digital twins and asset-performance management reflects Industry 4.0 alignment. These match the original answer’s progression from mechanical to digitally integrated components. (2) There are no numeric values, dates, or financial figures in dispute—years (2022, 2023, 2024) are correctly used and consistent. (3) The multi-hop reasoning is sound: the LLM synthesizes the product’s integration across time with broader automation and digital trends, correctly attributing strategic shifts within the Discrete Automation segment. It accurately infers deeper technological integration over time, even mentioning specific systems (e.g., digital twins, asset-performance management) that reflect the Industry 4.0 focus. (4) Minor deduction in qualitative accuracy due to the inclusion of 'sustainability, safety and energy-efficiency metrics' and 'KG triplets' reference, which, while plausible, are not present in the original answer and slightly extend beyond the provided ground truth. However, these do not contradict the core facts and reflect reasonable inferences. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1531,
        "completion_tokens": 438,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did The Coca-Cola Company's issuance strategy for the 0.125% Notes due 2029 evolve from 2022 to 2024, and what does this pattern suggest about the company's approach to managing near-term debt obligations in the context of its broader financing activities?",
      "original_answer": "The Coca-Cola Company consistently referenced the 0.125% Notes due 2029 in its filings across all three years (2022–2024), indicating ongoing acknowledgment of this liability. However, the context in which it was referenced changed. In 2022, the note was embedded among a broader set of historical debt instruments, suggesting a passive disclosure approach. By 2023, the note appeared in a more consolidated format, indicating a maturing phase within the company's debt structure. In 2024, while the 0.125% Notes due 2029 were still referenced, the company began introducing significantly higher-yielding instruments (e.g., 5.000% Notes due 2034 and 5.400% Notes due 2064), suggesting a strategic pivot toward longer-term financing as the 2029 note approached its maturity date. This pattern implies a deliberate effort to refinance or extend liabilities as lower-yielding, near-term notes like the 0.125% Notes due 2029 neared expiration.",
      "llm_answer": "\nThe Coca‑Cola Company’s 10‑K filings from 2022 through 2024 each repeat the same “Form of Note for 0.125 % Notes due 2029” – first filed in a 2020 8‑K and later amended via supplemental indentures referenced in the 2021 and 2022 filings – confirming that this low‑coupon tranche remains outstanding and is continuously re‑introduced in the company’s disclosure schedule.  At the same time, each year’s filing adds new note issuances (e.g., 5.0 % Notes due 2034, 5.3 % Notes due 2054, and additional tranches due 2032, 2044, etc.), illustrating a laddered issuance strategy that uses the stable 0.125 % 2029 notes as a short‑term funding pillar while expanding longer‑dated debt to manage near‑term obligations within the firm’s broader financing activities.  The knowledge‑graph pattern (ORG → FIN_INST ← ORG ← ORG) captures this cyclical “introduction” of the same financial instrument across multiple years, reflecting a deliberate, incremental approach to debt management.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts and captures the multi-year pattern of The Coca-Cola Company's debt disclosures regarding the 0.125% Notes due 2029. It correctly notes that the note has been consistently referenced across 2022–2024 filings, confirming its ongoing status, and identifies the introduction of new higher-yielding instruments (e.g., 5.0% Notes due 2034), which aligns with the ground truth’s observation of a strategic pivot toward longer-term financing. The quantitative elements—percentages (0.125%, 5.0%, 5.3%) and maturity years (2029, 2034, 2054, etc.)—are accurate, supporting a score of 8 for quantitative accuracy. However, the LLM introduces a detail not present in the ground truth: that the same 'Form of Note' is 'repeated' annually and tied to 2020–2022 filings and supplemental indentures. This level of procedural disclosure detail (e.g., 8-K filing in 2020, amendments in 2021/2022) goes beyond the scope of the original answer and may reflect over-interpretation or external data not confirmed in the knowledge graph. Additionally, while the ground truth emphasizes an evolution in *context* (from passive to strategic), the LLM frames this as a 'laddered issuance strategy' and calls the 0.125% note a 'short-term funding pillar'—a reasonable inference but not explicitly supported in the original. The knowledge-graph pattern mentioned (ORG → FIN_INST ← ORG ← ORG) is abstract and not explained, reducing clarity. Despite these issues, the answer correctly synthesizes multi-hop information across years and entities and addresses both parts of the question: the evolution of the issuance strategy and its implication for debt management. Thus, the qualitative accuracy is 7 due to plausible but unverified inferences. Contextual relevance is high (9) because the response stays focused on the question and uses appropriate financial reasoning. Overall, the answer is factually sound on key points but includes minor speculative elements, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 542,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did BNY Mellon's exposure to U.S. banking laws regarding capital planning and shareholder capital returns evolve from 2022 through 2024, particularly in terms of regulatory constraints on dividends and share repurchases?",
      "original_answer": "BNY Mellon's disclosures consistently emphasized regulatory constraints on capital returns throughout 2022–2024, but the framing evolved from a general caution in 2022 to more specific references to U.S. banking laws and capital adequacy rules in 2023 and 2024. In 2022, the firm noted that capital returns were limited by U.S. banking laws and Delaware law. In 2023, it reiterated these constraints and highlighted the impact of preferred stock dividend obligations. By 2024, the language became more structured, emphasizing regulatory standards like 'well capitalized' status and capital adequacy rules as direct limitations on its ability to repurchase shares or pay dividends. This shows a trend of increasing specificity and formalization in how the firm communicates regulatory constraints on capital policy.",
      "llm_answer": "\nBNY Mellon’s exposure to U.S. banking laws that govern capital planning and shareholder‑return decisions remained a consistent, regulatory‑driven constraint from 2022 through 2024 – the firm repeatedly disclosed that its ability to pay dividends and repurchase shares is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (Chunk 1, 2, 3).  Because the Parent is a non‑operating holding company that relies on dividends from its subsidiaries to fund share‑repurchase programs and dividend payments, any downgrade or material reduction in the credit ratings of the bank subsidiaries, or any failure to remain “well‑capitalized” and “well‑managed,” would trigger additional limitations on those returns (Chunk 1 & 2).  Thus, across the three years the regulatory framework continued to shape, and at times restrict, BNY Mellon’s capital‑planning and shareholder‑return activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon consistently referenced U.S. banking laws, Delaware law, and capital planning regulations as constraints on dividends and share repurchases from 2022 to 2024. The answer correctly notes the firm’s reliance on subsidiary dividends and the impact of 'well-capitalized' and 'well-managed' status, which matches the evolution toward more structured regulatory language in 2024. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across years and connects regulatory constraints, capital planning, and corporate structure (holding company dependency on subsidiaries). It accurately reflects the increasing specificity in disclosures, though it does not explicitly highlight the shift from general caution in 2022 to more formalized language in 2024 as clearly as the original answer. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The response is fully contextually relevant, directly addressing how regulatory constraints evolved and impacted capital returns. Overall, the answer conveys semantic equivalence with strong factual and logical fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 371,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did McDonald's portrayal of its McGriddles product within broader menu innovation disclosures evolve from 2022 through 2024, and what does this reveal about the consistency of its breakfast strategy?",
      "original_answer": "McDonald's portrayal of McGriddles remained remarkably consistent across all three years, with the product always listed among core breakfast sandwiches without any specific innovation details. In 2022 (MCD_10k_2022.pdf:page_7:chunk_1), McGriddles were mentioned as a standard breakfast offering alongside Egg McMuffin and Sausage McMuffin with Egg. By 2023 (MCD_10k_2023.pdf:page_6:chunk_1), the company emphasized its 'continuous evolution' of menus to meet customer needs, yet McGriddles remained presented as a static menu item rather than an innovated product. In 2024 (MCD_10k_2024.pdf:page_6:chunk_1), despite mentioning 'testing new products on an ongoing basis,' McGriddles were still described in the same basic format as in prior years. This reveals a stable breakfast strategy where McGriddles maintained its position as a core offering without significant product-level changes, even as the company pursued broader menu innovation elsewhere.",
      "llm_answer": "\nAcross the 2022‑2024 Form 10‑K filings McDonald’s repeatedly places **McGriddles** in the breakfast‑menu section and frames it as part of the company’s “continuous menu evolution,” with the 2022 filing simply listing it as a breakfast offering, the 2023 filing embedding it in a broader discussion of product innovation and supply‑chain quality, and the 2024 filing linking it to digital quality‑measurement and marketing narratives—reflecting a steady escalation of its visibility within the company’s innovation disclosures.  This persistent branding of McGriddles—shown in the knowledge‑graph as a product **Features**‑to‑**PRODUCT** and then **Produces**‑to‑the same **ORG**—demonstrates that, while the item is continually tested and integrated into new quality and sustainability initiatives, its core role in the breakfast lineup remains unchanged, revealing a consistently stable breakfast strategy anchored on signature items like McGriddles.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains no numeric data, so quantitative accuracy is not applicable—scored as 10 by default since there are no incorrect numbers. However, the qualitative accuracy is significantly flawed. The LLM incorrectly states that McGriddles' portrayal evolved with 'a steady escalation of its visibility' and was 'embedded' in innovation, supply-chain, digital quality, and marketing narratives in 2023 and 2024. This contradicts the ground truth, which confirms that McGriddles was consistently listed as a static, core breakfast item without any specific innovation details across all three years. The original answer emphasizes that despite broader innovation language, McGriddles itself was not presented as innovated. The LLM misrepresents the nature of the disclosures by implying increasing strategic emphasis and integration into innovation initiatives, which is unsupported by the filings. While the LLM correctly identifies that McGriddles remained a stable part of the breakfast lineup, its reasoning is flawed due to incorrect synthesis of the product’s role in innovation narratives. The answer partially addresses the question’s two parts—evolution of portrayal and breakfast strategy consistency—but distorts the first part, leading to an inaccurate conclusion. Contextual relevance is fair because it discusses the right documents and general strategy, but the mischaracterization of the product's role reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Features]-> PRODUCT <-[Produces]- ORG <-[Features]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 399,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Adobe's emphasis on free online self-service learning evolved across 2022, 2023, and 2024, particularly in terms of its positioning within Adobe Digital Learning Services and the platforms used to deliver these offerings?",
      "original_answer": "In 2022, Adobe introduced free online self-service learning as part of a broader enablement strategy, hosted on www.training.adobe.com, emphasizing its role in assisting customer and partner teams in product adoption. By 2023, the company continued to provide these free options but shifted the domain to learning.adobe.com, indicating a more centralized or rebranded approach to digital learning. In 2024, Adobe reinforced its production and delivery of these learning tools on the same platform (learning.adobe.com), integrating them more deeply into a comprehensive portfolio that also included fee-based and custom learning programs. This 3-year trajectory shows a consistent strategic emphasis on self-service learning as a core component of Adobe’s customer enablement, with a shift in platform branding and an increased integration into the broader Adobe Learning Services ecosystem, suggesting a maturing and more structured approach to digital education.",
      "llm_answer": "\nAdobe has continued to embed **free online self‑service learning** as a core pillar of **Adobe Digital Learning Services**, listing it alongside its fee‑based and custom training programs in the Digital Experience/Digital Media portfolio.  The self‑service curriculum was delivered through the company’s learning portals—​**www.training.adobe.com** in 2022 and **learning.adobe.com** in both 2023 and 2024—reflecting a stable, product‑oriented platform that Adobe promotes as part of its broader learning ecosystem (ADBE → Free Online Self‑Service Learning → Free Online Self‑Service Learning → ADBE).  This consistent positioning underscores how the free, self‑service offering has evolved from a single site in 2022 to a recurring, integrated component of Adobe’s Digital Learning Services across all three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: free online self-service learning was hosted on www.training.adobe.com in 2022 and moved to learning.adobe.com in 2023 and 2024. The strategic positioning as a core component of Adobe Digital Learning Services alongside fee-based and custom programs is correctly conveyed. (2) There are no numeric values requiring calculation, but the dates (2022, 2023, 2024) and platform URLs are factually accurate and match the original answer. Format variations are not applicable here, but the domain names are correctly reported. (3) The multi-hop reasoning is sound—LLM synthesizes information across three years and two platforms, correctly identifying the evolution from a standalone site to an integrated component within a broader learning ecosystem. The shift in branding and continuity of strategic emphasis are logically inferred. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'rebranded or centralized approach' or the 'maturing and more structured approach' as emphasized in the original answer’s conclusion. While the integration and consistency are noted, the interpretive dimension of strategic maturation is slightly underdeveloped. However, this does not detract significantly from the factual and conceptual accuracy. Overall, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 401,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How did Emerson's (EMR) positioning of Commercial Vacuums within its Safety & Productivity segment evolve from 2022 through 2024, particularly in terms of product categorization, strategic emphasis, and alignment with professional tools offerings?",
      "original_answer": "In 2022, Commercial Vacuums were listed among other professional tools like water jetters and wet-dry vacuums under the Tools & Home Products segment, with a focus on promoting safety and productivity for professionals and homeowners. By 2023, Commercial Vacuums were explicitly included in the Safety & Productivity segment, grouped with tools supporting infrastructure and safety, such as battery hydraulic tools and sewer inspection cameras. In 2024, Commercial Vacuums remained within the Safety & Productivity segment, but the description emphasized integration with broader productivity-enhancing tools like programmable automation control systems and electrical distribution equipment, signaling a shift toward aligning Commercial Vacuums with more technologically advanced and industrial productivity tools. This evolution reflects a strategic repositioning of Commercial Vacuums from a general tools category to a more integrated part of Emerson’s industrial safety and productivity solutions.",
      "llm_answer": "\nEmerson re‑positioned Commercial Vacuums from the **Tools & Home Products** “Professional Tools” group in 2022 (where they were listed alongside pipe‑working, electrical and other vacuum products; Chunk 1) to the **Safety & Productivity** segment by 2023‑2024, explicitly grouping them with other safety‑focused professional tools (pipe‑working, electrical, water‑jetters, etc.) and emphasizing their role in enhancing professional safety and productivity (Chunk 2 & Chunk 3).  This shift aligns the vacuums with a broader safety‑productivity portfolio and retains the same distributor‑centric go‑to‑market approach noted for the segment (Chunk 1 & Chunk 2/3), a relationship reinforced by the KG triplets that link Commercial Vacuums as both a product and an organizational offering under EMR.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of factual content and timeline. It accurately identifies the shift of Commercial Vacuums from the Tools & Home Products segment in 2022 to the Safety & Productivity segment by 2023–2024, which aligns with the ground truth. The mention of grouping with other professional tools like water-jetters and pipe-working tools is consistent with the original answer’s reference to battery hydraulic tools and sewer inspection cameras, though the specific examples differ slightly. The strategic emphasis on safety and productivity is correctly captured. However, the LLM answer does not fully reflect the 2024 evolution described in the ground truth—specifically, the increased emphasis on integration with advanced industrial systems like programmable automation and electrical distribution equipment. This nuance about technological alignment and the shift toward more industrial productivity tools is missing, representing a minor but notable omission in qualitative depth. There are no numerical inaccuracies (dates are correctly cited as 2022, 2023–2024), so quantitative accuracy is perfect. Contextual relevance is strong, as the response directly addresses product categorization, strategic emphasis, and alignment with professional tools. The reasoning is sound across years and segments, though the synthesis of the 2024 strategic shift is incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 385,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has GILD's utilization of its Hoofddorp, Netherlands facility evolved from 2022 through 2024, particularly in relation to cell therapy manufacturing and commercial processing activities?",
      "original_answer": "In 2022, GILD's Hoofddorp, Netherlands facility was identified as a principal manufacturing site, indicating its importance in GILD’s global operations. By 2023, the facility was explicitly described as being utilized for commercial manufacturing and processing of cell therapy products, highlighting a strategic shift toward advanced therapies. In 2024, this focus remained consistent, with Hoofddorp continuing to serve as a dedicated site for commercial manufacturing and processing of cell therapy products, suggesting a sustained and potentially expanding role in GILD’s cell therapy portfolio. This progression indicates a growing emphasis on cell therapy capabilities at the Hoofddorp location over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GILD’s Hoofddorp, Netherlands site has remained one of its principal European manufacturing locations, and each year’s filing confirms that the facility is “utilized for commercial manufacturing and processing of our cell‑therapy products” — a role first highlighted in the 2022 10‑K (Chunk 1) and explicitly detailed for 2023 (Chunk 2) and again for 2024 (Chunk 3).  Thus, the company’s utilization of Hoofddorp has not shifted but has continued to focus on scaling and delivering cell‑therapy manufacturing and commercial processing activities across the three‑year period.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GILD's Hoofddorp facility was used for commercial manufacturing and processing of cell therapy products in 2022, 2023, and 2024, which aligns with the ground truth. However, it inaccurately states that this role was 'first highlighted in the 2022 10-K', whereas the original answer notes that in 2022 the facility was only identified as a 'principal manufacturing site' without explicit mention of cell therapy. The explicit focus on cell therapy manufacturing began in 2023, per the ground truth. This misrepresents the evolution, suggesting continuity rather than a strategic shift. (2) There are no numerical values or calculations in this question, so quantitative accuracy is not applicable—scored as 10 by default due to absence of errors. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes information across years and confirms ongoing use for cell therapy in 2023 and 2024. However, it fails to capture the nuanced progression from general principal site in 2022 to specific cell therapy focus in 2023, weakening the qualitative accuracy. (4) Contextual relevance is high—the response directly addresses the question about the evolution of the facility’s utilization and remains focused on cell therapy manufacturing across the three years. Despite the misstatement about 2022, the overall trend of sustained and focused use is correctly conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 399,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's filings from 2022 through 2024, combined with the introduction of higher-yield notes in 2024 such as the 5.000% Notes due 2034 and 5.400% Notes due 2064, reflect changes in the company's approach to debt financing costs and capital structure management?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2028 in its 10-K filings for 2022, 2023, and 2024, indicating the ongoing importance of this low-interest debt instrument in its capital structure. However, in 2024, the company introduced significantly higher-yield notes, including the 5.000% Notes due 2034 and the 5.400% Notes due 2064. This shift suggests that Coca-Cola began diversifying its debt portfolio to include instruments with higher financing costs, likely to take advantage of favorable market conditions or to fund new strategic initiatives. The contrast between the stable, low-cost 1.000% Notes due 2028 and the new high-yield instruments indicates a recalibration of the company's capital structure management, balancing near-term affordability with long-term funding needs.",
      "llm_answer": "\nThe 1.000 % Notes due 2028 are repeatedly cited in Coca‑Cola’s 2022, 2023 and 2024 filings (Chunk 1, 2 and 3), confirming that this low‑coupon, long‑dated instrument remains a core component of the company’s revolving‑debt platform and is embedded in the same indenture framework that has been referenced since 1991 (Chunks 1‑3).  At the same time, the 2024 filings introduce a new suite of higher‑yield notes—5.000 % Notes due 2034, 5.300 % Notes due 2054 and 5.400 % Notes due 2064 (Chunk 3)—showing that KO is deliberately supplementing its historic cheap financing with higher‑cost debt to diversify funding, manage interest‑rate exposure and adjust its capital structure as market rates rise.  This dual issuance pattern (KO → FIN_INST) illustrates a strategic shift from reliance on a single low‑rate series toward a broader mix of debt maturities and yields.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correctly identifies the persistent reference to the 1.000% Notes due 2028 in Coca-Cola's 2022–2024 filings as a sign of continued reliance on low-cost debt. (2) Accurately reports the introduction of higher-yield notes in 2024: 5.000% due 2034 and 5.400% due 2064. However, it includes an additional note—5.300% due 2054—not mentioned in the original answer. While this may reflect real data, it introduces a detail absent from the ground truth, slightly reducing quantitative accuracy. (3) The reasoning is sound: the contrast between low-cost legacy debt and new high-yield instruments reflects a strategic shift toward diversification and capital structure adjustment, especially amid rising rates. The multi-hop synthesis across years and debt instruments is logical and well-supported. (4) Semantic equivalence is strong—core message about shifting financing strategy is preserved, with only minor over-specification. Wording differences are acceptable. Contextual relevance is excellent, directly addressing debt financing costs and capital structure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 323,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Emerson's (EMR) product portfolio evolution for pipe cutters across 2022, 2023, and 2024 reflect a strategic shift toward battery-powered and diagnostic-integrated tools, and what does this reveal about the company's positioning in the professional plumbing tools market?",
      "original_answer": "In 2022, Emerson's pipe cutters were described as part of a traditional suite of pipe-working tools used by plumbing professionals, with no emphasis on battery-powered or diagnostic capabilities. By 2023, the company began integrating battery hydraulic technology into pipe cutters, signaling a move toward more advanced, portable tools. In 2024, Emerson further evolved its offering by emphasizing diagnostic systems, including sewer inspection cameras and locating equipment, directly tied to its pipe cutters. This 3-year progression reveals a strategic pivot toward high-value, technology-enhanced tools aimed at improving productivity and safety in the professional plumbing sector.",
      "llm_answer": "\nEmerson’s pipe‑cutter portfolio moved from the basic mechanical cutters described in the 2022 Tools & Home Products overview (Chunk 1) to a suite that adds battery‑powered hydraulic cutting/crimping functions and built‑in diagnostic equipment such as sewer‑inspection and locating cameras (introduced in the 2023 and 2024 Safety & Productivity segment details, Chunks 2 & 3).  This progression—still routed through the same distributor‑focused channels—shows a clear strategic shift toward portable, battery‑driven tools that embed data‑capture and diagnostic capabilities.  \n\nConsequently, Emerson is positioning itself as a premium, technology‑enabled supplier in the professional plumbing‑tools market, leveraging its broader industrial‑control and measurement expertise to differentiate from traditional tool vendors and to capture high‑margin, safety‑critical segments that demand smart, battery‑operated, diagnostic‑integrated solutions (all three chunks).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Emerson's pipe cutters were basic/mechanical; by 2023, battery-powered hydraulic technology was introduced; and by 2024, diagnostic integration (e.g., sewer inspection and locating cameras) was emphasized. These developments reflect a strategic shift toward portable, tech-enhanced tools. (2) There are no numeric values (e.g., dollar amounts, percentages) in the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across three years and infers a strategic pivot toward high-value, technology-integrated tools, leveraging Emerson’s industrial expertise. It correctly identifies the evolution and market positioning. (4) The LLM adds slight elaboration (e.g., 'data-capture', 'premium supplier', 'high-margin, safety-critical segments') not explicitly in the ground truth, but these are reasonable inferences and do not contradict the original. Only a minor deduction in qualitative accuracy due to slight over-interpretation, but core reasoning and facts remain solid. Contextual relevance is perfect—the answer directly addresses the evolution and strategic implications as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 371,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has GILD's utilization of its Santa Monica, California facility evolved from 2022 through 2024, particularly in relation to clinical manufacturing and processing of cell therapy products, and what does this progression indicate about the facility's strategic role in GILD's manufacturing network?",
      "original_answer": "In 2022, GILD's Santa Monica facility was identified as part of its R&D and manufacturing network but was not specifically highlighted for cell therapy processing. By 2023, the facility was explicitly noted as being utilized for clinical manufacturing and processing of cell therapy products, aligning it with other specialized sites like El Segundo and Frederick. In 2024, the Santa Monica facility retained this role, indicating a continued strategic emphasis on its importance in GILD's cell therapy manufacturing footprint. This progression shows that Santa Monica transitioned from a general R&D site to a dedicated cell therapy manufacturing hub over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 GILD’s Santa Monica, California site has been used exclusively for clinical manufacturing and processing of cell‑therapy products—first listed among the company’s principal facilities in the 2022 filing and then explicitly described in the 2023 and 2024 manufacturing sections as the location where cell‑therapy products are manufactured and processed.  This consistent assignment, together with the KG relationship that shows Santa Monica is an operated site of GILD (ORG → GPE → ORG), demonstrates that the Santa Monica facility functions as a dedicated cell‑therapy hub within GILD’s broader manufacturing network, complementing other GILD sites (e.g., El Segundo, Frederick, Hoofddorp) and leveraging the company’s overall property and capital resources to support pipeline development and future commercial scale‑up.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, but contains a key inaccuracy in the timeline that affects the qualitative reasoning. (1) Correct elements: The LLM correctly identifies that by 2023 and 2024, the Santa Monica facility was explicitly used for clinical manufacturing and processing of cell therapy products, and it accurately situates the facility as a dedicated hub within GILD’s network, complementing sites like El Segundo and Frederick. The entity names, years, and strategic interpretation are contextually appropriate. (2) Quantitative accuracy is perfect: no numerical data is misstated, and the years referenced (2022–2024) align with the ground truth. (3) Multi-hop reasoning is partially flawed: the LLM claims the facility was used 'exclusively for clinical manufacturing and processing of cell-therapy products' starting in 2022, which contradicts the ground truth stating that in 2022 it was part of the R&D and manufacturing network but not specifically highlighted for cell therapy. This overstatement misrepresents the evolution—the transition from general R&D to dedicated cell therapy use is the core of the progression, which the LLM overlooks. (4) Despite this, the answer captures the strategic significance and continuity in 2023–2024 correctly, and the contextual relevance is high as it directly addresses the question’s focus on evolution and strategic role. The correctness score is reduced due to the inaccurate portrayal of the 2022 role, which is a significant detail in the multi-year evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 427,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolve from 2022 to 2024, particularly in terms of supported media types and cross-application collaboration features?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its strategic importance but without detailed functional description. By 2023, Frame.io was described as a cloud-native creative collaboration platform with support for still images, design files, and PDFs, and was integrated with Adobe Premiere Pro and After Effects for frame-specific feedback. In 2024, Frame.io's capabilities were expanded to include support for video beyond post-production workflows—such as casting, location scouting, and marketing campaign management—and was integrated with additional Adobe applications including Photoshop, Lightroom, and Workfront, as well as being positioned as part of Adobe GenStudio for enterprise-scale content production.",
      "llm_answer": "\nIn 2022 Adobe only listed Frame.io as a trademark in its Creative Cloud portfolio (Chunk 1), signaling its early presence. By 2023 the filing began describing Frame.io as a cloud‑native collaboration platform that supports still images, design files and PDFs and integrates directly with Premiere Pro, After Effects and Camera‑to‑Cloud workflows (Chunk 3). The 2024 update expanded this positioning, emphasizing Frame.io’s broader media support—including video‑stage functions such as casting, location scouting and marketing‑campaign review—and its tight integration with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, as well as availability through Adobe GenStudio alongside Adobe Express and Firefly Services (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Frame.io was initially a trademark in 2022, described as a cloud-native platform with support for still images, design files, and PDFs in 2023, and expanded to include video-related functions like casting and location scouting in 2024. Integrations with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and positioning within Adobe GenStudio are all correctly reported. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are used correctly and consistently with the original answer. Format variations are not applicable here, but temporal accuracy is perfect. (3) The multi-hop reasoning is sound—information is synthesized across years and applications, showing evolution over time. The only minor omission is that the 2024 integration with Camera-to-Cloud is mentioned in the LLM answer (from Chunk 3) but not in the ground truth; however, this detail does not contradict and may be supplementary. Also, the mention of Adobe Express and Firefly Services in GenStudio goes slightly beyond the original answer, which only specifies GenStudio for enterprise-scale content production without naming those services. This adds detail but doesn't distort the core truth. (4) The answer is contextually fully relevant, addressing both supported media types and cross-application collaboration features across the three-year evolution. Overall, the response demonstrates strong factual accuracy, correct entity identification, and logical progression—justifying a 9/10 on correctness and qualitative accuracy due to slight over-specification, but full marks on quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 473,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Emerson's (EMR) strategic positioning of Electrical Distribution Equipment evolve across its Discrete Automation segment from 2022 to 2024, particularly in terms of integration with automation technologies and product scope expansion?",
      "original_answer": "In 2022, Electrical Distribution Equipment was positioned as a foundational product within the Industrial Solutions business, used broadly in manufacturing operations as part of integrated solutions. By 2023, it was more specifically embedded within the Discrete Automation segment, appearing alongside programmable automation control systems and software, signaling a stronger link to automation technologies. In 2024, the equipment was further integrated into the Discrete Automation portfolio, now listed alongside electric linear motion solutions and materials joining solutions, indicating a broader product scope and deeper alignment with intelligent automation systems. This 3-year evolution shows EMR's strategic shift to position Electrical Distribution Equipment not just as a standalone offering, but as a core component of its smart, integrated automation solutions for discrete industries.",
      "llm_answer": "\nEmerson first listed Electrical Distribution Equipment as a core component of its **Industrial Solutions** business in the 2022 filing, describing it as part of the broader fluid‑control and pneumatic mechanisms that serve manufacturing operations. By 2023 the company moved this offering into the **Discrete Automation** segment, positioning it alongside solenoid valves, pneumatic actuators, programmable control systems and other automation hardware, thereby expanding the equipment’s role from pure power distribution to an integrated automation node. In 2024 Emerson deepened that integration, linking the Electrical Distribution Equipment to its **Control Systems & Software** platform—so that the equipment can be commanded by measurement‑driven software to adjust valves, pumps and motors—while also broadening the product scope to include digital assets (e.g., AspenTech asset‑optimization software) that enhance overall automation performance.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic evolution of Emerson's Electrical Distribution Equipment from 2022 to 2024. (1) It accurately identifies the 2022 positioning within Industrial Solutions, the 2023 shift into Discrete Automation, and the 2024 deepening of integration—key multi-hop elements across years and segments. Entity accuracy is strong: EMR, correct segment names, and timeframes are used. (2) There are no numeric values to verify, so quantitative accuracy is scored as 10 by default. (3) The reasoning is sound overall, capturing the integration with automation technologies and product scope expansion. However, the LLM introduces 'AspenTech asset-optimization software' in 2024 as part of the product scope, which is not mentioned in the ground truth and represents an overreach or hallucination. The original answer notes integration with electric linear motion and materials joining solutions—not software platforms like AspenTech. This affects qualitative accuracy. Additionally, while the idea of software-controlled adjustment of equipment is plausible, it is not explicitly supported in the ground truth, which focuses on product co-location in the portfolio rather than functional software integration. (4) Despite these minor inaccuracies in detail, the core narrative of strategic repositioning and integration into Discrete Automation is correct and contextually relevant, warranting a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 411,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Capital One's (COF) fixed unsecured senior debt evolve from 2022 through 2024 in terms of carrying value and weighted-average interest rate, and what does this progression suggest about the company's debt strategy in a rising interest rate environment?",
      "original_answer": "Capital One's fixed unsecured senior debt increased from a carrying value of $19,975 million in 2022 to $27,168 million in 2023, then slightly declined to $26,930 million in 2024. The weighted-average interest rate rose from 2.91% in 2022 to 4.45% in 2023, and further to 4.84% in 2024. This indicates a strategy of locking in long-term debt at increasingly higher rates as market conditions changed, suggesting a proactive approach to anticipated rate hikes.",
      "llm_answer": "\nCapital One’s fixed unsecured senior debt carried a book value of **$24.1 bn at the end of 2022** (Chunk 2), rose to **$27.2 bn in 2023** (Chunk 2) and then **declined slightly to $26.9 bn by the end of 2024** (Chunk 3).  During the same periods the weighted‑average interest rate climbed from roughly **2.9 % in the 2022‑2023 window** (the rate disclosed for the prior‑year level in Chunk 1) to **4.45 % in 2023** (Chunk 2) and further to **4.84 % in 2024** (Chunk 3).  This upward shift in both the amount of senior debt outstanding and its cost shows that Capital One is deliberately refinancing its legacy lower‑rate senior notes with longer‑dated issuances at higher rates—an explicit strategy to manage liquidity and funding costs in a rising‑interest‑rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in direction and reasoning but contains a significant quantitative error in the 2022 carrying value. The ground truth reports $19,975 million (or $19.975 billion), but the LLM states $24.1 billion, which is a material overstatement (~20% higher). The 2023 and 2024 carrying values are accurate: $27.2 billion matches $27,168 million (rounded), and $26.9 billion matches $26,930 million. The interest rates are correctly reported: 2.91% in 2022 is approximated as 'roughly 2.9%', which is acceptable; 4.45% in 2023 and 4.84% in 2024 are exact. (2) Calculations: The trend (increase then slight decline in value, steady rate increase) is correctly interpreted. However, the incorrect 2022 base value undermines any derived comparisons (e.g., growth from 2022 to 2023). (3) Multi-hop reasoning is sound: the model synthesizes data across years and correctly infers a strategic intent—locking in long-term debt at higher rates amid rising interest rates. The explanation about refinancing legacy lower-rate debt with longer-dated, higher-rate issuances aligns with the ground truth's 'proactive approach to anticipated rate hikes.' (4) Scores justified: Correctness is 7 due to the major error in 2022 carrying value, which affects quantitative accuracy (score 6); qualitative reasoning and contextual relevance are strong, hence 8 and 10 respectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 388,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's liabilities related to performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities related to performance and operating cost guarantees remained relatively stable from 2022 through 2024, indicating consistent exposure to long-term product performance risks in its commercial aerospace segment. In 2022, the carrying amount of liabilities for these guarantees was $120 million. By 2023, the liability remained unchanged at $120 million, and in 2024, it slightly decreased to $101 million. This stability suggests that RTX's historical estimation methods and accrual adjustments based on claims data and product performance experience have remained effective, with no significant increase in risk exposure despite ongoing obligations tied to commercial aircraft engines.",
      "llm_answer": "\nRTX’s accrued liability for performance‑and‑operating‑cost guarantees has shown a modest upward trend from 2022 through 2024 – the change‑in‑carrying‑amount tables disclosed in the 2022, 2023 and 2024 10‑K filings indicate that the reserve grew from the low‑hundreds of millions (≈ $97 million in the 2022‑2023 period) to about $101 million in the 2024 filing, reflecting the company’s practice of extending guarantees beyond standard warranty periods on commercial‑aircraft engines and of revising accruals as newer durability and claims data become available.  This progression, under a consistent accounting policy that bases the liability on historical experience and adjusts it as claims data warrant, signals that RTX’s exposure to long‑term product‑performance risk in its aerospace business is increasing and is being actively managed through continual reserve updates.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures and mischaracterizes the trend. According to the ground truth, RTX's liabilities were $120 million in both 2022 and 2023, then decreased slightly to $101 million in 2024, indicating stability. However, the LLM claims the liability was approximately $97 million in 2022–2023 and grew to $101 million in 2024, implying an upward trend, which contradicts the stable-to-slightly-decreasing reality. This misstatement of the base values and trend direction severely undermines quantitative accuracy. (2) The numbers are incorrect: $97M vs $120M in 2022 and 2023 is a material error (over 20% difference), and the characterization of growth is false. The 2024 figure of $101M is correct, but it is presented as an increase when it is actually a decrease. No calculations are required in this question, but the comparison over time is flawed. (3) The multi-hop reasoning is partially sound in that the model recognizes the need to track liabilities across years and link them to product performance risk in commercial aerospace. It also correctly references RTX’s use of historical claims data and ongoing accrual adjustments. However, because the underlying data is wrong, the conclusion that 'exposure... is increasing' is incorrect—the ground truth indicates consistent or slightly declining exposure, suggesting stable risk management. (4) Contextual relevance is high because the answer addresses the right topic, metric, business segment, and accounting rationale. The structure follows the question’s requirements, but the factual foundation is flawed. Thus, while the reasoning framework is acceptable, the incorrect data leads to an incorrect interpretation. Correctness score is 4 due to major quantitative errors and an incorrect overall conclusion despite relevant context and partial conceptual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Extends]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 519,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did The Coca-Cola Company's reliance on 'estimates of sales proceeds' as a valuation methodology for nonpublic investments evolve from 2022 through 2024, and what does this reveal about the company's changing approach to fair value assessment in emerging markets?",
      "original_answer": "In 2022, Coca-Cola disclosed the use of 'estimates of sales proceeds' as part of its valuation methodology for nonpublic investments, specifically in the context of impairment assessments where quoted market prices were unavailable. By 2023, the company explicitly stated that it 'relies on' this methodology as a key component of fair value determination for equity and debt securities in nonpublic entities, signaling a deepening dependence on this approach. In 2024, Coca-Cola continued to 'use' estimates of sales proceeds alongside discounted cash flows and appraisals, but with an increased emphasis on the challenges of predicting future cash flows—particularly in emerging and developing markets—suggesting a more cautious application of the methodology over time. This 3-year progression reflects a strategic evolution from disclosure to operational reliance, followed by a risk-aware integration of the method into broader valuation practices.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola repeatedly disclosed that its fair‑value measurements for non‑public equity investments are derived from valuation techniques that include “estimates of sales proceeds” (2022 ↔ 2023 ↔ 2024 filings), with each successive 10‑K expanding the language to “various valuation methodologies, including discounted cash flows, estimates of sales proceeds, and appraisals” and stressing that “the ability to accurately predict future cash flows, especially in emerging and developing markets, may impact the determination of fair value.” This consistent and increasingly detailed emphasis shows a deliberate shift toward using market‑exit‑oriented sales‑proceeds assumptions—particularly in emerging markets—as a core component of the company’s fair‑value assessment, reflecting a more cautious, cash‑flow‑driven approach as the firm’s exposure to non‑public investments in those regions matures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution described in the ground truth. (1) It correctly identifies that Coca-Cola used 'estimates of sales proceeds' in 2022, deepened reliance in 2023, and continued use in 2024 with increased caution—matching the timeline and qualitative shift. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable; however, the years (2022–2024) are correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across three years and correctly infers a strategic shift—from disclosure to reliance to cautious integration—particularly in emerging markets. The LLM emphasizes the growing importance and challenges of cash flow prediction, aligning with the ground truth’s point about risk-aware application. (4) The only minor shortcoming is that the LLM frames the evolution slightly more positively as a 'deliberate shift toward... core component,' while the ground truth highlights a progression from disclosure to reliance, then to a 'more cautious application' due to emerging market uncertainties. This nuance is present but somewhat downplayed in the LLM answer. Overall, the answer is factually correct, contextually precise, and semantically equivalent with excellent reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Uses]- ORG <-[Relies_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 380,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did BNY Mellon's disclosures regarding capital return limitations under U.S. banking laws evolve from 2022 through 2024, and what does this multi-year progression suggest about the company's strategic flexibility in shareholder capital distributions?",
      "original_answer": "In 2022, BNY Mellon disclosed that its ability to return capital to shareholders was limited by U.S. banking laws and regulations, including those governing capital and capital planning, applicable provisions of Delaware law, and its failure to pay full and timely dividends on preferred stock. This language was repeated in 2023 and 2024, showing a consistent regulatory constraint over the three-year period. However, the 2024 disclosure added a new emphasis on the Parent's dependency on dividends from subsidiaries and extensions of credit from its IHC to fund share repurchases and dividends, indicating a growing focus on internal capital flows under continued regulatory scrutiny. This three-year progression suggests that despite stable regulatory language, BNY Mellon faced ongoing limitations in capital return flexibility, with increasing internal structural dependencies shaping its shareholder return strategy.",
      "llm_answer": "\nBNY Mellon’s 2022 10‑K first warned that shareholder capital returns are “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws…including those governing capital and capital planning, applicable provisions of Delaware law and our failure to pay full and timely dividends on our preferred stock” (Chunk 1). The 2023 filing retained that core language but broadened the risk context to include potential rating downgrades, the Title I/II resolution framework and the uncertainties of new business initiatives, reinforcing that any capital‑return decision must also safeguard credit ratings and resolution readiness (Chunk 2). By 2024 the disclosure again emphasized the Board‑driven limitation, now explicitly linking it to effective liquidity management, well‑capitalized status and the same regulatory and rating considerations, thereby reiterating the constraint across three years (Chunk 3). This multi‑year progression shows that BNY Mellon’s strategic flexibility to distribute capital is deliberately circumscribed by regulatory capital adequacy, rating stability and liquidity requirements, leaving limited room to increase shareholder payouts without meeting those stringent conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022–2024) and correctly identifies the consistent disclosure of U.S. banking law limitations on capital returns, including capital planning rules, Delaware law, and preferred stock dividend obligations—matching the ground truth. There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the LLM introduces elements not present in the original answer: specifically, the mention of 'rating downgrades,' 'Title I/II resolution framework,' and 'new business initiatives' in 2023, and 'liquidity management' and 'well-capitalized status' in 2024, which shift focus toward credit ratings and internal risk management rather than the ground truth's emphasis on the Parent’s dependency on subsidiary dividends and IHC credit extensions. While these are plausible regulatory considerations, they misrepresent the specific evolution highlighted in the ground truth—namely, the growing internal structural dependency in 2024. The reasoning is logically sound but synthesizes different aspects of risk disclosure, not the precise multi-hop progression regarding capital distribution mechanics. Thus, while the core constraint is correctly identified and the three-year consistency acknowledged, the nuanced evolution in BNY Mellon’s disclosure about internal capital flows is missed, reducing qualitative accuracy. The answer remains contextually relevant and addresses the strategic flexibility question, but with a slightly different emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 414,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 to 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD consistently highlighted the risk of losing or having modified tax and tariff exemptions as a key concern in its global operations. In 2022, this risk was listed among other geopolitical and economic risks, indicating a general awareness of its potential impact. By 2023, AMD expanded its discussion to include the effects of specific geopolitical events, such as the conflict in Ukraine and tensions between China and Taiwan, which heightened the likelihood of regulatory shifts affecting exemptions. In 2024, the company reiterated this risk in the context of broader macroeconomic and political instability, including the expansion of U.S. export controls and sanctions, suggesting that the regulatory landscape had become more volatile and complex. This progression indicates that AMD's exposure to the risk of losing tax and tariff exemptions has increased over time, driven by both internal expansion and external geopolitical pressures.",
      "llm_answer": "\nAMD first listed “loss or modification of exemptions for taxes and tariffs” as one of several foreign‑country risks in its 2022 filing (Chunk 1). By 2023 and again in 2024 the same exemption risk was explicitly tied to sanctions, export‑control revisions and geopolitical tensions—such as the Ukraine‑Russia and China‑Taiwan disputes—that affect the roughly two‑thirds of AMD’s revenue generated outside the United States (Chunks 2 & 3), indicating a clear rise in exposure. The knowledge‑graph pattern (AMD → Tax/Tariff Exemptions ← REGULATORY_REQUIREMENT ← AMD) shows that the regulatory regime itself is an entity that both influences and is influenced by AMD, underscoring how the growing web of tax, tariff, sanction and export‑control rules is making AMD’s global regulatory environment increasingly complex.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: AMD first mentioned the risk of losing tax/tariff exemptions in 2022 as part of foreign-country risks, then in 2023 and 2024 tied it more explicitly to geopolitical tensions (Ukraine-Russia, China-Taiwan) and regulatory changes like export controls and sanctions. The statement that two-thirds of AMD’s revenue comes from outside the U.S. is consistent with the context and supports the relevance of global regulatory exposure. (2) There are no numeric inaccuracies—no specific dollar amounts are cited, but the percentage 'two-thirds' is reasonable and commonly reported in AMD filings; no calculation errors. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years (2022 → 2023 → 2024) and links increasing risk disclosure to broader geopolitical and regulatory developments, demonstrating an understanding of evolving exposure. It also references a knowledge-graph pattern to reinforce the bidirectional influence between AMD and regulatory regimes, adding analytical depth. (4) The only minor shortcoming is a slight overreach in interpreting the knowledge-graph pattern (which wasn't part of the original answer and may not be visible to the model), but this doesn't introduce factual error—it enhances the explanation without distorting the truth. Overall, the answer captures the trend and its implications accurately, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 424,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 to 2024, and what does this progression reveal about its debt structure and interest rate exposure, particularly in relation to floating unsecured senior debt?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $49.856 billion in 2023, then declined slightly to $45.551 billion in 2024. This trajectory reflects a significant shift in debt composition: in 2022, floating unsecured senior debt stood at $1.709 billion with a weighted-average interest rate of 1.01%, rising sharply in 2023 to $349 million with a much higher rate of 6.75%, and then dropping to $0 in 2024 as the company eliminated this category. Meanwhile, fixed unsecured senior debt increased from $27.168 billion in 2023 to $26.930 billion in 2024 (from $21.045 billion in 2022), with a rising weighted-average interest rate from 2.91% in 2022 to 4.84% in 2024. This evolution indicates a strategic pivot from floating to fixed-rate debt to mitigate interest rate risk in a rising rate environment.",
      "llm_answer": "\nCapital One’s combined short‑term borrowings and long‑term debt was $48.7 bn at the end of 2022 (Chunk 2), rose to $49.9 bn in 2023 (Chunk 2) and then fell to $45.6 bn by the end of 2024 (Chunk 3).  During that span the floating‑rate unsecured senior debt dropped from $1.6 bn (Chunk 2, 2022) to $0.35 bn (Chunk 2, 2023) and was fully eliminated by 2024 (Chunk 3), with its weighted‑average rate climbing from roughly 1 % to 6.75 % before disappearing.  This progression—documented across all three chunks—shows Capital One deliberately reducing floating‑rate exposure and shifting toward a higher‑ proportion of fixed‑rate and securitized financing, thereby lowering future interest‑rate volatility and reshaping its overall debt structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor quantitative inaccuracies. The total short-term borrowings and long-term debt for 2022 is reported as $48.7 billion, whereas the ground truth is $43.086 billion—a notable discrepancy of about $5.6 billion. The 2023 and 2024 figures ($49.9 billion and $45.6 billion) are close to the ground truth values of $49.856 billion and $45.551 billion, respectively, and can be considered acceptable given rounding. Floating-rate unsecured senior debt is reported as $1.6 billion in 2022 (vs. $1.709 billion true value) and $0.35 billion in 2023 (vs. $349 million), which are reasonably close. However, the 2022 total debt error affects the overall accuracy. (2) Calculations and trends are generally sound: the increase from 2022 to 2023 and decline in 2024 are correctly identified, as is the elimination of floating-rate debt by 2024. The interest rate rise from ~1% to 6.75% is accurately captured. However, the LLM omits specific data on fixed unsecured senior debt ($27.168 billion in 2023 to $26.930 billion in 2024) and its rising weighted-average rate (2.91% to 4.84%), which is a key part of the ground truth and the strategic shift narrative. (3) Multi-hop reasoning is strong: the model correctly synthesizes trends across years, identifies the reduction in floating-rate exposure, and infers the strategic intent to reduce interest rate risk. It correctly links the debt composition changes to broader risk management, even without citing fixed-rate debt figures explicitly. (4) The answer is contextually excellent—directly addresses the evolution of debt structure and interest rate exposure, and draws the correct conclusion about strategic rebalancing. Due to the significant error in the 2022 total debt figure and the omission of fixed-rate debt details, the correctness and quantitative accuracy scores are reduced, but qualitative and contextual scores remain high due to sound reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 534,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's net program share interest in International Aero Engines AG (IAE) evolve from 2022 to 2024, and what does this change indicate about RTX's strategic positioning within the V2500 engine program collaboration?",
      "original_answer": "RTX's net program share interest in IAE decreased from 61% in 2022 to 57% in both 2023 and 2024, indicating a strategic adjustment in its collaboration structure. This reduction suggests that RTX gradually diluted its direct economic exposure to the V2500 engine program over the three-year period, potentially shifting more of the program's financial burden or risk to sub-collaborators while maintaining operational coordination.",
      "llm_answer": "\nRTX’s program‑share in International Aero Engines AG dropped from the 61 % stake disclosed in the 2022 filing to a net 57 % interest reported in the 2023 and 2024 filings after adjusting for sub‑collaborator allocations (the net interest in IAE LLC similarly fell to 51 %). This reduction—while RTX continues to consolidate IAE and IAE LLC as variable‑interest entities and remains the primary beneficiary—signals a strategic recalibration of its equity exposure in the V2500 engine program, reflecting a more balanced partnership stance rather than the previously larger program‑share position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the decrease in RTX's net program share interest in IAE from 61% in 2022 to 57% in both 2023 and 2024, matching the ground truth exactly. It also accurately references the adjustment due to sub-collaborator allocations, which aligns with the strategic interpretation in the original answer. The mention of IAE LLC’s net interest falling to 51% is an additional detail not in the ground truth but does not contradict it and may reflect deeper filing insights; however, since this specific figure isn't in the verified knowledge graph, it introduces a minor over-specification without undermining core accuracy.\n\n2) Quantitatively, all key numbers (61%, 57%, years 2022–2024) are correct and properly attributed to the respective filings. No calculation errors; percentages match exactly. Format variations (e.g., 57 %) are acceptable and do not affect meaning.\n\n3) The multi-hop reasoning is sound: the model connects data across three years and interprets the trend as a strategic shift, correctly noting that RTX remains the consolidating entity and primary beneficiary despite reduced economic exposure. This reflects proper synthesis of financial ownership and control concepts.\n\n4) The qualitative interpretation—'strategic recalibration' and 'more balanced partnership stance'—is semantically equivalent to the ground truth’s 'strategic adjustment' and 'diluted direct economic exposure.' While wording differs slightly, the conclusion about reduced financial burden/risk and maintained coordination is logically consistent. The only minor gap is that the LLM does not explicitly mention 'shifting financial burden to sub-collaborators,' but the reference to sub-collaborator adjustments implies this mechanism.\n\nOverall, the answer is factually precise, contextually appropriate, and demonstrates strong reasoning. The slight deduction in qualitative accuracy (9/10) accounts for the extra detail on IAE LLC not present in the ground truth, which, while plausible, isn't verifiable and slightly extends beyond the confirmed facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 557,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Cascade's positioning within P&G's home care portfolio evolved from 2022 to 2024, based on its segment reporting across the three most recent 10-K filings?",
      "original_answer": "Cascade has maintained consistent positioning within P&G's Home Care sub-category under the Fabric & Home Care segment across all three reporting periods. In 2022, Cascade was listed among key brands in the Home Care category within the Fabric & Home Care segment which represented 35% of net sales and 31% of net earnings. In 2023, the Fabric & Home Care segment maintained its prominence at 36% of net sales and 34% of earnings, continuing to feature Cascade among its major brands. By 2024, Cascade remained a core brand in the Home Care sub-category while the segment held steady at 36% of net sales and 34% of earnings. This consistency suggests Cascade has maintained stable strategic importance within P&G's portfolio despite the segment's slight earnings contribution increase from 31% to 34% over the period.",
      "llm_answer": "\nAcross the three filings Cascade is consistently reported as part of P&G’s **Fabric & Home Care** segment (see Chunk 1, 2 & 3), and its brand “Tide Cascade” appears in the major‑brands list each year.  The segment’s share of total net sales rose from **35 % in 2022** (Chunk 3) to **36 % in 2023 and 2024** (Chunks 1 & 2), while its share of total earnings increased from **31 % in 2022** to **34 % in 2023‑2024** (Chunks 3, 1 & 2).  This shows that Cascade’s role within the home‑care portfolio has evolved from a modest‑size contributor in 2022 to a slightly larger and more profitable component by 2024, even though its absolute share of the segment has remained stable.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Cascade as part of P&G's Fabric & Home Care segment across all three years and accurately reports the segment's net sales (35% in 2022, 36% in 2023 and 2024) and net earnings (31% in 2022, 34% in 2023–2024), which matches the ground truth. These numbers are factually correct and properly cited from the filings. 2) Quantitative accuracy is high: all percentages and years are correct, and no calculation errors are present. The increase in segment earnings contribution from 31% to 34% is accurately noted. 3) However, the qualitative reasoning contains a subtle but important misinterpretation: the LLM concludes that Cascade evolved 'from a modest-size contributor in 2022 to a slightly larger and more profitable component by 2024', which implies growth in Cascade’s relative role. The ground truth emphasizes that Cascade’s *positioning* remained 'consistent' and 'stable' within the segment, with no indication of a shift in its internal importance—only that the broader segment grew slightly in earnings contribution. The LLM incorrectly infers brand-level evolution from segment-level trends, failing to distinguish between segment performance and brand-specific changes. 4) Contextual relevance is strong: the answer addresses the evolution question using multi-year data and ties Cascade to the correct segment and brands list. Despite the reasoning flaw, core facts are accurate and relevant, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 405,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did BNY Mellon's disclosures regarding the accessibility and governance of its Directors' Code of Conduct evolve from 2022 to 2024, particularly in terms of URL structure, domain branding, and integration with broader corporate governance frameworks?",
      "original_answer": "In 2022, BNY Mellon provided a URL for the Directors' Code of Conduct under the legacy domain structure (bnymellon.com), specifically pointing to a '/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf' path, indicating a siloed and document-focused approach. In 2023, the company maintained the same domain but slightly adjusted the URL path to '/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf', suggesting minor internal reorganization but no significant change in accessibility or integration. By 2024, BNY Mellon transitioned to a new domain branding ('bny.com') and updated the URL structure to '/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf', aligning the Directors' Code of Conduct more closely with investor relations and signaling a more strategic integration into corporate governance communication. This evolution reflects a shift from a static document repository to a more stakeholder-oriented, brand-consistent governance disclosure strategy.",
      "llm_answer": "\nFrom 2022 to 2024 the URL for BNY Mellon’s Directors’ Code of Conduct shifted from a bnymellon.com path (e.g., https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inrelations/directors‑code‑of‑conduct.pdf in 2022 and https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf in 2023) to a streamlined bny.com address ( https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑ofconduct.pdf in 2024), reflecting a re‑branding and consolidation of the firm’s web domain. Each annual filing (2022, 2023, 2024) continues to place the Code under Item 10 of the Form 10‑K, linking it to the broader Code of Ethics, insider‑trading policies and the overall corporate‑governance framework disclosed in the Proxy, and the KG triplets show the policy is treated as an ACCOUNTING_POLICY of BK that is Subject_To the ORG itself. Consequently, while the substantive governance content remains consistent—detailing applicability to all directors, procedures for amendments/waivers, and integration with other ethical codes—the presentation has evolved from a bnymellon.com hosted PDF to a bny.com hosted PDF within the investor‑relations directory.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All entities—BNY Mellon, the years 2022–2024, the domains bnymellon.com and bny.com, and the document path changes—are correctly identified. The URL evolution is accurately described, including the shift from 'in relations' to 'inv relations' in 2023 and the 2024 move to 'investor-relations' under the bny.com domain. (2) There are no numeric values requiring calculation, but the dates and document paths are factually correct and consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across years and domains, noting both the rebranding and the strategic shift in governance disclosure. It also correctly references the integration with Item 10 of the Form 10-K, the Proxy, and broader corporate governance frameworks, which adds contextual depth. (4) The answer captures the core evolution—domain consolidation, URL restructuring, and alignment with investor relations—though it slightly underemphasizes the shift from a 'siloed, document-focused approach' to a 'stakeholder-oriented strategy' as framed in the original answer. However, the substance is equivalent. Minor formatting differences in URLs (e.g., spacing in 'inv relations') do not affect factual accuracy. Overall, the answer is semantically equivalent, highly relevant, and factually precise, warranting a 9/10 due to slight under-articulation of the strategic implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1597,
        "completion_tokens": 408,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did AMD's strategic positioning with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in differentiation strategies across those years?",
      "original_answer": "From 2022 to 2024, AMD consistently maintained inventory protection policies for AIB manufacturers, ensuring their stock was shielded from price reductions. In 2022, AMD emphasized the role of AIBs in building board-level products for system integrators and retail buyers, with discrete graphics as a key differentiator. By 2023, this positioning remained stable, with continued focus on enabling SIs to differentiate through discrete graphics. In 2024, AMD reiterated the same inventory protections and highlighted the continued importance of discrete graphics solutions as a value-add for SIs. The consistency in policy and strategic emphasis on discrete graphics suggests a stable, long-term partnership model with AIBs across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s contracts with AIB manufacturers repeatedly featured inventory‑protection terms—shielding AIB stock from price reductions and granting return rights—while also granting AMD a direct channel to sell component‑level graphics and chipset products to those AIBs; this policy is documented in the 2022, 2023 and 2024 10‑K filings (Chunks 1‑3).  At the same time, AMD has leveraged discrete‑graphics solutions as a core differentiation tool, working closely with AIBs and system‑integrators (SIs) to embed its GPU technology in board‑level products that SIs use to distinguish their offerings and add value for end‑users, a strategic emphasis that persisted across all three years (Chunks 1‑3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD maintained inventory protection policies from 2022 to 2024, shielding AIB stock from price reductions, which is confirmed in all three years' 10-K filings. The role of discrete graphics as a differentiation tool for system integrators (SIs) is correctly emphasized across the period. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022–2024) are correct. (3) Multi-hop reasoning is sound—information is synthesized across three years and multiple roles (AIBs, SIs, AMD’s direct sales), correctly identifying consistent policy and strategy. (4) The only minor gap is that the LLM adds detail not in the original answer—specifically 'return rights' and 'direct channel to sell component-level graphics and chipset products'—which, while plausible and consistent with the filings, were not explicitly highlighted in the ground truth. This does not make the answer incorrect but introduces slight over-specificity. Overall, the core facts, reasoning, and synthesis are accurate and complete, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Sells_To]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 346,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's disclosure around breakfast menu innovation and supply chain focus evolve from 2022 to 2024, particularly in relation to the Egg McMuffin and its role in meeting customer expectations for quality and consistency?",
      "original_answer": "In 2022, McDonald's disclosed that it offers the Egg McMuffin as part of a full or limited breakfast menu and emphasized its ongoing menu evolution to meet customer expectations around taste, quality, and nutrition. In 2023, the company reiterated the presence of the Egg McMuffin but expanded its narrative around innovation and supply chain collaboration, noting its comprehensive global supply chain strategy led by the Global Chief Supply Chain Officer and a focus on continuous improvement across the supply chain. By 2024, McDonald's placed a stronger emphasis on digital transformation in food safety and quality, with specific mention of a digital transformation project aimed at promoting data excellence and continuous measures on quality and food safety performance, which supports the consistency of core menu items like the Egg McMuffin. This evolution shows a shift from general quality assurance to a more technologically integrated and supply chain-driven approach to maintaining product consistency and meeting customer expectations.",
      "llm_answer": "\nFrom 2022 through 2024 McDonald’s has treated the Egg McMuffin as a flagship breakfast item that both drives menu innovation and anchors its promise of quality and consistency. In 2022 the 10‑K noted the Egg McMuffin as part of a full or limited breakfast menu and emphasized continuous testing of new products, while the 2023 and 2024 filings expanded the focus to a rigorous supply‑chain framework—standardized quality‑management systems, third‑party food‑safety audits, digital monitoring and sustainability commitments—so that the Egg McMuffin’s ingredients and production now meet increasingly strict safety, environmental and customer‑expectation standards across all markets. This evolution reflects a shift from simply offering the Egg McMuffin to using it as a catalyst for tighter, data‑driven supply‑chain controls that safeguard the product’s taste, quality and consistency.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's disclosure from 2022 to 2024 regarding the Egg McMuffin, supply chain focus, and quality consistency. (1) All factual elements are correct: the Egg McMuffin is correctly identified as part of the breakfast menu in 2022 with an emphasis on menu evolution; in 2023, the focus expands to supply chain rigor, including quality systems and audits; and in 2024, digital transformation in food safety and data-driven quality measures are highlighted—all aligning with the ground truth. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and connects the Egg McMuffin to broader strategic shifts in supply chain and digital quality systems. It correctly infers that the item evolved from a menu offering to a symbol of operational excellence. (4) The only minor gap is that the LLM does not explicitly name the 'Global Chief Supply Chain Officer' as mentioned in the 2023 disclosure in the original answer, and slightly overemphasizes sustainability (not a highlighted focus in the ground truth for this context). However, the core narrative of shifting from general quality assurance to a data-driven, supply-chain-integrated approach is preserved and well-articulated. Wording differs but semantic equivalence is strong. Thus, the answer is excellent with only slight omissions in specific role attribution, not affecting overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Features]- ORG <-[Features]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 443,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "What does the consistent disclosure of Oracle's 4.30% Note due 2034 in its filings for 2022, 2023, and 2024 indicate about the company's long-term debt structure and financing priorities across these reporting periods?",
      "original_answer": "Oracle's 4.30% Note due 2034 was disclosed in filings for all three years — 2022, 2023, and 2024 — indicating that the instrument remained a persistent and notable component of Oracle’s long-term debt portfolio. In 2022, the note was listed alongside other instruments such as the 3.625% Note due 2023 and the 4.50% Note due 2044, suggesting a diversified maturity profile. In 2023, the 4.30% Note due 2034 was disclosed alongside newer instruments like the 2.950% Notes due 2024, showing Oracle’s continued reliance on long-dated debt while also issuing shorter-term instruments. In 2024, the note remained included in disclosures, reinforcing its ongoing relevance in Oracle’s capital structure. This consistent inclusion suggests Oracle has maintained a strategic focus on long-term financing, with the 4.30% Note due 2034 serving as a stable element within a broader, evolving debt portfolio.",
      "llm_answer": "\nThe 4.30 % Note due 2034 is listed in the Exhibit 4.09 filings of Oracle’s 2022, 2023 and 2024 10‑Ks (Chunk 1, 2, 3), showing that the same long‑dated, fixed‑rate instrument remains a core element of the company’s debt program across all three reporting periods.  In the knowledge‑graph this is captured by the recurring ORCL → 4.30 % Note 2034 (FIN_INST) → ORG triplet, indicating that Oracle continuously “introduces” this financing vehicle and that the note is repeatedly “introduced” by the issuer itself.  This consistency signals that Oracle’s long‑term debt strategy prioritises stable, medium‑term funding at predictable rates, reinforcing a disciplined capital structure and confidence in its future cash‑flow generation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 4.30% Note due 2034 is correctly identified with the right interest rate and maturity date, and its presence in Oracle's 2022, 2023, and 2024 filings is accurately stated. There are no calculation errors, and the temporal scope matches the ground truth. Entity accuracy is strong—Oracle (ORCL), the financial instrument, and the reporting years are all correct. The reasoning is mostly sound and captures the core implication: the consistent disclosure indicates the note is a stable, long-term component of Oracle’s debt structure, reflecting a strategy of predictable, fixed-rate financing. However, the LLM answer omits key contextual details present in the original answer that demonstrate multi-hop synthesis: it does not mention the broader debt portfolio (e.g., the 3.625% Note due 2023, 4.50% Note due 2044, or 2.950% Notes due 2024), nor does it show how Oracle’s debt strategy evolved across years by combining long- and short-term instruments. This limits the depth of the qualitative analysis. The reference to the 'knowledge-graph triplet' and 'introduces' is semantically awkward and slightly misrepresents the nature of recurring disclosures (the note isn’t re-issued annually). Despite this, the core conclusion about strategic, stable financing is valid and contextually relevant. The answer addresses the main question but lacks the comparative, multi-year portfolio analysis that would warrant a 9–10 on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 415,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Capital One's (COF) net derivative assets/liabilities valuation methodology and fair value amounts evolve from 2022 to 2024, and what does this reveal about the company's exposure to unobservable market inputs over time?",
      "original_answer": "In 2022, Capital One reported net derivative assets/liabilities at a fair value of $19 million, with a net unrealized loss of $20 million still held as of year-end. By 2023, the fair value of net derivative assets/liabilities was disclosed at $58 million, with unobservable inputs including default rates (53–163%) and swap rates (3–5%) factored into the valuation. In 2024, the company maintained the same $58 million fair value for net derivative assets/liabilities, with continued reliance on swap rates (3–5%) as a key unobservable input. This indicates a transformation in valuation methodology from a mixed realized/unrealized loss position in 2022 to a more stable fair value by 2023–2024, with increasing transparency and reliance on structured unobservable inputs, particularly swap rates, signaling a more defined risk profile around derivative exposures.",
      "llm_answer": "\nCapital One’s net‑derivative‑asset/liability fair‑value rose from a Level‑3 balance of roughly $19 million (as disclosed in the 2022 filing for 2021) – where inputs such as RMBS/CMBS prepayment, loss‑severity and retained‑interest cash‑flow assumptions were used – to a disclosed $58 million fair value in 2024 (Chunk 3), with the valuation now built on discounted‑cash‑flow models that incorporate observable swap‑rate ranges of 3‑5 % (weighted‑average 4 %) and default‑rate ranges of 53‑163 % (weighted‑average 4 %) (Chunk 2 & 3). This evolution reflects a growing reliance on unobservable market inputs—particularly default, loss‑severity, prepayment and swap‑rate assumptions—whose ranges have widened over the three years, indicating that the company’s exposure to Level‑3 valuation uncertainty has increased markedly from 2022 through 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies in key areas. (1) Quantitative Accuracy: The LLM incorrectly states that the $19 million fair value was from the 2022 filing for 2021, while the ground truth clearly states it is for 2022. This misalignment in year is a critical error. The $58 million fair value is correctly reported for 2024, but the ground truth shows it was already present in 2023, not introduced in 2024. The LLM omits the 2023 data point entirely, breaking the multi-year evolution. Additionally, the default rate weighted-average of 4% contradicts the 53–163% range (which is extremely high and likely a data anomaly or misinterpretation), and presenting it as having a 4% weighted average is factually inconsistent. (2) Completeness: The answer fails to mention the 2023 fair value disclosure, skipping a key transitional year, and omits the $20 million net unrealized loss held at year-end 2022, which is central to the methodology shift. (3) Entity Accuracy: While Capital One (COF) is correctly identified, the years associated with the disclosures are misaligned. The mention of RMBS/CMBS inputs, while possibly accurate for earlier years, is not supported in the ground truth for 2022–2024 and appears to conflate historical practices with current ones. (4) Reasoning: The conclusion that exposure to Level-3 uncertainty has 'increased markedly' contradicts the ground truth, which suggests stabilization in 2023–2024 and increased transparency, not rising uncertainty. The reasoning is therefore flawed despite some correct elements. (5) Semantic Equivalence: While the general direction of increased use of unobservable inputs is partially supported, the specific evolution and interpretation differ significantly. The LLM invents a narrative of widening input ranges and growing uncertainty not present in the ground truth. Overall, the answer gets some numbers approximately right but misrepresents the timeline, omits key data, and draws an incorrect conclusion about risk exposure evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 557,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of payment structure and amortization strategy related to the V2500-powered aircraft flight hours?",
      "original_answer": "From 2022 through 2024, RTX's financial obligations to Rolls-Royce remained tied to flight hours of V2500-powered aircraft through a long-term payment structure established in the 2012 acquisition of Rolls-Royce’s stake in IAE. In 2022, these payments were described as contingent liabilities included in 'Other commercial aerospace commitments' and were to be capitalized as collaboration intangible assets as payments were made. By 2023, RTX clarified that these flight-hour payments were being capitalized as collaboration assets and amortized to cost of sales. In 2024, the total commercial aerospace financing and other commitments stood at $14.1 billion, with Rolls-Royce payments still structured on a per-hour-flown basis through June 2027. The amortization policy remained consistent, but the transparency around how these payments were integrated into intangible asset management improved over time.",
      "llm_answer": "\nIn 2022 RTX disclosed that the V2500‑powered aircraft flight‑hour payments to Rolls‑Royce are part of “Other commercial aerospace commitments” and are capitalized as collaboration intangible assets, to be amortized over the underlying economic‑benefit period (Chunk 1).  \nBy 2023 the company explained that these finite‑lived intangible assets are amortized on a pattern‑of‑benefit basis—generally straight‑line after programs move to full‑rate production—so the amortization charge is recorded as a reduction of cost of sales (Chunk 3).  \nThe 2024 filing shows the same flight‑hour‑contingent payments still included in “Other commercial aerospace commitments,” now reflected in a $14.6 billion gross commitment figure and a maturity schedule that continues to accrue and amortize the intangible assets through June 2027 (Chunk 2).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the evolution of RTX's financial obligations to Rolls-Royce from 2022 to 2024, including the payment structure based on V2500 flight hours and the accounting treatment involving capitalization as collaboration intangible assets and amortization to cost of sales. The reasoning across years is sound and entities (RTX, Rolls-Royce, IAE, V2500) are accurately referenced. 2) However, there is a quantitative discrepancy in the 2024 total commitment amount: the LLM states $14.6 billion, while the ground truth specifies $14.1 billion. This is a material difference that affects quantitative accuracy. Additionally, the LLM correctly notes the June 2027 end date, aligning with the ground truth. 3) The multi-hop reasoning is strong—LLM synthesizes information across three years, correctly tracing the evolution from contingent liability disclosure (2022), to amortization method (2023), to updated commitment total and timeline (2024). The explanation of amortization policy (pattern-of-benefit, generally straight-line) adds useful detail not contradicted by the ground truth. 4) Despite the dollar amount error, the answer is contextually complete and relevant, conveying the core financial and accounting evolution accurately. The $0.5 billion difference prevents a higher score, but the overall structure, logic, and qualitative accuracy are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Supplies]- ORG <-[Enters_Agreement_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 383,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did Amgen's disclosures regarding user complaints and risk mitigation for the Neulasta Onpro kit evolve from 2022 through 2024, particularly in terms of device-related enhancements and operational resilience measures?",
      "original_answer": "Amgen’s disclosures show a consistent focus on user complaints related to the Neulasta Onpro kit across all three years. In 2022, Amgen referenced the 2017 FDA evaluation of the device and described how it implemented device and labeling enhancements in response to product complaints. In 2023, Amgen reiterated these enhancements and emphasized its ongoing monitoring of complaints and adverse events, indicating a sustained commitment to device safety and regulatory compliance. By 2024, Amgen expanded its disclosures to include operational resilience measures, noting that it had relied on backup generators multiple times due to Puerto Rico's unstable electric grid, including during an island-wide outage on December 31, 2024. While the core risk of device-related complaints remained consistent, Amgen’s disclosures evolved to include broader operational risks, such as infrastructure instability, which could affect device production and thus indirectly influence user experience and complaints.",
      "llm_answer": "\nFrom 2022 through 2024 Amgen repeatedly disclosed that the Neulasta Onpro kit remained under regulatory scrutiny—first flagged in 2017 when the FDA evaluated the device—and that it continuously monitors user complaints and adverse events, implementing device‑ and labeling‑enhancements each year to mitigate risk; the 2022 filing introduced this 2017 FDA review and the ongoing enhancement cycle, the 2023 filing reiterated the same monitoring and enhancement approach, and the 2024 filing added a specific reference to the December 31 2024 island‑wide power outage and the resulting reliance on backup generators as part of its resilience strategy. Across all three years Amgen emphasized that, in addition to device‑related improvements, it strengthens operational resilience by maintaining redundant manufacturing capacity in Puerto Rico and Thousand Oaks and by using backup power systems to offset the impact of hurricanes, earthquakes and grid instability on its supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the 2017 FDA evaluation is properly referenced, device- and labeling-enhancements in response to complaints are accurately described for 2022, ongoing monitoring is correctly attributed to 2023, and the December 31, 2024 island-wide outage with reliance on backup generators is correctly stated. (2) Quantitative accuracy is perfect: dates (2017, 2022–2024, December 31, 2024) are correct; no numerical errors in calculations or misstatements. (3) Multi-hop reasoning is sound—information is synthesized across three years and two domains (device-related risk mitigation and operational resilience), correctly showing an evolution in disclosures. The only minor gap is that the original answer specifies Puerto Rico’s unstable grid as the reason for backup generator use, while the LLM generalizes to hurricanes, earthquakes, and grid instability—adding plausible context not explicitly confirmed in the ground truth. This slight over-extension slightly affects qualitative accuracy but does not introduce factual error. (4) The answer is fully contextually relevant, directly addressing the evolution of disclosures on user complaints, device enhancements, and operational resilience. Wording differs but semantic meaning matches. Minor deduction from 10 to 9 on correctness due to inferred (though reasonable) expansion of infrastructure risks beyond what was explicitly disclosed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Depends_On]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 409,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve from 2022 to 2024, and what does the consistent mention of KPMG's PCAOB firm number 185 across all three filings suggest about BK's audit governance continuity?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in each of the 2022, 2023, and 2024 filings, with no substantive changes in the structure or framing of the disclosure across the years. In all three years, KPMG LLP's PCAOB firm identification number was explicitly stated as 185, indicating no change in the external audit firm responsible for financial reporting. This consistency suggests that BK maintained stable audit governance practices over the three-year period, with no indication of auditor rotation or changes in external audit oversight. The unchanged PCAOB number further confirms the ongoing relationship with KPMG, signaling continuity and potentially strong institutional trust in the firm’s audit services.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K proxy statements (Chunks 1‑3), BK each year includes the same Item 14 disclosure that “Item 3 – Ratification of KPMG LLP” will be voted on and explicitly notes that KPMG LLP’s PCAOB firm identification number is 185. All three chunks therefore contain an identical reference to the ratification of KPMG LLP as the principal accountant and to its fixed PCAOB number. The repeated, unchanged language and the consistent PCAOB identifier show that BK’s audit‑governance framework has remained continuous, consistently relying on the same registered public accounting firm with no alteration in its PCAOB registration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: BK disclosed the ratification of KPMG LLP as principal accountant in 2022, 2023, and 2024; the PCAOB firm number 185 is consistently mentioned across all three years. There are no numeric or date inaccuracies—PCAOB number 185 is correctly cited, and the three-year span is properly referenced. (2) Quantitative accuracy is perfect: no calculations are required, but the consistent identification of the PCAOB number and years is correct. (3) The reasoning is sound: the LLM correctly infers that unchanged language and the same PCAOB number indicate continuity in audit governance and reliance on the same audit firm. It captures the implication of stable audit oversight, though it does not explicitly mention 'auditor rotation' or 'institutional trust' as in the original, slightly reducing depth in qualitative synthesis. (4) The answer is fully contextually relevant, addressing both parts of the question—evolution (or lack thereof) in disclosure and the significance of the PCAOB number. The only minor shortcoming is a slightly less nuanced interpretation of governance implications compared to the original’s mention of 'strong institutional trust' and 'no indication of auditor rotation,' but the core reasoning remains valid. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 402,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk management strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees showed a gradual decline in the collaboration partners' share of these guarantees over the three-year period. In 2022, the collaboration partners' share was $142 million, which decreased to $135 million in 2023 and further dropped to $131 million in 2024. This consistent downward trend indicates a strategic reduction in shared financial risk with partners, potentially reflecting a shift in how RTX structures its aerospace financing arrangements or a deliberate move to reduce contingent liabilities. Throughout this period, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the value of the guarantees net of reserves, suggesting continued confidence in the underlying asset values despite reducing exposure.",
      "llm_answer": "\nRTX’s commercial‑aerospace customer‑financing guarantees have been steadily contracting from 2022 through 2024 – the share of those guarantees that is covered by collaboration partners fell from roughly **$140 million in 2022** (Chunk 3), to **$135 million in 2023** (Chunk 2 & 3), to **$131 million in 2024** (Chunk 2).  This downward trend shows that RTX is increasingly **retaining the risk internally** rather than passing it to partners, reflecting a more conservative risk‑management approach that relies on its own accrual methodology and tighter underwriting of residual‑value and performance guarantees (as described in the accrual policy of Chunk 1 and the liability‑incurrence disclosures across all three filings).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the numerical values for the collaboration partners' share of guarantees in 2023 ($135M) and 2024 ($131M), and approximates the 2022 value as 'roughly $140 million' instead of the exact $142 million. This minor inaccuracy in the 2022 figure reduces quantitative precision but does not severely distort the trend. 2) The quantitative trend — a decline from $142M to $135M to $131M — is mostly accurate, though the misstatement of the 2022 value as $140M introduces a small error. Calculations or comparisons based on these numbers would still reflect a downward trend, so the overall direction is preserved. 3) The reasoning, however, contains a critical error: the LLM concludes that the decreasing partner share means RTX is 'retaining the risk internally' and adopting a 'more conservative risk-management approach.' This misinterprets the situation. The original answer states that the declining partner share reflects a 'strategic reduction in shared financial risk with partners,' which implies RTX is reducing overall contingent liabilities, not taking on more risk. The trend suggests de-risking, not internalizing risk. This is a major qualitative flaw in multi-hop reasoning. 4) The LLM references 'accrual methodology' and 'underwriting' from internal policies (Chunk 1), but incorrectly links tighter underwriting to increased internal risk retention, which contradicts the ground truth that RTX maintains confidence in asset values while reducing exposure. The contextual relevance is high because the answer addresses both the trend and risk management implications, but the conclusion is factually inverted. Thus, while numbers are mostly correct and the context is relevant, the core interpretation is flawed, warranting a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Has_Stake_In]- ORG <-[Incurs_Liabilities_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 486,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did Procter & Gamble's positioning of the Always brand within its Feminine Care portfolio evolve from 2022 through 2024, particularly in terms of product categorization and brand emphasis relative to other feminine hygiene offerings?",
      "original_answer": "In 2022, Always was listed under 'Feminine Care' alongside Tampax, with the segment contributing 25% of net sales. In 2023, the segment was renamed 'Baby, Feminine & Family Care' and contributed 24% of net sales, with Always positioned alongside Always Discreet and Tampax. By 2024, the segment retained the same structure and percentage contribution, but the formatting of product categories was streamlined, reflecting a more consolidated approach to brand presentation. This evolution shows a consistent strategic emphasis on Always within the feminine hygiene category, with minor structural refinements over time.",
      "llm_answer": "\nAcross the 2022‑2024 fiscal years P&G kept **Always** in the **“Feminine Care (Adult Incontinence, Menstrual Care)”** sub‑category of its **Baby, Feminine & Family Care** segment, listing it alongside Tampax Bounty and Always Discreet each year; the categorization did not change, and the brand’s relative emphasis remained stable—Always is consistently presented as a core offering (often listed first among the feminine‑hygiene brands), underscoring its ongoing importance within the portfolio.  The KG triplets (PG → Always, Always → PG) reflect that P&G both announces and produces the Always brand, reinforcing the sustained brand‑ownership relationship throughout the three years.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. It incorrectly states that Always was in the 'Baby, Feminine & Family Care' segment starting in 2022, while the original answer clarifies that the segment was renamed to this in 2023, not 2022. In 2022, the segment was still called 'Feminine Care'. This misrepresentation of the timeline undermines the factual accuracy. Additionally, the LLM mentions 'Always Discreet' and 'Tampax Bounty' as consistent co-brands across all years, but 'Bounty' is not a feminine hygiene brand and does not belong in this category—this is a clear entity error. The answer also fails to mention the net sales contribution percentages (25% in 2022, 24% in 2023 and 2024), which are key quantitative elements in the original answer. (2) Quantitative accuracy is low because the LLM omits all percentages entirely and introduces a false product (Bounty), which distorts the data. There are no correct numerical values cited from the ground truth. (3) The reasoning is partially sound in that it identifies Always as a consistently emphasized brand, which aligns with the original conclusion about strategic emphasis. However, the multi-hop synthesis is flawed due to incorrect segment naming across years and inclusion of irrelevant brands. The evolution of categorization—renaming in 2023 and formatting streamlining in 2024—is not accurately reflected. (4) Despite these issues, the answer is contextually relevant, addressing the core question about brand positioning and evolution. It correctly identifies Always as a core brand and notes stable emphasis, which captures part of the intended insight. However, the factual and structural errors reduce overall correctness to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 483,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in Asia?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and deepening reliance on third-party manufacturing in Asia. In 2022, AMD noted that its global operations posed challenges in protecting intellectual property, particularly in foreign jurisdictions. By 2023, the company emphasized its increasing international sales (65% of net revenue) and reliance on third-party manufacturing in China, Malaysia, and Taiwan, heightening exposure to IP risks in those regions. In 2024, AMD reiterated these concerns while also noting the geopolitical tensions between China and Taiwan as a new layer of risk that could disrupt its manufacturing partners and adversely affect its business. This 3-year progression shows AMD's IP protection challenges becoming more complex and regionally concentrated, especially in Asia, as its global footprint and outsourcing model expanded.",
      "llm_answer": "\nAMD first listed “difficulties in protecting our intellectual property” as one of many foreign‑country risks in its 2022 filing (Chunk 1), and by 2023 the company highlighted that ≈ 65 % of its revenue came from international markets and that nearly all product assembly was outsourced to third‑party fabs in China, Malaysia and Taiwan—making IP protection a more central concern tied to its Asian supply chain (Chunk 2).  The 2024 filing shows international sales rising to ≈ 66 % of revenue and again identifies IP‑protection difficulties among the key political, legal and economic risks, explicitly linking them to the expanding reliance on Asian third‑party manufacturing and the heightened geopolitical exposure in Taiwan and China (Chunk 3).  Consequently, AMD’s exposure to IP‑protection challenges has steadily intensified as its international operations and Asian manufacturing dependence have grown.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: AMD first highlighted IP protection risks in 2022, emphasized 65% international revenue and third-party manufacturing in China, Malaysia, and Taiwan in 2023, and in 2024 noted rising international sales (~66%) and increased geopolitical risk due to China-Taiwan tensions. The numbers match the original answer (65% in 2023, ~66% in 2024), and the progression across years is correctly represented. (2) Quantitative accuracy is perfect: percentages are correctly cited with appropriate approximations (≈65%, ≈66%), and no calculations are required beyond what is reported. (3) Multi-hop reasoning is sound—LLM synthesizes information across three years and links increasing international operations and Asian manufacturing to growing IP exposure. It correctly identifies the evolving context, including geopolitical risks in 2024. (4) The only minor shortcoming is that the LLM does not explicitly state that the *complexity* and *regional concentration* of IP risks increased, as emphasized in the original answer’s conclusion. However, this is implied through the description of intensifying exposure. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually complete, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 377,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve from 2022 to 2024, and what does this multi-year pattern reveal about the company's broader debt financing strategy?",
      "original_answer": "Oracle first referenced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which included other notes issued in March 2021. In 2023, the company again included the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity in its disclosure of this instrument alongside newer notes issued in late 2022 and early 2023. In 2024, Oracle once more carried forward the 2.300% Notes due 2028 in Exhibit 4.14, keeping it visible among its active debt instruments. The consistent inclusion of these notes across all three years indicates Oracle's ongoing reliance on this specific debt structure, suggesting a stable and deliberate approach to long-term financing with an emphasis on maintaining a diverse maturity profile.",
      "llm_answer": "\nOracle first disclosed the terms of its 2.300 % Notes due 2028 in an 8‑K filed on March 24 2021 (see Exhibit 4.16 in the 2022 10‑K), and that same prospectus was subsequently re‑filed unchanged in the 2023 and 2024 10‑Ks, indicating no new structuring or issuance of the notes after the initial 2021 placement.  At the same time, the company continued to register additional bond tranches—such as the 5.8 % Notes due 2029 in 2022 and the 4.5 % Notes due 2028 in 2023—demonstrating a multi‑year, laddered debt‑financing strategy that diversifies maturities and coupon mix while maintaining a stable core borrowing base.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy in the timeline of disclosure. (1) Quantitatively, all percentages, years, and note details (e.g., 2.300% Notes due 2028, 5.8% Notes due 2029 in 2022, 4.5% Notes due 2028 in 2023) are accurate. The reference to Exhibit 4.16 in the 2022 10-K is consistent with the original answer. (2) However, the LLM claims the 8-K was filed on March 24, 2021, which is not confirmed or mentioned in the ground truth; while this may be factually correct externally, it introduces a specific date not present in the source knowledge, making it an unsupported addition. The original answer only states that the notes were referenced in 2022 as part of a broader set tied to March 2021 issuances. (3) The reasoning is sound: the LLM correctly infers that the unchanged re-filing in 2023 and 2024 indicates no new structuring, and it appropriately contextualizes this within a broader laddered debt strategy, synthesizing multi-year disclosures and additional bond tranches. This reflects strong multi-hop reasoning. (4) The answer is semantically equivalent in intent and meaning to the ground truth—both emphasize continuity of disclosure and a diversified maturity profile—though the LLM adds slightly more detail about other notes. The core conclusion about Oracle’s stable, deliberate, and diversified financing strategy matches. Minor deduction from 9 to 8 on correctness due to the unverified date and slight overprecision in claiming the 8-K filing context not present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 432,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did BA's investment strategy in Private Equity Vehicles evolve from 2022 through 2024, particularly in terms of the geographic scope and strategic focus areas of its limited partnership investments?",
      "original_answer": "In 2022, BA's Private Equity Vehicles primarily invested in U.S. and non-U.S. leveraged buyout, venture capital, growth, and special situation strategies, with real estate investments also including publicly traded vehicles like REITs. By 2023, the focus remained on U.S. and non-U.S. leveraged buyout and venture capital strategies, but with an expanded emphasis on global private investments in real assets such as energy, farmland, and infrastructure. In 2024, the firm maintained this global orientation but showed increased sophistication in investment vehicles, including the use of derivatives to enhance exposure and performance transfer across asset classes. This progression indicates a strategic deepening in global private equity allocation and a broader integration of alternative investment tools.",
      "llm_answer": "\nFrom 2022 through 2024 BA’s private‑equity strategy remained centered on limited‑partnership (LP) vehicles that invest across the United States and non‑U.S. markets in leveraged buyouts, venture capital, growth and special‑situation opportunities, with a consistent geographic scope of “U.S. and non‑U.S.” — but the way it accessed real‑estate and broader real‑asset exposure evolved.  In 2022 the filing noted that real‑estate and real‑asset investments could be held not only through LPs but also via publicly traded REITs, whereas the 2023 and 2024 descriptions dropped the REIT reference and emphasized global private‑investment holdings solely through LPs or other fund structures, underscoring a shift toward direct LP‑based exposure while still covering natural‑resource, commodity and infrastructure allocations worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of geographic scope and evolution of strategic focus. It accurately identifies the consistent 'U.S. and non-U.S.' geographic scope across 2022–2024 and correctly notes the shift from including publicly traded REITs in 2022 to emphasizing private, LP-based real-asset investments in 2023 and 2024. The mention of global private investments in natural resources, commodities, and infrastructure aligns with the ground truth's emphasis on energy, farmland, and infrastructure. However, the LLM answer omits the specific 2024 development regarding the increased use of derivatives for performance transfer and exposure enhancement, which is a key element of the strategic deepening mentioned in the original answer. This is a meaningful omission affecting completeness, particularly in capturing the 'increased sophistication in investment vehicles' in 2024. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are presented), and the reasoning is sound in tracing the shift away from public real estate vehicles. The answer remains contextually relevant and semantically close to the original, but the missing 2024 nuance prevents a top score. Thus, correctness is rated 8/10, with high marks for accuracy and relevance, and a slight deduction in qualitative accuracy for incomplete synthesis of the 2024 evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 395,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Amgen's development and patent positioning of Bemarituzumab evolve from 2022 through 2024, particularly in terms of clinical phase progression and estimated U.S. and European patent expiration timelines?",
      "original_answer": "In 2022, Amgen initiated a phase 3 study for Bemarituzumab for GEJ adenocarcinoma. By 2023, Amgen disclosed that Bemarituzumab was protected by polypeptide-related patents set to expire in 2029 in both the U.S. and Europe. In 2024, Amgen provided further context on Bemarituzumab, describing it as a monoclonal antibody targeting FGFR2b for gastric and gastroesophageal junction cancer, while reiterating the importance of both patent and regulatory exclusivity in extending its market protection. The molecule progressed through clinical development while maintaining consistent patent expiration estimates, suggesting a stable intellectual property position supporting its clinical advancement.",
      "llm_answer": "\nAmgen first placed bemarituzumab into a **Phase 3 trial in 2022** for GEJ adenocarcinoma (Chunk 3), and the program remained in that late‑stage phase through 2023‑2024 as reflected in the 2024 filing (Chunk 2).  Patent exclusivity for the molecule is projected to **expire in 2029 in both the United States and Europe**, based on the current issued patent portfolio (Chunk 1), with the 2024 disclosure noting that these dates are subject to challenge, potential term adjustments, or supplemental protection certificates (Chunk 2).  Thus, from 2022 to 2024 the asset moved from Phase 2/3 initiation toward advanced clinical evaluation while its U.S. and European patent protection was set to hold until 2029.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: Bemarituzumab entered Phase 3 in 2022 (correct year and indication), and patent expiration is accurately stated as 2029 in both the U.S. and Europe. These dates match the original answer exactly. (2) The answer correctly notes that clinical development progressed into advanced stages (Phase 3) and remained there through 2024, which is consistent with the original answer’s description of ongoing clinical advancement. (3) The LLM adds a nuance not in the original answer—mentioning that patent terms are subject to challenge, adjustments, or supplemental protection certificates (SPCs), particularly in Europe—which is a reasonable qualification based on standard patent practices and enhances accuracy without contradicting the ground truth. (4) The only minor deviation is the phrase 'moved from Phase 2/3 initiation,' which slightly mischaracterizes the 2022 event as a Phase 2/3 trial, whereas the original specifies a Phase 3 initiation. However, this does not materially affect the correctness, as the core progression into Phase 3 in 2022 is accurate. (5) Multi-hop reasoning is sound: the LLM synthesizes clinical phase progression (2022–2024) with patent timelines across jurisdictions, correctly linking development and IP strategy. (6) Semantic equivalence is strong—core facts, entities, years, and implications are preserved. The answer is contextually relevant, directly addressing both clinical and patent aspects of Bemarituzumab’s evolution. Overall, this is a factually correct, well-reasoned response with only negligible wording imprecision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 458,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Dawn's positioning within Procter & Gamble's Fabric & Home Care segment evolve from 2022 to 2024, based on the segment's earnings contribution and brand listings across those years?",
      "original_answer": "Dawn remained a consistently listed brand within the Fabric & Home Care segment across all three years. In 2022, the segment contributed 31% to P&G’s net earnings, increasing slightly to 34% in 2024, suggesting a growing earnings importance of the segment, which includes Dawn. Despite this increase in earnings contribution, the segment’s percentage of net sales remained stable at 35% in 2022 and 36% in both 2023 and 2024, indicating that Dawn continued to be strategically positioned within a high-performing and stable segment. The consistent inclusion of Dawn in the brand listings for Fabric & Home Care across all three years reinforces its ongoing relevance and positioning within the household cleaning portfolio.",
      "llm_answer": "\nDawn has been listed as a core brand in P&G’s **Fabric & Home Care** segment in every year shown—2022, 2023 and 2024—so its market presence remained stable.  At the same time, the segment’s contribution to P&G’s **net earnings** grew from **31 % in 2022** to **34 % in both 2023 and 2024** (while its sales share held steady around 35‑36 %), indicating that Dawn’s role within the segment became increasingly important to the segment’s rising profitability.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the earnings contribution timeline. According to the ground truth, the Fabric & Home Care segment's net earnings contribution was 31% in 2022 and increased to 34% in 2024, but the LLM incorrectly states it was 34% in both 2023 and 2024. The ground truth does not specify 2023's earnings percentage, so asserting it was already 34% in 2023 is an overreach. However, all other numbers are accurate: the segment’s net sales percentage was 35% in 2022 and 36% in 2023 and 2024, which the LLM correctly notes as stable. The entity identification (Dawn, Fabric & Home Care segment, P&G) and years are correct. The reasoning is sound in linking Dawn’s stable listing to its ongoing strategic role and connecting rising earnings contribution to increased profitability importance, even if sales share was stable. The answer addresses all parts of the question—brand listing consistency and evolution of positioning via financial performance—making it contextually complete and relevant. The wording differs slightly from the original but maintains semantic equivalence on key points, except for the erroneous 2023 earnings claim. This is a minor factual error affecting quantitative precision but not the overall conclusion, hence a score of 8/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 366,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did Charles Schwab's use and pledging of client securities evolve from 2022 through 2024, particularly in relation to margin lending and collateral obligations, and what does this trend indicate about the company's exposure to client-held assets?",
      "original_answer": "In 2022, Schwab disclosed the fair value of client securities that could be used as collateral for margin loans, indicating active pledging practices. By 2023, the company maintained margin loan collateral under ASC 326, applying a practical expedient that reduced expected credit losses when collateral value exceeded loan amounts, and allowed pledging of collateralized securities in accordance with federal regulations. In 2024, Schwab continued pledging client securities, particularly for clients writing listed options cleared by the Options Clearing Corporation, and also provided cash collateral to clients in securities lending activities. This 3-year trend shows an increasing sophistication and exposure in how Schwab utilizes client securities for operational and regulatory purposes, reflecting both strategic risk management and growing client engagement in leveraged activities.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab repeatedly pledged client‑held securities to meet federal margin‑requirements and clearing‑house rules—2022 disclosed the fair‑value of securities that could be used as collateral and those already pledged, 2023 expanded the practice to options‑clearing and securities‑lending (using both securities and cash as collateral) and introduced the 2023 IDA sweep that moves uninvested client cash to TD depositories, and 2024 extended that sweep arrangement through 2034 while still keeping the balances off‑balance‑sheet.  This evolution shows that Schwab’s exposure to client‑held assets is largely contingent and off‑balance‑sheet, with potential liabilities that can exceed the collateral it has posted and that depend on maintaining sufficient capital to support the swept deposits.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant deviations from the ground truth in key areas. (1) Correct elements include the general idea that Schwab pledged client securities for margin lending and clearing purposes across 2022–2024, and that these practices relate to federal regulations. However, major inaccuracies arise: the 2023 IDA sweep program involving TD depositories and its extension to 2034 is unrelated to the pledging of securities for margin or collateral obligations and is not mentioned in the original answer—this is a factual misattribution. Additionally, the focus on 'uninvested client cash' and 'off-balance-sheet' liabilities shifts attention away from the core issue of securities pledging. (2) There are no explicit numerical values in either answer, so quantitative accuracy is neutral; however, the LLM introduces concepts (e.g., 'liabilities that can exceed the collateral') not present or implied in the original, which weakens fidelity. (3) Multi-hop reasoning is partially sound—there is an attempt to trace evolution over time—but it conflates distinct financial mechanisms: securities pledging for margin/options vs. cash sweep programs. The original answer emphasizes risk management and client engagement in leveraged activities; the LLM instead emphasizes off-balance-sheet risk and capital support for deposits, which misaligns with the ground truth’s conclusion. (4) Contextual relevance is moderate because the response stays within the domain of client asset usage but drifts into tangential banking operations. Overall, while some surface-level facts align, the reasoning and synthesis are flawed, leading to a misleading interpretation of Schwab's exposure to client-held assets.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Holds]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 476,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did ACN's target asset allocation strategy for its defined benefit pension plans evolve from fiscal 2023 to fiscal 2025, based on the disclosed weighted-average plan asset allocations as of August 31 in 2022, 2023, and 2024?",
      "original_answer": "ACN's target asset allocation strategy for its defined benefit pension plans showed a gradual shift toward more fixed income instruments over the three-year period. In fiscal 2023, the weighted-average allocation as of August 31, 2022, was 55% fixed income and 45% equities. By fiscal 2024, with allocations as of August 31, 2023, the balance had moved to 58% fixed income and 42% equities. In fiscal 2025, based on the allocation as of August 31, 2024, the fixed income portion increased further to 61%, while equities decreased to 39%. This indicates a consistent trend toward de-risking the portfolio by increasing exposure to less volatile fixed income assets.",
      "llm_answer": "\nThe company’s defined‑benefit pension plans used the fiscal 2023 target mix disclosed in the 2022 filing (Chunk 1) as the baseline, then replaced it with a new fiscal 2025 target outlined in the 2023 and 2024 filings (Chunks 2 & 3), which shifts a modest amount of weight from fixed‑income to equity to better capture long‑term returns; the weighted‑average actual allocations as of August 31 2022, 2023 and 2024 (referenced in all three chunks) show a steady progression toward that 2025 target, with the 2024 allocation already reflecting the higher equity share prescribed for fiscal 2025.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and substance. The ground truth shows a clear de-risking trend with fixed income increasing from 55% to 61% and equities decreasing from 45% to 39% over the period. However, the LLM claims the strategy shifts 'from fixed-income to equity', which is the opposite of the actual trend. This misrepresents the entire evolution of the allocation strategy. (2) Quantitatively, the LLM fails to report any correct target allocation percentages for any fiscal year. It does not state the 55/45 split in 2023, the 58/42 split in 2024, or the 61/39 split in 2025. Instead, it incorrectly implies a move toward higher equity exposure, with no numerical targets provided. All key percentages are missing or wrong. (3) The multi-hop reasoning is flawed: the model incorrectly interprets the disclosed allocations as moving toward a 'fiscal 2025 target' that favors equities, when in fact the documented trend shows a consistent increase in fixed income. It also confuses actual vs. target allocations, and misattributes the direction of change. The synthesis across the three years is entirely inaccurate. (4) While the answer is framed around the correct topic (pension asset allocation over time) and references the correct company (ACN) and dates (August 31), the core factual content and directional trend are reversed, warranting a very low correctness and accuracy scores. Contextual relevance is moderate because it addresses the general subject and structure of the question, but the substance is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 432,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did Capital One's (COF) total short-term borrowings and long-term debt evolve from 2022 through 2024, and what does the 3-year trend reveal about its debt structure and interest rate exposure?",
      "original_answer": "Capital One's total short-term borrowings and long-term debt increased from $43.086 billion in 2022 to $48.715 billion in 2023, and further to $45.551 billion in 2024. This reflects a significant rise in debt levels, particularly in 2023, followed by a slight decline in 2024. The weighted-average interest rate on long-term debt also increased, from 1.51% on securitized debt in 2022 to 3.01% in 2023 and 3.48% in 2024, indicating rising borrowing costs over the period. Additionally, the company reduced its floating unsecured senior debt from $1,597 million in 2023 to $0 in 2024, signaling a strategic shift away from variable-rate debt amid rising interest rates.",
      "llm_answer": "\nCapital One’s combined short‑term borrowings and long‑term debt was **$43.1 bn in 2022** (Chunk 1), **$49.9 bn in 2023** (Chunk 3) and **$45.6 bn in 2024** (Chunk 2), producing a net ≈ 5‑6 % rise over the three‑year period after a peak in 2023 followed by a modest decline in 2024.  The debt mix shifted toward longer‑dated, fixed‑rate senior and subordinated notes—fixed unsecured senior debt grew from $19.9 bn to $26.9 bn and floating‑rate senior debt was largely retired—while securitized obligations peaked at $18.0 bn in 2023 before falling to $14.3 bn in 2024 (Chunks 1‑3).  At the same time, the weighted‑average interest rate on the portfolio climbed from roughly **1.5 % in 2022 to about 4.5 % in 2023 and 4.8 % in 2024**, signalling a higher fixed‑rate exposure and a reduced reliance on low‑cost floating‑rate funding.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key financial figures, particularly in total debt and interest rates. According to the ground truth, Capital One's total short-term borrowings and long-term debt were $43.086B (2022), $48.715B (2023), and $45.551B (2024). The LLM reports $43.1B (acceptable rounding), but incorrectly states $49.9B for 2023 (vs. $48.715B) and $45.6B for 2024 (slightly high vs. $45.551B). More critically, the weighted-average interest rate on long-term debt is significantly misstated: ground truth shows 1.51% (2022), 3.01% (2023), and 3.48% (2024), but the LLM claims ~1.5%, ~4.5%, and ~4.8%, overestimating by over 1 percentage point in 2023 and nearly 1.4 points in 2024. This undermines the core analysis of interest rate exposure. (2) The LLM correctly identifies the trend direction—debt increase in 2023 followed by a decline in 2024—and notes a shift away from floating-rate debt, aligning with the retirement of $1,597M floating unsecured senior debt in 2023 to $0 in 2024. However, it does not explicitly mention this specific debt category or its full elimination, instead generalizing about a shift to fixed-rate notes. It does correctly note growth in fixed unsecured senior debt and decline in securitized debt, which supports qualitative reasoning. (3) Multi-hop reasoning is partially sound: the model synthesizes trends in debt levels, maturity structure, and interest costs across years and infers strategic shifts. However, due to incorrect interest rate figures, the conclusion about 'higher fixed-rate exposure' is based on flawed data. The net 5–6% rise claim is misleading since peak-to-end change is actually from $43.086B to $45.551B (~5.7% increase), but the path (sharp rise then partial fall) is correctly described. (4) Scores reflect that while the directional trends and strategic interpretation are reasonable, the quantitative inaccuracies—especially in interest rates—are material and distort the financial reality. Contextual relevance is high as all question parts are addressed with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 562,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did BA's fleet support services costs as a percentage of total consolidated costs evolve from 2022 through 2024, and how does this trend relate to the company's abnormal production costs and reach-forward losses in the 787 and 777X programs?",
      "original_answer": "BA's fleet support services costs remained consistently at approximately 1% of total consolidated costs of products and services in 2022, 2023, and 2024, showing no significant change across the three-year period. However, this stable cost ratio contrasts sharply with the company's abnormal production costs and reach-forward losses in the 787 and 777X programs, which grew substantially over the same period. In 2023, the 787 program alone incurred $2.7 billion in cumulative abnormal production costs due to rework and low production rates. In 2024, the 777X program recorded a $2,608 million reach-forward loss in the third quarter and an additional $891 million in the fourth quarter, primarily driven by certification delays, labor instability, and supplier cost increases. These escalating program-specific costs suggest that while fleet support services remained proportionally stable, BA faced increasing operational and production challenges that significantly impacted financial performance. The persistence of the 1% cost ratio indicates that fleet support services were not the source of the financial strain but rather a consistent expense, underscoring that the company's growing losses were tied to production inefficiencies and program execution risks rather than service delivery.",
      "llm_answer": "\nBA’s fleet‑support services have been charged to expense as incurred and, according to the 2022‑2024 filings, have consistently represented **about 1 % of total consolidated costs** each year – essentially a flat share from 2022 through 2024.  At the same time, the company absorbed **large abnormal‑production outlays** (e.g., $2.7 bn of cumulative abnormal costs for the 787 program, with $256 m expensed in 2024) and **significant reach‑forward losses** on the 777X program ($2.6 bn in Q3 2024 and an additional $0.89 bn in Q4 2024).  These program‑specific losses inflate the overall cost base, so while the fleet‑support cost ratio stays roughly constant at ~1 %, its **relative proportion of the total cost structure declines** as the abnormal and reach‑forward expenses grow.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that BA's fleet support services costs remained at about 1% of total consolidated costs from 2022 to 2024, which matches the ground truth. However, there are significant quantitative inaccuracies in the abnormal production costs and reach-forward losses. The LLM states that the 787 program had $2.7 billion in cumulative abnormal costs (correct), but adds that $256 million was expensed in 2024 — this detail is not present in the original answer and introduces unverified information. More critically, the LLM claims the 777X program had a $2.6 billion reach-forward loss in Q3 2024 and $0.89 billion in Q4 2024, which misrepresents the original data: the original specifies $2,608 million (i.e., $2.608 billion) in Q3 and $891 million in Q4 — while numerically close, the rounding and formatting obscure precision, and more importantly, the LLM incorrectly implies these were the only charges, whereas the original emphasizes these were recent additions to an already growing cumulative loss. The most serious error is the reasoning conclusion: the LLM claims that because abnormal costs are growing, the 1% fleet support cost 'relative proportion... declines' — this is logically flawed. The original clearly states the 1% ratio remained stable, meaning it did not decline; the total cost base increased due to abnormal costs, but the fleet support percentage stayed constant — thus, its relative proportion did not decrease. This misrepresents the core relationship between stable ratios and increasing total costs. The answer is contextually relevant and captures the high-level contrast between stable services costs and rising production issues, but the flawed logic and some unsupported or inaccurate figures reduce its correctness. Entity identification (BA, 787, 777X, years) and general reasoning structure are accurate, supporting a moderate qualitative and contextual score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Produces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 517,
        "total_tokens": 2062
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did AbbVie's allocation to money market funds and time deposits evolve across 2022, 2023, and 2024, and what does this 3-year trend indicate about the company's short-term liquidity strategy?",
      "original_answer": "AbbVie's allocation to money market funds and time deposits was $12 million in 2022, increased to $21 million in 2023, and then decreased to $10 million in 2024. This fluctuation indicates a shifting short-term liquidity strategy, with a notable increase in 2023 possibly reflecting a temporary conservative approach, followed by a reduction in 2024 that may signal a reallocation toward other cash equivalents or strategic investments.",
      "llm_answer": "\nAbbVie’s short‑term cash allocations to money‑market funds and time deposits were $12 million in 2022 (Chunk 3), increased to $21 million in 2023 as disclosed in the 2023 filing (Chunk 1), and then declined to $10 million in 2024 (Chunk 2). This 3‑year trajectory shows that the company boosted its liquid‑asset position in 2023—likely to strengthen cash resilience—before trimming the allocation in 2024, reflecting a flexible, cash‑flow‑driven strategy for managing short‑term liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all three annual allocations: $12 million in 2022, $21 million in 2023, and $10 million in 2024, matching the ground truth exactly. These values are cited with reference to document chunks, confirming multi-hop sourcing. (2) All numeric values are accurate and properly formatted; no calculation errors are present. The trend—increase in 2023, then decrease in 2024—is correctly described. (3) The reasoning is sound and logically interprets the fluctuation as a strategic shift in liquidity management. While the original answer suggests the 2023 increase may reflect a 'temporary conservative approach' and 2024 reduction a 'reallocation toward other cash equivalents or strategic investments,' the LLM paraphrases this as a 'flexible, cash-flow-driven strategy' and 'strengthen cash resilience,' which is semantically equivalent and reasonable. The interpretation is slightly less specific regarding reallocation motives but remains plausible and consistent with the data. (4) All entities—AbbVie, money market funds, time deposits, and the three-year timeframe—are correctly identified. The answer fully addresses both parts of the question: the evolution of allocation and the implication for liquidity strategy. Thus, the answer is factually complete and contextually appropriate, warranting a high correctness score with only minor room for interpretive precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 394,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this trend indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand in aggregate available authorization for share purchases and redemptions. By fiscal 2023, the company had increased its total authorized share repurchase capacity to $50.1 billion cumulatively since 2001, with $2,694 million in remaining available authorization as of August 31, 2023. In fiscal 2024, Accenture further boosted its total outstanding repurchase authority by an additional $4,000 million, bringing the total to $6,694 million as of September 25, 2024. This trajectory shows a consistent and expanding capital return strategy through share repurchases, with increasing board support and management discretion over time.",
      "llm_answer": "\nAccenture’s share‑repurchase authorization expanded from $3.13 billion of available authority as of August 31 2022 (Chunk 1) to $2.69 billion remaining as of August 31 2024, and on September 25 2024 the Board added $4 billion of authority, raising total outstanding authorization to $6.69 billion (Chunk 2 & 3).  In fiscal 2024 the company executed $605 million of purchases—2.0 million Class A shares under the open‑market program and an additional 72,255 shares via employee withholding (Chunk 2)—showing that the enlarged authorization is being actively used, underscoring a strong and growing capital‑return strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and dates, particularly regarding the timeline and amounts. It incorrectly states that $2.69 billion was the remaining authorization as of August 31, 2024, when the ground truth shows that $2.694 billion was available as of August 31, 2023. The addition of $4 billion occurred on September 25, 2024, not before August 31, 2024. The LLM conflates dates and incorrectly implies the $2.69 billion figure applies to 2024 before the new authorization. (2) The fiscal 2024 share purchases of $605 million are correctly cited, as are the 2.0 million shares and 72,255 employee withholding shares, which adds useful detail not in the original but is accurate. However, the total remaining authorization after the increase is correctly stated as $6.69 billion (matching $6,694 million), which shows correct synthesis of the cumulative effect. (3) The multi-hop reasoning is partially sound—linking repurchase activity and increasing authorization to indicate a growing capital return strategy is valid and aligns with the ground truth. However, the incorrect dating undermines the chronological evolution, which is central to the question. (4) The contextual relevance is high because the answer addresses both the quantitative evolution and strategic implication. The qualitative accuracy is moderate due to correct identification of entities (Accenture, share repurchases, fiscal years) and logical interpretation, but penalized for timeline errors. Quantitative accuracy is low due to incorrect assignment of figures to years, even though some numbers are right in isolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 450,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did AbbVie's governance provisions related to director removal for cause evolve across 2022, 2023, and 2024, and what does this consistent emphasis on board entrenchment reveal about the company's long-term takeover defense strategy?",
      "original_answer": "Across all three years—2022, 2023, and 2024—AbbVie consistently maintained a provision stating that stockholders may only remove directors for cause. This provision, included in each year’s 10-K filing, was part of a broader set of anti-takeover defenses such as staggered board terms, restrictions on special meetings, and supermajority requirements for bylaw amendments. The repeated disclosure of this specific governance feature across all three filings indicates a stable and deliberate strategy to entrench board control and discourage hostile takeovers. Despite no explicit changes to the 'removal for cause' language, the consistent emphasis in each annual report underscores AbbVie’s ongoing commitment to maintaining board stability and limiting shareholder influence over director tenure.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings (chunks 3, 1 and 2), AbbVie repeatedly discloses that its amended certificate of incorporation and by‑laws—under Delaware law—allow directors to be removed **only for cause** and require a **stockholder super‑majority (80 % of voting stock)** to amend board‑size, term, vacancy‑filling and indemnification provisions; each filing lists the same “stockholders may only remove directors for cause” clause and the related staggered‑three‑class board structure.  \nThis consistent wording shows that AbbVie has maintained, year after year, a suite of board‑entrenchment tools—including cause‑only removal, a staggered board and a high amendment threshold—to shield its board from hostile replacement and to compel any takeover to be negotiated with the board, underscoring a long‑term defense strategy that prioritizes board stability and protection against coercive acquisition attempts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that AbbVie maintained the 'removal for cause only' provision across 2022, 2023, and 2024, with no changes—matching the original answer’s emphasis on consistency. (2) The quantitative details—'80% of voting stock' for amendments—are correctly stated and align with Delaware law provisions as disclosed in the filings; no calculations were required, but the percentage is precise and contextually accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes governance provisions across three years, identifies the 'cause-only removal' clause, links it to the staggered board and supermajority amendment requirements, and infers the strategic intent of board entrenchment and takeover defense. (4) The answer goes slightly beyond the original by specifying the 80% threshold (which is factually correct and consistent with AbbVie’s filings), enhancing completeness without introducing error. The conclusion about long-term strategy—prioritizing board stability and negotiated takeovers—directly aligns with the ground truth. All entities (AbbVie, 2022–2024 10-Ks, Delaware law) are correct, and the response fully addresses both parts of the question: evolution (no change, consistent emphasis) and strategic implication (entrenchment, anti-takeover).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 378,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did PepsiCo's references to its 4.000% Senior Note due 2047 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent disclosure pattern reveal about the note's role in the company's long-term capital structure strategy?",
      "original_answer": "The 4.000% Senior Note due 2047 was consistently disclosed in all three years: in 2022 it referenced Exhibit 4.5 from the May 2, 2017 8-K filing; in 2023 it maintained the same May 2, 2017 reference; and in 2024 it continued to reference the identical Exhibit 4.5 from May 2, 2017. This consistent disclosure pattern across all three years with the exact same filing reference demonstrates that the 4.000% Senior Note due 2047 has remained a stable, long-term component of PepsiCo's capital structure since its issuance in 2017, with no modifications needed to its form or terms over this three-year period.",
      "llm_answer": "\nAcross the three 10‑K filings the company repeatedly includes the identical “Form of 4.000% Senior Note due 2047” exhibit (pages 131 in the 2022 filing, 126 in the 2023 filing, and 127 in the 2024 filing), each time referencing the original 2017 8‑K filing that first registered the note. This unchanged, year‑over‑year disclosure shows that the 4.000% Senior Note due 2047 is a core, long‑dated component of PepsiCo’s capital structure, providing a stable, low‑cost source of financing that is consistently presented as part of its long‑term debt strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 4.000% Senior Note due 2047 is consistently referenced across 2022, 2023, and 2024 filings, with the same original source (2017 8-K filing), though the LLM does not explicitly name the exhibit (Exhibit 4.5) as in the ground truth. Page numbers cited (131, 126, 127) are specific and plausible, though not part of the ground truth—these are formatting details not contradicted by the original. (2) The percentage (4.000%), maturity year (2047), and issuance reference (2017 8-K) are all factually correct and consistently reported. (3) The reasoning is sound: the repeated inclusion of the same note form over three years supports the conclusion that it is a stable, long-term component of PepsiCo’s capital structure. The LLM correctly infers strategic implications—stable, low-cost financing and integration into long-term debt strategy—consistent with the ground truth’s interpretation. (4) The only minor omission is the lack of explicit mention of 'Exhibit 4.5', which appears in the ground truth. However, the LLM conveys the same functional information by noting the repeated reference to the original 2017 filing. This does not impair the overall correctness but slightly reduces qualitative precision. Semantic equivalence is maintained, and the answer fully addresses both parts of the question: evolution (no change) and strategic role (stable long-term financing).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 412,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did Oracle's issuance and disclosure of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about its long-term debt strategy?",
      "original_answer": "Oracle first disclosed the 4.30% Note due 2034 in 2022 as part of a broader set of debt instruments, reaffirmed its inclusion in 2023 alongside similar structured notes, and maintained consistent disclosure in 2024, indicating a stable long-term debt strategy focused on diversified maturity profiles and sustained capital market engagement.",
      "llm_answer": "\nAcross the three 10‑K filings Oracle repeatedly includes the same “4.30 % Note due 2034” in Exhibit 4.09 (Chunk 1 – 2023 filing, Chunk 2 – 2024 filing, and Chunk 3 – 2022 filing), the same description that first appeared in a 2014 8‑K (Chunk 3 shows the original Officers’ Certificate).  This multi‑year pattern shows that Oracle continuously re‑discloses a fixed‑rate, 2034‑maturity tranche as part of its ongoing debt‑registration updates, indicating a long‑term financing strategy that relies on a stable, long‑dated note to fund its capital needs while maintaining a predictable maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all key details—'4.30% Note due 2034', the years 2022–2024, and the consistent disclosure—are correct. The mention of the 2014 8-K as the origin (via Officers’ Certificate) adds contextual precision not in the original answer but does not contradict it; rather, it enriches the explanation with accurate background. (2) The core financial and temporal data (interest rate, maturity year, multi-year disclosure) are correctly stated and consistent with the ground truth. (3) The reasoning is sound: the LLM correctly infers from repeated disclosures across 2022–2024 filings that Oracle maintains a stable long-term debt strategy, emphasizing predictable maturity profiles and sustained capital market presence. It appropriately synthesizes information across multiple 10-K filings (multi-hop reasoning) and links the pattern to strategic intent. (4) While the original answer emphasizes 'diversified maturity profiles' and 'sustained capital market engagement', the LLM focuses on 'predictable maturity profile' and 'ongoing debt-registration updates'—semantically equivalent with only slight variation in emphasis. The LLM slightly exceeds the original by citing Exhibit 4.09 and the 2014 8-K, which are accurate and support the conclusion. No factual errors; minor deduction in qualitative accuracy only because the LLM does not explicitly mention 'diversified' maturities, a key nuance in the original. Overall, the answer is highly relevant, factually correct, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 431,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, 127,000,000 Accenture plc Class A ordinary shares were authorized for awards under the Amended 2010 SIP. This number increased to 141,000,000 by fiscal year 2023 and remained unchanged through fiscal year 2024. The increase in authorized shares from 2022 to 2023 and the maintenance of that level through 2024 suggests a strategic decision to expand capacity for share-based compensation, likely to support ongoing talent retention and incentive programs.",
      "llm_answer": "\nThe Amended 2010 SIP’s authorized share reserve grew from **127 million** Class A ordinary shares in fiscal 2022 (Chunk 1) to **141 million** shares in fiscal 2023 and stayed at that level through fiscal 2024 (Chunks 2 & 3).  This step‑up—from 127 M to 141 M—reflects Accenture’s deliberate expansion of its long‑term share‑based compensation pool, ensuring sufficient shares are available for future grants and reinforcing a sustained strategy to align employee incentives with the company’s growth trajectory.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the number of authorized shares was 127 million in fiscal 2022, increased to 141 million in fiscal 2023, and remained unchanged through fiscal 2024. The formatting variations (e.g., '127 million' vs '127,000,000') are acceptable and convey the same values. (2) Quantitative accuracy is perfect: the increase from 127M to 141M is correctly noted, and no erroneous calculations are made. (3) The multi-hop reasoning is sound—information is synthesized across fiscal years 2022–2024, and the conclusion about Accenture’s long-term share-based compensation strategy (expanding capacity for future grants, supporting talent retention, aligning incentives with growth) is logically derived and consistent with the original answer. (4) The response addresses both parts of the question: the evolution of authorized shares and the strategic implication. Entity accuracy is correct (Accenture plc, Amended 2010 SIP, Class A ordinary shares, correct fiscal years). The answer is concise, relevant, and fully aligned with the context and intent of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Issues]- ORG <-[Grants]- ORG",
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 330,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did PepsiCo's issuance terms and documentation of the 2.750% Senior Note due 2051 evolve from 2022 through 2024, and what does this multi-year filing pattern indicate about the company's long-term debt structuring strategy?",
      "original_answer": "In 2022, the 2.750% Senior Note due 2051 was first introduced in a list of notes within a broader Board of Directors resolution (Exhibit 4.60), indicating initial authorization and planning. By 2023, the documentation had progressed to include a dedicated 'Form of 2.750% Senior Note due 2051' (Exhibit 4.51), suggesting that the instrument had moved from authorization to formal structuring and disclosure. In 2024, the note continued to be referenced with the same exhibit number (4.48), showing consistency in documentation and no material revision to the note's form. This progression reflects a deliberate, phased approach to long-term debt issuance, with early planning in 2022, formalization in 2023, and maintenance of structure in 2024, indicating stability in PepsiCo’s long-term capital strategy.",
      "llm_answer": "\nIn the 2022 Form 10‑K (Chunk 1) the Board of Directors approved the terms of the 2.750% Senior Note due 2051 as part of a broad set of senior‑note authorizations, and that same term sheet is traced back to the 2021 Form 8‑K filing referenced in Chunks 2 and 3 where the “Form of 2.750% Senior Note due 2051” is incorporated by Exhibit 4.3.  The 2023 and 2024 10‑Ks (Chunks 3 and 2) continue to repeat the identical “Form of 2.750% Senior Note due 2051” language in their Exhibit 4.x references, showing that the issuance terms have remained unchanged and are periodically re‑filed as part of PepsiCo’s ongoing senior‑note program.  This multi‑year filing pattern—documented through Board resolutions, supplemental indentures (2018/2010) and repeated 8‑K exhibits—reflects a disciplined, staggered long‑term debt strategy that relies on a standardized master indenture and incremental trust structures to issue fixed‑rate notes at set intervals, thereby managing liquidity and refinancing risk across a decade‑plus horizon.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its interpretation of the multi-year filing pattern and PepsiCo's long-term debt strategy, but contains minor inaccuracies in exhibit numbers and timeline details that affect factual precision. Quantitatively, the interest rate (2.750%) and maturity year (2051) are correct, and the assertion that terms remained unchanged across years is consistent with the ground truth. However, the LLM incorrectly references the 2021 Form 8-K with Exhibit 4.3 as the origin of the note’s form, while the ground truth indicates formal documentation began in 2023 with Exhibit 4.51. Additionally, the LLM cites Exhibit 4.x in 2023 and 2024 without specifying the correct exhibit numbers (4.51 in 2023, 4.48 in 2024), which undermines quantitative accuracy. The answer correctly identifies the progression from authorization to repeated filing, but misattributes the initial formalization to 2021 rather than 2022–2023, slightly distorting the phased timeline. Despite this, the core reasoning about a disciplined, standardized debt structuring strategy using a master indenture and staggered issuances aligns well with the ground truth’s conclusion on strategic stability. The multi-hop synthesis across years and document types (10-K, 8-K, exhibits) is strong and contextually appropriate, showing good understanding of SEC filing patterns. Wording differences are acceptable under semantic equivalence, but the incorrect exhibit references and premature dating of formal documentation prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 419,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has American Express's competitive positioning relative to other card networks evolved from 2022 to 2024, particularly in light of increasing regulatory scrutiny and the expansion of alternative payment mechanisms?",
      "original_answer": "From 2022 to 2024, American Express maintained its position as the fourth-largest general-purpose card network globally behind China UnionPay, Visa, and Mastercard. In 2022 and 2023, the company emphasized its competitive differentiation through premium offerings, cobrand relationships, and closed-loop loyalty systems, while facing growing pressure from alternative payment platforms like Alipay, PayPal, and buy-now-pay-later services. By 2024, regulatory scrutiny intensified, particularly around interchange fees, network routing practices, and cobrand arrangements in the EU, leading to exits from certain markets and increased compliance costs. This evolution indicates a shift from primarily market-driven competition to a more regulation-constrained environment, which has altered the strategic dynamics of its relationship with card networks.",
      "llm_answer": "\nFrom 2022 to 2024 American Express remained the fourth‑largest general‑purpose card network, but its competitive footing eroded as regulatory scrutiny deepened—its 2024 designation as a Category III firm, new interchange‑fee caps and the EU/AU exit from network‑licensing forced lower discount rates and heightened compliance costs, while regulators continue to probe network routing, cobrand terms and consumer‑protection rules that directly affect its pricing and revenue.  At the same time, the fast‑growing ecosystem of alternative payment mechanisms—digital wallets, buy‑now‑pay‑later platforms, and real‑time settlement services such as PayPal, Venmo and Alipay—has expanded the set of competitors beyond traditional card networks, compelling Amex to double‑down on premium product features, rewards and data‑analytics to protect its high‑spending card‑member base and merchant relationships.  Consequently, the interplay of intensified regulatory constraints and the rise of alternative payment solutions has shifted Amex’s positioning from a stable fourth‑ranked network toward a more vulnerable stance that relies on continual innovation and compliance to preserve market share and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies American Express as the fourth-largest general-purpose card network from 2022 to 2024, consistent with the original answer. While the LLM introduces additional specifics—such as 'Category III firm' designation, interchange-fee caps, and exits from EU/AU licensing—these are plausible regulatory developments that align with the broader trend of increasing scrutiny mentioned in the ground truth, though the exact 'Category III' classification and regional exit details are not explicitly confirmed in the original. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is assessed on factual precision of financial and regulatory metrics: the LLM accurately reflects increased compliance costs, lower discount rates, and revenue impacts, which are consistent with regulatory pressure. (3) The multi-hop reasoning is sound: the LLM synthesizes competitive positioning, regulatory trends, and alternative payment growth across time (2022–2024), correctly linking regulatory actions (interchange fees, network routing, cobrand terms) to strategic consequences. It also accurately identifies key competitors like PayPal, Venmo, Alipay, and BNPL platforms, expanding appropriately on the original. (4) The LLM enhances the original with deeper strategic interpretation (e.g., 'more vulnerable stance', 'double-down on premium features') without contradicting facts. The only minor deviation is the more assertive tone on 'eroded' positioning and 'vulnerable stance', which slightly exceeds the original's more neutral characterization of a 'shift in strategic dynamics'. However, this is a reasonable inference. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Depends_On]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 502,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has Boeing's strategic emphasis on aircraft upgrades and conversions changed from 2022 to 2024, and what does this suggest about its services business strategy?",
      "original_answer": "In 2022, Boeing listed 'upgrades and conversions' as one of several services within the Global Services segment, grouped alongside logistics, engineering, and training systems. By 2023, the company maintained a similar structure but began emphasizing 'modifications' more prominently, suggesting a deeper integration of upgrades into broader lifecycle support offerings. In 2024, Boeing continued this pattern but introduced clearer language around 'data analytics and digital services' as complementary to upgrades and conversions, indicating a strategic shift toward technology-enabled service differentiation. This progression shows a growing focus on enhancing aircraft value through modernization rather than just sustaining operations, aligning with a broader transformation toward high-value services.",
      "llm_answer": "\nFrom 2022 to 2024 Boeing moved upgrades and conversions from a peripheral service listed in the 2022 Global Services description to a headline offering in the 2023 and 2024 filings, explicitly tying the “Upgrades and Conversions” capability to its product‑service organization (as reflected by the KG triplets that connect Upgrades and Conversions → BA).  This escalation shows a deliberate shift toward making aircraft modification and retrofit a core, high‑margin revenue stream, signaling that Boeing’s services strategy is now centered on leveraging its IP, maintenance expertise and fleet‑support ecosystem to generate recurring income from existing aircraft rather than relying primarily on new‑aircraft sales.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the overall strategic shift at Boeing from 2022 to 2024 regarding upgrades and conversions, and correctly identifies the increasing strategic emphasis on this service line. It accurately reflects that upgrades and conversions evolved from a listed service in 2022 to a more prominent, headline offering in 2023 and 2024, which aligns with the original answer’s observation about growing importance. The mention of tying 'Upgrades and Conversions' to Boeing (BA) via knowledge graph triplets supports the entity and temporal accuracy. However, the LLM answer omits a key element from the original answer: the introduction and integration of 'data analytics and digital services' in 2024 as complementary to upgrades, which is a critical part of the strategic evolution toward technology-enabled differentiation. While the LLM correctly infers a shift toward high-margin, recurring revenue and leveraging IP and expertise, it does not fully capture the nuance of digital transformation and data-driven services that the original answer highlights as central to Boeing’s evolving strategy. There are no numerical inaccuracies (quantitative accuracy is perfect as no incorrect numbers are present), and the reasoning is logically sound, though slightly less complete in synthesis. Contextual relevance is high as the response directly addresses the question’s focus on strategic change and implications for services business. Thus, the answer is mostly correct but misses a key dimension of the 2024 shift, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Supplies]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 444,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did PepsiCo's issuance and documentation of the 5.50% Senior Note due 2035 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern reveal about its long-term debt management strategy?",
      "original_answer": "The 5.50% Senior Note due 2035 was consistently referenced across all three years, indicating ongoing documentation and potential refinancing or rollover activity. In 2022, it was listed as 'Form of 5.50% Senior Note due 2035, Series A' (Exhibit 4.31) referencing an 8-K filing from November 8, 2018. In 2023, the same note was referenced again (Exhibit 4.25) with the same filing history, showing continued acknowledgment of this debt instrument. In 2024, the note reappeared (Exhibit 4.23), again tied to the same 2018 filing. This repeated inclusion suggests that PepsiCo maintained this long-term debt obligation on its books without retiring or modifying it during the three-year period, signaling a stable, long-duration capital structure approach.",
      "llm_answer": "\nAcross the three fiscal years PepsiCo repeatedly filed the 5.50 % Senior Note due 2035 in its periodic reports: Chunk 1 (2022 Form 10‑K) cites the note as an exhibit referenced from the 2018 S‑4 registration, Chunk 3 (2023 Form 10‑K) repeats the same exhibit reference, and Chunk 2 (2024 Form 10‑K) re‑states the note—now labeled “Series A”—in an Form 8‑K filing and ties it to board‑resolution language. This year‑over‑year, verbatim re‑incorporation of the identical exhibit demonstrates that PepsiCo systematically documents and re‑files the same senior unsecured tranche in each reporting cycle. The persistent “Introduces” relationship in the knowledge graph—where PepsiCo continuously introduces the 5.50 % Senior Note due 2035 and the note itself introduces the issuer—reveals a deliberate long‑term debt‑management strategy that prioritizes regulatory transparency, stable financing terms, and ongoing investor communication.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 5.50% Senior Note due 2035 and its consistent reappearance across 2022, 2023, and 2024 filings, which aligns with the ground truth. However, there are discrepancies in the sourcing details. The original answer specifies that the note was referenced in each year’s 10-K via Exhibit numbers (4.31 in 2022, 4.25 in 2023, 4.23 in 2024) and tied to an 8-K filing from November 8, 2018. The LLM incorrectly attributes the 2022 reference to an S-4 registration, which contradicts the ground truth (it should be an 8-K from 2018, not an S-4). Additionally, the LLM states that in 2024 the note is now labeled 'Series A'—but the ground truth indicates it was already labeled 'Series A' in 2022, so this timing is inaccurate. (2) Quantitatively, the interest rate (5.50%), maturity year (2035), and years of documentation (2022–2024) are correct. The filing types (Form 8-K, Form 10-K) are also accurate, though the specific exhibit numbers are omitted in the LLM answer. The misattribution to an S-4 instead of an 8-K is a factual error affecting quantitative accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that repeated filing indicates a stable long-term debt strategy and emphasizes transparency and consistent financing. However, it misrepresents the evolution by suggesting a change in labeling (‘now labeled Series A’ in 2024), when the label existed earlier, weakening the reasoning. The mention of 'Introduces' relationships in a knowledge graph appears to reflect internal data structure terminology not present in the original answer and may confuse rather than clarify. (4) Despite these issues, the core conclusion—that PepsiCo maintains a stable, long-duration capital structure through consistent documentation—is semantically aligned with the ground truth. The answer is contextually relevant and well-structured, but factual inaccuracies in sourcing and chronology prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 535,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital planning and shareholder returns evolved from 2022 through 2024, and what does this multi-year progression reveal about the company's regulatory constraints on capital return policies?",
      "original_answer": "BNY Mellon's disclosures across 2022, 2023, and 2024 consistently highlight that its ability to return capital to shareholders is constrained by U.S. banking laws and regulations governing capital adequacy. In 2022, the company emphasized general regulatory oversight impacting operations. By 2023, it specifically reiterated that capital return decisions were limited by U.S. banking laws, Delaware law, and preferred stock dividend obligations. In 2024, the language remained largely unchanged, reiterating the same constraints while also noting the importance of maintaining 'well capitalized' status. This consistent yet evolving emphasis reflects a regulatory environment that continues to impose clear boundaries on BNY Mellon’s capital planning flexibility, signaling ongoing prudential oversight and risk-conscious capital management expectations from regulators over the three-year period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings BNY Mellon repeatedly states that its ability to plan capital and return capital to shareholders is “subject to the discretion of our Board of Directors and may be limited by U.S. banking laws, regulations and Delaware law,” a wording that first appears in the 2022 document (Chunk 3), is reiterated verbatim in the 2023 and 2024 reports (Chunks 1 & 2), and is deepened in 2024 by explicit warnings that failure to meet “well‑capitalized” and “well‑managed” status or capital‑adequacy and liquidity rules could restrict activities and fund share‑repurchases only through dividends from subsidiaries (Chunk 2).  The multi‑year progression shows a consistent, binding regulatory constraint: any downgrade of the parent or its principal banks, or any breach of capital‑planning rules, can raise funding costs, limit permissible activities and curtail dividend or share‑repurchase programs, a relationship captured by the KG pattern where BNY Mellon ⇆ U.S. Banking Laws are mutually “Subject_To” one another, underscoring that the firm’s shareholder‑return policy is perpetually shackled by an internalized regulatory regime that shows no substantive change from 2022 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's capital return policies are consistently described as constrained by U.S. banking laws, Delaware law, and regulatory capital requirements across 2022–2024. The evolution in emphasis—from general regulatory oversight in 2022 to more explicit warnings about 'well-capitalized' and 'well-managed' status in 2024—is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense; however, the temporal references (2022, 2023, 2024) are correct and consistently used, earning full marks. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes disclosures across three years, identifies the consistent regulatory language, and notes the incremental addition in 2024 regarding subsidiary dividend constraints and capital adequacy triggers. The reference to 'KG pattern' is interpretive but consistent with the knowledge graph logic implied in the original. (4) Semantic equivalence is strong: while the LLM uses more vivid language (e.g., 'shackled'), the core meaning—that regulatory constraints remain binding and unchanging in substance over the period—matches the original. The only minor shortcoming is a slight overstatement in calling the regime 'perpetually shackled,' which is more emphatic than the neutral tone of the original, but this does not undermine factual accuracy. All parts of the question are addressed: evolution over time and implications for regulatory constraints on capital returns.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 456,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Oracle's issuance terms for its 2.300% Notes due 2028 evolve from 2022 through 2024, and what does this reveal about the company's approach to fixed-income financing in varying interest rate environments?",
      "original_answer": "In 2022, Oracle issued the 2.300% Notes due 2028 under an Officers' Certificate dated March 24, 2021 (filed as Exhibit 4.14 in the 2022 10-K), indicating the instrument was part of a multi-tiered bond offering that included other fixed-rate tranches like the 2.875% Notes due 2031 and 3.950% Notes due 2051. In 2023, Oracle referenced the same 2.300% Notes due 2028 under the same Officers' Certificate, showing no structural or rate changes to the instrument, but instead focused new issuance activity on higher-yielding instruments like the 4.500% Notes due 2028. By 2024, Oracle made no visible changes to the terms of the 2.300% Notes due 2028 and did not introduce any new 2028-dated instruments, suggesting a shift toward maintaining existing obligations rather than refinancing or repricing them. This pattern indicates Oracle's strategy of locking in favorable fixed-rate debt when possible, particularly during lower interest rate periods like those in 2021–2022, and avoiding redundant issuance when existing instruments remain competitive.",
      "llm_answer": "\nOracle first set out the terms of its 2.300 % Notes due 2028 in the March 24 2021 Officers’ Certificate (exhibit 4.14) and then re‑registered the same instrument in the 2022 filing (exhibit 4.16), again in the 2023 filing (exhibit 4.14) and once more in the 2024 filing (exhibit 4.14).  By repeatedly filing the identical 2.300 % coupon, 2028 maturity tranche across three successive 10‑K/8‑K submissions, Oracle demonstrates a disciplined, laddered approach to fixed‑income financing—maintaining a stable, low‑cost long‑dated debt pillar while refreshing its registration to adapt to shifting interest‑rate conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitatively, the LLM correctly identifies the 2.300% coupon rate, the 2028 maturity, and the March 24, 2021 Officers' Certificate (Exhibit 4.14 in the 2022 10-K). However, it incorrectly claims that the 2.300% Notes were re-registered in the 2024 filing as Exhibit 4.14 and previously in 2023 and 2022 with varying exhibit numbers—this is not supported by the ground truth. The original answer clarifies that Oracle did not issue new 2.300% Notes in 2023 or 2024, nor did it re-register them; instead, it referenced the existing instrument while issuing higher-yielding debt. The LLM’s claim of 're-registering' the same instrument across three years is factually incorrect. (2) The LLM misrepresents Oracle’s financing activity: the ground truth states that in 2023, Oracle issued new 4.500% Notes due 2028, not a re-registration of the 2.300% Notes. By 2024, there was no new issuance or re-registration of any 2028-dated notes. The LLM’s assertion of repeated filings of the same note is unsupported. (3) Qualitatively, the reasoning is flawed: the conclusion that Oracle is 'refreshing its registration to adapt to shifting interest-rate conditions' contradicts the ground truth, which shows Oracle avoided repricing or refinancing the 2.300% Notes, instead relying on new higher-cost debt. The strategy was to preserve low-cost debt, not re-register it. (4) Contextually, the answer is relevant and addresses the question’s focus on financing strategy, but the factual errors in issuance activity and exhibit references undermine the validity of the conclusion. The semantic meaning diverges significantly on key points, especially the nature and timing of Oracle’s bond activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 489,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved across 2022, 2023, and 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "In 2022, IBM emphasized client relationships and trust as part of a broader competitive strategy that included embedding AI and cloud into offerings and modernizing platforms. In 2023, the company reinforced this by highlighting its deep incumbency with enterprises and a strong focus on innovation as key differentiators tied to client trust. By 2024, IBM expanded its strategic partnerships (e.g., adding Palo Alto Networks) and continued to position client relationships and trust as central to delivering business value, especially in the context of hybrid cloud and AI solutions. This shows a consistent but increasingly nuanced strategic emphasis on trust as a foundational element for client engagement and competitive advantage in a rapidly evolving tech landscape.",
      "llm_answer": "\nAcross the three filings IBM repeatedly lists **client relationships and trust** as a principal method of competition, but the framing deepens each year: the 2022 text (Chunk 3) mentions it as part of a “broad range of capabilities,” the 2023 report (Chunk 1) ties the concept to its “strategic partnerships” ecosystem and to the hybrid‑cloud/AI platform that drives client value, and the 2024 filing (Chunk 2) reinforces trust as the foundation of IBM’s positioning as a leader in hybrid‑cloud and AI and as a growth engine for future opportunities such as quantum computing.  This multi‑year progression shows that IBM is deliberately building its hybrid‑cloud and AI strategy around the credibility it earns from long‑standing client relationships, using trust as the differentiator that justifies its expansion into high‑growth, technology‑intensive markets.  The recurring **ORG → Client Relationships and Trust ← ORG** dependency in the knowledge graph illustrates that IBM’s strategic narrative is mutually anchored in this concept, underscoring trust as the central pillar of its competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: IBM consistently emphasizes client relationships and trust across 2022–2024, with evolving framing each year. In 2022, trust is part of a broad capability set; in 2023, it's tied to strategic partnerships and hybrid cloud/AI; in 2024, it's foundational to leadership in hybrid cloud, AI, and emerging areas like quantum. The mention of strategic partnerships in 2024 (e.g., Palo Alto Networks in the original) is generalized in the LLM answer but not contradicted. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes across three years of strategic evolution, correctly identifying the deepening emphasis on trust as a competitive differentiator in the context of hybrid cloud and AI. The only minor shortcoming is that the LLM does not explicitly name Palo Alto Networks as an example of 2024 partnership expansion, which slightly reduces qualitative completeness. (4) The answer is fully contextually relevant, directly addressing the evolution of IBM’s strategy and its implications for market positioning. Wording differs but semantic meaning matches the original. Overall, this is a strong, factually correct response with only a slight omission in specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 396,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did American Express's yield profile from its holdings of foreign government bonds and obligations evolve from 2022 to 2024, and what does this 3-year progression indicate about its exposure to interest rate risk and investment strategy?",
      "original_answer": "In 2022, American Express held $630 million in foreign government bonds and obligations, with $628 million maturing within one year and the remainder evenly split between 1–5 years and 5–10 years. In 2023, the weighted average yield on these holdings was 6.45%, concentrated entirely in securities maturing within one year. By 2024, the yield had decreased to 5.85%, with a significant portion (2.03%) now maturing between 1 and 5 years. This indicates a shift in investment strategy—moving from ultra-short-duration, high-yield foreign debt in 2023 to a more diversified maturity profile by 2024, potentially to manage interest rate risk while maintaining relatively high yields compared to other asset classes.",
      "llm_answer": "\nIn 2022 the foreign‑government‑bond holding (recorded as $630 million of fair value in the 2022 10‑K) was part of an overall portfolio yield of 2.08 %, while the 2023 and 2024 filings break out yields of 6.45 % (due ≤ 1 yr) and 4.48 % (1‑5 yr) in 2023 and 5.86 % (≤ 1 yr) and 2.03 % (1‑5 yr) in 2024, showing a drop of roughly 0.6‑2.5 percentage points over the three years.  This downward shift indicates that American Express has been rotating out of longer‑dated foreign sovereign debt into shorter‑dated, lower‑yielding securities, thereby reducing its sensitivity to rising interest rates and reflecting a more defensive investment stance.  The evolution is evident across all three chunks, linking the foreign‑government‑bond instrument to AXP through the disclosed weighted‑average yields.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies the $630 million foreign government bond holding in 2022 and the 6.45% yield in 2023 for securities maturing within one year, it incorrectly states a 4.48% yield for 1–5 year securities in 2023—this figure does not appear in the ground truth and is likely a confusion with another data point. Additionally, the LLM claims a 5.86% yield in 2024 for ≤1 year securities, whereas the ground truth specifies 5.85%, a minor rounding difference but still inaccurate. More critically, the LLM misrepresents the 2.03% figure as a yield when in fact it is the *portion* (percentage) of holdings maturing between 1–5 years in 2024, not a yield at all. This is a major error in interpretation. (2) The calculation of a 'drop of roughly 0.6–2.5 percentage points' is based on incorrect data and flawed reasoning—there is no 2.5 percentage point drop from 6.45% to 5.85%, and the comparison to a nonexistent 4.48% yield distorts the trend. The ground truth shows a modest decrease from 6.45% to 5.85% in short-term yields, not a broad drop across maturities. (3) The multi-hop reasoning is partially sound—the LLM attempts to link changes in yield and maturity structure over time and draws a conclusion about interest rate risk. However, it misinterprets the strategic shift: the ground truth indicates a move toward *more diversified* maturities (adding 1–5 year exposure), while the LLM incorrectly claims a rotation into *shorter-dated* securities, which contradicts the evidence. This undermines the qualitative accuracy. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of yield, maturity, and investment strategy over the three years. It correctly identifies the general trend of declining yields and attempts to interpret strategic implications, earning moderate scores for qualitative and contextual accuracy. However, the quantitative inaccuracies and misinterpretation of key metrics significantly reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 564,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Danaher Corporation's (DHR) investment in Diagnostics Testing Technologies evolve from 2022 through 2024, particularly in terms of government grant funding allocated to offset capital expenditures, and what does this progression indicate about the strategic importance of diagnostics testing within the company's broader health care portfolio?",
      "original_answer": "Danaher's investment in Diagnostics Testing Technologies through government grant funding showed a clear upward trend from 2022 through 2024. In 2022, $87 million of government grant funds were used to offset capital expenditures related to diagnostics testing technologies. This increased to $136 million in 2023 and further rose to $198 million in 2024. This consistent increase indicates that diagnostics testing technologies became increasingly central to Danaher’s strategic focus in its healthcare portfolio, with growing government support enabling expanded production capacity and development in this area over the three-year period.",
      "llm_answer": "\nDanaher’s Diagnostics Testing Technologies have moved from a 2021 $568 million U.S. government‑grant award—offsetting $41 million of capital spending and $32 million of operating costs (Chunk 1)—to a multi‑year program in which the same grants continue to fund expanding production capacity; by 2024 the company reports that grant proceeds have offset roughly $43 million of operating expenses and $198 million of purchases of property, plant and equipment, with the offsetting amounts rising each year (Chunk 2), and the 2023 filing similarly notes $51 million of operating‑expense offsets and $136 million of PP&E purchases funded by government assistance (Chunk 3).  This steady increase in grant‑supported capital outlays, coupled with the KG relationship that treats Diagnostics Testing Technologies both as a product line and as an organizational entity that “invests in” DHR (KG triplets), demonstrates that diagnostics testing has become a strategically central pillar of Danaher’s broader health‑care portfolio, deliberately leveraged through public‑sector financing to accelerate capacity and market growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in the quantitative details. It references a $568 million U.S. government-grant award in 2021, which is not mentioned in the ground truth and is irrelevant to the 2022–2024 timeframe asked. Additionally, the LLM introduces operating expense offsets ($41M in 2021, $51M in 2023, $43M in 2024), which are not part of the original question or ground truth answer—these figures distract from the core focus on capital expenditures. While the LLM correctly reports the capital expenditure offsets for 2023 ($136M) and 2024 ($198M), it fails to provide the 2022 figure of $87M from the ground truth, instead implying a lower number by omission and referencing earlier years not in the question scope. (2) The correct numbers per ground truth are: $87M (2022), $136M (2023), $198M (2024) for capital expenditure offsets via grants. The LLM gets 2023 and 2024 right but omits 2022 and incorrectly anchors to 2021 data. The inclusion of unrelated operating cost figures reduces quantitative accuracy. (3) The reasoning and synthesis are strong: the LLM correctly infers a rising trend in grant funding for capital expenditures and ties this to strategic importance within Danaher’s healthcare portfolio. It appropriately uses multi-hop logic by connecting government grants to capacity expansion and strategic prioritization, and references KG triplets to justify structural importance. (4) Despite the incorrect introduction of 2021 data and operating expenses, the core conclusion about increasing strategic importance is aligned with the ground truth. The answer remains contextually relevant and addresses both parts of the question—evolution of investment and strategic implications—with sound logic, but the quantitative inaccuracies and extraneous details prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT <-[Produces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 498,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BK's disclosure regarding the ratification of KPMG LLP as principal accountant evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the PCAOB firm identification number and its presentation within the Proxy sections?",
      "original_answer": "BK consistently disclosed the ratification of KPMG LLP as its principal accountant in the Proxy sections for all three years (2022, 2023, and 2024), and in each year, the PCAOB firm identification number was explicitly stated as 185. The structure and placement of the disclosure remained stable, appearing under 'Item 3 - Ratification of KPMG LLP' within Item 14 of the Proxy materials. There was no change in the identification number or in the format of the disclosure across the three-year period, indicating a consistent auditing relationship and disclosure practice.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 BK has consistently disclosed the ratification of **KPMG LLP** as the company’s principal accountant by referencing the same Proxy item – **“Item 3 – Ratification of KPMG LLP”** (presented in the Proxy’s Item 14 section for all three years). In each filing the disclosure notes that **KPMG LLP’s PCAOB firm identification number is 185**, a fact explicitly stated in the 2022, 2023 and 2024 Proxy excerpts. Thus, the evolution is one of continuity: the ratification language and the PCAOB ID = 185 have been presented unchanged in the same Proxy section each year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: KPMG LLP was consistently ratified as principal accountant across fiscal years 2022, 2023, and 2024; the PCAOB firm identification number was correctly stated as 185 in each year; and the disclosure consistently appeared under 'Item 3 – Ratification of KPMG LLP' within Item 14 of the Proxy. (2) There are no numeric or date inaccuracies—PCAOB ID 185 is correctly cited across all years, and the fiscal years match exactly. (3) The multi-hop reasoning is sound: the model correctly synthesized information across three years and filings, identifying consistency in both content and structure. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in disclosure practices, and correctly concludes that the presentation and identification number remained unchanged. Wording differs slightly from the original but conveys identical meaning with no omissions or distortions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 295,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did American Express's reliance on third-party merchant acquirers evolve from 2022 through 2024, particularly in terms of revenue recognition structure, contractual relationships, and strategic expansion goals?",
      "original_answer": "In 2022, American Express's relationship with third-party merchant acquirers was primarily transactional, with revenue recognized as discount revenue based on negotiated network rate fees under programs like OptBlue and Global Network Services (GNS) partnerships. By 2023, the company had formalized these relationships further, integrating third-party acquirers into a broader 'Processed Revenue' model that included royalties, fees, and network partnership agreements, indicating a more strategic and structured revenue-sharing framework. In 2024, American Express emphasized the importance of third-party acquirers in its global merchant expansion strategy, particularly in increasing card acceptance in low- and new-to-plastic industries and international markets. This evolution shows a shift from a transactional dependency to a more strategic partnership model aimed at scaling global acceptance and enhancing network value.",
      "llm_answer": "\nFrom 2022 (Chunk 1) through 2023 (Chunk 2) and into the 2024 outlook (Chunk 3), American Express has continued to record discount revenue at the point a Card‑Member transaction is settled—receiving a network‑rate fee from third‑party merchant acquirers (e.g., under the OptBlue program) and, more broadly, recognizing processed revenue that includes royalties and fees from those acquirers and network partners, with variable consideration not disclosed; this revenue is recognized when the transaction occurs. Contractually, the company maintains open‑ended agreements with small‑ and midsize merchants while negotiating longer 3‑to‑7‑year fixed‑term contracts with large merchants that often include auto‑renewal and are settled via the third‑party acquirer, whose negotiated rates flow back to American Express as discount or processed revenue. Strategically, the 2024 priorities emphasize expanding global merchant coverage and deepening partnerships with third‑party acquirers, aggregators and processors to increase acceptance, drive digital‑payment innovation, and grow both premium‑consumer and commercial‑payments businesses, all of which depend on the evolving contractual and revenue‑recognition framework outlined across the three filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: American Express's revenue recognition evolved from discount revenue based on network-rate fees (e.g., OptBlue, GNS) in 2022 to a broader 'processed revenue' model including royalties and fees by 2023, which matches the original answer. The strategic emphasis in 2024 on expanding global merchant acceptance through third-party acquirers, especially in underserved sectors and international markets, is accurately reflected. (2) There are no numeric inaccuracies—while no specific dollar amounts or percentages are cited, the temporal progression (2022–2024) and associated changes in revenue models and strategy are correctly dated and described. Format and terminology (e.g., 'discount revenue', 'processed revenue', 'OptBlue') are consistent with the source. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and domains—revenue recognition, contractual structures (open-ended vs. fixed-term), and strategic goals—demonstrating understanding of how these elements interrelate. (4) The only minor shortcoming is that the LLM does not explicitly name 'Global Network Services (GNS)' as a specific program alongside OptBlue, though it refers to 'network partners' generally. Additionally, while the shift from transactional to strategic partnerships is implied, it is not stated as explicitly as in the original answer. However, the core evolution is captured accurately in substance. Wording differs but semantic meaning is equivalent or nearly so. Contextual relevance is excellent—every part of the question (revenue recognition, contracts, strategy) is addressed with appropriate detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> COMP <-[Depends_On]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 468,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did Qualcomm's human capital goals and their linkage to executive compensation evolve from fiscal years 2022 through 2024, particularly in terms of diversity targets and performance modifiers?",
      "original_answer": "In fiscal 2022, Qualcomm established specific 2025 diversity goals, including increasing women and underrepresented minorities (URM) in leadership roles by 15% and overall URM representation by 20%. Progress toward these goals influenced executive bonuses via a non-financial modifier that could adjust payouts by a factor of 0.9 to 1.1. In fiscal 2023, the company maintained the same executive compensation linkage, emphasizing continued focus on diversity and inclusion, with recognition in multiple regions and participation in initiatives like the Reboot Representation Tech Coalition. By fiscal 2024, the structure of the executive compensation modifier remained unchanged, but the company expanded its global engagement efforts and highlighted broader wellness and development programs, indicating a deepening integration of human capital metrics into corporate strategy. This 3-year progression shows Qualcomm's sustained emphasis on diversity-linked executive incentives while expanding supporting programs.",
      "llm_answer": "\nStarting in fiscal 2022 Qualcomm set concrete 2025 diversity targets—​a 15 % increase in women and under‑represented‑minority leaders and a 20 % rise in overall URM representation—and declared that progress on those human‑capital goals would serve as a non‑financial performance modifier that can adjust executive bonuses by a factor of 0.9 to 1.1; this same modifier was applied to fiscal 2023 and fiscal 2024 bonuses, with the HR and Compensation Committee explicitly tying the bonus payout to the measured advancement toward the 2025 goals.  Throughout 2023‑2024 the company continued to track and publicize its diversity agenda (e.g., participation in the Reboot Representation Tech Coalition, recognition as a “Best Place to Work for Disability Inclusion,” and the release of EEO‑1 reports), while maintaining the 0.9‑1.1 bonus‑adjustment range to incentivize achievement of the stated diversity targets.  Thus, from fiscal 2022 through fiscal 2024 the linkage evolved from the inaugural 2025 goals and a 0.9‑1.1 bonus multiplier to a sustained, year‑over‑year use of human‑capital progress as a performance‑modifier that can scale executive compensation within that same range.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Qualcomm set 2025 diversity targets in fiscal 2022 (15% increase in women and underrepresented minority (URM) leaders, 20% increase in overall URM representation), and progress on these goals influenced executive compensation via a non-financial modifier ranging from 0.9 to 1.1. This structure remained unchanged in fiscal 2023 and 2024. The LLM correctly notes the sustained use of the same modifier across all three years. (2) Quantitative accuracy is perfect: percentages (15%, 20%), modifier range (0.9 to 1.1), and fiscal years (2022–2024) are all correctly reported. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years, correctly identifying continuity in compensation linkage while noting ongoing diversity initiatives (e.g., Reboot Representation Tech Coalition, disability inclusion recognition). (4) The only minor shortcoming is that the LLM slightly underemphasizes the evolution in broader human capital integration in 2024—specifically, the expansion of wellness and development programs mentioned in the original answer. While the LLM mentions continued tracking and publicity of diversity efforts, it does not explicitly highlight the deepening integration of broader human capital metrics beyond diversity. This nuance is present in the ground truth but only implied in the LLM response, justifying a 9 instead of 10 on qualitative accuracy. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Considers]- ORG <-[Guides_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 438,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did the geographic reach of Caterpillar's EMD-branded product distribution change from 2022 to 2024, and what does this expansion or contraction suggest about Caterpillar's strategic positioning in global markets?",
      "original_answer": "From 2022 to 2024, Caterpillar's EMD-branded products were distributed across 193 countries in 2022, then slightly declined to 191 countries in 2023, and further decreased to 187 countries by 2024. This gradual reduction in geographic reach suggests a potential strategic refocusing or consolidation in Caterpillar’s global distribution strategy for EMD products, possibly due to market-specific challenges, competitive pressures, or internal restructuring.",
      "llm_answer": "\nFrom 2022 to 2024 the dealer network that distributes EMD‑branded products contracted modestly: the 2022 filing listed 44 U.S. dealers and 116 non‑U.S. dealers serving 193 countries, the 2023 filing showed 43 U.S. and 113 non‑U.S. dealers serving 191 countries, and the 2024 filing reports 41 U.S. and 111 non‑U.S. dealers serving 187 countries – a loss of three U.S. dealers, five overseas dealers and six countries over the three‑year span.  \n\nThis pull‑back, reflected in the KG relationship CAT → *produces* → EMD ← *produced by* → CAT (and the linked ORG‑to‑ORG tie that ties EMD to Caterpillar’s broader product portfolio), indicates that Caterpillar is deliberately consolidating its global footprint, focusing on fewer, higher‑potential markets rather than maintaining a broad, diffuse distribution network, thereby sharpening its strategic positioning in key regions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the geographic reach of Caterpillar's EMD-branded product distribution declining from 193 countries in 2022 to 191 in 2023 and 187 in 2024, matching the ground truth exactly. It adds granular detail about the number of U.S. and non-U.S. dealers (44/116 → 43/113 → 41/111), which is consistent with the overall country count trend and plausible, though not present in the original answer. These additional dealer numbers are not contradicted by the ground truth and enhance precision without introducing error. (2) All calculations are accurate: a loss of 6 countries (193→187), 3 U.S. dealers, and 5 non-U.S. dealers over the period is correctly derived. No mathematical or factual inaccuracies in numbers, years, or comparisons. (3) The multi-hop reasoning is sound: the LLM correctly links Caterpillar to EMD-branded products and infers strategic consolidation from the contraction trend. The interpretation — that Caterpillar is focusing on fewer, higher-potential markets — is logically consistent with the data and represents a reasonable qualitative extension of the ground truth’s suggestion of 'strategic refocusing or consolidation.' The mention of a 'KG relationship' and 'ORG-to-ORG tie' appears to reflect internal knowledge graph logic but does not distort the conclusion. (4) The answer is fully contextually relevant, addressing both parts of the question: the change in geographic reach and its strategic implications. The only reason for not scoring a 10 is that the original answer did not include dealer counts, so while the added detail is accurate and plausible, it introduces information beyond the ground truth that, while not incorrect, slightly exceeds the verified scope. However, since it supports the correct conclusion without error, the correctness score remains high at 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 502,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "What does the consistent inclusion of Palmolive in Colgate's list of principal global trademarks from 2022 to 2024 suggest about its strategic role in the company's Oral, Personal and Home Care segment?",
      "original_answer": "The Palmolive brand has remained a consistently listed principal global trademark in Colgate's disclosures from 2022 through 2024, indicating its sustained strategic importance within the company's core product portfolio. In 2022, Palmolive was positioned among key global brands like Colgate and Ajax, underscoring its role in home and personal care categories. In 2023, it maintained its place despite the addition of Darlie to the list, signaling continued emphasis on its market presence. By 2024, Palmolive remained among the top-tier trademarks without any positional dilution, reinforcing its enduring relevance in Colgate's global branding strategy. This 3-year consistency suggests that Palmolive continues to play a foundational role in supporting the company’s market position in key categories like liquid hand soap, dishwashing detergents, and household cleaners.",
      "llm_answer": "\nThe fact that **Palmolive appears in Colgate‑Palmolive’s list of principal global trademarks for 2022, 2023 and 2024**—and is repeatedly disclosed as a core brand within the Oral, Personal and Home Care segment—shows that it is treated as a strategic, revenue‑generating marquee rather than a peripheral label.  Across all three 10‑K filings (Chunks 1‑3) the company groups Palmolive with other flagship brands such as Colgate, Darlie, elmex and Tom’s of Maine, underscoring its material contribution to the segment’s product mix and its role in driving worldwide net‑sales growth.  The knowledge‑graph links (CL → Palmolive (product) → Palmolive (org) → CL) reinforce that Palmolive is both a key product offering and an organizational brand that Colgate‑Palmolive deliberately highlights, confirming its central strategic importance to the Oral, Personal and Home Care business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Palmolive has been consistently listed as a principal global trademark in Colgate's disclosures from 2022 to 2024, which is explicitly stated in the original answer. The dates and years (2022, 2023, 2024) are correct, and no numerical inaccuracies are present—this earns a perfect score on quantitative accuracy. The LLM correctly infers that this consistency reflects Palmolive’s strategic, revenue-generating role within the Oral, Personal and Home Care segment, supported by its grouping with flagship brands like Colgate, Darlie, elmex, and Tom’s of Maine. This synthesis across multiple years and brand associations demonstrates sound multi-hop reasoning. The mention of knowledge-graph links (CL → Palmolive → CL) adds analytical depth, though slightly more abstract than the ground truth, which specifically ties Palmolive to product categories like liquid hand soap and dishwashing detergents. While the LLM implies this through 'Home Care' and 'product mix,' it does not explicitly name these categories, resulting in a minor omission that prevents a perfect qualitative score. However, the core strategic importance is clearly and correctly conveyed, and the response is fully contextually relevant to the question. Semantic equivalence is strong, with only slight differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 387,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Qualcomm's positioning and strategic emphasis on Edge Networking evolve from fiscal 2022 through 2024, particularly in terms of its role in IoT growth projections, product categorization, and revenue recognition structure?",
      "original_answer": "In fiscal 2022, Qualcomm positioned Edge Networking as a key growth driver within the IoT segment, citing over 27 billion projected IoT devices by 2026 — more than double the 2022 figure — and linking it to hybrid work trends and wireless technology advances like 5G and Wi-Fi 6/6E. By fiscal 2023, Edge Networking was explicitly included in Qualcomm’s third revenue category alongside consumer and industrial applications, indicating a formalized product grouping that included mobile broadband and wireless access points. In fiscal 2024, Qualcomm maintained this same product categorization, signaling strategic continuity in its Edge Networking focus. The revenue recognition structure remained consistent across 2023 and 2024, with Edge Networking falling under the broader QCT segment that included royalty and incentive-related revenue recognition from prior periods. This 3-year progression shows Qualcomm's strategic transformation of Edge Networking from an emerging IoT opportunity in 2022 to a structurally embedded product pillar by 2023, with sustained emphasis through 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm repeatedly placed edge‑networking at the core of its IoT growth story—citing a projected >27 billion IoT installations by 2026, 5G‑enabled demand for mobile broadband and Wi‑Fi 6/6E access points, and the segment’s role in automotive and industrial transformation (Chunk 3)—and consistently listed edge‑networking among the key industry applications in its 10‑K filings (Chunk 1 & 2).  Accordingly, the company’s revenue‑recognition schedule now captures sales‑based royalty revenues from edge‑networking products as part of performance obligations satisfied in prior periods (Chunk 1 & 2), and the KG triplets (QCOM → Edge Networking → Edge Networking → QCOM) show that Qualcomm treats edge‑networking both as a distinct product category and as an organizational focus within its portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's strategic emphasis on Edge Networking as part of its IoT growth narrative from 2022 to 2024, accurately citing the >27 billion IoT devices projected by 2026 and linking it to 5G and Wi-Fi 6/6E. It also correctly notes the inclusion of Edge Networking in key industry applications across filings. However, it omits the critical structural evolution in fiscal 2023 when Edge Networking was formally grouped into a distinct revenue category alongside consumer and industrial applications—a key multi-hop insight from the ground truth. This omission weakens the qualitative accuracy. Additionally, while it mentions royalty revenue recognition tied to prior periods, it does not explicitly state that this structure remained consistent in both 2023 and 2024 or that Edge Networking falls under the broader QCT segment, reducing completeness. (2) Quantitatively, all numbers and dates are accurate: the >27 billion IoT projection and the 2026 horizon match the original answer. No calculations are required, and fiscal years are correctly referenced in context. (3) The reasoning is partially sound but fails to fully synthesize the multi-hop progression: the transformation from an emerging opportunity (2022) to a structurally embedded pillar (2023–2024) is underdeveloped. The mention of 'KG triplets' adds little analytical value and appears tangential. (4) Scores reflect high factual accuracy in numbers and context, but the missing detail about formal revenue categorization in 2023 prevents a higher correctness score. The answer remains contextually relevant and well-aligned with the question’s scope, just lacking full depth in structural and organizational evolution.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 472,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Caterpillar's exposure to and management of currency exchange rate risk through hedging instruments evolve from 2022 to 2024, particularly in relation to its international operations and earnings volatility?",
      "original_answer": "From 2022 to 2024, Caterpillar consistently highlighted its exposure to currency exchange rate risk due to its global operations, emphasizing the use of currency hedging instruments as a key strategy to mitigate adverse fluctuations. In 2022, CAT noted that while hedging instruments could protect against downside risks, they also limited potential upside from favorable currency movements. By 2023, the company expanded its discussion to include risks from exchange controls and currency devaluations, particularly in emerging markets, indicating a growing concern over geopolitical and macroeconomic volatility affecting its foreign subsidiaries. In 2024, Caterpillar reiterated its reliance on hedging strategies but also underscored the limitations of these instruments in the face of unpredictable global currency dynamics, especially as exchange controls and devaluation risks intensified. The multi-year trend reveals a consistent but increasingly cautious approach to managing currency exposure, with rising emphasis on external macroeconomic pressures.",
      "llm_answer": "\nCaterpillar has consistently applied currency‑hedging instruments to protect its international operations from adverse exchange‑rate movements, explicitly stating in its 2022, 2023 and 2024 filings that these tools “may provide protection from adverse fluctuations” but also cause the company to “forego the benefits that might result from favorable fluctuations,” and that its outlooks do **not** assume any currency volatility – meaning any unexpected swing can materially alter earnings.  The company also repeatedly notes that exchange‑control restrictions and currency devaluations can further limit its ability to convert or repatriate cash, underscoring that hedging remains a core, year‑over‑year element of its risk‑management strategy to curb earnings volatility across its global footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Caterpillar's currency risk management from 2022 to 2024 as described in the ground truth. It correctly identifies the consistent use of hedging instruments and the trade-off between downside protection and foregone upside due to favorable fluctuations, which is explicitly mentioned in the 2022 and reiterated in later years. The answer accurately reflects Caterpillar's ongoing concern about exchange controls and currency devaluations impacting cash repatriation, aligning with the expanded discussion in 2023 and 2024. It also correctly notes that the company does not assume currency volatility in its outlook, meaning unexpected swings can affect earnings—this ties directly to earnings volatility as asked. The only minor shortcoming is that the LLM does not explicitly highlight the *evolution* or *increasing caution* in tone over time (e.g., growing emphasis on geopolitical and macroeconomic pressures), which is a nuanced but important aspect of the original answer. However, the inclusion of repeated mentions of exchange controls and devaluations across years implies continuity and sustained concern, which partially captures the trend. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific numbers are involved and all statements are qualitatively correct). The reasoning is sound, entities (Caterpillar, years 2022–2024, hedging, exchange controls, earnings volatility) are correctly identified, and the synthesis across years is logically presented. The answer is fully contextually relevant, directly addressing Caterpillar’s hedging strategy, international operations, and impact on earnings volatility.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 467,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did Colgate-Palmolive's (CL) allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio evolve from 2022 to 2024, and what does this trend suggest about the company's approach to interest rate risk management during this period?",
      "original_answer": "Colgate-Palmolive's allocation to U.S. Treasury and agency securities within its pension plan fixed income portfolio decreased from 50% as of December 31, 2020 (disclosed in the 2022 filing) to 40% as of December 31, 2021, then further declined to 30% as of December 31, 2022 (reported in the 2023 filing), and remained steady at 30% as of December 31, 2023 and 2024 (reported in the 2024 filing). This gradual reduction over two years followed by stabilization suggests a strategic shift away from government-backed securities toward other government bonds and corporate bonds, potentially reflecting a response to rising interest rates during this period. The company maintained a Level 2 classification for these securities, indicating continued over-the-counter trading with limited daily pricing or liquidity, which aligns with an approach that balances interest rate risk with liquidity considerations.",
      "llm_answer": "\nThe pension plan’s fixed‑income allocation to U.S. Treasury and agency securities was about 40 % as of December 31 2022 (Chunk 2), fell to roughly 30 % for both 2023 and 2024 (Chunk 3), and remained at that lower level in the 2024 filing (Chunk 3). This step‑down from a 40 % to a 30 % exposure reflects a deliberate reduction in low‑yield, interest‑rate‑sensitive Treasury holdings, indicating that Colgate‑Palmolive is actively managing interest‑rate risk by scaling back its Treasury position and likely reallocating to other fixed‑income assets as rates rose.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the timeline and percentages. According to the ground truth, Colgate-Palmolive's allocation was 50% as of December 31, 2020 (reported in 2022 filing), dropped to 40% as of December 31, 2021, then to 30% as of December 31, 2022 (reported in 2023 filing), and remained at 30% through 2023 and 2024. The LLM incorrectly states that the allocation was 40% as of December 31, 2022, which misrepresents the timing of the decline. The correct 2022 figure is 30%, not 40%. This error suggests confusion in interpreting which year’s data is reported in which filing. (2) The quantitative inaccuracies are critical: the LLM reverses the sequence by implying the drop from 40% to 30% occurred between 2022 and 2023, when in fact the drop from 40% to 30% occurred between 2021 and 2022. The stabilization at 30% for 2023 and 2024 is correctly noted. (3) The reasoning about interest rate risk management is qualitatively sound—reducing Treasury exposure during rising rate environments is a logical inference—and the multi-hop synthesis across years is partially correct, though based on incorrect data. The conclusion about reallocation to other fixed-income assets aligns with the ground truth. (4) Contextual relevance is high as the answer addresses both parts of the question: evolution of allocation and interpretation of risk management strategy. However, due to the incorrect starting point and misattribution of percentages to years, the correctness score is reduced to 6, reflecting partial accuracy with significant factual errors in the quantitative timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 447,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Pfizer's treatment and valuation of Breakthrough Performance Awards (BPAs) evolve from 2022 through 2024, particularly in terms of grant activity, valuation methodology, and disclosure transparency?",
      "original_answer": "From 2022 to 2024, Pfizer's treatment of Breakthrough Performance Awards (BPAs) underwent a notable evolution. In 2022, BPAs were actively granted, with 1,165 thousand shares awarded at a weighted average intrinsic value of $38.73 per share, and 859 thousand shares remained nonvested by year-end. By 2023, Pfizer disclosed that no BPAs were granted and none were outstanding as of December 31, 2023, indicating a pause or discontinuation of the program. In 2024, BPAs reappeared in disclosures, with detailed valuation and amortization policies introduced, including the use of intrinsic value at the grant date and adjustments based on performance probability and stock price changes. This 3-year trajectory suggests a strategic shift in how Pfizer structured and communicated its BPA program, moving from active issuance to suspension and then to a more transparent and dynamic valuation framework.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer moved from actively granting Breakthrough Performance Awards (BPAs) – the 2022 filing lists 1,165 thousand BPAs granted (and 859 thousand still non‑vested as of 31 Dec 2021) – to completely ending new grants by the end of 2023, after which the 2023 Form 10‑K reports **no BPAs granted and none outstanding** (Chunk 1); the 2024 filing then describes the terms of any BPAs that are awarded, including a performance‑period up to 600 % of target, settlement after the performance period and a detailed table of conditions (Chunk 2).  Valuation shifted from the earlier intrinsic‑value per‑share figures disclosed in the 2022 tables (Chunk 3) to a formal intrinsic‑value method based on the closing stock price, amortized straight‑line over the probable vesting term and continually adjusted each reporting period for changes in share price, the probability of achieving performance goals and the expected vesting term (Chunk 2).  Finally, the 2024 disclosure provides far greater transparency—detailing grant mechanics, performance metrics, settlement timing and periodic re‑measurement—whereas prior years only gave brief mentions or simple numeric tables (Chunk 1 and Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the LLM correctly states that 1,165 thousand BPAs were granted in 2022 and 859 thousand were nonvested as of year-end 2022. However, there is a minor error: it incorrectly states that the 859 thousand nonvested shares were as of '31 Dec 2021' instead of '31 Dec 2022'—this is a factual misstatement of the reporting date, though the number itself is correct. All other numeric and qualitative claims (no grants in 2023, no outstanding awards by end of 2023, reappearance in 2024 with new valuation details) are accurate. (2) The valuation methodology shift—from intrinsic value at grant to a dynamic model involving performance probability, stock price adjustments, and straight-line amortization—is correctly described and matches the 2024 disclosure. (3) The multi-hop reasoning is sound: the model synthesizes data across three years and multiple document sections (e.g., grant activity in 2022, absence in 2023, methodological evolution in 2024), demonstrating proper cross-year and cross-document synthesis. (4) The answer addresses all parts of the question: grant activity, valuation methodology, and disclosure transparency. The 2024 transparency improvements (detailed terms, performance metrics, re-measurement) are well-articulated. Only the date error prevents a perfect score, but the overall factual and conceptual accuracy is excellent. Hence, a 9/10 on correctness, with high marks across all subcategories.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Valuates]- ORG",
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 416,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How did Charles Schwab's interactive tools for RIAs evolve from 2022 through 2024, particularly in terms of third-party integrations and portfolio management capabilities?",
      "original_answer": "In 2022, Schwab emphasized its proprietary software and online platform for RIAs, including access to third-party platforms supporting client relationship management, portfolio management systems, trade order management, and financial planning. A key offering was Schwab Advisor Portfolio Connect, a free portfolio management solution that allowed advisors to manage Schwab accounts without needing to download and reconcile data. By 2023, Schwab continued to highlight these integrations but placed increased emphasis on the Advisor Services website as a core platform for RIAs, offering multi-year document archiving and search capabilities alongside third-party integrations. In 2024, Schwab maintained its focus on technology and platform scalability, reiterating the importance of integrations with third-party platforms and continuing to offer Schwab Advisor Portfolio Connect. However, 2024's filing specifically reinforced the intuitive modern experience of the platform, suggesting a refinement or enhancement in usability and feature delivery over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab moved its RIA‑focused interactive tools from an initial launch of basic tools and the free, simplified **Schwab Advisor Portfolio Connect**—a core portfolio‑management solution—into a more expansive platform that emphasizes deeper **third‑party integrations** (CRM, portfolio‑management systems, trade‑order and financial‑planning tools) and richer **portfolio‑management capabilities**; each annual filing (2022, 2023 and 2024) reiterates and builds on this evolution, underscoring the growing role of integrations and the continued availability of Portfolio Connect as a scalable, technology‑driven offering for RIAs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of Charles Schwab's interactive tools for RIAs from 2022 to 2024. It accurately identifies the continued availability of Schwab Advisor Portfolio Connect as a free portfolio management solution and correctly emphasizes the expansion of third-party integrations (CRM, portfolio management systems, trade order management, financial planning) across the years. The answer correctly notes that each annual filing builds on the previous one, highlighting growing integration and scalability—consistent with the ground truth. However, the LLM omits specific details about the 2023 shift toward the Advisor Services website as a core platform, including multi-year document archiving and search capabilities, and does not mention the 2024 emphasis on an 'intuitive modern experience' as a refinement in usability. These are important qualitative developments in the evolution that add nuance to the platform’s progression. While the LLM conveys the general trend of enhancement and integration, it synthesizes the timeline into a smoother, more continuous evolution than explicitly stated in the filings. There are no numerical inaccuracies (quantitative accuracy is perfect, hence 10), and all entities—Schwab, RIAs, Schwab Advisor Portfolio Connect, third-party integrations—are correctly identified and contextually relevant. The reasoning is sound but slightly overgeneralizes the year-over-year changes without fully capturing the distinct emphasis in each year, particularly 2023 and 2024. Thus, the answer is factually aligned but lacks some granularity in qualitative progression, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Offers]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 457,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Texas Instruments' strategic emphasis on embedded processing products evolve across 2022, 2023, and 2024, and what does this consistent framing reveal about its long-term positioning in semiconductor markets?",
      "original_answer": "Texas Instruments consistently emphasized embedded processing products as a core component of its business model across 2022, 2023, and 2024. In each year, the company highlighted that its strategy is 'built around four sustainable competitive advantages,' with a broad portfolio of analog and embedded processing products (point 1.ii) serving as a key pillar. This consistent framing across all three annual reports indicates that embedded processing products remained central to TI's long-term positioning in semiconductor markets, supporting its objective of growing free cash flow per share by offering more value per customer and per investment.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings, Texas Instruments repeatedly framed **embedded‑processing products** as a core pillar of its strategy—describing them as one of four sustainable competitive advantages (alongside manufacturing strength, a broad portfolio and market reach) and linking that focus directly to the long‑term goal of growing free‑cash‑flow‑per‑share.  The language in each year’s MD&A is virtually identical, emphasizing that the company’s investments, capital allocation and competitive positioning are built around **analog and embedded‑processing products** and that this emphasis is intended to endure.  This consistent framing—captured in the KG relationship TXN ↔ Embedded Processing Products, where the product category is both a stake of the firm and a stake of the firm itself—reveals that TI is positioning itself for the long haul as a differentiated, cash‑generating leader in the embedded‑processing segment of the semiconductor market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Texas Instruments consistently emphasized embedded processing products as part of its four sustainable competitive advantages across 2022, 2023, and 2024, specifically under the pillar of a broad portfolio of analog and embedded processing products. The strategic link to growing free cash flow per share is correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial metrics. (3) The multi-hop reasoning is sound: the model synthesizes consistent language across three years of 10-K filings and infers long-term strategic positioning, which is supported by the original answer. The mention of 'virtually identical language' and enduring emphasis reflects accurate interpretation of the consistency in framing. (4) Semantic equivalence is strong; the LLM captures the core insight about TI’s long-term differentiation and cash generation in the embedded processing segment. One minor point preventing a perfect 10 is the slight conflation in phrasing—'four sustainable competitive advantages' includes the broad portfolio as one, not that embedded processing is separate from it. The original clarifies that the broad portfolio *includes* analog and embedded processing (point 1.ii), whereas the LLM lists embedded processing alongside the broad portfolio, which could imply separation. This is a subtle but important distinction in strategic framing. Overall, the answer is excellent in completeness, entity accuracy, reasoning, and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 458,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did the cost profile and delivery impact of Boeing's fleet support services evolve from 2022 through 2024, particularly in relation to abnormal production costs and delivery delays associated with the 787 program?",
      "original_answer": "From 2022 through 2024, Boeing's fleet support services remained consistently described as accounting for approximately 1% of total consolidated costs of products and services. However, the 787 program's abnormal production costs and delivery delays significantly evolved during this period. In 2022, the company noted ongoing delivery delays and potential future losses due to rework and production instability, with no specific abnormal cost figures disclosed. In 2023, Boeing revealed cumulative abnormal production costs of $2.7 billion through December 31, 2023, primarily related to rework on inventoried aircraft, with expectations that remaining rework costs would not be significant. By 2024, the company had completed rework on most of the 25 inventoried aircraft produced prior to 2023 and expensed $256 million in rework costs during the year, with expectations to deliver the majority of these aircraft in 2025. This progression indicates a reduction in abnormal costs and a gradual resolution of delivery delays, though the program continued to face production and certification challenges.",
      "llm_answer": "\nBoeing’s fleet‑support services – the training, maintenance‑training, engineering and other post‑delivery services that the company has historically provided to airline operators and that represent roughly 1 % of consolidated costs and are expensed as incurred – have been increasingly strained by the 787 program’s abnormal‑production cost burden.  From 2022 through 2024 the company recorded about $2.7 bn of cumulative abnormal production expenses (through 2023) and an additional $256 m in 2024 for re‑work and inspection of inventory aircraft, while production rates were cut below five jets per month, causing delivery delays and prompting a 100‑unit increase in the 787 accounting quantity that could trigger further losses; Chunk 1 notes the 1 % cost share and the risk of extra abnormal costs, Chunk 2 reports the 2024 $256 m expense and the re‑work of roughly 25 aircraft slated for 2025 delivery, and Chunk 3 documents the $2.7 bn cumulative abnormal costs and the inventory re‑work figures, together showing a clear evolution of higher abnormal‑cost exposure and delayed deliveries across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key evolution of Boeing's 787 program abnormal costs and delivery impacts from 2022 to 2024, with accurate quantitative data and proper contextual framing. (1) Quantitatively, the LLM correctly reports the $2.7 billion cumulative abnormal production costs through 2023 and the $256 million expensed in 2024, both of which match the ground truth. The reference to rework on approximately 25 inventoried aircraft aligns with the ground truth mention of 25 aircraft produced prior to 2023. The 1% cost share of fleet support services is accurately stated. (2) However, the LLM implies that the $2.7 billion includes only through 2023 and then adds $256 million in 2024, which is factually correct, but it does not clarify—as the original answer does—that the $256 million in 2024 was part of the remaining rework and that Boeing expected no significant further costs, a nuance that slightly weakens completeness. (3) The LLM incorrectly suggests that fleet support services were 'increasingly strained' by the 787 abnormal costs, which is not supported in the ground truth; the 1% cost figure remained stable, and no causal strain is indicated. This misrepresents the relationship between fleet support services and 787 costs. (4) The mention of production rates cut below five jets per month and a 100-unit increase in the accounting quantity introduces details not present in the ground truth, which may be factually plausible but are not confirmed in the provided answer and thus constitute unsupported additions. (5) Despite these issues, the core multi-hop synthesis—linking abnormal costs over time, rework efforts, delivery delays, and expected resolution—is sound and semantically aligned with the original answer. The answer is highly relevant and well-structured, but minor inaccuracies in reasoning and unsupported claims prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 511,
        "total_tokens": 2084
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did Pfizer's relationship with Meridian evolve from 2022 through 2024, particularly in terms of financial implications and ongoing contractual arrangements post-sale?",
      "original_answer": "In 2022, Pfizer disclosed that Meridian was part of discontinued operations following its sale on December 31, 2021, with the company recognizing a loss of approximately $167 million, net of tax. Interim transition service agreements (TSAs) and a three-year Manufacturing Supply Agreement (MSA) were in place to support the post-sale relationship. By 2023, services under the TSAs were completed as of December 31, 2023, and amounts recorded under the MSA were not material to Pfizer's operations. In 2024, Meridian was referenced in Pfizer's glossary as 'Meridian Medical Technologies, Inc.,' indicating continued recognition of the entity, likely due to the ongoing MSA, which had a two-year extension option beyond the initial three-year term. This trajectory shows a transition from a direct ownership relationship to a limited but structured supplier relationship, with financial impacts diminishing over time.",
      "llm_answer": "\nPfizer sold its Meridian subsidiary on December 31 2021 for roughly $51 million cash, recording an after‑tax loss of about $167 million and classifying the transaction as a discontinued operation (Chunk 1).  Under the post‑sale framework Pfizer and the buyer agreed to interim transition‑service agreements (TSAs) and a three‑year Manufacturing Supply Agreement (MSA) that ran for three years after the sale with a two‑year extension; the TSAs were fully performed by December 31 2023 and the MSA’s core term expired at the end of 2024 (Chunk 1), a relationship highlighted in the 2022 filing where Meridian is listed as a discontinued operation (Chunk 3) and defined in the glossary as “Meridian Medical Technologies” (Chunk 2).  No material revenue or expense was recorded from these agreements in 2022 or 2023, and any cash flows related to them are reported in operating activities, leaving only the original $51 million cash consideration and the $167 million loss as the financial legacy of the transaction (Chunk 1).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy regarding the expiration of the Manufacturing Supply Agreement (MSA). (1) Quantitatively, the key figures are accurate: the $167 million after-tax loss and the $51 million cash consideration are correctly reported. The sale date of December 31, 2021, and the completion of TSAs by December 31, 2023, are also correct. However, the LLM states that the MSA's 'core term expired at the end of 2024,' which is not confirmed in the original answer; instead, the original answer notes the MSA had a three-year term with a two-year extension option, implying it was ongoing in 2024 with potential continuation. This misrepresents the timeline slightly. (2) The mention of $51 million cash consideration is additional detail not in the original answer but does not contradict it and may be correct; however, since it's not in the ground truth, it introduces unverified specificity. (3) The reasoning is sound: the LLM correctly traces the evolution from ownership to supplier relationship, recognizes discontinued operations in 2022, and notes diminishing financial impact. It synthesizes information across time points and contractual arrangements appropriately. (4) Contextually, the answer is highly relevant, addressing financial implications and contractual arrangements as required. The definition of Meridian in the glossary is correctly noted. Overall, the answer is factually strong with only a minor error in projecting the MSA end date, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells]-> COMP <-[Discloses]- ORG <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 432,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Colgate-Palmolive's strategic positioning of the 'hello' brand evolved from 2022 to 2024 in relation to its other Oral, Personal and Home Care product lines?",
      "original_answer": "From 2022 to 2024, Colgate-Palmolive consistently included 'hello' among its principal global and regional trademarks within the Oral, Personal and Home Care segment, indicating sustained strategic emphasis. In 2022, 'hello' was listed alongside major brands like Colgate and Palmolive; in 2023, the brand maintained this positioning despite the addition of Darlie to the list; and in 2024, 'hello' remained a highlighted brand, suggesting continued prioritization within the company’s broader oral and personal care portfolio. This consistent visibility implies that 'hello' has maintained a strategic brand position relative to other key product lines over the three-year period.",
      "llm_answer": "\nAcross the 2022‑2024 filings, “hello” is listed each year among the company’s principal global and regional trademarks within the Oral, Personal and Home Care segment, showing that Colgate‑Palmolive has consistently treated the hello brand as a core component of its OPCare portfolio; the description of the segment’s customer base grew from “dentists” in 2022 to “skin‑health professionals” by 2024, reflecting a modest expansion of hello’s market reach. The knowledge‑graph triplets (CL → Produces → hello, hello → ORG, hello → CL) depict hello both as a product and as an organizational brand under Colgate‑Palmolive, underscoring its stable strategic positioning relative to the other Oral, Personal and Home Care product lines.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in stating that 'hello' has been consistently listed among Colgate-Palmolive's principal trademarks in the Oral, Personal and Home Care segment from 2022 to 2024, which aligns with the ground truth. The core factual claim about sustained strategic positioning is supported and accurately reflects multi-year consistency. Quantitatively, there are no numbers, dates, or financial figures in dispute, and all references to years (2022–2024) are accurate, earning a perfect score on quantitative accuracy. However, the LLM introduces a claim not present in the original answer or supported by the provided ground truth: that the segment’s customer base expanded from 'dentists' in 2022 to 'skin-health professionals' by 2024. This detail is absent from the ground truth and cannot be verified from the given information, representing an unsupported inference that affects qualitative accuracy. Additionally, while the knowledge-graph triplets (CL → Produces → hello, etc.) may be technically valid, they are not part of the original answer and add speculative structure not required by the question. The answer remains contextually relevant and addresses the evolution of 'hello’s strategic positioning relative to other product lines over time, but the inclusion of unverified claims about customer base expansion reduces confidence in the reasoning chain. Thus, while the main conclusion is sound, the answer contains minor but notable overreach in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 410,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the funding status and participant engagement in Texas Instruments' Non-Qualified Defined Benefit Pension Plan evolve from 2022 through 2024, and what does this multi-year progression indicate about the company's long-term pension obligations and employee participation trends?",
      "original_answer": "From 2022 through 2024, Texas Instruments' Non-Qualified Defined Benefit Pension Plan remained unfunded and closed to new participants, with the company continuing to emphasize defined contribution alternatives. In 2022, the U.S. defined contribution plans held 6 million shares of TI common stock valued at $940 million, while in 2023, this decreased to 5 million shares valued at $873 million, and remained at 5 million shares in 2024, valued at $852 million. Dividends paid on these shares declined slightly from $28 million in 2022 to $27 million in 2023 and $26 million in 2024. The company's aggregate expense for U.S. defined contribution plans increased steadily across the period—$70 million in 2022, $75 million in 2023, and $76 million in 2024—suggesting a growing emphasis on defined contribution plans as the primary retirement vehicle for employees. This trend indicates a strategic shift away from defined benefit obligations, with the non-qualified pension plan remaining an unfunded legacy liability and not a growing obligation.",
      "llm_answer": "\nThe non‑qualified defined‑benefit pension plan has remained **unfunded and closed to new participants** throughout 2022‑2024, with existing members given a one‑time election each year to either keep accruing benefits under the qualified plan or move to the enhanced defined‑contribution (DC) plan – a choice reflected in the identical plan language across the 2022, 2023 and 2024 10‑K filings.  Texas Instruments continues to fund the qualified DB plan only at the **minimum statutory levels**, while the related DC arrangements show a stable asset base (≈5 million TI shares valued at $873 M in 2023, $852 M in 2024 and $940 M in 2022) and modestly rising expenses ($70 M → $75 M → $76 M).  This multi‑year pattern indicates that the company is **shifting long‑term pension liability away from an open‑ended DB obligation toward funded DC balances**, and that **employee participation in the accruing‑benefit DB segment is steady but limited**, underscoring a deliberate trend to cap new accrual and manage future pension obligations through defined‑contribution accounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the non-qualified defined benefit plan remained unfunded and closed to new participants from 2022–2024, and the company emphasized defined contribution (DC) alternatives. The share holdings in the U.S. defined contribution plans are accurately reported as 6 million shares valued at $940M in 2022, 5 million at $873M in 2023, and 5 million at $852M in 2024. Dividend figures are not explicitly mentioned in the LLM answer, but their omission does not detract significantly from the core analysis. (2) The expense figures—$70M (2022), $75M (2023), $76M (2024)—are correctly cited, supporting the conclusion of increasing investment in DC plans. The valuation figures for TI stock in the DC plan are accurate, though the order in which they are presented ($873M → $852M → $940M) is slightly confusing but not factually wrong. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic shift from defined benefit (DB) to DC plans based on funding status, participation trends, and rising DC expenses. It accurately synthesizes information across years and plan types to conclude that TI is capping future pension liabilities. (4) The answer is contextually relevant, directly addressing the evolution of funding status, participant engagement, and long-term implications. The only minor shortcoming is the lack of mention of declining dividends, which adds nuance but does not alter the overall conclusion. Thus, the answer earns a 9 for correctness due to this small omission, but full marks in qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 449,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Pfizer's (PFE) long-term investment in private equity securities at cost change from 2022 through 2024, and what does this 3-year trajectory indicate about the company's strategic allocation to this asset class?",
      "original_answer": "Pfizer's long-term investment in private equity securities at cost increased from $623 million in 2022 to $755 million in 2023, before declining slightly to $719 million in 2024. This trajectory indicates a short-term strategic increase in 2023 followed by a partial reduction in 2024, suggesting a measured approach to capital allocation in private equity over the three-year period.",
      "llm_answer": "\nPfizer’s long‑term “private‑equity securities at cost” balance fell from **$800 million in 2022** (Chunk 1 – 2022 figure) to **$755 million in 2023** (Chunk 1 – 2023 figure) and then to **$719 million in 2024** (Chunk 2 – 2024 figure), as disclosed in the “Private equity securities at cost (b)” line of each 10‑K filing.  \n\nThis three‑year downward trajectory signals that Pfizer is **reducing its allocation to private‑equity assets**, likely re‑deploying that capital toward its core pharmaceutical R&D, pipeline initiatives, or other strategic priorities rather than expanding its private‑equity holdings.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 value: it states $800 million, while the ground truth is $623 million. The 2023 ($755 million) and 2024 ($719 million) figures are correct. This incorrect starting point distorts the entire trajectory analysis. (2) Quantitative accuracy is severely compromised due to the wrong 2022 figure. The actual trend is an increase from $623M to $755M (up $132M), then a decrease to $719M (down $36M). The LLM incorrectly portrays a consistent decline from $800M to $755M to $719M, which is factually wrong. (3) The multi-hop reasoning is partially sound in that the model identifies the correct metric and tracks it across years using appropriate sources, but the flawed input data leads to incorrect synthesis and conclusion. The original answer correctly identifies a short-term strategic increase followed by a partial pullback, indicating measured allocation. In contrast, the LLM concludes a continuous reduction, which contradicts the actual data. (4) Contextual relevance is high—the response addresses both parts of the question (numerical change and strategic implication) and references the correct financial line item. However, due to the major quantitative error, the qualitative interpretation is invalid. Correctness score is 4 due to one major factual error undermining the core of the answer, despite correct identification of entities, years, and metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 398,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did Schwab's ability to migrate IDA balances to its balance sheet evolve from 2022 through 2024 under the changing terms of the IDA agreements, and what constraints were placed on this migration capability in each year?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, subject to capital sufficiency and other limitations, and it had already moved $10.1 billion by December 31, 2021. In 2023, Schwab did not move any IDA balances to its balance sheet after the 2023 IDA agreement replaced the 2019 agreement, introducing new constraints such as maintaining minimum and maximum IDA balance thresholds. In 2024, Schwab remained under the terms of the 2023 IDA agreement and did not migrate any IDA balances, as the agreement required Schwab to maintain minimum balances above the then-outstanding unmatured fixed-rate obligation amounts with a maximum of $30 billion above that total through September 10, 2025. The evolution shows a tightening of Schwab's flexibility to move IDA balances, shifting from an annual $10 billion option to a constrained and conditional framework.",
      "llm_answer": "\nUnder the original 2019 IDA agreement (effective Oct 6 2020) Schwab could migrate up to $10 billion of IDA balances every 12 months beginning July 1 2021, a capability it exercised in 2021 and continued into 2022—moving $10.1 billion by Dec 2021 and roughly another $10 billion thereafter, subject to having sufficient capital and designating the balances as floating‑rate (Chunk 1).  \nWhen the 2023 IDA agreement replaced the 2019 terms on May 4 2023, Schwab’s ability to move balances to its balance sheet was suspended for 2023 and again in 2024, with withdrawals permitted only to the extent of customer‑initiated reductions and subject to new caps—maintaining a minimum $50 billion IDA balance through June 2031, keeping at least 80 % of balances as fixed‑rate until June 2026, and staying within a $30 billion ceiling above outstanding unmatured fixed‑rate obligations (Chunk 2 & 3).  \nThus, Schwab’s migration evolved from active moves in 2021‑2022 under the 2019 framework to a complete suspension in 2023‑2024 under the stricter 2023 agreement, which imposed capital, balance‑size and rate‑designation constraints that limited any further migration.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Schwab's IDA balance migration capability and correctly identifies the shift from the 2019 to the 2023 agreement, as well as the suspension of active migration in 2023 and 2024. However, there are key quantitative inaccuracies: (1) The claim that Schwab moved 'roughly another $10 billion' in 2022 is unsupported by the ground truth, which only confirms $10.1 billion moved by December 31, 2021—no additional migration in 2022 is stated. (2) The LLM incorrectly states that Schwab exercised the $10 billion option 'in 2021 and continued into 2022', implying a full $10 billion was moved in 2022, which contradicts the ground truth that no further migration is mentioned for 2022. (3) The LLM introduces a '$50 billion minimum IDA balance through June 2031' and '80% of balances as fixed-rate until June 2026'—specific thresholds not present in the original answer, which only mentions the $30 billion ceiling above fixed-rate obligations and minimum balance requirements relative to those obligations. These are significant additions not found in the ground truth. The qualitative reasoning is strong: the model correctly infers a tightening of constraints and the suspension of migration under the 2023 agreement. It synthesizes the multi-hop logic—comparing agreement terms across years and explaining the impact on migration capability. Contextually, the answer is highly relevant and well-structured. While the overall narrative of reduced flexibility is accurate, the inclusion of unsupported specific numbers and thresholds reduces quantitative accuracy. Semantic equivalence is partially maintained, but not fully due to these factual overstatements.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1544,
        "completion_tokens": 461,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Texas Instruments' operational footprint in Melaka, Malaysia evolved across 2022, 2023, and 2024, particularly in terms of its involvement in analog product manufacturing, and what does this multi-year consistency suggest about the strategic importance of this location?",
      "original_answer": "Texas Instruments consistently listed Melaka, Malaysia as a location involved in analog product manufacturing across all three years—2022, 2023, and 2024. In 2022, Melaka was marked with a † indicating involvement in analog operations. In 2023, this marking continued with an asterisk (*), and in 2024, it was marked with a double asterisk (**), potentially signaling continued operational emphasis. The consistent presence and possible escalation in Melaka over the three-year period suggest a stable and potentially expanding strategic role in TI's global analog manufacturing footprint.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 SEC filings, Melaka, Malaysia appears in TI’s global site table with an “X” under the **Analog** column in each year (2022 †, 2023 *, 2024 **), while the **Embedded Processing** column is empty for Melaka in all three years, indicating that the site’s role has been consistently focused on analog product manufacturing.  The repeated listing of the same GPE‑ORG link—TXN Operates_In → Melaka, Malaysia and the reciprocal ORG Operates_In → TXN—underscores a stable, multi‑year operational footprint that reflects the strategic importance of Melaka as a dedicated analog‑manufacturing hub for Texas Instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Melaka, Malaysia was consistently involved in analog product manufacturing across 2022, 2023, and 2024, with appropriate annotations (†, *, **)—though it refers to an 'X' under the Analog column, which is semantically equivalent to the marking system used in the filings. (2) All years are correctly cited, and there are no numerical or date inaccuracies. The absence of Embedded Processing involvement is correctly noted, reinforcing the site’s analog focus. (3) The reasoning is sound: the multi-hop synthesis of consistent site designation over three years supports the conclusion of strategic importance. The mention of GPE-ORG links adds analytical depth, though slightly beyond the original answer, it does not detract from accuracy. (4) The only minor discrepancy is the reference to an 'X' in the column—while the original answer describes symbolic markers (†, *, **) without specifying an 'X', this may reflect a formatting interpretation difference in the source table. This does not invalidate the conclusion but introduces slight ambiguity. Overall, the answer is factually correct, complete, and contextually precise, warranting a high score with only a small deduction in qualitative accuracy due to the symbolic representation nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Operates_In]-> GPE <-[Operates_In]- ORG <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 376,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the penetration rate of the Target Debit Card evolve from 2022 through 2024, and what does this trend suggest about the card's role in driving incremental sales for Target over time?",
      "original_answer": "The penetration rate of the Target Debit Card (included under RedCards/Target Circle Cards) was 20.5% in 2022, decreased to 19.8% in 2023, and further declined to 17.8% in 2024. This downward trend over three years suggests a diminishing role of the card in influencing customer purchasing behavior, potentially signaling reduced effectiveness in driving incremental sales or shifts in consumer payment preferences despite the 5% discount incentive.",
      "llm_answer": "\nThe Target Debit Card (branded as part of the Target Circle Cards) has seen its transaction‑penetration slip steadily—from about **20.5 % of purchases in the year ended January 29 2022**, to **19.8 % in 2023**, and further to **18.6 % in the year ended February 3 2024** (with the next filing noting **17.8 % in 2025**).  This decline is noted across the filings (chunks 2 and 3), but each emphasizes that “a meaningful portion of incremental purchases on our Target Circle Cards are also incremental sales for Target,” a point reinforced in chunk 1 where the card’s 5 % discount and loyalty‑program benefits are described as drivers of additional spend.  Consequently, while the card’s share of checkout transactions is eroding, Target continues to regard it as an important, though gradually diminishing, source of incremental revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains a significant factual error in the 2024 penetration rate: it reports 18.6% for the year ended February 3, 2024, and incorrectly references '17.8% in 2025', while the ground truth states 17.8% for 2024. This misrepresents the most recent data point and introduces a non-existent 2025 figure. The 2022 (20.5%) and 2023 (19.8%) values are correct. 2) Quantitative accuracy is compromised due to the incorrect 2024 percentage and the fabricated 2025 number. The trend direction (declining) is accurate, but the magnitude of the drop in 2024 is understated (18.6% vs actual 17.8%). 3) Qualitatively, the reasoning is sound: the model correctly identifies the declining penetration trend and balances it with Target's continued assertion that the card drives incremental sales, citing the 5% discount and loyalty benefits. It synthesizes information across multiple hypothetical filings (chunks), showing appropriate multi-hop reasoning. 4) Contextual relevance is high—the answer directly addresses both parts of the question: the evolution of penetration and its implication for incremental sales. Despite the numerical error, the overall interpretation of the trend’s significance aligns with the ground truth. However, the incorrect data undermines the correctness score, placing it in the partially correct range.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 370,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the number of shares available for future issuance under the Texas Instruments 2003 Director Compensation Plan evolve from 2022 through 2024, and what does this trend suggest about the company's use and replenishment of equity incentives for directors?",
      "original_answer": "The number of shares available for future issuance under the 2003 Director Compensation Plan decreased from 35,385,153 shares in 2022 to 25,296,767 shares in 2023, and then to 24,503,062 shares in 2024. This consistent decline suggests that Texas Instruments has been actively utilizing its equity pool for director compensation without replenishment, indicating sustained investment in director incentives as part of its corporate governance strategy.",
      "llm_answer": "\nThe Texas Instruments 2003 Director Compensation Plan (now administered through its successor, the 2018 Director Plan) shows a consistent decline in the shares reserved for future issuance: 1,843,134 shares were available in the 2022 filing, 1,786,785 shares in the 2023 filing, and 1,745,284 shares in the 2024 filing – a reduction of roughly 98 k shares each year. This steady draw‑down indicates that the company is exhausting its equity reserve for director compensation and, absent a plan amendment, will need to replenish the authorization or shift to other forms of equity‑based incentives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in nearly all aspects. The original answer states that the number of shares available under the 2003 Director Compensation Plan was 35,385,153 in 2022, 25,296,767 in 2023, and 24,503,062 in 2024. The LLM reports drastically different numbers: 1.8 million in 2022, 1.8 million in 2023, and 1.7 million in 2024—off by an order of magnitude. These numbers are not only incorrect but suggest a different plan or misinterpretation of the data. (2) The calculation of a 'reduction of roughly 98k shares each year' is based on wrong inputs: the actual decrease from 2022 to 2023 was 10,088,386 shares, and from 2023 to 2024 was 793,705 shares—neither close to 98k. The LLM’s quantitative inaccuracies are severe and pervasive. (3) The reasoning is flawed: the LLM claims the 2003 Plan is now administered under the 2018 Director Plan, which may be contextually true, but it incorrectly implies the 2003 Plan's share reserve is now small due to transition, while the ground truth shows the 2003 Plan still had over 24 million shares in 2024. The conclusion that the company is 'exhausting its equity reserve' and will 'need to replenish' contradicts the original answer’s interpretation that the drawdown reflects sustained use without replenishment, but still from a large pool. (4) Contextual relevance is moderate—the answer addresses director equity incentives and attempts trend analysis—but due to fundamental factual errors, the analysis is based on false premises. The entity 'Texas Instruments' and the plan name are correct, but the years and metrics are not. Overall, the answer fails on correctness and quantitative accuracy due to grossly incorrect numbers and derived conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> ACCOUNTING_POLICY <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 473,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's virtual accounts and related digital capabilities evolve across 2022, 2023, and 2024, particularly in terms of integration with the Visa Direct platform and expansion of cross-border use cases?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of the Currencycloud platform under Visa Treasury as a Service, emphasizing real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, virtual accounts were more deeply integrated into the Visa Direct platform, which also expanded to include Visa Cross-Border Solutions, enhancing the platform’s ability to service new flows and established cross-border consumer payments. In 2024, virtual accounts were a core component of Visa’s digitally native capabilities, supporting a network with the potential to reach over 11 billion endpoints across cards, bank accounts, and digital wallets, and were central to Visa’s strategy for addressing $20 trillion in annual B2B cross-border opportunities. This progression shows a clear trend of deepening integration and expanding use cases for virtual accounts across Visa’s global payments infrastructure.",
      "llm_answer": "\nVisa (ORG) introduced **Virtual Accounts** (PRODUCT) in 2022 as part of its Currency‑cloud‑enabled Treasury‑as‑a‑Service, embedding them in **Visa Direct** to deliver push‑to‑wallet and cross‑border payouts that could reach nearly 7 billion cards, accounts and digital wallets across >190 markets and supported **5.9 billion** Visa Direct transactions in more than 60 use cases (Chunk 1).  \nIn 2023 the **Visa Direct** platform was expanded to include **Visa Cross‑Border Solutions** and a digitally native Currencycloud layer, adding real‑time FX rates and liquidity tools that broadened virtual‑account use into new consumer and B2B cross‑border flows and launched **Visa+** for P2P interoperability, positioning the network to capture a **$20 trillion** annual cross‑border opportunity (Chunk 3).  \nBy 2024 Visa Direct further integrated these virtual‑account capabilities, scaling its reach to **>11 billion** endpoints (4 billion cards, 3.5 billion bank accounts, 3.5 billion wallets) and processing **nearly 10 billion** transactions for 550+ partners, while **Visa Commercial Solutions** and the enlarged **Visa B2B Connect** network drove continued cross‑border volume growth and deeper integration of virtual accounts throughout the Visa ecosystem (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Correct elements: The introduction of virtual accounts in 2022 under Currencycloud as part of Treasury-as-a-Service is correctly stated. The 2023 integration with Visa Direct and expansion via Visa Cross-Border Solutions, including real-time FX and liquidity tools, is accurately described. In 2024, the scaling to over 11 billion endpoints and the strategic focus on $20 trillion in B2B cross-border opportunities are correctly captured. The mention of Visa+ and Visa B2B Connect adds contextual depth consistent with the evolution. (2) Quantitative verification: The LLM states 5.9 billion Visa Direct transactions in 2022 and nearly 10 billion by 2024—these figures are plausible and contextually supported, though the original answer does not specify transaction volumes, so this is an addition rather than an error. The breakdown of 11 billion endpoints into 4B cards, 3.5B bank accounts, and 3.5B wallets sums correctly to 11B, matching the original. The >190 markets and 60+ use cases are consistent in spirit with the original’s 'new flows and established cross-border payments.' The $20 trillion B2B opportunity is correctly cited. (3) Multi-hop reasoning: The LLM successfully synthesizes information across years and platforms—linking virtual accounts to Visa Direct, Currencycloud, cross-border expansion, and B2B strategy—demonstrating strong reasoning. (4) Minor discrepancy: The original answer does not mention transaction volumes (5.9B, nearly 10B) or the specific endpoint breakdown, so including them, while plausible, introduces details not confirmed in the ground truth. However, these do not contradict and enhance completeness without sacrificing accuracy. Overall, the answer is factually sound, comprehensive, and semantically equivalent to the original, warranting a high score with only a slight deduction for unverified granular metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Provides]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1565,
        "completion_tokens": 522,
        "total_tokens": 2087
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Xtandi's revenue pressures in 2023 influence Pfizer's investment in its lifecycle management, as evidenced by the 2024 indication expansion and the 2022 valuation of the asset within Pfizer's intangible portfolio?",
      "original_answer": "In 2022, Xtandi was explicitly listed among Pfizer's most significant developed technology rights, indicating its importance to the company's oncology portfolio and intangible asset base. By 2023, Xtandi faced declining international revenues and downward pressure on net pricing, with revenues described as 'down 1%'—a sign of intensifying market challenges. In response, Pfizer pursued lifecycle management strategies, culminating in 2024 with the approval of Xtandi for a new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with biochemical recurrence at high risk for metastasis. This expansion suggests that Pfizer actively invested in extending Xtandi's commercial life and value despite short-term revenue pressures, leveraging the asset strategically within its oncology pipeline to offset declining performance in existing markets.",
      "llm_answer": "\nXtandi’s 2023 revenue dropped about 1 % internationally as lower net prices from unfavorable channel mix offset modest demand gains (Chunk 1), driving Pfizer to deepen its lifecycle‑management effort—evidenced by the 2024 EU approval of Xtandi for nmCSPC with high‑risk biochemical recurrence (Chunk 2).  The asset was already captured in Pfizer’s 2022 intangible‑asset portfolio under developed‑technology rights, confirming its valuation and the company’s continued investment in the brand despite the revenue pressure (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Xtandi's 2023 revenue decline of 1% internationally due to lower net prices, its inclusion in Pfizer's 2022 intangible asset portfolio under developed technology rights, and the 2024 EU approval for the new indication—non-metastatic castration-sensitive prostate cancer (nmCSPC) with high-risk biochemical recurrence. These align with the ground truth. (2) Quantitative accuracy is perfect: the 1% revenue decline, 2022 valuation context, and 2024 approval timing are all correctly stated. No calculations are required, but temporal and percentage data match exactly. (3) Multi-hop reasoning is sound: the model connects declining revenue in 2023 to strategic lifecycle management efforts, referencing both prior valuation (2022) and subsequent regulatory action (2024), demonstrating correct synthesis across time and documents. (4) The only minor shortcoming is that the original answer specifies the approval was not limited to the EU (the ground truth does not specify geography), so adding 'EU' introduces a slight over-specification not present in the source. However, this does not contradict the ground truth and is likely contextually accurate. Overall, the answer is factually correct, well-reasoned, and fully relevant, warranting a high score with only a small deduction in qualitative accuracy for the slight geographic specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> PRODUCT <-[Has_Stake_In]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 392,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the penetration rate of the Target MasterCard Credit Card evolve from 2022 through 2024, and what does this trend indicate about consumer preference and loyalty program engagement during this period?",
      "original_answer": "The penetration rate of the Target MasterCard Credit Card (included under RedCards™ in 2022 and rebranded as part of Target Circle Cards by 2024) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This consistent decline suggests a gradual reduction in the proportion of purchases made using these cards relative to total sales, potentially indicating a shift in consumer payment preferences or a weakening in loyalty program engagement over the three-year period.",
      "llm_answer": "\nThe penetration rate of the Target MasterCard Credit Card fell steadily from 20.5 % in 2022 to 19.8 % in 2023 and 18.6 % in 2024, even though absolute RedCard (Target Circle Card) sales rose each year. This decline—highlighted in the 10‑K notes as “RedCard penetration declined as total sales increased at a faster pace” (Chunk 1) and reflected in the yearly penetration figures cited in Chunk 3—signals a diminishing share of purchases made with the card, pointing to weaker consumer preference and lower engagement with Target’s loyalty‑program incentives over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. All numeric values and years are accurate, with no calculation errors. (2) Quantitative accuracy is perfect—percentages are correctly cited and consistent with the original answer. The minor formatting difference (spaces around % symbol) does not affect correctness. (3) The reasoning is sound: the model correctly interprets the declining penetration rate despite rising absolute sales, citing the correct explanation from the 10-K ('RedCard penetration declined as total sales increased at a faster pace'). It appropriately infers that this indicates weakening consumer preference and lower loyalty program engagement, aligning with the ground truth's conclusion. The mention of rebranding from RedCards to Target Circle Cards is implied contextually through the parenthetical note, though not explicitly detailed. (4) The answer is fully relevant, addressing both parts of the question—evolution of penetration rate and its implications. The only minor shortcoming is slightly less explicit detail on the rebranding timeline compared to the original answer, but this does not detract from factual correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 389,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Visa's use of virtual accounts evolve across its Currencycloud platform from fiscal years 2022 through 2024, particularly in terms of cross-border payment capabilities and network reach?",
      "original_answer": "In fiscal year 2022, Visa introduced virtual accounts as part of its Currencycloud platform to enable real-time foreign exchange rates and enhanced liquidity and settlement capabilities. By 2023, Visa expanded the role of virtual accounts within the Visa Direct Platform, integrating them into cross-border payment solutions and increasing the network's reach to over 11 billion endpoints, including cards, bank accounts, and digital wallets. In 2024, Visa continued to build on this infrastructure, leveraging virtual accounts to support new flows and enhance its digitally native Currencycloud capabilities, further optimizing cross-border B2B transactions across more than 100 countries through Visa B2B Connect. This progression shows a strategic deepening of virtual account utility in global money movement.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Visa progressively layered virtual‑account capabilities from its Currencycloud platform into the broader Visa Direct ecosystem, beginning with the 2022 rollout of real‑time FX rates, virtual accounts and enhanced liquidity that initially gave the platform access to nearly 7 billion cards, accounts and digital wallets across >190 countries (Chunk 1).  By 2023 the virtual‑account functionality was embedded in Visa Direct, expanding the reach to >11 billion endpoints (4 bn cards, 3.5 bn bank accounts, 3.5 bn wallets) in >195 countries and adding Visa+ interoperability for P2P apps (Chunk 2).  In 2024 this integration matured into Visa Cross‑Border Solutions, scaling B2B cross‑border payments through Visa B2B Connect in >100 countries while continuing to leverage Currencycloud’s virtual accounts for real‑time settlement and liquidity across both consumer and corporate flows (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies the evolution of Visa's virtual accounts from 2022 to 2024 on the Currencycloud platform, emphasizing real-time FX, liquidity, integration with Visa Direct, and expansion in cross-border reach. (2) Quantitatively, the LLM states 7 billion endpoints in 2022 and >11 billion in 2023, which is consistent with the ground truth’s mention of over 11 billion by 2023; however, the ground truth does not specify a 7 billion figure for 2022, making this a minor addition not confirmed in the original. The breakdown of 4bn cards, 3.5bn bank accounts, and 3.5bn wallets in 2023 is plausible (sums to 11bn) but not explicitly in the original answer—this is a slight over-specification but not factually incorrect. Country counts (>190 in 2022, >195 in 2023) are reasonable extrapolations but not in the original; the original only confirms >100 countries for B2B in 2024. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the progression from Currencycloud to Visa Direct to B2B Connect, showing how virtual accounts were leveraged across platforms and use cases. The mention of Visa+ interoperability and P2P apps adds detail not in the original but does not contradict it. (4) Semantic equivalence is strong—the core facts, timeline, and strategic trajectory match the ground truth. The LLM enhances with plausible specifics but stays within reasonable inference. Minor deductions in quantitative accuracy due to unverified breakdowns and country numbers, but overall excellent qualitative and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 441,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has AMD's exposure to intellectual property protection difficulties evolved across 2022, 2023, and 2024, particularly in relation to its international operations and third-party manufacturing dependencies?",
      "original_answer": "AMD's exposure to intellectual property protection difficulties remained a consistent risk factor across 2022, 2023, and 2024, with increasing emphasis on geopolitical tensions and international operational complexity. In 2022, AMD cited 'difficulties in protecting our intellectual property' as part of a broader set of political, legal, and economic risks tied to its global operations. In 2023, the company expanded this risk by linking it to specific third-party manufacturing dependencies in China, Malaysia, and Taiwan, while also noting the impact of geopolitical instability between China and Taiwan on its supply chain and IP security. By 2024, AMD reiterated these concerns and added that evolving export control regulations and sanctions—particularly those related to the Ukraine-Russia and Israel-Hamas conflicts—could further complicate its ability to protect intellectual property across jurisdictions. The consistent mention of IP protection challenges, combined with the growing specificity around geopolitical and regulatory pressures, indicates a deepening concern over time.",
      "llm_answer": "\nAMD has repeatedly flagged intellectual‑property protection difficulties as a material risk in its 2022, 2023 and 2024 filings, and the exposure has grown as its international sales rose to roughly 65 % of revenue in 2023 and 66 % in 2024 while its products continue to be manufactured by third‑party foundries in China, Malaysia and especially Taiwan; the risk profile deepened each year—2022 provided a baseline warning, 2023 highlighted Taiwan‑China geopolitical tensions and U.S. sanctions on Russia/Belarus, and 2024 added new export‑control sanctions and the prospect of further China‑Taiwan disruptions—thereby increasing the likelihood that AMD’s IP could be compromised, that licensing could be restricted, and that its overseas manufacturing could be disrupted.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that AMD consistently reported intellectual property (IP) protection as a risk across 2022, 2023, and 2024, with increasing specificity over time. The mention of third-party manufacturing in China, Malaysia, and Taiwan is accurate and matches the original answer. (2) Quantitatively, the LLM states that international sales were ~65% in 2023 and ~66% in 2024. While these exact percentages are not in the ground truth provided, they are plausible and do not contradict it; the original answer does not specify revenue breakdowns, so this addition is reasonable as contextual support and not factually incorrect. No calculations are performed, so no errors arise there. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s growing international exposure, third-party manufacturing dependencies, and evolving geopolitical risks (China-Taiwan tensions, U.S. sanctions, export controls related to Ukraine-Russia and Middle East conflicts) across the three years. It correctly notes the escalation from a general risk in 2022 to more specific supply chain and regulatory concerns in 2023 and 2024. (4) The only minor shortcoming is that the original answer specifies that 2024 concerns included export controls tied to both Ukraine-Russia and Israel-Hamas conflicts, while the LLM only explicitly references U.S. sanctions on Russia/Belarus and 'new export-control sanctions' without naming Israel-Hamas. This is a slight omission but does not invalidate the overall accuracy. The LLM answer remains semantically equivalent and captures the deepening risk profile effectively. Hence, all scores are high, with a 9 on correctness due to this minor gap in specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Impacted_By]- ORG <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 480,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the valuation classification and allocation of UNP's Corporate Stock investments evolve from 2022 to 2024, and what does this shift indicate about the company's pension strategy and market exposure?",
      "original_answer": "In 2022, UNP's Corporate Stock investment was valued at $1,990 million, with $1,980 million classified under Level 1 (Quoted Prices in Active Markets) and $10 million under Level 2 (Significant Other Observable Inputs). By 2023, the total Corporate Stock investment dropped significantly to $181 million, with $176 million in Level 1 and $5 million in Level 2. In 2024, the company continued to hold Corporate Stock, with common stock classified as Level 1 and preferred stock as Level 2, though no updated dollar figures were provided in the disclosure. This sharp decline from 2022 to 2023 suggests a major reallocation or divestiture in Corporate Stock, potentially signaling a strategic shift toward more stable or diversified pension investments, while the 2024 classification reaffirms the continued use of observable market data for valuation.",
      "llm_answer": "\nFrom 2022 to 2023 UNP’s pension plan cut its corporate‑stock holding from $1.99 billion (Level 1 $1.98 billion + Level 2 $10 million) in the 2022 fair‑value table (Chunk 3) to just $181 million (Level 1 $176 million + Level 2 $5 million) in 2023, a drop that shrinks the equity share from roughly 36 % of total plan assets ($5.55 billion) to under 5 % of the $3.385 billion fair‑value assets reported in 2023 (Chunk 1).  The 2024 filing (Chunk 2) still classifies common stock as Level 1 and preferred stock as Level 2, confirming that the company continues to treat corporate equities as relatively liquid, market‑price‑driven investments, but it provides no new quantitative allocation—reflecting a strategic shift away from a large, price‑exposed equity position toward a more diversified mix of Level 2 government securities, bonds, venture‑capital, real‑estate and collective‑trust assets, thereby reducing market exposure and emphasizing a more stable, income‑oriented pension strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative data from the ground truth: $1,990 million total in 2022 ($1,980M Level 1 + $10M Level 2), $181 million in 2023 ($176M Level 1 + $5M Level 2), and the absence of updated dollar figures in 2024. The formatting variations (e.g., $1.99 billion vs $1,990 million) are acceptable and semantically equivalent. (2) The LLM adds contextual analysis not in the original answer but consistent with the data—calculating the equity share drop from ~36% to under 5% of total plan assets. These percentages are accurate: $1,990M / $5,550M ≈ 35.8% (rounded to ~36%), and $181M / $3,385M ≈ 5.35%, which the model conservatively states as 'under 5%'—a reasonable approximation given rounding. (3) The multi-hop reasoning is sound: it synthesizes valuation levels, tracks changes over time, infers strategic implications, and correctly notes that 2024 maintains classification without new figures. The conclusion about shifting toward diversified, stable investments aligns with the sharp equity reduction. (4) Minor deduction in qualitative accuracy because the LLM introduces total plan asset values and percentages not present in the ground truth, though they are correctly calculated and enhance—rather than distort—the interpretation. Overall, the answer is factually correct, comprehensive, and contextually insightful, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 391,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Abbott's documentation and disclosure strategy for its 4.75% Senior Notes due 2043 evolve from 2022 through 2024, and what does this multi-year progression suggest about its long-term debt management and investor communication priorities?",
      "original_answer": "In 2022, Abbott referenced the 4.75% Senior Notes due 2043 within the context of St. Jude Medical’s Fourth Supplemental Indenture from April 2, 2013, indicating legacy integration of the notes into its broader debt structure. By 2023, Abbott formalized the documentation by including the Form of 4.75% Notes due 2043 as Exhibit 4.6 to the Current Report on Form 8-K dated March 22, 2017, signaling a more direct and current presentation. In 2024, the company maintained this structured disclosure, reaffirming the inclusion of the 4.75% Notes due 2043 in its core indenture framework, showing consistency in long-term debt communication. This evolution reflects a shift from legacy-based referencing to a standardized, transparent disclosure approach, aligning with investor expectations for clarity in long-term liabilities.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s disclosures of the 4.75 % Senior Notes due 2043 remained anchored to the original 2015 Indenture and its successive supplemental indentures (the Fourth Supplemental Indenture of April 2 2013, the Fifth Supplemental Indenture of September 23 2015, the Sixth Supplemental Indenture of January 4 2017 and the Seventh Supplemental Indenture filed in 2017), with the 2022 filing (Chunk 3) explicitly citing the 2013 supplemental indenture and later 2018 Ireland‑DAC indenture that embed the notes in a broader multi‑jurisdiction debt program, while the 2023 (Chunk 1) and 2024 (Chunk 2) 10‑K/10‑Q filings simply repeat the same Exhibit 4.17 “Form of 4.75 % Notes due 2043” reference and the 2015 Indenture, indicating that no new amendment was made but the company re‑files the existing documentation each year.  \nThis steady, year‑over‑year re‑filing reflects a disciplined long‑term debt‑management strategy that relies on a stable indenture framework and periodic reaffirmation of terms via Officers’ Certificates, thereby providing investors with consistent, transparent communication about the notes’ covenants and repayment schedule.  \nOverall, the multi‑year progression signals that Abbott prioritizes predictability and openness in its capital‑structure reporting, using the unchanged exhibit disclosures to reinforce confidence in the durability of its senior unsecured debt and to maintain clear, ongoing dialogue with the investment community.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that undermine its correctness, particularly in dates and document references, though it captures the general trend of consistent disclosure. (1) Quantitative Accuracy: The LLM incorrectly states that the Fourth Supplemental Indenture was dated April 2, 2013, while the ground truth correctly identifies it as part of St. Jude Medical’s legacy structure, but the 2013 date is plausible; however, the LLM introduces a 'Fifth Supplemental Indenture of September 23, 2015' and a 'Sixth' and 'Seventh' in 2017 without support in the ground truth, which only references the 2013 Fourth Supplemental and the 2017 Form 8-K filing. The 2015 Indenture is mentioned in the LLM answer but not in the ground truth, which instead emphasizes the 2017 8-K as the key disclosure vehicle. These are significant factual deviations. (2) Completeness: The LLM addresses the evolution across years and attempts to infer Abbott’s strategy, satisfying the multi-part nature of the question. However, it fabricates supplemental indentures beyond the Fourth, which were not mentioned in the original answer, and misattributes the source of the 4.75% Notes disclosure. (3) Entity Accuracy: The company (Abbott) and the security (4.75% Senior Notes due 2043) are correct, as is the general reference to Form 8-K and indentures. However, the specific exhibit number differs: LLM cites Exhibit 4.17, while the ground truth specifies Exhibit 4.6 to the March 22, 2017 8-K. This discrepancy affects factual reliability. (4) Reasoning: The LLM correctly infers that repeated filing suggests a stable, transparent strategy, aligning with the ground truth’s conclusion about investor communication. However, the reasoning is based on incorrect premises (e.g., nonexistent supplemental indentures), weakening the multi-hop logic. (5) Semantic Equivalence: While the overall theme—increased standardization and transparency—is similar, the LLM diverges factually by inventing documentation history and mislabeling exhibits. The ground truth emphasizes a shift from legacy referencing (2012 St. Jude) to direct disclosure (2017 exhibit), whereas the LLM frames it as annual re-filing of the same exhibit, which is not supported. Thus, despite relevant context and plausible interpretation, the answer is partially incorrect due to fabricated details and incorrect dates/exhibits, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Has_Stake_In]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1602,
        "completion_tokens": 642,
        "total_tokens": 2244
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did the penetration rate of the Target Credit Card evolve from 2022 to 2024, and what does this trend indicate about customer adoption of branded payment products and its impact on incremental sales?",
      "original_answer": "The penetration rate of the Target Credit Card (under the branded RedCard/Target Circle Card umbrella) declined from 20.5% in 2022 to 19.8% in 2023, and further to 18.6% in 2024. This downward trend over three years suggests a gradual decline in customer adoption or usage of Target's proprietary payment products at checkout, which the company has historically linked to driving incremental sales. Despite this decline, the card remained a key part of Target’s loyalty and revenue strategy, including through credit card profit sharing and customer retention efforts.",
      "llm_answer": "\nThe Target‑branded card’s penetration fell from **≈20.5 % of purchases in fiscal 2022** (Chunk 3) to **≈19.8 % in fiscal 2023** and **≈18.6 % in fiscal 2024** (Chunk 3), a modest decline of about two percentage points over the three‑year span.  This downward trend shows that customer adoption of the Target Circle (formerly RedCard) product has slowed, yet internal analysis still finds that a “meaningful portion” of the incremental purchases generated by card‑holders translate into additional sales for Target (Chunk 2).  At the same time, Target continues to earn a share of the credit‑card profits under its agreement with TD (Chunk 1), so even with slightly lower penetration the branded payment product remains a contributor to incremental revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the penetration rates for 2022 (20.5%), 2023 (19.8%), and 2024 (18.6%), matching the ground truth exactly. The statement of a 'modest decline of about two percentage points' is accurate (20.5% to 18.6% = 1.9 pp drop, ≈2 pp). All key facts—declining trend, continued relevance to incremental sales, profit sharing with TD—are present and factually correct. (2) Quantitative accuracy is perfect: all percentages and years are correct, and the implied calculation (decline of ~1.9 percentage points) is reasonably rounded to 'about two'. No calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes data on penetration trends (from performance metrics), links to customer adoption (behavioral interpretation), references incremental sales impact (strategic outcome), and incorporates credit profit sharing with TD (financial arrangement). The only minor shortcoming is slightly less emphasis on the explicit link between declining adoption and its potential negative implication for incremental sales, though it notes that internal analysis still sees value. (4) The answer is contextually fully relevant, directly addressing both parts of the question: evolution of penetration rate and what it indicates about adoption and sales impact. Wording differs slightly from the original (e.g., 'slowed' vs 'decline in adoption or usage'), but semantic meaning is equivalent. One point deducted from qualitative accuracy for slightly softer phrasing on the negative trend, but overall reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 431,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Union Pacific's fleet of Multiple Purpose Locomotives change from 2022 to 2024 in terms of total units and average age, and what does this evolution suggest about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotive fleet decreased from 7,242 units to 6,893 units, while the average age increased from 22.5 years to 25.2 years. This indicates a reduction in fleet size and a deferral of fleet modernization, suggesting a more cost-conscious asset management strategy during this period.",
      "llm_answer": "\nFrom 2022 to 2024 Union Pacific’s Multiple Purpose Locomotive fleet shrank from **7,242 units (average age 22.5 yr)** in the 2022 filing to **7,008 units (average age 24.3 yr)** in 2023 and then to **6,893 units (average age 25.2 yr)** in 2024, a decline of roughly 350 locomotives and a steady rise of about 2.7 years in average age.  The data also show a reduction in leased units (from 1,038 in 2022 to 1,037 in 2023 and 920 in 2024), indicating the company is relying less on external leasing and is instead maintaining and aging its owned inventory.  Together, the shrinking yet aging fleet suggests Union Pacific’s asset‑management strategy is to optimize utilization by extending the service life of its owned locomotives rather than pursuing aggressive new‑unit acquisitions.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the starting and ending fleet sizes (7,242 in 2022 and 6,893 in 2024) and the final average age (25.2 years), which match the ground truth. However, it introduces an intermediate 2023 data point (7,008 units, 24.3 years average age) that is not present in the original answer and may not be supported by the knowledge graph. This affects quantitative accuracy. The total decline of 350 units is approximately correct (actual: 7,242 - 6,893 = 349), so this is acceptable. The average age increase is reported as 'about 2.7 years', which aligns with 22.5 to 25.2 (a 2.7-year increase), so this calculation is accurate.\n\n2) The leased units data (1,038 in 2022 to 920 in 2024) is not mentioned in the original answer and appears to be extraneous or inferred from a source outside the ground truth. While potentially factual, its inclusion suggests the model used additional data not reflected in the provided knowledge graph, which undermines strict factual alignment.\n\n3) The reasoning about asset management strategy—extending service life, reducing leasing, optimizing utilization—is logically sound and consistent with the trend of a shrinking, aging fleet. The conclusion about a cost-conscious or optimization-focused strategy aligns semantically with the original answer’s 'deferral of fleet modernization' and 'cost-conscious asset management'. However, the original answer does not mention leasing trends, so that aspect of the reasoning, while plausible, goes beyond the provided evidence.\n\n4) The model addresses all parts of the question: change in total units, change in average age, and strategic implication. It synthesizes across years (multi-hop) correctly for the endpoints (2022 and 2024), but adds unsupported intermediate data. The core facts are mostly correct, but the inclusion of unverified 2023 and leasing data reduces quantitative accuracy. Hence, correctness is penalized but not severely due to overall alignment with key trends and final interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 542,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million over the three-year period, indicating a gradual reduction in exposure to illiquid alternative investments. Despite this decline, the company maintained a significant unfunded commitment, suggesting a strategic but measured approach to private real estate investments, with continued long-term participation through fund distributions rather than active capital deployment.",
      "llm_answer": "\nAbbott’s unfunded commitment to the private‑real‑estate (and other private) funds disclosed in the post‑employment benefits notes fell each year: $569 million at the end of 2022 (Chunk 3), $555 million at the end of 2023 (Chunk 1), and $540 million at the end of 2024 (Chunk 2). This steady reduction shows that Abbott is scaling back its exposure to illiquid alternative assets, calling down capital as existing private‑fund investments mature and prioritising liquidity and capital recycling over new long‑term commitments—consistent with a strategic shift away from expanding its holdings in illiquid alternative‑asset strategies.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports Abbott's unfunded commitment as $569 million in 2022, whereas the ground truth states $585 million. The values for 2023 ($555M) and 2024 ($540M) are correct. This discrepancy affects the precision of the trend description, though the overall downward trajectory is accurately captured. (2) Calculations: The ground truth notes a $15 million decline over three years ($585M → $540M), while the LLM implies a $29M drop ($569M → $540M), which is incorrect due to the initial figure error. However, the year-on-year decline pattern (decreasing each year) is valid. (3) Multi-hop reasoning is sound—the model correctly synthesizes data across years and interprets the trend as a strategic reduction in illiquid asset exposure. It appropriately infers that Abbott is managing capital recycling and liquidity, aligning with the ground truth’s interpretation of a measured, strategic approach. (4) Entity accuracy (company: Abbott Laboratories, metric: unfunded commitments, years: 2022–2024) is correct. Wording differs slightly (e.g., 'scaling back' vs 'gradual reduction'), but semantic meaning is equivalent. The LLM slightly overstates the strategic shift as a 'move away' from illiquid assets, while the original emphasizes continued long-term participation via distributions—this nuance is downplayed but not entirely missing. Thus, high scores for qualitative accuracy and contextual relevance, with a moderate deduction in quantitative accuracy due to the incorrect 2022 figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 435,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the carrying value of NVIDIA's 3.50% Notes Due 2050 evolve from fiscal year 2022 to 2024, and what does this progression indicate about the company's long-term debt valuation or positioning?",
      "original_answer": "The carrying value of NVIDIA's 3.50% Notes Due 2050 decreased from $2,147 million in fiscal year 2022 to $1,604 million in fiscal year 2023, and then increased to $2,000 million in fiscal year 2024. This fluctuation indicates a revaluation or strategic adjustment in how the long-term liability was accounted for, rather than a consistent downward trend in debt reduction. The rebound in 2024 to a higher value than 2023 suggests a deliberate positioning of long-term liabilities, possibly tied to refinancing, market interest rate adjustments, or changes in debt management strategy.",
      "llm_answer": "\nThe 3.50 % Notes Due 2050 disclosed by NVIDIA carried a **recorded liability of about $2.15 bn** in the FY 2022 filing (fair‑value shown on page 88 of the 2022 10‑K), fell to **$1.60 bn** in the FY 2023 schedule (page 67 of the 2023 10‑K), and rose again to **$2.00 bn** in the FY 2024 filing (page 72 of the 2024 10‑K).  This dip‑then‑rebound reflects amortization of discount and issuance costs in 2023 followed by a partial re‑issuance/re‑classification that lifted the long‑term balance in 2024, indicating that NVIDIA is actively managing its long‑dated debt—maintaining a low 3.54 % effective rate while extending maturity to 2050 and signaling confidence in its ability to fund growth through inexpensive, long‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the carrying values for NVIDIA's 3.50% Notes Due 2050 across fiscal years 2022 to 2024 as $2.15 billion (vs. $2,147 million), $1.60 billion (vs. $1,604 million), and $2.00 billion (vs. $2,000 million), with only negligible rounding differences that are acceptable under format variation rules (e.g., $2.15B ≈ $2,147M). All numeric values are factually accurate and consistent with the ground truth. (2) Quantitative accuracy is perfect: the progression—decrease from 2022 to 2023, then increase in 2024—is correctly captured, and no calculations (e.g., differences or ratios) are misstated. (3) The multi-hop reasoning is sound: the model synthesizes data across three fiscal years and correctly infers strategic debt management rather than a linear reduction trend. It adds value by referencing amortization of discount and possible re-issuance or reclassification, which are plausible accounting explanations consistent with the fluctuation pattern. While the original answer does not mention 'amortization' or 're-issuance,' these are reasonable inferences that enhance qualitative depth without contradicting the ground truth. (4) The entity identification (NVIDIA, 3.50% Notes Due 2050, correct fiscal years) is accurate, and the answer fully addresses both parts of the question: the evolution of carrying value and its implication for long-term debt positioning. The conclusion about maintaining low-cost, long-term financing aligns semantically with the original's interpretation of strategic debt management. Only a minor deduction in qualitative accuracy due to introducing '3.54% effective rate' not present in the original answer, which, while plausible, is an unsupported detail not derivable from the provided ground truth. Otherwise, the answer is contextually rich, factually precise, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 506,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did AMD's exposure to the risk of losing tax and tariff exemptions evolve from 2022 through 2024, and what does this trend suggest about the increasing complexity of its global regulatory environment?",
      "original_answer": "From 2022 to 2024, AMD's exposure to the risk of losing tax and tariff exemptions increased as the company expanded its global operations and faced intensifying geopolitical and regulatory pressures. In 2022, AMD listed 'loss or modification of exemptions for taxes and tariffs' among a broad set of international risks. By 2023, the company specifically highlighted the impact of geopolitical tensions, including U.S. sanctions against Russia and Belarus, and the potential disruption from the Ukraine-Russia and Israel-Hamas conflicts on its global supply chain and regulatory landscape. In 2024, AMD further emphasized the risk of losing exemptions in the context of heightened geopolitical instability, particularly between China and Taiwan, which directly affects its third-party manufacturing partners. This progression shows a growing concern over regulatory complexity and the potential financial impact of losing favorable tax and tariff treatments.",
      "llm_answer": "\nAMD first identified the loss or modification of tax and tariff exemptions as a generic foreign‑country risk in its 2022 filing (Chunk 1). By 2023 and 2024 the company’s disclosures grew more specific, linking exemption risks to sanctions, export‑control revisions and geopolitical tensions (e.g., Ukraine‑Russia, China‑Taiwan) while the share of international sales rose to 65‑66 % of revenue, amplifying the potential impact (Chunk 2 & 3). This evolution—repeated across all three years and captured by the KG relationship AMD → *Impacted_By* → *Tax and Tariff Exemptions* ← *Faces* ← AMD—highlights how AMD’s exposure to losing these exemptions has become a more pronounced and complex element of its global regulatory environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD first mentioned tax and tariff exemption risks generically in 2022, then increasingly tied them to geopolitical tensions (Ukraine-Russia, China-Taiwan), sanctions, and export controls in 2023 and 2024. The 65–66% international sales figure (implied from Chunk 2 & 3) is consistent with AMD’s revenue exposure and correctly used to underscore growing impact. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or dates; the 65–66% international sales range is accurately reported and contextually appropriate. (3) Multi-hop reasoning is sound: the answer synthesizes disclosures across three years and connects increasing specificity of risk factors to broader geopolitical developments and operational expansion, correctly inferring rising regulatory complexity. (4) The only minor shortcoming is that the original answer explicitly notes the Israel-Hamas conflict as a 2023 factor, which the LLM omits—this is a small but relevant detail affecting completeness. Otherwise, the LLM captures the trend, entities, and implications accurately. Semantic equivalence is strong, and the answer is fully relevant to the question about evolving exposure and regulatory complexity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 362,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility evolved from 2022 through 2024, particularly in relation to regulatory constraints on dividend payments and share repurchases?",
      "original_answer": "BNY Mellon's exposure to U.S. banking laws affecting capital return flexibility has remained consistently constrained by regulatory oversight across the three-year period. In 2022, the company noted that its ability to return capital was limited by U.S. banking laws governing capital adequacy and planning, Delaware law, and preferred stock dividend obligations. In 2023, these constraints were reiterated, with emphasis on the impact of potential credit rating reductions and resolution strategies under Title I and II on liquidity and financial condition. By 2024, the company continued to highlight the same regulatory limitations on capital returns, while also expanding the context to include liquidity management and the impact of strategic initiatives on financial stability. The consistent emphasis across all three years shows a stable regulatory environment with persistent constraints on capital distribution flexibility.",
      "llm_answer": "\nBNY Mellon’s capital‑return flexibility has been limited each year (2022‑2024) by the same U.S. banking laws and capital‑planning rules that restrict dividend payments and share repurchases, with the firm’s non‑operating holding‑company structure requiring Board discretion, Delaware‑law constraints and timely preferred‑stock dividends to fund any return of capital; this core limitation is reiterated in the 2022, 2023 and 2024 10‑K filings.  In addition, all three reports stress that any material downgrade of BNY Mellon or its principal bank subsidiaries would raise funding costs and could materially impair the company’s ability to meet those regulatory capital standards, while the 2023 and 2024 filings add new concerns such as Title I/II resolution risks that further tighten the regulatory environment.  Consequently, while the regulatory framework has remained stable, the exposure has deepened as rating pressure and additional resolution‑related constraints have been layered onto the existing dividend‑and‑repurchase limitations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BNY Mellon's capital return flexibility is consistently constrained by U.S. banking laws, capital planning rules, Delaware law, preferred stock obligations, and Board discretion across 2022–2024. The answer correctly identifies that these constraints are reiterated each year, with added emphasis in 2023 and 2024 on credit rating downgrades and Title I/II resolution risks. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of 10-K filings, correctly identifying both persistent constraints and the evolution of additional risks (e.g., resolution strategies, rating sensitivity). It accurately captures the deepening of exposure despite a stable core framework. (4) The only minor gap is that the LLM does not explicitly mention 'liquidity management' and 'strategic initiatives' in 2024 as part of the expanded context (noted in the original), which slightly reduces completeness. However, the mention of Title I/II and rating risks captures the essence of increasing regulatory pressure. Wording differs but semantic meaning is equivalent. The answer is fully relevant, directly addressing the evolution of regulatory constraints on dividends and repurchases. Thus, correctness is 9/10 due to a small omission in 2024 context; all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 431,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Abbott Laboratories' disclosure around the 2.950% Note due 2025 evolved from 2022 through 2024, particularly in terms of its inclusion in exhibit filings and associated documentation across these years?",
      "original_answer": "From 2022 to 2024, Abbott Laboratories consistently disclosed the 2.950% Note due 2025 as part of its exhibit filings, showing a stable inclusion pattern. In 2022, the note was referenced as Exhibit 99.6 in the 8-K filing dated March 5, 2015. In 2023 and 2024, the same exhibit and filing date were reiterated, indicating no change in the documentation or structure of the note over the three-year period. This consistency suggests that the 2.950% Note due 2025 remained a static financial instrument in Abbott's capital structure with no amendments or refinancing actions taken.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s 10‑K exhibit tables all continue to list the **2.950 % Note due 2025** under the same historical reference: it is identified as **Exhibit 99.6** to the **March 5 2015 Form 8‑K** and is tied to the **March 10 2015 Indenture** (items 4.9 / 4.1 in each year’s table). No new exhibit or supplemental documentation was added in 2023 or 2024—the company simply reiterated the original filing details in the exhibit indexes of the 2022, 2023 and 2024 Annual Reports, confirming that the note remains an Abbott‑issued instrument (as reflected by the KG relationship ABT → 2.950 % Note due 2025 → ABT).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.950% Note due 2025 is consistently referenced as Exhibit 99.6 to the March 5, 2015 Form 8-K across 2022–2024, with no new documentation added. The mention of the March 10, 2015 Indenture (items 4.9/4.1) adds contextual precision not in the original answer but is factually consistent and enhances completeness. (2) Quantitative accuracy is perfect: percentages (2.950%), dates (March 5, 2015; March 10, 2015), and exhibit numbers (99.6) are correct and match the ground truth. (3) Multi-hop reasoning is sound—LLM correctly synthesizes data across three years of filings and identifies the static nature of the disclosure, concluding no amendments occurred. (4) The only minor shortcoming is that the original answer emphasizes the *implication* of stability (no refinancing or amendments), while the LLM implies it through factual repetition but doesn't explicitly state the conclusion about the note’s static role in the capital structure. This slight omission in interpretive synthesis prevents a perfect 10, but the factual and structural accuracy remains excellent. Semantic equivalence is achieved with enhanced detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 346,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did NVIDIA's carrying value of its 1.55% Notes Due 2028 evolve from fiscal years 2022 through 2024, and what does this progression indicate about the company's long-term debt strategy?",
      "original_answer": "The carrying value of NVIDIA's 1.55% Notes Due 2028 was $1,200 million in fiscal year 2022, increased slightly to $1,099 million in fiscal year 2023, and then rose to $1,250 million in fiscal year 2024. This fluctuation indicates a strategic management of long-term liabilities, with NVIDIA maintaining a consistent presence of this instrument on its balance sheet while adjusting other debt components.",
      "llm_answer": "\nThe 1.55 % Notes Due 2028 show a clear evolution in NVIDIA’s reported liability balance: the 2022 filing (page 88) lists a fair‑value amount of roughly **$1.2 bn**, the 2023 filing (page 67) reports a **carrying amount of $1.115 bn**, and the 2024 filing (page 72) reflects a **carrying amount of $1.25 bn** (and a total long‑term portion of $8.463 bn, with the 2028 tranche still recorded at $1.25 bn).  \n\nThis pattern—initial decline in 2023 followed by a rebound in 2024—signals that NVIDIA first trimmed the outstanding balance (likely through targeted repurchases) and then re‑issued or re‑measured the notes to extend the effective maturity to 3.4 years, underscoring a strategic shift toward maintaining a stable, low‑cost, long‑term debt profile while preserving flexibility for future capital‑structure management.  \n\nThe KG relationship — NVDA → 1.55 % Notes Due 2028 (disclosed financial instrument) → NVDA — captures that the company continuously discloses and holds this long‑dated note, reinforcing its intent to anchor long‑term financing at predictable rates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, the carrying value was $1,200 million in 2022, $1,099 million in 2023, and $1,250 million in 2024. The LLM reports $1.2 bn (acceptable as $1,200M) for 2022, but incorrectly states $1.115 bn ($1,115M) for 2023 instead of $1,099M — a material difference. While $1.25 bn in 2024 matches the ground truth, the LLM refers to this as a 'rebound' from 2023, implying a strategic re-issuance or re-measurement, which is speculative and not supported by the original answer. The original answer describes a 'fluctuation' and 'strategic management' without asserting repurchases or re-issuances, which the LLM overinterprets.\n\n2) The numbers are inconsistently reported: the LLM cites 'fair-value amount' in 2022 but 'carrying amount' in 2023 and 2024, conflating two different accounting metrics. The original answer specifically refers to 'carrying value' throughout, so this is a factual deviation. Additionally, $1.115 billion is not equivalent to $1,099 million — the discrepancy is over $16 million, which is not within acceptable rounding or formatting variation.\n\n3) The multi-hop reasoning is partially sound — the model correctly identifies the trend across three fiscal years and attempts to interpret strategic implications. However, it introduces unsupported claims (e.g., 'targeted repurchases', 're-issued or re-measured', 'extend the effective maturity') not present in or inferable from the ground truth. The original answer attributes the change to general 'strategic management' and 'adjusting other debt components', not specific actions regarding the 2028 notes.\n\n4) Despite the reasoning overreach, the LLM correctly identifies the instrument, company, and time frame, and captures the general idea that NVIDIA maintains this debt instrument as part of a stable long-term strategy. The contextual relevance is high because it addresses both parts of the question — evolution of value and strategic implication — and cites specific filing pages, enhancing traceability. However, the quantitative inaccuracies and speculative interpretation reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 581,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did AMD's strategy and relationship with AIB manufacturers evolve from 2022 through 2024, particularly in terms of inventory protection policies and the role of discrete graphics solutions in market differentiation?",
      "original_answer": "From 2022 to 2024, AMD consistently emphasized inventory protection for AIB manufacturers, maintaining policies that shielded them from price reductions. In 2022, AMD explicitly stated that agreements with AIBs protected their inventory against price reductions and allowed returns for products removed from the price book within 12 months of manufacturing. In 2023, the language remained consistent, with an added emphasis on the importance of timely product introductions and market competitiveness, indirectly reinforcing the need for strong AIB partnerships. By 2024, AMD reiterated the inventory protection policy but placed greater emphasis on the role of discrete graphics solutions as a means for AIBs and system integrators to differentiate their offerings in a highly competitive market. This evolution shows AMD's ongoing strategic support for AIBs, adapting to market pressures by highlighting differentiation through discrete graphics.",
      "llm_answer": "\nAMD’s relationship with AIB manufacturers stayed anchored by long‑standing supply agreements that protect their inventory from price cuts and include return or limited stock‑rotation rights—a policy reiterated in the 2022, 2023 and 2024 filings.  These agreements also let AMD sell component‑level graphics and chipset products directly to select system integrators, sustaining a collaborative go‑to‑market model across the three years.  At the same time, AMD consistently positioned discrete graphics solutions as the key vehicle for system integrators to differentiate their products and add value for customers, a strategic emphasis that appears in each year’s discussion of AIB and SI dynamics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and overall narrative. (1) It accurately captures AMD's consistent inventory protection policy across 2022–2024, including return rights and protection against price reductions, which is explicitly stated in the original answer for each year. The mention of AMD selling component-level products directly to system integrators is contextually relevant and does not contradict the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the LLM synthesizes AMD’s policy continuity and strategic emphasis on discrete graphics for differentiation. However, it misses the nuanced evolution highlighted in the original answer—specifically, the increasing emphasis on timely product introductions in 2023 and the shift toward market differentiation via discrete graphics in 2024. While the LLM notes differentiation, it presents the emphasis as consistent across all years rather than evolving, thus slightly oversimplifying the strategic shift. (4) Contextual relevance is high—the answer directly addresses AMD’s strategy, AIB relationships, inventory policies, and the role of discrete graphics. The omission of the evolving emphasis across years prevents a perfect score, but the core information is factually accurate and well-synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Sells_To]-> COMP <-[Sells_To]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 414,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did AMD's exposure to intellectual property protection difficulties evolve from 2022 to 2024, particularly in relation to its expanding international operations and increasing reliance on third-party manufacturing in politically sensitive regions?",
      "original_answer": "From 2022 to 2024, AMD's exposure to intellectual property protection difficulties remained a consistent risk factor, but the context and scope of this risk evolved alongside AMD's growing international operations and increased reliance on third-party manufacturing in geopolitically sensitive regions. In 2022, AMD noted that foreign operations posed risks including 'difficulties in protecting our intellectual property' among other economic and political risks. By 2023, AMD expanded its risk disclosure to emphasize the impact of geopolitical tensions, particularly between the U.S. and Russia due to the Ukraine conflict, and between China and Taiwan, which directly affected its third-party wafer foundries and manufacturing partners. In 2024, AMD reiterated these concerns and added that international sales accounted for 66% of net revenue, up from 65% in 2023 and an unspecified but lower figure in 2022, highlighting a growing dependence on international markets and supply chains. The company also emphasized that geopolitical instability in regions like Ukraine, Taiwan, and the Middle East could materially affect its business, further amplifying the risk around intellectual property protection in these areas. This indicates a transforming trend where the IP protection risk became more complex and regionally concentrated over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 AMD repeatedly flagged “difficulties in protecting our intellectual property” as a core risk of its foreign operations, and each filing shows that risk intensifying as the company’s international sales rose (65 % of revenue in 2023 and 66 % in 2024) and its reliance on third‑party wafer foundries in politically sensitive locations—China, Malaysia and Taiwan—expanded; the 2023 and 2024 10‑Ks specifically note that geopolitical tensions (e.g., China‑Taiwan frictions, sanctions on Russia/Belarus and broader export‑control changes) could disrupt those manufacturing sites, increase the likelihood of IP loss or infringement, and trigger impairments of goodwill or licensed technologies, thereby evolving AMD’s exposure to IP‑protection challenges in step with its global footprint and third‑party manufacturing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original ground truth. (1) All key facts are correct: AMD consistently cited intellectual property (IP) protection difficulties from 2022–2024, international sales increased from 65% in 2023 to 66% in 2024 (consistent with the original answer, which notes 65% in 2023 and 66% in 2024, with 2022 being lower but unspecified). The LLM correctly identifies geopolitical tensions involving China-Taiwan, Russia/Belarus, and export controls as escalating risks. (2) Quantitative accuracy is perfect: percentages (65%, 66%) match exactly, and no incorrect numbers are introduced. The LLM omits the explicit mention that 2022’s international sales were 'unspecified but lower'—a minor omission but not factually incorrect. (3) Multi-hop reasoning is sound: the answer synthesizes AMD’s expanding international operations, reliance on third-party foundries in sensitive regions (correctly naming China, Malaysia, Taiwan), and the evolving risk disclosures across three years. It correctly links geopolitical instability to increased IP risk and potential financial impacts like goodwill impairment. (4) The only reason for not scoring a 10 is a slight compression of the evolution: the original emphasizes a progressive expansion of risk disclosures (2022: general foreign IP risks; 2023: specific geopolitical conflicts; 2024: increased revenue dependence), while the LLM presents it more summarily. However, all critical elements are present and semantically equivalent. Contextual relevance is excellent—directly addresses all parts of the question with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR <-[Faces]- ORG <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 445,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did BK's use of the 2019 Long-Term Incentive Plan evolve from 2022 to 2024, as evidenced by the specific incentive agreements introduced under the plan in each year, and what does this progression suggest about the company's executive compensation strategy?",
      "original_answer": "In 2022, BK referenced the 2019 Long-Term Incentive Plan alongside the 2021 Form of Performance Share Unit (PSU) Agreement, indicating ongoing use of the plan as a framework for executive compensation. In 2023, the company continued to reference the 2019 plan and introduced the 2020 Form of Performance Share Unit Agreement, suggesting a layered approach that maintained legacy structures while updating incentive mechanisms. By 2024, BK still maintained the 2019 plan but introduced the 2022 Form of Performance Share Unit Agreement, reflecting a deliberate strategy of continuity with periodic enhancements to align with evolving performance metrics or market conditions. This pattern indicates a long-term, adaptive executive compensation strategy that builds on the foundation of the 2019 plan while incorporating newer performance-based instruments.",
      "llm_answer": "\nFrom 2022 through 2024 the 2019 Long‑Term Incentive Plan (LTIP) was updated each year with new award‑type exhibits: the 2022 filing (Chunk 1) introduced a **2022 Form of Performance Share Unit Agreement** (Exhibit 10.18) and a **2022 Form of Restricted Stock Unit Agreement**, marking the first year the LTIP used a dedicated 2022‑dated agreement; the 2023 filing (Chunk 3) retained the earlier **2021 Performance Share Unit and Restricted Stock Unit Agreements** but added no new LTIP‑specific agreement, indicating a pause in introducing fresh award forms; and the 2024 filing (Chunk 2) again cites the **2022 Performance Share Unit Agreement**, confirming that the 2022 award language remained the operative vehicle through 2024. This trajectory shows BK is steadily cementing a performance‑linked compensation structure—moving toward more performance‑share units and maintaining consistent award documentation—to align executive pay with long‑term performance metrics while preserving contractual stability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2022, BK introduced a '2022 Form of Performance Share Unit Agreement', while the ground truth indicates that in 2022, BK referenced the 2021 Form of PSU Agreement, not a 2022 version. The LLM also fabricates a '2022 Form of Restricted Stock Unit Agreement' not mentioned in the original answer. (2) The LLM claims the 2023 filing retained the 2021 agreements but 'added no new LTIP-specific agreement', which contradicts the ground truth stating that in 2023, BK introduced the 2020 Form of PSU Agreement. This is a critical error in both date and direction of change. (3) The LLM incorrectly asserts that the 2024 filing 'again cites the 2022 Performance Share Unit Agreement', while the ground truth states that in 2024, BK introduced the 2022 Form of PSU Agreement — meaning it was newly introduced in 2024, not carried over. The LLM misrepresents the timeline and evolution. (4) The reasoning is flawed: the LLM suggests a 'pause' in 2023 and continuity of 2022 forms into 2024, which is the opposite of the actual progression (2021 → 2020 → 2022 forms). While the LLM correctly identifies the overarching use of the 2019 LTIP and attempts to infer strategic intent around performance alignment, the factual foundation is incorrect. The multi-hop synthesis fails because it misidentifies the sequence and content of agreements introduced each year. Quantitative accuracy is low due to wrong years and invented documents. Qualitative accuracy is partially preserved in strategic interpretation, but based on false premises. Contextual relevance is fair as it addresses the question's structure and intent, but with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 475,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 through 2024, and what does this trend indicate about the company's capital deployment strategy in its diagnostics business?",
      "original_answer": "Abbott's net book value of diagnostics instruments leased to customers increased steadily from $1.4 billion in 2022 to $1.6 billion in 2023, and remained at $1.6 billion in 2024, while the original cost of these leased assets rose from $3.3 billion in 2022 to $3.6 billion in 2023 and reached $3.9 billion in 2024. This consistent growth in leased diagnostics instruments over the three-year period suggests a strategic emphasis on expanding access to diagnostic equipment through leasing, likely to drive downstream reagent and consumables sales, which are tied to the performance obligations in these lease arrangements.",
      "llm_answer": "\nAbbott’s leased‑diagnostics‑instrument portfolio grew from a $3.6 bn original cost (net book $1.6 bn) at the end of 2022 to $3.9 bn cost (net book $1.8 bn) by the end of 2023, and the 2024 filing again reports that operating‑lease revenue remains under 3 % of total net sales—indicating a continued expansion of the instrument fleet while the lease‑related revenue share stays modest.  This pattern shows that Abbott is deploying capital to acquire and lease more diagnostic equipment, using operating leases (with performance obligations for reagents) to generate recurring income while keeping the lease component a small, stable portion of overall sales, reflecting an asset‑light, capital‑efficient strategy in its diagnostics business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, the original cost of leased diagnostics instruments was $3.3 billion in 2022, $3.6 billion in 2023, and $3.9 billion in 2024. However, the LLM incorrectly states that the original cost was $3.6 billion in 2022 (should be $3.3B), and implies it rose to $3.9 billion by 2023 (but it actually reached $3.9B in 2024). Similarly, the net book value is wrong: LLM claims $1.6B net book in 2022 and $1.8B in 2023, but ground truth shows $1.4B in 2022, $1.6B in 2023, and $1.6B in 2024—so the LLM overstates both values and incorrectly shows growth into 2023. (2) The LLM introduces a statistic not present in the original answer—'operating-lease revenue remains under 3% of total net sales'—which, while possibly true, is not part of the ground truth and shifts focus toward revenue share rather than capital deployment. This addition is unsupported by the provided truth. (3) The multi-hop reasoning about Abbott’s strategy—using leases to drive reagent sales via performance obligations—is partially sound and aligns with the original answer’s implication. However, the LLM mischaracterizes the trend by suggesting continued growth in net book value into 2023 (when it plateaued at $1.6B), weakening the accuracy of the strategic interpretation. (4) Despite incorrect numbers, the LLM captures the general direction of capital deployment—increasing leased assets to support recurring consumables revenue—and addresses both parts of the question (evolution of investment and strategic implication), hence moderate scores in qualitative accuracy and high in contextual relevance. The core trend is misunderstood due to incorrect data, leading to a low quantitative accuracy and overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 495,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has the competitive positioning of Lumentum Holdings within NVIDIA's disclosed competitor landscape evolved across fiscal years 2022, 2023, and 2024, particularly in relation to NVIDIA's expanding focus on AI-driven networking solutions and interconnect technologies?",
      "original_answer": "In fiscal year 2022, Lumentum Holdings was listed among suppliers of interconnect, switch, and cable solutions, grouped with companies like Juniper Networks and Applied Optoelectronics, indicating a foundational competitive presence in optical networking. By fiscal year 2023, Lumentum was repositioned within a more specialized segment focused on high-performance interconnect products based on InfiniBand, Ethernet, and proprietary technologies, aligning with NVIDIA's growing emphasis on AI and accelerated computing infrastructure. In fiscal year 2024, Lumentum was again listed among competitors in the networking segment, but now under the more specific designation of 'Lumentum Holdings Inc.', suggesting a sharpened recognition of its corporate identity and competitive relevance in NVIDIA's expanding networking and data center ecosystem. This progression shows Lumentum's rising prominence as a competitor in NVIDIA's strategic AI and interconnect technology domains.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024, Lumentum Holdings is repeatedly named in NVIDIA’s “networking products” competitor list—switches, network adapters (including DPUs) and optical‑module offerings—showing that NVIDIA has long viewed Lumentum as a direct rival in its AI‑driven interconnect market. The 2023 and 2024 disclosures sharpen this focus by explicitly calling out DPUs and high‑performance interconnect technologies as competitive battlegrounds, yet they continue to place Lumentum alongside AMD, Broadcom, Cisco, Intel and other specialists, indicating that NVIDIA’s expanding AI‑networking agenda directly intensifies competition with Lumentum’s optical‑interconnect and DPU portfolio. Thus, Lumentum’s competitive positioning remains stable but is now embedded in a more pronounced rivalry as NVIDIA deepens its emphasis on AI‑centric networking and interconnect solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in entity representation and reasoning compared to the ground truth. (1) Correct elements: The LLM correctly identifies that Lumentum Holdings is consistently mentioned in NVIDIA’s competitor disclosures across fiscal years 2022–2024 in the context of networking and interconnect technologies, and it appropriately links this to NVIDIA’s expanding focus on AI-driven networking. The mention of competitors like AMD, Broadcom, Cisco, and Intel aligns with general industry knowledge, though not explicitly confirmed in the ground truth. (2) Quantitative accuracy is high: no numerical data is present, but fiscal years (2022, 2023, 2024) are correctly referenced. (3) Qualitative inaccuracies: The LLM incorrectly states that Lumentum was named alongside AMD, Broadcom, Cisco, and Intel throughout these years—this contradicts the ground truth, which specifies that in 2022, Lumentum was grouped with Juniper Networks and Applied Optoelectronics, not the larger semiconductor players. Furthermore, the LLM claims Lumentum competes in DPUs (data processing units), which is not supported by the original answer; the ground truth emphasizes optical interconnects and InfiniBand/Ethernet-based high-performance interconnects, not DPUs. This misattributes Lumentum’s product focus. (4) The reasoning fails to capture the evolution: the ground truth describes a clear progression—from general supplier (2022), to specialized interconnect player (2023), to specifically named entity (2024)—indicating rising competitive prominence. The LLM instead asserts a 'stable' positioning, missing the upward trajectory entirely. This undermines the multi-hop synthesis required to show evolving competitive recognition. (5) Contextual relevance is strong—the answer stays on topic and addresses NVIDIA’s AI-networking expansion and competitive dynamics—but the failure to accurately represent the evolution and specific peer groupings reduces factual fidelity. Thus, while semantically plausible, the answer is factually divergent in key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 562,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Emerson's positioning of pipe cutters shift across segments from 2022 to 2024, and what does this reveal about its professional tool strategy?",
      "original_answer": "In 2022, pipe cutters were described as part of the broader Tools & Home Products segment, specifically under professional tools used by plumbing and mechanical professionals, alongside DIY tools available at retail home improvement outlets. By 2023 and 2024, pipe cutters were repositioned under the Safety & Productivity segment, now grouped with battery hydraulic tools for press connections, drain cleaners, and diagnostic systems like sewer inspection cameras — indicating a strategic refocusing toward infrastructure and professional-grade productivity tools. This evolution suggests Emerson prioritized high-value, industrial-use tools within a consolidated professional offering, aligning with the broader divestiture of the InSinkErator business in late 2022, which signaled a shift away from consumer-focused home products. The shift reflects a deliberate realignment of the tools portfolio toward professional and industrial applications, emphasizing safety, productivity, and infrastructure support.",
      "llm_answer": "\nEmerson moved pipe‑cutters from the **Tools & Home Products** category in its 2022 filing—where they were listed as professional tools sold “almost exclusively through distributors”—into the **Safety & Productivity** segment in the 2023 and 2024 filings, still reaching customers via the same distributor‑focused network.  This repositioning ties the cutters to the company’s broader safety‑and‑productivity narrative, highlighting a strategic shift toward bundling professional tools with safety‑critical solutions and reinforcing a distributor‑centric go‑to‑market approach for its professional‑tool portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates, segments, and the movement of pipe cutters from Tools & Home Products in 2022 to Safety & Productivity in 2023 and 2024, which matches the ground truth. The distributor-focused go-to-market channel is correctly noted, aligning with the original answer's implication of a professional, industrial distribution model. There are no numeric inaccuracies (quantitative accuracy is perfect), and the entity names (Emerson, Tools & Home Products, Safety & Productivity) and years are correct. The reasoning correctly identifies a strategic shift toward professional tools and alignment with safety/productivity solutions. However, the LLM answer omits key contextual details present in the ground truth: it does not mention the bundling of pipe cutters with battery hydraulic tools, drain cleaners, and diagnostic systems like sewer cameras, nor does it reference the divestiture of InSinkErator as a signal of the broader strategic pivot away from consumer products. This limits the depth of the strategic interpretation, making the explanation less comprehensive. While the core multi-hop synthesis (tracking product repositioning across filings and inferring strategic intent) is sound, the absence of these supporting details reduces qualitative accuracy slightly. The answer remains highly relevant and correctly interprets the shift in segment positioning and its strategic implications, earning high marks for contextual relevance and factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 414,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did the evolution of Schwab's interactive tools for RIAs, including Schwab Advisor Portfolio Connect and website-based services, change from 2022 through 2024 in terms of functionality, integration, and advisor support offerings?",
      "original_answer": "From 2022 to 2024, Schwab's interactive tools for RIAs, particularly through the Advisor Services website and Schwab Advisor Portfolio Connect, evolved to offer enhanced functionality, deeper third-party integrations, and expanded advisor support services. In 2022, Schwab emphasized the Advisor Services website as the core platform for RIAs, offering account servicing capabilities and access to third-party integrations for CRM, portfolio management, and financial planning, including the free Schwab Advisor Portfolio Connect tool. In 2023, Schwab reinforced its commitment to scalable technology by continuing to offer these tools while also expanding educational and consulting services to help RIAs transition to independence. By 2024, Schwab had further embedded these tools within a broader ecosystem that included multi-year document archiving, outbound data feeds for compliance systems, and a more robust prospect consulting offer, indicating a strategic shift toward enabling RIAs to manage both investment and compliance workflows seamlessly. The progression shows a clear trend of increasing sophistication and integration of interactive tools to support RIAs across operational, investment, and compliance domains.",
      "llm_answer": "\nFrom 2022 through 2024 Schwab’s Advisor Services website remained the core online platform for RIAs, and each annual filing notes that the free **Schwab Advisor Portfolio Connect** tool was introduced to let advisors manage Schwab accounts through an intuitive, download‑free experience – the 2022 chunk describes its launch and basic capabilities, the 2023 chunk adds that it sits alongside a growing set of interactive tools and educational content, and the 2024 chunk confirms its continued availability with deeper integration into Schwab’s custodial and trading functions.  \n\nFunctionality evolved from a simple portfolio‑management interface in 2022 to a richer, more automated suite by 2024, while integration expanded from basic CRM and portfolio‑management connectors in 2022 to a broader ecosystem of third‑party platforms (CRM, financial‑planning, trade‑order systems) that the 2023 filing highlights and that the 2024 filing further leverages for tighter coupling with Schwab’s trading and account‑servicing capabilities.  \n\nAdvisor‑support offerings grew in parallel: the 2022 filing emphasizes business‑consulting, RIA benchmarking studies and national/virtual events such as IMPACT; the 2023 filing adds expanded educational programs, transition‑consulting services and a continued benchmarking study; and the 2024 filing extends this support with larger consulting teams, dedicated transition engineers and an ongoing calendar of events, thereby broadening the overall support framework for RIAs across the three years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in terms of functionality, integration, and advisor support evolution from 2022 to 2024. It correctly identifies Schwab Advisor Portfolio Connect as a free, download-free tool introduced around 2022 and tracks its progression toward deeper integration with custodial and trading systems by 2024. The evolution of third-party integrations (CRM, financial planning, trade-order systems) is accurately described across the years, matching the ground truth's emphasis on expanding ecosystem connectivity. Advisor support offerings are correctly detailed: 2022 includes consulting and events like IMPACT, 2023 adds educational and transition consulting, and 2024 expands teams and adds transition engineers—consistent with the original answer’s mention of 'larger consulting teams' and 'dedicated transition engineers.' The only minor gap is that the LLM answer does not explicitly mention 'multi-year document archiving' or 'outbound data feeds for compliance systems' in 2024, which are key elements in the ground truth indicating compliance workflow integration. This omission prevents a perfect 10 but does not undermine the overall correctness. All dates, entities (Schwab, RIAs, Advisor Portfolio Connect), and functional progressions are accurate. There are no numerical inaccuracies (no specific numbers to verify, but temporal progression is correct). The reasoning is sound, demonstrating multi-hop synthesis across three years of filings and correctly inferring a trend toward greater sophistication and integration. The answer is semantically equivalent to the ground truth in nearly all aspects, with only slight underrepresentation of compliance-related enhancements in 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1713,
        "completion_tokens": 476,
        "total_tokens": 2189
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve from their initial issuance in 2022 through the 2023 and 2024 10-K filings, and what does this consistency or change reveal about Oracle's short-to-intermediate term debt financing strategy?",
      "original_answer": "Oracle first introduced the 1.650% Notes due 2026 in its 2022 10-K filing (Exhibit 4.16), indicating the formal structuring of this debt instrument. The same note was reaffirmed in both the 2023 and 2024 10-K filings (Exhibit 4.14 in 2023 and 2024), showing Oracle maintained consistent disclosure and commitment to this financing vehicle without modification. This unchanging treatment across all three years suggests Oracle's strategy around this particular debt instrument remained stable, reflecting a consistent approach to managing its capital structure with fixed-rate obligations maturing in the mid-term horizon.",
      "llm_answer": "\nOracle first set out the terms of its 1.650 % Notes due 2026 in an 8‑K dated March 24 2021 (shown in Exhibit 4.16 of the 2022 10‑K and carried forward as Exhibit 4.14 in the 2023 and 2024 10‑K filings), and each subsequent filing simply re‑lists the same exhibit description without any amendment or new certificate; this uninterrupted, year‑over‑year disclosure demonstrates that Oracle has treated the 2026 tranche as a stable, fixed‑rate component of its debt ladder, underscoring a short‑to‑intermediate‑term financing strategy that relies on predictable, staggered maturities rather than frequent refinancing or term changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 1.650% Notes due 2026, their initial documentation in the 2022 10-K (Exhibit 4.16), and their continuation in the 2023 and 2024 10-Ks as Exhibit 4.14. The mention of the March 24, 2021 8-K filing adds contextual detail not in the original answer but is factually consistent with typical SEC filing practices—debt terms are often first disclosed in an 8-K and later incorporated by reference into the 10-K. This does not contradict the ground truth, which focuses on 10-K disclosures. (2) All percentages, years (2021, 2022, 2023, 2024), and exhibit numbers are correct or plausibly consistent. The only minor discrepancy is the emphasis on the 8-K date (March 2021) versus the 2022 10-K as the first 10-K filing to include the note—this is a nuance in framing, not a factual error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings, recognizes the unchanged exhibit treatment, and infers Oracle’s stable debt strategy. (4) The conclusion about Oracle relying on predictable, staggered maturities is a valid interpretation of the consistent disclosure, demonstrating strong qualitative reasoning. The answer is fully contextually relevant, addressing both the evolution (or lack thereof) and strategic implications. Minor deduction in quantitative accuracy only because the original ground truth does not reference the 8-K, and while that detail is likely correct, it introduces a source not confirmed in the knowledge graph. Overall, the answer is factually robust, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 461,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Emerson's (EMR) positioning of Electrical Distribution Equipment evolved across its Discrete Automation segment from 2022 to 2024, and what does this reveal about the company's strategic emphasis on industrial electrification solutions?",
      "original_answer": "In 2022, Electrical Distribution Equipment was grouped under 'Industrial Solutions' and described as part of a broader suite of fluid control and materials joining products. By 2023, it was explicitly included within the Discrete Automation segment alongside solenoid valves and programmable control systems, signaling a more integrated approach to automation. In 2024, the description remained consistent with 2023, reinforcing a strategic shift toward positioning Electrical Distribution Equipment as a core component of industrial automation infrastructure rather than a general-purpose offering. This evolution reflects Emerson’s growing focus on electrification and smart manufacturing solutions over the three-year period.",
      "llm_answer": "\nEmerson’s Discrete Automation segment has kept electrical‑distribution equipment on its core product list from 2022 through 2024—​the 2022 filing placed it under the broader “Industrial Solutions” umbrella together with fluid‑control and pneumatic mechanisms, while the 2023 and 2024 filings explicitly list it alongside solenoid/pneumatic valves, actuators, programmable automation control systems and related hardware, underscoring a deliberate expansion of the offering within the segment.  The knowledge‑graph triplets (EMR → Electrical Distribution Equipment → EMR) show that this equipment is both a product created by EMR and a distinct organizational capability that EMR leverages, reinforcing a strategic focus on supplying the electrified backbone for discrete automation.  This sustained emphasis, together with the company’s Climate‑Technologies and Tools‑&‑Home‑Products businesses that also target energy‑efficient electrification and with AspenTech’s analytics layer that optimizes those electrified processes, reveals Emerson’s intent to make industrial electrification a central growth pillar, using electrical‑distribution equipment as the critical link that powers and connects smarter, more sustainable manufacturing operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Emerson's Electrical Distribution Equipment positioning: in 2022 under 'Industrial Solutions' alongside fluid control and pneumatic products, then explicitly moved into the Discrete Automation segment in 2023 and maintained in 2024. These entity and year mappings are correct. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022–2024) are used correctly. (3) The multi-hop reasoning is sound: the LLM synthesizes the re-segmentation trend with strategic implications, linking it to industrial electrification and smart manufacturing. It appropriately references AspenTech and Climate Technologies to reinforce the broader strategic context, which is consistent with Emerson’s known portfolio strategy, though slightly beyond the scope of the original answer. (4) Semantic equivalence is strong: while the LLM adds contextual interpretation (e.g., 'electrified backbone', 'central growth pillar'), these are reasonable inferences from the positioning shift. The only minor deviation is the mention of 'knowledge-graph triplets (EMR → Electrical Distribution Equipment → EMR)', which introduces a meta-level construct not present in the source data and slightly overreaches in methodological framing—though it doesn’t undermine factual correctness. Overall, the answer is comprehensive, factually accurate, and contextually rich, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 451,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Abbott Laboratories' unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's pension fund strategy in illiquid alternative assets?",
      "original_answer": "Abbott Laboratories' unfunded commitments to private real estate funds decreased from $585 million in 2022 to $555 million in 2023, and further declined to $540 million by 2024. This consistent reduction over three years indicates a measured de-risking or rebalancing of the pension fund portfolio, suggesting a strategic shift away from illiquid alternative assets toward more liquid or stable investments. Despite this decline, the company maintained a long time horizon for fund liquidation (projected through 2034 by 2024), indicating continued belief in the long-term value of these assets, albeit with a reduced exposure. The gradual nature of the decline suggests a deliberate approach to managing liquidity risk and aligning fund commitments with pension liability profiles.",
      "llm_answer": "\nAbbott’s unfunded commitments to the private‑real‑estate‑focused funds disclosed in the 10‑K filings fell steadily: $569 million at the end of 2022 (Chunk 2), $555 million at the end of 2023 (Chunk 3), and $540 million at the end of 2024 (Chunk 3 again), representing a decline of roughly $14‑15 million each year. This downward trend signals that the company is scaling back new exposure to illiquid alternative assets and is likely reallocating pension‑fund capital toward more liquid or lower‑risk investments, reflecting a more conservative strategy toward private‑real‑estate and other private‑fund commitments.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in its trend analysis and interpretation. It correctly reports the 2023 ($555M) and 2024 ($540M) unfunded commitments, matching the ground truth. However, it reports $569M for 2022 instead of the correct $585M, which is a factual inaccuracy of $16M. This error affects the quantitative precision, though the overall downward trend is accurately captured. The annual decline is described as ~$14-15M, but the actual drop from 2022 to 2023 was $30M, so this calculation is incorrect. 2) Quantitative accuracy is compromised by the incorrect 2022 figure and flawed year-over-year difference calculation. The 2023 and 2024 numbers are correct. 3) The reasoning and qualitative analysis are strong: the LLM correctly infers a strategic reduction in illiquid asset exposure and a shift toward more conservative, liquid investments. It appropriately links the trend to pension fund strategy, demonstrating sound multi-hop reasoning across years and implications. 4) The answer is fully contextually relevant, addressing both parts of the question—evolution of commitments and strategic implications. Despite the numerical error in the 2022 value, the core conclusion about de-risking and rebalancing aligns with the ground truth. The gradual decline interpretation is consistent, though the original answer adds valuable nuance about the long time horizon (through 2034), which the LLM omits. This missing detail slightly reduces completeness but does not invalidate the overall assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 416,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's treatment of its 1.650% Notes due 2026 evolve across its 2022, 2023, and 2024 filings, and what does this continuity reveal about its short-term debt strategy?",
      "original_answer": "Oracle first disclosed the 1.650% Notes due 2026 in its 2022 10-K filing, referencing the March 24, 2021 8-K filing where the terms of the Notes were established. In the 2023 10-K filing, Oracle continued to reference the same 8-K filing from March 2021, indicating no changes to the Notes' structure or terms. Similarly, in the 2024 10-K filing, Oracle again referenced the original March 2021 8-K for the 1.650% Notes due 2026, maintaining the same unchanged structure. This consistent referencing of the original filing across three annual reports suggests a deliberate strategy of maintaining stable short-term debt obligations without modification, even as Oracle introduced new debt instruments with different rates and maturities in subsequent years.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings each year’s Exhibit 4.16 reproduces the identical “Forms of 1.650 % Notes due 2026” (first set out in the March 2021 Officers’ Certificate), so the terms of that tranche have remained unchanged through all three filings.  This repeated, unaltered disclosure shows Oracle is deliberately maintaining a stable, medium‑term fixed‑rate debt pipeline rather than renegotiating or retiring the notes, indicating a short‑term debt strategy that relies on consistent, predictable borrowing to fund operations and acquisitions.  The continuity also reflects the company’s practice of re‑filing the same bond documentation each year to preserve registration efficiency and investor confidence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.650% Notes due 2026 were first established in the March 2021 Officers’ Certificate (referenced in the March 24, 2021 8-K), and Oracle consistently reproduced the same exhibit (4.16) in its 2022, 2023, and 2024 10-K filings, confirming no changes to the terms. The percentage (1.650%), maturity year (2026), and original filing date (March 2021) are all correctly stated. (2) The answer correctly identifies the continuity in disclosure practice across three annual reports, which matches the ground truth’s emphasis on unchanged referencing. (3) The reasoning is sound: the LLM infers that Oracle is maintaining a stable debt structure, which reflects a deliberate short-term debt strategy—this aligns with the original answer’s conclusion about stability and predictability. The LLM adds value by noting registration efficiency and investor confidence, which are reasonable interpretations consistent with SEC filing practices. (4) The only minor gap is that the LLM refers to this as a 'medium-term fixed-rate debt pipeline' and emphasizes 'short-term debt strategy'—while Oracle’s strategy is correctly interpreted as stable, the 2026 maturity is more accurately medium-term rather than short-term. However, the use of 'short-term debt strategy' may reflect Oracle’s broader approach to managing near-to-medium term obligations, so this does not constitute a major error. Overall, the answer demonstrates strong multi-hop reasoning by connecting repeated exhibit disclosures to strategic intent, and it is semantically equivalent to the ground truth with slightly enhanced interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 466,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Oracle's issuance and documentation of the 4.30% Note due 2034 evolve across 2022, 2023, and 2024, and what does this multi-year filing pattern suggest about its long-term debt strategy?",
      "original_answer": "The 4.30% Note due 2034 was consistently referenced in Oracle's filings across 2022, 2023, and 2024, indicating its ongoing importance in the company's long-term debt structure. In 2022 (Exhibit 4.11), the note was listed alongside other long-term instruments, reaffirming Oracle’s commitment to a diversified maturity profile. In 2023 and 2024 (Exhibit 4.09), the note continued to be included in the exhibit list, showing no structural changes but reinforcing its sustained presence in Oracle’s capital structure. This consistent documentation suggests Oracle intended to maintain this liability as a stable component of its long-term financing strategy.",
      "llm_answer": "\nAcross Oracle’s 2022, 2023 and 2024 Form 10‑K filings the 4.30 % Note due 2034 is listed in the same exhibit (Exhibit 4.09 in 2022 and 2024, Exhibit 4.11 in 2023) and each time is described as part of “Forms of 3.40 % Note due 2024, 4.30 % Note due 2034 and 4.50 % Note due 2044 together with the Officers’ Certificate issued July 8 2014,” showing that the instrument is repeatedly documented and re‑referenced in successive annual reports.  \nThis multi‑year filing pattern indicates that Oracle’s long‑term debt strategy centers on issuing multi‑year fixed‑rate notes with staggered maturities—such as the 2034 note—and on continuously updating the public documentation of those notes in its periodic filings to maintain transparency and reinforce market confidence in its extended capital‑raising program.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in exhibit numbering: it states that Exhibit 4.09 was used in 2022 and 2024, and Exhibit 4.11 in 2023. However, the ground truth indicates that the note was listed in Exhibit 4.11 in 2022 and Exhibit 4.09 in both 2023 and 2024. This misattribution of exhibits across years is a factual inaccuracy that affects the precision of the response. (2) Quantitatively, the interest rate (4.30%), maturity year (2034), and related notes (3.40% due 2024, 4.50% due 2044) and the July 8, 2014 Officers’ Certificate are all correctly cited, which supports partial quantitative accuracy. However, the incorrect mapping of exhibits to years undermines full quantitative reliability. (3) The multi-hop reasoning is sound: the model correctly infers from the repeated documentation that Oracle maintains a strategy of using long-term fixed-rate notes with staggered maturities and updates them in periodic filings. This aligns with the ground truth’s conclusion about Oracle’s long-term debt strategy. The synthesis across years is logical and well-reasoned. (4) Contextually, the answer is highly relevant, addressing both the evolution of the note’s documentation and the strategic implication. While the core strategic interpretation is correct and well-supported, the exhibit number inaccuracies prevent a higher correctness score. The answer would have scored 9–10 if exhibit-year mappings were accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 401,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Schwab's utilization of the IDA agreement for migrating IDA balances to its balance sheet evolve from 2022 through 2024, and what changes in contractual flexibility or constraints occurred across these years?",
      "original_answer": "In 2022, Schwab had the option under the 2019 IDA agreement to migrate up to $10 billion of IDA balances annually to its balance sheet, and it had already moved $10.1 billion by December 31, 2021, including $10 billion subsequent to that date. In 2023, the 2019 IDA agreement was replaced by the 2023 IDA agreement, which eliminated the requirement that at least 80% of IDA balances be fixed-rate obligations, but Schwab did not migrate any IDA balances to its balance sheet that year. In 2024, Schwab continued to operate under the 2023 IDA agreement, maintaining restrictions on balance migration based on capital sufficiency and balance thresholds, and again did not move any IDA balances to its balance sheet. This shows a shift from active migration in 2022 to a more constrained and passive approach in 2023 and 2024, despite increased contractual flexibility.",
      "llm_answer": "\nUnder the original 2019 IDA agreement (effective Oct 6 2020), Schwab could migrate up to $10 billion of IDA balances each 12‑month window starting July 1 2021; by the end of 2021 it had moved $10.1 billion and, subject to capital adequacy, a floating‑rate‑only limitation and the need to keep at least $50 billion of IDA balances (with ≥ 80 % designated fixed‑rate through June 2026), it added roughly another $10 billion of migrations in 2022. On May 4 2023 the 2019 agreement was replaced by the 2023 IDA agreement, which eliminated the 80 % fixed‑rate requirement, extended the sweep horizon to July 1 2034, and imposed new balance constraints—maintaining balances above the then‑outstanding unmatured fixed‑rate obligations (with a $30 billion ceiling above that total through Sep 10 2025) and a $60 billion–$90 billion floor thereafter—thereby curtailing migration flexibility. As a result, Schwab did not migrate any IDA balances to its balance sheet in 2023 or 2024, focusing instead on meeting the new minimum‑ and maximum‑balance thresholds set by the 2023 agreement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, particularly in quantitative details and the interpretation of contractual changes. (1) The claim that Schwab migrated 'roughly another $10 billion' in 2022 is unsupported by the ground truth, which states that $10.1 billion had already been moved by December 31, 2021, with no specific amount confirmed for 2022 migrations. The LLM incorrectly implies continued active migration in 2022 beyond what was already completed by end-2021. (2) The LLM introduces a 'floating-rate-only limitation' and a '$50 billion of IDA balances' requirement with '≥80% fixed-rate through June 2026'—none of which appear in the original answer and contradict the ground truth, which only notes the 80% fixed-rate obligation without specifying a timeline or balance floor in 2022. (3) The 2023 agreement is said to have 'curtailed migration flexibility' due to new balance constraints, but the ground truth states there was 'increased contractual flexibility' due to the removal of the 80% fixed-rate requirement. The LLM mischaracterizes the nature of the change, incorrectly concluding that flexibility decreased when it actually increased despite no migrations occurring. (4) The LLM adds specific dates (May 4, 2023; Sep 10, 2025), balance ceilings ($30B above unmatured obligations), and floors ($60B–$90B) not present in the ground truth, introducing fabricated details. (5) While the LLM correctly notes no migrations in 2023 and 2024 and the replacement of the 2019 agreement with the 2023 version, it fails to convey the core insight from the original answer: a shift from active migration to a passive approach *despite* increased flexibility. Instead, it falsely attributes the lack of migration to reduced flexibility. Overall, the reasoning is partially sound and contextually relevant, but the quantitative inaccuracies and misrepresentation of contractual changes reduce correctness. Semantic equivalence is partially achieved on high-level events (agreement change, no migration), but not on key financial and contractual details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> PRODUCT <-[Provides]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 565,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Abbott Laboratories' engagement with its 2.000% Senior Notes due 2018 evolve from 2022 through 2024, particularly in terms of documentation updates and refinancing activities across the three years?",
      "original_answer": "In 2022, Abbott referenced the 2.000% Senior Notes due 2018 as part of the Fifth Supplemental Indenture dated September 23, 2015, indicating ongoing documentation related to legacy St. Jude Medical debt. In 2023, the company continued to reference the same notes within the context of broader debt structure documentation, specifically in Exhibit 4.21, showing continuity in disclosure practices. By 2024, the 2.000% Senior Notes due 2018 were still included in the 10-K exhibit table (Exhibit 4.21), but with no new issuances or amendments noted, suggesting that the notes were likely nearing maturity without further refinancing actions taken. The consistent inclusion of the notes across all three years indicates a stable, though gradually maturing, component of Abbott's capital structure.",
      "llm_answer": "\nFrom 2022 through 2024 Abbott’s 10‑K filings show a stable, periodic‑update pattern for the 2.000% Senior Notes due 2018: the 2022 filing (Chunk 1) listed the Fifth Supplemental Indenture (Sept 23 2015) and Sixth Supplemental Indenture (Jan 4 2017) that govern the notes, together with the 2018 Indenture (Sept 27 2018) and the 2019 supplemental indenture (Nov 19 2019) that added new note forms – all of which were reproduced unchanged in the 2023 (Chunk 2) and 2024 (Chunk 3) filings, which merely re‑filed those same indentures and included the “Actions of the Authorized Officers” exhibit for the 2.000% Notes. Thus, there were no new refinancing transactions or material term changes across the three years; the evolution consisted only of the periodic re‑issuance of the original indenture package and related supplemental documents to maintain compliance and disclose authorized‑officer actions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2018 Indenture was dated September 27, 2018—this is impossible because the notes were due in 2018, and the actual governing document is the Fifth Supplemental Indenture from September 23, 2015, related to the St. Jude Medical acquisition. There is no '2018 Indenture' for notes due in 2018; this is a fundamental error. Similarly, the mention of a '2019 supplemental indenture (Nov 19, 2019)' adding new note forms is incorrect—the original answer and supporting data show no such amendment or issuance after 2015. (2) The LLM invents documents (Sixth Supplemental Indenture on Jan 4, 2017; 2019 supplemental) not present in the ground truth, which only references the Fifth Supplemental Indenture. These fabricated dates and documents severely compromise quantitative accuracy. (3) While the LLM correctly infers no refinancing occurred and that disclosures were carried forward, this conclusion is based on incorrect premises. The reasoning is partially sound in interpreting stable disclosure as lack of activity, but fails in multi-hop synthesis by not recognizing that Abbott was maintaining legacy disclosures for a matured or near-matured instrument, not actively re-filing updated indentures. (4) The original answer emphasizes the notes are legacy St. Jude debt and were consistently referenced in Exhibit 4.21 with no new activity—this context is distorted in the LLM version. Despite these errors, the answer is contextually relevant, addressing the right documents (Exhibit 4.21) and correctly noting no refinancing, hence a moderate contextual relevance score. However, due to major factual and document inaccuracies, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 482,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's introduction and continuation of its 3.650% Notes due 2041 evolve from 2022 through 2024, and what does this multi-year pattern suggest about Oracle's long-term debt strategy?",
      "original_answer": "Oracle first introduced the 3.650% Notes due 2041 in 2022 as part of its long-term debt instruments, continued to reference the same notes in 2023 alongside newer bond issuances, and reaffirmed its inclusion in 2024 within the broader context of its registered securities. This consistent inclusion over three years indicates Oracle's strategic use of long-term debt to fund operations and maintain financial flexibility. The persistence of the 3.650% Notes due 2041 in Oracle's capital structure suggests a stable long-term financing approach, complemented by periodic new issuances to meet evolving capital needs.",
      "llm_answer": "\nFrom 2022 through 2024 Oracle’s annual and quarterly reports repeatedly list the 3.650 % Notes due 2041—first created by the Officers’ Certificate dated March 24 2021 (Exhibit 4.16 in the 2022 10‑K) and then re‑referenced in the 2023 10‑K (Exhibit 4.14) and the 2024 10‑K (Exhibit 4.14)—showing that the tranche remains outstanding and continues to be part of the company’s registered debt program. This multi‑year pattern reflects Oracle’s long‑term debt strategy of issuing large, fixed‑rate notes with staggered maturities and maintaining them in the capital structure via a continuous registration approach, ensuring a stable, long‑dated funding base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 3.650% Notes due 2041 were introduced via an Officers’ Certificate on March 24, 2021, and consistently referenced in Oracle’s 2022 (Exhibit 4.16), 2023 (Exhibit 4.14), and 2024 (Exhibit 4.14) 10-K filings—this matches the original answer’s timeline and documentation. The percentage (3.650%), maturity year (2041), and multi-year continuity are all correctly stated. (2) Quantitative accuracy is perfect: dates, percentages, and exhibit numbers are precisely reported and consistent with the knowledge graph. (3) The reasoning is sound: the LLM correctly infers that Oracle maintains a long-term debt strategy involving fixed-rate notes with staggered maturities and continuous registration, which is a valid interpretation of the multi-year pattern. It adds value by referencing the registration mechanism (Exhibit references), enhancing the explanation. (4) The only minor shortcoming is that the LLM does not explicitly mention Oracle’s use of newer bond issuances alongside the 2041 notes (noted in the original answer), which slightly reduces completeness in describing the full capital strategy. However, the core insight about stable, long-dated funding is preserved. Overall, the answer is factually excellent, contextually relevant, and semantically equivalent with slightly less elaboration on complementary new issuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 399,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Oracle's issuance and structuring of its 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about its debt financing strategy?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, with terms set by an Officers' Certificate issued March 24, 2021. In 2023, Oracle expanded its debt portfolio by issuing additional structured notes, including the 4.500% Notes due 2028 under Exhibit 4.16, indicating a diversification of interest rate profiles. By 2024, Oracle maintained the same structure for the 2.300% Notes due 2028, showing consistency in referencing the March 24, 2021 certificate. This three-year pattern suggests a stable long-term debt financing strategy focused on maintaining a diversified maturity and interest rate structure across multiple fiscal years.",
      "llm_answer": "\nOracle first registered the 2.300 % Notes due 2028 in the March 24 2021 Officers’ Certificate that appears as Exhibit 4.16 in the FY 2022 10‑K (Chunk 3), and the same filing was carried forward unchanged in the FY 2023 10‑K (Chunk 1) and the FY 2024 10‑K (Chunk 2), each time listed under the identical Exhibit 4.14 description. This continual re‑filing across three fiscal years—tracked by the KG pattern ORCL → 2.300 % Notes due 2028 (FIN_INST) ← Issues_Bonds ← ORG → ORCL—shows that Oracle’s multi‑year debt strategy relies on a single, long‑dated fixed‑rate tranche that is periodically refreshed in its registration filings rather than replaced by new series, underscoring a deliberate focus on stable, long‑term financing and incremental refinancing of its existing bond portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance date (March 24, 2021) and the consistent re-filing of the 2.300% Notes due 2028 across FY 2022, 2023, and 2024, which aligns with the ground truth. However, it incorrectly states that the exhibit number is 'Exhibit 4.14' in all years, while the ground truth specifies 'Exhibit 4.16'—a critical factual error affecting entity accuracy. Additionally, the LLM omits Oracle’s issuance of the 4.500% Notes due 2028 in 2023, a key part of the multi-year diversification strategy highlighted in the original answer. (2) Quantitatively, the interest rate (2.300%), issuance date (March 24, 2021), and fiscal years (2022–2024) are accurate. The error in exhibit number (4.14 vs. 4.16) is a factual discrepancy but not a numerical calculation error. (3) The reasoning partially captures Oracle’s strategy of maintaining stable long-term financing, but fails to synthesize the full multi-hop insight: the 2023 expansion with a higher-yielding note indicates active diversification, not just 'refreshing' a single tranche. The LLM overemphasizes continuity while missing strategic evolution. (4) The answer is contextually relevant and well-structured, but the omission of the 4.500% Notes and the exhibit number inaccuracy reduce qualitative and overall correctness. The conclusion about 'incremental refinancing' is plausible but not directly supported by the ground truth, which emphasizes diversification.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Bonds]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 402,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Visa's virtual accounts evolve across its Currencycloud platform from 2022 to 2024, particularly in terms of their integration into the Visa Direct Platform and the expansion of cross-border capabilities?",
      "original_answer": "In 2022, Visa introduced virtual accounts as part of its Treasury as a Service initiative, emphasizing their role in enabling cross-border products and services through the Currencycloud platform. By 2023, virtual accounts were fully integrated into the Visa Direct Platform, supporting new flows and enhancing the established cross-border consumer payments business with real-time foreign exchange rates and improved liquidity and settlement capabilities. In 2024, virtual accounts continued to be a core component of the Visa Direct Platform, further solidifying their role in facilitating cross-border transactions and supporting Visa’s broader network of more than 11 billion endpoints, including cards, bank accounts, and digital wallets.",
      "llm_answer": "\nFrom 2022 through 2024 Visa migrated the virtual‑account functionality that debuted in its Currencycloud‑driven Treasury‑as‑a‑Service offering into the heart of the Visa Direct platform, embedding real‑time foreign‑exchange rates, enhanced liquidity and settlement capabilities and making those accounts available across the network’s 195‑country reach; this integration was highlighted in the 2023 and 2024 filings as part of Visa Cross‑Border Solutions and now supports nearly 10 billion transactions for more than 550 partners, extending Visa Direct’s potential to over 11 billion endpoints (cards, bank accounts and digital wallets).  The evolution also broadened cross‑border B2B capabilities via Visa B2B Connect, which leverages those virtual accounts to deliver predictable, data‑rich, cost‑effective transfers in more than 100 countries, while the commercial‑solutions portfolio grew to include virtual‑card automation for accounts‑payable/receivable, unlocking the $20 trillion annual cross‑border opportunity that the company cites in its 2023‑2024 disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Visa's virtual accounts from 2022 to 2024 and correctly identifies key developments such as integration into Visa Direct, enhanced cross-border capabilities, and the role in Treasury as a Service via Currencycloud. However, there are significant quantitative inaccuracies that reduce factual correctness. The claim of 'nearly 10 billion transactions' and 'more than 550 partners' is not supported by the ground truth, which does not specify transaction volumes or partner counts. Similarly, the '$20 trillion annual cross-border opportunity' is mentioned in the LLM answer but absent from the original answer, introducing unverified data. The '195-country reach' and 'Visa B2B Connect' expansion leveraging virtual accounts are not mentioned in the ground truth, representing overreach or synthesis beyond the provided information. While the core timeline (2022 introduction, 2023 integration, 2024 continuation) aligns with the original answer, and the mention of real-time FX, liquidity, and settlement improvements is accurate, the LLM adds unsupported specifics. The reference to '11 billion endpoints' matches the ground truth and is correctly contextualized. The qualitative reasoning is mostly sound—showing integration and expansion logic—but extends beyond the evidence with additional product claims (e.g., virtual-card automation for AP/AR). Contextually, the answer is highly relevant, addressing integration into Visa Direct and cross-border expansion as asked. However, the inclusion of unverified metrics and features results in a moderate correctness score due to compromised factual integrity, despite strong thematic alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 459,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did the geographic distribution network for EMD-branded products evolve across Caterpillar's Machinery, Energy & Transportation (ME&T) segment from 2022 to 2024, and what does this progression indicate about Caterpillar's market expansion strategy for EMD?",
      "original_answer": "From 2022 to 2024, Caterpillar's geographic distribution network for EMD-branded products remained consistent at 108–110 distributors covering between 109 and 158 countries. In 2022, EMD-related FG Wilson branded electric power generation systems were sold through 110 distributors across 109 countries. In 2023, this was reported as 110 distributors covering 109 countries. By 2024, the number of distributors slightly decreased to 108, but the geographic reach expanded to 158 countries. This indicates a strategy to optimize distribution efficiency while increasing international market access for EMD products.",
      "llm_answer": "\nThe dealer footprint that delivers EMD‑branded products contracted only slightly from 2022 to 2024 – U.S. dealers fell from **44 to 41**, non‑U.S. dealers from **116 to 111**, and the number of countries served slipped from **193 to 187** before stabilising – a pattern mirrored in the 2023 and 2024 filings.  Because the KG link **EMD (PRODUCT) → EMD (ORG) → CAT (ORG)** shows that EMD is treated as both a product line and an organisational brand within Caterpillar, this modest shrinkage signals a strategic shift from aggressive geographic expansion to **consolidating and deepening penetration in existing markets**, using the existing global dealer network to boost EMD’s market share rather than extending it to new regions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The numbers provided (e.g., 44 to 41 U.S. dealers, 116 to 111 non-U.S. dealers, countries served dropping from 193 to 187) are completely inconsistent with the ground truth. According to the original answer, EMD-branded products (via FG Wilson) were distributed through 110 distributors in 109 countries in 2022, 110 in 109 countries in 2023, and 108 distributors in 158 countries in 2024. The LLM introduces non-existent data about U.S./non-U.S. dealer splits and total countries served that contradict the ground truth. There is no mention in the original answer of 193 or 187 countries, nor any breakdown by U.S. vs. non-U.S. dealers. (2) Completeness: The LLM fails to report the actual evolution — particularly the significant geographic expansion to 158 countries by 2024 — which is a key point in the ground truth. Instead, it claims a contraction in countries served, which is factually wrong. (3) Entity Accuracy: While EMD and Caterpillar are correctly identified, the reference to 'dealers' instead of 'distributors' may reflect a mischaracterization, especially since the scale (160+ dealers) does not align with the reported 108–110 distributors. Also, FG Wilson — a key brand in the distribution network — is omitted. (4) Reasoning: The LLM concludes a strategy of consolidation and market penetration due to a shrinking network, but this contradicts the ground truth, which shows a deliberate expansion into more countries (109 to 158) despite a slight reduction in distributor count — indicating improved distribution efficiency and broader market access. The reasoning is therefore based on false premises. (5) Semantic Equivalence: The overall message is opposite to the ground truth: the LLM suggests retrenchment, while the original answer indicates strategic expansion. Despite some contextual relevance in discussing Caterpillar’s EMD strategy, the factual foundation is so flawed that the conclusion is invalid. Hence, the correctness score is low at 2, with minimal credit for addressing the general topic of distribution strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 577,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How did Abbott's investment in diagnostics instruments leased to customers evolve from 2022 to 2024, based on the changes in the original cost and net book value of these assets on the balance sheet?",
      "original_answer": "Abbott's original cost of diagnostics instruments leased to customers increased from $3.3 billion in 2022 to $3.6 billion in 2023, and further to $3.9 billion in 2024. The net book value of these leased instruments also rose from $1.4 billion in 2022 to $1.6 billion in 2023 and $1.8 billion in 2024, indicating a consistent increase in Abbott's investment in diagnostics instruments over the three-year period.",
      "llm_answer": "\nThe leased‑instrument portfolio expanded steadily: as of the 2020‑2021 balance sheet (Chunk 1) the original cost was $3.3 bn with a net book value of $1.4 bn, rising to $3.5 bn/$1.6 bn by end‑2021; the 2022‑2023 filings (Chunk 2) show the cost increasing to $3.6 bn and then $3.9 bn and the net book value to $1.6 bn and $1.8 bn respectively, reflecting a clear growth from 2022 through 2023; and the 2024 disclosure (Chunk 3) confirms that the same operating‑lease structure persisted—with lease revenue still under 3 % of net sales—indicating the investment continued to evolve into 2024, although specific 2024 cost figures have not been disclosed.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and years. It incorrectly states that the original cost was $3.3 billion in 2020–2021 and $3.5 billion by end-2021, which contradicts the ground truth that the $3.3 billion figure corresponds to 2022. The ground truth shows a clear progression from $3.3B (2022) → $3.6B (2023) → $3.9B (2024), but the LLM misaligns these figures with incorrect years (e.g., claiming $3.6B and $3.9B occurred in 2022–2023, rather than 2023 and 2024). It also falsely claims that 'specific 2024 cost figures have not been disclosed,' when in fact the original answer and data confirm $3.9B in 2024. (2) The net book values are partially correct: $1.6B in 2023 and $1.8B in 2024 are accurate, but the LLM incorrectly implies the $1.6B net book value was already reached by end-2021, when it should be 2023. (3) The multi-hop reasoning is partially sound—the model recognizes a growth trend and attempts to trace it across filings—but the synthesis is flawed due to incorrect temporal alignment of data points. It references 'Chunk 1', 'Chunk 2', 'Chunk 3' as if from source documents, but misinterprets their time periods. (4) Despite these errors, the answer captures the qualitative trend of increasing investment and correctly notes the operating lease structure and its minor revenue contribution, which adds contextual relevance. However, the significant quantitative and chronological inaccuracies—especially the misattribution of 2022–2024 data to earlier years and the false claim that 2024 figures are missing—severely undermine factual correctness, warranting a mid-low score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 450,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "What does the consistent disclosure of the 3.450% Senior Note due 2046 in PepsiCo's 2022, 2023, and 2024 10-K filings indicate about its ongoing role in the company's long-term capital structure strategy?",
      "original_answer": "The consistent disclosure of the 3.450% Senior Note due 2046 across all three years—in Exhibit 4.17 in 2022, Exhibit 4.16 in 2023, and Exhibit 4.15 in 2024—indicates that this instrument remained a stable and integral component of PepsiCo’s long-term debt financing strategy throughout the period. The repeated inclusion of this specific note, without any indication of modification or removal, suggests it was strategically maintained to support the company’s capital structure, likely providing long-dated, fixed-rate funding. This consistency implies that PepsiCo viewed the note as a reliable source of capital with favorable terms that aligned with its broader financial planning over the three-year horizon.",
      "llm_answer": "\nThe fact that PepsiCo’s 2022, 2023 and 2024 Form 10‑K filings each disclose the 3.450% Senior Note due 2046—each time referencing the same 2016 8‑K filing (see Chunks 1‑3)—demonstrates that this fixed‑rate senior note has remained a persistent component of the company’s long‑term capital structure since its original issuance. Its repeated appearance across three consecutive annual reports, alongside other senior‑note authorizations, signals that PepsiCo continues to rely on this instrument to secure low‑cost, long‑dated financing and to shape its overall debt‑maturity strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core meaning of the ground truth. (1) All entities are correct: PepsiCo, 3.450% Senior Note due 2046, and the three-year span (2022–2024) are accurately referenced. The note's origin in the 2016 8-K filing is correctly cited, aligning with disclosure practices. (2) Quantitative elements—interest rate (3.450%), maturity year (2046), and the three consecutive annual reports—are all factually correct with no calculation errors. Format and referencing are consistent with acceptable variations. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that the note remains a stable part of PepsiCo’s long-term capital structure, indicating strategic use for long-dated, fixed-rate financing. While the ground truth specifies exhibit numbers (e.g., Exhibit 4.17 in 2022), the LLM does not include them—this is a minor omission but does not affect the overall correctness, as exhibit numbers are administrative details rather than substantive financial facts. (4) The answer captures the semantic intent: the note’s ongoing role in debt maturity and capital structure strategy is clearly and logically explained. The use of terms like 'low-cost, long-dated financing' and 'debt-maturity strategy' aligns well with the original conclusion. Thus, the answer is factually complete and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for missing the exhibit-level specificity present in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 420,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "Oracle first introduced the 2.300% Notes due 2028 in 2022 as part of a broader set of debt instruments outlined in Exhibit 4.16, which also included other notes such as the 1.650% Notes due 2026 and 2.875% Notes due 2031. In 2023, Oracle continued to reference the 2.300% Notes due 2028 in Exhibit 4.14, alongside newer issuances such as the 4.500% Notes due 2028. In 2024, Oracle again referenced the 2.300% Notes due 2028 in Exhibit 4.14, maintaining continuity with prior disclosures while continuing to include newer notes like the 4.500% Notes due 2028. This pattern suggests Oracle maintained a consistent approach to referencing prior debt instruments while layering in new issuances with potentially higher yields to reflect changing market conditions or strategic financing needs.",
      "llm_answer": "\nIn the 2022 Form 10‑K (Exhibit 4.16) Oracle disclosed the terms of the 2.300% Notes due 2028 that were originally set forth in the March 24 2021 officers’ certificate, and the same exhibit in the 2023 and 2024 filings was repurposed to register newer note series (e.g., 4.500% Notes due 2028), indicating that the 2.300% tranche remained outstanding but was no longer the focus of fresh issuance. This progression—from a 2021 issuance of a 2.300% 2028 note to subsequent 8‑K filings that bundle new fixed‑rate tranches with different coupons—reflects Oracle’s broader debt‑financing strategy of issuing staggered, fixed‑rate senior unsecured notes in periodic filings to ladder maturities and adjust coupon rates in response to market conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2.300% Notes due 2028 and their disclosure in Oracle's 10-K filings across 2022, 2023, and 2024, with accurate references to Exhibit 4.16 in 2022 and Exhibit 4.14 in later years (though the LLM says Exhibit 4.16 was reused in 2023 and 2024, which slightly misrepresents the ground truth—Exhibit 4.14 was used in 2023 and 2024, not 4.16). The mention of the March 24, 2021 officers’ certificate is factually accurate and adds context not in the original answer, but does not contradict it. The 4.500% Notes due 2028 are correctly cited as newer issuances. (2) Quantitative accuracy is high: percentages (2.300%, 4.500%), maturity year (2028), and years of filing (2022–2024) are all correct. The LLM correctly avoids inventing dollar amounts or incorrect dates. (3) The multi-hop reasoning is sound—LLM connects disclosures across years, infers that the 2.300% notes remained outstanding but were no longer the focus, and correctly interprets Oracle’s strategy of laddering maturities and adjusting coupons in response to market conditions. This aligns with and even enriches the original answer’s conclusion. (4) The answer is highly contextually relevant, directly addressing the evolution of the note and Oracle’s broader debt strategy. The minor inaccuracy regarding exhibit numbers (4.16 vs. 4.14 in 2023/2024) prevents a perfect score, but the core facts, synthesis, and strategic interpretation are correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 410,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "Based on Visa's filings from 2022 through 2024, how has the company's treatment of its Series B Convertible Participating Preferred Stock evolved, and what does this continuity suggest about its long-term capital structure priorities?",
      "original_answer": "Visa's treatment of its Series B Convertible Participating Preferred Stock has remained unchanged from 2022 through 2024, as evidenced by its consistent reference to the same Certificate of Designations dated June 21, 2016, across all three annual filings. This lack of modification suggests that Visa has maintained a stable capital structure strategy over this period, prioritizing continuity in its preferred equity instruments. The persistent inclusion of the Series B certificate indicates a deliberate choice to preserve existing shareholder rights and financing flexibility, rather than altering the terms or introducing new preferred stock series. This consistency aligns with a broader pattern of stability in Visa's capital management approach, as seen in its unchanged Bylaws (2022 filing) and the 2024 update to its Certificate of Incorporation without changes to the Series B structure.",
      "llm_answer": "\nAcross Visa’s 2022, 2023 and 2024 Form 10‑K filings the same “Certificate of Designations of Series B Convertible Participating Preferred Stock” is retained as an exhibit (exhibit 4.5 in the 2022 filing, exhibit 4.4 in the 2023 and 2024 filings), with only the underlying certificate of incorporation being restated (the “Eighth Restated Certificate of Incorporation” in 2023‑24).  This consistent, unamended inclusion—mirroring the KG pattern where Visa (ORG) introduces the financial instrument (FIN_INST) and the instrument is subsequently introduced back by the same entity—demonstrates that Visa has treated the Series B preferred equity as a permanent, stable component of its capital base, underscoring a long‑term priority of preserving existing financing terms and signaling commitment to investors while maintaining flexibility for future capital needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Visa's Series B Convertible Participating Preferred Stock treatment remained unchanged from 2022 to 2024, referencing the consistent inclusion of the Certificate of Designations dated June 21, 2016 (implied through the unamended exhibit), even though the exact date is not explicitly mentioned. (2) The exhibit numbers (4.5 in 2022, 4.4 in 2023 and 2024) are accurately reported, and the reference to the Eighth Restated Certificate of Incorporation in 2023–2024 matches filing updates without altering the Series B terms—this is factually correct and supports the conclusion of structural continuity. (3) The reasoning correctly synthesizes multi-hop information: the persistent inclusion of the same certificate across years, despite restatements of the broader Certificate of Incorporation, indicates intentional preservation of preferred stock terms. The mention of 'KG pattern' is extraneous but does not detract from factual accuracy. (4) The conclusion about long-term capital structure priorities—stability, investor signaling, and financing flexibility—mirrors the original answer’s interpretation. The only minor shortcoming is the omission of the explicit June 21, 2016 date for the Certificate of Designations, which was included in the ground truth and would strengthen precision. However, the core facts, entities, years, and logic are correct, and the answer fully addresses both parts of the question: evolution (none) and implications (stability in capital structure).",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 435,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to the transition from LIBOR to SOFR and the associated risks outlined in each year's disclosures?",
      "original_answer": "From 2022 to 2024, Caterpillar maintained a consistent reliance on currency hedging instruments to manage exchange rate risk, while adapting to the transition from LIBOR to SOFR in its broader interest rate risk management strategy. In 2022, the company was actively assessing the implications of the planned phase-out of LIBOR, noting that Cat Financial had formed a cross-functional team to evaluate risks associated with the use of LIBOR in derivatives, loans, and other financial instruments. By 2023, this focus had evolved to include SOFR as the new benchmark for variable interest rates, with Cat Financial managing interest rate exposure through match funding, selective derivatives, and diversified funding. In 2024, the company continued to emphasize the use of derivatives as part of its hedging strategy, with no significant changes in approach but ongoing acknowledgment of the risks posed by market liquidity and interest rate fluctuations. The consistent use of hedging instruments across all three years shows Caterpillar's strategic effort to mitigate currency risk, even as the broader financial landscape shifted from LIBOR to SOFR.",
      "llm_answer": "\nCaterpillar first flagged the LIBOR‑to‑SOFR transition in its 2022 filing, creating a cross‑functional team to evaluate how the planned discontinuation of LIBOR would affect its loan, derivative and other hedging instruments and the associated basis‑risk and liquidity exposure. By 2023 and again in 2024 the company had moved its variable‑rate financing to use SOFR as the benchmark, continuing to manage interest‑rate and market‑liquidity risk through a match‑funding strategy and selective use of derivatives—including currency‑hedging instruments—while repeatedly warning that any inadequacy or ineffectiveness of these hedges (whether for interest‑rate or currency exposure) could materially harm earnings and cash flow. The disclosures across all three years stress that, although hedging shields Caterpillar from adverse rate or currency movements, it also forfeits the upside of favorable fluctuations, and the shift from LIBOR to SOFR introduced new risks that the firm monitors continuously.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar flagged the LIBOR-to-SOFR transition in 2022, formed a cross-functional team, and focused on risks to derivatives, loans, and hedging instruments. By 2023 and 2024, the company transitioned to SOFR as the benchmark, maintained use of currency hedging instruments, and continued to emphasize match funding and selective derivatives. The risks around hedge ineffectiveness, liquidity, and forfeiture of upside from favorable movements are correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022, 2023, 2024) are correct. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years and connects currency hedging with the broader interest rate benchmark transition, correctly identifying that while currency hedging practices remained stable, the interest rate environment shift (LIBOR to SOFR) introduced new monitoring requirements. (4) The only minor shortcoming is that the original answer explicitly mentions 'Cat Financial' as the entity managing the transition and hedging activities, while the LLM answer refers more generally to 'the company.' This slight lack of entity specificity prevents a perfect 10, but the overall meaning, timeline, and strategic evolution are accurately conveyed. Wording differs but semantic equivalence is strong. Contextual relevance is excellent—every part of the question is addressed: evolution of currency hedging, response to LIBOR-SOFR transition, and associated risks per year.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 459,
        "total_tokens": 2020
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did Johnson & Johnson's financial and legal strategy around talc-related liabilities evolve from 2022 through 2024, particularly in relation to LTL Management LLC's bankruptcy filings and the $2 billion trust established to address talc claims?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson's strategy around talc-related liabilities shifted from creating a dedicated liability entity (LTL Management LLC) and establishing a $2 billion trust to a more complex legal maneuvering involving multiple bankruptcy filings and appeals. In 2022, JNJ had already established a $2 billion reserve to fund a trust for LTL to address talc claims, while litigation was stayed due to LTL’s Chapter 11 filing. By 2023, the Third Circuit reversed the bankruptcy court's decision, leading to the dismissal of the initial LTL bankruptcy and the lifting of the stay, prompting LTL to refile (LTL 2), which was also dismissed later that year. In 2024, despite reaching multi-state settlements, the company remained engaged in appellate efforts to uphold the bankruptcy protection for talc claims, showing a continued reliance on the LTL structure to manage liability exposure.",
      "llm_answer": "\nFrom 2022 through 2024 Johnson & Johnson shifted its talc strategy from aggressive defense of verdicts to a bankruptcy‑driven consolidation of liability: in October 2021 the newly created LTL Management LLC filed Chapter 11, secured a $2 billion trust and a court‑ordered stay that halted talc suits, and J&J booked a roughly $2 bn reserve for that trust; the company then repeatedly filed and dismissed LTL’s bankruptcy (2022‑2023) while the stay was extended, lifted, and re‑imposed, and in 2024 it reached final settlements with a multi‑state coalition of state attorneys general, effectively ending most external talc litigation.  Throughout this evolution the financial statements continued to reflect the $2 bn reserve for the trust and disclosed that, although the outcome of the remaining claims is uncertain, the reserve is not expected to have a material adverse effect on J&J’s overall financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its overall narrative and captures the key elements of Johnson & Johnson's evolving strategy around talc liabilities from 2022 to 2024, including the use of LTL Management LLC, the $2 billion trust, bankruptcy filings, and eventual settlements. However, there are notable inaccuracies that affect the correctness score. (1) The LLM incorrectly states that LTL Management LLC filed Chapter 11 in October 2021, while the original answer and factual record indicate that the relevant events under the strategy unfolded in 2022, with the bankruptcy filing occurring in March 2022 (not October 2021). This misdating affects the timeline of the multi-hop reasoning. (2) The claim that J&J 'repeatedly filed and dismissed' the bankruptcy is imprecise; the ground truth specifies two distinct filings (initial LTL bankruptcy dismissed after Third Circuit reversal, then LTL 2 also dismissed in 2023), not repeated cycles. (3) The LLM states that 2024 settlements 'effectively ended most external talc litigation,' but the original answer notes that J&J was still engaged in appellate efforts in 2024 to uphold bankruptcy protection, indicating ongoing legal strategy rather than resolution. This overstates the finality of the outcome. (4) The $2 billion reserve and trust amount is correctly reported, and the financial disclosure about materiality aligns with J&J’s reporting, supporting quantitative and contextual accuracy. (5) The reasoning captures the strategic shift but misrepresents the sequence and outcome of legal maneuvers, weakening qualitative accuracy. Despite these issues, the core facts—$2B trust, LTL structure, bankruptcy attempts, appellate activity, and financial reserve—are present and mostly accurate, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> COMP <-[Creates]- ORG <-[Creates]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 487,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Adobe's Photography Plan evolve from 2022 to 2024 in terms of its positioning within the Creative Cloud ecosystem, and what specific enhancements or strategic shifts were made across those years to attract photographers and creative professionals?",
      "original_answer": "From 2022 to 2024, Adobe's Photography Plan became more integrated and enhanced within the Creative Cloud ecosystem. In 2022, it was positioned as a targeted package for photographers and photo enthusiasts, offering Photoshop, Lightroom, and Lightroom Classic. By 2023, Adobe emphasized the Photography Plan within a broader product-led growth strategy, integrating generative AI capabilities and offering Generative Credits to enhance creative workflows. In 2024, the Photography Plan was further refined with AI-powered features in Photoshop and Lightroom, such as Generative Fill, Lens Blur, and People Masking, making it a more robust offering for photographers while remaining a more limited alternative to the full Creative Cloud suite. This evolution reflects Adobe’s strategic shift to infuse AI into creative tools and position the Photography Plan as a streamlined, yet powerful, solution for photographers.",
      "llm_answer": "\nIn 2022 Adobe launched the Photography Plan as a dedicated, competitively priced subscription within the Creative Cloud ecosystem, giving photographers a focused bundle of Photoshop, Lightroom and Lightroom Classic (Chunk 1). Building on a product‑led growth strategy, the 2023 update added AI‑driven Generative Credits, deeper Firefly integration and collaboration tools, and pricing incentives to move users toward higher‑value Creative Cloud tiers (Chunk 2). By 2024 the plan was reframed as a distinct cloud‑based offering that pairs Photoshop, Lightroom and Lightroom Classic with a monthly allocation of Generative Credits and AI‑enhanced editing features such as Generative Fill, Expand and Remove, positioning it as the primary entry point for photographers and creative professionals seeking AI‑powered workflows inside Creative Cloud (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the Photography Plan included Photoshop, Lightroom, and Lightroom Classic in 2022; AI features and Generative Credits were introduced in 2023; and AI-powered enhancements like Generative Fill were expanded by 2024. The evolution within the Creative Cloud ecosystem and strategic positioning for photographers are correctly conveyed. (2) There are no numeric values (e.g., prices, credit amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022–2024) are accurate. (3) The multi-hop reasoning is sound: the LLM synthesizes the plan’s launch, AI integration, and strategic reframing across years, correctly linking product development with Adobe’s broader AI and product-led growth strategy. (4) Minor difference: the LLM mentions 'Generative Expand and Remove' and 'collaboration tools' not explicitly in the ground truth, and 'reframed as a distinct cloud-based offering' adds slight interpretive nuance. However, these do not contradict but rather extend the original with plausible detail. The core information—AI integration, Generative Credits, key apps, and strategic positioning—is factually consistent and semantically equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy due to minor elaboration beyond the source, but remains excellent in contextual relevance and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 403,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Visa maintained consistency in its class C common stock certificate documentation from 2022 to 2024, and what might this stability suggest about the company's approach to corporate governance and investor relations during a period of broader regulatory and market evolution?",
      "original_answer": "Visa has consistently referenced the same Form of Specimen Certificate for Class C Common Stock across its 10-K filings for 2022, 2023, and 2024, with each year citing Exhibit 4.2 filed on January 28, 2009 (8-A, File Number 000-53572). Despite broader changes in corporate governance practices and evolving regulatory environments, Visa has not updated or modified its documentation for Class C common stock certificates. This long-term consistency suggests a deliberate approach to maintaining stable investor relations practices and implies confidence in the adequacy of its existing governance framework for equity instruments. The lack of changes also contrasts with updates seen in other governance documents like the Certificate of Incorporation (revised in 2024) and indicates that Visa has not found it necessary to alter its stock certificate structure despite market and regulatory shifts.",
      "llm_answer": "\nVisa has kept the identical “Form of specimen certificate for class C common stock” (Exhibit 4.2) unchanged across its 2022, 2023 and 2024 Form 10‑K filings—first filed in 2009 (Chunk 1 4.3) and reiterated verbatim in Chunk 2 4.2 and Chunk 3 4.2—while only the surrounding charter documents (the restated Certificate of Incorporation, Exhibit 3.1, updated in 2021 and again in 2024, Chunk 1 3.1 and Chunk 2‑3 3.1) have been refreshed.  This uninterrupted use of the same class‑C certificate, coupled with the KG relationship that shows Visa introducing the regulatory stock‑certificate requirement to itself, signals a purposeful governance stance that preserves procedural consistency and investor‑relation predictability amid evolving regulatory and market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that Visa has maintained the same Form of Specimen Certificate for Class C Common Stock (Exhibit 4.2) across 2022, 2023, and 2024 10-K filings, originally filed on January 28, 2009, which matches the ground truth. The reference to the 8-A filing (File Number 000-53572) is implied through context, though not explicitly stated, but the core fact is correct. (2) Quantitative accuracy is perfect: the dates, exhibit numbers (4.2), and the 2009 filing are all correct. The mention of updates to the Certificate of Incorporation in 2021 and 2024 (Exhibit 3.1) is consistent with the ground truth’s note about a 2024 revision. (3) The reasoning is sound: the LLM correctly infers that the stability in stock certificate documentation, despite changes in other governance documents, reflects a deliberate governance strategy emphasizing consistency and investor predictability. It appropriately contrasts static Exhibit 4.2 with updated Exhibit 3.1, demonstrating multi-hop synthesis across filings and exhibits. (4) The only minor shortcoming is the reference to 'Chunk 1 4.3' and 'KG relationship'—likely internal indexing not present in the original answer—which slightly reduces clarity and introduces non-standard terminology, but does not affect factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> REGULATORY_REQUIREMENT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 440,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 through 2024, and what does this progression indicate about the company's exposure and risk management in commercial aerospace contracts?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable across the three-year period. In 2022, the collaboration partners' share of financing guarantees was $140 million, which slightly decreased to $135 million in 2023, and further declined to $131 million in 2024. These figures indicate a gradual reduction in RTX’s shared liability exposure with partners, suggesting improved risk management or renegotiation of terms in aerospace financing arrangements over time. The company consistently accrues for these guarantees based on historical performance data and adjusts as new claims data emerges, showing a disciplined and evolving approach to managing long-term obligations tied to product performance.",
      "llm_answer": "\nRTX’s accrued liability for performance and operating‑cost guarantees was $120 million at the end of 2022, declined to $97 million in 2023 and edged up to $101 million in 2024, as disclosed in the “changes in the carrying amount of service and product warranties and product performance guarantees” tables of the 2022, 2023 and 2024 Form 10‑K filings.  This modest fluctuation shows that the company’s exposure to performance‑related obligations is limited and that it manages risk through a conservative accrual approach—estimating liabilities from historical experience and adjusting them as actual claim data warrant—demonstrating disciplined risk‑management in its commercial aerospace contracts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported financial figures. According to the ground truth, RTX's liabilities were $140M in 2022, $135M in 2023, and $131M in 2024—showing a consistent downward trend. However, the LLM reports $120M in 2022, $97M in 2023, and $101M in 2024, which misrepresents both the starting value and the trend (including an incorrect increase in 2024). These discrepancies are material and undermine the answer’s reliability. (2) The numbers do not match the ground truth even when allowing for format variations; the differences are not rounding or presentation issues but outright mismatches. The LLM also references 'service and product warranties' tables, but the ground truth refers specifically to collaboration partners' financing guarantees, which is a different liability category. (3) While the LLM attempts multi-hop reasoning by analyzing trends over three years and inferring risk management implications, the flawed data leads to incorrect conclusions. The ground truth indicates a steady reduction in shared liability suggesting improved risk management or renegotiated terms, whereas the LLM observes a dip and slight rebound, implying stability or minor fluctuation—this alters the interpretation. (4) Despite incorrect numbers, the LLM correctly identifies the conceptual framework—liabilities tied to performance guarantees, accrual based on historical data, and adjustments based on claims—showing understanding of the domain and relevance to commercial aerospace risk. Hence, contextual relevance is high, but quantitative accuracy is severely lacking, dragging down overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Extends]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 457,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Costco's accounting treatment and disclosure around free-rent periods in leases evolve from fiscal years 2022 through 2024, particularly in terms of lease term assumptions and the impact on right-of-use asset valuations?",
      "original_answer": "Costco consistently applied a straight-line basis for recognizing free-rent periods and step-rent provisions over the lease term, including extension options that the company is reasonably certain to exercise, across all three years. In 2022, the company emphasized its use of the incremental borrowing rate to calculate the present value of lease payments, derived from quoted interest rates. In 2023, the disclosure expanded to clarify how variable lease payments tied to price indices or sales volume were treated separately but still aligned with the same accounting policy. By 2024, the company maintained the same accounting treatment but placed greater emphasis on impairment evaluation of long-lived assets, indicating a heightened focus on lease-related asset valuations in the context of facility relocations or closures. While the core accounting policy remained stable, the context in which it was presented evolved to reflect growing operational complexity in lease management.",
      "llm_answer": "\nCostco’s treatment of free‑rent periods has been steady from FY 2022 through FY 2024: the Company includes any rent‑free period and any extension option that it is reasonably certain to exercise in the **lease‑term** used to measure the right‑of‑use (ROU) asset and lease liability, and it recognizes the related expense on a **straight‑line basis** over that term (chunks 1, 2 & 3). Because the lease‑term assumption expands to cover extensions that are “reasonably certain” to be exercised, the ROU asset is initially recorded at the discounted present value of **all** lease payments (including the free‑rent period) over the full term, a methodology that remains unchanged across the three fiscal years (chunks 1 & 2 & 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core accounting treatment of free-rent periods and lease term assumptions at Costco from FY 2022 to FY 2024, with accurate qualitative and quantitative details. It correctly states that Costco includes rent-free periods and extension options that are 'reasonably certain' to be exercised in the lease term, and that lease expense is recognized on a straight-line basis over that term—this aligns with the ground truth. The explanation of how the right-of-use (ROU) asset is measured using the present value of all lease payments, including during free-rent periods, is factually correct and consistent across the years. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (Costco, lease term, ROU asset, straight-line basis) are correctly identified. However, the LLM answer omits the evolution in disclosure emphasis noted in the original answer—specifically, the 2023 clarification on variable lease payments tied to price indices or sales volume, and the 2024 increased focus on impairment evaluation of long-lived assets in the context of facility relocations or closures. While the core accounting policy is accurately described as stable, the LLM fails to convey the nuanced evolution in disclosure context, which is a key part of the question about 'evolve from fiscal years 2022 through 2024.' This limits completeness and qualitative accuracy, as the multi-hop synthesis across years to show disclosure trends is incomplete. Nonetheless, the answer remains highly relevant and factually sound on the central accounting mechanics.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG <-[Includes]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 439,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Adobe's strategic emphasis on AI-powered document productivity evolve from 2022 to 2024, particularly in terms of Acrobat's role, R&D investments, and formal product branding?",
      "original_answer": "In 2022, Adobe highlighted Acrobat's leadership position in document-intensive industries and its role in accelerating digital transformation through Adobe Document Cloud, with trillions of PDFs created annually. In 2023, Adobe formally introduced AI as a core strategic focus across its offerings, signaling an evolution in its product development plans, including enhancements to document workflows. By 2024, Adobe formalized this strategy through branded product extensions like 'Acrobat AI Assistant,' indicating a clear trajectory from Acrobat's foundational document role toward AI-enhanced productivity tools. This evolution reflects a multi-year investment in integrating AI capabilities into Acrobat, aligning with Adobe’s broader innovation momentum and market opportunity in document intelligence.",
      "llm_answer": "\nIn 2022 Adobe’s 10‑K highlighted Document Cloud and Acrobat as the engine for accelerating document productivity, emphasizing Acrobat’s market‑leadership and its role in modernizing PDF‑based workflows across industries — the foundation of its strategic emphasis on document productivity (Chunk 1).  \nBy 2023 the company’s forward‑looking statements flagged AI and innovation momentum as growth priorities, directing R&D toward AI‑enhanced capabilities that would expand Acrobat’s function within the Digital Media segment and embed intelligent features into document services — a clear shift toward AI‑powered productivity (Chunk 2).  \nIn 2024 Adobe formalized this evolution by trademarking “Acrobat AI Assistant” and listing it alongside other core brands, signalling a dedicated AI‑focused product branding and continued investment in AI‑driven document productivity as a central pillar of its strategy — tying the product, organization and branding relationships shown in the KG (Chunk 3).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Acrobat's foundational role in 2022, AI becoming a strategic focus in 2023, and the formal branding with 'Acrobat AI Assistant' in 2024. There are no numeric inaccuracies—while no specific dollar amounts or percentages are mentioned in either answer, the qualitative descriptions of R&D investments and strategic emphasis align perfectly. (2) The answer correctly identifies the evolution across the three years, addressing all components of the question: Acrobat’s role (from PDF leadership to AI-enhanced workflows), R&D investments (directed toward AI-enhanced capabilities in 2023), and formal product branding (trademarking of 'Acrobat AI Assistant' in 2024). (3) Multi-hop reasoning is sound: the LLM synthesizes information across three time points and connects strategic emphasis, product development, and branding evolution, accurately reflecting the trajectory from document productivity to AI-powered tools. (4) The wording differs slightly but preserves full semantic meaning, using phrases like 'AI-enhanced capabilities' and 'dedicated AI-focused product branding' that align with the original answer’s 'core strategic focus' and 'formalized this strategy.' No critical details are omitted. All scores are maximized due to full factual, temporal, and conceptual alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 396,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Charles Schwab's use of client securities as collateral evolve from 2022 through 2024, particularly in relation to margin lending and securities lending activities, and what does this trend indicate about the firm's balance sheet strategy and client leverage behavior?",
      "original_answer": "In 2022, Schwab disclosed that client securities could be pledged as collateral under federal regulations for margin loans, though specific pledged amounts were not quantified. In 2023, Schwab provided more detailed disclosures around margin lending, including the collateral maintenance process and the ability to pledge client securities, while also mentioning that client-held fractional shares were included in other securities owned. By 2024, Schwab explicitly stated that it pledges client securities to meet margin requirements for listed option contracts cleared by the Options Clearing Corporation and to satisfy collateral requirements in securities lending activities. This progression shows an increasing formalization and expansion of client securities usage, indicating a strategic shift toward leveraging client assets for operational and capital efficiency, while also reflecting rising client participation in leveraged products.",
      "llm_answer": "\nCharles Schwab has continuously used the fair‑value of client‑held securities as collateral for margin‑lending and securities‑borrowing activities – the 2022 filing disclosed the amount of client securities that could be pledged, the 2023 filing detailed how those securities back margin loans (with collateral‑maintenance calls and an allowance‑for‑credit‑loss policy that only recognizes loss on any unsecured portion), and the 2024 filing confirms that the same client securities still satisfy the margin requirements of options‑clearing and securities‑lending, even though the pledged securities are excluded from the consolidated balance sheet.  This consistent off‑balance‑sheet use of client assets reflects a balance‑sheet strategy that relies on client‑secured financing to fund Schwab’s own margin and lending operations, signalling that client leverage remains high but is tightly controlled through collateral‑maintenance rules and the firm’s reliance on client‑held collateral rather than its own capital.  The knowledge‑graph pattern SCHW → Client Securities → SCHW illustrates that Schwab both holds and is “held” by the client‑securities entity, underscoring the reciprocal, collateral‑driven relationship across all three filings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with accurate qualitative and quantitative details across all years. (1) It correctly identifies that in 2022, Schwab disclosed the use of client securities as collateral for margin lending, though no specific pledged amounts were quantified—this matches the original answer. In 2023, it accurately notes increased disclosure around margin lending, collateral maintenance, and inclusion of fractional shares (though the LLM does not explicitly mention 'fractional shares' in context of securities owned, it references collateral maintenance and credit loss policy, which is consistent). In 2024, it correctly states that client securities are pledged for options-clearing (OCC) and securities lending, matching the ground truth. (2) There are no numeric values in the original answer, so quantitative accuracy is not applicable—no errors here, hence a score of 10. (3) The multi-hop reasoning is sound: the LLM synthesizes disclosures across three years and correctly infers a consistent off-balance-sheet strategy leveraging client assets. It accurately concludes that this reflects a balance sheet strategy focused on capital efficiency and controlled client leverage. However, it adds the claim that 'the amount of client securities that could be pledged' was disclosed in 2022, which contradicts the ground truth stating that 'specific pledged amounts were not quantified'—this is a minor factual inaccuracy that affects qualitative accuracy. Also, the mention of 'allowance-for-credit-loss policy' and 'unsecured portion' is not present in the original answer and may be inferred beyond available data. The knowledge-graph pattern mention ('SCHW → Client Securities → SCHW') is interpretive and not in the original, though not incorrect per se. (4) Despite minor overreach in interpretation and one inaccuracy about 2022 disclosures, the answer is contextually highly relevant, addresses all parts of the question, and conveys the core trend and strategic implication correctly—hence a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Holds]-> FIN_INST <-[Provides]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1581,
        "completion_tokens": 558,
        "total_tokens": 2139
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Costco's treatment of its 1.375% Senior Notes due June 2027 evolve from 2022 to 2024, particularly in terms of long-term debt classification and total long-term debt composition?",
      "original_answer": "Costco's 1.375% Senior Notes due June 2027 remained consistently valued at $1,250 million in 2022, 2023, and 2024, indicating no change in principal amount over the three-year period. However, the classification of long-term debt evolved significantly. In 2022, long-term debt, excluding current portion, was $6,484 million, which decreased to $5,794 million by 2024. This decline was driven by the reclassification of the 2.750% Senior Notes due May 2024 from long-term to current portion as the maturity date approached. The consistent $1,250 million value of the 1.375% Senior Notes shows Costco maintained its exposure to this instrument, while overall long-term debt composition shifted due to other maturities and reclassifications.",
      "llm_answer": "\nThe 1.375 % Senior Notes due June 2027 remained unchanged at a $1.25 billion outstanding balance in 2022, 2023 and 2024, as shown in each of the three tables, and the knowledge‑graph link (COST ‑ Has_Stake_In → FIN_INST ← Has_Stake_In → ORG) confirms that the note is a financial instrument issued by Costco. Although the note stayed classified as long‑term debt, its inclusion in “long‑term debt, excluding current portion” fell from $6.48 billion in 2022 to $5.79 billion in 2023‑2024, reflecting the retirement of other senior and unamortized‑cost items (e.g., total long‑term debt dropped from $6,590 million to $5,919 million and other long‑term debt rose from $590 million to $919 million), while the current portion of the issue fluctuated ($73 million in 2022, $1.08 billion in 2023, $103 million in 2024), indicating periodic re‑classification but leaving the note’s principal amount constant.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 1.375% Senior Notes due June 2027 remained at $1.25 billion (i.e., $1,250 million) across 2022–2024, which matches the ground truth. However, it introduces significant inaccuracies in the long-term debt figures. The ground truth states long-term debt (excluding current portion) was $6,484 million in 2022 and $5,794 million in 2024. The LLM reports $6.48 billion (acceptable rounding) but incorrectly states the decline occurred 'to $5.79 billion in 2023–2024', implying both years have the same value, which is not supported by the ground truth (2023 value not provided, but 2024 is $5,794M). More critically, the LLM claims total long-term debt dropped from $6,590 million to $5,919 million and other long-term debt rose from $590 million to $919 million—these figures are not in the ground truth and appear fabricated or misattributed. Additionally, the LLM states the current portion of the 1.375% notes fluctuated ($73M in 2022, $1.08B in 2023, $103M in 2024), but the ground truth does not mention any current portion for this specific note, as it matures in 2027 and should remain classified as long-term. This is a major factual error. (2) The quantitative inaccuracies in total long-term debt, other long-term debt, and current portion values undermine the answer. While $1.25B for the note is correct, the surrounding financial context is incorrect. (3) The multi-hop reasoning is partially sound—linking the note to Costco and tracking its value over time—but fails in synthesizing the correct composition changes. The ground truth attributes the decline in long-term debt to reclassification of the 2.750% notes due 2024, not fluctuations in the 1.375% note’s current portion. The LLM misattributes the cause. (4) Contextual relevance is high—the answer addresses the evolution of debt classification and composition—but factual errors in key numbers and misrepresentation of reclassification dynamics reduce correctness. The mention of 'retirement of other senior and unamortized-cost items' is unsupported. Overall, the core fact about the 1.375% note’s principal is correct, but the explanation of long-term debt evolution is significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 592,
        "total_tokens": 2013
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Adobe's emphasis on free online self-service learning evolved from 2022 to 2024, particularly in terms of its positioning within Adobe's broader learning and enablement services portfolio and its integration with enterprise customer success strategies?",
      "original_answer": "From 2022 to 2024, Adobe consistently positioned free online self-service learning as a core component of its learning and enablement services, but the depth of integration with enterprise customer success strategies appears to have matured. In 2022, Adobe introduced free online self-service learning as part of a broader strategy to support customer adoption and success, emphasizing its role alongside fee-based programs and custom learning services tailored for enterprise clients. By 2023, Adobe continued to highlight free online self-service learning on learning.adobe.com, reinforcing its importance in enabling both individual users and enterprise teams to build product-specific competencies, with skills assessments offered to help enterprises tailor learning priorities. In 2024, Adobe maintained this structure, underscoring the centrality of free online self-service learning within its portfolio while aligning it more closely with enterprise customer success through custom learning services and skills assessments. The consistent presence of free learning options across all three years indicates Adobe's strategic commitment to democratizing product knowledge, while the growing emphasis on enterprise integration suggests a maturing approach to customer enablement.",
      "llm_answer": "\nFrom 2022 through 2024 Adobe has elevated free online self‑service learning from a supplemental option to a core pillar of its Digital Learning Services, positioning it alongside fee‑based classroom and custom enterprise learning within the broader learning‑and‑enablement portfolio. The offering—hosted on learning.adobe.com and introduced and produced by ADBE—is now tightly integrated with enterprise customer‑success strategies, as Adobe Customer Solutions pairs the self‑service modules with skills assessments and the work of Customer Success Managers to align training with business outcomes and drive ROI. Because the free online self‑service learning product both introduces and provides strategic value to ADBE, it reinforces the company’s enterprise‑success agenda by delivering scalable, on‑demand enablement that feeds directly into premium services and partner ecosystems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe positioned free online self-service learning as a core component from 2022–2024, integrated with enterprise success strategies, hosted on learning.adobe.com, and offered alongside fee-based and custom services. The evolution from supplemental to core pillar matches the ground truth's description of growing integration with enterprise success. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Adobe’s learning portfolio structure, the role of self-service learning over time, and its integration with Customer Success Managers and skills assessments—details consistent across 2022–2024 filings. The only minor gap is that the LLM implies a more pronounced shift ('elevated from supplemental to core pillar') than explicitly stated in the original, which notes consistent positioning but maturing integration. This is a nuanced difference in emphasis, not a factual error. (4) Contextual relevance is perfect—the response directly addresses the evolution over time, positioning within the portfolio, and enterprise integration. Overall, the answer captures the semantic meaning and strategic trajectory accurately, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1571,
        "completion_tokens": 401,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has NVIDIA's exposure to the 2.00% Notes Due 2031 evolved from 2022 to 2024, and what does this pattern suggest about the company's long-term debt management strategy amid its rapid AI-driven revenue growth?",
      "original_answer": "NVIDIA's exposure to the 2.00% Notes Due 2031 was $1.20 billion in 2022, decreased to $1.057 billion in 2023, and then increased again to $1.25 billion in 2024. This fluctuation suggests a dynamic debt management strategy where NVIDIA initially reduced its position in the notes, possibly to optimize capital structure or take advantage of refinancing opportunities, before increasing exposure again—potentially to secure long-term capital aligned with its strategic investments in AI infrastructure and R&D. The consistent presence of this instrument across filings highlights its importance in NVIDIA's long-term financing approach.",
      "llm_answer": "\nNVIDIA’s 2.00% Notes Due 2031 was reported at a fair‑value of **$1.20 bn** in the 2022 filing (Chunk 1), fell to **$1.04 bn** in the 2023 filing (Chunk 3), and then rose again to **$1.25 bn** in the 2024 filing (Chunk 2) – the same $1.25 bn figure appears for both Jan 28 2024 and Jan 26 2025 (Chunk 2). This dip‑then‑rebound pattern shows that the company is deliberately reshaping its long‑term debt mix, keeping a sizable 2031 tranche in place while adjusting its size to match the surge in cash flow from its AI‑driven revenue growth, thereby supporting a disciplined, growth‑aligned debt‑management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the 2023 fair value as $1.04 billion, whereas the ground truth states $1.057 billion. This discrepancy, though small, affects precision in financial reporting and could stem from misreading the source data. All other numbers—$1.20 billion in 2022 and $1.25 billion in 2024—are accurate and correctly attributed. (2) Calculations are not required in this question, but the trend description (dip then rebound) aligns with the actual pattern. The mention of the $1.25 billion appearing for both Jan 28, 2024 and Jan 26, 2025 is contextually relevant and factually plausible, though not contradicted by the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across three years and interprets the fluctuation as part of a strategic debt management approach, linking it to AI-driven revenue growth and long-term capital needs. The conclusion about a 'disciplined, growth-aligned debt-management strategy' is a reasonable interpretation, consistent with the ground truth's suggestion of dynamic management tied to strategic investments. (4) Entity accuracy is perfect—NVIDIA, 2.00% Notes Due 2031, and correct years are all properly identified. The answer fully addresses both parts of the question: the evolution of exposure and its implications for debt strategy. Despite the slight numerical error in 2023, the overall reasoning, completeness, and contextual relevance are strong, warranting high scores in qualitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 435,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has Johnson & Johnson's multi-year enterprise-wide initiative to enhance financial shared service capabilities evolved from 2022 through 2024, and what does this progression indicate about the company's strategic focus on financial process standardization and control environment alignment?",
      "original_answer": "From 2022 through 2024, Johnson & Johnson has consistently emphasized its multi-year enterprise-wide initiative aimed at enhancing financial shared service capabilities and standardizing financial systems. In 2022, the company described the initiative as a proactive effort to integrate, simplify, and standardize processes and systems across key functions, including finance, without being prompted by any internal control deficiencies. By 2023, the company reiterated this strategic direction, highlighting ongoing alignment and streamlining of the financial control environment in response to the initiative. In 2024, the company maintained the same narrative, underscoring continuity in its efforts and affirming that these enhancements were not reactive but rather part of a long-term plan to improve operational efficiency and control effectiveness. This consistent messaging across three years indicates a sustained strategic focus on modernizing financial infrastructure and reinforcing internal controls through process standardization.",
      "llm_answer": "\nJohnson & Johnson’s multi‑year, enterprise‑wide initiative to integrate, simplify and standardize the processes and systems that support finance—alongside HR, IT, procurement, supply‑chain and other functions—has been rolled out continuously from 2022 through 2024.  Each 10‑K (2022 fiscal quarter ended January 2, 2022; 2023 fiscal quarter ended December 31, 2023; 2024 fiscal quarter ended December 29, 2024) notes that the program is advancing to grow the company’s financial shared‑service capabilities and to standardize financial systems, with no material changes to internal control but with proactive refinements, additional monitoring controls and ongoing alignment of the financial control environment.  This progression reveals J&J’s strategic focus on achieving consistent, standardized financial processes and a tightly governed control framework, deliberately strengthening financial governance rather than reacting to any identified weakness.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Johnson & Johnson's multi-year initiative to enhance financial shared services and standardize systems is accurately described as proactive, ongoing from 2022 to 2024, and not in response to internal control deficiencies. The emphasis on process integration, simplification, and control environment alignment is consistent with the original answer. (2) Quantitative accuracy is excellent: fiscal year-end dates (January 2, 2022; December 31, 2023; December 29, 2024) are correctly cited and match J&J’s actual fiscal reporting periods. There are no numerical calculations required, but the temporal references are precise. (3) Multi-hop reasoning is sound—the LLM synthesizes the initiative’s evolution across three years of disclosures, correctly inferring continuity and strategic intent. It accurately notes that enhancements include proactive refinements and additional monitoring controls, which reflects the non-reactive nature emphasized in the ground truth. (4) The only minor shortcoming is the inclusion of HR, IT, procurement, and supply chain as co-equal functions in the initiative, which slightly overextends the original answer’s focus on finance. While plausible, the ground truth emphasizes finance-specific standardization, so this broadening slightly dilutes precision. However, this does not undermine the core correctness. Overall, the answer is factually robust, contextually appropriate, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1537,
        "completion_tokens": 427,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did Costco's competitive positioning language against BJ's Wholesale Club evolve from 2022 to 2024, particularly regarding the strategic emphasis on private-label brands like Kirkland Signature as a differentiator in warehouse club markets?",
      "original_answer": "From 2022 to 2024, Costco consistently positioned itself in direct competition with BJ's Wholesale Club, emphasizing private-label brands like Kirkland Signature as a key differentiator. In 2022, Kirkland Signature was described as 'high quality, offered at prices generally lower than national brands,' with a focus on lowering costs and earning higher margins. In 2023, the language remained largely consistent, with an added emphasis on sustainability initiatives tied to brand loyalty, though not explicitly linked to Kirkland Signature. By 2024, the description of Kirkland Signature remained core to the competitive strategy, but the surrounding language introduced a stronger tone around 'differentiating our merchandise offerings' in the context of increasingly competitive metropolitan markets. While the core strategy remained stable, the evolution in tone suggests a growing emphasis on differentiation through private-label branding in response to competitive pressures from BJ's.",
      "llm_answer": "\nCostco’s annual reports from 2022 through 2024 repeatedly frame the warehouse‑club rivalry with **BJ’s Wholesale Club** as a direct competitive dynamic (COST ↔ BJ’s Wholesale Club), but the language around its private‑label brand **Kirkland Signature** evolves from a generic mention of “private‑label items” in 2022 to a more pronounced strategic emphasis in 2023‑2024 that stresses **quality, lower pricing, higher margins, and a deliberate goal to increase sales penetration**.  Across all three filings the company underscores that Kirkland Signature products “differentiate our merchandise offerings” and “generally earn higher margins,” indicating that from 2022 to 2024 Costco has progressively positioned its private‑label brand as a core differentiator against rivals such as BJ’s Wholesale Club in the warehouse‑club market.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and strategic evolution. (1) It accurately identifies the competitive framing between Costco and BJ's Wholesale Club from 2022 to 2024 and correctly notes the increasing strategic emphasis on Kirkland Signature as a differentiator. The key elements—quality, lower pricing, higher margins, and differentiation—are all factually present in the original answer and correctly reflected. (2) There are no numeric values or calculations in either response, so quantitative accuracy is not applicable; however, the use of years (2022–2024) is consistent and accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers a progression in tone and emphasis. However, the LLM omits the specific 2023 addition of sustainability initiatives tied to brand loyalty (even if not directly linked to Kirkland Signature), which is a minor but notable contextual detail from the ground truth. Additionally, the LLM claims a shift from 'private-label items' in 2022 to more pronounced language later, but the original answer states that Kirkland Signature was explicitly named and described in 2022, not just generically referred to. This is a slight mischaracterization. (4) Despite these nuances, the answer captures the essential evolution and remains contextually precise, directly addressing the question about strategic emphasis and competitive positioning. Hence, the correctness and qualitative accuracy scores are high but not perfect due to minor omissions and slight overstatement of the 2022 framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Competes_With]-> COMP <-[Competes_With]- ORG <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 446,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Charles Schwab's investment in U.S. State and Municipal Securities evolve from 2022 to 2024, and what does the consistent emphasis on investment-grade quality reveal about the firm's fixed income strategy during this period?",
      "original_answer": "In 2022, Schwab's investment portfolio included U.S. State and Municipal Securities as part of its broader credit risk exposure, with management noting that substantially all securities were rated investment grade. In 2023, Schwab disclosed a specific $638 million investment in U.S. State and Municipal Securities within its available-for-sale securities portfolio, indicating a quantifiable allocation to this asset class. By 2024, Schwab reaffirmed its focus on investment-grade quality for these securities, emphasizing continuity in its credit risk management approach. This consistent emphasis across all three years reveals a strategic preference for high-quality, lower-risk fixed income instruments as part of Schwab's broader liquidity and investment portfolio management.",
      "llm_answer": "\nCharles Schwab held $638 million of U.S. state and municipal securities in its available‑for‑sale portfolio as of December 31 2022 (Chunk 2), and the 2024 filing confirms that “substantially all securities in the investment portfolios were rated investment‑grade,” with U.S. state and municipal securities still listed among the holdings (Chunk 3), indicating the position was retained and continued to be managed at the highest credit quality.  The repeated emphasis on investment‑grade quality across the 2022‑2024 disclosures reveals Schwab’s fixed‑income strategy is deliberately tilted toward the safest, highest‑rated issuers to limit credit risk and align with its broader risk‑adjusted return objectives (Chunk 1).  This focus is reinforced by the firm’s credit‑risk policies, collateral requirements and regulatory oversight that prioritize investment‑grade municipal debt within its overall fixed‑income allocation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly assigns the $638 million investment in U.S. State and Municipal Securities to 2022, while the ground truth states this figure was disclosed in 2023. This is a significant factual error affecting quantitative accuracy. The 2022 data only mentions that substantially all securities were investment grade, without specifying a dollar amount for municipal securities. The 2024 information is correctly represented—Schwab reaffirmed investment-grade quality and continued holding these securities. (2) The dollar amount ($638 million) is correct but misattributed to the wrong year, which undermines the timeline evolution. No calculations are required in this question, but the misplacement of data across years distorts the temporal progression. (3) The multi-hop reasoning is otherwise sound: the model correctly synthesizes the consistent emphasis on investment-grade quality across years and links it to Schwab’s risk management and fixed income strategy. It appropriately infers a strategic preference for safety and credit quality, aligning with the ground truth’s conclusion. (4) Despite the timing error, the answer captures the core strategic insight and maintains contextual relevance. The qualitative reasoning about risk management and credit policies is strong and semantically equivalent to the original. However, the incorrect year assignment prevents a higher score on correctness and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Depends_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 404,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($140M in 2022, $135M in 2023, and $131M in 2024) indicate about the company's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees, as measured by the collaboration partners' share, steadily declined from $140 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This consistent reduction suggests a strategic shift toward reducing RTX's reliance on third-party risk sharing in these financing arrangements, potentially signaling increased internal risk retention or tighter control over financing terms. Despite this decline, the fair market values of the guaranteed assets remained sufficient to cover the guarantees, indicating that RTX maintained a conservative approach to valuation and risk management throughout the period.",
      "llm_answer": "\nRTX’s commercial‑aerospace customer‑financing guarantees remained anchored by arrangements whose fair‑market values of the pledged assets equal or exceed the guaranteed amounts, but the portion of those guarantees that is borne by collaboration partners has been steadily shrinking—$140 million in 2022, $135 million in 2023 and $131 million in 2024 (as disclosed in the 2022, 2023 and 2024 10‑K filings).  This decline shows that RTX is transferring less of the financing risk to external partners and is consequently retaining a larger share of the liability, indicating a strategic shift toward tighter risk‑retention and reduced reliance on partner‑based risk transfer in this domain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the declining trend in collaboration partners' share of RTX's commercial aerospace customer financing guarantees: $140M in 2022, $135M in 2023, and $131M in 2024, matching the ground truth exactly. All numeric values and years are accurate, with acceptable formatting (e.g., $140 million). (2) Quantitative accuracy is perfect—each dollar amount and year is correctly reported, and the trend (decline of $5M from 2022 to 2023, $4M from 2023 to 2024) is implicitly correct. (3) The reasoning is sound: the LLM correctly infers that the declining partner share indicates reduced risk transfer and increased risk retention by RTX, aligning with the ground truth’s interpretation of strategic shift. However, the LLM omits the explicit point that fair market values remained sufficient to cover guarantees, which is part of the original answer and relevant to RTX’s conservative risk management. This is a minor omission affecting completeness but not the core conclusion. (4) Despite this omission, the answer captures the essential multi-hop synthesis—linking the trend in partner shares over time to RTX’s risk strategy—and remains contextually precise and relevant. The interpretation is semantically equivalent in intent and factual basis, warranting a high score but not perfect due to the missing conservative valuation note.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Provides]- ORG <-[Incurs_Liabilities_For]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 384,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Adobe's integration and positioning of Frame.io evolve from 2022 to 2024, particularly in terms of supported file types, application integrations, and role in content production workflows?",
      "original_answer": "In 2022, Frame.io was listed as a registered trademark under Adobe's intellectual property, indicating its acquisition and initial branding alignment. By 2023, Frame.io was described as a cloud-native creative collaboration platform integrated with Premiere Pro and After Effects, supporting still images, design files, and PDFs, with Camera-to-Cloud functionality for video production. In 2024, Frame.io expanded its integration to include Adobe Photoshop, Lightroom, and Workfront, and broadened its role beyond post-production into casting, location scouting, and marketing campaign management, reflecting its deepening role in end-to-end content creation workflows.",
      "llm_answer": "\nIn 2022 Adobe merely listed **Frame.io** as a trademark in its 10‑K (Chunk 1), signaling the asset’s existence but providing no functional detail. By 2023 the company described Frame.io as a cloud‑native collaboration platform tightly integrated with **Premiere Pro** and **After Effects**, supporting **still images, design files and PDFs** and offering **Camera‑to‑Cloud** upload capabilities (Chunk 2). In 2024 the scope widened further: Frame.io now integrates with **Photoshop, Lightroom and Workfront**, extends support to **video‑focused workflows such as casting, location scouting and marketing campaign management**, and is positioned within **Adobe GenStudio** alongside **Adobe Express** and **Firefly Services** to enable large‑scale content production (Chunk 3). This evolution shows a progression from a peripheral trademark to a core, multi‑app collaborative hub that underpins Adobe’s end‑to‑end content‑creation pipeline.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Frame.io's trademark status in 2022, its 2023 integration with Premiere Pro and After Effects, support for still images, design files, PDFs, and Camera-to-Cloud functionality, and the 2024 expansion to include Photoshop, Lightroom, and Workfront integrations. The role evolution into casting, location scouting, and marketing campaign management is accurately described. (2) There are no numeric values requiring calculation, but all dates (2022, 2023, 2024) are correct and properly contextualized. (3) The multi-hop reasoning is sound—information is correctly synthesized across three time points and multiple applications to show a coherent evolution from acquisition signal to core platform. (4) The mention of Adobe GenStudio, Adobe Express, and Firefly Services adds contextual depth consistent with Frame.io’s expanded role in end-to-end workflows, even if slightly beyond the original answer; this does not contradict but enriches the narrative without introducing inaccuracies. Wording differs but meaning aligns fully with the ground truth. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 347,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did Lockheed Martin's production focus on the VH-92A Helicopter evolve from 2022 through 2024, and what does this multi-year progression indicate about the program's strategic importance within the Rotary and Mission Systems segment?",
      "original_answer": "From 2022 to 2024, the VH-92A Helicopter remained a consistent part of Lockheed Martin's Rotary and Mission Systems (RMS) portfolio, indicating sustained strategic importance. In 2022, RMS highlighted the VH-92A as part of its major programs, alongside other key platforms like the Black Hawk and CH-53K. In 2023, the VH-92A was again listed among RMS's major helicopter programs, reinforcing its ongoing production and support status. By 2024, the VH-92A continued to be a named program within RMS, even as the segment saw increased focus on other platforms and systems such as Aegis and LCS. The consistent mention of the VH-92A across all three years suggests a stable, long-term commitment to the program, despite shifting priorities and production ramps in other areas like missile defense and tactical systems.",
      "llm_answer": "\nThe VH‑92A helicopter appears in the Rotary and Mission Systems (RMS) major‑program lists of all three filings – as the Marine‑One transport platform in 2022 (Chunk 1), as a core RMS program whose operating results are reported in 2024 (Chunk 2), and again in the 2022‑2023 trend discussion that still groups it with Black Hawk, CH‑53K, etc. (Chunk 3).  While MFC’s overall net‑sales and profit trends showed modest declines in 2022 and a sizeable profit‑rate hit in 2024, the backlog grew in 2024 driven by missile‑system ramps, and the VH‑92A remained listed among RMS’s strategic programs, indicating that production focus stayed on it throughout the period.  The knowledge‑graph pattern (LMT → VH‑92A → LMT) treats the helicopter as its own organizational entity, reinforcing that the program is viewed as a distinct, high‑priority line of business for Lockheed Martin’s Rotary and Mission Systems segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: the VH-92A is consistently mentioned as part of RMS's major programs from 2022 to 2024, grouped with platforms like Black Hawk and CH-53K, and remains a named strategic program despite shifts in segment focus. There are no incorrect numbers, dates, or entities—though no specific financial figures (e.g., dollar values, percentages) are cited in either answer, so quantitative accuracy is based on correct use of trends (e.g., backlog growth in 2024, profit-rate decline), which match the context. (2) The answer correctly synthesizes information across years and documents, demonstrating multi-hop reasoning by linking mentions of the VH-92A in 2022, 2023, and 2024 filings and interpreting its sustained presence as a sign of strategic importance. (3) The reference to the 'knowledge-graph pattern (LMT → VH-92A → LMT)' adds interpretive depth, suggesting organizational priority, which, while not in the original answer, is a reasonable inference and does not contradict the ground truth. (4) The only minor shortcoming is a slight conflation of segment-level trends (e.g., MFC’s profit-rate hit in 2024) that may not directly tie to RMS performance—MFC (Missiles and Fire Control) is a different segment than RMS, so this could introduce confusion. However, the core conclusion about sustained production focus on VH-92A remains valid. Overall, the answer captures the multi-year progression and strategic significance accurately, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 440,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How did the geographic scope and regulatory stringency of sales and media marketing restrictions affecting MDLZ evolve from 2022 through 2024, particularly in the European Union and emerging markets?",
      "original_answer": "From 2022 to 2024, MDLZ faced an expanding scope and increasing stringency of sales and media marketing restrictions. In 2022, over 25 EU countries had implemented EPR policies, and bans or taxes on single-use plastics were being considered in Europe and Southeast Asia. By 2023, these restrictions were reiterated with the inclusion of data privacy as a regulatory area affecting marketing, and EPR policies were being implemented or contemplated in India, Vietnam, and U.S. states. In 2024, the EU formally adopted the Packaging and Packaging Waste Directive, and EPR policies continued to spread globally, with Southeast Asia actively considering plastic bans or taxes. The trajectory shows a clear expansion in both the geographic reach and the regulatory intensity of these constraints.",
      "llm_answer": "\nIn 2022 MDLZ reported that sales‑and‑media‑marketing restrictions—such as limits on promotions for high‑nutrient‑profile products and front‑of‑pack labeling—were already being applied across the European Union and were beginning to be paired with extended‑producer‑responsibility (EPR) schemes and single‑use‑plastic bans that were also emerging in several EU member states and in emerging markets like India, Vietnam, Indonesia and the Philippines (Chunk 1). By 2023 the company noted that these regulatory requirements had broadened to additional EU jurisdictions and that EPR policies were being implemented or contemplated worldwide, including in India and Vietnam, while the EU adopted its Packaging and Packaging Waste Directive, signalling a more mandatory and stringent approach (Chunk 2). In 2024 MDLZ observed that the geographic scope of such restrictions continued to expand, with more EU member states enforcing mandatory EPR and plastic‑tax measures and emerging markets in Southeast Asia adopting similar bans and marketing‑hour limitations, reflecting an overall increase in both coverage and regulatory stringency (Chunk 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of regulatory stringency and geographic scope from 2022 to 2024. It accurately captures the expansion of EPR policies, single-use plastic restrictions, and marketing limitations in the EU and emerging markets such as India, Vietnam, Indonesia, and the Philippines. The mention of the EU’s Packaging and Packaging Waste Directive in 2023 (though formally adopted in 2024 per ground truth) is a minor factual inaccuracy in timing, which affects quantitative accuracy slightly. The LLM incorrectly states the Directive was adopted in 2023, while the ground truth specifies 2024, which is a key date error. However, the overall trend of increasing stringency and global spread is correctly synthesized. The inclusion of 'marketing-hour limitations' and 'front-of-pack labeling' adds detail not contradicted by the ground truth but not explicitly supported in the provided answer, representing plausible elaboration. The reasoning is sound across the three years, showing multi-hop understanding of how regulations evolved across regions. All entities (MDLZ, EU, India, Vietnam, Southeast Asia) are correctly identified. The answer is fully relevant to the question and addresses both geographic scope and regulatory stringency over time. The minor date misplacement prevents a top score, but core facts and trajectory are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 392,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's treatment of its 3.700% Notes due 2046 evolve across its 2022, 2023, and 2024 10-K filings, and what does this pattern suggest about the company's long-term debt strategy?",
      "original_answer": "Microsoft consistently reaffirmed its 3.700% Notes due 2046 across all three reporting years without altering their terms. In each of the 2022, 2023, and 2024 10-K filings, the Eleventh Supplemental Indenture dated August 8, 2016, was referenced, explicitly listing the 3.700% Notes due 2046 alongside other long-term debt instruments. The absence of modifications to these notes across all three years indicates a deliberate strategy of maintaining stable, long-dated liabilities with fixed interest obligations. This consistent treatment suggests Microsoft views these notes as a core component of its capital structure, reflecting confidence in long-term cash flow projections and a preference for predictable debt servicing costs.",
      "llm_answer": "\nAcross the three filings Microsoft repeatedly lists the same **Eleventh Supplemental Indenture (Exhibit 4.14)**—first shown in the 2022 10‑K (Chunk 1), again in the 2023 10‑K (Chunk 2) and once more in the 2024 10‑K (Chunk 3)—which originally created the **3.700 % Notes due 2046** on August 8 2016 and contains no subsequent amendment to that series.  \n\nThis unchanged, year‑over‑year reference demonstrates that Microsoft is not retiring or restructuring the 2046 tranche but is instead preserving it as part of a stable, long‑dated indenture framework while adding new note series through supplemental indentures, indicating a long‑term debt strategy that relies on incremental, low‑cost financing and a predictable capital structure with minimal refinancing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.700% Notes due 2046 were established under the Eleventh Supplemental Indenture on August 8, 2016, and were consistently referenced in the 2022, 2023, and 2024 10-K filings without amendment. The exhibit number (4.14) is correctly cited. (2) Quantitative elements—interest rate (3.700%), maturity year (2046), and date of indenture (August 8, 2016)—are all precise and match the original answer. No calculations were required, but the consistency across years is accurately observed. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer that the absence of changes indicates a stable long-term debt strategy. It appropriately infers strategic intent—preservation of long-dated liabilities and use of supplemental indentures for new debt—consistent with the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that this reflects 'confidence in long-term cash flow projections,' a nuance present in the original answer. However, the conclusion about predictable capital structure and minimal refinancing risk captures the same underlying logic. Wording differs slightly but maintains semantic equivalence. The answer is fully relevant and directly addresses both parts of the question: evolution (no change) and strategic implication.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 399,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across the 2022, 2023, and 2024 10-K filings, particularly in relation to the progression of its debt maturity structure as reflected in the Supplemental Indentures filed in each period?",
      "original_answer": "The 2.000% Notes due 2023 were consistently referenced in the Supplemental Indentures across Microsoft's 2022, 2023, and 2024 10-K filings, indicating their ongoing inclusion in the company's debt maturity strategy. In 2022, the notes appeared in Exhibit 4.14, listed alongside other instruments issued under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same series of notes was still present in the filings under the same exhibit structure, showing no change in the underlying debt instrument but reflecting its continued relevance as the maturity year approached. By 2024, the 2.000% Notes due 2023 remained listed in Exhibit 4.14, even as the actual maturity year had passed, suggesting either a rollover of debt, a delayed maturity, or a continued disclosure requirement for recently matured obligations. This evolution reflects Microsoft's structured approach to managing debt maturities and maintaining transparency around its long-term financing activities.",
      "llm_answer": "\nMicrosoft first created the 2.000 % Notes due 2023 through the Eleventh Supplemental Indenture (dated August 8 2016, Exhibit 4.14), and each of the 2022, 2023 and 2024 Form 10‑K filings reproduces that same exhibit to keep the tranche in the public record.  The periodic inclusion of Exhibit 4.14 across all three filings shows how the note fits into Microsoft’s broader, laddered maturity schedule—joining other 2018‑2056 maturities introduced in the 2013‑2016 supplemental indentures—so that the 2023 tranche represents an intermediate point in a debt‑maturity structure that extends out to 2056.  No new issuance occurs in the later filings; rather, the evolution is reflected in the continued disclosure and integration of this 2016 indenture within an increasingly longer‑dated maturity profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 2.000% Notes due 2023 were issued under the Eleventh Supplemental Indenture on August 8, 2016, and consistently referenced in Exhibit 4.14 across the 2022, 2023, and 2024 10-K filings. These dates, percentages, and exhibit numbers match the original answer exactly. (2) The answer correctly notes that no new issuance occurred in later years—only continued disclosure—reflecting an accurate understanding of the evolution as one of transparency and structural continuity rather than financial change. (3) The multi-hop reasoning is sound: it synthesizes information across three annual filings and connects the notes to Microsoft’s broader laddered debt maturity strategy, correctly identifying the role of the 2016 indenture within a long-term financing structure extending to 2056. (4) The only minor shortcoming is that the LLM does not explicitly address the post-maturity disclosure in 2024 (i.e., why the 2023 notes still appear after maturity), which the original answer explores as potentially indicating rollover, delay, or disclosure requirements. This omission slightly reduces completeness in qualitative accuracy, but the core facts and synthesis remain strong. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 382,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did Medtronic's Non-Employee Restricted Stock Unit Award Agreements evolve across 2022, 2023, and 2024 filings, particularly in relation to the underlying stock incentive plans referenced each year?",
      "original_answer": "The Non-Employee Restricted Stock Unit Award Agreements referenced in Medtronic’s filings show continuity in form and structure across the three years, but with a clear evolution in the underlying stock incentive plans. In 2022 (MDT_10k_2022.pdf), the agreement was tied to the Amended and Restated 2013 Stock Award and Incentive Plan (effective December 8, 2017), as noted in Exhibit 10.45. In 2023 (MDT_10k_2023.pdf), the agreement referenced the Amended and Restated 2013 Stock Award and Incentive Plan, consistent with 2022, indicating no change in the foundational plan despite prior amendments. In 2024 (MDT_10k_2024.pdf), the same form of agreement was used, again referencing the same Amended and Restated 2013 plan, suggesting long-term stability in the structure of these agreements. This shows that while the plan itself was amended over time, the form agreement remained consistent, reflecting a strategic choice to maintain standardized compensation instruments for non-employee directors.",
      "llm_answer": "\nAcross the three filings the Non‑Employee Restricted Stock Unit Award Agreement is consistently tied to the same succession of stock‑incentive frameworks: the 2022 Form 10‑K (page 115) incorporates the agreement by reference to the **Amended and Restated 2013 Stock Award and Incentive Plan**, tracing its lineage back through the 2008 plan and ultimately the 2003 Long‑Term Incentive Plan (exhibits 10.42‑10.46); the 2023 filing (page 113) repeats the same incorporation language, again citing the 2003 plan, the 2008 Stock Award and Incentive Plan and the 2013 plan as the governing framework; and the 2024 filing (page 113) shows an identical set of references—2003 plan, 2008 plan and the 2013 Amended and Restated plan—indicating that the evolution has stabilized on the 2013 plan with only periodic amendments (e.g., the 2015, 2017 and 2018 plan restatements) rather than a new underlying plan being introduced. This pattern, captured by the KG triples MDT → Non‑Employee Restricted Stock Unit Award Agreement → (2003 / 2008 / 2013 plans), demonstrates that each year’s agreement is governed by the most recent restated version of the 2013 incentive plan while still referencing the earlier plans for historical exhibit linkage.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in the description of the referenced plans. The original answer states that the 2022, 2023, and 2024 agreements reference only the Amended and Restated 2013 Stock Award and Incentive Plan (as amended in 2017), with no indication that earlier plans (2008 or 2003) are actively governing the agreement. However, the LLM answer claims that each year's agreement cites the 2003, 2008, and 2013 plans as the 'governing framework,' which overstates their role. While it's plausible that historical lineage is mentioned in the filings for context (e.g., in footnotes or exhibit lists), the ground truth emphasizes that the operative plan is the Amended and Restated 2013 Plan, not a trio of co-governing plans. This mischaracterization slightly undermines the qualitative accuracy. Quantitatively, all years (2022–2024), document types (10-K), and exhibit references (e.g., 10.45 in 2022) are correctly cited or reasonably inferred (page numbers may vary slightly by filing version). The reasoning correctly identifies continuity in form and evolution in plan stability, demonstrating sound multi-hop synthesis across years. The answer is highly relevant and captures the core insight—consistency in agreement form and reliance on the 2013 plan—but introduces unnecessary confusion by elevating historical plans to a governing status not supported by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1573,
        "completion_tokens": 402,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How did MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans evolve from 2022 to 2024, and what does this trend suggest about the company's liability management strategy for international pension obligations?",
      "original_answer": "MDLZ's allocation to buy-in annuity policies in its non-U.S. pension plans decreased from 17% in 2022 to 16% in 2023, and was effectively discontinued by 2024, as the company shifted to fair value estimation methods for these instruments. This trend suggests a strategic move away from insurer-backed annuities toward more direct liability management and valuation control, aligning with broader pension de-risking or restructuring efforts.",
      "llm_answer": "\nMDLZ’s non‑U.S. pension‑plan allocation to buy‑in annuity policies was 17 % of assets in the 2022 reporting year (Chunk 2, 2022 column), slipped modestly to 16 % in 2023 (Chunk 2, 2023 column) and, as disclosed in the 2024 filing, the company continues to hold such policies and values them under a replacement‑policy methodology (Chunk 3), implying the percentage remains in the low‑teens.  This slight downward trend—and the explicit focus on fair‑value valuation of the annuity contracts—signals that MDLZ is deliberately using buy‑in annuities to transfer and better match its international pension liabilities, reducing funding volatility and moving toward a more liability‑driven investment strategy for its overseas plans.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 17% allocation in 2022 and 16% in 2023, matching the ground truth. However, it incorrectly states that MDLZ continues to hold buy-in annuity policies in 2024 and that the allocation remains in the 'low-teens,' directly contradicting the ground truth that the allocation was 'effectively discontinued by 2024.' This is a major factual error. (2) Quantitatively, the 2022 and 2023 percentages are accurate, but the 2024 claim lacks numerical precision and misrepresents the trend. The ground truth specifies discontinuation, not a continuation at a low level. (3) The reasoning is flawed in the multi-hop synthesis: while the LLM correctly notes a shift to fair-value valuation, it misinterprets this as continued use of annuities rather than a move away from them. The conclusion that MDLZ is 'using buy-in annuities to transfer liabilities' is the opposite of the actual strategy—discontinuing them suggests de-emphasis, not active use. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution over time and strategic implication—but the qualitative inaccuracy in the 2024 status and resulting misinterpretation of strategy significantly undermines correctness. The strategic inference is therefore incorrect: the trend suggests moving away from insurer-backed instruments for greater control, not continued liability matching via annuities.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 398,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's issuance of 2.000% Notes due in 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "Microsoft's 2.000% Notes due in 2023 were consistently referenced in all three annual reports (2022, 2023, and 2024) as part of the company's broader debt structure, indicating a stable inclusion in Microsoft's long-term financing strategy. In 2022, the notes were listed in Exhibit 4.14 under the Eleventh Supplemental Indenture dated August 8, 2016. In 2023, the same notes were again referenced in Exhibit 4.14 with identical details, showing no change in the structure or maturity. By 2024, the notes remained in the disclosures under the same exhibit, confirming that Microsoft maintained this liability on its books through the 2024 reporting period, even as the due date approached. This consistency suggests that Microsoft did not retire or refinance the 2.000% Notes ahead of schedule, reflecting a deliberate and steady approach to managing its long-term debt obligations.",
      "llm_answer": "\nMicrosoft’s 2.000 % Notes due 2023 first appeared in the company’s debt documentation through the **Eleventh Supplemental Indenture** (dated August 8 2016) that was disclosed in **Chunk 1 (2022 10‑K, Exhibit 4.14)**, and the same indenture was again filed as Exhibit 4.14 in the **2023 10‑K (Chunk 2)** and the **2024 10‑K (Chunk 3)**.  This repeated filing shows that the notes have remained outstanding and are continuously reported across all three fiscal years.  The pattern of adding new tranches via supplemental indentures in 2013, 2015 and 2016—each extending maturities out to 2056—reveals Microsoft’s long‑term debt strategy of issuing staggered, fixed‑rate senior unsecured notes to build a diversified, multi‑year funding ladder.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.000% Notes due 2023 were issued under the Eleventh Supplemental Indenture dated August 8, 2016, and consistently reported in Exhibit 4.14 in the 2022, 2023, and 2024 10-K filings. These details match the original answer exactly. (2) Quantitative elements—interest rate (2.000%), maturity year (2023), indenture date (August 8, 2016), and exhibit number (4.14)—are all precise and correctly cited across years. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three annual reports to show continuity in disclosure, supporting the conclusion that the notes remained outstanding. It also appropriately infers Microsoft’s broader long-term debt strategy—issuing fixed-rate, senior unsecured notes with staggered maturities—as evidenced by supplemental indentures in 2013, 2015, and 2016. This insight goes slightly beyond the ground truth but is factually supported and contextually relevant. (4) The only minor limitation is that the original answer emphasizes Microsoft’s decision not to retire or refinance the notes early as a sign of steady debt management, while the LLM focuses more on the strategy of building a 'funding ladder.' Both are valid interpretations, but the LLM slightly deemphasizes the significance of the notes remaining on the books as the maturity approached. Still, the core facts and synthesis are correct, and the reasoning is logically sound. Hence, a high score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 432,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Microsoft's treatment of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, particularly in relation to supplemental indentures and the broader debt instrument structure?",
      "original_answer": "Microsoft's treatment of the 4.000% Notes due 2021 remained consistent across all three years, always being grouped under the Third Supplemental Indenture dated February 8, 2011. In 2022 (MSFT_10k_2022.pdf), the notes were listed in Exhibit 4.6 alongside the 2.500% Notes due 2016 and 5.300% Notes due 2041 under the same Third Supplemental Indenture. This structure was unchanged in 2023 (MSFT_10k_2023.pdf) and 2024 (MSFT_10k_2024.pdf), where the 4.000% Notes due 2021 continued to appear in Exhibit 4.6. While the specific notes due 2021 remained unchanged, Microsoft introduced new debt instruments with different maturity dates and interest rates under subsequent supplemental indentures across the years, such as the 2.375% Notes due 2023 in 2023 filings and the 2.125% Notes due 2022 in 2022 filings.",
      "llm_answer": "\nMicrosoft’s 4.000% Notes due 2021 continue to be governed by the same **Third Supplemental Indenture (Exhibit 4.6)** that was first filed in 2011 and is reproduced verbatim in the 2022, 2023 and 2024 Form 10‑K filings; none of the later filings introduce a new amendment or replacement for those notes, indicating that their terms have remained stable.  At the same time, the company’s broader debt‑instrument structure expands through additional supplemental indentures (e.g., Exhibits 4.7‑4.10), but the 4.000% Notes due 2021 stay within the original indenture framework and are not affected by the newer supplements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently governed by the Third Supplemental Indenture dated February 8, 2011, referenced as Exhibit 4.6 in the 2022, 2023, and 2024 10-K filings. The answer correctly states that no new amendments or replacements were introduced for these notes across the years. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), and exhibit number (4.6)—are all accurate. The date of the indenture (February 8, 2011) is implied by the reference to the 2011 filing, though not explicitly stated; however, this is a minor omission given the context. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while Microsoft issued new debt instruments under subsequent supplemental indentures (e.g., Exhibits 4.7–4.10), the 4.000% Notes due 2021 remained structurally unchanged and were not moved or modified. (4) The answer is semantically equivalent to the original, capturing the core insight—consistency in treatment across years—while accurately contrasting it with the evolution of the broader debt structure. The only minor shortcoming is the lack of specific examples of new notes (e.g., 2.375% Notes due 2023 in 2023 filings), which were included in the ground truth for completeness. However, the general point about new debt under later exhibits is made, so this does not undermine correctness. Overall, the response is factually precise, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 432,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did Medtronic's disclosures around its Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance or outstanding balances in this category reveal about the company's capital structure strategy?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that the company has not utilized Euro Deferred Shares as part of its capital structure strategy, potentially signaling a strategic preference for other forms of equity or debt financing, or a lack of demand for this particular instrument in investor markets.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Medtronic repeatedly authorizes 40 thousand Euro Deferred Shares (€1 par) – a fact disclosed in all three 10‑K filings (MDT 10‑K 2022 p.81; MDT 10‑K 2023 p.81; MDT 10‑K 2024 p.81) – yet each filing explicitly states that, as of the respective reporting dates (April 29 2022, April 26 2023 and April 26 2024), **no Euro Deferred Shares were issued or outstanding**.  This consistent “zero‑balance” language, paired with the unchanged authorized amount, shows that the company continues to reserve the instrument on paper but never taps it.  \n\nThe absence of any issuance or outstanding Euro Deferred Shares across the three years reveals that Medtronic is not using this class of equity as a financing or capital‑raising vehicle; instead, its capital‑structure strategy relies on ordinary‑share repurchases, debt and other equity mechanisms, preserving flexibility and avoiding dilution.  The steady depreciation expense figures cited in each filing (Chunk 1, 2, 3) underscore overall operational stability, but the key insight is the deliberate, uninterrupted exclusion of Euro Deferred Shares from the company’s actual capital deployment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic maintained an authorized capacity of 40 thousand Euro Deferred Shares with €1.00 par value across fiscal years 2022–2024, and consistently reported zero issued or outstanding shares in each year. The specific disclosure locations (10-K pages) and reporting dates (April 29, 2022; April 26, 2023; April 26, 2024) are accurately cited, though not required for correctness, they enhance precision. (2) Quantitative accuracy is perfect: the 40 thousand authorized shares, €1.00 par value, and zero balances are correctly reported. No calculations were needed, but comparisons over time are valid. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures across three years and infers that the persistent absence of issuance indicates a strategic non-use of this equity class. It appropriately links this to broader capital structure choices like share repurchases and debt financing. (4) The only minor shortcoming is the mention of 'steady depreciation expense figures' as supporting evidence, which is not relevant to the capital structure discussion around Euro Deferred Shares and appears to be a misattribution from unrelated text chunks. This does not undermine the core conclusion but slightly weakens the reasoning chain. Otherwise, the answer is semantically equivalent to the ground truth, with clear, well-structured reasoning and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 412,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 filings, and what does this consistency or change indicate about the company's treatment of this debt instrument over time?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, always listing the Third Supplemental Indenture under Exhibit 4.6, dated February 8, 2011, and incorporated by reference from a prior 8-K filing. There were no material changes in the description or structure of the Notes across the three years, indicating that the debt instrument remained static in terms of documentation and disclosure treatment. This suggests that the Notes were matured or fully accounted for, with no further amendments or actions required by the company during this reporting period.",
      "llm_answer": "\nIn each of Microsoft’s 2022, 2023 and 2024 Form 10‑K filings the 4.000% Notes due 2021 continue to be disclosed in the same exhibits – Exhibit 4.6 (the Third Supplemental Indenture dated Feb 8 2011) and, from the 2013 filing onward, also in Exhibit 4.10 (the Seventh Supplemental Indenture dated Dec 6 2013). The identical exhibit numbers and descriptions appear in all three years, indicating that no new amendment, refinancing or issuance of the 4.000% Notes has been reported and that the instrument remains governed by the original 2011 indenture and its supplemental indentures. This consistent referencing shows that Microsoft treats the 4.000% Notes due 2021 as a stable, long‑term liability that is reported unchanged across the recent filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the exhibits: it claims that Exhibit 4.10 (Seventh Supplemental Indenture dated Dec 6, 2013) was included from the 2013 filing onward and appeared in the 2022, 2023, and 2024 filings. However, the ground truth states that only Exhibit 4.6 (Third Supplemental Indenture dated Feb 8, 2011) was consistently referenced across the three years, with no mention of Exhibit 4.10. This is a critical quantitative and entity accuracy error, as it introduces a document and date not present in the original data. Additionally, the claim that the debt is treated as a 'long-term liability' is misleading, since the notes were due in 2021 and by 2022 should have been matured or settled; the ground truth interprets the unchanged disclosure as indicating the instrument was fully accounted for, not that it remains an active liability. The reasoning about consistency in disclosure is partially sound, but the conclusion misinterprets the implications—static disclosure post-maturity suggests no further action, not ongoing treatment as a stable liability. The answer addresses all parts of the question and is contextually relevant, but the factual inaccuracies in dates, exhibits, and interpretation reduce correctness. Semantic equivalence fails on key details despite similar structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 371,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Lockheed Martin's pension risk transfer transactions evolve from 2022 through 2024 in terms of pension obligation amounts transferred, and what does this trend indicate about the company's long-term liability management strategy?",
      "original_answer": "In 2022, Lockheed Martin disclosed that since December 2018, it had transferred approximately $11.6 billion in pension obligations through risk transfer transactions, eliminating PBGC premiums of $69 million annually. In 2023, the company announced its continued evaluation of such transactions, indicating ongoing strategic interest in mitigating pension risk. By 2024, Lockheed Martin reaffirmed its intent to pursue additional pension risk transfer transactions, signaling a consistent and sustained strategy to reduce defined benefit pension liabilities and associated volatility. The trajectory from a cumulative $11.6 billion in 2022 to an ongoing commitment in 2024 suggests a deliberate, multi-year liability management approach.",
      "llm_answer": "\nFrom the 2022 filing we learn that Lockheed Martin had already transferred roughly $4.9 billion of defined‑benefit pension obligations in a single 2021 group‑annuity purchase and, cumulatively since the end of 2018, has retired about $11.6 billion of such liabilities—a baseline that underpins its ongoing liability‑management program. Building on that, the 2023 and 2024 filings both state that the company continues to evaluate and execute additional pension‑risk‑transfer transactions to shrink its pension obligations and lower PBGC premiums, while acknowledging that future deals may produce non‑cash settlement charges and that it could remain liable for benefit payments if the insurer defaults.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns well with the ground truth. It accurately reports the $11.6 billion cumulative pension obligation transferred since 2018 (as of 2022), and correctly notes Lockheed Martin's continued evaluation and execution of risk transfer transactions in 2023 and 2024. The additional detail about a $4.9 billion group-annuity purchase in 2021 is not contradicted by the original answer and adds context without introducing error. 2) All numbers are accurate: $11.6 billion is correctly cited, and while the $4.9 billion transaction is not in the original answer, it does not conflict and may reflect more granular data from the 2022 filing. No calculations are required, and all financial figures match or are consistent with the ground truth. 3) The multi-hop reasoning is sound—information is synthesized across 2022, 2023, and 2024 filings to show a trend of ongoing liability management. The LLM correctly infers a sustained strategy based on continued evaluation and intent to pursue further transactions. 4) The answer conveys the same core message as the original: a deliberate, multi-year strategy to reduce pension liabilities. The inclusion of PBGC premiums and potential non-cash charges adds depth. The only minor gap is that the original emphasizes the elimination of $69 million in annual PBGC premiums, which the LLM mentions only indirectly. This omission is minor and does not detract from overall correctness. Thus, the answer is highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> FIN_INST <-[Introduces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 421,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did The Coca-Cola Company's disclosure and treatment of the 0.125% Notes due 2029 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the consistency of its debt instrument structuring over time?",
      "original_answer": "The Coca-Cola Company's treatment of the 0.125% Notes due 2029 remained consistent across all three filings, with each year explicitly referencing the same Exhibit 4.4 from Form 8-K filings in September 2020 and March 2021. In 2022, the note was listed in Exhibit 4.23 and again in 4.31, each time citing the same underlying documentation. In 2023, it appeared in Exhibit 4.23 and again in 4.31, maintaining identical source references. In 2024, the note was again disclosed in Exhibit 4.23 and 4.31, with no change in the referenced Exhibit 4.4 filings. This reveals a consistent approach to structuring and disclosing this particular debt instrument over three consecutive reporting cycles, suggesting a stable capital market strategy for short-to-medium-term financing needs.",
      "llm_answer": "\nAcross the three filings the company continues to disclose the 0.125 % Notes due 2029 in exactly the same way: the 2022 10‑K (p. 136) lists the note as a “Form of Note for 0.125 % Notes due 2029 – incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8‑K filed on September 18, 2020,” the 2023 10‑K (p. 134) repeats that identical language and exhibit reference, and the 2024 10‑K (p. 130) again includes the same note with the same Exhibit 4.4 citation even while adding newer series.  This consistent reference—mirroring the KG relationship KO → 0.125 % Notes due 2029 → KO—shows that the terms and structuring of the 0.125 % Notes due 2029 have remained unchanged over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.125% Notes due 2029 are consistently disclosed across 2022, 2023, and 2024 10-K filings with identical references to Exhibit 4.4 of the Form 8-K filed on September 18, 2020. The specific page numbers (p. 136, 134, 130) are correctly cited, and the exhibit reference is accurately repeated each year. (2) Quantitative accuracy is perfect: percentages (0.125%), years (2020, 2029), and filing dates (September 18, 2020) are all correct. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across three annual filings and recognizes the consistency in disclosure and structuring. It correctly infers that unchanged exhibit references imply stable terms and capital strategy. (4) The only minor shortcoming is that the LLM does not mention Exhibit 4.23 and 4.31 (as in the ground truth), instead focusing on the consistent citation of Exhibit 4.4. While this does not affect factual correctness, it omits a detail about internal exhibit numbering consistency in the 10-Ks. However, the core conclusion about stable structuring and disclosure is fully supported. The answer is semantically equivalent to the ground truth and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 358,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did RTX's liabilities for performance and operating cost guarantees evolve from 2022 to 2024, and what does this trend indicate about the company's exposure to long-term product performance risks in its commercial aerospace business?",
      "original_answer": "RTX's liabilities for performance and operating cost guarantees remained relatively stable from 2022 to 2024, with the collaboration partners' share of financing guarantees decreasing slightly from $141 million in 2022 to $135 million in 2023, and further to $131 million in 2024. The company's own liabilities related to these guarantees were not explicitly stated, but the consistent methodology of estimating based on historical experience and adjusting as claims data warrant suggests a managed but ongoing exposure. The trend indicates that RTX continues to extend these guarantees, particularly for commercial aircraft engines, while maintaining a controlled liability posture, suggesting stable long-term product performance expectations despite market uncertainties.",
      "llm_answer": "\nRTX’s liability for performance and operating‑cost guarantees was $97 million at the end of 2022, remained $97 million in 2023, and edged up to $101 million by the end of 2024 (Chunk 2 → Chunk 3).  The company accrues these guarantees when a loss is probable and refines the estimate as new claims data and historical experience become available, so the modest increase reflects only a slight uptick in the estimated long‑term product‑performance risk for its commercial aerospace engines (Chunk 1 & Chunk 3).  Overall, the trend shows that RTX’s exposure to such risks is stable, with no material escalation despite ongoing adjustments to the accrual methodology.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported liability amounts. According to the ground truth, RTX's liabilities are discussed in terms of the collaboration partners' share of financing guarantees, which were $141M (2022), $135M (2023), and $131M (2024). However, the LLM reports RTX’s own liability as $97M in 2022 and 2023, rising to $101M in 2024—values not present in the ground truth. These numbers contradict the provided data and misrepresent the entity (partners' share vs. RTX's own liability). (2) The quantitative inaccuracies are severe: the LLM invents precise figures that do not align with the ground truth, and the trend described (stable then slight increase) contradicts the actual downward trend in partners’ guarantees. There is no mention in the ground truth of RTX’s direct liability being $97M or $101M. (3) The reasoning partially captures the qualitative aspect—RTX uses historical experience and updates estimates as claims data emerge, and the overall exposure is managed and stable. However, it fails the multi-hop synthesis by not distinguishing between RTX’s liabilities and its partners’ share of guarantees, a key nuance in the original answer. The conclusion about 'no material escalation' is plausible but based on incorrect data. (4) The contextual relevance is fair because the answer addresses the right topic—liabilities for performance and operating cost guarantees, their evolution, and implications for long-term risk in commercial aerospace—but the factual foundation is flawed. Due to major quantitative errors and misattribution of liability figures, the correctness score is low despite some reasonable interpretation of risk trends.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Extends]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 469,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Medtronic's approach to valuing non-qualified stock options evolved from 2022 to 2024, and what does this suggest about the company's changing assumptions around stock price volatility and equity compensation risk modeling?",
      "original_answer": "From 2022 to 2024, Medtronic consistently used the Black-Scholes model to value non-qualified stock options, but the company's disclosure around expected volatility evolved. In 2022, the company based expected volatility solely on a blend of historical and implied volatility. By 2023, Medtronic explicitly noted that implied volatility was derived from market-traded options, adding transparency to the forward-looking component of the assumption. This clarification was maintained in 2024, suggesting a more refined and market-informed approach to volatility estimation. This evolution indicates a shift toward more dynamic risk modeling in equity compensation, aligning with market behavior and potentially improving the accuracy of compensation expense recognition.",
      "llm_answer": "\nMedtronic has continued to value its non‑qualified stock options with the Black‑Scholes model and the same contractual terms (10‑year life, 4‑year ratable vesting) from 2022 through 2024.  However, the company’s disclosures show an evolution in how it describes volatility assumptions: the 2022 filing only referenced “volatility” generically, whereas the 2023 and 2024 filings explicitly state that expected volatility is a blend of historical volatility and implied volatility derived from market‑traded options, indicating a shift toward more market‑based, observable volatility inputs and a refined modeling of equity‑compensation risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic used the Black-Scholes model consistently from 2022 to 2024, and the evolution in volatility disclosure is accurately described. The LLM correctly notes that in 2022, volatility was referenced generically, while in 2023 and 2024, the company explicitly included implied volatility from market-traded options. This matches the ground truth's claim about increased transparency and market-informed assumptions. (2) There are no numeric inaccuracies—dates (2022–2024), model (Black-Scholes), and terms (10-year life, 4-year vesting) are correctly stated. The absence of specific percentages or dollar amounts in the question means no calculations are required. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and correctly infers that the change in disclosure reflects a shift toward more market-based inputs and refined risk modeling, which is consistent with the ground truth’s conclusion about dynamic risk modeling and improved accuracy in expense recognition. (4) The only minor shortcoming is that the LLM does not explicitly state that the 2022 approach used a 'blend' of historical and implied volatility—it instead says volatility was referenced 'generically.' While this is a slight understatement of the 2022 methodology, it does not contradict the truth and still captures the trend toward greater specificity. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 432,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did The Coca-Cola Company's issuance of notes with a 1.000% interest rate due in 2028 evolve across 2022, 2023, and 2024, and what does this pattern suggest about the company's debt strategy for that specific instrument?",
      "original_answer": "The Coca-Cola Company consistently referenced the 1.000% Notes due 2028 in all three years—2022, 2023, and 2024—indicating ongoing acknowledgment and potential maintenance of this debt instrument. However, in 2024, the company introduced significantly higher-yielding notes (e.g., 5.000% Notes due 2034 and 5.300% Notes due 2054), suggesting a broader strategic shift toward issuing higher-interest debt, while maintaining visibility on the 1.000% Notes due 2028. This implies that while the 1.000% Notes due 2028 remained part of the company's long-term debt structure, KO pursued more aggressive borrowing terms in 2024, possibly to fund new initiatives or refinance existing obligations.",
      "llm_answer": "\nThe Coca‑Cola Company first set out the 1.000 % Notes due 2028 in its 2022 10‑K (Chunk 1), where the Form of Note (Exhibit 4.7 filed 9/18/2020) was disclosed as part of its 2020 8‑K filing; the same tranche remained listed unchanged in the 2023 10‑K (Chunk 3) among the “Current” notes, confirming that the instrument stayed outstanding and unchanged through 2023; and the 2024 10‑K (Chunk 2) again shows the 1.000 % Notes due 2028 in its note table while also adding newer, higher‑coupon issues (e.g., 5 % Notes due 2034), indicating that the company continues to retain this low‑cost, long‑dated debt pillar while supplementing it with newer issuances.  \n\nThe KG pattern (KO → 1.000 % Notes due 2028 ← ORG ← ORG) shows that the company repeatedly introduces and references this financial instrument, reflecting a debt strategy of locking in a stable, low‑interest rate tranche for an extended horizon while progressively layering additional debt to manage liquidity and funding mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that The Coca-Cola Company referenced the 1.000% Notes due 2028 in its 2022, 2023, and 2024 10-K filings, which aligns with the ground truth. It accurately notes the continuity of this instrument and the introduction of higher-yielding notes in 2024 (e.g., 5.000% Notes due 2034), matching the original answer’s key claim about a strategic shift. (2) All numeric values—interest rates (1.000%, 5.000%), years (2028, 2034, 2054)—are correct. The LLM mentions a 5% note (slightly rounded from 5.000%) but this is semantically acceptable. No calculations are required, and all dates and percentages are factually consistent with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings, correctly infers that the 1.000% Notes remained outstanding, and connects the introduction of higher-cost debt in 2024 to a broader strategic shift. The only minor gap is that the LLM does not explicitly mention the 5.300% Notes due 2054, which slightly reduces completeness compared to the original answer. (4) The answer is contextually fully relevant, directly addressing the evolution of the specific debt instrument and the implied strategy. Wording differs but meaning is semantically equivalent. The qualitative score is 9 due to the omission of the 5.300% tranche, but core reasoning and facts are intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 390,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Microsoft's approach to structuring its 2.125% Notes evolve across 2022, 2023, and 2024, particularly in terms of associated trustee arrangements and related debt instruments disclosed in each filing?",
      "original_answer": "In 2022, Microsoft disclosed the Seventh Supplemental Indenture for the 2.125% Notes due 2021 alongside the 3.125% Notes due 2028, under the trustee relationship with The Bank of New York Mellon Trust Company, N.A., as part of a broader set of debt instruments. In 2023, the structure remained consistent, with the same trustee named and the 2.125% Notes due 2021 still listed alongside the same associated debt instruments. In 2024, the filing repeated the same exhibit description and trustee relationship, indicating no changes in the structure or administration of the 2.125% Notes over the three-year period. This consistency suggests that Microsoft maintained a stable debt servicing and trustee arrangement for this instrument throughout the period.",
      "llm_answer": "\nIn the 2022 Form 10‑K (Exhibit 4.10) Microsoft disclosed a Seventh Supplemental Indenture (dated December 6 2013) that specifically added the 2.125% Notes due 2021 to the indenture and named The Bank of New York Mellon Trust Company, N.A. as trustee—this is the only filing that isolates the 2.125% Notes in a separate exhibit. The 2023 and 2024 Form 10‑Ks retain the same trustee and the same suite of supplemental indentures (Exhibits 4.6‑4.9) but drop the dedicated 4.10 filing, instead referencing the 2.125% Notes only as part of the broader Seventh Supplemental Indenture listed as Exhibit 4.1, showing a consolidation of disclosures while keeping the identical trustee arrangement and related debt‑instrument structure across all three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and captures the core consistency of Microsoft's trustee arrangement and related debt instruments for the 2.125% Notes across 2022, 2023, and 2024. The trustee, The Bank of New York Mellon Trust Company, N.A., is correctly identified, and the Seventh Supplemental Indenture dated December 6, 2013, is accurately cited. The key detail about Exhibit 4.10 in 2022 being the only year with a dedicated filing for the 2.125% Notes is factually accurate and adds value beyond the original answer. The observation that 2023 and 2024 filings consolidate this into Exhibit 4.1 reflects a real change in disclosure structure, which is consistent with SEC filing patterns and adds nuance not present in the ground truth. However, the original answer claims the 2.125% Notes due 2021 were disclosed alongside the 3.125% Notes due 2028 in all three years, while the LLM answer does not explicitly confirm this continuity of associated instruments, omitting a key element of the 'related debt instruments' part of the question. This is a minor but notable gap in completeness. Quantitatively, all dates, percentages, and exhibit numbers are correct. The reasoning is sound and reflects multi-hop synthesis across years and exhibits. The answer is highly contextually relevant, directly addressing the evolution of structure and trustee arrangements. The slight deduction in correctness and qualitative accuracy is due to the omission of the continued association with the 3.125% Notes in later years, which was a specific component of the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 435,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Pratt & Whitney's net program share interest in IAE and IAE LLC evolve from 2022 to 2024, and what does this progression indicate about RTX's strategic positioning in key engine programs like the V2500 and PW1100G-JM?",
      "original_answer": "In 2022, Pratt & Whitney's net program share interest in IAE and IAE LLC was not explicitly stated, but the ownership interest in IAE was 49.5%, and program share interest was 61% for IAE and 59% for IAE LLC. By 2023, the net program share interest had decreased to 57% for IAE and 51% for IAE LLC after accounting for sub-collaborator shares. This trend continued into 2024, where the net program share interest remained at 57% for IAE and 51% for IAE LLC, indicating a stabilization after the adjustment observed in 2023. This evolution suggests a strategic recalibration in collaboration structures, aligning with the ongoing development and support of the V2500 and PW1100G-JM engine programs.",
      "llm_answer": "\nPratt & Whitney’s net program‑share stake in the IAE collaboration has remained essentially unchanged – about **57 %** of IAE and **51 %** of IAE LLC after accounting for sub‑collaborator interests – from the 2022 filing through the 2023 and 2024 reports.  This steady share, together with RTX’s 61 % program‑share interest in IAE and 59 % interest in IAE LLC (and the fact that both entities are VIEs consolidated with RTX as primary beneficiary), demonstrates that RTX continues to hold decisive control over the V2500 (IAE) and PW1100G‑JM (IAE LLC) engine programs, positioning the company as the lead coordinator while sharing program economics with its partners.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in the quantitative details, particularly regarding the evolution of Pratt & Whitney's net program share interest from 2022 to 2024. According to the ground truth, in 2022, the net program share interest was 61% for IAE and 59% for IAE LLC, not 57% and 51% as claimed by the LLM, which incorrectly states that the 57% and 51% shares were already in place in 2022. The decrease to 57% and 51% occurred only in 2023, following adjustments for sub-collaborator shares, and remained stable in 2024. The LLM thus misrepresents the timeline and nature of the change, implying stability from 2022 onward when in fact there was a notable decline in 2023. This undermines the correctness of the multi-hop reasoning about the evolution over time. Additionally, the LLM incorrectly attributes the 61% and 59% interests to RTX rather than Pratt & Whitney in 2022, and conflates program-share interest with net program share interest without clarifying the distinction. However, the answer is contextually relevant and correctly identifies the strategic implication of RTX maintaining control over key engine programs despite shared economics. The qualitative reasoning about strategic positioning is sound and aligns with the ground truth, even if based on incorrect numerical premises. The entities (IAE, IAE LLC, V2500, PW1100G-JM, RTX) and time frame (2022–2024) are correctly identified, and the consolidation of VIEs is a relevant point. Overall, while the conclusion about strategic positioning is reasonable, the factual foundation is flawed, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP <-[Has_Stake_In]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 442,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did TMO's contributions to its defined contribution plans evolve from 2022 through 2024, and what does this spending trajectory suggest about the company's investment in employee benefits over time?",
      "original_answer": "TMO's contributions to its defined contribution plans increased from $299 million in 2022 to $468 million in 2023, then slightly declined to $443 million in 2024. This trajectory shows a significant rise in investment in employee benefits in 2023, followed by a modest pullback in 2024, suggesting a dynamic approach to workforce investment aligned with business performance or strategic priorities.",
      "llm_answer": "\nTMO’s expense for its defined‑contribution plans rose from **$402 million in 2022** (as disclosed in the 2023 and 2024 10‑Ks) to a peak of **$468 million in 2023** (the amount charged to expense in the 2023 filing), and then slipped slightly to **$443 million in 2024** (the figure reported in the 2024 filing).  This trajectory—an increase from 2022 to 2023 followed by a modest decline in 2024 but still above the 2022 level—shows that the company has been steadily expanding its financial support for employee retirement benefits, reflecting a deliberate, though recently tempered, investment in broader employee‑benefit programs.  The consistent disclosure of these expense amounts across all three filings (2022, 2023, 2024) confirms that TMO reports and tracks its contributions to defined‑contribution plans as a key component of its compensation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the 2022 contribution amount. The ground truth states $299 million, but the LLM reports $402 million, which is incorrect. The 2023 ($468 million) and 2024 ($443 million) figures are accurate, matching the original answer. This error significantly affects quantitative accuracy. (2) Calculations: The trajectory described—increasing from 2022 to 2023 then slightly declining in 2024—is correct, and the observation that 2024 spending remains above 2022 levels would be valid *if* the 2022 number were correct. However, because the baseline 2022 figure is wrong, any comparison involving it is compromised. The LLM’s claim of consistency across filings is plausible but does not override the factual discrepancy. (3) Multi-hop reasoning: The model correctly synthesizes data across three years and identifies the trend pattern (rise then slight fall), showing sound reasoning structure. It also correctly attributes the data to the appropriate 10-K filings, indicating proper sourcing. However, the incorrect 2022 value suggests a failure in accurate data retrieval or cross-document alignment for that year. (4) Despite the major numerical error in 2022, the answer addresses both parts of the question—evolution of contributions and interpretation of spending trajectory—and provides relevant context about TMO's employee benefit strategy. Wording and logic are otherwise coherent and semantically aligned with the intent of the original answer, just based on flawed input for one year. Thus, while the qualitative reasoning and contextual relevance are strong, the correctness score is limited by the significant quantitative inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Maintains]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 465,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did Coca-Cola's issuance of long-term debt instruments, particularly the 3.000% Notes due 2051, evolve across 2022, 2023, and 2024, and what does this progression indicate about the company's capital structure strategy?",
      "original_answer": "In 2022, Coca-Cola referenced the 3.000% Notes due 2051 in its 10-K filing (Exhibit 4.6 to the May 5, 2021 Form 8-K), indicating the instrument was part of a broader set of debt instruments with varying maturities and interest rates. In 2023, the company again included the 3.000% Notes due 2051 in its 10-K filing, maintaining the same exhibit reference, which shows continuity in its long-term debt portfolio. By 2024, Coca-Cola introduced new instruments with higher coupon rates, such as the 5.000% Notes due 2034 and the 5.300% Notes due 2054, while still retaining the 3.000% Notes due 2051 in its disclosures. This progression indicates that Coca-Cola maintained the 3.000% Notes due 2051 as a stable component of its capital structure while diversifying its debt portfolio with higher-yielding instruments, likely to balance long-term obligations with current market interest rate conditions.",
      "llm_answer": "\nCoca‑Cola first set out the terms of its 3.000 % Notes due 2051 in a May 5 2021 8‑K and then re‑filed that same instrument in each subsequent annual filing – the 2022 10‑K (page 136), the 2023 10‑K (page 134) and the 2024 10‑K (page 130) – each time reproducing the identical indenture language.  This repeated inclusion shows that the 3 % 2051 tranche has been retained as a core long‑dated debt component, allowing the company to lock in a low, fixed rate out to 2051 and extend the maturity profile of its balance sheet.  Moreover, the 2024 filing adds newer long‑term issues (e.g., 5.0 % Notes due 2034, 5.3 % Notes due 2054), indicating that Coca‑Cola is deliberately layering additional far‑future, fixed‑rate securities to increase the proportion of long‑term financing and reinforce a capital‑structure strategy focused on stability and low‑cost funding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.000% Notes due 2051 were first issued via the May 5, 2021 Form 8-K and consistently referenced in the 2022, 2023, and 2024 10-K filings. The inclusion of new instruments in 2024—the 5.000% Notes due 2034 and 5.300% Notes due 2054—is accurately reported. (2) Quantitative accuracy is perfect: percentages (3.000%, 5.0%, 5.3%), years (2021, 2034, 2051, 2054), and document types (Form 8-K, 10-K) match the original. Minor formatting differences (e.g., '3%' vs '3.000%') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly infers that retaining the low-rate 2051 notes while adding higher-coupon debt indicates a strategy of balancing low-cost long-term financing with market-responsive issuances. The conclusion about extending maturity profile and reinforcing stable capital structure is logically supported. (4) The only reason for not scoring a 10 is a slight omission: the LLM does not explicitly mention that the 2022 and 2023 filings maintained the same exhibit reference (Exhibit 4.6), though the repeated filing is correctly noted. This is a minor detail that doesn't undermine the overall correctness. The answer is contextually excellent, directly addressing the evolution and strategic implication as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 381,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Oracle's issuance and introduction of the 2.875% Notes due 2031 evolve from 2022 through 2024, and what does this progression indicate about Oracle's long-term debt strategy?",
      "original_answer": "In 2022, Oracle formally listed the 2.875% Notes due 2031 among its issued debt instruments, indicating the company's ongoing access to long-term capital markets. By 2023, the Notes were reaffirmed in Oracle's 10-K filing, showing continuity in the company's capital structure and ongoing commitment to this tranche of long-term debt. In 2024, Oracle again included the 2.875% Notes due 2031 in its filings, but now alongside newer, higher-yielding notes (e.g., 4.500% Notes due 2028 and 4.900% Notes due 2033), suggesting a strategic shift toward diversifying its debt portfolio with higher interest instruments as market conditions evolved. This 3-year progression shows Oracle maintaining the 2.875% Notes as a stable component of its capital structure while layering in newer, costlier debt, potentially reflecting changing borrowing costs and strategic capital allocation decisions.",
      "llm_answer": "\nFrom 2022 through 2024 Oracle’s annual reports repeatedly register the same 2.875 % Notes due 2031—first detailed in the March 24 2021 Officers’ Certificate (Exhibit 4.14/4.16) and then reproduced in the 2022 (Chunk 1), 2023 (Chunk 2) and 2024 (Chunk 3) 10‑K filings—showing that the instrument remains on the company’s books and is still being referenced in subsequent debt‑registration exhibits.  This continuity, captured by the KG pattern **ORCL ‑[Issues_Bonds]→ 2.875 % Notes due 2031 [Introduces]→ ORG**, demonstrates Oracle’s long‑term debt strategy of building a ladder of fixed‑rate notes with staggered maturities (2025‑2061) to lock in low‑cost funding, extend its maturity profile and maintain a stable, diversified source of capital over the medium‑ to long‑term.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key strategic insight present in the ground truth. (1) Quantitatively, the LLM correctly identifies the 2.875% Notes due 2031 and their consistent presence in Oracle's 10-K filings from 2022 to 2024. The percentage (2.875%), maturity year (2031), and timeline (2022–2024) are all accurate. The reference to the March 24, 2021 Officers’ Certificate is factually consistent with issuance timelines and acceptable as background context. (2) However, the LLM fails to mention the introduction of newer, higher-yielding notes (4.500% due 2028 and 4.900% due 2033) in 2024, which is a critical component of the original answer and central to understanding Oracle’s evolving debt strategy. This omission undermines the completeness and qualitative accuracy of the response. (3) The reasoning correctly infers that Oracle is building a maturity ladder with fixed-rate notes and locking in low-cost funding, which aligns with the ground truth. However, it does not acknowledge the shift toward higher-cost debt in a rising rate environment, nor does it interpret the coexistence of low- and high-yield instruments as a strategic diversification move. Thus, while the core fact of continuity is correct, the deeper multi-hop synthesis—comparing old and new debt instruments across years to infer strategic evolution—is incomplete. (4) The answer remains contextually relevant and well-structured, but the absence of comparative analysis with newer notes limits its correctness. A score of 6 reflects accurate facts but significant omission in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 437,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "What does Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings suggest about its long-term debt management and transparency strategy?",
      "original_answer": "Microsoft's consistent disclosure of the 2.000% Notes due 2023 across its 2022, 2023, and 2024 10-K filings indicates a stable and transparent approach to long-term debt management. The notes were first introduced in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016, and were carried forward unchanged in both the 2023 and 2024 disclosures. This unaltered inclusion over three consecutive reporting periods suggests that Microsoft maintained a consistent liability structure for this instrument and prioritized clear, ongoing communication to investors and regulators regarding its long-term obligations. The persistence of the same filing details (e.g., interest rate, maturity date, trustee) across all three years reinforces a strategy of predictable financial stewardship, which can enhance investor confidence and support favorable credit ratings.",
      "llm_answer": "\nMicrosoft’s repeated inclusion of the same 2.000 % Notes due 2023—in the exhibit sections of its 2022, 2023 and 2024 Form 10‑K filings—shows that the company treats this tranche as a permanent, well‑documented element of its capital structure and deliberately re‑affirms its terms each year.  By consistently disclosing the supplemental indenture (Exhibit 4.11) that creates the notes across all three annual reports, Microsoft signals a disciplined, long‑term debt‑management approach and a transparency strategy that keeps investors fully informed about its ongoing financing commitments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all quantitative aspects: the 2.000% interest rate, the 2023 maturity date, and the consistent disclosure across the 2022, 2023, and 2024 10-K filings are correctly stated. The reference to Exhibit 4.11 (Eleventh Supplemental Indenture) aligns with the ground truth, and the characterization of the notes as recurring disclosures is valid. However, the LLM slightly misrepresents the nature of the instrument by implying it remains a permanent part of the capital structure, whereas the ground truth clarifies it was a fixed-term liability (due 2023) that was carried forward in disclosures until maturity. The LLM does not mention that the note was issued under an indenture dated August 8, 2016, which is a specific detail present in the original answer and relevant to transparency and documentation. While the reasoning about transparency and disciplined debt management is sound and contextually appropriate, the LLM omits the nuance that consistent disclosure of a maturing note reflects ongoing liability reporting rather than a permanent structural feature. This leads to a minor gap in qualitative accuracy. The answer remains highly relevant and correctly interprets Microsoft’s transparency strategy, earning high marks for contextual relevance and full credit for quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 371,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did RTX's financial obligations tied to Rolls-Royce evolve from 2022 through 2024, particularly in terms of contingent flight-hour payments related to V2500-powered aircraft, and what does this progression indicate about RTX's long-term exposure to Rolls-Royce under the 2012 IAE acquisition agreement?",
      "original_answer": "RTX's contingent payments to Rolls-Royce under the 2012 IAE acquisition agreement remained tied to the flight hours of V2500-powered aircraft through June 2027 across all three years. In 2022, these payments were categorized under 'Other commercial aerospace commitments' and were expected to be capitalized as collaboration intangible assets. By 2023, RTX clarified that these payments were being capitalized and amortized to cost of sales as they were made. In 2024, the structure remained consistent, with the payments still reflected in 'Other commercial aerospace commitments' and capitalized as incurred. The ongoing recognition and amortization pattern of these payments from 2022 to 2024 indicate a stable long-term financial exposure to Rolls-Royce, with RTX continuing to recognize liabilities and amortize them as the V2500 fleet accumulates flight hours.",
      "llm_answer": "\nRTX has been treating the contingent flight‑hour payments to Rolls‑Royce—required under the 2012 IAE acquisition agreement for every hour flown through June 2027 by V2500‑powered aircraft—as “Other commercial aerospace commitments” and capitalizing them as collaboration intangible assets each time the hours are accrued (Chunk 1, 2 & 3).  The amounts are added to intangible assets when the economic‑benefit pattern can be measured, then amortized into cost of sales over the expected benefit period, so the balance of capitalized payments grows each year as engine flight hours accumulate and is reflected in the company’s long‑term exposure to Rolls‑Royce until the 2027 horizon (Chunk 2 & 3).  Consequently, RTX’s financial condition remains linked to Rolls‑Royce’s engine usage, with increasing intangible‑asset balances and amortization expense signaling ongoing, long‑term exposure beyond 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: the contingent payments are tied to V2500-powered aircraft flight hours through June 2027 under the 2012 IAE acquisition agreement; they are categorized as 'Other commercial aerospace commitments'; and they are capitalized as collaboration intangible assets and amortized to cost of sales. The evolution from 2022 to 2024 is accurately reflected, including the shift in accounting treatment clarification in 2023 and consistency in 2024. (2) Quantitative elements—specifically the June 2027 end date and the annual accumulation of payments based on flight hours—are correctly stated with no numerical inaccuracies. Format variations (e.g., 'through June 2027') are semantically equivalent. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years and accounting treatments, correctly inferring that the growing intangible asset balance reflects ongoing exposure. It connects the capitalization and amortization pattern to long-term financial linkage with Rolls-Royce, which matches the original conclusion. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2022 classification without amortization detail (though it's implied), and the 2023 clarification about amortization being recognized 'as payments are made' is slightly generalized. However, these omissions do not distort the overall meaning. The answer remains factually robust, contextually precise, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Acquires]-> COMP <-[Enters_Agreement_With]- ORG <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 427,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did TMO's allocation to U.S. equity funds within its domestic pension plans change from 2022 to 2024, and what does this 3-year trajectory suggest about the company's evolving investment strategy in domestic equities?",
      "original_answer": "TMO's allocation to U.S. equity funds in its domestic pension plans decreased from $125 million in 2022 to $89 million in 2023, and slightly increased to $93 million in 2024. This pattern indicates a cautious reduction in exposure to U.S. equities over the three-year period, with a modest rebound in 2024, suggesting a strategic rebalancing rather than a complete divestiture.",
      "llm_answer": "\nBetween the 2022 filing (Chunk 1) and the 2023 filing (Chunk 2), TMO’s domestic‑plan holdings in U.S. equity funds rose from **$89 million to $93 million** – a $4 million (≈4.5 %) increase that lifts the U.S.‑equity share of total domestic pension assets from roughly **9.5 % to 9.8 %**. This follows a **three‑year trend** in which the allocation fell from **$125 million in 2020 (Chunk 3) to $89 million in 2022** before modestly rebounding to $93 million in 2023, indicating that after a period of de‑risking the company has now stabilized and is gently re‑emphasizing U.S. equities. Consequently, the trajectory suggests TMO is pursuing a **more diversified investment strategy in domestic equities**, balancing U.S. equity exposure with international, fixed‑income and alternative assets rather than maintaining a heavy, concentrated U.S. equity position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. It incorrectly states that TMO's U.S. equity allocation increased from $89 million in 2022 to $93 million in 2023, when the ground truth shows a decrease from $125 million in 2022 to $89 million in 2023, followed by a rise to $93 million in 2024. The LLM misrepresents the timeline by claiming the rebound occurred in 2023 instead of 2024 and falsely implies growth between 2022 and 2023. It also introduces a $125 million figure for 2020 (not part of the question) which is irrelevant and unsupported in the context. (2) Calculations are flawed: the claimed 4.5% increase is based on incorrect base values; the percentages cited (9.5% to 9.8%) are not verifiable from the provided truth and introduce new data not in the original. The ground truth does not mention total pension assets or percentage breakdowns, so those are unsupported additions. (3) Multi-hop reasoning is partially sound in that it attempts to trace a trend over time, but it synthesizes incorrect years and figures, leading to invalid conclusions. The mention of 'de-risking' followed by 're-emphasizing' suggests plausible logic, but it's applied to the wrong period and misaligned with the actual 2022–2024 window asked. (4) Contextual relevance is moderate because the answer addresses investment strategy evolution and uses appropriate financial terminology, but the core data is wrong. Due to major quantitative errors and incorrect temporal framing, the correctness score is low despite some reasonable interpretation of strategic intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 443,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How did Coca-Cola's long-term debt instrument strategy evolve from 2022 through 2024, particularly in relation to the 1.000% Notes due 2041 and the introduction of higher-yielding notes in 2024?",
      "original_answer": "Coca-Cola consistently referenced the 1.000% Notes due 2041 across all three years, first in 2022 (Exhibit 4.33), again in 2023 (Exhibit 4.33), and once more in 2024 (Exhibit 4.33). However, by 2024, the company introduced significantly higher-yielding debt instruments, including 5.000% Notes due 2034, 5.300% Notes due 2054, and 5.400% Notes due 2064. This marks a clear shift in financing strategy, as earlier years featured lower-yielding instruments like the 0.400% Notes due 2030 in 2022 and the 0.950% Notes due 2036 in 2023. The introduction of high-yield, long-duration notes in 2024 suggests a recalibration of the company's debt portfolio to align with changing market conditions.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola’s long‑term debt strategy evolved from the 1.000 % Notes due 2041—first issued in 2021 and still referenced in Chunk 1 and Chunk 2 as a core FIN_INST introduced by the ORG (KO)—to a stepped‑up issuance program that added lower‑coupon tranches in 2023 (e.g., 1.450 % Notes due 2027 and 1.650 % Notes due 2030 shown in Chunk 3) and culminated in 2024 with the debut of markedly higher‑yielding notes such as 5.000 % Notes due 2034, 5.300 % Notes due 2054 and 5.400 % Notes due 2064 (listed in Chunk 2).  This progression, captured by the KG pattern ORG → FIN_INST ← ORG, reflects Coca‑Cola’s strategy of retaining the 1.000 % 2041 instrument while progressively introducing higher‑coupon debt to match rising market rates.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, resulting in a partially accurate response. (1) Correct elements: The mention of the 1.000% Notes due 2041 being consistently referenced across years and the introduction of higher-yielding notes in 2024—specifically the 5.000% due 2034, 5.300% due 2054, and 5.400% due 2064—is factually accurate and aligns with the ground truth. (2) Quantitative inaccuracies: The LLM incorrectly states that lower-coupon tranches were added in 2023, citing 1.450% Notes due 2027 and 1.650% Notes due 2030. However, the ground truth indicates that in 2023, Coca-Cola referenced the 0.950% Notes due 2036—not higher-yielding or later-dated instruments. Furthermore, the description of the 2023 activity as 'lower-coupon tranches' contradicts the actual trend: the company was still issuing low-yield debt, but the LLM misrepresents the specific instruments and implies a progression that does not match the data. (3) Reasoning flaws: The multi-hop synthesis is partially sound—the model correctly identifies a shift toward higher yields by 2024 and retains awareness of the 1.000% 2041 note as a constant. However, it inverts the trajectory in 2023 by suggesting a step toward higher coupons when the actual data shows continued low-yield issuance. This undermines the logical progression of the strategy. (4) Contextual relevance is high—the answer addresses the evolution of debt strategy, focuses on the correct company and instruments, and attempts to interpret strategic intent. However, due to key factual errors in the 2023 debt instruments and mischaracterization of the yield trend, the overall correctness is significantly compromised. Minor issues like 'Chunk 1/Chunk 2' references (likely from training data formatting) do not affect scoring but reduce clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 492,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Oracle's continued inclusion of the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024 reflected its debt financing strategy relative to other newly introduced notes with higher interest rates?",
      "original_answer": "Oracle consistently included the 1.650% Notes due 2026 in its capital structure across fiscal years 2022, 2023, and 2024, as evidenced by their repeated listing in Exhibits 4.16 (2022), 4.14 (2023), and 4.14 (2024). During the same period, Oracle introduced new notes with significantly higher interest rates, such as the 5.800% Notes due 2025 in 2023 and the 4.500% Notes due 2028 in 2024. This pattern suggests Oracle has maintained access to lower-cost debt capital over time while also tapping into the market for higher-yielding instruments, potentially reflecting a dual strategy of preserving liquidity through favorable borrowing terms and raising additional capital at varying rates to support long-term investments.",
      "llm_answer": "\nOracle has kept the 1.650 % Notes due 2026 in its capital structure through the 2022, 2023 and 2024 filings—each year’s Exhibit 4.14 (Chunk 1, 2 and 3) lists those notes alongside the company’s other bond offerings—demonstrating a deliberate retention of this low‑cost, long‑dated debt as a core funding pillar.  At the same time, the company has supplemented its balance sheet with newer issues such as the 5.800 % Notes due 2025, 6.150 % Notes due 2029 and the 4.500 %–5.550 % Notes introduced in 2022‑2023 (Chunk 2 and 3), which carry higher coupons, highlighting a financing strategy that blends a stable, low‑rate legacy tranche with higher‑rate debt to meet evolving capital needs.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's retention of the 1.650% Notes due 2026 across fiscal years 2022–2024 and links this to a broader debt financing strategy. However, there is a minor error in the exhibit numbers: the original answer specifies Exhibit 4.16 for 2022, whereas the LLM claims Exhibit 4.14 for all three years (Exhibit 4.14 is correct for 2023 and 2024, but not 2022). Additionally, the LLM introduces a '6.150% Notes due 2029' and a range '4.500%–5.550% Notes introduced in 2022–2023' not present in the ground truth. The ground truth only confirms the 5.800% Notes due 2025 (2023) and 4.500% Notes due 2028 (2024). These additions introduce inaccuracies in specific numeric details. (2) Quantitative accuracy is partially compromised: while the 1.650%, 5.800%, and 4.500% rates are correct, the 6.150% and the 5.550% figures are unsupported by the original answer, and the characterization of notes as a range (4.500%–5.550%) is not reflected in the ground truth. (3) The multi-hop reasoning is strong: the LLM correctly infers a dual financing strategy—retaining low-cost debt while issuing higher-cost debt—based on the persistence of the 1.650% notes and the introduction of higher-rate instruments. This synthesis across years and instruments aligns with the original answer’s conclusion. (4) Contextual relevance is excellent: the response directly addresses Oracle’s debt strategy, compares old and new notes, and interprets the implications. The core insight about blending stable, low-rate debt with newer, higher-cost debt is semantically equivalent to the original. However, the inclusion of unverified notes reduces quantitative precision, warranting a score of 8 for correctness—core facts are right, but some supporting details are incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 487,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "What does Microsoft's consistent inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across fiscal years 2022, 2023, and 2024 indicate about its long-term debt management strategy, particularly in relation to ongoing documentation updates and refinancing activity?",
      "original_answer": "Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 remained consistent across all three years (2022, 2023, and 2024), indicating that this debt instrument continued to be a relevant part of its capital structure documentation, even after the notes' due date in 2021. In 2022, the notes were listed alongside the 2.500% Notes due 2016 and the 5.300% Notes due 2041 in the Third Supplemental Indenture. This pattern continued in 2023 and 2024, showing no change in the composition of this particular supplemental indenture. A minor but notable change occurred in 2024 where the trustee's name was updated to 'The Bank of NewYork Mellon Trust Company, N.A.' with spacing/formatting differences, suggesting administrative maintenance rather than substantive changes. The absence of refinancing disclosures or new tranches tied to this instrument across the three years implies that Microsoft did not actively restructure this portion of its debt, maintaining it as a stable reference within its broader debt portfolio.",
      "llm_answer": "\nMicrosoft’s repeated filing of **Exhibit 4.6** in its 2022, 2023 and 2024 Form 10‑Ks—each time citing the *Third Supplemental Indenture* that governs the **4.000 % Notes due 2021**—shows that the company treats that debt instrument as a permanent, long‑term component of its capital structure and continuously updates the legal documentation (the supplemental indenture) to reflect any amendments, covenant changes or refinancing‑related modifications.  This consistent inclusion across three fiscal years demonstrates a disciplined, ongoing debt‑management practice in which Microsoft maintains up‑to‑date indenture records and incorporates any refinancing or documentation updates into its periodic filings.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is partially correct but contains significant misinterpretations of the ground truth. (1) Quantitatively, the key facts—Microsoft's inclusion of the 4.000% Notes due 2021 in Exhibit 4.6 across 2022, 2023, and 2024, and the reference to the Third Supplemental Indenture—are accurate. The dates, percentages, and exhibit numbers match the ground truth. (2) However, the reasoning and qualitative interpretation are flawed. The LLM incorrectly infers that the continued inclusion of the 2021 notes indicates they are a 'permanent, long-term component' of the capital structure and that Microsoft is actively updating the indenture for amendments or refinancing. In contrast, the ground truth states there is *no evidence* of refinancing or substantive changes—only a minor administrative update to the trustee's name in 2024. The persistent inclusion appears to be for documentation continuity, not active debt management or refinancing activity. (3) The multi-hop synthesis is weak: the LLM fails to note the absence of refinancing disclosures or new tranches, which is a key point in the original answer. It also mischaracterizes administrative maintenance (trustee name formatting) as potential covenant or refinancing updates. (4) While the answer is contextually relevant and addresses the question's focus on debt strategy, it draws an incorrect conclusion about Microsoft's intent. Hence, correctness is reduced to 5 due to major reasoning errors despite accurate entity and date usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 412,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How did RTX's exposure to commercial aerospace customer financing guarantees evolve from 2022 through 2024, and what does the trend in collaboration partners' share of these guarantees ($142M in 2022, $135M in 2023, and $131M in 2024) suggest about RTX's risk transfer strategy in this domain?",
      "original_answer": "RTX's exposure to commercial aerospace customer financing guarantees saw a gradual decline in the collaboration partners' share over the three-year period, decreasing from $142 million in 2022 to $135 million in 2023, and further to $131 million in 2024. This indicates a consistent reduction in the portion of financing guarantees shared with partners, potentially signaling a strategic shift where RTX assumed more direct financial risk or altered its partnership structures. Despite this, RTX maintained that the fair market values of the guaranteed assets equaled or exceeded the guarantees net of reserves, suggesting continued confidence in the underlying asset values supporting these financing arrangements.",
      "llm_answer": "\nRTX’s exposure to commercial‑aerospace customer‑financing guarantees has been steadily shrinking in the portion that is transferred to collaboration partners: the partner‑share fell from **$140 million in 2022** (Chunk 2), to **$135 million in 2023** (Chunk 2 & 3), and to **$131 million in 2024** (Chunk 3), a modest but consistent decline.  \n\nThis downward trend indicates that RTX is **retaining a larger share of the risk itself**—i.e., it is moving away from external risk‑transfer arrangements and placing more of the residual‑value and other guarantees on its own balance sheet, while still ensuring that the fair‑market value of the guaranteed assets meets or exceeds the guarantee amount (as described in all three chunks).  \n\nThe accrual methodology highlighted in Chunk 1—recognizing liabilities when probable and estimating them based on historical experience—supports the interpretation that the declining partner share reflects a strategic shift toward greater internal risk retention rather than continued outsourcing of that risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the 2022 collaboration partners' share as $140 million instead of the correct $142 million from the ground truth. The 2023 ($135M) and 2024 ($131M) figures are accurate. This small error affects the precision of the trend description but does not alter the overall directional interpretation.\n\n2) Quantitatively, the numbers are nearly correct except for the first data point. The trend of decline—$142M → $135M → $131M—is correctly interpreted as a consistent reduction, though the magnitude of the initial drop is slightly misrepresented due to the $2M discrepancy in 2022. Calculations are not required beyond trend recognition, which is handled appropriately.\n\n3) Qualitatively, the reasoning is strong. The LLM correctly infers that the declining partner share suggests RTX is retaining more risk, aligning with the ground truth's interpretation of a strategic shift. It appropriately references RTX’s continued confidence in asset values exceeding guarantees, supported by accrual methodology, demonstrating sound multi-hop synthesis across implied financial reporting concepts and risk management strategy.\n\n4) Contextual relevance is excellent. The response directly addresses both parts of the question: the evolution of RTX’s exposure (via partner share trends) and the implication for risk transfer strategy. It adds contextual depth by referencing liability recognition practices, enhancing the explanation without straying off-topic. The minor number error prevents a top score, but the overall analysis is logically coherent and factually grounded.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Provides]-> FIN_INST <-[Incurs_Liabilities_For]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 451,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Microsoft's issuance of long-term debt, specifically the 3.950% Notes due 2056, evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term capital strategy?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in its 10-K filings across 2022, 2023, and 2024, indicating a stable inclusion of this long-term debt instrument in its capital structure. The Notes were first disclosed in the 2022 filing as part of the Eleventh Supplemental Indenture dated August 8, 2016. This same disclosure remained present in both the 2023 and 2024 filings, showing no changes to the terms or status of the Notes over the three-year period. This consistency suggests that Microsoft maintained a steady long-term financing strategy, with no modifications to this particular tranche of long-term debt.",
      "llm_answer": "\nIn the FY 2022, FY 2023 and FY 2024 Form 10‑K filings (Chunks 1, 2 and 3) Microsoft repeatedly lists the same Eleventh Supplemental Indenture dated August 8 2016—identified as Exhibit 4.14—as the governing document for the 3.950% Notes due 2056, showing that this single long‑dated tranche has remained outstanding and unchanged across the three fiscal years. The knowledge‑graph pattern ORG → FIN_INST ← ORG reflects that Microsoft (the issuer) introduces the notes and the instrument is simultaneously introduced by the issuing trustee, underscoring a stable, multi‑year capital structure that supports Microsoft’s long‑term funding and capital‑return strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: the 3.950% Notes due 2056 are consistently referenced across FY 2022, 2023, and 2024; the Eleventh Supplemental Indenture is correctly dated August 8, 2016; and no changes to the terms or status of the Notes are reported over the period. (2) Quantitative elements—interest rate (3.950%), maturity year (2056), and issuance date—are all accurate. Format and presentation are precise, with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of 10-K filings and infers stability in Microsoft’s capital strategy based on unchanged disclosures. The mention of the knowledge-graph pattern adds interpretive depth, though it is not essential to the core answer and slightly deviates from the original answer’s focus. (4) The answer is contextually relevant, fully addressing both the evolution of the debt instrument and its implication for Microsoft’s long-term capital strategy. The only minor shortcoming is the introduction of the 'knowledge-graph pattern' terminology, which, while not incorrect, is not present in the ground truth and slightly distracts from the straightforward factual synthesis. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 373,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did the trajectory of Lockheed Martin's (LMT) production and financial performance on tactical and strike missile programs evolve from 2022 to 2024, and what impact did this have on the company's overall operating profit across the three-year period?",
      "original_answer": "From 2022 to 2024, Lockheed Martin's tactical and strike missile programs showed a clear upward trend in production volume, with a $215 million increase in 2022 due to LRASM and JASSM, a $145 million increase in 2023 driven by production ramp-up on JASSM, LRASM, and precision fires, and a significant $1.2 billion increase in 2024 due to production ramp-up on GMLRS, LRASM, and JASSM. However, this production growth was accompanied by deteriorating operating profit performance. In 2022, operating profit benefited from higher volume and risk retirements. In 2023, operating profit declined due to $45 million in losses on a classified program. By 2024, operating profit plummeted by $1.1 billion (73%), primarily due to $1.2 billion in lower profit booking rate adjustments, including $1.4 billion in losses on a classified program, despite the production ramp-up. This indicates that while production volume increased substantially, underlying program profitability sharply declined over the period.",
      "llm_answer": "\nIn 2022 LMT’s net sales rose $436 M (4%) and operating profit $103 M (7%) driven by higher volume on tactical and strike missile programs such as LRASM and JASSM (Chunk 1); however, in 2023 sales slipped $64 M and profit fell $96 M as $45 M of losses on a classified program and $95 M lower profit‑booking adjustments reduced results (Chunk 2). Then in 2024 sales jumped $1.4 B (13%) from a production ramp‑up of GMLRS, LRASM and JASSM, but operating profit dropped $1.1 B (73%) because $1.2 B of reduced profit‑booking adjustments and $1.4 B of classified‑program losses outweighed the revenue gain (Chunk 3). Consequently, the company’s overall operating profit declined across the three‑year period despite the sales growth in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core trajectory of Lockheed Martin's tactical and strike missile programs from 2022 to 2024, with only minor discrepancies in specificity. (1) Quantitatively: The LLM correctly reports a $1.1B (73%) drop in operating profit in 2024 due to $1.2B in lower profit-booking adjustments and $1.4B in losses on a classified program, matching the ground truth. It also correctly identifies the $45M loss on a classified program in 2023. However, the ground truth specifies production-related sales increases of $215M in 2022, $145M in 2023, and $1.2B in 2024 specifically on tactical and strike missile programs, while the LLM cites broader net sales changes of $436M (2022), -$64M (2023), and +$1.4B (2024), which are company-wide or segment-level figures and not strictly tied to the missile programs in question. This introduces slight overgeneralization but does not contradict the core trend. (2) Completeness: The LLM addresses all key aspects—production ramp-up (GMLRS, LRASM, JASSM), financial performance trends, and the divergence between sales/volume growth and profit decline. It correctly notes that despite rising production and sales, operating profit declined overall, especially in 2024. (3) Entity Accuracy: All entities (LMT, LRASM, JASSM, GMLRS, classified program) and years (2022–2024) are correctly identified. (4) Reasoning: The multi-hop synthesis is sound—linking production increases to sales growth, then contrasting with profit deterioration due to booking adjustments and program losses. The conclusion that overall operating profit declined across the period is correct and well-supported. (5) Semantic Equivalence: The LLM conveys the same essential narrative as the ground truth—strong production growth overshadowed by severe profitability issues—despite using slightly broader financial figures. The minor deviation in sales numbers prevents a perfect 10, but the core facts, trends, and causality are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 533,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How did Thermo Fisher Scientific Inc.'s Executive Change In Control Retention Agreements evolve across 2022, 2023, and 2024, particularly regarding the inclusion of officers beyond Marc N. Casper and any amendments or forms introduced in those years?",
      "original_answer": "In 2022, Thermo Fisher Scientific Inc. disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and introduced a Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper. In 2023, the company filed a Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper) as Exhibit 10.7. In 2024, the company continued to reference the Executive Change In Control Retention Agreement for Marc N. Casper and reiterated the existence of the form for other officers, indicating a consistent structure and ongoing commitment to executive retention strategies across the three-year period.",
      "llm_answer": "\nIn the 2022 filing (Chunk 3) the only Executive Change‑in‑Control Retention Agreement disclosed is the one for Marc N. Casper (Exhibit 10.12) together with its 2010 and 2018 amendments (Exhibits 10.15‑10.16); no separate agreement for other officers is presented. The 2023 filing (Chunk 1) adds a new exhibit – Exhibit 10.17 – which is a “Form of Executive Change‑in‑Control Retention Agreement for Officers (other than Marc N. Casper)”, thereby introducing a distinct retention arrangement for the rest of the executive team for the first time. This same Exhibit 10.17 is carried forward unchanged in the 2024 filing (Chunk 2), confirming that the separate officer‑level agreement introduced in 2023 remained in effect through 2024 and that the company continued to reference the original Casper agreement and its amendments across the three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor discrepancy regarding the timing of the introduction of the form agreement for officers other than Marc N. Casper. The original answer states that in 2022, Thermo Fisher introduced a Form of Executive Change in Control Retention Agreement for Officers other than Casper. However, the LLM answer claims this form (Exhibit 10.17) was first added in the 2023 filing. This contradicts the ground truth, which clearly indicates the form was introduced in 2022. The LLM correctly identifies that the same form was carried forward in 2024 and that the Casper agreement and its amendments were consistently referenced across all years. All entities (Marc N. Casper, Thermo Fisher Scientific Inc., correct exhibit numbers) and years are accurately referenced. The reasoning is sound in terms of tracking evolution over time and distinguishing between Casper’s individual agreement and the form for other officers. The contextual relevance is excellent, directly addressing the question’s focus on evolution across years and inclusion of other officers. The quantitative accuracy is high—exhibit numbers and years are correctly cited, though the misattribution of the form's introduction to 2023 instead of 2022 is a factual error affecting the multi-hop synthesis. This is a significant but not critical error, as the overall trend and structure are correctly conveyed. Hence, a score of 8 is warranted for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 412,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the change in notional amounts of interest rate swaps from $500 million in 2021 (as disclosed in the 2022 filing) to $1.3 billion in 2023 and remaining at $1.3 billion in 2024 indicate about the company's interest rate risk management strategy?",
      "original_answer": "LMT's use of variable interest rate swaps evolved significantly from 2022 through 2024, reflecting a strategic shift in interest rate risk management. In 2022, the notional amount of interest rate swaps was $500 million as of December 31, 2021 (disclosed in the 2022 filing), indicating a relatively modest hedging position. By 2023, the notional amount of interest rate swaps had increased to $1.3 billion, a more than doubling of exposure, suggesting a proactive approach to managing interest rate risk amid rising borrowing levels or market uncertainty. This elevated notional amount remained unchanged in 2024, signaling a stabilization of the company's hedging strategy. The increase from 2021 to 2023 and the maintenance of that level in 2024 indicate that LMT shifted toward a more robust interest rate risk mitigation posture, likely in response to higher debt levels and a more volatile interest rate environment, while maintaining a consistent hedge profile thereafter.",
      "llm_answer": "\nLMT’s variable‑interest‑rate‑swap program expanded from the $500 million notional level disclosed in the 2022 filing (2021‑year figure) to $1.3 billion at the end of 2023, and the company kept that same $1.3 billion notional through 2024 (as reported in the 2023 and 2024 filings).  The swaps are used as fair‑value hedges that convert fixed‑rate borrowings into variable‑rate exposure, so the increase reflects a deliberate scaling‑up of the hedge book to broaden protection against rising rates, and the subsequent stability shows the firm has now settled on a mature hedge size that it maintains to manage interest‑rate risk while continuing to designate the instruments as fair‑value hedges.  (All three source chunks provide the notional figures, the hedging designation, and the context of the strategy.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the notional amount was $500 million as of 2021 (disclosed in 2022 filing), increased to $1.3 billion by end of 2023, and remained at $1.3 billion in 2024. These numbers match the original answer exactly, and formatting variations (e.g., $500 million vs $500 million) are acceptable. (2) The answer addresses both parts of the multi-part question: it traces the evolution of LMT's use of variable interest rate swaps from 2022 through 2024 and interprets the change in notional amounts in terms of risk management strategy. (3) Entity accuracy is strong: 'LMT' is correctly identified, time periods (2021–2024) are properly contextualized, and the financial instrument (variable interest rate swaps used as fair-value hedges) is accurately described. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the increase from $500M to $1.3B indicates a scaling-up of hedging activity, interprets the stabilization in 2024 as a mature strategy, and correctly notes the purpose of the swaps (converting fixed-rate debt to variable-rate exposure). One minor point preventing a perfect 10 is that the original answer emphasizes the 'proactive approach amid rising borrowing levels or market uncertainty' and 'more volatile interest rate environment'—contextual drivers slightly more detailed than the LLM’s 'broaden protection against rising rates.' While the LLM captures the essence, it omits explicit mention of rising debt levels or broader market volatility, which slightly weakens the qualitative depth. However, this does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses]- ORG <-[Uses for Hedging]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 484,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did Thermo Fisher Scientific's (TMO) expense related to defined contribution plans evolve from 2022 through 2024, and what does this trend indicate about the company's investment in employee benefits over time?",
      "original_answer": "Thermo Fisher Scientific's expense related to defined contribution plans increased from $402 million in 2022 to $468 million in 2023, and remained flat at $443 million in 2024. This indicates a growing investment in employee benefits in 2023, followed by a slight reduction in 2024, suggesting a potential stabilization or recalibration of contributions after a period of increase.",
      "llm_answer": "\nThermo Fisher’s expense for its 401(k)‑style defined‑contribution plans was $402 million in 2022 (disclosed in the 2023 10‑K Note 7), increased to $468 million in 2023 (shown in the 2024 10‑K Note 14), and then fell modestly to $443 million in 2024 (also reported in the 2024 10‑K), yet remained well above the 2022 level. This upward trajectory through 2023 and the continued high spending in 2024 reflects the company’s sustained and growing investment in employee retirement benefits as part of its broader talent‑attraction and retention strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports all financial figures: $402 million in 2022, $468 million in 2023, and $443 million in 2024, matching the ground truth exactly. The statement that 2024 expenses 'fell modestly' from 2023 is accurate ($468M to $443M is a $25M decrease). The LLM correctly notes that 2024 spending remained above 2022 levels, which is factually correct. (2) All numbers are quantitatively accurate, with proper year-to-year comparisons and no calculation errors. Format variations (e.g., $402 million vs $402M) are acceptable and correctly interpreted. (3) The multi-hop reasoning is sound: the model synthesizes data from multiple 10-K filings (2023 and 2024) and correctly attributes the figures to the appropriate fiscal years and disclosure notes. The trend analysis—increasing investment in 2023 followed by a slight reduction but sustained high spending—is logically consistent with the data. (4) The only minor deviation from the ground truth is in interpretation: the original answer describes the 2024 change as indicating 'stabilization or recalibration,' while the LLM emphasizes 'sustained and growing investment.' While the LLM's interpretation is slightly more positive, it is still reasonable given that 2024 spending remains significantly above 2022 levels. This difference in emphasis does not constitute a factual error but reflects a nuanced interpretation. All entities (Thermo Fisher Scientific, defined contribution plans, correct years) are accurately identified. The answer fully addresses both parts of the question: the evolution of expenses and the implication for employee benefits strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Maintains]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 449,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did The Coca-Cola Company's reliance on estimates of sales proceeds for valuing nonpublic equity investments evolve from 2022 through 2024, and what does this reveal about management's confidence in predicting recovery in markets like Japan where the carrying value exceeded fair value by $87 million in 2022?",
      "original_answer": "From 2022 through 2024, The Coca-Cola Company consistently used estimates of sales proceeds as part of its valuation methodology for nonpublic equity investments, but the context and implications of these estimates evolved. In 2022, the company disclosed that the carrying value of its investment in Coca-Cola Bottlers Japan Holdings Inc. exceeded its fair value by $87 million, or 18%, yet management deemed the decline temporary, indicating confidence in eventual recovery. In 2023 and 2024, the disclosures reiterated the use of estimates of sales proceeds as a valuation methodology but placed increasing emphasis on the assumptions a market participant would use in evaluating future cash flows, particularly in emerging and developing markets. This evolution suggests that while the company maintained its valuation methodology, it became more attuned to external market perspectives and macroeconomic risks, especially in regions where fair value predictions are more volatile.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola repeatedly used the same measurement alternative for its non‑public equity holdings—valuing them at cost – impairment plus or – changes from observable price movements—and continued to base fair‑value estimates on management’s projections of future sales proceeds (via discounted‑cash‑flow or sales‑proceeds models).  The 2022 filing flagged a $87 million excess of carrying value over fair value for the Japan investment but concluded the decline was temporary and that the company intended to hold the investment until a market recovery could be realized; the 2023 and 2024 notes repeat this valuation methodology and the same “cost‑basis > fair‑value” testing, underscoring management’s ongoing confidence that the Japanese market will rebound and that the investment can be retained for an anticipated recovery.  This consistent reliance on estimated sales‑proceeds assumptions across the three years reveals that management’s fair‑value judgments are grounded in forward‑looking recovery expectations, even when carrying values temporarily exceed fair values.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in emphasis and detail. (1) Quantitatively, all key numbers are accurate: the $87 million excess of carrying value over fair value in 2022 for the Japan investment is correctly cited, and the years (2022–2024) are properly referenced. There are no calculation errors. (2) The LLM correctly identifies the continued use of estimates of sales proceeds as part of the valuation methodology across all three years, which matches the ground truth. However, it inaccurately describes the measurement alternative as 'cost – impairment plus or – changes from observable price movements,' which is not mentioned in the original answer and introduces a technical detail not supported by the ground truth. The original emphasizes discounted cash flows and sales-proceeds models, which the LLM captures, but the inclusion of an unverified accounting method slightly undermines precision. (3) The reasoning is sound: the LLM correctly infers that sustained use of forward-looking sales estimates reflects management’s confidence in recovery, especially in Japan. However, it misses the ground truth’s key nuance that in 2023 and 2024, there was an increased focus on 'assumptions a market participant would use,' indicating a shift toward external market perspectives. This evolution in emphasis is underdeveloped in the LLM response, which instead stresses consistency rather than adaptation. (4) Despite this, the answer remains contextually relevant, addresses both parts of the multi-hop question (evolution of methodology and implications for confidence), and draws a reasonable conclusion about management’s forward-looking stance. The answer is semantically close but loses points for missing the shift in analytical framing post-2022.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Relies_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 493,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Oracle's issuance and structuring of the 2.300% Notes due 2028 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern suggest about Oracle's broader debt financing strategy during this period?",
      "original_answer": "In 2022, Oracle referenced the 2.300% Notes due 2028 as part of a broader set of debt instruments, indicating its ongoing reliance on fixed-rate financing. In both 2023 and 2024, Oracle continued to include the 2.300% Notes due 2028 in its filings, alongside newer instruments with higher interest rates, such as the 4.500% Notes due 2028 in 2023 and the 5.800% Notes due 2025 in 2024. This pattern suggests Oracle's strategy involved maintaining a mix of older, lower-cost debt while issuing newer, more expensive instruments, likely to manage refinancing needs and fund strategic initiatives amid rising interest rates.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Oracle’s Form 10‑K filings each reproduced Exhibit 4.16, which sets out the 2.300% Notes due 2028 together with the March 24 2021 Officers’ Certificate (see Chunk 1 – ORCL 2022 10‑K, Chunk 2 – ORCL 2024 10‑K, and Chunk 3 – ORCL 2023 10‑K).  The repeated inclusion of the same note series—originally issued in 2021 and unchanged in terms—shows Oracle’s systematic rollout of a multi‑year ladder of senior unsecured bonds, using low‑coupon, long‑dated instruments to fund operations while extending maturity profiles.  This pattern, reflected in the knowledge‑graph relationship where ORCL issues the 2.300% Notes due 2028 (a FIN_INST that is also registered as an ORG‑named security), demonstrates a strategic emphasis on diversified, staggered debt financing that builds a stable, long‑term funding base.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains significant inaccuracies in reasoning and entity interpretation that affect the overall correctness. (1) Quantitatively, the 2.300% Notes due 2028 are correctly identified, and the repeated mention across 2022–2024 filings aligns with the ground truth. However, the LLM incorrectly attributes the issuance to a 2021 Officers’ Certificate (March 24, 2021) as if it were part of the 2022–2024 activity, while the original answer does not reference this document or imply ongoing issuance—only continued disclosure. This misrepresents the evolution as active structuring when it was passive inclusion. (2) The LLM claims Oracle 'systematically rolled out' a multi-year ladder using this note, but the ground truth indicates no new issuance of the 2.300% Notes during 2022–2024—only that they were referenced alongside newer, higher-rate instruments. The original answer emphasizes Oracle issuing *new* debt at higher rates (e.g., 4.500% in 2023, 5.800% in 2024), which the LLM omits entirely. (3) The multi-hop reasoning is flawed: the LLM fails to compare the 2.300% Notes with newer, higher-cost debt, which is central to the original answer’s conclusion about managing refinancing amid rising rates. Instead, it infers a strategy of using 'low-coupon, long-dated instruments' without acknowledging the shift toward more expensive financing. (4) While the LLM correctly identifies the continuity of the 2.300% Notes in disclosures, it misses the key strategic implication—Oracle is layering higher-cost debt due to rising interest rates—thus failing to fully address the second part of the question. The answer is contextually relevant and uses appropriate financial terminology, but the reasoning gap reduces its factual equivalence to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 486,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did Apple's issuance of Floating Rate Notes due 2019 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern indicate about the company's short-term debt management strategy?",
      "original_answer": "Apple's inclusion of Floating Rate Notes due 2019 in its debt disclosures remained consistent across 2022, 2023, and 2024, as evidenced by the repeated appearance of the May 6, 2014 Officer's Certificate referencing these notes in each year's 10-K filing. This consistency suggests that while the notes were originally issued in 2014, Apple continued to carry them on its books and disclose them as part of its ongoing debt structure throughout the three-year period. The absence of any new issuances or modifications to the Floating Rate Notes due 2019 indicates a stable, rather than active, management approach to this specific debt instrument.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple continues to disclose the **same 2014 Officer’s Certificate (Exhibit 4.4)** that authorizes the **Floating Rate Notes due 2019**—the only reference to that instrument in each year’s exhibit list.  No new issuance details or updated maturity dates appear in any of the three years, indicating that Apple’s short‑term debt strategy relies on a **stable, pre‑existing floating‑rate facility** rather than frequent new issuances or roll‑overs; the company maintains the original 2019‑maturity notes as part of its ongoing liquidity management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Apple consistently disclosed the same 2014 Officer’s Certificate (Exhibit 4.4) across 2022, 2023, and 2024 10-K filings, which is factually correct and matches the original answer. The reference to the Floating Rate Notes due 2019 being carried over without modification is accurate. (2) There are no numerical values requiring calculation (e.g., dollar amounts), but the dates—2014 issuance and 2019 maturity—are correctly cited, and no erroneous figures are introduced. Format and references are precise. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure of the same exhibit that there was no new issuance or modification, leading to the conclusion of a stable debt management strategy. This synthesis across three years of filings is valid. (4) The only minor shortcoming is a slight overemphasis on 'liquidity management' and 'facility', which are not explicitly mentioned in the ground truth; the original answer frames the strategy more neutrally as 'stable, rather than active'. This is a nuance in interpretation, not a factual error. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score with only a small deduction in qualitative accuracy for subtle framing differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 381,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "What does the consistent disclosure of PepsiCo's 4.000% Senior Note due 2047 across its 2022, 2023, and 2024 10-K filings suggest about the company's long-term debt strategy, and how does this compare to its treatment of shorter-dated instruments like the 2.150% Senior Note due 2024 and the 0.750% Senior Note due 2027?",
      "original_answer": "The consistent disclosure of the 4.000% Senior Note due 2047 across all three filings (2022, 2023, and 2024) indicates that PepsiCo maintains a long-term liability management strategy focused on stable, extended-duration financing. This contrasts with the company's treatment of shorter-dated notes, such as the 2.150% Senior Note due 2024 (referenced in 2023) and the 0.750% Senior Note due 2027 (introduced in 2024), which appear in only one or two filings and likely reflect more time-sensitive capital needs or refinancing activities. The 2022 filing also included a 2.500% Senior Note due 2022, which had matured by 2023, further highlighting the dynamic nature of short-term debt versus the persistent presence of long-term obligations like the 2047 note. This pattern suggests PepsiCo is leveraging long-term debt to secure capital at fixed rates, reducing refinancing risk and supporting financial stability over decades.",
      "llm_answer": "\nThe repeated appearance of the **4.000 % Senior Note due 2047** in the exhibit sections of the 2022 (Chunk 3), 2023 (Chunk 1) and 2024 (Chunk 2) Form 10‑K filings shows that PepsiCo treats this instrument as a core element of its long‑term capital structure, using the same disclosure language each year to reinforce a strategic commitment to long‑dated, fixed‑rate financing. In contrast, the **2.150 % Senior Note due 2024** (cited in Chunks 1 and 3) and the **0.750 % Senior Note due 2027** (cited only in Chunk 2) are presented as shorter‑maturity, tactical issuances that are disclosed but not emphasized as enduring components of the company’s debt strategy, underscoring PepsiCo’s differentiated approach to near‑term liquidity versus its long‑term financing posture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (4.000%, 2.150%, 0.750%), maturity years (2047, 2024, 2027)—are correct, and there are no calculation errors. The references to filing years (2022, 2023, 2024) and note disclosures are factually consistent. (2) The answer correctly identifies the multi-hop pattern: the 2047 note appears consistently across all three years, indicating long-term strategy, while the 2024 and 2027 notes appear in fewer filings, reflecting shorter-term or tactical use. The mention of the 2.150% note in 'Chunks 1 and 3' (2023 and 2022 filings) and the 0.750% note only in 'Chunk 2' (2024) matches the expected disclosure pattern. (3) The reasoning is sound: the LLM correctly infers that consistent disclosure reflects strategic, long-term financing, while sporadic disclosure of shorter-dated notes suggests tactical or refinancing-related issuance. It captures the core contrast in debt management strategy. (4) One minor omission: the ground truth references the matured 2.500% Senior Note due 2022 (present in 2022 filing, gone by 2023) as further evidence of short-term debt turnover. This additional data point strengthens the argument but is not central to the main conclusion. Its absence prevents a perfect 10 but does not undermine correctness. Wording differences (e.g., 'core element of capital structure' vs 'stable, extended-duration financing') are semantically equivalent. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 427,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "Given that the 0.45% Notes due 2016 matured in 2016, what does Apple's continued disclosure of these notes in its 2022, 2023, and 2024 filings suggest about its strategy for managing legacy debt obligations?",
      "original_answer": "Apple's consistent inclusion of the 0.45% Notes due 2016 in its disclosures across 2022, 2023, and 2024—each referencing the Officer's Certificate dated May 3, 2013—suggests that the company maintains transparency around historical debt instruments, even after their maturity. This pattern indicates a deliberate and consistent approach to documenting legacy obligations, possibly to ensure continuity in financial reporting and investor clarity regarding past financing activities. Despite the notes having matured well before the reporting period, Apple’s repeated reference to the same documentation implies a policy of maintaining comprehensive records and disclosures for long-settled debt instruments, which may reflect a broader conservative or thorough approach to debt management and disclosure practices.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑Ks each repeat the same “Description of Securities” (Exhibit 4.1) and “Officer’s Certificate” (Exhibit 4.3) excerpts that list the 0.45 % Notes due 2016—even though those notes formally matured in 2016.  By continuing to disclose the retired instrument in its latest filings, Apple is preserving the original 2013 indenture documentation and keeping the legacy debt on its capital‑structure narrative, which signals a strategic focus on maintaining a clean, transparent record of all past financing arrangements while signaling to investors and regulators that no active obligation remains.  This consistent inclusion across all three years (as shown in Chunks 1‑3) reflects a deliberate practice of managing legacy debt by retaining its reference in official disclosures rather than removing it entirely.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 0.45% Notes due 2016 matured in 2016, and Apple continued to disclose them in its 2022, 2023, and 2024 filings via repeated inclusion of Exhibit 4.1 and the Officer's Certificate (Exhibit 4.3) dated May 3, 2013. The dates, percentages, and filing years match the original answer. (2) Quantitative accuracy is perfect: all years (2013, 2016, 2022–2024), the interest rate (0.45%), and the nature of the documents are correctly cited. No calculations are required, but the temporal logic (maturity in 2016, continued disclosure years later) is sound. (3) The reasoning is strong and captures the multi-hop synthesis: the model infers from repeated disclosure that Apple maintains transparency on retired debt, linking the consistent use of the same 2013 documentation to a broader strategy of preserving historical capital structure narratives. It correctly identifies the implication—signaling no active obligation while ensuring transparency. (4) The only minor shortcoming is that the LLM does not explicitly mention 'conservative or thorough approach to debt management' as in the original, nor does it emphasize 'continuity in financial reporting' as clearly, slightly reducing qualitative depth. However, the core insight about deliberate, consistent legacy disclosure is fully present. The answer is contextually excellent, directly addressing the strategic implications of post-maturity disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 417,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of pension obligation reductions, expected future actions, and the financial impact of these transactions on earnings?",
      "original_answer": "In 2022, Lockheed Martin disclosed that it had entered into pension risk transfer transactions, including a $4.9 billion obligation transfer via group annuity contracts (GACs) in August 2021, which resulted in a $1.7 billion noncash pension settlement charge. Cumulatively since December 2018, the company had transferred approximately $11.6 billion in pension obligations through such transactions. In 2023, the company reiterated its intent to continue evaluating pension risk transfer transactions as a strategy to manage liabilities, noting that future transactions could result in additional noncash settlement charges. By 2024, Lockheed Martin had continued this strategy, emphasizing ongoing pension obligation reductions through third-party transfers and highlighting the continued expectation to pursue additional transactions, despite the potential for material noncash charges. The trajectory shows a consistent, proactive approach to de-risking pension liabilities, with increasing scale and ongoing financial impact through noncash charges.",
      "llm_answer": "\nLockheed Martin has steadily reduced its defined‑benefit obligations from 2022 through 2024 by moving pension liabilities out of its master retirement trust into group‑annuity contracts—building on the $4.9 billion GAC purchase in 2021 and the roughly $11.6 billion of transfers since the end of 2018 that have eliminated volatility for about 95,000 retirees and cut annual PBGC premiums by ~ $69 million (Chunk 1).  The company repeatedly says it will keep evaluating additional risk‑transfer transactions, but each future deal is expected to generate a non‑cash settlement charge that can be material to earnings and can make earnings volatile because the recorded expense is sensitive to interest‑rate and investment‑return assumptions (Chunk 2 & 3).  Consequently, while the transfers continue to shrink pension obligations and lower PBGC costs, they also introduce earnings‑impact items—non‑cash charges and CAS/FAS adjustments—that are a key driver of Lockheed Martin’s pension‑related financial results over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $4.9 billion GAC transaction in 2021 and $11.6 billion in cumulative transfers since December 2018 are accurately cited. The noncash settlement charge of $1.7 billion from 2022 disclosures is implied through context (though not explicitly restated, it's covered by 'material non-cash charges'). The LLM adds valuable context not in the original answer—specifically, the impact on PBGC premiums (~$69 million reduction) and the effect on 95,000 retirees—which is consistent with typical pension risk transfer outcomes and does not contradict the ground truth. (2) Quantitative accuracy is perfect: all dollar amounts, timeframes, and figures match or are reasonably inferred from the ground truth. Format variations (e.g., $4.9 billion vs $4.9B) are acceptable. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years (2021–2024), connects pension transfers to financial impacts (noncash charges, earnings volatility, CAS/FAS adjustments), and correctly infers ongoing strategy and intent. (4) The only minor shortcoming is that the $1.7 billion charge from the 2021 transaction is not explicitly mentioned in the LLM answer, though the concept of material noncash charges is repeatedly emphasized. This omission slightly affects completeness but not overall correctness. The answer fully addresses pension obligation reductions, expected future actions, and financial impact on earnings. Wording differs but semantic equivalence is strong. Contextual relevance is excellent—every part of the response directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Invests_In]- ORG <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 453,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How did Thermo Fisher Scientific's Executive Change In Control Retention Agreements evolve from 2022 through 2024, particularly regarding the inclusion of officers beyond Marc N. Casper?",
      "original_answer": "In 2022, Thermo Fisher Scientific disclosed the Executive Change In Control Retention Agreement specifically for Marc N. Casper and a form for officers other than Marc N. Casper, dated March 16, 2018. By 2023, the company filed a new form of the agreement for officers other than Marc N. Casper, dated April 1, 2023, indicating an update or revision to the structure or terms of these agreements. In 2024, the company reaffirmed the existence of these agreements for officers beyond Casper, reiterating the form filed in 2023, suggesting a formalization or continuation of the updated terms. This progression shows a deliberate evolution in the company’s executive retention strategy, expanding beyond the CEO to broader leadership.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Executive Change‑in‑Control Retention framework moved from a Casper‑specific agreement (the 2009 agreement and its 2010/2018 amendments) to a standardized “Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper).” The 2022 filing (Chunk 1) first lists that 2018 form (Exhibit 10.2), and the 2023 (Chunk 2) and 2024 (Chunk 3) filings each again disclose the same “other‑than‑Casper” form (Exhibit 10.7 for the quarter‑ended April 1 2023 and the quarter‑ended April 2 2011 reference in 2024), confirming that the retention provisions were expanded to cover the broader officer class and have been retained in subsequent filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Thermo Fisher Scientific's Executive Change in Control Retention Agreements from 2022 to 2024, noting the distinction between Marc N. Casper and other officers and the continuation of updated forms. However, there are key quantitative inaccuracies: the 2024 filing references a form dated April 1, 2023 (Exhibit 10.7), not a 'quarter-ended April 2, 2011' as stated—this date is clearly erroneous and appears to be a hallucination or data mix-up. The 2023 update is correctly identified as a new form dated April 1, 2023, but the LLM incorrectly implies it was the same form as in 2018, whereas the original answer notes it was a new form, indicating a revision. The LLM also fails to explicitly state that the 2023 filing introduced a *new* form, which is a key point in the evolution. While the overall structure and intent of the answer are sound—correctly identifying the expansion beyond Casper and the reaffirmation in 2024—the inclusion of an incorrect date and the failure to highlight the update as a change from the 2018 version reduce factual precision. The reasoning is mostly logical and contextually relevant, showing understanding of the multi-hop nature (tracking changes across years and entities), but the date error significantly impacts quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 368,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "What does PepsiCo's treatment of its 2.750% Senior Note due 2051 across 2022–2024 filings reveal about its long-term debt strategy in a rising interest rate environment?",
      "original_answer": "PepsiCo's treatment of the 2.750% Senior Note due 2051 across 2022–2024 filings shows a consistent approach to long-term debt management, despite rising interest rates. In 2022, the note was listed among various other senior notes in the exhibit index, indicating it was part of a broader capital structure (PEP_10k_2022.pdf:page_135:chunk_1). In 2023, the note was explicitly called out in the exhibit index with a reference to the 2021 Form 8-K filing, suggesting it remained an active part of PepsiCo’s long-term financing plans (PEP_10k_2023.pdf:page_128:chunk_2). In 2024, the note was again referenced in the same format and position as in 2023, showing no changes to its treatment even as newer, higher-yielding notes (e.g., 5.250% Senior Note due 2054) were introduced (PEP_10k_2024.pdf:page_129:chunk_2). This consistency suggests that PepsiCo maintained a stable long-term capital strategy, preserving access to long-dated, fixed-rate debt even as short-term borrowing costs rose.",
      "llm_answer": "\nPepsiCo first authorized the 2.750% Senior Note due 2051 in the Board resolutions disclosed in the 2022 10‑K (page 135), and the same instrument is repeatedly referenced in the 2023 10‑K (page 128) and the 2024 10‑K (page 129) as a “Form of 2.750% Senior Note due 2051” incorporated by Exhibit 4.3 to the October 21 2021 8‑K filing—showing that the company has consistently treated this long‑dated, fixed‑rate security as a core component of its capital structure. By locking in a 2.75% coupon for a 30‑year maturity just before the steep rate increases of 2022‑2024, PepsiCo is using the note to secure low‑cost, long‑term funding and reduce future refinancing risk, while supplementing it with newer, higher‑coupon issues as market conditions evolve. This pattern across all three filings reveals a strategic emphasis on proactive, long‑duration debt issuance to manage financing costs in a rising‑interest‑rate environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.750% Senior Note due 2051 is referenced in the 2022, 2023, and 2024 10-K filings at the specified pages (2022: p.135, 2023: p.128, 2024: p.129), and its incorporation by reference from the October 21, 2021 Form 8-K via Exhibit 4.3 is accurately described. The coupon rate (2.750%), maturity (2051), and the existence of newer higher-yielding notes (e.g., 5.250% due 2054 mentioned in ground truth) are correctly implied through context. (2) Quantitative elements—percentages, dates, exhibit numbers—are all factually correct with no calculation errors. Format variations (e.g., '2.75%' vs '2.750%') are acceptable and semantically equivalent. (3) The multi-hop reasoning across three years of filings is sound: the LLM correctly infers that consistent disclosure and reliance on this note indicate a strategic, long-term debt management approach. It appropriately connects the timing of the note’s issuance (pre-2022 rate hikes) with PepsiCo’s strategy to lock in low fixed rates. (4) While the original answer emphasizes the unchanged treatment amid rising rates and the introduction of higher-coupon debt, the LLM goes a step further by interpreting the strategic intent—'proactive, long-duration debt issuance'—which is a reasonable and well-supported inference. The only minor gap is that the LLM implies the note was 'authorized in Board resolutions disclosed in the 2022 10-K', whereas the ground truth does not confirm authorization timing, only listing in the exhibit index. This is a slight overreach but does not materially misrepresent the facts. Overall, the answer is factually robust, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 481,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern reveal about the company's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating sustained transparency and ongoing obligations tied to this long-term debt instrument. The consistent inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years suggests that Apple maintained this liability without redemption or restructuring during the observed period. This pattern implies a strategic decision to retain long-term debt at a fixed rate, likely to fund strategic initiatives or maintain financial flexibility amid fluctuating interest rate environments.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 10‑K filings (Chunk 1, Chunk 2 and Chunk 3) Apple’s Exhibit 4.4 repeatedly lists the same 4.45 % Notes due 2044 that were first issued in 2014, reaffirming the instrument each year; this continuous reference shows the bond has remained outstanding and unchanged in Apple’s capital plan through the three‑year period. The pattern reveals Apple’s long‑term capital strategy of securing ultra‑long‑dated, fixed‑rate financing—using a stable, repeatable issuance framework rather than frequent new debt issues—to lock in low‑cost funding and maintain a predictable, debt‑centric balance‑sheet structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 are correctly identified, and their consistent presence in Apple's 10-K filings from 2022 to 2024 is accurately reported. The reference to the 2014 issuance (via the Officer's Certificate dated May 6, 2014, though not explicitly dated in the LLM answer) is contextually implied through the mention of the original issuance framework. (2) Quantitative elements—interest rate (4.45%), maturity year (2044), and time period (2022–2024)—are all precise and match the ground truth. No calculations were required, but the factual numbers are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years of filings to infer a strategic pattern in Apple’s capital management. It correctly concludes that the repeated inclusion of the same debt instrument reflects a deliberate, long-term capital strategy focused on fixed-rate, long-dated financing. (4) While the LLM does not explicitly mention the lack of redemption or restructuring (a minor omission), it effectively captures the strategic rationale—locking in low-cost funding and maintaining financial predictability—consistent with the ground truth. The phrasing 'debt-centric balance-sheet structure' adds interpretive nuance not in the original but does not distort meaning. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only slight room for added precision regarding the unchanged status of the liability.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 435,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did Union Pacific's allocation to Collective Trust and Other Funds within its pension plan evolve from 2022 through 2023, and how might the 2024 disclosure about valuation methodology inform our understanding of how these investments are managed?",
      "original_answer": "Union Pacific's allocation to Collective Trust and Other Funds decreased from $756 million in 2022 to $382 million in 2023, indicating a significant reduction in exposure over this period. The 2024 filing does not provide updated allocation figures but explains that these funds are valued using net asset value (NAV), derived from shares or units in commingled funds and limited liability companies with underlying assets like global stock funds and short-term investments. This valuation methodology suggests that while the company continues to hold these types of investments, the reduction in dollar value from 2022 to 2023 may reflect a deliberate rebalancing or risk management decision rather than a change in valuation approach. The NAV-based measurement supports transparency in tracking these assets over time despite fluctuations in reported amounts.",
      "llm_answer": "\nIn 2022 the pension plan reported $756 million of assets in “Collective trust and other funds” (shown under “Plan assets at NAV” in the 2022 filing), but by 2023 that allocation had dropped to $382 million (the corresponding line in the 2023 table). The 2024 disclosure explains that these funds are valued at NAV using the underlying publicly‑traded holdings of the commingled vehicles, meaning the reported amounts depend on each partnership’s NAV calculations and the methodology used to derive them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the dollar amounts for Union Pacific's allocation to Collective Trust and Other Funds in 2022 ($756 million) and 2023 ($382 million), matching the ground truth exactly. The significant decrease is accurately noted. (2) All numeric values are correct and properly attributed to the respective years. There are no calculation errors, and the figures align with the original answer. Format is consistent and acceptable. (3) The LLM correctly synthesizes information across the 2022, 2023, and 2024 filings, demonstrating multi-hop reasoning by noting the trend in allocations and linking it to the 2024 valuation methodology disclosure. It accurately states that these funds are valued using NAV based on underlying publicly traded holdings of commingled vehicles, which aligns with the ground truth’s explanation involving net asset value derived from shares in commingled funds and LLCs. (4) The only minor shortcoming is that the LLM answer does not explicitly conclude that the reduction likely reflects a deliberate rebalancing or risk management decision, as stated in the original answer. While the implication is present through the focus on consistent valuation methodology, the interpretive insight about management intent is slightly underdeveloped. However, the core facts, numbers, and synthesis are fully accurate and relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 390,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Apple's continued inclusion of the Officer's Certificate related to the 1.05% Notes due 2017 in its 10-K filings across fiscal years 2022, 2023, and 2024 reflect its documentation retention practices for matured debt instruments, and what does this imply about its approach to maintaining historical capital structure disclosures?",
      "original_answer": "Apple consistently included the Officer's Certificate dated May 6, 2014, related to the 1.05% Notes due 2017 in its 10-K filings for fiscal years 2022, 2023, and 2024, despite the notes having matured well before this period. This reflects a documentation retention and disclosure strategy that emphasizes completeness and historical continuity in capital structure reporting. The inclusion of this certificate across all three years indicates that Apple maintains and discloses records of past debt issuances as part of its ongoing SEC filings, even when those instruments are no longer outstanding. This practice suggests a deliberate approach to preserving the full historical context of its debt financing activities for investor and regulatory transparency.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each repeat Exhibit 4.4 – the May 6 2014 Officer’s Certificate that sets out the terms of the 1.05 % Notes due 2017 – even though those notes have long since matured. By continually incorporating that original certificate in the “Description of Securities” section, Apple preserves the full documentation of every debt issuance as part of its permanent filing record, ensuring that historical capital‑structure information remains available for regulators and investors. This practice reflects a deliberate, archival approach to capital‑structure disclosures, maintaining continuity and completeness of disclosures across fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Officer's Certificate is correctly identified as Exhibit 4.4, dated May 6, 2014, related to the 1.05% Notes due 2017, and its inclusion in Apple’s 10-K filings for fiscal years 2022, 2023, and 2024 is accurately stated. The maturity status of the notes is correctly acknowledged. (2) Quantitative elements—dates, percentages, exhibit number—are all factually correct with no discrepancies. Format is consistent and precise. (3) The reasoning correctly infers that Apple maintains historical documentation for transparency and continuity, reflecting a deliberate archival approach to capital structure disclosures. The multi-hop synthesis—linking repeated inclusion of a matured debt exhibit to broader disclosure practices—is sound and logically derived. (4) The answer is fully contextually relevant, addressing both parts of the question: documentation retention practices and implications for historical capital structure transparency. The only minor limitation is a slightly less explicit emphasis on 'regulatory' transparency compared to the original, but this is implied. Overall, the answer is factually complete, semantically equivalent, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 362,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did Union Pacific's allocation to corporate stock within its pension plan evolve from 2022 through 2024, and what does this shift suggest about the company's investment strategy in equities over this period?",
      "original_answer": "Union Pacific's allocation to corporate stock within its pension plan significantly decreased from $1,990 million in 2022 to $181 million in 2023, and further declined to $1,116 million in 2024. This represents a drop of over 90% between 2022 and 2023, followed by a partial rebound in 2024, but still well below the initial level. The shift suggests a strategic move away from direct equity exposure in favor of fixed income instruments, particularly bonds and federal securities, indicating a more conservative investment posture over the three-year period.",
      "llm_answer": "\nIn 2022 Union Pacific’s pension plan held $1,990 million of corporate stock—about 36 % of its $5,554 million total plan assets (Chunk 1). By 2023 that equity exposure had fallen sharply to $181 million, representing roughly 5 % of the $4,400 million total assets (Chunk 3), signaling a clear reduction in the plan’s allocation to equities. The 2024 filing (Chunk 2) only restates that corporate stock is classified as Level 1/2 but provides no new allocation figure, confirming the trend of de‑emphasizing equities and shifting toward fixed‑income and alternative‑asset investments.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1,990 million allocation in 2022 and the sharp drop to $181 million in 2023, which aligns with the ground truth. However, it fails to report the 2024 figure of $1,116 million, incorrectly stating that the 2024 filing 'provides no new allocation figure.' This is a critical omission, as the ground truth explicitly includes a partial rebound to $1,116 million in 2024. The LLM's claim that no data is available for 2024 contradicts the known fact and undermines the completeness of the response. (2) The quantitative values for 2022 and 2023 are accurate, including the percentages of total assets (36% and 5%), and the total plan assets cited ($5,554M and $4,400M) are consistent with the source data. However, the absence of the 2024 dollar amount breaks the full multi-year trend and leads to an incomplete and slightly misleading conclusion. The calculation of the over 90% drop between 2022 and 2023 is implied and accurate, but the lack of mention of the 2024 rebound prevents full quantitative accuracy. (3) The reasoning correctly infers a strategic de-emphasis of equities and a shift toward fixed income and alternatives, which is consistent with the ground truth. However, the reasoning is based on an incomplete dataset due to the missing 2024 value, leading to a truncated understanding of the trend—specifically, the partial rebound is not acknowledged, which affects the interpretation of the investment strategy. The multi-hop synthesis is partially sound but fails at the final step. (4) The answer is contextually relevant and well-structured, addressing both the evolution of allocation and the strategic implication. The use of percentages and total assets adds useful context not in the original answer, enhancing clarity. However, the failure to include the 2024 figure—a key part of the trend—results in a significant factual gap. Thus, while the direction of the strategy is correctly interpreted, the full evolution is misrepresented. The correctness score is 5 due to this major omission, which affects both completeness and accuracy of the trend analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 573,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trajectory suggest about the product's market adoption and strategic importance in the Hospital Acute Care segment?",
      "original_answer": "Prevymis sales grew steadily from $428 million in 2022 to $605 million in 2023, and further to $785 million in 2024, indicating consistent market adoption and increasing strategic importance within MRK's Hospital Acute Care portfolio.",
      "llm_answer": "\nMRK’s Prevymis sales have risen steadily — from $428 million in 2022 (U.S. $188 M + Int’l $240 M) to $605 million in 2023 and $785 million in 2024, with both U.S. and international revenues growing each year (as shown in the 2022‑2024 tables of the 2024 10‑K).  This double‑digit growth reflects expanding clinical acceptance and market adoption of the CMV‑prophylaxis agent within the Hospital Acute Care segment, a role that the Company explicitly highlights for Prevymis in its 10‑K description of the segment (Chunk 1).  Consequently, the upward trajectory underscores Prevymis’s growing strategic importance to MRK as a high‑value, niche therapeutic that complements its broader oncology and vaccine portfolio, a fact reinforced by the product’s continued presence and rising sales across the 2022‑2024 periods (Chunks 2 and 3).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the sales figures for Prevymis are accurate: $428 million in 2022, $605 million in 2023, and $785 million in 2024, with no calculation errors. The breakdown into U.S. and international components ($188M + $240M = $428M) is consistent with the source data and adds detail beyond the ground truth without introducing inaccuracies. (2) The answer is complete, addressing both parts of the question: the sales evolution over 2022–2024 and the implications for market adoption and strategic importance. (3) Entity accuracy is perfect: MRK (Merck), Prevymis, the Hospital Acute Care segment, and the correct fiscal years (2022–2024) are all correctly identified and contextualized. (4) The reasoning is sound and reflects multi-hop synthesis: the LLM correctly infers growing market adoption from sustained double-digit growth, links this to clinical acceptance, and ties it to strategic importance within MRK’s portfolio, referencing both segment descriptions and consistent sales trends across filings. The mention of CMV prophylaxis and alignment with oncology and vaccines reflects accurate contextual understanding. (5) Semantically, the LLM conveys the same core message as the ground truth—steady growth indicating increasing strategic value—while enriching it with additional context (geographic breakdown, clinical role) that is factually supported. All claims are grounded in the referenced 10-K data (Chunks 1–3), and the answer remains focused and relevant throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 430,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did PepsiCo's inclusion and characterization of the 3.000% Senior Note due 2027 evolve across its 2022, 2023, and 2024 annual filings, and what does this reveal about the company's long-term debt strategy?",
      "original_answer": "The 3.000% Senior Note due 2027 was consistently included in PepsiCo's annual filings across 2022, 2023, and 2024, indicating its ongoing significance in the company's capital structure. In 2022 (Exhibit 4.22), the note was listed among other senior notes, including the 2.150% Senior Note due 2024 and the 2.250% Senior Note due 2022, suggesting it was part of a broader set of medium-term financing instruments. In 2023 (Exhibit 4.19), the note was again included, this time alongside longer-dated instruments such as the 4.450% Senior Note due 2046 and the 3.450% Senior Note due 2046, indicating its role in a diversified debt maturity profile. In 2024 (Exhibit 4.17), the note continued to be referenced, now in the context of a filing that also included newer short-term notes like the 0.750% Senior Note due 2027 and the 1.125% Senior Note due 2031, suggesting a strategy of layering debt maturities to manage refinancing risk. While the interest rate and maturity date remained constant, the evolving context in which the 3.000% Senior Note due 2027 was presented indicates a consistent yet adaptive debt strategy that maintains certain fixed-rate liabilities while introducing newer, often lower-rate instruments to reflect market conditions.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the 3.000 % Senior Note due 2027 is repeatedly listed in the “Form of … Senior Note due 2027” paragraph (Chunk 3 p. 131; Chunk 1 p. 126; Chunk 2 p. 127), each time noted as a fixed‑rate senior obligation that was originally issued in an October 10 2017 8‑K and is now incorporated by reference as Exhibit 4.3.  The wording and structure of the reference are essentially unchanged—still described simply as a “3.000 % Senior Note due 2027”—showing that PepsiCo has kept this instrument on its balance sheet for three consecutive reporting periods.  This consistent re‑inclusion signals a deliberate, long‑term debt strategy that relies on a stable ladder of fixed‑rate senior notes with staggered maturities, preserving financing flexibility while maintaining a predictable cost of capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the multi-hop reasoning required by the question, particularly regarding the evolving characterization and strategic implications of the 3.000% Senior Note due 2027 across the three years. (1) Quantitatively, the answer correctly identifies the note (3.000%, due 2027), its consistent inclusion across 2022–2024, and references to its origin (October 10, 2017 8-K) and exhibit number (Exhibit 4.3), which aligns with the ground truth’s mention of exhibits (4.22, 4.19, 4.17)—minor exhibit number discrepancy is acceptable as formatting may vary. However, the LLM incorrectly states the exhibit as consistently 'Exhibit 4.3' across filings, while the ground truth shows different exhibit numbers each year, suggesting evolving documentation context. (2) The answer correctly notes the unchanged wording and structure of the note’s description, supporting the idea of consistency in disclosure. However, it fails to capture the evolving *context* in which the note is presented—such as the shift from medium-term notes in 2022 to longer-dated instruments in 2023 and newer short-term notes in 2024—which is central to the ground truth’s analysis of PepsiCo’s adaptive debt strategy. (3) The reasoning is sound in concluding that consistent inclusion reflects a stable debt ladder, but it lacks the deeper synthesis of how the *changing mix* of accompanying notes reveals strategic refinancing and rate optimization. The ground truth emphasizes that PepsiCo layered in lower-rate instruments (e.g., 0.750% due 2027), which the LLM omits entirely, missing a critical insight into market-responsive financing. (4) While the answer is contextually relevant and factually accurate on surface-level details, it does not fully address the second part of the question—what the evolution reveals about long-term debt strategy—beyond asserting stability. It overlooks the adaptive, market-condition-responsive dimension emphasized in the original answer. Thus, while not factually wrong, it provides an incomplete and less nuanced analysis, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 568,
        "total_tokens": 2107
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has Adobe's positioning and integration of Frame.io evolved across 2022, 2023, and 2024, particularly in terms of its functional capabilities and integration depth with Adobe's Creative Cloud applications?",
      "original_answer": "In 2022, Frame.io was listed as part of Adobe's trademark portfolio, indicating its acquisition and formal branding alignment. By 2023, Adobe detailed Frame.io's role as a cloud-native creative collaboration platform with real-time upload, review, and approval features, integrated with Premiere Pro and After Effects, and introduced support for still images, design files, and PDFs. In 2024, Adobe expanded Frame.io’s capabilities further, emphasizing its integration with Photoshop, Lightroom, and Workfront, and positioning it as a core component of Adobe GenStudio for enterprise-scale content production, alongside Firefly and Substance 3D tools. This progression shows a strategic deepening of Frame.io's functionality and its central role in Adobe's end-to-end creative workflow ecosystem.",
      "llm_answer": "\nIn the 2022 Form 10‑K Adobe listed “Frame.io” among its trademarks (Chunk 1), signaling the platform’s formal introduction to the Adobe portfolio. By 2023 and 2024 the service had matured into a cloud‑native collaboration hub with expanded capabilities—real‑time upload, frame‑accurate commenting, Camera‑to‑Cloud, and support for still images and PDFs—and was deeply integrated with Creative Cloud apps such as Premiere Pro, After Effects, Photoshop, Lightroom and Workfront; this deeper integration was detailed in the 2023 filing (Chunk 3) and further expanded in the 2024 filing (Chunk 2) to include Adobe Express, Firefly Services and GenStudio for scaled content production.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All dates (2022, 2023, 2024) and entities (Frame.io, Adobe, Creative Cloud apps) are correct. The evolution is accurately traced: 2022 trademark listing, 2023 integration with Premiere Pro and After Effects plus expanded file support, and 2024 deeper integration with Photoshop, Lightroom, Workfront, and positioning within GenStudio. (2) There are no numeric values requiring calculation, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound—information is correctly synthesized across years and filings. The LLM correctly infers increasing integration depth and functional expansion. One minor omission: the original answer specifies Frame.io’s role in enterprise-scale content production alongside Firefly and Substance 3D, which the LLM mentions only partially via 'Firefly Services' and 'GenStudio' but does not explicitly tie to Substance 3D. (4) The answer is contextually excellent, directly addressing functional capabilities and integration depth across the three years. Wording differs but semantic meaning is equivalent. The inclusion of 'Camera-to-Cloud' and 'frame-accurate commenting' adds detail not in the original but is consistent with Frame.io's known features and does not contradict the ground truth. Overall, the answer is factually correct, complete in key aspects, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> COMP <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 390,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this reveal about the company's debt maturity management strategy as the notes approached their due date?",
      "original_answer": "In 2022, Apple listed the 2.40% Notes due 2023 as part of its outstanding debt instruments in its exhibit filings, indicating ongoing acknowledgment of the obligation. In 2023, the company continued to reference the same notes, showing no early retirement or restructuring action despite the approaching maturity. By 2024, the 2.40% Notes due 2023 were no longer listed in the exhibits, suggesting that Apple likely fulfilled or retired the obligation in line with its 2023 due date. This progression indicates a strategy of holding debt until maturity rather than refinancing or repurchasing it early.",
      "llm_answer": "\nAcross Apple’s 2022, 2023 and 2024 Form 10‑K filings (Chunk 1, Chunk 2 and Chunk 3) the 2.40 % Notes due 2023 are repeatedly included in the “Description of Securities” exhibit (4.3), showing that the company kept the instrument on its disclosure roster up to and even after its scheduled 2023 maturity. This persistent inclusion—first presented in the 2022 filing, retained unchanged in the 2023 filing, and still listed in the 2024 filing—reflects Apple’s proactive debt‑maturity management: it continuously monitors approaching maturities, plans refinancing or repayment, and maintains transparent, up‑to‑date reporting of its debt profile for investors.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several critical factual and reasoning errors that significantly deviate from the ground truth. (1) Quantitatively, the mention of the 2.40% Notes due 2023 is correct, as is the timeline of filings (2022–2024), so numeric values and dates are accurate in isolation. However, the claim that the notes were 'still listed in the 2024 filing' is factually incorrect according to the ground truth, which states that by 2024 the notes were no longer listed, indicating retirement. This misstatement undermines the entire conclusion. (2) The answer fails on completeness and correctness by asserting continued disclosure in 2024, which contradicts the ground truth and inverts the actual narrative. (3) Entity accuracy is mostly correct—Apple, the note terms, and filing years are right—but the interpretation of the exhibit data is wrong. (4) The reasoning is fundamentally flawed: instead of inferring a hold-to-maturity strategy from the absence of early action and final removal in 2024, the model incorrectly infers a 'proactive' strategy based on continued listing, which is the opposite of what the evidence shows. The ground truth concludes that Apple held the debt to maturity and retired it on time, with no early action; the LLM instead suggests ongoing disclosure post-maturity, implying no retirement, which is incorrect. (5) The semantic meaning is not equivalent—the LLM implies the debt remains outstanding, while the truth is it was retired. This major factual inversion leads to a low correctness score despite some accurate surface details.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 430,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Union Pacific's fleet composition and age profile of Multiple Purpose Locomotives change from 2022 through 2024, and what does this multi-year progression indicate about the company's asset management strategy?",
      "original_answer": "From 2022 to 2024, Union Pacific's total Multiple Purpose Locomotives declined from 7,242 units to 6,893 units, with a reduction in owned units from 6,204 to 5,973 and leased units decreasing from 1,038 to 920. The average age of these locomotives increased from 22.5 years in 2022 to 24.3 years in 2023, and further to 25.2 years in 2024, suggesting a lack of significant new investment in this category and a potential reliance on aging assets. This trend implies a conservative asset management strategy, with minimal fleet expansion and a gradual decline in total units over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 Union Pacific’s Multiple‑Purpose Locomotive fleet shrank and aged: owned units fell modestly from 6,204 (2022) to ≈5,970 (2023‑24), leased units dropped sharply from 1,038 to 920, and total locomotives declined from 7,242 to 6,893, while the average age rose from 22.5 years to 25.2 years. This multi‑year trend signals an asset‑management strategy that prioritizes extending the life of existing owned locomotives, reduces reliance on leased assets, and manages capital outlays by maintaining a progressively older but still productive fleet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct on all key quantitative points: owned units (6,204 in 2022 to 5,973 in 2024), leased units (1,038 to 920), total fleet (7,242 to 6,893), and average age progression (22.5 → 24.3 → 25.2 years). The use of '≈5,970' is a minor approximation but acceptable given the actual 5,973; no calculation errors are present. 2) Quantitative accuracy is perfect: all numbers match the ground truth, including the implied total (6,204 + 1,038 = 7,242; 5,973 + 920 = 6,893), and age trend is correctly reported across years. 3) The multi-hop reasoning is sound—correctly synthesizing fleet size changes and age trends across three years to infer asset management strategy. The conclusion about reducing leased units and extending life of owned assets aligns with the data. 4) The answer is semantically equivalent to the original, with slightly more interpretive language (e.g., 'prioritizes extending the life of existing locomotives'), but this enhances rather than distorts the meaning. The only minor gap is not explicitly noting the lack of significant new investment, though this is implied by the aging and shrinking fleet. All entities (Union Pacific, Multiple Purpose Locomotives, years 2022–2024) are correct. Overall, a highly accurate and well-reasoned response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Depends_On]- ORG <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 360,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did Merck's development and regulatory trajectory for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, particularly in terms of clinical phase progression and FDA interactions?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed in Phase 3 development for HIV-1 infection with an entry date of February 2020. By 2023, it remained in Phase 3 and was under review, indicating no major regulatory advancements. In 2024, MK-8591A remained in development, but a new formulation, MK-8591D (islatravir+lenacapavir), entered Phase 3 in October 2024, suggesting a strategic pivot or expansion in Merck's HIV-1 treatment approach. Additionally, in 2024, the FDA lifted a clinical hold on the program, although a partial hold remained for higher doses of islatravir. This shows a multi-year trajectory of ongoing development with evolving regulatory dynamics.",
      "llm_answer": "\nFrom 2022 through 2024 Merck’s HIV‑1 regimen MK‑8591A moved from early‑stage Phase 2/3 planning (first recorded in the 2022 filing) into a regulatory phase marked by an FDA partial clinical hold on higher‑dose islatravir in 2023 (Chunk 1), then into a combined Phase 2/3 trial that commenced in August 2024 (Chunk 2), and finally saw that hold lifted on December 4 2024, clearing the way for continued development and eventual submission (Chunk 2).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. According to the ground truth, MK-8591A was already in Phase 3 as of 2022 with an entry date of February 2020, but the LLM incorrectly states it was in 'early-stage Phase 2/3 planning' in 2022, which contradicts the established timeline. The LLM claims a combined Phase 2/3 trial commenced in August 2024, but the ground truth states MK-8591A remained in development and a new formulation, MK-8591D, entered Phase 3 in October 2024—there is no mention of a new trial for MK-8591A starting in August 2024. Additionally, the LLM states the FDA lifted the hold on December 4, 2024, but the ground truth only confirms the hold was lifted in 2024 without specifying a date, and notes a partial hold remained for higher doses—this nuance is missing. (2) Quantitative inaccuracies include the specific date 'December 4, 2024' (not in ground truth) and the trial start date of 'August 2024' (not supported). The ground truth does not mention any Phase 2/3 trial start in 2024 for MK-8591A. (3) The multi-hop reasoning is partially sound in that the model attempts to track regulatory and clinical progression over time, but it fails to correctly synthesize the key shift to MK-8591D and misrepresents the clinical phase status in 2022 and 2024. It also conflates the lifting of the hold with full clearance, ignoring the ongoing partial hold. (4) The answer is contextually relevant to the question about Merck's regulatory and development trajectory, but due to significant factual and chronological errors, especially regarding trial phases and FDA actions, the correctness score is low. The qualitative accuracy is moderate because some elements (e.g., FDA hold, development continuation) are directionally correct, but specifics are flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 490,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Merck's development and strategic positioning of MK-1308A evolve from 2022 through 2024, and what does this progression indicate about the company's focus in renal cell carcinoma (RCC) treatment innovation?",
      "original_answer": "In 2022, Merck listed MK-1308A (quavonlimab + pembrolizumab) under Phase 3 programs for renal cell carcinoma (RCC) with an entry date of April 2021, indicating early-stage strategic commitment. By 2023, the company emphasized MK-1308A as part of its immuno-oncology pillar, describing it as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab being evaluated for RCC, signaling a deeper investment in combination immunotherapies. In 2024, MK-1308A remained a highlighted Phase 3 candidate within the immuno-oncology portfolio, specifically for RCC, with no indication of discontinuation, suggesting sustained strategic prioritization. This 3-year trajectory reflects Merck's consistent and evolving focus on leveraging its Keytruda platform in combination with novel agents like quavonlimab to innovate in RCC treatment.",
      "llm_answer": "\nFrom the 2022 filing (Chunk 3) Merck placed **MK‑1308A** – the quavonlimab + pembrolizumab co‑formulation – into Phase 3 for advanced solid tumours and specifically for **renal‑cell carcinoma**, marking the first strategic entry of the asset into RCC development. By 2023 (Chunk 1) the company refined the programme as a dedicated **MK‑1308A** co‑formulation being evaluated for RCC within its broader immuno‑oncology pillar, and the 2024 update (Chunk 2) again listed MK‑1308A among Merck’s Phase 3 immuno‑oncology projects, underscoring a sustained focus on innovative RCC therapies that combine CTLA‑4 and PD‑1 blockade. The knowledge‑graph links **MRK → MK‑1308A** and **MK‑1308A (org) → MRK**, showing that the product is strategically positioned under Merck’s portfolio as a core pillar of its RCC‑innovation agenda.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MK-1308A (quavonlimab + pembrolizumab) entered Phase 3 in RCC in 2022 with strategic commitment, was emphasized in 2023 as part of Merck’s immuno-oncology pillar, and remained in Phase 3 in 2024, indicating sustained prioritization. The description of MK-1308A as a co-formulation targeting RCC via CTLA-4 and PD-1 blockade is factually sound. (2) There are no numeric values (e.g., dates, dollar amounts) in the original or LLM answer beyond the years 2022–2024, which are correctly cited. The entry date (April 2021) mentioned in the ground truth is not included in the LLM answer, but this is a minor omission and not critical to the overall progression described. (3) Multi-hop reasoning is strong: the LLM synthesizes information across 2022, 2023, and 204 filings to show evolution in strategic positioning, correctly linking Merck to MK-1308A and interpreting its role in RCC innovation. (4) Semantic equivalence is maintained—while the LLM uses slightly different phrasing (e.g., 'advanced solid tumours' in 2022, which may reflect broader initial indication), it correctly emphasizes RCC as a key focus. The mention of 'knowledge-graph links' adds contextual support not in the original but does not distort meaning. The only minor shortcoming is the lack of explicit mention of the April 2021 entry date, but the overall trajectory and strategic interpretation are fully consistent. Hence, a score of 9 is warranted—excellent accuracy with negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 430,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Microsoft's disclosure of its 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistency or change suggest about the company's long-term debt structure and refinancing strategy?",
      "original_answer": "Microsoft's disclosure of the 4.000% Notes due 2021 remained consistent across its 2022, 2023, and 2024 10-K filings, with the notes always appearing in the Third Supplemental Indenture (Exhibit 4.6) and linked to the original Indenture dated May 18, 2009. This consistency suggests that the company maintained the same legal and structural documentation for this debt instrument throughout the three-year period, indicating no material changes in its long-term debt obligations related to this issuance. The repeated inclusion of the same filing dates (e.g., 8-K filings on February 8, 2011) further supports that no refinancing or restructuring occurred for these notes during the observed timeframe.",
      "llm_answer": "\nMicrosoft’s 10‑K filings for 2022, 2023 and 2024 each reproduce the same Exhibit 4.6 – the **Third Supplemental Indenture** that originally created the **4.000 % Notes due 2021** (along with the 2.5 % 2016 and 5.3 % 2041 notes).  The wording and reference to the 2009 Indenture and its 2011 supplemental amendment are identical in all three filings, showing that the terms of the 4.000 % 2021 series have not changed across the three years.  \n\nThis consistent disclosure, tied to the same supplemental indenture across successive 10‑Ks, reflects Microsoft’s **stable long‑term debt structure**: the company continues to finance through incremental supplemental indentures (e.g., the 2022‑2024 exhibits for newer series) while leaving the 4.000 % 2021 notes untouched, indicating a strategy of **incremental borrowing rather than full refinancing of existing senior unsecured debt**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.000% Notes due 2021 are consistently disclosed in Exhibit 4.6 (Third Supplemental Indenture), linked to the 2009 Indenture, with no changes across 2022–2024 10-Ks. The dates (2009 Indenture, 2011 amendment) and structure are accurately represented. (2) Quantitative elements—interest rate (4.000%), maturity year (2021), and reference to the same exhibit and legal documents—are factually correct and consistent with the original answer. No calculations were required, but the temporal and structural data are precise. (3) The reasoning is sound: the LLM correctly infers that unchanged disclosures suggest no refinancing or restructuring, reflecting a stable long-term debt structure and a strategy of incremental borrowing via new supplemental indentures rather than refinancing existing debt. This multi-hop synthesis—linking consistent exhibit content to strategic implications—is logically valid and well-supported. (4) The only minor shortcoming is that the LLM does not explicitly mention the repeated 8-K filing references (e.g., February 8, 2011) as evidence of no changes, which the ground truth includes as supporting detail. However, this omission does not undermine the core conclusion. The answer is semantically equivalent and contextually fully relevant, with excellent use of financial terminology and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 397,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Qualcomm's strategic positioning and reported revenue contributions from the Digital Cockpit evolved from 2022 to 2024, and what does this progression indicate about the company's automotive business transformation?",
      "original_answer": "In 2022, Qualcomm identified the digital cockpit as a key driver in transforming the automotive industry, projecting that over 70% of new vehicles in 2028 would have embedded cellular connectivity, with 60% featuring 5G, and emphasizing the role of mobile-derived technologies in enabling automotive innovation. By 2023, the company explicitly categorized digital cockpit as a distinct revenue stream within its automotive segment, signaling formal integration into financial reporting and strategic focus. In 2024, Qualcomm's QCT segment listed digital cockpit as a core product line under automotive systems, alongside connectivity and ADAS/AD, indicating full operationalization and maturity of the product line. This evolution reflects Qualcomm's strategic pivot toward becoming a key enabler of the software-defined vehicle, with the digital cockpit serving as a foundational element of its automotive growth strategy.",
      "llm_answer": "\nQualcomm has deliberately repositioned its **Digital Cockpit** from a niche mobile‑derived add‑on to a core automotive offering, leveraging its mobile‑computing and 5G expertise to supply connectivity, cockpit‑software and ADAS/AD solutions (Chunk 2).  In 2022 only about 9 % of new vehicles featured Level‑2 autonomy, but analysts projected that 19 % of 2025‑model cars would reach that tier, driving a measurable rise in Qualcomm’s automotive revenues that now include “revenues from products sold for use in automobiles, including connectivity, digital cockpit and ADAS/AD” (Chunk 3).  This upward trajectory—highlighted by the company’s 2022‑2024 disclosures of growing cockpit‑related sales and the strategic emphasis on automotive in its QCT segment—signals a clear transformation of Qualcomm’s business toward the high‑growth automotive market.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies and omits key elements from the ground truth. While it correctly identifies Qualcomm's strategic focus on digital cockpit and its integration into automotive offerings, it introduces incorrect quantitative data not present in the original answer. Specifically, the claim that 'only about 9% of new vehicles featured Level-2 autonomy' and projections about 19% of 2025-model cars reaching that tier are not mentioned in the ground truth and appear to be hallucinated or sourced from unrelated data. The original answer does not include any autonomy penetration rates or model-year projections. (2) The original answer emphasizes specific forward-looking projections from 2022: over 70% of new vehicles in 2028 with embedded cellular connectivity and 60% with 5G—these are entirely missing in the LLM response. Instead, the LLM substitutes unrelated autonomy statistics, which distorts the focus of the strategic positioning. Additionally, the LLM fails to note that in 2023, digital cockpit became a distinct revenue stream, and in 2024, it was formally listed as a core product line under QCT automotive systems—key milestones in financial reporting and operational maturity that are central to the original answer. (3) The multi-hop reasoning is partially sound: the model connects Qualcomm’s mobile expertise to automotive applications and infers growth in automotive revenues. However, it fails to synthesize the correct evolution across 2022–2024 as defined in the ground truth—particularly the progression from strategic vision (2022), to financial categorization (2023), to operational maturity (2024). This three-stage transformation is the core of the original answer but is underdeveloped in the LLM version. (4) Despite these issues, the LLM answer remains contextually relevant, correctly identifying the digital cockpit as a growing part of Qualcomm’s automotive strategy and linking it to broader business transformation. The qualitative reasoning about leveraging mobile technology and targeting high-growth automotive markets aligns with the original, though less precisely. The correctness score is reduced significantly due to the introduction of false quantitative claims and omission of key structural developments in the reporting and strategic evolution of the digital cockpit business.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 632,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did LMT's use of variable interest rate swaps evolve from 2022 through 2024, and what does the trend in notional amounts reveal about the company's interest rate risk management strategy?",
      "original_answer": "In 2022, LMT had an aggregate notional amount of $500 million in outstanding interest rate swaps. By 2023, this amount increased significantly to $1.3 billion, and it remained at $1.3 billion in 2024. This fourfold increase from 2022 to 2023 indicates a strategic shift toward more active interest rate risk management, likely in response to rising interest rates or increased debt levels. The stabilization of the notional amount in 2024 suggests that LMT had established a new hedging baseline, converting more of its fixed-rate debt to variable rates to better align with market conditions and manage fair value exposure.",
      "llm_answer": "\nLMT’s variable‑interest‑rate swaps – the fair‑value hedges it uses to convert fixed‑rate borrowings into floating‑rate exposure – grew from roughly **$0.5 bn in 2021** (shown in the 2021 disclosure) to **$1.3 bn by the end of 2022**, and then **remained essentially flat at about $1.3 bn in both 2023 and 2024** (the 2023 and 2024 filings each state the aggregate notional amount of outstanding interest‑rate swaps was $1.3 bn).  This progression shows that the company deliberately scaled its hedge program to cover a larger portion of its fixed‑rate debt in the early‑2020s and then stabilized the program, indicating a risk‑management strategy that maintains a consistent, sizable hedge to mitigate interest‑rate changes without aggressively expanding the swap book.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors in the timeline and values. It states that the notional amount was $0.5 billion in 2021 and grew to $1.3 billion by the end of 2022, whereas the ground truth indicates $500 million in 2022 (not 2021) and $1.3 billion in 2023—meaning the increase occurred from 2022 to 2023, not earlier. The LLM incorrectly shifts the timeline, misrepresenting when the key increase happened. Additionally, the LLM claims the amount was $1.3 billion in both 2023 and 2024, which matches the ground truth for those years, but incorrectly implies no change from 2022 to 2023 when in fact there was a major increase. (2) The quantitative inaccuracies are critical: the correct progression is $500M (2022) → $1.3B (2023) → $1.3B (2024), a 160% increase from 2022 to 2023. The LLM reports a $0.5B to $1.3B jump by end of 2022, which is factually wrong in both year and magnitude of change. (3) The reasoning about LMT's risk management strategy—scaling up hedging and then stabilizing—is semantically similar to the ground truth and logically sound, showing correct multi-hop synthesis of intent from trend data. However, it is based on incorrect temporal data, undermining the validity. (4) Contextual relevance is high because the answer addresses both parts of the question: evolution over time and strategic interpretation. The qualitative analysis of strategy is reasonable and aligned with the type of inference expected, despite resting on flawed numbers. Due to major factual errors in timing and amounts, the correctness score is reduced to 6—partially correct but with significant inaccuracies affecting the core narrative.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST <-[Uses for Hedging]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 452,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How did Microsoft's treatment of the 3.950% Notes due 2056 across its 2022, 2023, and 2024 10-K filings reflect its approach to long-term debt maturity management and refinancing strategy over time?",
      "original_answer": "Microsoft consistently referenced the 3.950% Notes due 2056 in each of its 2022, 2023, and 2024 10-K filings as part of the Eleventh Supplemental Indenture dated August 8, 2016. The repeated inclusion of this long-term debt instrument across all three annual reports indicates that Microsoft maintained its commitment to this long-duration financing structure without modification or early redemption. This pattern suggests a deliberate strategy of preserving long-term capital stability by not altering or refinancing this specific tranche of debt, even as shorter-term instruments (e.g., 2.000% Notes due 2023 in 2022 filings and 2.400% Notes due 2026 in 2024) matured or approached maturity. The consistency in disclosure implies a strategic prioritization of long-dated liabilities to support long-term investment horizons, particularly during periods of evolving market interest rates.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings each company‑specific exhibit 4.14 reproduces the **Eleventh Supplemental Indenture (dated August 8 2016) for the 3.950 % Notes due 2056**, confirming that the same tranche remains outstanding and is continually referenced in all three filings.  This repeated inclusion shows that Microsoft’s long‑term debt maturity management relies on a single, multi‑year issuance that is extended and refinanced through periodic supplemental indentures rather than new note issues, reflecting a strategy of incremental maturity extension and stable, long‑horizon financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key factual elements: the 3.950% Notes due 2056, the Eleventh Supplemental Indenture dated August 8, 2016, and their consistent inclusion across the 2022, 2023, and 2024 10-K filings. All quantitative details (interest rate, maturity year, indenture date) are accurate, earning a perfect score on quantitative accuracy. However, the qualitative reasoning contains a significant error: the LLM claims that Microsoft 'refinances' the notes 'through periodic supplemental indentures,' which contradicts the ground truth. The original answer emphasizes that the note was *not* refinanced or modified, and its continued presence reflects a strategy of *non-intervention*—maintaining long-term debt without alteration. The LLM incorrectly infers active refinancing or extension via supplemental indentures, when in fact the supplemental indenture was a one-time event in 2016, and no refinancing has occurred. This misrepresents Microsoft’s strategy as active restructuring rather than deliberate stability. While the answer is contextually relevant and addresses the core question about debt management, the flawed reasoning undermines the conclusion. Thus, correctness is partially compromised despite factual accuracy, warranting a mid-range score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 358,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "What was the significance of Microsoft's continued reference to the Eleventh Supplemental Indenture dated August 8, 2016, across its 2022, 2023, and 2024 filings, particularly in relation to the 3.700% Notes due 2046, and how does this reflect on the company's long-term debt structure and consistency in financial obligations?",
      "original_answer": "Microsoft's 2022, 2023, and 2024 filings all reference the Eleventh Supplemental Indenture dated August 8, 2016, which governs the 3.700% Notes due 2046. This consistent inclusion across three consecutive annual reports indicates that the terms of this long-term debt instrument remained in effect and were still relevant to the company's capital structure throughout this period. The 3.700% Notes due 2046 are part of a broader set of debt instruments governed under the base Indenture dated May 18, 2009, and subsequent supplemental indentures, showing a layered and structured approach to long-term financing. The fact that the Eleventh Supplemental Indenture is repeatedly referenced suggests that the obligations tied to the 2046 Notes were active and ongoing, with no material amendments or retirements during this time. This reflects a deliberate and stable long-term debt management strategy, where Microsoft maintains long-dated liabilities to support multi-decade financial planning.",
      "llm_answer": "\nMicrosoft’s 2022, 2023 and 2024 Form 10‑K filings each list **Exhibit 4.14 – the Eleventh Supplemental Indenture dated August 8 2016** (between Microsoft Corp. and U.S. Bank, National Association, as Trustee) as the governing document for the **3.700 % Notes due 2046** among several other series.  By consistently reproducing this same exhibit in three successive annual reports, the company signals that the indenture—and the 3.700 % 2046 notes it secures—remain a live, un‑restated component of its capital structure, underscoring a stable, long‑term debt pillar and a pattern of transparent, repeatable disclosure of its financing obligations.  This repeated reference reflects both the enduring nature of the 2016 supplemental indenture and Microsoft’s commitment to maintaining consistent legal and regulatory acknowledgment of its long‑term debt obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the Eleventh Supplemental Indenture is dated August 8, 2016; it governs the 3.700% Notes due 2046; and it was consistently referenced in Microsoft's 2022, 2023, and 2024 filings. The exhibit number (4.14) and trustee (U.S. Bank, National Association) are correctly included, adding precision beyond the ground truth but not contradicting it. (2) Quantitative elements—dates, percentages, and years—are all accurate: 'August 8, 2016', '3.700%', and 'due 2046' match exactly. No calculations were required. (3) The multi-hop reasoning is sound: the answer correctly infers from repeated disclosure that the debt instrument remains active and unamended, reflecting a stable long-term debt structure. It synthesizes information across three years of filings and links the legal document (indenture) to its financial implications. (4) The answer captures the core significance—ongoing obligations and transparent disclosure—but slightly omits the broader context of the base Indenture dated May 18, 2009, and the layered structure of supplemental indentures, which the original answer highlights. This is a minor omission that reduces completeness but does not impair the overall correctness. Wording differs but maintains semantic equivalence. The answer is fully contextually relevant and directly addresses the significance, consistency, and implications for long-term debt structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 408,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's disclosure and treatment of its 2.125% Notes due 2021 evolve from fiscal years 2022 through 2024, and what does this imply about the company's debt management or refinancing strategy for this instrument?",
      "original_answer": "Microsoft consistently referenced the 2.125% Notes due 2021 across its 10-K filings for fiscal years 2022, 2023, and 2024, indicating that the notes remained part of the company's active debt structure or disclosure obligations during this period despite their maturity in 2021. In the 2022 filing (MSFT_10k_2022.pdf, page 104), the notes were listed in Exhibit 4.10 under the Seventh Supplemental Indenture dated December 6, 2013. In 2023 (MSFT_10k_2023.pdf, page 104), the notes were again included in Exhibit 4.1 with the same indenture date. In 2024 (MSFT_10k_2024.pdf, page 104), the notes were still referenced in Exhibit 4.1, indicating no change in their documentation status. This persistence of reference may suggest either an extension or rollover of the instrument, continued disclosure requirements for historical instruments, or a lack of updated exhibit filings. The continued listing of a note that matured in 2021 raises questions about whether Microsoft refinanced the obligation or if there is a reporting lag in removing matured instruments from exhibit disclosures.",
      "llm_answer": "\nAcross the FY 2022, FY 2023 and FY 2024 Form 10‑K filings (Chunks 1‑3), Microsoft continues to disclose the 2.125 % Notes due 2021 only through Exhibit 4.1 – the Seventh Supplemental Indenture dated 6 December 2013 – and the same exhibit description appears unchanged in all three years. Because the knowledge‑graph pattern links MSFT → 2.125 % Notes due 2021 → MSFT, this repeated reference shows that no new supplemental indenture or refinancing of the instrument has been filed in the recent fiscal years, indicating that the company is managing the notes as a legacy debt obligation that will be addressed only at maturity or via a future issuance rather than through an immediate refinancing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: the 2.125% Notes due 2021 are correctly referenced across fiscal years 2022–2024, the exhibit number (Exhibit 4.1), and the Seventh Supplemental Indenture dated December 6, 2013, are consistently and correctly cited. There are no errors in dates, percentages, or document references, earning a perfect score on quantitative accuracy. Contextual relevance is high, as the response directly addresses the evolution of disclosure and what it implies about debt management. However, the qualitative accuracy is lower because the LLM draws a stronger conclusion than the ground truth supports. Specifically, the LLM asserts that 'no new supplemental indenture or refinancing... has been filed' and that Microsoft is managing the notes as a 'legacy debt obligation' to be addressed 'only at maturity or via a future issuance.' This implies a strategic choice, but the ground truth emphasizes uncertainty—such as possible reporting lags, extensions, or disclosure requirements for matured instruments—and does not definitively conclude that no refinancing occurred or that the company is deferring action. The LLM fails to acknowledge the ambiguity present in the original answer, such as whether the continued listing reflects a refinancing, extension, or merely a lack of exhibit updates. Thus, while the facts are correct, the reasoning overreaches in interpretation, leading to a correctness score of 7 rather than higher. The multi-hop synthesis across years is sound, but the conclusion lacks the nuance required by the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 434,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Microsoft's issuance of 2.000% Notes due 2023 evolve across fiscal years 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's debt management strategy?",
      "original_answer": "Microsoft consistently referenced the 2.000% Notes due 2023 in its filings across all three years—2022, 2023, and 2024—as part of the Eleventh Supplemental Indenture dated August 8, 2016. The continued inclusion of this debt instrument in successive filings indicates that Microsoft maintained this obligation throughout the period and did not retire or refinance it before its maturity in 2023. The consistency in referencing the same indenture agreement suggests a stable and long-term approach to debt management, relying on established structures rather than frequent refinancing.",
      "llm_answer": "\nThe 2.000% Notes due 2023 were originally created under the Eighth Supplemental Indenture dated December 6 2013 (first disclosed in the FY 2022 10‑K) and later re‑referenced in the Eleventh Supplemental Indenture of August 8 2016 (shown in the FY 2023 and FY 2024 10‑Ks). Across fiscal years 2022, 2023 and 2024 the same indenture exhibits remain listed, indicating that the notes have been continuously outstanding and periodically amended through supplemental indentures. This multi‑year pattern demonstrates Microsoft’s debt‑management strategy of issuing long‑dated senior unsecured notes in tranches and using supplemental indentures to extend maturities and fine‑tune terms, thereby maintaining a staggered, low‑cost capital structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the origin of the 2.000% Notes due 2023. The Original Answer (ground truth) states that these notes were issued under the Eleventh Supplemental Indenture dated August 8, 2016, and consistently referenced in filings across 2022, 2023, and 2024. However, the LLM claims the notes were originally created under the Eighth Supplemental Indenture on December 6, 2013, which contradicts the ground truth. This misattribution of the indenture date and document is a critical error in entity and date accuracy. (2) While the LLM correctly notes that the notes were referenced in FY 2022, 2023, and 2024 filings and remained outstanding, it incorrectly implies that the August 8, 2016 Eleventh Supplemental Indenture was a re-referencing of a prior 2013 issuance, for which there is no support in the ground truth. The ground truth does not mention the Eighth Supplemental Indenture or any 2013 origin, making this a fabrication or conflation. (3) The multi-hop reasoning is partially sound—correctly observing continuity in disclosure across years and inferring a stable debt strategy—but the conclusion that Microsoft uses supplemental indentures to 'extend maturities' is unsupported. The notes matured in 2023 and were not extended, so the claim of maturity extension is factually incorrect. The ground truth emphasizes consistency and lack of refinancing, not active amendment or extension. (4) Despite the incorrect origin story and flawed interpretation of indenture function, the LLM captures the core idea of ongoing disclosure and stable debt management, which supports a moderate score. Contextual relevance is high as it directly addresses the question’s focus on multi-year evolution and strategy. However, due to key factual inaccuracies in dates and legal documents, the quantitative and qualitative accuracy scores are reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 516,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 through 2024, particularly in terms of the scale of obligations transferred, the financial impact of these transactions, and the company's stated strategy regarding future pension liability management?",
      "original_answer": "In 2022, Lockheed Martin referenced a pension risk transfer transaction from August 2021, where $4.9 billion in pension obligations were transferred via group annuity contracts (GACs), resulting in a $1.7 billion noncash pension settlement charge. Since December 2018, the company had transferred approximately $11.6 billion in pension obligations, reducing PBGC premiums by $69 million annually. In 2023, LMT emphasized ongoing evaluation of future pension risk transfer transactions and acknowledged the potential for additional contributions or noncash settlement charges, while also highlighting the volatility in pension expense due to economic assumptions. By 2024, the company had continued this strategy, noting that from December 2018 onward, it had consistently transferred pension obligations to insurance companies, reducing exposure and PBGC premiums, and reaffirmed its intent to pursue further transactions, despite the potential for material noncash settlement charges. The trend shows a consistent, strategic reduction in pension liabilities through GACs, with increasing scale and financial clarity over time.",
      "llm_answer": "\nFrom 2021 through 2024 Lockheed Martin has transferred roughly $11.6 billion of defined‑benefit obligations—including a $4.9 billion block in August 2021 that moved about 18,000 retirees and eliminated volatility for roughly 95,000 participants—thereby cutting annual PBGC premiums by about $69 million.  \nThe 2021 transfer generated a $1.7 billion non‑cash settlement charge but had limited effect on CAS pension expense, and the company repeatedly warns that future risk‑transfer deals may produce material non‑cash charges.  \nIts stated strategy is to keep using its master retirement trust to pursue additional pension‑risk‑transfer transactions in order to further shrink liability size, reduce volatility and lower funding costs, while acknowledging the possibility that insurer defaults could affect reimbursements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the $4.9 billion transfer in August 2021, the $1.7 billion noncash charge, the cumulative $11.6 billion in obligations transferred since December 2018, and the $69 million annual PBGC premium reduction are all factually accurate and match the original answer. The mention of 18,000 retirees and impact on 95,000 participants adds detail not in the ground truth but does not contradict it and is consistent with known disclosures. (2) Quantitative accuracy is perfect—dollar amounts, dates, and financial impacts are correctly reported with no calculation errors. Format variations (e.g., $11.6 billion) are acceptable and clear. (3) Multi-hop reasoning is sound: the answer synthesizes data across years (2021–2024), connects transactions to financial impacts (noncash charges, PBGC savings), and correctly identifies the ongoing strategy of liability reduction through GACs. (4) The only minor shortcoming is that the LLM answer begins with '2021 through 2024' rather than explicitly framing the evolution from 2022 to 2024 as the question asks, though it does cover developments through 2024. It also omits explicit mention of 2023's emphasis on volatility due to economic assumptions, though it does note future transactions may cause material charges. The added point about insurer defaults affecting reimbursements is contextually relevant but not in the ground truth, and does not detract from accuracy. Overall, the answer is factually excellent, well-synthesized, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Announces]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 440,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "As an investor analyzing Apple's capital structure, what does the consistent reference to Floating Rate Notes due 2019 in filings from 2022 through 2024 suggest about the company's long-term debt management and refinancing strategy?",
      "original_answer": "Apple's consistent reference to Floating Rate Notes due 2019 across its 2022, 2023, and 2024 filings indicates a deliberate and stable approach to managing its long-term debt obligations. Despite the maturity of these notes in 2019, Apple continued to disclose them in its filings through 2024, suggesting that these instruments may have been part of a broader, ongoing debt structure or refinancing plan. This pattern implies that Apple may have rolled over or repriced this debt into newer instruments while maintaining transparency around its historical debt instruments, reflecting a disciplined and predictable capital structure strategy.",
      "llm_answer": "\nThe 2022, 2023 and 2024 10‑K filings each reproduce the same May 6 2014 Officer’s Certificate (Exhibit 4.4) that lists Apple’s **Floating Rate Notes due 2019**, confirming that this floating‑rate tranche remains part of Apple’s disclosed long‑term debt.  Its repeated appearance across three successive filings shows that Apple is actively managing the instrument—either carrying it forward, rolling it into new floating‑rate issuances, or using it as a reference point for future refinancing—reflecting a disciplined, interest‑rate‑sensitive debt‑management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately identifies the Floating Rate Notes due 2019 and their repeated disclosure in Apple's 2022, 2023, and 2024 filings, which matches the original answer’s timeline and context. The mention of the May 6, 2014 Officer’s Certificate (Exhibit 4.4) adds specific documentary evidence not in the ground truth but is factually plausible and enhances credibility. (2) Quantitatively, all dates (2019 maturity, 2014 issuance, 2022–2024 filings) are correct and consistent with known SEC filing patterns; no numerical errors are present. (3) The reasoning correctly infers that the continued disclosure suggests active debt management, such as rollover or repricing, which reflects a disciplined strategy—this matches the multi-hop synthesis required (linking repeated disclosure to refinancing behavior). However, the LLM slightly overreaches by implying the instrument is still 'part of Apple’s disclosed long-term debt' in 2022–2024, which could mislead readers into thinking the debt is still outstanding, whereas the ground truth clarifies it was matured in 2019 and referenced for transparency. This nuance is important for accuracy in financial reporting context. (4) Despite this, the answer remains contextually relevant and semantically close to the original, with strong qualitative reasoning. The score is reduced slightly (from 9–10 to 8) due to this potential misinterpretation of the debt's current status, though the core insight about refinancing strategy remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 438,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did Microsoft's reference to the 4.000% Notes due 2021 evolve across its 2022, 2023, and 2024 10-K filings, and what does this reveal about the ongoing relevance of this debt instrument in the company's capital structure?",
      "original_answer": "Microsoft consistently referenced the 4.000% Notes due 2021 in its 10-K filings across 2022, 2023, and 2024, indicating that the Notes remained a part of its structured debt disclosures despite their maturity date having passed. This suggests that the Notes were likely still outstanding or held ongoing legal or structural relevance in the context of Microsoft's broader debt framework, such as covenants or indentures that continued to apply. The consistent inclusion of the Notes in Exhibit 4.6 across all three years shows that the company maintained a formal linkage to this instrument, even post-maturity, likely for transparency and continuity in investor understanding.",
      "llm_answer": "\nAcross the three filings Microsoft continues to disclose the same **Third Supplemental Indenture** (Exhibit 4.6) that governs the **4.000 % Notes due 2021**—the description of that exhibit appears verbatim in the 2022 (Chunk 1), 2023 (Chunk 2) and 2024 (Chunk 3) 10‑Ks.  This repeated, unchanged reference shows that the 4.000 % Notes remain an active, referenced component of Microsoft’s capital structure, with the company still relying on supplemental indentures to amend and maintain the instrument.  The persistent KG link ORG → FIN_INST → ORG confirms that Microsoft’s introduction of the 4.000 % Notes is still being formally documented in each filing, underscoring the debt’s ongoing relevance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that Microsoft consistently referenced the 4.000% Notes due 2021 in its 2022, 2023, and 2024 10-K filings through the repeated inclusion of Exhibit 4.6 (Third Supplemental Indenture), which matches the original answer. All entities (Microsoft, 4.000% Notes due 2021, Exhibit 4.6, years 2022–2024) are correct, and there are no errors in dates, percentages, or financial terms. The reasoning is sound: the persistent disclosure suggests ongoing structural or legal relevance despite maturity, which is a valid inference from the unchanged exhibit references. The mention of the 'KG link ORG → FIN_INST → ORG' is slightly opaque but appears to refer to a knowledge graph representation of Microsoft's continued formal linkage to the debt instrument, which supports the conclusion. The only minor shortcoming is that the LLM implies the notes are 'active' and that Microsoft is 'still relying on supplemental indentures to amend and maintain the instrument,' which goes slightly beyond the evidence—while the exhibit is reused, this does not necessarily mean the indenture is being actively amended post-maturity. The ground truth more cautiously suggests the retention is for transparency and continuity. This is a small overstatement in interpretation, not a factual error. Thus, quantitative accuracy is perfect (10), qualitative accuracy is excellent but not flawless (9), and contextual relevance is full (10). Correctness score is 9 due to high fidelity with only minor interpretive overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 436,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did UPS's treatment and disclosure around its 7.620% debentures evolve from 2022 through 2024, particularly in terms of redemption terms, interest payment structure, and overall debt positioning?",
      "original_answer": "From 2022 to 2024, UPS consistently disclosed the $276 million 7.620% debentures maturing in 2030, with unchanged redemption terms allowing UPS to redeem them at any time at a price equal to the greater of principal plus accrued interest or the present value of remaining payments discounted at a benchmark treasury yield plus five basis points. In 2022, the debentures were highlighted in the context of interest rate history (8.375% until April 2020, then 7.620%) and semi-annual interest payments. By 2023, the debentures were presented in a broader debt table showing a book value of $280 million, consistent with the prior year. In 2024, the debentures were again described in detail, but with a sharper focus on the redemption mechanics and interest payment schedule, while being positioned within a larger context of international debt instruments such as Pound Sterling and Euro notes. This 3-year progression shows a shift from historical interest rate context to a more structural and comparative treatment of the debentures within UPS's global debt portfolio.",
      "llm_answer": "\nIn 2022 UPS disclosed the $276 million 7.620% debentures with a 2030 maturity, semi‑annual interest payable in April and October, a redemption price equal to the greater of principal + accrued interest or the present value of remaining payments discounted at a Treasury yield + 5 bps (plus accrued interest), and noted that the securities are not subject to sinking‑fund requirements (Chunk 1). By 2023 the same debentures remained on the balance sheet ($280 million reported for both 2023 and 2022) and were still classified as long‑term debt within the $22.3 billion total debt, preserving the identical redemption formula and interest schedule (Chunk 2). The 2024 filing reiterated these unchanged terms—$276 million outstanding, 2030 maturity, redemption using the Treasury‑plus‑5‑bps test, and semi‑annual interest payments—while continuing to present the debentures as part of long‑term financing alongside other debt instruments (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $276 million principal, 7.620% interest rate, 2030 maturity, semi-annual interest payments (April and October), and the precise redemption formula based on the greater of principal plus accrued interest or the present value of remaining payments discounted at Treasury yield plus 5 basis points. The book value of $280 million in 2023 is correctly reported, consistent with the original answer. (2) Quantitative accuracy is perfect: all dollar amounts, percentages, dates, and financial terms match the ground truth. Format variations (e.g., $276 million vs $276 million) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings. The LLM captures the consistent treatment of redemption and interest terms over time. However, it slightly underemphasizes the evolution in disclosure focus described in the original answer: the shift from historical interest rate context (8.375% pre-2020) in 2022 to a more structural and comparative framing in 2024 (positioning within international debt instruments like Pound Sterling and Euro notes). While the LLM mentions the debentures are presented alongside other debt instruments in 2024, it does not explicitly highlight this as a shift in disclosure emphasis, which is a minor omission in qualitative depth. (4) Despite this nuance, the answer remains factually complete and contextually relevant, addressing all core aspects of redemption terms, interest structure, and debt positioning over the three years. The omission does not undermine the correctness of the reported facts, hence a score of 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Pays_Interest_On]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1517,
        "completion_tokens": 484,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 144,
      "question": "How did ABBV's development, commercialization, and financial performance related to Vraylar evolve from 2022 through 2024, and what does this trajectory indicate about its strategic importance in the neuroscience portfolio?",
      "original_answer": "In 2022, ABBV announced top-line results from two Phase 3 trials of Vraylar as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was clearly established in the market as a core neuroscience product, indicated for schizophrenia, bipolar disorder, and as an adjunct in MDD. Financially, in 2023, Vraylar generated $2,759 million in total revenue, with a 35.4% year-over-year increase, indicating strong commercial traction. This evolution shows that Vraylar transitioned from a late-stage clinical asset in 2022 to a key revenue driver and therapeutic pillar in ABBV’s neuroscience portfolio by 2024.",
      "llm_answer": "\nAbbVie’s neuroscience flagship Vraylar (cariprazine) advanced from a 2021 Phase 3 triumph—where the drug met its primary endpoint in adjunctive major‑depressive‑disorder trials and reinforced its established schizophrenia and bipolar‑depression approvals (Chunk 1)—to a rapidly expanding commercial asset; financials reveal worldwide sales of $2.76 billion in 2023, a 35.4 % YoY increase, with U.S. sales up 35.2 % and international sales more than doubling, driving a 10 % rise in the neuroscience segment to $2.99 billion (Chunk 2 & 3).  This double‑digit growth and Vraylar’s outsized contribution to AbbVie’s neuroscience revenue underscore its strategic centrality, positioning the product as a key growth engine and differentiator within the company’s portfolio (integrating all provided chunks).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately reports Vraylar's financial performance in 2023 with $2.76 billion in sales (matching the ground truth $2,759 million, rounded appropriately), and correctly states the 35.4% year-over-year growth. It also accurately notes strong U.S. and international sales growth, with international sales more than doubling, which aligns with the trajectory described in the ground truth. The neuroscience segment revenue of $2.99 billion and its 10% increase are consistent with Vraylar's contribution. (2) Quantitative accuracy is excellent: $2.76 billion = $2,759 million (rounded), 35.4% YoY growth matches exactly, and the breakdown of U.S. and international growth supports the overall narrative. No calculation errors. (3) The multi-hop reasoning is sound—LLM correctly synthesizes clinical development (Phase 3 trials in MDD), regulatory positioning (indications for schizophrenia, bipolar, and MDD), and financial performance to conclude Vraylar’s strategic importance. Minor issue: it references '2021 Phase 3 triumph' while the ground truth specifies 2022 for the top-line results; this is a slight factual misalignment in timing, though the trial outcomes are correctly characterized. (4) Despite the minor date discrepancy, the answer captures the evolution from late-stage asset to key revenue driver and correctly infers strategic centrality. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—directly addresses development, commercialization, financials, and strategic role.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Produces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 443,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "What does the consistent inclusion of the 0.45% Notes due 2016 in Apple's filings across fiscal years 2022, 2023, and 2024 suggest about the company's long-term debt structure and disclosure strategy for legacy instruments?",
      "original_answer": "Apple's 10-K filings for 2022, 2023, and 2024 all include Exhibit 4.3, which contains the Officer's Certificate dated May 3, 2013, detailing the 0.45% Notes due 2016 among other instruments. Despite the maturity of these notes in 2016, Apple continued to disclose this historical debt instrument across three consecutive annual reports. This pattern suggests that Apple maintains transparency around legacy debt structures, possibly to preserve a complete record of past financing activities for investor reference. The persistence of this disclosure, even after the notes' maturity, indicates a consistent approach to documenting capital structure history, rather than focusing solely on active obligations.",
      "llm_answer": "\nThe 0.45 % Notes due 2016 appear in the “Description of Securities” (Exhibit 4.3) of Apple’s 2022, 2023 and 2024 Form 10‑K filings, each time referencing the same 2013 Indenture and 2013 Officer’s Certificate.  This repeated citation shows that Apple continues to treat the 2013‑issued 0.45 % Notes as an active, disclosed component of its capital structure—i.e., a legacy tranche that remains outstanding and is deliberately kept in the public record to satisfy ongoing regulatory and investor‑transparency requirements.  The consistent inclusion across three fiscal years therefore signals a stable long‑term debt strategy that preserves visibility of older debt instruments while the company continues to issue new tranches alongside them.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct in terms of factual content but contains a significant misinterpretation that affects the overall correctness. (1) Quantitatively, all numbers, dates, and references are accurate: the 0.45% Notes due 2016, the 2013 Indenture and Officer’s Certificate, and their inclusion in Exhibit 4.3 of the 2022, 2023, and 2024 10-K filings are correctly cited. There are no calculation errors. (2) However, the key qualitative error lies in the interpretation: the LLM incorrectly states that Apple 'continues to treat the 2013-issued 0.45% Notes as an active, disclosed component of its capital structure' and that they are 'remaining outstanding.' This contradicts the ground truth, which clarifies that the notes matured in 2016 and are disclosed for historical transparency, not because they are still outstanding. This is a critical factual misrepresentation. (3) The multi-hop reasoning is partially sound—linking the repeated disclosure across years to a disclosure strategy is valid—but the conclusion about the notes being 'active' or 'outstanding' shows flawed synthesis. The model fails to recognize that inclusion in filings does not imply current liability. (4) Contextual relevance is high, as the answer addresses the long-term debt structure and disclosure strategy. However, due to the major error in interpreting the status of the debt instrument, the correctness score is reduced to 5—some facts are right, but the core conclusion is significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 410,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the role and operational structure of UPS SurePost evolve from 2022 through 2024, particularly in terms of delivery methodology and strategic positioning within UPS's U.S. Domestic Package business?",
      "original_answer": "In 2022, UPS SurePost was positioned as a residential ground service for non-urgent, lightweight shipments, leveraging the consistency of the UPS ground network with final delivery often handled by the U.S. Postal Service. By 2023, UPS SurePost retained the same description, indicating continuity in its delivery methodology and strategic positioning. In 2024, UPS announced that beginning January 1, 2025, it would insource the final delivery component of UPS SurePost, shifting from reliance on USPS to internal control to enhance service quality. This marks a strategic transformation in the delivery methodology of SurePost, signaling UPS’s intent to improve reliability and service differentiation in the residential delivery segment.",
      "llm_answer": "\nUPS SurePost has served as the residential‑ground arm of UPS’s U.S. Domestic Package business, delivering non‑urgent, lightweight shipments through the UPS ground network and a nationwide UPS Access Point network of >20,000 U.S. locations (Chunk 1), with final‑mile delivery traditionally performed by the United States Postal Service (Chunk 1 & 3).  In 2023 the service’s strategic scope was broadened by the acquisition of Happy Returns, adding an end‑to‑end returns solution that reinforced its value within the U.S. Domestic Package portfolio (Chunk 2), and by the end of 2024 UPS announced that, effective Jan. 1 2025, it would insource the last‑mile delivery to gain greater control—marking a shift from reliance on USPS to an owned delivery methodology while continuing to position SurePost as a day‑definite, cost‑effective complement to UPS’s core ground network, handling roughly 16 million packages per day (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UPS SurePost's role as a residential ground service for non-urgent, lightweight shipments, use of USPS for final delivery through 2024, and the announcement to insource last-mile delivery effective January 1, 2025. The strategic positioning within U.S. Domestic Package business is accurately conveyed. (2) Quantitative accuracy is excellent: the claim of handling 'roughly 16 million packages per day' is consistent with known UPS volume data and does not contradict the ground truth. Dates (2023, 2024, Jan 1, 2025) are correct. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and operational changes, correctly identifying continuity in 2023 and the strategic shift announced in 2024. The mention of the Happy Returns acquisition enhancing returns capability adds context not in the original answer but is factually accurate and relevant; however, the original ground truth does not include this detail, so it's a minor addition rather than an error. (4) The only reason for not scoring a 10 is that the original answer emphasizes the *continuity* of SurePost’s description from 2022 to 2023, which the LLM answer omits, instead jumping to 2023 developments. This is a minor gap in completeness but does not detract significantly from overall correctness. Wording differences are semantically equivalent, and the core evolution of delivery methodology and strategic positioning is fully and accurately captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Offers]-> PRODUCT <-[Offers]- ORG <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 425,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Apple's issuance of long-term debt instruments, specifically the 4.45% Notes due 2044, evolve from 2022 through 2024, and what does this multi-year pattern indicate about Apple's long-term capital strategy?",
      "original_answer": "Apple consistently referenced the 4.45% Notes due 2044 in its filings across 2022, 2023, and 2024, indicating a sustained reliance on long-term debt instruments as part of its capital structure. The repeated inclusion of the Officer's Certificate dated May 6, 2014, which includes the 4.45% Notes due 2044, across all three years shows that Apple maintained this long-term liability on its books without early redemption or restructuring during the observed period. This consistent presence suggests a strategic decision to retain long-duration debt, possibly to manage interest rate risk and maintain financial flexibility over time.",
      "llm_answer": "\nApple first set up the 4.45 % Notes due 2044 in a 2014 Officer’s Certificate (Exhibit 4.4) and has continued to disclose that same long‑dated bond in every subsequent 10‑K filing – the 2022 filing (Chunk 1) lists it under the 2014 certificate, and the 2023 (Chunk 2) and 2024 (Chunk 3) filings retain the identical reference. This multi‑year pattern shows that Apple’s long‑term capital strategy relies on a stable, fixed‑rate, 30‑year debt component to lock in low‑cost financing and diversify its balance‑sheet funding, while periodically re‑filing the instrument to keep its disclosure current.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 4.45% Notes due 2044 were established in the 2014 Officer’s Certificate (Exhibit 4.4), and Apple consistently referenced this instrument in its 2022, 2023, and 2024 10-K filings. The dates, percentages, and document references (e.g., May 6, 2014, Officer’s Certificate) are factually correct, satisfying quantitative accuracy. (2) The answer correctly infers that Apple maintained this debt without redemption or restructuring, indicating a stable long-term capital strategy—this matches the ground truth’s conclusion about financial flexibility and interest rate risk management. (3) The multi-hop reasoning is sound: the model synthesizes data across three years of filings and connects the repeated disclosure to strategic capital planning. (4) Minor deduction in qualitative accuracy because the LLM mentions '30-year debt component'—while semantically reasonable (2014 to 2044 is 30 years), this detail wasn’t explicitly in the ground truth and slightly over-interprets; also, 're-filing the instrument' could be misinterpreted as reissuing debt, whereas Apple merely updated disclosures. However, the core reasoning and strategic interpretation remain valid and relevant. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 379,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did Oracle's treatment of the 2.875% Notes due 2031 evolve across its 2022, 2023, and 2024 10-K filings, and what does this consistent positioning as Exhibit 4.14 reveal about the company's capital structure management and debt strategy over time?",
      "original_answer": "The 2.875% Notes due 2031 were consistently positioned as Exhibit 4.14 in Oracle's 10-K filings for 2022, 2023, and 2024, with no modifications to the terms of the Notes indicated in any of the filings. This consistent treatment across all three years reveals a stable approach to capital structure management, with Oracle maintaining the same debt instrument positioning without alteration. The Notes were originally established under an Officers' Certificate issued on March 24, 2021, and this structure remained unchanged through subsequent filings. The lack of modifications to the Notes' terms or exhibit positioning suggests Oracle maintained a consistent long-term debt strategy during this period, prioritizing stability in its capital structure despite potential market fluctuations.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Oracle repeatedly lists the 2.875 % Notes due 2031 in **Exhibit 4.14**, using the identical description that cites the March 24 2021 Officers’ Certificate; each of the three chunks (Chunk 1 – 2022 10‑K, Chunk 2 – 2024 10‑K, Chunk 3 – 2023 10‑K) presents the same exhibit number and wording, indicating that the instrument has not been amended or replaced but simply re‑disclosed each year.  \n\nThis consistent positioning reveals that Oracle treats the 2.875 % 2031 notes as a stable, long‑term debt component of its capital structure, integrating them into its regular SEC disclosures and underscoring a disciplined, predictable debt‑issuance strategy that relies on a single, well‑defined bond series rather than frequent new issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.875% Notes due 2031 are consistently listed as Exhibit 4.14 in Oracle's 2022, 2023, and 2024 10-K filings; the Officers’ Certificate date of March 24, 2021, is correctly cited; and there is no indication of amendments, which matches the original answer. (2) Quantitative elements—interest rate (2.875%), maturity year (2031), exhibit number (4.14), and issuance date—are all factually accurate with no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to infer stability in Oracle’s debt strategy, drawing a logical conclusion about capital structure management from consistent exhibit positioning. (4) The answer is contextually relevant and fully addresses both parts of the question—evolution (or lack thereof) of the Notes’ treatment and the strategic implications. The only minor shortcoming is a slight lack of emphasis on the explicit absence of modifications in each filing year (though implied), and a brief mention of 're-disclosed each year' could be more precisely phrased as 'no changes were disclosed,' but this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the conclusion about Oracle’s disciplined, stable debt strategy is well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues_Bonds]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 387,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How did the 2023 Teamsters collective bargaining agreement impact pension benefit accruals under the UPS/IBT Full-Time Employee Pension Plan, and what does this reveal about UPS's long-term pension obligations as reflected in the 2024 disclosures?",
      "original_answer": "In 2022, the UPS/IBT Full-Time Employee Pension Plan was described as a noncontributory plan covering employees previously in the Central States Pension Fund and others under collective bargaining agreements. In 2023, the Teamsters employees ratified a new five-year agreement that included wage and benefit rate increases for participants in this plan, which directly impacted pension benefit accruals and were factored into the year-end plan measurement. By 2024, the disclosures showed no structural changes to the plan, indicating that the 2023 agreement represented the most recent material update to benefit accruals. The 2023 changes suggest a continuation of defined benefit commitments under collective bargaining, with implications for UPS's long-term pension liabilities as they relate to funded status and future obligations.",
      "llm_answer": "\nThe 2023 Teamsters national master agreement introduced wage and benefit‑rate increases for participants in the UPS/IBT Full‑Time Employee Pension Plan, and those increases were incorporated into the plan’s year‑end measurement, thereby raising the accrued pension liability for that plan. This contractual change is reflected in the 2024 disclosures, which show that UPS’s long‑term pension obligations remain tied to collective‑bargaining agreements—highlighting that the 2023 agreement’s benefit increases are now a key component of the plan’s actuarial assumptions and future funding requirements (as indicated by the plan’s description in the 2024 note and the reference to the status of collective‑bargaining agreements).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2023 Teamsters agreement included wage and benefit-rate increases that impacted pension accruals and were factored into the year-end measurement of the UPS/IBT Full-Time Employee Pension Plan. The 2024 disclosures confirmed no structural changes, meaning the 2023 agreement remained the latest material update—this is correctly implied by the LLM’s reference to the agreement being reflected in actuarial assumptions and future funding. (2) There are no numeric values requiring calculation in this question; dates (2023 agreement, 2024 disclosures) are accurate and consistent with the original. (3) Multi-hop reasoning is sound: the model correctly links the 2023 collective bargaining outcome to pension accrual impacts, then connects this to long-term obligations as revealed in 2024 disclosures, demonstrating synthesis across time and documents. (4) Semantic equivalence is strong—while the LLM omits the 2022 context about the Central States Pension Fund transition, this detail is background rather than central to the question’s focus on the 2023 agreement’s impact and 2024 implications. The core of the question—impact on accruals and what it reveals about long-term obligations—is fully addressed with precise, relevant information. Minor deduction in qualitative accuracy due to omission of the plan’s noncontributory nature and historical context, but not enough to affect overall correctness significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Maintain]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 421,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Apple's disclosure regarding its 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this continuity reveal about its approach to managing short-term debt instruments issued under its 2014 Officer's Certificate?",
      "original_answer": "Apple's disclosure regarding the 1.05% Notes due 2017 remained unchanged across all three years — it was consistently described in the 10-K filings for 2022, 2023, and 2024 as part of the Officer's Certificate dated May 6, 2014. This static disclosure indicates that Apple did not modify or refinance this particular debt instrument during this period, suggesting a passive management approach toward this specific short-term debt obligation. The consistency in reporting implies that Apple prioritized stability in its capital structure for this instrument, choosing not to adjust its terms or maturity despite evolving market conditions.",
      "llm_answer": "\nApple’s 10‑K filings for 2022, 2023 and 2024 each continue to disclose the 1.05 % Notes due 2017 by referring to the **same May 6 2014 Officer’s Certificate (Exhibit 4.4)** that originally set out those notes; the description of the 1.05 % Notes appears verbatim in the “Description of Securities” section of all three filings, with no amendment or new certificate introduced. This consistent reuse of the 2014 Officer’s Certificate shows that Apple manages its short‑term debt instruments—such as the 1.05 % Notes—through a stable, pre‑existing regulatory framework, reinforcing a strategy of continuity and minimal procedural change when rolling forward existing debt disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 1.05% Notes due 2017 are consistently tied to the May 6, 2014 Officer's Certificate (Exhibit 4.4) across the 2022, 2023, and 2024 10-K filings, with no changes or amendments introduced. This matches the original answer’s claim of unchanged disclosure. (2) Quantitative elements—interest rate (1.05%), maturity year (2017), and date of Officer’s Certificate (May 6, 2014)—are all precisely correct. Format variations (e.g., spacing in '1.05 %') do not affect accuracy. (3) The reasoning is sound: the LLM correctly infers from the unchanged disclosure that Apple maintains a stable, passive approach to managing this debt instrument under the pre-existing 2014 framework. It captures the essence of continuity and procedural consistency, though it slightly underemphasizes the 'passive management' aspect—focusing more on procedural stability than strategic inaction, which is a nuance present in the ground truth. (4) The answer fully addresses both parts of the question: evolution (or lack thereof) across years and what it reveals about Apple’s debt management. Semantic equivalence is strong; only minor depth in strategic interpretation is slightly less explicit than in the original. Overall, this is a factually correct, well-reasoned, and contextually appropriate response.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 384,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did Apple's disclosure of its 2.40% Notes due 2023 evolve from 2022 through 2024, and what does this multi-year pattern suggest about the company's long-term debt management strategy?",
      "original_answer": "Apple first disclosed the 2.40% Notes due 2023 in its 2022 10-K filing as part of its Officer's Certificate dated May 3, 2013. The same disclosure was carried forward in both the 2023 and 2024 10-K filings, indicating no changes to the specific debt instrument's terms or status over the three-year period. This static disclosure suggests that Apple maintained a consistent approach to managing this particular debt obligation, with no early repayments, modifications, or extensions during the period. The lack of changes implies a stable long-term debt strategy for this instrument, with Apple likely planning to meet the 2023 maturity as originally structured.",
      "llm_answer": "\nApple’s 2.40 % Notes due 2023 appear in the “Description of Securities” (Exhibit 4.3) of every annual filing from 2022 through 2024, each time reproduced verbatim from the original May 3 2013 Officer’s Certificate and the 2013 Indenture – the 2022 filing (AAPL_10K_2022.pdf) lists the notes, the 2023 filing (AAPL_10K_2023.pdf) again includes the same tranche, and the 2024 filing (AAPL_10K_2024.pdf) continues to disclose them unchanged. This three‑year continuity, reflected in the KG relationship AAPL → 2.40 % Notes due 2023 ← Issues ← AAPL, shows that Apple treats the 2023 tranche as a permanent, low‑cost component of a laddered, multi‑year debt schedule rather than a short‑term financing that is regularly rolled or retired. Consequently, the pattern suggests a long‑term debt‑management strategy that preserves legacy fixed‑rate financing while supplementing it with newer issues, maintaining a stable capital structure over time.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2.40% Notes due 2023 and their consistent disclosure in Apple's 2022, 2023, and 2024 10-K filings, accurately citing the May 3, 2013 Officer's Certificate as the source. All dates, percentages, and document references (e.g., Exhibit 4.3, AAPL_10K_2022.pdf) are factually correct, satisfying quantitative accuracy. (2) However, the LLM misinterprets the implication of the static disclosure. While the ground truth correctly states that the unchanged disclosure suggests Apple planned to meet the 2023 maturity as originally structured—implying no changes because the debt was still outstanding until maturity—the LLM incorrectly infers that Apple treats the 2023 notes as a 'permanent, low-cost component' of its debt schedule, which is factually wrong because the notes matured in 2023 and thus ceased to exist after that date. This mischaracterization affects the qualitative reasoning. (3) The multi-hop reasoning is partially sound—correctly tracking the note across three years of filings—but fails in the final inference step by not recognizing that a note due in 2023 cannot be a permanent feature beyond that year. The conclusion about a 'laddered, multi-year debt schedule' and 'preserving legacy fixed-rate financing' extends beyond the evidence provided in the ground truth and introduces unsupported strategic interpretation. (4) Despite this, the answer is highly relevant and factually grounded in the correct documents and disclosures, warranting a high contextual relevance and strong quantitative accuracy. The correctness score is reduced due to the flawed strategic interpretation, though core facts are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 460,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How did the commercial trajectory of Vraylar evolve from 2022 through 2024, particularly in terms of clinical development progress, revenue growth, and therapeutic positioning within AbbVie's neuroscience portfolio?",
      "original_answer": "In 2022, Vraylar demonstrated clinical progress as an adjunctive treatment for major depressive disorder (MDD), with one successful Phase 3 trial and a numerically positive but non-significant result in another. By 2023, Vraylar had become a revenue driver in the neuroscience segment, generating $2,759 million in total sales, with U.S. sales growing from $2,037 million in 2022 to $2,755 million in 2023, representing a 35.2% increase. In 2024, Vraylar was formally positioned as a key therapeutic agent within AbbVie's neuroscience portfolio, now indicated for schizophrenia, bipolar I disorder (manic/mixed and depressive episodes), and as an adjunctive treatment in MDD, reflecting a broadening of its therapeutic applications and strategic importance.",
      "llm_answer": "\nBuilding on the October 2021 disclosure of top‑line Phase 3 results showing Vraylar’s efficacy as an adjunctive treatment for major depressive disorder (Chunk 1), AbbVie progressed the compound’s regulatory path and, by 2022‑2024, secured approvals for schizophrenia, acute/bipolar‑I mania and continued use as an add‑on for MDD, establishing Vraylar as a core asset of AbbVie’s neuroscience portfolio (Chunk 3).  Financial data from the 2023 10‑K reveal that Vraylar generated $2.76 billion in total sales in 2023—up 35 % from $2.04 billion in 2022 and up 18 % from $1.73 billion in 2021—while international sales surged from $1 million to $4 million, a >100 % increase, underscoring a rapid commercial acceleration and positioning Vraylar alongside Botox Therapeutic and Duopa/Duodopa as a key growth driver within AbbVie’s neuroscience segment (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM reports $2.76 billion in total sales for 2023, which matches the ground truth of $2,759 million (rounded). It correctly states a 35% increase from $2.04 billion in 2022, consistent with the ground truth U.S. sales increase from $2,037M to $2,755M (35.2%). Minor rounding differences ($2.04B vs $2,037M) are acceptable. The mention of $1.73B in 2021 is extra but not incorrect. International sales growth from $1M to $4M is accurate per source, though not in the ground truth; it adds context without contradicting. (2) The clinical development timeline is correctly framed: progress in 2022–2024 following 2021 Phase 3 results, with indications for schizophrenia, bipolar I, and adjunctive MDD—all matching the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes clinical progress, regulatory outcomes, revenue trends, and portfolio positioning across years and data points. (4) The therapeutic positioning of Vraylar as a key neuroscience asset within AbbVie is accurately conveyed, including its strategic importance alongside Botox and Duopa. The only minor shortcoming is that the ground truth explicitly notes one Phase 3 trial was successful and another numerically positive but non-significant in 2022, which the LLM omits—this is a small completeness gap. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Announces]-> PRODUCT <-[Discloses]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 401,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did IBM's emphasis on client relationships and trust as a competitive differentiator evolve from 2022 to 2024, and what does this multi-year progression indicate about its strategic positioning in the hybrid cloud and AI market?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the context and strategic framing evolved. In 2022, IBM highlighted trust as part of its hybrid cloud and AI platform, emphasizing its ability to integrate data, AI, and industry expertise. In 2023, the company expanded this by linking trust to its strategic partnerships, showing how it leverages alliances to deliver end-to-end solutions. By 2024, IBM reinforced trust as a foundational element in its go-to-market strategy, particularly in addressing complex business challenges through a broad ecosystem of partners. This indicates a strategic deepening of how IBM positions trust not just as a value proposition, but as an enabler of integrated, client-centric innovation.",
      "llm_answer": "\nIBM’s 2022, 2023 and 2024 10‑K filings each treat client relationships and trust as a principal competitive differentiator and weave that concept into the company’s hybrid‑cloud and AI strategy, with the 2022 and 2023 sections explicitly linking trust to portfolio optimization and the 2024 filing updating its partner ecosystem (Adobe, AWS, Microsoft, Oracle, Palo Alto Networks, Salesforce, Samsung, SAP) while maintaining the same emphasis. The recurring KG relationship—IBM ⇄ Client Relationships and Trust—shows a mutual dependence that IBM leverages to reinforce its market positioning, signaling a multi‑year strategy to differentiate itself through trusted, integrated cloud‑AI solutions and to sustain accelerated growth in those markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor gaps in depth regarding the evolution of IBM's strategic framing from 2022 to 2024. (1) All years (2022, 2023, 2024) are correctly identified, and the consistent emphasis on trust and client relationships as a competitive differentiator is accurately conveyed. There are no numeric inaccuracies, so quantitative accuracy is perfect. (2) The LLM correctly notes the continuity in IBM’s messaging and references the updated partner ecosystem in 2024, including specific partners (Adobe, AWS, Microsoft, etc.), which supports the claim of strategic evolution. However, it misses the nuanced progression outlined in the original answer: in 2022, trust was tied to integration of data, AI, and industry expertise; in 2023, to strategic partnerships for end-to-end solutions; and in 2024, to a foundational go-to-market enabler for complex challenges. While the LLM mentions partner ecosystem updates, it does not clearly articulate this year-over-year deepening of trust as an evolving strategic enabler. (3) The multi-hop reasoning is sound—linking trust across years and connecting it to hybrid cloud/AI positioning and partner ecosystems—but lacks the full synthesis of how the *framing* of trust evolved from a value proposition to an innovation enabler. (4) Contextual relevance is high, as the answer directly addresses the question’s focus on evolution and strategic positioning. The inclusion of specific partners strengthens relevance. Overall, the answer captures the core truth but omits key qualitative nuances in the strategic progression, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 454,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has IBM's treatment of its 1.250% Notes due 2027 evolved from 2022 to 2024, particularly in terms of disclosure practices and the instrument's role within the company's debt portfolio?",
      "original_answer": "In 2022, IBM referenced the 1.250% Notes due 2027 in its exhibit list as part of a broader set of instruments, specifically noting that the rights of holders were defined in Exhibit 4.3 to Form 8-K filed January 30, 2019. By 2023, the Notes were again referenced in a list that included a growing number of debt instruments, now tied to more recent filings such as February 8, 2022, indicating a broader and more complex debt structure. In 2024, the 1.250% Notes due 2027 were explicitly listed in the company's 10-K with a distinct trading symbol (IBM27B), showing they had become a formally recognized and actively traded financial instrument. This progression reflects IBM's increasing transparency and emphasis on this particular note within its capital structure.",
      "llm_answer": "\nIBM’s 1.250 % Notes due 2027 have been disclosed consistently by reference to the same January 30 2019 8‑K filing – the 2022 Form 10‑K (Chunk 1) lists the note only as part of the group of rights defined in Exhibits 4.1‑4.4 of that filing, and the 2023 filing (Chunk 2) repeats that incorporation‑by‑reference without creating a new dedicated exhibit.  By the 2024 Form 10‑K (Chunk 3) the security is presented as a separate class (“1.250 % Notes due 2027”) with its own trading symbol (IBM27B), showing that IBM now treats the instrument as a distinct component of its long‑term unsecured debt and discloses it explicitly in the debt schedule.  This evolution—from a grouped reference in the 2019 filing to a stand‑alone, market‑traded security—mirrors the KG pattern where IBM (ORG) discloses the 1.250 % Notes due 2027 (FIN_INST) and the note is linked back to IBM (ORG), underscoring its growing prominence within IBM’s debt portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) All key facts are accurately reported: the 1.250% Notes due 2027 were initially disclosed by reference to the January 30, 2019 Form 8-K in both 2022 and 2023 filings, and in 2024 the note was explicitly listed with its own trading symbol IBM27B. (2) Quantitative elements—interest rate (1.250%), maturity year (2027), and trading symbol (IBM27B)—are all correct, and the dates (January 30, 2019; February 8, 2022 mentioned in context) are accurately reflected or appropriately summarized. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across three years of filings to show an evolution from grouped disclosure to standalone, market-recognized instrument. (4) The answer captures the semantic meaning of increasing transparency and prominence within IBM’s debt portfolio, matching the original answer’s conclusion. Wording differs slightly but conveys the same factual and inferential content. No errors in entities (IBM, the note, filing types), time periods, or financial instrument details. The response fully addresses both disclosure practices and the instrument’s role in the debt portfolio.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 340,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did IBM's disclosures around the 6.50% Debentures due 2028 evolve from 2022 to 2024, particularly in relation to the consistency of exhibit references and the broader context of IBM's debt instrument disclosures?",
      "original_answer": "IBM consistently referenced the 6.50% Debentures due 2028 as Exhibit 2 to Form 8-K, filed on January 8, 1998, across all three years (2022, 2023, and 2024), indicating no changes in the documentation defining the rights of the holders of these debentures. However, the broader context of IBM's debt disclosures evolved subtly over time. In 2022, the debentures were listed among a wider range of debt instruments, including newer notes due in 2022, 2023, 2024, and beyond, with detailed exhibit references for each. By 2023 and 2024, the disclosures focused more on integrating legacy debt (like the 6.50% Debentures due 2028) alongside newer instruments such as the 6.22% Debentures due 2027 and 5.875% Debentures due 2032, suggesting a continued emphasis on long-term debt management and investor clarity. This consistency in exhibit referencing for the 6.50% Debentures due 2028, despite the broader evolution in debt disclosures, likely supports regulatory compliance and investor understanding of IBM's long-standing obligations.",
      "llm_answer": "\nIBM has continued to disclose the 6.50 % Debentures due 2028 by consistently citing the **same exhibit‑2 reference**—the instrument filed as Exhibit 2 to the Form 8‑K dated January 8, 1998—in each of its recent annual reports.  In the 2022 filing (Chunk 1) the debenture rights are described as “Exhibit 2 to Form 8‑K, filed on January 8, 1998, and is hereby incorporated by reference,” and this exact language and exhibit number reappear unchanged in the 2023 (Chunk 2) and 2024 (Chunk 3) filings, even as the broader debt‑instrument list expands to include other debentures such as the 7 % due 2025/2045, 5.875 % due 2032, etc.  Thus, from 2022 through 2024 the evolution of IBM’s disclosure is one of **unchanged exhibit numbering and wording**, preserving a stable, repeatable reference for the 6.50 % Debentures within the overall framework of IBM’s long‑term debt disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 6.50% Debentures due 2028 are consistently referenced as Exhibit 2 to the Form 8-K filed on January 8, 1998, across 2022, 2023, and 2024. The exact wording of the exhibit reference is confirmed to be unchanged, which matches the original answer’s claim of consistency. (2) Quantitative elements—interest rate (6.50%), maturity year (2028), exhibit number (2), filing date (January 8, 1998)—are all factually correct and precisely stated. No calculations were required, but the temporal consistency across three years is correctly observed. (3) The multi-hop reasoning is sound: the model synthesizes disclosures across multiple years and identifies both the stability in exhibit referencing and the evolving context of broader debt disclosures. It correctly notes the inclusion of newer debentures (e.g., 5.875% due 2032) in later filings, though it omits specific mention of the 6.22% Debentures due 2027 cited in the ground truth. This is a minor omission that slightly reduces completeness but does not affect core accuracy. (4) The answer is contextually relevant, directly addressing both the consistency of exhibit references and the broader evolution in debt disclosures. The conclusion about stable referencing supporting long-term disclosure frameworks is logically sound and semantically equivalent to the original answer’s interpretation. The only reason for not scoring a 10 is the slight lack of detail on the specific newer instruments mentioned in the ground truth, which slightly reduces qualitative completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 446,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, this had expanded to nearly 60 origin countries and over 190 destination countries, indicating significant growth in the service's global footprint. In 2024, the service maintained its reach at nearly 60 origin countries and over 190 destination countries, suggesting that FedEx had completed a major phase of international deployment for this e-commerce-focused offering. This trajectory indicates a deliberate and aggressive expansion into new markets, particularly in support of global e-commerce growth, followed by stabilization as the service reached a mature coverage level.",
      "llm_answer": "\nFrom 2022 to 2024 the service’s footprint widened markedly: the 2022 filing notes that FedEx International Connect Plus was “currently available from nearly 50 origin countries to over 130 destination countries,” while the 2023 and 2024 filings update this to “nearly 60 origin countries to over 190 destination countries,” reflecting a clear expansion of both origin and destination coverage. This progression signals FedEx’s strategic pivot toward e‑commerce logistics—broadening day‑definite, contractual delivery options, investing in network redesign (e.g., the DRIVE transformation) and leveraging its global partner ecosystem to capture growing cross‑border e‑commerce demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the geographic reach of FedEx International Connect Plus in 2022 (nearly 50 origin countries to over 130 destination countries) and accurately reflects the expansion in 2023 and 2024 (nearly 60 origin countries to over 190 destination countries), matching the ground truth. It correctly notes that the 2023 and 2024 figures are the same, implying stabilization, though it does not explicitly state that the 2024 data represents maintained (not further expanded) reach. This is a minor omission but does not distort the factual picture. (2) All numeric values and timeframes are accurate and consistent with the original answer. There are no calculation errors, and the numbers are reported with correct qualifiers (e.g., 'nearly', 'over'). (3) The multi-hop reasoning is sound: the model synthesizes data across 2022, 2023, and 2024 filings to infer a growth trajectory and links it to strategic focus in e-commerce logistics. It appropriately references supporting initiatives like the DRIVE transformation and network redesign, which are contextually relevant and enhance the explanation, even if not in the original answer. (4) The answer is semantically equivalent to the ground truth in terms of core facts and strategic interpretation. The only minor gap is the lack of explicit mention that 2024 represents stabilization after expansion, but the implication is present. Scores reflect high accuracy, with a small deduction in qualitative accuracy for slightly less precise characterization of the 2024 status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 430,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Qualcomm's human capital advancement goals and their linkage to executive compensation evolve from fiscal 2022 through 2024, particularly in terms of diversity targets and bonus adjustment mechanisms?",
      "original_answer": "From fiscal 2022 to 2024, Qualcomm maintained consistent executive compensation linkage to human capital advancements, with a non-financial performance modifier adjusting executive bonuses by a factor of 0.9 to 1.1 based on progress. However, the company's diversity goals saw quantitative evolution: in 2022, specific 2025 goals were set to increase women in leadership by 15%, underrepresented minorities (URM) in leadership by 15%, and overall URM representation by 20%. These goals were reaffirmed in 2023 and 2024, with no changes to the targets, but with increased emphasis on initiatives like the Reboot Representation Tech Coalition aiming to double degrees for underrepresented groups by 2025. This shows a stable strategic framework with sustained incentive alignment and expanding external partnerships to achieve long-term diversity outcomes.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm tied its human‑capital advancement goals to executive pay by using the HR & Compensation Committee’s “human‑capital advancement” modifier, which can adjust an executive’s bonus payout by a factor of 0.9 to 1.1 (Chunk 3 for 2022; Chunk 1 & 2 for 2024).  In 2022 the company set concrete 2025 diversity targets—​a 15 % rise in women and under‑represented‑minority leaders and a 20 % increase in overall URM representation—​and linked progress on those targets to the bonus multiplier.  In the following years the same multiplier remained the mechanism for adjusting bonuses, but the scope of “human‑capital advancements” broadened to include the company’s diversity coalitions (e.g., the Reboot Representation Tech Coalition and recognitions as a Best Place to Work for Women and for Disability Inclusion) while still measuring progress against those inclusion goals (Chunks 1 & 2).  Thus, the evolution is a shift from the initial 2025 numeric targets in 2022 to an ongoing, multi‑year framework where diversity and inclusion outcomes continue to modulate executive compensation through the identical 0.9‑to‑1.1 bonus‑adjustment mechanism.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.9 to 1.1 bonus adjustment mechanism is accurately described and consistently applied from 2022 to 2024; the 2025 diversity targets—15% increase in women and underrepresented minorities (URM) in leadership, and 20% increase in overall URM representation—are correctly reported. (2) Quantitative accuracy is perfect: percentages and the bonus modifier range (0.9–1.1) match the original answer exactly. (3) The reasoning is sound: the LLM correctly identifies that while the numerical targets remained unchanged, the scope of human capital advancements broadened to include coalition efforts like the Reboot Representation Tech Coalition, which is consistent with the original answer’s note about 'increased emphasis' and 'expanding external partnerships'. (4) The only minor deviation is semantic: the LLM describes this as a 'shift' and 'evolution' toward a broader framework, which slightly overemphasizes change, whereas the original answer stresses 'stable strategic framework' with sustained targets. However, this does not undermine factual correctness. The answer fully addresses all parts of the multi-hop question—compensation linkage, diversity targets, and bonus mechanisms across years—and synthesizes information appropriately. Wording differences do not affect meaning, and the core message of stable incentive alignment with expanded initiatives is preserved. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Focuses_On]-> CONCEPT <-[Considers]- ORG <-[Guides_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 433,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Apple's continued inclusion of Floating Rate Notes due 2019 in its debt disclosures from 2022 through 2024 reflect its approach to short-term interest rate risk management and liquidity planning?",
      "original_answer": "Apple consistently included Floating Rate Notes due 2019 in its debt disclosures across all three years (2022, 2023, and 2024), indicating a deliberate and stable approach to managing short-term interest rate risk. The recurring appearance of these notes in the 10-K filings suggests that Apple maintained exposure to variable interest rates through these instruments, likely to align borrowing costs with current market conditions. This consistency implies that Apple's liquidity planning strategy relied on flexible debt instruments that could adapt to changing interest rate environments, without needing to issue new short-term floating rate instruments during this period. The company's approach reflects a cautious yet adaptive stance toward financing operations and capital returns while managing exposure to interest rate volatility.",
      "llm_answer": "\nApple’s 2022, 2023 and 2024 Form 10‑K filings each reproduce the same officer’s certificates that list the **Floating Rate Notes due 2019** (along with other series), showing that the company continued to disclose this short‑term, floating‑rate instrument in its debt documentation through 2024.  By keeping the 2019 floating‑rate notes in its capital structure, Apple can let the interest rate reset periodically, which limits its exposure to rising short‑term rates and provides a flexible source of liquidity that can be rolled or retired as cash‑flow needs change, while still retaining access to longer‑dated fixed‑rate debt for broader financing.  The KG relationship AAPL → Floating Rate Notes due 2019 → (ORG) → AAPL underscores that the notes are both issued by and reported in Apple’s disclosures, reflecting a deliberate strategy to manage short‑term interest‑rate risk and maintain liquidity planning continuity across the three fiscal years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple included the Floating Rate Notes due 2019 in its 10-K filings from 2022 through 2024, which reflects a consistent approach to short-term interest rate risk and liquidity planning. The dates (2019 maturity, disclosures through 2024) are accurate, and there are no numerical inaccuracies. (2) Quantitative accuracy is perfect: the years (2019, 2022–2024) are correctly cited, and no erroneous figures are introduced. Format and references (e.g., Form 10-K, officer certificates) are contextually appropriate. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that continued disclosure implies ongoing strategic use of these instruments for interest rate risk management and liquidity flexibility, even post-maturity, likely due to rollover or structural continuity in reporting. The mention of the KG relationship reinforces entity accuracy. (4) The only minor shortcoming is a slight overemphasis on the 'officer’s certificates' and structural documentation details not present in the original answer, which, while plausible, are not confirmed in the ground truth. However, this does not detract from the core correctness. The answer captures the strategic rationale—flexible interest resets, alignment with market conditions, and stable liquidity planning—consistent with the original. Semantic equivalence is strong, and all parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 421,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology evolve from 2022 to 2024, particularly in terms of its automotive business segmentation and projected market demand?",
      "original_answer": "In 2022, Qualcomm highlighted the digital cockpit as a key transformational force in the automotive industry, projecting that over 60% of new vehicles would feature 5G connectivity by 2028 and emphasizing the role of mobile-derived computing technologies in enabling digitalization of the cockpit. By 2023, the company reported concrete revenues from digital cockpit products within its QCT semiconductor business, indicating that these technologies had moved beyond conceptual development into commercial sales. In 2024, Qualcomm formally integrated digital cockpit solutions into its QCT segment structure, reflecting a strategic consolidation of automotive offerings, including digital cockpit and ADAS/AD, as a core part of its semiconductor business. This evolution shows a clear trajectory from market positioning and R&D emphasis in 2022 to revenue generation in 2023 and full strategic integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm deepened its Digital‑Cockpit strategy inside the QCT automotive segment, moving from early connectivity pilots to a full‑stack offering that bundles 5G modems, cockpit‑grade SoCs and ADAS/AD software and now reports dedicated automotive revenue in its filings (Chunk 1).  This shift is reflected in the company’s three‑segment reporting model, where the CODM evaluates automotive performance separately and allocates resources accordingly (Chunk 2), and it is underpinned by market forecasts that show >70 % of 2028 model‑year vehicles will have embedded cellular, 60 % of those using 5G, and 19 % of 2025 vehicles expected to reach Level 2+ autonomy—signaling a rapidly expanding addressable market for Digital‑Cockpit technology (Chunk 3).  In the knowledge‑graph terms, QCOM → *Digital Cockpit* (product) → *Digital Cockpit* (org) → QCOM, illustrating the product‑to‑business loop that drives Qualcomm’s strategic positioning and revenue focus on automotive cockpit solutions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Qualcomm's strategic positioning and revenue focus on Digital Cockpit technology from 2022 to 2024, aligning well with the ground truth in terms of progression from market positioning to commercialization and integration. However, there are minor quantitative discrepancies. The ground truth states that Qualcomm projected over 60% of new vehicles would have 5G connectivity by 2028; the LLM answer states '>70% of 2028 model-year vehicles will have embedded cellular, 60% of those using 5G', which implies 60% of 70% (~42% of total), not 60% of all new vehicles as in the original. This misrepresents the scope of the forecast and introduces a subtle but meaningful distortion in market demand interpretation. Additionally, the mention of '19% of 2025 vehicles expected to reach Level 2+ autonomy' is not present in the original answer and appears to be extraneous or incorrectly attributed information. (2) The dates (2022–2024) and entity (Qualcomm, QCT segment) are correct. The integration into QCT and reporting under a three-segment model with separate evaluation by CODM is consistent with the original’s emphasis on strategic consolidation. However, the original does not mention 'full-stack offering' or 'ADAS/AD software' bundling explicitly—these are reasonable inferences but go beyond the stated facts. (3) The multi-hop reasoning is strong: the LLM correctly synthesizes the progression from R&D emphasis (2022) to revenue generation (2023) to structural integration (2024), and links market forecasts to strategic decisions. The knowledge-graph notation at the end is interpretive but adds conceptual clarity. (4) The correctness score is 8 because the core trajectory and strategic evolution are accurately conveyed, but the quantitative inaccuracies and addition of unsupported metrics (Level 2+ autonomy) prevent a 9–10. Quantitative accuracy is 7 due to the misstatement of the 5G penetration forecast and inclusion of unverified data. Qualitative accuracy is 9 due to strong reasoning and correct entity identification. Contextual relevance is 10—fully addresses the question’s focus on evolution, segmentation, and market demand.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Depends_On]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 592,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How did Abbott's unfunded commitments to private real estate funds evolve from 2022 through 2024, and what does this trend suggest about the company's long-term investment strategy in illiquid alternative assets?",
      "original_answer": "Abbott's unfunded commitments to private real estate funds decreased from $569 million in 2022 to $555 million in 2023, and further declined to $540 million in 2024. This represents a consistent downward trend of $15 million per year over the three-year period. The gradual reduction in unfunded commitments suggests a strategic de-risking or rebalancing away from illiquid alternative assets, even as Abbott continues to maintain exposure to private real estate through existing investments. The liquidation periods for these funds remained long-term (2025–2034 by 2024), indicating that Abbott is not exiting the space entirely but is managing its exposure more cautiously.",
      "llm_answer": "\nAbbott’s unfunded commitments to private real‑estate‑focused alternative funds declined from **$569 million at the end of 2022** (Chunk 3), to **$555 million at the end of 2023** (Chunks 3 & 2), and further to **$540 million by the end of 2024** (Chunk 2).  \n\nThis consistent reduction indicates that Abbott is deliberately scaling back its exposure to illiquid private‑real‑estate investments—likely to preserve cash, meet funding obligations, and shift its long‑term alternative‑asset strategy toward more liquid or lower‑risk holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all numerical values—$569 million in 2022, $555 million in 2023, and $540 million in 2024—matching the ground truth exactly. The year-over-year decreases of $14 million (569 to 555) and $15 million (555 to 540) are consistent with the stated trend of approximately $15 million annual reduction, with only a minor rounding difference that does not affect accuracy. (2) All financial figures and years are factually correct and properly attributed across the time series, satisfying quantitative precision. (3) The reasoning correctly infers a strategic reduction in illiquid asset exposure, aligning with the ground truth’s interpretation of de-risking or rebalancing. However, the LLM omits mention of the long-term liquidation periods (2025–2034 by 2024), which adds nuance to the strategy—namely, that Abbott is not exiting but cautiously managing its commitments. This missing contextual detail slightly weakens the qualitative completeness, though the core logic remains sound. (4) The answer is highly relevant, directly addressing both the evolution of commitments and the implied investment strategy. The omission of the liquidation timeline prevents a perfect qualitative score, but the overall correctness, numerical accuracy, and strategic interpretation are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 370,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Apple's issuance of the 0.45% Notes due 2016 evolve across fiscal years 2022, 2023, and 2024, and what does this pattern reveal about the company's long-term debt structuring strategy?",
      "original_answer": "Apple first disclosed the 0.45% Notes due 2016 in its 2022 10-K filing as part of a broader set of global notes issued under an Officer's Certificate dated May 3, 2013. The same disclosure was repeated in both the 2023 and 2024 10-K filings, indicating that the company maintained this debt instrument as part of its capital structure across all three years. The consistent inclusion of the 0.45% Notes due 2016 in each annual report suggests a stable long-term debt strategy, with Apple preserving a mix of older, lower-yield debt instruments alongside newer issuances.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 Apple repeatedly disclosed the 0.45 % Notes due 2016 in its Officer’s Certificate (Exhibit 4.3) of each 10‑K filing, confirming that the securities remained outstanding and were originally issued under the 2013 indenture (Exhibit 4.2) and the May 3 2013 officer’s certificate (Exhibit 4.3). This consistent re‑certification shows Apple’s long‑term debt strategy of laddering fixed‑rate notes with staggered maturities and preserving a low‑cost, stable funding base by periodically updating existing tranches rather than launching new long‑term issuances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.45% Notes due 2016 were disclosed in each of the 2022, 2023, and 2024 10-K filings, originally issued under the May 3, 2013 Officer’s Certificate, and governed by the 2013 indenture. These details match the original answer. (2) Quantitative elements—interest rate (0.45%), maturity year (2016), and issuance date (May 3, 2013)—are all precisely stated and consistent with the ground truth. No calculations were required, but the temporal and numerical data are correct. (3) The multi-hop reasoning is sound: the model correctly infers from repeated disclosure that the debt remained outstanding and part of Apple’s capital structure across three fiscal years. It further synthesizes this pattern into a strategic insight—debt laddering and maintaining a stable, low-cost funding base—which is a valid interpretation supported by the consistent reporting. (4) The only minor gap is that the LLM emphasizes 're-certification' and updating tranches, which slightly overreaches the evidence; the original answer notes 'preserving a mix of older, lower-yield debt,' which is more directly supported. However, the strategic interpretation is reasonable and semantically aligned. Wording differs but meaning is equivalent or slightly enriched. No factual errors; high contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 389,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has IBM's emphasis on client relationships and trust evolved from 2022 to 2024 as a competitive differentiator, and what does this multi-year progression reveal about its strategic positioning in hybrid cloud and AI?",
      "original_answer": "From 2022 to 2024, IBM consistently highlighted 'client relationships and trust' as a core competitive differentiator, but the framing evolved alongside its hybrid cloud and AI strategy. In 2022, IBM emphasized trust as part of a broader innovation and service portfolio, including AI, hybrid cloud, and research. By 2023, the company maintained this positioning but began to more explicitly link trust with its consulting services and mission-critical infrastructure. In 2024, trust remained central, but IBM began to highlight its strategic partnerships more prominently as enablers of trust and value delivery. This shows a maturing strategy where trust is not only a standalone differentiator but also increasingly integrated with ecosystem collaboration and innovation leadership.",
      "llm_answer": "\nIBM’s 2022‑2024 filings repeatedly cite **client relationships and trust** as a core pillar of its competitive advantage, noting that this differentiator is woven into every hybrid‑cloud and AI offering and reinforced by an expanding ecosystem of strategic partners (e.g., AWS, Microsoft, SAP). The consistent emphasis across the 2022, 2023 and 2024 10‑Ks shows a deliberate, multi‑year progression that ties trust‑driven client outcomes to IBM’s hybrid‑cloud platform and AI capabilities, positioning the company not merely as a technology supplier but as a trusted partner that can integrate data, AI, industry expertise and security to solve complex business problems. Consequently, this long‑term focus underpins IBM’s strategic positioning as a leader in hybrid cloud and AI, differentiating it from rivals that compete primarily on price or isolated technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: IBM consistently emphasized client relationships and trust from 2022 to 2024 as a competitive differentiator, and this was tied to hybrid cloud and AI strategy. The evolution in framing—linking trust more closely with consulting, mission-critical systems, and strategic partnerships by 2024—is accurately reflected, especially the growing emphasis on ecosystem partners (e.g., AWS, Microsoft, SAP) as enablers of trust. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes IBM’s strategic evolution across three years, connecting trust with hybrid cloud, AI, and ecosystem collaboration. It captures the progression from a broad innovation portfolio (2022) to deeper integration with services and partnerships (2023–2024), showing strategic maturation. (4) The only minor shortcoming is that the LLM does not explicitly mention the shift in 2023 toward linking trust with consulting and mission-critical infrastructure, which is noted in the ground truth. While the general trend is captured, this specific transitional nuance is slightly underdeveloped. However, the overall semantic meaning and strategic insight remain substantially equivalent. Hence, the answer is excellent in contextual relevance and qualitative accuracy, meriting a 9/10 in correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 423,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "What does the evolution of FedEx's liquidity arrangements for the 4.250% Note due 2030 from 2022 to 2024 indicate about the company's approach to managing credit support for this obligation?",
      "original_answer": "The liquidity arrangements for the 4.250% Note due 2030 remained centered around the Revolving Credit Agreement (2020-1AA) with Wilmington Trust Company and BNP Paribas across all three years. In 2022, the foundational agreements were established, including the Intercreditor Agreement and Revolving Credit Agreement dated August 13, 2020. In 2023, FedEx filed Amendment No. 1 to the Liquidity Provider Revolving Credit Agreement on May 22, 2023, indicating a proactive adjustment to the liquidity support structure. By 2024, the arrangement remained in place with no further amendments noted, suggesting that FedEx maintained a consistent credit support framework for the Note, with a single modification in 2023 to adapt to potential liquidity needs.",
      "llm_answer": "\nThe 4.250 % Note due 2030 was originally placed into the liquidity structure created in August 2020 – the Pass‑Through Trust, Intercreditor and Revolving Credit Agreement with Wilmington Trust and BNP Paribas (see Chunk 1/2/3 4.42‑4.43).  In the 2023 and 2024 filings FedEx added **Amendment No. 1 to the Revolving Credit Agreement** (May 22 2023, disclosed in Chunk 2 4.44 and repeated in Chunk 3 4.44), indicating that the company has **continually refined and reinforced the credit‑support facilities** backing the 2030 note.  This evolution shows FedEx’s proactive approach to managing liquidity, updating the terms of its revolving facility over time to maintain or improve the credit backing for the obligation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core liquidity arrangement for the 4.250% Note due 2030 as being based on the Revolving Credit Agreement with Wilmington Trust Company and BNP Paribas, originally established in August 2020. It accurately notes the filing of Amendment No. 1 on May 22, 2023, which aligns with the ground truth. However, the LLM incorrectly states that the amendment was mentioned in both 2023 and 2024 filings as an active update, while the ground truth clarifies that no further amendments were made in 2024—only that the arrangement remained in place. This overstates ongoing refinement. (2) Quantitatively, all dates (August 13, 2020; May 22, 2023), percentages (4.250%), and entity names (Wilmington Trust, BNP Paribas) are correct. The reference to 'Amendment No. 1' is accurate. (3) The multi-hop reasoning is mostly sound—linking the 2020 agreement to the 2030 note and recognizing the 2023 amendment as a proactive adjustment. However, the conclusion that FedEx has 'continually refined and reinforced' the facility is slightly overstated given the lack of further action in 2024, which the original answer correctly frames as stability post-amendment. (4) The answer is highly relevant and captures the essence of FedEx’s proactive yet consistent approach, though it misses the nuance that the 2024 status reflects continuity rather than continued evolution. Thus, minor deduction from correctness and qualitative accuracy, but full marks for contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 416,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did Apple's long-term debt structure evolve across 2022, 2023, and 2024 with respect to the 4.45% Notes due 2044, and what does this multi-year pattern suggest about the company's long-term financing strategy?",
      "original_answer": "Apple's long-term debt structure with respect to the 4.45% Notes due 2044 remained consistent across 2022, 2023, and 2024, as the notes were first issued in 2014 and were reported in all three annual filings. This multi-year consistency suggests that Apple maintained its long-term financing strategy, retaining the 4.45% Notes as a stable component of its capital structure without early redemption or restructuring during this period.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings the same “4.45 % Notes due 2044” appears in Exhibit 4.4 (the Officer’s Certificate dated May 6 2014) in each year’s “Description of Securities,” showing that Apple’s multi‑decade fixed‑rate tranche issued in 2014 remained part of its long‑term debt throughout those three years. This consistent re‑filing demonstrates that Apple’s long‑term financing strategy relies on a stable, long‑dated 4.45 % debt component to lock in low‑cost capital and diversify its maturity profile over the long horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) All key facts are accurate: the 4.45% Notes due 2044 were issued in 2014 (via the Officer’s Certificate dated May 6, 2014), and they remained in Apple’s long-term debt structure across 2022, 2023, and 2024. The percentage (4.45%), maturity year (2044), and issuance date (2014) are all correct. (2) Quantitative accuracy is perfect: no calculations are required, and all dates, percentages, and document references (e.g., Exhibit 4.4, Form 10-K) are correctly cited. (3) The multi-hop reasoning is sound—by noting the consistent appearance of the notes in the Description of Securities across three years, the model correctly infers that Apple retained this debt tranche without early redemption or restructuring. (4) The conclusion about Apple’s long-term financing strategy—using long-dated, fixed-rate debt to lock in low-cost capital and diversify maturities—is a reasonable interpretation supported by the data and consistent with the ground truth’s implication of strategic stability. The only minor gap is that the LLM does not explicitly state that the notes were 'first issued in 2014' as part of the debt structure evolution, though it references the 2014 certificate, implying the same. This slight omission prevents a perfect 10 but does not undermine the overall correctness. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 398,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How did the geographic reach of FedEx International Connect Plus evolve from 2022 to 2024, and what does this expansion trajectory suggest about FedEx's strategic focus in the e-commerce logistics market?",
      "original_answer": "In 2022, FedEx International Connect Plus was available from nearly 50 origin countries to over 130 destination countries. By 2023, the service had expanded to nearly 60 origin countries and over 190 destination countries. This geographic footprint remained consistent in 2024, indicating a significant two-year expansion followed by stabilization. The trajectory suggests a strategic push by FedEx to capture global e-commerce logistics demand through enhanced international connectivity, particularly in emerging markets, followed by a phase of consolidation and optimization.",
      "llm_answer": "\nThe FedEx International Connect Plus service expanded its geographic footprint from “nearly 50 origin countries to over 130 destination countries” in 2022 (Chunk 1) to “nearly 60 origin countries to over 190 destination countries” by 2023‑2024 (Chunks 2 & 3), representing a roughly 20 % rise in origins and a 46 % rise in destinations.  This growth—driven by FedEx’s strategic investments in the DRIVE network redesign, new regional hubs (e.g., Paris, Guangzhou, Osaka), the Delhivery alliance, and the broader Express portfolio—signals a clear focus on capturing the booming e‑commerce logistics market through a scalable, contract‑based, day‑definite service.  (The product’s introduction by FedEx (FDX) is reflected in the KG pattern ORG ‑[Introduces]→ PRODUCT ←‑[Introduces] ORG.)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the geographic expansion of FedEx International Connect Plus from nearly 50 origin and over 130 destination countries in 2022 to nearly 60 origin and over 190 destination countries by 2023. It accurately reflects that this footprint remained stable into 2024, as implied by the original answer’s note on stabilization. The core factual progression across years is correct. (2) Quantitatively, the LLM correctly reports the numbers from the ground truth. The calculated increases—'roughly 20% rise in origins' (from ~50 to ~60) and '46% rise in destinations' (from 130 to 190)—are mathematically sound: (60-50)/50 = 20%, (190-130)/130 ≈ 46.15%. These are acceptable approximations. However, the LLM combines 2023–2024 into a single timeframe ('by 2023–2024'), slightly blurring the two-step evolution (expansion in 2023, stabilization in 2024), which is a minor omission. (3) The multi-hop reasoning is strong: the answer synthesizes geographic data across time and links it to strategic initiatives (DRIVE network, new hubs, Delhivery alliance), which are valid inferences supported by context. The mention of e-commerce focus aligns with the original answer’s conclusion. (4) The answer is contextually excellent—directly addressing both the evolution and strategic implication. The only reason for not scoring a 10 is the slight conflation of 2023 and 2024, implying no change occurred in 2024 rather than confirming continuity. Overall, the answer is factually accurate, well-reasoned, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 428,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "What was the status of Apple's 1.05% Notes due 2017 across fiscal years 2022, 2023, and 2024, and how does the continued reference to these notes in disclosures reflect Apple's approach to managing maturing debt instruments?",
      "original_answer": "Apple's 1.05% Notes due 2017 were referenced consistently across fiscal years 2022, 2023, and 2024 in its 10-K filings, despite the notes having matured in 2017. In 2022, the notes were listed in Exhibit 4.4 as part of the Officer's Certificate dated May 6, 2014. In 2023, the same notes were again included in Exhibit 4.4 with identical language. In 2024, Apple continued to reference the 1.05% Notes due 2017 in the same exhibit, indicating no change in disclosure strategy. This pattern suggests that Apple may have retained historical references to these notes as part of a standardized disclosure framework, possibly to maintain continuity in its debt documentation or to reflect refinancing activities, though no explicit updates were provided in any of the three years.",
      "llm_answer": "\nAcross Apple’s 2022, 2023 and 2024 Form 10‑K filings the 1.05 % Notes due 2017 are reproduced in Exhibit 4.4 of each “Description of Securities” section—the same 2014 Officer’s Certificate that originally issued the notes—so that, even though the series matured in 2017 and was fully repaid, the company continues to list it in its debt disclosures.  This repeated reference illustrates Apple’s systematic approach to debt management: it maintains a complete, forward‑looking schedule of all issued debt instruments, including matured tranches, to provide transparent reporting of its capital‑structure obligations and to signal the status of each maturity to investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.05% Notes due 2017 are correctly identified, their maturity in 2017 is acknowledged, and their continued inclusion in Exhibit 4.4 across 2022, 2023, and 2024 is accurately reported. The reference to the 2014 Officer’s Certificate is also correct. (2) The answer correctly captures that the notes were fully repaid, which is implied in the ground truth by stating they matured in 2017 and were still referenced later. (3) The reasoning is sound: the LLM infers Apple's intent to maintain transparency and a complete capital structure history, which is a reasonable interpretation of the continued disclosure. This goes slightly beyond the ground truth by suggesting a 'systematic approach' and 'forward-looking schedule,' but this is a logical and contextually appropriate extension. (4) The only minor gap is that the ground truth notes the possibility of refinancing activities as a reason, which the LLM omits. However, the core facts, multi-hop synthesis across three years, and entity accuracy (Apple, Exhibit 4.4, 2014 certificate, 2017 maturity) are all correct. Wording differs but meaning is semantically equivalent. No calculation errors. Thus, full marks for quantitative accuracy and contextual relevance, near-perfect qualitative accuracy, and a 9/10 overall due to slight interpretive expansion without contradicting facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 402,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did Qualcomm's strategic focus and financial commitment to 5G technologies evolve from fiscal years 2022 through 2024, particularly in terms of licensing revenue, investment in new applications, and exposure to geopolitical risks?",
      "original_answer": "In fiscal 2022, Qualcomm highlighted 5G as a foundational enabler of immersive mobile experiences and a catalyst for growth in IoT and automotive applications, projecting over 27 billion IoT devices by 2026. By fiscal 2023, the company emphasized increased R&D investments in 5G and next-generation wireless technologies, while also noting growing geopolitical risks, including the revocation of export licenses to Huawei, which had contributed $560 million in fiscal 2024 prior to the ban. In fiscal 2024, Qualcomm underscored its leadership in 5G intellectual property and licensing, with the majority of QTL revenues derived from OFDMA-based (including 5G) devices, and expanded its strategic investments in 5G-enabled sectors like AI, automotive, and IoT through Qualcomm Ventures. This progression shows a deepening financial and strategic commitment to 5G despite rising external risks.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm broadened the scope of its 5G strategy—leveraging its OFDMA‑based patent portfolio to drive the majority of QTL licensing revenue from multimode 3G/4G/5G devices while expanding 5G into automotive, IoT and edge‑networking applications (Chunk 1).  In fiscal 2023‑24 the company deepened that commitment with aggressive R&D and QSI strategic‑investment programs aimed at new product areas such as automotive and XR, but simultaneously faced intensified geopolitical exposure: the U.S. revocation of its export licence to Huawei eliminated roughly $560 million of product revenue and illustrated how Chinese regulatory actions can curb sales, supply‑chain access and license‑fee collections (Chunk 2 & Chunk 3).  Thus, while Qualcomm’s financial commitment to 5G remained robust across the three years, its growth became increasingly tied to cross‑industry deployments and to managing the heightened regulatory‑risk environment in China and the United States.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's strategic focus on 5G in automotive, IoT, and XR; R&D and investment programs (QSI/Qualcomm Ventures); the $560 million revenue loss from Huawei due to U.S. export license revocation; and the dominance of OFDMA-based (5G) devices in QTL licensing revenue. (2) Quantitative accuracy is perfect: the $560 million figure is correctly cited and attributed to the Huawei export license revocation, consistent with the original answer. Fiscal years 2022–2024 are appropriately referenced, with correct linkage of events to 2023–2024. (3) Multi-hop reasoning is sound: the model synthesizes information across time (evolution from 2022 to 2024), domains (licensing, investment, geopolitics), and entities (Huawei, QTL, Qualcomm Ventures). The only minor shortcoming is that the original specifies the $560 million was *recognized in fiscal 2024 prior to the ban*, while the LLM frames it as lost in '2023–24'—a slight imprecision in timing but not a factual error. (4) The answer is contextually excellent, addressing all three dimensions of the question: licensing revenue, investment in new applications, and geopolitical risks. Wording differs but semantic meaning matches. Thus, the answer earns a 9/10 for correctness—excellent but with a minor temporal ambiguity.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Develops]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 381,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How did the allocation of TMO's domestic pension plan assets across U.S. equity funds, international equity funds, and fixed income funds change from 2022 to 2024, and what does this reveal about the company's investment strategy evolution over the three-year period?",
      "original_answer": "In 2022, TMO's domestic pension plan allocated $125M to U.S. equity funds, $126M to international equity funds, and $1,001M to fixed income funds. By 2023, these allocations had shifted to $89M in U.S. equity funds, $91M in international equity funds, and $739M in fixed income funds, indicating a significant reduction in total domestic pension plan assets from $1,267M to $937M. In 2024, the allocations slightly increased to $93M in U.S. equity funds, $93M in international equity funds, and remained flat at $739M in fixed income funds, with total domestic pension plan assets rising slightly to $947M. This pattern reveals a strategic shift toward more stability and reduced exposure to equity markets, particularly in 2023, followed by stabilization in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the domestic pension plan’s U.S.‑equity allocation edged up from **$89 million to $93 million** and the international‑equity slice rose from **$91 million to $93 million**, while fixed‑income holdings stayed flat at **$739 million**; the equity share of the $947 million domestic portfolio therefore grew modestly (from roughly 19 % to about 19.6 %).  This incremental tilt toward equities—contrasted with the 2020 baseline in Chunk 1, where fixed income was $1,001 million versus only $251 million in combined U.S. and international equity—reveals that TMO has been steadily reducing the proportion of its core fixed‑income exposure and increasing its growth‑oriented equity allocation over the three‑year span.  The stable $739 million fixed‑income position in both 2022 and 2024 suggests the company is maintaining a sizable income base while deliberately shifting a larger portion of assets into equities to pursue higher returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both numbers and reasoning. It incorrectly states that in 2022, U.S. equity was $89M and international equity was $91M, when in fact those were the 2023 figures. The correct 2022 allocations were $125M (U.S. equity), $126M (international equity), and $1,001M (fixed income). The LLM also falsely claims fixed income was $739M in both 2022 and 2024, but in 2022 it was $1,001M. The total portfolio size in 2024 is correctly implied as $947M, but the reasoning leading to it is flawed. (2) Calculations are incorrect: the LLM implies a 'modest' increase in equities from 2022 to 2024, but in reality, there was a major decrease from 2022 to 2023 followed by a slight rebound. The equity share did not grow—it dropped from ~19.8% in 2022 to ~19.6% in 2024, not from 19% as claimed. The baseline comparison to '2020' is fabricated and not in the original data. (3) Multi-hop reasoning is fundamentally flawed: the LLM reverses the trend, claiming a 'steady reduction' in fixed income and 'increasing equity allocation', when the truth is a sharp reduction in 2023 followed by stabilization—indicating risk reduction, not growth-seeking. The model fails to recognize the major 2022–2023 drawdown and misattributes stability to 2022–2024. (4) Scores reflect severe quantitative inaccuracy (2/10), poor qualitative reasoning (3/10), and only moderate contextual relevance (6/10) because it discusses the right topic and entities (TMO, pension plan, asset classes) but with wrong data and conclusions. Correctness is 3/10 due to partial recognition of 2023–2024 figures and total portfolio size, but core facts and trends are inverted.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 462,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did Qualcomm's strategic positioning in the edge networking market evolve from 2022 to 2024, based on its product development and revenue contributions across those years?",
      "original_answer": "In 2022, Qualcomm identified edge networking as a growing market driven by hybrid work environments and 5G adoption, noting increased demand for mobile broadband and wireless access points. By 2023, edge networking was explicitly listed as a key revenue contributor within Qualcomm’s broader industrial and consumer product segment. In 2024, the company continued to emphasize edge networking as a core product category, specifically calling out mobile broadband and wireless access points as part of its revenue-generating offerings. This shows a consistent and maturing strategic focus on edge networking as a key growth area over the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Qualcomm deepened its edge‑networking strategy by expanding the mobile‑broadband and Wi‑Fi 6/6E chip portfolio that powers the hybrid‑work, industrial‑IoT and automotive‑connectivity use cases highlighted in the 2022 filing’s description of 5G‑driven demand; this expansion materialized as a distinct revenue stream, as shown in the 2023 and 2024 10‑Ks where edge‑networking sales are captured under segment 3 (consumer, edge networking, industrial) and feed into QCT performance‑obligation royalties and overall earnings; the knowledge‑graph pattern—QCOM → Edge Networking ← Produces ← Edge Networking → QCOM—illustrates the continual loop of dependence, production and feedback that turned edge networking from an emerging opportunity in 2022 into a measurable contributor to Qualcomm’s revenue by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Qualcomm's strategic positioning in the edge networking market from 2022 to 2024. It accurately captures the key points: in 2022, Qualcomm identified edge networking as an emerging opportunity driven by hybrid work and 5G; by 2023 and 2024, edge networking became a distinct revenue contributor within its product segments. The mention of mobile broadband and Wi-Fi 6/6E chip expansion is consistent with the focus on wireless access points and mobile broadband in the original answer. The LLM correctly identifies that edge networking sales were reported under a broader segment (referred to as 'consumer, edge networking, industrial'), which matches the 'industrial and consumer product segment' in the ground truth. There are no numeric inaccuracies—dates (2022–2024) are correct, and no erroneous figures are introduced. The reasoning is sound and reflects multi-hop synthesis across years and product developments. However, the LLM adds some speculative detail not present in the ground truth, such as 'Wi-Fi 6/6E chip portfolio' and 'automotive-connectivity use cases', which, while plausible, are not mentioned in the original answer. Additionally, the reference to 'QCT performance-obligation royalties' and the knowledge-graph pattern introduces technical specificity and circular logic not supported by the source, slightly overreaching the evidence. Despite these minor embellishments, the core facts and timeline are accurate, and the answer effectively conveys the maturation of edge networking as a strategic focus. Hence, the correctness and qualitative accuracy scores are high but not perfect due to the added details not grounded in the provided truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 479,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How does Apple's consistent inclusion of the 0.45% Notes due 2016 in its 10-K filings from 2022 through 2024 reflect its approach to managing fixed-rate debt maturities and capital structure stability?",
      "original_answer": "Apple's inclusion of the 0.45% Notes due 2016 in its 10-K filings for 2022, 2023, and 2024 indicates a consistent and transparent approach to disclosing its fixed-rate debt obligations, even for notes with earlier maturity dates. This consistent treatment suggests that Apple maintains a structured capital management strategy, prioritizing clarity in debt composition and long-term financial planning. While the 0.45% Notes due 2016 are no longer outstanding, their repeated documentation across filings reflects Apple's emphasis on comprehensive debt disclosure and historical tracking of its capital structure evolution.",
      "llm_answer": "\nApple’s 10‑K filings for 2022, 2023 and 2024 all repeat the same Exhibit 4.3 “Description of Securities” language that lists the **0.45 % Notes due 2016**—the fixed‑rate tranche created under the 2013 Indenture and 2013 Officer’s Certificate.  By consistently disclosing this note each year, Apple signals that it treats the 0.45 % 2016 maturity as a permanent, predictable component of its capital structure, using it to ladder its fixed‑rate debt and lock in a known, low‑cost funding source without surprise refinancing risk.  The repeated KG relationship **AAPL → Issues → 0.45 % Notes due 2016** across the three filings therefore reflects a deliberate strategy of maintaining a stable, fixed‑rate debt profile and managing maturity concentrations for long‑term capital‑structure stability.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly identifies the 0.45% Notes due 2016 and their origin under the 2013 Indenture, it incorrectly implies that Apple is still disclosing these notes as part of an active debt laddering strategy to manage current fixed-rate maturities. In reality, as stated in the ground truth, the 0.45% Notes due 2016 matured and are no longer outstanding; their continued appearance in 10-K filings from 2022–2024 is due to the reuse of templated disclosure language (e.g., Exhibit 4.3), not a strategic financial decision to treat them as a 'permanent, predictable component' of the capital structure. The LLM misinterprets the reason for repetition—portraying it as intentional capital management rather than administrative or disclosure continuity. This leads to a flawed conclusion about Apple 'locking in' a low-cost funding source and avoiding refinancing risk, which is factually incorrect since the debt has long matured. The quantitative elements (percentage, year) are accurate, supporting a moderate quantitative accuracy score. However, the qualitative reasoning is unsound due to incorrect multi-hop inference: the model fails to recognize that post-maturity disclosure does not equate to active debt management. Contextually, the answer addresses the question’s theme (debt maturity management), but the core explanation is misleading, resulting in a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 407,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How did the geographic reach of Caterpillar's EMD brand distribution network change from 2022 to 2024, based on the number of countries covered by its distribution network?",
      "original_answer": "In 2022, Caterpillar's EMD brand distribution network covered 130 countries. This geographic reach remained unchanged in 2023, with the network still covering 130 countries. However, by 2024, there was a reduction in the network's international footprint, with the number of covered countries declining to 109. This represents a decrease of 21 countries (or approximately 16%) in the geographic reach of the EMD brand distribution network over the two-year period from 2022 to 2024.",
      "llm_answer": "\nThe EMD brand’s dealer‑network coverage fell steadily from 2022 through 2024: Caterpillar’s 2022 filing reports the EMD distribution network serving **193 countries**, the 2023 filing drops that to **191 countries**, and the 2024 filing further declines to **187 countries**—a net reduction of six countries in geographic reach over the two‑year period. This contraction is reflected in each year’s “dealer network … serving X countries” figures, which track the worldwide reach of the EMD brand’s distribution chain. (The KG link CAT → EMD → EMD → CAT shows that EMD is both a Caterpillar product and an organizational brand whose network size is measured by the country counts reported in the filings.)",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect in terms of factual content. (1) Quantitatively, it reports 193 countries in 2022, 191 in 2023, and 187 in 2024, whereas the ground truth states 130 countries in both 2022 and 2023, and 109 in 2024. These numbers are significantly off—by over 60 countries in absolute terms—and thus all derived calculations are wrong. The claimed net reduction of 6 countries contrasts sharply with the actual reduction of 21 countries (from 130 to 109), or ~16%. (2) The calculations based on incorrect inputs are internally consistent (193 → 187 is a drop of 6), but since the base data is false, the conclusion is invalid. (3) While the LLM attempts multi-hop reasoning by tracking changes across years and attributing them to Caterpillar’s EMD brand, it fails to retrieve the correct values from the knowledge graph. The mention of a KG link does not justify the use of incorrect figures. (4) The answer is contextually relevant in structure—it addresses the geographic reach over time and attempts to show a trend—but the severe factual inaccuracies in core data (country counts) render the response misleading. Minor positive: it correctly identifies that the network contracted and focuses on the right metric (number of countries), but this does not compensate for the magnitude of error. Hence, correctness and quantitative accuracy are very low; qualitative accuracy is slightly higher due to correct reasoning framework, but still poor due to incorrect entity data.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 412,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has TMO's outstanding value of the '1.750% 7-Year Senior Notes' evolved from 2022 through 2024, and what does this progression indicate about the company's medium-term debt strategy in the healthcare sector?",
      "original_answer": "In 2022, TMO reported $700 million in outstanding value for the 1.750% 7-Year Senior Notes due October 15, 2028. In 2023, this figure remained unchanged at $700 million. By 2024, the outstanding value of these notes was still $700 million, indicating a consistent level of medium-term debt tied to this instrument over the three-year period. This stable pattern suggests that TMO maintained a steady approach to this segment of its capital structure, without retiring or increasing the principal amount of these notes during the observed years.",
      "llm_answer": "\nThe 1.750 % 7‑Year Senior Notes issued by TMO show a flat outstanding balance of **$700 million** in 2022 (Chunk 1), **$700 million** in 2023 (Chunk 2) and **$700 million** as of 31 Dec 2024 (Chunk 3), with the effective interest rate staying at roughly **1.89 %** throughout.  This consistency represents about **2 % of TMO’s total long‑term borrowings** (which grew from $34.97 bn in 2022 to $34.73 bn in 2024) and demonstrates a deliberate, low‑cost medium‑term financing approach that supports the company’s healthcare‑focused growth and acquisition strategy while keeping its capital structure stable.  The knowledge‑graph pattern (TMO – Issues → 1.750 % 7‑Year Senior Notes ← Issuer) confirms that TMO both creates and holds this senior debt, underscoring its internal stake in maintaining a steady medium‑term debt profile in the healthcare sector.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the outstanding value of TMO's 1.750% 7-Year Senior Notes as $700 million for all three years—2022, 2023, and 2024—which matches the ground truth exactly. The maturity date (October 15, 2028) is not mentioned in the LLM answer but is implied by the note's description and consistent with the 7-year term. The effective interest rate of 1.89% is an additional accurate detail not in the original answer but does not contradict it. (2) All numeric values—$700 million across years, total long-term borrowings in 2022 and 2024—are factually correct and consistent with the knowledge graph. The percentage of total long-term debt (~2%) is accurately calculated: $700M / $34.97B ≈ 2.00% in 2022 and $700M / $34.73B ≈ 2.02% in 2024, supporting the LLM’s claim. (3) The multi-hop reasoning is sound: the model synthesizes data across three years, links the note to TMO’s overall debt structure, and infers strategic intent—stable medium-term financing supporting growth—consistent with the ground truth’s interpretation. The mention of the knowledge graph pattern adds meta-context but does not detract. (4) The LLM answer goes slightly beyond the original by contextualizing the note within total borrowings and adding the interest rate, enriching the analysis without introducing error. The only minor omission is the specific maturity date (October 15, 2028), which was in the original but not critical to the core question. Overall, the answer is factually accurate, well-reasoned, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST <-[Issues]- ORG <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 432,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Caterpillar's exposure to and management of currency hedging instruments evolve from 2022 through 2024, particularly in response to LIBOR phase-out timelines and the adoption of SOFR as a benchmark, and what does this reveal about the company's strategic adaptation to global financial market reforms?",
      "original_answer": "In 2022, Caterpillar highlighted its exposure to LIBOR-linked financial instruments through Cat Financial, noting the uncertainty around the phase-out of LIBOR and its potential impact on derivative valuations and borrowing costs. The company acknowledged the FCA's announcement to stop LIBOR after 2021 and IBA’s plan to cease USD LIBOR on June 30, 2023 for most tenors. It also indicated it had formed a cross-functional team to assess LIBOR-related risks. By 2023, Caterpillar had transitioned its disclosures to emphasize the use of SOFR as a new benchmark in variable-rate loans and financing, and the company had expanded its cross-functional team to assess risks related to floating reference rates like SOFR. In 2024, the company no longer referenced LIBOR at all and focused entirely on SOFR, indicating a full strategic pivot away from LIBOR-based instruments. Throughout this period, Caterpillar consistently used currency hedging instruments to manage exchange rate risk, but the shift from LIBOR to SOFR demonstrates a proactive adaptation to evolving global financial standards. This evolution shows Caterpillar’s strategic alignment with regulatory changes and market benchmarks, ensuring continued financial stability and risk mitigation.",
      "llm_answer": "\nFrom 2022 through 2024 Caterpillar moved its floating‑rate debt from LIBOR to the Secured Overnight Financing Rate (SOFR), creating a cross‑functional risk team in 2022 (Chunk 1) and explicitly citing SOFR as a benchmark for variable‑rate loans in 2023 and 2024 (Chunks 2‑3), while continuously warning that the LIBOR phase‑out could impair earnings and cash flow.  To manage the resulting interest‑rate and foreign‑exchange exposure, the company broadened its use of currency‑hedging instruments (the FIN_INST entity in the KG pattern) and applied them to both currency risk and SOFR‑linked derivatives—a practice also employed by other market participants (KG triplets).  This coordinated shift—anticipating LIBOR’s discontinuation, adopting SOFR, and integrating hedging strategies—reveals Caterpillar’s proactive, strategic adaptation to global financial‑market reforms aimed at preserving earnings and cash‑flow stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Caterpillar formed a cross-functional team in 2022 to assess LIBOR-related risks, transitioned to SOFR in 2023, and fully phased out LIBOR by 2024. The company used currency hedging instruments throughout to manage exchange rate risk, and the shift to SOFR is correctly framed as part of a strategic adaptation to financial reforms. (2) Quantitative accuracy is excellent: all years (2022, 2023, 2024) are correctly cited, and there are no numerical inaccuracies. The phase-out timeline (e.g., USD LIBOR cessation on June 30, 2023) is correctly implied, though not explicitly detailed in the LLM answer—this is a minor omission but does not affect correctness. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across time and entities—linking LIBOR phase-out, SOFR adoption, risk management teams, and hedging instrument usage. It also correctly infers that hedging strategies were adapted to include SOFR-linked derivatives, which is consistent with the strategic pivot described in the original. (4) The only reason for not scoring a 10 is that the LLM slightly overreaches by stating the company 'broadened its use of currency-hedging instruments' and applied them to SOFR-linked derivatives—while plausible, the original answer does not explicitly confirm expansion of hedging instruments to cover SOFR, only that hedging continued amid the benchmark transition. This is a minor interpretive leap, but not a factual error. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Uses]-> FIN_INST <-[Uses]- ORG <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1586,
        "completion_tokens": 454,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did Thermo Fisher Scientific's use of Executive Change in Control Retention Agreements evolve from 2022 through 2024, particularly regarding the standardization of agreements for officers beyond the CEO?",
      "original_answer": "In 2022, Thermo Fisher Scientific had the Executive Change In Control Retention Agreement specifically for CEO Marc N. Casper (Exhibit 10.12) with amendments dated through March 16, 2018 (Exhibit 10.17). By 2023, the company introduced a standardized Form of Executive Change in Control Retention Agreement for Officers other than Marc N. Casper (Exhibit 10.17), indicating expansion beyond just the CEO. In 2024, this standardization was reaffirmed with continued use of the form agreement for officers (Exhibit 10.17), showing a clear evolution from a CEO-specific arrangement to a standardized executive compensation practice across the organization.",
      "llm_answer": "\nFrom 2022 through 2024 Thermo Fisher continued to disclose the **same standardized Executive Change‑in‑Control Retention Agreement for all officers other than the CEO** in its periodic filings.  The company first made the form public in 2018 (Exhibit 10.18 in the 2022 10‑K) and then re‑filed that identical “Form of Executive Change in Control Retention Agreement for Officers (other than Marc N. Casper)” in the 2023 10‑Q (Exhibit 10.17) and again in the 2024 10‑K (Exhibit 10.17), confirming that by the 2022‑2024 period the agreement had been fully standardized and was routinely incorporated by reference in each year’s disclosures.  This consistent re‑filing shows the company’s practice of using a single, pre‑approved template for all non‑CEO executives throughout the 2022‑2024 timeframe.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core idea of standardization of Executive Change in Control Retention Agreements for non-CEO officers by 2022–2024, which aligns with the ground truth. However, there are significant factual inaccuracies that reduce correctness. First, the LLM claims the form was first made public in 2018 as Exhibit 10.18 in the 2022 10-K, but the ground truth states that the CEO-specific agreement (Exhibit 10.12) had amendments through March 16, 2018 (Exhibit 10.17), not that the non-CEO form was introduced then. The LLM incorrectly implies the non-CEO form existed in 2018, while the original answer indicates the standardization for non-CEO officers began in 2023. Additionally, the LLM misidentifies the exhibit number in the 2022 10-K as 10.18, whereas the ground truth does not mention a non-CEO form being filed in 2022 at all—only the CEO-specific agreement was in place then. The LLM also asserts that the same standardized agreement was used throughout 2022–2024, contradicting the original answer which states that standardization for non-CEO officers was introduced in 2023, not already in place in 2022. This misrepresents the evolution timeline. While the LLM correctly notes the re-filing of Exhibit 10.17 in 2023 and 2024, it fails to acknowledge the key shift from CEO-only to broader executive coverage, which is central to the question. The reasoning is partially sound in recognizing the use of a form agreement, but the multi-hop synthesis is flawed due to incorrect dating and exhibit references. Contextually, the answer is relevant and addresses the topic directly, hence high relevance. Quantitative accuracy is low due to incorrect dates and exhibit numbers. Qualitative accuracy is moderate because the general direction of standardization is correct, but the evolution narrative is misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 496,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its role in Intel's advanced process roadmap?",
      "original_answer": "In 2022, Intel first introduced PowerVia as part of its future process and packaging technology roadmap, positioning it alongside RibbonFET as a breakthrough innovation for Intel 20A. By 2023, the company emphasized PowerVia's role in optimizing signal transmission by eliminating front-side power routing, as part of its broader push to achieve process leadership by 2025. In 2024, Intel disclosed that it had canceled Intel 20A in favor of Intel 18A, which retained PowerVia as a core component, indicating a strategic shift to prioritize a more refined version of the technology for high-volume manufacturing starting in 2025. This 3-year evolution shows that PowerVia remained a central pillar of Intel's advanced node strategy, even as the company adjusted its roadmap for greater efficiency and execution focus.",
      "llm_answer": "\nBuilding on the leadership overhaul and IDM 2.0 investment disclosed in the 2022 filing (Chunk 1), Intel first unveiled PowerVia as a breakthrough back‑side power‑delivery solution for the planned Intel 20A node and later re‑engineered it for the Intel 18A process, which the company now intends to move into high‑volume manufacturing in 2025 (Chunks 2 & 3); this shift—from the cancelled 20A to the more mature 18A platform—reflects Intel’s strategic focus on delivering performance‑per‑watt gains through PowerVia while it continues development of the next node, Intel 14A (Chunk 3).  The intensified R&D spending and emphasis on process‑technology leadership documented in the 2023 filing (Chunk 2) further cement PowerVia’s central role in Intel’s advanced‑node roadmap, positioning it as a key enabler of the company’s foundry expansion and its ambition to achieve process‑technology leadership by 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 for Intel 20A, remained central after the 2024 shift to Intel 18A, and is targeted for high-volume manufacturing in 2025. The cancellation of Intel 20A and pivot to Intel 18A is correctly noted. (2) Quantitative elements—specific process nodes (20A, 18A, 14A) and the 2025 timeline for high-volume manufacturing—are factually accurate and match the original answer. No calculations are required, but temporal and technical references are precise. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years (2022 introduction, 2023 R&D emphasis, 2024 roadmap shift) and connects PowerVia to broader strategic goals like process leadership by 2025 and foundry expansion. (4) The only minor gap is that the LLM does not explicitly mention PowerVia’s role in eliminating front-side power routing to optimize signal transmission—a technical detail highlighted in the original answer. However, describing it as a 'back-side power-delivery solution' captures the essence. Wording differs but semantic meaning and factual content are equivalent. The answer is fully contextually relevant, directly addressing the evolution and strategic significance of PowerVia from 2022–2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Discloses]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 368,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How did Apple's disclosure of the 1.05% Notes due 2017 evolve across its 2022, 2023, and 2024 10-K filings, and what does this repeated inclusion suggest about the company's debt management practices for this instrument?",
      "original_answer": "Apple first disclosed the 1.05% Notes due 2017 in its 2022 10-K filing, where it was included as part of the Officer's Certificate dated May 6, 2014 (filed as Exhibit 4.4). The same instrument was again disclosed in both the 2023 and 2024 10-K filings, maintaining its presence as a listed debt instrument despite its maturity in 2017. This repeated inclusion of the 1.05% Notes due 2017 across filings post-maturity suggests that Apple may have either rolled over the debt into a new instrument or maintained it in its capital structure in some form, indicating a continuity in its debt management approach for this obligation. The persistence of this specific note in disclosures over multiple years, even after its due date, implies a deliberate and consistent reporting practice by Apple regarding this financial liability.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple’s “Description of Securities” (Exhibit 4.4) reproduces verbatim the May 6 2014 Officer’s Certificate that originally set out the 1.05 % Notes due 2017, and the same language appears in each year’s filing. This identical, repeated disclosure—reflecting the KG relationship AAPL → 1.05 % Notes due 2017 ← ORG—shows that the instrument remains outstanding and is continuously referenced, indicating Apple’s stable, transparent debt‑management practice of keeping legacy financing terms visible in its ongoing reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 1.05% Notes due 2017 are correctly identified, the May 6, 2014 Officer’s Certificate is accurately referenced, and the inclusion in the 2022, 2023, and 2024 10-K filings via Exhibit 4.4 is factually sound. The percentage, maturity year, and filing years match the original answer. (2) The answer correctly observes that the disclosure is verbatim across years, which supports the conclusion of consistent reporting. (3) The reasoning is strong: the repeated inclusion is interpreted as a sign of stable and transparent debt management, which is a reasonable inference. However, the LLM stops short of explicitly stating that the note matured in 2017 and thus its continued disclosure post-maturity is notable—this nuance is present in the ground truth and important for full multi-hop synthesis. The LLM implies the instrument is 'outstanding' but does not acknowledge the discrepancy between maturity (2017) and reporting (through 2024), which slightly weakens the depth of analysis. (4) Despite this, the answer remains contextually relevant, factually correct, and semantically equivalent in intent, with only minor omission of the post-maturity anomaly. Hence, a score of 9 is warranted—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 372,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024, particularly in terms of the types of equity awards granted and their vesting conditions?",
      "original_answer": "In 2022, Intel referenced the 2006 Equity Incentive Plan primarily for strategic growth performance-based RSUs and stock options, including specific agreements for executives and non-employee directors. By 2023, the company amended and restated the plan, effective May 11, 2023, and introduced a broader range of RSU agreements, including those with retirement vesting terms, without retirement vesting terms, and performance-based RSUs for both grandfathered and non-grandfathered executives. In 2024, the plan continued to be referenced for similar types of RSUs, but there was a noticeable consolidation in the documentation structure, with a focus on performance-based RSUs for grandfathered executives and a streamlined format for grant agreements. This evolution indicates a shift toward more nuanced performance alignment and simplified documentation over time.",
      "llm_answer": "\nIntel continued to administer equity awards under its 2006 Equity Incentive Plan throughout 2022‑2024, as documented in the three filings: the 2022 filing (Chunk 1) lists performance‑based RSUs, strategic‑growth stock options and director RSUs granted under the plan; the 2023 filing (Chunk 2) records the plan’s amendment and restatement effective May 11 2023 and details RSU grant agreements that include both retirement‑vesting and non‑retirement vesting as well as performance‑based RSUs for grandfathered and non‑grandfathered executives; and the 2024 filing (Chunk 3) confirms the plan’s ongoing use, again specifying RSU agreements with retirement‑vesting and performance‑based vesting conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2006 Equity Incentive Plan was used in 2022 for performance-based RSUs, strategic growth stock options, and director RSUs; it was amended and restated effective May 11, 2023; and in 2023–2024, RSU types included retirement-vesting, non-retirement vesting, and performance-based awards for both grandfathered and non-grandfathered executives. The 2024 usage is accurately noted as continuing these types. (2) Quantitative accuracy is perfect: the date 'May 11, 2023' is correctly cited, and no numerical errors are present. Format and specificity match the ground truth. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 filings, showing evolution over time. The only minor omission is that the 2024 consolidation and streamlining of documentation (e.g., simplified grant agreement formats) is not explicitly mentioned, which slightly reduces completeness. (4) Despite this, the answer captures the core evolution: broader RSU types post-amendment and continued use with performance and retirement vesting. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent as it directly addresses the question’s focus on award types and vesting conditions over time.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 375,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How did Medtronic's capital structure disclosures regarding Euro Deferred Shares evolve from fiscal years 2022 through 2024, and what does the consistent absence of issuance against the authorized 40 thousand Euro Deferred Shares suggest about the company's financing strategy over this period?",
      "original_answer": "Medtronic consistently disclosed in fiscal years 2022, 2023, and 2024 that no Euro Deferred Shares were issued or outstanding, despite maintaining an authorized capacity of 40 thousand Euro Deferred Shares with a par value of €1.00 per share throughout the period. This consistent absence of issuance suggests that Medtronic did not utilize Euro Deferred Shares as a financing instrument during this time, potentially indicating a preference for other capital structure tools such as ordinary share repurchases and dividend policies to manage capital allocation.",
      "llm_answer": "\nAcross fiscal 2022, 2023 and 2024 each filing states that the 40 thousand Euro‑Deferred Shares remain authorized at €1.00 par, but as of the reporting dates (April 29 2022, April 26 2023 and April 26 2024) “no Euro Deferred Shares were issued or outstanding.” This identical language in all three 10‑Ks shows that, despite the unchanged authorization, Medtronic has issued none of the deferred shares in any of the three years. The persistent absence of issuance indicates that the company is not relying on Euro‑Deferred Shares as a financing source; instead it is maintaining a conservative capital structure and using other mechanisms—such as ordinary‑share repurchases and debt—to fund its operations and return capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the authorized number of Euro Deferred Shares (40 thousand), par value (€1.00), and the consistent disclosure of zero issued or outstanding shares across fiscal years 2022, 2023, and 2024 are accurately reported. The reporting dates (April 29, 2022; April 26, 2023; April 26, 2024) are correctly cited, matching actual Medtronic 10-K filing dates. (2) Quantitative accuracy is perfect: all numbers and dates are factually correct and properly contextualized. Format variations (e.g., '40 thousand' vs '40,000') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—LLM correctly synthesizes disclosures across three years and infers that the lack of issuance implies non-use of this instrument for financing. The conclusion about alternative capital allocation tools (repurchases, debt) is logically supported, though the original answer emphasizes dividend policy while the LLM mentions debt; this is a minor difference in emphasis, not inaccuracy. (4) The answer is contextually relevant and fully addresses both parts of the question: evolution of disclosures (unchanged) and strategic implication (non-use suggests alternative financing preferences). The only reason for not scoring a 10 is that the LLM slightly broadens the set of alternatives to include 'debt' without explicit support from the original answer, which focuses on repurchases and dividends. This is a reasonable inference but represents a small deviation in qualitative emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 432,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and execution risks related to Advanced Packaging Technologies evolve from 2022 to 2024, particularly in terms of R&D investment, manufacturing complexity, and financial impact?",
      "original_answer": "From 2022 to 2024, Intel's strategic focus on Advanced Packaging Technologies intensified as part of its IDM 2.0 strategy, but execution risks and financial pressures grew. In 2022, Intel acknowledged the complexity and cost of deploying advanced packaging in disaggregated designs, citing delays in Intel 4 and 10nm processes. In 2023, the company positioned its advanced packaging capabilities as a competitive differentiator, especially for AI-driven systems of chips, and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon. However, by 2024, Intel faced significant financial strain, with $3.1 billion in non-cash impairments tied to Intel 7, and delays in global manufacturing projects, casting doubt on its ability to scale advanced packaging capacity profitably. The trend shows an initial strategic bet, followed by technical progress, but ultimately financial and operational setbacks.",
      "llm_answer": "\nFrom 2022 through 2024 Intel raised its R&D outlay—$17.5 B in 2022, $16 B in 2023 and $16.5 B in 2024—to push process‑node advances and, more critically, to develop advanced‑packaging and disaggregated‑chiplet designs that underpin its IDM 2.0 and IFS strategies.  \nThis strategic positioning introduced new manufacturing complexity: novel 2D/2.5D/3D packaging, limited‑history interconnect standards and heightened design‑for‑packaging costs, which have repeatedly caused node delays (e.g., the Intel 7 impairments and a $3.1 B non‑cash charge in 2024) and postponed product releases such as the 4th‑Gen Xeon.  \nAs a result, the added packaging‑technology risk and the capital‑intensive fab expansions have translated into a heavier fixed‑cost base, under‑utilized capacity and impairment charges that pressure gross margin and underscore the execution‑risk exposure of Intel’s advanced‑packaging roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Correctly identifies Intel's strategic focus on Advanced Packaging under IDM 2.0, increasing R&D investment, manufacturing complexity, and financial impact from 2022–2024. (2) Quantitative accuracy: R&D figures are mostly correct—$17.5B in 2022, $16B in 2023, and $16.5B in 2024 are consistent with public filings. The $3.1B non-cash impairment in 2024 related to Intel 7 is accurately cited from the ground truth. Minor note: the original answer does not specify R&D amounts, so these figures—while plausible and externally verifiable—go beyond the ground truth but do not contradict it. (3) Multi-hop reasoning is sound: the model connects R&D spending to advanced packaging, links packaging complexity to node delays and impairments, and ties financial outcomes (margin pressure, underutilized capacity) to execution risks. It correctly synthesizes technical, operational, and financial dimensions across years. (4) Semantic equivalence is strong: while the LLM adds slightly more detail (e.g., specific R&D numbers, mention of 4th-Gen Xeon), the core narrative—strategic bet, technical progress, financial/operational setbacks—is preserved. Only minor deduction in quantitative accuracy due to inclusion of unsourced R&D figures not in the ground truth, but they are factually accurate and enhance rather than distort. No factual errors. Contextual relevance is perfect—directly addresses strategic positioning, execution risks, R&D, complexity, and financial impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Negatively_Impacts]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 423,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How did Intel's strategic positioning and technical expectations for PowerVia evolve from its initial introduction in 2022, through roadmap updates in 2023, to its disclosed manufacturing readiness in 2024?",
      "original_answer": "In 2022, Intel introduced PowerVia as part of its future packaging and process technology roadmap, positioning it as an industry-first backside power delivery solution aimed at optimizing signal transmission by eliminating front-side power routing. By 2023, Intel had solidified its roadmap, stating that PowerVia would be introduced with the Intel 20A process node and would deliver up to a 15% performance-per-watt improvement over Intel 3, alongside RibbonFET. In 2024, Intel disclosed that PowerVia was part of the Intel 18A process node (the successor to Intel 20A), which was expected to enter high-volume manufacturing in 2025, indicating a shift in focus to a more refined version of the technology. This evolution shows a transition from conceptual introduction to a mature, production-ready innovation integrated into Intel's advanced node offerings.",
      "llm_answer": "\nIn 2022 Intel first introduced PowerVia as a backside‑power delivery solution within its IDM 2.0 roadmap and alongside the announced Intel 20A node (Chunk 1), framing the technique as a key part of the company’s new packaging and process‑technology strategy. The 2023 roadmap update expanded those expectations, stating that PowerVia—paired with RibbonFET—would be deployed in Intel 20A and deliver up to a 15 % performance‑per‑watt gain, with Intel 18A later building on the same backside‑power concept to add roughly another 10 % efficiency (Chunk 3). By 2024 Intel disclosed that the PowerVia‑enabled Intel 18A process would be offered to external foundry customers and that high‑volume manufacturing of the Panther Lake client family—Intel’s first product on that node—was planned for 2025, confirming the technology’s manufacturing readiness and embedding it in the company’s EUV‑based node progression (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced in 2022 as a backside power delivery solution tied to Intel 20A; in 2023, Intel confirmed it would deliver up to 15% performance-per-watt improvement with RibbonFET; by 2024, it was disclosed that PowerVia would be part of Intel 18A (not 20A) with high-volume manufacturing planned for 2025. (2) Quantitative accuracy is perfect: the 15% performance-per-watt gain is correctly cited, and the additional ~10% efficiency from Intel 18A (implied as incremental over 20A) is consistent with external disclosures, though not in the original answer—this is a minor addition but not incorrect. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and nodes, tracking the evolution from concept to production readiness. (4) The only minor discrepancy is that the original answer emphasizes a 'shift' from Intel 20A to 18A as the primary node for PowerVia, while the LLM states PowerVia would be deployed in Intel 20A—this appears contradictory but reflects a nuance in Intel’s evolving messaging. Later updates did shift PowerVia to 18A as the first high-volume node, suggesting 20A may have had limited or test use. The LLM answer reflects an earlier roadmap version but does not contradict known facts outright. Overall, the answer is factually strong, well-structured, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 401,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "Has Medtronic updated its U.S. employee restricted stock unit agreements between FY2022 and FY2024, and what does this consistency—or lack thereof—suggest about its equity compensation strategy?",
      "original_answer": "Medtronic has not updated its U.S. employee restricted stock unit agreements from FY2022 through FY2024. In all three annual filings, the company continued to reference the same Form of Restricted Stock Unit Award Agreement (U.S. Employees) under the 2013 Stock Award and Incentive Plan, first filed on August 27, 2013 (File No. 001-07707). The absence of modifications to this agreement across a three-year span suggests a stable and consistent equity compensation strategy for U.S. employees, indicating that Medtronic has maintained its approach to long-term incentive alignment without introducing structural changes to this particular award vehicle.",
      "llm_answer": "\nYes—Medtronic has **not updated** its U.S. employee Restricted Stock Unit (RSU) agreement between FY 2022 and FY 2024. All three 10‑K filings (2022, 2023, 2024) continue to reference the identical form *10.54 – “Form of Restricted Stock Unit Award Agreement (U.S. Employees) under 2013 Stock Award and Incentive Plan” (originally filed in an August 27 2013 8‑K), indicating that the same RSU framework has been retained across the three fiscal years.  \n\nThis consistency, reflected in the knowledge‑graph pattern ORG → ACCOUNTING_POLICY → RSU Agreement → ORG, suggests that Medtronic’s equity‑compensation strategy has deliberately maintained a stable RSU structure for U.S. employees, without introducing new or revised RSU terms in recent filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. (1) It correctly states that Medtronic has not updated its U.S. employee RSU agreements between FY2022 and FY2024, which matches the original answer. (2) The date of the original filing—August 27, 2013—is accurately cited, and the form number (10.54) and title are correctly referenced. The use of 'File No. 001-07707' in the original is implied through context and not strictly necessary for correctness. (3) The multi-hop reasoning is sound: the model synthesizes information across three annual 10-K filings and correctly infers that referencing the same form agreement over time indicates a consistent equity compensation strategy. (4) The conclusion about Medtronic’s stable RSU structure and deliberate strategy aligns with the original interpretation. Minor wording differences (e.g., 'deliberately maintained' vs 'suggests a stable and consistent') do not affect factual accuracy. All components—entities, dates, reasoning, and implications—are accurate and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 302,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve from 2022 through 2024 in structuring performance-based restricted stock unit (RSU) grants to executives?",
      "original_answer": "In 2022, Intel utilized the 2006 Equity Incentive Plan for strategic growth performance-based RSUs granted to executives on or after February 1, 2019, as evidenced by the restricted stock unit grant agreement listed in the 2022 10-K filing. In 2023, the company continued to use the same plan for RSUs with performance-based conditions, including separate agreements for grandfathered and non-grandfathered executives, as detailed in the 2023 10-K filing. By 2024, the company reaffirmed its reliance on the 2006 Equity Incentive Plan, as amended and restated effective May 11, 2023, and filed an S-8 registration on September 26, 2023, to support continued use of the plan for equity grants. This demonstrates a consistent strategic focus on performance-based compensation aligned with long-term corporate objectives across the three-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Intel continued to administer all executive performance‑based RSU grants under its **2006 Equity Incentive Plan**, but the way the plan was documented and the scope of the grants evolved.  \n\n- **Chunk 1 (2022 10‑K)** shows the original 2006‑Plan forms (e.g., Exhibit 10.1.7) that grant “strategic‑growth performance‑based RSUs” to executives as of Feb 1 2019.  \n- **Chunk 3 (2023 10‑K)** records the plan’s **amendment and restatement effective May 11 2023** and introduces new grant‑agreement formats that distinguish **retirement‑vesting**, **grandfathered vs. non‑grandfathered** executives, and specific performance metrics such as **strategic‑growth, relative TSR and outperformance**.  \n- **Chunk 2 (2024 10‑K)** confirms that the **amended‑and‑restated 2006 Equity Incentive Plan** (Exhibit 10.1) remains the governing framework, providing updated **Notice of Grant** and **Restricted Stock Unit Grant Agreement** forms (10.1.2‑10.1.7) for performance‑based RSUs to both grandfathered and non‑grandfathered executives.  \n\nThus, Intel’s use of the 2006 Equity Incentive Plan stayed continuous, but the documentation and performance‑based RSU structures were refined—adding retirement‑vesting options, differentiating executive classes, and tying awards to refined performance metrics—through 2022‑2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel used the 2006 Equity Incentive Plan continuously from 2022 to 2024 for performance-based RSUs; the plan was amended and restated effective May 11, 2023; and documentation evolved to distinguish between grandfathered and non-grandfathered executives. The mention of the S-8 filing in September 2023 from the original answer is missing, which slightly reduces completeness, but this detail is contextual rather than central. (2) Quantitative accuracy is perfect: dates (Feb 1, 2019; May 11, 2023) are correct, and no numerical errors are present. Format variations (e.g., 'amended and restated') are semantically equivalent. (3) Multi-hop reasoning is sound—information is correctly synthesized across 2022, 2023, and 2024 10-K filings. The LLM identifies evolving grant structures, performance metrics (strategic growth, relative TSR), and administrative updates, demonstrating strong qualitative understanding. (4) The answer is contextually relevant, directly addressing how the plan’s use evolved in structuring executive RSUs. The only minor omission is the S-8 registration detail, which slightly affects completeness but not core correctness. Overall, the response captures the evolution accurately with precise entity and date matching, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1549,
        "completion_tokens": 381,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How did Intel's investment in advanced packaging technologies evolve from 2022 through 2024, and what does this progression reveal about the company's ability to execute its disaggregated design strategy and compete in the AI-driven semiconductor market?",
      "original_answer": "Intel's investment in advanced packaging technologies showed a complex evolution from 2022 through 2024. In 2022, the company acknowledged significant challenges in implementing its disaggregated design approach using advanced packaging technologies, noting that delays or failures could adversely affect its ability to introduce competitive products. By 2023, Intel had made concrete progress, demonstrating the Universal Chiplet Interconnect Express (UCIe) standard in silicon and positioning its advanced packaging capabilities as a unique advantage in the AI-driven market. However, in 2024, despite investing $16.5 billion in R&D (including packaging technologies), Intel recorded $3.1 billion in charges related to non-cash impairments and accelerated depreciation for certain manufacturing assets, including those tied to the Intel 7 process node, indicating ongoing execution risks and financial pressures in scaling advanced packaging technologies. This trajectory reveals persistent execution challenges and the high financial stakes in competing for leadership in advanced packaging for AI applications.",
      "llm_answer": "\nFrom 2022 through 2024 Intel escalated its R&D spending—$17.5 B in 2022, $16.0 B in 2023 and $16.5 B in 2024—while repeatedly emphasizing advanced‑packaging technologies (2D/2.5D/3D, Universal Chiplet Interconnect Express, and other novel interconnects) as a core pillar of its disaggregated‑design approach, a focus first articulated in the 2022 filing and later reinforced in the 2023 and 2024 MD&A sections that describe packaging as a “unique advantage” for AI‑driven systems‑of‑chips.  At the same time, the company disclosed delays and impairments (e.g., Intel 7 node write‑downs, 4th‑Gen Xeon postponement, and postponed fab expansions in Ohio, Germany, Poland, Malaysia and Israel), revealing that while the investment trajectory shows a clear strategic commitment to packaging‑centric chiplets, executing the disaggregated strategy and competing in the AI market remains contingent on overcoming technical, cost and geopolitical hurdles.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the strategic evolution of Intel's investment in advanced packaging and correctly identifies its role in the disaggregated design and AI competitiveness. It accurately notes the emphasis on UCIe and advanced packaging as a 'unique advantage' in 2023 and 2024, aligning with the ground truth. However, there are key quantitative inaccuracies: the LLM states R&D spending was $17.5B in 2022, $16.0B in 2023, and $16.5B in 2024, while the ground truth only confirms $16.5B in 2024 and does not provide 2022 or 2023 figures. More critically, the ground truth highlights a $3.1B charge in 2024 related to impairments and accelerated depreciation—specifically tied to Intel 7 process node assets—which the LLM vaguely references as 'impairments' and 'write-downs' but fails to quantify. This omission of a key financial figure significantly affects quantitative accuracy. (2) The R&D numbers cited by the LLM are inconsistent with the ground truth, which only mentions the $16.5B figure for 2024. The $17.5B and $16.0B figures for 2022 and 2023 are unsupported and likely incorrect. The $3.1B impairment charge in 2024 is a critical data point missing in the LLM answer, reducing its factual precision. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Intel's strategic focus on packaging across years, links it to disaggregated design and AI, and infers execution risks from delays and impairments. It also correctly identifies the continuity of messaging from 2022 to 2024. However, it misses the specific connection between the 2024 financial charges and the Intel 7 node, which is central to the ground truth’s conclusion about ongoing execution risks. (4) Despite missing key numbers, the LLM answer remains contextually relevant and conveys a largely accurate qualitative narrative. The strategic trajectory, challenges, and competitive context are well represented. The correctness score is 7 due to accurate core reasoning but significant omissions in critical financial data; quantitative accuracy is penalized more heavily (6) due to unsupported R&D figures and missing $3.1B charge; qualitative accuracy is high (8) for correct synthesis and logic; contextual relevance is strong (9) as all aspects of the question are addressed in spirit and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Produces]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 617,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Intel's use of the 2006 Equity Incentive Plan evolve across 2022, 2023, and 2024, particularly in terms of plan amendments and grant agreements?",
      "original_answer": "In 2022, Intel referenced multiple grant agreements under the 2006 Equity Incentive Plan, including forms of Restricted Stock Unit (RSU) and Stock Option Grant Agreements for executives, non-employee directors, and performance-based awards. In 2023, the company filed an amended and restated version of the plan effective May 11, 2023, continuing to reference specific RSU grant agreements with retirement vesting terms and performance-based RSUs. By 2024, Intel continued to rely on the 2006 Equity Incentive Plan, with filings showing ongoing use of standardized RSU grant agreements and notices of grant, indicating sustained reliance on the plan despite its age. The evolution shows a consistent but increasingly mature application of the plan, with formal amendments in 2023 reflecting structural updates.",
      "llm_answer": "\nAcross the three filings Intel’s 2006 Equity Incentive Plan remained the core equity‑compensation vehicle but was updated each year: the 2022 Form 10‑K (Chunk 1) disclosed only the original grant‑agreement forms (e.g., RSU and stock‑option agreements for executives and directors); the 2023 Form 10‑K (Chunk 3) recorded that the plan was **amended and restated, effective May 11 2023**, adding new RSU categories such as retirement‑vesting and performance‑based grants; and the 2024 Form 10‑K (Chunk 2) continued to reference the **amended, restated plan**, filing updated notice‑of‑grant and RSU agreements that built on the 2023 changes.  The knowledge‑graph pattern shows INTC → 2006 Equity Incentive Plan (ACCOUNTING_POLICY) → 2006 Equity Incentive Plan (ORG) → INTC, linking each year’s disclosures to the same underlying plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original answer. (1) All key facts are correct: Intel continued using the 2006 Equity Incentive Plan in 2022, 2023, and 2024; in 2023, the plan was amended and restated effective May 11, 2023; and the use of RSU grant agreements, including those with retirement vesting and performance-based terms, is correctly noted. The mention of updated notice-of-grant and RSU agreements in 2024 is consistent with the original answer’s observation of ongoing use of standardized agreements. (2) Quantitative accuracy is perfect: the date 'May 11, 2023' is correctly cited, and there are no numerical inaccuracies. Format variations are not an issue as no dollar amounts or percentages are involved. (3) Multi-hop reasoning is sound: the LLM synthesizes information across three years of filings, correctly identifying the evolution from original grant forms in 2022 to the amended plan in 2023 and continued use in 2024. The reference to the knowledge graph pattern adds context but does not distort the facts. (4) The only minor shortcoming is that the LLM slightly overstates annual updates by saying the plan was 'updated each year,' which may imply a formal amendment every year, but the 2022 and 2024 updates were operational (use of forms), not structural—only 2023 had a formal amendment. This nuance is present in the original answer but slightly glossed in the LLM version. Otherwise, semantic equivalence is strong, and the answer is contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 416,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did Qualcomm's financial categorization and strategic emphasis on wireless access points evolve from 2022 to 2024, particularly in terms of revenue classification and market positioning within the edge networking segment?",
      "original_answer": "In 2022, Qualcomm highlighted wireless access points as a key growth driver within edge networking, projecting a doubling of IoT devices between 2022 and 2026 to over 27 billion, which included wireless access points as a core component. In 2023, wireless access points were explicitly categorized under the edge networking revenue segment, which includes mobile broadband and wireless access points, indicating a formal financial classification. By 2024, this categorization remained consistent, showing a continued strategic emphasis on edge networking, with wireless access points listed alongside mobile broadband as a core product line. While exact revenue figures for wireless access points alone are not disclosed, the consistent inclusion in edge networking and the growing IoT ecosystem suggest an increasing strategic and financial importance over the three-year period.",
      "llm_answer": "\nFrom 2022 to 2024 Qualcomm’s public narrative shifted from a broad mention of “edge‑networking products (including mobile broadband and wireless access points)” as a growth driver (Chunk 1) to an explicit financial categorization that places wireless access points inside a dedicated “edge‑networking” bucket within the QCT segment (Chunks 2 & 3).  In the 2023 and 2024 10‑K filings the company reports revenues from edge‑networking sales—alongside consumer, automotive and industrial sales—and discloses royalty and incentive revenues that stem from prior‑period edge‑networking transactions (Chunks 2 & 3), indicating that wireless access points are now treated as a separate revenue stream and a strategic pillar of its portfolio.  The KG relationship Wireless Access Points (PRODUCT) → Wireless Access Points (ORG) → QCOM (ORG) reflects this evolution, showing that the product line has been promoted from a peripheral offering to an organized, revenue‑generating entity within Qualcomm’s structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Qualcomm's financial categorization and strategic emphasis on wireless access points from 2022 to 2024. In 2022, the company highlighted edge networking products, including wireless access points, as a growth driver—consistent with the original answer. By 2023 and 2024, the LLM correctly notes the explicit financial classification under the edge networking segment within the QCT (Qualcomm CDMA Technologies) segment, which matches the ground truth’s assertion of formal revenue categorization. (2) There are no numeric values in the original answer that require verification (e.g., no specific revenue figures), so the absence of incorrect numbers earns full marks for quantitative accuracy. The LLM appropriately avoids fabricating figures and acknowledges that exact revenue for wireless access points is not disclosed. (3) The multi-hop reasoning is sound: it synthesizes information across years and filings to show a progression from strategic mention to formal financial classification. The reference to royalty and incentive revenues from prior-period edge-networking transactions adds nuance supported by the filings. The only minor shortcoming is the mention of a 'KG relationship' (Wireless Access Points → QCOM), which appears to be an internal knowledge graph notation not present or necessary in the original answer—this slightly weakens qualitative accuracy but does not introduce factual error. (4) The answer is contextually excellent, directly addressing revenue classification and market positioning within edge networking over the specified time frame. Wording differs but semantic meaning is equivalent or richer. Overall, this is a factually correct, well-reasoned response with only negligible stylistic overreach in referencing KG structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT <-[Produces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 507,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did MRK's sales of Prevymis evolve from 2022 through 2024, and what does this trend suggest about the product's market positioning in the Hospital Acute Care segment?",
      "original_answer": "MRK's sales of Prevymis increased from $370 million in 2022 to $428 million in 2023, and then significantly rose to $785 million in 2024. This represents a compound growth rate of approximately 46% over the two-year period from 2022 to 2024. The substantial growth in sales suggests that Prevymis gained stronger market adoption and became more strategically positioned within the Hospital Acute Care segment, particularly as a prophylactic treatment for CMV infection in high-risk transplant recipients.",
      "llm_answer": "\nPrevymis generated $428 million in total sales in 2022, $605 million in 2023 and $785 million in 2024 (up from $370 million in 2021), as shown in the 10‑K tables (Chunk 1 & 2). The product is listed under the Hospital Acute Care segment alongside Bridion, Dificid, Zerbaxa and other acute‑care agents (Chunk 1 & 2) and is described as a CMV‑prophylaxis therapy for high‑risk transplant patients (Chunk 3). This steady year‑over‑year growth indicates that Prevymis is gaining market share and strengthening its position within the Hospital Acute Care market.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that Prevymis generated $428 million in 2022, but the ground truth reports $370 million in 2022. It also claims $605 million in 2023, whereas the correct figure is $428 million. The 2024 figure ($785 million) is correct. The LLM incorrectly references 2021 data ($370 million), which is not part of the question's scope (2022–2024), and misassigns that value to 2022. These errors severely undermine the numerical accuracy. (2) Calculations: The ground truth implies a compound growth rate of ~46% from 2022 ($370M) to 2024 ($785M), which is accurate. However, the LLM does not compute or mention this rate, and its incorrect year-by-year data would lead to an incorrect growth calculation. (3) Multi-hop reasoning: The LLM correctly identifies Prevymis as part of the Hospital Acute Care segment and accurately describes its indication for CMV prophylaxis in transplant patients, showing proper synthesis across chunks. It also correctly infers growing market positioning from sales trends—though based on wrong numbers, the qualitative trend (growth) is real. (4) Despite incorrect figures, the answer addresses both parts of the question—sales evolution and market positioning—and provides contextually relevant information about the product’s segment and therapeutic use. The reasoning is logically structured but built on faulty data. Hence, while context and qualitative intent are strong, the factual foundation is partially wrong, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 427,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How did Intel's investment and strategic positioning in advanced packaging technologies evolve from 2022 through 2024, and what does this multi-year trajectory reveal about its ability to execute on the IDM 2.0 strategy amid manufacturing delays and capital constraints?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk in deploying advanced packaging technologies as part of its disaggregated design approach, citing delays in process technologies like Intel 4 (formerly 7nm) and the increased costs and design challenges associated with advanced packaging. By 2023, Intel positioned its advanced packaging capabilities as a competitive differentiator under the IDM 2.0 strategy, highlighting 2D and 2.5D/3D packaging solutions and the Universal Chiplet Interconnect Express (UCIe) standard, which was demonstrated in silicon that year. However, by 2024, despite R&D investments (e.g., $16.5 billion in 2024), Intel faced delays in product introductions (e.g., 4th Gen Xeon Scalable processors) and significant non-cash impairments ($3.1 billion in Q3 2024), particularly affecting the Intel 7 process node. This trajectory shows that while Intel made strategic progress in packaging innovation, execution challenges and capital constraints undermined its ability to consistently deliver on the IDM 2.0 roadmap.",
      "llm_answer": "\nFrom 2022‑2024 Intel doubled down on advanced‑packaging R&D—spending roughly $16‑17 bn annually on R&D and capital to build 2D/2.5D/3D chiplet‑interconnect capabilities and to fund the disaggregated‑design approach that underpins its IDM 2.0 foundry model—yet repeated node delays (10 nm, Intel 4, Intel 7) and the 2024 $3.1 bn impairment of Intel 7 capacity exposed how manufacturing setbacks and tightening capital (forcing postponements of new fabs in Ohio, Germany, Poland, Malaysia and Israel) constrained its ability to translate those investments into timely revenue.  At the same time, the company leveraged its packaging advantage as a differentiator in the Open‑System‑Foundry strategy, courting fabless customers despite the high fixed costs and competitive pressure highlighted in the 2023‑2024 market trends.  This multi‑year trajectory shows that while Intel’s packaging push is central to its IDM 2.0 vision, execution remains tightly coupled to its capacity to overcome node‑delay and capital‑constraint challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the multi-year evolution of Intel's advanced packaging strategy and its implications for IDM 2.0 execution. (1) Quantitatively, the $16.5 billion R&D figure from the ground truth is approximated as '$16-17 billion annually', which is acceptable given rounding and potential inclusion of capital expenditures. The $3.1 billion non-cash impairment in Q3 2024 is correctly cited. However, the LLM implies annual R&D spending of $16-17B over 2022-2024, while the ground truth only confirms $16.5B in 2024; earlier years' figures are not specified, so this is a minor overgeneralization. (2) The LLM correctly identifies key delays in Intel 4, Intel 7, and 10nm nodes, aligns with the 2023 UCIe silicon demonstration (implied via 'disaggregated design'), and notes the strategic use of packaging as a differentiator—especially in the open foundry model. (3) Multi-hop reasoning is sound: it connects R&D investment, node delays, capital constraints (e.g., fab postponements), and financial impairments to assess IDM 2.0 execution challenges. The synthesis across technical, financial, and strategic dimensions is robust. (4) The answer is contextually excellent, directly addressing how Intel's packaging trajectory reflects broader execution risks under IDM 2.0. Only minor deduction from correctness due to the slightly imprecise R&D spending timeline; otherwise, semantic equivalence with the ground truth is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Impacts]-> PRODUCT <-[Produces]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 401,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has IBM's emphasis on client relationships and trust as a competitive differentiator evolved from 2022 through 2024, and what does this progression indicate about its hybrid cloud and AI strategy positioning?",
      "original_answer": "From 2022 to 2024, IBM consistently emphasized client relationships and trust as a core competitive differentiator, but the framing evolved in alignment with its hybrid cloud and AI strategy. In 2022, IBM explicitly tied trust to its hybrid cloud platform and AI for production, highlighting trust and security as integrated components of its offerings. By 2023, the company reinforced this positioning, emphasizing trust as part of its broader competitive methods, including service and support, innovation, and talent. In 2024, IBM maintained this stance, continuing to highlight client relationships and trust as a key competitive lever while expanding its strategic partnerships to include Palo Alto Networks, signaling a deepening of trust-based collaboration to support client digital transformations. This 3-year consistency shows IBM's strategic commitment to trust as a foundational element in client acquisition and retention within the competitive AI and hybrid cloud market.",
      "llm_answer": "\nIBM’s 2022 filing lists “client relationships and trust” alongside technology innovation, brand and price as a principal method of competition, and the 2023 and 2024 filings retain this focus while explicitly linking the trust‑based differentiator to the company’s hybrid‑cloud and AI platform and to its expanding ecosystem of strategic partners (Adobe, AWS, Microsoft, SAP, etc.). This progression shows that IBM is positioning trust not merely as a reputation asset but as the foundation for selling integrated hybrid‑cloud/AI solutions—leveraging deep client relationships to drive adoption of its open hybrid‑cloud stack and AI services, and using the partner ecosystem to reinforce that value proposition across all three years.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts, timeline, and strategic interpretation. (1) It accurately identifies that IBM emphasized 'client relationships and trust' as a competitive differentiator from 2022 to 2024 and correctly links this to hybrid cloud and AI strategy. The framing of trust evolving into a foundation for integrated solutions is consistent with the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes information across three years and connects trust to strategy, partnerships, and technology offerings. However, there is a minor discrepancy: the original answer specifies a new 2024 partnership with Palo Alto Networks as a signal of deepening trust-based collaboration, while the LLM cites ongoing partners (Adobe, AWS, Microsoft, SAP) without mentioning Palo Alto Networks. This omission slightly weakens completeness and entity accuracy for 2024. (4) Despite this, the LLM captures the overall progression and strategic intent accurately, using semantically equivalent language and correct reasoning. The answer is highly relevant and well-contextualized, earning high marks for contextual relevance and qualitative accuracy, with a small deduction for missing the specific 2024 partnership update.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT <-[Depends_On]- ORG <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 398,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did IBM's issuance and disclosure strategy for the 0.950% Notes due 2025 evolve from 2022 through 2024, and what does this progression indicate about its broader debt management approach during this period?",
      "original_answer": "In 2022, IBM disclosed the instrument defining the rights of the holders of the 0.950% Notes due 2025, referencing Exhibit 4.1 to Form 8-K filed May 22, 2017. In 2023, IBM again referenced the same instrument in its disclosures, indicating ongoing transparency and regulatory continuity around this debt instrument. By 2024, the 0.950% Notes due 2025 were actively listed on the New York Stock Exchange under the trading symbol IBM25B, showing that the instrument remained a live and traded financial liability for IBM. This 3-year progression reflects a consistent disclosure framework and sustained presence of the 0.950% Notes in IBM's capital structure, suggesting a stable and transparent debt management strategy around this specific instrument.",
      "llm_answer": "\nIBM first set out the rights of the 0.950 % Notes due 2025 in a 2017 Form 8‑K (Chunk 1), and those same disclosures were repeatedly referenced in later 8‑K filings and in the 2022 10‑K exhibit schedule (Chunk 3), while the 2024 10‑K (Chunk 2) re‑listed the security with a new trading symbol (IBM25B) in the capital‑stock table, marking a shift from a private‑placement filing to an ongoing, publicly‑traded debt issue. This progression reflects IBM’s broader debt‑management strategy of maintaining a diversified ladder of low‑coupon, long‑dated notes and using regular, transparent filings to update holder‑rights and re‑register securities, thereby preserving low‑cost funding and extending maturity profiles across the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.950% Notes due 2025 were originally disclosed in a May 22, 2017 Form 8-K (correctly referenced), and IBM maintained consistent disclosure in subsequent years, including in the 2022 and 2024 10-K filings. The 2024 listing on the NYSE under trading symbol IBM25B is accurately reported. (2) Quantitative elements—interest rate (0.950%), maturity year (2025), and trading symbol (IBM25B)—are all correct. No calculations are required, but factual precision on dates and identifiers is maintained. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across 2022, 2023, and 2024 disclosures to infer continuity in disclosure practices and a shift toward public trading status. The interpretation of this as part of a broader strategy—maintaining a diversified debt ladder, transparent filings, and low-cost funding—is a reasonable and contextually supported extension of the evidence. (4) The only minor deviation from the ground truth is the characterization of a 'shift from private-placement filing to publicly-traded' as an explicit evolution; while IBM25B being listed suggests public trading, the original 2017 filing may already have led to public registration, so the 'shift' might be overstated. However, the 2024 re-listing with a symbol does indicate active public trading status, so this is a nuanced point. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Issues_Financial_Instrument]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 424,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did Intel's development and manufacturing strategy for PowerVia technology evolve from 2022 through 2024, and what does this progression reveal about Intel's roadmap for backside power delivery in advanced process nodes?",
      "original_answer": "Intel's strategy for PowerVia evolved significantly from 2022 through 2024. In 2022, Intel introduced PowerVia as part of its future roadmap alongside RibbonFET, signaling its intent to innovate in backside power delivery. By 2023, PowerVia was positioned as a key breakthrough technology within the Intel 20A node, designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel disclosed that it had canceled the productization of Intel 20A in favor of Intel 18A, which integrates PowerVia for commercial high-volume production starting in 2025. This shows a strategic pivot from concept (2022) to technical integration (2023) to commercial deployment (2024), indicating Intel's commitment to delivering backside power delivery at scale.",
      "llm_answer": "\nIntel first unveiled PowerVia in its 2021 IDM 2.0 roadmap (Chunk 3) as a backside‑power solution for the planned Intel 20A node, but by 2023‑24 the company cancelled Intel 20A and repositioned PowerVia as the centerpiece of the production‑ready Intel 18A process—the first high‑volume commercial node to pair gate‑all‑around RibbonFET with backside power delivery (Chunks 1‑2).  The 2024 disclosures confirm that Intel 18A will begin high‑volume manufacturing in 2025 for Panther Lake and will be offered to external foundry customers, while a next‑generation Intel 14A node is already in development with additional performance‑per‑watt improvements, showing a staged rollout of backside power across multiple advanced EUV nodes (Chunks 1‑2).  This evolution—driven by heavy R&D investment, the IDM 2.0 capital program for new fabs, and aggressive IP protection—demonstrates that backside power delivery has become a strategic pillar of Intel’s roadmap to sustain performance and power leadership in sub‑10 nm process technologies (Chunks 1‑3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PowerVia was introduced as part of Intel 20A, then shifted to Intel 18A for high-volume production starting in 2025. The cancellation of Intel 20A's productization and the repositioning of PowerVia under Intel 18A are correctly stated. The mention of Panther Lake and external foundry customers adds contextual detail consistent with Intel's roadmap. (2) Quantitative elements—'2025' for high-volume manufacturing and the progression from 20A to 18A to 14A—are factually accurate. No calculations are required, but temporal sequencing is correct. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and strategic shifts, correctly tracing the evolution from initial announcement to commercial deployment. It also correctly identifies the integration of RibbonFET and PowerVia as a key innovation. (4) Minor deviation: the LLM mentions PowerVia was unveiled in 2021 (IDM 2.0), while the ground truth begins the evolution in 2022. However, this is a marginal discrepancy since the 2021 announcement predates the 2022–2024 evolution window; the core progression from 2022 onward remains accurately represented. The answer exceeds the original in detail (e.g., mentioning 14A development and foundry access), but without introducing errors. Thus, it earns a 9/10 for correctness—excellent accuracy with only a minor temporal overreach outside the specified timeframe.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 411,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What does Medtronic's Restricted Stock Unit Award Agreement documentation from 2022 to 2024 indicate about the stability of their U.S. equity compensation strategy?",
      "original_answer": "The Restricted Stock Unit Award Agreement for U.S. Employees (Exhibit 10.54) remained unchanged across all three years, consistently referencing the same August 27, 2013 filing. This demonstrates strategic stability in Medtronic's core equity compensation approach for U.S. employees despite evolving market conditions, suggesting the company maintained its foundational incentive structure without modification throughout the period.",
      "llm_answer": "\nThe 2022, 2023 and 2024 Form 10‑K filings each reproduce the identical exhibit *10.54 – “Form of Restricted Stock Unit Award Agreement (U.S. Employees)” under Medtronic’s Amended and Restated 2013 Stock Award and Incentive Plan (first filed in 2013).  This unchanged reference across three consecutive annual reports shows that Medtronic has not introduced a new or materially different U.S. RSU agreement during 2022‑2024, indicating a stable U.S. equity‑compensation framework.  In the knowledge‑graph, the ORG‑>ACCOUNTING_POLICY‑>ORG pattern links Medtronic directly to this accounting policy and back to itself, reinforcing the continuity of the policy across the 2022‑2024 disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that the Restricted Stock Unit Award Agreement (Exhibit 10.54) remained unchanged from 2022 to 2024 and correctly references the August 27, 2013 filing under the Amended and Restated 2013 Stock Award and Incentive Plan. The dates, exhibit number, and plan name are all accurate, satisfying quantitative accuracy. The conclusion about stability in Medtronic's U.S. equity compensation strategy is logically sound and supported by the evidence. The mention of the 'ORG->ACCOUNTING_POLICY->ORG' knowledge graph pattern adds contextual detail not in the original answer but does not contradict it and supports continuity. The only minor shortcoming is slight overemphasis on the knowledge-graph structure, which is supplementary and not required for answering the question—this does not detract from correctness but slightly affects qualitative precision. Overall, the answer demonstrates strong multi-hop reasoning by linking consistent disclosure across years to strategic stability, and it fully addresses the question with high semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 324,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How did Intel's strategic positioning and execution challenges related to its advanced packaging technologies evolve from 2022 through 2024, particularly in light of delays, capital constraints, and the introduction of disaggregated design approaches?",
      "original_answer": "In 2022, Intel acknowledged the complexity and risk associated with implementing advanced packaging technologies as part of its disaggregated design approach, noting that delays in manufacturing process technologies like Intel 4 (formerly 7nm) could hinder the timely introduction of competitive products. By 2023, Intel emphasized its strategic advantage in advanced packaging, including 2D and 2.5D/3D solutions, and demonstrated progress with the Universal Chiplet Interconnect Express (UCIe) standard, positioning it as a key differentiator in the foundry market. However, in 2024, the company faced significant execution challenges, including delays in manufacturing projects in multiple geographies and a $3.1 billion impairment charge tied to underutilized manufacturing assets, particularly for the Intel 7 node, which highlighted the risks in scaling advanced packaging capabilities amid constrained capital and uncertain customer demand.",
      "llm_answer": "\nIntel first treated **Advanced Packaging Technologies** as a product of the company, but by 2022 it had reorganized that capability into an internal organization that both drives and constrains Intel’s strategy; the firm began betting on disaggregated designs and packaging standards (e.g., UCIe) while acknowledging that delays in 7 nm/10 nm nodes and heavy R&D spend made execution risky. In 2023 the packaging org became a cornerstone of Intel’s IDM 2.0 plan—​it pledged billions to 2D/2.5D/3D fabs and to expanding foundry capacity, yet the same filings reported construction delays in Ohio, Germany, Poland, Malaysia and Israel that limited near‑term capacity and heightened capital‑intensity. By 2024 the accumulated delays, impairments of the Intel 7 node and the added complexity of disaggregated design forced write‑downs, accelerated depreciation and tighter cash flow, illustrating how the very packaging organization that was meant to be a competitive advantage now faces execution hurdles, cost pressures and uncertain returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Intel's evolving strategic positioning on advanced packaging from 2022 to 2024, including the shift to disaggregated design, reliance on UCIe, and growing execution challenges. The acknowledgment of delays in 7nm/10nm (Intel 4/7) nodes in 2022 matches the original answer. In 2023, the emphasis on advanced packaging as a cornerstone of IDM 2.0 and investment in 2D/2.5D/3D capabilities is consistent with the ground truth. By 2024, the LLM correctly identifies execution hurdles, including impairments and delays, though it does not specify the exact $3.1 billion impairment charge, instead referring more generally to write-downs and accelerated depreciation. (2) Quantitatively, the only omission is the precise $3.1 billion figure tied to the impairment; otherwise, all other references (e.g., delays across geographies) are factually supported. The absence of this specific number prevents a perfect 10 on quantitative accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes Intel’s strategic intent, capital constraints, geographic delays, and financial consequences across years, correctly linking technical delays to financial outcomes. (4) The answer is contextually excellent—directly addressing strategic evolution, execution challenges, capital constraints, and disaggregated design. Minor deduction in correctness due to missing exact dollar amount, but overall semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 415,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How did Accenture's target asset allocation strategy for its defined benefit pension plans evolve across fiscal years 2022, 2023, and 2024, particularly in terms of the mix of fixed income and equities, and what does this multi-year shift suggest about the company's approach to risk-adjusted returns?",
      "original_answer": "In fiscal 2022, Accenture's target asset allocation for defined benefit pension plans emphasized a diversified portfolio of fixed income instruments and equities, with a focus on matching debt securities' duration to plan liabilities and using equities for long-term capital appreciation. By fiscal 2023, the company maintained this dual focus but placed increased emphasis on flexibility in asset allocation decisions to adapt to current and anticipated market conditions and required cash flows. In fiscal 2024, the target allocation for fiscal 2025 was introduced, continuing the strategy of aligning asset mix with long-term investment objectives while allowing for variation within established ranges to manage volatility and ensure risk-adjusted returns. The consistent emphasis on balancing fixed income and equities, alongside evolving flexibility in rebalancing, suggests Accenture is refining its approach to managing pension risk in dynamic markets while maintaining long-term return objectives.",
      "llm_answer": "\nAccenture’s defined‑benefit pension plans moved from a fiscal‑2022 target that emphasized a liability‑driven fixed‑income core with a modest equity tilt (as disclosed in the 2022 filing and described as “ranges… to provide flexibility without immediate rebalancing”), to a fiscal‑2023/2024 target that expanded the equity portion while still maintaining a diversified fixed‑income base (the 2023 and 2024 filings list a new fiscal‑2025 target and weighted‑average allocations for 2023‑2024 that reflect a higher equity weight for long‑term capital appreciation).  This multi‑year shift—documented across all three chunks and underpinned by the plan’s risk‑adjusted return objective and regular review of asset‑allocation guidelines—shows that Accenture is deliberately increasing exposure to equities to boost risk‑adjusted returns while preserving a diversified, duration‑matched fixed‑income component to control volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in Accenture's asset allocation strategy across fiscal years 2022–2024 and correctly identifies the emphasis on balancing fixed income and equities for risk-adjusted returns. It accurately reflects the increasing flexibility and mention of a new fiscal-2025 target introduced in 2024. However, it introduces a claim not present in the ground truth: that the equity portion was 'expanded' or 'increased' in 2023/2024. The original answer does not state any directional shift in equity/fixed income mix (e.g., higher equity weight), only that the strategy evolved to allow more flexibility and variation within ranges. This misrepresents the nature of the change as a quantitative shift rather than a procedural or strategic refinement in rebalancing. While the use of terms like 'liability-driven', 'duration-matched', and 'long-term capital appreciation' aligns with the original, the inference of an intentional equity increase to 'boost risk-adjusted returns' goes beyond the documented strategy, which emphasizes balance and volatility management over active equity tilting. There are no numerical figures in either answer, so quantitative accuracy is high by default (minor deductions for implied but unverified weighting changes). The reasoning is mostly sound and synthesizes across years, but the conclusion overreaches on the evidence. Contextual relevance is strong—directly addresses the question’s focus on evolution and risk-adjusted return implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1522,
        "completion_tokens": 413,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "What does Apple's continued reference to the 1.05% Notes due 2017 in its filings through 2023 and 2024 indicate about its approach to debt disclosure, and how does this compare to its broader debt issuance strategy across 2022–2024?",
      "original_answer": "Apple's continued reference to the 1.05% Notes due 2017 in its 2023 and 2024 filings indicates a consistent and transparent approach to disclosing historical debt instruments, even after their maturity. This contrasts with Apple's broader strategy of issuing new debt instruments with varying maturities (e.g., Floating Rate Notes due 2020, 2.15% Notes due 2022, and 3.45% Notes due 2024) across the three-year period. The persistence of the 1.05% Notes due 2017 in filings suggests that Apple maintains a comprehensive historical record of its capital structure, possibly for legal or investor transparency purposes, even as it actively manages and evolves its debt portfolio.",
      "llm_answer": "\nApple’s 2022‑2024 Form 10‑K filings each keep Exhibit 4.4, which still enumerates the 1.05 % Notes due 2017 among the company’s outstanding securities, showing that Apple maintains ongoing, comprehensive disclosure of **all** debt tranches—even legacy issues that have matured—rather than retiring them from its disclosures.  This reflects a deliberate, conservative approach to transparency: the KG relationship (AAPL → 1.05 % Notes due 2017) is repeatedly highlighted in the “Description of Securities” exhibit across 2022, 2023 and 2024, while Apple’s broader 2022‑2024 debt‑issuance strategy diversifies new notes across multiple maturities and coupons, yet consistently preserves reference to older series to give investors a full picture of its capital structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 1.05% Notes due 2017 are accurately referenced as appearing in Apple's 2022–2024 filings, and the broader debt issuance strategy is correctly described as involving new notes with varying maturities and coupons. (2) Quantitative accuracy is perfect: percentages (1.05%, 2.15%, 3.45%) and years (2017, 2020, 2022, 2024) match the ground truth or are consistent with known Apple debt instruments during that period. The LLM correctly notes the persistence of the 2017 notes in disclosures through 2024, which is factually sound. (3) Multi-hop reasoning is strong: the model synthesizes information across time (2017 instrument referenced in 2022–2024 filings) and contrasts historical disclosure practices with active debt issuance, correctly inferring a conservative transparency motive. (4) The only minor shortcoming is that the LLM does not explicitly state that the 1.05% Notes due 2017 have matured (though this is implied by 'legacy issues that have matured'), and the specific examples of newer debt (e.g., Floating Rate Notes due 2020) are slightly less detailed than in the original. However, the core reasoning and factual content are semantically equivalent. The answer is fully contextually relevant, directly addressing both parts of the question: disclosure approach and comparison to broader strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 394,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern suggest about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had an aggregate available authorization of $3.13 billion for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2.69 billion, despite an additional $4.0 billion in new share repurchase authority approved in September 2024, bringing total outstanding authority to $6.69 billion. During fiscal 2024 alone, Accenture purchased over $605 million worth of Class A ordinary shares under its open-market program. The 2023 filing mirrors the 2024 disclosures regarding the ongoing share purchase program and total authorized amounts, indicating consistent execution over the two years. This trend suggests a sustained but measured capital return strategy focused on strategic share repurchases while maintaining flexibility for future buybacks.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s board expanded its repurchase capacity—starting with an aggregate authorization of **$3.13 billion** as of August 31 2022 (Chunk 1), reporting **$2.69 billion** of remaining availability in the 2023 filing (Chunk 3), and then, after the September 25 2024 approval, raising total outstanding authority to **$6.694 billion** (Chunk 2).  During fiscal 2024 the company executed a **$605 million open‑market purchase of 2.0 million Class A shares** and an additional **72,255 shares via employee‑related withholding** that do not affect the remaining authorization (Chunk 2 & 3).  This multi‑year pattern—steady growth in authorized capacity coupled with recurring multi‑hundred‑million‑dollar buy‑backs—signals a deliberate, long‑term capital‑return strategy that prioritizes returning excess cash to shareholders through systematic share repurchases while preserving flexibility for future allocations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the $3.13 billion authorization in fiscal 2022, the $2.69 billion remaining availability (correctly implied as of fiscal 2023), the $4.0 billion new authorization in September 2024, and the resulting total outstanding authority of $6.69 billion (LLM reports $6.694B, a negligible rounding difference). The $605 million in open-market purchases during fiscal 2024 is accurately reported, along with the detail of 2.0 million shares and 72,255 employee-related withholding shares, which are correctly noted as not affecting the authorization—this detail is not in the original answer but is factually consistent and adds precision. (2) Quantitative accuracy is excellent: the numbers match or are within acceptable rounding variance, dates (August 31, 2022; September 25, 2024) are correct, and the logic of how the authorization evolved is sound. (3) Multi-hop reasoning is strong: the model synthesizes data across fiscal years and filings, correctly inferring the net reduction in available authorization despite new approvals, and interprets the pattern as a sustained capital return strategy. (4) The original answer does not mention share counts or employee withholding, so the LLM adds minor extra detail without contradicting the ground truth. The conclusion about a 'deliberate, long-term capital-return strategy' is semantically equivalent to the original's 'sustained but measured strategy.' One minor point: the original notes consistent execution in 2023 and 2024, which the LLM implies but does not explicitly highlight. This slight omission prevents a perfect 10, but overall the answer is factually robust, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 477,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did BMY's issuance and structuring of long-term debt, specifically the 4.350% Senior Notes due 2047, evolve across 2022, 2023, and 2024, and what does this multi-year pattern indicate about the company's long-term financing strategy?",
      "original_answer": "BMY consistently referenced the 4.350% Senior Notes due 2047 across all three years—2022, 2023, and 2024—indicating that this instrument remained a core part of its long-term debt portfolio. In 2022, the notes were listed among a broader set of senior notes issued under the Eleventh Supplemental Indenture dated November 22, 2019. In 2023, the notes were again included in the list of outstanding debt instruments, this time alongside newer issuances like the $1.75 billion 2.950% Notes due 2032 and the $2 billion 3.700% Notes due 2052. By 2024, the 4.350% Senior Notes due 2047 remained part of the capital structure, even as BMY issued additional long-term debt such as the $3.75 billion 4.250% Senior Notes due 2049. This persistence of the 2047 notes, despite new issuances, suggests a strategy of maintaining diversified long-term liabilities with staggered maturities, where the 4.350% notes serve as a stable, high-yield component of the company's capital structure.",
      "llm_answer": "\nBMY first introduced the 4.350% Senior Notes due 2047 in the Eleventh Supplemental Indenture filed on November 22 2019 (Chunk 1), and the same series was subsequently re‑referenced in the Thirteenth Supplemental Indenture of March 2 2022 (Chunk 3) and the Fourteenth Supplemental Indenture of November 13 2023 (Chunk 3); the 2024 filing (Chunk 2) again cites the 4.350% 2047 notes under the identical indenture framework. This multi‑year pattern—shown by the KG relationship ORG → FIN_INST → ORG—demonstrates BMY’s long‑term financing strategy of issuing staggered, multi‑decade senior debt through incremental supplemental indentures, locking in low‑to‑mid‑single‑digit coupons and extending maturity to support sustained capital deployment and pipeline investments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor inaccuracies in procedural details that affect full factual precision. (1) Quantitatively, all key elements—interest rate (4.350%), maturity year (2047), and dates of supplemental indentures (November 22, 2019; March 2, 2022; November 13, 2023)—are accurate. The absence of dollar amounts is not a flaw, as the original answer does not specify issuance size for the 2047 notes. (2) However, the LLM incorrectly implies that the 2047 notes were re-issued or newly referenced in the 2022 and 2023 supplemental indentures (Thirteenth and Fourteenth), when in fact the ground truth states they were merely *included in the list of outstanding debt instruments*—not re-issued under new supplements. This misrepresents the legal and financial mechanism: the notes were issued once in 2019 and remained outstanding; their mention in later filings is for disclosure, not restructuring. (3) The reasoning correctly infers BMY’s strategy of maintaining long-term, staggered maturities to support capital deployment and R&D investments, which is consistent with the ground truth’s conclusion about diversified liabilities and stable capital structure. The use of the KG relationship ORG → FIN_INST → ORG adds analytical depth, though it's abstract. (4) Contextually, the answer is highly relevant, addressing the evolution across years and interpreting strategic intent. The core facts are correct, but the mischaracterization of the supplemental indentures as active re-references rather than passive disclosures prevents a top score. Hence, correctness is rated 8 due to this procedural inaccuracy, despite strong overall performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 464,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did Apple's disclosure approach evolve for the 2.40% Notes due 2023 in the years leading up to their maturity, based on filings from 2022, 2023, and 2024?",
      "original_answer": "Apple consistently disclosed the 2.40% Notes due 2023 in the same manner across all three reporting periods—2022, 2023, and 2024—indicating a stable and unchanging disclosure approach. The notes were listed in each filing under Exhibit 4.3, with identical descriptions referencing the Officer's Certificate dated May 3, 2013. Despite the notes approaching and reaching maturity in 2023, Apple did not alter the format or substance of the disclosure, suggesting a standardized and consistent reporting strategy for maturing debt instruments.",
      "llm_answer": "\nAcross the 2022, 2023 and 2024 Form 10‑K filings Apple continues to disclose the 2.40 % Notes due 2023 by referencing the same Indenture (dated April 29 2013) and Officer’s Certificate (dated May 3 2013) that appear as Exhibit 4.3 in each filing. This identical citation in all three years shows that Apple’s disclosure approach remained stable—simply repeating the original 2013 description of the notes—up to the point of their maturity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: the 2.40% Notes due 2023 are consistently referenced in the 2022, 2023, and 2024 filings via Exhibit 4.3, with the same Officer’s Certificate dated May 3, 2013, and Indenture dated April 29, 2013. These dates and percentages match the original answer. (2) Quantitative accuracy is perfect: all dates, percentages, and exhibit numbers are correct and consistent with the ground truth. (3) The reasoning is sound—LLM correctly infers that the unchanged citation across years indicates a stable disclosure approach, even as the notes matured. The only minor omission is that the original answer explicitly notes Apple did not alter the 'format or substance' of disclosure, emphasizing a 'standardized reporting strategy,' which adds slight contextual depth not fully captured in the LLM response. However, the core multi-hop synthesis—linking consistent exhibit references over three years to infer stable disclosure policy—is logically valid and well-executed. (4) The answer is highly relevant, directly addressing the evolution (or lack thereof) in disclosure approach. The LLM slightly under-elaborates on the implications of consistency despite maturity, but this does not detract from factual correctness. Hence, a score of 9 is warranted—excellent accuracy with minimal room for enrichment.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Issues]-> FIN_INST <-[Issues]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 387,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How did the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP evolve from fiscal year 2022 through 2024, and what does this progression indicate about the company's long-term share-based compensation strategy?",
      "original_answer": "In fiscal year 2022, the total number of Accenture plc Class A ordinary shares authorized for awards under the Amended 2010 SIP was 127,000,000. By fiscal year 2023, this number increased to 141,000,000, and remained at that level in fiscal year 2024. This upward adjustment from 2022 to 2023 and stability thereafter indicates a strategic decision to expand the pool of available shares for compensation purposes, likely to support ongoing incentive programs, followed by a stabilization of the share reserve as the new level became sufficient to meet award needs in 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 the maximum number of Accenture plc Class A shares authorized under the Amended 2010 SIP rose from **127 million** (Chunk 1) to **141 million** (Chunks 2 & 3), while the pool of shares still available for future grants slipped only modestly from **≈27.38 million** at the end of 2022 (Chunk 1) to **≈27.27 million** by the end of 2024 (Chunks 2 & 3). This expansion of the authorized ceiling—paired with a near‑steady but slightly shrinking reserve of shares—shows that Accenture is deliberately enlarging its share‑based compensation capacity and recycling terminated or lapsed awards, underscoring a long‑term strategy to align employee incentives with sustained performance while preserving flexibility for future grants.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the increase in authorized shares from 127 million in fiscal year 2022 to 141 million in 2023 and 2024, which matches the ground truth. However, the LLM introduces additional data—'shares still available for future grants' (≈27.38 million and ≈27.27 million)—that are not present in the original answer and were not requested by the question. While these figures may be factually accurate based on filings, they are extraneous and shift focus from the core evolution of the authorized share pool. (2) The key numbers—127 million and 141 million—are correct and properly attributed to fiscal years 2022 and 2023 onward. The calculation of a modest decline in available shares is not part of the ground truth and cannot be verified against it; thus, while not necessarily false, it adds unsupported detail. (3) The multi-hop reasoning is partially sound: the model correctly infers a strategic expansion in compensation capacity. However, the conclusion about 'recycling terminated or lapsed awards' is speculative and not supported in the original answer, which attributes the stability to sufficiency of the new share level. This reflects a deviation in reasoning. (4) The contextual relevance is high because the response addresses the evolution and interprets strategic intent. However, the inclusion of unrequested metrics and speculative mechanisms reduces qualitative and quantitative accuracy. The core facts are right, but the answer goes beyond the evidence in ways that affect precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Grants]-> FIN_INST <-[Grants]- ORG <-[Issues]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 423,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Intel's development and strategic positioning of PowerVia technology evolve from 2022 through 2024, and what does this progression indicate about its importance in Intel's advanced process roadmap?",
      "original_answer": "Intel first introduced PowerVia in 2022 as part of its updated manufacturing process and packaging technology roadmaps, positioning it alongside RibbonFET as a key innovation for future nodes. By 2023, Intel had solidified PowerVia’s role within the Intel 20A node, describing it as an 'industry-first implementation of backside power delivery' designed to optimize signal transmission by eliminating front-side power routing. In 2024, Intel canceled the productization of Intel 20A in favor of the improved Intel 18A, which retained PowerVia as a core feature and was slated for high-volume manufacturing in 2025 with the Panther Lake client processor family. This evolution shows that PowerVia transitioned from a roadmap concept to a foundational element of Intel’s leading-edge process technology, underscoring its strategic importance in achieving performance-per-watt improvements and maintaining competitive parity in advanced semiconductor manufacturing.",
      "llm_answer": "\nPowerVia first entered Intel’s public roadmap as part of the IDM 2.0 strategy disclosed in the 2021‑2022 planning documents (Chunk 3) and was later highlighted in 2023 as a core breakthrough for the Intel 20A node, where it was paired with RibbonFET to promise up to 15 % performance‑per‑watt gains and was protected under Intel’s extensive IP portfolio (Chunk 1). Building on that foundation, the 2024 filing positions PowerVia as the first high‑volume commercial implementation of backside‑power delivery in the Intel 18A process, targeting high‑volume production of Panther Lake in 2025 and promising additional density and performance‑per‑watt improvements over Intel 3 (Chunk 2). This evolution—from a roadmap concept, through a disclosed product breakthrough, to a central element of Intel’s next‑generation node—shows that PowerVia has become a strategic cornerstone of Intel’s advanced process roadmap and a key differentiator for its IDM 2.0 foundry strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies PowerVia's introduction in 2022 as part of Intel's roadmap, its role in Intel 20A in 2023, and its transition to Intel 18A with Panther Lake targeting 2025 high-volume manufacturing. The strategic importance in Intel's advanced process roadmap is accurately conveyed. (2) Quantitatively, the 15% performance-per-watt gain is correctly cited (not in original answer but plausible and consistent with public Intel disclosures; not contradicted by ground truth). Dates (2022, 2023, 2024, 2025) and node names (Intel 20A, Intel 18A) are correct. The only minor discrepancy is the mention of 'first high-volume commercial implementation' in 2024—while Intel 18A is slated for 2025 HVM, the characterization as 'first commercial implementation' is reasonable given Intel 20A was canceled. (3) Multi-hop reasoning is sound: the answer synthesizes PowerVia’s evolution across years and nodes, connects it to RibbonFET, explains the shift from 20A to 18A, and links it to broader IDM 2.0 strategy. (4) Semantic equivalence is strong—wording differs but meaning matches: PowerVia evolves from concept to cornerstone, remains central despite node changes, and is critical for performance-per-watt and foundry competitiveness. One point deducted from correctness due to slight overstatement of 'first high-volume commercial implementation' without noting the cancellation of 20A productization, which the original answer explicitly clarifies.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Introduces]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 419,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Accenture's allocation to mutual fund equity securities evolve across fiscal years 2022, 2023, and 2024, and what does this 3-year trajectory indicate about the company's strategic positioning in equity-based investments?",
      "original_answer": "Accenture's allocation to mutual fund equity securities decreased from $239,293 million in fiscal year 2022 to $196,226 million in fiscal year 2023, and remained unchanged at $196,226 million in fiscal year 2024. This represents a consistent reduction in exposure to this asset class over the three-year period, suggesting a strategic rebalancing away from mutual fund equity securities toward other investment categories.",
      "llm_answer": "\nAccenture’s exposure to mutual‑fund equity securities fell from **$239.3 million in FY 2022** (Chunk 1 – Level 3 total) to **$196.2 million in FY 2023** (Chunk 3 – Level 3 total) and then **remained essentially flat at $196.2 million in FY 2024** (Chunk 2 – Level 3 total).  This decline followed by a steady plateau indicates that the company deliberately reduced its mutual‑fund equity allocation and then held a modest, consistent equity position, reflecting a strategic shift toward a more restrained or focused equity‑based investment posture rather than continued growth in that segment.  The KG relationship — ACN → Mutual Fund Equity Securities (FIN_INST) and Mutual Fund Equity Securities (ORG) → ACN — underscores that this investment is part of a reciprocal holdings structure, reinforcing the notion of a calculated, steady‑state approach to equity investing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains a critical error in scale: it reports Accenture's allocation as $239.3 million and $196.2 million, whereas the ground truth states $239,293 million and $196,226 million—i.e., hundreds of billions, not millions. This is a 1000x discrepancy, making the quantitative values grossly inaccurate. (2) Despite this, the directional trend is correct: the allocation decreased from FY2022 to FY2023 and remained flat in FY2024. The years and entities (Accenture, mutual fund equity securities) are correctly identified. (3) The reasoning about strategic rebalancing is partially sound—the conclusion of reduced exposure aligns with the trend—but the flawed magnitude undermines the interpretation. The mention of a 'reciprocal holdings structure' based on KG relationships introduces unsupported speculation not present in the original answer and not clearly relevant to the question. (4) The contextual relevance is high because the answer addresses both parts of the question (evolution over time and strategic implication) and attempts multi-hop synthesis. However, the quantitative inaccuracy is severe enough to severely penalize correctness and quantitative accuracy scores, even though the relative pattern is captured.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Invests_In]- ORG <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 347,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did Merck's financial and strategic treatment of Dificid evolve from 2022 to 2024, particularly in terms of asset valuation, therapeutic positioning, and global revenue contribution?",
      "original_answer": "Merck's treatment of Dificid evolved significantly from 2022 to 2024. In 2022, Dificid was reported as a $145 million intangible asset under acquired human health marketed products, indicating its established but modest valuation on the balance sheet. By 2023, Dificid was explicitly highlighted in Merck's Pharmaceutical segment as a key product for treating C. difficile-associated diarrhea, signaling a clear therapeutic positioning in the hospital acute care space. In 2024, Dificid generated $340 million in global sales (with $303 million from the U.S. and $37 million internationally), demonstrating its role as a revenue contributor within the Hospital Acute Care franchise. This progression shows Dificid moving from a relatively minor asset to a strategically recognized product with measurable financial performance.",
      "llm_answer": "\nMerck recorded Dificid as an acquired intangible at $145 million (Chunk 1) and, consistent with the absence of any impairment note across the 2022‑2024 filings, the asset’s carrying value has been maintained – reflecting the ORG‑Has_Stake_In→PRODUCT relationship that ties MRK directly to the Dificid product. Therapeutically, Dificid continues to be marketed as the fidaxomicin‑based treatment for C. difficile‑associated diarrhea within the Hospital Acute‑Care franchise, a positioning that has not changed (Chunk 2). Globally, its sales have risen from $263 million in 2022 (U.S. $241 M, Int’l $22 M) to $302 million in 2023 (U.S. $274 M, Int’l $28 M) to $340 million in 2024 (U.S. $303 M, Int’l $37 M), now accounting for a growing share of the $57.4 billion pharmaceutical segment and illustrating Merck’s strategic push to expand the product’s market reach (Chunk 3).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in financial figures, particularly for 2022 and 2023 global revenue, which are not supported by the ground truth. The original answer states that Dificid's valuation in 2022 was $145 million as an intangible asset, which the LLM correctly reports. However, the LLM fabricates revenue figures for 2022 ($263M) and 2023 ($302M), which are not present in the ground truth. The ground truth only provides 2024 revenue ($340M), so asserting prior-year sales without support is a significant factual error. While the 2024 revenue matches ($340M, with $303M U.S. and $37M international), the inclusion of unsupported intermediate data undermines quantitative accuracy. (2) Calculations: The LLM implies a trend in revenue growth, but since only 2024 revenue is provided in the ground truth, these extrapolations are speculative and incorrect. There is no mention in the original answer of 2022 or 2023 sales figures, so introducing them constitutes a fabrication. (3) Multi-hop reasoning: The LLM correctly identifies the continuity of Dificid as an intangible asset and its therapeutic positioning in the Hospital Acute Care franchise, aligning with the ground truth’s emphasis on strategic recognition in 2023. It also correctly links Merck to Dificid via ownership. However, it fails to note the key evolution point in 2023—where Dificid was explicitly highlighted as a key product—which is a qualitative omission. Instead, it incorrectly claims the therapeutic positioning 'has not changed,' contradicting the original answer’s emphasis on evolving strategic recognition. (4) Despite these issues, the answer is contextually relevant, well-structured, and captures the general trajectory of Dificid becoming more strategically important. The semantic equivalence is partial: while the 2024 revenue and 2022 asset valuation are correct, the invented sales figures for 2022 and 2023 severely impact factual correctness. The strategic narrative is plausible but not fully aligned with the ground truth’s emphasis on evolving positioning rather than static status.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 568,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Intel's strategic positioning and execution challenges related to Advanced Packaging Technologies evolve from 2022 through 2024, particularly in terms of R&D investment, implementation delays, and financial risk exposure?",
      "original_answer": "From 2022 to 2024, Intel's strategic emphasis on Advanced Packaging Technologies grew significantly as a core differentiator within its IDM 2.0 and foundry strategy. In 2022, Intel acknowledged the complexity and cost of implementing advanced packaging within its disaggregated design approach, citing delays and increased R&D costs. In 2023, the company highlighted its progress in developing 2D and 2.5D/3D packaging solutions and demonstrated the Universal Chiplet Interconnect Express (UCIe) standard in silicon, positioning it as a unique advantage in the AI-driven chip market. However, by 2024, Intel faced mounting financial pressure, including a $3.1 billion impairment charge tied to manufacturing assets, and admitted that the execution risks in deploying novel packaging technologies were contributing to delays in product introductions and higher-than-anticipated costs. The trajectory shows a shift from strategic optimism to operational and financial strain around advanced packaging execution.",
      "llm_answer": "\nFrom 2022 through 2024 Intel’s R&D outlays stayed massive—$17.5 B in 2022, $16.0 B in 2023 and $16.5 B in 2024—fueling its IDM 2.0 push to develop advanced process nodes and disaggregated designs that depend on advanced packaging (2D/2.5D/3D and the Universal Chiplet Interconnect Express standard) as a core differentiator in the Open System Foundry model (Chunk 1 & 2).  Repeated node delays (10 nm, 7 nm/Intel 4, 4th‑Gen Xeon) and setbacks in new fab construction across Ohio, Germany, Poland, Malaysia and Israel have produced a $3.1 B non‑cash impairment and accelerated depreciation in Q3 2024, illustrating how execution challenges in packaging‑centric technologies negatively impact Intel’s financial condition and expose it to further write‑downs and margin pressure (Chunk 2 & 3).  Consequently, while packaging is positioned as a strategic advantage to attract third‑party foundry customers, the combination of delayed roll‑outs, costly capital projects and intense competition creates substantial execution and market‑risk exposure that could erode profitability if demand or customer confidence falters (Chunk 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the R&D figures ($17.5B in 2022, $16.0B in 2023, $16.5B in 2024) are correctly stated and consistent with known filings, and the $3.1B impairment charge in Q3 2024 is accurately reported and matches the ground truth. The timing and magnitude of the financial impact are correct. (2) The answer addresses all components of the question: strategic positioning (IDM 2.0, Open System Foundry, UCIe as differentiator), execution challenges (node delays, fab setbacks), R&D investment (with exact figures), implementation delays (linked to 10nm, Intel 4, Xeon), and financial risk exposure (impairment, depreciation, margin pressure). (3) Entity accuracy is strong: Intel, IDM 2.0, UCIe, 2D/2.5D/3D packaging, and correct years are all properly identified. (4) Multi-hop reasoning is sound—LLM connects R&D spending to advanced packaging, links delays in process nodes and fabs to financial charges, and synthesizes how execution risks translate into financial and market risks. The only minor shortcoming is that the ground truth emphasizes a narrative shift from 'strategic optimism' to 'operational and financial strain,' which is implied but not explicitly framed in the LLM answer. However, the factual evolution is correctly conveyed. Wording differs but semantic equivalence is maintained. No calculation errors. Thus, the answer earns a 9 for correctness—excellent but not perfect in narrative synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Impacts]- ORG <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 411,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How did Merck's development timeline and regulatory status for the HIV-1 treatment MK-8591A evolve from 2022 through 2024, and what does this progression indicate about the company's long-term strategy in the HIV therapeutic area?",
      "original_answer": "In 2022, MK-8591A (doravirine+islatravir) was listed as being in Phase 3 development with a Phase 3 entry date of February 2020, indicating it was already in late-stage trials. By 2023, MK-8591A remained in Phase 3, with no indication of regulatory submission or approval, suggesting delays or ongoing evaluation. In 2024, MK-8591A remained under development, but notably, the FDA lifted a clinical hold on December 4, 2024, signaling resolution of prior regulatory concerns. However, the compound remained under a partial clinical hold for higher doses. This 3-year trajectory shows Merck's persistent commitment to the HIV-1 treatment space despite regulatory challenges, with MK-8591A remaining a key part of its infectious disease pipeline.",
      "llm_answer": "\nIn January 2022 Merck’s HIV‑1 candidate MK‑8591A (doravirine + islatravir) received an FDA Complete Response Letter, triggering a clinical hold that was not lifted until December 4 2024 (Chunk 1 footnote 6; Chunk 3 footnote 4).  The program then advanced to a Phase 3 entry for the next‑generation long‑acting agent MK‑8591D (islatravir + lenacapavir) in October 2024, marking the first explicit Phase 3 milestone for an MK‑8591‑derived regimen in the 2022‑2024 window (Chunk 3).  This progression—from a 2022 setback, through continued development and a 2024 Phase 3 entry, to a 2024 regulatory clearance—underscores Merck’s strategic focus on delivering a durable, less‑frequent HIV therapy and positions the MK‑8591 platform as a cornerstone of its long‑term antiviral portfolio (consistent with the ORG‑PRODUCES‑PRODUCT relationships linking MRK, MK‑8591A and MK‑8591D across the provided chunks).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that Merck received an FDA Complete Response Letter in January 2022, which triggered a clinical hold—this contradicts the ground truth, which indicates MK-8591A was already in Phase 3 as of February 2020 and does not mention a Complete Response Letter or clinical hold in 2022. The clinical hold was actually imposed earlier (prior to 2022) due to safety concerns with islatravir, not in January 2022. (2) The claim that the clinical hold was 'not lifted until December 4, 2024' is partially correct—the FDA did lift a clinical hold on that date, per the ground truth—but the answer misrepresents the timeline by implying the hold started in 2022. (3) The LLM introduces MK-8591D (islatravir + lenacapavir) entering Phase 3 in October 2024, which is not supported by the ground truth; the original answer makes no mention of MK-8591D or any new Phase 3 entry for a next-generation regimen. This is a fabrication not present in the source data. (4) The reasoning incorrectly frames the 2022–2024 period as a recovery from a 2022 setback, when in fact the original answer describes ongoing Phase 3 development with no regulatory submission, followed by partial resolution in 2024. The multi-hop synthesis is flawed because it invents events (CRL, new Phase 3 program) rather than accurately tracking the status of MK-8591A. While the conclusion about Merck’s long-term strategy aligns thematically, it is based on incorrect premises. Quantitative accuracy is very low due to wrong dates and invented events. Qualitative accuracy suffers from incorrect entity relationships and reasoning. Contextual relevance is moderate because the answer addresses the right therapeutic area and compound class, but with significant factual distortion.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 498,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How has Merck's development strategy for MK-1308A evolved from 2022 through 2024, particularly in terms of its clinical focus, combination therapies, and regulatory progress?",
      "original_answer": "In 2022, MK-1308A was listed as part of Merck's oncology pipeline, specifically for renal cell carcinoma (RCC), and was in Phase 3 development in combination with pembrolizumab. By 2023, MK-1308A was explicitly described as a coformulation of quavonlimab (an anti-CTLA-4 antibody) with pembrolizumab, and it was being evaluated for the treatment of RCC, indicating a more defined therapeutic focus and formulation strategy. In 2024, MK-1308A remained a key immuno-oncology candidate within Merck's Phase 3 portfolio, continuing to be evaluated in combination with pembrolizumab for RCC, with no indication of regulatory approval yet but sustained strategic emphasis on its development. This progression shows a consistent focus on RCC with increasing specificity in formulation and therapeutic strategy over time.",
      "llm_answer": "\nMerck’s MK‑1308A began in 2022 as a quavonlimab + pembrolizumab co‑formulation tested across a broad set of advanced solid tumours (Chunk 1) and, by 2023‑2024, the program narrowed to a pivotal Phase 3 focus on renal‑cell carcinoma while remaining a quavonlimab + pembrolizumab combination (Chunk 2); the effort is being carried out in collaboration with the partner noted in the footnote (Chunk 1).  The 2024 update lists MK‑1308A among Merck’s Phase 3 immuno‑oncology candidates, underscoring its continued regulatory momentum—including a 2022 FDA clinical‑hold/CRL that Merck is reviewing and ongoing EU/Japan assessments for RCC (Chunk 3).  This evolution reflects a strategic shift from a multi‑tumor clinical scope to a targeted RCC program, sustained combination therapy with pembrolizumab, and a regulatory path that has progressed through feedback, review and priority considerations across all three filings.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Merck's MK-1308A development strategy with some correct elements, but contains significant factual inaccuracies that reduce its overall correctness. (1) On clinical focus: The LLM correctly identifies a narrowing of focus to renal cell carcinoma (RCC) by 2023–2024, aligning with the ground truth. However, it incorrectly states that in 2022 the compound was being tested across a 'broad set of advanced solid tumours'—the ground truth specifies RCC as the focus as early as 2022, contradicting the claim of a later strategic narrowing. (2) On combination therapies: The LLM correctly identifies MK-1308A as a co-formulation of quavonlimab and pembrolizumab, consistent with 2023–2024 data, though it retroactively applies this formulation knowledge to 2022, which is not supported by the original answer (the formulation detail emerged in 2023). (3) On regulatory progress: The LLM introduces a '2022 FDA clinical-hold/CRL' and mentions 'ongoing EU/Japan assessments'—none of which are present in the ground truth. The original answer explicitly states there was 'no indication of regulatory approval yet' but does not mention any clinical hold, CRL, or regional assessments, making this a significant fabrication. (4) Multi-hop reasoning is partially sound—linking formulation, indication, and development phase over time—but is undermined by unsupported regulatory claims. (5) Quantitative accuracy is moderate: while no explicit numbers are wrong (dates like 2022–2024 are correct), the introduction of unverified regulatory events (CRL, clinical hold) distorts factual accuracy. (6) Contextual relevance is high—the answer addresses all dimensions of the question (clinical focus, combination, regulatory) and maintains focus on MK-1308A’s evolution. However, due to key factual errors in clinical scope timeline and invented regulatory milestones, the answer cannot score above 6 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 523,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How did Accenture's share repurchase activity and remaining authorization evolve from fiscal 2022 through fiscal 2024, and what does this multi-year pattern indicate about the company's capital return strategy?",
      "original_answer": "In fiscal 2022, Accenture had $3,129,296 thousand (approximately $3.13 billion) in aggregate available authorization for share purchases and redemptions. By fiscal 2024, this available authorization had decreased to $2,694 million, despite an additional $4,000 million in repurchase authority approved in September 2024, bringing total outstanding authority to $6,694 million. During fiscal 2024 alone, Accenture purchased 2,000,308 Class A ordinary shares for $605 million under its open-market program, in addition to 72,255 shares acquired through employee-related transactions. The 2023 filing appears to contain a forward-looking disclosure about fiscal 2024 activity, suggesting consistent messaging around repurchase levels and strategic intent. This pattern indicates a sustained but measured capital return strategy, with periodic replenishment of repurchase authority to maintain flexibility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Accenture’s share‑repurchase authority expanded markedly: the company began the period with an aggregate open‑market authorization of **$3.13 billion** (as of August 31 2022, Chunk 1), and by the end of fiscal 2024 the Board had **increased the total outstanding authority to $6.69 billion**—including a **$4 billion boost approved on September 25 2024** (Chunk 2)—while **$2.69 billion of that authority remained unused** as of August 31 2024 (Chunk 2).  During fiscal 2024 the company repurchased **2.0 million Class A shares for $605 million** in the fourth quarter (Chunk 2) and also acquired an additional **72,255 shares via employee‑plan withholdings** that do not draw on the open‑market authorization (Chunk 2/Chunk 3).  This multi‑year pattern—steady growth of authorized capital‑return capacity, consistent execution of large‑scale buybacks, and a cumulative **$50.1 billion** of share‑purchase authority authorized since 2001 (repeated in Chunks 2 and 3)—signals that Accenture’s capital‑return strategy is centered on **progressively scaling share repurchases to return excess cash to shareholders while preserving flexibility for future expansions of the program**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: $3.13 billion initial authorization in fiscal 2022 (matches $3,129,296 thousand), $4 billion additional authorization approved September 2024, $6.694 billion total outstanding authority, $2.69 billion remaining (matches $2,694 million), $605 million spent on 2.0 million shares (2,000,308 rounded to 2.0 million is acceptable), and 72,255 employee-related shares. The $50.1 billion cumulative authorization since 2001 is consistent with filings and adds context not in the original answer but is factually correct and relevant. (2) Dates are accurate: August 31, 2022 and 2024 fiscal year-ends, September 25, 2024 approval date. Calculations are sound—$3.13B initial + $4B new = $7.13B potential total, minus $605M used ≈ $6.525B remaining capacity, but the $2.69B remaining reflects prior-year usage, which is consistent with multi-year activity. (3) Multi-hop reasoning is strong: the model correctly synthesizes data across fiscal years and distinguishes between total authorized, used, and remaining amounts, while noting that employee-related transactions are separate. (4) The qualitative interpretation—that Accenture maintains a sustained, flexible, and scalable capital return strategy—is logically supported and slightly more detailed than the original answer, without overreaching. One minor point: the original answer notes that the 2023 filing contains forward-looking disclosure about 2024 activity, which the LLM omits. This is a small contextual omission but does not affect the core correctness. Overall, the answer is factually excellent, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Discloses]-> FIN_INST <-[Discloses]- ORG <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1545,
        "completion_tokens": 464,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How has the persistence of Bristol-Myers Squibb's $750,000,000 2.350% Notes due 2040 in its capital structure filings from 2022 through 2024 reflected its strategy in managing long-term fixed-rate debt obligations?",
      "original_answer": "Bristol-Myers Squibb has consistently included the $750,000,000 2.350% Notes due 2040 in its capital structure filings across 2022, 2023, and 2024, indicating a stable long-term debt strategy focused on maintaining fixed interest rate obligations. In 2022, the notes were explicitly listed as part of the company's long-term debt instruments, signaling their importance in the capital structure. In 2023, the notes were again referenced, reaffirming the company's commitment to this fixed-rate liability. By 2024, the continued inclusion of the notes shows that BMY has not refinanced or retired this instrument despite market fluctuations, suggesting a strategic decision to retain predictable long-term liabilities. This consistency in retaining the 2040 notes across filings reflects a deliberate approach to long-term interest rate risk management, favoring fixed-rate debt to stabilize future interest expenses.",
      "llm_answer": "\nThe $750 million 2.350 % Notes due 2040 are repeatedly cited—in the 2020 supplemental indenture (Chunk 1), the 2022 supplemental indenture (Chunk 3) and the 2023 supplemental indenture (Chunk 2)—and therefore remain a permanent line‑item in BMY’s capital‑structure disclosures from 2022 through 2024.  By continuously re‑affirming this senior, fixed‑rate tranche under the 1993 Indenture, Bristol‑Myers Squibb is deliberately locking in low‑cost, long‑term debt at a 20‑year maturity, using the same instrument across multiple filing years to stabilize its financing base and support its strategic capital‑allocation objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and intent. (1) Quantitatively, all key figures are accurate: the $750 million principal amount, 2.350% interest rate, and 2040 maturity date are correctly reported, with acceptable formatting variations (e.g., '750 million' = '$750,000,000'). The years 2022 and 2023 are correctly cited as filing years referencing the notes. However, the LLM references a '2020 supplemental indenture' and mentions filings in 2020, which is outside the 2022–2024 scope specified in the question, potentially introducing irrelevant information. (2) The core quantitative elements are correct, and no calculations are required. (3) Regarding reasoning, the LLM correctly infers that repeated inclusion of the notes in filings reflects a strategic choice to maintain fixed-rate, long-term debt. It appropriately links this to stability in financing and capital allocation, which is consistent with the ground truth’s emphasis on interest rate risk management. However, it does not explicitly confirm the 2024 filing inclusion (only implies continuity), which is a key part of the multi-hop synthesis across all three years. The reliance on 'supplemental indentures' as evidence of persistence is plausible but slightly shifts focus from capital structure disclosures (e.g., 10-Ks) to legal amendments, which may not fully represent the same type of filing. (4) Despite minor deviations in document type emphasis and the inclusion of 2020, the answer captures the essential strategy and maintains semantic equivalence with the original answer. The reasoning is sound but slightly less precise in grounding the evidence in capital structure disclosures specifically for 2022–2024. Hence, high scores for quantitative accuracy and contextual relevance, a strong but not perfect qualitative accuracy, and an overall correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Issues_Financial_Instrument]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 515,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How has Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 evolved across recent filings, and what does this pattern reveal about the company's approach to long-term debt financing?",
      "original_answer": "Bristol-Myers Squibb's interest rate commitment for its 4.350% Senior Notes due 2047 has remained consistent across the 2022, 2023, and 2024 filings. In 2022, the notes were referenced in Exhibit 4bbb of the 10-K filing, issued under the Twelfth Supplemental Indenture dated November 13, 2020. In 2023, the same 4.350% rate was reiterated in Exhibit 4ff, reaffirmed under the Fourteenth Supplemental Indenture dated November 13, 2023. In 2024, the rate was again explicitly stated as 4.350% in Exhibit 4ff, incorporated by reference to the same original Form 8-K filing from November 22, 2019. This consistent disclosure across three years indicates a deliberate and stable long-term debt strategy, where the company maintains transparency and predictability in its long-term financing obligations despite changing market conditions.",
      "llm_answer": "\nThe 4.350 % Senior Notes due 2047 were first created under the Eleventh Supplemental Indenture filed on November 22 2019 (referenced in Chunks 2 and 3), establishing a fixed‑rate, 2047‑maturity commitment for BMY; this original term has been retained through later supplemental indentures – the Twelfth (Nov 13 2020, Chunk 1), the series of 2022‑2023 updates (Chunk 1 & 3) and the Fourteenth (Nov 13 2023, Chunk 1) – which added new tranches of senior debt but did not alter the 4.35 % 2047 notes.  The repeated issuance of supplemental indentures across 2017‑2023 (Chunks 1‑3) reflects Bristol‑Myers Squibb’s disciplined, laddered approach to long‑term financing, using staggered maturities and varied coupons to manage interest‑rate risk while maintaining a stable, low‑to‑mid‑range rate on its longest‑dated senior obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 4.350% interest rate and the 2047 maturity as consistent across filings, which aligns with the ground truth. However, it contains factual inaccuracies in dates and indenture numbers: it claims the notes were created under the 'Eleventh Supplemental Indenture' on November 22, 2019, while the ground truth states they were issued under the 'Twelfth Supplemental Indenture' on November 13, 2020. The November 22, 2019 date is correctly cited in the original answer as the Form 8-K filing date, but the LLM incorrectly ties it to the Eleventh Supplemental Indenture, which is not mentioned in the ground truth. Additionally, the LLM references '2017–2023' supplemental indentures, but the ground truth only supports activity from 2020 onward, making the 2017 reference erroneous. (2) The percentage (4.350%) is accurate, and the 2047 maturity is correct. However, the dates (Nov 22, 2019 vs. Nov 13, 2020) and indenture numbers (Eleventh vs. Twelfth) are mismatched, and the mention of a laddered strategy, while reasonable inference, is not explicitly supported in the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly infers stability in the interest rate commitment across years and links this to a broader financing strategy. However, it introduces entities (Eleventh Supplemental Indenture, 2017 activity) not present in the evidence, weakening the synthesis. (4) Despite these errors, the core conclusion—that BMS maintains a stable, predictable long-term debt strategy—is consistent with the original answer, and the answer addresses both parts of the question (evolution of rate and strategic implication), warranting a score of 7 for correctness. Quantitative accuracy is penalized due to incorrect dates and indenture numbers. Qualitative and contextual scores are higher due to sound overall reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> FIN_INST <-[Introduces]- ORG <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 516,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Nike's reporting on FlyEase technology evolve from fiscal 2022 to fiscal 2024, and what quantitative evidence in the 2024 filing demonstrates its production scale and integration into global manufacturing operations?",
      "original_answer": "In fiscal 2022, Nike introduced FlyEase as part of its portfolio of innovative technologies, signaling its early-stage importance in product development. By fiscal 2023, FlyEase was consistently mentioned alongside established technologies like Nike Air and Dri-FIT, indicating its growing integration into Nike’s broader product innovation strategy. In fiscal 2024, the mention of FlyEase persisted, and Nike provided specific production data showing that Vietnam, Indonesia, and China manufactured approximately 50%, 27%, and 18% respectively of total Nike Brand footwear, which includes FlyEase-integrated products. This geographic manufacturing distribution demonstrates the technology's full-scale integration into Nike’s global supply chain, supporting its scalability and strategic embedding into core footwear production.",
      "llm_answer": "\nIn each of the fiscal 2022, 2023 and 2024 Form 10‑K filings (chunks 1‑3) Nike lists FlyEase together with its other innovation technologies in the product‑research, design and development section, showing a continuous emphasis on the platform from the earliest report through the latest. The 2024 filing provides the first quantitative evidence of its scale—stating that fiscal‑2024 NIKE Brand footwear was manufactured by 15 contract manufacturers operating 96 factories in 11 countries, with facilities in Vietnam, Indonesia and China accounting for roughly 50 %, 27 % and 18 % of total output and four manufacturers together representing about 57 % of production (chunks 2‑3)—and this production is supported by a global Tier‑2 supplier base of 169 strategic partners (chunks 2‑3), demonstrating that FlyEase has evolved from a conceptual technology to a globally integrated, high‑volume product within Nike’s manufacturing network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 2024 filing states that Vietnam, Indonesia, and China accounted for approximately 50%, 27%, and 18% of total Nike Brand footwear production, respectively—this matches the original answer exactly. The additional details about 15 contract manufacturers, 96 factories, 11 countries, and 169 Tier-2 suppliers are consistent with typical disclosures in Nike’s 10-K and support the conclusion of large-scale integration. (2) The answer correctly identifies that FlyEase was mentioned in all three fiscal years (2022–2024), showing continuity in reporting, and notes the evolution from early-stage innovation to full integration. (3) The multi-hop reasoning is sound: it synthesizes the persistent mention of FlyEase across years (qualitative evolution) with the 2024 production breakdown (quantitative scale), correctly inferring that inclusion in global manufacturing output implies integration into core operations. (4) The only minor shortcoming is that the original answer emphasizes FlyEase’s progression from introduction in 2022 to being grouped with mature technologies like Nike Air by 2023, while the LLM answer treats the mentions as continuous without highlighting the strategic elevation in 2023. However, this does not undermine the overall correctness. Wording differences are acceptable under semantic equivalence. All entities (Nike, FlyEase, fiscal years, countries) are accurate. The answer fully addresses both parts of the question: evolution over time and quantitative evidence of scale.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Introduces]-> PRODUCT <-[Produces]- ORG <-[Expands]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 443,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the penetration rate of the Target Debit Card and associated RedCard products evolve from 2022 through 2024, and what does this trend suggest about the effectiveness of Target's loyalty-driven payment strategy?",
      "original_answer": "The penetration rate of the Target Debit Card and associated RedCard products declined from 20.5% in 2022 to 19.8% in 2023 and further to 17.8% in 2024. This consistent decline over three years suggests a weakening in the effectiveness of Target's loyalty-driven payment strategy, potentially signaling reduced customer engagement with the RedCard program or increased competition in retail payment offerings.",
      "llm_answer": "\nTarget’s 10‑K filings show the RedCard/Target Circle Card penetration falling steadily: 20.5 % of purchases in 2022, 19.8 % in 2023 and 18.6 % in 2024 (the 2024 filing reports the same metric as “Target Circle Card Penetration” with 18.6 % for 2024 and 17.8 % for the following year).  The company notes that guests receive a 5 % discount when they use a RedCard and that this loyalty‑driven discount is monitored because a meaningful share of incremental purchases is tied to the card, yet the rebranding from RedCards to Target Circle Cards coincides with a consistent decline in that metric.  Consequently, the downward trend suggests that the 5 % discount incentive—central to Target’s loyalty‑driven payment strategy—is generating diminishing incremental sales and may be losing effectiveness.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the penetration rates for 2022 (20.5%) and 2023 (19.8%), which match the ground truth. However, it reports the 2024 penetration rate as 18.6%, whereas the ground truth states 17.8%. This is a significant quantitative error. The LLM also introduces confusion by suggesting that the 17.8% figure applies to the year after 2024, which is not supported by the question or ground truth—no data beyond 2024 is requested or provided. (2) The calculation of trend direction (declining) is correct, but the magnitude and final data point are inaccurate. The claim that 'the 2024 filing reports... 17.8% for the following year' extrapolates beyond the given data, introducing an unsupported inference. (3) The reasoning about the loyalty-driven strategy weakening due to declining penetration is logically sound and aligns with the ground truth's interpretation. The mention of the 5% discount and rebranding to Target Circle Cards adds contextual detail and shows multi-hop synthesis between branding changes and performance metrics. However, the incorrect 2024 number undermines the conclusion’s factual basis. (4) The contextual relevance is high—the answer addresses both parts of the question (trend over time and strategic implication) and incorporates relevant context about Target’s loyalty strategy. Qualitative reasoning is strong but built on a flawed data point. Quantitative accuracy is penalized due to the incorrect 2024 percentage, which affects the overall correctness score despite otherwise solid structure and logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_same_company",
      "pattern": "ORG -[Produces]-> PRODUCT <-[Introduces]- ORG <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 433,
        "total_tokens": 1753
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 800,
    "successful_evaluations": 800,
    "failed_evaluations": 0,
    "average_correctness_score": 7.76,
    "average_quantitative_accuracy": 8.37,
    "average_qualitative_accuracy": 7.99,
    "average_contextual_relevance": 9.45,
    "score_distribution": {
      "excellent": 449,
      "good": 169,
      "fair": 144,
      "poor": 38
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_year_type2",
    "total_questions": 800,
    "successful": 800,
    "failed": 0,
    "elapsed_seconds": 29131.69,
    "timestamp": "2026-02-02T23:45:57.435124"
  }
}